Professional Documents
Culture Documents
Food, Nutrition,
Physical Activity,
and the Prevention
Research Fund
Cancer
World
of Cancer:
SECOND EXPERT REPORT
a Global Perspective
Cancer Research
Institute for
American
World Cancer World Cancer Wereld Kanker World Cancer Fonds Mondial
American Institute Research Fund
Research Fund for Cancer Research Research Fund Onderzoek Fonds de Recherche
International Hong Kong contre le Cancer
Readers may make use of the text and graphic material in this Report
for teaching and personal purposes, provided they give credit to
World Cancer Research Fund and American Institute for Cancer Research.
ISBN: 978-0-9722522-2-5
A project of
World Cancer Research Fund
International
P re f a c e
I am very grateful to the special group of distinguished scientists who made up the Panel
and Secretariat for this major review of the evidence on food, nutrition, physical activity
and cancer. The vision of WCRF International in convening this Panel and confidence in
letting a strong-willed group of scientists have their way is to be highly commended.
In our view, the evidence reviewed here that led to our recommendations provides a
wonderful opportunity to prevent cancer and improve global health. Individuals and
populations have in their hands the means to lead fuller, healthier lives. Achieving that
will take action, globally, nationally, and locally, by communities, families, and
individuals.
It is worth pausing to put this Report in context. Public perception is often that experts
disagree. Why should the public or policy-makers heed advice if experts differ in their
views? Experts do disagree. That is the nature of science and a source of its strength.
Should we throw up our hands and say one opinion is as good as another? Of course not.
Evidence matters. But not evidence unguided by human thought. Hence the process that
was set up for this review: use a systematic approach to examine all the relevant evidence
using predetermined criteria, and assemble an international group of experts who, having
brought their own knowledge to bear and having debated their disagreements, arrive at
judgements as to what this evidence means. Both parts of the exercise were crucial: the
systematic review and, dare I say it, the wisdom of the experts.
The elegance of the process was one of the many attractions to me of assuming the role
of chair of the Panel. I could pretend that it was the major reason, and in a way it was, but
the first reason was enjoyment. What a pleasure and a privilege to spend three years in
the company of a remarkable group of scientists, including world leaders in research on
the epidemiology of cancer, as well as leaders in nutrition and public health and the
biology of cancer, to use a relatively new methodology (systematic literature reviews),
supported by a vigorous and highly effective Secretariat, on an issue of profound
importance to global public health: the prevention of cancer by means of healthy patterns
of eating and physical activity. It was quite as enjoyable as anticipated.
Given this heady mix, the reasons why I might have wanted to take on the role of Panel
chair were obvious. I did question the wisdom of WCRF International in inviting me to do
it. Much of my research has been on cardiovascular disease, not cancer. What I described
as my ignorance, WCRF International kindly labelled impartiality.
WCRF also appreciated the parallels between dietary causes of cardiovascular disease
and cancer. There is a great deal of concordance. In general, recommendations in this
Report to prevent cancer will also be of great relevance to cardiovascular disease. The only
significant contradiction is with alcohol. From the point of view of cancer prevention, the
best level of alcohol consumption is zero. This is not the case for cardiovascular disease,
where the evidence suggests that one to two drinks a day are protective. The Panel
therefore framed its recommendation to take this into account.
The fact that the conclusions and recommendations in this Report are the unanimous
view of the Panel does not imply that, miraculously, experts have stopped disagreeing. The
Panel debated the fine detail of every aspect of its conclusions and recommendations with
remarkable vigour and astonishing stamina. In my view, this was deliberation at its best. If
conclusions could simply fall out of systematic literature reviews, we would not have
needed experts to deliberate. Human judgement was vital; and if human, it cannot be
infallible. But I venture to suggest this process has led to as good an example of evidence-
based public health recommendations as one can find.
Throughout the Panels deliberations, it had in mind the global reach of this Report.
Most of the research on diet and cancer comes from high-income countries. But
iv
noncommunicable diseases, including cancer, are now major public health burdens in
every region of the world. An important part of our deliberations was to ensure the
global applicability of our recommendations.
One last point about disagreement among experts: its relevance to the link between
science and policy. A caricature would be to describe science as precise and policy-makers
as indecisive. In a way, the opposite is the case. Science can say: could be, might be,
some of us think this, and some think that. Policy-makers have either to do it or not
do it more often, not. Our effort here was to increase the precision of scientific
judgements. As the Report makes clear, many of our conclusions are in the could be
category. None of our recommendations is based on these could be conclusions. All are
based on judgements that evidence was definite or probable. Our recommendations, we
trust, will serve as guides to the population, to scientists, and to opinion-formers.
But what should policy-makers do with our judgements? A year after publication of
this Report, we will publish a second report on policy for diet, nutrition, physical activity,
and the prevention of cancer. As an exercise developing out of this one, we decided to
apply, as far as possible, the same principles of synthesis of evidence to policy-making.
We enhanced the scientific panel that was responsible for this Report with experts in
nutrition and food policy. This policy panel will oversee systematic literature reviews on
food policy, deliberate, and make recommendations.
The current Report and next years Policy Report have one overriding aim: to reduce
the global burden of cancer by means of healthier living.
Michael Marmot
v
Contents
Chapter 2 T h e c a n c e r p ro c e s s 30 Chapter 8 D e t e rm i n a n t s o f w e i g h t g a i n ,
o v e rw e i g h t , o b e s i t y 322
2.1 Basic concepts and principles 31
2.2 Cellular processes 32 Chapter 9 C a n c e r s u rv i v o r s 342
2.3 Carcinogen metabolism 36
2.4 Causes of cancer 37 C h a p t e r 1 0 F i n d i n g s o f o t h e r re p o r t s 348
2.5 Nutrition and cancer 41
2.6 Conclusions 46 10.1 Method 349
10.2 Interpretation of the data 350
Chapter 3 Judging the evidence 48 10.3 Nutritional deficiencies 350
10.4 Infectious diseases 351
3.1 Epidemiological evidence 49 10.5 Chronic diseases other than cancer 352
3.2 Experimental evidence 52 10.6 Cancer 355
3.3 Methods of assessment 55 10.7 Conclusions 358
3.4 Causation and risk 57
3.5 Coming to judgement 58 C h a p t e r 1 1 R e s e a rc h i s s u e s 360
3.6 Conclusions 62
PA RT T H R E E R E C O M M E N D AT I O N S 365
PA RT T W O E V I D E N C E A N D J U D G E M E N T S 63
Chapter 12 Public health goals and
Chapter 4 Foods and drinks 66 p e r s o n a l re c o m m e n d a t i o n s 368
4.1 Cereals (grains), roots, tubers and plantains 67 12.1 Principles 369
4.2 Vegetables, fruits, pulses (legumes), nuts, 12.2 Goals and recommendations 373
seeds, herbs, spices 75 12.3 Patterns of food, nutrition and
4.3 Meat, poultry, fish and eggs 116 physical activity 391
4.4 Milk, dairy products 129
4.5 Fats and oils 135
4.6 Sugars and salt 141 APPENDICES 395
4.7 Water, fruit juices, soft drinks and hot drinks 148
4.8 Alcoholic drinks 157 A p p e n d i x A P ro j e c t p ro c e s s 396
4.9 Food production, processing, preservation
and preparation 172 A p p e n d i x B T h e f i r s t W C R F / A I C R E x p e rt R e p o rt 398
4.10 Dietary constituents and supplements 179
4.11 Dietary patterns 190 Appendix C WCRF global network 400
G l o s s a ry 402
Chapter 5 Physical activity 198
R e f e re n c e s 410
Chapter 6 G ro w t h , d e v e l o p m e n t , b o d y
composition 210 Index 506
vi
CHAPTER BOXES Box 4.6.1 Sugar, sugars, sugary foods and drinks 142
Box 4.6.2 Salt and salty, salted and salt-preserved
PA RT O N E B A C K G R O U N D foods 143
Box 4.6.3 Chemical sweeteners 143
Chapter 1 I n t e r n a t i o n a l v a r i a t i o n s a n d t re n d s Box 4.6.4 Refrigeration 144
Box 4.7.1 High temperature, and irritant drinks
Box Egypt 6 and foods 150
Box South Africa 8 Box 4.7.2 Contamination of water, and of foods
Box China 10 and other drinks 150
Box 1.1 Measurement of food supply Box 4.8.1 Types of alcoholic drink 159
and consumption 13 Box 4.9.1 Food systems 173
Box India 14 Box 4.9.2 Organic farming 174
Box Japan 16 Box 4.9.3 Regulation of additives and
Box UK 18 contaminants 175
Box 1.2 Measurement of cancer incidence Box 4.9.4 Water fluoridation 176
and mortality 18 Box 4.10.1 Food fortification 182
Box Poland 20 Box 4.10.2 Functional foods 182
Box Spain 22 Box 4.10.3 Levels of supplementation 183
Box USA 24
Box Mexico 26 Chapter 5 Physical activity
Box Australia 27
Box Brazil 28 Box 5.1 Energy cost and intensity of activity 200
Box 5.2 Sedentary ways of life 201
Chapter 2 T h e c a n c e r p ro c e s s
Chapter 6 G ro w t h , d e v e l o p m e n t , b o d y c o m p o s i t i o n
Box 2.1 Nutrition over the life course 34
Box 2.2 Oncogenes and tumour suppressor genes 35 Box 6.2.1 Sexual maturity 232
Box 2.3 Mechanisms for DNA repair 37 Box 6.2.2 Age at menarche and risk of
Box 2.4 Body fatness and attained height 39 breast cancer 232
Box 2.5 Energy restriction 46
Chapter 7 Cancers
Chapter 3 Judging the evidence
Box 7.1.1 Cancer incidence and survival 246
Box 3.1 Issues concerning interpretation of Box 7.2.1 Epstein-Barr virus 251
the evidence 50 Box 7.5.1 Helicobacter pylori 266
Box 3.2 Dose-response 52 Box 7.8.1 Hepatitis viruses 278
Box 3.3 Forest plots 53 Box 7.13.1 Human papilloma viruses 303
Box 3.4 Systematic literature reviews 54
Box 3.5 Experimental findings 55 Chapter 8 D e t e rm i n a n t s o f w e i g h t g a i n ,
Box 3.6 Effect modification 56 o v e rw e i g h t , o b e s i t y
Box 3.7 Energy adjustment 57
Box 3.8 Criteria for grading evidence 60 Box 8.1 Energy density 324
Box 8.2 Fast food 325
Box 8.3 Body fatness in childhood 326
PA RT T W O E V I D E N C E A N D J U D G E M E N T S Box 8.4 Television viewing 331
Box 4.1.1 Wholegrain and refined cereals and Box 9.1 Conventional and unconventional
their products 69 therapies 345
Box 4.1.2 Foods containing dietary fibre 69 Box 9.2 Use of supplements by cancer survivors 346
Box 4.1.3 Glycaemic index and load 69
Box 4.1.4 Aflatoxins 70 Chapter 10 F i n d i n g s o f o t h e r re p o r t s
Box 4.2.1 Micronutrients and other bioactive
compounds and cancer risk 78 Chapter 11 R e s e a rc h i s s u e s
Box 4.2.2 Phytochemicals 79
Box 4.2.3 Preparation of vegetables and nutrient
bioavailability 79 PA RT T H R E E R E C O M M E N D AT I O N S
Box 4.2.4 Foods containing dietary fibre 80
Box 4.3.1 Processed meat 117 Chapter 12 Public health goals and personal
Box 4.3.2 Nitrates, nitrites and N-nitroso re c o m m e n d a t i o n s
compounds 118
Box 4.3.3 Foods containing iron 118 Box 12.1 Quantification 371
Box 4.3.4 Heterocyclic amines and polycyclic Box 12.2 Making gradual changes 372
aromatic hydrocarbons 119 Box 12.3 Height, weight and ranges of BMI 375
Box 4.3.5 Cantonese-style salted fish 120 Box 12.4 When supplements are advisable 387
Box 4.4.1 Foods containing calcium 131 Box 12.5 Regional and special circumstances 392
Box 4.5.1 Hydrogenation and trans-fatty acids 137
vii
F O O D , N U T R I T I O N , P H Y S I C A L A C T I V I T Y, A N D T H E P R E V E N T I O N O F C A N C E R : A G L O B A L P E R S P E C T I V E
Acknowledgements
Panel Jim Mann DM PhD FFPH Robert Beaglehole ONZM World Health Organization
FRACP FRSNZ DSc (WHO)
Sir Michael Marmot University of Otago Chair 2003 Geneva, Switzerland
MB BS MPH PhD FRCP FFPH Dunedin, New Zealand Was at: World Health Denise Coitinho PhD
Chair Organization (WHO) Ruth Bonita MD
University College London Hilary J Powers PhD RNutr Geneva, Switzerland Chizuru Nishida PhD MA
UK University of Sheffield, UK Now at: University of Pirjo Pietinen DSc
Auckland, New Zealand
Tola Atinmo PhD K Srinath Reddy MD DM MSc
University of Ibadan, Nigeria Institute of Medical Sciences Additional
New Delhi, India Panel observers members for policy
Tim Byers MD MPH panel
University of Colorado Health Elio Riboli MD ScM MPH Food and Agriculture
Sciences Center Was at: International Agency Organization of the United Barry Popkin PhD MSc BSc
Denver, CO, USA for Research on Cancer Nations (FAO) Carolina Population Center,
(IARC), Lyon, France Rome, Italy University of North Carolina,
Junshi Chen MD Now at: Imperial College Guy Nantel PhD Chapel Hill, NC, USA
Chinese Centre for Disease London, UK Prakash Shetty MD PhD
Control and Prevention Jane Wardle PhD MPhil
Beijing, Peoples Republic of Juan A Rivera PhD International Food Policy University College London, UK
China Instituto Nacional de Salud Research Institute (IFPRI)
Publica Washington DC, USA Nick Cavill MPH
Tomio Hirohata MD Cuernavaca, Mexico Lawrence Haddad PhD British Heart Foundation
DrScHyg PhD Marie Ruel PhD Health Promotion
Kyushu University Arthur Schatzkin MD DrPH Research Group
Fukuoka City, Japan National Cancer Institute International Union of University of Oxford, UK
Rockville, MD, USA Nutritional Sciences (IUNS)
Alan Jackson CBE MD FRCP Mark Wahlqvist MD AO
FRCPCH FRCPath Jacob C Seidell PhD
University of Southampton Free University Amsterdam Mechanisms Working Group
UK The Netherlands John Milner PhD
W Philip T James CBE MD David E G Shuker PhD FRSC Methodology Task Force
DSc FRSE FRCP The Open University Jos Kleijnen MD PhD
International Obesity Task Milton Keynes, UK Gillian Reeves PhD
Force
London, UK Ricardo Uauy MD PhD Union Internationale Contre
Instituto de Nutricion y le Cancer (UICC)
Laurence N Kolonel MD PhD Tecnologia de los Alimentos Geneva, Switzerland
University of Hawaii Santiago, Chile Annie Anderson PhD
Honolulu, HI, USA Curtis Mettlin PhD
Walter C Willett MD DrPH Harald zur Hausen MD DSc
Shiriki Kumanyika PhD MPH Harvard School of Public
University of Pennsylvania Health United Nations Childrens
Philadelphia, PA, USA Boston, MA, USA Fund (UNICEF)
New York, NY, USA
Claus Leitzmann PhD Steven H Zeisel MD PhD Ian Darnton-Hill MD MPH
Justus Liebig University University of North Carolina Rainer Gross Dr Agr
Giessen, Germany Chapel Hill, NC, USA
viii
A C K N O W L E D G E M E N T S
Systematic Rajendra Persad ChM FEBU Carlos A Gonzalez PhD MPH Karen Robinson MSc
Literature Review FRCS MD Johns Hopkins University
Centres United Bristol Healthcare Catalan Institute of Oncology Baltimore, MD, USA
Trust & Bristol Urological Barcelona, Spain
University of Bristol, UK Institute, UK Xuguang (Grant) Tao MD
Vittorio Krogh MD MSc PhD
George Davey Smith Massimo Pignatelli MD PhD Istituto Nazionale Tumori Johns Hopkins University
FMedSci FRCP DSc FRCPath Milan, Italy Baltimore, MD, USA
University of Bristol , UK University of Bristol, UK
Sylvie Menard ScD
Jonathan Sterne PhD MSc Jelena Savovic PhD Istituto Nazionale Tumori University of Leeds, UK
MA University of Bristol, UK Milan, Italy
University of Bristol, UK David Forman PhD FFPH
Steve Thomas MB BS PhD Eugenio Mugno ScD University of Leeds, UK
Chris Bain MB BS MS MPH FRCS Istituto Nazionale Tumori
University of Queensland University of Bristol, UK Milan, Italy Victoria J Burley PhD MSc
Brisbane, Australia RPHNutr
Tim Whittlestone MA MD Valeria Pala ScD University of Leeds, UK
Nahida Banu MB BS FRCS Istituto Nazionale Tumori
University of Bristol, UK United Bristol Healthcare Milan, Italy Janet E Cade PhD BSc
Trust, UK RPHNutr
Trudy Bekkering PhD Sabina Sieri ScD University of Leeds, UK
University of Bristol, UK Luisa Zuccolo MSc Istituto Nazionale Tumori
University of Bristol, UK Milan, Italy Darren C Greenwood MSc
Rebecca Beynon MA BSc University of Leeds, UK
University of Bristol, UK
Istituto Nazionale Johns Hopkins Doris S M Chan MSc
Margaret Burke MSc Tu m o r i M i l a n , I t a l y U n i v e r s i t y, B a l t i m o re , University of Leeds, UK
University of Bristol, UK MD, USA
Franco Berrino MD Jennifer A Moreton PhD MSc
David de Berker MB BS MRCP Istituto Nazionale Tumori Anthony J Alberg PhD MPH University of Leeds, UK
United Bristol Healthcare Milan, Italy University of South Carolina
Trust, UK Columbia, SC, USA James D Thomas
Patrizia Pasanisi MD MSc University of Leeds, UK
Anna A Davies MSc BSc Istituto Nazionale Tumori Kristina Boyd MS
University of Bristol, UK Milan, Italy Johns Hopkins University Yu-Kang Tu PhD MSc DDS
Baltimore, MD, USA University of Leeds, UK
Roger Harbord MSc Claudia Agnoli ScD
University of Bristol, UK Istituto Nazionale Tumori Laura Caulfield PhD Iris Gordon MSc
Milan, Italy Johns Hopkins University University of Leeds, UK
Ross Harris MSc Baltimore, MD, USA
University of Bristol, UK Silvana Canevari ScD Kenneth E L McColl FRSE
Istituto Nazionale Tumori Eliseo Guallar MD DrPH FMedSci FRCP
Lee Hooper PhD SRD Milan, Italy Johns Hopkins University Western Infirmary
University of East Anglia Baltimore, MD, USA Glasgow, UK
Norwich, UK Giovanni Casazza ScD
Istituto Nazionale Tumori James Herman MD Lisa Dyson MSc
Anne-Marie Mayer PhD MSc Milan, Italy Johns Hopkins University University of Leeds, UK
University of Bristol, UK Baltimore, MD, USA
Elisabetta Fusconi ScD
Andy Ness PhD FFPHM MRCP Istituto Nazionale Tumori Genevieve Matanoski MD
University of Bristol, UK Milan, Italy DrPH
Johns Hopkins University
Baltimore, MD, USA
ix
F O O D , N U T R I T I O N , P H Y S I C A L A C T I V I T Y, A N D T H E P R E V E N T I O N O F C A N C E R : A G L O B A L P E R S P E C T I V E
x
A C K N O W L E D G E M E N T S
xi
F O O D , N U T R I T I O N , P H Y S I C A L A C T I V I T Y, A N D T H E P R E V E N T I O N O F C A N C E R : A G L O B A L P E R S P E C T I V E
Noel Cameron BEd MSc Elizabeth TH Fontham DrPH Victor Kipnis PhD Tony McMichael MB BS PhD
Loughborough University, UK Louisiana State University of National Cancer Institute FAFPHM
Moira Chan-Yeung MBBS Public Health Rockville, MD, USA The Australian National
FRCP FACP New Orleans, LA, USA University
University of Hong Kong Paul Knekt PhD Canberra, Australia
China Terrence Forrester MB BS DM National Public Health
FRCP Institute Dominique Michaud ScD
Robert Clarke DSc PhD University of the West Indies Helsinki, Finland Harvard School of Public
Lombardi Comprehensive Kingston, Jamaica Health
Cancer Center, Georgetown Thilo Kober PhD Boston, MA, USA
University Teresa Fung ScD RD MSc Cochrane Haematological
Washington DC, USA Simmons College and Malignancies Group Anthony B Miller MD FRCP
Harvard School of Public Cologne, Germany FACE
Steven K Clinton MD PhD Health University of Toronto
The Ohio State University Boston, MA, USA Suminori Kono PhD MD MSc Canada
Columbus, OH, USA Kyushu University
John Garrow MD PhD FRCP Fukuoka, Japan Sidney Mirvish PhD
Karen Collins MS RD University of London, UK University of Nebraska
Nutrition Advisor Nancy Kreiger PhD MPH Omaha, NE, USA
AICR Glenn Gibson PhD Cancer Care Ontario and
University of Reading, UK University of Toronto Max Parkin MD
Brian Cox MBChB PhD Canada International Agency for
FAFPHM Ian Gilmore MD PRCP Research on Cancer (IARC)
University of Otago Royal College of Physicians Petra Lahmann PhD Lyon, France
Dunedin, New Zealand London, UK University of Queensland
Brisbane, Australia Charlotte Paul MB ChB PhD
Cindy Davis PhD Vay Liang W Go MD University of Otago
National Cancer Institute University of California Fabio Levi MD MSc Dunedin, New Zealand
Rockville, MD, USA Los Angeles, CA, USA Institut Universitaire de
Mdecine Sociale et John Reilly PhD
Diana Dyer MS RD Per Hall MD PhD Prventive University of Glasgow, UK
Ann Arbor, MI, USA Karolinska Institutet Lausanne, Switzerland
Stockholm, Sweden Richard Rivlin MD
Jonathan Earle MB BCh FCAP Ruth Lewis MSc Strang Cancer Research
Memorial Sloan Kettering Laura Hardie PhD Cardiff University, UK Laboratory
Cancer Center University of Leeds, UK New York, NY, USA
New York, NY, USA Albert B Lowenfels MD
Peter Herbison MSc New York Medical College Andrew Roddam DPhil
Alison Eastwood MSc University of Otago New York, NY, USA Cancer Research UK
University of York, UK Dunedin, New Zealand Epidemiology Unit
Graham A MacGregor FRCP University of Oxford
Ibrahim Elmadfa PhD Melvyn Hillsdon PhD St Georges University of Oxford, UK
University of Vienna University of Bristol, UK London, UK
Austria Leo Schouten MD PhD
Edward Hurwitz DC PhD Geoffrey Marks PhD MS Nutrition and Toxicology
Dallas English PhD MSc University of Hawaii University of Queensland Research Institute Maastricht
University of Melbourne Honolulu, HI, USA Brisbane, Australia The Netherlands
Victoria, Australia
Susan Jebb PhD John Mathers PhD DipNutr Jackilen Shannon PhD MPH
Michael Fenech PhD MSc BSc MRC Human Nutrition University of Newcastle, UK RD
Commonwealth Scientific and Research Oregon Health and Science
Industrial Research Cambridge, UK Sam McClinton MD FRCS University
Organization (CSIRO) NHS Grampian Portland, OR, USA
Adelaide, Australia Stanley B Kaye MD FRCP Aberdeen, UK
FMedSci Keith Singletary PhD
Justin Fenty MSc The Institute of Cancer Fiona Mensah University of Illinois
University of Nottingham, UK Research University of York, UK Urbana, IL, USA
Sutton, UK
Lynn Ferguson DSc DPhil MSc Margaret McCredie PhD Rashmi Sinha PhD
Univerity of Auckland Tim Key PhD University of Otago National Cancer Institute
New Zealand Cancer Research UK Dunedin, New Zealand Rockville, MD, USA
Epidemiology Unit,
University of Oxford
Oxford, UK
xii
A C K N O W L E D G E M E N T S
Rachael Stolzenberg-Solomon WCRF/AICR Report Kate Coughlin BSc Ivana Vucenik PhD
PhD MPH RD Executive Team Science Programme Manager Associate Director for
National Cancer Institute WCRF International Research
Baltimore, MD, USA Marilyn Gentry AICR
President Cara James
Boyd Swinburn MB ChB MD WCRF Global Network Associate Director for Joan Ward
Deakin University Research Research Administration
Melbourne, Australia Kelly Browning AICR Assistant
Chief Financial Officer From 2003 to 2005 WCRF International
Peter Szlosarek MRCP PhD WCRF Global Network From 2001 to 2003
St Bartholomews Hospital Jennifer Kirkwood
London, UK Kate Allen PhD Research Administration Julia Wilson PhD
Director Assistant Science Programme Manager
Paul Talalay MD WCRF International WCRF International WCRF International
Johns Hopkins University From 2003 to 2004
Baltimore, MD, USA Kathryn L Ward
Senior Vice-President Anja Kroke MD PhD MPH Art & production
Margaret Thorogood PhD AICR Consultant
University of Warwick, UK University of Applied Sciences Chris Jones
Deirdre McGinley-Gieser Fulda, Germany Design and Art Director
Stewart Truswell MD DSc WCRF International 2002 Design4Science Ltd
FRCP London, UK
University of Sydney Jeffrey R Prince PhD Kayte Lawton
Australia Vice-President for Education Research Administration Emma Copeland PhD
and Communications Assistant Text Editor
Paolo Vineis MD MPH AICR WCRF International Brighton, UK
Imperial College From 2006 to 2007
London, UK Rosalind Holmes
Secretariat Lisa Miles MSc Production Manager
Steven Waggoner MD Science Programme Manager London, UK
Case Comprehensive Cancer Martin Wiseman FRCP WCRF International
Center FRCPath From 2002 to 2006 Mark Fletcher
Cleveland, OH, USA Project Director Graphics
WCRF International Sarah Nalty MSc Fletcher Ward Design
Christopher P Wild PhD Science Programme Manager London, UK
University of Leeds, UK Geoffrey Cannon WCRF International
Chief Editor Ann OMalley
Anthony Williams DPhil FRCP WCRF International Edmund Peston Print Manager
FRCPCH Research Administration AICR
St Georges University of Ritva R Butrum PhD Assistant
London, UK Senior Science Advisor WCRF International Geoff Simmons
AICR From 2004 to 2006 Design & Production Manager
Frederic M Wolf PhD MEd WCRF UK
University of Washington Greg Martin MB BCh MPH Serena Prince
Seattle, WA, USA Project Manager Research Administration
WCRF International Assistant
Jian-Min Yuan MD PhD WCRF International
University of Minnesota, Susan Higginbotham PhD From 2004 to 2005
Minneappolis, MN, USA Director for Research
AICR Melissa Samaroo
Maurice Zeegers PhD MSc Research Administration
University of Birmingham, UK Steven Heggie PhD Assistant
Project Manager WCRF International
WCRF International From 2006 to 2007
From 2002 to 2006
Elaine Stone PhD
Alison Bailey Science Programme Manager
Science Writer WCRF International
Redhill, UK From 2001 to 2006
xiii
F O O D , N U T R I T I O N , P H Y S I C A L A C T I V I T Y, A N D T H E P R E V E N T I O N O F C A N C E R : A G L O B A L P E R S P E C T I V E
Summary
Introduction summarised here. A more detailed explanation of this
process is given in Chapter 3 and the research teams and
This summary provides an abbreviated version of the full investigators involved are listed on pages viiixi.
Report. It highlights the wealth of information and data This Report is a guide to future scientific research, cancer
studied by the Panel and is designed to give readers an prevention education programmes, and health policy
overview of the key issues contained within the Report, around the world. It provides a solid evidence base for
notably the process, the synthesis of the scientific evidence, policy-makers, health professionals, and informed and
and the resulting judgements and recommendations. interested people to draw on and work with.
T h e f i r s t a n d s e c o n d R e p o rt s
Food, Nutrition and the Prevention of Cancer: a global per- Overview of the second expert Report
spective, produced by the World Cancer Research Fund
together with the American Institute for Cancer Research, This Report has a number of inter-related general purposes.
has been the most authoritative source on food, nutrition, One is to explore the extent to which food, nutrition, phys-
and cancer prevention for 10 years. On publication in 1997, ical activity, and body composition modify the risk of can-
it immediately became recognised as the most authoritative cer, and to specify which factors are most important. To the
and influential report in its field and helped to highlight the extent that environmental factors such as food, nutrition,
importance of research in this crucial area. It became the and physical activity influence the risk of cancer, it is a pre-
standard text worldwide for policy-makers in government ventable disease. The Report specifies recommendations
at all levels, for civil society and health professional organ- based on solid evidence which, when followed, will be
isations, and in teaching and research centres of academic expected to reduce the incidence of cancer.
excellence.
Since the mid-1990s the amount of scientific literature on P a r t 1 B a c k g ro u n d
this subject has dramatically increased. New methods of Chapter 1 shows that patterns of production and con-
analysing and assessing evidence have been developed, sumption of food and drink, of physical activity, and of body
facilitated by advances in electronic technology. There is composition have changed greatly throughout human
more evidence, in particular on overweight and obesity and history. Remarkable changes have taken place as a result
on physical activity; food, nutrition, physical activity, and of urbanisation and industrialisation, at first in Europe,
cancer survivors is a new field. The need for a new report North America, and other economically advanced coun-
was obvious; and in 2001 WCRF International in collabora- tries, and increasingly in most countries in the world.
tion with AICR began to put in place a global process in Notable variations have been identified in patterns of can-
order to produce and publish the Report in November 2007. cer throughout the world. Significantly, studies consistently
show that patterns of cancer change as populations migrate
H o w t h i s R e p o rt h a s b e e n a c h i e v e d from one part of the world to another and as countries
The goal of this Report is to review all the relevant research, become increasingly urbanised and industrialised. Pro-
using the most meticulous methods, in order to generate a jections indicate that rates of cancer in general are liable
comprehensive series of recommendations on food, nutri- to increase.
tion, and physical activity, designed to reduce the risk of Chapter 2 outlines current understanding of the biology
cancer and suitable for all societies. This process is also the of the cancer process, with special attention to the ways in
basis for a continuous review of the evidence. which food and nutrition, physical activity, and body com-
Organised into overlapping stages, the process has been position may modify the risk of cancer. Cancer is a disease
designed to maximise objectivity and transparency, separat- of genes, which are vulnerable to mutation, especially over
ing the collection of evidence from its assessment and the long human lifespan. However, evidence shows that
judgement. First, an expert task force developed a method only a small proportion of cancers are inherited.
for systematic review of the voluminous scientific literature. Environmental factors are most important and can be mod-
Second, research teams collected and reviewed the litera- ified. These include smoking and other use of tobacco;
ture based upon this methodology. Third, an expert Panel infectious agents; radiation; industrial chemicals and pollu-
has assessed and judged this evidence and agreed recom- tion; medication; and also many aspects of food, nutrition,
mendations. The results are published in this Report and physical activity, and body composition.
xiv
S U M M A R Y
Chapter 3 summarises the types of evidence that the physical activity themselves affect the risk of obesity and
Panel has agreed are relevant to its work. No single study associated factors. The judgements, which concern the bio-
or study type can prove that any factor definitely is a cause logical and associated determinants of weight gain, over-
of, or is protective against, any disease. In this chapter, weight, and obesity, are based on a further systematic
building on the work of the first report, the Panel shows literature review, amplified by knowledge of physiological
that reliable judgements on causation of disease are based processes.
on assessment of a variety of well-designed epidemiologi- The relevance of food, nutrition, physical activity, and
cal and experimental studies. body composition to people living with cancer, and to the
The prevention of cancer worldwide is one of the most prevention of recurrent cancer, is summarised in Chapter 9.
pressing challenges facing scientists and public health Improved cancer screening, diagnosis, and medical services
policy-makers, among others. These introductory chapters are, in many countries, improving survival rates. So the
show that the challenge can be effectively addressed and number of cancer survivors people living after diagnosis
suggest that food, nutrition, physical activity, and body of cancer is increasing.
composition play a central part in the prevention of cancer. The Panel agreed that its recommendations should also
take into account findings on the prevention of other chron-
P a rt 2 E v i d e n c e a n d J u d g e m e n t s ic diseases, and of nutritional deficiencies and nutrition-
The judgements made by the Panel in Part 2 are based on related infectious diseases, especially of childhood. Chapter
independently conducted systematic reviews of the litera- 10, also based on a systematic literature review, is a sum-
ture commissioned from academic institutions in the USA, mary of the findings of expert reports in these areas.
UK, and continental Europe. The evidence has been metic- The research issues identified in Chapter 11 are, in the
ulously assembled and, crucially, the display of the evi- view of the Panel, the most promising avenues to explore in
dence was separated from assessments derived from that order to refine understanding of the links between food,
evidence. Seven chapters present the findings of these nutrition, physical activity, and cancer, and so improve the
reviews. The Panels judgements are displayed in the form prevention of cancer, worldwide.
of matrices that introduce five of these chapters, and in the
summary matrix on the fold-out page inside the back cover. P a rt 3 R e c o m m e n d a t i o n s
Chapter 4, the first and longest chapter in Part 2, is con- Chapter 12, the culmination of the five-year process, pre-
cerned with types of food and drink. The judgements of the sents the Panels public health goals and personal recom-
Panel are, whenever possible, food- and drink-based, mendations. These are preceded by a statement of the
reflecting the most impressive evidence. Findings on principles that have guided the Panel in its thinking.
dietary constituents and micronutrients (for example foods The goals and recommendations are based on convinc-
containing dietary fibre) are identified where appropriate. ing or probable judgements made by the Panel in the chap-
Evidence on dietary supplements, and on patterns of diet, ters in Part 2. These are proposed as the basis for public
is included in the two final sections of this chapter. policies and for personal choices that, if effectively imple-
Chapters 5 and 6 are concerned with physical activity mented, will be expected to reduce the incidence of cancer
and with body composition, growth, and development. for people, families, and communities.
Evidence in these areas is more impressive than was the Eight general and two special goals and recommenda-
case up to the mid-1990s; the evidence on growth and tions are detailed. In each case a general recommendation
development indicates the importance of an approach to is followed by public health goals and/or personal recom-
the prevention of cancer that includes the whole life mendations, together with further explanation or clarifica-
course. tion as required. Chapter 12 also includes a summary of the
Chapter 7 summarises and judges the evidence as evidence, justification of the goals and recommendations,
applied to 17 cancer sites, with additional briefer sum- and guidance on how to achieve them.
maries based on narrative reviews of five further body sys- The process of moving from evidence to judgements and
tems and cancer sites. The judgements shown in the to recommendations has been one of the Panels main
matrices in this chapter correspond with the judgements responsibilities, and has involved discussion and debate
shown in the matrices in the previous chapters. until final agreement has been reached. The goals and rec-
Obesity is or may be a cause of a number of cancers. ommendations here have been unanimously agreed.
Chapter 8 identifies what aspects of food, nutrition, and The goals and recommendations are followed by the
xv
F O O D , N U T R I T I O N , P H Y S I C A L A C T I V I T Y, A N D T H E P R E V E N T I O N O F C A N C E R : A G L O B A L P E R S P E C T I V E
Panels conclusions on the dietary patterns most likely to The Panels recommendations
protect against cancer. In order to discern the big picture of
healthy and protective diets, it is necessary to integrate a The Panels goals and recommendations that follow are
vast amount of detailed information. The Panel used a guided by several principles, the details of which can be
broad, integrative approach that, while largely derived from found in Chapter 12. The public health goals are for
conventional reductionist research, has sought to find pat- populations, and therefore for health professionals; the
terns of food and drink consumption, of physical activity, recommendations are for people, as communities, families,
and of body fatness, that enable recommendations designed and individuals.
to prevent cancer at personal and population levels. The Panel also emphasises the importance of not smoking
The goals and recommendations are designed to be gen- and avoiding exposure to tobacco smoke.
erally relevant worldwide and the Panel recognises that in
national settings, the recommendations of this Report will Format
be best used in combination with recommendations, issued The goals and recommendations begin with a general state-
by governments or on behalf of nations, designed to prevent ment. This is followed by the population goal and the per-
chronic and other diseases. In addition, the Panel cited sonal recommendation, together with any necessary
three specific cases where the evidence is strong enough to footnotes. These footnotes are an integral part of the
be the basis for goals and recommendations, but which cur- recommendations. The full recommendations, including
rently are relevant only in discrete geographical regions: further clarification and qualification, can be found in
mat in Latin America, Cantonese-style salted fish in the Chapter 12.
Pearl River Delta in Southern China, and arsenic contami-
nating water supplies in several locations. Further details on
nutritional patterns and regional and special circumstances
can be found in section 12.3.
The main focus of this Report is on nutritional and other
biological and associated factors that modify the risk of can-
cer. The Panel is aware that as with other diseases, the risk
of cancer is also modified by social, cultural, economic, and
ecological factors. Thus the foods and drinks that people
consume are not purely because of personal choice; likewise
opportunities for physical activity can be constrained.
Identifying the deeper factors that affect cancer risk enables
a wider range of policy recommendations and options to be
identified. This is the subject of a separate report to be pub-
lished in late 2008.
The public health goals and personal recommendations of
the Panel that follow are offered as a significant contribu-
tion towards the prevention and control of cancer through-
out the world.
xvi
S U M M A R Y
RECOMMENDATION 1 RECOMMENDATION 2
xvii
F O O D , N U T R I T I O N , P H Y S I C A L A C T I V I T Y, A N D T H E P R E V E N T I O N O F C A N C E R : A G L O B A L P E R S P E C T I V E
RECOMMENDATION 3 RECOMMENDATION 4
F O O D S A N D D R I N K S T H AT PLANT FOODS
PROMOTE WEIGHT GAIN Eat mostly foods of plant origin
Average energy density of diets3 to be lowered Relatively unprocessed cereals (grains) and/or pulses
towards 125 kcal per 100 g (legumes), and other foods that are a natural source of
dietary fibre, to contribute to a population average
Population average consumption of sugary drinks2 of at least 25 g non-starch polysaccharide daily
to be halved every 10 years
PERSONAL RECOMMENDATIONS
PERSONAL RECOMMENDATIONS
Eat at least five portions/servings
Consume energy-dense foods1 4 sparingly (at least 400 g or 14 oz) of a variety2 of
non-starchy vegetables and of fruits every day
Avoid sugary drinks2
Eat relatively unprocessed cereals (grains)
Consume fast foods5 sparingly, if at all and/or pulses (legumes) with every meal3
1
Energy-dense foods are here defined as those with an energy content of more
than about 225275 kcal per 100 g Limit refined starchy foods
2
This principally refers to drinks with added sugars. Fruit juices should also be
limited People who consume starchy roots or tubers4
3
This does not include drinks
4
Limit processed energy-dense foods (also see recommendation 4). Relatively as staples also to ensure intake of sufficient
unprocessed energy-dense foods, such as nuts and seeds, have not been shown non-starchy vegetables, fruits, and pulses (legumes)
to contribute to weight gain when consumed as part of typical diets, and these
and many vegetable oils are valuable sources of nutrients 1
5
This is best made up from a range of various amounts of non-starchy vegetables
The term fast foods refers to readily available convenience foods that tend to
and fruits of different colours including red, green, yellow, white, purple, and
be energy-dense and consumed frequently and in large portions
orange, including tomato-based products and allium vegetables such as garlic
2
Relatively unprocessed cereals (grains) and/or pulses (legumes) to contribute
to an average of at least 25 g non-starch polysaccharide daily
3
These foods are low in energy density and so promote healthy weight
4
For example, populations in Africa, Latin America, and the Asia-Pacific region
Justification
Consumption of energy-dense foods and sugary drinks is
increasing worldwide and is probably contributing to the
global increase in obesity. Justification
An integrated approach to the evidence shows that most
This overall recommendation is mainly designed to prevent diets that are protective against cancer are mainly made up
and to control weight gain, overweight, and obesity. from foods of plant origin.
Further details of evidence and judgements can be found in
Chapter 8. Higher consumption of several plant foods probably protects
Energy density measures the amount of energy (in kcal against cancers of various sites. What is meant by plant-
or kJ) per weight (usually 100 g) of food. Food supplies that based is diets that give more emphasis to those plant foods
are mainly made up of processed foods, which often contain that are high in nutrients, high in dietary fibre (and so in non-
substantial amounts of fat or sugar, tend to be more energy- starch polysaccharides), and low in energy density. Non-
dense than food supplies that include substantial amounts starchy vegetables, and fruits, probably protect against some
of fresh foods. Taken together, the evidence shows that it is cancers. Being typically low in energy density, they probably
not specific dietary constituents that are problematic, so also protect against weight gain. Further details of evidence
much as the contribution these make to the energy density and judgements can be found in Chapters 4 and 8.
of diets. Non-starchy vegetables include green, leafy vegetables,
Because of their water content, drinks are less energy- broccoli, okra, aubergine (eggplant), and bok choy, but not,
dense than foods. However, sugary drinks provide energy for instance, potato, yam, sweet potato, or cassava. Non-
but do not seem to induce satiety or compensatory reduc- starchy roots and tubers include carrots, Jerusalem arti-
tion in subsequent energy intake, and so promote overcon- chokes, celeriac (celery root), swede (rutabaga), and turnips.
sumption of energy and thus weight gain. Continued on next page
xviii
S U M M A R Y
RECOMMENDATION 5 RECOMMENDATION 6
PERSONAL RECOMMENDATION
PERSONAL RECOMMENDATION
If alcoholic drinks are consumed,
People who eat red meat1
limit consumption to no more than two drinks a day
to consume less than 500 g (18 oz) a week,
for men and one drink a day for women1 2 3
very little if any to be processed2
1
Red meat refers to beef, pork, lamb, and goat from domesticated animals 1
This recommendation takes into account that there is a likely protective effect
including that contained in processed foods for coronary heart disease
2
Processed meat refers to meat preserved by smoking, curing or salting, or 2
Children and pregnant women not to consume alcoholic drinks
addition of chemical preservatives, including that contained in processed foods 3
One drink contains about 1015 grams of ethanol
Justification Justification
An integrated approach to the evidence also shows that The evidence on cancer justifies a recommendation not to
many foods of animal origin are nourishing and healthy if drink alcoholic drinks. Other evidence shows that modest
consumed in modest amounts. amounts of alcoholic drinks are likely to reduce the risk of
coronary heart disease.
People who eat various forms of vegetarian diets are at low
risk of some diseases including some cancers, although it is The evidence does not show a clear level of consumption of
not easy to separate out these benefits of the diets from alcoholic drinks below which there is no increase in risk of
other aspects of their ways of life, such as not smoking, the cancers it causes. This means that, based solely on the
drinking little if any alcohol, and so forth. In addition, meat evidence on cancer, even small amounts of alcoholic drinks
can be a valuable source of nutrients, in particular protein, should be avoided. Further details of evidence and judge-
iron, zinc, and vitamin B12. The Panel emphasises that this ments can be found in Chapter 4. In framing the recom-
overall recommendation is not for diets containing no meat mendation here, the Panel has also taken into account the
or diets containing no foods of animal origin. The evidence that modest amounts of alcoholic drinks are likely
amounts are for weight of meat as eaten. As a rough con- to protect against coronary heart disease, as described in
version, 300 g of cooked red meat is equivalent to about Chapter 10.
400450 g raw weight, and 500 g cooked red meat to about The evidence shows that all alcoholic drinks have the
700750 g raw weight. The exact conversion will depend same effect. Data do not suggest any significant difference
on the cut of meat, the proportions of lean and fat, and the depending on the type of drink. This recommendation
method and degree of cooking, so more specific guidance is therefore covers all alcoholic drinks, whether beers, wines,
not possible. Red or processed meats are convincing or spirits (liquors), or other alcoholic drinks. The important
probable causes of some cancers. Diets with high levels of factor is the amount of ethanol consumed.
animal fats are often relatively high in energy, increasing The Panel emphasises that children and pregnant women
the risk of weight gain. Further details of evidence and should not consume alcoholic drinks.
judgements can be found in Chapters 4 and 8.
Recommendation 4, continued from page xviii of relatively unprocessed cereals (grains), non-starchy veg-
The goals and recommendations here are broadly similar etables and fruits, and pulses (legumes), all of which contain
to those that have been issued by other international and substantial amounts of dietary fibre and a variety of
national authoritative organisations (see Chapter 10). They micronutrients, and are low or relatively low in energy den-
derive from the evidence on cancer and are supported by sity. These, and not foods of animal origin, are the recom-
evidence on other diseases. They emphasise the importance mended centre for everyday meals.
xix
F O O D , N U T R I T I O N , P H Y S I C A L A C T I V I T Y, A N D T H E P R E V E N T I O N O F C A N C E R : A G L O B A L P E R S P E C T I V E
RECOMMENDATION 7 RECOMMENDATION 8
P R E S E R VAT I O N , P R O C E S S I N G , D I E TA R Y S U P P L E M E N T S
P R E PA R ATION
Aim to meet nutritional needs
Limit consumption of s a l t1 t h ro u g h d i e t a l o n e 1
A v o i d m o u l d y c e re a l s ( g r a i n s ) o r p u l s e s ( l e g u m e s )
PERSONAL RECOMMENDATIONS
xx
S U M M A R Y
BREASTFEEDING C A N C E R S U R V I V O R S1
M o t h e r s t o b re a s t f e e d ; c h i l d re n t o b e b re a s t f e d 1 F o l l o w t h e re c o m m e n d a t i o n s
f o r c a n c e r p re v e n t i o n 2
Justification Justification
The evidence on cancer as well as other diseases shows Subject to the qualifications made here, the Panel has
that sustained, exclusive breastfeeding is protective for the agreed that its recommendations apply also to cancer sur-
mother as well as the child. vivors. There may be specific situations where this advice
may not apply, for instance, where treatment has compro-
This is the first major report concerned with the prevention mised gastrointestinal function.
of cancer to make a recommendation specifically on breast-
feeding, to prevent breast cancer in mothers and to prevent If possible, when appropriate, and unless advised otherwise
overweight and obesity in children. Further details of evi- by a qualified professional, the recommendations of this
dence and judgements can be found in Chapters 6 and 8. Report also apply to cancer survivors. The Panel has made
Other benefits of breastfeeding for mothers and their this judgement based on its examination of the evidence,
children are well known. Breastfeeding protects against including that specifically on cancer survivors, and also on
infections in infancy, protects the development of the its collective knowledge of the pathology of cancer and its
immature immune system, protects against other childhood interactions with food, nutrition, physical activity, and body
diseases, and is vital for the development of the bond composition. In no case is the evidence specifically on can-
between mother and child. It has many other benefits. cer survivors clear enough to make any firm judgements or
Breastfeeding is especially vital in parts of the world where recommendations to cancer survivors. Further details of
water supplies are not safe and where impoverished fami- evidence and judgements can be found in Chapter 9.
lies do not readily have the money to buy infant formula Treatment for many cancers is increasingly successful,
and other infant and young child foods. This recommenda- and so cancer survivors increasingly are living long enough
tion has a special significance. While derived from the evi- to develop new primary cancers or other chronic diseases.
dence on being breastfed, it also indicates that policies and The recommendations in this Report would also be expect-
actions designed to prevent cancer need to be directed ed to reduce the risk of those conditions, and so can also be
throughout the whole life course, from the beginning of recommended on that account.
life.
xxi
F O O D , N U T R I T I O N , P H Y S I C A L A C T I V I T Y, A N D T H E P R E V E N T I O N O F C A N C E R : A G L O B A L P E R S P E C T I V E
I n t ro d u c t i o n
The proposals that cancer might be preventable, and that abundantly clear that the incidence of all the common
food, nutrition, physical activity, and body composition cancers in humans is determined by various potentially
might affect the risk of cancer, were first made before controllable external factors. This is surely the most
science emerged in its modern form in the 19th and 20th comforting fact to come out of cancer research, for it
centuries. Throughout recorded history, wise choices of means that cancer is, in large part, a preventable disease.1
food and drink, and of habitual behaviour, have been This is the conclusion of a report on diet and the
recommended to protect against cancer, as well as other prevention of cancer published a quarter of a century
diseases, and to improve well-being. before this Report.
Reports such as this, which incorporate systematic Since the early 1980s, relevant United Nations agencies,
examination of all relevant types of research, differ from national governments, authoritative non-governmental
ancient, historical, and even relatively recent accounts, and organisations, and researchers and other experts in the
descriptive studies of the type detailed in Chapter 1, not field have agreed that food and nutrition, physical activity,
only in the quantity and quality of evidence, but also in the and body composition are individually and collectively
reliability of the judgements and recommendations that important modifiers of the risk of cancer, and taken
derive from it. together may be at least as important as tobacco.
By the mid-1990s the general consensus became more
T h e p u r p o s e o f t h i s R e p o rt solidly based on methodical assessment of the totality of
This Report has been commissioned and resourced by the the relevant literature. Thus: It is now established that
World Cancer Research Fund (WCRF) International and its cancer is principally caused by environmental factors, of
sister organisation the American Institute for Cancer which the most important are tobacco; diet and factors
Research (AICR), who provided the Secretariat that has related to diet, including body mass and physical activity;
supported the Panel responsible for the Report. Panel and exposures in the workplace and elsewhere. This
members, observers, review centres, and other contributors statement introduces the recommendations made in the
are listed on the preceding pages. The five-year project that first WCRF/AICR report.
has resulted in this Report follows a previous five-year Expert reports may be accompanied by guidebooks
project that resulted in the first WCRF/AICR report written for general readers. Thus: A healthy eating
published in 1997, which was the responsibility of the strategy is an important part of protecting yourself
former distinguished international multidisciplinary panel against a long list of diseases. These include heart disease,
chaired by Professor John Potter. stroke, several common cancers, cataract formation, other
This Report has two overall general purposes. The first is age-related diseases, and even some types of birth defects.
to summarise, assess, and judge the most comprehensive When combined with not smoking and regular exercise, this
body of evidence yet collected and displayed on the subject kind of healthy diet can reduce heart disease by 80 per
of food, nutrition, physical activity, body composition, and cent, and stroke and some cancers by 70 percent, compared
the risk of cancer, throughout the life-course. The second with average rates.2 This is a conclusion of a book written
purpose is to transform the evidence-derived judgements by a member of the Panel responsible for this Report.
into goals and personal recommendations that are a Some general judgements are now well known and not a
reliable basis for sound policies and effective actions at matter for serious debate. Cancer in general, and cancers
population, community, family, and individual level, in of different types and sites, are agreed to have various
order to prevent cancer, worldwide. causes, among which are inherited genetic predisposition
and the increasing likelihood that cells will accumulate
W h a t i s a l re a d y k n o w n genetic defects as people age. This is discussed in more
The Panel is aware of the general consensus shared by detail in Chapter 2. Also, people die less frequently from
scientists, health professionals, and policy-makers on the nutritional deficiencies, infectious diseases, predation, and
relationships between food, nutrition, physical activity, accidents, whereas chronic diseases including cancer
body composition, and the risk of cancer. which are more common in older people become more
This consensus, based on the findings of a rapidly common.
growing mass of increasingly well-designed However, cancer is not an inevitable consequence of
epidemiological and experimental studies and other ageing, and peoples susceptibility to it varies. There is
relevant evidence, emerged in the early 1980s. Thus: It is abundant evidence that the main causes of patterns of
xxii
I N T R O D U C T I O N
xxiii
F O O D , N U T R I T I O N , P H Y S I C A L A C T I V I T Y, A N D T H E P R E V E N T I O N O F C A N C E R : A G L O B A L P E R S P E C T I V E
World Health Organization in its 2003 report on diet, evidence that greater body fatness (there termed high
nutrition, and the prevention of chronic diseases. Some body mass) is a convincing or probable cause of cancers of
members of the expert consultation responsible for the the endometrium, breast (postmenopausal), and kidney.
WHO report, including its chair and vice-chair, have served For this Report, the commissioned SLRs not only included
as members of the Panel responsible for this Report. the evidence linking body fatness directly with cancer, but
In further adapting the format of the matrices used in a separate review was also commissioned specifically on
the first report, the Panel was careful to distinguish the biological and associated determinants of body fatness
between evidence strong enough to justify judgements of itself. The evidence and the Panels judgements, which
convincing or probable causal relationships, on which include assessment of the physiology of energy
recommendations designed to prevent cancer can be metabolism, are summarised in Chapters 6 and 8.
based, and evidence that is too limited in amount, The Panel is aware that weight gain, overweight, and
consistency, or quality to be a basis for public and personal obesity, and their antecedent behaviours, are critically
health recommendations, but which may nevertheless in determined by social, cultural, and other environmental
some cases be suggestive of causal relationships. factors. This is one topic for the separate report on policy
implications to be published in late 2008.
Food-based approach
Since the 1990s a broad food- and drink-based approach to Cancer survivors
interpreting the evidence on food, nutrition, and the risk of There are increasing numbers of cancer survivors people
cancer has increasingly been used, in contrast to the who have at some time been diagnosed with cancer. What
overwhelming research emphasis on individual food should those people living with cancer do? Particularly
constituents. The previous report included three chapters since the 1990s, this question is being asked increasingly,
showing the findings on dietary constituents (including as more and more people are diagnosed with and treated
energy and related factors, notably physical activity), for cancer, and are seeking ways in which they can add to
foods and drinks, and food processing (meaning their medical or surgical management to help themselves
production, preservation, processing, and preparation), in to remain healthy. Are the circumstances of people who
that order. have recovered from cancer any different from those of
This Report has taken a food-based approach, as shown people who are free from cancer? Questions such as these
throughout Chapter 4, more closely reflecting the nature of are addressed in Chapter 9.
the evidence. Thus many findings on dietary constituents
and micronutrients, when their dietary sources are from Life-course approach
foods rather than supplements, are here identified as, for Unlike this Report, the reviews conducted for the first
example, findings on foods containing dietary fibre or report did not consider the literature on food and nutrition
foods containing folate. Findings on methods of food in the first two years of life. Increasingly, evidence is
processing are, wherever possible, shown as part of the accumulating on the importance of early life-events on
evidence on the associated foods, so that, for example, later health. Evidence and judgements on the impact of
meat processing is integrated with the evidence on meat. birth weight and adult attained height on cancer risk are
The evidence and judgements focused on cancer are presented in Chapter 6, though the detailed processes
summarised and displayed in Chapter 7. underpinning these associations with cancer risk are not
yet clear. Findings on the relationship between not being
Physical activity breastfed and later overweight and obesity in children are
The scope of the work of this Panel is wider than that of reported in Chapter 8, and on lactation and lower breast
the previous panel. The previous report judged that the cancer risk in the mother are reported in Chapter 7. These
evidence that physical activity protects against cancer of findings form part of a general life-course approach
the colon was convincing. Since then evidence on physical summarised in Chapter 2, reflecting an appreciation of the
activity (and physical inactivity, especially when this importance of the accumulation of nutritional and other
amounts to generally sedentary ways of life) has become experiences throughout life, as well as genetic endowment,
more impressive. Correspondingly, the review centres were in influencing susceptibility to disease.
requested specifically to examine the literature on physical
activity (and inactivity) as well as on foods and drinks. The Goals and recommendations
results of this work, and the Panels judgements, are shown The Panels recommendations are set out in Chapter 12
in Chapter 5. and in abbreviated form in the Summary, on the preceding
pages.
Body fatness The previous report agreed 14 recommendations. This
As with physical inactivity, the evidence that body fatness Report makes eight general and two special
including degrees of fatness throughout the range of recommendations for specific target groups. These are set
body weight, from underweight and normal to overweight out in more detail than in the previous report. As before,
and obesity, as well as any specific effect of weight gain principles that guide the goals and recommendations are
directly influences risk of some cancers has also become set out. The recommendations themselves are displayed in
more impressive. The previous report judged that the boxes and are accompanied by text that justifies them, and
xxiv
I N T R O D U C T I O N
by practical guidance. The recommendations are addressed scale this represents over 3 to 4 million cases of cancer that
to people, as members of communities and families and can be prevented in these ways, every year.
also as individuals. In many of its forms, cancer is a disease that can cause
Recommendations and options addressed to UN and great suffering and claims many lives. The overall
other international organisations, national governments, commitment of scientists and other professionals
industry, health professional and civil society organisations, committed to disease prevention, as exemplified by this
and the media are set out in the separate report on policy Report, is to reduce the rates not just of cancer, but of all
implications, to be published in late 2008. diseases, so that more people enjoy good health until they
eventually die in old age.
A note of caution
The Panel is confident that its findings are soundly based,
and that its recommendations, when translated into R e f e re n c e s
effective public policy programmes and personal choices, 1.
National Research Council. Diet, Nutrition and Cancer. Washington
will reduce the risk of cancer. That said, the available DC: National Academy of Sciences, 1982
evident is imperfect. The Panels conclusions derive from
2.
Willett W. Summary. In: Eat, Drink, and Be Healthy. The Harvard
Medical School Guide to Healthy Eating. New York: Free Press, 2003
the best evidence now available, which reflects past and 3.
Doll R, Peto R. The causes of cancer: quantitative estimates of
recent research priorities mostly in high-income countries, avoidable risks of cancer in the United States today. J Natl Cancer Inst
though synthesised and judged in as meticulous and 1981;66:1191-308.
rigorous way as possible. What is here is therefore an
incomplete picture.
The tendency of reports such as this is to consider
diseases in isolation. In the case of this Report, the
relationship of weight gain, overweight, and obesity on the
risk of some cancers is so clear that determinants of these
factors have also been considered. But the Panel agrees, as
evident in Chapters 10 and 12, that many chronic diseases,
including type 2 diabetes and its precursors, cardiovascular
diseases and their precursors, and also perhaps other
diseases of the digestive, musculoskeletal, and nervous
systems, are to a large extent caused by environmental
factors, including inappropriate food and nutrition,
physical inactivity, overweight and obesity, and associated
factors. Following from this, future reports should consider
the promotion of health and the prevention of disease as a
whole.
H o w m u c h c a n c e r i s p re v e n t a b l e ?
As shown in its title, the purpose of this Report is to
prevent cancer. The term prevention needs definition. It
does not mean the elimination of cancer. It means
reduction in its occurrence, such that at any age fewer
people have cancer than otherwise would be the case.
If all factors are taken into account, cancer is mostly a
preventable disease. The authors of a landmark study
published in the early 1980s concluded: It is highly likely
that the United States will eventually have the option of
adopting a diet that reduces its incidence of cancer by
approximately one third, and it is absolutely certain that
another one third could be prevented by abolishing
smoking.3 Cancers of some sites, notably of the colon, are
generally agreed to be greatly or mostly affected by food
and nutrition.
Since then, authoritative estimates of the preventability
of cancer by means of food and nutrition and associated
factors have been in broad agreement with the around one
third figure. The estimate of the previous WCRF/AICR
Report was that cancer is 30 to 40 per cent preventable
over time, by appropriate food and nutrition, regular
physical activity, and avoidance of obesity. On a global
xxv
Part 1
> V } `
Chapter 1
International variations and trends 4
Chapter 2
The cancer process 30
Chapter 3
Judging the evidence 48
P A R T 1
Introduction to Part 1
BACKGROUND
Part 1 of the Report begins with two chapters summarising the first lines of
evidence from observations of human populations, and from experimental
and basic science, pointing to the conclusion that cancer is preventable. The
third chapter summarises the types of evidence that are relevant in
identifying the causes of cancer, and explains the process used by the Panel
to assess the strength of this evidence and to come to judgement.
With the establishment of reliable records in the second half of the 20th
century, notable variations have been identified in patterns of cancer
throughout the world. Some cancers, such as those of the upper
aerodigestive tract, stomach, liver, and cervix, are more common in lower
income countries; others, such as those of the colorectum, breast, ovary,
endometrium, prostate, and lung, are more common in higher income
countries.
2
important and can be modified. These include smoking and other use of
tobacco; infectious agents; radiation; industrial chemicals and pollution;
medication and also many aspects of food, nutrition, physical activity, and
body composition. Essentially this is good news. It means that healthy
environments can stop cancer before it starts. The evidence also indicates that
such environments, including the factors that are the subject of this Report,
may be able to check the cancer process after it has started.
The third chapter summarises the types of evidence that the Panel has agreed
are relevant to its work. No one study can prove that any factor definitely is a
cause of or is protective against any disease. Also while some study designs
are more reliable than others, they often cannot be used to answer many types
of question; so no one kind of study, however careful its methods, can ever
produce definitive results. In this chapter, building on the work of the first
report, the Panel shows that all study designs have strengths and weaknesses,
and that reliable judgements on causation of disease are based on assessment
of a variety of well designed epidemiological and experimental studies.
The judgements made by the Panel in Part 2 of this Report are based on
independently commissioned and conducted systematic reviews of the
literature. This has ensured that the evidence has been assembled using
methods that are as meticulous as possible, and that the display of the
evidence is separated from assessments derived from this evidence, which are
made in Part 2.
3
P A R T I B A C K G R O U N D
C H A P T E R 1
International variations
and trends
The first lines of evidence suggesting that cancer is aerodigestive tract (of the mouth, pharynx, larynx,
a largely preventable disease have come from nasopharynx, and oesophagus), and of the stomach,
studies noting variations in cancer incidence across liver (primary), and cervix. Rates of some cancers,
time and place. The most impressive initial evidence especially stomach cancer, are now generally
showing that patterns of cancer are altered by decreasing.
environmental factors, and are not mainly In contrast, high-income countries, and urbanised
genetically determined, comes from studies and industrialised areas of middle- and low-income
describing changes in the rates of different cancers regions and countries, have higher rates of
in genetically identical populations that migrate colorectal cancer and of hormone-related cancers (of
from their native countries to other countries. Such the breast, ovary, endometrium, and prostate). Lung
studies consistently show that changes in the rates cancer is now the most common type in the world
of some of the most common cancers, including because of the increase in tobacco smoking and
those of the stomach, colorectum, breast, and exposure to environmental tobacco smoke. Rates of
prostate, can be remarkable, even over one or two these cancers, some of which may have been
generations. historically rare, are increasing.
This first introductory chapter summarises current Globally, the number of people with cancer is
knowledge of the variations in food, nutrition, projected to double by the year 2030, with most of
physical activity, body composition, and cancer in this increase likely to occur in middle- and low-
different parts of the world. This assessment income countries. Such an increase would only
provides strong circumstantial evidence that partly be accounted for by the projected rise in the
continues to prompt systematic studies including size and average age of the global population. This
interventions of various types, and also reports such makes the task of cancer prevention all the more
as this, which collect and judge the available urgent and important.
evidence. Such systematic work has already led the
United Nations and other international bodies,
national governments, and authoritative
independent organisations to be confident that
most cancers are largely preventable.
Patterns of food and drink, of physical activity,
and of body composition have changed remarkably
throughout human history. With industrialisation
and urbanisation, food supplies usually become
more secure, and more food is available for
consumption. In general, diets become more energy
dense, containing fewer starchy foods, more fats
and oils, sugars, and additives, and often more
alcoholic drinks. At the same time, patterns of
physical activity change: populations become
increasingly sedentary, their need for energy from
food drops, and rates of overweight and obesity
increase.
These changes correlate with changes in the
patterns of cancer throughout the world. Middle-
and low-income regions and countries within Africa,
Asia, and Latin America have generally experienced
comparatively high rates of cancers of the upper
4
C H A P T E R 1 I N T E R N AT I O N A L V A R I AT I O N S A N D T R E N D S
This chapter outlines the historic, recent, and current varia- 1.1 Food systems and diets: historical and
tions and trends in food, nutrition, physical activity, over- current
weight and obesity, and in patterns of cancer.
Peoples diets reflect the times and situations in which they Throughout history, food systems, and thus human diets,
live. It is only relatively recently in history that urbanindus- have been and are shaped by climate, terrain, seasons, loca-
trial ways of life have evolved, with many or most people tion, culture, and technology. They can be grouped into three
living in towns and cities rather than in the countryside. In broad types: gathererhunter, peasantagricultural, and
much of Africa and Asia, most people still live in rural com- urbanindustrial. These and other food systems (for exam-
munities, and peasantagricultural and urbanindustrial ple, pastoralist, the semi-mobile farming of herds of large
ways of life still coexist in most countries. Such patterns animals such as sheep and cattle) have their roots in histo-
change very rapidly as countries become increasingly ry. All have coexisted in recent millennia with the exception
urbanised and industrialised. of industrial food systems, which are the consequence of the
The different food systems and diets that are part of these industrial revolution that began in Europe in the late 18th
diverse ways of life affect peoples levels of physical activity, century. These systems still exist in the world today.
their body composition and stature, their life expectancy, and
patterns of disease, including cancer. With the move to 1.1.1 Gathererhunter
urbanindustrial ways of life, populations have become taller Since the emergence of Homo sapiens around 250 000 years
and heavier, their life expectancy has increased, and they are ago, gathererhunter food systems have taken different
usually adequately nourished (although poverty, and even forms, depending on the environments in which people lived.
destitution, remains a major problem in most big cities). On These systems still exist in parts of the world that are remote
the other hand, urban populations are at increased risk of from cities and roads. They supply diets that usually include
chronic diseases such as obesity, type 2 diabetes, coronary moderate amounts of starchy foods, and which are high in
heart disease, and also some cancers. dietary fibre and low in sugar, mostly from fruits and
This chapter also summarises some available information honey.48 Methods of food preparation include pulverising,
on eight common cancers, irrespective of any recognised links drying, and roasting. These diets are usually high in foods
to food, nutrition, and physical activity; these factors are dealt of animal origin (ranging from large animals to insects, and
with later in the Report. Four are endemic in middle- and low- also fish and other seafood, depending on location), and
income countries: cancers of the oesophagus, stomach, liver, thus in animal protein. It is sometimes thought that
and cervix. Four are endemic in high-income countries, and gathererhunter diets are high in fat, which is not the case
are in general increasing in middle- and low-income countries: because wild animals are lean. Recent analyses suggest that
cancers of the lung, colon and rectum, breast, and prostate. gathered food generally provides rather more dietary bulk
Information on the trends and projections of levels of physi- and energy than hunted food.49
cal activity, and overweight and obesity, is summarised. People in gathererhunter societies are necessarily physi-
Descriptive epidemiology, including studies of changing dis- cally active, and are often tall and usually lean (only chiefs,
ease patterns in migrant populations, is covered. These stud- or old or incapacitated people might be overweight or
ies can generate hypotheses about relationships between food, obese). The diets of food-secure gathererhunter societies
nutrition, physical activity, and the risk of cancer. However, may be diverse and high in micronutrients.50 51 Diets are
they serve mainly as a foundation for studies that provide liable to become monotonous and deficient in various nutri-
stronger evidence. ents, as well as in energy, when food supplies are chronically
The 12 national examples provided throughout this chap- insecure, or at times of acute food shortage. It is sometimes
ter summarise some of the trends in foods and drinks, obesi- claimed that gathererhunter food systems generate diets to
ty, physical activity, and cancer in countries around the world. which the human species is best adapted.48 However, life
These are Egypt and South Africa (Africa); China, India, and expectancy in gathererhunter societies is and has been usu-
Japan (Asia); the UK, Poland, and Spain (Europe); the USA, ally relatively low.
Brazil, and Mexico (the Americas); and Australia (Asia- Evidence of cancer has occasionally been found in human
Pacific).1-47 and other fossil and ancient remains.52 Historically, cancer
5
P A R T I B A C K G R O U N D
Egypt
In 2004 Egypt had a population of just over total area. Egypt has a lower-middle-income men and 70 for women (figure 1.1).46
74 million. Nearly the whole population economy, with a gross domestic product of Chronic diseases account for 83.6 per
lives within the Nile Valley and the Nile 4274 international dollars per person (figure cent of deaths, while infectious diseases,
Delta, less than 4 per cent of the countrys 1.3). Life expectancy at birth is 66 years for maternal, perinatal, and nutritional condi-
2 58 Respiratory disease
7 10
Diabetes
9
0
Bladder
Lung
Liver
Breast
Cervix
Bladder
Other
Data from World Health Organization46 Data from International Agency for Research on Cancer20
of any type seems to have been uncommon among gather- cereals are refined). They include varying amounts of foods
erhunter peoples, if only because their average life of animal origin, and of vegetables and fruits, depending on
expectancy was low. In modern gathererhunter societies, relative food security. Surplus food is stored for consump-
the incidence of cancer rises after contact with industrialised tion in winter and during hard times, and methods of food
and urbanised ways of life, which usually involve shifts in preparation also include fermentation, used for foods as well
patterns of diet and physical activity.53 These points gener- as for the production of alcoholic drinks (see chapters 4.8
ally also apply to pastoralist societies. and 4.9).
The dominant indigenous cereal crop varies in different
1.1.2 Peasantagricultural parts of the world: wheat is grown in the Middle East; bar-
In recent millennia, and until very recently in history, almost ley, rye, and oats in colder, northern climates; millet and rice
all human populations have been rural and mostly peas- in Asia; maize (corn) in the Americas; and sorghum and teff
antagricultural, and the majority still are in most regions of in Africa. Indigenous staple crops also include roots and
Asia, many regions of Africa, and some parts of Latin tubers such as cassava (manioc), yams, potatoes, and also
America. Peasantagricultural food systems involving the cul- plantains. Pulses (legumes) are also farmed to ensure agri-
tivation of wheat may have first developed around 9000 cultural and nutritional balance; and other crops such as
years ago in the Fertile Crescent of the Middle East, includ- vegetables and fruits are also cultivated. Birds and animals
ing the region between the Tigris and Euphrates rivers (with- are domesticated and bred for food, and fish and seafood
in modern Iraq). These systems also developed contribute to the diets of communities living beside water.57
independently in Asia, with rice as the staple food, and in As with gathererhunters, the diets of peasantagricul-
the Americas, with corn (maize) as the staple.54 The key fac- tural societies may be diverse and high in micronutrients.
tor in these systems is land settlement, itself determined by Again, when food supplies are chronically insecure, or at
the cultivation and breeding of crops and also animals, birds, times of acute food shortage (including times of war), diets
and fish for human consumption and use.55 In and around are liable to become monotonous and deficient in various
Egypt, people began to make bread from wheat about 6000 nutrients, as well as in energy.
years ago.56 Peasantagricultural societies are necessarily physically
Typically, diets derived from these systems are plant-based: active, although not constantly so: the main times of inten-
they are high or very high in cereals (grains), complement- sive physical work include building field systems, sowing,
ed with animal sources of protein. These diets are therefore harvesting, and storing. The level of energy balance and of
high in starchy foods and usually in dietary fibre (unless the physical activity varies greatly, depending in part on how dif-
6
C H A P T E R 1 I N T E R N AT I O N A L V A R I AT I O N S A N D T R E N D S
tions account for 12.2 per cent; 4.2 per cent 23.5 per cent of all women had a BMI of Consumption of sugars and oils increased
of deaths are due to injuries. The first fig- over 30. By 2000, this figure had risen to 41 substantially and pulses (legumes)
ure gives a breakdown of deaths caused by per cent.46 Fewer data are available for decreased in importance.15 Since the 1970s,
chronic diseases.46 men, but in 1994, the mean BMI for men consumption of all major food groups has
Bladder cancer is the most common type aged 2044 was 26.6, rising increased. However, between 1990 and
of cancer in men, followed by cancers of the to 28.4 for men over 45. In 2002, among 1994 there was a 20 per cent decrease in
lung and liver.20 In women, the dominant all men, 45 per cent had a BMI of between total household food consumption, because
cancers include those of the breast, cervix, 25 and 29.99 and 20 per cent had a BMI of subsidies were removed and food prices
and bladder (for age-standardised rates of over 30.15 See figure 1.4 for projections of rose sharply.15 A national study in 1981
these cancers, see the second figure).20 The the proportions of men and women pre- found that only 24 per cent of urban and
high incidence of bladder cancer is likely to dicted to have a BMI of 30 or more in 15 per cent of rural households ate ready-
be related to bilharzia, a parasitic infection 2015.46 made foods, and meat was eaten more fre-
of the bladder.20 There is also a high inci- The average amount of available food quently in urban households compared
dence of hepatitis C virus, a cause of liver energy rose between 1964 and 2004, from with rural households.15 A repeat survey in
cancer.20 Also see box 7.8.1 It is predicted around 2240 to 3290 kcal/person per day 1998 found that poultry had become the
that there will be a 3.5-fold increase in liver (9400 to 13 800 kJ/person per day).1 Early main source of animal protein and that
cancer by 2030.12 dietary studies in Egypt demonstrated that wheat bread was the most popular type,
For the period 19911994, 46 per cent of corn bread was the staple food and that although homemade wheat-maize bread
men and 48 per cent of women between protein intake was about 100 g/day.15 was common in rural areas. Another study
the ages of 20 and 44 were classified as People from higher-income households highlighted differences in dietary fat
sedentary.46 In 2003, women aged 1549 consumed more dairy products and those intake: in urban women, 27.5 per cent of
had a mean body mass index (BMI) of 28.6. from urban households consumed a wider dietary energy came from fat (mainly as
In teenagers (1319 year olds), average BMI variety of foods. Between 1950 and 1990, vegetable oil) compared with 22.5 per cent
was 23.9; women in their 30s had a mean there was a shift towards a dependence on in rural women.15 Between 1981 and 1998,
BMI of 29.0, while those over 45 had a BMI wheat rather than other cereals (grains), people increasingly ate meals away from
of 31.3. In total, 77.3 per cent of women and a sustained rise in the consumption of home (20.4 per cent of all meals in 1981
aged 1549 had a BMI of over 25. In 1992, meat, fish, and dairy products.15 compared with 45.8 per cent in 1998).15
ficult it is to cultivate the land. The degree of physical activ- are less reliable than those kept in urbanised societies. But
ity and so of body mass in peasantagricultural communi- there is reasonable evidence that relatively common cancers
ties depends mostly on relative food security.58 in peasantagricultural societies include those causally
People in these societies who are prosperous, especially associated with chronic infections, such as cancers of the
those who own land farmed by others, may quite often stomach, liver, and cervix.60
become overweight or obese. But in general, and largely
because of the nature of their dietary staples, peasantagri- 1.1.3 Urbanindustrial
culturalists are usually short and lean. This is still evident in Indigenous or traditional peasantagricultural systems have
rural peasant communities whose food systems remain tra- coexisted with urbanindustrial food systems in most coun-
ditional: for instance, in Africa, Latin America, and in Asia, tries since the creation and growth of cities, and the begin-
notably India and China.58 ning of the industrial revolution. This movement started in
Agriculture enabled the development of towns and then Europe in the 18th century, and then spread to North
cities: throughout the world, walled, urban settlements America and elsewhere. Britain is one exception to this coex-
became surrounded by fields cultivated by peasants. These istence: it was the first country to become mostly urban, with
people subsisted on the food they produced, and the surplus hired workers replacing peasants on increasingly large and
fed the community living within the walls. In times of war, relatively mechanised farms. The Americas are another
the fortified settlement became a refuge for the farmers. This exception: settlers, mostly from Europe, displaced native
crowding of populations into towns and cities caused a sharp populations and developed mechanised agricultural sys-
rise in the rates of infectious diseases, mostly notably among tems.61 In continental Europe, some balance between rural
infants and young children, pregnant and lactating women, and urban ways of life has been preserved. Throughout the
and infirm and old people.59 Mediterranean coastal regions, and in the Middle East, mod-
The average life expectancy of peasantagriculturists ern food systems have deep, historical roots.62 In most of
in general is probably a little longer than that of Africa and Asia, including countries with large cities, the
gathererhunters, with a greater percentage of people basic economies and cultures have remained predominantly
surviving into what would be regarded as late-middle and rural, but this is changing.63
old age. Urbanindustrial food systems have characteristics distinct
The prevalence and incidence of various cancers in tradi- from peasantagricultural and gathererhunter systems.
tional rural societies is often uncertain, even following the Their original purpose was to ensure reliable and adequate
establishment of cancer registers in many countries: records supplies of food of an agreed minimum nutritional quality
7
P A R T I B A C K G R O U N D
South Africa
In 2001 South Africa had a population of women (figure 1.1).46 The most common cancers in men are
nearly 47.5 million.3 The country has a mid- Chronic diseases account for 53.9 per cent those of the prostate, lung, oesophagus,
dle-income economy, with a gross domestic of deaths, while infectious diseases, maternal, colorectum, and bladder.20 Since HIV and
product of 8506 international dollars per perinatal, and nutritional conditions account AIDS became epidemic, Kaposis sarcoma
person (figure 1.3), which masks extreme for 40.2 per cent; 5.9 per cent of deaths are has become more common in both men
socioeconomic inequalities.46 Life expectan- due to injuries. The figure below gives a break- and women. For women, the most common
cy at birth is 47 years for men and 49 for down of deaths caused by chronic diseases.46 cancers are those of the cervix, breast,
Cancer 30
7
25
20
10 51 Respiratory disease
15
10
Diabetes 5
20
0
Prostate
Lung
Oesophagus
Kaposi's
sarcoma
Colorectum
Bladder
Cervix
Breast
Colorectum
Lung
Oesophagus
Other
Data from World Health Organization46 Data from International Agency for Research on Cancer20
to entire populations. Technology has been the main driving lic health recommendations, notably when food security has
force behind these systems. For instance, various food-preser- been threatened by wars.69
vation techniques were developed as part of the industrial Urbanindustrial food systems generate relatively energy-
revolution, and there has been further innovation since that dense diets. These are fairly high in meat, and milk and their
time. These include bottling, canning, refrigeration, and products, and in total fats, hardened fats, processed starch-
packaging; the extensive use of sugar and salt; and tech- es and sugars, salt, baked goods, soft drinks, and often also
nologies that suppress, convert, or eliminate perishable qual- alcoholic drinks. These diets are relatively low in both
ities in fresh foods (see chapters 4.6 and 4.9). The clearing dietary fibre and starchy staple foods, other than products
of land to rear cattle and sheep, and the development of rail- made from wheat, which has become the dominant cereal
ways, refrigeration, and other technologies, have made meat, in most countries outside Asia and Africa. Recent advances
milk, and their products cheap and plentiful all year round. in food technology have further altered patterns of food pro-
Sugar derived from cane is the most profitable edible cash duction and consumption, particularly in high-income
crop, and sugars and syrups made from cane, beet, and now countries. Patterns of production and consumption of
also corn are used to sweeten and preserve breakfast foods, vegetables and fruits and fish vary between different
baked foods, desserts, soft drinks, and a vast array of other urbanindustrial food systems, depending on factors such as
manufactured products.64 65 Steel roller mills, invented in the climate and geographical location.70
1870s, separate the components of wheat and enable pro- Efficient urbanindustrial food systems can ensure the
duction of uniform quality white bread, which has become constant supply of food to all sections of the population,
a staple food.66 Hydrogenation, which converts oils to hard even to the lowest-income and marginalised groups. In high-
fats (see chapter 4.5), has made margarine a basic item of er-income countries and regions, this, together with basic
food, and provides ingredients used in the manufacturing of public health initiatives, has helped to greatly reduce rates
many processed foods.67 Perhaps the most remarkable of nutritional deficiencies and other diseases, which people
change following the industrialisation of food systems has are more vulnerable to if they have inadequate food supplies.
been the precipitate drop in breastfeeding.68 At various times, As a result of these food systems, people have become gen-
urbanindustrial food systems have been adjusted in erally taller and heavier.
response to the then current knowledge of nutrition and pub- Since the industrial revolution, as populations have moved
8
C H A P T E R 1 I N T E R N AT I O N A L V A R I AT I O N S A N D T R E N D S
colorectum, lung, and oesophagus (for age- also prevalent. There has been a miscon- BMI, and commonly consumed foods were
standardised rates of these cancers, see the ception of benign obesity: being thin is maize, sugar, tea, milk, and brown bread.
second figure).20 Diseases of poverty and associated with HIV and AIDS, and moder- Urban households ate less maize porridge
chronic diseases coexist, but it is predicted ately overweight women are thought of as but more vegetables and fruits, animal-
that by 2010, deaths from AIDS will account attractive and affluent.24 Overall, in 1998, based products, and fats and oils. It was
for twice as many deaths as those from all 21.1 per cent of men and 25.9 per cent of only in urban areas that fruits and milk
other causes combined.5 41 women had a BMI of at least 25; 10.1 per appeared in the top 10 list of foods and
For the period 20022003, 44 per cent of cent of men and 27.9 per cent of women drinks consumed by more than 85 per cent
men and 49 per cent of women aged 1869 had a BMI of at least 30. See figure 1.4 for of people. In men, alcoholic drinks made a
were classified as sedentary (figure 1.6).46 projections of the proportions of men and significant contribution to dietary energy
Some regional studies suggest that young women who will have a BMI of 30 or more (1014 per cent). People living in rural areas
women who did not finish school have low in 2015. obtained a higher proportion of total
levels of physical activity.24 There is a lack of The average amount of available food dietary energy from carbohydrates, where-
physical education in schools, and poor energy rose between 1964 and 2004, from as the most urbanised populations derived
environment and high crime rates prevent around 2700 to 3000 kcal/person per day one third of their energy from animal foods
leisure activity outside school.24 (11 400 to 12 600 kJ/person per day). In the high in protein.
In 1998 men aged 1524 had an average same period, sugar consumption dropped Urbanisation is generally accompanied
body mass index (BMI) of 21.1; for those from 420 to 370 kcal/person per day (1800 by an improvement in micronutrient
aged 3565, average BMI remained con- to 1500 kJ/person per day).1 The National intakes, but this way of life is also associat-
stant at around 25. Just 7.8 per cent of men Food Consumption survey of 1999 found ed with increases in overweight and obesi-
aged 2534 had a BMI of over 30 compared that stunting was the most common nutri- ty.44 Other studies have suggested shifts
with 17.3 per cent of men aged 4554. In tional disorder, affecting almost one fifth of towards a Western dietary pattern in peo-
the same year, women aged 1524 had an children aged 19, with the lowest levels in ple living in both urban and rural areas, typ-
average BMI of 23.7; for those aged 3564, urban areas. There was a similar pattern for ified by a decrease in starchy foods and
average BMI remained constant at around underweight, where 10 per cent of children dietary fibre consumption, and an increase
29. In women aged 2534, 27 per cent had aged 13 consumed less than half of their in fat. They have also shown that half of
a BMI of over 30 compared with 45 per cent suggested daily dietary needs, and 26 per the population does not eat the locally
of women aged 4564.46 Although under- cent consumed less than two thirds.25 In recommended four portions of fruits
nutrition remains a problem among rural rural areas, adults from lower-income and vegetables each day, while a quarter
children, obesity and associated diseases are households were shorter and had a lower eats none.10
from rural to urban areas, there have been rapid and pro-
Figure 1.1 Life expectancy at birth
found changes in both the nature and quality of their foods
Years and drinks, and the patterns of diseases they suffer.71
Asia-Pacific North America
90 Urbanindustrial food systems have evidently improved peo-
Africa Asia Europe Latin
America ples strength and health in early life. They are also a factor
80
in the doubling of average life expectancy since 1800, and
70
the increase in global population from around 1 billion in
1800 to 6.5 billion in 2006.72 The range of current life
60 expectancy in selected countries is illustrated in figure 1.1.
In the second half of the 20th century, attention focused
50
on the apparent ill-effects of these food systems on people,
40 mostly in later life. By the 1980s, it was generally agreed that
these industrialised diets increase the risk of some chronic
30 diseases, usually of later life, which had become common or
epidemic in higher-income industrialised countries. These
20
included obesity, type 2 diabetes, and coronary heart disease.
10 At the same time, in examining patterns of both diet and can-
cer across the world, and among migrants, it was increas-
0
ingly thought that these diets were partly responsible for
Egypt
South Africa
Japan
China
India
Australia
Spain
UK
Poland
USA
Mexico
Brazil
9
P A R T I B A C K G R O U N D
China
In 2004 China had a population of over 1.3 1.3). Life expectancy at birth is 70 years for 2004 found that there has been a shift
billion. The one-child policy introduced in men and 74 for women (figure 1.1).46 towards nutrition-related chronic diseases
1979 has reduced annual population Chronic diseases account for 78.9 per cent such as type 2 diabetes, cancer, and cardio-
growth to 1.07 per cent. The United Nations of deaths, while infectious diseases, mater- vascular disease.14
estimates that the population will have nal, perinatal, and nutritional conditions Stomach cancer is the most common type
increased to nearly 1.5 billion by 2025.46 The account for 11.7 per cent; 9.3 per cent of of cancer in men, although it has declined
country has a lower-middle-income econo- deaths are due to injuries.46 The figure slightly since 1980.20 Lung cancer has risen
my, with a gross domestic product of 5581 below gives a breakdown of deaths caused steadily over the same period.20 Liver cancer
international dollars per person (figure by chronic diseases.46 A study published in has risen since 1990, although levels are now
Lung
Liver
Oesophagus
Colorectum
Stomach
Lung
Breast
Liver
Oesophagus
Other
Data from World Health Organization46 Data from International Agency for Research on Cancer20
alisation is thought to be the single main force shifting tial to sustain young populations that walk or cycle to work
populations from the countryside into cities, changing the that is physically demanding, are unsuitable for ageing pop-
dominant food systems from peasantagricultural to ulations who sit for most of the day, even if they engage in
urbanindustrial, and transforming patterns of disease. This some recreational physical activity.
phenomenon includes the unprecedented and accelerating There is some evidence that these very recently introduced
movement of money, goods, and ideas. All this has been urbanindustrial food systems have lowered the rates of
made possible by new international, political, and econom- nutritional deficiencies and infectious diseases of early life
ic policies, by the creation of supranational regulatory bod- in middle- to low-income countries and regions. But the
ies such as the World Trade Organization, and by the apparent impact on the rates of chronic diseases in these
electronic revolution.76-78 areas is of increasing public health concern. In most of these
Peoples levels of physical activity have also changed dra- regions, with the exception of sub-Saharan Africa, childhood
matically as a result of the move from peasantagricultural overweight, obesity, and type 2 diabetes have become com-
to urbanindustrial ways of life. In 1950, the UN reference mon and, in some countries, epidemic.70
man weighing 65 kg (143 lbs) was estimated to be in ener- The Panel emphasises that there is no reason to think that
gy balance at an average of 3200 kilocalories (kcal)/day urbanindustrial food systems are intrinsically harmful. They
(13398 kilojoules [kJ]/day); the reference woman weighing were first developed using relatively crude technologies, and
55 kg (121 lbs) was estimated to be in energy balance at 2300 at a time when something was known of their positive
kcal/day (9630 kJ/day). Today in the USA, average weights impact on growth and strength, but little of their long-term
are much higher, yet the figure for the reference person (men impact on health. Since then, many new technologies have
and women combined) is taken to be 2000 kcal/day (8374 been developed, and there is a clearer understanding that
kJ/day) for the purposes of nutrition food labelling. The rea- some methods of preserving and processing food are bene-
son for this drop in human energy requirements is because ficial, whereas others are a factor in increasing the risk of
three of the four settings for physical activity occupation- disease. Future developments can ensure universal food
al, household, and transport (see Chapter 5) have become security, avoid earlier mistakes, and reduce the risk of chron-
increasingly mechanised. Energy-dense food systems, essen- ic diseases, including cancer.
10
C H A P T E R 1 I N T E R N AT I O N A L V A R I AT I O N S A N D T R E N D S
stabilising.20 The incidence of cancer of the energy rose between 1964 and 2004, from varied, resulting in a diet low in saturated
oesophagus has remained stable since the around 1850 to 2940 kcal/person per day fatty acids and high in n-3 polyunsaturated
1980s and cancers of the colorectum are also (7760 to 12 290 kJ/person per day). This is fatty acids; people there eat green, leafy
relatively common.20 For women, the most largely due to an increase in the availabili- vegetables with almost every meal.26 The
common cancers are those of the lung, ty of fats and oils, meat, and sugar.1 The incidence of nutrition-related diseases and
stomach, and breast, which have risen 19571962 famine was followed by a liber- deaths from these diseases are lower in this
steadily since the 1980s; of the liver, which alisation of food production. Economic region than in other parts of China.
has risen since 1990; and of the oesophagus. growth has reduced poverty and Chinese Snacking contributes minimal energy
For age-standardised rates of these cancers, diets now are influenced by the Western intake to Chinese diets (0.9 per cent).
see the second figure.20 pattern: cereals (grains) and lower-fat mixed However, snacking and eating food away
For the period 20022003, 10 per cent of dishes are being replaced with animal foods from home are increasing among children
men and 12 per cent of women aged 1869 and edible fats.14 Recent national nutrition- from middle- and high-income groups.
were classified as sedentary (figure 1.6).46 al surveys show that energy intake from ani- Foods commonly eaten away from home
These figures are likely to increase, with fur- mal sources increased from 8 per cent in include cereals (grains), vegetables and
ther urbanisation and greater use of vehi- 1982 to 25 per cent in 2002, and that ener- fruits, meat, eggs, and fish. Between 1991
cles for transport. Between 1980 and 2003, gy from fat, particularly among people liv- and 1997, the proportion of children from
the number of cars produced in China ing in urban areas, increased from 25 to 35 low-income households eating foods away
quadrupled to more than 2 million.84 per cent over the same period.84 Intake of from home did not change, but there was
In 1997 men aged 2464 had an average cereals (grains) has also decreased substan- an increase among children from higher-
body mass index (BMI) of around 25; just 2.1 tially since the mid-1980s among urban and income groups, with a 10 per cent increase
per cent of men aged 2074 had a BMI of rural populations, with a larger decrease in in the consumption of foods from animal
over 30. In the same year, women aged the consumption of coarse grains compared sources eaten away from home. Eating food
2529 had an average BMI of 22.2, and with refined varieties. The biggest drop in prepared away from home accounted for 15
those aged 3564 had a BMI of around 25. cereal intake has been among people in the per cent of total energy intake for all
Just 3.7 per cent of women had a BMI of lowest-income groups. Vegetable and fruit Chinese children during this period.27
over 30.46 In 2002, 18.9 per cent of men and intakes have decreased since 1989, although Despite these statistics, only 10 per cent of
women aged 18 and above had a BMI of they are highest in urban populations. Fat Chinese children and young people con-
over 25, and 2.9 per cent of them had a BMI intake is also increasing and many adults sumed any snacks during the study period,
of over 30. See figure 1.4 for projections of obtain 30 per cent or more of their overall and there was little evidence then that they
the proportions of men and women who energy intake from fat.14 Regional varia- consumed significant amounts of soft
will have a BMI of 30 or more in 2015. tions also exist: for example, the dietary pat- drinks, although this is now changing
The average amount of available food tern around the city of Hangzhou is very rapidly.
1.2 Foods and drinks, physical activity, plant sources such as roots and tubers, cereals (grains), and
body composition fruits.
However, this pattern is changing, with proportionally
1.2.1 Foods and drinks more dietary energy available for consumption now coming
Substantial changes have occurred in the patterns of foods from animal sources. Since the 1960s, estimates for animal
and drinks supplied and consumed throughout the world, sources for low-income countries have risen from around
and these changes are becoming increasingly rapid. Also see 160 to 340 kcal/day (670 to 1400 kJ/day). During the same
Chapter 4. period, estimates of the energy available for consumption
Economic development is generally accompanied by from plant sources have also risen, from 1900 to 2340
quantitative and qualitative changes in food supplies and kcal/day (7900 to 9800 kJ/day) (figure 1.2). There have
therefore in diets. This nutrition transition may reduce the been similar changes in the availability of both animal and
risk of some dietary deficiencies and improve overall nutri- plant sources of energy in high-income countries. However,
tion. But it can also be accompanied by adverse shifts in the in these cases, the proportion of energy from animal sources
composition of diets, for instance, with a greater proportion is much greater: around one third or 940 kcal/day (3900
of energy coming from fats and oils, and added sugars. Over kJ/day).81 The proportion of dietary energy available from
recent years, such dietary changes have been rapid in the cereals (grains) has remained constant at around 50 per
middle- and low-income countries of Asia, Africa, the Middle cent, though dietary energy available from cereals (grains),
East, and Latin America.63 79 80 in particular rice and wheat, have decreased slightly in low-
The Food and Agriculture Organization (FAO) of the UN income countries. This trend is likely to continue until the
records global differences in the availability of food crops and 2030s in middle- and low-income countries.81
commodities (box 1.1). These data provide information on Large variations exist across the world in the amounts of
the average amounts of food available for consumption, fat available for consumption. The highest availability is in
rather than actual food consumption. Animal products have Europe and North America; the lowest is in Africa. The quan-
traditionally made up a small proportion of food availabili- tity of available fat in diets has increased globally since the
ty in low-income countries; most dietary energy comes from 1960s, with the exception of sub-Saharan Africa.81 These
11
P A R T I B A C K G R O U N D
Figure 1.2 Changes in available energy from animal Figure 1.3 Gross domestic product per capita, 2004
and plant food sources
International $ Asia-Pacific North America
kcal Low income Middle income High income
40 000
3500
2000
20 000
1500
15 000
1000 10 000
500 5000
0
0
Egypt
Japan
China
India
Australia
UK
Spain
Poland
USA
Mexico
Brazil
South Africa
Total
Plant
Animal
Total
Plant
Animal
Total
Plant
Animal
Data from Food and Agriculture Organization1 Data from World Health Organization46
Food energy from animal and plant food sources in selected low-, Current gross domestic product per capita for selected countries in
middle-, and high-income countries, 19671999 international dollars
changes are accounted for by an increase in the availability kcal/day (5400 kJ/day) from these foods.83 In low-income
and consumption of plant oils in lower-income countries.82 countries between the 1960s and 1990s, consumption of
Palm oil intake is increasing in South-East Asia, and olive oil meat rose by 150 per cent, and of milk and dairy products
is now consumed widely in Europe and not just in by 60 per cent. By 2030, it is predicted that consumption of
Mediterranean countries. animal products could rise by a further 44 per cent, with the
Analysis of food balance sheet data suggests that available biggest contribution coming from poultry. If stocks of fish can
energy for consumption has increased steadily on a world- be maintained, fish consumption is likely to rise by 1920
wide basis. Since the 1960s, this has increased globally by kg/person in the same period. Owing to decreases in the cost
approximately 450 kcal/person per day (1900 kJ/person per of these foods in real terms, low-income countries have high-
day), and by more than 600 kcal/person per day (2500 er levels of meat and fat consumption at much lower levels
kJ/person per day) in low-income countries.81 Regional dif- of gross domestic product (GDP) than was the case in coun-
ferences exist. For example, there has been little change in tries that underwent socioeconomic transition in the 1960s
sub-Saharan Africa, and in Asia the amount of available ener- and 1970s. Figure 1.3 shows the GDP of selected countries.
gy has risen dramatically: in China by almost 1000 kcal/per- According to food consumption surveys, only a minority of
son per day (4200 kJ/person per day). These data need to the worlds adult population consumes the commonly rec-
be interpreted with caution, as they do not relate directly to ommended minimum daily amount of vegetables and fruits
energy consumption (box 1.1). Global average available of 400 g/person. Low-income countries have the lowest
energy is predicted to rise from around 2800 kcal/person per intakes of vegetables and fruits, and vegetables are general-
day (11700 kJ/person per day) (19971999 average) to ly more readily available than fruits.43 In India, for example,
2940 (12 300 kJ) in 2015, and to 3050 (12 800 kJ) in 2030. levels of vegetable and fruit intake have remained static at
Again, see box 1.1. 120140 g/day. Australia, Japan, and North America have
With increasing socioeconomic status, the proportion of high levels of intake, for example 300 g/day in Australia. In
energy in diets from staples such as cereals (grains) and roots Europe, average consumption is between 250 and 350 g/day
and tubers declines, whereas the proportion of energy from often much higher in Mediterranean countries, for
fats and oil, and animal protein (including from meat, milk, instance 550 g/day in Spain and Scandinavian countries
and eggs) increases. For example, in China, energy intake have particularly high fruit intakes.43 Countries in Europe,
from foods of animal origin has increased significantly: the Latin America, North America, and South-East Asia have seen
average Chinese adult now consumes more than 1300 an increase in the availability of vegetables and fruits for con-
12
C H A P T E R 1 I N T E R N AT I O N A L V A R I AT I O N S A N D T R E N D S
The data here on energy, foods, and drinks are those of energy. Balance sheets over- surveys or household income/expenditure
are taken from food balance sheets com- estimate food consumption in high-income surveys.
piled by the Food and Agriculture countries, where substantial amounts of Household income/expenditure surveys,
Organization of the United Nations. These food are wasted or fed to pets. They such as the World Banks Living Standards
are statistical data on the production, underestimate consumption in countries Measurement Study, look at multiple
trade, and use of agricultural commodities that are not dominated by urbanindustri- aspects of household welfare and behav-
for all countries. Food balance sheets are al food systems, and where many people iour, and collect data on the quantities of
the most common and widely used data grow their own food, raise animals, or food purchased by a representative sample
sets for food supply estimates. A food bal- gather wild food such as fungi and berries. of households. These surveys provide
ance sheet provides estimates of the food It follows that balance sheet data showing detailed information about foods con-
available for human consumption, and an increases in food energy over time tend to sumed in and away from the home over a
overall picture of a countrys food supply reflect economic development and greater limited time period, and can be used to
during a specified period of time, which use of money, rather than actual increases document differences in regional, geo-
can be compared between countries. in availability. graphical, or household socioeconomic
It follows that these estimates of avail- The accuracy of a food balance sheet characteristics. While these surveys are
ability are not measures of consumption. also depends on the reliability of the generally more useful than food balance
They record information about the supply underlying statistics of supply, use, and sheets for assessing household consump-
of food (production, imports, stock population. Also, the data do not take into tion, they are less readily available. Balance
changes, and exports) and about how it is account regional differences, so the infor- sheets are often available for a large num-
used (as feed and seed, in processing, and mation may not be representative of the ber of countries and for most years.
wastage, as well as food). The amounts of entire country. In countries where there is Food balance sheets, household income/
foods and drinks recorded on these bal- wide variation in income and food access, expenditure surveys, and methods of assess-
ance sheets are expressed per person (in for example, the overall supply picture pro- ing individual dietary intakes (see Chapter
kg/person per year or kcal/person per day). vided by the balance sheet is of limited use. 3) all provide information on food supply
The estimates in food balance sheets In such cases, food balance sheets can be and consumption, and they have different
that need to be treated with most caution complemented with national nutrition purposes, uses, and limitations.
sumption since the 1960s. In contrast, in eastern and cen- are either overweight or obese have risen considerably. In
tral Africa, availability has decreased since the mid-1980s. 2002, there were 184 million overweight and 31 million
Studies in children suggest that their eating patterns vary obese people in China, out of a population of 1.3 billion.14
around the world. For instance, children living in the USA The prevalence of overweight and obesity among 718 year
and the Philippines consume one third of their daily energy olds increased substantially between 1985 and 2000.84
away from home, and snacks provide one fifth of their daily Between 1989 and 1997, one study estimated that the pro-
energy. In contrast, children living in Russia and China eat portion of overweight and obese men in China rose from 6.4
very little food away from the home. Snacks provide about to 14.5 per cent, and in women from 11.5 to 16.2 per cent.85
16 per cent of dietary energy for Russian children, but Another study, in nine Chinese provinces, found that
account for only 1 per cent in Chinese children.2 between 1989 and 2000 there was a 13.7 per cent increase
A US study showed that between 1977 and 2001, con- in the proportion of men, and a 7.9 per cent increase in the
sumption of sweetened drinks increased by 135 per cent. proportion of women, who were overweight or obese.
During the same period, milk consumption decreased by 38 During the same period, there was an average 2 per cent
per cent, resulting in an overall daily increase of 278 kcal decrease in the number of men and women who were clas-
(1164 kJ) from drinks.31 sified as underweight.86
The World Health Organization MONICA Project moni-
1.2.2 Overweight and obesity tored 10 million adults in 21 countries over a 10-year peri-
There have been rapid changes in rates of overweight and od in the 1980s and 1990s. During this time, the mean body
obesity throughout the world since the 1980s, at the same mass index (BMI) increased in most populations, with the
time as the urbanisation and industrialisation of middle- and largest increases in regions of Australia and the USA. Over
low-income countries. Such countries often experience the the course of the project, the overall average BMI increased
dual burden of nutritional deficiencies and chronic diseases. by 1.5.87 However, average BMI decreased in Russia and
Also see Chapters 6 and 8. Central Europe, and in certain regions of Italy and
The most recent estimates suggest that in 2002 there were Switzerland. The UK has one of the highest rates of excess
1 billion overweight or obese people worldwide, with weight in Europe. This has increased threefold since 1980;
Chinese people accounting for approximately one fifth. The in 2003, 65 per cent of men and 56 per cent of women were
example of China is remarkable. Historically, China, which overweight, with 22 per cent of men and 23 per cent of
is classed as a lower-middle-income economy by the World women classified as obese.88
Bank, had a lean population. But the prevalence of under- Historically, food insecurity, undernutrition, and under-
weight adults has decreased and the numbers of people who weight, and their likely contribution to infection, have been
13
P A R T I B A C K G R O U N D
India
In 2004 India had a population of over 1.1 China to reach the 1-billion mark.46 India dollars per person (figure 1.3). Life
billion, growing at a rate of about 1.2 per has a low-income economy, with a gross expectancy at birth is 61 years for men and
cent a year; it was the next country after domestic product of 1830 international 63 for women (figure 1.1).46
Cardiovascular disease 30
Men Women
25
13
3 Cancer 20
15
12
57 Respiratory disease 10
5
15 Diabetes
0
Oral
Pharynx
Lung
Oesophagus
Cervix
Breast
Oral
Oesophagus
Other
Data from World Health Organization46 Data from International Agency for Research on Cancer20
South Africa
China
India
Japan
UK
Spain
Poland
USA
Brazil
Mexico
Australia
14
C H A P T E R 1 I N T E R N AT I O N A L V A R I AT I O N S A N D T R E N D S
Chronic diseases account for 58.1 per aged 4054 had an average BMI of 23.6.46 energy rose between 1964 and 2004, from
cent of all deaths, while infectious diseases, For men aged 2070, 25.4 per cent had a around 2050 to 2470 kcal/person per day
maternal, perinatal, and nutritional condi- BMI of over 25.46 Women aged 2024 had (8580 to 10 360 kJ/person per day).1
tions account for 32.9 per cent; 9 per cent an average BMI of 20.9, rising to an aver- Recently, though, there have been large
of deaths are due to injuries.46 The first fig- age of 24 at age 30; and women aged increases in the consumption of animal
ure gives a breakdown of deaths caused by 3069 also had a BMI of around 24.46 In products, fats, and sugars. The proportion
chronic disease.46 total, 35.8 per cent of women aged 2070 of energy from fat has increased each year,
Common cancers in men include those of had a BMI of over 25.46 A review from 2002 although within India there are differences:
the oral cavity and pharynx.20 Although established that the prevalence of for higher-income groups, 32 per cent of
these cancers have declined since the late preschool obesity was about 1 per cent, but energy comes from fat, compared with
1970s, the incidence remains high.20 Cancers stunting remained a problem in over half 17 per cent in lower-income groups.39
of the oesophagus and lung have also of all children.39 Obesity has been uncom- Since 1975 there has been a reduction in
decreased slightly in the same period.20 In mon in India and varies with socioeconomic cereal (grains) consumption, particularly
women, cancer of the cervix is the most com- status, being more common in high-income coarse grains, although this has not affect-
mon type, and has been since the 1970s; households. In the 1970s, 2.1 per cent of ed overall energy consumption. This is
breast cancer has increased steadily during men and 2.9 per cent of women had a BMI probably due to large increases in intakes
this time.20 Cancers of the oral cavity and of 25 or more, while less than 0.5 per cent of fats and animal protein, and also of milk
oesophagus have declined slightly since the of men and women had a BMI of 30 or and milk products. In lower-income house-
late 1970s (for age-standardised rates of more.46 By 1998 these figures had risen: 4.4 holds, fat comes mainly from vegetable
these cancers, see the second figure).20 per cent of men and 4.3 per cent of women foods, with very little consumption of ani-
For the period 20022003, 10 per cent of had a BMI of 25 or more.46 See figure 1.4 mal fats, whereas in the highest-income
men and 16 per cent of women aged 1869 for projections of the proportions of men households, the majority of fat is from ani-
were classified as sedentary (figure 1.6).46 and women who will have a BMI of 30 or mal sources. India is a major producer of
In 2000 men aged 2024 had an average more in 2015.46 vegetables and fruits, much of which are
body mass index (BMI) of 20.7, while those The average amount of available food exported.
work has become increasingly mechanised, and vehicles are not do enough physical activity getting from one place to
used more often for transport. Occupational and household another.91 In Europe, people living in more northerly regions
physical activity has reduced dramatically in high-income such as Scandinavia have higher levels of activity than those
countries. Also see Chapters 5, 6 and 8. living further south, for example, in Mediterranean coun-
There is as yet no globally accepted, quantified definition tries. Women tend to exercise less than men and this differ-
of physical inactivity, or of the extent to which populations ence is greatest in southern European countries.42
or people should be physically active. In 2002, the WHO A study conducted in 1953 demonstrated that more than
recommended a minimum of 30 minutes moderate-intensi- half of US school children failed a minimum standard of
ty physical activity most days; it found that at least 60 per
cent of the worlds population fails to achieve this level of
physical activity.91
The proportion of people employed in agriculture can Figure 1.5 Projected levels of inactivity in selected
regions in 2020
reflect the level of work-related activity undertaken in a
country, and there may be a linear relationship between the
two.91 Thus, it is likely that, compared with high-income Insufficient Inactive
countries, transport-related and occupational and household
Africa 4555 1020
physical activity is higher in low-income countries.
USA/Canada 3550 1730
Transport-related physical activity (cycling, walking) is high-
Latin America 2545 1747
er in those countries with the lowest gross domestic prod-
uct and low car ownership, and this differs little between Middle East 3042 1530
15
P A R T I B A C K G R O U N D
Japan
In 2004 Japans population was just over 30 039 international dollars per person (fig- cent of all deaths, while infectious diseases,
128 million, with 79 per cent living in urban ure 1.3). Life expectancy at birth is 79 years maternal, perinatal, and nutritional condi-
areas.46 The country has a high-income for men and 86 for women (figure 1.1).46 tions account for 10.5 per cent; 10.8 per
economy, with a gross domestic product of Chronic diseases account for 78.7 per cent of deaths are due to injuries. The first
Cardiovascular disease 60
Men Women
50
2 14
Cancer 40
6 37 30
Respiratory disease 20
10
Diabetes
44 0
Stomach
Colorectum
Lung
Liver
Prostate
Oesophagus
Pancreas
Breast
Colorectum
Stomach
Lung
Cervix
Other
Data from World Health Organization46 Data from International Agency for Research on Cancer20
16
C H A P T E R 1 I N T E R N AT I O N A L V A R I AT I O N S A N D T R E N D S
figure gives a breakdown of deaths caused indicate that in 2015 almost 900 000 people decreased, from 75 per cent of energy in
by chronic diseases.46 will develop cancer and 450 000 will die the 1940s to 41.3 per cent in 2000. Energy
In men, cancer of the stomach is the most from cancer.47 from fat increased from 6.9 per cent in 1949
common type of cancer. This is followed by Regional studies suggest that 6870 per to 25 per cent in 1988, and to 26.5 per cent
colorectal, lung, liver, and prostate cancers, cent of men and 7082 per cent of women, in 2002. Total fat intake has increased sig-
which have increased since the 1960s. aged 2070, are physically inactive. nificantly following the countrys econom-
Cancer of the oesophagus has remained In men there has been a steady increase ic growth, from 15 g/person per day in the
steady since the 1960s, although the inci- in body mass index (BMI) since the mid- 1940s to 59 g in 1983, remaining at around
dence of cancer of the pancreas has 1970s. In 2002, 17.5 per cent of men aged this level in 2002. The percentage of ener-
increased since then.20 In women, breast 2029 and around 30 per cent of those gy in diets from protein has risen from 12.4
cancer is the most common type and its inci- aged 3060 had a BMI of over 25. Only 7 per per cent in the 1940s to 15.9 per cent in
dence has risen since the 1970s.20 Colorectal cent of women aged 2029, 19 per cent of 2000. However, there has been a larger
cancer is the next most common type, and those aged 4049, and 25.6 per cent of increase in the percentage of protein from
this has also increased. Stomach cancer inci- those aged 5059 had a BMI of over 25. See animal sources: from 18.6 per cent in the
dence has decreased since the 1960s, but figure 1.4 for projections of the proportions 1940s to more than 50 per cent in 2000. In
the rate remains high; lung cancer has risen of men and women who will have a BMI of 2002, people were continuing to eat more
steadily since the 1960s.20 The incidence of 30 or more in 2015. green and yellow vegetables, with people
cancer of the cervix increased during the The average amount of available food over 50 tending to eat the most vegetables.
1960s and remained high in the 1970s, but energy rose between 1964 and 2004, from Fruit intake peaked in 1975 and has since
has since declined (for age-standardised around 2570 to 2760 kcal/person per day decreased and stabilised. In 2002, Japanese
rates of these cancers, see the second fig- (10 780 to 11 540 kJ/person per day). Meat diets did not provide the recommended
ure). 20 However, the total numbers of new consumption also increased during this intake of calcium: although consumption of
cancer cases and cancer deaths are set to time.1 Steamed rice was the staple food milk and dairy products had increased, con-
rise because Japan has an ageing popula- until 1950, and accounted for 80 per cent of sumption of fish and shellfish had declined
tion. Cancer has been the leading cause of energy intake before 1935. Dietary intake slightly. Salt intake remained high, at over
death in Japan since 1981 and projections of cereals (grains), almost all rice, has 12 g/person per day. 23
inactive.91 Clearly, levels of physical activity will vary in dif- ageing world population; improved screening, detection, and
ferent areas and countries around the world. In Europe, for treatment, which increases the number of people living with
example, the former Soviet Union states and countries in a diagnosis of cancer (see Chapter 9); the projected increas-
eastern Europe are at the lower end of the estimates, with es in tobacco smoking in many countries; and the increase
western European countries at the higher end. Indeed, these in the number of people with HIV/AIDS in some countries.
figures are expected to rise further in western Europe and it The global age-adjusted incidence of cancer is also likely to
is estimated that 5060 per cent of adults will not be suffi- increase. Also see box 1.2.
ciently physically active by 2020. Also see figure 1.5. The per- Globally, the most commonly diagnosed cancers (exclud-
centage of adults currently classified as sedentary in selected ing all types of skin cancer) are those of the lung, colon and
national examples is shown in figure 1.6. Using different def- rectum, and breast, with lung cancer being the leading cause
initions, the amount of adults (aged over 16 years) classi- of cancer death.94 95 Geographical and socioeconomic dif-
fied as sedentary for the UK are 60 per cent of men and 66 ferences exist for the most common cancers. In low-income
per cent of women. For the USA 52 per cent of men and 65 countries, the most prevalent cancers include those of which
per cent of women (aged over 18 years) are classified as infectious agents are a major cause, while in high-income
sedentary.46 countries, they include hormone-related cancers. In high-
income countries, and among men, prostate cancer is the
1.2.4 Cancer most common type, followed by cancers of the lung, stom-
Patterns of cancer and trends, incidence, and projections vary ach, and colon and rectum. In low-income countries, and
greatly in different parts of the world. Also see Chapter 7. among men, lung cancer is the most common type, followed
In 2002 there were more than 10 million new cases of can- by cancers of the oesophagus, stomach, and liver. Breast can-
cer (excluding non-melanoma skin cancers) recorded world- cer is the most common type among women living in high-
wide, and nearly 7 million cancer deaths. By 2020 these income countries, followed by cancers of the lung, colon and
figures are estimated to rise to over 16 million new cases, rectum, and endometrium. Breast cancer is also the most fre-
with 10 million deaths. There may be more than 20 million quent type among women living in low-income countries,
new cases of cancer in 2030.93 Indications suggest that, at followed by cancers of the lung, stomach, and cervix.94 96
that time, 70 per cent of cancer deaths will be in low-income
countries. 1.2.4.1 Oesophagus
This projected increase is accounted for by a combination Oesophageal cancer is the seventh most common type of
of factors: the projected increase in global population; an cancer worldwide, with more than 460 000 new cases record-
17
P A R T I B A C K G R O U N D
UK
In 2001 the UK population was nearly 60 of deaths are due to injuries. The first fig- ing steadily since the 1960s, is now decreas-
million.30 The UK is a high-income economy, ure below gives a breakdown of deaths ing, and stomach cancer incidence has
with a gross domestic product of 31 300 caused by chronic diseases.46 declined since the 1960s.20 In women, breast
international dollars per person (figure Prostate cancer is the most common can- cancer is the most common type, and
1.3). Life expectancy at birth is 76 years for cer type in men and has increased steadily although rates were fairly constant during
men and 81 for women (figure 1.1). since the 1970s.20 Lung cancer incidence the 1960s and 1970s, they have risen steadi-
Chronic diseases account for 84 per cent peaked in the 1960s, remained high until ly since then.20 The incidence of colorectal
of all deaths, while infectious diseases, the mid-1980s, and is now declining.20 cancer has remained steady since the
maternal, perinatal, and nutritional condi- Colorectal cancer has risen steadily since 1960s.20 Lung cancer rose from the 1960s to
tions account for 11 per cent; 4.9 per cent 1960.20 Bladder cancer, which had been ris- 1980s, and has remained steady since
Lung
Colorectum
Bladder
Stomach
Breast
Colorectum
Lung
Ovary
Endometrium
Other
Data from World Health Organization46 Data from International Agency for Research on Cancer20
Increases in BMI UK
ed in 2002. Because it has a poor survival rate, it is the fifth more common in parts of China than in Europe and
most common cause
Per cent adults ofBMI
with cancer
2529.9death, responsible
Per cent for 30
adults with BMI nearly North America.94 97 Other areas of high risk include southern
000 deaths in 2002.
39050 and eastern Africa, south-central Asia, and some countries
Incidence rates vary widely between countries. Studies in South America.
40
suggest that cancer of the oesophagus is 100 times Geographical variability of exposure to established car-
30
Box
20 1.2 Measurement of cancer incidence and mortality
After
10 cancer registers were established in cer. These rates are usually expressed as the registries prepare cancer-incidence statis-
various countries in the second half of the number of new cases (or deaths) each year tics. With types of cancer where survival is
20th 0 century, descriptive studies showed for every 100 000 people. high, cancer mortality statistics will not
1980 2003 1980 2003
reliably for (UK)the first time that rates and
(England) (UK) Cancers are not usually diagnosed until
(England) reflect occurrence rates. But globally, it
trends of different cancers vary, sometimes they produce symptoms, so there is a peri- is easier to obtain statistics for mortality
Men
substantially across different countries. od of time Women
between the first stages of can- than for incidence, so these are often used
This variation suggested that cancer is not cer development and its identification. This for comparisons between population
justData
genetically
from Department of Health48
inherited and et al49
that different
and Rosenbaum length of time can vary greatly, and there groups.
cancers have different causes. are also considerable differences in survival It can also be difficult to compare can-
Many countries publish annual incidence times and how types of cancer respond to cer incidence globally: not all countries and
and mortality rates for cancer. The inci- treatment. regions are covered by cancer registries,
dence rate refers to the number of new Many countries and international agen- and these organisations may use different
cancer cases reported; the mortality rate cies track mortality statistics with causes definitions and collect different data, both
refers to the number of deaths from can- of death, and national or regional cancer geographically and over time.
18
Data from World Health Organization46 Data from Inte
C H A P T E R 1 I N T E R N AT I O N A L V A R I AT I O N S A N D T R E N D S
dren.22 Children in the British Isles have the since the mid-1980s.
10
highest rates of skin cancer in Europe.11 Over the same peri-
In 2003, 64 per cent of men and 76 per od, intakes of fish
0
cent of women aged 1669 were classified and fish dishes and 1980 2003 1980 2003
as sedentary.46 A study to examine exercise eggs and egg dishes (UK) (England) (UK) (England)
patterns in adults in 1991 and again in 1999 have decreased.19
Men Women
found that only 4 in 10 adults had man- Large studies sug-
aged to meet and maintain the current rec- gest that fat intake
Data from Department of Health48 and Rosenbaum et al49
ommended level of activity, or to increase has decreased be-
their level. During the study period, the cause people now
majority either reduced their activity level consume less whole
or maintained it below the recommended milk, butter, and red meat, and more veg- portions of vegetables and fruits. Instead,
level, and 15 per cent of the sample was etables and fruits.35 Men surveyed between men ate an average of 2.7 portions while
inactive, both in 1991 and 1999.33 2000 and 2001 were more likely to eat women had 2.9.19 The survey also showed
In the UK, body mass index (BMI) has foods containing fats, oils, and sugars, as that vegetable and fruit consumption was
risen steadily since the mid-1970s. For the well as meat and meat products, and soft particularly low in young adults, and that
proportions of men and women in 1980 and alcoholic drinks. people from low-income households were
and in 2003 with a BMI of between 25 and In the same survey, and compared with less likely to eat fruit and yogurt.19 It
29.9, or of over 30, see the figure on this older men and all women, young men were appears that more-educated adults put
page. Also see figure 1.4 for projections of more likely to eat savoury snacks and soft dietary guidelines into practice, reducing
the proportions of men and women who drinks, and less likely to eat eggs, fish, and the amount of fat in their diets and increas-
will have a BMI of 30 or more in 2015. fruit.19 Women ate more fruit, although ing the amount of vegetables and fruits
The average amount of available only 13 per cent of men and 15 per cent of they eat.3
food energy rose between 1964 and 2004, women ate the recommended five daily
cinogens can explain some of these differences. In high- high-income countries (almost 70 per cent in 1980); almost
income countries, alcohol and smoking tobacco are the main half were predicted to occur in middle- and low-income
carcinogenic agents, whereas chewing tobacco is more com- countries in 2005.94 95 The USA and Europe have the high-
mon in India. Pockets of high incidence occurring in parts est numbers of lung cancer cases for both men and women,
of China and in the Caspian littoral of Iran may be due to but the incidence appears to have peaked, and may now
general nutritional deficiencies. Incidence of adenocarcino- be declining in the USA and in parts of northern Europe. It
ma of the lower third of the oesophagus is steadily increas- is, however, still increasing in southern and eastern Europe.
ing in the USA and Europe, which is likely to be linked to Men are more likely to develop lung cancer than women,
an increasing incidence of acid reflux from the stomach due almost certainly because, on average, they smoke more than
to obesity.94 95 Also see chapter 7.3. women. Worldwide, 1 billion men and 250 million women
currently smoke tobacco. It is estimated that throughout the
1.2.4.2 Lung 20th century, 100 million people died from tobacco use.93
Lung (pulmonary) cancer has been the most common type Also see chapter 7.4.
of cancer in the world since 1985, with around 1.35 million
new cases recorded in 2002. It is also the most common 1.2.4.3 Stomach
cause of cancer death. In 2002, 1.2 million people died from Stomach (gastric) cancer is now the fourth most common
lung cancer. type of cancer worldwide, with around 925 000 new cases
Between 1985 and 2002, the estimated number of lung recorded in 2002. It is the second most common cause of
cancer cases worldwide rose by 51 per cent, and the num- death from cancer, with around 700 000 deaths annually.
ber of cases in middle- and low-income countries has Until about the mid-1980s, stomach cancer was the most
increased steadily over recent years. Previous estimates indi- common type in the world. Since then, rates have fallen sub-
cated that the majority of lung cancer cases occurred in stantially in all high-income countries, and overall rates are
19
P A R T I B A C K G R O U N D
Poland
In 2004 Poland had a population of around birth is 71 years for men and 79 for women tions account for 3.9 per cent; 7.9 per cent
38.5 million. The country has an upper-mid- (figure 1.1).46 of deaths are due to injuries. The first fig-
dle-income economy, with a gross domestic Chronic diseases account for 88.2 per ure gives a breakdown of deaths caused by
product of 12647 international dollars per cent of all deaths, while infectious diseases, chronic diseases.46
person (figure 1.3).46 Life expectancy at maternal, perinatal, and nutritional condi- Lung cancer is the most common type of
Lung
Colorectum
Prostate
Bladder
Stomach
Breast
Colorectum
Cervix
Lung
Endometrium
Ovary
Other
Data from World Health Organization46 Data from International Agency for Research on Cancer20
now about 15 per cent lower than in 1985.94-96 Exposures to the hepatitis B and C viruses are known to
Stomach cancer is now much more common in Asia than increase the risk of developing liver cancer; 85 per cent of
in the USA or Europe. Indeed, 42 per cent of cases occur in cases in low-income countries are attributed to exposures to
China alone.94 97 High-risk areas are China, Japan, eastern these two viruses. Also see chapter 7.8.
Europe, and Central and South America. Low-risk areas are
South-East Asia, northern and eastern Africa, the USA, and 1.2.4.5 Colon and rectum
Australia and New Zealand. In most countries, incidence has Colorectal cancer (of the colon or rectum) is the third most
dropped by about 15 per cent compared with 1985. common type of cancer worldwide, with just over 1 million
The bacterium Helicobacter pylori is an established cause new cases recorded in 2002. Mortality is approximately half
of stomach cancer. Reduction in stomach cancer rates can be that of the incidence, and nearly 530 000 deaths were
explained partly by reduced exposure to H pylori and part- recorded in 2002, making it the fourth most common cause
ly by increased use of refrigeration to preserve foods.94 97 Also of death from cancer.
see chapter 7.5. There is a large geographical difference in the global dis-
tribution of colorectal cancers. Incidence varies up to 25-fold
1.2.4.4 Liver between countries with the highest rates (the USA, Australia
Liver (hepatic) cancer is the sixth most common type of can- and New Zealand, and in parts of Europe) and those with
cer worldwide, with around 625 000 new cases recorded in the lowest rates (in Africa and Asia). Intermediate levels
2002. The poor prognosis makes it the third most common occur in South America.
cause of cancer death, with around 600 000 deaths in 2002. Incidence of colorectal cancer may be stabilising in parts
In most countries, the incidence of liver cancer is stable of northern and western Europe, and possibly declining
and there is little difference in survival rates between high- gradually in the USA. Elsewhere, however, the incidence is
and low-income countries. More than 80 per cent of cases increasing rapidly, particularly in Japan and in middle- and
occur in middle- and low-income countries. Areas with a low-income countries.94 96
high incidence are China (55 per cent of all new cases), sub- As shown in 1.3, the incidence of colorectal cancer increas-
Saharan Africa, and eastern and south-eastern Asia. es quickly when people migrate from low- to high-risk areas
Incidence is lower in high-income countries and in Latin of the world. Indeed, the incidence rate is higher in Japanese
America, although Japan and areas of southern Europe have people born in the USA than in white people born in the
intermediate incidence levels.94 96 USA. Also see chapter 7.9.
20
C H A P T E R 1 I N T E R N AT I O N A L V A R I AT I O N S A N D T R E N D S
cancer in men and age-adjusted incidence aged 3044 had a BMI of 24.1, while those Tobacco smoking and alcoholic drink con-
has remained stable since the 1970s.20 The aged 4559 had a BMI of 26.7.46 Only 1.5 per sumption are underlying factors in overall
incidence of colorectal cancer has increased cent of women aged 1529 had a BMI of mortality trends in eastern Europe. An
since 1990, and both prostate and bladder over 30, rising to 22.5 per cent of those aged analysis of national household budget and
cancers have increased slightly since the 4559, and 23.7 per cent of women aged individual dietary surveys carried out in the
1970s.20 Stomach cancer incidence peaked in 6074.46 In a study of adults in Warsaw, the 1990s found that, each day, the average
the late 1970s and has declined steadily since. average adult BMI remained stable between person ate around 300 g of dairy products
Breast and colorectal cancers are the most 1983 and 1993 at approximately 27.46 Overall and the same amount of cereals (grains)
common types in women and their rates in 1996, 10.3 per cent of men and 12.4 per and roots and tubers, although consump-
have risen steadily since the 1970s.20 Cancer cent of women had a BMI of 30 or more.46 tion of pulses (legumes) was very low.38 A
of the cervix has remained steady since the See figure 1.4 for projections of the propor- study of students found that women ate
mid-1970s, whereas cancers of the lung, tions of men and women who will have a meat and drank beer less frequently than
ovary, and endometrium have increased in BMI of 30 or more in 2015.46 men, and they ate more fruit and drank
this period (for age-standardised rates of The average amount of available food more milk.8 Another local study, in Warsaw,
these cancers, see the second figure).20 energy rose between 1964 and 2004, from reported decreases in intakes of total ener-
In 1996, 31 per cent of men and 32 per around 3310 to 3520 kcal/person per day gy, dietary cholesterol, and dietary animal
cent of women aged 1575 were classified (13 850 to 14 730 kJ/person per day). The fats, and an increase in vegetable oil intake
as sedentary.46 amount of energy available from sugars between 1984 and 2001.45 Another study
In 1996 men aged 1529 had an average and meat increased during this period, found that between 1990 and 2000, the
body mass index (BMI) of 23.1.46 This rose to while the energy available from animal fats proportion of men eating fruit each day
25.9 for men aged 3044, while those aged fell substantially.1 In 1989 Poland began the increased from 36 to 42 per cent. Levels of
4575 had a BMI of between 26 and 27.46 transition from a centrally planned to a intake were stable in women, with around
Only 2.4 per cent of men aged 1529 had a market economy. This resulted in dramatic 60 per cent eating fruit every day. In con-
BMI of over 30, rising to 10.8 per cent of increases in food prices, and although the trast, over the same decade, only 2223 per
those aged 3044, and 17.5 per cent of 4559 transition gave people a better choice of cent of men limited their fat intake,
year olds.46 In the same year, women aged foods, there was a decline in food demand although more women did during this peri-
1529 had an average BMI of 21.2.46 Women and alterations in dietary patterns.37 od (an increase from 23 to 45 per cent).40
1.2.4.6 Breast Cervical cancer is the seventh most common cause of death
Breast cancer is the most common type of cancer in women, from cancer overall, and the third most common in women,
and the third most common cancer overall. Incidence rates and was responsible for nearly 275 000 deaths in 2002.
are increasing in most countries, with an estimated 1.15 mil- Over 80 per cent of cases occur in low-income countries.
lion new cases recorded in 2002. Breast cancer is the sixth Areas with the highest incidence rates are sub-Saharan Africa,
most common cause of death from cancer overall. However, the Caribbean, Central and South America, and south-cen-
it is the second most common cause of cancer death in tral and South-East Asia. Incidence rates are lowest in Europe,
women, with just over 410 000 deaths recorded in 2002. the USA, Japan, China, and Australia and New Zealand.
The incidence of breast cancer is highest in high-income The incidence has dropped substantially in high-income
countries (although not in Japan) and more than half of all countries following the introduction of cervical screening
cases occur in these countries. Although breast cancer has programmes. The major established cause of cervical cancer
been less common in women living in low-income countries, is infection with certain subtypes of human papilloma
age-adjusted incidence is increasing, and the rates of viruses (HPV). Other cofactors (parity, contraception, HIV
increase are often greater in these countries. infection, and smoking) can also modify the risk of this
Globally, estimates indicate that breast cancer incidence cancer in women infected with HPV.94 96 97 Also see
has increased by 0.5 per cent annually since 1990. However, chapter 7.13.
certain cancer registries, such as those in China and other
parts of Asia, are recording annual increases in incidence of 1.2.4.8 Prostate
up to 4 per cent. Rates are low in Africa, with the lowest inci- Prostate cancer is the third most common type of cancer in
dence in central Africa.94 96 men, and the sixth most common cancer overall, with near-
Migrant studies show that breast cancer rates change when ly 680 000 new cases recorded in 2002. The majority of cases
women move to a new country. See 1.3. Also see chapter are diagnosed in men over the age of 65, and this cancer
7.10. accounted for just over 220 000 cancer deaths in 2002. This
made it the eighth most common cause of death from can-
1.2.4.7 Cervix cer overall, and the sixth most common in men.
Cancer of the cervix is the second most common type of can- Prostate cancer is more common in high-income countries,
cer among women, and the eighth most common cancer but the incidence remains low in Japan. Incidence rates have
overall, with around 500 000 new cases recorded in 2002. been influenced by screening programmes, which increase
21
P A R T I B A C K G R O U N D
Spain
In 2004 Spain had a population of over ure 1.3).46 Life expectancy at birth is 77 years maternal, perinatal, and nutritional condi-
43 million. The country has a high-income for men and 83 for women (figure 1.1).46 tions account for 5.5 per cent; 6.9 per cent
economy, with a gross domestic product of Chronic diseases account for 87.4 per cent of deaths are due to injuries. The first figure
24 325 international dollars per person (fig- of all deaths, while infectious diseases, below gives a breakdown of deaths due
19 40
Cancer
35 30
3
Respiratory disease 20
10
10
Diabetes
33 0
Lung
Colorectum
Prostate
Bladder
Oral
Breast
Colorectum
Endometrium
Ovary
Cervix
Other
Data from World Health Organization46 Data from International Agency for Research on Cancer20
1.3 Migrant and other ecological studies Italy 1.43 1.49 0.37 0.7 0.48 0.8
22
C H A P T E R 1 I N T E R N AT I O N A L V A R I AT I O N S A N D T R E N D S
to chronic diseases.46 BMI of 26, and 4575 year olds had a BMI energy rose between 1964 and 2004, from
Lung cancer is the most common cancer of 27.46 In total, 35 per cent of men aged around 2700 to 3480 kcal/person per day
type in men and incidence rates have 2564 had a BMI of over 27, and 12.2 per (11 330 to 14 590 kJ/person per day), due
increased dramatically since the 1970s.20 cent had a BMI of over 30.46 Women aged largely to an increase in the availability of
Rates of colorectal, prostate, bladder, and 2534 had an average BMI of 23, while sugars and meat.1 The Mediterranean-style
oral cancers have risen since records began those aged 3544 had a BMI of 25, and diet is often seen as the healthiest in
in the 1970s.20 Breast cancer is the most 4574 year olds had a BMI of between 27 Europe, but Spanish diets have recently
common type in women and the rate has and 28.46 Overall, 25.7 per cent of women shifted towards being high in fat and dairy
doubled since the 1970s.20 Colorectal cancer aged 2564 had a BMI of over 27, and 12.1 products, with only moderate amounts of
is the next most common type, which has per cent had a BMI of over 30.46 vegetables. Dairy and fruit intakes are the
seen a steady rise during this period.20 Over the period 19771993, the propor- highest in Europe, but so is the proportion
Cancers of the endometrium and cervix tion of people with energy-intensive jobs of energy in diets from fat.29 Between 1964
have remained steady since the 1970s, but halved. In children aged 67, there has and 1990, consumption of plant-based
cancer of the ovary has risen (for age-stan- been a marked increase in obesity and over- foods decreased from 1289 to 995 g/person
dardised rates of these cancers, see the sec- weight, higher even than in US children of per day. In the same period, intakes of cere-
ond figure).20 the same age. Obesity in adolescents is also als (grains), pulses (legumes), and potatoes
A survey in 1997 found that 76 per cent among the highest in the world.29 Between all halved. While consumption of other veg-
of adults aged 16 and over did no regular 1990 and 2000, 45 per cent of men and 32.2 etables remained stable, fruit intake dou-
exercise during their leisure time29; 46 per per cent of women had a BMI of 25 or bled to 327 g/person per day. Consumption
cent of adults were classified as sedentary, more, and 13.4 per cent of men and 15.8 of animal products increased from 407 to
with only 7 per cent of adults recording any per cent of women had a BMI of 30 or 743 g/person per day due to a large
physical activity each week.29 more. See figure 1.4 for projections of the increase in the amounts of meat, poultry,
Between 1994 and 1997, men aged proportions of men and women who will milk, and dairy products in peoples
2534 had an average body mass index have a BMI of 30 or more in 2015.46 diets, although intakes of animal fats
(BMI) of 25, while those aged 3544 had a The average amount of available food decreased.29
Figure 1.8 Cancer among female Iranian migrants Figure 1.9 Incidence of colorectal cancer in Asian
to British Columbia, Canada migrants to USA and their descendants
Age-standardised incidence in women per 100 000 Ethnicity Birth place Incidence rate per 100 000 people
to which such hypotheses are upheld or refuted by the total- people who have migrated from eastern Asia to the
ity of the relevant published literature, including more robust Americas; from the Indian subcontinent to Africa and the
observational and also experimental types of study. UK; from Europe to Australia; and from Africa to the
The most compelling evidence, suggesting that the main Caribbean, and then to the UK. All of these population move-
causes of cancers of most sites are environmental (due to fac- ments are accompanied by marked changes in patterns of
tors that people are exposed to) rather than genetically diet, physical activity, and disease.
inherited comes from studies of migrant populations. Migrations from Japan to the USA, from the Caribbean to
There are many migrant populations. Examples include the UK, and from European countries to Australia have been
23
P A R T I B A C K G R O U N D
USA
In 2004 the USA had a population of almost Prostate cancer is the most common type the second figure below).20
300 million. The country has a high-income of cancer in men and the incidence rate has In 2003, 22 per cent of men and 27 per
economy, with a gross domestic product of more than doubled since the 1970s.20 Lung cent of women aged 2065 were classi-
39 901 international dollars per person (fig- cancer peaked in the early 1980s and has fied as sedentary; physical inactivity was
ure 1.3), which masks socioeconomic since declined slightly.20 Rates of colorectal more prevalent among people with a low
inequalities.46 Life expectancy at birth is 75 and bladder cancer have remained stable, income.91
years for men and 80 for women (figure although melanoma has increased steadi- In 2002 men aged 2024 had an average
1.1).46 ly.20 Breast cancer is the most common type body mass index (BMI) of 26.2, while those
Chronic diseases account for 84.7 per in women, followed by lung cancer, and aged 2529 had a BMI of 27, and men aged
cent of all deaths, while infectious diseases, both have increased since the 1970s.20 Over 3065 had a BMI of between 27 and 29.46
maternal, perinatal, and nutritional condi- the same period, the incidence of cancers of While 19.7 per cent of men aged 2024 had
tions account for 6.7 per cent; 8.6 per cent the colon and rectum and of the ovary have a BMI of over 30, this rose to 23.6 per cent
of deaths are due to injuries. The first fig- remained stable, while cancer of the of those aged 3034, and 30 per cent of
ure below gives a breakdown of deaths endometrium has decreased slightly (for 4044 year olds.46 Women aged 2024 had
caused by chronic diseases.46 age-standardised rates of these cancers, see an average BMI of 26.2, while those aged
20
Diabetes
29 0
Prostate
Lung
Colorectum
Bladder
Melanoma
Breast
Lung
Colorectum
Endometrium
Ovary
Other
Data from World Health Organization46 Data from International Agency for Research on Cancer20
studied in some
Increases detail, as have movements of populations
in BMI USA stomach cancer, which corresponded to the length of time
from rural to urban areas within countries. Both types of the migrants stayed in Australia. However, their risk of col-
migration
Per cent result in dietary changes, which are followed, orectal cancer increased proportionally to the length of their
within
45 one or two generations, by changes in disease pat- stay.100 See figure 1.7. A later study demonstrated that
terns. Patterns of cancer among migrant groups often change deaths from breast cancer among Italian migrants to
40
faster than they do among people who remain in their home Australia were half that of Australian-born women during
country
35 or among people native to the host country. the first five years after emigrating. However, after 17 years,
In the 1980s, one study demonstrated that breast cancer Italian migrants had similar death rates (due to breast can-
incidence
30 increased almost threefold in first-generation cer) to women born in Australia.101
Japanese women who migrated to Hawaii, and up to five- Following migration, the incidence of certain cancers may
25
fold in the second generation. Colorectal cancer incidence increase, whereas the incidence of other cancers may
increased
20 almost fourfold in the first generation but did not decrease. Thus among Iranian immigrants to Canada, in
increase further with subsequent generations.99 In this same women, breast cancer incidence rate increased fourfold, and
15
population, the incidence of stomach cancer dropped by colorectal cancer incidence rate doubled; but there was a
almost
10
half in the first generation, and dropped further in dramatic decrease in cancers of the stomach and oesopha-
the second generation.99 gus in both sexes.102 See figure 1.8.
Another
5 study, published in 1980, of European migrants Another study showed that breast cancer incidence
to Australia demonstrated a reduction in the death rate from increased threefold within one generation in Polish migrants
0
190662 197174 1976 198894 19992000
24 Men Women
BMI 2529.9 BMI 2529.9
C H A P T E R 1 I N T E R N AT I O N A L V A R I AT I O N S A N D T R E N D S
2529 had a BMI of 27.4, and 3065 year and fruits. Between
Increases in BMI USA
olds had a BMI of between 28 and 30.46 1970 and 2000,
While 23.1 per cent of women aged 2024 average population
Per cent
had a BMI of over 30, this rose to 30.9 per consumption of
45
cent of women aged 2529, and to more meat and poultry
than 40 per cent of those aged 5564.46 The per person increas- 40
obesity epidemic began earlier in the USA ed by 11 per cent:
than in other high-income countries. people ate less beef 35
Between 1906 and 1962, 10.4 per cent of but more poultry.16
men and 15 per cent of women had a BMI Analysis of national 30
of 30 or more.46 By 1999/2000, these figures food surveys de-
25
had increased to 27.7 per cent of men and monstrated that
34 per cent of women (see figure).46 In 2002 between 1977 and
20
a US health survey found that almost 75 per 2001, people con-
cent of people were trying to prevent sumed more sweet- 15
weight gain.106 See figure 1.4 for projec- ened drinks and less
tions of the proportions of men and milk. The portion 10
women who will have a BMI of 30 or more sizes of sweetened
in 2015.46 drinks increased and 5
The average amount of available food they contributed
0
energy rose between 1964 and 2004, from more energy to
190662 197174 1976 198894 19992000
around 2930 to 3750 kcal/person per day diets: an increase
(12 250 to 15 690 kJ/person per day).1 from 50 to 140 Men Women
Between 1977 and 1996, the average pro- kcal/person per day
BMI 2529.9 BMI 2529.9
portion of meals eaten in restaurants or (210 to 600 kJ/per-
fast-food outlets rose from 9.6 to 23.5 per son per day). During BMI 30+ BMI 30+
cent, and fast food now accounts for 20 per the same period,
cent of dietary energy.2 fruit drinks increas-
Data from World Health Organization46
Vegetable and fruit intakes have ed from 20 to 45
increased since the 1980s across all income kcal/person per day
levels, and people now eat more fresh and (80 to 190 kJ/person
frozen vegetables and fruits than canned. per day); energy intake from milk dropped and they consumed one third of their total
Potatoes are commonly eaten. Bananas from 140 to 100 kcal/person per day (600 to energy away from home.2 Energy from soft
are the most popular fruit.34 More than 410 kJ/person per day), with the largest drinks, fast foods, and salty snacks doubled
80 per cent of men and 70 per cent of drop in milk consumption among those between 1977 and 1996, and soft drinks
women aged 2064 fail to eat the recom- aged 218.31 Another study revealed that 93 now provide 8.5 per cent of total energy in
mended five daily portions of vegetables per cent of young people ate snack foods young peoples diets.2
to the USA.103 Japanese, Chinese, and Filipino people who environmental and suggest that patterns of food, nutrition,
migrate to the USA have a higher risk of colorectal cancer and physical activity are important among these causes.
than their counterparts who do not migrate. One study of Migrants share a common genetic background, as do their
US-born Japanese men demonstrated incidence rates of col- parents and children: the genetic pool of any population does
orectal cancer twice as high as Japanese men born in coun- not change within a generation or two. But as shown in
tries other than the USA or Japan and 60 per cent higher Chapter 2, different patterns of environmental exposure can
than in white people born in the USA (figure 1.9).104 and do alter patterns of DNA damage and gene expression,
Data from more recent migrant studies show that cancer and so cancer, in a relatively short time.
incidence rates generally become similar to those of the
adopted country in second-generation immigrants.17 105 This
is illustrated in first-generation immigrants to Sweden, 1.4 Conclusions
where the incidence of all cancers was 5 and 8 per cent lower
for men and women, respectively, compared with native Between the early 2000s and 2030, the global absolute num-
Swedes.17 By the second generation, however, the incidence ber of cancer cases is projected by UN agencies to double,
was only marginally below the figures for people native to most of all in the middle- and low-income countries of Africa
Sweden.105 and Asia. Some of this increase can be attributed to the
Correlation studies, and migrant studies in particular,
prove that the main determinants of patterns of cancer are Continued on page 29
25
P A R T I B A C K G R O U N D
Mexico
In 2004 Mexico had a population of over be overweight or obese.18 One fifth of higher in the south of the country than the
107 million. The country has an upper-mid- school-age children are overweight or north.
dle-income economy, with a gross domes- obese, and the risk of body fatness rises if Folate intakes were lower in urban
tic product of 10 158 international dollars their mother has a school education and areas, in the north of the country, and in
per person (figure 1.3). Life expectancy at higher socioeconomic status.18 Men aged Mexico City, compared with the south and
birth is 72 years for men and 77 for women 2029 had an average body mass index in rural areas.7 This demonstrates regional
(figure 1.1).46 (BMI) of 25.2, while those aged 3039 had differences in diets, particularly in the
Chronic diseases account for 72.4 per a BMI of 26.9, and men aged 4059 had a amounts of green, leafy vegetables people
cent of all deaths, while infectious diseases, BMI of 27.5. While 11.8 per cent of men eat. Preschool children in the north and in
maternal, perinatal, and nutritional condi- aged 2029 had a BMI of over 30,46 this Mexico City had the highest intakes of fat
tions account for 16.5 per cent; 16.49 per rose to 20.9 per cent of 3039 year olds.46 and the lowest intakes of dietary fibre.
cent of deaths are due to injuries. The first Around 25 per cent of men aged between Children in the south, those indigenous to
figure below gives a breakdown of the 40 and 69 had a BMI of over 30. Women the country, and those of lower socioeco-
deaths caused by chronic diseases.46 aged 2029 had an average BMI of 25.6.46 nomic status had higher intakes of dietary
Prostate cancer is the most common type This rose to 27.9 for those aged 3039, and fibre and starchy foods, the lowest fat
of cancer in men, followed by lung, stom- to 29 for women aged 4069. While 16.7 intakes, and the highest risk of inadequate
ach, and colorectal cancers. Cancer of the per cent of women aged 2029 had a BMI micronutrient intakes for vitamin A, vita-
cervix is the most common type in women, of over 30, this rose to 29.6 per cent of min C, folate, calcium, iron, and zinc.7 In
followed by cancers of the breast, stomach, those aged 3039. Around 40 per cent of women, there was a risk of inadequate vit-
and ovary (for age-standardised rates of women aged 4059 had a BMI of over 30.46 amin A, vitamin C, and folate intake.
these cancers, see the second figure See figure 1.4 for projections of the pro- Consumption of starchy staple foods and
below).20 Women living in rural areas have portions of men and women who will have intakes of folate, calcium, and iron were
a higher risk of cancer of the cervix com- a BMI of 30 or more in 2015.46 significantly higher in rural women com-
pared with those living in urban areas.32 The average amount of available food pared with those living in urban areas.
Stomach cancer incidence has risen since energy rose between 1964 and 2004, from Saturated fatty acid consumption was
1980, and this increase is more evident in around 2470 to 3150 kcal/person per day lower in the south, reflecting the greater
men.20 (10 350 to 13 1780 kJ/person per day).1 contribution of beans and cereals (grains)
In 20022003, 17 per cent of men and 18 In 1999, micronutrient deficiencies re- in diets.6 Women in urban areas, and those
per cent of women aged 1869 were clas- mained a problem.36 Undernutrition was of higher socioeconomic status, consumed
sified as sedentary (figure 1.6).46 more prevalent in the indigenous popula- more cholesterol, saturated fatty acids, and
Between 1995 and 1999, the prevalence tion, in people of lower socioeconomic total fat.6 Across the country as a whole,
of overweight and obesity in children rose status, and in rural areas and the south. dietary fibre consumption was found to be
from 13.6 per cent to 19.5 per cent.18 One in five children under the age of 5 inadequate, but intakes were higher in
Geographically, the highest prevalence of years was stunted, and 2 per cent were central and south Mexico, mainly because
overweight and obesity is in Mexico City classified as suffering from wasting. Rates peoples diets contained beans and cereals
and in the northern region. Across the of stunting and wasting were three times (grains), although their intake of vegeta-
country as a whole, girls are more likely to higher in rural than urban areas, and were bles and fruits was low.
20
28 31 Cancer
15
Respiratory disease 10
5
16 Diabetes
18
0
8
Prostate
Lung
Stomach
Colorectum
Cervix
Breast
Stomach
Ovary
Other
Data from World Health Organization46 Data from International Agency for Research on Cancer20
26
C H A P T E R 1 I N T E R N AT I O N A L V A R I AT I O N S A N D T R E N D S
Australia
In 2004 the population of Australia was This rose to 43.8 per cent of those aged sumption was decreasing in adolescents,
over 20 million. The country has a high- 2529, and to between 50 and 70 per cent although the intake of milk products was
income economy, with a GDP of 31 454 of men aged 3075.46 Between 17 and 20 declining only among girls. Fewer adoles-
international dollars per person (figure per cent of men aged 3569 had a BMI of cents ate cereals (grains) compared with
1.3).46 Life expectancy at birth is 78 years over 30.46 The average BMI of women aged other age groups, although cereals and
for men and 83 for women (figure 1.1).46 1824 was 22.8.46 This rose to 24.9 for cereal products contributed 3437 per cent
Chronic diseases account for 86.9 per women aged 3034, and those aged 4075 of their total dietary energy. Cereal products
cent of all deaths, while infectious diseases, had a BMI of between 25 and 27.1.46 The contributed the greatest amount of food by
maternal, perinatal, and nutritional condi- proportion of women with a BMI of over 25 weight to adults diets, followed by milk and
tions account for 4.7 per cent; 8.4 per cent increased with age: 19.9 per cent of women milk products, then pulses (legumes). Fruit
of deaths are due to injuries. The first fig- aged 1824, and 3455 per cent of those consumption increased with age, whereas
ure below gives a breakdown of the deaths aged 3075. Overall, between 15 and 20 per intakes of cereals (grains), milk, meat, and
due to chronic diseases.46 cent of women aged 3075 had a BMI of poultry decreased. Adults in the Northern
In men, prostate cancer is the most com- over 30.46 There has been a steady increase Territory consumed more meat, poultry,
mon type and rates have doubled since the in BMI since 1980, when 40.6 per cent of game, and alcoholic drinks, and less veg-
1970s. Colorectal cancer has increased and men and 20.2 per cent of women had a BMI etables and fruits, than people living in
lung cancer has declined slightly. There has of 25 or more, and 9.3 per cent of men and other areas. Men were slightly more likely
been a large increase in the incidence of 8 per cent of women had a BMI of 30 or to eat food away from home (64 per cent)
melanoma and a slight increase in bladder more.46 In 2000, 48.2 per cent of men and compared with women (57 per cent).
cancer. In women, breast cancer is the most 29.9 per cent of women had a BMI of 25 or Almost one third of adults thought that
common type and the rate has increased more, and 19.3 per cent of men and 22.2 they should be eating more fruit, and 25 per
since the 1970s. Colorectal cancer is the per cent of women had a BMI of 30 or cent thought they should eat fewer high-fat
next most common type, although this has more.46 See figure 1.4 for projections of the foods.4 Fruit and vegetable consumption
remained stable. There has been a large proportions of men and women who will was highest in 1839 year-olds, with 4050
increase in melanoma, and lung cancer has have a BMI of 30 or more in 2015.46 per cent consuming a combination of at
doubled since the late 1970s, although can- The average amount of available food least one portion of fruit and three portions
cer of the endometrium has remained sta- energy remained stable between 1964 and of vegetables each day, although this
ble (for age-standardised rates of these 2004: around 3130 and 3120 kcal/person per amount then declined steadily with age.
cancers, see the second figure below).20 day (13100 and 13 070 kJ/person per day), Only 37.6 per cent of children (1217 year
In 2001, 30 per cent of men and 32 per respectively.1 The most recent National olds) ate this quantity of vegetables and
cent of women aged 1575 were classified Nutritional Survey in 1995 found that 90 per fruits and, in total, 37.2 per cent of people
as sedentary.46 cent of the people surveyed ate cereals over the age of 12 failed to eat this amount.
In the same year, men aged 1824 had (grains) or cereal products, and milk or milk A study of people aged 2075 living in
an average body mass index (BMI) of 24.3, products, the day before the interview. Queensland found that 63 per cent of par-
while those aged 2529 had a BMI of 25.3, However, half of the men and one third of ticipants drank too much alcohol, 40 per
and men aged 3075 had a BMI of the children had not eaten fruit, and 20 per cent were not sufficiently physically active,
between 26 and 27.5.46 Of men aged cent of children had not eaten vegetables and less than half ate the recommended lev-
1824, 34.3 per cent had a BMI of over 25.46 the day before the interview. Fruit con- els of fruits and vegetables.13
Colorectum
Lung
Melanoma
Bladder
Breast
Colorectum
Melanoma
Lung
Endometrium
Other
Data from World Health Organization46 Data from International Agency for Research on Cancer20
27
P A R T I B A C K G R O U N D
Brazil
In 2004 Brazil had a population of over 185 improved provision of healthcare rather than 2015.46 In 1975, for every obese woman,
million. The country has a middle-income changes in incidence. approximately another two were under-
economy, with a gross domestic product of In 1997, 28 per cent of men and 31 per weight. Between 1975 and 1989, the
8140 international dollars per person (fig- cent of women aged 1869 were classified prevalence of underweight almost halved,
ure 1.3), which masks extreme socioeco- as sedentary (figure 1.6).46 while the prevalence of obesity doubled;
nomic inequalities.46 Life expectancy at In 1997 men aged 2065 had an average so by 1997 there were two obese women
birth is 67 years for men and 74 for women body mass index (BMI) of between 23 and for every underweight woman.28
(figure 1.1).46 25.46 Just 2.1 per cent of men aged 2024 The average amount of available food
Chronic diseases account for 75.3 per had a BMI of over 30, rising to 9.1 per cent energy rose between 1964 and 2004, from
cent of all deaths, with infectious diseases, of 3034 year olds, 11.4 per cent of 4044 2313 to 3157 kcal/person per day (9684 to
maternal, perinatal, and nutritional con- year olds, and 12.3 per cent of men aged 13 218 kJ/person per day), largely due to an
ditions accounting for 16.2 per cent; 8.5 5054.46 Women aged 2039 had an increase in the availability of meat and
per cent of deaths are due to injuries. The average BMI of between 22.5 and 24.9, oils.1 In one study, people living in urban
first figure below gives a breakdown of while from age 40 onwards, average BMI areas ate more vegetables and fruits than
deaths caused by chronic diseases.46 remained between 25 and 27.46 Just 5.2 those living in rural areas; intake increased
Prostate cancer is the most common type of per cent of women aged 2024 had a BMI with age, schooling, and income. However,
cancer in men. This is followed by lung, stom- of over 25, rising to 17.4 per cent of those only 41 per cent of adults reported eating
ach, colorectal, and bladder cancers. Breast aged 4044, and 25.5 per cent of women fruit every day and 30 per cent reported
cancer is the most common type in women, aged 6064.46 The proportion of men and daily vegetable intake.21 Wasting and
followed by cancers of the cervix, colorectum, women with a BMI of 30 or more has stunting in children due to undernutrition
stomach, and lung (for age-standardised rates increased steadily since the mid-1970s.46 In have decreased rapidly since 1975,
of these cancers, see the second figure 1975, just 2.1 per cent of men and 6 per although it remains a major problem in
below).20 Age-standardised mortality rates for cent of women had a BMI of 30 or more; the north-eastern region of the country.
childhood cancers have declined since 1980 this rose to 6.4 per cent and 12.4 per cent Obesity among children is low, but those
and there has been a decrease in mortality in 1996/7.46 See figure 1.4 for projections from higher income households in the eco-
from oral and pharyngeal cancers since the of the proportions of men and women nomically developed south-eastern region
early 1980s.9 These figures may represent who will have a BMI of 30 or more in are more likely to be overweight.28
Lung
Stomach
Colorectum
Bladder
Breast
Cervix
Colorectum
Stomach
Lung
Other
Data from World Health Organization46 Data from International Agency for Research on Cancer20
28
C H A P T E R 1 I N T E R N AT I O N A L V A R I AT I O N S A N D T R E N D S
29
P A R T I B A C K G R O U N D
C H A P T E R 2
Food and nutrition modify the risk of cancers at a the ability of humans to evolve and adapt.
large number of sites. This means that some foods Ultimately it is both the genetic information
and drinks, dietary constituents (or their balance in (genotype) and its expression that control the
diets), and methods of food production, processing, characteristics (or phenotype) of an individual. Any
preservation, and preparation influence the exposure during the life course that affects the
development of some cancers. More recently, genotype or its expression may also have an effect
evidence has accumulated about the effects of on the phenotype. At any point in time, the
physical activity and body composition on the risk of phenotype is related not only to the genotype but
a number of cancers, suggesting that bioenergetics also to a host of environmental factors, including
is another factor determining cancer risk and tumour nutritional exposures. This accumulated metabolic
behaviour. experience may begin during maternal and early life,
Since the mid-1990s, great progress has been made and proceed throughout a persons lifetime.
in understanding the cancer process, and which The purpose of this second introductory chapter is
internal and external factors modify cancer risk. to summarise current knowledge and thinking on the
Mapping of the human genome has enabled the biology of the cancer process, with special reference
establishment and development of new disciplines to food and nutrition, physical activity, and body
devoted to understanding biological processes at composition. In Part 2 of this Report, epidemiological
the most basic level, including those that prevent and mechanistic evidence is summarised, and the
cancer, those that cause cancer, and those that Panels assessments and judgements are made,
modify its behaviour. based on a balance of all relevant evidence.
Evolution in living organisms depends on the
accumulation of adaptations as a result of changes
in the expression of the genetic information carried
in DNA. Even with no changes in the DNA,
alterations in how the message in the genetic code is
translated can lead to functional changes. More
importantly, the DNA itself is susceptible to
mutation changes in the genetic code itself as a
result of damage from external causes such as
radiation or simply due to the process of
metabolism. Such mutations are the essential basis
for human evolution, by producing adaptations that
are beneficial in particular environmental
circumstances. At the same time, some mutations
can contribute to the harmful changes in cells that
eventually lead to cancer.
The integrity of the genetic information is
protected by many systems that prevent DNA
damage, or remove or repair damaged DNA if it
occurs. Imperfections in these systems limit the
ability to block all damage and allow both helpful
and harmful mutations to occur. Cancers result when
sufficient mutations have accumulated, most
presenting at an age that was rarely reached in the
evolutionary past of human beings. The
development of cancer may be seen as a corollary of
30
C H A P T E R 2 T H E C A N C E R P R O C E S S
This chapter summarises the wealth of biological evidence Human adults are made up of around 1013 (or
that documents the ability of food and nutrition, physical 10 000 000 000 000) cells, which are renewed and replaced
activity, and body composition to influence several stages of constantly. About 510 per cent of cancers result directly
the process of the development of cancer. from inheriting genes associated with cancer, but the major-
Nutrients and food constituents have effects that can either ity involve alterations or damage accumulated over time to
inhibit several events that lead to cancer, or contribute to the genetic material within cells. The causes of damage are
cancer development, by altering DNA itself, or by altering both endogenous (internal) and exogenous (environmental).
how the genetic message in DNA is translated. Physical Food, nutrition, and physical activity are important envi-
activity and variations in body composition also appear to ronmental factors in the development of cancer.
influence cancer risk. Indeed, overall dietary patterns can Cancer can also be seen as a group of diseases that affects
indirectly influence cell growth by way of changes in gen- many different tissues and types of cell, and can be defined
eral metabolic, regulatory, and endocrine effects. by their tissue of origin. Approximately 85 per cent of adult
The normal functioning of all biological processes, includ- cancers develop from the epithelial cells of the inner and
ing those of the human body, depends on the availability of outer linings of the body and are called carcinomas. Cancers
substrate and nutrients. Good nutrition defined as appro- of glandular tissue such as the breast are called adenocarci-
priate provision of food and nutrients from the level of the nomas; cancers from bone and muscle derived from meso-
whole organism to the cellular and intracellular level is derm cells (embryonic cells that grow to form muscle, blood,
needed for normal structure and function. When a person is bone, and connective tissue), are called sarcomas.
not suitably nourished, either through under- or overnutri- Each type of cancer has different characteristics, but one
tion, this impacts on the tissue microenvironment, compro- feature of all these diseases is unregulated cell growth and/or
mising both structure and function. cell death. Apart from haematological cancers such as
Understanding the mechanisms underlying cancer devel- leukaemias, this results in a tumour or mass, and cancerous
opment is central to improving its prevention and treatment. cells often invade the surrounding tissue. Spread of cancer
The main body of this Report comprises the Panels judge- cells from the primary site to other parts of the body is called
ments on a series of systematic literature reviews (SLRs) on metastasis. Benign tumours do not invade or metastasise.
evidence linking food, nutrition, and physical activity to can- Malignant tumours do not remain localised but can invade
cer. All evidence on the mechanisms of the cancer process is and/or metastasise.
also based on rigorous review criteria. However, the evidence
presented in this chapter is a summary of this literature, and 2.1.2 Genetic material
the references cited are illustrative examples only. Full details The genetic material of mammalian cells is composed of dou-
of the methods used for the reviews are contained in the SLR ble-stranded DNA made from four organic bases cytosine,
specification manual. The full SLRs and this manual are con- guanine, adenine, and thymine within a helical spine
tained on the CD included with this Report. comprising deoxyribose (a sugar) and phosphate. The com-
bination of a base with phosphate and deoxyribose is called
a nucleotide. Humans have 3 billion base pairs in the DNA
2.1 Basic concepts and principles code that encode approximately 30 000 different genes.
The nucleus of a cell contains DNA, and the information
2.1.1 Cancer in the code is read to generate proteins in the cytoplasm of
Cancer is a group of more than 100 diseases characterised by the cell. This is achieved by transcribing the DNA into RNA,
uncontrolled cellular growth as a result of changes in the and then translating the information in RNA to synthesise
genetic information of cells. Cells and tissues are complex sys- protein. For transcription, the two DNA strands separate and
tems with critical stages and checkpoints to ensure normal an intermediary, complementary copy of the DNA is made
growth, development, and function. Normally the division, dif- from mRNA (which differs slightly in structure from DNA
ferentiation, and death of cells are carefully regulated. All can- and is single stranded). For translation, the RNA leaves the
cers start as a single cell that has lost control of its normal nucleus and binds to an organelle in the cytoplasm called the
growth and replication processes. ribosome. The RNA nucleotides encode for 21 different
31
P A R T I B A C K G R O U N D
32
C H A P T E R 2 T H E C A N C E R P R O C E S S
several types of genes including oncogenes and tumour sup- process called phosphorylation. A regulated process of phos-
pressor genes (box 2.2), and factors in the cellular environ- phorylation and dephosphorylation is necessary for the
ment that influence their expression. Maintenance of the appropriate initiation, transmission, and cessation of signals.
DNA sequence and structure as cells divide is essential: sev-
eral cellular mechanisms exist to ensure this is achieved. 2.2.2 Gene expression
Gene expression is the process by which the information
2.2.1 Cell signalling within a gene is turned on or turned off. The information
Cells detect and respond to external stimuli and send mess- is used to create the associated proteins and modify the
ages to other cells through a molecular mechanism known amounts produced. Also see figure 2.1.
as cell signalling. Transcription factors are proteins involved in the regula-
Cells within a tissue normally communicate with each tion of gene expression and carry the signal from the
other through a network of locally produced chemicals called cytoplasm to the nucleus. They bind to the promoter regions
cytokines (including some growth factors). Cell proliferation of genes and have the effect of either switching gene
is a tightly controlled and coordinated process, and is stim- expression on or off. There are also nuclear receptors, such
ulated by growth factors. These soluble proteins can be pro- as retinoic acid receptors, that function as transcription
duced locally, either from the same cell (autocrine), or from factors by binding directly to specific DNA sequences.
different cells (paracrine), or as hormones (endocrine) pro- Some so-called housekeeping genes are expressed by
duced by a distant tissue and transported in the blood. almost all cell types. These genes generally encode proteins
Growth factors bind to specific receptors on the cell surface that participate in basic cell functions such as metabolic
and transmit a signal into the cell, which is relayed to the pathways and synthesis, and processing of DNA, RNA, or pro-
nucleus. In the nucleus, genes are switched on to produce teins. Other genes have more restricted expression, and
the proteins necessary for cell division. are expressed only in specific cell types, and/or stages of
Getting the growth signal from the outside of the cell to development.
the nucleus requires a series of steps. The shape of the recep- Gene expression can also be influenced by changes outside
tor changes when the growth factor binds to it, which caus- the DNA of genes. DNA is closely organised and tightly pack-
es part of the receptor to become activated, usually by a aged in the nucleus of cells. To achieve this, DNA is spooled
around proteins called his-
tones. Histone structure can
be modified either, like DNA
itself, by methylation, or
more commonly by acetyla-
tion (addition of an acetyl
group). Acetylation and
deacetylation (removal) are
mediated by the enzymes
histone acetyl transferase
(HAT) and histone deacety-
lase (HDAC), respectively.
HATs relax the packaged
DNA structure, which is asso-
ciated with enhanced tran-
scription, whereas HDACs
stabilise the structure with
higher levels of packaging,
and so suppress transcrip-
tion. Butyrate, produced in
the colon by bacterial
fermentation of non-starch
polysaccharide (dietary
fibre), diallyl disulphide
from garlic and other allium
vegetables, and sulphora-
phane, a glucosinolate from
cruciferous vegetables, can
behave as histone deacety-
lase inhibitors,16 and act to
maintain DNA stability or
Food, nutrition, obesity, and physical activity can influence fundamental processes shown here, enhance transcription.
which may promote or inhibit cancer development and progression. Micro RNAs (miRNAs) are
33
P A R T I B A C K G R O U N D
RNA molecules that do not encode proteins; instead they division (see 2.5.1), so maintaining the particular structur-
function as negative regulators of gene expression. Some al and functional characteristics of the cells of specific
mutations in miRNAs have been associated with human can- tissues.
cers, and they can function as oncogenes or tumour sup- Dietary constituents contribute to epigenetic modulation
pressor genes (box 2.2). miRNAs are short, single-stranded of promoter regions in both normal and malignant cells. For
RNA molecules of approximately 22 nucleotides. For example, dietary folate and other methyl-donors such as
instance, to silence (turn off) genes, they may bind to com- choline, methionine, and betaine are essential for DNA
plementary mRNA sequences and degrade them before they synthesis and epigenetic regulation of DNA. Appropriate
have been translated. Profiling miRNA signatures within can- gene expression is maintained by appropriate patterns of
cer cells may aid the diagnosis, classification, and treatment methylation; folate is an important determinant of normal
of cancer. For example, a certain miRNA that is downregu- methylation. In addition, dietary constituents such as genis-
lated in lung cancer is associated with decreased survival.17 tein, which do not provide methyl groups, have also been
Research on the interactions between nutrition and non-cod- reported to modify DNA methylation.
ing RNA molecules is at an early stage but is potentially rel- Imbalances or lack of specific dietary constituents may
evant to cancer. potentially increase the risk of cancer by inducing an imbal-
ance in DNA precursors, leading to altered DNA synthesis
2.2.3 Epigenetic regulation and repair, and may impair appropriate patterns of DNA
Gene expression can also be altered without changing the methylation, with consequences for gene expression. For
DNA sequence. This is called epigenetic modulation. example, inadequate folate availability means cells tend to
Methylation of DNA the addition of a methyl group incorporate uracil into DNA in place of thymine. Global
(CH3) plays a role in gene silencing. Methylation occurs hypomethylation of DNA is an early epigenetic event in cer-
only to cytosine residues located next to guanine bases in the vical carcinogenesis, and the degree of hypomethylation
DNA sequence. These CpG dinucleotide sequences are found increases with the grade of cervical cancer.18 19 Global
throughout the genome; in about half of all genes, clusters hypomethylation of DNA and site-specific hypermethylation
of CpG sequences, so-called CpG islands, are located in the may also be relevant in colorectal cancer.20 A host of bio-
promoter region that normally functions to promote expres- active food constituents from alcohol to zinc has been
sion of the gene. Transcription factors cannot bind to these reported to influence DNA methylation patterns.
sites when methylated and so the gene is silenced. For active Nevertheless, it remains to be determined how important
genes, the CpG islands in the promoter regions are general- these changes are in the overall cancer process. The poten-
ly not methylated. tial cancer-protective effects of green, leafy vegetables (see
Controlled DNA methylation also provides a mechanism chapter 4.2) are often attributed to their folate content.
for cell differentiation. In normal cells, genes may be per- Folates function as a coenzyme in the metabolism of single-
manently silenced so that they can no longer be expressed, carbon compounds for nucleic acid synthesis and amino acid
in a way that is transmitted into daughter cells during cell metabolism.
34
C H A P T E R 2 T H E C A N C E R P R O C E S S
2.2.4 Differentiation to different growth factors. In the cancer process, one char-
Cells become specialised to perform their particular function acteristic of cells that are accumulating DNA damage is that
through a process known as differentiation. they become de-differentiated and undergo epithelial-
Although each cell within the body contains the entire mesenchymal transition (EMT), characterised by loss of
genome with the same genes, only some genes are active in cell adhesion and increased cell mobility. In addition, dur-
any one cell at any one time. Gene expression controls the ing differentiation, other genes can be silenced by chromatin
subset of genes expressed and the timing of expression, and modification, including DNA methylation and histone mod-
this distinguishes one cell type from another by determin- ifications such as methylation and acetylation (see 2.2.2).
ing their particular structure and function. Stem cells are found among differentiated cells in almost
Hundreds of different cell types arise from one fertilised all adult tissues, where they maintain and regenerate tissues.
egg during development; this is achieved by proliferation Examples include haemopoietic stem cells for continuous
and differentiation of stem cells. Stem cells are unspecialised generation of red and white blood cells, and stem cells in
but can give rise to different specialised cell types. A small the basal layer of the epidermis and at the base of hair fol-
population of cells within the tumour mass of several forms licles in the skin, which can give rise to keratinocytes and
of human cancer, which have both the properties of stem hair follicles. Cellular differentiation also continues in solid
cells and also the characteristics of transformed cells, may tissues such as mammary tissue, which during pregnancy dif-
be important for the development of these tumours. As yet, ferentiates for later milk production. A systematic review has
our understanding of cancer stem cells is basic, although the shown that long-chain n-3 polyunsaturated fatty acids
concept was proposed as early as 1875.22 Several groups have (PUFAs) in fish oils promote differentiation of colonic epithe-
now isolated and identified cancer stem cells in both lial cells.30 31 Vitamin D and retinoic acid may also promote
haematopoietic and epithelial cancers, including cancers of the differentiation of cells.
breast,23 brain,24 25 ovary,26 prostate,27 colon,28 and stomach.29
It is clear that subtle changes in exposure to bioactive food 2.2.5 DNA damage and repair
constituents can have a profound effect on the differentiation Each time a cell divides into two new daughter cells, there
of these cells. is potential for an error in replication of the DNA (see 2.5.1).
In early embryos, proliferation of embryonic stem cells These mutations result in non-functioning genes or in pro-
increases the total number of cells. As the organism devel- teins with altered amino acid sequences that can change cell
ops, cells differentiate and become specialised to their par- function.
ticular function. Transcription factors specific to that cell type DNA is continuously exposed to damage from products of
turn on genes for that particular lineage of cells, so deter- normal intracellular metabolism, including reactive oxygen
mining its structure and function. species, hydroxyl radicals, and hydrogen peroxide; and also
At various stages of differentiation, cells become sensitive to damage from external factors such as ultra-violet (UV)
35
P A R T I B A C K G R O U N D
light, as well as other environmental factors including food, DNA adducts. These adducts distort the structure of DNA and
nutrition, and physical activity (see 2.4). There are several disrupt its replication, potentially causing mistranslation.
mechanisms for DNA repair (box 2.3), a vital defence in They can also break the DNA strand, which can result in
maintaining cellular integrity and preventing a cell being mutations or deletions of genetic material.
transformed from normal to cancerous. In addition to P450 enzymes, other systems such as per-
Various studies suggest that nutritional status and/or cer- oxidases (including the cyclooxygenases) and certain trans-
tain food constituents may influence DNA repair. Data from ferases, such as N-acetyltransferase and sulphotransferase,
observational studies suggest that severe malnutrition can can influence carcinogen bioactivation.42-44
impair DNA repair.34 Nucleotide excision repair has been Competing with this metabolic activation of carcinogens
found to be lower in adults with the lowest intakes of is the detoxification process catalysed by a second group of
folate.35 Studies of healthy adults consuming kiwi fruits,36 enzymes, known as phase II enzymes.45 They catalyse con-
cooked carrots,37 or supplements of coenzyme Q10 (an impor- jugation reactions, producing molecules that can be excret-
tant cofactor in metabolism)38 have demonstrated improved ed in bile or urine. Examples include acetyltransferases,
DNA repair in vitro. Selenium induces base-excision repair glutathione-S-transferases (GSTs), UDP-glucuronyltrans-
in vitro via p53 activation in cultured fibroblasts.39 ferases, NAD(P)H:quinone oxidoreductase, and sulpho-
Evidence exists that some dietary components can modify transferases. The induction of phase II enzymes is mediated
DNA damage and gene expression in exfoliated colonocytes. by the antioxidant response element, which is located in the
For example, the amount of single-strand breaks in exfoli- promoter region of specific genes.46
ated colorectal mucosal cells was significantly lower in Each of these enzymes represents a potential target for
healthy individuals consuming a vegetarian diet compared dietary components to influence carcinogen activation.
with a diet high in meat.40 Similarly, DNA damage in exfo- Specificity in response is evident since isothiocyanates from
liated lung epithelial cells can be influenced by dietary com- cruciferous vegetables have been shown to induce expression
ponents. Consumption of a lycopene-rich vegetable juice was of phase II detoxification enzymes without affecting expres-
associated with significantly decreased damage to the DNA sion of phase I enzymes.
of lung epithelial cells in healthy volunteers.41 The carcinogenic properties of polycyclic hydrocarbons,
Defects in any of the DNA repair mechanisms can predis- aromatic amines, N-nitroso compounds, and aflatoxins
pose to cancer. Several inherited conditions link such defects result from the metabolism of these compounds, which
to cancer incidence. For example, patients with hereditary produces carcinogenic by-products. Metabolising enzyme
non-polyposis colorectal cancer have defective mismatch activity can be modulated by dietary factors. The enzyme
repair (see chapter 7.9.2). CYP3A4 participates in the metabolism of over half of
Although the processes of cell development, signalling, all pharmaceutical agents, and is especially sensitive to
and DNA repair are tightly controlled, errors will occur dur- dietary effects. For example, interactions have been report-
ing the trillions of cell divisions that occur over a lifetime. ed between grapefruit juice, red wine, garlic, and various
This may result in inappropriate proliferation or failure of drugs.47 Fooddrug interactions involving CYP1A2, CYP2E1,
damaged cells to die. These changes could provide the glucuronysyltransferases, and GSTs have also been
altered cell with a growth advantage over the normal cells documented.48
in the tissue. If additional alterations occur, this can result The activity of phase I and II enzymes, and thus carcino-
in a cell with the potential to become cancerous. gen metabolism and cancer development, varies between
individuals. SNPs in several phase I and phase II enzymes
have been shown to modulate cancer risk.49 50 There is some
2.3 Carcinogen metabolism difficulty in synthesising this evidence and some studies may
give false positive results. Nevertheless, the literature shows
The chance of carcinogenesis occurring and then progress- tantalising evidence that relates genetic diversity to these
ing is modified by many factors, including food and nutri- enzymes in various processes linked to cancer development.
ion. Dietary constituents that modify carcinogenesis include Some specific examples of SNPs in cancer are listed below.
selenium, allyl sulphur, sulphuraphane, and isoflavonoids. GSTs are involved in the metabolism of environmental car-
Most dietary carcinogens require activation to produce cinogens and reactive oxygen species. People who lack these
reactive intermediates that bind to and damage DNA. Phase enzymes may be at higher risk for cancer because of a
I and phase II metabolising enzymes in the liver and in other reduced capacity to dispose of activated carcinogens.51 As
tissues are involved in this process. These are enzymes that shown in chapter 4.1, aflatoxins produced by moulds that
catalyse the metabolic detoxification of xenobiotics, drugs, contaminate certain types of foods such as cereals (grains)
and carcinogens produced through aerobic metabolism, and and peanuts are carcinogens that are activated by phase
thus protect cells against oxidative stress and reactive elec- I enzymes in the liver into reactive DNA metabolites that
trophilic carcinogen metabolites. cause DNA adducts. However, the number of adducts and
Metabolic activation of carcinogens is generally catalysed therefore the potency of aflatoxin B are influenced by other
by the cytochrome P450 (CYP) family of phase I enzymes enzymes such as GSTs, which eliminate carcinogens before
through oxidation, which usually makes the molecule more they can bind to DNA. Individuals with low expression of
water soluble. Some of the intermediates formed during this GSTs are also at higher risk for colorectal cancer; however,
process may be carcinogenic, and can bind to DNA, forming a diet high in isothiocyanates (derived from glucosinolates
36
C H A P T E R 2 T H E C A N C E R P R O C E S S
37
P A R T I B A C K G R O U N D
should add up to 100 per cent. This is not so. Reasonable esti- chemicals. These include cytokines, growth factors, reactive
mates for a number of separate or interactive factors may add oxygen and nitrogen species, cyclooxygenase, and lipoxyge-
up to well over 100 per cent because of the interactions. nase products. A chronic inflammatory environment can
increase proliferation and differentiation, inhibit apoptosis
2.4.1 Endogenous causes (programmed cell death), and induce angiogenesis (gener-
2.4.1.1 Inherited germ line mutations ation of new blood vessels). Chronic inflammatory condi-
As mentioned, only a minority (510 per cent) of cancers are tions, such as Barretts oesophagus and ulcerative colitis,
linked to single inherited genes. Such inherited alterations predispose to cancer. In Barretts oesophagus, reflux of acid
are termed germ line mutations, and are passed on from egg can cause the cells lining the gullet to undergo EMT, and
or sperm DNA. Individuals with inherited germ line muta- some areas can develop dysplasia and ultimately cancer.
tions will not definitely get cancer but have an increased risk Around 1 per cent of people with Barretts oesophagus will
of developing cancer compared with the general population. develop oesophageal cancer (this is between 30 and 125
Often mutations in tumour suppressor genes (box 2.2) times higher than the general population). Also see chapter
increase the chance of developing cancer at a young age. 7.3.2. Approximately 5 per cent of patients with ulcerative
These include retinoblastoma (a rare cancer of the eye), Li- colitis, a form of irritable bowel disease, will develop colon
Fraumeni syndrome, multiple endocrine neoplasia type 1, cancer. Also see chapter 7.9.2. Epidemiological and experi-
and kidney cancer in Von Hippel-Lindau disease. Mutations mental evidence has demonstrated that long-term use of
in the BRCA1 and BRCA2 (breast cancer susceptibility) genes non-steroidal anti-inflammatory drugs can inhibit cancer
cause 510 per cent of all breast cancer cases. These genes development in a number of tissues including colon,
normally produce DNA repair proteins. Patients with the oesophagus, and breast.76
syndrome familial adenomatous polyposis coli have a pre- Cancer induced by inflammation may be susceptible to
disposition to colorectal cancer due to mutations in the ade- nutritional influences. Thus, dietary constituents could be
nomatosis polyposis coli tumour suppressor gene.75 Other involved in generation of reactive oxygen species, could
common cancers, including those of the ovary, prostate, pan- influence antioxidant defences, or could suppress the inflam-
creas, and endometrium, may be related to inherited muta- matory process. For example, the glucocorticoid receptor
tions, but only in a small percentage of cases. pathway and the vitamin D receptor are capable of sup-
The other type of genetic mutation somatic gene pressing inflammation.
changes develops during the life course. Such somatic The immune system can be divided into innate and adap-
mutations are not passed on to offspring. This DNA damage tive responses. Innate immunity provides initial defences.
is caused by exposure to external factors such as radiation Adaptive immunity develops later and involves activation of
or carcinogens, or harmful products of normal aerobic lymphocytes and their differentiation into effector and mem-
metabolism. ory cells. The immune surveillance hypothesis proposes that
both the innate and adaptive immune systems constantly
2.4.1.2 Oxidative stress survey for and eliminate newly formed cancer cells, and that
Reactive oxygen species generated through normal oxidative onset and progression of cancer are kept under control by
metabolism have the potential to cause extensive DNA dam- the immune system.77 Immunosurveillance requires that the
age. The body has several mechanisms, which can scavenge immune system recognises something different about cancer
reactive oxygen species to prevent such damage occurring, cells compared with normal cells within the same tissue
or block the effects. often different proteins (termed tumour antigens) that are
Reactive oxygen species cause oxidative damage to DNA. expressed on the surface of a cancer cell.
During repair (see 2.2.5), the damaged, oxidised bases are This recognition of altered self allows the immune sys-
excreted in the urine. Levels of urinary 8-hydroxy-2'- tem to generate a response to these tumour antigens. They
deoxyguanosine, an oxidative DNA damage adduct, can be can be proteins that are only expressed by cancer cells, and
used as an indicator of oxidative DNA damage in humans newly expressed during cancer development; or proteins that
and rodents. Antioxidants can scavenge reactive oxygen have become mutated during the cancer process and so are
species. Vitamins C and E can donate electrons to free rad- different from the non-mutated protein; or proteins
icals and block their damaging activity. Dietary constituents expressed due to differentiation of cancer cells (termed dif-
such as ITCs and polyphenols can also activate the signalling ferentiation antigens); or proteins that are normally
pathways that lead to activation of the antioxidant response expressed by cells but that are expressed at much higher lev-
element (see 2.3), and upregulation of the expression of els by cancer cells. Evasion of immunosurveillance is some-
detoxifying enzymes. times referred to as a further hallmark of cancer78 (see 2.5),
although the evidence remains speculative.
2.4.1.3 Inflammation Specialised mucosal cells form the interface between the
Inflammation is a physiological response to infection, foreign inside and outside of the body.79 These are normally an effi-
bodies, trauma, or chemical or other irritation, and in the cient barrier against pathogens. The gut barrier consists of
acute phase can be helpful. However, chronic inflammation gut-associated lymphoid cells that can sense pathogens, and
can result in DNA damage and cancer promotion. participate in innate and adaptive responses.80 The function
Chronically inflamed tissue is infiltrated with a variety of of these cells is dependent on nutrition.81 82 For example, n-
inflammatory cells that produce a wide variety of bioactive 3 PUFAs can enhance immunity, whereas high concentrations
38
C H A P T E R 2 T H E C A N C E R P R O C E S S
of n-6 unsaturated fatty acids can have a suppressive effect.83 cannot be counteracted by nutritional supplements or
Various factors have been shown to modulate both inflam- antioxidants.83 Physical activity does not increase pro-inflam-
mation and immunity, including vitamins A and E, copper, matory cytokines, but instead increases anti-inflammatory
selenium, zinc, PUFAs, and epigallocatechin-3-gallate mediators.
(EGCG) from green tea.84 Zinc deficiency can lead to abnor- Chronic consumption of alcohol alters both innate and
malities in adaptive immune responses.85 adaptive immunity. Heavy drinkers are more vulnerable to
Immune status and chronic inflammation may explain pat- infections and, as shown in chapter 4.8, to liver cancer.92 One
terns of cancer in different parts of the world. Cancers caused possible mechanism is alteration in hepatic metabolism
by infectious agents, such as those of the liver and cervix (see resulting in functional iron deficiency that impairs immune
chapter 7.8 and 7.13) are more common in low-income function.93-95
countries, where undernutrition may impair peoples
immune responses. Undernutrition, with deficiencies in spe- 2.4.1.4 Hormones
cific micronutrients such as vitamin A, riboflavin, vitamin Lifetime exposure to oestrogen increased by early menar-
B12, folic acid, vitamin C, iron, selenium, and zinc, sup- che, late menopause, not bearing children, and late (over
presses most immune functions and may fail to control 30) first pregnancy raises the risk of, and may be seen as
chronic inflammation.86 87 By contrast, hormone-related a cause of, breast, ovarian, and endometrial cancers in
cancers such as those of the breast and prostate are more women. The reverse also applies: a reduction in lifetime
common in developed countries. exposure to oestrogen due to late menarche, early meno-
The cytokine IL-6 can act as a pro- or anti-inflammatory pause, bearing children, and early pregnancy may reduce the
cytokine. In cancer, IL-6 can either stimulate proliferation or risk of hormone-related cancers. Age at menarche and
exert anti-tumour effects by enhancing both innate and menopause are influenced by nutrition, with high-energy
adaptive immunity.88 Dietary phytoestrogens, such as soy diets leading to early puberty and late menopause, and low-
isoflavones, downregulate IL-6 gene expression and thus energy diets delaying puberty and advancing menopause.
potentially influence the development of hormone-related The oral combined contraceptive pill (containing both
cancers.89 oestrogen and progesterone) has been estimated to halve the
Circulating levels of IL-6 increase (up to 100-fold) risk of ovarian cancer, if taken for 5 years or more.96 This
following exercise; this reduces chronic inflammation protective effect can last for up to 15 years after women stop
by reducing pro-inflammatory mediators and elevating taking these oral contraceptives.97 Using any type of oral
anti- inflammatory mediators.90 Regular moderate and contraceptive may also have a slight protective effect against
occasional vigorous physical activity has been associated bowel cancer.98 In contrast, combined oral contraceptives
with enhanced immunity,91 but prolonged and intense can cause a slight and transient increase in breast cancer risk,
physical activity can cause immune suppression that but only for the duration of use.99 There may also be an
39
P A R T I B A C K G R O U N D
increase in the risk of cervical cancer, although this is part- Approximately 1 in 4 cancers in low-income countries are
ly related to sexual behaviour.100 estimated to be attributable to infection. In 2002, this rep-
Studies of women taking oestrogen-only hormone replace- resented some 1.9 million cancers or close to 1 in 5 of all
ment therapy have suggested that the risk of endometrial cancers worldwide104. Inadequate nutrition or dietary imbal-
cancer is doubled after 5 years of use,101 and the risk of ovari- ances can lead to immunodeficiencies and increased sus-
an cancer rises by 25 per cent after the same length of use.97 102 ceptibility to infections.
However, use of hormone replacement therapy that Dietary factors may influence host susceptibility to the
combines oestrogen and progesterone does not increase ovar- viral infection or persistence of the infection. For example,
ian cancer risk and may even protect against endometrial high folate intake is thought to reduce the susceptibility to
cancer.102 97 101 and the persistence of human papilloma virus.107
40
C H A P T E R 2 T H E C A N C E R P R O C E S S
of fish.109 They also accumulate in human milk, and can be 2.5 Nutrition and cancer
passed to the infant during breastfeeding. There is limited
experimental evidence suggesting that PCBs have sex The majority of cancers are not inherited. Cancer is, how-
steroid activity and alter oestrogen levels, which may con- ever, a disease of altered gene expression that originates in
tribute to breast cancer risk.109 changes to DNA, the carrier of genetic information. For a cell
Arsenic is genotoxic, causes gene mutations, and is car- to be transformed from normal to cancerous, it has to acquire
cinogenic to humans; arsenic in drinking water is absorbed different phenotypic characteristics that result from alter-
from the gastrointestinal tract.75 The Panels judgements on ations to the genotype. Most cancers develop to the stage of
arsenic are summarised in chapter 4.7. Arsenic can modify being clinically identifiable only years or decades after the
the urinary excretion of porphyrins in animals and humans. initial DNA damage.
It also interferes with the activities of several enzymes of the Cancer development, or carcinogenesis, requires a series of
haem biosynthetic pathway. There is clear evidence that sele- cellular changes. No single gene causes cancer. It is a multi-
nium binds heavy metals such as arsenic and thus modifies step process caused by accumulated errors in the genes that
their absorption.75 control cellular processes. One genetic mutation may allow
a single trait (such as increased survival) to be acquired by
2.4.2.5 Medication a lineage of cells, and descendants of these cells may then
A number of medical treatments modify the risk of some can- acquire additional genetic mutations. However, cancer only
cers. As indicated in 2.4.2.3, X-rays are carcinogenic, as is develops when several genes are altered that confer growth
radiation used as cancer treatment. and survival advantages over neighbouring normal cells.
The most notorious example has been diethylstilboestrol, The capacity of a cell to achieve effective cancer preven-
once prescribed in pregnancy and now withdrawn, which tion or repair is dependent on the extracellular microenvi-
caused cancers of the vagina and cervix of female children ronment, including the availability of energy and the
born to mothers who received this drug. Treatments that presence of appropriate macro- and micronutrients. Tumours
affect hormonal status have been studied extensively and are are not simply masses of cancer cells. Rather, they are het-
described in 2.4.1.4. Chemotherapy as cancer treatment dur- erogeneous collections of cancer cells with many other cell
ing childhood is followed by an increased risk of lymphoma types so-called stromal cells; cancer cells communicate
in adulthood.110 with stromal cells within the tumour. The tumour microen-
vironment comprises many cell types including infiltrating
2.4.2.6 Carcinogenic agents in food immune cells such as lymphocytes and macrophages,
Food may be contaminated with natural or man-made endothelial cells, nerve cells, and fibroblasts. All these cell
carcinogenic toxicants. These are within the scope of this types can produce growth factors, inflammatory mediators,
Report, and are assessed and judged in Part 2. and cytokines, which can support malignant transformation
Moulds and the toxins produced by some moulds cause and tumour growth, and attenuate host responses. In addi-
DNA adducts and are carcinogenic. Aflatoxin B, a product of tion, factors produced by the cancer cells themselves mod-
the Aspergillus fungus and a common contaminant of cere- ulate the activity and behaviour of the tumour stroma.
als (grains) and peanuts, is an established cause of liver Initiation is the exposure of a cell or tissue to an agent that
cancer (see chapter 4.1). Fumonisin B, a toxin produced by results in the first genetic mutation. This can be an inherit-
the fungus Fusarium verticillioides, may be found on maize ed mutation or an exogenous or endogenous (produced
and may be carcinogenic, although epidemiological studies through oxidative metabolism) factor. Even without exter-
are lacking. nal oxidative stress, hundreds of sites within DNA are dam-
Some carcinogenic compounds are formed during food aged each day but are normally repaired or eliminated.
preparation (see chapter 4.3 and 4.9). Heterocyclic amines Exposure to the carcinogen initiates DNA damage, usually
are formed by cooking meat at high temperatures, and poly- via the formation of DNA adducts. If left uncorrected, these
cyclic aromatic hydrocarbons can be produced in meat and adducts can be transferred to daughter cells during division
fish that has been grilled (broiled) or barbecued (charbroiled) and confer the potential for neoplastic (new and abnormal)
over a direct flame. Also see box 4.3.4. High environmental growth.
concentrations of polycyclic aromatic hydrocarbons, which Initiation alone is insufficient for cancer to develop. An ini-
also come from pollution caused by traffic and industry, tiated cell must go through a process of clonal expansion
can contaminate other foods such as cereals, vegetables, during promotion to become neoplastic; the larger the num-
and fruits. ber of initiated cells, the greater the risk of progressing to
Some N-nitroso compounds are carcinogens, and are cancer. Promotion involves exposure of the initiated cell to
formed in foods containing added nitrates or nitrites; exam- a promoting agent. This may allow alterations in the rate of
ples include fish and meat preserved with salting or preser- proliferation or additional DNA damage to occur, leading to
vatives, and smoking or drying. These carcinogens can also further mutations within the same cell, which alter gene
be generated from ingested foods containing nitrate or expression and cellular proliferation. Finally, these initiated
nitrite. N-nitroso compounds are also produced endoge- and promoted cells grow and expand to form a tumour mass.
nously in the stomach and colon of people who eat large DNA damage continues at this stage and cancer cells often
amounts of red meat or take nitrite supplements. Also see contain multiple copies of chromosomes. This clear, sequen-
box 4.3.2. tial process is typical of experimentally induced cancers but
41
P A R T I B A C K G R O U N D
may be less clear in sporadic cancers in humans. 2.5.1.1 Growth signal autonomy
At the end of the multistage process of carcinogenesis, the Unlike normal cells, cancer cells are not dependent on exter-
cell will bear some or all of the hallmarks of cancer111 (figure nal growth factors to stimulate their division. Instead, they
2.4). Several genes can contribute to each hallmark and one can generate their own signals or respond to lower concen-
gene (for example p53) can contribute to several of the hall- trations of external signals. This frees cancer cells from the
marks. These hallmarks or traits are shared by most, if not growth constraints of normal cells.
all, cancer cells. The six hallmarks of cancer cells are self-
sufficiency in growth signals; insensitivity to antigrowth 2.5.1.2 Insensitivity to antigrowth signals
signals; limitless replicative potential; evasion of apoptosis; Normal cells also receive growth inhibitory signals. Indeed,
sustained angiogenesis; and tissue evasion and metastasis.111 most cells of the body are quiescent and not actively divid-
Food, nutrition, and physical activity-related factors influ- ing. Cells respond to negative environmental signals such as
ence cellular processes and lead to cells accumulating these contact with other cells. Cancer cells have acquired muta-
traits (figure 2.5). tions that interfere with these pathways and so do not
respond to growth inhibitory signals.
2.5.1 Cell proliferation
Three hallmarks of cancer, namely growth signal autonomy, 2.5.1.3 Limitless replicative potential
evasion of growth inhibitory signals, and unlimited replication, Normal cells can divide a finite number of times. Once they
promote enhanced cell proliferation. Over a normal human have replicated 60 or 70 times they stop a process termed
lifetime, approximately 1016 (10000 000 000 000 000) cell senescence, which is thought to constitute a protective mech-
divisions will take place. The sequence of stages of a cell anism against unlimited proliferation. This preordained num-
dividing into two daughter cells is called the cell cycle (figure ber of cell doublings is controlled by telomeres. Telomeres
2.3). Normal cells require external signals from growth fac- are segments of DNA on the ends of chromosomes, which
tors, which stimulate them to divide. Proliferation of normal are shortened during each round of DNA replication.
cells depends, in part, on the presence in the cellular envi- Eventually when the telomeres are too short, the cell can no
ronment of signals that both promote and inhibit growth, and longer divide and it undergoes apoptosis.
the balance between them. By contrast, cancer cells have acquired the ability to main-
Most cells in adults are not in the process of actively divid- tain the length of their telomeres, which means they can
ing, but are in an inactive or quiescent state termed G. To replicate endlessly. Recent work has suggested that senes-
re-enter the cell cycle, cells must be stimulated with growth cence can be induced prematurely, particularly in premalig-
factors and have sufficient space and nutrients for division. nant cells, by activation of the normal, non-mutated forms
During the G1 phase, the cell increases in size, and syn- of genes such as p53 and Rb.111 This senescence is a normal
thesises RNA and proteins. At the end of the G1 phase, cells active process involving genetic and phenotypic changes that
must pass through the G1 checkpoint, which arrests the cycle may protect against cancer development; for example, it may
if damaged DNA is detected, ensuring that it is not replicat- be one mechanism preventing benign moles from progress-
ed. During the S phase, DNA is replicated. The S phase ends ing to malignant melanoma. However, in malignant
when the DNA content of the nucleus has doubled and the melanoma, cell markers of senescence are lost.112
chromosomes have been replicated. In experimental conditions, many constituents of food
When DNA synthesis is complete, the cell enters the G2 such as retinol, calcium, allyl sulphide, n-3 fatty acids, and
phase, during which the cell continues to increase in size and genistein are known to influence progression of cells
produce new proteins. The G2 checkpoint leads to arrest of through the cell cycle. These studies, when conducted in cells
the cell cycle in response to damaged or unreplicated DNA; in culture, need to be assessed cautiously because they may
otherwise the cell divides into two daughter cells during the not always adequately reflect events in vivo. However, they
M (mitosis) phase, and the M checkpoint ensures each can and do provide evidence additional to that gained from
daughter cell receives the correct DNA. The cell cycle is con- epidemiological studies. Also see chapter 3.1 and 3.2.
trolled by a set of proteins called cyclins and their specific Specific dietary components have effects on cell cycle pro-
cyclin-dependent kinases (CDKs). These join to form gression and proliferation in experimental settings. Some
cyclinCDK complexes, which activate transcription factors. known or hypothesised benefits of some dietary constituents
This in turn activates transcription of the genes required for are summarised here.
the next stage of the cell cycle, including the cyclin genes. Vitamin A (in the form of retinol) can lead to cell cycle
In this section, examples are given to illustrate the known arrest.113 Retinoids and carotenoids inhibit proliferation by
interactions between nutritional factors and these physio- binding retinoid receptors on the cell surface. Reduced
logical processes. expression of retinoid receptors occurs during development
Among the modulators of cell-cycle progression are of lung cancer114; retinoic acid receptor silencing is also com-
specific nutrients, which can either function as energy mon in other malignancies. Retinoic acid, a metabolite of vit-
sources or regulate the production and/or function of pro- amin A, has been used as a chemopreventive and therapeutic
teins needed to advance cells through the replicative cycle. agent in cervical cancer.115 Retinoids can inhibit proliferation
Vitamin A, vitamin B12, folic acid, vitamin D, iron, zinc, and of initiated cells by inducing apoptosis or inducing differen-
glucose all contribute to the control of cell cycle progression tiation of abnormal cells back to normal.116 Retinoids may
(figure 2.3). also cause regression of precancerous lesions in the cervix.117
42
C H A P T E R 2 T H E C A N C E R P R O C E S S
responsive genes.122
Calcium has a growth
inhibiting action on normal
and tumour gastrointestinal
cells.123 However, certain
dietary compounds can also
stimulate proliferation in
experimental cell lines, for
example, colonic cells can be
induced to hyperproliferate
by dietary haem iron.124
In a variety of animal
studies, certain dietary com-
ponents have shown reduc-
tions in experimentally
induced cancers. Allyl sul-
phides in garlic inhibit
experimentally induced
colon tumour formation.
Although this is not com-
pletely understood, experi-
ments with diallyl disulphide
suggest a block in the G2/M
phase in the progression of
the cell cycle, and induction
of apoptosis.125
Fish oil supplements
decrease the number of
tumours in experimental
models of colorectal can-
Nutrition may influence the regulation of the normal cell cycle, which ensures correct DNA cer.126 Long-chain n-3 PUFAs
replication. G0 represents resting phase, G1 the growth and preparation of the chromosomes for in fish oils can limit tumour
replication, S phase the synthesis of DNA, G2 the preparation of the cell for division, and M cell proliferation30 31 by
represents mitosis. modifying signalling path-
ways,127 128 129 for example,
by decreasing signalling of
Butyrate and diallyl disulphide can act as histone deacety- activated oncogenes.130 Animals that receive a diet supple-
lase inhibitors16 (see 2.2.2), and arrest the cell cycle. Folate mented with n-3 fatty acids have fewer colonic tumours than
is a necessary cofactor for DNA synthesis, and deficiency can those fed a diet supplemented with corn oil,131 due to dietary
reduce cell proliferation due to decreased DNA synthesis. fibre-altering, fatty acid-binding, protein expression in
Phenolic compounds, including genistein and EGCG, can colonocytes during tumour development.
inhibit some cyclins and cyclin-dependent kinases.118 Various growth factors and hormones involved in normal
Specifically, in people with oral leukoplakia, green tea (which cell processes can be used or produced by cancer cells to
contains EGCG) has been associated with significant decreas- maintain or augment uncontrolled cell proliferation. The
es in the size of cancers and of micronuclei formation in exfo- receptor for IGF-1 is overexpressed on many cancer cells.
liated oral cells.119 IGF-1 can enhance the growth of a variety of cancer cell
Phytoestrogens are found in high concentrations in soya lines132 by stimulating progression of the cell cycle from G1
beans, and have been shown in vitro to exhibit a plethora of to S phase.13
different anti-cancer effects, including inhibiting prolifera- Insulin itself can also act as a growth factor for tumour cell
tion.120 121 Glucosinolates from cruciferous vegetables are con- proliferation, both by binding to the insulin receptor on can-
verted in the liver to ITCs, which can arrest cell cycle cer cells and by stimulating increased IGF-1 production by the
progression, as well as induce phase 2 enzymes, which can liver.13 133 Insulin resistance increases with body fatness, in
promote carcinogen excretion (see 2.3). Only about one third particular abdominal fatness, and the pancreas compensates
of people have the types of microbial flora in their gut that by increasing insulin production. This hyperinsulinaemia is
are capable of metabolising the dietary isoflavone daidzein associated with a risk of cancers of the colon and endometri-
to equol. Compared with Western populations, Asian popu- um, and possibly of the pancreas and kidney.13 Leptin, a hor-
lations are more likely to produce equol, and this affects the mone produced by fat cells, can also stimulate proliferation
expression of genes involved in cell signalling and differen- of many premalignant and malignant cell types,134 as can a
tiation, and cell division. Equol can also modulate oestrogen- number of sex steroid hormones (see Chapter 6, and box 2.4).
43
P A R T I B A C K G R O U N D
44
C H A P T E R 2 T H E C A N C E R P R O C E S S
45
P A R T I B A C K G R O U N D
els of cancer.148 These include EGCG, curcumin, genistein, inhibitor in healthy people, which could decrease plasma
indole-3-carbinol, resveratrol, ITCs, lycopene, capsaicin, levels of VEGF.157
and organosulphur compounds.149 In premalignant cells,
retinoids, polyphenols, and vanilloids stimulate apoptosis.150 2.5.4 Tissue invasion and metastasis
Alpha-tocopherol (a form of vitamin E) has been shown both Normal cells in solid tissues maintain their position in the
to induce151 and to protect against apoptosis.152 body and generally do not migrate. As a cancer increases, it
eventually reaches the membrane encapsulating the organ.
2.5.3 Sustained angiogenesis Tumour cells secrete enzymes such as matrix metallopro-
Angiogenesis, the formation of new blood vessels, is essen- teases (MMPs), which digest the membrane and allow the
tial for the supply of nutrients and oxygen to any growing cancer to invade adjacent tissue. Once through the mem-
tissue, including tumours. Most cells within tissues reside brane, cancer cells can access other sites via the blood and
within 100 mm of a capillary blood vessel. The generation lymphatic systems. This migration of cancer cells, or metas-
of blood vessels in adults is fairly constant and tightly tasis, is a common characteristic of most cancer deaths.
controlled by a balance of angiogenesis inducers and There is limited evidence for dietary components to influ-
inhibitors. For a cancer to progress to a larger size, it must ence these late stages of cancer, although in vitro, EGCG,
acquire the ability to induce angiogenesis. Currently about resveratrol, quercetin, curcumin, and genistein can inhibit
35 proteins have been identified as angiogenesis activators one or more MMPs. Vitamin C can inhibit MMP production
or inhibitors.153 by a number of human cancer cell lines and prevent inva-
In experimental settings, one of the first dietary compo- sion of these lines in vitro.158 Vitamin E can inhibit metas-
nents for which a beneficial anti-angiogenic effect was tasis of pre-established tumours in mouse models of breast
clearly demonstrated was EGCG from green tea.154 Now cancer.159
some 20 different compounds consisting mainly of flavonoids
and isoflavones (including genistein) are documented as
being able to modulate the angiogenic process. Diets high 2.6 Conclusions
in n-6 fatty acids are associated with poor prognosis in breast
cancer patients, whereas those high in n-3 fatty acids appear Great progress has been made since the mid-1990s in the
to suppress angiogenesis.155 Long-chain n-3 PUFAs in fish understanding of the cancer process. Evidence is accum-
oils limit angiogenesis in other experimental cancers.30 31 ulating that shows or suggests that food and nutrition, and
Curcumin, quercetin, and resveratrol have all been shown to physical activity and associated factors, are important in
inhibit the angiogenic factor, vascular endothelial growth modification of the cancer process. Moreover, there is
factor (VEGF), in cultured cancer cells. Garlic extract may increased evidence that specific dietary patterns, foods and
inhibit experimentally induced angiogenesis, as it can sup- drinks, and dietary constituents can and do protect against
press endothelial cell motility, proliferation, and tube for- cancer, not only before the process starts, but also after-
mation.156 Phytoestrogens found in high concentrations in wards.
soya beans have also been shown to inhibit angiogenesis.120 Understanding the mechanisms that control cell structure
Energy restriction reduces blood vessel density in pre- and function, and so influence the cancer process, will aid
malignant and malignant breast pathologies.145 Exercise not only understanding of cancer as a whole, but also the
increases the levels of a circulating endogenous VEGF- development of preventive strategies.
46
P A R T I B A C K G R O U N D
C H A P T E R 3
The task of expert committees responsible for Judgements of the Panel are shown in the form of
reports such as this is to collect, discuss, and judge matrices at the beginning of the chapters of Part 2 of
scientific evidence, as a basis for recommendations this Report. Two key judgements in these matrices,
made in the public interest. The purpose of this third and in the text, are those of convincing and
introductory chapter is to summarise the process the probable. These denote the Panels judgements that
Panel has used in the five years of its work, in order the evidence of causality that a factor either
to ensure that its assessments, judgements, and decreases or increases the risk of cancer is strong
recommendations made in the chapters that follow enough to justify population goals and personal
are reliable. recommendations, which are made in Part 3. The
As shown in the previous chapters, while cancer is criteria agreed by the Panel for grading the evidence
a disease of cells and tissues, the main determinants convincing, probable, or limited, or else showing
of many cancers are environmental, which means that any substantial effect on the risk of cancer is
that most cancers are, at least in theory, unlikely, are also specified in this chapter.
preventable. Environmental factors that modify the
risk of cancer include food and nutrition, physical
activity, and body composition. One purpose of
scientific research in this field is to determine which
aspects of these factors protect against, and which
are causes of, cancers of various sites. Such research
is also concerned with which aspects are most
important that is, which have the most powerful
or general effects.
Some of the methods used by the Panel
responsible for this Report are new. Others are
developed from those used elsewhere, including in
the previous report. The best evidence that aspects
of food, nutrition, physical activity, and body fatness
can modify the risk of cancer does not come from
any one type of scientific investigation. It comes
from a combination of different types of
epidemiological and other studies, supported by
evidence of plausible biological mechanisms. Such
comprehensive evidence has been collected in the
form of 20 systematic literature reviews specially
commissioned as the basis for this Report, compiled
by nine independent centres of scientific excellence,
covering 20 cancer sites, the determinants of
obesity, and recommendations made by other
authoritative reports. These reviews amount to a
comprehensive examination of the relevant types of
epidemiological and experimental evidence,
organised using a common methodology. Their
findings, as summarised for and then assessed and
judged by the Panel, are shown in Part 2 of this
Report. The full systematic literature reviews are
contained on the CD included with this Report.
48
C H A P T E R 3 J U D G I N G T H E E V I D E N C E
Since the mid-1990s, the discipline of epidemiology has the introductory passages of the sections of Chapter 7, and
placed increasing emphasis on the use of meta-analyses and box 7.1.1.
systematic reviews, both of which have informed the Panel The International Agency for Research on Cancer (IARC),
responsible for this Report. Taken together with lines of evi- a branch of the World Health Organization, compiles inter-
dence from other types of study, these provide a reliable basis national cancer statistics using data from national and
for judgements and recommendations designed to improve regional cancer registries around the world.1 Cancer inci-
public health. dence rates are usually specified by gender and age. Cancer
The task of the Panel, with the supporting Secretariat, has mortality rates, generally derived from data collected rou-
been to commission, summarise, and display a comprehensive tinely on causes of death, are more widely available than
range of evidence; to assess and judge this evidence; and to cancer incidence rates.
draw conclusions and make recommendations based on this Descriptive epidemiology informs cancer surveillance
systematic and transparent process. Also see Appendix A. programmes, and is a basic tool for determining patterns
This chapter details the nature of the science relevant to of cancer, relative rates of cancer and other diseases, and
the work of the Panel. It also summarises the processes devel- changes in patterns and trends over time. Remarkable
oped from initial work done by a Methodology Task Force. changes in the incidence of cancers (for example, the
Its findings have been a foundation for the work of the Panel. general drop in rates of stomach cancer or the increase
The two most important parts of this process are the sys- in rates of lung cancer in many middle- and low-income
tematic literature reviews (SLRs), explained in box 3.4, and countries) provide first lines of evidence pointing to causa-
the criteria the Panel has agreed for grading the evidence, tion due to corresponding changes in environmental
described in box 3.8. These and other methods have deter- circumstances.
mined the Panels approach to gathering, summarising, Like all types of study, descriptive epidemiology has limi-
assessing, and judging evidence, and agreeing on population tations. Apparent trends in cancer incidence and mortality
goals and personal recommendations as a basis for the pre- may be due in part to changes and developments in screen-
vention of cancer. ing, diagnosis, or treatment. For example, the rapid rise in
the recorded incidence of prostate cancer in the USA, the UK,
and other higher-income countries is largely due to wide-
3.1 Epidemiological evidence spread use of diagnostic techniques that identify early
evidence of this cancer.
Epidemiological research describes and seeks to explain the
distribution of health and disease within human populations. 3.1.2 Ecological studies
The methods used are based mainly on comparative obser- Ecological studies are designed to explore relationships
vations made at the level of whole populations, special between environmental factors and disease amongst popu-
groups (such as migrants), or individuals within populations. lations rather than individuals.
This type of investigation is known as observational. By relat- Within the scope of this Report, ecological studies compare
ing differences in circumstances and behaviour to differences relationships between estimated levels of consumption of
in the incidence of disease, associations are identified that foods and drinks, levels of physical activity, and degrees of
may be causal. In epidemiological studies, an exposure is a body fatness with rates of cancer for populations. For exam-
factor or condition that may increase or decrease the risk of ple, as already mentioned, early observations found impres-
disease. In this Report, food, nutrition, physical activity, and sive correlations between national per capita intake of total
body composition are the exposures investigated. The meth- dietary fat and rates of breast cancer mortality, mapped
ods summarised here and applied to cancer are also used to across many countries,2 leading to the hypothesis that rela-
study and understand other diseases. tively high consumption of total fat was an important cause
of breast cancer.
3.1.1 Descriptive studies The findings of ecological studies, together with those
The most basic information about cancer comes from sta- from migrant and laboratory studies (see 3.1.3 and 3.2),
tistics on cancer incidence and mortality. See chapter 1.2.4, were important factors leading to judgements and recom-
49
P A R T I B A C K G R O U N D
Interpretation of epidemiological evidence middle- and low-income countries, but also Confounding. A confounder is a factor
on any and all aspects of foods and drinks, globally. associated with both the outcome (in this
physical activity, body composition, and case, cancer) and the exposure being stud-
associated factors, with the risk of cancer, Measurement. Many study exposures are ied, but is not an effect of the exposure. It
is never simple. General considerations difficult to determine and are thus mea- is never possible from observational studies
include the following, which need to be sured imprecisely. It is easier to measure to eliminate completely the possibility that
taken into account when evidence is assem- food intakes than intakes of dietary con- an evident effect of a constituent, or aspect
bled and assessed. This emphasises that stituents of foods. This can lead to an of a food or drink, is at least in part caused
expert judgement is essential. undue degree of importance being given to by another factor.
studies of aspects of food and nutrition
Patterns and ranges of intakes. Most stud- that happen to be more easily measured. Reporting bias. Studies reliant on self-
ies are carried out in high-income countries. reporting of dietary intake are prone to sys-
Their findings may have limited application Terminology. For some foods and drinks, tematic bias. People tend to over-report
in countries where dietary and physical and dietary constituents, there are no gen- consumption of foods and drinks they
activity patterns are different. They may erally agreed definitions. Examples include believe to be healthy, and under-report
also be unrevealing in their own countries dietary fibre and processed meat. Also, foods and drinks they believe to be
if the ranges examined are relatively nar- some common definitions may disguise real unhealthy. Under-reporting of energy
row. Some foods that are important dietary differences: different types of dietary fibre intake has been shown to be associated
constituents outside high-income countries have different biological effects. with factors such as age, overweight and
are often not examined. obesity, perceived body size, and other per-
Study design. The relative merits of differ- sonal characteristics.7-14 Allowance for this
Classification. Following from the above, ent types of epidemiological study design, is an inexact science. Also see 3.3.
studies usually classify foods and drinks, and the relative value of epidemiological
and physical activity in ways that corre- evidence compared with experimental evi- Production, preservation, processing,
spond to the patterns of high-income coun- dence, are likely to remain to some extent preparation. Studies of foods and drinks,
tries. Their findings may over-emphasise a matter of opinion. The special power of and of food groups, may neglect the
the significance (or insignificance) of foods randomised controlled trials (see 3.1.6), effects of methods of production, preser-
and drinks commonly consumed in high- most often used to test the effects of vation, processing, and preparation (includ-
income countries, and they may overlook dietary constituents as opposed to whole ing cooking). They are also inclined to
other foods and drinks consumed in diets, could lead to over-emphasis of the underestimate the significance of foods
other parts of the world. The same points importance of isolated constituents which, and drinks combined in dishes or meals,
apply to types of physical activity. This within the context of food and diets, may and as components of whole dietary
may impede understanding, not only in have other effects. patterns.
mendations made in reports on diet and cancer published in 3.1.3 Migrant studies
the 1980s.3-5 Migrant studies compare cancer rates for migrants, and for
While ecological studies, like other observational studies, their offspring, in their current country of residence, with
may suggest a relationship between a specific environmen- rates in their country of origin.16 These studies show that
tal factor (such as an aspect of food and nutrition) and populations migrating between areas with different cancer
disease, the actual causal relationship may be with a differ- incidence rates acquire the rates characteristic of their new
ent confounding factor, which may or may not be associat- location for some cancers, often after only one or two gen-
ed with the environmental factor being investigated.6 The erations. This shows that environmental, rather than inher-
example of total fat consumption and breast cancer is a case ited, factors are primarily responsible for the large differences
in point: total fat consumption, disposable income, and con- in cancer rates in different regions and countries (see chap-
sumption of alcoholic drinks might all correlate with one ter 1.3).17 Those diseases for which incidence shifts with
another, and also with breast cancer. See box 3.1. migration, such as cancer, are diseases with evidently impor-
Ecological studies are often used to identify associations tant environmental causes.
or trends that warrant further investigation. They have spe-
cial strengths, particularly when conducted between popu- 3.1.4 Case-control studies
lations, either internationally, or cross-culturally among In case-control studies, individuals diagnosed with a specif-
different populations within a country. Thus, the contrast in ic type of cancer (cases) are compared with otherwise sim-
dietary intake between countries is often much larger than ilar individuals who have not been diagnosed with cancer
the contrast within countries. In addition, average national (controls). The control group is a sample of the population
diets are likely to be more stable over time than the diets of from which the cases arose, and provides an estimate of how
communities, families, or individual people. For most coun- the exposures being studied are distributed in that popula-
tries, the changes in overall national dietary intakes over a tion. Identifying and enrolling appropriate controls is a major
decade or two are relatively small. challenge in case-control studies.18-20
50
C H A P T E R 3 J U D G I N G T H E E V I D E N C E
Case-control studies are subject to recall bias, which can called intervention and control groups, to receive or not
occur when participants reporting of various exposures receive an experimental intervention. The main use of RCTs
(dietary intake, medication, physical activity, and so on) is has generally been to test the efficacy of drugs and other
differentially affected by whether they are cases or controls medical treatments.
in the study. Selection bias is an increasing problem in high- In a double blind RCT, neither the participants nor the
income countries, where participation rates among both case investigators know to which group (intervention or control)
and control groups may be substantially less than 100 per the participant has been assigned. Blinding is used because
cent, and where participation may be related (in different the knowledge of group assignment might influence study
ways) to various exposures. However, case-control studies results, but it is usually impossible to achieve with trials
are usually less expensive than cohort studies, and can be involving physical activity, or those investigating foods and
completed over shorter periods of time. drinks in their usual form.
A nested case-control study is carried out within an exist- An effective use of RCTs is to test the effects of supple-
ing cohort study (see 3.1.5). In this type of study, all of the mentation with specified doses of dietary micronutrients
cases in the cohort are compared with a sample of the non- (as pills or by other means). However, pharmacological doses
cases. A nested case-control study has the strengths of a of supplements are often studied doses much higher
cohort study notably that diet is assessed among study than can be derived from diets and results may not be
participants prior to the diagnosis of cancer, so avoiding directly relevant to dietary intakes of that micronutrient.
recall bias but is less expensive to conduct, since only a Such trials may yield powerful evidence of the effect of a
sample of the non-cases are included in the analysis. specific dietary constituent. However, they are often con-
ducted as a result of promising epidemiological studies
3.1.5 Cohort studies that have shown protective effects of a particular group of
In prospective cohort studies (usually simply called cohort foods, and there is always a possibility that the actual active
studies), the diets, body compositions, and/or physical activ- agent or combination of agents in the foods has not been
ity levels of a large group (cohort) of people who are used in the trial. Dietary constituents that are or may be
assumed to be healthy are assessed, and the group is fol- protective when contained within foods may have unex-
lowed over a period of time. During the follow-up period, pected effects in isolation, especially at doses higher than
some members of the cohort will develop and be diagnosed those found in normal diets. For example, in the Alpha-
with cancer, while others will not, and comparisons are Tocopherol, Beta-Carotene Cancer Prevention Trial (ATBC
then made between these two groups. Because measure- Trial) of male smokers in Finland, high dose beta-carotene
ments are made before any cancer diagnosis, cohort studies supplementation was associated with increased incidence of
are not subject to recall bias. A single cohort study allows lung cancer.26
examination of the effects of diet and physical activity on RCTs are also used to test interventions designed to change
multiple types of cancer and other diseases. Also, in cohort behaviour, including dietary intakes and physical activity.
studies, blood and tissue samples are often collected and Such trials require a high level of commitment by partici-
stored for future analysis. Finally, cohort studies provide the pants, and learning how to conduct them well is a topic of
opportunity to obtain repeated assessments of participants active investigation.
diets at regular intervals, which may improve the dietary A unique and important strength of sufficiently large RCTs
assessment. is that confounding variables, both known and unknown,
Cohort studies may need to be very large (up to tens or will on average be distributed equally between the treatment
even hundreds of thousands of participants) to have and control groups, and will therefore not bias the study
sufficient statistical power to identify factors that may results.
increase cancer risk by as little as 20 or 30 per cent. Also,
meaningful comparisons between cases and non-cases can 3.1.7 Meta-analysis
be made only for factors that vary sufficiently within the Meta-analysis is a method used to combine the results of sev-
cohort. eral studies addressing similar questions. Unless an epi-
Cohort studies are expensive, so they have been conduct- demiological study is sufficiently large, modest but
ed mostly in high-income countries. The European potentially important associations can be missed, simply
Prospective Investigation into Cancer and Nutrition (EPIC), because of the inadequate statistical power of the individual
started in 1992, is a cohort of more than 520 000 men and study. Meta-analysis is used to provide summaries of select-
women in 10 European countries.21 22 In the US, large cohorts ed collections of studies.
include the Nurses Health Study, established in 1976, and the Study-level meta-analysis provides single estimates of
Nurses Health Study II, established in 1989, each with a effect using information from multiple studies of the same
cohort of more than 100 000 women.23-25 Increasing numbers design. These summary estimates can provide evidence
of cohort studies are now being conducted in middle- and regarding the presence or absence of an association, as well
low-income countries. as examining possible dose-response relationships (box 3.2).
Meta-analysis, often displayed graphically on a forest plot
3.1.6 Randomised controlled trials (box 3.3), can also identify heterogeneity between studies.
A randomised controlled trial (RCT) is an experiment in This heterogeneity can be quantified using a measure called
which participants are randomly assigned to groups, often I2, which ranges from 0 to 100 per cent, and indicates the
51
P A R T I B A C K G R O U N D
Dose response is a term derived from low and high levels of exposure, but the categories. Although this is done for sta-
pharmacology, where it denotes a change other way at intermediate levels of expo- tistical reasons and can make effects easi-
in the effect of a drug according to the sure, shown as J- or U-shaped curves. er to detect, the number and location of
dose used. This concept can be applied to In such cases, the exposure is evidently category boundaries may obscure the true
any exposure, including food, nutrition, beneficial or harmful only within certain relationship between exposure and the
and physical activity. For example, different ranges. outcome, and non-linear effects of expo-
amounts of food and drink consumed, or Throughout Chapters 46, this Report sure may be missed if insufficient cate-
of physical activity taken, may lead to a dif- uses two forms of dose-response graph as gories are used.
ferent likelihood of any particular out- a means of displaying graded responses. Evidence of dose response is important
come, such as cancer. Such a graded These show the direction and shape of the when framing recommendations. For
response, or biological gradient, may show association, and allow estimates to be example, if the evidence for cancer showed
that higher exposure leads to increased made of levels of exposure that may influ- no threshold of effect for alcoholic drinks,
risk, or to reduced risk, and vice versa. ence risk. In order to combine and quanti- such that the risk of cancer increased from
Dose responses take different forms. The fy study results, the dose-response curves having any amount of alcoholic drink,
effect may be linear, shown in graphic form are also presented with the exposure vari- however modest, then a recommendation
as a straight line. There may be a thresh- able displayed per standard unit of based on the evidence for cancer would be
old below which there is no effect, but increase. The demonstration of a biologi- to avoid alcoholic drinks. However, if there
above which there is an effect. This is cal gradient adds weight to evidence that is clear evidence of no effect below a cer-
shown as a horizontal line that inclines an exposure may be causal. Diet and phys- tain level of consumption, then the rec-
once the threshold is reached. Or the effect ical activity exposures are continuous vari- ommendation would differ accordingly.
may be to influence risk one way at both ables, but are often reported in discrete Also see chapter 4.8.
percentage of total variation across studies that is not due 3.2 Experimental evidence
to chance. In general, an I2 of 25 per cent or less indicates
low heterogeneity; around 50 per cent indicates moderate Epidemiological studies all have strengths and limitations. So
heterogeneity; and 75 per cent or more indicates high do laboratory and mechanistic studies; their main strength is
heterogeneity.27 control. The environment of these research studies is defined
For this Report, RCTs and ecological, cohort, and case-con- by chosen experimental conditions: precise manipulations can
trol studies have been the subjects of systematic review, and, be made and relatively exact measures taken. Occasionally
when possible (and separately) of study-level meta-analysis. the test participant is a human volunteer, but usually these
Studies were included in a meta-analysis only when suffi- studies are conducted in animals (in vivo) or using human
cient data were included in the publication. In addition to or animal cells grown in the laboratory (in vitro).
effect measures and their standard errors (or confidence Rodents (usually rats or mice) are the most commonly used
intervals, see box 3.3), key elements of adequate reporting animals in laboratory experiments. Their relatively short life-
included the number of people with and without disease span provides comparatively fast results in cancer studies, and
for each exposure category, and boundaries of exposure they offer a whole body system suited to a wide variety of
categories. tests. Rodent studies can show how nutrients and other com-
The SLRs on which the conclusions of this Report pounds might affect the cancer process. But it is known that
are based include original study-level meta-analyses some interventions that affect rodents do not affect humans,
undertaken by the independent centres of scientific excel- or do not affect them in the same ways or to the same degrees,
lence. The Panel considered all studies identified in the SLR, and vice versa. Also, experiments on animals may be highly
not just the results of the meta-analyses. Full details of artificial, using special breeds of rodents initially given mas-
the methods used for the meta-analyses are contained in sive doses of carcinogenic agents, and then fed nutrients or
the SLR specification manual. The full SLRs and the manu- other substances at levels far higher than humans would nor-
al are contained on the CD included with this Report. Also mally consume, or could ethically be given.
see box 3.4. Human or animal cells, sometimes derived from particu-
Pooled analysis is a type of meta-analysis where original lar cancers, can be grown in vitro in the laboratory and used
individual-level data from various published epidemiologi- in experiments to help researchers understand mechanisms
cal studies of the same type usually prospective cohort that may lead to the development of cancer. The Panels deci-
studies are combined and reanalysed. The combination sion on what types of experimental studies were admissible
of data from multiple studies creates a larger data set and as evidence for this Report is summarised in box 3.5.
increased statistical power. Published studies from pooling
projects, in addition to the SLR study-level results generat- 3.2.1 Human feeding studies
ed specifically for this Report, were taken into account by the Human volunteers can be studied in a controlled environ-
Panel in making its assessments and judgements. ment, such as within a metabolic unit, where their diets and
52
C H A P T E R 3 J U D G I N G T H E E V I D E N C E
activity levels can be highly regulated and measured. In some questions. Often the animals have tumours produced by irra-
studies, subjects live at the metabolic unit for short periods diation, viruses, chemicals, or other carcinogens, or they may
of time, eating only foods and meals provided as part of the be genetically prone to develop cancer. The effect of dietary
study. Since the nutrient composition of such diets can be or other interventions on the prevention or progression of
controlled and manipulated, investigators can study the such tumours is then investigated.
effects of various changes in nutrient intakes on factors such As indicated in 3.2, the strength of these studies is the tight
as hormone levels or cell proliferation assays, which may be control of experimental conditions. Their limitations are
important predictors of cancer or other diseases. These are their artificiality and the fact that no effect on rodents, how-
intermediate markers, however, and relating the results to ever unequivocal, can be assumed to apply to humans.
cancer occurrence may be problematic. Rather like the results of population ecological studies,
results from animal studies provide first lines of evidence
3.2.2 Live animal models that may prompt more persuasive research; they can also cor-
Laboratory animals can be used to test the effects of food, roborate such findings.
nutrition, and physical activity on the development of can-
cer. Human genes can be added to animals DNA (creating 3.2.3 In vitro studies
transgenic animal models) or key genes can be removed (cre- In vitro studies are conducted using cells or other test sys-
ating knockout animal models) to address specific research tems. Human cells, animal cells, mechanistic test systems,
53
P A R T I B A C K G R O U N D
The main basis for the Panels work in com- Current practice, when resources allow, and terms. The papers identified were
ing to judgement on the causal relation- is to separate the process of collecting and assessed for relevance using reproducible
ships between food, nutrition, physical displaying evidence from that of discussing criteria. Study characteristics and results
activity, and cancer is a series of 20 specially and judging evidence. Evidence is collect- were extracted and recorded. Data from
commissioned systematic literature reviews ed systematically, after agreeing criteria for different studies were combined and
(SLRs). These have all been conducted inclusion or exclusion for review. As well as analysed, using meta-analysis when appro-
according to a common, detailed specifi- reducing possible bias, this is a more com- priate. Key features of selected studies are
cation, following recommendations made prehensive and transparent approach. This presented in graphic form in Chapters 46
by the Methodology Task Force, which process was used by the previous report, and 8, to aid comparison and quality assess-
completed its work before the Panels first which at the time of its publication was the ment. Existing SLRs were also identified to
meeting. The SLRs form the main evidence most comprehensive in its and allied fields. ensure, as far as possible, that all relevant
basis for the assessments and judgements This current Report has made a step- papers were included.
made by the Panel in Part 2 of this Report, change in this process, by commissioning An important aspect of an SLR is that all
on which the Panels population goals and independent SLRs, and making full use of stages of searching, selection, assessment,
personal recommendations in Part 3 are electronic resources. and analysis are prespecified, objective,
based. The Panel, in commissioning the SLRs reproducible, openly documented, and
This approach differs from that used to and supplementary work, decided to subject to peer review at critical stages. As
prepare most other expert reports. require evidence from all relevant epi- stated, full details of the approach taken
Previously, expert reports concerned with demiological and experimental studies, can be found in the SLR specification man-
the prevention of disease, and other top- together with biological findings. The ual contained on the CD included with this
ics, have relied on less formal methods to alternative approach would have been to Report (together with the SLRs).
collect and assess relevant literature. Until agree a hierarchy of epidemiological evi- The SLRs included evidence published up
the 1980s, most such reports were assem- dence, perhaps with one study type given to the end of 2005, and the Panels con-
bled by members of panels of scientists pre-eminent importance. Instead, while clusions are based on these SLRs. To ensure
who, assisted by secretariats, wrote drafts allowing for some types of epidemiologi- that the Panels recommendations, which
of chapters themselves using their own cal study being more or less prone to bias are derived from their conclusions and
knowledge, either with or without addi- than others, the Panel has based its con- judgements, take into account developing
tional research. The panel then reviewed clusions and judgements on evidence accu- evidence, a further review of studies pub-
the draft report until consensus was mulated from different types of study. For lished during 2006 was conducted. This
achieved. In some cases, report authors the Panel to be convinced that a relation- review was more limited than the full SLRs:
took total responsibility for assembling and ship between an exposure and cancer is it was confined to exposures that had
judging the evidence. In the 1990s, more causal, or that it is probably causal, consis- been judged convincing, probable, sub-
ambitious reports placed greater emphasis tent evidence from different types of study stantial effect on risk unlikely, and limit-
on secretariats, which tended to take more was required, with the exception of ran- edsuggestive, based on the SLRs. (See box
responsibility for drafting the report, and domised controlled trials. 3.8 for an explanation of these terms.) At
for some original research, as directed by The teams responsible for producing the this second review stage, no further meta-
the panel. More recently, panels have SLRs gathered relevant studies in a com- analyses were performed and a review of
sometimes been informed by narrative mon, systematic fashion, using a protocol study quality was not included. For these
reviews commissioned from specialists and designed to limit the potential for bias in reasons, the results of this 2006 review
prepared independently from the panel deciding which evidence should be includ- have been noted but have not been used
process. Such reviews are usually written ed or excluded from analysis. to alter the Panels judgements based on
from the specialists existing knowledge, The first stage of the SLRs was a com- the full SLRs. A further process has been
and form background substrate for the prehensive search of the scientific literature established for a continuous review of
reports. Narrative reviews may be pub- and other sources catalogued on electron- evidence published since 2006, after pub-
lished separately.29 ic databases, using all relevant keywords lication of this Report.
and bacterial systems can be used. interventions. Therefore extrapolation of results to humans
Cell cultures can be primary, where tissue (such as a is limited.
tumour biopsy) is taken directly from humans or animals and
then cultured; or secondary, where the original cells are cul- 3.2.4 Biological pathways
tured a number of times. Such cell lines are commonly used Epidemiological and experimental evidence indicating a
in laboratory research, and can become immortal cultured causal association between an aspect of diet and cancer is
again and again. The cells or tissues are subjected to poten- strengthened when there is evidence of a plausible biologi-
tial carcinogens, and then markers of damage are measured. cal pathway or mechanism by which the cancer process may
Conducting studies in vitro has two main advantages. be modified. The Panel agreed that simply identifying such
First, specific, well defined interventions can be tested; and plausible mechanisms is not sufficient evidence for a causal
second, intracellular mechanisms can be examined. However, relationship; but it also agreed that the case for a causal rela-
these studies do not allow the study of integrated systems, tionship is strengthened when there is evidence of biologi-
such as how organs or the whole body responds to the cal plausibility.
54
C H A P T E R 3 J U D G I N G T H E E V I D E N C E
Narrative reviews of experimental studies and of evidence dietary recalls, food frequency questionnaires, and food diary
of plausible biological mechanisms were included in the SLRs or food record methods. Most of the studies included in this
that inform this Report. Summaries of these SLRs are pre- Report used dietary assessment data from individuals,
sented in Part 2, Chapters 410. Also see box 3.4. recorded using food frequency questionnaires.
Diet histories take the form of unstructured enquiries,
more useful in clinical settings than in research studies.
3.3 Methods of assessment Dietary recalls may use structured or unstructured methods,
and are often administered many times over the course of a
Some exposures are easier to measure than others. Thus, it study. In a 24-hour dietary recall, a record is made of every-
is relatively easy to assess the impact of tobacco smoking and thing a person can recall eating or drinking over the previ-
exposure to tobacco on cancer risk. Although tobacco smoke ous 24 hours. Automated systems for collecting and
is a mixture of many chemicals, and its interactions with analysing dietary recalls have been developed, which facil-
the body are complex, tobacco can be considered a single itate the use of this method of assessment in large studies.32
exposure. Food frequency questionnaires collect information on food
By contrast, diets are multidimensional exposures and in consumption patterns, typically over the past year. A record
free-living populations cannot be measured with complete is made of the frequency of consumption of perhaps 100 to
accuracy. Moreover, the foods and drinks people consume 150 items, and often includes information on serving sizes.
every day contain thousands of constituents, some well Food frequency questionnaires may be designed to gain
known, others unknown and unmeasured. The relationships detailed information about specific aspects of diets, such as
between food, nutrition, physical activity, and health and dis- intakes of fats or dietary fibre, leaving other components less
ease are complex and difficult to untangle. The presence or well characterised. A questionnaire for whole diets cannot
absence of effect modification (box 3.6) can create additional adequately capture the full variety and composition of indi-
challenges. vidual diets without becoming unwieldy. Food frequency
questionnaires are inexpensive, however, and are practical
3.3.1 Foods, drinks, and nutrients for use in large-scale epidemiological studies.
Peoples dietary intake varies from day to day and over the Food diary or food record methods rely on the participants
course of their lives. There are interrelationships between in the study recording everything they eat and drink over the
food components, between foods in whole diets, and course of one or more days. Participants may be asked to
between diets and other behavioural characteristics such as estimate portion sizes, or weigh foods and drinks.
physical activity or smoking. There are several methods for All dietary assessment methods that rely on self-reporting
assessing food and drink consumption, all with their own are subject to measurement error. Further errors are intro-
weaknesses and strengths. duced by the conversion of food data to nutrient data, using
tables of the chemical composition of foods, which give aver-
3.3.1.1 Dietary assessment methods age nutrient contents for defined foods. This implicitly
Food intakes can be measured for populations, groups, or assumes that all participants eat foods that have the same
individuals. The most commonly used techniques for assess- standard composition and portion size. But in reality, food
ing food and drink consumption are diet histories, 24-hour composition varies widely, depending on soil quality,
The Panel agreed a hierarchy of robust- nificantly influence judgements derived Class 2
ness recommended by the Methodology from consideration of the collective weight In vitro data from studies using human
Task Force, which completed its work of evidence from all other types of study. cells validated with an in vivo model;
before the Panels first meeting. The hier- For these reasons, eight types of exper- for example, a transgenic model.
archy of robustness was designed to deter- imental evidence were identified and split In vitro data from studies using primary
mine which types of human and animal into three classes: human cells.
experimental study are likely to be most In vitro data from studies using human
applicable to human cancer. This was done Class 1 cell lines.
for practical and scientific reasons. The In vivo data from studies in human
body of experimental literature is very volunteers (controlled human feeding Class 3
much larger than the body of epidemio- studies). In vitro data from studies on animal cells.
logical literature, and an exhaustive sys- In vivo data from studies using Data from mechanistic test systems; for
tematic review of this literature would genetically modified animal models example, isolated enzymes or genes.
have been impractical. Also, most experi- related to human cancer (such as gene
mental work, such as that conducted as a knockout or transgenic mouse models). For the systematic literature reviews in this
guide to toxicological regulations, either In vivo data from studies using rodent Report, only class 1 evidence was reviewed.
has no evident relevance to the work of cancer models designed to investigate Illustrative evidence from in vitro studies is
the Panel, or else would be unlikely to sig- modifiers of the cancer process. included only in Chapter 2.
55
P A R T I B A C K G R O U N D
56
C H A P T E R 3 J U D G I N G T H E E V I D E N C E
Studies may also require participants to undergo clinical 3.4 Causation and risk
examination, or provide tissue biopsy samples.
The duration of a study can also affect whether the full One of the Panels tasks has been to devise a transparent and
effects of exposures are identified. Relatively short-term objective method that enables evidence of relationships
prospective studies may miss any late effects on cancers. This between diet, physical activity, body fatness, and associated
is one reason why results from studies with long-term fol- factors, and cancer of one or more sites, to be judged as
low-up periods are particularly valuable. causal, with varying degrees of confidence.
Population-based cancer registries collect cancer incidence
and mortality data for the areas they serve, and produce can- 3.4.1 Inferring causation
cer registers. The Panel endorses the view of the panel responsible for the
In the US, the Surveillance, Epidemiology, and End Results previous report, that causal relationships between food and
(SEER) programme collects population-based data on newly nutrition, and physical activity can be confidently inferred
diagnosed cancers from registries that cover approximately when epidemiological evidence, and experimental and other
23 per cent of the US population.49 The European Network biological findings, are consistent, unbiased, strong, graded,
of Cancer Registries represents population-based cancer reg- coherent, repeated, and plausible. Individually, none of these
istries in Europe.50 Population-based registries are becoming factors is likely to be sufficient to infer a causal relationship
increasingly available in middle- and low-income countries. with confidence. Also, individual relationships may be defi-
In total, 57 countries and 186 cancer registries are repre- cient in various respects, but collectively can still be judged
sented in Volume VIII of the Cancer Incidence in Five as causal because of their cumulative weight.
Continents series published by IARC.1 Also see box 1.2. Many types of evidence can contribute to causal inference.
Cancer incidence data are coded in a standardised way, However strong the evidence from any single study, it will
using International Classification of Disease (ICD) codes that rarely justify a conclusion of causality. Increasing surviv-
have been established for oncology.51 These 10-digit codes ability of an observed relationship, when supported by fur-
specify the site of origin of the tumour (topography), the ther studies, or which produces corroborative evidence in
tumour or cell type (morphology), the behaviour of the other categories, as listed above, strengthens the evidence
tumour (malignant, benign, or in situ), and the tumour for a causal relationship.52 53
grade or degree of differentiation. With regard to food and nutrition, and physical activity,
In addition to providing cancer incidence and mortality single exposures are unlikely to act alone to cause or pre-
statistics, cancer registries are used by researchers to identi- vent cancer. In general, many factors act together as con-
fy people who are eligible to enrol in a case-control study, tributory or component causes, forming a complete causal
or to collect information on cancer diagnosis relating to peo- process. Component causes can interact biologically, even
ple who are enrolled in a cohort study. when exerting their effects at different times.30
One of the basic principles in controlled diets. The total amount of food consumed centage of total energy) or regression
human and animal feeding experiments to is determined primarily by body size and analysis to calculate nutrient residuals. In
evaluate the effect of a specific dietary fac- physical activity. an epidemiological analysis, the nutrient
tor is that the diets should be isocaloric Body size and physical activity are of density does not adequately adjust for
(i.e., total energy intake is the same in both interest in their own right, but their effects total energy intake if energy intake itself
groups). This is because differences in need to be disentangled from the effects is associated with disease risk. In this case,
energy intake between two groups would of a specific nutrient. This can be done by total energy intake must be added as a
cause one group to gain or lose more using energy-adjusted nutrient intakes. separate term to the model. Another
weight than the other. The effects of the Expressed another way, studies designed to method, that of energy partition, has
dietary factor being investigated could not change the intake of a specific nutrient been used in some studies, but this is not
then be distinguished from the effects of usually should do so by changing the com- an isocaloric analysis and thus does not
changes in weight. This is important, position of diets rather than total energy control for total energy intake.
because differences in weight themselves intake. Epidemiological studies therefore An additional advantage of energy-
may have different physiological effects. should adjust for energy and not rely on adjusted nutrient intakes is that they are
In epidemiological studies, there are sim- absolute intakes, which reflect both dietary often measured with less error than
ilar reasons to conduct isocaloric analyses. composition and variation in total energy absolute nutrient intakes. This is because
These use statistical methods to adjust intake due to differences in body size and over- or under-reporting of specific nutri-
intakes of the dietary factor under study physical activity. ents tends to be strongly correlated with
for total energy intake. The rationale for The best method to adjust for total over- or under-reporting of total energy
energy-adjusted intakes is that the energy intake has been a matter of con- intake, especially for macronutrients, being
absolute intake of a nutrient is a function siderable discussion.44-48 The two basic calculated from the same foods. These
of two factors: first, the total amount of approaches are to use the nutrient densi- errors are highly correlated, so tend to can-
food consumed, represented by total ener- ty (for example, expressing intake per unit cel each other when calculating nutrient
gy intake; and second, the composition of of energy or, for macronutrients, as a per- densities or energy-adjusted intakes.
57
P A R T I B A C K G R O U N D
3.4.2 The portfolio approach amount to strong evidence if consistently found in large, well
Many different types of study, all of which have strengths and designed studies.
weaknesses, investigate links between food, nutrition, phys-
ical activity, and cancer. Persuasive evidence comes from dif-
ferent types of epidemiological study, supported by 3.5 Coming to judgement
experimental findings that indicate a relevant biological
mechanism. A crucial part of the process that has informed this Report
The Panels judgements, presented in Part 2 of this Report, is the methods used by the Panel in judging whether the evi-
are based on its assessment of the evidence available in the dence that a relationship between aspects of food, nutrition,
scientific literature, with due consideration given to the physical activity, and body fatness, and cancers of the sites
advantages and disadvantages of each type of study design, specified, is or may be causal. The need for evidence from
and to the quality of individual studies. An inclusive or port- different types of study and the characteristics looked for in
folio approach has been taken, recognising the relative such studies have been outlined already. Here, the precise
strengths and weaknesses of different types of study, but in methods used by the Panel are explained.
which no single type of study design is given pre-eminence. The previous report broke new ground in a number of
In general, the strongest evidence comes from consistent respects. One was to display panel judgements in the form
findings from different types of studies, preferably also in of matrices within which panel judgements on causal rela-
diverse populations. tionships, of different degrees of confidence, were shown,
and repeated in the text of the report. This method has been
3.4.3 Quantification of risk adapted in other reports.29 Another was the specification of
Quantification of the risk of any disease is an essential basis criteria guiding these judgements. The previous report also
for public health policy planning. It also guides people in used explicit statements explaining why, on occasion, the
making their own decisions about how they lead their lives. panel had made judgements that did not obviously derive
It is not enough to know that the risk of cancer is affected from the evidence as presented. One general principle was
by diet. It is also important to know by how much. For exam- that of transparency. Readers and users of the previous report
ple, if consumption of alcohol increases the risk of breast can- have been able to follow its reasoning, to challenge any
cer, and diets high in vegetables decrease the risk of various judgements that might seem questionable, and to modify
cancers, to what extent may the incidence of cancer on a or reinforce judgements in the light of further and better
population basis be affected by these factors? And on a per- evidence.
sonal level, how can people best judge how their current The Panel responsible for this Report decided to adapt
diets and ways of life, and any changes they might want to those innovative approaches, and use them as the basis for
make, are likely to affect their own risk of cancer? its work. Some of the judgements made in this Report are
Quantifying risk helps to answer such questions. different from those based on the evidence available a
The strength of a relationship between any risk factor and decade previously, while others confirm or strengthen pre-
the occurrence of disease is commonly expressed in terms of vious judgements.
relative risk (RR). In cohort studies, this is the ratio of risk
(or incidence) of a disease among people with a particular 3.5.1 The matrix approach
characteristic (say, high consumption of red meat) to that An example of a matrix used in this Report is shown in fig-
among people without that characteristic (in this example, ure 3.1. This particular matrix displays the Panels judge-
low or no consumption of red meat). In case-control stud- ments on the likelihood that physical activity modifies the
ies, the odds ratio is used, which is the ratio of the odds of risk of cancers of specified sites. This matrix is used here as
exposure among cases to the odds of exposure among con- an example, to explain the nature of the matrices displayed
trols. Relative risks below 1.0 imply a protective effect: so a in all chapters in Part 2 of this Report. This matrix and its
relative risk of 0.5 for high compared with low vegetable con- judgements are discussed fully in Chapter 5.
sumption implies a halving of risk. Relative risks above 1.0 The title of the matrix is self-explanatory. In this and other
indicate an increased risk. cases, the introductory words are important: here, the
Absolute risk is also important. Small RR values, when footnote specifies that the physical activity referred to is of
consistent, are important when the number of people affect- all types.
ed is large. A large RR of a rare type of cancer amounts to The matrices display the Panels judgements on whether
only a small absolute risk, which may reasonably be con- particular aspects of food and nutrition, physical activity, and
sidered not significant, either by public health planners or body composition do or may modify (or not modify) the risk
by individuals assessing their own choices. By contrast, a of cancers of specific sites. The matrices are of course short-
small RR may amount to a large number of cases for a com- hand, and the entries cannot convey all nuances. Necessary
mon type of cancer. For example, an increased risk of 10 per clarifications and qualifications are stated in footnotes to the
cent implied by a RR of 1.10 amounts to many extra cases matrices.
of colorectal and breast cancer in Europe and North Matrix entries themselves need to be explained. For exam-
America, where these cancers are common. Assessment ple, an entry fruits or foods containing dietary fibre in a
of small RRs depends on the size and quality of the matrix column headed decreases risk means that the Panel
studies in which such risks are identified. Small RRs may has judged that these foods are or may be protective against
58
C H A P T E R 3 J U D G I N G T H E E V I D E N C E
59
P A R T I B A C K G R O U N D
This box lists the criteria finally agreed by so long as this can be explained mendations designed to reduce the inci-
the Panel that were necessary to support plausibly. dence of cancer. Any exceptions to this
the judgements shown in the matrices and Strong and plausible experimental require special explicit justification.
text of the Part 2 chapters. The grades evidence, either from human studies or All the following were generally
shown here are convincing, probable, relevant animal models, that typical required:
limited suggestive, limited no con- human exposures can lead to relevant Evidence from at least two independent
clusion, and substantial effect on risk cancer outcomes. cohort studies or at least five case-
unlikely. In effect, the criteria define these control studies.
terms. Probable The direction of effect is generally
These criteria are for evidence strong consistent though some unexplained
Convincing enough to support a judgement of a prob- heterogeneity may be present.
These criteria are for evidence strong able causal relationship, which would gen- Evidence for biological plausibility.
enough to support a judgement of a con- erally justify goals and recommendations
vincing causal relationship, which justifies designed to reduce the incidence of cancer. Limited no conclusion
goals and recommendations designed to All the following were generally Evidence is so limited that no firm conclu-
reduce the incidence of cancer. required: sion can be made.
A convincing relationship should be Evidence from at least two independent This category represents an entry level,
robust enough to be highly unlikely to be cohort studies, or at least five case- and is intended to allow any exposure for
modified in the foreseeable future as new control studies. which there are sufficient data to warrant
evidence accumulates. All of the following No substantial unexplained Panel consideration, but where insufficient
were generally required: heterogeneity between or within study evidence exists to permit a more definitive
Evidence from more than one study type. types in the presence or absence of an grading. This does not necessarily mean a
Evidence from at least two independent association, or direction of effect. limited quantity of evidence. A body of evi-
cohort studies. Good quality studies to exclude with dence for a particular exposure might be
No substantial unexplained confidence the possibility that the graded limited no conclusion for a
heterogeneity within or between study observed association results from number of reasons. The evidence might be
types or in different populations random or systematic error, including limited by the amount of evidence in terms
relating to the presence or absence of confounding, measurement error, and of the number of studies available, by
an association, or direction of effect. selection bias. inconsistency of direction of effect, by
Good quality studies to exclude with Evidence for biological plausibility. poor quality of studies (for example, lack
confidence the possibility that the of adjustment for known confounders), or
observed association results from Limited suggestive by any combination of these factors.
random or systematic error, including These criteria are for evidence that is too Exposures that are graded limited no
confounding, measurement error, and limited to permit a probable or convincing conclusion do not appear in the matrices
selection bias. causal judgement, but where there is evi- presented in Chapters 46, but do appear
Presence of a plausible biological dence suggestive of a direction of effect. in Chapters 7 and 8.
gradient (dose response) in the The evidence may have methodological When an exposure is graded limited
association. Such a gradient need not flaws, or be limited in amount, but shows no conclusion, this does not necessarily
be linear or even in the same direction a generally consistent direction of effect. indicate that the Panel has judged that
across the different levels of exposure, This almost always does not justify recom- there is evidence of no relationship. With
3.5.3 The food-based approach rather than simply a marker for the particular foods in which
Terms used in the text of this Report and in the matrices it is found; or for other dietary constituents found in the
reflect the Panels decision that the Report, and its judge- same foods; or other associated health-related factors. In
ments and recommendations, should whenever possible be chapter 4.10, some micronutrients appear in matrices grad-
based on foods and drinks rather than on nutrients. This ed as convincing or probable. These judgements are
food- (and drink-) based approach is also apparent in the derived from the findings of good quality, randomised, con-
overall structure of the Report. Chapter 4, the first chapter trolled trials, sometimes also supported by observational
in Part 2, on foods and drinks, is the longest chapter. This is studies, clearly showing that supplements of these micronu-
in part because dietary constituents associated with foods are trients, rather than the foods containing them, affect the risk
grouped with these foods. Thus, matrix entries in chapter 4.1 of cancer.
identify foods containing dietary fibre (rather than dietary Sometimes the studies that are the basis for the Panels work
fibre), and in 4.8 identify alcoholic drinks (rather than alco- have used markers of exposure. Thus, many epidemiological
hol or ethanol). Chapters 4, 5, and 6 also include material studies use body mass index as a marker of body fatness.
presented graphically, such as the forest plots described in When there is clear evidence of an underlying mechanism for
box 3.3. body fatness, the Panel has agreed that the term body fatness
The food-based approach is also justified because of the best represents the causal factor. Usually, anthropometric
uncertainty that any food constituent is a true causal factor, indices other examples being waist to hip ratio and waist
60
C H A P T E R 3 J U D G I N G T H E E V I D E N C E
further good quality research, any expo- confidence, the possibility that the on risk unlikely with a lower confidence
sure graded in this way might in the future absence of an observed association than this would not be helpful, and could
be shown to increase or decrease the risk results from random or systematic overlap with judgements of limited sug-
of cancer. Where there is sufficient evi- error, including inadequate power, gestive or limited no conclusion.
dence to give confidence that an exposure imprecision or error in exposure
is unlikely to have an effect on cancer risk, measurement, inadequate range of Special upgrading factors
this exposure will be judged substantial exposure, confounding, and selection These are factors that form part of the
effect on risk unlikely. bias. assessment of the evidence that, when pre-
There are also many exposures for which Absence of a demonstrable biological sent, can upgrade the judgement reached.
there is such limited evidence that no gradient (dose response). So an exposure that might be deemed a
judgement is possible. In these cases, evi- Absence of strong and plausible limited suggestive causal factor in the
dence is recorded in the full SLR reports experimental evidence, either from absence, say, of a biological gradient,
contained on the CD included with this human studies or relevant animal might be upgraded to probable in its
Report. However, such evidence is usually models, that typical human exposures presence. The application of these factors
not included in the summaries and is not lead to relevant cancer outcomes. (listed below) requires judgement, and the
included in the matrices in this printed way in which these judgements affect the
Report. Factors that might misleadingly imply an final conclusion in the matrix are stated.
absence of effect include imprecision of Presence of a plausible biological
Substantial effect on risk unlikely the exposure assessment, an insufficient gradient (dose response) in the
Evidence is strong enough to support a range of exposure in the study population, association. Such a gradient need not
judgement that a particular food, nutri- and inadequate statistical power. Defects be linear or even in the same direction
tion, or physical activity exposure is unlike- in these and other study design attributes across the different levels of exposure,
ly to have a substantial causal relation to a might lead to a false conclusion of no so long as this can be explained
cancer outcome. The evidence should be effect. plausibly.
robust enough to be unlikely to be modi- The presence of a plausible, relevant A particularly large summary effect size
fied in the foreseeable future as new evi- biological mechanism does not necessarily (an odds ratio or relative risk of 2.0 or
dence accumulates. rule out a judgement of substantial effect more, depending on the unit of
All of the following were generally on risk unlikely. But the presence of exposure) after appropriate control for
required: robust evidence from appropriate animal confounders.
Evidence from more than one study models or in humans that a specific mech- Evidence from randomised trials in
type. anism exists, or that typical exposures can humans.
Evidence from at least two independent lead to cancer outcomes, argues against Evidence from appropriately controlled
cohort studies. such a judgement. experiments demonstrating one or
Summary estimate of effect close to Because of the uncertainty inherent in more plausible and specific mechanisms
1.0 for comparison of high versus low concluding that an exposure has no effect actually operating in humans.
exposure categories. on risk, the criteria used to judge an expo- Robust and reproducible evidence from
No substantial unexplained sure substantial effect on risk unlikely are experimental studies in appropriate
heterogeneity within or between study roughly equivalent to the criteria used animal models showing that typical
types or in different populations. with at least a probable level of confi- human exposures can lead to relevant
Good quality studies to exclude, with dence. Conclusions of substantial effect cancer outcomes.
circumference do not appear in the matrices. relationships). Its decisions here have been enlightened by
As exceptions to this approach, the Panel has made judge- the rapid development since the mid-1990s of the technique
ments on adult attained height and greater birth weight, of systematic review, using search techniques enabled by the
as shown in the matrices. Many epidemiological studies have electronic revolution.
reported on height and birth weight. It is thought that asso- Since the mid-1990s, about as many studies in the field
ciations between height, birth weight, and cancer risk reflect of this Report have been published as were published in the
some causal association with a combination of genetic, hor- previous 35 years. This development has not just been one
monal, nutritional, and other factors. Uncertainty as to the of quantity but also of design and quality. In particular, many
mechanisms underlying the observations with adult attained cohort studies have been published in the period analysed
height and birth weight mean that the Panel was not able by the SLRs, and some of these have also been pooled. The
to determine the appropriate causal factors to be shown in Panel agreed that in general, cohort studies provide more
the matrices. Instead, the anthropometric markers have been impressive evidence than case-control and other epidemio-
included, with appropriate footnotes. logical study designs, and this decision affected the criteria
for judgement. For this reason, while the best evidence
3.5.4 The basis for robust judgements comes from a number of different study designs, the Panel
The Panel has been particularly careful in deciding the cri- agreed that reasonably strong and consistent evidence was
teria for judgement on causal relationships (or lack of such needed from studies where biases could reasonably be
61
P A R T I B A C K G R O U N D
excluded. Usually this evidence came from cohort studies public health goals and personal recommendations.
with a prospective design or, where available and appropri-
ate, from randomised controlled trials, to allow a judgement Limited and below
of convincing or probable. This was not a requirement spec- For the two types of limited judgement, the evidence falls
ified for the previous report. See box 3.8. short of a higher judgement for a variety of reasons. There
A consequence is that the same amount of evidence for any are also many exposures for which evidence was so limited
particular association has sometimes led to a different judge- that it did not warrant detailed consideration. In these cases,
ment and level of matrix entry from the previous report. evidence is recorded in the full SLR reports contained on the
Sometimes, in cases where there is a greater quantity of evi- CD included with this Report. However, this evidence is not
dence, this might not lead to a higher classification, and included in the summaries or matrices in this printed Report.
could even possibly lead to a lower one. These refinements
are intended to give as robust an assessment as possible, Absence of a causal relation
given current understanding. In these respects, the criteria The strength of this judgement corresponds to that for con-
used by the Panel are more stringent than those pioneered vincing or probable (and replaces the previous reports no
by the previous panel. relationship category). This judgement does not reflect the
The Panel agreed that the criteria for their judgements absence of evidence, which in itself is not evidence of
should be detailed and precise. But such criteria do not absence of effect. As with judgements of convincing or
lead to automatic judgements. However meticulous, they probable, evidence from both observational studies and ran-
cannot replace expert judgement. If a reviewer or a Panel domised trials contribute to such an inference.
member felt that important considerations had been over-
looked by the overall agreed process, this was discussed,
and the Panels final judgement specified, with reasons 3.6 Conclusions
provided.
Reports such as this address issues of public importance.
3.5.5 The grading criteria They are informed by a process of collection, display, dis-
Specification of criteria for the grading of judgements cussion, and judgement of evidence as the basis for recom-
enables a common, transparent approach. But as indicated, mendations made in the public interest.
any such criteria cannot fully capture the sophistication and We, the members of the Panel responsible for this Report,
nuances of all the studies considered, or the nature and qual- have had the responsibility to ensure that the judgements we
ity of different studies. have made in Part 2, and the public health goals and per-
In using the criteria specified here, the Panel has taken into sonal recommendations we have specified in Part 3, are
account additional factors including, but not confined to, the clearly and reliably based on current evidence.
type, number, and size of studies; their design and execu- In the five years of our work, we have built on the work of
tion; the nature of any intervention; the definition of cases the previous report, and have been supported by the findings
and non-cases; the selection of any comparison group; meth- of a preliminary Methodology Task Force; by the evidence
ods of characterising exposure and outcome; length and gathered and presented by independent SLR centres; by
completeness of follow-up; and the methods used to ascer- observers from United Nations and other international organ-
tain cases. isations; and by the Reports Secretariat. As far as we know,
Other factors might lead to one or another grading. Failure the whole process, which has also included eight face-to-face
to achieve a higher grade might result from several small Panel meetings, each lasting up to four days, is the most com-
deficits against a number of standards, or from a major short- prehensive and rigorous of its kind yet undertaken.
fall in one particular aspect of evidence. Panel expertise was As this chapter shows, no method used to ascertain causal
essential in judging whether criteria were met, or upgrad- relationships between food, nutrition, physical activity, and
ing factors (box 3.8) were applicable, as well as deciding cancer is perfect. But we believe that the integrated and
what constituted substantial heterogeneity, high-quality sometimes innovative approaches we have taken, sum-
study design, and so on. The criteria provide a consistent marised here, have enabled us to make sound judgements
basis for judgement, not a set of boxes to be ticked. As well and reliable recommendations. We have also done our best
as these upgrading factors, particular reasons why any spe- to make sure that the methods we have used are explained
cific judgement was reached are presented under the rele- and displayed transparently, so they can be readily accessed
vant exposure and cancer site in Chapters 47. and challenged as science develops, or from different points
The following grading criteria specify the quantity, quali- of view. We believe this best serves science, and also the
ty, and nature of evidence that can lead to associations being cause of cancer prevention.
graded differently.
Convincing, probable
In considering the criteria allowing a judgement that the evi-
dence of a causal relationship was convincing, or that the
evidence showed a probable causal relationship, the Panel
was conscious that both judgements were liable to generate
62
Part 2
` i Vi > `
` } i i
Chapter 4
Foods and drinks 66
Chapter 5
Physical activity 198
Chapter 6
Growth, development, body composition 210
Chapter 7
Cancers 244
Chapter 8
Determinants of weight gain, overweight, obesity 322
Chapter 9
Cancer survivors 342
Chapter 10
Findings of other reports 348
Chapter 11
Research issues 360
P A R T 2
Introduction to Part 2
EVIDENCE AND JUDGEMENTS
The brief of the Panel, and of the systematic literature review teams that
provided the basis for the Panels work, has included the task of presenting a
clear, strong, and reliable foundation for the final recommendations. These in
turn form the basis of sound policies and effective programmes to reduce the
rates of cancer in populations, and the risk of cancer in people, whether as
members of communities, or as families, or as individuals.
In this central part of the Report, seven chapters display the findings of the
independently assembled systematic literature reviews, and the judgements of
the Panel derived from these reviews and other evidence as needed. The Panels
judgements are displayed in the form of matrices that introduce five of these
chapters. Judgements of convincing and probable causal relationships,
shown in the top part of these matrices, are the basis for recommendations
made in Part 3 of the Report.
Chapter 4, the first and longest chapter that follows, is concerned with types of
food and drink. The judgements of the Panel are generally food- and drink-
based, reflecting the evidence. Findings on dietary constituents and
micronutrients are identified as, for example, on foods containing dietary
fibre or foods containing folate. For consistency, findings on methods of food
processing are, where possible, shown as part of the whole evidence on the
associated foods so that, for example, the processing and preparation of meat
is integrated with the evidence on meat. Evidence specifically on dietary
supplements and on patterns of diet is included in the two final sections of this
chapter.
Chapters 5 and 6 are concerned with physical activity, and with body
composition, growth, and development. Evidence in these areas is more
impressive than was the case up to the mid-1990s; the evidence on growth and
development indicates the importance of a whole life-course approach to the
prevention of cancer. As with the chapter on foods and drinks, these chapters
include detailed summaries of the evidence collected in the systematic
literature reviews together with graphic representations of the most significant
evidence.
Chapter 8, in which judgements are also based on the evidence from the
systematic literature reviews amplified by knowledge of physiological
processes, concerns the biological and associated determinants of weight gain,
overweight, and obesity. Before work on this chapter began, the Panel agreed
that a comprehensive review of the evidence would be likely to show that
64
obesity is or may be a cause of a number of cancers. It was therefore important
to identify what aspects of food, nutrition, and physical activity themselves
affect the risk of obesity and associated factors.
The Panel agreed that its final recommendations should be principally based on
the evidence concerning cancer, and also should take into account findings on
food, nutrition, physical activity, and the prevention of other chronic diseases,
and of nutritional deficiencies and nutrition-related infectious diseases,
especially of childhood. Chapter 10, which is also based on a systematic
literature review, is a summary of the findings of expert reports in these areas.
The proposals for further research contained in Chapter 11 are, in the view of
the Panel, the most promising avenues to explore in order to refine
understanding of the links between food, nutrition, physical activity, and
cancer, and so improve the prevention of cancer, worldwide.
65
P A R T 2 E V I D E N C E A N D J U D G E M E N T S
C H A P T E R 4
This chapter, with the following chapters in Part production, preservation, processing, and
Two, forms the basis for the population goals and preparation (including cooking), that have not been
personal recommendations in Part Three. incorporated in previous sections. The final section
The Panel decided that the evidence on food, summarises evidence on dietary patterns, including
nutrition, and cancer is generally most persuasive being breastfed.
for foods rather than for specific nutrients or other The pattern that emerges, though different in
food constituents; and that the evidence from some important respects, is largely similar to that
epidemiological and experimental studies in this based on the evidence gathered in the mid-1990s,
field, usually undertaken to address questions although the confidence with which various
about cancers of specific or related sites, is most exposures are judged to cause or protect from
usefully synthesised in terms of foods and drinks. cancer has sometimes changed.
The detailed evidence on foods and drinks is
presented in this chapter, and that on physical
activity and on body composition in the following
two chapters. These three chapters include
summaries of the evidence, including meta-analyses
presented in graphic form, as well as the Panels
judgements. Chapter 7 presents the evidence on
cancer sites in more summarised form.
In this chapter, whenever possible and
appropriate, the evidence on dietary constituents,
and on food production, preservation, processing,
and preparation (including cooking), is integrated
with the evidence on foods and drinks. So here, for
example, the evidence on carotenoids is considered
together with the evidence on vegetables and
fruits; the evidence on methods of cooking meats is
considered with the evidence on red meat and on
processed meats; and the evidence on ethanol is
considered with alcoholic drinks.
The result is not perfect. There is no single, ideal
way of categorising the evidence on food and
nutrition. But an approach emphasising foods and
drinks is consistent with the generally accepted
view that food-based dietary guidelines and
recommendations are particularly valuable as a
foundation for policies designed to improve public
health.
The first two sections of this chapter summarise
and judge the evidence on plant foods; the next
two sections that on animal foods; and the
following two sections that on fats and oils, and
sugars and salt. The next two sections concern
drinks, the second of which covers alcoholic drinks.
These are followed by sections concerned with
those aspects of dietary constituents, and with food
66
C H A P T E R 4 F O O D S A N D D R I N K S
CEREALS (GRAINS), STARCHY ROOTS AND TUBERS, PLANTAINS, AND THE RISK OF CANCER
In the judgement of the Panel, the factors listed below modify the risk of cancer. Judgements are graded according to the strength of the evidence.
Substantial
effect on risk None identified
unlikely
1 Foods that may be contaminated with aflatoxins include cereals (grains), and also pulses (legumes), seeds, nuts, and some vegetables and fruits (see chapter 4.2).
2 Includes both foods naturally containing the constituent and foods which have the constituent added (see chapter 3.5.3). Dietary fibre is contained in plant foods
(see chapter 4.2 and box 4.1.2).
For an explanation of all the terms used in the matrix, please see chapter 3.5.1, the text of this section, and the glossary.
These starchy plant foods have been the staple sources of The Panel judges as follows:
dietary energy and bulk for humans since the Foods containing dietary fibre probably protect against
development of settled communities and agriculture. They colorectal cancer; and there is limited evidence
have to be prepared in some way to make them edible. In suggesting that such foods protect against oesophageal
whole or relatively unprocessed forms, they are also cancer. Dietary fibre is found in plant foods: vegetables,
sources of dietary fibre and various micronutrients. fruits, and pulses (legumes) (see chapter 4.2), as well as
Cereals in whole form contain essential fats. When the in cereals, roots, tubers, and plantains. All these foods are
outer layers of these foods are removed and they are highest in dietary fibre when in whole or minimally
refined, most of what remains is starch and protein. processed form.
In general, with industrialisation and urbanisation, Foods high in dietary fibre may have a protective effect
consumption of these foods decreases, and more is because of being bulky and relatively low in energy
consumed in the form of cereal products, which are density. See chapters 6.1, 7.3, 7.9, and Chapter 8 for
typically more energy-dense and which may contain discussion of the role of energy density in weight gain,
substantial amounts of fat, sugar, or salt. Pure starch from overweight, and obesity, and of weight gain, overweight,
these foods is also used as an ingredient in many and obesity in the risk of some cancers, including those of
processed foods. Wheat, rice, maize (corn), and potatoes the oesophagus and colorectum.
and their products are now the main cereals and The Panel also judges that the evidence that foods
roots/tubers produced and consumed globally. contaminated with aflatoxins are a cause of liver cancer is
Overall, the Panel judges that evidence indicating that convincing. Cereals (grains) and peanuts (see chapter
cereals (grains), roots, tubers, or plantains affect the risk 4.2) are the foods most commonly infested by these
of any cancer, remains insubstantial. fungal toxins. Contamination is most widespread in
67
P A R T 2 E V I D E N C E A N D J U D G E M E N T S
countries with hot, damp climates and poor storage 4.1.1 Definitions, sources
facilities.
Within the remit of this Report, the strongest evidence, Cereals (grains)
corresponding to judgements of convincing and Cereals (grains) are the seeds and energy stores of cultivat-
probable, shows that foods containing dietary fibre ed grasses. The main types are wheat, rice, maize (corn),
probably protect against colorectal cancer; and that foods millet, sorghum, barley, oats, and rye. In some countries,
contaminated with aflatoxins are a convincing cause of cereal is also a term for dry foods made from grains and
liver cancer. Also see chapter 4.2 for judgements of other ingredients, often eaten with milk for breakfast.
probable protective effects of foods containing various
micronutrients also found in cereals, roots, and tubers, Roots, tubers, plantains
particularly when relatively unprocessed. Roots and tubers are energy stores of plants. Names and def-
initions can vary around the world potatoes are tubers,
which are the tips of underground stems that swell with
Cereals (grains) are the staple foods in large parts of the world, starch (a polysaccharide) and water. While potatoes are
supplying most of the energy and bulk in diets. In some regions, often classed as vegetables (in the USA, for instance), they
roots, tubers, or plantains are staple foods as well as or instead are grouped separately from non-starchy vegetables in this
of cereals (grains). These generalisations apply to practically Report. Sweet potatoes, sometimes called yams in North
all settled rural and most urban populations. Monotonous America, are a type of storage root rather than a tuber, but
poverty diets containing very high levels of these foods, par- true yams are starchy tubers. Cassava (manioc) and yucca
ticularly if refined, are low and sometimes inadequate in pro- are elongated roots, and sago is a starchy food made from
tein and other nutrients. Gathererhunter and pastoral the pith of some types of palm tree. Taro is cultivated for its
communities usually consume less of these starchy foods. Their edible leaves, as well as its starchy corm, which is similar to
nutrient content is variable, largely depending on the degree a tuber. Plantains are one of several fruits used as vegeta-
to which they are refined. bles: they grow on trees and look like bananas, but only a
Consumption of cereals, roots, and tubers in general gradu- small proportion of the starch is converted to sugar during
ally drops with industrialisation and urbanisation, and an the ripening process, which makes them similar to potatoes
increasing amount of wheat in particular is grown for animal to cook with.
feed. These foods are increasingly used as a basis for or ingre-
dients in processed products that are often energy-dense,
high in fats or sugars, and sometimes salt. In lower-income Box 4.1.1 Wholegrain and refined
countries, total population consumption of these foods cereals and their products
may amount to 6080 per cent of total energy, and in high- Many of the cereals (grains) that we consume are refined. Grains
income countries, usually to less than 30 per cent. Also see are first broken into pieces and then refined, sifting away the
Chapter 1. bran, germ and, usually, the aleurone layer. This removes most
Early reports concerned with nutritional deficiencies gen- of the fibre, oil, and B vitamins, as well as approximately 25 per
erally did not pay much attention to these foods and instead cent of the protein. Polishing, as often performed on rice,
removes additional nutrients. Many high-income countries
gave priority to energy- and nutrient-dense foods of animal
therefore fortify refined cereals, including flour, with B vitamins
origin, such as milk, eggs, and meat. Beginning in the 1970s, and iron. Wholegrain products generally contain the con-
interest in dietary fibre increased, following informal epi- stituents of the grain but, given the absence of an internation-
demiological findings that diets high in dietary fibre were ally accepted definition, intact grains are present to a variable
associated with a lower risk of a number of chronic diseases.1 extent. The extent to which the grain remains intact influences
2
By the 1990s, it was generally agreed that diets relatively physiological processes in the bowel and hence health.
high in cereals (grains) and other starchy staple foods, prefer- Cereal foods may be eaten in wholegrain form, although con-
ably relatively unrefined, protect against obesity, type 2 dia- sumption in refined forms, such as white rice, bread, or pasta,
betes, coronary heart disease, and perhaps also digestive is generally much more common, particularly in high-income
disorders.3 4 Evidence that such diets protect against cancer countries. Refined grains are considered easier than wholegrains
to cook and to chew; are light in colour which is attractive
of any site has been less impressive, but epidemiological
to many consumers; and also have a longer shelf-life than
studies tend not to distinguish between degrees of refine- wholegrain products, as the oil in bran goes rancid relatively
ment of cereals, roots, and tubers. quickly.
This section (4.1) includes cereal products and dietary Breakfast cereals, particularly in the United States and parts
fibre. It also includes contamination by aflatoxins, though of Europe, also account for a significant proportion of grain
this may also affect other plant foods (also see chapter 4.2). eaten. Many breakfast cereals, although based on grains
Non-starchy root vegetables such as carrots are included in (whole or refined), may contain substantial amounts of added
chapter 4.2. Micronutrients found in plant foods are includ- sugars. Grains are further processed to provide ingredients such
ed in chapter 4.2, though most of these are also found in as corn syrup, starch, or alcohol. They also form the basis of
cereals (grains), roots, tubers, and plantains. many animal feeds.
Processed grains have a higher glycaemic index than
unprocessed grains and, generally, the greater the degree of
processing, the greater the glycaemic index (box 4.1.3).
68
C H A P T E R 4 F O O D S A N D D R I N K S
Box 4.1.2 Foods containing dietary fibre Box 4.1.3 Glycaemic index and load
The concept of dietary fibre arose from observations of the low The degree to which different foods and meals raise blood glu-
prevalence of colon cancer, diabetes, and coronary heart disease cose depends not only on the nature of the carbohydrate, but
in parts of Africa amongst people whose diets were high in also on the characteristics of the foods consumed. Glycaemic
unrefined carbohydrates and whose stools were typically bulky, index (GI) is a measure of the degree to which a food raises
and often or sometimes semisolid. Considerable efforts have blood glucose compared with a standard food (usually glucose
been dedicated to characterising the dietary components of or white bread) under standard conditions. The test food must
what has come to be called dietary fibre that might confer contain the same amount of available carbohydrate (usually 50
health benefit. Naturally occurring dietary fibre is only derived grams) as the standard. GI was originally used as an aid to food
from plant foods. Pulses (legumes) and minimally processed choice in diabetes and has more recently been applied to peo-
cereals are particularly concentrated sources, but vegetables and ple without diabetes. The rise in blood glucose after consuming
fruits also contain significant amounts. Dietary fibre isolated a food depends not only on the GI but also on the amount of
from plant cell walls and in synthetic forms are increasingly food eaten. A related measure, glycaemic load (GL), takes into
entering the food supply. account both the GI of a food as well as the actual amount of
High intakes of dietary fibre, variously defined, have been carbohydrate consumed. The GL of a food may be measured
associated with reduced risk of cardiovascular disease as well as directly or calculated by multiplying the GI of a food by the num-
of some cancers. Definitions of dietary fibre vary. Some are ber of carbohydrate grams in a serving of the food.
based on chemical analyses of the components of plant cell Factors that influence the GI of a food include the type of car-
walls, such as non-starch polysaccharide, others on physiologi- bohydrate, how the food is processed or cooked, and the other
cal effects the carbohydrates that enter the large bowel hav- components present in the food (for example, fat, protein,
ing escaped digestion in the small intestine being defined as fibre). There is some relationship (inverse) between GI and fibre
dietary fibre. The latter definition includes oligosaccharides and content, although some foods high in fibre have a high GI and
resistant starch. The World Health Organization and Food and vice versa. Factors can affect GI by influencing speed of absorp-
Agriculture Organization have recently proposed that only poly- tion, for instance higher fat foods tend to have a low GI. The
saccharides which form part of plant cell walls should be regard- calculated GI of a mixed meal or whole diet has been shown in
ed as dietary fibre and that the health benefits of resistant some studies to correlate with the actual GI obtained by feed-
starch and oligosaccharides are more appropriately considered ing a mixed meal. Although the concept of GI has been contro-
separately. versial, the GI and GL of diets have predicted risks of type 2
diabetes and coronary heart disease and related biomarkers,
independent of dietary fibre, in prospective epidemiological
studies, suggesting that GI and GL may be useful markers.
The relevance to cancer might lie in the fact that the rise in
This section refers to starchy roots, tubers, and plantains. blood glucose after a meal is closely linked to that of insulin,
Carrots, beets, parsnips, turnips, and swedes are non-starchy which apart from its crucial role in carbohydrate and lipid
roots, and are classified as non-starchy vegetables in this metabolism, is also one of a family of important growth factors
Report. Also see chapter 4.2. (also see Chapter 2).
4.1.2 Composition
Cereals (grains)
The relative amounts of dietary constituents in cereals and Roots, tubers, and plantains
cereal foods depend largely on the degree of refinement and Roots and tubers are less concentrated stores of starch,
other forms of processing (box 4.1.1). Starch makes up although this accounts for almost all of their raw weight
about 70 per cent of the raw weight of the storage tissues apart from water. Starch content varies from around 1520
(endosperm) of unprocessed cereal grains. The outer parts per cent in sweet potatoes to 2530 per cent in cassava and
of the grain (the bran and the aleurone layer) contain non- yams, which translates into around 8095 per cent of the
starch polysaccharide, a type of carbohydrate that charac- dietary energy of these roots and tubers. Cooking sweet
terises dietary fibre (box 4.1.2). potatoes makes them taste sweet because an enzyme con-
Cereals also contain variable amounts of protein, oils, B verts as much as 75 per cent of the starch into maltose (a
vitamins, vitamin E and tocotrienols, iron, and various trace disaccharide). Roots and tubers eaten with the skin on are
elements, as well as phytochemicals, some of which, such high in dietary fibre. These foods are generally poor sources
as the antioxidants, are bioactive (box 4.1.2). The germ is of protein, so although protein deficiency is uncommon,
the embryonic part of cereal plants and contains oils, pro- populations that subsist on these foods, and do not eat pro-
teins, and fibre. Various cereals contain other specific com- tein-rich pulses (legumes), are at risk of deficiency, especially
ponents. Wheat contains gluten (a mixture of proteins). Rye children weaned on thin gruels made with these low-protein
has high levels of pentosans and oats contain beta-glucans, foods. They contain variable amounts of other nutrients.
both of which are non-starch polysaccharides, a character- Potatoes contain vitamin C, for example, and the orange
ising feature of dietary fibre. varieties of sweet potatoes contain carotenoids. Yams con-
Cereals (grains) and pulses (legumes) may be contami- tain many bioactive compounds and taro corms are high in
nated with aflatoxins. See box 4.1.4. vitamin B6, fibre, and manganese.
69
P A R T 2 E V I D E N C E A N D J U D G E M E N T S
4.1.3 Consumption patterns it is used to make grits, cornmeal (used for polenta as well
as corn breads), corn flour, tortillas, tamales, and corn chips.
Cereals and grains It is also the basis of corn starch (a thickener), corn syrup
As societies moved to more settled, agricultural ways of life (a sweetner), and corn oils. Sweetcorn is also eaten as a veg-
1015 000 years ago, cereals became the main staple foods; etable, either on or off the cob. Rice is usually processed to
the types of cereal crops grown depended largely on climate remove the bran and aleurone layers, turning brown rice
and terrain. Wheat, barley, oats, and rye are traditionally sta- into white. It is also used to make flour (the basis for gluten-
ple foods for people living in the Middle East and Europe; free breads), rice powder, noodles, rice paper, rice milk,
and with rice in Asia; maize (corn) in the Americas; and Japanese mochi, and lao-chao (Chinese fermented rice).
sorghum and millet in Africa. But the market for cereals and Barley is used primarily in Asia (tsampa and miso soya paste)
their products is now global, although some, such as and in North Africa (soups, porridges, and flat breads).
sorghum, remain largely regional. Whole rye grains are milled and used to make bread in some
The importance of starchy staples in food systems and north and east European countries. Whole oats are made
diets is broadly connected to economic and industrial devel- into porridges and used in muesli and baked goods, such
opment. Both in higher-income countries and across the as biscuits. Fonio, millet, sorghum, teff, and triticale are
world, there has been a long-term decline in their con- traditional crops and staples in parts of Africa and Asia.
sumption. With increasing urbanisation in lower-income Many grains are also fermented to make alcoholic drinks (see
countries, wheat and maize are replacing traditional staple chapter 4.8.1).
foods. An important exception is Asia, where rice remains the
staple grain. Cereal cultivation and consumption tends to be Roots, tubers, and plantains
highest in most of Asia and lowest in Oceania, parts of Roots, tubers, and plantains are staple foods in some parts
Europe, and North America. of the world. For instance, populations in some regions
Globally, cereal foods provide more than 45 per cent of of sub-Saharan Africa, Latin America, and Oceania base
dietary energy; diets based on these foods tend to be bulky their diets on these foods. Globally, starchy roots provide
with a low energy density (see chapter 8.8.4). Cereals pro- around 5 per cent of dietary energy. Consumption is high-
vide more than 50 per cent of dietary energy in low-income est in the Pacific islands and parts of Africa, with cassava and
countries, but only around 30 per cent in high-income coun- yams providing more than 40 per cent of dietary energy in
tries. While grains contribute roughly 20 per cent of dietary Ghana. Potatoes can provide as much as 10 per cent of
energy in Australia, North America, and central Europe, they dietary energy in North America and Europe. Globally, plan-
can provide as much as 70 per cent in parts of Asia (main- tains provide less than 0.5 per cent of dietary energy, but
ly from rice). Although more wheat is grown than rice on a they are locally important in some African, Latin American,
global basis, much of it is used for animal feed. Rice is the and Caribbean countries, where they can provide more than
principal food for half of the worlds population. 15 per cent of dietary energy. Some populations do not rely
Cereals are very versatile once they have been processed on any of these foods for instance, pastoralist societies
from the raw grain. Wheat is mainly milled to make flour such as the Maasai hunters in East Africa, and the Inuit and
for bread, pastries, cakes, and pasta. Maize (corn) is a sta- other Arctic populations, maintain their traditional ways of
ple food in Latin America and parts of Asia and Africa, where life and diets.
70
C H A P T E R 4 F O O D S A N D D R I N K S
Interpretation of the evidence on any and all foods and 4.1.5 Evidence and judgements
drinks, their constituents, their methods of production,
preservation, processing and preparation, and other factors, The full systematic literature review (SLR) is contained on
with the risk of cancer, is never simple, for general and spe- the CD included with this Report.
cific reasons.
4.1.5.1 Cereals (grains)
4.1.4.1 General The evidence was too limited in amount, consistency, or
For general considerations that may affect interpretation of quality to draw any conclusions.
the evidence, see chapters 3.3 and 3.5, and boxes 3.1, 3.2,
3.6, and 3.7. 4.1.5.2 Roots, tubers, and plantains
Relative risk (RR) is used in this Report to denote ratio The evidence was too limited in amount, consistency, or
measures of effect, including risk ratios, rate ratios, haz- quality to draw any conclusions.
ard ratios, and odds ratios.
4.1.5.3 Foods containing dietary fibre
4.1.4.2 Specific Colorectum
Some considerations specific to cereals (grains), roots, Sixteen cohort studies9-37 and 91 case-control studies inves-
tubers, and plantains are as follows. tigated dietary fibre and colorectal cancer. The Harvard pool-
ing project also analysed original data from 13 separate
Classification. Cereals is a broad classification. Different cohort studies.38
cereals have different nutritional composition and biological An association was apparent from many, though not all,
effects, as do different types of dietary fibre. Any effects cohort studies. Ten studies showed decreased risk when com-
of specific cereals or their constituents may not become paring high with low intake groups,14 19 21 25-29 33 34 which was
apparent. statistically significant in one (figure 4.1.1).28 Two reported
non-significant increased risk,36 39 one showed no effect on
Patterns and ranges of intake. Little evidence relates to roots, risk,30 and one reported no association.18 One study report-
or tubers other than potatoes, or plantains, some of which, ed non-significant decreased risk in women and non-
such as cassava (manioc) or yams, are staple foods in some significant increased risk in men23; one study reported
parts of the world. non-significant increased risk in women and non-significant
Terminology. Potatoes are usually (as here) defined as tubers, decreased risk in men.37 Meta-analysis was possible on eight
but are sometimes (in the USA especially) included with veg- studies, giving a summary effect estimate of 0.90 (95% con-
etables. Bananas, a significant item in many diets, may be fidence interval (CI) 0.840.97) per 10 g/day increment,
(as here) defined as a fruit, or else with plantains as a starchy with moderate heterogeneity (figure 4.1.2). A dose-response
food. There is no internationally agreed definition for dietary relationship was apparent from cohort data.
fibre (box 4.1.1). Because of the abundant prospective data from cohort
studies, case-control studies were not summarised.
Measurement. Non-starch polysaccharides are measured pre- The Harvard pooled analysis from 13 prospective cohort
cisely by the Englyst method,8 but there are fewer epidemi- studies (725 628 participants, followed up for 6 to 20 years,
ological data on non-starch polysaccharides specifically than 8081 colorectal cancer cases) gave a significant inverse asso-
for dietary fibre. The various analytical techniques used to ciation in the age-adjusted model (0.84, 95% CI
assess the fibre content of foods give widely different results. 0.770.92).38 However, the association was attenuated
and no longer statistically significant after adjusting for
Confounding. In high-income countries, high intakes of other risk factors (0.94, 95% CI 0.861.03). One compari-
wholegrain cereal products tend to go together with other son group was statistically significant when maximally
health-conscious dietary and other habits. Also there is pos- adjusted, others were not. Compared with dietary fibre
sible confounding between dietary fibre and other dietary intake of 10 to < 15 g/day, the pooled effect estimate was
constituents and in general with healthier dietary patterns 1.18 (95% CI 1.051.31) for less than 10 g/day (low com-
and ways of life. Data on dietary fibre come predominantly pared with moderate intake). All other measures were not
from dietary sources, that is, plant-based foods (also see box associated with risk of colorectal cancer. The pooled analy-
4.1.1 and chapter 4.2); therefore, no effect can be attributed sis therefore found that, after accounting for other dietary
to different types and sources of dietary fibre. risk factors, high dietary fibre intake was not associated
71
P A R T 2 E V I D E N C E A N D J U D G E M E N T S
Figure 4.1.1 Dietary fibre and colorectal cancer; Figure 4.1.2 Dietary fibre and colorectal cancer;
cohort studies cohort studies
0.2 0.5 1 2 5
Relative risk, highest vs lowest exposure category
with a reduced risk of colorectal cancer. The nine case-control studies produced 13 independent
Fibre exerts several effects in the gastrointestinal tract but effect estimates. Of these, 11 estimates were of decreased
the precise mechanisms for its probable protective role are risk,50-53 55 56 58 61 which were statistically significant in eight.
not clearly understood. Fibre dilutes faecal contents, decreas- One estimate indicated no effect on risk54 and one other gave
es transit time, and increases stool weight.40 Fermentation non-significant increased risk.62 The data were most
products, especially short-chain fatty acids, are produced by consistent when stratified for adenocarcinomas; of six
the gut flora from a wide range of dietary carbohydrates that studies, five reported significant decreased risk; results were
reach the colon. Short-chain fatty acids, particularly less consistent for squamous cell carcinoma. All studies
butyrate, can induce apoptosis and cell cycle arrest, and pro- were adjusted for alcohol and smoking except one, which
mote differentiation. Fibre intake is also strongly correlated was adjusted for alcohol but not smoking.50
with intake of folate. The ecological studies were inconclusive. Neither was sta-
tistically significant, with one in the direction of increased
A clear dose-response relationship is apparent from and the other of decreased risk.
generally consistent cohort studies, supported by There is no evidence of a plausible biological mechanism
evidence for plausible mechanisms, but residual through which dietary fibre reduces the risk of oesophageal
confounding could not be excluded. Foods containing cancer. It is not possible to conclude whether an as yet
dietary fibre probably protect against colorectal cancer. unknown mechanism is responsible for an apparent reduc-
tion in risk, or whether it is due to other components found
The Panel is aware that since the conclusion of the SLR, six in the vegetables and fruits that contain dietary fibre.
cohort studies41-46 and one case-control study47 have been pub-
lished. This new information does not change the Panel judge- There is limited evidence from sparse and inconsistent
ment (see box 3.8). case-control studies only, suggesting that foods
containing dietary fibre protect against oesophageal
Oesophagus cancer.
One cohort study,48 nine case-control studies,49-58 and two
ecological studies59 60 investigated dietary fibre and cancer 4.1.5.4 Aflatoxins
of the oesophagus. (Also see box 4.1.4; chapter 4.9; and chapter 7.8). There are
There was some evidence of an association between dietary two approaches to measuring aflatoxin intake. The first uses
fibre and reduced oesophageal cancer risk. The single cohort local food tables to estimate exposure to aflatoxins from diet.
study reported decreased risk when comparing high with low The second approach uses biomarkers of exposure. These are
intakes, with an effect estimate of 0.50, though no assess- derived from knowledge of aflatoxin metabolism. In humans,
ment of statistical significance was included.48 metabolised products of aflatoxins can be detected in blood,
72
C H A P T E R 4 F O O D S A N D D R I N K S
urine, or breastmilk. Biomarkers of exposure are more accu- studies and some of the case-control studies.
rate and precise. The areas in the world where there is considerable afla-
toxin contamination of foods coincide with the areas where
Liver primary liver cancer rates are high. The epoxide product of
Five cohort studies63-70 and seven case-control studies71-79 aflatoxin AFB1 is known to be genotoxic and is formed in the
assessed associations between biomarkers of exposure to liver.80 It damages DNA, causing G:C base pairs to become
aflatoxin and hepatocellular carcinoma. T:A. GST enzymes can repair this damage with varying effi-
The cohort studies used a variety of different biomarkers ciency between genotypes. Recent studies have shown that
for exposure to aflatoxin, some in blood and some in urine. aflatoxins can damage the p53 gene, which is an important
Despite this variety, all five studies reported increased risk regulator of normal growth.67 Damage to p53 DNA can lead
for the highest levels when compared to the lowest, and all to increased proliferation of abnormal cells and formation
of these reported at least one measure that resulted in a sta- of cancers.
tistically significant increased risk (figure 4.1.3). Studies that The synergistic effect of hepatitis virus infection and afla-
adjusted for hepatitis virus infection tended to show the toxin exposure might be explained by hepatitis virus increas-
greater effects.65 66 There is some evidence of an interaction ing the production of the enzyme (CYP1A2) that produces
whereby the risk is increased by a multiplicative effect if afla- the genotoxic metabolite of aflatoxin.81 It is also possible that
toxin exposure is combined with hepatitis infection. One the hepatitis virus increases the number of G:C to T:A trans-
study showed that people with hepatitis virus antibodies and versions, or that it inhibits nucleotide repair, or that it acts
biomarkers of aflatoxin exposure had a higher risk than those as a tumour promoter.
with hepatitis virus antibodies alone, with an effect estimate
of 10.0 (95% CI 1.660.9).65 The evidence is ample and consistent and is supported
There is evidence from some of the cohort studies for inter- by strong evidence for mechanisms operating in
action with glutathione-S-transferase (GST) genotype.63 64 humans. A dose response is apparent from both cohort
GST is an enzyme involved in the metabolic pathway that and case-control studies. The evidence that aflatoxins
detoxifies aflatoxins. Different genotypes show varying effi- and aflatoxin-contaminated foods are a cause of liver
ciencies at this task. Two genes (GSTT1 and GSTM1) were cancer is convincing.
assessed separately. For each, it is possible to have a posi-
tive or negative genotype. In each case, a negative genotype
increases risk of hepatocellular carcinoma when exposed to 4.1.6 Comparison with previous report
aflatoxins. There is clear, consistent evidence that
GSTM1/GSTT1 positive genotypes protect against the The previous report concluded that dietary fibre/non-starch
increased risk of liver cancer from hepatitis infection com- polysaccharides possibly protect against cancers of the pan-
bined with aflatoxin exposure, which supports a causal role creas, colorectum, and breast. The previous report also con-
for aflatoxins in hepatocellular carcinoma. cluded that wholegrain cereals possibly decrease the risk of
Four case-control studies showed statistically significant stomach cancer and that refined cereals possibly increase the
increased risk for the highest levels of biomarkers when com- risk of oesophageal cancer.
pared to the lowest.71 74 78 79 Two studies showed no effect Since the mid-1990s, evidence for a protective effect of
on risk.73 77 One study showed a non-significant decreased dietary fibre against colorectal and oesophageal cancer risk
risk.72 Heterogeneity may be explained by the diversity in has become somewhat stronger. The finding of the previous
methods of exposure assessment. report, suggesting that the degree of refinement (other than
A dose-response relationship is apparent from most cohort relative amounts of dietary fibre) may be a factor in modi-
fication of the risk of some cancers, was not found.
The previous report classified bananas as plantains. Here
they are classified as fruits. The previous report considered
Figure 4.1.3 Aflatoxins and liver cancer;
cohort studies dietary fibre separately from cereals (grains) and other plant
foods. Here, dietary fibre is considered in the context of cere-
Relative risk (95% CI) als (grains) and other plant foods.
73
P A R T 2 E V I D E N C E A N D J U D G E M E N T S
74
C H A P T E R 4 F O O D S A N D D R I N K S
75
P A R T 2 E V I D E N C E A N D J U D G E M E N T S
In the judgement of the Panel, the factors listed below modify the risk of cancer. Judgements are graded according to the strength of the evidence.
Convincing
Substantial
effect on risk Foods containing beta-carotene9: prostate; skin (non-melanoma)
unlikely
1 Judgements on vegetables and fruits do not include those preserved by salting and/or pickling.
2 Includes both foods naturally containing the constituent and foods which have the constituent added (see chapter 3.5.3).
3 Mostly contained in tomatoes and tomato products. Also fruits such as grapefruit, watermelon, guava, and apricot.
4 Also found in some roots and tubers notably potatoes. See chapter 4.1.
5 Also found in cereals (grains) and in some animal foods. See chapters 4.1 and 4.3.
6 Also found in plant seed oils. See chapter 4.5.
7 Including soya and soya products.
8 Vitamin B6. Also found in cereals. See chapter 4.1.
9 The evidence is derived from studies using supplements and foods containing beta-carotene: see chapter 4.10.
For an explanation of all the terms used in the matrix, please see chapter 3.5.1, the text of this section, and the glossary.
76
C H A P T E R 4 F O O D S A N D D R I N K S
against prostate cancer; and foods containing folate here. Chapter 4.1 includes dietary fibre, only found naturally
probably protect against pancreatic cancer. Also see in plant foods. Chapter 4.1 also includes aflatoxins, which
chapter 4.1 for the evidence that foods containing dietary also contaminate pulses (legumes), notably peanuts, nuts
fibre, found in plant foods (particularly when in whole or and seeds, and other plant foods. The micronutrients includ-
relatively unprocessed forms), probably protect against ed here, as contained in vegetables, fruits, pulses (legumes),
colorectal cancer. nuts and seeds, are also found in other plant foods, and some
also in animal foods.
77
P A R T 2 E V I D E N C E A N D J U D G E M E N T S
Box 4.2.1 Micronutrients and other bioactive compounds and cancer risk
Vegetables, fruits, pulses (legumes), nuts, As a rule of thumb, the greater the inten- breakfast cereals also contain this vitamin.
and seeds are sources of a wide variety of sity of the colour of the fruit or vegetable, Pyridoxine is one of a group of water-
micronutrients and other bioactive com- the more beta-carotene it contains. soluble compounds collectively known as
pounds. Foods containing several of these The most concentrated source of vitamin B6. This vitamin is involved in neu-
constituents have been identified in the sys- lycopene is tomatoes, but it is also present rotransmitter synthesis, red blood cell for-
tematic literature reviews, on which this in watermelon, red (bell) peppers, pink or mation and function, niacin (vitamin B3)
chapter is based, as being associated with red grapefruit, pink-fleshed guava, and formation, steroid hormone function, and
cancer risk. These are carotenoids (includ- persimmons. nucleic acid synthesis (also see chapter
ing beta-carotene and lycopene), folate, The B-vitamin folate is a family of com- 4.2.5.5).15 Food sources include bananas,
vitamin C, vitamin D, vitamin E, quercetin, pounds essential for human health. Folic fish, poultry, liver, potatoes eaten with the
pyridoxine, and selenium. Mechanisms by acid, the synthetic form, is used to fortify skin, green, leafy vegetables, beans, pulses
which they might affect cancer risk are dis- manufactured cereal products, spreads, (legumes), nuts, wholegrains, and fortified
cussed in chapter 4.2.5. However, it is not and, in some countries, flour or grains. breakfast cereals.
possible to ascribe the association between Folates are involved in a number of meta- Selenium is a mineral element that
these foods and lower cancer risk to a bolic pathways, especially in the synthesis occurs in different chemical forms. It is
causal effect of specific compounds with of purines and pyrimidines, which are toxic in large amounts, but is essential in
confidence, as each food contains a com- important for DNA synthesis and cell repli- the diet at trace levels. It is present at vary-
plex mixture of different constituents, all of cation (also see chapter 4.2.5.4). Sources of ing concentrations in different soils; and
which might also contribute to any effect. dietary folate include liver, beans, spinach, since plants take up selenium from the soil,
Carotenoids are found in varying con- broccoli, romaine lettuce, chicory, oranges, these levels determine the amount present
centrations in all vegetables, particularly and papaya. in vegetables. Thus selenium deficiency is
those that are red or orange. They are a Vitamin C (ascorbic acid) is a water-solu- more prevalent in regions where the soil
family of more than 600 fat-soluble ble vitamin. Humans, like a small number of selenium content is low. Selenium is a com-
red/orange pigments that comprise xan- other animals, cannot synthesise vitamin C, ponent of the amino acids selenocysteine
thophylls (such as lutein) and carotenes so it is an essential part of diets. Vitamin C and selenomethionine, which are inte-
(such as alpha- and beta-carotene, and is essential for collagen synthesis and also grated into proteins to form selenopro-
lycopene). Some carotenoids, most impor- has antioxidant activity. Severe deficiency teins. Selenoproteins include antioxidant
tantly beta-carotene, can be converted by causes scurvy. It is added to many foods, enzymes such as glutathione peroxidases,
the body to retinol and are sometimes including bread and soft drinks, in small thioredoxin reductase, which is important
called pro-vitamin A carotenoids. These amounts as an antioxidant preservative. for DNA synthesis, and iodothyronine deio-
compounds tend to be the main dietary Natural dietary sources are vegetables, dinase, which is important for the synthe-
source of vitamin A in low-income coun- tubers, and fruits, including red/yellow sis of thyroid hormones.16 Dietary sources
tries. (bell) peppers, kiwi fruits, broccoli, papaya, of selenium include brazil nuts, fish, whole-
Only about half of the 50 or so citrus fruits, strawberries, and potatoes, but grains, wheatgerm, and sunflower seeds.
carotenoids in human diets can be absorb- it is destroyed by heat or contact with the Quercetin is a flavonoid, which is a type
ed. They have antioxidant and other bioac- air (for instance, when vegetables are of polyphenol; it is not an essential dietary
tivities that are discussed in chapter 4.10. chopped), or lost into cooking water. component. Many studies in cultured cells
Sources of carotenoids include spinach, Vitamin E is a fat-soluble vitamin and a and animals suggest that quercetin has
kale, butternut squash, pumpkin, red (bell) potent antioxidant that occurs as eight dif- antioxidant activity, which could give rise
peppers, carrots, tomatoes, cantaloupe ferent forms: alpha- and gamma-toco- to a range of biological activities, including
melon, and sweet potatoes. pherol are the most common. The most reducing inflammation (also see chapter
Beta-carotene is found in yellow, orange, important dietary sources of vitamin E are 4.2.5.9). Quercetin is found in apples,
and green fruits and green, leafy vegeta- vegetable oils such as palm, sunflower, green and black tea, onions, raspberries,
bles including carrots, spinach, lettuce, corn, soya bean, and olive oils. Nuts, sun- red wine, red grapes, citrus fruits, leafy,
tomatoes, sweet potatoes, broccoli, can- flower seeds, and wheatgerm are also green vegetables, cherries, elderberries,
taloupe melon, oranges, and winter squash sources. Wholegrains, fish, peanut butter, broccoli, blueberries, cranberries, and
(pumpkin). green, leafy vegetables, and fortified bilberries.
content, and the oils produced from them are considered in plants are used as herbs or spices, such as the leaves (sage,
chapter 4.4. bay, or basil), stems (ginger, lemongrass), bark (cinnamon),
rhizomes (ginger), roots (horseradish), flower buds (cloves),
Herbs, spices, and condiments stamens (saffron), seeds (mustard, cumin), kernels (nut-
Herbs and spices, which are generally used to flavour or pre- meg), and fruits (peppers).
serve foods, are of plant origin, although a very small num- A condiment is a substance that adds taste to other foods;
ber of animal products are classed as spices (such as the term is often used for sauces added at the table, which
ambergris). Definitions of herbs and spices vary, but herbs are usually of plant origin. Examples include vinegars,
are usually the fresh or dry leaves or whole plant, while ketchups, chutneys, harissa, mustard, and soy sauce. Salt is
spices are produced from other parts of the plant, such as neither a herb nor a spice, although it is used as a condiment
the seeds, and are usually dried.5 Many different parts of (see chapter 4.5).
78
C H A P T E R 4 F O O D S A N D D R I N K S
Box 4.2.2 Phytochemicals methods. For instance, the outer leaves of lettuces can have
higher levels of some micronutrients than the inner leaves;
Plants contain a wide range of biologically active compounds, and harvested, unripe fruit that ripens in transit may have
some of which are known as phytochemicals. There may be as lower levels of nutrients than fruits ripened on the plant
many as 100 000 different compounds, which determine par- (box 4.2.1).6
ticular properties in plants, and in the fruits and vegetables they Vegetables and fruits contain vitamins, minerals, dietary
produce, such as flavour and colour. Phytochemicals are classi- fibre, and other bioactive compounds, such as phytochemi-
fied according to their chemical structure and functional char- cals (box 4.2.2). This is a collective term for a variety of plant
acteristics, and include salicylates, phytosterols, saponins,
components that often perform important functions in the
glucosinolates, polyphenols, protease inhibitors, monoterpenes,
plant, such as providing colour, flavour, or protection, but
phytoestrogens, sulphides, terpenes, and lectins.
It is widely believed that the health benefits of diets high in are not essential in the human diet. They include salicylates,
fruits and vegetables are likely to be due partly to the presence flavonoids, glucosinolates, terpenes, lignans, and
of phytochemicals. For instance, several act as antioxidants, pre- isoflavones. All of these groups of compounds have been
venting oxidative damage to cells, proteins, and DNA. It is like- shown either in humans or in laboratory experiments to have
ly that other bioactive phytochemicals have yet to be identified, potentially beneficial health effects when they are included
and those that are known may have additional properties in the in diets. However, the bioavailability of these compounds
body that are not yet understood. But it is thought that nutri- is variable (box 4.2.3) and their ultimate heath effects
ents, phytochemicals, and other, as yet unknown, bioactive com- uncertain.
ponents act together to influence physiological responses.
Plant cell walls are the main source of dietary fibre, and
Although many phytochemicals are bioactive, they are not
all whole fruits and vegetables (but not their juices) contain
essential in the diet and there is no daily requirement, so they
are not classed as nutrients. Humans have developed tastes for varying amounts of fibre (box 4.2.4). Most vegetables and
some phytochemicals, such as the hot flavours of mustard oil, fruits are low energy-dense foods, although there are excep-
bitter alkaloids, and irritating capsaicins. There is genetically tions, for example, avocados, nuts, and seeds.
inherited variation in sensitivity to some tastes, for example, the Some families of fruits and vegetables have characteristic
bitter taste of isothiocyanates in cruciferous vegetables such as components that may confer a particular health benefit (or
cabbage. risk) to the whole family. For instance, cruciferous vegeta-
bles are sources of glucosinolates and their products isoth-
iocyanates and indoles. Allium vegetables and others, such
as chicory and Jerusalem artichokes, store energy as inulin
4.2.2 Composition (chains of fructose sugars) rather than starch (chains of glu-
cose sugars). The body cannot digest inulin, which is called
Vegetables and fruits a prebiotic a substance that is claimed to have health ben-
The composition of fruits and vegetables depends both on efits by promoting the growth of certain types of gut bacte-
species and on subtype, as well as on the environmental, ria. Allyl sulphides and allicin in garlic are distinctive flavour
farming, production, and storage conditions. These include molecules that give vegetables of the onion family their
factors such as sun exposure, soil quality, agricultural prac- sting (box 4.2.3). Green, leafy vegetables are sources of
tices, harvesting time, ripeness, length of time between har- folate, and tomatoes have high levels of lycopene. All of
vest and consumption, and preservation and preparation these components, as well as other phytochemicals (box
79
P A R T 2 E V I D E N C E A N D J U D G E M E N T S
80
C H A P T E R 4 F O O D S A N D D R I N K S
to that seen in low-income countries. Intakes are highest in energy availability. The highest availability is in the Middle
some parts of Africa, the Middle East, southern Europe, and East and parts of Europe, and the lowest is in South America
Oceania, and lowest in other parts of Africa and Asia. Fruit and parts of Africa; intakes range from 3 per cent of total
consumption also tends to be low in north-eastern Europe. energy in parts of the Middle East to virtually zero in many
Intakes range from as much as 20 per cent of daily energy low-income countries.
in parts of Africa to as little as 0.5 per cent in parts of Asia. Coconuts represent 0.5 per cent of daily energy availabil-
The availability of fruit has increased globally in recent ity globally, although coconuts can be locally important in
decades, although there was a slight decrease in the 1990s. tropical islands, for instance in parts of Oceania, Asia (Sri
Most countries have national recommendations for the Lanka and Indonesia), the Caribbean, and in the African
daily amount of vegetables and fruits that need to be eaten islands. In parts of Oceania, for example, coconuts provide
to maintain optimal health (Chapter 10). These vary, but as much as 20 per cent of energy in the diet.
they tend to recommend three or more servings per day of Sunflower, rape, mustard, and sesame seeds together sup-
vegetables and two or more servings per day of fruits; a serv- ply 0.2 per cent of daily energy intake globally. There are
ing is about 80 g (or half a US cup). In most high-income fewer data available for seeds than for many other foods,
countries for which data were available, daily consumption although sesame seed intake is relatively high in parts of
of vegetables fell short of this target, although this is not due Africa and Asia, providing a maximum of 3.9 per cent of
to lack of availability; indeed, availability is high due to the energy in parts of central Africa. Oils from seed crops are
wide use of refrigeration. Fruit consumption tended to be widely used (see chapter 4.5.3).
closer to national targets. Seasonal availability influences
overall availability, although less so in high-income countries Herbs, spices, and condiments
where vegetables and fruits are more likely to be imported. Although spices are consumed in small amounts to flavour
food, they are such a regular feature of some diets that they
Pulses (legumes) account for a measurable quantity of daily energy intake.
Globally, pulses supply 2 per cent of total energy intake Worldwide, spices provide 0.3 per cent of available dietary
(based on availability) and 3.5 per cent of daily protein energy and in parts of Asia they constitute as much as 1.8
intake.17 The highest availability is in parts of Africa, South per cent. Herbs and spices tend to be part of the tradition-
America, Asia, and the Middle East. In these areas, pulses al diet in the areas from which they originate, and many tra-
are a dietary staple, and can account for as much as 20 per ditional cuisines are characterised by the use of herbs, spices,
cent of daily energy intake and 50 per cent of protein intake. and condiments. Most are now available worldwide,
In societies with high intakes of meat and other foods of ani- although their use still varies greatly in different parts of the
mal origin, pulses are less important in diets, and are usu- world. Many herbs and spices are believed to have medici-
ally consumed infrequently or in small amounts. Peanuts and nal or tonic value and have been used in this way at least
soya beans account for most of the legume products eaten since the times of the earliest medical records. Many mod-
around the world. ern pharmaceuticals are derived from herbs and other plants.
Soya bean availability per person represents 0.5 per cent Many herbs and some spices are biologically very potent:
of daily energy intake globally, but it is notably high in parts the modern pharmacopoeia lists drugs, many of which have
of Asia, and higher than average in parts of Africa and been isolated from herbs, sometimes known as plants with
Central America. In parts of Asia, soya beans account for up healing powers. There are some in vivo experimental data
to 4.9 per cent of daily energy availability and 15 per cent for potentially beneficial effects in the cases of turmeric, saf-
of protein. fron, ginger, pepper, garam masala (a herb and spice mix),
Pulses are eaten in a variety of ways around the world; for and also eugenol and myristin, constituents of a number of
instance, Japanese and Chinese bean curd (tofu), Chinese herbs and spices.
mung bean sprouts, Mexican chilli and refried beans, Indian Conversely, it is at least theoretically possible that some
dahl, Middle Eastern falafel and hummus, Indonesian cul- condiments have adverse effects. Two examples are hot chilli
tured soya bean cakes (tempeh), Cuban black beans and rice, juices and harissa, a fiery condiment; both are consumed in
Boston baked beans, French cassoulet, Brazilian feijoada, substantial quantities in Mexico and the Mahgreb countries
Swedish pea soup, and US peanut butter. Soya beans are par- of North Africa, respectively, and both irritate the mouth and
ticularly versatile and their products are a common feature throat.
in manufactured foods, although they are not commonly
eaten whole. Soya foods include soya drinks and flour, tofu,
tempeh, textured vegetable protein, and the many products 4.2.4 Interpretation of the evidence
that can be prepared from these foods. Fermented soya beans
produce soy sauce and miso. Soya bean oil is also used wide- 4.2.4.1 General
ly (see chapter 4.5.3). For general considerations that may affect interpretation of
the evidence, see chapter 3.3 and 3.5, and boxes 3.1, 3.2,
Nuts and seeds 3.6 and 3.7.
Nuts and seeds were an important part of human diets before Relative risk (RR) is used in this Report to denote ratio
the advent of agriculture and they remain locally important measures of effect, including risk ratios, rate ratios, haz-
in a few areas. Globally, tree nuts supply 0.4 per cent of daily ard ratios, and odds ratios.
81
P A R T 2 E V I D E N C E A N D J U D G E M E N T S
large extent on the soil selenium content of the area in which Franceschi 1991 0.80 (0.550.68)
Franceschi 1992 0.40 (0.200.80)
the foods were grown. Blood and toenail levels of selenium Zheng 1993 1.73 (0.793.78)
are thought to be fairly accurate indicators of intake and Kune 1993 0.30 (0.110.85)
De Stefani 1994 0.40 (0.190.85)
have been used in several studies. Takezaki 1996 0.80 (0.591.08)
Esteve 1996 0.61 (0.450.81)
Confounding. Smokers consume fewer vegetables and fruits Levi 1998 0.14 (0.080.23)
De Stefani 1999 0.50 (0.290.87)
than non-smokers.18 19 Fat intake inversely correlates with Franceschi 1999 0.50 (0.330.76)
vegetable and, particularly, fruit intake in the USA.20 Recent De Stefani 1999 0.57 (0.301.08)
studies of the effects of fruits and vegetables in cancers Garrote 2001 0.78 (0.401.52)
Bosetti 2002 0.17 (0.110.27)
thought to be caused by smoking have controlled for the Marchioni 2003 0.86 (0.541.38)
effect of smoking. Folate intake is correlated with intake of Lissowska 2003 0.17 (0.070.27)
82
C H A P T E R 4 F O O D S A N D D R I N K S
Raw vegetables
Twenty-three case-control studies reported separate risk esti-
mates for raw vegetable consumption.24 27 28 33 36-43 45 47 50 58-
65
All of these reported comparisons of risk between high and
low intake groups, which produced reduced risk estimates
Figure 4.2.3 Non-starchy vegetables and mouth,
pharynx, and larynx cancer; case-control in 2224 27 28 33 36-43 45 47 50 58 60-65; 16 of these were statistical-
studies: dose response ly significant.24 33 36-40 42 43 47 50 60-63 65 No studies reported sta-
tistically significant increased risk estimates. Meta-analysis
of 7 case-control studies gave an effect estimate of 0.71 (95%
De Stefani 1994
CI 0.590.86) per 50 g/day, with moderate heterogeneity.37
39 42 45 59 62 65
These studies also provided evidence of a dose-
Levi 1998
response relationship. The heterogeneity could be partially
explained by variable exposure definitions. These results are
De Stefani 2000 consistent with data for non-starchy vegetables.
83
P A R T 2 E V I D E N C E A N D J U D G E M E N T S
assessed carrots, but some looked at tubers and carrots or vegetables and oesophageal cancer. Eight case-control stud-
non-starchy root vegetables or yellow/orange vegetables. ies investigated vegetable and fruit consumption (com-
One cohort study, looking at tubers and carrots, report- bined)95 104 107 114 120-123; 16 case-control studies investigated
ed a non-significant increased risk when comparing high raw vegetables40 60 85 95-97 103 109 113 114 124-129; 1 cohort study66
against low intakes, with a wide confidence interval (1.9, and 5 case-control studies86 93 107 124 125 investigated crucif-
95% CI 0.66.0).66 Another that reported on carotene-rich erous vegetables; 1 cohort study82 and 8 case-control stud-
fruits and vegetables found a non-significant reduced risk ies86 101 103 107 109 111 129 130 investigated allium vegetables; 1
when comparing the highest intake group against the low- cohort study66 and 11 case-control studies86 96 98 111 124 127 131-
est (0.50, p value for linear trend 0.10).70 The third, which 135
investigated green, leafy vegetables; 1 cohort study66 and
evaluated yellow/orange vegetables in postmenopausal US 9 case-control studies58 62 109 111 113 129-132 136 investigated
women, reported a significant reduced risk for the same com- tomatoes.
parison (0.58, 95% CI 0.390.87).71
All of the 18 case-control studies reported comparisons of Non-starchy vegetables
risk between high- and low-intake groups.23 24 26-29 39 41-43 46 Data suggest an association with reduced risk. Of the five
49 50 63 65 72-75
Sixteen reported reduced risk estimates,23 26-29 cohort studies, three reported decreased risk when compar-
39 41-43 50 63 65 72-75
6 of which were statistically significant.49 ing the highest intake group against the lowest, one of which
72 75
The other 2 were non-significant in the direction of was statistically significant (0.66, 95% CI 0.440.99, non-
increased risk.24 27 28 39 43 46 The majority of studies were starchy vegetables82; 0.5, p value for linear trend 0.1, yel-
hospital-based and analysed carrots as a separate exposure.
Tomatoes
One cohort study66 and 12 case-control studies26-29 39-43 46 50 Figure 4.2.4 Non-starchy vegetables and oesophageal
58 62 65
investigated tomatoes and mouth, larynx, or pharynx cancer; cohort and case-control studies
cancers.
Relative risk (95% CI)
The cohort study reported a non-significant increased risk
when comparing the highest intake group against the low- Cohort
est, with a wide confidence interval (1.7, 95% CI 0.83.7).66 Hiryama 1990 1.06 (0.911.24)
ative risk of smoking is large (particularly when combined Sammon 1998 2.30 (1.064.89)
Lauroy 1998 0.24 (0.113.54)
with alcoholic drinks). It is therefore difficult to eliminate De Stefani 1999 0.50 (0.290.87)
confidently the possibility of residual confounding with ways Takazaki 2000 0.60 (0.450.78)
of life associated with smoking: for instance, smokers con- De Stefani 2000 0.64 (0.341.20)
Levi 2000 0.19 (0.110.33)
sume fewer vegetables than non-smokers. Nayor 2000 0.53 (0.360.87)
Cheng 2000 0.56 (0.221.34)
Oesophagus
Five cohort studies,70 80-83 37 case-control studies22 40 60 84-115
and 6 ecological studies51 52 116-119 investigated non-starchy
84
C H A P T E R 4 F O O D S A N D D R I N K S
Raw vegetables
Figure 4.2.5 Non-starchy vegetables and oesophageal
cancer; case-control studies Sixteen case-control studies investigated raw vegetables and
oesophageal cancer.40 60 85 95-97 103 109 113 114 124-129
Relative risk (95% CI) All of these studies reported associations with decreased
risk, which were statistically significant in 10.40 60 85 95 97 109
Jun-Lao Li 1989 1.08 (1.031.14) 113 126 127 129
Dose-response meta-analysis was possible on five
De Stefani 2000 0.81 (0.660.99)
Levi 2000 0.66 (0.580.74) studies, giving a summary effect estimate of 0.69 (95% CI
Cheng 2000 0.90 (0.741.11) 0.580.83) per 50 g/day increment (figures 4.2.6 and 4.2.7).
De Stefani 2005
Summary estimate
0.94 (0.861.02)
0.87 (0.721.05)
This exposure category could be less disparate than other
vegetable groupings, as it is clear that preserved vegetables
are not included and variation in cooking methods is
0.5 0.75 1 1.5 2
removed. This may account for the lack of heterogeneity in
Relative risk, per 50 g/day
direction of effect in this subcategory of vegetables.
low/orange vegetables70; and 0.8, 95% CI 0.601.0 and p Relative risk (95% CI)
value for trend 0.08, stated as not statistically significant,
non-starchy vegetables80). The other two reported a non- De Stefani 2000
Levi 2000
0.38 (0.210.69)
0.64 (0.570.72)
significant increased risk (1.06, 95% CI 0.911.24, non- Cheng 2000 0.83 (0.681.02)
starchy vegetables81; and 1.02, 95% CI 0.881.19, fresh Sharp 2001 0.84 (0.750.95)
De Stefani 2003 0.60 (0.480.76)
non-starchy vegetables83) (figure 4.2.4). Summary estimate 0.69 (0.580.83)
Most (29) of the case-control studies published decreased
risk estimates when comparing the highest intake group
0.25 0.5 0.75 1 1.5
against the lowest,40 60 85-90 94-99 101-105 107-109 111-115 which were
Relative risk, per 50 g/day
statistically significant in 14 (figure 4.2.4).40 88 89 94 97-99 101
102 104 105 109
Five studies reported statistically significant
increased risk.84 91 93 100 106 110 Meta-analysis was possible on
5 of the case-control studies, giving a summary effect
estimate of 0.87 (95% CI 0. 721.05) per 50 g/day incre-
ment, with high heterogeneity (figure 4.2.5). A potential
cause of heterogeneity is the disparate nature of the expo- Figure 4.2.7 Raw vegetables and oesophageal cancer;
case-control studies: dose response
sure definition in different studies, some of which included
pickled and cured vegetables, cooked or uncooked
vegetables.
Two of the ecological studies reported a statistically sig- Castelletto 1994
85
P A R T 2 E V I D E N C E A N D J U D G E M E N T S
Non-starchy root vegetables and tubers The general mechanisms through which vegetables could
One cohort study66 and six case-control studies114 122 128 132 plausibly protect against oesophageal cancer are outlined
136 141 142
reported separate risk estimates for consumption of below.
non-starchy root vegetables and tubers.
The single cohort study showed a non-significant increased There is more evidence, including on vegetable
risk for the highest intake group when compared to the low- subtypes, from case-control studies than from cohort
est, after adjustment.66 All six case-control studies showed studies, but both are moderately consistent and there
non-significant decreased risk with increased intake.114 122 128 is some evidence for a dose-response relationship.
132 136 141 142
There is evidence for plausible mechanisms. Non-
starchy vegetables probably protect against
Cruciferous vegetables oesophageal cancer.
One cohort study66 and five case-control studies86 93 107 124 125
reported separate risk estimates for consumption of crucif- The Panel is aware that since the conclusion of the SLR, one
erous vegetables. cohort140 and two case-control studies78 143 have been pub-
The single cohort study showed a non-significant lished. This new information does not change the Panel judge-
decreased risk for increased intake of cauliflower or swede ment (see box 3.8).
and a non-significant increased risk for cabbage, after adjust-
ment.66 Three case-control studies showed decreased risk Stomach
with increased intake,93 107 124 which was statistically signif- Ten cohort studies,71 80 140 144-150 45 case-control studies,109
icant in two.93 124 One study showed a non-significant 151-195
and 19 ecological studies51 52 116-119 196-209 investigated
increased risk125; and one study showed a non-significant total vegetables. Eleven cohort studies,71 144 150 210-218 21 case-
increased risk in women and a non-significant decreased risk control studies,89 165 169 178 179 188 191 219-232 and 8 ecological
in men.86 studies233-240 investigated green-yellow vegetables; 6 cohort
studies70 140 144 146 150 241, 13 case-control studies,162 174 175 179
Allium vegetables 180 187 223 227 229 230 232 242 243
and 2 ecological studies202 240
One cohort study82 and eight case-control studies86 101 103 107 investigated green, leafy vegetables; 3 cohort studies70 146 241
109 111 129 130
reported separate risk estimates for allium and 19 case-control studies58 109 129 152 156 164 171 172 174 232 243-
vegetable consumption. 251
investigated tomatoes; 2 cohort studies150 214 and 6 case-
The single cohort study showed that garlic intake had no control studies157 165 169 226 228 243 investigated white or pale
effect on risk.82 Four case-control studies showed non-sig- vegetables; 6 cohort studies,146 148 214 252-254 25 case-control
nificant decreased risk with increased intake.101 103 107 130 Two studies,109 129 161 162 167 172 174 183 184 191 219 225 226 243 247 248 250 255-
studies showed non-significant increased risk.86 111 One study 264
and 3 ecological studies202 208 238 investigated raw vegeta-
showed a statistically significant decreased risk for garlic and bles; 5 cohort studies144 146 148 253 265 and 6 case-control
that onions/leeks had no effect on risk109; and one study studies158 161 162 164 257 266 267 investigated non-starchy veg-
showed a statistically significant reduced risk for onions and etables and fruits.
a non-significant increased risk for garlic.129
Non-starchy vegetables
Green, leafy vegetables Of 12 independent estimates from the 10 cohort studies that
One cohort study66 and 11 case-control studies86 96 98 111 124 investigated non-starchy vegetable consumption, none was
127 131-135
reported separate risk estimates for green, leafy veg- statistically significant.71 80 140 144-150 Seven studies showed
etable consumption. non-significant reduced risk71 140 144-147 150 and 2 reported
The single cohort study showed no effect for the highest non-significant increased risk.80 149 One study showed non-
intake group of lettuce when compared to the lowest.66 Ten significant increased risk in women and non-significant
case-control studies showed decreased risk with increased decreased risk in men.148 Most effect estimates were close to
intake,96 98 111 124 127 131-135 which was statistically significant 1. Meta-analysis was possible on 9 independent estimates
in five.96 127 132-134 One study showed a non-significant from 7 cohort studies, giving a summary effect estimate of
increased risk in women and a non-significant decreased risk 0.98 (95% CI 0.911.06) per 100 g/day, with moderate het-
in men.86 erogeneity (figure 4.2.8).
Of 45 case-control studies that reported on non-starchy
Tomatoes vegetable consumption, 28 reported statistically significant
One cohort study66 and nine case-control studies58 62 109 111 decreased risk.109 151-153 156-160 163 164 168 169 171 173 176-179 181 182
113 129-132 136
reported separate risk estimates for consumption 184 185 187 190 192
The majority of the 17 remaining studies that
of tomatoes. reported no significant effect on risk were in the direction of
The single cohort study showed a non-significant increased decreased risk.155 162 165-167 170 172 174 183 191 194 195 Four studies
risk for the highest intake group of lettuce, when compared showed non-significant increased risk,180 188 189 193 1 study
to the lowest, after adjustment.66 Eight case-control studies showed no effect on risk,154 and 1 study stated that there was
showed decreased risk with increased intake,58 62 109 111 113 129 no significant association.175 One study showed non-signif-
131 132 136
which was statistically significant in two.62 129 One icant decreased risk in women and non-significant increased
study showed no effect on risk.130 risk in men186; and 1 study showed statistically significant
86
C H A P T E R 4 F O O D S A N D D R I N K S
Figure 4.2.8 Non-starchy vegetables and stomach cancer; Figure 4.2.9 Green-yellow vegetables and stomach
cohort and case-control studies cancer; cohort and case-control studies
Cohort Cohort
Chyou 1990 Men 0.76 (0.531.10) Chyou 1990 Men 0.74 (0.521.05)
Guo 1994 1.05 (0.931.18) Kasum 2002 Women 0.57 (0.191.75)
Botterweck 1998 0.92 (0.781.09) Kobayashi 2002 0.56 (0.330.94)
McCullough 2001 Men 0.98 (0.841.02) Ngoan 2002 0.41 (0.180.94)
McCullough 2001 Women 1.16 (1.001.34) Khan 2004 Men 0.66 (0.113.89)
Fujino 2002 Men 1.12 (0.931.34) Khan 2004 Women 0.18 (0.022.13)
Fujino 2002 Women 1.03 (0.771.36) Summary estimate 0.63 (0.480.82)
Kobayashi 2002 0.86 (0.721.02)
Gonzalez 2006 0.91 (0.661.28) Case control
Summary estimate 0.98 (0.911.06) Lee 1990 0.94 (0.681.29)
Cai 1991 0.44 (0.380.50)
Case control
Negri 1991 0.24 (0.130.44)
Risch 1985 0.84 (0.730.97)
Hoshiyama and Sasaba 1992 0.49 (0.320.74)
You 1988 0.81 (0.750.86)
Ji 1998 Men 0.77 (0.690.86)
De Stefani 1990 0.40 (0.270.60)
Ji 1998 Women 0.89 (0.771.04)
Menik 1992 0.36 (0.160.80)
Ward 1999 0.33 (0.240.46)
Hansson 1993 0.60 (0.460.79)
Hamada 2002 1.09 (0.412.93)
Cornee 1995 0.85 (0.571.28)
Nishimoto 2002 0.62 (0.333.43)
De Stefani 1998 0.39 (0.320.48)
Hara 2003 1.59 (0.733.43)
Ji 1998 Men 0.86 (0.820.90)
Ito 2003 Women 0.55 (0.380.81)
Ji 1998 Women 0.94 (0.861.01)
Lissowska 2004 0.28 (0.120.66)
Ward 1999 0.22 (0.110.43)
Summary estimate 0.59 (0.460.75)
Mathew 2000 0.52 (0.181.46)
De Stefani 2001 0.89 (0.601.32)
Takezaki 2001 0.47 (0.260.81)
Sriamporn 2002 0.86 (0.561.33) 0.5 1 2
Hara 2003 1.06 (0.841.33)
Sipetic 2003 0.07 (0.030.15)
Relative risk, per 100 g/day
Suh 2003 1.04 (0.891.22)
Lagiou 2004 0.51 (0.390.68)
Lissowska 2004 0.90 (0.741.09)
Boccia 2005 1.09 (0.562.12)
Nan 2005 0.90 (0.661.25)
Summary estimate 0.70 (0.620.79)
decreased risk in men and non-significant increased risk in Meta-analysis was possible on 6 independent estimates from
women.161 No studies reported statistically significant 5 studies, giving a summary effect estimate of 0.63 (95% CI
increased risk. Meta-analysis was possible on 20 studies, giv- 0.480.82) per 100 g/day, with no heterogeneity (figure
ing a summary effect estimate of 0.70 (95% CI 0.620.79) 4.2.9).
per 100 g/day, with high heterogeneity (figure 4.2.8). This Of the 21 case-control studies that reported on green-
heterogeneity tended to reflect differences in size, rather yellow vegetable consumption, 16 showed decreased risk,89
than direction, of effect. 165 169 178 179 191 219 220 222-228 230-232
statistically significant in
A dose-response relationship was apparent from case- 12.89 165 169 178 179 191 220 222 223 226 231 232 The remaining 5 stud-
control but not cohort data. ies reported increased risk,111 188 221 229 1 of which was sta-
Results from ecological studies reporting on non-starchy tistically significant.221 Meta-analysis was possible on 12
vegetable consumption were mixed, with almost as many independent estimates from 11 studies, giving a summary
studies reporting increased risk as reported decreased effect estimate of 0.59 (95% CI 0.460.75) per 100 g/day,
risk.51 52 116-119 196-209 with high heterogeneity (figure 4.2.9).
All of the studies adjusted for age and sex; none was
Green-yellow vegetables adjusted for infection with Helicobacter pylori. Nine studies
Eight of the 11 cohort studies that reported on green-yellow were maximally adjusted, seven of which reported a
vegetable consumption showed decreased risk,71 144 150 210 211 significant negative association with higher consumption of
214-217
statistically significant in 4.150 210 215 216 Two other stud- green-yellow vegetables, and the other two reported no
ies showed non-significant increased risk212 213 and 1 other significant association.
study reported no statistically significant association.218 A dose-response relationship was apparent from both
87
P A R T 2 E V I D E N C E A N D J U D G E M E N T S
Figure 4.2.10 Green-yellow vegetables and stomach Figure 4.2.11 White or pale vegetables and stomach
cancer; cohort and case-control studies: cancer: cohort and case-control studies
dose response
Relative risk (95% CI)
Cohort
Cohort Kobayashi 2002 0.52 (0.231.18)
Khan 2004 Men 0.63 (0.094.12)
Chyou 1990 Men Khan 2004 Women 0.15 (0.012.34)
Summary estimate 0.49 (0.241.01)
Kasum 2002 Women
0.5 1 2
Case control Relative risk, per 100 g/day
Lee 1990
Cai 1991
Negri 1991
Ji 1998 Men
Ji 1998 Women
Nine case-control studies showed decreased risk with
increased intake,179 187 223 227 229 230 232 242 243 which was sta-
Ward 1999
tistically significant in three,223 232 243 and in men, but not
Hamada 2002 women, in a fourth study.227 Two further studies showed
Nishimoto 2002 non-significant increased risk174 180; one study showed no
Hara 2003
effect on risk162; and one study stated that there was no sig-
nificant association.175 Meta-analysis was possible on six
Ito 2003 Women
case-control studies, giving a summary effect estimate of
Lissowska 2004 0.90 (95% CI 0.701.16) per 100 g/day, with no hetero-
geneity.162 179 180 187 229 230
One ecological study showed statistically significant
0 100 200 300 400
decreased risk240 with high intake, the other showed non-
Green-yellow vegetables (g/day)
significant increased risk.202
One cohort study146 and 15 case-control studies152 156 164
167 172 231 243-246 261 268-271
also reported separately on lettuce
and salad leaves. The single cohort study showed a non-
significant decreased risk with increased intake. The effect
estimate was 0.88 (95% CI 0.382.60) per 50 g/day.146
Twelve case-control studies showed decreased risk with
cohort and case-control data on green-yellow vegetable increased intake of lettuce or salad leaves,152 156 164 167 231 243
consumption (figure 4.2.10). 246 261 268-271
which was statistically significant in 7.156 243 246
Five out of the eight ecological studies that reported on 261 268-270
Two studies showed non-significant increased
green-yellow vegetable consumption showed decreased risk risk.172 245 One study showed no effect on risk.244 Meta-
with increased consumption,236-240 two showed no associa- analysis was possible on 5 case-control studies that investi-
tion,233 234 and one study showed increased risk.235 gated lettuce or salad leaves, giving a summary effect
This exposure included green-yellow vegetables, green estimate of 0.43 (95% CI 0.240.77) per 50 g/day, with high
vegetables, yellow vegetables, yellow-orange vegetables, car- heterogeneity.152 231 268-270 Heterogeneity was related
rots and pumpkins, and high-carotenoid vegetables. primarily to the size, and not the direction, of the effect.
88
C H A P T E R 4 F O O D S A N D D R I N K S
Figure 4.2.12 Raw vegetables and stomach cancer; Figure 4.2.13 Raw vegetables and stomach cancer;
cohort and case-control studies case-control studies: dose response
Jedrychowski 1981
Cohort
Botterweck 1998 0.51 (0.054.73) Jedrychowski 1986
Galanis 1998 0.81 (0.531.23)
Khan 2004 Men 0.63 (0.162.51) Buiatti 1989
Khan 2004 Women 2.03 (0.1429.46)
Coggon 1989
Summary estimate 0.80 (0.541.18)
89
P A R T 2 E V I D E N C E A N D J U D G E M E N T S
Non-starchy vegetables and fruits starchy vegetables from this grouping); in addition, there
All five cohort studies showed decreased risk for the high- was 1 relevant pooling project publication.336 Three cohort
est intake group when compared to the lowest,144 146 148 253 studies337-339 and 1 case-control study321 investigated non-
265
which was statistically significant in two,253 265 and in starchy vegetables specifically; 5 cohort studies285 292 299 340
men, but not women, in a third study.148 Meta-analysis was 341
and 17 case-control studies65 301 307 312 320-322 326 330 342-350
possible on two cohort studies, giving a summary effect esti- investigated green, leafy vegetables (excluding cruciferous);
mate of 0.81 (95% CI 0.581.14) per 100 g/day.146 253 All 2 cohort studies investigated non-starchy root vegetables and
six case-control studies showed decreased risk with increased tubers289 291; and 6 cohort studies,285 289 293 299 339 341 21 case-
intake,158 161 162 164 257 266 267which was statistically significant control studies,65 261 304 307 313 320-322 325-327 342 344 346-348 351-358
in four.158 162 164 257 Meta-analysis was possible on two case- and 1 ecological study333 investigated carrots specifically.
control studies, giving a summary effect estimate of 0.79
(95% CI 0.630.99) per 100 g/day.162 267 Total vegetables
The stomach is a particularly unusual chemical environ- Out of 19 effect estimates from 17 cohort studies, 14 showed
ment and it is possible that, in addition to the general mech- reduced risk with higher levels of vegetable consumption,282
anisms described below, specific mechanisms apply, for 283 286-289 291-297 299 300
which was statistically significant in 3286
instance, in relation to nitrosamine formation. 297 299 300
and in women only in another285; 1 reported no
effect on risk,298 2 showed increased risk,284 290 none of which
A substantial amount of evidence is available, was statistically significant, and 2 showed non-significant
including on specific subtypes, particularly green- increased risk in men but not women.285 296 Meta-analysis
yellow vegetables, with a dose-response relationship in was possible on 10 studies, all of which adjusted for smok-
case-control, but not cohort data. There is evidence for ing, giving a summary effect estimate of 0.95 (95% CI
plausible mechanisms. Vegetables probably protect 0.920.98) per 80 g serving/day, with no heterogeneity.282
against stomach cancer. 283 285-287 292 296 297 300
Two studies did not adjust for smoking,
1 of which showed a non-significant lower vegetable intake
Nasopharynx in cases than in controls,295 and the other reported no effect
Five case-control studies272-276 and two ecological studies51 on risk.298
277
investigated non-starchy vegetables and nasopharyngeal Pooled analysis from 8 cohort studies (over 430 000 par-
cancer; a further four case-control studies investigated green ticipants, followed up for 6 to 16 years, more than 3200 lung
vegetables.278-281 Preserved vegetables were excluded from cancer cases) showed a non-significant reduced risk when
all categories. comparing high against low intake groups (0.88, 95% CI
Eight of the case-control studies reported reduced risk 0.781.00), with a p value for trend of 0.12.336
when comparing high against low intake groups,272 273 275 276 Out of 27 case-control studies, 17 showed reduced risk
278-281
which was statistically significant in three of the non- with higher levels of vegetable consumption,301-304 306-312 314
starchy vegetable studies272 275 276 and in two of the green 316 317 319 322 325-331
which was statistically significant in 8303
vegetable studies.279 280 One other study stated that there was 304 306 308-310 314 316 319 325-328
; 7 studies showed non-significant
no significant association.274 All studies were based in China. increased risk305 313 315 318 320 323 324 and 1 study showed no
The ecological studies produced mixed results. One effect on risk.321 Meta-analysis was possible on 10 studies,
showed significant correlations between the consumption all of which adjusted for smoking, giving a summary effect
of fresh vegetables and reduced risk of nasopharyngeal car- estimate of 0.67 (95% CI 0.530.86) per serving/day, with
cinoma after adjusting for age (r2 = -0.77, p = 0.009 among high heterogeneity.303 308 309 313 316 317 323 325 326 328 329 Three
men and r2 = -0.75, p = 0.013 among women).51 The second studies did not adjust for smoking, all of which showed
study showed an increasing risk with increases statistically significant decreased risk.306 316 319
in local consumption of non-starchy vegetables (r2 = 2.36).277 A dose-response relationship was apparent from both
This study did not report any adjustments for potential cohort and case-control data.
confounding variables or whether the finding was signifi- Most of the ecological studies are suggestive of an associ-
cant. ation between increased vegetable consumption and
The general mechanisms through which vegetables could decreased risk.
plausibly protect against nasopharyngeal cancer are outlined
below. Non-starchy vegetables
All three cohort studies reported non-significant reduced risk
The evidence for non-starchy vegetables is sparse but when comparing highest and lowest vegetable intakes, with
generally consistent. There is limited evidence effect estimates of 0.9 (lung cancer mortality, 95% CI
suggesting that non-starchy vegetables protect against 0.611.33),337 0.75 (95% CI 0.411.37),338 and 0.54 (p value
nasopharyngeal cancer. for trend 0.2, squamous and small-cell carcinomas only)
when comparing the highest with the lowest intake
Lung groups.339 The single case-control study reported a non-
Seventeen cohort studies,282-300 27 case-control studies,301-331 significant increased risk when comparing high and low
and 6 ecological studies52 116 332-335 investigated total veg- vegetable intakes.321
etables and lung cancer (some studies did not separate non-
90
C H A P T E R 4 F O O D S A N D D R I N K S
91
P A R T 2 E V I D E N C E A N D J U D G E M E N T S
92
C H A P T E R 4 F O O D S A N D D R I N K S
93
P A R T 2 E V I D E N C E A N D J U D G E M E N T S
4.2.5.2 Fruits
Figure 4.2.16 Garlic consumption and colorectal cancer;
Mouth, pharynx, and larynx
case-control studies
One cohort study,447 35 case-control studies21 22 24-26 28 30-33 35
Relative risk (95% CI)
36 39-50 59-61 63 64 67 69 72 74 448-450
and 2 ecological studies52 68
investigated fruits and mouth, pharynx, and larynx cancers;
Huetal 1991 0.21 (0.040.98) and 1 cohort study,66 23 case-control studies23 26-29 31 33 34 37-
Le Marchand 1997 Men 0.80 (0.541.19)
39 41-43 45-47 50 63 65 75 451 452
and 1 ecological study52 investigated
Le Marchand 1997 Women 0.90 (0.591.37) citrus fruits. In addition, 1 cohort study54 and 6 case-control
Franceschi 1998 0.90 (0.801.01)
studies33 39 45 55-57investigated non-starchy vegetables and
Levi 1999 0.39 (0.210.71)
fruits in combination (also see evidence on non-starchy
Kamel 2002 0.83 (0.441.55)
vegetables, chapter 4.2.5.1).
4.2.5.1.2 Carrots
Cervix Figure 4.2.17 Fruits and mouth, pharynx, and larynx
cancer; cohort and case-control studies
Five case-control studies440-444 and one ecological study445
investigated carrots and cervical cancer.
Relative risk (95% CI)
Case-control studies were consistent in showing reduced
risk for the highest levels of consumption, which was sta- Cohort
tistically significant in three.440-442 All studies used hospital- Chyou 1995 0.82 (0.641.04)
based controls and none adjusted for human papilloma virus Summary estimate 0.82 (0.641.04)
of their pro-vitamin A activity. Carotenoids are recognised Marchioni 2003 0.96 (0.861.08)
antioxidants and low blood levels of dietary antioxidants are Gaudet 2004 0.90 (0.741.10)
Kapil 2005 0.17 (0.100.31)
associated with human papilloma virus persistence.446
Summary estimate 0.72 (0.590.87)
that carrots protect against cervical cancer. Relative risk, per 100 g/day
94
C H A P T E R 4 F O O D S A N D D R I N K S
Figure 4.2.18 Citrus fruits and mouth, pharynx, and Figure 4.2.20 Citrus fruits and mouth, pharynx, and larynx
larynx cancer; case-control studies cancer; case-control studies: dose response
Franco 1989
Franco 1989 0.72 (0.560.93)
Zheng 1993 0.45 (0.310.66) Zheng 1993
Levi 1998 0.88 (0.820.95)
Levi 1998
De Stefani 2000 0.27 (0.140.52)
Bosetti 2002 0.91 (0.850.97) De Stefani 2000
Pisa 2002 0.71 (0.510.99)
Bosetti 2002
Gaudet 2004 0.89 (0.731.10)
Summary estimate 0.76 (0.660.87) Pisa 2002
Gaudet 2004
LaVecchia 1991
came from the varying size, not direction, of effect.
De Stefani 1994
A dose-response relationship was apparent from case-
De Stefani 2000 control but not cohort data for both general and citrus fruits
Bosetti 2002 (figures 4.2.19 and 4.2.20). There is some suggestion that
Marchioni 2003
the greatest effect appears to be with the first increment.
That is, some fruit consumption confers a protective effect
Gaudet 2004
compared to none. However, it is not clear that the effect
Kapil 2005 continues in a linear fashion with increased doses.
One ecological study found no significant association
between citrus fruit consumption and cancer mortality in
men or women.52
0 200 400 600 800 1000
Studies that reported on combined intake of non-starchy
Fruits (g/day)
vegetables and fruits showed evidence of an association with
decreased risk (see chapter 4.2.5.1).
The general mechanisms through which fruits could plau-
sibly protect against mouth, pharynx, and larynx cancer are
outlined below.
95
P A R T 2 E V I D E N C E A N D J U D G E M E N T S
Figure 4.2.21 Fruits and oesophageal cancer; cohort Figure 4.2.22 Fruits and oesophageal cancer;
and case-control studies case-control studies
0.2 0.5 1 2 5
Relative risk, highest vs lowest exposure category
studies,33 85 86 88 90 97 105 111 113 124 125 128 130 132 133 136 459 and 1 CI 0.81.1; adjusted for smoking),80 and 0.99 (95% CI
ecological study52 investigated citrus fruits. 0.851.15; not adjusted for smoking).82
Thirty-two of the case-control studies reported reduced
General fruits risk for the highest intake groups when compared to the low-
All of the cohort studies reported reduced risk with higher est (figure 4.2.21),22 40 60 84 86 87 89 95 96 98 99 102 104 108-110 113-115
intakes of fruit,80 82 83 447 which was statistically significant 125-129 134-136 138 453-456
which was statistically significant in
in two.83 447 One study reported a statistically significant 24.40 60 84 86 87 89 95 96 102 104 110 113-115 127 134-136 138 454-456 One
dose-response relationship, with a risk estimate of 0.68 study reported statistically significant increased risk,100 one
(95% CI 0.530.88) per 100 g/day after adjustment for reported no effect on risk,112 and one reported no statistically
smoking.447 The other three reported risks for the highest significant association.94 Meta-analysis was possible on eight
intake groups relative to the lowest, with risk estimates of studies, giving a summary effect estimate of 0.56 (95% CI
0.8 (95% CI 0.70.9; not adjusted for smoking),83 0.9 (95% 0.420.74) per 100 g/day, with high heterogeneity (figure
96
C H A P T E R 4 F O O D S A N D D R I N K S
The single cohort study, which was specific to oranges and Alavanja 2004 (pesticide applicators) 0.89 (0.591.35)
Alavanja 2004 (applicator spouses) 0.65 (0.281.51)
was adjusted for smoking, showed a non-significant Breslow 2000 0.92 (0.711.18)
decreased risk for the highest when compared to the lowest Feskanich 2000 (HPFS) Men 1.05 (0.941.17)
intake groups, with an effect estimate of 0.50 (95% CI Feskanich 2000 (NHS) Women 0.94 (0.871.02)
Fraser 1991 0.47 (0.320.69)
0.301.00), with a p value for trend of 0.03.66 This risk esti- Fu 1997 0.94 (0.671.32)
mate was for cancers of the upper aerodigestive tract; 22 out Holick 2002 0.94 (0.891.00)
Jansen 2004 0.84 (0.651.09)
of 71 cases were oesophageal cancers. Miller 2002 0.96 (0.861.07)
Fifteen of the case-control studies reported decreased risk Olson 2002 0.91 (0.860.96)
for the highest intake groups when compared to the lowest,33 Shibata 1992 0.99 (0.871.14)
Skuladottir 2004 0.95 (0.861.05)
85 86 88 90 97 105 111 113 124 125 130 132 133 136 459
which was statisti- Takezaki 2003 0.63 (0.241.63)
cally significant in 10 (figure 4.2.23).33 85 86 88 97 105 113 132 133 Vorrips 2000 0.92 (0.860.98)
136 459
The other study reported a non-significant increased Summary estimate 0.94 (0.900.97)
50 g/day, with high heterogeneity (figure 4.2.24).33 97 128 130 Brennan 2000 1.08 (0.522.28)
De Stefani 2002 0.84 (0.661.06)
132 133
Four of these studies adjusted for smoking.33 97 128 132 Gao 1993 0.45 (0.300.67)
133
Heterogeneity may be partially explained by differential Hu 2002 1.04 (0.851.27)
The general mechanisms through which fruits could plau- Rachtan 2002
Raunoi-Ravina 2002
0.49 (0.320.75)
1.19 (0.741.91)
sibly protect against cancer are outlined below. De Stefani 1999 0.67 (0.540.82)
Suzuki 1994 1.33 (0.563.18)
Swanson 1997 0.91 (0.761.09)
The evidence, including on fruit subtypes, though Summary estimate 0.80 (0.680.94)
mostly from case-control studies, is consistent, with a
dose-response relationship. There is evidence for
0.05 1 2
plausible mechanisms. Fruits probably protect against
Relative risk, per serving/day
oesophageal cancer.
The Panel is aware that since the conclusion of the SLR, one
cohort study140 and two case-control studies143 460 have been
97
P A R T 2 E V I D E N C E A N D J U D G E M E N T S
Case control The Panel is aware that since the conclusion of the SLR, one
Swanson 1997
case-control study478 has been published. This new information
Suzuki 1994
Stefani 1999
does not change the Panel judgement (see box 3.8).
Ruano-Ravina 2002
Rachtan 2002 Stomach
Pawlega 1997 Sixteen cohort studies,71 80 144-147 149 150 213-217 252-254 414 51
Lagiou 2004 case-control studies,89 109 129 151 154 156 158-163 167-169 174-176 178-180
Kreuzer 2002 182 184-187 189-191 193 195 219 221 222 224-227 229 230 246 255-258 260 261 264
Ko 1997
Hu 2002
270 479-482
and 23 ecological studies52 116 118 119 197 198 200-202 204-
Gao 1993 investigated fruits.
209 234 236-240 483-485
De Stefani 2002 Ten cohort studies reported decreased risk for the highest
Brennan 2000 intake groups when compared to the lowest,71 80 144 146 150 214-
Axelsson 1996 217 253 254
which was statistically significant in one,253 and in
women only in a second study.216 Six studies showed
increased risk,145 147 149 213 214 252 414 which was statistically sig-
0 1 2 3 4 5
nificant in one.213 Meta-analysis was possible on eight stud-
Fruits (servings/day)
ies, giving a summary effect estimate of 0.95 (95% CI
0.891.02) per 100 g/day, with low heterogeneity (figure
4.2.27).
One of the cohort studies considered in the meta-analysis
above (EPIC, more than 521 000 participants in over 10
European countries) reported results stratified by H pylori
cancer cases) showed a statistically significant reduced risk for status. The effect estimate for the H pylori-negative group
the highest intake group when compared to the lowest (0.77, was 0.72 (95% CI 0.391.33) and 0.98 (95% CI 0.811.2)
95% CI 0.670.87), with a p value for trend of < 0.001.336 for the positive group.140
Twenty-one case-control studies showed decreased risk for Forty case-control studies showed decreased risk for the
the highest intake groups when compared to the lowest,261 highest intake groups when compared to the lowest,89 109 151
303 305 306 308 309 311 312 315 317 318 320-322 324 327 328 331 343 346 349 350 156 158-160 162 163 167-169 174 176 178-180 184 186 187 189-191 195 219 221 222
98
C H A P T E R 4 F O O D S A N D D R I N K S
99
P A R T 2 E V I D E N C E A N D J U D G E M E N T S
The Panel is aware that since the conclusion of the SLR, one The Panel is aware that since the conclusion of the SLR, one
cohort study516 has been published. This new information does cohort530 and five case-control studies 261 380 531-533 have been
not change the Panel judgement (see box 3.8). published. This new information does not change the Panel
judgement (see box 3.8).
Liver cancer
One cohort study216 517 and five case-control studies89 518-521 General mechanisms fruits
investigated fruits and liver cancer. Fruits, in particular citrus fruits, are sources of vitamin C and
The single cohort study showed non-significant decreased other antioxidants, such as phenols and flavonoids, as well
risk for the highest intake groups when compared to the low- as potentially bioactive phytochemicals. Vitamin C traps free
est (0.98, 95% CI 0.751.21).216 517 radicals and reactive oxygen molecules, protecting against
Four case-control studies showed decreased risk for the oxidation damage. It also regenerates other antioxidant
highest intake groups when compared to the lowest,89 518 520 vitamins such as vitamin E.534 Vitamin C also inhibits
521
which was statistically significant in two.89 518 One study the formation of carcinogens and protects DNA from
showed non-significant increased risk.519 Heterogeneity mutagenic attack.535
could be partly explained by poor study quality and varying Beta-carotene and other carotenoid antioxidants are also
adjustment for known confounders. found in fruits. Some fruits contain high levels of flavonoids,
The general mechanisms through which fruits could plau- including apples (quercetin) and grapefruit (naringin).
sibly protect against liver cancer are outlined below. In addi- Flavonoids have antioxidant effects and can also inhibit
tion, grape extracts and auraptene (from citrus fruit) have carcinogen-activating enzymes. Flavonoids can also alter the
shown protective effects against the development of hepa- metabolism of other dietary agents. For instance, quercetin
tocellular carcinoma in rats.522-525 directly inhibits expression of CYP1A1 (a cytochrome P450
enzyme that helps to metabolise toxins), resulting in
The evidence is sparse and inconsistent. There is decreased DNA damage.475 The phytochemical antioxidants
limited evidence suggesting that fruits protect against contained in fruit could reduce free-radical damage gener-
liver cancer. ated by inflammation. A single study reported that apples
given in physiological quantities inhibited carcinogen-
The Panel is aware that since the conclusion of the SLR, one induced mammary cancer in rodents in a dose-response
case-control study526 has been published. This new information manner.536
does not change the Panel judgement (see box 3.8). There is a complex mixture of phytochemicals present in
whole vegetables and these may have additive and syner-
Colorectum gistic effects responsible for anti-cancer activities.
Twenty cohort studies214 216 359-372 374-376 378 379 527-529 and 57
case-control studies investigated fruits and colorectal cancer. 4.2.5.3 Foods containing carotenoids
Thirteen cohort studies showed decreased risk with Mouth, pharynx, and larynx
increased intake,214 216 360-364 366 371 374-376 378 which was sta- Two cohort studies537 538 investigated total serum carotenoids
tistically significant in two.360 364 No studies reported statis- and two case-control studies539 540 investigated total dietary
tically significant increased risk. Meta-analysis was possible carotenoids and mouth, pharynx, and larynx cancers.
on eight cohort studies, giving a summary effect estimate of Ten case-control studies investigated pro-vitamin A caro-
0.97 (95% CI 0.921.03) per serving/day, with high het- tenoids.26-29 47 48 450 451 541-544 Three cohort studies investigat-
erogeneity.360 362-364 366 370 529 When results were stratified by ed serum alpha-carotene537 538 545; one cohort study
100
C H A P T E R 4 F O O D S A N D D R I N K S
Beta-carotene
The single cohort study that investigated dietary beta- Figure 4.2.28 Carotenoids and lung cancer;
carotene intake reported that there was no significant asso- cohort studies
ciation, but provided no further details.71 All three cohort
studies that investigated serum levels showed decreased risk Relative risk (95% CI)
for the highest group when compared to the lowest,537 538 545
Shekelle 1981 0.97 (0.950.99)
which was statistically significant in one.537 The effect esti-
mates were 0.10 (95% CI 0.020.46; adjusted for smok- Wright 2004 0.99 (0.971.01)
ing),537 0.42 and 0.88 for oral/oropharyngeal and laryngeal Summary estimate 0.98 (0.960.99)
101
P A R T 2 E V I D E N C E A N D J U D G E M E N T S
102
C H A P T E R 4 F O O D S A N D D R I N K S
Oesophagus All case-control studies showed decreased risk for the high-
Three cohort studies537 545 580 and one case-control study581 est intake group when compared to the lowest,86 585 587 which
investigated serum beta-carotene; 10 case-control studies was statistically significant in one585 and in men, but not
investigated dietary beta-carotene and oesophageal cancer95 women, in another (figure 4.2.30).86
107 125 141 548 582-587
; one cohort study70 and three case- The general mechanisms through which foods containing
control studies 86 585 587
investigated dietary pro-vitamin A carotenoids, including beta-carotene, could plausibly protect
carotenoids. against oesophageal cancer are outlined below.
Dietary lycopene
0.2 0.5 0.75 1 1.5 2 5 Two cohort studies showed non-significant decreased risk for
Relative risk, highest vs lowest exposure category the highest intake groups when compared to the lowest,590
614
the other study showed non-significant increased risk.613
Meta-analysis was possible on all three cohort studies, giv-
ing a summary effect estimate of 0.97 (95% CI 0.641.45)
per 5 mg/day, with low heterogeneity (figures 4.2.31 and
103
P A R T 2 E V I D E N C E A N D J U D G E M E N T S
Prostate
Also see chapter 4.10.6.4.2 for evidence on beta-carotene
4.2.32). One of these studies also reported cumulative mea- supplements. Six cohort studies147 360 591 594 613 635 636 and 21
sures of lycopene consumption, which is a robust measure case-control studies595 598 599 602 616 617 619-621 624 625 637-648 inves-
of long-term consumption.590 The effect estimate was 0.95 tigated dietary beta-carotene and prostate cancer.
(95% CI 0.920.99) per 5 mg/day. All studies were fully Ten cohort studies576 594 626 628-630 635 649-652 and five case-
adjusted. control studies584 596 608 619 653 investigated serum or plasma
Two of the cohort studies reported separately on advanced beta-carotene.
104
C H A P T E R 4 F O O D S A N D D R I N K S
105
P A R T 2 E V I D E N C E A N D J U D G E M E N T S
somal breakage and rearrangement can all occur if this ini- est levels when compared to the lowest, with an effect esti-
tial damage is left unrepaired. This damage could plausibly mate of 0.45 (95% CI 0.240.82).680
be prevented or limited by dietary antioxidants found in The Panel is aware of an additional cohort study, published
fruits and vegetables.675 after the conclusion of the literature review, which showed
Many of the carotenoids, including beta-carotene, are also a statistically significant decreased risk for the highest intake
retinoid (vitamin A) precursors. The pro-vitamin A groups when compared to the lowest.681 The effect estimate
carotenoids may be converted to retinol where they function was 0.25 (95% CI 0.110.59) for dietary folate and 0.33
in cellular differentiation, immunoenhancement, and acti- (95% CI 0.150.72) for total folate (combining dietary and
vation of carcinogen-metabolising enzymes.580 676 supplemental sources). No association was observed with
Lycopene is the most potent carotenoid antioxidant, has folate supplements only.
an antiproliferative effect, reduces plasma low-density One of the case-control studies reported a statistically sig-
lipoprotein cholesterol, improves immune function, and nificant reduced risk for the highest intake groups when com-
reduces inflammation. pared to the lowest.679 The other reported a non-significant
decreased risk in women and no effect on risk in men.509
4.2.5.4 Foods containing folate The ecological study showed a statistically significant
Foods naturally containing folates are vegetables, fruits, and decreased risk in areas of high folate intake.515
liver, but increasingly foods such as breakfast cereals are for- The possible differential effect between folate from foods
tified with folic acid. and from supplements could be explained by folate serving
as a marker for fruit and vegetable intake, by a different
Pancreas metabolic effect of the folic acid in supplements, or by con-
Three cohort studies,677 678 two case-control studies,509 679 founders associated with supplement use.
and one ecological study515 investigated folate from foods The general mechanisms through which foods containing
and/or supplements, and pancreatic cancer. folate could plausibly protect against pancreatic cancer are
One cohort study reported a statistically significant outlined below.
reduced risk for the highest intake groups (without specify-
ing the source of folate) when compared to the lowest677; one The evidence available is sparse but a dose-response
reported no effect on risk in men678 and the other reported relationship was apparent from cohort studies. There is
a non-significant increased risk in women.678 Meta-analysis limited evidence suggesting that foods containing
was possible on all three cohort studies, giving a summary folate protect against pancreatic cancer.
effect estimate of 0.94 (95% CI 0.801.11) per 100 g/day,
with high heterogeneity.677 678 The Panel is aware that since the conclusion of the SLR, one
When these results were stratified according to dietary or cohort study681 has been published. This new information does
supplemental folate, this heterogeneity was removed. Two not change the Panel judgement (see box 3.8).
cohort studies reported separately on dietary folate.678 Both
reported non-significant decreased risk; meta-analysis was Oesophagus
possible on both, giving a summary effect estimate of 0.86 Eight case-control studies investigated dietary folate113 124 125
(95% CI 0.731.00) per 100 g/day, with no heterogeneity and two case-control studies investigated red
136 548 583 585 587
(figure 4.2.33). All three cohort studies reported separately cell and/or plasma folate.682-684
on supplemental folate, showing non-significant increased All eight case-control studies that investigated dietary
risk, with no heterogeneity.677 678 folate reported decreased risk for the highest intake groups
In addition, one of the cohort studies included a nested when compared to the lowest,113 124 125 136 548 583 585 587 which
case-control study investigating blood folate levels. This was statistically significant in two.583 587 Most studies adjust-
reported a statistically significant decreased risk for the high- ed for smoking and alcohol.
Both case-control studies that investigated red cell and/or
plasma folate reported that levels were lower (statistically
significant) in cases than controls.682-684 One study was
Figure 4.2.33 Folate and pancreatic cancer; adjusted for smoking and alcohol.684
cohort studies
The general mechanisms through which foods containing
Relative risk (95% CI)
folate could plausibly protect against oesophageal cancer are
outlined below. In addition, folate may reduce human papil-
Skinner 2004 Women 0.85 (0.631.15) loma virus proliferation in cells.685
Skinner 2004 Men 0.86 (0.711.04)
Summary estimate 0.86 (0.731.00)
The evidence, from case-control studies only, is sparse.
There is limited evidence suggesting that folate
0.5 0.75 1 1.5 2
protects against oesophageal cancer.
The Panel is aware that since the conclusion of the SLR, one
case-control study78 has been published. This new information
does not change the Panel judgement (see box 3.8).
106
C H A P T E R 4 F O O D S A N D D R I N K S
Colorectum published. This new information does not change the Panel
Nine cohort studies investigated dietary folate and colorec- judgement (see box 3.8).
tal cancer.686-694 Two cohorts investigated serum folate.694 695
Seven cohort studies that investigated dietary folate General mechanisms foods containing folate
showed decreased risk for the highest intake groups when Also see Chapter 2. Folate plays an important role in the syn-
compared to the lowest, 686-690 692 693 which was statistically thesis and methylation of DNA.703 Abnormal DNA methyl-
significant in one.689 Two cohort studies reported non- ation leading to aberrant gene expression has been
significant increased risk.691 694 Meta-analysis was possible on demonstrated in several types of cancer. Folate deficiency
four studies, giving a summary effect estimate of 0.84 (95% may produce misincorporation of uracil instead of thymine
CI 0.760.93) per 100 g/day, with low heterogeneity into DNA. The effects of folate deficiency and supplemen-
(figure 4.2.34).686 689 692 696 tation on DNA methylation are gene- and site-specific, and
One study of serum folate levels showed statistically sig- appear to depend on cell type, target organ, stage of trans-
nificant decreased risk for the highest intake groups when formation, and degree and duration of folate depletion.
compared to the lowest, with an effect estimate of 0.52 (95% Animal studies have shown that dose and timing of folate
CI 0.270.97).695 The other showed a non-significant intervention are critical in determining its effect: excep-
decreased risk for colon cancer (0.96, 95% CI 0.42.3) and tionally high folate doses, and intervention after the forma-
a non-significant increased risk for rectal cancer incidence tion of microscopic neoplastic foci, may promote rather than
(2.94, 95% CI 0.8410.33).694 suppress colorectal carcinogenesis, at least in the animal
Because of the abundant prospective data from cohort models studied.704
studies, case-control studies were not summarised. There is a known interaction between folate and alcohol
A published meta-analysis of seven cohort studies and nine and the risk of some cancers.
case-control studies reported a statistically significant
decreased risk of colorectal cancer for the highest dietary 4.2.5.5 Foods containing pyridoxine (vitamin B6)
folate intake when compared to the lowest (0.75, 95% CI Oesophagus
0.640.89).697 Six case-control studies investigated foods containing pyri-
The general mechanisms through which foods containing doxine and oesophageal cancer.88 125 548 583 585 587
folate could plausibly protect against colorectal cancer are All six studies showed decreased risk for the highest intake
outlined below. In addition, folate intake is also strongly cor- groups when compared to the lowest,88 125 548 583 585 587 which
related with intake of dietary fibre, which probably prevents was statistically significant in four.88 125 583 585 All studies
colorectal cancer (also see chapter 7.1). adjusted for alcohol and five adjusted for smoking.
Together with folate and cobalamin (B12), vitamin B6 is
The evidence from cohort studies is plentiful, with a involved in one-carbon metabolism and thus is important for
dose-response relationship, but there is unexplained DNA synthesis, repair, and methylation.
inconsistency. Residual confounding from dietary fibre is
possible. There is limited evidence suggesting that foods The evidence, from case-control studies only, was
containing folate protect against colorectal cancer. sparse. There is limited evidence suggesting that
pyridoxine protects against oesophageal cancer.
The Panel is aware that since the conclusion of the SLR, four
cohort698-701 and two case-control studies380 702 have been The Panel is aware that since the conclusion of the SLR, one
case-control study78 has been published. This new information
does not change the Panel judgement (see box 3.8).
107
P A R T 2 E V I D E N C E A N D J U D G E M E N T S
108
C H A P T E R 4 F O O D S A N D D R I N K S
intake groups when compared to the lowest,576 626 629 635 650 Lung
which was statistically significant in one.576
652 713 718 723-725
Two cohort studies,288 464 two case-control studies,469 557 and
One cohort study showed no effect on risk.627 Meta-analysis two ecological studies728 729 investigated dietary selenium
was possible on seven cohort studies, giving a summary and lung cancer.
effect estimate of 0.99 (95% CI 0.971.00) per mg/l, with Ten cohort studies,463 575 577 730-738 seven case-control stud-
no heterogeneity.576 626 713 723-725 ies,570 571 739-743 and four ecological studies729 744-746 investi-
Both case-control studies showed decreased risk for the gated plasma or serum selenium; three cohort studies747-749
highest intake groups when compared to the lowest,619 653 investigated selenium levels in nails.
which was statistically significant in one.653
Dietary selenium
Serum gamma-tocopherol One cohort study showed non-significant decreased risk for
All six cohort studies showed decreased risk for the highest the highest intake group when compared to the lowest.464
intake groups when compared to the lowest,576 626 627 629 650 One cohort study showed non-significant increased risk in
718 724
which was statistically significant in two.650 724 Meta- non-smokers and non-significant decreased risk in
analysis was possible on all six cohort studies, giving a sum- smokers.288 Both case-control studies showed a non-signifi-
mary effect estimate of 0.90 (95% CI 0.810.996) per mg/l, cant increased risk for the highest intake group when com-
with moderate heterogeneity. pared to the lowest.469 557 One ecological study showed
The single case-control study showed non-significant statistically significant decreased risk in high-intake areas,728
decreased risk for the highest intake groups when compared the other showed no consistent association.729
to the lowest.619
The general mechanisms through which foods containing Plasma or serum selenium
vitamin E could plausibly protect against prostate cancer Seven cohort studies showed decreased risk for the highest
are outlined below. Vitamin E has also been shown to selenium levels when compared to the lowest,463 575 731-734
inhibit the growth of human prostate tumours induced in 736-738
which was statistically significant in two.733 737 Four
mice.726 studies showed increased risk,577 730 735 738 which was statis-
tically significant in two.735 738 Meta-analysis was possible on
The evidence, mostly from case-control studies, was four cohort studies, giving a summary effect estimate of
inconsistent. There is limited evidence suggesting that 0.969 (95% CI 0.9400.999) per 10 g/l, with low hetero-
foods containing vitamin E protect against prostate geneity.577 731 733 736
cancer. Six case-control studies showed decreased risk for the
highest levels when compared to the lowest,570 739-743 which
The Panel is aware that since the conclusion of the SLR, two was statistically significant in four.739 740 742 743 One study
cohort studies632 633 have been published. This new information showed non-significant increased risk.571
does not change the Panel judgement (see box 3.8). One ecological study showed statistically significant
decreased risk in areas of high plasma selenium729; the oth-
General mechanisms foods containing vitamin E ers showed no consistent effect.729 744-746
Vitamin E is an antioxidant that has been reported to pre-
vent DNA damage, enhance DNA repair, prevent lipid per- Nails
oxidation, and prevent activation of carcinogens such as Two cohort studies showed decreased risk for the highest
nitrosamines. Vitamin E protects vitamin A and selenium in selenium levels when compared to the lowest,748 749 which
the body. In addition to acting as a free-radical scavenger, was statistically significant in one.749 One study showed non-
vitamin E enhances the bodys immune response, which may significant increased risk.747
play a role in cancer defences.727 The general mechanisms through which selenium could
plausibly protect against lung cancer are outlined below.
4.2.5.8 Foods containing selenium
Data from selenium levels in serum or nails can be inter- The evidence available is sparse. There is limited
preted more robustly than dietary data because they are less evidence to suggest that foods containing selenium
prone to certain sources of error; serum data are a short-term protect against lung cancer.
reflection of intake; levels in nails are cumulative and reflect
long-term intake. Prostate
It is not possible to rule out residual confounding between One cohort,713 750 7 case-control studies,599 601 639 715 716 751 752
selenium levels and healthy lifestyles. Individuals with high- and 2 ecological studies729 753 754 investigated dietary sele-
er selenium levels may be more likely to be following sev- nium; 12 cohort studies652 730 732 755-765 and 4 case-control
eral strategies to improve their health, including taking studies716 741 752 754 766 767 investigated serum or plasma sele-
supplements. nium; and 3 cohort studies,615 724 768 3 case-control studies,717
It is plausible that an effect attributed to selenium could 769 770
and 1 ecological study771 investigated levels in nails.
only be apparent in areas of selenium deficiency. Further to this, 1 randomised controlled trial772 773 and 2
cohorts612 628 713 investigated selenium supplements (see
chapter 4.10.6.4.5).
109
P A R T 2 E V I D E N C E A N D J U D G E M E N T S
A dose-response relationship is apparent from the studies Nomura 2000 0.80 (0.641.00)
on advanced or aggressive disease (figure 4.2.38). Li 2004 0.89 (0.801.00)
All four of the case-control studies showed decreased risk Summary estimate 0.87 (0.790.97)
0.5 1 2 8 10 12 14 16
110
C H A P T E R 4 F O O D S A N D D R I N K S
111
P A R T 2 E V I D E N C E A N D J U D G E M E N T S
Selenoproteins appear to reach their maximal levels highest intake groups when compared to the lowest,109 157 161
relatively easily at normal dietary selenium intake and 165 179 185-187 190 219 247 249 250 271
which was statistically signifi-
not to increase with selenium supplementation. It is, how- cant in six.109 161 165 179 190 249 Six studies reported increased
ever, plausible that supraphysiological amounts of selenium risk,162 224 243 251 270 482 which was statistically significant in
might affect programmed cell death, DNA repair, carcinogen two.224 243 270 The remaining four studies reported no effect
metabolism, immune system, and anti-angiogenic effects.797 on risk,180 244 or stated that there was no significant effect
on risk.175 Meta-analysis was possible on eight studies, giv-
4.2.5.9 Foods containing quercetin ing a summary effect estimate of 0.93 (95% CI 0.870.99)
Lung per 20 g/day, with moderate to high heterogeneity.157 162 179
Two cohort studies147 798 and three case-control studies327 477 180 186 187 247 249
799
investigated foods containing quercetin and lung cancer. A dose-response relationship is apparent from case-control
Both cohort studies showed statistically significant but not cohort data.
decreased risk for the highest intake groups when compared One ecological study reported a statistically significant
to the lowest.147 798 The effect estimates were 0.63 (95% CI association, so that higher soya consumption was associated
0.520.78)147 and 0.42 (95% CI 0.250.72).798 Both studies with lower stomach cancer risk.208 The other 15 reported no
adjusted for smoking. significant association.116-119 197 198 200-203 209 236 238 239 801
Two case-control studies showed decreased risk for the
highest intake groups when compared to the lowest,327 477 Soya and soya products
which was statistically significant in one.327 One study Both cohort studies showed decreased risk for the highest
reported non-significant increased risk.799 The effect esti- intake groups when compared to the lowest,802 803 which was
mates were 0.58 (95% CI 0.390.85),327 0.7 (95% CI statistically significant in one.803 The effect estimates were
0.41.1),477 and 1.89 (95% CI 0.724.92).799 The latter study 0.60 (44 cases, 95% CI 0.401.10)802 and 0.86 (121 cases,
may have been over-adjusted. 95% CI 0.770.96) per 20 g/day.803 The smaller study was
Quercetin is a flavonoid. It is an antioxidant and also not adjusted for any confounders.
directly inhibits expression of CYP1A1 (a cytochrome P450 All nine case-control studies showed decreased risk for the
enzyme that helps to metabolise toxins), resulting in highest intake groups when compared to the lowest,109 129 159
decreased formation of DNA adducts.475 Elevated CYP1A1 178 184 194 226 229 262
which was statistically significant in five.129
activity has been associated with increased risk of lung can- 159 178 184 226
Meta-analysis was possible on seven studies, giv-
cer, primarily in smokers.476 The evidence for CYP1A1/ ing a summary effect estimate of 0.82 (95% CI 0.720.94)
flavonoid interactions is supported by the observation that per 20 g/day, with high heterogeneity.109 129 159 178 194 226 229
protective associations of flavonoids are associated with Heterogeneity is derived from the size, and not the direction,
specific CYP1A1 genotypes.476 477 of the effect.
A dose-response relationship is apparent from case-control
The evidence available is sparse and inconsistent. data, as well as from one of the two cohort studies.
There is limited evidence suggesting that foods Both ecological studies reported statistically significant
containing quercetin protect against lung cancer. inverse relationships, with stomach cancer risk decreasing in
areas of increased soya consumption.208 804
4.2.5.10 Pulses (legumes) The general mechanisms through which pulses (legumes),
Studies conducted in Western countries, as most cohorts soya and soya products could plausibly protect against stom-
have been, are likely to have limited power to detect an asso- ach cancer are outlined below. In addition, laboratory exper-
ciation between pulses, and particularly soya intake, and iments have shown that genistein slows down the
cancer risk because consumption tends to be low. development of stomach cancers promoted by sodium chlo-
ride by increasing apoptosis, and lowering cell proliferation
Stomach and blood vessel growth.805 Additionally, in a rodent model,
Three cohort studies,144 146 241 22 case-control studies,109 157 a diet containing miso inhibited N-nitrosamine-induced
161 162 165 175 179 180 185-187 190 219 224 243 244 247 249-251 270 271 482
stomach tumours.806
2 cross-sectional studies,196 800 and 16 ecological studies116-
119 197 198 200-203 208 209 236 238 239 801
investigated pulses The evidence, mostly from case-control studies, is
(legumes) and stomach cancer. Two cohort studies,802 803 inconsistent. There is limited evidence suggesting that
9 case-control studies,109 129 159 178 184 194 226 229 262 and 2 eco- pulses (legumes), including soya and soya products,
logical studies208 804 investigated soya and soya products. protect against stomach cancer.
112
C H A P T E R 4 F O O D S A N D D R I N K S
113
P A R T 2 E V I D E N C E A N D J U D G E M E N T S
tected against cancers of the liver, prostate, and kidney. 4.2.7 Conclusions
Since the mid-1990s, a number of cohort studies have
somewhat weakened the overall evidence for the protective The Panel concludes:
effects of vegetables and fruits. A number of judgements of Findings from cohort studies conducted since the mid-1990s
probable protective effects are made for non-starchy veg- have made the overall evidence that vegetables, or fruits,
etables and for fruits (mouth, pharynx, larynx, oesophagus, protect against cancers, somewhat less impressive. In no case
stomach, and (fruits only) lung). In general, the reason for now is evidence of protection judged to be convincing.
this is that the more recent cohort studies failed to show the However, there is evidence that some types of vegetables,
effect seen in case-control studies. and fruits in general, probably protect against a number of
The previous report also made judgements on types of veg- cancers. The few judgements on legumes (pulses), nuts,
etables and fruits in a footnote, while choosing not to enter seeds, and (with two exceptions) herbs and spices, reflect the
these into the matrix. The evidence that green vegetables small amount of epidemiological evidence.
protected against lung and stomach cancer was judged con- Non-starchy vegetables probably protect against cancers of
vincing; and probable for mouth and oesophageal cancer. the mouth, pharynx, and larynx, and those of the oesopha-
The evidence that cruciferous vegetables protected against gus and stomach. There is limited evidence suggesting that
colorectal and thyroid cancer was judged probable. The evi- they also protect against cancers of the nasopharynx, lung,
dence that allium vegetables protected against stomach can- colorectum, ovary, and endometrium. Allium vegetables prob-
cer was judged probable. The evidence that raw vegetables ably protect against stomach cancer. Garlic (an allium veg-
and citrus fruits protected against stomach cancer was etable, commonly classed as a herb) probably protects against
judged convincing. These classifications are somewhat dif- colorectal cancer.
ferent from those made in this Report, but mostly also gen- Fruits in general probably protect against cancers of the
erated more confident judgements than are made here. mouth, pharynx, and larynx, and of the oesophagus, lung,
Vitamins, minerals, and other bioactive constituents of and stomach. There is limited evidence suggesting that fruits
foods and drinks were assessed as such in the previous also protect against cancers of the nasopharynx, pancreas,
report, whereas here they are assessed either as contained liver, and colorectum.
in foods and drinks or (see chapter 4.10) as supplements. There is limited evidence suggesting that carrots protect
The previous report judged that carotenoids (in food) prob- against cervical cancer; and that pulses (legumes), including
ably protected against lung cancer; that vitamin C (in food) soya and soya products, protect against stomach and prostate
probably protected against stomach cancer; and that these cancers. There is limited evidence suggesting that chilli is a
vitamins and vitamin E possibly protected against cancers of cause of stomach cancer.
a number of sites. Fruits and non-starchy vegetables are low energy-dense
The previous panel regretted the lack of evidence on puls- foods. For a discussion of the effect of such foods and drinks
es (legumes), nuts, seeds, herbs, and spices, and made no on weight gain, overweight, and obesity, and the role of
significant judgements. Since then, evidence on soya and its weight gain, overweight, and obesity in the risk of some can-
products, and on garlic (as well as allium vegetables in gen- cers, see Chapters 6, 7, and 8.
eral) and chilli, has increased and allowed some judgements. Evidence that vegetables, fruits, and pulses protect against
The previous report judged that aflatoxin contamination some cancers is supported by evidence on various micronu-
was a probable cause of liver cancer. Since then, the overall trients, which act as markers for consumption of vegetables,
evidence, particularly on the underlying mechanisms, has fruits, and pulses (legumes), and other plant foods. Foods
strengthened. containing folate probably protect against pancreatic cancer,
The previous report emphasised evidence on vegetables and there is limited evidence suggesting that these also pro-
and on fruits as a whole, while noting evidence on categories tect against oesophageal and colorectal cancers. Foods con-
of vegetables and fruits. This Report has not made any sep- taining carotenoids probably protect against cancers of the
arate judgement on raw vegetables and fruits. The previous mouth, pharynx, and larynx, and also lung cancer. Foods con-
report classified bananas as plantains. Here they are classi- taining the carotenoid beta-carotene probably protect against
fied as fruits. The previous report considered micronutrients oesophageal cancer; and foods containing lycopene, found in
and phytochemicals contained in foods of plant origin in sep- tomatoes and also fruits such as watermelon, guavas, and
arate chapters. Here, the evidence has been characterised in apricots, probably protect against prostate cancer. Foods con-
terms of foods containing specified micronutrients, and they taining vitamin C, found in some vegetables, citrus and other
are considered together with vegetables and fruits, pulses fruits, and potatoes, probably protect against oesophageal
(legumes), nuts and seeds, and other plant foods. Similarly, cancer. There is limited evidence suggesting that foods con-
the previous report considered dietary fibre separately from taining quercetin, such as apples, tea, and onions, protect
cereals (grains) and other plant foods. Here, dietary fibre is against lung cancer.
considered in the context of cereals (grains) and other plant Evidence on foods containing other micronutrients
foods, including those assessed in this section. is grouped here, for ease of reference. Foods containing
114
C H A P T E R 4 F O O D S A N D D R I N K S
115
P A R T 2 E V I D E N C E A N D J U D G E M E N T S
In the judgement of the Panel, the factors listed below modify the risk of cancer. Judgements are graded according to the strength of the evidence.
Substantial
effect on risk None identified
unlikely
1 The term red meat refers to beef, pork, lamb, and goat from domesticated animals.
2 The term processed meat refers to meats preserved by smoking, curing, or salting, or addition of chemical preservatives.
3 This style of preparation is characterised by treatment with less salt than typically used, and fermentation during the drying process due to relatively high outdoor
temperature and moisture levels. This conclusion does not apply to fish prepared (or salted) by other means.
4 Includes both foods naturally containing the constituent and foods which have the constituent added (see chapter 3.5.3).
5 Although red and processed meats contain iron, the general category of foods containing iron comprises many other foods, including those of plant origin.
6 The evidence is mostly from meats preserved or cooked in these ways.
7 Found mostly in fortified foods and animal foods.
For an explanation of all the terms used in the matrix, please see chapter 3.5.1, the text of this section, and the glossary.
These animal foods are sources of protein and The Panel judges as follows:
micronutrients. The amount and nature of the fat content The evidence that red meats and processed meats are a
of meat, poultry, and fish depends on methods of rearing, cause of colorectal cancer is convincing. Cantonese-style
processing, and preparation, as well as the type of animal. salted fish is a probable cause of nasopharyngeal cancer.
Production and consumption of red meat and processed This finding does not apply to any other type of fish
meat generally rise with increases in available income. product. Cantonese-style salted fish is also subject to
Consumption of beef and products made with beef is still fermentation.
increasing, notably in China and other middle- and low- There is limited evidence suggesting that fish, and also
income countries. In many countries, poultry is now also foods containing vitamin D, protect against colorectal
intensively reared and consumption has increased greatly. cancer. There is limited evidence suggesting that red meat
Much fish is now farmed. is a cause of cancers of the oesophagus, lung, pancreas
In general, the Panel judges that the evidence on red meat and endometrium; that processed meat is a cause of
and processed meat is stronger than it was in the mid-1990s. cancers of the oesophagus, lung, stomach and prostate;
Epidemiological evidence on other methods of preserving and that foods containing iron are a cause of colorectal
and preparing meats and other animal foods is sparse; the cancer. There is also limited evidence that animal foods
overall evidence remains suggestive, at most. The evidence that are grilled (broiled), barbecued (charbroiled), or
on poultry, fish, and eggs is generally insubstantial. smoked, are a cause of stomach cancer.
116
C H A P T E R 4 F O O D S A N D D R I N K S
Red meat can be relatively high in animal fats. For a 4.3.1 Definitions and sources
discussion of the role of animal fats on cancer, see chapter
4.4 and Chapter 7. Meat can also be energy dense. For Meat and poultry
discussion on the role of energy-dense foods on weight In this Report, meat includes all animal flesh apart from fish
gain, overweight, and obesity, and the role of weight gain, and seafood. Meat can be further classed as either red meat,
overweight, and obesity in the risk of some cancers, see which generally refers to flesh from animals that have more
Chapters 6 and 8. red than white muscle fibres (in this Report, beef, goat, lamb,
The strongest evidence, corresponding to judgements of and pork), or poultry, which usually has more white than red
convincing and probable, shows that red meat and muscle fibres (from birds such as chickens, guinea fowl, and
processed meat are causes of colorectal cancer, and that turkeys). Meat can also be categorised by dividing it into
Cantonese-style salted fish is probably a cause of meats from skeletal muscles or the internal organs (offal,
nasopharyngeal cancer. The Panel also notes limited such as the brain, liver, heart, intestines, and tongue). Meat
evidence suggesting that red meat and processed meat are can also be divided according to whether the animal was
causes of other cancers. domesticated or wild. Most meats consumed around the
world today are from domesticated animals. Wild meats,
that is from non-domesticated or free-ranging species, are a
It is generally, though not universally, agreed that humans significant source of protein and energy among some popu-
evolved as omnivores, and that healthy diets usually include lations. Some non-domesticated animals, such as deer or buf-
foods of plant and of animal origin including meat, poul- falo, are also farmed. However, the evidence presented in
try, fish, and eggs, as well as milk and other dairy products. this chapter applies only to meat from domesticated animals.
Most people who do not eat meat, flesh, or any food of ani- Some meats are processed in various ways (box 4.3.1).
mal origin do so for religious or ethical reasons. Impoverished
communities eat little flesh and meat is reserved for feasts. Fish
Partly because meat-eating is a sign of prosperity and partly This Report uses the culinary definition of fish, which
because many people enjoy eating meat, poultry, and fish, includes shellfish. There are more than 27 000 species of salt
production and consumption generally rise as available and freshwater fish; many more crustaceans, bivalves, and
income increases. Consumption of beef is, for example, now cephalopods can also be eaten. Fish and shellfish are the only
increasing very rapidly in China, and consumption of burg- foods that, globally, are still obtained in significant quanti-
ers made from beef is increasing worldwide. ties from the wild. But many species are on the verge of com-
Early reports concerned with nutritional deficiencies iden- mercial extinction and aquaculture is increasing worldwide.
tified meat, poultry, and fish as good sources of protein, iron, For instance, more than a third of the salmon eaten world-
and other nutrients, and eggs as a complete food, especially wide is farmed. Like meat, fish is also processed, for instance
for children. By contrast, in the second half of the 20th cen- by drying, salting, and smoking.
tury, reports on meat, poultry, fish, and eggs tended to focus
on red meat as a source of fat and saturated fatty acids and Eggs
on eggs as a source of dietary cholesterol in the causation Eggs are the ova of animals and in this Report mean only
of coronary heart disease. These reports promoted poultry
and fish as better choices than red meat, either because they
contain less fat and saturated fatty acids or, in the case of Box 4.3.1 Processed meat
oily fish, they contain unsaturated fats identified as protec-
tive. Little attention has been given to flesh from wild ani- What is processed meat? The question is important because, as
mals and birds, despite this being known to have a different shown here, the evidence that processed meat is a cause of
colorectal cancer is convincing.
nutritional profile lower in total fat and higher in unsat-
In the broad sense of the word, most meat is processed cook-
urated fatty acids. On the other hand, since the mid-1990s
ing is a process. But as commonly used, the term processed meat
more attention has been given in epidemiological studies to refers to meats (usually red meats) preserved by smoking, curing,
processed meat as a cause or possible cause of cancers of or salting, or by the addition of preservatives. Meats preserved
some sites. only by refrigeration, however they are cooked, are usually not
For discussion of the role of red meat and processed meat classified as processed meat.
in energy-dense foods and drinks, the effect of energy-dense There is no generally agreed definition of processed meat. The
foods and drinks on weight gain, overweight, and obesity, term is used inconsistently in epidemiological studies. Judgements
and the role of weight gain, overweight, and obesity in the and recommendations are therefore less clear than they could be.
risk of some cancers, see Chapters 6 and 8. Ham, bacon, pastrami, and salami are processed meats. So are
sausages, bratwursts, frankfurters, and hot dogs to which nitrites
In this Report, methods of production, preservation, pro-
or nitrates or other preservatives are added (box 4.3.2). Minced
cessing, and preparation (including cooking), that are sole-
meats sometimes fall inside this definition, often if they are pre-
ly or mainly to do with meat and other animal foods, are served chemically, but not always. The same point applies to ham-
included here. Processed meat as a category is included here. burgers. Given the importance of this issue, transnational
The mineral iron is also covered here, although it is also burger caterers should specify the methods they use to process
found in plant foods. their products.
117
P A R T 2 E V I D E N C E A N D J U D G E M E N T S
118
C H A P T E R 4 F O O D S A N D D R I N K S
119
P A R T 2 E V I D E N C E A N D J U D G E M E N T S
4.3.5.1 Meat
Eggs 4.3.5.1.1 Red meat
Worldwide, eggs provide 1.2 per cent of available food ener- Some studies may have included processed meats in their
gy. Egg consumption is highest in the Far East, North classification of red meat intake.
America, and Europe, ranging from nearly 3 per cent in these
areas to virtually zero in many African countries; it is sig- Colorectum
nificantly higher in high-income countries. Preserved eggs Sixteen cohort studies8-24 and 71 case-control studies inves-
(pickled, salted, or cured) are traditional in some cultures. tigated red meat and colorectal cancer.
All of the cohort studies that reported analyses of risk for
the highest intake group when compared to the lowest
4.3.4 Interpretation of the evidence showed increased risk (figure 4.3.1),8-24 which was statisti-
cally significant in four (one of these was specific to rapid-
4.3.4.1 General acetylator genotypes).9 10 12 18 23 Meta-analysis was possible
For general considerations that may affect interpretation of
the evidence, see chapters 3.3 and 3.5, and boxes 3.1, 3.2,
3.6 and 3.7. Figure 4.3.1 Red meat and colorectal cancer;
Relative risk (RR) is used in this Report to denote ratio cohort studies
measures of effect, including risk ratios, rate ratios, haz-
ard ratios, and odds ratios. Relative risk (95% CI)
have different nutritional profiles and biological effects, one Tiemersma 2002 Women 1.20 (0.512.84)
Wei 2003 Men 1.35 (0.802.27)
obvious example being white fish and oily fish. These are Wei 2003 Women 1.31 (0.732.36)
often not distinguished in epidemiological studies. Chen 2003 1.48 (0.852.59)
English 2004 1.40 (1.021.93)
Norat 2004 1.17 (0.921.49)
Terminology. As yet, there is no agreed definition for
processed meat. Some studies count minced meat, or ham,
bacon, and sausages as processed meats; others do not. See 0.2 0.5 1 2 5
the footnote to the matrix and box 4.3.1. Relative risk, highest vs lowest exposure category
120
C H A P T E R 4 F O O D S A N D D R I N K S
Figure 4.3.2 Red meat and colorectal cancer; Figure 4.3.3 Red meat and colorectal cancer;
cohort studies cohort studies
0.2 0.5 1 2 5 9
The Panel is aware that since the conclusion of the SLR, six There is limited evidence, from case-control studies,
cohort27-32 and four case control studies33-36 have been pub- some of which were poor quality, suggesting that red
lished. This new information does not change the Panel judge- meat is a cause of oesophageal cancer.
ment (see box 3.8).
The Panel is aware that since the conclusion of the SLR, one
Oesophagus cohort study51 has been published. This new information does
Twelve case-control studies37-50 investigated red meat and not change the Panel judgement (see box 3.8).
oesophageal cancer.
Eight studies reported increased risk for the highest intake Lung
group when compared to the lowest,37-39 41-45 49 50 which was One cohort study52 and nine case-control studies53-62 inves-
statistically significant in five.37 41 42 45 Three studies reported tigated red meat and lung cancer.
121
P A R T 2 E V I D E N C E A N D J U D G E M E N T S
The single cohort study showed increased risk for the high- Five case-control studies showed increased risk for the
est intake group when compared to the lowest, with an effect highest intake group when compared to the lowest,46 76-79
estimate of 1.6 (95% CI 1.02.6; p value for trend < 0.014), which was statistically significant in two.77 78 Two studies
based on 158 cases.52 showed non-significant reduced risk.80 81 Meta-analysis was
Seven case-control studies showed increased risk for the possible on six studies, giving a summary effect estimate of
highest intake group when compared to the lowest,53-58 60 61 1.20 (95% CI 1.031.39) per 50 g red meat/day, with mod-
which was statistically significant in four.54 55 60 61 One study erate heterogeneity.46 76-80
reported non-significant decreased risk59 and one study The general mechanisms through which red meat could
showed no effect on risk.62 All except the latter study adjust- plausibly cause cancer are outlined below.
ed for smoking.
The general mechanisms through which red meat could The evidence, mostly from case-control studies, is
plausibly cause cancer are outlined below. sparse. There is limited evidence suggesting that red
meat is a cause of endometrial cancer.
There is limited evidence, mostly from inconsistent
case-control studies, suggesting that red meat is a The Panel is aware that since the conclusion of the SLR, one
cause of lung cancer. case-control study82 has been published. This new information
does not change the Panel judgement (see box 3.8).
Pancreas
Seven cohort studies63-69 and four case-control studies46 70-72 General mechanisms
investigated red meat and pancreatic cancer. There are several potential underlying mechanisms for an
Six cohort studies showed increased risk for the highest association between red meat consumption and cancer,
intake group when compared to the lowest,63-65 67-69 which including the generation by stomach and gut bacteria of
was statistically significant in one,64 and two of the studies potentially carcinogenic N-nitroso compounds. Some red
also had statistically significant tests for trend.65 67 One study meats are also cooked at high temperatures, resulting in the
reported a non-significant increased risk that was very close production of heterocyclic amines and polycyclic aromatic
to no effect.66 Meta-analysis was possible on two studies, giv- hydrocarbons (box 4.3.4). Haem promotes the formation
ing a summary effect estimate of 1.00 (95% CI 0.951.05) of N-nitroso compounds and also contains iron. Free iron can
per 20 g/day, with no heterogeneity.63 66 However, the two lead to production of free radicals (box 4.3.3). Iron overload
included studies were not typical. The effect estimates for the also activates oxidative responsive transcription factors,
highest intake group when compared to the lowest in the pro-inflammatory cytokines, and iron-induced hypoxia
other five cohort studies were 1.45 (95% CI 1.191.76),64 signalling.83
1.73 (95% CI 0.992.98; with a statistically significant test
for trend),65 2.4 (95% CI 16.1; with a statistically signifi-
cant test for trend),67 1.1 (95% CI 0.91.2),68 and 1.4 (95%
CI 0.44.8) for men and 2.7 (95% CI 0.88.9) for women.69 Figure 4.3.5 Processed meat and colorectal cancer;
All of the case-control studies showed increased risk for cohort studies
the highest intake group when compared to the lowest,46 70-
Relative risk (95% CI)
72
which was statistically significant in three.46 71 72 Meta-
analysis was possible on three case-control studies, giving a Philips 1975 2.05 (1.504.06)
summary effect estimate of 1.11 (95% CI 1.081.15) per 20 Goldbohm 1994 Men 1.84 (0.853.97)
The general mechanisms through which red meat could Bostick 1994 Women 1.51 (0.723.17)
Gaard 1996 Women 3.50 (1.0211.95)
plausibly cause cancer are outlined below. In addition, both Gaard 1996 Men 1.98 (0.705.59)
the secretory function of the pancreas and cell turnover with- Kato 1997 Women 1.09 (0.592.02)
in the pancreas are altered by the types of foods eaten.73 Pietinen 1999 Men 1.20 (0.751.92)
Tiemersma 2002 Men 1.00 (0.511.95)
Amino acids and fatty acids stimulate more pancreatic secre- Tiemersma 2002 Women 0.80 (0.431.50)
tions than do carbohydrates.74 Flood 2003 Women 0.97 (0.731.28)
Wei 2003 Men 1.27 (0.871.85)
Evidence from cohort studies is less consistent than Wei 2003 Women 1.32 (0.951.83)
English 2004 1.50 (1.112.02)
that from case-control studies. There is limited Chao 2005 Men 1.11 (0.801.54)
evidence suggesting that red meat is a cause of Chao 2005 Women 1.16 (0.851.58)
pancreatic cancer. Norat 2005 1.42 (1.091.85)
122
C H A P T E R 4 F O O D S A N D D R I N K S
Fourteen cohort studies8-10 14-19 21 27 69 84 85 and 44 case-control Pietinen 1999 0.99 (0.791.24)
Chao 2005 Men 1.40 (1.041.88)
studies investigated processed meat and colorectal cancer. Chao 2005 Women 1.14 (0.642.05)
Twelve cohort studies showed increased risk for the high- Norat 2005 1.30 (0.931.80)
est intake group when compared to the lowest (figure Larsson 2005 Women
Summary estimate
1.13 (0.851.51)
1.21 (1.041.42)
4.3.5),8-10 14-19 21 27 69 85 which was statistically significant in
three.9 14 15 85 One study reported non-significant decreased
risk and one study reported that there was no effect on risk.84 0.2 0.5 1 2 5
Meta-analysis was possible on five studies, giving a summary Relative risk, per 50 g/day
The Panel is aware that since the conclusion of the SLR, five
cohort28 30 32 86 87 and two case-control studies36 88 have been
published. This new information does not change the Panel Figure 4.3.8 Processed meat and colorectal cancer;
judgement (see box 3.8). cohort studies: dose response
Oesophagus
Two cohort studies89 90 and eight case-control studies40 41 43
investigated processed meat and oesophageal
44 49 50 91-94
123
P A R T 2 E V I D E N C E A N D J U D G E M E N T S
There is limited evidence, mostly from case-control The evidence is inconsistent. There is limited evidence
studies, suggesting that processed meat is a cause of suggesting that processed meat is a cause of stomach
oesophageal cancer. cancer.
The Panel is aware that since the conclusion of the SLR, one The Panel is aware that since the conclusion of the SLR, one
cohort study51 has been published. This new information does cohort135 and two case-control studies136 137 have been pub-
not change the Panel judgement (see box 3.8). lished. This new information does not change the Panel judge-
ment (see box 3.8).
Lung
Four cohort studies52 69 95 96 and 10 case-control studies33 55- Prostate
57 59 97-104
investigated processed meat and lung cancer. Four cohort studies138-141 and six case-control studies142-147
Three cohort studies reported non-significant increased investigated processed meat and prostate cancer.
risk for the highest intake group when compared to the low- All four cohort studies showed increased risk for the high-
est.69 95 96 One study reported no effect on risk.52 95 Meta- est intake group when compared to the lowest,138-141 which
analysis was possible on two of the studies, giving a was statistically significant in two.139 141 Meta-analysis was
summary effect estimate of 1.03 (95% CI 0.921.16) per possible on all four cohort studies, giving a summary effect
serving/week, with no heterogeneity.52 All four cohort stud- estimate of 1.11 (95% CI 0.9951.25) per serving/week,
ies adjusted for smoking. with high heterogeneity. Heterogeneity was caused by vary-
Six case-control studies reported increased risk for the ing size, not direction, of effect.
highest intake group when compared to the lowest,33 56 57 59 Two of these studies reported separately on advanced
99 100 102-104
which was statistically significant in two.100 102 or aggressive cancer. Both showed increased risk with
Four studies reported non-significant decreased risk.55 97 98 101 increasing intake of processed meat,138 141 which was statis-
All of the studies adjusted for smoking. tically significant in one.141 Meta-analysis was possible on
The general mechanisms through which processed meat both studies, giving a summary effect estimate of 1.09 (95%
could plausibly cause cancer are outlined below. CI 0.981.22) per serving/week, with moderate hetero-
geneity.
There is limited, inconsistent evidence suggesting that Four case-control studies showed non-significant
processed meat is a cause of lung cancer. decreased risk with increasing intake of processed meat143-
145 147
; two showed non-significant increased risk.142 146 Meta-
Stomach cancer analysis was possible on five case-control studies, giving a
Eight cohort studies,51 69 105-110 21 case-control studies,49 111- summary effect estimate of 1.01 (95% CI 0.981.04) per
132
1 cross-sectional study,133 and 1 ecological study134 inves- serving/week, with low heterogeneity.143-147 The general
tigated processed meat and stomach cancer. mechanisms through which processed meat could plausibly
Five cohort studies showed increased risk for the highest cause cancer are outlined below.
intake group when compared to the lowest,51 106-108 110 which
was statistically significant in one.51 Two studies reported There is limited evidence from sparse and inconsistent
non-significant decreased risk105 109; and one showed no studies suggesting that processed meat is a cause of
effect on risk in men and non-significant decreased risk in prostate cancer.
women.69 Meta-analysis was possible on all eight cohort
studies, giving a summary effect estimate of 1.02 (95% CI The Panel is aware that since the conclusion of the SLR, two
1.001.05) per 20 g/day, with no heterogeneity. cohort studies148 149 have been published. This new information
Thirteen case-control studies showed increased risk for the does not change the Panel judgement (see box 3.8).
highest intake group when compared to the lowest,49 113 117
119-121 124-132
which was statistically significant in seven.120 125 General mechanisms
128-132
Three studies showed decreased risk,118 122 123 which Nitrates are produced endogenously at the low pH in the
was statistically significant in one118; and one showed no stomach and are added as preservatives to processed meats,
effect on risk.116 Four other studies reported no significant both of which may contribute to N-nitroso compound pro-
difference between mean intakes in cases and controls.111 112 duction and exposure. N-nitroso compounds are suspected
114 115
Meta-analysis was possible on nine studies, giving a mutagens and carcinogens.150 Many processed meats also
summary effect estimate of 1.13 (95% CI 1.011.25) per contain high levels of salt and nitrite. Some processed meats
20 g/day, with high heterogeneity.49 117-119 121 123 128-130 are also cooked at high temperatures, resulting in the pro-
A dose-response relationship is apparent from case-control duction of heterocyclic amines and polycyclic aromatic
but not cohort data. hydrocarbons. Red meat contains haem iron. Haem promotes
The single ecological study reports a statistically significant the formation of N-nitroso compounds and also contains
correlation between increased processed meat and stomach iron. Free iron can lead to production of free radicals (box
cancer risk.134 4.3.3).
The general mechanisms through which processed meat
could plausibly cause cancer are outlined below.
124
C H A P T E R 4 F O O D S A N D D R I N K S
4.3.5.2 Poultry assessed in the 1960s, 1970s, and 1980s. The p value for
The evidence was too limited in amount, consistency, or trend for the association between each decades intake and
quality to draw any conclusions. increased risk was < 0.001, 0.014, and 0.21, respectively.
Seventeen of the case-control studies showed increased
4.3.5.3 Fish, shellfish risk for the highest intake group when compared to the low-
Colorectum est,169-178 182-188 which was statistically significant in nine.170
Nineteen cohort studies8-10 14-18 21 23 69 85 151-161 and 55 case- 172 173 176 178 182 185-188
One study showed a non-significant
control studies investigated fish and colorectal cancer. decreased risk168; three studies reported that there was no
Nine cohort studies showed decreased risk for the highest association.179-181 Meta-analysis was possible on nine stud-
intake group when compared to the lowest,8 15-17 21 69 85 154 ies, giving a summary effect estimate of 1.28 (95% CI
157 158 160
which was statistically significant in two.15 16 Eight 1.131.44) per serving/ week, with high heterogeneity (fig-
studies showed non-significant increased risk.9 10 18 23 151-153 ure 4.3.9). Heterogeneity was related to size, and not direc-
155 156 159
One study showed no effect on risk14 and one study tion, of effect.
reported that there was no statistically significant associa-
tion.161 Meta-analysis was possible on seven cohort studies,
giving a summary effect estimate of 0.96 (95% CI 0.921.00) Figure 4.3.9 Salted fish and nasopharyngeal cancer;
per serving/week, with low heterogeneity.8 9 14 18 21 158 160 case control
Because of the abundant prospective data from cohort
Relative risk (95% CI)
studies, case-control studies were not summarised.
Heterogeneity may be partially explained by varying def- Yuan 2000 1.73 (0.664.52)
initions of fish in different studies that included fresh and/or Lee 1994 1.17 (0.851.61)
Zheng 1994 2.50 (1.633.85)
salted or dried fish. It is also possible that high fish intake Sriamporn 1992 1.35 (1.061.72)
is associated with low meat intake, which is a potential con- Yu 1989 1.10 (1.001.21)
founder that has not been adjusted for. Yu 1986 1.31 (1.131.51)
Weiming 1995 1.71 (1.082.70)
It is biologically plausible that fish n-3 polyunsaturated Cai 1996 1.06 (1.001.02)
fatty acids (PUFAs) protect against cancer. Fish oils reduce Zou 1999 1.32 (1.131.54)
tumours in animal studies.162 Likely mechanisms are thought Summary estimate 1.28 (1.131.44)
The Panel is aware that since the conclusion of the SLR, six Lee 1994 4.40 (0.7226.76)
Zheng 1994 4.07 (0.3645.80)
cohort28 30 164 165 and two case-control studies33 166 have been Zheng 1994b 17.20 (2.28104.79)
published. This new information does not change the Panel West 1993 1.30 (0.672.52)
Adult intake
The single cohort study showed increased risk for the high-
est intake group when compared to the lowest. Intake was
125
P A R T 2 E V I D E N C E A N D J U D G E M E N T S
126
C H A P T E R 4 F O O D S A N D D R I N K S
127
P A R T 2 E V I D E N C E A N D J U D G E M E N T S
There is limited, inconsistent evidence, mostly from cancer, see chapter 4.4. Meat may also be energy dense. For
case-control studies, that grilled (broiled) or discussion on the role of energy-dense foods on weight gain,
barbecued (charbroiled) animal foods are causes of overweight, and obesity, and the role of weight gain, over-
stomach cancer. weight, and obesity in the risk of some cancers, see Chapters
6 and 8.
4.3.7 Conclusions
128
C H A P T E R 4 F O O D S A N D D R I N K S
In the judgement of the Panel, the factors listed below modify the risk of cancer. Judgements are graded according to the strength of the evidence.
Convincing
Substantial
effect on risk None identified
unlikely
1 Milk from cows. Most data are from high-income populations, where calcium can be taken to be a marker for milk/dairy consumption. The Panel judges that a higher
intake of dietary calcium is one way in which milk could have a protective effect.
2 Effect only apparent at high calcium intakes (around 1.5 g/day or more). Evidence for milk and dairy products (but not calcium) was derived only from data for
countries with populations that have high calcium and dairy consumption.
3 Includes diets that naturally contain calcium and that contain foods fortified with calcium. See box 4.10.1.
4 Although both milk and cheese are included in the general category of dairy products, their different nutritional composition and
consumption patterns may result in different findings.
For an explanation of all the terms used in the matrix, please see chapter 3.5.1, the text of this section, and the glossary.
Milk and products made from milk, such as cheese, butter, Overall, the Panel judges that the evidence on milk and
ghee, and yoghurt, have been consumed ever since suitable dairy products, and on calcium, shows that their impact
animals were domesticated. Whole milk and cheese and on the risk of cancer varies in different tissues.
yoghurt made from whole milk have a high proportion of
energy from fat and from protein, although the absolute The Panel judges as follows:
concentrations in liquid milk are lower than those in cheese Milk probably protects against colorectal cancer. There is
due to the higher water content. They also contain a limited evidence suggesting that milk protects against
number of vitamins, including retinol and riboflavin, and bladder cancer. There is limited evidence suggesting that
minerals, particularly calcium. In countries where cheese is a cause of colorectal cancer. Diets high in
consumption of milk and dairy products is high, these are calcium are a probable cause of prostate cancer; and there
the main sources of calcium. Low-fat dairy products retain is limited evidence suggesting that high consumption of
all of the protein, the water-soluble vitamins, and the milk and dairy products is a cause of prostate cancer.
mineral content. However, the fat-soluble vitamins are The strongest evidence, corresponding to judgements of
significantly reduced. Low-fat milk or whole milk is convincing and probable, shows that milk probably
sometimes fortified with vitamins A and D. protects against colorectal cancer, and that diets high in
Until the late 19th century, milk from animals was used as calcium are a probable cause of prostate cancer.
a substitute for human milk for feeding infants. Adults did
not usually consume such milks; if they did, it was in low
amounts. Populations that kept milk-giving animals Milk and dairy products are important components of diets
consumed other dairy products. From the early 20th in some but not all parts of the world. Until recently in his-
century, a number of factors were responsible for cows milk tory, milk from several ruminant animals was used as a par-
becoming almost a staple food in the USA and some tial substitute for or in addition to human milk; but these
European countries. These included the industrialisation of milks were usually consumed infrequently and, if at all, later
cattle farming; the identification of milk as a basic food, in childhood or by adults. In countries where milk-giving
especially for children; and the development of refrigeration animals were raised, their products were consumed in the
techniques and ultra-heat treated packaging. Dried milk is form of cheese, butter, ghee, and in fermented form as
now a common ingredient in many processed foods. yoghurts or in combination with alcoholic drinks.
129
P A R T 2 E V I D E N C E A N D J U D G E M E N T S
From the late 19th century, consumption of cows milk bred to produce copious amounts of milk. Around the world,
greatly increased in the USA, the UK, and some other other bovine animals used to supply milk include zebu cows
European countries. This was a result of a massive increase in Asia, water buffalo in Asia and some parts of Europe, and
in dairy farming supported by new techniques such as con- yaks, although usually only in the mountainous regions in
densation, drying, and cooling. In the 20th century, Asia. Goats and sheep are also important and widespread
consumption was further boosted by pasteurisation and milk-producing animals, as well as camels, which live in arid
doorstep delivery, the decline of breastfeeding, and the com- climates around the world. In some areas of the world, other
mon view that modified cows milk is a suitable food for animals such as horses, old- and new-world camels, and rein-
infants and an excellent food for young children. Dried milk deer are locally important.
is a mainstay of programmes of food aid to impoverished Fresh milk can be consumed raw (untreated) or, as is com-
countries. However, populations living outside North America mon in many high-income countries, pasteurised (see chap-
and northern Europe have until recently consumed little milk ter 4.9.3). Milk is also commonly processed into a wide
as such, and dairy products consumed are in the form of variety of foods including cream, concentrated milks,
yoghurt or products derived from it. This may be due to the cheese, fats such as butter and ghee, and fermented foods
limited capacity to digest lactose beyond infancy observed in such as yoghurt.
these populations. Yoghurt is fermented, which lowers lactose
concentration, and is therefore better tolerated.
Reports in the early part of the 20th century of different 4.4.2 Composition
forms of malnutrition in young children, which documented
a requirement for high amounts of animal protein to cure Milk and dairy products in whole form have a high propor-
these conditions, supported the categorisation of milk, eggs, tion of energy from fat and protein, and contain some vita-
and meat as protective foods. By contrast, reports published mins and minerals.1 The precise composition varies between
since the 1960s have identified whole milk and dairy prod- species and breeds, and with the nature of their feed. Sheep
ucts, which have a high proportion of energy from fat and sat- and yak milks are particularly high in protein; buffalo, sheep,
urated fatty acids, as foods that contribute to the pathogenesis and yak milks are high in fat. Typical whole cows milk con-
of coronary heart disease. More recently, some reports con- tains 3.4 g protein and 3.6 g fat per 100 g.1 Reduced fat
cerned with the prevention of osteoporosis in Western pop- (semi-skimmed) and low-fat (skimmed) milks are produced
ulations have recommended high intakes of calcium. from whole milk, and the foods made from these milks have
This chapter is concerned with milk and its products. The a correspondingly lower fat and fat-soluble vitamin content
evidence on milk is on milk from cows, and the evidence on than those made from whole milk.
cheese is from all sources. It does not consider human milk Around two thirds of the fatty acids in cows milk are sat-
or infant formula. For human milk, see chapter 4.11. Nor does urated. Polyunsaturated fatty acids make up less than 4 per
it consider soya drinks or other plant-derived alternatives. For cent of milk fat (see chapter 4.5.2). Fat accounts for half of
soya drinks, see chapter 4.2. For butter, see chapter 4.5. the energy in whole milk. Milk contains all the essential
Calcium is included here because in countries where milk amino acids in the appropriate proportions for humans (see
and dairy products are important in diets, these are the main chapter 4.10.1).
sources of what is a generally high intake of calcium. Dietary The only significant carbohydrate found in milk is the
calcium also comes from bones when these are consumed disaccharide lactose. Milk products such as cheese and
(small or tinned fish, for example, and in stews), egg shells, yoghurt contain varying amounts of lactose. Hard cheeses
and from some plant foods. In many countries, plant foods contain only traces, soft cheeses 23 per cent, yoghurts 4 per
are the main source of calcium. See chapters 4.1, 4.2, and 4.4. cent, compared to 5 per cent found in whole milk; this is
because cheese and yoghurt have been fermented by bacte-
ria used in the production of these foods.
4.4.1 Definitions, sources Milk, cheese, and yoghurt contain high levels of calcium
(box 4.4.1). They are also sources of riboflavin and vitamin
Milk is produced by all mammal species to suckle their B12, and full-fat dairy products are sources of retinol, and
young. It has evolved to be the ideal nourishment for mam- to a lesser extent, other fat-soluble vitamins. Milk also con-
malian infants of each species and, in normal conditions, tains several growth factors and hormones, though these are
contains all the nutrients they need at that stage of their probably digested in the stomach. However, milk consump-
lives. Although all mammal species produce milk, only a few tion has been shown to elevate circulating levels of insulin-
are employed widely as milk producers, and they are all like growth factor.
ruminants. Milk from other species must be modified before
feeding to infants to allow for their limited capacity to
metabolise and excrete nitrogenous compounds and salts in 4.4.3 Consumption patterns
early life.
Ruminant animals have a large, multichambered stomach Consumption of milk and dairy products throughout the
that contains microbes, which allows them to ferment cel- world is highly variable. The overall global average of around
lulose and extract nutrients from green and dried grasses. 5 per cent of available dietary energy2 conceals wide varia-
Some species or breeds (notably European cows) have been tions. The range is from 1015 per cent of dietary energy in
130
C H A P T E R 4 F O O D S A N D D R I N K S
131
P A R T 2 E V I D E N C E A N D J U D G E M E N T S
The evidence is inconsistent from both cohort and nificant in two.67 80 Two studies showed non-significant
case-control studies. There is limited evidence increased risk69 71 78 79 and two studies showed non-signifi-
suggesting that milk and dairy products are a cause of cant increased risk in women and non-significant decreased
prostate cancer. risk in men.68 73 76 Meta-analysis was possible on four stud-
ies, giving a summary effect estimate of 0.94 (95% CI
The Panel is aware that since the conclusion of the SLR, two 0.851.03) per serving/day, with low heterogeneity (figures
cohort studies64 65 and one case-control study66 have been pub- 4.4.1 and 4.4.2).72 73 76 81
lished. This new information does not change the Panel judge- In addition, there was a pooled analysis from 10 cohort
ment (see box 3.8). studies which included 534 536 participants with 4992 cases
of colorectal cancer. Milk intake was related to a statistical-
4.4.5.1.1 Milk ly significant reduced risk of colorectal cancer (relative risk
Colorectum (RR) 0.78; 95% CI 0.690.88) for the highest intake group
Thirteen cohort studies67-82 and 36 case-control studies inves- when compared to the lowest.102
tigated milk and colorectal cancer. Fifteen cohort studies72-
77 79 80 82-101
and 58 case-control studies investigated dietary Dietary calcium
calcium. Eleven studies showed decreased risk with increased intake
of calcium,76 79 82 84 85 90-93 99 which was statistically significant
Milk in three.84 85 90 One study showed non-significant increased
Nine cohort studies showed decreased risk with increased risk74; one study showed non-significant increased risk in
intake of milk,67 69 70 72 74 75 77 80-82 which was statistically sig- women and non-significant decreased risk in men73; and two
studies showed non-significant decreased risk of colon can-
cer and non-significant increased risk of rectal cancer.88 89
Meta-analysis was possible on 10 cohort studies giving a sum-
Figure 4.4.1 Milk and colorectal cancer; cohort studies
mary effect estimate of 0.98 (95% CI 0.951.00) per 200
mg/day, with low heterogeneity (figure 4.4.3).72 73 76 77 79 83
Relative risk (95% CI)
87 90 98 99
When meta-analysis was restricted to eight studies
Keamey 1996 Men 0.80 (0.571.11) that reported results separately for colon cancer, a summary
Gaard 1996 Women 1.05 (0.741.49)
effect estimate of 0.95 (95% CI 0.920.98) per 200 mg/day
Gaard 1996 Men 0.98 (0.861.11)
Ma 2001 Men 0.64 (0.351.19) was produced, with no heterogeneity.72 73 76 77 83 87 89 90
McCullough 2003 Women 1.08 (0.861.36)
McCullough 2003 Men 0.86 (0.721.01)
Dose-response plot
Summary estimate 0.94 (0.851.03)
Figure 4.4.4 shows the dose-response curve for dietary cal-
cium intake and colorectal cancer incidence.
0.2 0.5 1 2 5
In addition, there was a pooled analysis from 10 cohort
Relative risk, per serving/day
studies which included 534 536 participants with 4992
cases of colorectal cancer. Dietary calcium intake was
related to a statistically significant reduced risk of colorec-
tal cancer (RR 0.86; 95% CI 0.780.95) for the highest
132
C H A P T E R 4 F O O D S A N D D R I N K S
Figure 4.4.4 Dietary calcium and colorectal cancer; The evidence is inconsistent and comes mainly from
cohort studies: dose response evidence on dietary calcium. There is limited evidence
suggesting that milk protects against bladder cancer.
4.4.5.1.2 Cheese
Colorectum
Eleven cohort studies67 68 70 72 74 78-80 82 126-128 and 25 case-
control studies investigated cheese and colorectal cancer.
0 500 1000 1500 2000
Eight cohort studies showed increased risk with increased
Dietary calcium (mg/day)
intake of cheese, none of which was statistically significant.67
68 70 72 74 79 80 126 127
Two studies reported non-significant
decreased risk78 82 and one study reported that there was no
significant association.128 Two meta-analyses were possible
133
P A R T 2 E V I D E N C E A N D J U D G E M E N T S
on three and two cohort studies, respectively, giving sum- A dose-response relationship was apparent from cohort but
mary effect estimates of 1.14 (95% CI 0.821.58) per serv- not case-control data.
ing/day72 79 126 and 1.11 (95% CI 0.881.39) per 50 g/day,80 One ecological study from Germany showed a significant
82
both with low heterogeneity. increased risk of prostate cancer with higher calcium
Because of the abundant prospective data from cohort intakes.146 Another study from Taiwan reported a non-
studies, case-control studies were not summarised. significant decreased risk with higher calcium intakes.145
No specific mechanism has been identified but cheese High calcium intake downregulates the formation of 1,25
could plausibly cause colorectal cancer through the indirect dihydroxy vitamin D(3) from vitamin D, thereby increasing
mechanisms connected to saturated fats. Saturated fats cell proliferation in the prostate.7 Prostate cancer tumours
intake increases insulin production and expression of insulin in rats treated with 1,25 dihydroxy vitamin D(3) were sig-
receptors on colonic cells.129 Saturated fats can also induce nificantly smaller and presented smaller numbers of lung
expression of certain inflammatory mediators associated metastases.147
with carcinogenesis.130
Epidemiological evidence for cheese intake is consistent- The evidence, from both cohort and case-control
ly in contrast to the probable protective effect from milk. studies, is substantial and consistent with a dose-
response relationship. There is evidence for plausible
The evidence is inconsistent. There is limited evidence mechanisms. Diets high in calcium are a probable
suggesting that cheese is a cause of colorectal cancer. cause of prostate cancer.
The Panel is aware that since the conclusion of the SLR, two The Panel is aware that since the conclusion of the SLR, two
cohort studies66 103 104 and one case-control study66 have been cohort studies64 65 have been published. This new information
published. This new information does not change the Panel does not change the Panel judgement (see box 3.8).
judgement (see box 3.8).
134
C H A P T E R 4 F O O D S A N D D R I N K S
In the judgement of the Panel, the factors listed below modify the risk of cancer. Judgements are graded according to the strength of the evidence.
Convincing
Probable
Substantial
effect on risk None identified
unlikely
1 Includes both foods naturally containing the constituent and foods that have had the constituent added (see Chapter 3).
For an explanation of all the terms used in the matrix, please see chapter 3.5.1, the text of this section, and the glossary.
Fats and oils are the most energy-dense constituents of the role of fats and oils in energy-dense foods and drinks,
food supplies and diets. Their contribution to total dietary the effect of energy-dense foods and drinks on weight
energy increases with industrialisation and urbanisation. gain, overweight, and obesity, and the role of weight gain,
Meat from most industrially bred animals is higher in fat overweight, and obesity in the risk of some cancers, see
than that from wild animals, and such meat fats, together Chapters 6 and 8.
with fat from milk and dairy products, are a major source
of fat in most high-income countries. Many processed
foods contain substantial amounts of oils from plant Fats or oils may be an intrinsic part of the plant or animal,
sources. Production and consumption of animal fats and as contained in the germ of cereals (grains) and the tissues
oil from plant sources have greatly increased in recent of animals, or extracted and added to food in manufacture,
decades, most of all in China and elsewhere in Asia. cooking, or at the table.
In general, the Panel judges that there is only limited Production and consumption of fats and oils in general
evidence suggesting that diets relatively high in fats and rises with industrialisation and urbanisation, and in partic-
oils (in total, or any type) are in themselves a cause of any ular with the extent to which animal production is intensi-
cancer. This judgement contrasts with those of some fied, milk and dairy products are consumed, and processed
earlier reports, which concluded from evidence then foods include extracted oils. Availability and price are also
available that diets high in fats and oils might be a key factors. In lower-income countries, average population
substantial cause of some cancers. Overall, the evidence consumption of fat may amount to less than 15 per cent,
does not suggest that diets relatively high in fats and oils though usually to 2030 per cent of total energy; in high-
might protect against the risk of any cancer. income countries, usually to 3040 per cent. On a global
basis, and most notably in China and elsewhere in Asia, pro-
The Panel judges as follows: duction and consumption of animal fats and plant oils are
There is limited evidence suggesting that total fat is a increasing.
cause of lung cancer, and of postmenopausal breast Early reports issued in the context of food insecurity in
cancer; that animal fat is a cause of colorectal cancer; industrialised countries, including Europe and North
and that consumption of butter is a cause of lung cancer. America, recommended maintenance and even an increase
The Panel stresses that the principal cause of lung in consumption of fats and oils. In the second half of the 20th
cancer is tobacco smoking. century, reports on fats, oils, and chronic diseases tended to
The evidence on fats and oils does not justify any focus on the possible role of diets relatively high in fats and
judgement of convincing or probable. For discussion of oils in the causation of obesity, type 2 diabetes, coronary
135
P A R T 2 E V I D E N C E A N D J U D G E M E N T S
heart disease, and cancers of some sites. In recent decades, A small amount of dietary fat is essential to allow absorp-
more attention has been given to issues of the nutritional tion of fat-soluble vitamins (A, D, E, and K) and to provide
quality of fats and oils. Distinctions are made between rela- the essential fatty acids that cannot be made by the body.
tively saturated (including hydrogenated) fats, such as from Fat also helps food to taste more interesting and be more
meat, milk, and their products, or from hydrogenated oils in palatable, for instance in terms of its texture. Linoleic acid
baked goods and many other processed foods; relatively and alpha-linolenic acid are the two essential fatty acids, and
monounsaturated oils, notably olive oil; and relatively are found in vegetables, nuts, and seed oils; lower levels are
polyunsaturated oils, from seeds, nuts, fish, and other also found in meat, eggs, and dairy products. Oily fish also
sources, some of which like vitamins are essential to contain long-chain unsaturated fatty acids, which influence
human health and life. These distinctions are to some extent inflammatory processes in the body.1 For instance, eicos-
reflected in the studies reviewed here. apentaenoic and docosahexaenoic acids, and related fatty
For discussion of the role of fats and oils in energy-dense acids, are precursors to prostaglandins, which are hormone-
foods and drinks, the effect of energy-dense foods and drinks like compounds with diverse effects, including roles in blood
on weight gain, overweight, and obesity, and the role of vessel dilation and constriction, blood clotting, and inflam-
weight gain, overweight, and obesity in the risk of some can- mation.
cers, see Chapters 6 and 8. Cholesterol is found only in foods of animal origin, such
In this Report, fats and oils are classified as foods. This sec- as cheese, butter, meat, seafood, and egg yolks. Most of the
tion also covers dietary cholesterol, as well as total fat and cholesterol in the body is manufactured in the liver, rather
individual fatty acids as dietary constituents. Food process- than coming from these dietary sources.1 The proportion and
es affecting the composition of fats and oils, such as hydro- types of saturated and unsaturated fatty acids eaten in the
genation, are also covered here. diet are more important influences on cholesterol meta-
bolism than the amount of dietary cholesterol.
136
C H A P T E R 4 F O O D S A N D D R I N K S
goose fats are semiliquid at room temperature. Soya bean oil is the most widely consumed oil in the
In general, the amount and type of body fat carried by ani- world, particularly in North America, as well as in some
mals and poultry depend on how they live, and this deter- Asian and African countries. Sunflower seed oil is the sec-
mines the fat content of their meat, unless some of it has ond most widely consumed vegetable oil (particularly in
been removed during processing. Wild and free-living land Europe, South Africa, Argentina, Chile, and New Zealand)
animals and birds are lean, and much of their fat is unsatu- and palm oil the third (particularly in some African, Asian,
rated; domesticated animals and birds carry more fat, which and Latin American countries, as well as in Australia). Olive
is higher in saturated fatty acids. Indeed, they are often bred oil is the most widely consumed oil in southern Europe (par-
to be more fatty, so that their meat is more succulent. ticularly in Greece, Italy, and Spain). Rapeseed oils are most
common in northern Europe and Canada, while groundnut
oil is common in some African countries.
4.5.3 Consumption patterns The industrial revolution brought significant changes to
food supplies, methods of food production, and hence peo-
Consumption of total fats and oils varies greatly throughout ples diets (see chapter 1.1.3). Before then, it is thought that
the world. Average intake of total fat is highest (3040 per the amounts of n-6 and n-3 oils in diets had been roughly
cent of total energy) in most urbanised and industrialised equal. But with the move to urbanindustrial ways of life,
regions such as Europe, North America, Australia, and New vegetable oils (which are predominantly n-6) became cheap
Zealand, where people consume relatively more meat and and widely available. The ratio of n-6 to n-3 fatty acids is
milk and their products. By contrast, fat usually accounts for now thought to be between 10 and 20 to 1 in many high-
only 2030 per cent of total energy in lower-income parts of income countries.4
the world, for instance in Africa, Asia, and Latin America; The World Health Organization recommends limiting aver-
this may be even lower in rural areas, where people consume age fat intake for populations to between 15 and 30 per cent
low levels of added fats or oils (for instance, from processed of total daily energy intake, and saturated fatty acids to less
foods). However, in general, consumption of fats and in than 10 per cent.5 In higher-income countries, fat con-
particular plant oils is increasing in middle- and low- sumption as a percentage of total energy has been decreas-
income countries. (Also see Chapter 1.) ing for some time. However, this is no longer the case in
Higher amounts of separated animal fats (as distinct from some countries such as the USA, where the percentage of
the fats that are naturally components of foods of animal ori- energy from fat has started to increase again.
gin) are consumed in high-income countries. Availability is
typically highest in North America, northern Europe,
Australia, and New Zealand as much as 10 per cent in 4.5.4 Interpretation of the evidence
parts of northern Europe, compared with less than 0.5 per
cent in much of Africa and Asia.3 4.5.4.1 General
More plant oils are also consumed in high-income coun- For general considerations that may affect interpretation
tries; availability is highest in North America, southern of the evidence, see chapters 3.3 and 3.5, and boxes 3.1, 3.2,
Europe and some parts of the Middle East, and lowest in 3.6 and 3.7.
parts of Asia and Africa. Greece has the highest level of con- Relative risk (RR) is used in this Report to denote ratio
sumption almost 20 per cent of dietary energy com- measures of effect, including risk ratios, rate ratios, haz-
pared with 1.4 per cent in Laos. ard ratios, and odds ratios.
137
P A R T 2 E V I D E N C E A N D J U D G E M E N T S
4.5.4.2 Specific pants, followed up for 6 to 16 years, more than 3100 lung can-
Some considerations specific to fats and oils are as follows. cer cases) showed a non-significant increased risk of 1.01 (95%
CI 0.981.05) per 5 per cent daily energy intake from fat.37
Patterns and ranges of intake. In high-income countries Twelve of the case-control studies showed increased risk for
where most studies are undertaken, average consumption of the highest intake group when compared to the lowest,16 17 19-
fats and oils is relatively high and variation in consumption 21 23 25 27-29 31 32
which was statistically significant in
is not great. five.16 17 19-21 25 31 No studies reported statistically significant
reduced risk. Most (12) of these studies adjusted for
Classification. Studies tend to use classifications relevant to smoking.16 19-22 24 25 27 30-32
coronary heart disease, some of which may not be relevant The ecological studies reported mixed results, most of which
to cancer. Thus, they examine not only animal and vegetable were not statistically significant.33-35 One study reported a sta-
fats; meat, fish, and dairy fats; but also saturated and unsat- tistically significant decreased risk with increased fat intake.36
urated fatty acids; monounsaturated and polyunsaturated Although no evidence for plausible mechanisms was found,
fatty acids; n-3 and trans-fatty acids; and oleic, linoleic, and based on the epidemiological evidence, there is limited evi-
other individual fatty acids. This makes aggregation and dence suggesting that total fat is a cause of lung cancer.
analysis of intakes of fats and oils as a whole, problematic.
The mixed results from cohort studies contrast with
Study design. Practically all studies have analysed con- the more consistent results from other studies. Overall,
sumption of fats and oils as an issue of quantity (percentage there is limited evidence suggesting that consumption
of total energy intake) rather than nutritional quality (effect of total fat is a cause of lung cancer. The Panel
of different types of fats and oils). But oils are complex mix- emphasises that the principal cause of lung cancer is
tures of nutrients and other bioactive compounds, some of smoking tobacco.
which may have harmful effects on cancer risk and others
beneficial effects. Breast (all ages)
Nineteen cohort studies,38-60 49 case-control studies,61-118 and
Reporting bias. The use of questionnaires to record con- 10 ecological studies119-128 investigated total fat intake and
sumption of fats and oils may change behaviour. As people breast cancer.
become more conscious of what they consume, they tend to
under-report true consumption of foods and drinks they Breast (premenopause)
regard as unhealthy, including fats and oils. So studies using Total fat intake for all ages, and also for premenopausal
questionnaires may disproportionately underestimate con- breast cancer, did not give any overall indication of effect.
sumption of fats and oils.
Breast (postmenopause)
Nine cohort studies38 40 43 45 50-52 57-59 and 16 case-control stud-
4.5.5 Evidence and judgements ies62-65 75 79 85 86 96-98 101 102 109 110 112 116 reported results specif-
ically for postmenopausal breast cancer.
The relationship between the risk of cancer and fat and oil Six cohort studies showed increased risk with increasing
intake may be assessed as weight of fat consumed or adjust- fat intake,38 40 45 50-52 59 which was statistically significant in
ed for total energy intake, so that fat is assessed as a pro- three.38 51 52 Three studies reported non-significant reduced
portion of total dietary energy.6 Where this is the case, this risk.40 43 57 58 Meta-analysis was possible on five cohort stud-
has been stated below. ies, giving a summary estimate of 1.06 (95% CI 0.991.14)
The full systematic literature review (SLR) is contained on per 20 g/day, with moderate heterogeneity.38 43 45 50 51
the CD included with this Report. Pooling project data (7329 invasive postmenopausal
breast cancer cases among 351 821 women) showed a
4.5.5.1 Total fats reduced risk, with an estimate of 0.96 (95% CI 0.861.08)
Lung per 25 g increase in energy-adjusted total fat. Menopausal
Nine cohort studies,7-15 17 case-control studies,16-32 and 4 status was not an effect modifier on these data.129 130
ecological studies33-36 investigated total fat and lung cancer. Eleven case-control studies showed increased risk with
(Also see chapter 7.4.) increasing fat intake,62 64 65 75 85 86 96-98 102 109 110 112 which was
Six cohort studies showed non-significant increased risk for statistically significant in three.97 109 112 Five studies showed
the highest intake group when compared to the lowest.7 8 10 decreased risk,63 64 79 101 116 which was statistically significant
11 13 14
Three studies showed decreased risk,9 12 15 which was in one.64 Meta-analysis was possible on seven control stud-
statistically significant in one.15 Meta-analysis was possible on ies, giving a summary estimate of 1.11 (95% CI 1.061.16),
two cohort studies, with a summary effect estimate of 1.01 with no heterogeneity.62 63 65 75 97 102 109
(95% confidence interval (CI) 0.941.09) per 10 g fat/day, There is also evidence on percentage energy from fat. There
with high heterogeneity.11 12 Six of the studies adjusted for are four cohort studies131-134; three reported decreased risk.131
smoking, including the two studies in the meta-analysis and 133 134
The other study reported non-significant increased
not including the statistically significant reduced risk.7-12 risk.132 There were two case-control studies; both reported a
Pooled analysis from 8 cohort studies (over 430 000 partici- non-significant decreased risk.135 136
138
C H A P T E R 4 F O O D S A N D D R I N K S
that can enter the breast epithelial cells. Sex hormone-bind- Because of the abundant prospective data from cohort
ing globulin decreases with increasing body mass index and studies, case-control studies were not summarised.
insulin resistance.
Energy-dense diets (among other factors) lower the age There is a limited amount of fairly consistent evidence
of menarche. Early menarche is an established risk factor for suggesting that consumption of foods containing
breast cancer. animal fat is a cause of colorectal cancer.
Evidence from prospective epidemiological studies of The Panel is aware that since the conclusion of the SLR, one
different types shows inconsistent effects on the whole, cohort study155 has been published. This new information does
while case-control studies show a significant positive not change the Panel judgement (see box 3.8).
association. Mechanistic evidence is speculative.
Overall, there is limited evidence suggesting that
consumption of total fat is a cause of postmenopausal 4.5.6 Comparison with previous report
breast cancer.
The panel responsible for the previous report judged it pos-
4.5.5.1.1 Butter sible that diets relatively high in total fat, and/or in satu-
Lung rated/animal fat, were causes of cancers of the lung,
Two cohort studies8 141 and eight case-control studies142-149 colorectum, breast, endometrium, and prostate. That panel
investigated butter and lung cancer. (Also see chapter 7.4.) noted a pattern whereby diets relatively high in fat could
One cohort study showed statistically significant increased increase the risk of some cancers, and pointed out that fats
risk, with a summary estimate of 1.8 (95% CI 1.03.0) for and oils are energy-dense, and agreed that energy-dense
the highest intake group when compared to the lowest.8 The diets increase the risk of obesity, itself a risk factor for some
other cohort study showed non-significant decreased risk in cancers.
three independent estimates: 0.92 (95% CI 0.651.30) for The previous report judged that diets high in dietary cho-
men; 0.90 (95% CI 0.461.77) for women; and 0.94 (95% lesterol were a possible cause of cancers of the lung and pan-
CI 0.621.42) for non-smokers.141 Both studies adjusted for creas. The overall evidence now does not support an
smoking. association.
Seven case-control studies showed increased risk for the Since the mid-1990s, the results of cohort studies have
highest intake group when compared to the lowest,143-149 overall tended to weaken the evidence on fats and oils as
which was statistically significant in three.143 145 149 One study direct causes of cancer.
showed a non-significant decreased risk.142 Most studies
adjusted for smoking.142 143 145-149
Although no evidence for plausible mechanisms was found, 4.5.7 Conclusions
based on the epidemiological evidence, there is limited evi-
dence suggesting that butter is a cause of lung cancer. The Panel concludes:
Findings from cohort studies conducted since the mid-1990s
There is a limited amount of inconsistent evidence have made the overall evidence associating fats and oils with
suggesting that consumption of butter is a cause of the risk of any cancer somewhat less impressive.
lung cancer. There is limited evidence suggesting that total fat is a
139
P A R T 2 E V I D E N C E A N D J U D G E M E N T S
140
C H A P T E R 4 F O O D S A N D D R I N K S
In the judgement of the Panel, the factors listed below modify the risk of cancer. Judgements are graded according to the strength of the evidence.
Convincing
Substantial
effect on risk None identified
unlikely
1 Salt here means total salt consumption, from processed foods, including salty and salted foods, and also salt added in cooking and at the table.
2 Sugars here means all non-milk extrinsic sugars, including refined and other added sugars, honey, and as contained in fruit juices and syrups.
It does not include sugars naturally present in whole foods such as fruits. It also does not include lactose as contained in animal or human milk.
For an explanation of all the terms used in the matrix, please see chapter 3.5.1, the text of this section, and the glossary.
Sugars are sweeteners and, in some forms, also a is confined to stomach cancer, and that on sugars is
preservative and a bulking agent. Free sugars in the solid limited.
state or as syrups are ingredients in many processed foods
and drinks. Nutritionally, sugars supply energy and The Panel judges as follows:
nothing else. Sugars added to food were a luxury until Salt is a probable cause of stomach cancer. Salt-preserved
sugar from cane became a major international cash crop, foods are also a probable cause of stomach cancer. There
beginning in the 16th century. Consumption of added is limited evidence suggesting that sugars are a cause of
sugars, from beet as well as cane, and syrups increased colorectal cancer. Within the remit of this Report, the
rapidly in industrialised countries in the 19th and 20th strongest evidence, corresponding to judgements of
centuries. High-fructose corn syrups are now also used convincing and probable, shows that salt, and also salt-
extensively. Overall consumption of sugars is increasing preserved foods, are probably causes of stomach cancer.
worldwide, particularly in lower-income countries. In
recent decades, and in many countries, consumption of
added sugars, notably in the form of sugary drinks, Extrinsic, mainly refined, sugars amount to a substantial
accounts for a substantial proportion of energy intake. part of most industrialised food supplies. Sugars and syrups
Salt (sodium chloride) is also a preservative. The manufactured from cane, beet, and corn are profitable cash
sodium and chloride in salt are essential nutrients in small crops and are ingredients in many processed foods and
amounts. In nature, foods are generally low or very low in drinks.
sodium. Like sugar, salt historically was scarce and a There is reason to believe that humans have evolved with
precious commodity; the Romans paid their labourers in a built-in desire for sweet foods. It has also been proposed
salt, thus the word salary (from sal for salt). that humans have a specific appetite for salt that might have
Consumption of salt, in the form of many processed, evolved because sodium is scarce in nature. In any case, as
salted, and salty foods, or of salt added in cooking and at sugars and salt become readily available and increasingly
table, remains variable. Consumption of salt, and salty and cheap, consumption tends to rise. In industrialised settings,
salt-preserved foods, is high in some maritime nations sugars and salt are mostly consumed, not in food prepara-
such as Japan, Portugal, and other Portuguese-speaking tion or at the table, but as ingredients of processed foods.
countries. In inland regions, such as landlocked African Reports concerned with undernutrition have often, and
countries, consumption has been very low. still do, recommend substantial consumption of sugars and
Overall, the Panel judges that the evidence on salt fats; their energy density enables quick weight gain, and the
141
P A R T 2 E V I D E N C E A N D J U D G E M E N T S
taste preference promotes energy consumption. By contrast, Box 4.6.1 Sugar, sugars, sugary foods,
reports concerned with prevention of chronic diseases fre- and drinks
quently recommend restraint in consumption of sugars. One
reason for this is that sugars are the dietary cause of dental As indicated in chapter 4.6.4, it is particularly difficult to mea-
caries. Sugars in the amounts typically consumed in many sure and assess the overall effect of sugars as possible modifiers
of the risk of any disease, including cancer. This is partly because
industrialised countries have also been identified as a cause
of inconsistency in the classification of sugars. Sometimes sugar
of obesity, and therefore also indirectly of obesity-related dis-
is equated with sucrose, which has been the chief sugar in
ease. Reports concerned with nutritional deficiencies often human diets, but now is less so. Some studies investigate only
recommend the iodisation of salt supplies, to prevent goitre. packet sugar purchased for use in the home; this is in general
Reports concerned with the prevention of chronic diseases a relatively small and diminishing proportion of total sugars con-
frequently highlight that salt intakes are usually greatly in sumed. Other studies include sugars as found naturally in fruits
excess of requirements, and recommend substantial decreas- and milk.
es in salt consumption to prevent hypertension and cardio-
vascular disease, especially stroke.
For sugared drinks, see chapter 4.7. For the contribution
of sugar to weight gain, overweight, and obesity in drinks
or through energy density of foods, see Chapter 8. For salt- 4.6.1.2 Salt
ed animal products, including Cantonese-style salted fish, see The term salt, in common usage, refers to sodium chloride.
chapter 4.3. It is now a cheap commodity. Like sugar, salt is a preserva-
Non-caloric chemical sweeteners are included here. tive and a flavour enhancer. Both salt and sugar trap free
water from foods, thus preventing microbial proliferation
and spoilage. Salt is found in some rocks and dissolved in
4.6.1 Definitions, sources seawater, and can be extracted from seawater by evapora-
tion. Both sodium and chloride are essential components of
4.6.1.1 Sugars the diet in small amounts.
Sugars here means all sugars in the diet. These are mainly Usually most salt in diets is contained in processed foods,
but not only extrinsic sugars, which include sucrose (com- with only a relatively small amount added in cooking or at
monly called sugar), maltose, lactose, glucose, and fructose; the table (box 4.6.2). Some traditional diets include sub-
in foods and drinks, including juices and milk, and in honey stantial amounts of salt-preserved foods, including salted
and syrups, including high-fructose corn syrup; refined sug- meat, fish, vegetables, and sometimes also fruits; and also
ars added to food in processing, preparation (cooking), and salted foods such as bacon, sausages, and ham, which con-
at the table. Intrinsic sugars are those naturally present in tain from 3 to 5 g of salt per 100 g. Industrialised diets include
whole foods such as fruits. many processed foods that are not salt-preserved but con-
Sugars are now cheap and are used widely as sweeteners, tribute substantial amounts of salt to the diet, even if they
preservatives, and bulking agents. They also often have the do not seem salty, as well as more obviously salty foods such
function of making processed starches, fats, and other ingre- as potato crisps (chips), salted nuts, and other salty snack
dients more palatable. Also see box 4.6.1 foods. Most of the sodium consumed in urban environments
Sucrose is refined from sugar beet and sugar cane. Maltose comes from salt added to processed foods, and thus is beyond
and glucose are refined predominantly from corn. High-fruc- the control of typical consumers. Many foods such as bread,
tose corn syrup comprises a mixture of glucose with fructose, soups, breakfast cereals, and biscuits may contain substantial
commonly in close to equal amounts, and is now used in amounts of salt; anything from 1 to 4 g per 100 g.
great quantity in food and drink manufacture, particularly in
the USA.
The amount of sugars in manufactured foods and drinks 4.6.2 Composition
varies. Sugared drinks are about 10 per cent by weight added
sugars, and up to 100 per cent of their energy comes from 4.6.2.1 Sugars
sugars. Sugars are often added to fruit juices. Jams and other Sugars are simple carbohydrates, and provide 3.75 kilo-
preserves are about 60 per cent sugars. Cakes, biscuits (cook- calories per gram (see chapter 4.10.1). Sugars are single
ies), and other baked goods contain starches, fats, and sug- molecules such as glucose, fructose, and galactose (mono-
ars in varying proportions. Most chocolate and much saccharides), or two molecules bound together (disaccha-
confectionery are high in sugars. It is often supposed that rides) such as sucrose (fructose and glucose), lactose
almost all added sugars are contained in obviously sweet (glucose and galactose), or maltose (two glucose molecules).
foods: this is not so. Breakfast cereals may contain anything The body metabolises different sugars at different rates;
from negligible amounts to 50 per cent sugars. Yoghurts may for instance, fructose is absorbed and metabolised more
contain anything between 0 to 20 per cent sugars; and ready- slowly than either glucose or sucrose. It is also slightly sweet-
to-eat desserts even more. Many canned products include er than glucose or sucrose, and thus is able to replace them
added sugars. Savoury processed foods, such as soups, pick- in lower total amounts. Non-caloric chemical sweeteners pro-
les, bread, and buns, often contain significant amounts of duce a sweet taste, but are not sugars (box 4.6.3).
sugars. There is no dietary requirement for sugars. The World
142
C H A P T E R 4 F O O D S A N D D R I N K S
Box 4.6.2 Salt, and salty, salted, and Box 4.6.3 Chemical sweeteners
salt-preserved foods
Chemical sweeteners such as saccharin, cyclamates, and aspar-
As indicated in chapter 4.6.4.2, it is difficult to measure salt tame have been thought to be possible causes of cancer. This is
intake, or the contribution from separate sources (salty, salted, because some animal studies have shown that very high doses
or salt-preserved foods). The most reliable estimates come from of saccharin, in particular, increase the incidence of bladder can-
measuring the amount of sodium excreted in the urine. cer in rats. In common with many chemical additives, some sweet-
Salt is itself readily identified, although it is sometimes com- eners can be shown to be carcinogenic in experimental settings
bined in studies with other sodium compounds. Some studies in massive amounts, far greater than humans could consume in
investigate only salt added in cooking or at the table, but this foods and drinks.
is usually a small proportion of total salt consumption. Results The evidence from epidemiological studies does not suggest
from such studies are liable to produce different results, com- that chemical sweeteners have a detectable effect on the risk of
pared with those from studies that have examined total salt con- any cancer.
sumption.
It has been thought that any effect of salt on stomach can-
cer (see chapter 4.6.5.2) is principally the result of regular
consumption of salted and salt-preserved foods, rather than salt
as such. This is partly because such foods are a substantial part
in different parts of the world. Diets in high-income coun-
of traditional Japanese and other Asian diets, where incidence tries contain roughly twice the amount of sugars as those in
of stomach cancer has been and still is high. However, the inci- lower-income countries. In North America and some
dence of this cancer is also high in countries where traditional European countries, average consumption is around 1517
diets contain substantial amounts of salty as distinct from salt- per cent of dietary energy, with a fairly wide range around
preserved foods; and the concentration of salt in many this average. In the USA, in the last decades of the 20th cen-
processed foods consumed in Europe and North America tury, many processed foods were reformulated to contain less
approaches that of salt-preserved foods. fat but more sugars. In some parts of Asia, consumption is
negligible, although globally sugar supplies are increasing
rapidly. Children in high-income countries usually obtain a
higher proportion of their daily energy from sugar than
Health Organization recommends that average consumption adults.11
of sugars by populations should be less than 10 per cent of Consumption of sugars has generally increased over the
total energy.1 last century, particularly in high-income countries, and also
more recently in many countries undergoing economic tran-
4.6.2.2 Salt sition in Asia, Africa, the Middle East, and Latin America.
Pure salt, as sodium chloride, contains no metabolisable
energy. Formulated, granulated table salts often include 4.6.3.2 Salt
additives, such as anti-caking agents, which prevent salt crys- The use of salt as a preservative has generally decreased as
tals from sticking together; potassium iodide, included to industrial and domestic use of refrigeration has increased
prevent iodine deficiency; traces of other sodium compounds (box 4.6.4). But diets containing few salt-preserved foods
(carbonate or thiosulphate); and also sugar, to stabilise the may nevertheless be high in salt.
potassium iodide. Sea salt may be refined to almost pure The average adult daily intake of salt worldwide varies
sodium chloride, or unrefined, in which case they may from less than 6 g to 18 g. Very high levels of intake are
include traces of other minerals, algae, and a few salt-toler- found in Japan, some parts of China, Korea, Portugal, Brazil,
ant bacteria. Salt may also be flavoured, for example with and other Portuguese-speaking countries, where diets con-
celery or garlic. tain substantial amounts of salt-preserved, salt-pickled, salt-
Sodium is essential for the body to function normally. It ed, or salty foods. The average adult intake is around 912
is a major electrolyte in extracellular fluid. The bodys sodi- g per day in high-income countries, including Europe and
um content and its concentration in body fluids are con- North America.
trolled homeostatically to very precise limits; excess sodium
is excreted in the urine. Sodium is also involved in regula-
tion of osmolarity, acid-base balance, and the membrane 4.6.4 Interpretation of the evidence
potential of cells. The daily requirement for sodium has been
estimated at around 500 mg for adults. On a pragmatic basis, 4.6.4.1 General
WHO recommends restricting average salt consumption for For general considerations that may affect interpretation of
populations to less than 5 g per day.1 the evidence, see chapters 3.3 and 3.5, and boxes 3.1, 3.2,
3.6 and 3.7.
Relative risk (RR) is used in this Report to denote ratio
4.6.3 Consumption patterns measures of effect, including risk ratios, rate ratios, haz-
ard ratios, and odds ratios.
4.6.3.1 Sugars
Sugars supply on average around 8 per cent of dietary ener- 4.6.4.2 Specific
gy worldwide. This figure disguises a wide range of intakes Classification. Studies of sugars may be of total sugars; of
143
P A R T 2 E V I D E N C E A N D J U D G E M E N T S
Freezing and cooling by use of natural ice monplace in the cities and towns of tropi- influences risk of those cancers, the
and snow is a method of food preservation cal countries; poorer rural communities still risk of which is affected by the above
traditionally available only in cold climates rely on drying, fermenting, salting, bot- factors.
or in winter in temperate climates. Natural tling, tinning, and other methods of food Evidence amounting to a judgement of
ice refrigeration on an industrial scale first preservation, as well as their own gardens convincing or probable for such factors
developed in the late 19th century, when and farms. It is unlikely that refrigeration is summarised in earlier sections of this
refrigerated containers used in trains, itself has any direct effect on the risk of chapter, and in Chapter 7, and relates to
ships, and then later trucks, greatly cancer. Its effects are indirect. cancers of the mouth, pharynx, larynx,
increased the production and consumption nasopharynx, oesophagus, lung, stomach,
of red meat. Domestic freezing, chilling, Refrigeration: pancreas, liver, and colorectum.
and refrigeration on a mass scale is a phe- Enables consumption of fresh perishable In particular, many studies have noted a
nomenon mostly of the second half of the foods including seasonal vegetables and reciprocal relationship between use of
20th century. fruits all year round, as well as of fresh refrigeration and consumption of salt and
Today, much perishable food is sold meat. foods preserved with salt. Meta-analysis of
frozen or chilled. Together with the Reduces microbial and fungal eight case-control studies2-9 has shown a
growth of industrial refrigeration, domes- contamination of perishable foods, significant association between the use of
tic refrigerators began to be used in the notably cereals (grains) and pulses refrigeration (usually as gauged by poss-
USA, Australia, and New Zealand on any (legumes). ession of a domestic refrigerator) and
scale in the 1920s, and in Europe and Japan Reduces the need for and use of salting, reduced risk of stomach cancer.
mostly since the 1950s. In Japan, for exam- smoking, curing, and pickling as The one cohort study10 identified mea-
ple, households possessing refrigerators methods of preserving vegetables, sured effects in the Netherlands over a
increased from 9 per cent in 1960 to 91 per fruits, and meat. 25-year period, in which almost the entire
cent in 1970, and 99 per cent in 2004. population had access to commercial and
Supermarkets with freezers, chill cabinets, It can therefore be said that refrigeration domestic refrigeration, and did not find
and domestic refrigerators are now com- (including freezing and chilling) indirectly any association.
sugars added at the table; of sugary foods and/or drinks; of 4.6.5.1 Sugars
sucrose; or of added sugars generally; and may or may not Colorectum
include those sugars naturally present in foods. Studies using One cohort study13 and 7 case-control studies14-20 investi-
such varying classifications are difficult to compare. gated sugars as foods and colorectal cancer. Seven cohort
Similarly, studies of salt may be of salt added in cooking studies21-27 and 16 case-control studies investigated sugars
and/or at the table; of salty or salted foods; or of salt con- as nutrients, defined as sucrose or fructose.
sumption as a whole. These studies are also difficult to com-
pare. See box 4.6.1 and box 4.6.2. Sugars as foods
The single cohort study stated that there was no association
Measurement. Measurement of salt intake is notoriously dif- between usually adding sugar to cereals and colorectal
ficult, and is best done by measuring the excretion of sodi- cancer.13
um in urine over a 24-hour period. But this method has only All seven case-control studies showed increased risk with
rarely been used. increased sugar intake,14-20 which was statistically significant
in two.17 18 The classification of sugars as foods varied con-
Study design. See Classification. Also studies may under- siderably between studies.
estimate the amounts of sugars and of salt in foods and
drinks consumed outside the home. Sugars as nutrients
Four cohort studies reported on total sugar intake.21 22 25 26 One
Reporting bias. Added sugars are generally regarded as study reported a non-significant increased risk for the highest
unhealthy, and studies that depend on self-reporting may dis- intake group when compared to the lowest, with an effect esti-
proportionately underestimate the consumption of sugars. mate of 1.03 (95% confidence interval (CI) 0.731.44).22 One
study reported a non-significant lower sugar intake in cases
than controls.21 Two cohort studies stated that there was no
4.6.5 Evidence and judgements association between sugar intake and risk.25 26
Three cohort studies reported on sucrose intake.23 24 27 Two
The full systematic literature review (SLR) is contained on cohort studies showed non-significant increased risk when
the CD included with this Report. comparing the highest intake group against the lowest.23 27
The relationship between the intake of sugars and the risk Effect estimates were 1.45 (95% CI 0.882.39)23 and 1.30
of cancer is often adjusted for total energy intake, meaning (95% CI 0.991.69) in men.27 One study reported a non-
that sugars are assessed as a proportion of total dietary ener- statistically significant decreased risk (0.89 (95% CI
gy.12 Where this is the case, this has been stated. 0.721.11) in women).27
144
C H A P T E R 4 F O O D S A N D D R I N K S
Three cohort studies reported separate results for fruc- was inconsistent with this summary, with an effect estimate
tose23 24 27; one reported a significant increased risk in men of 0.53 (95% CI 0.310.91) for the highest intake group
of 1.37 (95% CI 1.051.78).27 Two other studies reported when compared to the lowest; however, this study did not
non-significant decreased risk.23 27 adjust for other factors.29 The two cohort studies that report-
Because of the abundant prospective data from cohort ed increased risk used much more detailed questionnaires to
studies, case-control studies were not summarised. assess salt intake (150 compared to 27 items). They also
In most, though not all, animal experiments, sucrose and adjusted for a greater number of confounders than the study
fructose are associated with increased colonic proliferation and that reported decreased risk.
aberrant crypt foci. These sugars may interfere with levels of Twelve of the case-control studies showed increased risk
blood glucose and/or triglycerides, either directly or through with increased salt intake,2 32 34 35 39 40 42-46 which was statis-
hormones like insulin and others (also see Chapter 2).28 tically significant in six.32 40 42-45 None of the studies showed
statistically significant decreased risk. Most other studies
The evidence is hard to interpret. There is limited reported either risk estimates close to 1.0 or reported that
evidence suggesting that sugar is a cause of colorectal there was no statistical association. Meta-analysis was pos-
cancer. sible on eight case-control studies, giving a summary effect
estimate of 1.01 (95% CI 0.991.04) per 1 g/day, with high
4.6.5.2 Salt heterogeneity (figure 4.6.1).
Stomach A dose-response relationship was apparent from cohort but
Three cohort studies,10 29 30 21 case-control studies,2 4 31-48 not case-control data.
and 12 ecological studies49-60 investigated total salt use and Seven ecological studies reported increased risk with
stomach cancer. Two cohort studies10 61 and 13 case-control increased salt intake,49 52-55 57 58 which was statistically sig-
studies4 9 39 43 62-71 investigated salt added at the table; 1 nificant in four.53 54 57 58 The remaining five studies reported
cohort study72 and 8 case-control studies4 39 73-78 investigat- either a decreased risk with increased salt intake50 56 59 60 or
ed sodium intake. no association,51 none of which was statistically significant.
Stomach cancer rates are highest in those areas of the world,
Total salt use such as parts of Asia and Latin America, where diets are tra-
Two cohort studies showed increased risk with increased salt ditionally salty due to the regular consumption of meat, fish,
intake,10 30 which was statistically significant in one study in vegetables, and other foods preserved by salting, as well as
men but not women.30 One study showed statistically sig- of salty foods.
nificant decreased risk.29 Meta-analysis was possible on two
cohort studies, giving a summary effect estimate of 1.08 Salt added at the table
(95% CI 1.001.17) per 1 g/day, with moderate hetero- Both cohort studies reported that there was no significant
geneity (figure 4.6.1). The study that could not be included effect, and estimates were close to one (1.0) (95% CI
0.61.6)61 and 0.9 (95% CI 0.561.44).10
Twelve case-control studies showed increased risk for the
Figure 4.6.1 Total salt use and stomach cancer; cohort highest intake group when compared to the lowest,4 9 39 43 62-
and case-control studies 64 66-71
which was statistically significant in eight.4 9 43 62-64 67
One other study reported similar intakes in cases and
Relative risk (95% CI) control.65
Cohort
Van de brandt 2003 1.07 (0.971.18) Sodium
Tsugane 2004 Men 1.14 (1.081.21) The single cohort study showed a non-significant decreased
Tsugane 2004 Women 1.01 (0.921.11)
Summary estimate 1.08 (1.001.17)
risk.72
Six case-control studies showed increased risk for the high-
Case control est intake group when compared to the lowest,39 73-77 which
You 1988 1.00 (0.991.01)
Nazario 1993 1.17 (1.081.27)
was statistically significant in three.39 74 77 Two studies
Ramon 1993 1.36 (1.011.82) showed decreased risk, which was statistically significant in
Ye 1998 1.03 (0.991.07)
both.4 78 Meta-analysis was possible on five studies, giving
Setiawan 2000 1.02 (0.991.04)
Munoz 2001 0.96 (0.931.00) a summary effect estimate of 1.18 (95% CI 1.021.38) per
Tsukino 2004 0.98 (0.881.10) 1 g/day, with high heterogeneity.39 74-76 78
Setiawan 2005 1.00 (0.861.16)
Setiawan 2005 0.96 (0.991.04)
Summary estimate 1.01 (0.991.04) Interaction with Helicobacter pylori infection
Two case-control studies that investigated total salt use also
investigated the potential for interaction with H pylori infec-
0.5 0.75 1 1.5 2
tion (also see box 7.5.1).79 80 One study was suggestive of a
Relative risk, per g/day
multiplicative effect on risk for high salt use and H pylori pos-
itive status79; the other stated that there was no association.80
Salt intake may be inversely related to the availability of
refrigeration both within and between populations. Salt-
145
P A R T 2 E V I D E N C E A N D J U D G E M E N T S
preserved foods may be eaten more by those to whom no heterogeneity (figure 4.6.2).
refrigeration is not available. Eleven case-control studies showed increased risk for the
There is evidence from laboratory experiments that high highest intake groups when compared to the lowest,6-8 41 45
salt intake damages the lining of the stomach.81 It has also 91 94-98
which was statistically significant in seven.6-8 45 94-96
been shown to increase endogenous N-nitroso compound Two studies showed non-significant decreased risk.4 99 Four
formation.82 In addition, a high salt diet has been shown to studies reported either the same intakes in cases and con-
have a synergistic interaction with gastric carcinogens.82 It trols or no statistical association.33 90 92 93 Meta-analysis was
may only contribute to gastric cancer in subjects who have possible on four case-control studies, giving a summary effect
H pylori infections and are also exposed to a chemical estimate of 5.2 (95% CI 2.4910.83) per one serving/day,
carcinogen. with high heterogeneity (figure 4.6.2).
A dose-response relationship is apparent from case-control,
There is a substantial amount of evidence from studies but not cohort data (figure 4.6.3).
on total salt use, salt added at the table, and sodium Heterogeneity may be partly explained by variation
intake. For total salt use, a dose-response relationship between studies in the precise foods being assessed.
was apparent from cohort but not case-control studies. The single ecological study showed non-significant
For sodium intake, a dose-response was also apparent decreased risk in areas of increased salt consumption.100
from case-control studies. The mechanistic evidence is The mechanisms through which salt could plausibly cause
strong. Salt is a probable cause of stomach cancer. stomach cancer are given above.
The Panel is aware that since the conclusion of the SLR, one The evidence from both case-control and cohort
cohort83 and two case-control studies84 85 have been published. studies is consistent. A dose-response relationship is
This new information does not change the Panel judgement (see apparent from case-control but not cohort studies.
box 3.8). There is robust evidence for mechanisms operating in
humans. Salted and salty foods are a probable cause of
4.6.5.2.1 Salted and salty foods stomach cancer.
Stomach
Four cohort studies86-89, 17 case-control studies4 6-8 33 41 45 90-
99
and 1 ecological study100 investigated salted or salty foods Figure 4.6.3 Salted/salty foods and stomach cancer; cohort
and case-control studies: dose response
and stomach cancer.
Three cohort studies showed non-significant increased
risk with increased salt intake.86 88 89 One study reported
Cohort
that there was no association.87 Meta-analysis was possible
on three cohort studies, giving a summary effect estimate
Galanis 1998
of 1.32 (95% CI 0.901.95) per one serving/day with
Ngoan 2002
Cohort
Galaris 1998 1.14 (0.612.13) Case control
Ngoan 2002 1.21 (0.682.16)
Khan 2004 Men 1.76 (0.585.32)
Demirer 1990
Khan 2004 Woman 6.01 (0.8542.61)
Summary estimate 1.32 (0.901.95)
Hirayama 1992 Men
Case control
Demirer 1990 116.86 (13.161037.90)
Hirayama 1992 Women
Hirayama 1992 Men 2.85 (2.133.81)
Hirayama 1992 Women 3.53 (2.345.34)
Ward 1999 113.13 (3.763403.01) Ward 1999
Sriamporn 2002 3.98 (0.6524.22)
Summary estimate 5.20 (2.4910.83)
Sriamporn 2002
0.5 1 2 6
0 0.2 0.4 0.6 0.8 1 1.2 1.4
146
C H A P T E R 4 F O O D S A N D D R I N K S
The Panel is aware that since the conclusion of the SLR, two
case-control studies84 85 have been published. This new infor-
mation does not change the Panel judgement (see box 3.8).
4.6.7 Conclusions
147
P A R T 2 E V I D E N C E A N D J U D G E M E N T S
In the judgement of the Panel, the factors listed below modify the risk of cancer. Judgements are graded according to the strength of the evidence.
Substantial
effect on risk Coffee: pancreas; kidney
unlikely
1 The International Agency for Research on Cancer has graded arsenic and arsenic compounds as class 1 carcinogens. The grading for this entry applies specifically to
inorganic arsenic in drinking water.
2 As drunk traditionally in parts of South America, scalding hot through a metal straw. Any increased risk of cancer is judged to be caused by epithelial damage
resulting from the heat, and not by the herb itself.
For an explanation of all the terms used in the matrix, please see chapter 3.5.1, the text of this section, and the glossary.
Water is essential. Without water, people die in a matter of cavity by mat, and possibly by other very high-
days. As well as adequate supplies of water, a major public temperature drinks. For evidence relating sugared soft
health issue throughout the world is the safety of domestic drinks to body fatness, see Chapter 8.
and other water. Water quality may be compromised by
chemical or microbiological contamination. The Panel judges as follows:
Fruit juices made from fruits or fruit pulps are often The evidence that inorganic arsenic in drinking water is a
concentrated for storage and transport, then diluted with cause of lung cancer is convincing. Water contaminated in
water to produce the final product. Sugar and other this way is probably a cause of skin cancer. Arsenic and
ingredients are frequently added in this final arsenic compounds are recognised carcinogens. There is
reconstitution process. Soft drinks are usually made from limited evidence suggesting that water contaminated in
water, sugar, colourings, flavourings, and mixtures of this way is a cause of cancers of the kidney and bladder.
herbs and other ingredients, to give a distinctive taste and Mat, a herbal infusion, as drunk traditionally in parts
character. Consumption of branded, carbonated soft of Latin America, is probably a cause of oesophageal
drinks, and cola drinks in particular, has increased greatly cancer. Damage caused by the very high temperature of
in the 20th century, and continues to increase throughout the drink, rather than by the herb itself, is judged to be
the world. The rise is most marked in lower income responsible. There is limited evidence suggesting that
groups. mat is a cause of cancers of the mouth, pharynx, and
Tea and coffee are now the main hot drinks consumed larynx, for the same reason. There is also limited evidence
worldwide. Both contain stimulants and other bioactive suggesting that high-temperature drinks are a cause of
constituents, and many people add milk and sugar. A great oesophageal cancer.
variety of herbal infusions are also drunk, including mat, It is unlikely that coffee has any substantial effect on the
the traditional hot drink in parts of South America. risk of cancer either of the pancreas or of the kidney.
Overall, the Panel judges that the direct evidence relating Within the remit of this Report, the strongest evidence,
non-alcoholic drinks to cancer is contamination of water corresponding to judgements of convincing or probable,
supplies with inorganic arsenic and irritation of the oral shows that inorganic arsenic in drinking water is a cause
148
C H A P T E R 4 F O O D S A N D D R I N K S
of lung cancer and probably a cause of skin cancer. Mat is the health of the individual and external conditions such as
probably a cause of oesophageal cancer. It is unlikely that temperature and humidity.
coffee has any substantial effect on the risk of either Water can be used as a vehicle to provide fluoride and can
cancer of the pancreas or of the kidney. contribute to intakes of essential elements, calcium, iron,
and copper, depending on its origin and the piping materi-
als used.
Chapter 4.7 concerns all non-alcoholic drinks. The water content of the body is around 70 per cent: mens
Water, including that contained in drinks and foods, is an bodies contain a higher proportion of water than those of
invariable part of all diets. Bottled spring and mineral waters women because women have more body fat, which has min-
are consumed by people who can afford them. Juices made imal amounts of water. Adults produce an average of around
from fruits and water, often sweetened (at first with honey 1.5 litres of urine each day and lose an additional litre of
and then sugar), have been drunk throughout history. water through breathing, from the skin by evaporation or
Cordials, squashes, and other drinks made mainly from sweating, and in the faeces. Approximately 80 per cent of
colourings and flavourings, with some fruit juices, herbs, or water intake comes from drinks; food provides the other 20
other ingredients added, started to become popular from the per cent.
beginning of the 19th century. Carbonated sweet drinks Tap water quality is regulated in most countries based on
(sometimes known as sodas) such as cola were first mass- World Health Organization guidelines for drinking water
manufactured in the USA and are now commonly consumed that includes tap water and bottled water.1
throughout the world. Around the world, ground, rain, and river waters are also
Tea was cultivated and drunk in China for over a thousand drunk, often without first being treated to secure safety. More
years. Then, from the 18th century, it became commonly than 1 billion people (around 15 per cent of the worlds pop-
drunk in Britain, and was cultivated in India and other coun- ulation) lack access to safe, clean water2 and are at risk of
tries, and drunk in other parts of the world. The original teas exposure to water-borne contaminants and infectious dis-
were green and drunk without adding milk or sugar. eases. Arsenic, the bacterium Helicobacter pylori, and para-
Manufacture of black teas came later; from the 19th centu- sitic schistosomes are among the many contaminants that
ry, teas became the main hot stimulant drink in Britain, may be found in water supplies. In many low-income coun-
almost always drunk with milk and often with sugar added. tries, access to clean water is limited for the low-income
Coffee was cultivated in and exported to many parts of the segments of the populations and those living in rural areas.
world from the 19th century; it remains the main cash crop
in a number of tropical countries such as Ethiopia and Brazil. 4.7.1.2 Fruit juices
Coffee is the main hot stimulant drink in the Americas, many Fruit juices include liquids extracted from whole or pulped
European countries, and also in the Arab world. In some fruits. Commercially prepared fruit juices may be pasteurised
parts of the world, coffee is usually drunk black, with or to extend shelf-life, and concentrated at source to be recon-
without sugar; in other countries, milk or cream is often stituted before packaging, closer to the point of sale.
added. Chocolate is also consumed as a beverage.
Reports concerned with infectious diseases, especially of 4.7.1.3 Soft drinks
childhood, usually emphasise the importance of safe water The term soft drinks is used for a wide range of coloured
supplies. Reports concerned with the prevention of chronic and flavoured non-alcoholic drinks, usually sold in cans, car-
diseases sometimes specify sugared soft drinks as contribu- tons, or bottles. They may be carbonated (such as cola drinks
tors to overweight and obesity. They occasionally recom- or lemonade) or still (such as fruit squashes). Some soft
mend substantial consumption of water as healthy in itself drinks are milk-based (milkshakes and yoghurt drinks).
and preferable to soft or alcoholic drinks. Depending on the ingredients, some soft drinks may be mar-
Contaminants of water, and also of foods and other drinks, keted with health claims, and are sometimes known as func-
are grouped here with water. High-temperature foods are tional drinks (also see box 4.10.2).
grouped here with high-temperature drinks.
For the relationship between sugared drinks and body fat- 4.7.1.4 Hot drinks
ness, see Chapter 8. The most common hot drinks currently consumed are tea
and coffee. These are infusions (brewed using boiling water)
usually drunk hot, sometimes very hot (box 4.7.1). Coffee
4.7.1 Definitions, sources is made from ground, roasted coffee beans the dried seeds
of coffee plant berries. The beans naturally contain caffeine.
4.7.1.1 Water Decaffeinated coffees are produced by various processes,
Water comes from rain, underground aquifers accessed by using water, organic solvents, steam, or by interfering with
wells, springs, and freshwater lakes and rivers. the expression of the gene coding for caffeine. Instant cof-
People cannot live without water, which is vital for the nor- fee comprises the soluble solids derived from dried, double-
mal functioning of the body. Even mild dehydration (water brewed coffee. Coffee is a large bush native to Ethiopia,
loss of 12 per cent of the body weight) can produce symp- cultivated in many hot and humid climates. The main cof-
toms such as dry mouth and headaches. Stopping all fluid fee-exporting countries are Brazil, Vietnam, and Colombia.
intake may cause death in days, the number depending on Although many herbal infusions are known as teas, tea is
149
P A R T 2 E V I D E N C E A N D J U D G E M E N T S
specifically the infusion of the dried leaves of the plant tains higher trace amounts of various minerals and other
Camellia sinensis. Green tea is made from leaves that have substances, often detectable to taste. Some spring water is
first been cooked, pressed, and dried. To produce black tea, naturally carbonated. Bottled water is either still or car-
the fresh leaves are withered, rolled repeatedly, allowed to bonated, sometimes artificially. The safety of water in terms
turn deep brown, and then air-dried until they are dark in of chemical and microbial contamination is well regulated
colour. Tea leaves contain caffeine and theophylline. by the WHO programme on chemical safety, but unfortu-
Decaffeinated teas are produced using similar processes to nately, monitoring and surveillance in most countries are
those used for coffee. Most tea is grown in Asia. limited.
Mat is a type of herbal tea prepared from the dried leaves Arsenic residues can arise from agricultural, mining, and
of the plant Ilex paraguariensis that has stimulant properties industrial practices, or may occur naturally from volcanic
similar to the other methylxanthine-containing drinks (cof- activity. WHO guidelines recommend that levels of arsenic
fee and tea). in drinking water should not exceed 10 g/l.4 Levels of
Herbal and other teas are also consumed cold. Iced teas arsenic in affected areas may range from tens to hundreds,
are popular in the USA and some other countries: these are or even thousands, of micrograms per litre. In unaffected
sugared and considered here as soft drinks. areas, levels are typically less than 10 g/l. Inorganic arsenic
(arsenate or arsenite) is the form that predominantly cont-
aminates drinking water.
4.7.2 Composition Arsenic is classified as a human carcinogen by the
International Agency for Research on Cancer. Drinking water
4.7.2.1 Water contaminated with arsenic is also classed separately as a
Water is a molecule comprising hydrogen and oxygen: chem- human carcinogen.5
ically, H2O. Rainwater may contain traces of air pollutants; The bacterium H pylori is found in water supplies conta-
water from underground aquifers may contain traces of min- minated with faeces. It is an established necessary cause of
erals from surrounding rocks and other surfaces. Ground distal stomach cancer (see box 7.5.1).
water may also be contaminated with natural minerals as Chronic schistosomiasis (infestation with schistosomes) is
well as with various industrial and agricultural chemicals, a known cause of bladder and liver cancer (see chapters
some of which are carcinogenic in laboratory conditions (box 7.16 and 7.8).6 It is caused by contact with water contam-
4.7.2). Mineral water from springs and other sources con- inated by parasite eggs.
Box 4.7.1 High-temperature, and irritant Box 4.7.2 Contamination of water, and of
drinks and foods foods and other drinks
Constant mechanical irritation of epithelial surfaces causes Water contaminants that are causes of cancer are inorganic
inflammation, which predisposes to the development of cancer arsenic (reviewed here) and Helicobacter pylori and schistosomes
(see Chapter 2). It has also been suggested that foods and drinks (see Chapter 7).
with chemically irritant components may be a cause of cancers Many other contaminants of water are identified as or have
of those sites with which they come into direct contact. Again, been thought to be carcinogenic, usually as a result of animal
there is not much evidence for this theory, with the possible and other experiments, or else as a result of industrial accidents
exception of chilli and stomach cancer (see chapter 4.2). or gross overuse. These include herbicides and pesticides, fer-
There is, however, some evidence that some thermally hot tilisers that contain and release nitrates, and disinfectants that
(and therefore irritant) drinks are a cause of cancers of those also produce potentially toxic contaminants such as chlorinat-
sites with which they come into direct contact. As shown in this ed and brominated organic compounds. They also include chem-
section, mat, the herbal infusion, is probably a cause of cancer icals deliberately added to drinking water as public health
of the oesophagus, and there is limited evidence suggesting that measures, notably chlorine and fluoride.
it is also a cause of other cancers of the oral cavity. This is prob- These and other industrial, agricultural, and other chemicals
ably not because of any carcinogen in the herb itself, but are the subject of tests and regulations for toxicity and safety
because of the way the infusion is traditionally drunk in the in use. Nevertheless, they are often popularly believed to be sig-
pampas region within the southern cone of Latin America, in nificant causes of cancer. This subject is controversial and is like-
northern Argentina, Paraguay, and southern Brazil. It is drunk ly to remain so.
extremely hot from a gourd through a metal straw, which is Currently there is no substantial epidemiological evidence
often kept rested in the mouth, rather like the stem of a tobac- that any of these substances, singly or in combination, as cur-
co pipe.3 There is no substantive evidence that mat prepared rently regulated and usually consumed in water, or in foods and
in the style of tea, loose or in sachets (bags), affects the risk of other drinks, has any significant effect on the risk of any can-
cancer. cer. The Panel considers that the evidence is insufficient to con-
There is also limited evidence suggesting that various other clude that usual intakes of industrial, agricultural, and other
very hot drinks and foods are a cause of cancer of the oesoph- chemicals have an effect on the risk of human cancer. Toxicity
agus when they are consumed regularly. The implications of this and carcinogenicity of pollutants as a result of industrial acci-
evidence, while so far not strong, suggest that more research dents or overuse are outside the scope of this Report.
may be warranted (see chapter 4.7.5.6).
150
C H A P T E R 4 F O O D S A N D D R I N K S
4.7.2.2 Fruit juices Most people who do not have access to clean drinking
Bottled or canned or otherwise packaged fruit juices are water live in Asia, sub-Saharan Africa, and some parts of
made from the fruits they contain or from fruit pulp. As well Latin America. High concentrations of arsenic in drinking
as added water, they usually also contain some added sug- water have been found in areas of Bangladesh, China, and
ars, preservatives, and other additives. They often contain West Bengal (India), and also in more localised areas of
trivial amounts of dietary fibre. Fruit and vegetable juices Argentina, Australia, Chile, Mexico, Taiwan, China, the USA,
have different nutritional properties from whole fruits and and Vietnam. In many of these regions, the drinking water
vegetables. For these reasons, the international at least five source is groundwater naturally contaminated by arsenic-
a day campaign to encourage people to eat more fruits and rich geological formations.10
vegetables (at least five portions per day) recommends that
juices only count as one portion per day, irrespective of the 4.7.3.2 Fruit juices
amount consumed. There is little information on the general or local consump-
tion of fruit juices.
4.7.2.3 Soft drinks
Soft drinks are made from water, colourings, flavourings, and 4.7.3.3 Soft drinks
herbal or other ingredients. They may or may not contain In 2004, global consumption of soft drinks was estimated at
fruit juice. They also contain either sugars or, in diet form, 480 000 million litres (including bottled water),11 of which
chemical sweeteners (see chapter 4.6 and box 4.6.3). They cola and other carbonated drinks accounted for 40 per cent.
may or may not be carbonated. The original formulations of In terms of sales, carbonated drinks are the largest single cat-
cola drinks contained stimulants from the coca and cola egory. World sales of cola drinks continue to rise, as do more
plants. Soft drinks may also include yoghurt and other milk recently, sales of bottled waters, fruit juices, and function-
derivatives, as yoghurt drinks or fruit smoothies, and also al drinks. The USA is the biggest per capita consumer of soft
added vitamins and minerals. Sports drinks contain sugars, drinks, followed by Mexico and Chile. The USA alone
electrolytes, and other additives. accounts for more than a 20 per cent share of the global
total. Asia is the fastest growing market for soft drinks: sales
4.7.2.4 Hot drinks are increasing at around 3.5 per cent each year.
The main hot drinks are tea (usually black tea but also green Average consumption of soft drinks in the USA is around
tea, which is often preferred in China) and coffee. Both con- a 12-ounce can (about 350 ml) per person/day. Older chil-
tain various antioxidants and phenolic compounds, some of dren consume about this amount, and sometimes more. Most
which have been shown to have anti-cancer properties in lab- of these drinks are sugared. At this level, soft drinks con-
oratory conditions.7 They both also contain caffeine (and the tribute a substantial proportion of total sugars intake.
related compound theophylline in tea). There is more caffeine
in tea leaves than in coffee beans, but brewed coffee contains 4.7.3.4 Hot drinks
more caffeine than brewed tea. Caffeine and theophylline are After water, tea and coffee are the most commonly con-
bioactive, quickening reaction times, relieving fatigue, and sumed drinks in the world. There are various different meth-
stimulating the cardiovascular and central nervous systems. ods of preparing these hot drinks depending on culture and
Tea and coffee, when drunk without adding milk, cream, personal preference. Coffee consumption is high in northern
sugar, lemon, or honey, contain no energy and trivial Europe and North America. Low-income countries export
amounts of some micronutrients; the bioactive chemicals most of the worlds coffee; high-income countries consume
they contain are mentioned above. When these drinks are approximately seven times as much (per capita) as low-
consumed frequently, both may be substantial dietary income countries.
sources of some of these bioactive constituents. Thus, coffee Average worldwide consumption of tea is around 0.5 kg
is a major source of some antioxidants in the US diet.8 per person/year; this is exceeded significantly in several
Asian countries (notably, China, India, and Japan), and in
the UK and Ireland. Worldwide, black tea is the most popu-
4.7.3 Consumption patterns lar type, although green tea is more commonly drunk in Asia.
Mat, as traditionally prepared, is drunk almost exclusively
4.7.3.1 Water in parts of South America.
Environmental conditions, health, activity levels, and other
factors determine the amount of water needed, but there is
no international recommendation for daily consumption. 4.7.4 Interpretation of the evidence
The Institute of Medicine in the USA recommends 2.7 litres
per day total water for women and 3.7 litres for men. The 4.7.4.1 General
UKs Food Standards Agency estimates that most people For general considerations that may affect interpretation of
need to drink at least 1.2 litres of fluids per day. More the evidence, see chapters 3.3 and 3.5, and boxes 3.1, 3.2,
than half of the worlds population has access to drinking 3.6 and 3.7.
water through taps in their homes or outside. Tap Relative risk (RR) is used in this Report to denote ratio
water should be regulated to meet international quality measures of effect, including risk ratios, rate ratios, hazard
guidelines, such as those prepared by WHO.9 ratios, and odds ratios.
151
P A R T 2 E V I D E N C E A N D J U D G E M E N T S
4.7.4.2 Specific well water.13 The other study reported a quantified effect
Classification. Different types of tea, coffee, and soft drinks estimate, which was 3.66 (95% CI 1.817.03), but this study
are consumed in different cultures. The ways in which tea (based in Japan) did not adjust for smoking.17
and coffee are prepared and drunk also vary. For coffee, this Both case-control studies showed increased risk of lung
includes the degree of roasting, the methods of brewing cancer for the highest intake group compared to the lowest,18
(which determine the strength and composition), and the 19
which was statistically significant in one.19 The other study
different substances added. Similarly, tea may be consumed did not report confidence intervals. Effect estimates were
with or without milk and in different strengths. Associations 3.0118 and 8.9 (95% CI 4.019.6).19
seen in one population but not another may reflect some Ecological studies were made in populations from
aspect of the drink as consumed in that population rather Argentina,27 Belgium,21 Chile,29 China,23 Switzerland,20 and
than the drinks themselves. In some studies, fruit juices and Taiwan,22-26 30 as well as worldwide.28 Eight studies showed
bottled waters are included in the definition of soft drinks. increased risk of lung cancer with increasing levels of arsenic
in drinking water,21-25 27 29 30 which was statistically signifi-
Measurement. Fluid intake is best estimated from urine cant in four.24 27 29 30 Two studies showed decreased risk,20 26
collection, but this is rarely done. Instead, estimates are which was statistically significant in one.26 One study report-
usually made from food frequency questionnaires. ed different inconsistent results for men and women (corre-
lation coefficients of -0.51 for men and 0.07 for women).28
Confounding. In interpreting the results of epidemiological One study showed that measures to lower arsenic levels in
studies of all types of drink, confounding by other habits drinking water by using tap water rather than well water
should be considered. For example, heavy consumers of soft were associated with a fall in lung cancer rates in a region
drinks, tea, or coffee may also be smokers and drinkers of of Taiwan with endemic black foot disease.25
alcohol. The general mechanisms through which arsenic could
People who are physically active often consume more liq- plausibly cause cancer are outlined below. In addition, sol-
uid than those who are not. Physical activity is therefore a con- uble arsenic in drinking water induces lung cancers in ani-
founder of the relationship between the volume of fluid drunk mal models and causes chronic lung disease.5
and cancer risk, but may not be adequately adjusted for.
The evidence is ample and consistent, both from
Reporting bias.Soft and cola drinks are often identified as cohort and case-control as well as ecological studies.
unhealthy, and studies that depend on self-reporting may There is a dose-response relationship and the effect
disproportionately underestimate consumption. size is relatively large. There is robust evidence for
mechanisms. The evidence that arsenic is a cause of
lung cancer is convincing.
4.7.5 Evidence and judgements
Skin
The full systematic literature review (SLR) is contained on Two cohort studies,31 32 5 case-control studies,33-37 1 cross-
the CD included with this Report. sectional study,38 and 11 ecological studies20 22 24 27 29 30 39-43
investigated arsenic in drinking water and skin cancer.
4.7.5.1 Water Both cohort studies showed non-significant increased risk
The evidence was too sparse or inconsistent to draw any con- with increasing levels of arsenic in the water31 32; however,
clusion about the relationship between water quantity and for one study the increased risk was apparent in women but
cancer risk. not in men.32 Effect estimates were 1.82 (95% CI 0.54.66)
for women and 0.83 (95% CI 0.172.43) for men in Utah,32
4.7.5.1.1 Water-borne contaminants: arsenic and 1.21 (95% CI 1.001.47) per 100 g/l.31
Ecological studies based on known arsenic concentrations in Two case-control studies measured arsenic levels in toe-
water may be interpreted more robustly than for many other and fingernails.36 37 Such measures are less subject to error
dietary exposures. and bias than some other methods to assess actual exposure
to a carcinogen. One study reported a significant increased
Lung risk for melanoma with a risk estimate of 1.65 (95% CI
Two cohort studies,12-17 2 case-control studies18 19 and 12 1.272.14) per 100 ng/g36; the other study reported non-sig-
ecological studies20-30 investigated arsenic in drinking water nificant increased risk 1.02 (95% CI 0.901.17) per 100 ng/g
and lung cancer. for basal cell carcinoma and 1.12 (95% CI 0.951.32) for
Both cohort studies showed statistically significant squamous cell carcinoma.37
increased risk of lung cancer for the highest intake group Two case-control studies that reported on dietary arsenic
compared to the lowest.12-17 Although meta-analysis was not showed increased risk with increased intake,33 35 which was
possible, both studies reported that a dose-response rela- statistically significant in one.33 One study reported a non-
tionship was apparent. One study (in Taiwan) based in a significant decreased risk.34
population with endemic black foot disease, a manifestation The cross-sectional study showed a statistically significant
of arsenicosis, reported an effect estimate of 3.29 (95% con- increased risk, with a partially adjusted effect estimate of
fidence interval (CI) 1.606.78) for average arsenic level in 5.04 (95% CI 1.0723.8) for > 0.71 versus 0 parts per mil-
152
C H A P T E R 4 F O O D S A N D D R I N K S
lion average arsenic content in water.38 effect on risk,54 60 including the single case-control study that
All 11 ecological studies reported increased risk for skin measured arsenic levels in finger- or toenails.60
cancer with increased arsenic exposure,20 22 24 27 29 30 39-43 Six ecological studies showed increased risk with higher
which was statistically significant in 4,24 29 30 40 41 and statis- levels of arsenic in drinking water; all were statistically
tically significant in women but not in men in 127; and sig- significant.22 24 29 30 40 62 64 Two studies reported decreased
nificant in men but not women in another study.20 The effect risk,47 61 which was statistically significant in one.47 One
increased with age (cumulative exposure), where that was study showed a non-significant decreased risk in men and a
measured, and the reported effect estimates were usually non-significant increased risk in women.20 Two studies did
large, more than half being greater than 2.5. not provide quantified results.48 63
The general mechanisms through which arsenic could The general mechanisms through which arsenic could
plausibly cause cancer are outlined below. plausibly cause cancer are outlined below. In addition,
arsenic in drinking water is well absorbed in the gastro-
The evidence is consistent, from cohort, case-control intestinal tract, and both inorganic arsenic and its methyl-
and ecological studies. There is robust mechanistic ated metabolites are excreted in urine.49 Arsenic can modify
evidence. Arsenic is a probable cause of skin cancer. the urinary excretion of porphyrins in animals and humans.50
153
P A R T 2 E V I D E N C E A N D J U D G E M E N T S
cant decreased risk in men.74 Meta-analysis was possible on which was statistically significant in
96 101 107 109 111 113 118
eight cohort studies, giving a summary effect estimate of one.118 Three studies showed no effect on risk88 98 and one
1.00 (95% CI 0.941.07) per cup/day, with low hetero- study stated there was no significant effect on risk.110 Four
geneity (figure 4.7.1). other studies reported different effects in men and women;
Some, though not all, of the cohort studies suggest a J- however none was statistically significant.100 108 115 117 Meta-
shaped dose-response relationship. An effect at high levels analysis was possible on 26 studies, giving a summary effect
of coffee consumption cannot be excluded. estimate of 1.04 (95% CI 1.011.07) per cup/day, with mod-
Case-control studies reported inconsistent results.77 84-119 erate heterogeneity (figures 4.7.1 and 4.7.2). Studies that
Eighteen studies reported increased risk,84-87 89-91 94 97 99 102- did not adjust for smoking behaviour were more likely to
106 112 114 116 119
of which nine were statistically significant.85 report increased risk. Confounding with smoking could not
87 94 102 112 114
Eleven studies reported decreased risk,77 92 93 95 be excluded.
The ecological studies overall showed an increased mor-
tality between coffee consumption and pancreatic cancer.120-
130
Correlation coefficients ranged from +0.15122 to
Figure 4.7.1 Coffee and pancreatic cancer; cohort and +0.59.124 125
case-control studies
There is ample evidence, including prospective data,
Relative risk (95% CI) which is consistent and with low heterogeneity, and
Cohort
which fails to show an association. It is unlikely that
Snowdon 1984 0.98 (0.691.40) coffee has any substantial effect on the risk of
Zheng 1993 Men 0.93 (0.811.08) pancreatic cancer.
Shibata 1994 1.13 (0.791.62)
Stensvold 1994 Men 0.97 (0.831.14)
Stensvold 1994 Women 1.08 (0.851.37)
Harnack 1997 Women 1.24 (1.021.49)
Michaud 2001 Men 0.86 (0.741.00)
Michaud 2001 Women 0.96 (0.871.07)
Lin 2002 Men 1.14 (0.921.41)
Lin 2002 Women 0.86 (0.581.26)
Stolzenberg-Solomon 2002 Men 1.05 (0.941.17) Figure 4.7.2 Coffee and pancreatic cancer;
Summary estimate 1.00 (0.941.07) cohort studies: dose response
Case control
Elinder 1981 0.85 (0.661.09)
MacMahon 1981 1.13 (1.051.23)
Snowdon 1984
Wynder 1983 Men 1.01 (0.931.10)
Wynder 1983 Women 1.00 (0.901.10)
Gold 1985 1.06 (0.891.26) Zheng 1993
Mack 1986 1.20 (1.071.34)
La Vechhia 1987 1.06 (0.891.27)
Shibata 1994
Gorham 1988 1.15 (0.981.35)
Falk 1988 Men 1.09 (1.031.16)
Falk 1988 Women 1.06 (0.971.15) Stensvold 1994 Men
Clavel 1989 Women 2.00 (1.223.28)
Olsen 1989 All respondents 0.97 (0.871.08)
Stensvold 1994 Women
Clavel 1989 Men 1.32 (0.911.92)
Cuzick 1989 0.93 (0.831.05)
Farrow 1990 Men 1.03 (0.941.13) Honack 1997 Women
Jain 1991 1.00 (1.001.00)
Ghadirian 1991 0.99 (0.931.05) Michaud 2001 Men
Bueno de Mesquita 1992 0.78 (0.611.00)
Stefanati 1992 1.14 (0.801.62)
Lyon 1992 1.15 (1.021.30) Michaud 2001 Women
Zatonski 1993 0.53 (0.271.02)
Kalapothaki 1993 0.85 (0.681.06) Lin 2002 Men
Sciallero 1993 1.02 (0.841.24)
Partanen 1995 0.97 (0.921.03)
Gullo 1995 1.25 (1.121.40) Lin 2002 Women
Silverman 1998 Men 1.05 (0.981.13)
Silverman 1998 Women 1.03 (0.941.13) Stolzenberg-Solomon
Villeneuve 2000 Men 1.05 (0.941.17)
2002 Men
Villeneuve 2000 Women 0.99 (0.881.12)
Kreiger 2001 Women 1.00 (0.771.32)
Summary estimate 1.04 (1.011.07)
0 2 4 6 8 10
0.5 0.8 1 1.2 2
Coffee (cups/day)
Relative risk, per cup/day
154
C H A P T E R 4 F O O D S A N D D R I N K S
155
P A R T 2 E V I D E N C E A N D J U D G E M E N T S
156
C H A P T E R 4 F O O D S A N D D R I N K S
In the judgement of the Panel, the factors listed below modify the risk of cancer. Judgements are graded according to the strength of the evidence.
Limited
suggestive
Substantial
effect on risk Alcoholic drinks (adverse effect): kidney3
unlikely
1 The judgements for men and women are different because there are fewer data for women. Increased risk is only apparent above a threshold of 30 g/day of ethanol
for both sexes.
2 Cirrhosis is an essential precursor of liver cancer caused by alcohol. The International Agency for Research on Cancer has graded alcohol as a class 1 carcinogen for
liver cancer. Alcohol alone only causes cirrhosis in the presence of other factors.
3 The evidence was sufficient to judge that alcoholic drinks were unlikely to have an adverse effect on the risk of kidney cancer; it was inadequate to draw a
conclusion regarding a protective effect.
For an explanation of all the terms used in the matrix, please see chapter 3.5.1, the text of this section, and the glossary.
Many plant and some animal foods can be fermented to cause of cancers of a number of sites and that, in general,
produce alcoholic drinks; alcohol has been made this way the evidence is stronger than it was in the mid-1990s. The
for thousands of years. evidence does not show any safe limit of intake. The
The main alcoholic drinks consumed, in ascending order effect is from ethanol, irrespective of the type of drink.
of alcohol (ethanol) content, are beers and ciders; wines; Ethanol is classified by the International Agency for
wines fortified with spirits; and spirits (liquors) and Cancer Research as a human carcinogen.
liqueurs. The alcohol content of the many different drinks
within each of these categories varies. The Panel judges as follows:
Alcoholic drinks induce changes in mood; they also The evidence that alcoholic drinks are a cause of cancers
produce physical effects such as loss of coordination. In of the mouth, pharynx, and larynx, oesophagus,
most countries they are the legal intoxicant of choice, colorectum (men), and breast is convincing. They are
used as a social and professional lubricant; however, probably a cause of liver cancer, and of colorectal cancer
certain cultures forbid the drinking of alcohol. in women. It is unlikely that alcoholic drinks have a
With industrialisation and urbanisation, and the ready substantial adverse effect on the risk of kidney cancer.
availability of alcoholic drinks (which may or may not be In final summary, the evidence is that alcoholic drinks
taxed), consumption tends to rise. are a cause of cancers of the mouth, pharynx, and larynx;
Alcohol relaxes peoples social inhibitions, but it is the oesophagus; the colorectum in men, and the breast;
addictive; dependency on alcohol can seriously affect and probably of liver cancer and colorectal cancer in
peoples personal and professional lives. women. It is unlikely that alcoholic drinks have a
It has been known for a long time that prolonged high substantial adverse effect on the risk of kidney cancer.
consumption of alcohol is a cause of cirrhosis of the liver,
though not all people are equally susceptible. Knowledge
of its other ill-effects is more recent. Chapter 4.8 concerns all alcoholic drinks.
Overall, the Panel judges that alcoholic drinks are a Alcoholic drinks have been popular in most societies ever
157
P A R T 2 E V I D E N C E A N D J U D G E M E N T S
since the effects on mood of the fermented products of plant tent between about 16 and 20 per cent.
foods and some animal foods were discovered, probably in
Palaeolithic or even earlier times. 4.8.1.3 Spirits/liquors
Ethanol is the active ingredient in alcoholic drinks; the con- Spirits are usually produced from cereal grains and some-
centration varies, depending on the type of drink. In the past, times from other plant foods. They are distilled, to give a
beers were made from grains, ciders from fruits, mead from drink with a higher concentration of ethanol than either
honey, and brews from milk; these were followed by wines, beers or wines around 3550 per cent or higher. Some of
generally made from grapes and with higher concentrations the most globally familiar spirits are brandy (distilled wine),
of ethanol. The process of distillation was a later invention, whisky and gin (distilled from grains), rum (from molasses),
which produced more highly concentrated alcoholic drinks aguardente also known as cachaa (from sugar), vodka
made from grains, fruits, sugar, and other substrates. (sometimes from grain, sometimes potatoes), and tequila
Alcohol is liable to be addictive. Its specific effects are to and mescal (from agave and cactus plants). Spirits and
induce a mood of euphoria and disinhibition, which may be liqueurs are also made from fruits.
dangerous. Much domestic and other violence, and many
reckless and violent incidents, and crimes such as arson,
wounding, homicide, and car crashes, are alcohol-related. 4.8.2 Composition
Reports concerned with food, nutrition, and the preven-
tion of disease have often excluded alcohol. This is because Alcohol has an energy content of 7 kilocalories per gram, and
alcohol is also a drug, the impact of which is behavioural and is metabolised in the liver. On average, blood alcohol levels
social, as well as biological. More recently, alcoholic drinks reach a maximum between 30 and 60 minutes after
have been included in such reports because of the evidence drinking an alcoholic drink, and the body can metabolise
that low to moderate consumption protects against coronary 1015 g alcohol per hour.
heart disease (but not cerebrovascular disease), and also Alcohol alters the way the central nervous system func-
because of the evidence on cancer, given that ethanol is a tions. Very high alcohol consumption (where blood alcohol
human carcinogen. reaches 0.4 per cent) can be fatal, as can long-term, regu-
lar, high intakes.
158
C H A P T E R 4 F O O D S A N D D R I N K S
159
P A R T 2 E V I D E N C E A N D J U D G E M E N T S
Figure 4.8.1 Alcoholic drinks and mouth, pharynx, and Figure 4.8.2 Alcoholic drinks and mouth, pharynx, and
larynx cancer; cohort and case-control studies larynx cancer; cohort and case-control studies
Cohort Cohort
Gronbaek 1998 11.70 (4.9127.87) Kjaerheim 1998 1.26 (1.101.44)
Kjaerheim 1998 3.20 (1.646.25)
Boeing 2002 1.24 (1.181.30)
Boeing 2002 9.22 (2.7530.25)
Summary estimate 1.24 (1.181.30)
Case control
Case control
Maier 1992 9.00 (5.2115.54)
Martinez 1969 1.02 (1.011.04)
Wynder 1976 22.10 (7.8362.36)
Martinez 1969 Men 1.03 (1.011.05)
Herity 1982 5.60 (2.9912.48)
Elwood 1984 1.05 (1.041.06)
Elwood 1984 7.70 (3.1618.76)
Brownson 1987 1.02 (1.021.03)
Zagraniski 1986 4.00 (1.808.89)
Blot 1988 1.05 (1.041.06)
De Stefani 1987 9.30 (3.4924.81)
Brownson 1987 4.55 (2.818.37) Blot 1988 Women 1.04 (1.021.06)
160
C H A P T E R 4 F O O D S A N D D R I N K S
Figure 4.8.3 Alcoholic drinks and mouth, pharynx, and Figure 4.8.4 Alcoholic drinks and mouth, pharynx,
larynx cancer; cohort studies: dose response and larynx cancer; case-control studies:
dose response
Wines Spirits
Twenty-six case-control studies25 26 32 33 42 58 62 64 65 68 79 83-85 98 One cohort study,1 35 case-control studies,19 25 26 28 31-33 36 38
99 101 102 104 105 107-109
and four ecological studies94-96 110 report- 42 47 49 50 58 62 64 65 68 79 83-85 98 100-102 104 105 108 109 111-113
and 5 eco-
ed separately on wine drinking. logical studies94-96 106 114 reported separately on spirits.
Most of the case-control studies showed increased risk with The single cohort study showed a non-significant increased
increased intake,25 32 33 58 62 64 68 79 84 85 101 102 105 107-109 which risk with increased intake.1 Almost all case-control studies
161
P A R T 2 E V I D E N C E A N D J U D G E M E N T S
The general mechanisms through which alcohol could Zheng 1995 1.40 (0.623.18)
Kinjo 1998 Men 2.40 (1.773.25)
plausibly cause cancer are outlined below. In addition, alco- Kjaerheim 1998 Women 3.20 (1.646.25)
hol acts as a synergistic carcinogen with tobacco. Tobacco Khjo 1998 Women 2.00 (0.626.43)
Sakata 2005 2.40 (1.204.80)
may induce specific mutations in DNA that are less efficiently Tran 2005 0.92 (0.821.03)
repaired in the presence of alcohol. Alcohol may also func-
tion as a solvent, enhancing penetration of other carcino- Case control
Jozala 1983 26.70 (6.8710.374)
genic molecules into mucosal cells. Tuyns 1982 2.72 (1.037.16)
Rossi 1982 13.08 (4.5537.61)
Tuyns 1983 Men 101.03 (109.9928.52)
There is ample and consistent evidence, both from
Tuyns 1983 Women 11.04 (1.08112.57)
case-control and cohort studies, with a dose-response Adelhardt 1985 2.95 (1.127.76)
relationship. There is robust evidence for mechanisms Decarli 1987 10.43 (4.3724.90)
La Vecchia 1989 3.60 (0.9313.99)
operating in humans. The evidence that alcoholic Franceschi 1990 0.90 (0.571.42)
drinks are a cause of mouth, pharynx, and larynx De Stefani 1990 Men 5.27 (2.7110.24)
cancers is convincing. Alcohol and tobacco together De Stefani 1990 Women 1.89 (0.715.00)
Sankaranarayaran 1991 Men 2.33 (1.523.56)
increase the risk of these cancers more than either Choi 1991 Men 9.14 (3.7922.06)
acting independently. No threshold was identified. Valsecchi 1992 9.30 (5.1116.93)
Wang 1992 Men 2.10 (1.064.15)
Cheng 1992 11.45 (6.6619.69)
The Panel is aware that since the conclusion of the SLR, one Tavani 1993 2.30 (0.995.34)
cohort115 and four case-control studies116-119 have been pub- Kabat 1993 Men 10.90 (4.8824.32)
Kabat 1993 Women 13.20 (6.0828.68)
lished. This new information does not change the Panel judge- Parkin 1994 0.80 (0.591.08)
ment (see box 3.8). Castelletto 1994 8.00 (3.0121.27)
Hanaoka 1994 6.59 (2.5117.33)
Tavani 1994 5.40 (1.3920.91)
Oesophagus Gao 1994 Men 1.40 (1.071.84)
Eight cohort studies,1 3 120-125 56 case-control studies,33 61 67 Gao 1994 Women 0.60 (0.241.53)
Brown 1994 White Men 16.10 (6.6838.79)
80 126-182
and 10 ecological studies2 94 95 114 183-189 investigat- Brown 1994 Black Men 26.90 (11.8960.85)
ed alcoholic drinks and oesophageal cancers. Vaughan 1995 9.50 (4.0222.43)
Cheng 1995 1.50 (0.992.27)
Srivastava 1995 3.70 (1.509.11)
Total alcoholic drinks Gimeno 1995 4.40 (1.8610.40)
Eight cohort studies,1 3 120-125 56 case-control studies,33 61 67 Cheng 1995 Non-smokers 14.43 (3.6057.82)
80 126-137 139-182
and 10 ecological studies2 94 95 114 183-189 report- Vizcaino 1995
Nandakumar 1996 Men
0.90 (0.691.18)
1.80 (1.202.70)
ed on total alcoholic drinks. Garidou 1996 1.26 (1.091.45)
Six cohort studies showed increased risk for the highest Gammon 1997 7.40 (4.0013.69)
Dietz 1998 8.60 (3.8219.38)
intake group when compared to the lowest (figure 4.8.5),1 Tao 1999 1.54 (0.862.76)
3 120-122 124
which was statistically significant in four,1 120 122 Gao 1999 0.78 (0.381.62)
124
and in men, but not in women in a fifth study.121 Two Bosetti 2000 12.35 (8.3718.22)
Levi 2000 15.65 (6.8135.96)
studies showed non-significant decreased risk.123 125 Effect Nayar 2000 7.81 (3.285.61)
estimates for all studies are shown in the high to low forest Takezaki 2000 8.50 (5.5613.00)
plot (figure 4.8.5). Four studies did not adjust for smok- Takezaki 2001
Wu 2001
0.75 (0.461.22)
0.70 (0.471.04)
ing.122-125 Sharp 2001 0.86 (0.252.95)
Most case-control studies showed increased risk for the Dal Maso 2002 13.80 (4.0047.60)
Gao 2002 1.48 (0.782.81)
highest intake group when compared to the lowest (figure Boonyaphiphat 2002 5.84 (3.1510.83)
4.8.5),33 61 67 80 126 128-137 139 141-148 150-166 169 170 172 174 175 177-182 Engel 2003 9.40 (4.6019.20)
which was statistically significant in 25.33 61 67 80 128 129 132 133 Chita 2004 men 3.50 (1.727.10)
Wang 2004 3.45 (1.736.88)
135 137 139 141 145 147 148 150 152 153 155-166 170 172 174 175 178-180 182
Lee 2005 7.60 (5.2011.10)
A few studies showed decreased risk, but none was statisti- Yang 2005 6.71 (1.9223.42)
Trivers 2005 1.08 (0.811.44)
cally significant.140 149 167 168 171 173 176 Meta-analysis was pos-
sible on 20 case-control studies, giving a summary effect 0.2 0.5 1 2 5 10
estimate of 1.04 (95% CI 1.031.05) per drink/week, with Relative risk, highest vs lowest exposure category
high heterogeneity (figures 4.8.6 and 4.8.7).33 61 67 131 133 137
144 149 150 156 157 160 161 170 178-182
Heterogeneity is related pre-
dominantly to size, rather than direction, of effect and may
162
C H A P T E R 4 F O O D S A N D D R I N K S
Figure 4.8.6 Alcoholic drinks and oesophageal cancer; Figure 4.8.7 Alcoholic drinks and oesophageal cancer;
cohort and case-control studies case-control studies: dose response
Cohort
Case control
be partially explained by the variation in measurement of smoking.4 All case-control studies with the exception of
alcohol intake, variation in the outcome measured two173 176 also showed increased risk, which was statistical-
(oesophageal or upper aerodigestive tract), or by inadequate ly significant in seven.103 129 144 159 170 191 193 195-197 Meta-analy-
adjustment for smoking in some studies. There is a trend for sis was possible on five case-control studies, giving a
smaller effect estimates from more recent publications, which summary effect estimate of 1.05 (95% CI 1.031.07), with
could be due to improved methods of adjustment for con- high heterogeneity.144 159 170 193 197 About half of the studies
founders. Not all studies adjusted for smoking. did not adjust for smoking. The ecological studies were
There is some evidence of publication bias; with smaller inconsistent and one reported a statistically significant result,
studies tending to report larger effects. which was in the direction of increased risk.94
The ecological studies were not consistent.2 94 95 114 183-189
Two reported statistically significant results, both in the Wines
direction of increased risk.94 186 Ten case-control studies,143 144 159 161 170 173 190 194 195 one cross-
sectional study,200 and five ecological studies94 95 106 184 198
Beers reported separately on wine drinking.
One cohort study,4 15 case-control studies,103 129 143 144 159 170 All but one of the case-control studies showed increased
and seven ecological studies94 95 106 184 187 198 199
173 176 190-197
risk with increased intake,144 which was statistically
reported separately on beer drinking. significant in seven.159 161 170 190 195 About half of the studies
The single cohort study showed statistically significant adjusted for smoking. The single cross-sectional study
increased risk with increased intake after adjustment for showed non-significant increased risk.200 Most ecological
163
P A R T 2 E V I D E N C E A N D J U D G E M E N T S
smoking.4 All of the case-control studies also showed Flood 2002 Women 1.02 (0.851.21)
Pedersen 2003 1.00 (0.911.09)
increased risk, which was statistically significant in eight.139 Summary estimate 1.01 (0.951.08)
144 145 191 194 195 201 202
Most studies adjusted for smoking. The
single cross-sectional study showed non-significant increased 1
0.2 0.5 2 5
risk.200 The ecological studies were inconsistent and two Relative risk, per drink/day
reported statistically significant results; both were in the
direction of increased risk.94 106
The general mechanisms through which alcohol could
plausibly cause cancer are outlined below. In addition, alco-
hol acts as a synergistic carcinogen with tobacco. Tobacco
may induce specific mutations in DNA that are less efficiently
repaired in the presence of alcohol. Alcohol may also func- effect on risk for men and non-significant decreased risk for
tion as a solvent, enhancing penetration of other carcino- women,238 and one study reported no statistically significant
genic molecules into mucosal cells. association.236 Meta-analysis was possible on nine cohort
studies, of which one reported on colorectal cancer and eight
There is ample and consistent evidence, both from reported on colon cancer, giving a summary effect estimate
cohort and case-control studies, with a dose-response of 1.09 (95% CI 1.031.14) per 10 g/day, with moderate het-
relationship. There is robust evidence for mechanisms erogeneity(figures 4.8.10 and 4.8.11).
operating in humans. The evidence that alcoholic In a separate meta-analysis of nine studies for rectal can-
drinks are a cause of oesophageal cancer is convincing. cer, the summary effect estimate was 1.06 (95% CI
No threshold was identified. 1.011.12) per 10 g/day, with low heterogeneity (figure
4.8.12). It is apparent from the meta-analysis that the report-
The Panel is aware that since the conclusion of the SLR, one ed effect for men was larger and more often statistically sig-
cohort203 and four case-control studies204-207 have been pub- nificant than for women. Stratified meta-analyses for
lished. This new information does not change the Panel judge- colorectal cancer gave summary effect estimates of 1.09
ment (see box 3.8). (95% CI 1.021.15) for seven studies for men, and 1.00
(95% CI 0.891.40) for three studies for women. There was
Colorectum no statistically significant difference with cancer site. There
Twenty-four cohort studies investigated alcoholic drinks and was, however, apparent sexual dimorphism, with a larger
colorectal cancer.124 208-235 Thirteen cohort studies214 216 219 227 effect in men than in women, which explains the bulk of the
230 232 236-251
and 41 case-control studies investigated ethanol observed heterogeneity.
intake and colorectal cancer.
cohort studies, giving a summary effect estimate of 1.01 Harnack 2002 Women
Wei 2003 Men
1.08 (0.721.62)
1.55 (1.052.28)
(95% CI 0.951.08) per drink/day, with no heterogeneity Wei 2003 Women 1.14 (0.861.52)
(figure 4.8.8).
164
C H A P T E R 4 F O O D S A N D D R I N K S
Figure 4.8.10 Ethanol and colon cancer; cohort studies Figure 4.8.12 Ethanol and colorectal cancer; cohort studies
When data were analysed separately for drink type (beers, There is ample and generally consistent evidence from
wines, or spirits), they became insufficient to draw any firm cohort studies. A dose-response is apparent. There is
conclusions. evidence for plausible mechanisms. The evidence that
Pooled analysis from 8 cohort studies (over 475 000 par- consumption of more than 30 g/day of ethanol from
ticipants, followed up for 6 to 16 years, more than 4600 col- alcoholic drinks is a cause of colorectal cancer in men
orectal cancer cases) showed a significant increased risk for is convincing, and probably also in women.
the highest intake group when compared to the lowest, with
an effect estimate of 1.41 (95% CI 1.161.72) for those who The Panel is aware that since the conclusion of the SLR, four
consumed 45 g/day or greater.252 No increased risk was cohort255-258 and four case-control studies259-262 have been pub-
observed below intakes of 30 g/day. No significant hetero- lished. This new information does not change the Panel judge-
geneity was observed by sex or cancer site. ment (see box 3.8).
In addition, a published meta-analysis of 27 studies report-
ed a statistically significant increased risk, with a summary Breast
effect estimate of 1.10 (95% CI 1.051.14) per two Eleven cohort studies,183 263-271 31 case-control studies272-310
drinks/day. and 2 ecological studies311 312 investigated total alcoholic
Because of the abundant prospective data from cohort drinks and breast cancer at all ages. Four cohort studies313-
studies, case-control studies were not summarized. 316
and 19 case-control studies289 302 317-333 investigated alco-
The general mechanisms through which alcohol could holic drinks. Twenty-five cohort studies,315 334-364 29 case-
165
P A R T 2 E V I D E N C E A N D J U D G E M E N T S
control studies,280 282 317 318 332 333 365-391 and 4 ecological
Figure 4.8.13 Alcoholic drinks and breast cancer; cohort
studies392-395 investigated ethanol intake.
and case-control studies
lowest,263 264 267-271 which was statistically significant in Wu 1999 1.38 (0.842.26)
Wu 1999 1.08 (0.781.50)
three.267 269 270 Three studies showed non-significant Byrne 1996 0.99 (0.771.28)
decreased risk265 266; one study showed no effect on risk.183 Summary estimate 1.07 (0.891.29)
breast cancer.264 268 Both showed increased risk for the high- Rosenberg 1990 0.97 (0.861.10)
Viladiu 1996 0.97 (0.931.11)
est intake group when compared to the lowest, which was Freudenheim 1995 0.94 (0.791.13)
statistically significant in one.268 Three cohort studies Sneyd 1991 0.94 (0.811.09)
reported separately on postmenopausal breast cancer.264 268 Baughmater 2002 0.90 (0.791.03)
Summary estimate 1.05 (1.031.07)
269
Two showed increased risk for the highest intake group
when compared to the lowest,264 269 which was statistically
0.2 0.5 1 1.5 2 4 6
significant in one.269 The other study showed non-significant
Relative risk, per 5 times/week
decreased risk.268
Four additional cohort studies investigated alcoholic
drinks.313-316 All four showed non-significant increased risk
for breast cancer at unspecified ages. One study also report-
ed statistically significant increased risk for postmenopausal
breast cancer and non-significant decreased risk for pre-
menopausal breast cancer.315
Most of the 22 case-control studies that reported on all- Figure 4.8.14 Alcoholic drinks and breast cancer; cohort
age breast cancer and total alcoholic drinks showed and case-control studies: dose response
increased risk for the highest intake group when compared
to the lowest,273 274 280 282-285 287 288 290 295 297 301-303 305-309 318
which was statistically significant in seven.273 284 285 306 318
A few studies showed decreased risk, none was statistically Cohort
significant.276 291 295 298 302 304 Meta-analysis was possible on Wu 1999
10 case-control studies reporting on breast cancer at all ages, Byrne 1996
giving a summary estimate of 1.05 (95% CI 1.031.07) for
an increment of five times/week, with high heterogeneity
(figures 4.8.13 and 4.8.14).274 276 284 286 287 296 306 307 No het- Case control
study showed no effect on risk297 and the other study showed Lash 2000
non-significant decreased risk.278 282 310 Six studies reported Baughmater 2002
separately on postmenopausal breast cancer.277 278 281 282 289
Vlladiu 1996
297 306 310
Five of these showed increased risk,278 281 282 289 306
Sneyd 1991
310
which was statistically significant in one.306 The other
study reported non-significant decreased risk.297 Kinney 2000
In addition, 19 case-control studies investigated alcoholic Katsouyanni 1994
drinks.289 302 318-323 325-331 333 Most showed increased risk for
the highest intake group when compared to the lowest,
which was statistically significant in six.302 318 321 323 327 329 0 4 8 12 16 20 24 28
Two studies showed non-significant decreased risk317 324; one Alcoholic drinks (times/week)
study showed no effect on risk.332 Four studies reported sep-
arate results for premenopausal breast cancer.318 320 322 333 Of
these, two studies showed non-significant increased risk,318
333
one showed statistically significant increased risk in
166
C H A P T E R 4 F O O D S A N D D R I N K S
than 58 000 cases and more than 95 000 controls) showed Harvey 1987 1.10 (1.021.18)
Brandt 2004 1.08 (0.941.23)
a significant increased risk with increasing intake, with an Ferraroni 1998 1.06 (1.031.09)
effect estimate of 7.1 per cent increased risk (95% CI Trentham-Dietz 2000 1.05 (1.001.11)
5.58.7%; p < 0.00001) per 10 g/day.397 No significant het- Webster 1983 1.01 (0.951.08)
Summary estimate 1.06 (1.041.09)
erogeneity was observed by menopausal status.
Eighteen case-control studies investigated ethanol intake
and all-age breast cancer.280 282 317 318 332 365-371 374 378 379 381 383 0.2 0.5 1 1.5 2
Relative risk, per 10 g/day
384 386 387 390 391
Twelve case-control studies showed increased
risk for the highest intake group when compared to the low-
est,280 318 332 365 367-369 374 379 381 383 384 386 387 391 which was sta-
tistically significant in five.280 318 368 369 374 381 384 Five studies
167
P A R T 2 E V I D E N C E A N D J U D G E M E N T S
mechanisms operating in humans. The evidence that Goodman 1995 Men 1.11 (0.721.71)
Goodman 1995 Women 1.25 (0.781.99)
alcoholic drinks are a cause of premenopausal and Mutu 1989 1.50 (0.425.31)
postmenopausal breast cancer is convincing. No Yu 1999 1.39 (0.682.14)
case-control study400 has been published. This new information Case control
does not change the Panel judgement (see box 3.8). Stemhagen 1983 Men 1.30 (0.642.63)
Stemhagen 1983 Women 1.63 (0.922.89)
Inaba 1984 3.62 (1.687.79)
Liver Austin 1986 2.60 (1.265.35)
Fifteen cohort studies and 33 case-control
120 208 220 227 401-422
Harris 1988 Men 1.28 (0.692.39)
studies158 423-460 investigated alcoholic drinks and liver can- La Vecchia 1988 1.43 (0.832.46)
Harris 1988 Women 1.93 (0.665.63)
cer. Fourteen cohort studies6 120 227 244 403 404 409 410 412 416 422 Tsukuma 1990 Men 2.60 (1.703.99)
461-468
and 21 case-control studies158 427 431 434 436 440 446 452 456 Olubuyide 1990 Men 1.70 (0.903.21)
459 469-485
investigated ethanol intake. Olubuyide 1990 Women 1.40 (0.0450.00)
Hiyama 1990 8.00 (1.3049.36)
Qureshi 1990 3.04 (0.3129.54)
Total alcoholic drinks Yu 1991 Anti-HCV negative 2.10 (1.203.69)
Data are available from 15 cohort studies.120 208 220 227 401-422 Choi 1991 Men 2.46 (1.165.22)
Yamaguchi 1993 HBsAg negative 2.70 (1.814.02)
Eleven cohort studies showed increased risk for the highest Newton 1996 1.20 (0.502.89)
intake group when compared to the lowest,120 220 227 401-404 407- Wang 1996 1.28 (0.981.67)
410 413 414 416 417 420 422
which was statistically significant in Braga 2000 Men 1.68 (1.142.48)
Braga 2000 Women 1.30 (0.424.01)
two.120 401 Two studies showed non-significant decreased Mukaiya 1998 2.31 (1.204.42)
risk.405 406 412 418 419 Two studies stated that there was no sig- Mandishona 1998 2.00 (0.498.10)
Kuper 2000 1.90 (0.913.96)
nificant difference but did not provide further data.411 415 421 Yu 2002 1.38 (0.682.81)
Heterogeneity is partially explained by differences in Donato 2002 Men 2.70 (1.096.71)
whether and how studies have adjusted for hepatitis virus Donato 2002 Women 0.90 (0.332.49)
Munaka 2003 1.45 (0.812.60)
status. The effect estimates of eight studies are given in the Tsai 2004 2.55 (1.504.33)
high to low comparison forest plot (figure 4.8.17).
Data are available from 33 case-control studies.158 423-460
Twenty-eight case-control studies showed increased risk for
the highest intake group when compared to the lowest,158 423- 0.2 0.5 1 2 5
432 434-448 451-456 460
which was statistically significant in 12 (one Relative risk, highest vs lowest exposure category
of these studies reported a non-significant decreased risk in
women, but a statistically significant increased risk in
men440).158 423 427 429-432 434 439 440 442 444 446 447 454-456 Two studies
showed non-significant decreased risk.449 Three studies stat-
ed that there was no significant effect on risk.433 450 457-459 Meta-
analysis was possible on five studies, giving a summary effect
estimate of 1.18 (95% CI 1.111.26) per drink/week, with
high heterogeneity (figure 4.8.18).158 425 434 449 460 study stated that there was no significant effect on risk.464
A dose-response relationship is apparent from case-control Meta-analysis was possible on six cohort studies, giving a
but not cohort data. summary effect estimate of 1.10 (95% CI 1.021.17) per 10
g/day or 10 ml/day, with no heterogeneity (figure 4.8.19).
Alcohol (as ethanol) Twenty case-control studies showed increased risk for the
Ten cohort studies showed increased risk for the highest highest intake group when compared to the lowest,158 427 431
intake group when compared to the lowest,6 120 244 403 404 409 434 436 440 446 452 456 469 470 472-475 477-479 481-485
which was statisti-
410 416 422 461 465-468
which was statistically significant in five cally significant in 12.158 427 431 434 440 446 456 474 475 477-479 481 483-
(one of these studies reported a non-significant increased risk 485
One study showed non-significant decreased risk.476
in women, but a statistically significant increased risk in Meta-analysis was possible on 14 case-control studies, giv-
men461).6 120 244 416 461 465 468 Three studies in men with cir- ing a summary effect estimate of 1.17 (95% CI 1.091.25)
rhosis showed non-significant decreased risk.227 412 462 463 One per 10 g/day or 10 ml/day, with high heterogeneity (figure
168
C H A P T E R 4 F O O D S A N D D R I N K S
Figure 4.8.18 Alcoholic drinks and liver cancer; Figure 4.8.20 Ethanol and liver cancer; case-control studies
case-control studies
Relative risk (95% CI)
Relative risk (95% CI)
Infante 1980 Cirrhotic 5.01 (2.4210.37)
Austin 1986 HBsAg 1.07 (0.861.33)
Infante 1980 Non-cirrhotic 6.10 (2.2016.93)
Lu 1988 0.89 (0.771.02)
Yu 1983 1.12 (1.001.26)
Choi 1991 1.30 (1.191.41)
Inaba 1984 1.81 (1.272.59)
Yu 1991 1.39 (1.081.79)
Tsukuma 1990 1.17 (1.091.29)
Mukaiya 1998 1.21 (1.011.44)
Mayans 1990 1.19 (1.091.29)
Summary estimate 1.18 (1.111.26)
Yamaguchi 1993 Men 1.11 (1.061.15)
Arico 1994 0.93 (0.871.00)
Pyong 1994 Men 1.40 (1.161.69)
0.7 0.8 1 1.2 1.5
Shin 1996 1.05 (0.971.15)
Relative risk, per drink/week Zhang 1998 1.05 (0.951.17)
Mukaiya 1998 1.28 (1.051.57)
Kuper 2000 1.04 (0.961.13)
Hassan 2002 1.16 (1.031.30)
Gelatti 2005 1.28 (1.191.38)
Summary estimate 1.17 (1.091.25)
0.2 0.5 1 2 5
Relative risk, per 10 g/day
Sharp 2005
Ross 1992
Oshima 1984
4.8.20). Heterogeneity may be due to the inclusion of stud-
ies that reported alcoholic behaviour.
A dose-response relationship is apparent from cohort and Murata 1996
Wines
Three cohort studies6 410 486 and one case-control study425
reported separately on wine drinking.
One cohort study showed non-significant increased risk
with increased intake.410 Two studies stated that there was
no significant effect on risk.6 486 The single case-control study
showed non-significant increased risk.425
169
P A R T 2 E V I D E N C E A N D J U D G E M E N T S
Spirits Three studies showed no effect on risk495 497 509; three stud-
Two cohort studies 6 486
and five case-control studies 425 444 469
ies stated that there was no significant association505-507; two
472 479 487
reported separately on spirits. studies showed non-significant increased risk498 500; one
Both cohort studies showed no significant effect on risk.6 study showed a non-significant decreased risk in men and a
486
All case-control studies showed increased risk,425 444 469 472 non-significant increased risk in women.508 Meta-analysis
479 487
which was statistically significant in one444 479; and one was possible on two studies that adjusted for smoking, giv-
case-control study showed statistically significant increased ing a summary effect estimate of 0.92 (95% CI 0.711.20)
risk for consumption of illicit liquor.487 per serving/day, with moderate heterogeneity (figure
Several studies used participants judged to be at high risk 4.8.22).496 498
of developing liver cancer, that is, people who already had
liver cirrhosis. These results are particularly hard to interpret Alcohol (as ethanol)
as cirrhosis status affects drinking behaviour. Also the can- All four cohort studies showed decreased risk with increased
cer disease path may be different in people with cirrhosis. ethanol intake,6 492 510-513 which was statistically significant
Assessment of some studies was hampered by poor expo- in one.510 512 Meta-analysis was possible on two unadjusted
sure assessment, and not all studies adjusted for known con- studies, giving a summary effect estimate of 0.48 (95% CI
founders such as hepatitis B or C virus. 0.260.90) per serving/day, with no heterogeneity.492 511
The general mechanisms through which alcohol could Three case-control studies showed non-significant
plausibly cause cancer are outlined below. In addition, reg- decreased risk with increased ethanol intake.504 514 516 One
ular, high levels of alcohol consumption are known to cause study showed no effect on risk,515 and one study stated no
liver damage. Tumour promotion has been linked to inflam- significant association.503 Meta-analysis was possible on two
mation in the liver through alcohol-associated fibrosis and unadjusted studies, giving a summary effect estimate of 0.90
hepatitis.488 489 Alcohol consumption, even at moderate lev- (95% CI 0.771.05) per serving/day, with no heterogeneity
els, is associated with increases in levels of circulating hepati- (figure 4.8.23).514 515
tis C virus RNA in carriers. Hepatitis C virus infection is There is no known mechanism through which alcohol
highly prevalent among alcoholics with chronic liver disease could decrease kidney cancer risk.
and appears to accelerate the course of alcoholic liver disease
(see chapter 7.8). It is unlikely that alcohol increases the risk of kidney
cancer, though a protective effect cannot be excluded.
There is ample, generally consistent evidence from
both cohort and case-control studies. A dose-response
relationship is apparent. Alcohol is a cause of cirrhosis Figure 4.8.22 Ethanol and kidney cancer;
case-control studies
that predisposes to liver cancer, but the factors that
determine why some people are susceptible to Relative risk (95% CI)
cirrhosis are not known. Alcoholic drinks are a
probable cause of liver cancer. No threshold was Yuan 1998 1.01 (0.971.05)
identified. Parker 2002 0.76 (0.531.07)
Summary estimate 0.92 (0.711.20)
The Panel is aware that since the conclusion of the SLR, one
case-control study490 has been published. This new information 0.5 1 2
does not change the Panel judgement (see box 3.8). Relative risk, per unit/day
Kidney
Three cohort studies491-493 and 16 case-control studies308 494-
509
investigated alcoholic drinks and kidney cancer. Four
cohort studies6 492 510-513 and five case-control studies503 504
514-516
investigated ethanol intake. Figure 4.8.23 Alcoholic drinks and kidney cancer;
case-control studies
Total alcoholic drinks
Two cohort studies showed non-significant increased risk for Relative risk (95% CI)
the highest intake group when compared to the lowest.491 493 Mattioli 2002 0.90 (0.761.04)
One study showed a statistically significant decreased Lindblad 1997 1.00 (0.392.59)
risk.492 None of the studies was adjusted for smoking; effect Summary estimate 0.90 (0.771.05)
170
C H A P T E R 4 F O O D S A N D D R I N K S
The Panel is aware that since the conclusion of the SLR, one
cohort study517 has been published. This new information does
not change the Panel judgement (see box 3.8).
General mechanisms
Evidence suggests that reactive metabolites of alcohol, such
as acetaldehyde, may be carcinogenic. Additionally, the
effects of alcohol may be mediated through the production
of prostaglandins, lipid peroxidation, and the generation of
free-radical oxygen species. Alcohol also acts as a solvent,
enhancing penetration of carcinogens into cells. Alcohol has
been demonstrated to alter retinoid status in rodent studies
and, as a result, cellular growth, cellular differentiation, and
apoptosis are adversely altered. For all these pathways,
genetic polymorphisms might also influence risk.398
Lastly, heavy consumers of alcohol may have diets
deficient in essential nutrients, making tissue susceptible to
carcinogenesis.
4.8.7 Conclusions
171
P A R T 2 E V I D E N C E A N D J U D G E M E N T S
172
C H A P T E R 4 F O O D S A N D D R I N K S
the all-year round supply of fresh vegetables and fruits (see 4.9.1.1 Pesticides and herbicides
chapter 4.2). The use of synthetic pesticides and herbicides has increased
The industrialised farming methods that are part of most vastly since the middle of the 20th century. Nearly 2500
modern food systems in most countries use various tech- tonnes of these chemicals were used worldwide in 2001.1
nologies to maximise production. These include the use of The chlorinated pesticide dichloro-diphenyl-trichloro-
fertilisers, pesticides, and herbicides on food crops; and of ethane (DDT) has been banned from use in many countries.
veterinary drugs in rearing livestock and in aquaculture. Other organochlorine pesticides are now largely being
Fertilisers play a part in determining nutrient levels in plants, replaced with organophosphorus and carbamate pesticides.
as well as potentially modifying concentrations of other These newer types are less persistent in the environment,
bioactive microconstituents. Residues of these and other and have not been found to be carcinogenic in experimen-
chemicals applied to crops are washed from soils by the tal settings.
rain and can contaminate water supplies. See boxes 4.9.2 In many countries, the use of pesticides and herbicides is
and 4.9.3. regulated to minimise residues in foods and drinks, and there
Methods or consequences of food production, where epi- are internationally recommended maximum residue limits
demiological evidence shows or suggests an effect on the risk (box 4.9.3). The use of persistent organic pollutants
of cancer, are summarised and judged earlier in this chapter. (organochlorine pesticides, furans, dioxins, and polychlori-
These are fungal contamination (chapter 4.1), hot drinks nated biphenyls) will be banned by 2025 under the United
and foods (chapter 4.7), and arsenic contamination Nations Environment Programmes Stockholm Convention,
(chapter 4.7). which entered into force in May 2004.
Many of these contaminants have the potential to accu-
mulate within food systems, and residues of pesticides and
herbicides that have been banned from use, or are being
phased out, may still be present in foods eaten today. Some
contaminants, such as heavy metals and persistent organic
Box 4.9.1 Food systems
compounds, tend to be deposited in fatty tissues and are not
Food systems involve the production, preservation, processing, easily metabolised or excreted. They accumulate in living
and preparation (including cooking) of food. Gathererhunters creatures, in amounts higher than background levels (for
take food as it is found in nature and modify it by the use of fire. instance, in the soil). Dietary exposure increases with each
Pastoralists modify the animals that are a source of their food step up the food chain, as predators consume prey contam-
through breeding. Agriculture improves plants for human food inated with these residues.
use, by selective breeding and planting, and animals too are sub- There are theoretical grounds for concern, which are con-
ject to selective breeding. In Egypt, selectively bred wheat was
stantly reviewed by international and national regulatory
ground into flour, kneaded with water and other ingredients,
bodies. However, there is no epidemiological evidence that
and baked into bread as early as 4000 years ago.
Thousands of years before industrialisation, most food and current exposures are causes of cancers in humans, and so
drink consumed by the majority of people was modified in some the Panel has made no judgements. Nevertheless, a precau-
way in its production. This included preservation by drying, and tionary approach is wise for women of reproductive age,
later other methods such as salting, fermenting, pickling, curing, since vulnerability during embryonic phases of development
spicing, and freezing in cold climates; and various methods of is increased, and early exposure may result in increased risk
preparation and cooking, including boiling and roasting. at later stages in life.
Food systems were transformed as part of the industrial and
later, the technological revolution. But this was not the point at 4.9.1.2 Veterinary drugs
which foods and drinks became modified for the first time.
Industrial animal production, as distinct from organic farm-
Rather, many new processes were developed such as sterile bot-
ing (box 4.9.2), requires constant use of antimicrobial drugs
tling and canning. Then, beginning in the late 19th century, steel
roller mills were devised for the mass-manufacture of white flour to treat and prevent infectious diseases, and promote growth.
and thus white bread; refrigerated transport using railways and Residues of these antimicrobials can be found in foods and
ships made possible the industrial production and international drinks, normally at levels lower than internationally recom-
export of meat and dairy products. In the 20th century, com- mended maximum residue limits (box 4.9.3). When anti-
mercialisation of the hydrogenation process to turn liquid oils microbials have been found to be carcinogenic in animals,
into solid fats made margarine manufacture a big business, and their licence for that use has been withdrawn.
the mass manufacture of soft drinks developed. Hormonal anabolic agents are used in animal husbandry
What is now known as conventional farming, making exten- in some countries, including the USA, to prevent and ter-
sive use of chemical fertilisers, herbicides, and pesticides, and
minate pregnancy in cows and to promote growth. Their use
feed concentrates for animals, developed mainly in the second
has been banned in other countries as well as in the
half of the 20th century. More recent developments in food sys-
tems include the use of containers to transport foods and drinks European Union. Hormones designed to stimulate milk pro-
nationally and internationally; the development of supermar- duction include bovine somatotropin and porcine soma-
kets, of which the biggest are now transnational; and the increas- totropin. Many hormones have been found to be multisite
ing concentration of food producers, manufacturers, retailers, carcinogens in experimental settings.2 These include oestro-
and caterers. gens, classed as group 1, human carcinogens, by the
International Agency for Research on Cancer (IARC), prog-
173
P A R T 2 E V I D E N C E A N D J U D G E M E N T S
174
C H A P T E R 4 F O O D S A N D D R I N K S
175
P A R T 2 E V I D E N C E A N D J U D G E M E N T S
176
C H A P T E R 4 F O O D S A N D D R I N K S
4.9.4.4 Microwaving in use, as a basis for food safety regulations. The relevance
Microwaving exposes food to temperatures up to 200C. of such work to the actual levels consumed of substances
Microwaves are a form of electromagnetic radiation. They identified in this section is obscure. Also, it is commonly
cause vibration of water molecules, which produces heat. agreed, as in this Report, that information from animal and
There is no evidence that microwaves have any specific effect other experimental settings, which is unsupported by evi-
on food composition beyond that of heat. dence from epidemiological studies, is not a sound basis for
firm judgements.
4.9.4.5 Frying, grilling (broiling), barbecuing
(charbroiling) Confounding. Studies commonly report the difficulty in sep-
Also see box 4.3.4 in chapter 4.3. Frying, grilling (broiling), arating out specific methods of processing or cooking, when
and barbecuing (charbroiling) generate temperatures of up foods are characteristically processed and prepared in a num-
to 400C, and sometimes use a direct flame to cook food. ber of different ways.
These methods create high levels of carcinogenic com-
pounds. For any cooking involving wood fires, the type of
wood used can also be an important factor in determining 4.9.6 Evidence and judgements
which chemicals contaminate the food. Hardwoods such as
oak and hickory burn cleanly; others such as mesquite gen- The Panel decided to make no judgements on experimental
erate copious quantities of polycyclic aromatic hydrocarbons. findings of toxicity that are not supported by epidemiologi-
Because of the experimental evidence of carcinogen pro- cal or other evidence.
duction, it is prudent not to consume burned or charred The evidence considered by the Panel is in the systemat-
foods frequently or in large amounts. Industrial food prepa- ic literature review (SLR). Because the Panel made no judge-
ration methods are regulated. Because there is no support- ment on the isolated experimental data, this evidence is not
ing epidemiological or other evidence, the Panel made no summarised separately here.
judgements. The full SLR is contained on the CD included with this
There is too little evidence to draw any conclusion about Report.
the association between methods of preparation and risk of
cancer.
4.9.7 Comparison with previous report
4.9.5 Interpretation of the evidence In general, the previous report found that information from
animal and other experimental settings unsupported by epi-
4.9.5.1 General demiological evidence, was not a basis for judgement. In this
For general considerations that may affect interpretation of respect, the view of the Panel responsible for this Report is
the evidence, see chapters 3.3 and 3.5, and boxes 3.1, 3.2, similar. The findings of the previous report on food additives,
3.6 and 3.7. microbial contaminants, salt and salted foods, salted fish
Aspects of food production, preservation, processing, and (Cantonese-style), cured meats, and the grilling and barbe-
preparation (including cooking), where epidemiological evi- cuing of meat, fish, and other foods, were all contained in
dence enables judgements to be made, are summarised, with a chapter on food processing. The previous panels judge-
Panel judgements, in previous sections of this chapter. ments were mostly similar to those made here, with the
important exception of processed meat, which was not con-
4.9.5.2 Specific sidered separately from smoked and cured meats by the pre-
Measurement. It is practically impossible to measure small vious report. The judgements of this Report on these subjects
amounts of additives and trace amounts of contaminants in are made in previous sections of this chapter.
foods and drinks except by analysis. Epidemiological stud-
ies using usual methods of dietary assessment are therefore
generally uninformative. 4.9.8 Conclusions
Terminology. The terms used for different types of cooking The Panel concludes:
vary around the world. Broiling in the USA is called grilling The Panel decided to make no judgements on isolated exper-
in other countries. Barbecuing may mean grilling in flame imental findings that were not supported by epidemiologi-
or slow cooking near smoking embers. Results of studies in cal or other evidence.
these areas need to be interpreted with care, given that car- It is not possible to make any definitive judgement in the
cinogenic compounds are particularly generated when meat absence of epidemiological evidence. Nevertheless, the Panel
and other animal and plant foods are cooked in a flame, and concurs that, in general, it seems reasonable to conclude that
even more so when they are burned or charred. the changes made to foods and drinks within well regulat-
ed, modern food systems, and those made to foods and
Study design. Practically all studies of the topics covered in drinks as usually prepared and cooked, are of themselves
this section are laboratory experiments on animals. They are unlikely to modify the risk of cancer significantly.
commonly carried out to assess toxicity to determine safety There are important exceptions to this tentative conclusion
177
P A R T 2 E V I D E N C E A N D J U D G E M E N T S
178
C H A P T E R 4 F O O D S A N D D R I N K S
In the judgement of the Panel, the factors listed below modify the risk of cancer. Judgements are graded according to the strength of the evidence.
Substantial
effect on risk Beta-carotene7: prostate; skin (non-melanoma)
unlikely
1 The evidence is derived from studies using high-dose supplements (20 mg/day for beta-carotene; 25 000 international units/day for retinol) in smokers.
2 The evidence is derived from studies using supplements at a dose of 200 g/day.
3 The evidence is derived from studies using supplements at 200 g/day. Selenium is toxic at high doses.
4 The evidence is derived from studies using supplements at a dose of 25 000 international units/day.
5 Applies only to squamous cell carcinoma.
6 The evidence is derived from studies using supplements at a dose of 200 g/day. Selenium is toxic at high doses.
7 The evidence is derived from studies using supplements (at doses of 20, 30, 50 mg for prostate, and doses of 30, 50 mg/day for skin), and foods containing
beta-carotene: see chapter 4.2.
For an explanation of all the terms used in the matrix, please see chapter 3.5.1, the text of this section, and the glossary.
Nutritional science conventionally divides foods and The Panel judges as follows:
drinks into their chemical constituent parts, such as water, The evidence that high-dose beta-carotene supplements
carbohydrates, fats, proteins, vitamins, and minerals. are a cause of lung cancer in tobacco smokers is
Their biological functions are then explored, singly or in convincing. There is limited evidence suggesting that high-
combination. It is now increasingly agreed by the nutrition dose retinol supplements are a cause of lung cancer in
science community that research and also public health tobacco smokers.
can additionally benefit from a more integrated approach, Calcium probably protects against colorectal cancer. At
in which the emphasis is placed on foods and drinks. In specific doses, selenium probably protects against prostate
this Report, the evidence, its summaries, and the Panels cancer.
judgements are food-based, wherever possible. It is unlikely that beta-carotene has a substantial effect
Here, the evidence on macronutrients, micronutrients on the risk of either prostate cancer or non-melanoma
(isolated in the form of supplements), and bioactive skin cancer.
constituents of plant foods (also known as There is limited evidence suggesting that retinol at
phytochemicals) is summarised and judged. specific doses protects against squamous cell carcinoma of
Overall, the Panel judges that the evidence that dietary the skin. There is also limited evidence suggesting that
macronutrients specifically affect the risk of cancer is alpha-tocopherol protects against prostate cancer, and that
unimpressive. The evidence, based on observational data selenium at specific doses protects against colorectal and
and randomised controlled trials of supplements, that lung cancer. There is limited evidence suggesting that
certain vitamins and minerals affect the risk of specific selenium supplements are a cause of skin cancer.
cancers is, in some cases, impressive. Within the remit of this Report, the strongest evidence,
179
P A R T 2 E V I D E N C E A N D J U D G E M E N T S
corresponding to judgements of convincing or probable, maries and judgements of the evidence on dietary fibre, vit-
shows that high-dose beta-carotene supplements in amins, minerals, and trace elements as contained in foods,
tobacco smokers are a cause of lung cancer; that calcium and also on fats, oils, sugars, salt, and alcohol as foods. Also
probably protects against colorectal cancer; and that see chapters 4.1 to 4.8. This section is concerned with macro-
selenium probably protects against prostate cancer. It is nutrients and micronutrients as such, and with non-nutrient
unlikely that beta-carotene, or foods containing it, have a bioactive constituents of food (phytochemicals).
substantial effect on the risk of either prostate or skin
(non-melanoma) cancer. The Panel emphasises that this
evidence and these judgements relate to these 4.10.1 Macronutrients
micronutrients only at the specified doses.
Chemically, macronutrients are classified as carbohydrates,
fats, and proteins, and these categories have many sub-
Nutrition science in its conventional form as a biological dis- classifications. Diets need to include adequate amounts
cipline was created in the early 19th century following the of macronutrients for physical and mental growth and devel-
identification of carbohydrates, fats, and proteins. As nutri- opment, and for maintenance of normal tissue structure and
ents, these all supply energy and are essential for tissue struc- function. All macronutrients supply energy. Alcohol also
ture and function, and physical and mental growth and supplies energy, but there is no requirement for it. Also see
development. Later research has divided these macronutri- chapter 4.8.
ents into many constituent parts such as monosaccharides
and polysaccharides (including non-starch polysaccharides 4.10.1.1 Carbohydrates
or dietary fibre); saturated and unsaturated fatty acids Carbohydrates consist of monosaccharide sugars, or larger
(which themselves have many fractions); and amino acids. molecules of these units joined together: disaccharides (two
Many of these constituents of the main nutrients are known units), oligosaccharides (a few), or polymers (many). For
to have different metabolic, physiological, biochemical, and instance, glucose is a monosaccharide and starch is a poly-
other effects, in isolation or combination. mer of glucose units. Polysaccharides are sometimes called
Beginning in the early 20th century, a series of substances complex carbohydrates and sugars simple carbohydrates.
that do not supply energy were identified also as being vital Carbohydrates are generally the largest single source of
to life, typically in very small amounts: these are vitamins, energy in diets. They supply around 4 kilocalories per gram.
minerals, and trace elements. More recently a large number They form part of important structural components in the
of other substances that are not nutrients, in the sense of body and, in the form of glucose, are the principal and pre-
being essential components of metabolic processes or cell ferred energy source for metabolism. They also play major
structure, have been identified as bioactive. Because these roles in several essential cellular and physiological process-
are contained in plants, they are commonly known as es. Non-starch polysaccharides are the characterising feature
phytochemicals. of dietary fibre.
Reports concerned with specifying recommended dietary Glycaemic index and glycaemic load are terms used to
(or daily) amounts or reference values for nutrients, by their characterise foods and diets based on their effects on blood
nature, are structured accordingly. Compilations of the chem- glucose levels. Also see box 4.1.3 in chapter 4.1.
ical composition of foods, used as standard references in epi- Cereals (grains) and products made from them (such as
demiological studies of food, nutrition, and the risk of breads, pastas, and breakfast cereals), as well as starchy roots
diseases including cancer, also specify macro- and micro- and tubers, are all high in carbohydrates. These foods con-
constituents of foods and drinks, to varied degrees of com- tain a mixture of complex and simple carbohydrates and
pleteness and accuracy. other nutrients. Until recently, starches have been the main
Reports concerned with nutritional deficiencies charac- source of carbohydrate in human diets. With industrialisa-
teristically make recommendations for the relevant micro- tion and urbanisation, sugars have been added in increas-
constituents. Increasingly though, they often now make ing quantities in food preparation and as an ingredient in
recommendations for dietary patterns, diets, and foods and processed foods. Diets consumed in some high-income
drinks that are high in the microconstituents with which they countries now may contain roughly as much carbohydrate
are concerned. So a report on vitamin A deficiency may spec- in the form of sugars as they do starches. Diets high in com-
ify foods high in carotenoids and retinol, and may also rec- plex carbohydrates are usually associated with lower preva-
ommend methods of agriculture that emphasise such foods. lence of obesity, heart disease, and type 2 diabetes.
Reports concerned with prevention of chronic diseases were For summaries and judgements on dietary fibre, see chap-
initially structured in terms of dietary constituents, with only ter 4.1. For summaries and judgements on sugars, see
secondary reference to foods. But following a general inter- chapter 4.6. For food processing, see chapter 4.9.
national agreement that food-based dietary guidelines are
more useful, and often better reflect the science, such reports 4.10.1.2 Fat
now give more emphasis to foods and drinks, both in their Fats in diets are mostly made up from triglycerides three
analysis of evidence and in their recommendations. fatty acid molecules attached to a glycerol backbone.
The policy of this Report is to always emphasise foods and Triglycerides are lipids, a class of organic compounds char-
drinks. Thus, earlier sections of this chapter include sum- acterised by their solubility in organic solvents (such as ether
180
C H A P T E R 4 F O O D S A N D D R I N K S
and chloroform); they are usually insoluble in water. The ed into their constituent amino acids, which are then
body stores excess energy as lipids in the form of body fat absorbed into the blood. The body has the ability to make
(also known as adipose tissue). Lipids also form part of the some amino acids, but others, so called essential amino
structural components of cellular membranes as well as acids, must be obtained from foods and drinks.
being precursors of important hormones. Dietary sources of protein include meats, milk and
Dietary fats include solid fats and liquid oils. Their phys- cheese, pulses (legumes), nuts, and cereals (grains) and
ical form at a particular temperature is determined by the products made from them, such as breads. Animal proteins
chemical structure of their constituent fatty acids. Fats with from eggs, milk, and meat contain all the essential amino
a high proportion of saturated fatty acids are solid or semi- acids in the proportions needed by humans; soya protein is
solid at ambient temperatures; those with a higher amount the only plant food to do so. Other plant protein sources have
of unsaturated fatty acids are more likely to be oils. The dif- differing proportions of various essential amino acids, so
ferent degrees of saturation produce various effects in the diets without animal foods or soya need to include a vari-
body. Diets high in saturated fatty acids (and also trans-fatty ety of plant protein sources to provide enough of the essen-
acids) (see chapter 4.5 and box 4.5.1) increase circulating tial amino acids.
blood concentrations of cholesterol and the risk of cardio- For summaries and judgements on foods that contain
vascular disease. The World Health Organization recom- proteins, see chapters 4.1, 4.2, 4.3, and 4.4.
mends limiting total fat to between 15 and 30 per cent of
total daily energy intake and saturated fatty acids to less than
10 per cent.1 4.10.2 Micronutrients
Fats are the most concentrated energy source, supplying
around 9 kcal per gram. They also carry the fat-soluble vit- Micronutrients are essential constituents of diets needed in
amins (see chapter 4.10.2.1). The body can make all but two small quantities compared with macronutrients, and are not
of the fatty acids it needs linoleic acid and alpha-linolenic sources of energy. These are vitamins, minerals, and trace
acid, known as the essential fatty acids. Both are found in elements. Deficiency of any dietary constituents classified as
vegetables, nuts, and seeds and their oils, in varying quan- a micronutrient causes debility, disease, and eventually
tities. They are also found in meat, eggs, and dairy products, death.
but at lower levels. The long-chain fatty acids found in oily Many processed foods are fortified with synthetic vita-
fish (eicosapentaenoic and docosahexaenoic acids) can be mins and minerals (box 4.10.1). Others contain various
made to a limited extent in the body, where they play a role microconstituents such as phytochemicals, and sometimes
in inflammation.2 These and related fatty acids are precur- other ingredients such as bacteria and prebiotic polysac-
sors to prostaglandins; these hormone-like compounds have charides; these products are sometimes termed functional
other diverse effects, including roles in blood vessel dilation foods (box 4.10.2). Both types of product are often marketed
and constriction, blood clotting, and transmission of nerve with health claims relating to these added constituents or to
impulses. the whole food.
Nuts, seeds, meat, oily fish, whole milk and dairy prod-
ucts, cooking oils and fats, spreadable fats, and a wide range 4.10.2.1 Vitamins
of manufactured foods all contain varying amounts and types Vitamins are organic molecules, classed as fat- or water-
of fats. Those from animal sources usually have a higher pro- soluble, that are needed for metabolism but cannot be made
portion of saturated fatty acids, and these are common in in the body and so must be supplied in the diet. They have
processed foods. different specific functions in the body. For example, vitamin
For summaries and judgements on fats and oils as foods, K is needed for blood clotting and vitamin C for the pro-
see chapter 4.5. For summaries and judgements on foods duction of collagen in connective tissue.
that are or may be high in fats, see chapters 4.3 and 4.4. Vitamins A (retinol), D, E, and K are fat-soluble and can
only be digested, absorbed, and transported in conjunction
4.10.1.3 Proteins with dietary fats. So they are found mainly in fatty foods
Proteins are large organic molecules made up of amino acids such as liver and oily fish, milk and dairy products, animal
arranged in a chain. Short chains are called peptides, for fats (such as butter), and vegetable oils. The main sources
instance di- and tripeptides (made up of two and three of vitamin A are plant foods containing the retinol precur-
amino acids respectively). Longer chains are known as sors known as carotenoids, which are converted by the body
oligopeptides, and long chains as polypeptides. Proteins are to retinol (see box 4.2.1 in chapter 4.2). Preformed retinol,
fundamental structural and functional elements within every which is absorbed better than carotenes in plant foods, is
cell in the body. found only in animal products, of which liver is a particu-
Many proteins are enzymes that catalyse biochemical reac- larly rich source. Fat-soluble vitamins are stored in the liver
tions and are vital to metabolism. Others have structural or and in body fat stores. For this reason, they do not need to
mechanical functions, such as the proteins in the cytoskele- be consumed every day. For the same reason, some are toxic
ton, which give cells their shape and strength. They are also in high doses.
important in cell signalling, immune responses, cell adhe- Vitamin C and the B vitamins are water-soluble. The B
sion, and the cell cycle. group includes thiamin (vitamin B1), riboflavin (B2), niacin
Proteins supply around 4 kcal per gram. They are digest- (B3), pyridoxine (vitamin B6), biotin, pantothenic acid,
181
P A R T 2 E V I D E N C E A N D J U D G E M E N T S
182
C H A P T E R 4 F O O D S A N D D R I N K S
183
P A R T 2 E V I D E N C E A N D J U D G E M E N T S
4.10.6.4.1 Retinol The single RCT was the Beta-Carotene and Retinol
Skin Efficacy Trial (CARET) trial (table 4.10.2) among current
Two RCTs investigated retinol supplements and skin cancer and former smokers (some of whom were asbestos workers)
(table 4.10.1).4 5 who were given retinyl palmitate and beta-carotene, or
Both trials included only participants at risk of develop- placebo. It showed statistically significant increased risk of
ing non-melanoma skin cancer. The retinoid skin cancer pre- all lung cancers in the treated subjects, with an effect esti-
vention (actinic keratoses) trial (SKICAP-AK) included mate of 1.28 (95% CI 1.041.57). The risk of death from
people with a history of precancerous lesions (actinin ker- lung cancers was 1.46 (95% CI 1.072.00).9 The risk was
atoses); the retinoid skin cancer prevention (squamous cell especially elevated in those who had the intervention as well
carcinoma/basal cell carcinoma) trial (SKICAP-S/B) includ- as exposure to either asbestos or heavy smoking, although
ed people with a history of non-melanoma skin cancer. SKI- neither subgroup analysis was statistically significant. At
CAP-AK showed non-significant increased risk for basal cell follow-up (5 years after trial termination), the effect was
carcinoma, with an effect estimate of 1.14 (95% confidence reduced and no longer statistically significant, with an effect
interval (CI) 0.911.43), but it did show a statistically sig- estimate of 1.12 (95% CI 0.971.31).8
nificant decreased risk for squamous cell carcinoma 0.68 The other trial, which was not randomised, gave retinol
(95% CI 0.510.92), comparing intervention to placebo.5 or beta-carotene to asbestos-exposed people and used a
SKICAP-S/B produced no evidence of effect for either basal matched comparison group, giving an adjusted effect esti-
cell carcinoma (106 cases intervention group: 110 cases mate of 0.67 (95% CI 0.331.37).11
placebo group) or squamous cell carcinoma (41 cases each One cohort study was stratified according to smoking sta-
in intervention and placebo group).4 tus (current, former, and never).12 In current smokers, high-
Meta-analysis was possible on both trials, giving summary dose vitamin A supplements (synthetic beta-carotene or
effect estimates of 1.10 (95% CI 0.901.34) for basal cell car- retinol) were associated with an increased risk, with an effect
cinoma and 0.93 (95% CI 0.701.23) for squamous cell estimate of 3.42 (with no CI or value for trend reported),
carcinoma. when compared to no supplements. Men who never smoked
The mechanism of anti-tumour action of the retinoids is showed a non-significant decreased risk.12 The other cohort
not completely known but retinol is known to bind to cell study showed no effect on risk for men and non-significant
receptors with promotion of differentiation, alteration of decreased risk in women. Effect estimates were 1.0 (95% CI
membranes, and immunological adjuvant effects.6 0.661.51) for men and 0.65 (95% CI 0.391.06) for
women, when comparing supplement use to non-use.13 One
The evidence is sparse and studies were conducted on case-control study showed a non-significant increased risk
a narrowly defined population group (people at risk of with supplement use,14 the other showed no effect on risk.15
developing skin cancer). There is limited evidence It is possible that the potential protective associations pre-
suggesting that retinol supplements protect against sent at dietary intake amounts of vitamins are lost or
squamous cell skin cancer. reversed by pharmacological supplementation and the high-
er levels that this may supply.
The Panel is aware that since the conclusion of the SLR, one
case-control study7 has been published. This new information The evidence is sparse and inconsistent. There is
does not change the Panel judgement (see box 3.8). limited evidence suggesting that high-dose retinol
Lung
Two trials (one an RCT, the other a non-randomised trial),8-11 Table 4.10.2 Vitamin A supplements and
two cohort studies,12 13 and two case-control studies14 15 lung cancer; trials
investigated retinol or vitamin A supplements and lung
Trial Number of Intervention Length of Length of
cancer (table 4.10.2). name participants intervention follow-up
184
C H A P T E R 4 F O O D S A N D D R I N K S
185
P A R T 2 E V I D E N C E A N D J U D G E M E N T S
Table 4.10.4 Beta-carotene supplements and Table 4.10.5 Beta-carotene supplements and
prostate cancer; trials skin cancer; trials
Trial Number of Intervention Length of Length of Trial Number of Intervention Length of Length of
name participants intervention follow-up name participants intervention follow-up
Beta- 18 314 at 30 mg beta- 4 years 5 years Nambour 1621 Four treatment 4.5 years
Carotene high risk of carotene and (trial ended Skin Cancer groups: daily
and Retinol developing 25 000 IU early) Prevention application of
Efficacy lung cancer retinyl palmitate Trial sunscreen and
Trial Green 1999 beta-carotene
(CARET) supplementation
Omenn 1996 (30 mg per day);
Goodman sunscreen plus
placebo tablets;
2004
beta-carotene only;
Physicians 22 071 50 mg beta- 13 years or placebo only
Health carotene taken
Beta- 1805 (with 50 mg daily 5 years 15 years
Study (PHS) on alternate days
Carotene history of
Cook 2000
Trial non-melanoma
ATBC Study 29 133 20 mg of beta- 58 years 68 years Greenberg skin cancer)
(male carotene only or 1990
smokers) with 50 mg of
Physicians 22 071 50 mg beta- 12 years
Virtamo 2003 alpha-tocopherol
Health Study carotene taken
Heinonen 1998
(PHS) on alternate days
Frieling 2000
Hennekens
Prostate 1999
See also chapter 4.2.5.3 for evidence on foods containing Womens 39 876 50 mg of beta- 2 years 4 years
beta-carotene. Three RCTs9 10 16 18 26 and two cohort studies27 Health Study carotene taken
(WHS) on alternate days
28
investigated beta-carotene supplements (table 4.10.4).
Lee 1999
Two trials showed a non-significant increased risk for beta-
carotene supplementation compared to none9 10 16; the other
showed no effect on risk.18 Effect estimates were 1.26 (95%
CI 0.981.62) for the 1985 to 1993 follow-up period,16 1.01 summary effect estimate of 1.00 (95% CI 0.941.07) for
(95% CI 0.801.27),9 10 and 1.0 (95% CI 0.91.1).18 basal cell carcinoma and 1.01 (95% CI 0.951.06) for squa-
One cohort study showed a non-significant increased risk mous cell carcinoma.
for beta-carotene supplementation compared to none27; The single cohort study showed a non-significant
the other stated that there was no significant association.28 decreased risk for beta-carotene supplementation compared
The single reported effect estimate was 1.17 (95% CI to none. The effect estimate was 0.42 (95% CI 0.121.47).33
0.851.61).27
There is no evidence for any mechanism of action.
Figure 4.10.2 Beta-carotene supplements and non-
There is strong evidence from good quality trials, and melanoma skin cancer; trials
from cohort studies, which consistently fails to
demonstrate a protective effect. Beta-carotene Relative risk (95% CI)
186
C H A P T E R 4 F O O D S A N D D R I N K S
There is strong evidence from good quality trials that Wu 2002 Men 0.70 (0.431.14)
consistently fail to show an effect. It is unlikely that McCullough 2003 Men 0.60 (0.331.10)
beta-carotene has a substantial effect on the risk of McCullough 2003 Women 0.73 (0.301.76)
4.10.6.4.3 Alpha-tocopherol
Prostate
0.2 0.5 1 2 5
One RCT investigated alpha-tocopherol supplements and
Relative risk, highest vs lowest exposure category
prostate cancer (table 4.10.6).16 26
Adenomas
Table 4.10.6 Alpha-tocopherol supplements and Two RCTs showed decreased risk of adenomas with calcium
prostate cancer; trials supplementation,44-48 which was statistically significant in
one.44-47 Effect estimates were 0.81 (95% CI 0.670.99; 1200
Trial Number of Intervention Length of Length of mg calcium; adenoma incidence)44 and 0.66 (95% CI
name participants intervention follow-up
0.381.17; 4 g calcium; adenoma recurrence).48
ATBC Study 29 133 20 mg of beta- 58 years 68 years One additional trial showed a reduced risk of new ade-
(male carotene only or noma growth during a 3-year intervention of a daily mix-
smokers) with 50 mg of ture of beta-carotene 15 mg, vitamin C 150 mg, vitamin E
Virtamo 2003 alpha-tocopherol
75 mg, selenium 101 g, and calcium (1.6 g daily) as car-
Heinonen 1998
bonate (p value 0.035), though with no statistically signifi-
cant effect on the growth of pre-existing adenomas.49
Three cohort studies showed decreased risk with calcium
supplementation,50-52 which was statistically significant for
one.50 One study reported no significant association.53 Meta-
187
P A R T 2 E V I D E N C E A N D J U D G E M E N T S
Table 4.10.7 Selenium supplements and Table 4.10.9 Selenium supplements and
prostate cancer; trials skin cancer; trials
Trial Number of Intervention Length of Length of Trial Number of Intervention Length of Length of
name participants intervention follow-up name participants intervention follow-up
NPC Trial 974 men 200 g Mean Mean NPC Trial 1312 200 g Mean Mean
Clark 1998 with a selenium 4.5 years 6.5 years Combs 1997 people with selenium 4.5 years 6.4 years
Duffield- history of daily (primary Clark 1996 a history of daily (primary
Lillico 2003 non-melanoma endpoint was Duffield- non-melanoma endpoint was
skin cancers skin cancer) Lillico 2002 skin cancers skin cancer)
188
C H A P T E R 4 F O O D S A N D D R I N K S
squamous cell carcinoma and 1.10 (95% CI 0.951.28) for however, plausible that supraphysiological amounts of
basal cell carcinoma.61 selenium might affect programmed cell death, DNA repair,
The single cohort study stated that there was no statisti- carcinogen metabolism, immune system, and anti-angio-
cally significant association.33 genic effects.65
189
P A R T 2 E V I D E N C E A N D J U D G E M E N T S
190
C H A P T E R 4 F O O D S A N D D R I N K S
tioned here in this context. For evidence and judgement on including India, Sri Lanka, Thailand, Cambodia, Vietnam,
lactation, see Chapter 6; on being breastfed in relation to China, and Korea.
weight gain, overweight, and obesity, see Chapter 8. Such traditional Asian dietary patterns are of low energy
density. The staple cereal (grain) is usually rice, which is also
usually the main source of energy. Traditionally, rice paddy
4.11.1 Traditional and industrial dietary is often also used to breed fish. The amounts of vegetables,
patterns fruits, and fish in diets vary; consumption is relatively low
in impoverished communities, and often high in those that
Dietary patterns are determined by many factors. This first are more prosperous. In the more affluent centres of civili-
group includes some traditional and industrial dietary pat- sation, traditional Indian and Chinese cuisines have been
terns, determined mainly by climate and terrain, material and often remain extremely diverse. But they are almost
resources, technology, and culture. always made up mainly from foods of plant origin, again
with very extensive use of herbs and spices. As in the
4.11.1.1 Mediterranean Mediterranean region, large amounts of meat are usually
The traditional food systems of the territories on or near the reserved for special occasions. Japan is a maritime nation,
Mediterranean littoral, in southern-most Europe, the Middle and so the traditional dietary pattern is high in fish and
East, and northern-most Africa, are the fount of a number seafood and in salt and salt-preserved foods. The maritime
of great cuisines. These were developed by peoples, often regions of other Asian countries have the same dietary pat-
from the East, who settled in successive waves within what terns. Traditionally, most alcoholic drinks consumed in Asia
is now Spain, southern France and Italy, former Yugoslavia, are made from grains. Most foods are cooked at low tem-
Greece, Turkey, Cyprus, Crete, Lebanon, Israel, Palestine, peratures (steaming, boiling), although some high-temper-
Egypt, Libya, Algeria, Tunisia, and Morocco. The Med- ature methods are also used (stir-frying, deep-frying,
iterranean dietary patterns that have since evolved general- roasting). Tea is the traditional hot drink in China, India, Sri
ly have some common aspects. Lanka, and Japan. Consumption of fat and sugars is tradi-
Traditional Mediterranean diets are broadly characterised tionally low.
by high consumption of breads and other cereal foods usu- As with Mediterranean dietary patterns, and probably for
ally made from wheat, and of vegetables and fruits, fish, broadly the same nutritional reasons, traditional southern
cheese, olive oil, tree nuts (almonds and walnuts), and (in and eastern Asian dietary patterns are associated with rela-
non-Islamic countries) wine. Extensive use is made of many tively low rates of obesity, type 2 diabetes, coronary heart
herbs and spices. Meat is also consumed, but often only on disease, and some cancers. However, those that are high in
relatively special occasions or in small amounts in combi- salt are associated with elevated rates of hypertension and
nation with other foods in everyday dishes. Coffee, drunk stroke. Traditional Asian dietary patterns remain the norm
with added sugar (in modern times), is the traditional hot in rural and impoverished regions of southern and eastern
drink. Desserts may also be sweet but overall consumption Asia, but are now gradually becoming increasingly western
of sugar is low. or globalised in the urban and more prosperous parts of
Since the second half of the 20th century, much attention these countries.
has been given to the Mediterranean diet. This interest is These generalisations do not apply to the countries of
because of evidence associating the dietary patterns of the northern Asia, including those of the former USSR.
populations living in this region with low incidence of coro-
nary heart disease.4 It is usually thought that this associa- 4.11.1.3 Plant-based
tion is causal, and that the reasons include high consumption Plant-based diets are mainly but not necessarily solely made
of fresh foods, dietary fibre, vegetables, fruits, and fish; mod- up from foods of plant origin. Characteristically, cereals
est consumption of alcoholic drinks; and low intakes of sat- (whole or minimally processed grains) and other starchy
urated fatty acids. In addition, historically, habitual levels of foods, vegetables and fruits, pulses (legumes), herbs and
physical activity have been high. spices, plant oils, and other foods and ingredients of plant
Recommendations published since the early 1980s on origin are the basis of almost all everyday foods and meals.
food, nutrition, and the prevention of cancer have similari- Meat, poultry, fish, milk and dairy products, animal fats, and
ties with those for the prevention of coronary heart disease. other foods and ingredients of animal origin are consumed,
Mediterranean dietary patterns might therefore also be pro- usually in small amounts on normal days, but often abun-
tective against cancer, either generally or of specific sites. dantly on special and feast days. Consumption of alcoholic
Traditional Mediterranean dietary patterns are gradually drinks is also usually reserved for special social occasions.
becoming less common as the food supplies of the countries It is estimated that the dietary patterns of most of the
of the Mediterranean littoral become increasingly western worlds population perhaps around 4 billion people are
or globalised. plant-based. Traditional Mediterranean and southern and
eastern Asian dietary patterns (summarised above) are plant-
4.11.1.2 Asian based, as are the dietary patterns of most rural communi-
Traditional Asian cuisines are very diverse. But traditional ties in middle- and low-income countries. Most populations
Asian dietary patterns do have some qualities in common, that consume plant-based diets do not do so from choice, but
certainly those of southern and eastern Asian countries because for them, animals are valuable and animal foods are
191
P A R T 2 E V I D E N C E A N D J U D G E M E N T S
relatively costly. In some traditions (see chapters 4.11.1.1 4.11.2 Cultural dietary patterns
and 4.11.1.2), plant-based or vegetarian diets are consumed
as an expression of philosophy of life or of religion. These These dietary patterns are strongly influenced by cultural
cultures, teachings, or faiths often also include periodic peri- factors. These include ethical and religious beliefs, and
ods of fasting. beliefs about health. The distinction is somewhat arbitrary:
The nutritional profiles of plant-based dietary patterns are these patterns are also influenced by climate and terrain,
very variable, depending largely on the degree of variety of material resources, and technology.
the foods consumed, though their energy density is gener-
ally low. Traditional plant-based cuisines from all over the 4.11.2.1 Vegetarian and vegan diets
world combine cereals (grains) and other starchy foods with Plant-based dietary patterns need not be vegetarian, except
beans and other pulses (legumes) as the staple foods. When in a loose sense; but vegetarian diets are generally plant-
food supplies are secure they are generally adequate in ener- based. The distinction is more one of attitude than nutri-
gy, and also in protein, unless reliant on very low-protein tional profile. Typically, vegetarians are at least as concerned
starchy staples such as cassava (manioc). Plant-based diets about the ethics and environmental effects of consuming
may be of relatively low energy density, but not necessarily (and producing) animal foods as they are with their own
so. Most of the fatty acids in plant-based diets are unsatu- well-being and protection against disease.
rated. Levels of vitamins, minerals, trace elements, and phy- There are many types of vegetarian dietary patterns, and
tochemicals vary, again depending on the degree of variety all exclude red meat and processed meat made from red
in diets. meat. However, people whose intention is to be vegetarian
Obesity, type 2 diabetes, coronary heart disease, cancers may occasionally eat these meats; and many if not most will
of some sites, and other chronic diseases have been rare or consume some foods containing ingredients derived from
uncommon in those parts of the world where traditional animals that supply red meat, perhaps inadvertently.
dietary patterns are plant-based. Such diets are now com- Lacto-ovo vegetarians consume milk and dairy products
monly advocated and consumed by health-conscious people and also eggs. Vegans consume no foods of animal origin,
in high-income countries, partly on this basis. These diets are although some are stricter than others about what they eat.
also increasingly popular because of the epidemiological and People who avoid red meats may consume poultry and fish,
other evidence that components of plant-based dietary pat- and are sometimes termed semi-vegetarian. The dietary
terns are potentially protective against various chronic dis- practices of a number of religions are plant-based or vege-
eases including some cancers. tarian. Hindus are often vegetarian. Jains are vegan.
Rastafarians are semi-vegetarian. Zen macrobiotic food is
4.11.1.4 Western mostly vegetarian, although the main emphasis is on whole
The dietary patterns sometimes classified as western have foods. For Seventh-day Adventists, see chapter 4.11.5.5.
been generated by industrialised food systems, at first in Taken together, vegetarian dietary patterns are heteroge-
western Europe, then in the USA. These patterns have also neous, as is the nutritional profile of most types of vegetar-
evolved in countries settled mostly by British and western ian diets. Studies of some vegetarians have identified lower
European peoples, including those of the white populations rates of obesity and cardiovascular disease, and all-cause
of South Africa, Australia, New Zealand, and enclaves else- mortality. But people who are the subjects of such studies in
where in the world. This broad generalisation does not apply high-income countries, who are vegetarian as a matter of
to some countries of Latin America, but in general represents belief or choice, are frequently of higher socioeconomic sta-
the emerging dominant pattern observed in urban centres of tus compared with the general population. They are also less
the region. likely to smoke and more likely to be physically active (also
Western dietary patterns are energy dense, and are see chapter 4.11.5.4).
increasingly made up from processed foods.5 They are high
in meat, milk and other dairy products, fatty or sugary foods 4.11.2.2 Religious
such as processed meats, pastries, baked goods, confec- Seventh-day Adventists are a Christian denomination of
tionery, sugared and often also alcoholic drinks, with vari- about 14 million people who, among other ways of life as
able amounts of vegetables and fruits. The starchy staple part of their faith, are sparing in their consumption of meat
foods are usually breads, cereal products, or potatoes. A fea- and meat products; about half are lacto-ovo vegetarians.
ture of the global nutrition transition (see chapter 1.2.1) is Most avoid hot condiments and spices, tea and coffee, and
that western dietary patterns are becoming exported glob- alcoholic drinks. Smoking is proscribed. The effect of
ally with accelerating speed. Seventh-day Adventist ways of life on well-being and health
Western diets defined in this way are associated with has been the subject of a large number of studies. Rates of
overweight and obesity, type 2 diabetes, cardiovascular dis- chronic diseases are generally lower among Adventists, and
ease, stroke, some cancers, and other chronic diseases. this is usually attributed to be their generally healthy ways
However, the term western diet is potentially confusing: of life.
variations of such diets consumed within western countries Several other religions enjoin their adherents to refrain
can and do have very different nutritional profiles. from consumption of certain foods or beverages for
instance, Islam forbids consumption of pork and alcohol,
Judaism pork and other foods, and Hinduism beef.
192
C H A P T E R 4 F O O D S A N D D R I N K S
4.11.2.3 Healthy vary substantially; different types of diets are termed vege-
People who are conscious of the effects of food and nutri- tarian; and there are various types of Mediterranean diet.
tion on well-being, and on the risk of disease, may choose In general, there is considerable scope for variation within
to consume healthy diets. Such diets are featured in very any dietary pattern.
many popular television programmes, newspapers, maga-
zines, and books. However, there are as many healthy Confounding. Patterns of diet are interrelated with other
dietary patterns as there are concepts of what constitutes a habitual behaviour that may affect the risk of cancer, such
healthy diet; and for many people a healthy diet is seen as as smoking or physical activity; people who habitually con-
a diet regime designed to reduce excess body fat. In the USA, sume any type of diet for the sake of their health or for rea-
the Healthy Diet Indicator6 and also the Healthy Eating sons of belief, may also modify other aspects of their way of
Index are used to assess how well people adhere to the life. This is likely to confound results that appear to show
Dietary Guidelines for Americans. associations with the risk of cancer.
193
P A R T 2 E V I D E N C E A N D J U D G E M E N T S
meat, fish, and olive oil) was associated with a reduced risk factor analysis was a Japanese study looking at gallblad-
of recurrence of colorectal adenomas in women (RR 0.30 der/biliary tract cancer mortality using data collected
(95% CI 0.090.98), but not in men. 8 between 1958 and 1975.16 Western-style diets high in foods
with high levels of fats and proteins were associated with
4.11.5.2 Asian dietary patterns decreased risk. For breast cancer mortality in Japan, anoth-
A Japanese cohort study9 showed significant associations er ecological study found that westernised diets high in both
between certain dietary patterns and the risk of stomach can- animal and saturated fats were associated with increased
cer. These were for a traditional Japanese dietary pattern risk.17
in men (RR 2.88, 95% CI 1.764.72) and in women (RR Another Japanese cohort study showed no association
2.40, 95% CI 1.764.72); and for a healthy dietary pattern between a western dietary pattern and stomach cancer risk.9
in women (RR 0.56, 95% CI 0.320.96) but not in men. For colon cancer risk in the same Japanese cohort, western
There was no association found with the western dietary as well as traditional dietary patterns were associated with
pattern. In the same Japanese cohort,10 traditional and increased colon cancer risk in women, RR 2.06 (95% CI
western dietary patterns were both positively associated 1.103.84) and RR 2.06 (95% CI 1.104.45) respectively,
with colon cancer risk in women, but not in men: traditional but not in men.10
RR 2.06 (95% CI 1.103.84) and western RR 2.06 (95% CI Three dietary patterns were identified from analysis of a
1.104.45). Swedish cohort: healthy, including wholegrains, vegetables,
The narrative review did not identify any other studies on fruits, tomatoes, poultry, and fish; western, including
Asian dietary patterns and the risk of cancer. refined grains, fried potato, meat, processed meat, high-fat
For evidence and judgements on salt, salting, and salted dairy products, margarine/butter, sweets and soft drinks;
food, and the risk of stomach cancer, see chapter 4.6 and and drinker, including beer, wine, spirits, and snacks. The
chapter 7.5. only pattern significantly associated with increased risk of
renal cell carcinoma was the drinker pattern (RR 0.56, 95%
4.11.5.3 Western dietary patterns CI 0.340.95).18
The narrative review identified several studies that have used An analysis of the Nurses Health Study cohort also
data from large cohorts, mostly undertaken in the USA, to showed no evidence of an association between breast can-
derive various types of western dietary patterns from cer risk and either a prudent or a western dietary pattern.19
dietary intake information. This is done by combining key Similarly, no associations were reported between these
components of diets into what is then identified as types of dietary patterns and pancreatic cancer in a US cohort study.20
dietary pattern that may be related to the risk of cancer risk. Two western dietary patterns were identified from a US
Some case-control and ecological studies have also been car- cohort. These were a prudent type, characterised as being
ried out. high in wholegrains, vegetables, fruits, low-fat dairy prod-
Analysis of data from the Health Professionals Follow-Up ucts, poultry, and fish; and a typical type, characterised as
Study found no association between a western dietary pat- being high in refined cereals (grains), red and processed
tern and prostate cancer risk. In the study, this pattern was meats, high-fat dairy products, sweets, and desserts. Neither
characterised as being high in refined cereals (grains), red was associated with overall breast cancer risk. However,
and processed meats, fat, and sweets.11 Similarly, for breast the typical western pattern was associated with higher risk
cancer, another large cohort study reported no association of breast cancer among smokers (RR 1.44, 95%
between a western dietary pattern and breast cancer risk.12 CI 1.022.03).21
A drinker dietary pattern, characterised as being high in A Canadian case-control study identified an association
beer, wine, and spirits, was identified as being associated between prostate cancer risk and a processed dietary pat-
with a moderately increased risk of breast cancer (RR 1.27, tern, characterised as being high in refined cereals (grains),
95% CI 1.061.52). white bread, onions and tomatoes, red meat, processed meat,
A case-control study from Uruguay reported an association organ meats, vegetable oil and juice, soft drinks, and bottled
with increased breast cancer risk and a western diet; asso- water. No significant associations were found with healthy
ciations with decreased risk were found for traditional, living, traditional western, or beverages patterns.22
stew, and healthy dietary patterns.13 Another case-control A case-control study conducted in central Italy identified
study from Uruguay reported an association with increased a vitamin-rich as well as a traditional dietary pattern; both
stomach cancer risk and a starchy pattern; associations with were strongly associated with decreased risk of stomach
decreased risk were found for healthy and mixed patterns.14 cancer.23
A Swedish case-control study found that a diet high in For colon cancer, a case-control study reported a protec-
meat, red meat, high-fat dairy products, high-fat gravy, and tive effect of a prudent western dietary pattern and
sweets was significantly associated with increased risk of gas- increased risk with a typical western pattern.24 Another
tric cardia adenocarcinoma and oesophageal adenocarcino- reported a protective effect of a western physical activity
ma. It also found that a drinker pattern (high intakes of pattern.25
beer, spirits/liquor, and French fries) was significantly asso- Analysis of data from the French European Prospective
ciated with the risk of squamous cell carcinoma of the Investigation into Cancer and Nutrition (EPIC) cohort
oesophagus.15 showed a significant association between two western
One of the first studies to investigate diet and cancer using dietary patterns and increased risk of colorectal cancer. The
194
C H A P T E R 4 F O O D S A N D D R I N K S
first, RR 1.39 (95% CI 1.001.94), included cereal products, association with western and western drinker patterns, but
potatoes, processed meat, eggs, cheese, butter, sweets, cakes, an association with decreased risk and a fruits and vegeta-
pizzas and pies, and sandwiches. The second was a drinker bles pattern.34
pattern, RR 1.42 (95% CI 1.101.83), including processed A Canadian case-control study found that four dietary pat-
meat, alcoholic beverages, sandwiches, and snacks. A meat- terns were associated with increased risk of kidney cancer:
eater pattern, including meat, poultry, and margarine, was a dessert pattern in both men and women; a beef pattern
non-significantly associated with increased risk of colorectal and a juices pattern in men; and an unhealthy pattern
cancer, RR 1.58 (95% CI 0.982.53).26 among women.
In an Italian cohort study, four dietary patterns were iden-
tified: western, canteen, prudent, and salad vegetables. 4.11.5.4 Vegetarian dietary patterns
The salad vegetables pattern was associated with lower risk The narrative review identified several studies that have
of breast cancer, (RR 0.66, 95% CI 0.470.95).27 Another US investigated the relationship between vegetarian diets and
cohort study reported no association between either a the risk of cancer. These often did not adjust for potentially
vegetablefish/poultryfruit or a beef/porkstarch pattern confounding factors. One study found that when adjusted for
and postmenopausal breast cancer. But it found a significant age only, women who said they consumed vegetarian diets
association with decreased risk of invasive breast cancer and seemed to increase the risk of breast cancer (1.65, 95% CI
a traditional southern pattern, including legumes, salad, 1.012.7) (vegetarian versus non-vegetarian).35
and a low intake of mayonnaise salad dressing (RR 0.78, Plausible biological mechanisms have been identified by
95% CI 0.650.95).28 which vegetarian diets might specifically reduce the risk of
In the Netherlands Cohort Study on Diet and Cancer, fac- cancers of the colon, breast, and prostate (also see chapter
tor analysis identified five types of western dietary patterns. 4.2). Any effect of vegetarian diets is likely to be due not only
Both the salad vegetables and the sweet foods patterns to the exclusion of meat, but also to the inclusion of a larg-
were associated with decreased risk of lung cancer: RR 0.75 er number and wider range of plant foods, containing an
(95% CI 0.551.01) and RR 0.62 (95% CI 0.430.89), extensive variety of potential cancer-preventive substances.
respectively. The other three patterns were not significantly
associated with lung cancer risk. These were pork, processed 4.11.5.5 Seventh-day Adventist diets
meats, and potatoes, brown for white bread substitution, The SLRs identified a number of cohort studies on the rela-
and cooked vegetables.29 tionship between Seventh-day Adventist diets and also
One study found that associations between dietary pat- general ways of life and the risk of cancer. Two investi-
terns and colorectal cancer were not consistent across gated oesophageal cancer,36 37 seven stomach cancer,37-43 two
European countries. As part of the Dietary Patterns and kidney cancer,37 42 one breast cancer44 and three prostate can-
Cancer (DIETSCAN) project, factor analysis of three cer.37 41 45 For oesophageal, kidney, breast and prostate
European cohorts identified five dietary patterns. Two of cancer, results were mixed and usually not statistically sig-
these, vegetables and pork, processed meats, and potatoes, nificant, although they were slightly suggestive of reduced
were common across all three cohorts. The second dietary risk.
pattern was associated with increased risk of colon cancer For stomach cancer, meta-analysis of five cohort studies37-40
in one cohort of women (RR 1.62, 95% CI 1.122.34), and 42
gave a summary effect estimate of 0.60 (95% CI
with increased risk of rectal cancer in one cohort of men (RR 0.440.80), with low heterogeneity, with non-included stud-
2.21, 95% CI 1.074.57). Neither pattern was associated ies also reporting reduced risks. None of the studies that
with the risk of colorectal cancer in the third cohort.30 reported reduced risk was adjusted for known confounding
For thyroid cancer, a case-control study showed that var- factors such as smoking.
ious western dietary patterns of fruits, raw vegetables, and As not smoking is a feature of Seventh-day Adventism, the
mixed raw vegetables and fruits were associated with Panel concluded that data on the dietary patterns associated
reduced risk of thyroid cancer (RR 0.68, 0.71, and 0.73, with this faith are limited and no conclusion can be reached
respectively). However, a pattern of fish and cooked veg- for any cancer site.
etables was associated with an increased risk (RR 2.79).31 No conclusions can be based on this evidence, because the
Another case-control study showed that a dessert pattern data are too limited and not comparable across studies.
and a beef pattern were associated with increased risk of
kidney cancer. A juices factor was associated with increased 4.11.5.6 Meal frequency
risk of this cancer in men and an unhealthy pattern with The SLRs identified 20 case-control studies46-65 that investi-
increased risk in women.32 gated irregular eating and stomach cancer. All but 1 report-
One case-control study from Uruguay reported an associ- ed increased risk estimates and 15 were statistically
ation with increased risk of oral and pharyngeal cancers and significant. Meta-analysis of 16 case-control studies50-65 gave
a stew pattern, characterised by cooked vegetables, potato a summary effect estimate of 2.76 (95% CI 2.103.64) for
and sweet potato, and boiled meat. It also found a decreased irregular as opposed to regular eating (p < 0.001), but with
risk of these cancers associated with a vegetables and fruits high heterogeneity.
pattern, characterised by raw vegetables, citrus fruits, other However, the reference period was generally some years
fruits, liver, fish, and desserts.33 before cancer diagnosis. Irregular eating can be taken to
A case-control study of pancreatic cancer risk showed no mean frequent snacking or small meals, or missing main
195
P A R T 2 E V I D E N C E A N D J U D G E M E N T S
meals. But none of these studies defined irregular eating or 4.11.7 Conclusions
quantified the frequency with which meals might be
skipped. The Panel concludes:
Eight case-control studies investigated meal frequency and Currently, no firm judgements can be made on any possible
colorectal cancer.66-80 Most showed increased risks with relationship between dietary patterns and the risk of cancer.
increased frequency of meals. Meta-analysis of 11 estimates
from 7 of these studies67-69 76 78-80 gave a summary effect esti-
mate of 1.10 (95% CI 1.021.19), with high heterogeneity.
This evidence is also unclear. No cohort studies have been
identified as examining meal frequency. People who have
stomach or colorectal problems are likely to eat irregularly.
There is also high probability of confounding, as regular eat-
ing patterns are associated with generally healthy behaviour.
The significance of these findings on meal frequency and
stomach and colorectal cancer is unclear, in part because of
the high probability of confounding. For this reason, no
judgement is made.
196
P A R T 2 E V I D E N C E A N D J U D G E M E N T S
C H A P T E R 5
Physical activity
Physical activity is any form of movement using skeletal and mechanised settings throughout the world now lead
muscles. Until very recently in history, people necessarily these sedentary ways of life.
engaged in regular, moderate, and at least occasional Finally, the Panel agrees that the evidence assembled and
vigorous, physical activity. However, with urbanisation and judged in this chapter supports the general hypothesis that
industrialisation, general levels of physical activity have people have evolved and adapted to be physically active
declined. Machines now do most of the work previously throughout life. The Panel also agrees, therefore, that
done by hand; driving and using public transport have sedentary ways of life are unhealthy. It is aware of current
largely replaced walking and cycling. While people in trends and also projections (summarised in Chapter 1)
higher income countries and in urban settings in most showing that average physical activity levels are
countries may engage in some active forms of recreation, continuing to decrease throughout the world.
they remain largely inactive, and many spend much time Within the remit of this Report, the strongest evidence,
in sedentary recreations, such as watching television and corresponding to judgements of convincing and
using home computers. probable, shows that physical activity of all types protects
In general, the Panel judges that the evidence on against cancers of the colon, and also of the breast
physical activity and the risk of cancer, which has (postmenopause) and endometrium.
continued to accumulate since the early 1990s, shows or This chapter does not address the social or
suggests that regular, sustained physical activity protects environmental (or underlying and basic) determinants of
against cancers of some sites. These include colon cancer physical activity and its general decline; this is the subject
and female hormone-related cancers, independently of of an associated report to be published in late 2008.
other factors such as body fatness.
The Panel judges as follows. The evidence that physical
activity protects against colon cancer is convincing.
Physical activity probably protects against postmenopausal
breast cancer; the evidence suggesting that it protects
against premenopausal breast cancer is limited. Physical
activity probably protects against cancer of the
endometrium. The evidence suggesting that physical
activity protects against cancers of the lung and pancreas
is limited.
The Panel is impressed by the overall consistency of the
evidence and concludes that relatively high levels of
physical activity protect, or may protect, against cancers of
the colon, breast (postmenopause), and endometrium. To
prevent these cancers, the overall evidence supports the
message that the more physically active people are the
better; however, this excludes extreme levels of activity.
The Panel also agrees that since physical activity protects
against overweight, weight gain, and obesity, it also
protects against cancers for which the risk is increased by
these factors (see Chapter 8).
The evidence assembled for this Report gives an account
of the beneficial effects of higher compared to lower levels
of physical activity. However, the Panel further agrees that
the evidence can equally be interpreted as showing that
sedentary ways of life increase or may increase the risk of
these cancers. Most people in urbanised, industrialised,
198
C H A P T E R 5 P H Y S I C A L A C T I V I T Y
199
P A R T 2 E V I D E N C E A N D J U D G E M E N T S
running, cycling, dancing, and other activities that increase ical activity as they do in 30 minutes of moderate activity
oxygen uptake and improve cardiovascular function, among or 20 minutes of vigorous activity.
other things; or anaerobic, such as resistance training using
weights, which increases muscle strength and mass.1 5.2.2 Levels of physical activity
Physical activity increases energy expenditure and so is a For many years, planners responsible for keeping specified
factor in energy balance (see chapter 8.3.3). The intensity population groups (such as builders, soldiers, schoolchild-
of physical activity can be categorised according to the ren, or office workers) healthy and productive have compiled
degree to which it increases energy expenditure above basal estimates of the food or energy needed by these groups. Such
metabolism. A table showing the intensity of physical activ- estimates consistently show that some people need almost
ity involved in different forms of movement is included in as much energy from food for physical activity as they do
Chapter 12. for the basic functions of vital organs and the assimilation
of food. These are people who are moderately physically
active for roughly half of their waking day, are engaged in
5.2 Types and levels of physical activity light work or sitting or resting for most of the rest of their
waking hours, and are occasionally vigorously physically
5.2.1 Types of physical activity active.4
Conventionally, and for the purposes of this Report, overall In physically active populations where energy from food
physical activity is classified into four types. These are: is not freely available, people tend to be lean, and also small.
Occupational (at work) Below critical levels, as has been observed in Asia and in
Household (in the home) Europe, food scarcity makes regular, sustained physical work
Transport (such as travelling to and from work) difficult and even impossible.5 6
Recreational (leisure).
5.2.2.1 Energy costs of ways of life
Much of the evidence summarised and judged below uses The energy requirements of healthy adults are determined
these classifications. They also highlight differences between largely by their habitual physical activity levels (PALs). PALs
various ways of life. Populations and communities where are the ratio of a persons daily total energy expenditure
physical activity at work and at home depends on hand tools (TEE) to their basal energy expenditure, and thus take into
and walking (or riding or cycling) are overall physically account the greater energy required for performing the same
active or very active, even without recreational activity. task with a higher body mass.2 7
Conversely, people whose ways of life at work and at home A sustained PAL of 1.2 corresponds roughly to a bedrid-
are sedentary, and who use mechanised transport, will be den state. People whose occupations are exceptionally active,
overall sedentary, unless they engage in substantial amounts such as miners, woodcutters, soldiers, and athletes, may
of moderate and perhaps some vigorous physical recreational need more energy for physical activity than for their basic
activity away from work. In general, in high-income coun- functions. This translates into habitual PALs above 2.0. Such
tries recreational activity accounts for a greater proportion unusual people are mostly young adults, and these levels of
of an overall lower level of physical activity.2 physical activity are not sustained throughout life. PALs
Physical activity can also be classified by intensity: vigor- above 2.4 can only be sustained over a long period of time
ous, moderate, light, or sedentary (see boxes 5.1 and 5.2). by unusually physically fit people. Also see Chapter 12.
It is the combination of frequency, intensity, and duration In general, in high-income countries in the first decade of
that determines total physical activity levels. A person may the 21st century, average levels of physical activity usually
use the same total amount of energy in 1 hour of light phys- account for about 20 to 30 per cent of TEE, but for extreme-
200
C H A P T E R 5 P H Y S I C A L A C T I V I T Y
ly sedentary people this may be as little as 15 per cent.2 8 9 sification of different levels of overall physical activity, with
See box 5.2. quantified degrees of activity corresponding to terms such as
The combined contribution of multiple types of physical active and sedentary.
activity can also be characterised in terms of metabolic equiv-
alent (MET)-hours. METs are usually converted to MET-hours Measurement. Physical activity is rarely measured precise-
per day or per week, which are calculated as the sum of the ly. Ideally, studies would record the frequency, intensity, and
MET level for each activity multiplied by the duration the duration of peoples physical activity over an extended period
activity was performed. day and night. But studies are generally not designed to
obtain this information. Objective measures such as pedome-
ters and microcomputer sensors are not often used in large
5.3 Interpretation of the evidence studies. Instead, questionnaires are most frequently used.
201
P A R T 2 E V I D E N C E A N D J U D G E M E N T S
in general. Large studies carried out in the USA have shown Recreational
that physical inactivity is associated with higher overall can- Of the 24 cohort studies considered, 22 compared highest
cer incidence and mortality.10-12 These studies are support- to lowest physical activity groups. All but two of these stud-
ed by studies on animals.13 Mechanistic reasons why ies reported decreased risk, which was significant in seven
physical activity may protect against cancer (or why seden- studies.21 25 26 30 38 41 46 The Health Professionals Follow-Up
tary living may promote cancer) include healthier levels of Study reported an RR of 0.53 (95% confidence interval (CI)
circulating hormones and the ability of the more active body 0.320.88) comparing men in the highest quintile of physi-
to consume more food and nutrients without gaining weight cal activity to men in the lowest quintile, with evidence of
(see Chapter 2). Mechanisms by which physical activity may a dose-response relationship (p for trend = 0.03). In the
protect against colorectal cancer and female hormone-relat- highest quintile, men reported a median of 47 MET-hours of
ed cancers are summarised in the following sections. activity a week; in the lowest quintile, the median was 0.9
Evidence from the literature on physical activity and can- MET-hours.41
cer in general indicates that the relationship between phys- Five studies examined rectal cancer separately, comparing
ical activity and health is continuous: that is, there does not highest with lowest physical activity groups: two reported non-
appear to be a threshold below or above which no effect is significant decreased risk,25 27 one reported significant
found.14 15 This implies that, in general, the more physical- increased risk,30 and two reported non-significant increased
ly active people are, the better, within the range examined. risk.30 41 Fourteen studies that examined colorectal cancer are
The Panel agrees that this general judgment is supported by included in a highest versus lowest plot, shown in figure 5.4.4.
the evidence on physical activity and cancer, which is sum- A published meta-analysis of 19 cohort studies reported
marised, assessed, and judged below. significant decreased risk of colon cancer for men with high
The full SLRs are contained on the CD included with this levels of occupational activity, and also for men and women
Report. with high levels of recreational activity. Nine of these stud-
ies examined dose response; a significant inverse trend was
5.4.1 Colorectal reported in six studies. Physical activity was not associated
Eleven cohort studies investigated total physical activity and with decreased risk of cancer of the rectum.54
colon or colorectal cancer.16-26 Twelve cohort studies inves-
tigated occupational physical activity21 25 27-36 and 24 inves- Walking
tigated recreational activity.10 17 21 25-27 29 30 34 37-51 Five cohort Two cohort studies examined measures of walking. A sig-
studies investigated frequency of physical activity,10 16 26 50 52 nificant increased risk was found in men who reported a
and seven investigated intensity of physical activity.22 26 34 37 slower walking pace than others compared to those who
46 51 53
Case-control studies that investigated physical activ- said they had a faster walking pace than others.39 In a study
ity can be found in the full SLRs. Also see chapter 7.9. that examined time spent walking, decreased risk was report-
ed in men who walked for more than 60 minutes a day com-
Total physical activity pared to men who walked for less than 20 minutes a day,
Of the 11 cohort studies considered, 816-22 26
reported but this was not significant.51
202
C H A P T E R 5 P H Y S I C A L A C T I V I T Y
Figure 5.4.2 Occupational physical activity and colorectal Figure 5.4.4 Recreational physical activity and colorectal
cancer; cohort studies cancer; cohort studies
Severson 1989 Men 0.72 (0.521.00) Severson 1989 Men 0.66 (0.490.88)
Suadicani 1993 Men 0.69 (0.391.23) Lee 1991 Men 0.95 (0.641.12)
Thune 1996 Men 0.82 (0.591.14) Suadicani 1993 Men 0.77 (0.381.57)
Thune 1996 Women 0.69 (0.341.41) Bostick 1994 Women 0.95 (0.661.36)
Norat 2005 Men 0.43 (0.330.55) Thune 1996 Men, high BMI 1.05 (0.691.59)
Norat 2005 Women 0.51 (0.380.69) Thune 1996 Women, high BMI 0.93 (0.491.75)
Thune 1996 Men, low BMI 1.36 (0.742.51)
Thune 1996 Women, low BMI 0.45 (0.250.82)
0.2 0.5 1 2 5
Lee 1994 Men 1.10 (0.731.66)
Relative risk, highest vs lowest exposure category
Ford 1999 0.90 (0.621.29)
Wannamethee 2001 0.90 (0.801.35)
Nilsen 2001 Men 0.69 (0.500.95)
Nilsen 2001 Women 1.12 (0.931.52)
Malila 2002 Men 0.92 (0.601.24)
Tiemersma 2002 0.67 (0.460.96)
Figure 5.4.3 Occupational physical activity and rectal Wei 2003 Women 0.73 (0.531.01)
cancer; cohort studies Sanjoaquin 2004 0.82 (0.491.37)
203
P A R T 2 E V I D E N C E A N D J U D G E M E N T S
204
C H A P T E R 5 P H Y S I C A L A C T I V I T Y
5.4.3 Endometrium
0.6 0.8 1 1.2
Two cohort studies99 100 and four case-control studies101-104
Relative risk per 7 MET-hours per week
investigated total physical activity and cancer of the
endometrium. Three cohort studies105-107 and 10 case-con-
trol studies102-104 108-114 investigated occupational activity.
Four cohort studies107 115-117 and 10 case-control studies
205
P A R T 2 E V I D E N C E A N D J U D G E M E N T S
All three cohort studies reported significant decreased risk for Hirose 1996 0.60 (0.380.94)
Olsen 1997 0.67 (0.421.08)
the highest activity group when compared to the lowest. Effect
Jain 2000 0.64 (0.450.91)
estimates are shown in figure 5.4.8.
Moradi 2000 0.77 (0.591.00)
Seven case-control studies reported decreased risk for the Littman 2001 0.83 (0.591.16)
highest activity group when compared to the lowest,102 104 109- Matthews 2005 0.76 (0.511.14)
111 113 114
statistically significant in three.102 104 113 Three stud- Trentham-Dietz 2006 0.65 (0.490.86)
ies reported non-significant increased risk.103 108 112 All three
cohort studies and eight of the case-control studies were
included in a highest versus lowest analysis, most of which 0.1 0.5 1 2 3
showed reduced risk with highwe activity (figure 5.4.8). Relative risk, highest vs lowest exposure category
Recreational
Three cohort studies reported decreased risk for the highest
activity group when compared to the lowest107 115 116; this
was significant in two studies.115 116 One study reported non-
significant increased risk.117 See figure 5.4.9. the highest activity group when compared to the lowest,102
Nine case-control studies reported decreased risk for 104 108-111 118-120
statistically significant in three.109 119 120 These
studies are included in figure 5.4.9. Another study (not
included in this figure) reported no significant association.103
Figure 5.4.8 Occupational physical activity and
endometrial cancer; cohort and Mechanisms
case-control studies As with breast cancer, there are a number of mechanisms by
which physical activity may protect against cancer of the
Relative risk (95% CI) endometrium. These include the beneficial effect of physi-
cal activity on body fatness (see Chapter 6); effects on
Cohort
Moradi 1998 0.76 (0.670.86)
endogenous steroid hormone metabolism; and a possible
Weiderpass 2001 0.77 (0.660.90) strengthening of the immune system. Also, high levels of
Furberg 2003 0.49 (0.220.91) physical activity are associated with lower levels of circulat-
ing oestrogens and androgens in postmenopausal women.14
Case control
Levi 1993 0.67 (0.450.99) There is generally consistent evidence, mostly from
Shu 1993 1.11 (0.681.81)
case-control studies, showing lower risk of cancer of
Sturgeon 1993 0.50 (0.310.80)
the endometrium with higher levels of physical activity.
Kalandidi 1996 0.41 (0.180.91)
There is evidence for mechanisms operating in
Goodman 1997 0.70 (0.471.03)
Olson 1997 1.19 (0.761.87)
humans. Physical activity probably protects against
Moradi 2000 0.77 (0.461.28) cancer of the endometrium.
Matthews 2005 0.86 (0.631.18)
5.4.4 Lung
Five cohort studies investigated total physical activity25 51 122-
0.5 1 2 3 124
and two investigated non-recreational activity.10 125 Four
Relative risk, highest vs lowest exposure category cohort studies25 126-128 and two case-control studies112 129
investigated occupational activity. Eleven cohort studies10 25
51 126-128 130-134
and four case-control studies135-138 investigat-
ed recreational activity. Another two cohort studies
investigated a physical activity measure that did not fit into
206
C H A P T E R 5 P H Y S I C A L A C T I V I T Y
these categories.31 126 Also see chapter 7.4. 0.61.06).25 One study reported that mean hours per week
Total physical activity of sports activity were lower in cases (0.70) than in controls
Four of the five cohort studies reported decreased risk for the (1.10).133 The exposure examined varied, with some studies
highest activity group compared to the lowest25 51 123 124; this analysing leisure-time activities, sports, or exercise, and one
was significant in two.123 124 The other study reported non- examining endurance skiers. All but the two studies specified
significant decreased risk in people under the age of 63, RR above were adjusted for smoking.
0.84 (95% CI 0.691.03) per 20 hours a week; and non-sig- All four case-control studies reported a significant
nificant increased risk in people aged 63 and over, RR 1.11 decreased risk comparing high to low levels of activity.135-138
(95% CI 0.951.29) per 20 hours a week.122 The effect esti-
mates were RR 0.61 (95% CI 0.410.89),123 RR 0.74 (95% Mechanisms
CI 0.590.93),124 RR 0.70 (95% CI 0.481.01),25 and RR 0.76 No mechanisms were identified by which physical activity
(95% CI 0.401.43),51 comparing highest to lowest activity might have a specific effect on the risk of lung cancer. The
groups. All cohort studies were adjusted for smoking. possibility could not be dismissed that people with pulmonary
disease, who are at increased risk of lung cancer, might
Non-recreational activity reduce their level of physical activity.
Two cohort studies reported increased risk with inactivity The association between physical activity and lung cancer
(sedentary living)10 125; this was significant in one.10 In one is complex. Unlike many other cancers, lung cancer is not
study of men, the effect estimate was RR 2.0 (95% CI positively associated with body mass index (BMI). The Panel
1.23.5)10; in the other study, the estimates were RR 1.26 is aware that the observed association between physical activ-
(95% CI 0.712.24) for men and RR 1.41 (95% CI 0.593.35) ity and lung cancer may be a reflection of reverse causation
for women.125 Both studies were adjusted for smoking. due to chronic lung disease.
207
P A R T 2 E V I D E N C E A N D J U D G E M E N T S
Walking Mechanisms
Three cohort studies reported decreased risk for the highest Several mechanisms have been proposed for how physical
activity group compared to the lowest140 146; this was signif- activity may decrease the risk of prostate cancer. Exercise
icant in two.146 The effect estimates were RR 0.48 (95% CI may reduce prostate cancer risk by reducing levels of testos-
0.240.97) for women in the Nurses Health Study146; RR terone and insulin. Acute exercise may promote the forma-
0.45 (95% CI 0.260.80) for men in the Health Professionals tion of free radicals. In people who exercise consistently, this
Follow-up Study146; and RR 0.99 (95% CI 0.641.51) in a may induce the production of enzymes, such as superoxide
study of pancreatic cancer mortality.140 The Whitehall Study dismutase, that protect against oxidative stress. These
reported increased risk of pancreatic cancer mortality for enzymes may also protect against cancer, since dietary
slow compared to fast walkers (RR 1.1; 95% CI antioxidants have been linked to reduced cancer risk.
0.205.10).145
The Panel has noted the evidence presented here that
Vigorous physical activity is associated with reduced risk of
Three cohort studies reported non-significant decreased risk advanced or aggressive cancer of the prostate, but has
for the highest activity group compared to the lowest.140 146 not made a formal judgement.
149
Two studies reported non-significant increased risk.146 153
The single case-control study reported non-significant
decreased risk.141 5.5 Comparison with previous report
Moderate The panel responsible for the previous report judged that the
Two cohort studies reported increased risk for the highest evidence that physical activity protects against cancer of the
activity group compared to the lowest140 149; this was signif- colon was convincing. Evidence for cancer of the rectum was
icant in one.149 Two cohort studies reported decreased risk,146 judged to be unimpressive. Physical activity was judged to
which was significant in one.146 The single case-control study be possibly protective against cancers of the lung and of the
reported non-significant increased risk in men and no asso- breast. The previous report mentioned epidemiological,
ciation in women.141 experimental, and mechanistic evidence suggesting that
physical activity is generally protective against cancer, and
Mechanisms in particular against colon cancer and female hormone-relat-
Mechanisms by which physical activity may protect against ed cancers. The panel responsible for that report also con-
cancer of the pancreas include reduced insulin resistance and cluded that all types of physical activity were probably
reduced gut transit time, which has beneficial effects on bile beneficial and that people should remain physically active
content and secretion and general pancreatic activity.154 throughout life.
208
C H A P T E R 5 P H Y S I C A L A C T I V I T Y
209
P A R T 2 E V I D E N C E A N D J U D G E M E N T S
C H A P T E R 6
210
C H A P T E R 6 B O D Y C O M P O S I T I O N , G R O W T H , A N D D E V E L O P M E N T
In the judgement of the Panel, the factors listed below modify the risk of cancer. Judgements are graded according to the strength of the evidence.
Substantial
effect on risk None identified
unlikely
For an explanation of all the terms used in the matrix, please see chapter 3.5.1, the text of this section, and the glossary.
A key reason for the success of Homo sapiens is our body fatness and the risk of cancers of a number of sites is
adaptability. Humans have evolved to survive and flourish strong and generally consistent. The Panel emphasises that
in almost all environments and circumstances which, the risk of cancer is modified, not only by obesity, as
during the 250 000 years of our species existence, have usually defined, but by overweight as well, and even by
usually included occasional or regular food scarcity and degrees of body fatness generally regarded as healthy.
insecurity. We have built-in defences against starvation: our
own stores of fat that are used in times of need. The Panel judges as follows:
Food insecurity remains endemic, particularly in Africa The evidence that greater body fatness is a cause of
and Asia. But many people in the world now have access to adenocarcinoma of the oesophagus, and cancers of the
more than enough to eat and drink and are also relatively pancreas, colorectum, breast (postmenopause),
physically inactive (see Chapter 5). As a result, stores of endometrium, and kidney, is convincing. Greater body
body fat tend to increase. What is now a pandemic of fatness is probably a cause of cancer of the gallbladder.
overweight and obesity can be seen as a response to There is limited evidence suggesting that greater body
circumstances of plenty. One consequence, in the context of fatness is a cause of liver cancer. The evidence that greater
reduction in rates of nutritional deficiencies and infections abdominal (central) fatness is a cause of colorectal cancer
of childhood and early life, and the ageing of human is convincing; and greater abdominal fatness is probably a
populations, is an increase in the rates of chronic diseases. cause of cancers of the pancreas, breast (postmenopause),
These include cancer. and endometrium. By contrast, greater body fatness
Overall, the Panel judges that evidence on the degree of probably protects against premenopausal breast cancer.
211
P A R T 2 E V I D E N C E A N D J U D G E M E N T S
The Panel notes that there is limited evidence suggesting In this Report, the term body fatness refers to the degree
that low body fatness (underweight) is a cause of lung of body fatness across the whole range, not only the con-
cancer, but residual confounding with smoking and lung ventional categories of overweight and obesity.
disease cannot be ruled out.
See Chapter 8 for judgements on physical activity and
sedentary ways of life, the energy density of foods and 6.1.1 Definitions and patterns
drinks, breastfeeding, other factors, and the risk of weight
gain, overweight, and obesity. 6.1.1.1 Body fatness
Within the remit of this Report, the strongest evidence, Excess energy from food is stored as fat in the body in adi-
corresponding to judgements of convincing and pose tissue. The amount of this body tissue varies more from
probable, shows that greater body fatness and greater person to person than any other type (such as muscle, bone,
abdominal fatness are causes of cancer of the colorectum; or blood). The size and location of these fat stores also vary
that greater body fatness is additionally a cause of cancers considerably between populations, people, and over the
of the oesophagus (adenocarcinoma), pancreas, breast course of a persons life. Excess body fat is a cause of a num-
(postmenopause), endometrium, and kidney; and ber of chronic diseases and reduces life expectancy (also see
(probably) gallbladder. It also shows that greater Chapter 8).
abdominal fatness is probably a cause of cancers of the Since the 1980s, typical body compositions have changed,
pancreas, breast (postmenopause), and endometrium; but with a worldwide increase in average body fatness and in
that greater body fatness probably protects against overweight and obesity. This change is most notable in high-
premenopausal breast cancer. income countries, and in industrial and urban environments
in many if not most countries (see chapters 1.1.3 and 1.2.2).
In several low-income countries, high levels of body fatness
Body fatness and organ mass and composition, commonly exist alongside undernutrition in the same communities and
assessed by body size measurements, are key factors influ- even in the same families.3
encing health and well-being throughout the life course. Body fatness is difficult to measure directly or accurately.
The main concern of nutrition science, since its beginnings However, because body fatness is the most variable deter-
and until the mid-20th century, has been to protect popula- minant of weight, several weight-based measures are used
tions against the consequences of malnutrition in the clas- as markers of body fatness. The most common is the body
sic sense of the word. That is undernutrition, which mass index (BMI), a measure of weight adjusted for height.
increases vulnerability to infectious diseases, especially in BMI is calculated as weight in kilograms divided by height
infancy and childhood, and results in people who are small in metres squared (kg/m2). In most circumstances, BMI has
and weak, unable to be productive, and with low life been shown to be reliably linked to body fatness.4 But this
expectancy.1 This remains a central public health priority for method does not always provide an accurate measure:
middle- and low-income countries.2 unusually muscular and lean people (such as manual work-
In the final two decades of the 20th century and into this ers and power athletes) have a relatively high BMI, even if
century, a different and imperative public health nutrition they have relatively little body fat. See table 6.1.1 and also
concern has emerged: weight gain, overweight, and obesi- Chapter 8.
ty. At first, it was generally assumed that societies whose A BMI of between 18.5 and 24.9 is generally regarded as
babies are big, whose children grow fast, and whose adults healthy or normal (healthy or normal body fatness). This
are heavy and tall, were healthy. Compared to societies with is roughly equivalent to 1520 per cent body fat in adult
inadequate nutrition and poor public health provision, such men and 2530 per cent in adult women.5 The underweight
populations are indeed physically stronger, more productive, or thin range is a BMI below 18.5 (low body fatness). Above
have longer lives, and are generally healthier. 25 (high body fatness), there are common gradings for over-
This said, since the 1980s, a series of reports based on a weight, obesity, and extreme (morbid) obesity. The risk of
rapidly increasing evidence base have concluded that popu- type 2 diabetes and high blood pressure increases with BMI
lations of high-income countries, and now also populations with no clear threshold, but with a marked increase in risk
of many middle- and low-income countries, are becoming as BMI approaches 25.3 The ideal average BMI for popula-
overweight to an extent that is bad for health. These coun- tions has been estimated to be 2122.6
tries are almost exclusively those experiencing social, eco- The principal cut-off points shown in table 6.1.1 have
nomic, and nutritional transition. The nutritional transition been agreed by the World Health Organization and are based
is characterised by a shift from traditional diets that are low on the risks associated with being underweight, overweight,
in fat and high in fibre to high-energy Western diets that are or obese (see Chapter 8). However, the healthy ranges of
high in fat and low in fibre. It is now generally accepted that BMI vary between populations. The additional cut-off points
obesity, but also overweight short of obesity, increases the risk take this into account and are recommended for reporting
of a number of major chronic diseases including insulin resis- purposes, with a view to facilitating international compar-
tance, hyperlipidaemia, hypertension and stroke, type 2 dia- isons.
betes, and coronary heart disease, as well as cancers of some The principal BMI cut-offs are based on data primarily
sites.3 In this chapter, the evidence on body fatness and can- derived from populations of European origin living in high-
cer is summarised and judged. Also see Chapter 8. income countries, so they may not apply globally. Different
212
C H A P T E R 6 B O D Y C O M P O S I T I O N , G R O W T H , A N D D E V E L O P M E N T
213
P A R T 2 E V I D E N C E A N D J U D G E M E N T S
in the systematic literature reviews that informed the Panels 6.1.3 Evidence and judgements
judgements.
The full systematic literature review (SLR) is contained on
the CD included with this Report.
6.1.2 Interpretation of the evidence There are several general mechanisms through which body
fatness and abdominal fatness could plausibly influence can-
6.1.2.1 General cer risk. For example, increasing body fatness raises the
For general considerations that may affect interpretation of inflammatory response, increases circulating oestrogens, and
the evidence, see chapters 3.3 and 3.5, and boxes 3.1, 3.2, decreases insulin sensitivity. The physiological effects of obe-
3.6 and 3.7. sity are described in more detail in Chapter 8. The effects of
body fatness-related hormonal changes and inflammation on
6.1.2.2 Specific cancer processes are detailed in box 2.4. Additional site-
Some considerations specific to body fatness are as follows. specific mechanisms are described with the evidence for
each cancer site in the following sections.
Classification.The system of classifying underweight, nor-
mal weight, overweight, and degrees of obesity as discrete 6.1.3.1 Body fatness
ranges of BMI, is in general use. However, as shown in this Oesophagus
chapter and also Chapter 8, the relationship between body Three cohort studies19-21 and eight case-control studies22-29
fatness and cancer is continuous across the range of BMI. For investigated body fatness (as measured by BMI) and
this reason, the Panel has chosen to use the term body fat- oesophageal adenocarcinomas.
ness rather than overweight or obesity. All three cohort studies showed increased risk for the high-
est body fatness, as measured by BMI, when compared to the
Measurement. BMI is not a perfect marker of body fatness. lowest (figure 6.1.1); this was statistically significant in both
More precise techniques such as underwater weighing, mag- sexes in one study21 and in men but not women in two oth-
netic resonance imaging, computerised tomography, or dual- ers.19 20 Effect estimates were 2.58 in men (95% confidence
energy X-ray absorptiometry are rare in large-scale interval (CI) 1.813.68; p < 0.001) and 2.06 in women (95%
epidemiological studies due to their difficulty and expense. CI 1.253.39; p = 0.002)21; 2.40 in men (95% CI 1.304.42)
Abdominal fatness is usually measured either using the waist and 1.57 in women (95% CI 0.514.84)20; and 1.76 in men
to hip ratio or the waist circumference alone. There is a lack (95% CI 1.033.02) and 2.13 in women (95% CI
of consensus on how abdominal fatness is best measured, 0.974.71).19 The latter study was adjusted for smoking and
and measurement error is more likely than for some other alcohol but the other two were not.
anthropometric measures such as height and weight. The Seven case-control studies22-25 27-29 showed increased risk
currently proposed maximum cut-off points for healthy for the highest body fatness group, as measured by BMI, when
waist circumferences (94 cm or 37 inches for men; 80 cm or
31.5 inches for women) and for healthy waist to hip ratios
(1.0 for men; 0.8 for women) are based almost exclusively
on studies of cardiovascular or type 2 diabetes risk in white Figure 6.1.1 BMI and oesophageal adenocarcinoma;
cohort and case-control studies
populations in high-income countries. It is not known
whether they can be applied to other ethnic groups or out-
Relative risk (95% CI)
comes. The relationship between waist circumference and
Cohort
the size of intra-abdominal fat stores (as opposed to subcu-
taneous abdominal fat stores) may vary between different Tretli 1999 Men 2.40 (1.304.43)
ethnic groups.18 As body fatness tends to increase with age Tretli 1999 Men 1.57 (0.514.84)
in most populations, and is characteristically higher in
women than in men, it is important that studies take into Case control
account both age and sex. Measurement of change in weight Engel 2003 2.70 (1.684.34)
tends to be more precise than static measures such as weight Brown 1995 3.10 (1.815.32)
or BMI.
Chow 1998 Men 3.00 (1.755.14)
Chow 1998 Women 2.60 (0.808.47)
Reporting bias. Objective measures of height and weight, and
Kabal 1993 1.20 (0.602.40)
therefore BMI, are reliable. However, many studies rely on
self-reporting, which is liable to introduce bias. Although Wu 2001 1.91 (1.282.85)
214
C H A P T E R 6 B O D Y C O M P O S I T I O N , G R O W T H , A N D D E V E L O P M E N T
compared to the lowest (figure 6.1.1). This was statistically A dose-response relationship is apparent from case-control
significant in five studies,22-24 28 29 and in men but not women data (figure 6.1.3). Cohort data show a statistically signifi-
in a sixth.25 One study showed non-significant decreased cant trend in men and are suggestive of a similar trend in
risk.26 Meta-analysis was possible on four case-control women.
studies (all of which showed increased risk), giving an effect Studies that investigated body fatness, as measured by BMI,
estimate of 1.11 (95% CI 1.071.15) per kg/m2, with mod- and all types of oesophageal cancer or squamous cell carci-
erate heterogeneity (figure 6.1.2). This would produce an nomas showed inconsistent results. Only when results were
increased risk of 55 per cent for each 5 kg/m2, assuming a stratified by cancer type did a consistent pattern emerge, and
linear relationship, although a curvilinear dose-response then only for adenocarcinomas.
relationship cannot be ruled out. An association between body fatness and increased risk of
oesophageal adenocarcinoma is consistent, with known geo-
graphical and time trends for both BMI and adenocarcinomas.
Figure 6.1.2 BMI and oesophageal cancer; The general mechanisms through which body fatness
case-control studies could plausibly influence cancer risk are outlined in 6.1.3
(also see box 2.4).
Relative risk (95% CI)
The epidemiology is consistent, with evidence of a
Case control dose-response relationship. There is evidence for
Brown 1995 1.20 (1.121.29)
plausible mechanisms that operate in humans. The
evidence that greater body fatness is a cause of
Chow 1998 Men 1.11 (1.051.17) oesophageal adenocarcinoma is convincing.
Chow 1998 Women 1.08 (0.991.17)
The Panel is aware that since the conclusion of the SLR, two
Chen 2002 1.08 (1.031.13) cohort30 31 and five case-control studies32-36 have been pub-
lished. This new information does not change the Panel judge-
Engel 2003 1.11 (1.051.16)
ment (see box 3.8).
Summary estimate 1.11 (1.071.15)
Pancreas
Twenty-three cohort studies37-58 and 15 case-control stud-
0.5 0.75 1 1.5 2 ies59-73 investigated body fatness (as measured by BMI) and
Relative risk, per 1 kg/m2 pancreatic cancer.
Thirteen cohort studies showed increased risk with
increased body fatness,37 38 40 43 44 46 47 49 51 54 55 57 which was
statistically significant in four.47 49 54 55 Two studies showed
increased risk in both sexes42 50; this was statistically signif-
icant in women but not in men in one study,42 and in men
Figure 6.1.3 BMI and oesophageal cancer; case-control
studies: dose response
but not women in the other.50 One study showed increased
risk in both black and white men, which was significant for
white men only.56 Two studies showed non-significant
increased risk in women and non-significant decreased risk
in men.45 52 One study showed statistically significant
Brown 1995
increased risk in men and non-significant decreased risk in
women.39 Three studies showed non-significant decreased
risk41 48 53 and one study stated that there was no significant
Chow 1998 Men association.58 Meta-analysis was possible on 17 cohort stud-
ies, giving a summary effect estimate of 1.14 (95% CI
Chow 1998 Women 1.071.22) per 5 kg/m2, with moderate heterogeneity (fig-
ure 6.1.4). Most studies adjusted for smoking, with no appar-
ent difference between people who smoked and those that
Chen 2002
did not.
Five case-control studies showed increased risk with
Engel 2003 increased body fatness,62-66 which was statistically significant
in one,66 and in men but not women in another study.64 Five
studies showed decreased risk,61 68-71 which was statistical-
10 15 20 25 30 35
ly significant in one.69 Two studies showed non-significant
BMI (kg/m2 )
decreased risk in men and a non-significant increased risk
in women.59 72 One study showed a statistically significant
increased risk in men and a non-significant decreased risk
in women.67 One study showed non-significant decreased
215
P A R T 2 E V I D E N C E A N D J U D G E M E N T S
Figure 6.1.4 BMI and pancreatic cancer; cohort and Figure 6.1.5 BMI and pancreatic cancer; cohort and
case-control studies case-control studies: dose response
risk in both sexes when interviewed indirectly, a non-signif- The Panel is aware that since the conclusion of the SLR, two
icant decreased risk in women when interviewed directly, cohort studies30 74 have been published. This new information does
and a non-significant increased risk in men.60 One study stat- not change the Panel judgement (also see box 3.8).
ed that there was no significant association.73 Meta-analysis
was possible on 13 case-control studies, giving a summary Colorectum
effect estimate of 1.00 (95% CI 0.871.15) per 5 kg/m2, with Sixty cohort studies42 45 50 54-58 75-142 and 86 case-control stud-
high heterogeneity (figure 6.1.4). ies investigated body fatness (as measured by BMI) and can-
A dose-response relationship was apparent from cohort but cers of the colon and rectum.
not case-control data (figure 6.1.5). Although meta-analysis Most of the cohort studies showed increased risk with
assumes a linear relationship, some cohort studies are sug- increased body fatness,42 45 50 54 56-58 75 77 80-82 84-88 91-100 102-104
gestive of a curvilinear relationship, though not conclusive- 106 108-115 118-120 122 124-127 132 137 139 142
which was statistically
ly so. significant in approximately half of these studies.42 50 54 56-58
The general mechanisms through which body fatness 75 77 84-88 92-95 99 103 104 109 111 114 115 118-120 124 126 127 132 137 139 142
could plausibly influence cancer risk are outlined in 6.1.3 Relatively few studies showed lower risk with increased body
(also see box 2.4). fatness76 83 90 107 116; this was statistically significant in only
one.83 One study showed no effect on risk78 and three stat-
There is ample epidemiological evidence, which is ed that there was no association.79 89 101 Meta-analysis was
generally consistent, and there is a dose-response possible on 28 cohort studies, giving a summary effect esti-
relationship. There is evidence for plausible mechanisms mate of 1.03 (95% CI 1.021.04) per kg/m2, with moderate
that operate in humans. The evidence that greater body heterogeneity (figure 6.1.6). This would produce an
fatness is a cause of pancreatic cancer is convincing. increased risk of 15 per cent for each 5 kg/m2, assuming a
216
C H A P T E R 6 B O D Y C O M P O S I T I O N , G R O W T H , A N D D E V E L O P M E N T
Figure 6.1.6 BMI and colorectal cancer; cohort studies Figure 6.1.7 BMI and colon cancer, cohort studies
0.5 0.75 1 1.5 2 Figure 6.1.8 BMI and rectal cancer, cohort studies
Relative risk, per 1 kg/m2
217
P A R T 2 E V I D E N C E A N D J U D G E M E N T S
Figure 6.1.9 BMI and colorectal cancer; cohort studies: Figure 6.1.10 BMI and breast cancer (age unspecified);
dose response cohort and case-control studies
three.162 171 179 201 Eight studies showed decreased risk,161 172 Moorman 2001
Furberg 1999
0.97 (0.921.03)
0.97 (0.941.01)
173 184 186 194-197 202
which was statistically significant in two.173 Ferranoni 1991 0.97 (0.881.06)
Coates 1999 0.96 (0.940.98)
196 197
Two studies showed no effect on risk.50 204 Meta-analy- Kuru 2002 0.96 (0.901.01)
Chie 1998 0.95 (0.801.14)
sis was possible on 16 cohort studies, giving a summary Bagga 2002 0.95 (0.851.07)
effect estimate of 1.01 (95% CI 1.001.02) per 2 kg/m2, with Wenten 2001
Drewnowski 2000
0.95 (0.891.02)
0.94 (0.861.01)
moderate heterogeneity (figure 6.1.10). Petrek 1993 0.92 (0.811.04)
Zheng 2000 0.91 (0.831.01)
Forty-seven case-control studies showed increased risk Bouchardy 1990 0.90 (0.860.94)
with increased body fatness66 208 211 213 215 221 222 224 230 232 235 Mendonca 1999
Ueji 1997
0.90 (0.811.00)
0.90 (0.781.03)
236 239 240 251 252 254 255 257 260 261 265-267 269 276 277 281 282 285 294-296 Agurs-Collins 1998 0.89 (0.820.98)
298-301 305 306 309 310 313 314 316-319 323-326 329 332 334-337 341 343 344 347- Ibarluzea 2004 0.84 (0.770.90)
Summary estimate 1.02 (1.021.03)
350 352-356 359
; this was statistically significant in 2266 208 211 222
230 232 235 254 255 269 277 285 295 296 298 316-318 329 332 334 336 337 341 349
0.5 1 1.5 2
352 353 359
; 4 studies showed no effect on risk207 245 278 351; and Relative risk, per 2 kg/m2
the remaining 22 showed decreased risk,205 209 212 214 219 225
228 229 234 238 243 244 259 263 264 270 273 289-292 304 321 322 342 349
which
was statistically significant in 4 studies.214 263 264 291 One of
218
C H A P T E R 6 B O D Y C O M P O S I T I O N , G R O W T H , A N D D E V E L O P M E N T
Twenty-four cohort studies42 45 50 122 149-151 155-159 162 163 165 167 Yoo 2001
Talamini 1984
1.14 (1.081.21)
1.13 (1.021.25)
and 56 case-control stud-
169 170 174 175 178 180 182-185 187-195 199 200
Tung 1999 1.13 (1.011.25)
ies investigated body fatness,66 205-208 214 220 224-227 231 233 237 239 Lopez-Carrillo 1997
Graham 1991
1.13 (0.971.32)
1.11 (1.041.19)
241 242 244 246-250 253-259 261-263 268 271 274 275 279-283 286-288 293 295-297 Chow 2005 1.10 (1.011.19)
Magnusson 1998 1.09 (1.061.12)
302 304 308 311 315 321 322 327 329 331 333 336-341 345 349 352 357-359
(as mea- Rosenburg 1990 1.08 (0.991.18)
sured by BMI) and postmenopausal breast cancer. Trentham-Dietz 2000 1.08 (1.061.10)
Toti 1986 1.08 (1.021.14)
Nineteen cohort studies showed increased risk with Harris 1992 1.08 (1.001.16)
increased body fatness,42 45 50 122 149 151 155-159 162 163 165 167 174 Taioli 1995 1.07 (1.001.16)
Kohlmeier 1997 1.07 (1.011.13)
175 180 183-185 187-194 199 200
which was statistically significant in Li 2000 1.06 (1.001.13)
seven.42 45 149 158 162 163 174 175 180 183 189 192 Five studies showed Newcomb 1999 1.06 (1.041.09)
Shoff 2000 1.06 (1.041.09)
decreased risk,150 169 170 178 182 195 which was statistically sig- Swanson 1989 1.06 (1.011.11)
nificant in one.150 Meta-analysis was possible on 17 studies, Trentham-Dietz 1997
Dorn 2003
1.06 (1.041.08)
1.06 (1.011.11)
giving a summary effect estimate of 1.03 (95% CI 1.011.04) Carpenter 2003 1.06 (1.021.10)
more than 4300 breast cancer cases) showed a significant Petrek 1993
De Vasconcelos 2001
0.97 (0.851.11)
0.94 (0.851.03)
Adams-Campbell 1996 0.90 (0.830.98)
Summary estimate 1.05 (1.051.06)
219
P A R T 2 E V I D E N C E A N D J U D G E M E N T S
Figure 6.1.13 BMI and postmenopausal breast cancer; Figure 6.1.14 BMI and premenopausal breast cancer;
cohort studies: dose response case-control studies: dose response
risk.155 162 188 190 Three studies showed no effect on risk.122 third of these studies.214 218 223 231 237 250 262 268 303 304 326 327 330
220
C H A P T E R 6 B O D Y C O M P O S I T I O N , G R O W T H , A N D D E V E L O P M E N T
Figure 6.1.15 BMI and premenopausal breast cancer; Figure 6.1.16 BMI and premenopausal breast cancer;
cohort studies cohort studies: dose response
Manjer 2001
Galanis 1998 1.09 (0.961.25)
Toniolo 1994 1.09 (0.961.23)
Manjer 2001 1.00 (0.891.13) Vatten 1992
Tulinius 1997 1.00 (0.921.09)
Karaks 1998 0.99 (0.891.10)
Sonnenschein 1999 0.95 (0.841.07) Toniolo 1994
Huang 1997 0.95 (0.910.98)
Saadatien-Elahi 2002 0.94 (0.831.07)
Tehard 2004
Vatten 1992 0.94 (0.900.98)
Tehard 2004 0.93 (0.870.99)
Weiderpass 2004 0.92 (0.880.96) Sonnenschein 1999
Ahlgren 2004 0.92 (0.880.96)
Tornberg 1994 0.86 (0.800.92)
Kaaks 1998
Rissanen 2003 0.75 (0.620.90)
Summary estimate 0.94 (0.920.95)
Huang 1997
0.5 1 1.5
Relative risk, per 2 kg/m2 Galanis 1998
16 18 20 22 24 26 28 30 32
BMI (kg/m2)
221
P A R T 2 E V I D E N C E A N D J U D G E M E N T S
Figure 6.1.17 BMI and endometrial cancer; cohort and Figure 6.1.18 BMI and endometrial cancer; cohort studies:
case-control studies dose response
222
C H A P T E R 6 B O D Y C O M P O S I T I O N , G R O W T H , A N D D E V E L O P M E N T
The Panel is aware that since the conclusion of the SLR, one BMI and kidney cancer; cohort and
Figure 6.1.20
cohort study146 and one case control study459 have been pub- case-control studies: dose response
lished. This new information does not change the Panel judge-
ment (also see box 3.8).
Cohort
Kidney
Seventeen cohort studies and 20 case-
42 45 57 122 279 460-473 Flaherty 2005
control studies66 474-502 investigated body fatness (as mea- Oh 2005
sured by BMI) and kidney cancer.
Hiatt 1994
Fifteen cohort studies showed increased risk with
increased body fatness42 45 57 122 279 460-468 470-472; this was sta- Gamble 1996
tistically significant in seven studies,57 122 460 461 465 466 468 472 Chow 2000
and in women but not men in another.42 Two studies stated
that there was no statistically significant association.469 473 No
Case control
cohort studies showed decreased risk. Meta-analysis was pos-
sible on seven cohort studies that adjusted for smoking, giv- Boeing 1997
The Panel is aware that since the conclusion of the SLR, three
cohort studies30 52 142 and one case-control study505 have been
Figure 6.1.19 BMI and kidney cancer; cohort and
case-control studies
published. This new information does not change the Panel
judgement (also see box 3.8).
Relative risk (95% CI)
Cohort
Gallbladder
Chow 2000 1.37 (1.181.59) Five cohort studies,42 45 56 58 141 201 seven case-control stud-
Flaherty 2005 1.52 (1.002.31) ies,506-514 and two cross-sectional studies515-517 investigated
Oh 2005 1.43 (1.221.67)
Hiatt 1994 1.18 (0.821.70)
body fatness (as measured by BMI) and gallbladder cancer.
Van Dijk 2004 1.27 (1.231.31) Most cohort studies showed increased risk with increased
Bjorge 2004 1.28 (1.241.33)
body fatness. For two studies, results for the whole cohort
Gamble 1996 2.53 (1.125.68)
Summary estimate 1.31 (1.241.39) showed statistically significant increased risk.42 201 One study
reported significant increased risk for women and non-
Case control
significant increased risk for men,141 while another report-
Mattioli 2002 2.74 (1.405.32)
Boeing 1997 1.83 (1.212.76) ed statistically significant increased risk for women and
Summary estimate 2.05 (1.432.92) non-significant decreased risk for men.45 One study report-
ed a significant increased risk for white men and a non-
significant decreased risk for black men.56 Meta-analysis was
0.25 0.5 1 2 4
possible on four cohort studies, giving a summary effect
Relative risk, per 5 kg/m2
estimate of 1.23 (95% CI 1.151.32) per 5 kg/m2, with
moderate heterogeneity (figure 6.1.21).
Most case-control studies showed increased risk with
increased body fatness,506 507 509 510 513 514 which was
223
P A R T 2 E V I D E N C E A N D J U D G E M E N T S
Kuriyama 2005 Men 0.42 (0.044.77) There is a substantial amount of generally consistent
Kuriyama 2005 Women 1.91 (1.163.13) epidemiological evidence with some evidence of a dose
Engeland 2005 Men age 4574 1.10 (0.991.23) response. There is evidence for several plausible
Engeland 2005 Men age 2044 1.15 (0.921.44) mechanisms. Greater body fatness is a probable cause
Engeland 2005 Women age 2044 1.37 (1.241.50) of gallbladder cancer, directly and also indirectly
Engeland 2005 Women age 4574 1.19 (1.131.25) through the formation of gallstones.
Summary estimate 1.23 (1.151.32)
Liver
Six cohort studies42 44 54-57 525 and two case-control studies
0.25 0.5 1 2 5
investigated body fatness526 527 (as measured by BMI), or
Relative risk, per 5 kg/m2
obesity, and liver cancer.
Five cohort studies showed increased risk for the highest
body fatness group compared to the lowest.42 44 54 55 57 This
was statistically significant in two studies,54 57 and in men
but not women in another two.42 55 One cohort study showed
a statistically significant increased risk in white men and a
statistically significant in three.506 510 513 Two studies showed significant decreased risk in black men.56 Effect estimates
decreased risk,511 512 which was statistically significant in were 1.68 in women (95% CI 0.933.04) and 4.52 in men
one.512 One study showed no effect on risk in men, but a sta- (95% CI 2.946.94)42; 1.44 in white men (95% CI
tistically significant increased risk in women.508 Meta-analy- 1.281.61) and 0.68 in black men (95% CI 0.490.94)56;
sis was possible on all seven case-control studies,506-514 giving 1.56 in men (95% CI 1.152.12)57; 3.88 in men (95% CI
a summary effect estimate of 1.19 (95% CI 0.811.75) per 0.9615.69)44; 1.9 in both sexes (95% CI 1.52.5)54; and
5 kg/m2, with high heterogeneity. Heterogeneity could be at 1.70 in women (95% CI 0.953.05) and 3.60 in men (95%
least partly attributed to differences in the study participants CI 2.086.24).55
ethnicity or sex, or to the number of adjustments made in Neither case-control study showed any statistically signif-
the study. In addition, there was variation according to icant association.526 527
whether BMI was derived from direct measurements or self- The general mechanisms through which body fatness
reports of weight and height, as well as in the outcome mea- could plausibly influence cancer risk are outlined in 6.1.3
sured. For example, one cohort and one case-control study (also see box 2.4).
reported biliary tract cancer as opposed to gallbladder can-
cer specifically, and some studies reported incidence while The epidemiological evidence shows some
others reported mortality. inconsistencies, and the mechanistic evidence is
The general mechanisms through which body fatness speculative. There is limited evidence suggesting that
could plausibly influence cancer risk are outlined in 6.1.3 greater body fatness is a cause of liver cancer.
(also see box 2.5). In addition, obesity is a known cause of
gallstone formation and having gallstones increases the risk The Panel is aware that since the conclusion of the SLR, two
of gallbladder cancer (see chapter 7.7), possibly through bile cohort studies30 528 have been published. This new information
cholesterol supersaturation leading to cholesterol-based gall- does not change the Panel judgement (see box 3.8).
stones. High cholesterol in the bile is not necessarily relat-
ed to dietary cholesterol it can also be caused by insulin Lung
resistance, which can be caused by obesity. Insulin resistance Twenty-one cohort studies,42 57 76 88 122 144 529-545 24 case-con-
can independently increase cholesterol synthesis in the liver trol studies,546-573 and 1 ecological study574 investigated body
and decrease cholesterol absorption.518 Bile cholesterol lev- fatness (as measured by BMI) and lung cancer.
els are also gender-linked: women excrete more cholesterol Twenty cohort studies showed decreased risk with
in bile than men. increased body fatness42 57 76 88 122 529-545; this was statistical-
Owing to the link between gallstones and gallbladder can- ly significant in 12 studies,42 76 122 531 533-535 540 542 543 545 and in
cer, the Panel reviewed the dietary causes of having gall- women but not men in another study.536 One study showed
stones, especially in relation to body fatness. BMI increased no effect on risk.144 Meta-analysis was possible on 14 cohort
the risk of having gallstones in a linear fashion.519 Waist cir- studies,57 88 122 144 530 532 534 535 537 538 540 543-545 giving a summary
cumference was associated with gallstone risk in men, inde- effect estimate of 0.98 (95% CI 0.980.99) per kg/m2, with
pendently of BMI,520 and insoluble fibre in the diet showed high heterogeneity. This would produce a decreased risk of
224
C H A P T E R 6 B O D Y C O M P O S I T I O N , G R O W T H , A N D D E V E L O P M E N T
but not the direction of the effect. Folsom 2000 1.03 (1.011.05)
Beggs and Eggers tests suggested publication bias; that Maclnnis 2004 1.08 (1.041.13)
is, the smaller the study, the stronger the protective associ- Pischon 2006 Men 1.04 (1.041.13)
ation observed. Smaller studies, with results of weak or no
association, appear to have been less likely to be published. Pischon 2006 Women 1.03 (1.011.06)
Twenty-two case-control studies showed decreased risk Summary estimate 1.05 (1.031.07)
with increased body fatness,546-560 562-570 572 573 which was sta-
tistically significant in nine.548 550 551 553 557 563 564 566 567 570 572
0.8 0.9 1 1.1 1.2
Two studies showed increased risk,561 571 which was statisti-
Relative risk, per inch
cally significant in one.561 Meta-analysis was possible on 10
case-control studies,546 550 554 555 557 566-568 570 572 giving a sum-
mary effect estimate of 0.98 (95% CI 0.980.99) per kg/m2,
with low heterogeneity. The effect estimate was unchanged
when three studies that did not adjust for smoking were
excluded from the analysis.546 568 572
Figure 6.1.23 Waist to hip ratio and colorectal cancer;
The single ecological study showed a non-significant asso- cohort studies
ciation between increased body fatness and decreased risk.574
Smoking is the principal cause of lung cancer and may also Relative risk (95% CI)
be associated with lower BMI. There is a high potential for
confounding due to cigarette smoking, and residual con- Giovanucci 1995 Men 1.72 (1.102.68)
founding is therefore possible. In addition, it is possible that Martinez 1997 Women 1.27 (0.971.66)
people with undiagnosed lung cancer may lose weight, so Folsom 2000 Women 1.16 (1.031.29)
There is no known mechanism through which greater body Pischon 2006 Women 1.27 (1.111.46)
fatness could plausibly protect against lung cancer, or Pischon 2006 Men 1.30 (1.081.55)
through which low body fatness could increase risk. Summary estimate 1.30 (1.171.44)
6.1.3.2 Abdominal fatness five.87 97 115 137 142 Meta-analysis was possible on five cohort
Colorectum studies, giving a summary effect estimate of 1.30 (95% CI
Seven cohort studies87 92 97 115 118 137 142 and two case-control 1.171.44) per ratio increment of 0.1, with moderate het-
studies investigated waist circumference and colorectal erogeneity (figure 6.1.23). Most case-control studies report-
cancer. Six cohort studies82 87 92 97 115 137 142 and four case- ed increased risk with increased waist circumference.
control studies investigated waist to hip ratio. Because of the abundant prospective data from cohort
studies, case-control studies were not summarised.
Waist circumference The general mechanisms through which body fatness and
All seven cohort studies showed increased risk with increased abdominal fatness could plausibly influence cancer risk are
waist circumference, which was statistically significant in outlined in 6.1.3 (also see box 2.4). Many of these, such as
six.87 97 115 118 137 142 Meta-analysis was possible on four cohort increased circulating oestrogens and decreased insulin sen-
studies, giving a summary effect estimate of 1.05 (95% CI sitivity, are particularly associated with abdominal rather
1.031.07) per 2.5 cm (1 inch), with moderate heterogeneity than overall body fatness.
(figure 6.1.22). Both case-control studies reported increased
risk with increased waist circumference. There is ample, consistent epidemiological evidence
with a clear dose response and robust evidence for
Waist to hip ratio mechanisms that operate in humans. The evidence
All six cohort studies showed increased risk with increased that abdominal fatness is a cause of colorectal cancer
waist to hip ratio, which was statistically significant in is convincing.
225
P A R T 2 E V I D E N C E A N D J U D G E M E N T S
The Panel is aware that since the conclusion of the SLR, three Waist to hip ratio
cohort studies31 142 143 have been published. This new infor- Six cohort studies showed increased risk with increased waist
mation does not change the Panel judgement (see box 3.8). to hip ratio,157 159 163 170 174 180 187 199 575 which was statistical-
ly significant in four.163 170 187 199 575 Two studies showed non-
Pancreas significant decreased risk.189 576 Meta-analysis was possible
Three cohort studies investigated waist circumference and on five cohort studies, giving a summary effect estimate of
pancreatic cancer.46 74 Two cohort studies investigated waist 1.19 (95% CI 1.101.28) per ratio increment of 0.1, with
to hip ratio51 74 and one investigated patterns of weight gain.49 moderate heterogeneity (figure 6.1.24).
Five case-control studies showed increased risk with
Waist circumference increased waist to hip ratio,242 247 297 308 321 which was statis-
All three cohort studies showed increased risk with increased tically significant in three.242 297 308 Three studies showed
waist circumference, which was statistically significant in one. non-significant decreased risk.241 248 304 Meta-analysis was
Effect estimates were 1.32 (95% CI 0.732.37) per 20 cm (7.9 possible on seven case-control studies, giving a summary
inches) in women,46 1.74 (95% CI 1.003.01) per 20 cm (7.9 effect estimate of 1.07 (95% CI 1.001.14) per ratio incre-
inches) in men,46 and 1.13 (95% CI 1.011.26) per 10 cm ment of 0.1, with moderate heterogeneity (figure 6.1.24).
(3.9 inches).74 The latter study was published after the cut- The general mechanisms through which abdominal fatness
off date for inclusion in the SLR. However, the Panel was could plausibly influence cancer risk are outlined in 6.1.3
aware of the study and agreed to include it in its considera- (also see box 2.4). Many of these, such as increased circu-
tion of this exposure. lating oestrogens and decreased insulin sensitivity, are par-
ticularly associated with abdominal rather than overall
Waist to hip ratio body fatness.
Both cohort studies showed increased risk with increased waist
circumference, which was statistically significant in one. Effect There is a substantial amount of epidemiological
estimates were 1.12 (95% CI 0.811.55; high versus low)51 evidence but some inconsistency. There is robust
and 1.24 (95% CI 1.041.48) per ratio increment of 0.1.74 The evidence for mechanisms that operate in humans.
latter study was published after the cut-off date for inclusion Abdominal fatness is a probable cause of
in the SLR. However, the Panel was aware of the study and postmenopausal breast cancer.
agreed to include it in its consideration of this exposure.
Cohort
There is a substantial amount of epidemiological Kaaks 1998 2.04 (1.173.53)
evidence, generally consistent, and there is evidence for Wirfalt 2004 1.49 (1.112.01)
plausible mechanisms. Abdominal fatness is a probable Gapstur 1992 1.18 (1.051.31)
control studies207 242 304 investigated waist circumference and Attanamongkolg 2002 1.68 (1.132.49)
postmenopausal breast cancer. Eight cohort studies157 159 163 Hall 2000 White women 1.34 (1.001.81)
Hall 2000 Black women 1.34 (0.902.00)
170 174 180 187 189 199 575 576
and eight case-control studies241 242 Friedenreich 2002 1.32 (1.101.58)
247 248 297 304 308 321
investigated waist to hip ratio. Sonnichsen 1990 1.0 (0.921.12)
Franceschi 1996 0.97 (0.861.10)
All eight cohort studies showed increased risk with increased Petrek 1993 0.76 (0.411.42)
Summary estimate 1.07 (1.001.14)
waist circumference, which was statistically significant in
two.157 180 199 Meta-analysis was possible on four cohort stud-
0.25 1 2 3 4
ies,159 170 575 577 giving a summary effect estimate of 1.05 (95% Relative risk, per 0.1 increment
CI 1.001.10) per 8 cm (3.1 inches), with no heterogeneity.
All three case-control studies showed increased risk with
increased waist circumference, which was statistically sig-
nificant in two.207 242
226
C H A P T E R 6 B O D Y C O M P O S I T I O N , G R O W T H , A N D D E V E L O P M E N T
Figure 6.1.25 Waist to hip ratio and endometrial cancer; particularly associated with abdominal rather than overall
cohort and case-control studies body fatness.
when compared to the lowest.137 368 373 374 376 The effect esti- Brestom 2001 1.11 (0.991.24)
Folsom 1990 1.11 (1.031.20)
mate was 1.96 (95% CI 1.432.71) or 1.33 (95% CI Huang 1997 1.05 (1.021.08)
1.181.51) per ratio increment of 0.1 (figure 6.1.25).373 An Barnes-Josiah 1995 1.03 (1.021.03)
earlier report from the same study adjusted for BMI, which Summary estimate 1.03 (1.021.04)
showed non-significant decreased risk.446 Meta-analysis was Franceschi 1996 1.04 (1.001.07)
Trentham-Dietz 2000 0.97 (0.931.01)
possible on four case-control studies, giving a summary effect Summary estimate 1.05 (1.041.07)
estimate of 1.45 (95% CI 1.002.09) per ratio increment of
0.1, with high heterogeneity (figure 6.1.25). All four of these
case-control studies were adjusted for BMI. 0.5 1 1.5
Relative risk, per 5 kg gained
The general mechanisms through which abdominal fatness
could plausibly influence cancer risk are outlined in 6.1.3
(also see box 2.4). Many of these, such as increased
circulating oestrogens and decreased insulin sensitivity, are
227
P A R T 2 E V I D E N C E A N D J U D G E M E N T S
6.1.5 Conclusions
228
C H A P T E R 6 B O D Y C O M P O S I T I O N , G R O W T H , A N D D E V E L O P M E N T
In the judgement of the Panel, the factors listed below modify the risk of cancer. Judgements are graded according to the strength of the evidence.
Substantial
effect on risk None identified
unlikely
1 Adult attained height is unlikely to directly modify the risk of cancer. It is a marker for genetic, environmental, hormonal, and also nutritional factors affecting
growth during the period from preconception to completion of linear growth (see 6.2.1.3).
For an explanation of all the terms used in the matrix, please see chapter 3.5.1, the text of this section, and the glossary.
Growth in childhood is a predictor of age at sexual cancers of the colorectum and breast (postmenopause) is
maturity and eventual adult attained height. Food quantity convincing; and they probably also increase the risk of
and quality, and the extent of infections and infestations cancers of the pancreas, breast (premenopause), and ovary.
during crucial periods of growth, are critical in determining There is limited evidence suggesting that the factors that
speed of growth. Rate of growth has metabolic and lead to greater adult attained height, or its consequences,
hormonal effects, which can trigger lifelong consequences. increase the risk of endometrial cancer.
Since the recognition of the vital importance of nutrition In addition, the factors that lead to greater birth weight,
to human health and welfare, public health nutrition policy or its consequences, are probably a cause of
has emphasised the need for birth weights and rates of premenopausal breast cancer.
growth within ranges defined as those most likely to ensure A major question for future research is: what are
physical and mental development in childhood, and good the factors that determine height in adult life? And, given
health in adult life. Such policies are essential. New the theme of this Report, what is the relative importance
standards based on the ideal pattern of growth of healthy, of genetic and environmental factors, what is the role
breastfed infants have now been agreed by the World of nutrition, and when in the life course are nutritional
Health Organization. factors most relevant? Weighing such evidence, given
Overall, the Panel judges that evidence on the factors that that adequate birth weight and growth are essential for
lead to greater adult attained height, or its consequences, good health in infancy and childhood, and throughout
and the risk of cancers of a number of sites, is strong, life, is a major challenge for the biological and nutritional
consistent, and impressive. The Panel emphasises that sciences.
greater adult attained height, meaning how tall people are Within the remit of this Report, the strongest evidence,
as adults, is unlikely directly to modify the risk of cancer. It corresponding to judgements of convincing and
is a marker for genetic, environmental, hormonal, and probable, shows that the factors that lead to greater adult
nutritional factors affecting growth during the period from attained height, or its consequences, are a cause of cancers
preconception to completion of linear growth. of the colorectum and breast (postmenopause), and
probably also of cancers of the pancreas, breast
The Panel concludes: (premenopause), and ovary. In addition, the factors that
The evidence that the factors that lead to greater adult lead to greater birth weight, or its consequences, probably
attained height, or its consequences, increase the risk of increase the risk of premenopausal breast cancer.
229
P A R T 2 E V I D E N C E A N D J U D G E M E N T S
Linear growth, from preconception to adulthood, influences most sensitive to the availability of energy and nutrients.
health and well-being throughout life, as do body composi- Brain growth is protected more effectively than growth in
tion and shape. stature, which is protected more effectively than weight. So
Standards for birth weight and growth developed by the timing of an adverse influence on growth tends to be
expert panels for relevant United Nations agencies, and reflected in a persons body shape, both as a child and as an
approved by UN member states, form the basis for nation- adult. For instance, for lean tissue to be deposited efficient-
al, municipal, and local paediatric health policies and pro- ly and effectively, the appropriate pattern of nutrients must
grammes throughout the world. The WHO/UNU Multicentre be available in a timely way.
Growth Reference Study (MGRS) of healthy, breastfed If any nutrients are limited but energy intake is adequate
children is the basis for the WHO 2006 growth standards for or more than adequate a person will be predisposed
children aged 05 years.593 to excess body fatness. This is because their energy intake
However, no growth standard has been validated in terms will exceed the nutrients available in the body for laying
of lifelong risk for chronic diseases, including cancer. As with down lean tissue, so the excess energy is stored as fat. People
body weight (see chapter 6.1), policies and programmes con- who were of low birth weight have a greater tendency to
cerned with the physical and mental development of infants store fat, in particular abdominally.
and children, and growth until adulthood, have focused on
the need to protect populations against the consequences of 6.2.1.1 Birth weight
inadequate nutrition and retarded growth. This remains a A babys size and shape at birth indicates the extent and
central public health priority for middle- and low-income quality of intra-uterine growth and development. Birth
countries. weight can be measured simply and reliably, whereas head
In the 1990s, increasing concern, based on emerging evi- circumference, which marks growth of the brain, and length,
dence, was expressed by the scientific community in this which marks linear growth, are more difficult to measure reli-
field.594 The concern has been that the agreed standards had ably. Within the usual range, heavier (and longer) babies
overshot the mark for optimum growth and health. For sev- tend to become taller children and adults.
eral reasons, the agreed growth standards for the first peri- Birth weight predicts the risk of death and of various dis-
od of life seemed to have been set unnecessarily and eases in infancy and later in life. Very low birth weight
unhelpfully high. This perception was heightened by evi- less than 2.5 kg (5.5 lbs) for boys and 2.4 kg (5.3 lbs) for
dence of rapidly increasing rates of childhood overweight girls increases the risk of perinatal death and disease, or
and obesity, which tend to track into adult life (see box 8.3). death in infancy and young childhood, usually because of
As a result, new standards based on breastfed children were increased vulnerability to infection and infestation. It is well
agreed and ratified, and issued in 2005, as guides to opti- established, at least in high-income countries, that smaller
mum growth.593 size at birth, and at 1 year of age, predicts increased risk of
This is the general context in which the Panel has exam- chronic disease such as cardiovascular disease and type 2
ined the evidence on growth and development, and the risk diabetes during adult life.596 This is due to a reduced capac-
of cancer. ity to cope with the stress of environmental challenges, such
as a poor diet (including excess energy) and physical inac-
tivity. Very high birth weight may also be associated with
6.2.1 Definitions and patterns increased risk for instance, maternal diabetes or poor glu-
cose homeostasis can cause higher birth weight as well as
Growth increases metabolic capacity and also the ability to increased risk of diabetes in the infant.597 These findings
cope with environmental challenge. From a single cell at con- have been shown to be independent of smoking or socio-
ception, human growth progresses through embryogenesis economic status, although they may be accentuated in
and fetal development, involving cellular multiplication and the presence of these additional stress factors.598
differentiation in both structure and function. At birth, the The extent to which body fatness is a factor in any rela-
bodys tissues and organs are highly organised and regulat- tionship between low birth weight and disease in later life
ed. The timing and order of these processes are determined remains unclear. The associations described above are
by the selective expression of genes, which is both innate and strongest when low birth weight, or restricted fetal growth,
modifiable by the wider environment, including the avail- is followed by rapid growth during early childhood.599-602
ability of oxygen, energy, and nutrients. Nutrients also act Such effects can be experimentally induced in animals, lend-
by regulating hormones, growth factors, binding proteins, ing weight to the observed associations in humans being
and receptors, and their activity. causal.
For every tissue or organ, adverse environmental influ-
ences during critical periods of development, such as limit- 6.2.1.2 Infant and prepubertal growth
ed energy or nutrients, can restrict development and future The fetalinfant growth phase slows during the second half
capacity for function. The timing, severity, and duration of of the first year of life. The childhood phase of growth
any adverse exposure will determine the extent and pattern becomes established at 618 months. Any delay in the onset
of any restriction in capacity. of this growth phase tends to lead to shorter stature during
Growth can be divided into three phases: fetalinfant, childhood. Over an extended period of time, growth in
childhood, and puberty.595 During the first period, growth is height and weight is a smooth process, although there may
230
C H A P T E R 6 B O D Y C O M P O S I T I O N , G R O W T H , A N D D E V E L O P M E N T
be growth spurts or times of little change over shorter peri- supplies become more secure; it continues to increase when
ods. Growth, through the formation of new tissue, requires food is abundant (also see chapter 1.1). This trend has now
a dietary supply of energy (about 5 kilocalories per gram of slowed or even stopped in most high-income countries.
new tissue) and macronutrients such as amino acids and Increases in height between generations are generally due
fatty acids, as well as vitamins, minerals, and trace elements. to increased leg, rather than spine, length. Leg length is
Each individual factor is vital; if any are limited they will con- linked to prepubertal growth, particularly to infancy (below
strain normal growth and development. the age of 5); after this age, trunk growth becomes more
At any age, therefore, normal development requires prominent.604 605
appropriate genetic, hormonal, and nutritional factors to Growth hormones, insulin-like growth factors, and sex
support growth. These in turn require adequate quantity and hormone binding proteins all define the biological activity
quality of food, and minimal exposure to food and environ- of the respective hormones. These in turn impact on height,
mental toxicants, infection, and psychosocial stress. As an growth, sexual maturation (boxes 6.2.1 and 6.2.2), fat stor-
infant gets older, the body is increasingly able to cope with age, and many processes relevant to cancer (box 2.4). It is
environmental challenge. therefore plausible that nutritional factors that impinge on
The pattern and timing of any nutrient shortfall deter- height could also influence cancer risk, with adult height act-
mines the pattern of constrained growth. Patterns of growth ing as a marker of that early life experience, in the same way
failure are highly variable, comprising the differential effects that taller people have a decreased risk of cardiovascular dis-
on linear growth (stunting), weight (underweight and wast- eases, at least in high-income countries.606-608
ing), or on specific tissues. Thus stunting may be due to a Therefore, both birth weight and adult attained height are
period of slow growth or a delay to the onset of the child- markers of an aggregated fetal and childhood experience;
hood phase of growth. If growth has been constrained as the they are clearly also surrogates for important nutritional
result of an adverse circumstance, which is then removed, exposures, which impact on several hormonal and metabol-
there is a drive towards returning to the growth pattern ic axes, and which influence cancer risk (also see Chapter 2).
established previously or to the genetically determined
growth pattern. This catch-up growth may be in height or
weight, or some combination of the two; the term is often 6.2.2. Interpretation of the evidence
used without defining what type of growth is involved.
However, catch-up in linear growth after malnutrition is 6.2.2.1 General
rare beyond the first 23 years of life. For general considerations that may affect interpretation of
In the first 6 months of life, infants who are breastfed and the evidence, see chapters 3.3 and 3.5, and boxes 3.1, 3.2,
then weaned appropriately to mixed diets grow differently 3.6 and 3.7.
from those fed on formula. This is partly related to the
increased risk of infection for formula-fed infants and part- 6.2.2.2 Specific
ly due to the different compositions of human milk and for- Some considerations specific to growth and development are
mula feed. Normal child growth (under optimal as follows.
environmental conditions) from birth to 5 years is specified
in the WHO Child Growth Standards.593 Measurement. Weight at birth is usually recalled accurately
Throughout the world, particularly in high- and middle- by parents. As well as full height, proxy measures may be
income countries, and in urban areas generally, childhood used in some studies, including leg length, sitting height, or
obesity and type 2 diabetes are becoming more common. a ratio of these two. The ratio between overall height and
Childhood overweight and obesity often persists into adult limb length varies with genetic background and nutritional
life. This exposes people to the hormonal and physiological experience over the life course.
consequences of being overweight or obese earlier in adult
life, increasing their risk of related health problems at a rel-
atively young age (also see box 8.3). 6.2.3 Evidence and judgements
6.2.1.3 Adult attained height The full systematic literature review (SLR) is contained on
Genetic and early life environmental factors, even before the CD included with this Report.
birth, are important in determining adult height. The envi- As indicated in 6.2.1.3, there are several general mecha-
ronmental determinants of height attained in adulthood are nisms through which the factors that lead to greater adult
highlighted by the variation between generations in adop- attained height, or its consequences, could plausibly influ-
tion and migrant studies, where children are moved from a ence cancer risk. However, adult attained height is unlikely
poor or limited nutritional background to an area of high or to directly modify the risk of cancer. It is a marker for genet-
even overnutrition.603 Adult height is also linked to birth ic, environmental, hormonal, and also nutritional factors
weight, rate of growth, and age of puberty. Periods of peak affecting growth during the period from preconception to
growth (such as in infancy and adolescence) are particular- completion of linear growth. For example, adult height is the
ly important in determining adult height. result of several stages of growth from fetal life through
Adult height increases as populations become less vulner- childhood. These are all influenced by nutrition, particular-
able to undernutrition, infestation, and infection, and as food ly in infancy, which in turn affects hormone levels, and there-
231
P A R T 2 E V I D E N C E A N D J U D G E M E N T S
Sexual maturity is the biological capability halted.609 In low-income countries, and Nutrition, birth weight, rates of growth,
to have children. In girls, this is charac- particularly among the most disadvan- body fatness, and age of sexual maturity
terised by ovulatory cycles and/or menar- taged populations, the average age of are all connected. The effects of these
che, the onset of menstruation. In boys, menarche may be as high as 16.610 These factors may be different in either sex,
pubertal stages are less easy to charac- trends show the impact of environmental with increased body fatness lowering
terise, and indirect markers (secondary sex influences on age at menarche. the age at menarche but slowing male
characteristics) are used, such as the age of Adrenal sex hormone production nor- sexual maturation.611 Conversely, early
appearance of pubic hair. As a conse- mally rises at around 6 years of age menarche increases the risk of adult
quence, there are more data for sexual (adrenarchy) and coincides with a rise in obesity.
maturation in girls than boys. BMI (adiposity rebound). Growth hor- Undernutrition delays the onset of
There is considerable variation in the mone, insulin-like growth factors, and sex puberty in both boys and girls.612 Regular,
age of sexual maturity, both between and hormone binding proteins all define the intense physical activity can delay menar-
among populations. In high-income coun- biological activity of the respective hor- che or cause menstruation to stop in later
tries, the average age of menarche ranges mones. life. The combination of low birth weight
from 1213 years; this has dropped by Children with an early adiposity and rapid growth in early childhood also
around 3 years over the last 150 years, rebound have earlier sexual maturation accelerates the development of sexual
although the change has now generally and higher risk of later obesity. maturity.
fore many processes relevant to cancer (box 2.4). Site-spe- (95% CI 1.061.12) per 5 cm (2 inches), with no hetero-
cific mechanisms are described with the evidence for each geneity (figure 6.2.1).
cancer site. A dose-response relationship was apparent from cohort
data.
6.2.3.1 Adult attained height Because of the abundant prospective data from cohort
Colorectum studies, case-control studies were not summarised.
Twenty-one cohort studies58 80 82-84 87 88 91 93 108 109 115 117 119 120 The general mechanisms through which the factors that
and 16 case-control studies investigat-
124 126 133 140 142 621-625
lead to greater adult attained height, or its consequences,
ed adult attained height and cancer of the colon and rectum. could plausibly influence cancer risk are outlined in 6.2.1.3
Eighteen cohort studies showed increased risk with (also see box 2.4). Many of these, such as early-life nutri-
increased adult attained height58 80 82-84 87 88 109 115 117 120 124 tion, altered hormone profiles, and the rate of sexual matu-
126 142 622-625
; this was statistically significant in six,58 80 87 124 ration, could plausibly increase cancer risk
623 624
and in another study in men, but not in women.108 119
621
One study showed non-significant increased risk in There is ample prospective epidemiological evidence,
men and no effect on risk in women.140 Two studies showed which is consistent, and there is a clear dose response,
no effect on risk.91 93 133 Meta-analysis was possible on 12 with evidence for plausible mechanisms operating in
cohort studies, giving a summary effect estimate of 1.09 humans. The evidence that factors that lead to greater
Early menarche is an established risk factor pants) reported a 7 per cent per year whole period of adolescence and early
for breast cancer. From pooling project decrease in breast cancer risk with increas- adulthood.617
data, based on information from 322 647 ing age of menarche for premenopause The first onset of breast development in
women, 4827 breast cancer cases occurred cases (p < 0.05). Compared to those who girls occurs about two years before menar-
during follow-up, and the fully adjusted had their first period at 11 or younger, che. The years preceding menarche are
risk due to late menarche (at 15 years or women experiencing menarche at 15 years characterised by a sharp increase in adren-
above compared with under 12 years of or older had a risk of 0.66 (95% CI al androgens and the associated appear-
age) was 0.72 (95% confidence interval (CI) 0.450.97). There was no statistically signif- ance of the first pubic and axillary hairs,
0.620.82).613 icant effect for postmenopause cases.615 and the first enlargement of the breasts.
A meta-analysis of 21 epidemiological Menarche marks the start of the cyclic At this age, adrenal androgens play an
studies (including both case-control and production of oestrogen by the ovaries. important role in inducing hypothalamic
cohort) reported a risk reduction of about Therefore early menarche means that a changes leading to menarche.618 In adult-
9 per cent (95% CI 711) for each addition- woman is exposed to more oestrogen over hood, both before and after menopause,
al year of age at menarche. There was also the course of her lifetime.616 This is likely to high serum androgen levels are associated
a statistically significant gradient of risk be the mechanism by which age at menar- with increased breast cancer risk.619 620
when breast cancer was diagnosed early or che influences breast cancer risk. As well as Consequently, nutritional exposures in early
before menopause, and a risk of about 4 a longer lifetime exposure to oestrogen, life that influence sexual maturation in
per cent (95% CI 25) for later diagnoses.614 early menarche may be associated with women are also likely to have an indirect
A large cohort study (100 000 partici- increased oestrogen levels during the impact on later breast cancer risk.
232
C H A P T E R 6 B O D Y C O M P O S I T I O N , G R O W T H , A N D D E V E L O P M E N T
Figure 6.2.1 Height and colorectal cancer; Figure 6.2.2 Height and breast cancer (age unspecified);
cohort studies cohort and case-control studies
of colorectal cancer is convincing. The causal factor is Wenten 2001 1.08 (0.941.25)
Swanson 1989 1.08 (1.031.14)
unlikely to be tallness itself, but factors that promote
Shu 2001 1.08 (1.001.15)
linear growth in childhood. Hirose 1999 1.06 (1.001.11)
Adami 1977 1.05 (0.891.25)
The Panel is aware that since the conclusion of the SLR, three Hsieh 1990 1.04 (0.911.07)
Wenten 2001 1.03 (0.911.17)
cohort studies31 141 145 have been published. This new infor- Silva 2004 1.03 (0.901.17)
mation does not change the Panel judgement (see box 3.8). Yoo 2001 1.02 (0.931.11)
McCredie 1998 1.02 (0.951.09)
Age unspecified
Twenty cohort studies122 150 161 162 164 166 168 171 172 181 186 191 196 0.1 1 2 3 4
and 29 case-control studies205 208 214 218 221
203 627-630 632 634-637
Relative risk, per 5 cm
224 225 234 248 254 259 261 262 269 290 297 306 313 314 318 319 323 324 336 341
233
P A R T 2 E V I D E N C E A N D J U D G E M E N T S
tistically significant in seven.208 218 224 261 297 324 647 Seven stud-
Figure 6.2.3 Height and postmenopausal breast cancer;
ies showed decreased risk,214 225 269 306 313 314 336 646 which was
cohort and case-control studies
statistically significant in one.336 Meta-analysis was possible
on 25 case-control studies, giving a summary effect estimate Relative risk (95% CI)
of 1.03 (95% CI 1.011.04) per 5 cm (2 inches), with mod-
Cohort
erate heterogeneity (figure 6.2.2). Manjer 2001 1.21 (1.051.40)
A dose-response relationship was apparent from cohort Toniolo 1994 1.20 (1.001.44)
All three ecological studies showed increased risk with Vatten 1990 1.18 (0.991.41)
Barrett-Connor 1993 1.17 (0.761.81)
greater adult attained height.361 625 648 Van den Brandt 1997 1.17 (1.081.27)
Galanis 1998 1.16 (1.031.31)
Postmenopause Tryggvaddottir 2002 1.21 (1.031.22)
Twenty-two cohort studies122 151 155-157 162 168 170-172 174 175 178 Tulinius 1997 1.10 (1.001.22)
Tornberg 1998 1.10 (1.071.13)
180 183 185 187 189-191 193 199 200 577 626 631 634 636 637
and 34 case-con- Saadatien-Elahi 2002 1.10 (0.881.37)
trol studies205 206 208 214 217 220 224 225 231 241 242 247 253 256 257 259 261 Sonnenschein 1999 1.09 (0.951.25)
274 280 283 297 304 308 318 327 331 333 338 339 341 352 588 638-640 642 643 646 Kaaks 1998 1.08 (0.851.38)
647
investigated adult attained height and postmenopausal Palmer 2001 1.04 (0.941.14)
Wirfalt 2004 1.00 (0.881.13)
breast cancer. Summary estimate 1.11 (1.091.13)
Twenty-one cohort studies showed increased risk with
greater adult attained height,122 151 155-157 162 168 170-172 174 175 Case control
178 180 183 185 187 189-191 193 577 626 631 634 636 637
which was statisti- Chie 1996 2.35 (1.264.37)
Lebamowo 2003 1.40 (1.101.78)
cally significant in 12.122 155 162 168 171 172 175 178 183 191 193 577 626 Ng 1997 1.27 (1.051.53)
631 636
One study showed no effect on risk.200 Meta-analysis Shu 2001 1.24 (1.081.42)
was possible on 15 cohort studies, giving a summary effect Ziegler 1996 1.18 (0.941.49)
estimate of 1.11 (95% CI 1.091.13) per 5 cm (2 inches), Hansen 1997 1.17 (0.801.72)
Hall 2000 1.16 (1.001.34)
with no heterogeneity (figure 6.2.3). Radimer 1993 1.13 (0.981.31)
Pooled analysis from 7 cohort studies (more than 337 000 Terry 2002 1.13 (1.081.18)
participants, followed up for up to 11 years, with more than De Vasconcelos 2001 1.12 (0.901.40)
4300 breast cancer cases) showed a statistically significant Li 2003 1.11 (1.031.21)
Hislop 1986 1.09 (0.981.22)
increased risk of postmenopausal breast cancer with greater Magnusson 1998 1.08 (1.031.14)
adult attained height. The effect estimate was 1.07 (95% CI Hirose 1995 1.08 (0.991.17)
1.031.12) per 5 cm (2 inches).362 Trentham-Dietz 1997 1.07 (1.041.11)
Twenty-two case-control studies showed increased risk Adami 1977 1.07 (0.961.19)
Yoo 2001 1.06 (1.011.10)
with greater adult attained height,205 208 214 217 224 231 242 253 256 Hsieh 1990 1.05 (0.931.18)
257 259 261 279 280 283 297 318 331 338 339 352 588 638-640 642 643 647
which Li 2000 1.02 (0.941.10)
was statistically significant in 11.208 217 224 253 256 261 297 318 338 Friedenreich 2002 1.00 (0.861.16)
339 639
Nine studies showed non-significant decreased risk.206 Hall 2000 1.00 (0.841.16)
Rattanamongkolg 2002 0.98 (0.961.01)
220 225 241 274 304 327 333 341 646
Two studies showed no effect on Carpenter 2003 0.98 (0.951.00)
risk.308 Another study showed non-significant increased risk Tung 1999 0.97 (0.761.25)
in white women and no effect on risk in black women.247 Petrek 1993 0.97 (0.761.25)
Meta-analysis was possible on 27 case-control studies, giv- Franceschi 1996 0.97 (0.911.03)
Jams-Campbell 1996 0.90 (0.761.08)
ing a summary effect estimate of 1.02 (95% CI 1.011.03)
Taioli 1995 0.88 (0.751.03)
per 5 cm (2 inches), with high heterogeneity (figure 6.2.3). Summary estimate 1.02 (1.011.03)
A dose-response relationship was apparent from cohort
and from case-control data. 0.1 1 2 4
The general mechanisms through which the factors that Relative risk, per 5 cm
234
C H A P T E R 6 B O D Y C O M P O S I T I O N , G R O W T H , A N D D E V E L O P M E N T
Premenopause adult attained height,122 155 162 170 175 176 191 196 626 631 634 637
Seventeen cohort studies 122 155 162 170 175 176 178 185 189-191 196 198
which was statistically significant in two.196 634 637 Six stud-
626 631 634 636 637
and 38 case-control studies205 206 208 214 217 224 ies showed non-significant decreased risk.178 185 189 190 198 636
225 231 241 242 247 248 253 256 257 259 261 272 290 297 303 304 308 312 318 324-
Meta-analysis was possible on 11 cohort studies, giving a
investigated adult attained
327 339 341 346 352 588 638 640 644-647
summary effect estimate of 1.09 (95% CI 1.051.14) per 5
height and premenopausal breast cancer. cm (2 inches), with low heterogeneity (figure 6.2.4).
Eleven cohort studies showed increased risk with greater Pooled analysis from 7 cohort studies (more than 337 000
participants, followed up for up to 11 years, with more than
4300 breast cancer cases) showed a non-significant increased
risk of premenopausal breast cancer with greater adult
Figure 6.2.4 Height and premenopausal breast cancer; attained height. The effect estimate was 1.02 (95% CI
cohort and case-control studies 0.961.10) per 5 cm (2 inches).362
Twenty-three case-control studies showed increased risk
Relative risk (95% CI)
with greater adult attained height,206 208 214 217 224 231 242 247 256
Cohort 257 290 297 304 312 318 324-326 339 341 346 638 644 646 647
which was sta-
Palmer 2001 1.17 (1.081.26)
tistically significant in five.217 290 325 326 339 Thirteen studies
Tulinius 1997 1.16 (0.951.41)
Vatten 1992 1.16 (1.061.27)
showed non-significant decreased risk.205 225 248 253 259 261 272
Tornberg 1988 1.11 (0.981.26)
303 308 327 640 645
Two studies showed no effect on risk.241 352
Kaaks 1998 1.09 (0.931.29) 588
Meta-analysis was possible on 31 case-control studies,
Galanis 1998 1.04 (0.861.25)
giving a summary effect estimate of 1.04 (95% CI 1.021.06)
Manjer 2001 0.99 (0.871.14)
Tryggvadottir 2002 0.99 (0.791.24)
per 5 cm (2 inches), with moderate heterogeneity (figure
Sonnenschein 1999 0.99 (0.841.16) 6.2.4).
Saadatian-Elahi 2002 0.98 (0.801.21) A dose-response relationship was apparent from cohort
Toniolo 1994 0.92 (0.781.09)
and from case-control data.
Summary estimate 1.09 (1.051.14)
The general mechanisms through which factors associat-
Case control ed with adult attained height could plausibly cause cancer
Hall 2000 1.28 (1.001.63) are outlined in 6.2.1.3 (also see box 2.5). Many of these,
Tung 1999 1.25 (0.971.60)
such as early-life nutrition, altered hormone profiles, and the
Petrek 1993 1.24 (0.991.54)
Ng 1997 1.19 (0.911.55)
rate of sexual maturation, could plausibly increase cancer
Adebamowo 2003 1.16 (1.001.34) risk.
Ziegler 1996 1.15 (1.021.31)
McCredie 1996 1.15 (1.021.30)
There are fewer data for premenopausal than for
Adams-Campbell 1996 1.12 (0.891.42)
Swanson 1996 1.12 (1.061.18)
postmenopausal breast cancer. The epidemiological
De Vasconcelos 2001 1.11 (0.771.61) evidence is generally consistent with a dose response
Swanson 1997 1.10 (1.021.18) and evidence for plausible mechanisms. Greater adult
Friedenreich 2002 1.09 (0.961.22)
attained height or factors that lead to it are probably a
Verla-Tebit 2005 1.08 (0.991.18)
Trentham-Dietz 1997 1.08 (1.021.14)
cause of premenopausal breast cancer. The causal
Shu 2001 1.05 (0.951.16) factor is unlikely to be tallness itself, but factors that
McCredie 1998 1.03 (0.951.11) promote linear growth in childhood.
Sanderson 2002 1.02 (0.881.18)
Franceschi 1996 1.00 (0.921.10)
Yoo 2001 1.00 (0.911.10)
The Panel is aware that since the conclusion of the SLR, one
Hsieh 1990 0.99 (0.941.05) cohort study649 has been published. This new information does
Radimer 1993 0.98 (0.831.17) not change the Panel judgement (see box 3.8).
Peacock 1999 0.97 (0.901.04)
Hirose 1995 0.96 (0.891.03)
Hall 2000 0.95 (0.771.17)
Pancreas
Adami 1977 0.95 (0.591.42) Eight cohort studies,40 41 53 58 122 650-652 12 case-control stud-
Taioli 1995 0.94 (0.771.15) ies,60-63 67 70 73 653-657 and 1 ecological study625 investigated
Rattanamonkolg 2002 0.93 (0.801.09) adult attained height and pancreatic cancer.
Hislop 1986 0.92 (0.801.05)
Kumar 2005 0.91 (0.751.12)
Six cohort studies showed increased risk with greater adult
Hansen 1997 0.82 (0.451.49) attained height,40 41 53 122 650 652 which was statistically sig-
Ursin 1994 0.62 (0.113.63) nificant in one.40 One study showed no effect on risk.651
Summary estimate 1.04 (1.021.06) Another stated that there was no significant association.58
Meta-analysis was possible on six cohort studies, giving a
0.1 1 2 3 4 summary effect estimate of 1.11 (95% CI 1.051.17) per 5
Relative risk, per 5 cm cm (2 inches), with low heterogeneity (figure 6.2.5).
The Panel is aware of a further study, published after the
conclusion of the SLR, from the European Prospective
Investigation into Cancer and Nutrition. This reported a sta-
tistically significant increased risk for the highest adult
235
P A R T 2 E V I D E N C E A N D J U D G E M E N T S
Figure 6.2.5 Height and pancreatic cancer; cohort and Figure 6.2.6 Height and pancreatic cancer;
case-control studies cohort studies: dose response
Cohort
Ogren 1996
Ogren 1996 1.00 (0.811.24)
Tulinius 1997 Men 1.19 (0.971.45) Tulinius 1997 Men
Tulinius 1997 Women 1.31 (0.971.77)
Tulinius 1997 Women
Michaud 2001 Women 1.21 (1.021.34)
Stolzenberg-Solomon 2002 Men 1.04 (0.921.17) Michaud 2001 Women
Song 2003 Men 1.07 (0.951.20)
Giovanucci 2004 Men 1.07 (0.941.22)
Stolzenberg-Solomon 2002 Men
Summary estimate 1.11 (1.051.17) Song 2003 Men
236
C H A P T E R 6 B O D Y C O M P O S I T I O N , G R O W T H , A N D D E V E L O P M E N T
data, but not from case-control data. Although there is generally consistent evidence for
Both ecological studies showed an association between prospective epidemiological data, there is some
greater adult attained height and increased cancer inci- inconsistency in the evidence between cohort and
dence.625 671 case-control studies, and the mechanistic evidence is
The general mechanisms through which the factors that speculative. There is limited evidence that greater
lead to greater adult attained height, and its consequences, adult attained height or factors that lead to it are a
could plausibly influence cancer risk, are outlined in 6.2.1.3 cause of endometrial cancer. The causal factor is
(also see box 2.4). Many of these, such as early-life nutri- unlikely to be tallness itself, but factors that promote
tion, altered hormone profiles, and the rate of sexual matu- linear growth in childhood.
ration, could plausibly increase cancer risk.
6.2.3.2 Greater birth weight
There is some inconsistency, but the better quality Breast (premenopause)
epidemiological data show a clearer effect, with a Six cohort studies150 319 678-681 and four case-control studies312
dose-response relationship. There is evidence for 644 682 683
investigated birth weight and premenopausal breast
plausible mechanisms operating in humans. Adult cancer.
attained height or factors that lead to it are probably a All six cohort studies showed increased risk with greater
cause of ovarian cancer. The causal factor is unlikely to birth weight, which was statistically significant in three.150
be tallness itself, but factors that promote linear 679 680
Meta-analysis was possible on four cohort studies, giv-
growth in childhood. ing a summary effect estimate of 1.08 (95% CI 1.041.13)
per kg (2.2 lbs), with high heterogeneity (figure 6.2.8).
The Panel is aware that since the conclusion of the SLR, one Three case-control studies showed increased risk with
cohort study672 and one case-control study673 have been pub- greater birth weight,644 682 683 which was statistically signif-
lished. This new information does not change the Panel judge- icant in one.682 Another study showed non-significant
ment (see box 3.8). decreased risk.312
The general mechanisms through which the factors that
Endometrium lead to greater birth weight, or its consequences, could plau-
Ten cohort studies,168 369 371 372 375 379 382 385 674 675 16 case- sibly influence cancer risk are outlined in 6.2.1.1. Many of
control studies,254 389 396 402 404 409 416 419 420 422-424 434-437 446 453 these, such as long-term programming of hormonal systems,
578 579 657 676 677
and one ecological study625 investigated could plausibly increase cancer risk.
adult attained height and endometrial cancer.
Seven cohort studies showed increased risk with greater There is general consistency amongst the relatively few
adult attained height,168 369 372 375 379 382 674 which was statis- epidemiological studies, with some evidence for a dose
tically significant in one.379 One study showed significant response. The mechanistic evidence is speculative.
237
P A R T 2 E V I D E N C E A N D J U D G E M E N T S
1 2 3
Relative risk, per kg
The Panel is aware that since the conclusion of the SLR, one
cohort363 and one case-control study684 have been published.
This new information does not change the Panel judgement (see
box 3.8).
6.2.5 Conclusions
238
C H A P T E R 6 B O D Y C O M P O S I T I O N , G R O W T H , A N D D E V E L O P M E N T
6.3 Lactation
LACTATION, AND THE RISK OF CANCER
In the judgement of the Panel, the factors listed below modify the risk of cancer. Judgements are graded according to the strength of the evidence.
Probable
Substantial
effect on risk None identified
unlikely
For an explanation of all the terms used in the matrix, please see chapter 3.5.1, the text of this section, and the glossary.
Human milk is the natural, complete food for infants its benefits for the infant and young child during the peri-
until around 6 months of age. There is no completely od of breastfeeding, and then into the stage of weaning, and
adequate substitute. Breastfeeding is natural both for perhaps up to 5 years of age. This remains a central part of
the mother and her child, although some women find public health nutrition science, policy, and practice.687
that they are unable to or do not want to breastfeed. It is only recently that researchers and those concerned
Lactation is the process by which the mother produces with public health policies have paid substantial attention
her milk. to the effects of being breastfed on the health of the child
in later life, and on the effects of lactation on the health of
The Panel judges as follows: the mother.687 688 Thus, the previous report did not investi-
Evidence on lactation, breastfeeding by the mother, and gate what was then the small evidence base on breastfeed-
her risk of breast cancer at all ages thereafter, is strong ing and cancer risk (see 6.3.4).
and consistent. It is supported by strong evidence for As shown in the previous two sections of this chapter, it
plausible biological mechanisms. is becoming increasingly evident that early-life environment,
The Panel concludes that lactation protects against both including food and nutrition, is of fundamental importance
premenopausal and postmenopausal breast cancer. An to health and well-being throughout the life course. This has
implication of this finding, together with those in the important implications for overall judgements and recom-
earlier sections of this chapter, and also as summarised mendations designed to promote health and prevent disease,
and judged in Chapter 8, is that more emphasis should be and for public policy. These aspects are discussed in Part 3
given to factors acting throughout the life course that of this Report, and in an accompanying report on policy
modify the risk of cancer. There is limited evidence implications, to be published in late 2008.689
suggesting that lactation protects against cancer of the
ovary.
Within the remit of this Report, the strongest evidence, 6.3.1 Definition and patterns
corresponding to the judgement of convincing, shows
that lactation breastfeeding by the mother protects In this Report, the term lactation refers to the process by
her against breast cancer at all ages thereafter. which the mother produces milk to breastfeed. While lac-
tating women may express their milk for their own or anoth-
Human milk gives infants the best start in life. The view er child, or for storage in human milk banks, lactation is
sometimes expressed in the past, that infant formula may in usually synonymous with breastfeeding.
normal circumstances be a complete substitute for human Breastfeeding provides a complete source of nourishment
milk, is no longer held.685-687 for newborns and young infants, and human milk also con-
The main focus of attention on breastfeeding and human tains immunologically active components. The UN global
milk, throughout almost all of the last century, has been on strategy for infant and young child feeding recommends
239
P A R T 2 E V I D E N C E A N D J U D G E M E N T S
exclusive breastfeeding up to 6 months for the health of both results from minimal amounts of breastfeeding exclusive
mother and child.687 or not are combined with results from extended and exclu-
A mothers breasts change during pregnancy to prepare for sive breastfeeding.
lactation, although milk is not produced until after the baby
is born. Pituitary hormones promote milk production after 6.3.3 Evidence and judgements
birth, with suckling acting as the stimulus to let down milk
and to continue its production. During breastfeeding, men- The full systematic literature review (SLR) is contained on
struation reduces and often stops (amenorrhea). In almost the CD included with this Report.
all mammals, including humans, lactation induces a period
of infertility, which increases birth spacing. Babies tend to The principal mechanism through which lactation or breast-
be weaned earlier in high-income countries. It is recom- feeding could plausibly influence cancer risk is the hormonal
mended that solid foods are not introduced until the infant influence of the associated period of amenorrhea and infer-
is around 6 months old. With decreased suckling, lactation tility. This decreases lifetime exposure to menstrual cycles
slows and then stops, and this is usually accompanied by a and therefore alters hormone levels, particularly androgens,
return to normal menstruation. which can influence cancer risk (box 2.4). Site-specific mech-
Breastfeeding was almost universal at the beginning of the anisms are described with the evidence for each cancer site
20th century. It declined in the mid-1900s, but has been discussed below.
increasing since the 1970s.690 However, disparity remains
with socioeconomic status of mothers.691 In some low- Breast
income countries, high socioeconomic class or education One cohort study636 696 and 37 case-control studies207 208 219
level of mothers is associated with reduced breastfeeding, 244 249 254 264 294-297 302 354 355 591 697-720
investigated ever having
whereas the opposite is true in many high-income coun- breastfed, as compared to never having breastfed, and breast
tries.692 Older mothers and those educated to a higher level cancer. Five cohort studies164 177 721-724 and 55 case-control
are more likely to breastfeed in high-income countries.693 694 studies213 215 216 229 232 244 246 254 262 273 279 281 290-292 295 296 299-302
In Africa, more than 95 per cent of infants are breastfed, 306 312 318 335 337 340 349 355 356 697 699 701-705 707 712-714 717 725-748
inves-
often for a long duration, although exclusivity is low and the tigated the total duration of lactation.
rising prevalence of HIV may reduce breastfeeding.695 Also
see chapter 4.11. Ever compared to never
The single cohort study showed a statistically significant
decreased risk for ever having breastfed when compared to
6.3.2 Interpretation of the evidence never. The effect estimate, which was adjusted for repro-
ductive factors, was 0.95 (95% CI 0.910.99) per month of
6.3.2.1 General breastfeeding, based on 1120 cases (age unspecified). A sta-
For general considerations that may affect interpretation of tistically significant decreased risk was observed for pre-
the evidence, see chapters 3.3 and 3.5, and boxes 3.1, 3.2, menopausal breast cancer, 0.76 (95% CI 0.590.99) per
3.6 and 3.7. month of breastfeeding, but not for postmenopausal breast
cancer, 0.96 (95% CI 0.911.01) per month of breastfeed-
6.3.2.2 Specific ing.636 696
Some considerations specific to breastfeeding and lactation Twenty-eight case-control studies investigated breast can-
are as follows. cer (age unspecified).207 208 219 244 254 264 294 295 354 355 591 697 700
703-708 710-713 715-720
Twenty-four of these showed decreased
Patterns and ranges of duration. Most studies have been car- risk for ever having breastfed when compared to never,207 208
ried out in high-income countries where, since the second half 219 244 254 264 294 295 302 354 355 591 700 703-707 710-713 715-720
which was
of the 20th century and until recently, duration of breast- statistically significant in 10 studies.244 264 294 707 713 716 717 719
feeding exclusive or not has usually been brief. Therefore 720
Four studies showed non-significant increased risk.219 302
the findings of these studies may be of limited relevance to 697 708
areas of the world where breastfeeding practices differ. Sixteen case-control studies investigated premenopausal
breast cancer.207 208 244 249 295 297 355 698 699 701 702 705 707 709 712 714
Classification. Reports (as distinct from studies) concerned 716 718
Fourteen of these showed decreased risk for ever hav-
with chronic diseases have not usually considered breast- ing breastfed when compared to never,244 249 295 297 355 698 701
feeding or other factors specific to infancy and childhood, 702 705 707 709 712 714 716 718
which was statistically significant in
despite what is now the general agreement that the out- four.295 297 698 714 716 Two studies showed non-significant
comes of early life experience tend to track into adult life. increased risk.207 208 699
Also, there is no agreed classification for duration and exclu- Fourteen case-control studies investigated postmenopausal
sivity of breastfeeding. breast cancer.244 296 355 698 699 701 702 707 709 712-714 716 718 Ten of
these showed decreased risk for ever having breastfed when
Measurement. Studies reporting on breastfeeding use the compared to never,244 249 295 296 355 698 701 702 705 707 709 712-714 716
term with different meanings. Some studies have simply dis- 718
which was statistically significant in six.296 698 701 707 716 Four
tinguished between ever and never, which means that studies showed non-significant increased risk.249 295 699 705
240
C H A P T E R 6 B O D Y C O M P O S I T I O N , G R O W T H , A N D D E V E L O P M E N T
Siskind 1989 1.02 (0.961.08) increased total duration of lactation,215 229 244 254 262 273 281 290
Abramson 1966 1.02 (0.901.15)
295 299-302 306 318 335 337 349 355 356 703-705 707 713 717 725-727 729 734 736
Mendoca 1999 1.02 (0.941.10) 737 742-745 747 748
which was statistically significant in 18 stud-
Wrensch 2003 1.00 (0.871.15)
Trentham-Dietz 2000 1.00 (0.951.05)
ies.215 244 254 273 281 300 337 349 705 707 713 717 726 727 736 737 743 747 748
Do 2003 1.00 (0.961.04) Six studies showed non-significant increased risk291 292 697 730
Tessaro 2003 0.99 (0.931.06)
735 738 740 741
and three studies showed no effect of risk.232 340
Newcomb 1994 0.99 (0.971.01) 712
Meta-analysis was possible on 37 case-control studies,
Thomas 1993 0.99 (0.981.00)
Coogan 1999 0.99 (0.961.01)
giving a summary effect estimate of 0.98 (95% CI 0.970.98)
Gao Yu Tang 2000 0.99 (0.951.03) per 5 months of total breastfeeding, with moderate hetero-
Shu 2001 0.98 (0.951.00) geneity (figure 6.3.1).
Lai FuMing 1996 0.98 (0.931.03) Twenty-six case-control studies investigated pre-
Yavari 2005 0.97 (0.940.99)
menopausal breast cancer.216 244 254 281 290 295 312 337 355 699 701
McCredie 1998 0.96 (0.921.01)
Tao 1988 0.96 (0.940.99)
702 705 707 712-714 728-732 739 741 743 745 746 748
Twenty-four studies
Hu 1997 0.96 (0.911.02) showed decreased risk with increased total duration of lac-
Zheng 2001 0.96 (0.911.01) tation,216 244 254 281 290 295 312 337 355 699 701 702 705 707 712-714 728 729
Kuru 2002 0.95 (0.930.98) 731 732 739 743 745 746 748
which was statistically significant in
Layde 1989 0.95 (0.930.97)
Lopez-Carillo 1997 0.95 (0.920.99)
eight.254 295 707 713 714 732 739 745 746 One study showed no effect
Wenten 2001 0.95 (0.881.02) on risk741 and one study reported non-significant increased
Romieu 1996 0.95 (0.920.97) risk.730 Meta-analysis was possible on 19 case-control stud-
Hirose 1999 0.94 (0.900.98)
ies, giving a summary effect estimate of 0.98 (95% CI
Furberg 1999 0.94 (0.890.99)
Olaya-Contreras 1999 0.94 (0.880.99)
0.970.98) per 5 months of total breastfeeding, with mod-
Park 2000 0.93 (0.861.01) erate heterogeneity.216 244 254 281 295 312 355 701 702 712-714 729-732 741
Zheng 2000 0.93 (0.871.00) 743 745 746 748
Potischman 1990 0.93 (0.801.07)
Twenty-three case-control studies investigated post-
Yuan 1988 0.93 (0.880.98)
Wenten 2001 0.92 (0.841.00)
menopausal breast cancer.213 216 244 246 254 279 281 295 296 337 355
Haring 1992 0.91 (0.781.06)
699 701 702 705 707 712-714 728 730 731 739 741 743 748
Fourteen showed
Brandt 2004 0.90 (0.820.99) decreased risk with increased total duration of lactation,213
Becher 2003 0.90 (0.820.98) 216 244 246 279 281 296 337 355 699 701 705 707 713 714 728 745 746 748
which
Lee 2004 0.87 (0.790.86)
Summary estimate 0.98 (0.970.98)
was statistically significant in three.213 337 701 707 Two studies
showed no effect on risk739 743 and seven reported non-sig-
nificant increased risk.254 295 702 712 730 741 745 746 Meta-analysis
0.8 1 1.2 1.4
was possible on 18 case-control studies, giving a summary
Relative risk, per 5 months
effect estimate of 0.99 (95% CI 0.981.00) per 5 months of
total breastfeeding, with low heterogeneity.244 246 254 279 281 296
355 701 702 712 714 730 731 739 741 743 745 746
241
P A R T 2 E V I D E N C E A N D J U D G E M E N T S
There is robust evidence for plausible mechanisms that The Panel is aware that since the conclusion of the SLR, one
operate in humans. The evidence that lactation case-control study761 has been published. This new information
protects against both premenopausal and does not change the Panel judgement (see box 3.8).
postmenopausal breast cancer is convincing.
0.5 1 1.5 2
Relative risk, per 6 months
242
P A R T 2 E V I D E N C E A N D J U D G E M E N T S
C H A P T E R 7
Cancers
Every year an estimated 11 million people are The sequence of the sections of this chapter
diagnosed with cancer (excluding skin cancers) and corresponds roughly with the bodys systems, or
nearly 7 million people are recorded as dying from with sites that have anatomical, metabolic,
cancer. Projections for 2030 predict that these hormonal, or other features in common, and
figures will double. Cancer is increasing at rates generally follows the sequence of the previous
faster than the increase in global population. It is report.
becoming more common in high-income but also The structure of all the sections, where evidence
and most of all in middle- and low-income derives from these systematic reviews, is identical.
countries, absolutely and also relative to other After brief introductions, matrices display the
diseases. Panels judgements. In this chapter, the Panels
The scientific community is convinced that judgements also include the Limited no
inherited high susceptibility to cancer accounts for conclusion category, where evidence is, in the
only a small proportion of cases. Although we are Panels view, of such poor quality, or too sparse,
all more or less susceptible to various diseases, confused, or conflicting, to allow a conclusion.
most adult cancers are caused mainly by Footnotes to these matrices include important
environmental factors. This means that most explanations or qualifications.
cancers are at least in theory preventable. Then follow subsections on trends, incidence, and
One important cause of cancer is smoking, or survival; pathogenesis; and other established
other exposure to, tobacco. Infection, infestation, causes. The next subsection concerns interpretation
solar radiation, and other factors are also of the evidence, in which issues and problems
important. Food and nutrition, physical activity, related to specific cancer sites are summarised.
body composition, and other associated factors are Evidence and judgements are the central
also individually and collectively important subsections throughout this chapter. Here, the
modifiers of cancer risk. But there is a difference. evidence from the SLRs, reported more extensively
Smoking and exposure to tobacco, and these other with graphics in Chapters 4, 5, and 6, is also
factors, are all causes of cancer. By contrast, this summarised. The sequence of these subsections is
and the previous chapters show that food and the same as that of Chapters 46. The strongest
nutrition, and physical activity can protect against evidence on protection from cancer comes first,
cancer. When we are able to do so, we can choose followed by the strongest evidence on causation,
ways of life that protect both ourselves and the and so on. Within each passage, summaries of the
next generation against cancer. So our nutritional statistically most powerful epidemiological studies
state what we eat and drink, how active we are, come first, followed by other epidemiological
and how much body fat we carry not only as studies, and then summaries of the experimental
adults but also from and before birth, vitally affects literature and evidence of biological plausibility.
our risk of many cancers. This is followed by the Panels judgements, which
This chapter follows those on foods and drinks, take into account matters of quality and
physical activity, and body composition, growth, interpretation.
and development. Its purpose is to summarise the Then follows a subsection comparing the
evidence derived from independently commissioned judgements of this Report with those of the
and presented systematic literature reviews (SLRs), previous report, with indications of why these
and the Panels judgements and conclusions, as they differ when they do. All sections conclude with the
relate to cancers of 17 sites. Together, these amount Panels judgements for each cancer site.
to roughly 80 per cent of the incidence of, and
deaths from, all cancers worldwide. Evidence on a
number of other cancers is also summarised briefly,
based on narrative reviews.
244
C H A P T E R 7 C A N C E R S
245
P A R T 2 E V I D E N C E A N D J U D G E M E N T S
7.1.1 Trends, incidence, and survival cent of all cancer incidence, but just under 5 per cent of all
cancer deaths.2 Also see box 7.1.1.
Rates of cancers of the mouth and pharynx (age adjusted)
are stable or decreasing in many high-income countries. 7.1.2 Pathogenesis
There was a sharp increase between 1950 and 1980 in sev-
eral European countries, such as Germany and France, Mouth, pharynx, and larynx cancers, like other types, are the
although this has since reached a plateau and started to result of genetic alterations that lead to small, localised
decrease. Laryngeal cancer rates appear to have been lesions in the mucous membranes that grow in an abnormal
generally stable or decreasing since 1970.1 way (dysplasia). These lesions may then progress to carci-
Age-adjusted incidence rates of oral cancers range from noma in situ, and then become invasive cancers.
2040 per 100 000 people in parts of south-central Asia, Exposure to carcinogens, such as those in tobacco, can be
Europe, Oceania, and southern Africa, to less than 3 per prolonged and consistent. The mouth and pharynx are
100 000 in parts of eastern Asia, northern and western directly exposed to both inhaled carcinogens and those that
Africa, and Central America. Pharyngeal cancers (other than are ingested by drinking and chewing including, in the
those of the nasopharynx) follow broadly similar incidence case of chewing tobacco and betel quid, when it is spat out
patterns, although the overall incidence is lower, with highs after chewing. Chronic damage and inflammation caused by
of more than 10 per 100 000 in south-central Asia and west- stomach acid are also implicated; some studies have found
ern Europe, to a low of less than 1 per 100 000 in northern that laryngopharyngeal reflux (where stomach acid flows
Africa. Age-adjusted incidence rates of laryngeal cancer upwards to the larynx and/or pharynx) is associated with
range from more than 10 per 100 000 in South America, laryngeal cancers.7 8
south-central and western Asia, and southern, central, and Cancers of the mouth, pharynx, and larynx frequently
western Europe to less than 1 per 100 000 in many African show multiple, independent, malignant foci with second
countries.2 Rates are higher in men than in women by primary cancers occurring relatively frequently. This phe-
approximately three to one.2 In the USA, rates are higher nomenon occurs when an entire region of tissue is repeat-
among African-American people than in white people.3 edly exposed to carcinogens. Around 90 per cent of oral
Risk increases with age, and diagnoses of these three types cancers occur after exposure to tobacco or alcohol, or a com-
of cancer are most common in people aged 50 or over.4 bination of both.9
Although cure rates are high for early-stage cancers of the
mouth, pharynx, and larynx, second primary tumours are rel-
atively common at these sites.5 More than 60 per cent of 7.1.3 Other established causes
patients do not seek medical advice until the disease is at an
advanced stage; in these cases, long-term survival rates are 7.1.3.1 General
poor, especially if the cancer site is inaccessible.4 Five-year (Also see chapter 2.4.)
survival rates are around 60 per cent in the USA and 50 per Throughout this chapter, this section lists factors outside the
cent in the UK.3 6 These cancers account for just over 5 per scope of this Report, identified as established causes of can-
cer by the World Health Organization International Agency
for Research on Cancer, and other authoritative bodies.
These factors are as listed in chapter 2.4: tobacco use; infec-
Box 7.1.1 Cancer incidence and survival tious agents; radiation; industrial chemicals; and some med-
The cancer incidence rates and figures given in this Report are ications. Other diseases may also increase the risk of cancer.
those reported by cancer registries, now established in many In the same way, life events that modify the risk of cancer
countries. These registries record cases of cancer that have been causative and protective are also included.
diagnosed. However, many cases of cancer are not identified or Established effectively means beyond reasonable doubt
recorded: some countries do not have cancer registries; regions roughly the equivalent of the judgement of convincing
of some countries have few or no records; records in countries used in this Report. Occasionally, authoritative findings that
suffering war or other disruption are bound to be incomplete;
perhaps fall short of established are also included here.
and some people with cancer do not consult a physician.
Altogether, this means that the actual incidence of cancer is high-
Where possible, a note of interactive or multiplicative
er than the figures given here. effects with food, nutrition, and the other factors covered by
The cancer survival rates given in this chapter and elsewhere this Report is added, as is any indication of scale or relative
are usually overall global averages. Survival rates are generally importance. The factors here are almost all causative, where-
higher in high-income countries and other parts of the world as much of the evidence on food, nutrition, physical activi-
where there are established services for screening and early ty, and related factors shows or suggests protection against
detection of cancer and well established treatment facilities. cancer.
Survival also is often a function of the stage at which a cancer is
detected and diagnosed. The symptoms of some internal cancers 7.1.3.2 Specific
are often evident only at a late stage, which accounts for rela-
tively low survival rates. In this context, survival means that the
Other diseases. There is substantial evidence that gastric
person with diagnosed cancer has not died 5 years after diag-
nosis. Also see chapter 9. reflux increases the risk of oral cancers.
246
C H A P T E R 7 C A N C E R S
Tobacco use. Smoking, and other use of and exposure to ined were non-starchy vegetables and fruits (in combination)
tobacco, is the most important cause of oral cancers, includ- (1 cohort, 6 case-control); raw vegetables (23 case-control);
ing those of the mouth, pharynx, and larynx. These factors cruciferous vegetables (1 cohort, 14 case-control, and 1 eco-
are estimated to cause around 60 per cent per cent of all logical); green, leafy vegetables (1 cohort, 10 case-control);
laryngeal cancers. While alcoholic drinks are an independent carrots (3 cohort, 18 case-control); and tomatoes (1 cohort,
cause of these cancers, risk is multiplied if drinkers smoke 12 case-control). Most of the studies for the exposures
tobacco and if smokers drink .10 Chewing of betel quid (with grouped under non-starchy vegetables showed a decreased
or without added tobacco) also causes oral cancers.11 risk with increased intake. Meta-analysis showed a 28 per
cent decreased risk per 50 g per day (figure 4.2.2). The
Infection and infestation. Human papilloma viruses (HPVs) dose-response relationship suggested that the greatest effect
are a cause of oral cancers.12-14 was produced by the first increment; that is, that some
vegetable consumption confers a protective effect com-
pared with none (figure 4.2.3). However, it is not clear that
7.1.4 Interpretation of the evidence the effect continues in a linear fashion. It is possible that
this is an artificial phenomenon produced by residual
7.1.4.1 General confounding due to smoking. There is some unexplained
For general considerations that may affect interpretation of heterogeneity.
the evidence, see chapters 3.3 and 3.5, and boxes 3.1, 3.2, This is a wide and disparate category, and many different
3.6 and 3.7. plant food constituents are represented that could contribute
Relative risk is used in this Report to denote ratio mea- to a protective effect of non-starchy vegetables. These include
sures of effect, including risk ratios, rate ratios, hazard dietary fibre, carotenoids, folate, selenium, glucosinolates,
ratios, and odds ratios. dithiolthiones, indoles, coumarins, ascorbate, chlorophyll,
flavonoids, allylsulphides, flavonoids, and phytoestrogens,
7.1.4.2 Specific some of which are potentially antioxidants. Antioxidants trap
Considerations specific to cancers of the mouth, pharynx, free radicals and reactive oxygen molecules, protecting
and larynx include: against oxidation damage. It is difficult to unravel the rela-
tive importance of each constituent and is likely that any pro-
Classification. Some studies did not report separately on can- tective effect may result from a combination of influences on
cers of the mouth, pharynx, or larynx, but grouped these several pathways involved in carcinogenesis.
cancers with others as head and neck cancers or upper
aerodigestive tract cancers. The term head and neck can- A substantial amount of consistent evidence on non-
cer includes all of these sites plus cancers of the middle ear, starchy vegetables, including specific subtypes mostly
the nasal cavity, and the paranasal sinuses. The term upper from case-control studies, shows a dose-response
aerodigestive tract cancer includes all head and neck can- relationship. There is evidence for plausible
cers and oesophageal cancer (see 7.3). mechanisms. Non-starchy vegetables probably protect
against mouth, pharynx, and larynx cancers.
Confounding. High-quality studies adjust for smoking but
may still be subject to residual confounding. Because of the The Panel is aware that since the conclusion of the SLR, two
size of the effect of smoking, and the tendency for the diets cohort15 16 and two case-control studies17 18 have been pub-
of smokers to be low in vegetables and fruits, and for smok- lished. This new information does not change the Panel judge-
ers to have relatively lower body mass indices, residual con- ment. Also see box 3.8.
founding is a particular concern for these exposures.
Wherever possible, detailed stratification of the data accord- 7.1.5.2 Fruits
ing to smoking status was obtained. (Also see chapter 4.2.5.2.)
A total of 1 cohort study, 35 case-control studies, and 2 eco-
logical studies investigated fruits. Other groupings examined
7.1.5 Evidence and judgements were citrus fruits (1 cohort, 23 case-control, 1 ecological),
and non-starchy vegetables and fruits (in combination)
In total, 238 publications were included in the systematic lit- (1 cohort, 6 case-control). Most studies showed decreased
erature review (SLR) for cancers of the mouth, pharynx, and risk. Meta-analysis showed a 18 per cent decreased risk per
larynx. Fuller summaries of the epidemiological, experi- 100 g per day for general fruits, or 24 per cent per 50 g per
mental, and mechanistic evidence are in Chapters 46. day for citrus fruits (figures 4.2.17 and 4.2.18). The dose-
The full SLR is contained on the CD included with this response relationship suggested that the greatest effect was
Report. produced by the first increment; that is, that some fruit con-
sumption confers a protective effect compared to none.
7.1.5.1 Non-starchy vegetables However, it is not clear that the effect continues in a linear
(Also see chapter 4.2.5.1.) fashion (figures 4.2.19 and 4.2.20). It is possible that this is
A total of 31 case-control studies and 3 ecological studies an artificial phenomenon produced by residual confounding
examined non-starchy vegetables. Other groupings exam- due to smoking.
247
P A R T 2 E V I D E N C E A N D J U D G E M E N T S
The evidence, including that on fruit subtypes, though The evidence is sparse. There is limited evidence
mostly from case-control studies, is consistent, with a suggesting that mat is a cause of mouth, pharynx, and
dose-response relationship. There is evidence for larynx cancers.
plausible mechanisms. Fruits probably protect against
mouth, pharynx, and larynx cancers. 7.1.5.5 Alcoholic drinks
(Also see chapter 4.8.5.1.)
The Panel is aware that since the conclusion of the SLR, two Five cohort studies, 89 case-control studies, and 4 ecologi-
cohort studies15 16 and one case-control study18 have been pub- cal studies investigated alcoholic drinks. All cohort studies
lished. This new information does not change the Panel judge- and nearly all case-control studies showed increased risk.
ment. Also see box 3.8. Meta-analysis of cohort data showed a 24 per cent increased
risk per drink/week; case-control data showed a 3 per cent
7.1.5.3 Foods containing carotenoids increased risk per drink/week (figure 4.8.2). The cohort
(Also see chapter 4.2.5.3.) studies showed a curvilinear dose-response relationship.
Two cohort studies investigated total serum carotenoids, 10 It is biologically highly plausible that alcoholic drinks are
case-control studies investigated pro-vitamin A carotenoids, a cause of mouth, pharynx, and larynx cancers. IARC clas-
and 2 case-control studies investigated total dietary sifies alcohol as a Class 1 carcinogen. Reactive metabolites
carotenoids. Other groupings examined were dietary alpha- of alcohol such as acetaldehyde can be carcinogenic. There
carotene (1 cohort); serum alpha-carotene (3 cohort); is also an interaction with smoking. Tobacco may induce spe-
dietary beta-carotene (1 cohort, 7 case-control); serum beta- cific mutations in DNA that are less efficiently repaired in the
carotene (3 cohort, 2 case-control); dietary lycopene (1 presence of alcohol. Alcohol may also function as a solvent,
cohort, 4 case-control); and serum lycopene (1 cohort, 1 enhancing penetration of other carcinogenic molecules into
case-control). All of the serum studies and most of the mucosal cells. Additionally, the effects of alcohol may be
dietary studies showed decreased risk with increased mea- mediated through the production of prostaglandins, lipid
sures of carotenoids. Meta-analysis was not possible. peroxidation, and the generation of free radical oxygen
Information comes predominantly from dietary sources, not species. High consumers of alcohol may also have diets
supplements; therefore no effect can be attributed to low in essential nutrients, making tissues susceptible to
carotenoids separate from foods. carcinogenesis.
In trials, carotenoids have been effective at reducing cel-
lular damage within the mouth, which may act as a precur- There is ample and consistent evidence, both from
sor to cancers in this region. Carotenoids are antioxidants. case-control and cohort studies, with a dose-response
Oxidative damage is linked to the formation of tumours relationship. There is robust evidence for mechanisms
through several mechanisms. Oxidative stress damages DNA. operating in humans. The evidence that alcoholic
This might be prevented or limited by dietary antioxidants drinks are a cause of mouth, pharynx, and larynx
found in fruits and vegetables. cancers is convincing. Alcohol and tobacco together
increase the risk of these cancers more than either
There is a considerable amount of evidence, and acting independently. No threshold was identified.
though it is for different carotenoid types, it is
generally consistent, with a dose-response The Panel is aware that since the conclusion of the SLR, one
relationship. There is evidence for plausible cohort15 and four case-control studies21-24 have been published.
mechanisms. Foods containing carotenoids probably This new information does not change the Panel judgement.
protect against mouth, pharynx, and larynx cancers. Also see box 3.8.
The Panel is aware that since the conclusion of the SLR, one 7.1.5.6 Other exposures
cohort study15 has been published. This new information does Other exposures were evaluated. However, the data were
not change the Panel judgement. Also see box 3.8. either of too low quality, too inconsistent, or the number of
studies too few to allow conclusions to be reached. These
were as follows: cereals (grains) and their products; starchy
248
C H A P T E R 7 C A N C E R S
roots, tubers, and plantains; pulses (legumes); foods con- the mouth, pharynx, and larynx is convincing. The risk is
taining dietary fibre; meat; poultry; fish; eggs; milk and dairy multiplied when drinkers of alcohol also smoke tobacco.
products; total fat; foods containing animal fat; plant oils; Non-starchy vegetables, fruits, and foods containing
coffee; tea; frying, grilling (broiling), and barbecuing; pro- carotenoids probably protect against these cancers.
tein; vitamin A; retinol; thiamin; riboflavin; niacin; folate; There is limited evidence suggesting that mat, a herbal
vitamin C; vitamin E; iron; calcium; selenium; energy intake; infusion, when drunk scalding hot through a metal straw, as
and body fatness. is traditional in some parts of South America, is a cause of
Fourteen case-control studies examined body fatness, as oral cancer.
measured by body mass index (BMI). Meta-analysis pro- The main cause of these cancers is smoking and other use
duced a statistically significant decreased risk with increased of and exposure to tobacco.
BMI, and a dose-response relationship, but reverse causality
was implicated. That is, cancers of the mouth, pharynx, and
larynx cause significant weight loss, often before diagnosis.
Smoking is also associated with low BMI. For these reasons,
the data were judged insufficient to allow any conclusion to
be drawn.
7.1.6.1 General
The criteria used by the previous report for gauging the
strength of the evidence were not identical to the criteria
used for this Report. In particular, a judgement of convinc-
ing causal association was not conditional on supportive evi-
dence from prospective studies. This Report does make that
requirement. It also emphasises the special importance of
randomised controlled trials when applied appropriately,
especially where the results are positive. In these respects,
the criteria used for this Report are more stringent. See box
3.8 in chapter 3.
7.1.6.2 Specific
The previous report separated cancers of the mouth and
pharynx from cancer of the larynx. The panel responsible for
the previous report judged the evidence that vegetables and
fruits protect against cancers of the mouth and pharynx to
be convincing. It also judged that these foods probably pro-
tect against cancer of the larynx. Vitamin C was judged to
be possibly protective against cancers of the mouth and lar-
ynx. There is still little information from cohort studies,
which weakens the evidence base.
Evidence accumulated since the mid-1990s confirms the
previous judgement that the evidence that alcoholic drinks
are a cause of oral cancers is convincing. And in the previ-
ous report, the evidence that mat is a cause of oral cancers
was judged possible for cancers of the mouth and pharynx.
7.1.7 Conclusions
249
P A R T 2 E V I D E N C E A N D J U D G E M E N T S
7.2 Nasopharynx
Cancer of the nasopharynx is the 23rd most common type
of cancer worldwide. About 80 000 cases were recorded in FOOD, NUTRITION, PHYSICAL ACTIVITY,
2002, accounting for less than 1 per cent overall. In most AND CANCER OF THE NASOPHARYNX
parts of the world, this cancer is rare. It is relatively
In the judgement of the Panel, the factors listed below modify the risk of
common on and near the southern Chinese littoral, and cancer of the nasopharynx. Judgements are graded according to the
among communities who have migrated from that part of strength of the evidence.
China to other countries. It is twice as common in men as
in women. It is the 20th most common cause of death
DECREASES RISK INCREASES RISK
from cancer.
Overall, the Panel judges that there is a specific role for Convincing
Cantonese-style salted fish in the causation of cancer of Probable Cantonese-style
the nasopharynx. salted fish1
7.2.1 Trends, incidence, and survival central region of Guangdong Province in southern China,
which includes Hong Kong.25 Migrant populations from this
Age-adjusted rates of nasopharyngeal cancer are decreasing province carry the risk levels of the original population, but
in areas of high incidence, such as Hong Kong and this decreases over generations.26 Rates are approximately
Singapore.25 twice as high in men as in women.2
This cancer is predominantly a disease of low-income The age profile of nasopharyngeal cancer is different in
countries, with overall rates more than three times higher in areas of high compared with low incidence. Risk increases
middle- to low- than in high-income countries. Incidence is with age in most of the world, but in Guangdong Province
also higher in certain ethnic groups for instance Chinese it peaks between the ages of 45 and 54. In populations
and also Malay and Filipino people living in south-eastern where there is a moderate incidence of this cancer, risk
Asia. peaks in young adults.25 Overall 5-year survival rates are
Around the world, age-adjusted incidence rates range around 50 per cent.27 Also see box 7.1.1.
from 2030 per 100 000 people in parts of Hong Kong and There are two variants of nasopharyngeal squamous cell
south-eastern Asia, to less than 1 per 100 000 across most carcinoma: keratinising and non-keratinising. The non-ker-
of the Americas and Europe. atinising variant can be further divided into differentiated
This cancer also occurs in northern Africa, parts of the or undifferentiated. In North America, the proportions of
Middle East, and Micronesia and Polynesia. However, the each are 25, 12, and 63 per cent, respectively. In southern
highest rates are among Cantonese people who live in the China, the distribution is different: 2, 3, and 95 per cent.27
250
C H A P T E R 7 C A N C E R S
251
P A R T 2 E V I D E N C E A N D J U D G E M E N T S
Six case-control studies investigated general fruits and a 7.2.5.4 Other exposures
further five case-control studies investigated citrus fruits. Other exposures were evaluated. However, the data were
Preserved fruits were excluded from all categories. Most of either of too low quality, too inconsistent, or the number of
the studies for general fruits and all of the studies for citrus studies too few to allow conclusions to be reached. These
fruits showed a decreased risk. were as follows: cereals (grains) and their products; nuts and
This is a wide and disparate category, and many different seeds; meat; fish; shellfish and seafood; eggs; herbs, spices,
plant food constituents are represented that could contribute and condiments; tea; alcohol; plant oils; salted plant foods;
to a protective effect of fruits. These include dietary fibre, Chinese-style pickled cabbage; pickled radish; pickled mus-
carotenoids, folate, selenium, glucosinolates, dithiolthiones, tard leaf; Chinese-style preserved salted eggs; and ferment-
indoles, coumarins, ascorbate, chlorophyll, flavonoids, allyl- ed tofu/soya products.
sulphides, flavonoids, and phytoestrogens, some of which are
potentially antioxidants. Antioxidants trap free radicals and
reactive oxygen molecules, protecting against oxidation dam- 7.2.6 Comparison with previous report
age. It is difficult to unravel the relative importance of each
constituent and likely that a protective effect may result from 7.2.6.1 General
a combination of influences on several pathways involved in See 7.1.6.1, and box 3.8.
carcinogenesis. In addition, some components of citrus fruits
have been shown directly to inhibit Epstein-Barr virus acti- 7.2.6.2 Specific
vation.36 The previous report judged the evidence that Cantonese-style
salted fish is a cause of nasopharyngeal cancer to be con-
The evidence, from case-control studies only, is sparse. vincing. No further cohort studies have been conducted since
There is limited evidence suggesting that fruits protect the mid-1990s.
against nasopharyngeal cancer.
252
C H A P T E R 7 C A N C E R S
7.3 Oesophagus
Cancer of the oesophagus is the eighth most common type
of cancer worldwide. Around 460 000 cases occurred in FOOD, NUTRITION, PHYSICAL ACTIVITY, AND
2002, accounting for over 4 per cent overall. There are two CANCER OF THE OESOPHAGUS
common types of oesophageal cancer, adenocarcinoma
In the judgement of the Panel, the factors listed below modify the risk of
and squamous cell carcinoma, which have different cancer of the oesophagus. Judgements are graded according to the
patterns of occurrence. In general this cancer is not strength of the evidence.
increasing, except for adenocarcinomas, which are
increasing in high-income countries. Oesophageal cancer DECREASES RISK INCREASES RISK
is twice as common in men as in women. It is usually fatal
and is the sixth most common cause of death from cancer. Convincing Alcoholic drinks
Overall, the Panel judges that food and nutrition and Body fatness1
body fatness play an important role in the prevention and Probable Non-starchy Mat4
causation of cancer of the oesophagus. vegetables2
Fruits2
253
P A R T 2 E V I D E N C E A N D J U D G E M E N T S
epithelial cells, from which adenocarcinomas can develop.4 nocarcinomas in people with Barretts oesophagus.4
Adenocarcinoma of the oesophagus shows similarities with Some people have an abnormally strong lower
adenocarcinoma of the gastric cardia (see 7.5). Each type oesophageal sphincter (a condition called oesophageal
accounts for around half of all cases and both types are achalasia), which means swallowed food is retained in the
included in this Report. oesophagus. It causes a 15-fold increase in the risk of squa-
mous cell carcinomas, which may be due to chronic irrita-
tion of the lining of the oesophagus or its increased contact
7.3.1 Trends, incidence, and survival with food-borne carcinogens.45 46
Tylosis A is the late-onset, inherited familial disease where
Age-adjusted rates of oesophageal squamous cell carcinomas the outer horny layer of the skin thickens, affecting the palms
are generally declining, although in some high-income and soles (hyperkeratosis). Palmar and plantar hyperker-
regions, overall rates of oesophageal cancer are increasing. atosis is the single proven genetic abnormality associated
For instance, the incidence of oesophageal adenocarcinoma with a 25 per cent lifetime incidence of squamous cell can-
is rising rapidly in Europe and North America.39 In the USA, cer of the oesophagus.47
adenocarcinomas in white men increased fivefold between
1974 and the end of the 20th century, making it the fastest
increasing cancer studied in that country.40 7.3.3 Other established causes
Oesophageal cancer is, however, mainly a disease of low-
income countries, occurring around four times more com- (Also see chapter 2.4 and 7.1.3.1.)
monly in low- to middle- than in high-income countries.
Around the world, age-adjusted incidence rates range from Other diseases. Gastric reflux and oesophageal achalasia
more than 20 per 100 000 people in parts of eastern and both increase the risk of, and thus can be seen as a cause of,
southern Africa and eastern and south-central Asia to less this cancer. Barretts oesophagus can be seen as a precan-
than 5 per 100 000 in northern, western, and middle Africa, cerous condition.
Central America, and south-eastern Asia. Localised peaks in
incidence have been reported to exceed 100 per 100 000. For Tobacco use. Smoking is a cause both of oesophageal squa-
instance, in rural Linxian, China, oesophageal cancer is the mous cell carcinoma and of adenocarcinomas, increasing the
leading cause of death.41 In the USA, rates are higher among risk approximately twofold.10 39 Smoking is estimated to
African-American people than in white people. Worldwide, cause around 40 per cent of all cases. Chewing betel quid
rates are higher in men than in women, by around five to (on its own and also with tobacco quid) is also a cause of
two. In most populations, risk increases with age, with few oesophageal cancers.11
cases diagnosed in people under 40.
Oesophageal cancer does not usually produce symptoms Infectious agents. HPV (see box 7.13.1) is also a cause of this
at the early stages, so the disease is generally at an advanced cancer, and is estimated to be a cause of almost 25 per cent
stage when diagnosed. Survival rates are poor: around 10 of squamous cell carcinomas. Like other infectious agents, it
per cent at 5 years.3 6 This type of cancer accounts for a lit- may be a necessary cause but is not a sufficient cause. It may
tle over 4 per cent of all cancer incidence, but almost 6 per also play a role in the divergent geographical distributions
cent of all cancer deaths worldwide. Also see box 7.1.1. of this cancer.48
The epithelial cells lining the oesophagus are exposed direct- 7.3.4.1 General
ly to carcinogens in food. Repeated exposures, for instance, For general considerations that may affect interpretation of
to burns from very high-temperature drinks or irritation from the evidence, see chapters 3.3 and 3.5, and boxes 3.1, 3.2,
the direct action of alcohol, may cause inflammation. 3.6 and 3.7.
The role of irritation and inflammation in the development Relative risk is used in this Report to denote ratio mea-
of oesophageal cancer is supported by the finding that gas- sures of effect, including risk ratios, rate ratios, hazard
tro-oesophageal reflux (where stomach acid flows upwards ratios, and odds ratios.
to the oesophagus) increases the risk of adenocarcinomas by
as much as 40-fold.42 Barretts oesophagus is a probable 7.3.4.2 Specific
intermediate stage between gastro-oesophageal reflux dis- Considerations specific to cancer of the oesophagus include:
ease, with repeated gastro-oesophageal reflux, and devel-
oping oesophageal adenocarcinoma.43 Barretts oesophagus Classification.There are different types of oesophageal can-
is an acquired condition in which squamous cells are cer. Squamous cell carcinomas have different geographical
replaced by columnar epithelial cells; autopsy studies sug- and time trends from adenocarcinomas. Each follows a dif-
gest that it usually remains undiagnosed.44 The increasing ferent disease path, and may have different associated risk
use of endoscopes to investigate abdominal symptoms has factors. However, there were only sufficient data to conduct
resulted in the earlier detection of a small proportion of ade- separate analyses for body fatness. Therefore the ratio of
254
C H A P T E R 7 C A N C E R S
squamous cell carcinomas to adenocarcinomas in each study This is a wide and disparate category, and many different
is a potential cause of heterogeneity in all other summaries. plant food constituents are represented that could contribute
The oesophageal-gastric junction and gastric cardia are also to a protective effect of non-starchy vegetables. These
lined with columnar epithelial cells. Cancers in these areas include dietary fibre, carotenoids, folate, selenium, glucosi-
are often grouped with oesophageal cancers, although they nolates, dithiolthiones, indoles, coumarins, ascorbate,
may also be classed as stomach cancers (see 7.5).4 Different chlorophyll, flavonoids, allylsulphides, flavonoids, and phy-
approaches or definitions in different studies are another toestrogens, some of which are potentially antioxidants.
potential source of heterogeneity. Antioxidants trap free radicals and reactive oxygen mole-
cules, protecting against oxidation damage. It is difficult to
Confounding. Smoking is the main single cause of this can- unravel the relative importance of each constituent and it is
cer. High-quality studies adjust for smoking. likely that any protective effect may result from a combina-
tion of influences on several pathways involved in carcino-
genesis.
7.3.5 Evidence and judgements
There is more evidence, including on vegetable
In total, 262 publications were included in the SLR for subtypes, from case-control studies than from cohort
oesophageal cancer. Fuller summaries of the epidemiologi- studies, but both are moderately consistent, and there
cal, experimental, and mechanistic evidence are to be found is some evidence for a dose-response relationship.
in Chapters 46. There is evidence for plausible mechanisms (see
The full SLR is contained on the CD included with this chapter 4.2.5.1). Non-starchy vegetables probably
Report. protect against oesophageal cancer.
7.3.5.1 Foods containing dietary fibre The Panel is aware that since the conclusion of the SLR, one
(Also see chapter 4.1.5.3.) cohort49 and two case-control studies17 50 have been published.
One cohort study, nine case-control studies, and two eco- This new information does not change the Panel judgement.
logical studies investigated dietary fibre. Most were sugges- Also see box 3.8.
tive of a relationship with decreased oesophageal cancer
incidence. Data come predominantly from dietary sources, 7.3.5.3 Fruits
not supplements; therefore no specific effect can be attrib- (Also see chapter 4.2.5.2.)
uted specifically to dietary fibre itself, which is interpreted A total of 4 cohort studies, 36 case-control studies, and 7
simply as a marker of consumption of foods containing it. ecological studies investigated fruits; and 1 cohort study, 16
It is not clear whether there is an as yet unknown mech- case-control studies, and 1 ecological study investigated cit-
anism through which dietary fibre could exert a direct effect rus fruits. All of the cohort studies and most of the other
on oesophageal cancer, or whether the effect is mediated studies showed decreased risk with increased intake. Meta-
through other constituents of the foods (such as cereals analysis of case-control data showed a 22 per cent decreased
(grains), vegetables, and fruits) that contain dietary fibre. risk per 50 g of fruit per day, and 30 per cent decreased risk
per 50 g of citrus fruit per day (figures 4.2.22 and 4.2.24).
There is limited evidence, from sparse and inconsistent A dose-response relationship was apparent. Heterogeneity
case-control studies only, suggesting that foods could not be fully explained.
containing dietary fibre protect against oesophageal Fruits are sources of vitamin C and other antioxidants,
cancer. such as carotenoids, phenols, and flavonoids, as well as other
potentially bioactive phytochemicals. Antioxidants trap free
7.3.5.2 Non-starchy vegetables radicals and reactive oxygen molecules, protecting against
(Also see chapter 4.2.5.1.) oxidation damage.
A total of 5 cohort studies, 37 case-control studies, and 6 eco- It is difficult to unravel the relative importance of each
logical studies investigated non-starchy vegetables. Other constituent and it is likely that any protective effect may
groupings examined were vegetable and fruit consumption result from a combination of influences on several pathways
(combined) (8 case-control), raw vegetables (16 case-con- involved in carcinogenesis.
trol), cruciferous vegetables (1 cohort, 5 case-control), alli-
um vegetables (1 cohort, 8 case-control), green, leafy The evidence, including that on fruit subtypes, though
vegetables (1 cohort, 11 case-control), and tomatoes (1 mostly from case-control studies, is consistent, with a
cohort, 9 case-control). All of the studies of raw vegetables dose-response relationship. There is evidence for
and most of the other studies showed decreased risk with plausible mechanisms. Fruits probably protect against
increased intake. Meta-analysis of case-control data showed oesophageal cancer.
a 31 per cent decreased risk per 50 g of raw vegetables per
day (figures 4.2.6 and 4.2.7). Raw vegetables have a more The Panel is aware that since the conclusion of the SLR, one
consistent definition than non-starchy vegetables, which may cohort49 and two case-control studies50 51 have been published.
include preserved vegetables and a variety of cooking meth- This new information does not change the Panel judgement.
ods, leading to increased heterogeneity. Also see box 3.8.
255
P A R T 2 E V I D E N C E A N D J U D G E M E N T S
The evidence, from case-control studies only, is sparse. Much of the evidence on vitamin E, mostly from case-
There is limited evidence suggesting that folate control studies, was of poor quality. There is limited
protects against oesophageal cancer. evidence suggesting that foods containing vitamin E
protect against oesophageal cancer.
The Panel is aware that since the conclusion of the SLR, one
case-control study52 has been published. This new information 7.3.5.8 Foods containing beta-carotene
does not change the Panel judgement. Also see box 3.8. (Also see chapter 4.2.5.3.)
Ten case-control studies investigated dietary beta-carotene;
7.3.5.5 Foods containing pyridoxine (vitamin B6) three cohort studies and one case-control study investigat-
(Also see chapter 4.2.5.5.) ed serum beta-carotene; and one cohort study and three
Six case-control studies investigated foods containing pyri- case-control studies investigated dietary pro-vitamin A
doxine and oesophageal cancer. carotenoids. Most of these studies showed a relationship
All six studies showed a relationship between pyridoxine with decreased risk.
consumption and reduced risk of oesophageal cancer, with Data come predominantly from dietary sources, not sup-
none reporting contrary results. plements; therefore no effect can be attributed to carotenoids
Together with folate and cobalamin (vitamin B12), vita- separate from foods.
min B6 is involved in one-carbon metabolism and is impor- Carotenoids are antioxidants, which can prevent lipid oxi-
tant for DNA synthesis, repair, and methylation. dation and related oxidative stress. Some, such as beta-
carotene, are also pro-vitamin A carotenoids.
The evidence, from case-control studies only, was
sparse. There is limited evidence suggesting that There is a substantial amount of consistent evidence
pyridoxine protects against oesophageal cancer. available from both cohort and case-control studies.
Foods containing beta-carotene probably protect
The Panel is aware that since the conclusion of the SLR, one against oesophageal cancer.
case-control study52 has been published. This new information
does not change the Panel judgement. Also see box 3.8. 7.3.5.9 Red meat
(Also see chapter 4.3.5.1.1.)
7.3.5.6 Foods containing vitamin C Twelve case-control studies investigated red meat. Most were
(Also see chapter 4.2.5.6.) suggestive of increased risk.
One cohort study, 19 case-control studies, and 3 ecological There are several potential underlying mechanisms for a
studies investigated vitamin C. The single cohort study and positive association of red meat consumption with
nearly all of the case-control studies showed decreased risk oesophageal cancer, including the generation of potentially
with increased intake. carcinogenic N-nitroso compounds (see box 4.3.2). Some
Vitamin C traps free radicals and reactive oxygen mole- meats are also cooked at high temperatures, resulting in the
cules, protecting DNA from mutagenic attack, protecting production of heterocyclic amines and polycyclic aromatic
against lipid peroxidation, reducing nitrates, and stimulat- hydrocarbons (see box 4.3.4). Red meat contains haem iron.
ing the immune system. Free iron can lead to the production of free radicals (see box
4.3.3).
A substantial amount of consistent evidence is
available, both from cohort and from case-control There is limited evidence, from case-control studies,
studies. Foods containing vitamin C probably protect some of which were poor quality, suggesting that red
against oesophageal cancer. meat is a cause of oesophageal cancer.
The Panel is aware that since the conclusion of the SLR, one The Panel is aware that since the conclusion of the SLR, one
case-control study53 has been published. This new information cohort study54 has been published. This new information does
does not change the Panel judgement. Also see box 3.8. not change the Panel judgement. Also see box 3.8.
256
C H A P T E R 7 C A N C E R S
257
P A R T 2 E V I D E N C E A N D J U D G E M E N T S
7.3.6.1 General
See section 7.1.6.1 of this chapter, and box 3.8 in chapter 3.
7.3.6.2 Specific
The previous report judged the evidence that vegetables and
fruits protect against oesophageal cancer to be convincing.
Data published since then have been somewhat less consis-
tent.
At the time of the previous report, the evidence on body
fatness was unclear, because data on adenocarcinomas was
inadequate and not analysed separately.
The previous report judged it possible that carotenoids or
vitamin C protect against this cancer. The evidence base for
foods containing these nutrients is now stronger. The previ-
ous report judged it possible that mat and other very hot
drinks cause oesophageal cancer. The evidence on mat is
now stronger.
258
C H A P T E R 7 C A N C E R S
7.4 Lung
Cancer of the lung is the most common type of cancer
worldwide (excluding non-melanoma skin cancer). Around FOOD, NUTRITION, PHYSICAL ACTIVITY,
1.4 million cases were recorded in 2002, accounting for AND CANCER OF THE LUNG
over 12 per cent of all cancers. Three-quarters of all cases
In the judgement of the Panel, the factors listed below modify the risk of
occur in men. The disease is most common in high-income cancer of the lung. Judgements are graded according to the strength of
countries and is increasing in some low-income countries the evidence.
such as China. It is almost always fatal, and is the chief
cause of death from cancer: nearly 18 per cent of all DECREASES RISK INCREASES RISK
deaths from cancer are from this type.
Overall, the Panel emphasises that the principal cause of Convincing Arsenic in drinking
water1
lung cancer is smoking tobacco.
Beta-carotene
supplements2
The Panel judges as follows:
Probable Fruits3
The evidence that arsenic in drinking water and (in
Foods containing
smokers only) pharmacological doses of beta-carotene are carotenoids4
a cause of this cancer is convincing.
Fruits, and also foods containing carotenoids, probably Limited Non-starchy vegetables3 Red meat7
protect against lung cancer. suggestive Foods containing Processed meat8
There is limited evidence suggesting that non-starchy selenium4 Total fat
Foods containing
vegetables, selenium and foods containing it, foods quercetin4
Butter
containing quercetin, and physical activity protect against Retinol supplements2
5
Selenium
Low body fatness
lung cancer. Physical activity6
There is also limited evidence suggesting that red meat,
Limited Cereals (grains) and their products; starchy tubers;
processed meat, total fat, butter, pharmacological doses of no conclusion dietary fibre; pulses (legumes); poultry; fish; eggs;
retinol (smokers only), and low body fatness are causes of milk and dairy products; total fat; animal fats; plant
lung cancer. oils; soft drinks; coffee; tea; alcohol; preservation,
processing, and preparation; carbohydrate; protein
In final summary, the strongest evidence, corresponding vitamin A; thiamin; riboflavin; niacin; vitamin B6;
to judgements of convincing and probable, shows that folate; vitamin C; vitamin E; multivitamins; calcium;
arsenic in drinking water and pharmacological doses of copper; iron; zinc; pro-vitamin A carotenoids;
lycopene; flavonoids; culturally-defined diets;
beta-carotene (smokers only) are causes of lung cancer; body size, shape, and composition (except low
and that fruits and foods containing carotenoids probably body fatness); energy intake
protect against this cancer.
Substantial
effect on risk None identified
unlikely
The lungs are part of the aerodigestive system. They contain
hundreds of lobules, and each lobule contains a bronchiole, 1 The International Agency for Research on Cancer has graded arsenic and
its branches, and clusters of alveoli. This is where carbon arsenic compounds as Class 1 carcinogens. The grading for this entry applies
specifically to inorganic arsenic in drinking water.
dioxide (a product of respiration) is removed from the blood 2 The evidence is derived from studies using high-dose supplements
and replaced with oxygen, to fuel further respiration, pro- (20 mg/day for beta-carotene; 25 000 international units/day for retinol)
in smokers.
ducing energy. 3 Judgements on vegetables and fruits do not include those preserved by
About 9095 per cent of lung cancers are either small-cell 4
salting and/or pickling.
Includes both foods naturally containing the constituent and foods which
carcinoma or non-small-cell carcinoma. The latter has three have the constituent added (see chapter 3.5.3).
5 The evidence is derived from studies using supplements at a dose of
major subtypes: squamous cell carcinoma, adenocarcinoma, 200 g/day.
and large-cell carcinoma.4 Squamous cell carcinomas account 6 Physical activity of all types: occupational, household, transport, and
recreational.
for 3035 per cent, adenocarcinomas 3045 per cent, and 7 The term red meat refers to beef, pork, lamb, and goat from domesticated
large-cell carcinomas about 9 per cent of all lung cancers. animals.
8 The term processed meat refers to meats preserved by smoking, curing,
Small cell lung cancer (SCLC) accounts for 1015 per cent or salting, or addition of chemical preservatives.
of all lung cancers; this form is considered a distinct clinical For an explanation of all the terms used in the matrix,
pathological entity due to its characteristic aggressive biol- please see chapter 3.5.1, the text of this section,
and the glossary.
ogy, diffuse nature, propensity for early metastasis, and over-
all poor prognosis. Mesothelioma, which affects the pleura
(layer of cells covering the lung and chest cavity), is almost
always caused by previous exposure to asbestos.
259
P A R T 2 E V I D E N C E A N D J U D G E M E N T S
7.4.1 Trends, incidence, and survival The division of these new cells increases, and this eventual-
ly is followed by dysplasia of the lung mucosa. When this
Smoking and other exposure to tobacco smoke are the prin- process involves the full thickness of the mucosa, these dys-
cipal causes of lung cancer. The trend and incidence patterns plastic lesions become carcinoma in situ. Further invasion to
are explained largely by these exposures. Age-adjusted rates the depth of the basement membrane, and the subsequent
of lung cancer are decreasing in many high-income countries infiltration of the underlying stroma by malignant cells, sig-
due to decreased smoking. Global and regional trends in inci- nals invasive cancer. This process may take 1020 years.4
dence have mirrored the prevalence of smoking, with a time People with adenocarcinomas may have an associated his-
lag of around 35 years.63 Lung cancer was rare until the end tory of chronic lung disease, such as scleroderma, rheuma-
of the 19th century, with only 140 cases reported in the toid disease, sarcoidosis, or tuberculosis.4
world literature before 1898, and only 374 by 1912.63
Incidence peaked in most high-income countries in the sec-
ond half of the 20th century, and later for women than men. 7.4.3 Other established causes
The relative incidence of the various types of lung cancer
is gradually changing. Between 1980 and 2000, the pro- (Also see chapter 2.4 and section 7.1.3.1.)
portion of squamous cancers decreased as the proportion of
adenocarcinomas increased, possibly due to changes in Tobacco use. Smoking is the principal cause of lung cancer; it
smoking habits or products.64 Adenocarcinoma is now the is estimated to be responsible for 85 per cent of all types of this
most frequently diagnosed type in the USA and Japan; while cancer.66 In populations with a history of long-term cigarette
it is also showing signs of increasing in Europe, squamous use, the proportion has reached 90 per cent.10 Involuntary
cell carcinoma continues to be the predominant type. exposure to tobacco smoke (passive smoking) is also a cause
Lung cancer is mainly a disease of high-income countries, of lung cancer, including in people who have never smoked.10
where the smoking epidemic began earlier, and overall rates
are nearly double those in middle- to low-income countries. Industrial chemicals. Carcinogens that are causes of lung can-
Around the world, age-adjusted incidence ranges from more cer include aluminium; arsenic; asbestos (both lung cancer
than 60 per 100 000 people in North America and across and mesothelioma); chloromethyl methyl ether and/or bis-
much of Europe, to less than 5 per 100 000 in much of mid- chloromethyl ether; coal-tar fumes; erionite (mesothe-
dle Africa. Within Europe, rates are highest in eastern lioma); pollutants from iron and steel founding; untreated
European countries. In the USA, rates are higher among mineral oils; mustard gas; soot; talc containing asbestiform
African-American people than in white people. Worldwide, tremolite; and vinyl chloride.67
rates are higher in men than in women, by around three to
one. The incidence of lung cancer increases with age. Rates
will continue to rise in middle- and low-income countries as 7.4.4 Interpretation of the evidence
tobacco smoking increases.
The early stages of lung cancer do not usually produce symp- 7.4.4.1 General
toms, so the disease is generally at an advanced stage when it For general considerations that may affect interpretation of
is diagnosed. Survival rates are poor, around 10 per cent at the evidence, see chapters 3.3 and 3.5, and boxes 3.1, 3.2,
5 years, and are usually higher in women than men.3 6 SCLC 3.6 and 3.7.
has a worse prognosis than non-SCLC (a survival rate of only Relative risk is used in this Report to denote ratio mea-
around 5 per cent at 5 years), because SCLC has a tenden- sures of effect, including risk ratios, rate ratios, hazard
cy to metastasise (spread) early, and surgery is not usually ratios, and odds ratios.
successful.4 65 Lung cancer accounts for somewhat over 12
per cent of all cancer incidence, but for nearly 18 per cent 7.4.4.2 Specific
of all cancer deaths. Also see box 7.1.1. Considerations specific to cancer of the lung include:
260
C H A P T E R 7 C A N C E R S
7.4.5 Evidence and judgements Fruits are sources of vitamin C and other antioxidants,
such as carotenoids, phenols, and flavonoids, as well as other
In total, 561 publications were included in the SLR for lung potentially bioactive phytochemicals. Antioxidants trap free
cancer. Fuller summaries of the epidemiological, experi- radicals and reactive oxygen molecules, protecting against
mental, and mechanistic evidence are to be found in oxidation damage. In addition, flavonoids found in fruit
Chapters 46. directly inhibit the expression of a cytochrome P450
The full SLR is contained on the CD included with this enzyme. This helps to metabolise toxins and has been asso-
Report. ciated with increased risk of lung cancer, primarily in smok-
ers.68 It is difficult to unravel the relative importance of each
7.4.5.1 Non-starchy vegetables constituent, and it is likely that any protective effect may
(Also see chapter 4.2.5.1.) result from a combination of influences on several pathways
A total of 17 cohort studies, 27 case-control studies, and 6 involved in carcinogenesis.
ecological studies investigated total vegetables. Other group-
ings examined were non-starchy vegetables specifically (3 The evidence is ample and consistent. A dose-response
cohort, 1 case-control); green, leafy vegetables, excluding relationship is apparent from both cohort and case-
cruciferous (5 cohort, 17 case-control); non-starchy root veg- control studies and there is evidence for plausible
etables and tubers (2 cohort); and carrots (6 cohort, 21 case- mechanisms operating in humans. The evidence that
control, 1 ecological). Most studies showed decreased risk fruits protect against lung cancer is convincing.
with increased intake. Data are particularly consistent when
stratified for carrots. A pooled analysis of 8 cohort studies The Panel is aware that since the conclusion of the SLR, one
(more than 430 000 participants, followed up for 616 years, case-control study69 has been published. This new information
with more than 3200 lung cancer cases) showed a non-sig- does not change the Panel judgement. Also see box 3.8.
nificant decreased risk for the groups that ate the most veg-
etables. There was considerable heterogeneity, not all 7.4.5.3 Foods containing carotenoids
readily explained. (Also see chapter 4.2.5.3.)
This is a wide and disparate category, and many different A total of 11 cohort studies, 16 case-control studies, and 1
plant food constituents are represented that could contribute ecological study investigated total dietary carotenoids; 4
to a protective effect of non-starchy vegetables. These include cohort studies and 5 case-control studies investigated serum
dietary fibre, carotenoids, folate, selenium, glucosinolates, or plasma carotenoids. Other groupings examined were
dithiolthiones, indoles, coumarins, ascorbate, chlorophyll, dietary beta-cryptoxanthin (7 cohort, 8 case-control, 1 eco-
flavonoids, allylsulphides, flavonoids, and phytoestrogens, logical), and serum/plasma beta-cryptoxanthin (6 cohort, 1
some of which are potentially antioxidants. Antioxidants trap case-control). Nearly all cohort studies and most case-con-
free radicals and reactive oxygen molecules, protecting trol studies showed decreased risk with increased intake.
against oxidation damage. It is difficult to unravel the rela- Meta-analysis of cohort data showed a 2 per cent decreased
tive importance of each constituent and it is likely that any risk per 1 mg dietary carotenoid intake per day, or per
protective effect may result from a combination of influences 10 g beta-cryptoxanthin intake per day (figure 4.2.28). A
on several pathways involved in carcinogenesis. pooled analysis of 7 cohort studies (almost 400 000 partic-
ipants, followed up for 716 years, with more than 3100
A substantial amount of evidence is available but some lung cancer cases) showed a 24 per cent decreased risk for
studies were not adjusted for smoking. A dose the groups that consumed the most beta-cryptoxanthin.
response is apparent from both cohort and case- Several case-control studies did not adjust for smoking. Data
control studies. There is limited evidence suggesting come predominantly from dietary sources, not supplements;
that non-starchy vegetables protect against lung therefore no effect can be attributed to carotenoids separate
cancer. from foods.
Carotenoids are antioxidants, which can prevent lipid oxi-
7.4.5.2 Fruits dation and related oxidative stress. Some, such as beta-
(Also see chapter 4.2.5.2.) carotene, are also pro-vitamin A carotenoids.
Twenty-five cohort studies, 32 case-control studies, and 7
ecological studies investigated fruit consumption. Most of There is a substantial amount of evidence available
these showed decreased risk with increased intake. Meta- from both cohort and case-control studies. A clear
analysis of cohort data showed a 6 per cent decreased risk dose-response relationship is apparent from cohort
per 80 g serving/day; meta-analysis of case-control data studies. Foods containing carotenoids probably protect
showed a 20 per cent decreased risk per serving/day (figure against lung cancer.
4.2.25). A pooled analysis of 8 cohort studies (more than 430
000 participants, followed up for 616 years, with more than 7.4.5.4 Foods containing selenium
3200 lung cancer cases) showed a 23 per cent decreased risk (Also see chapter 4.2.5.8.)
for the groups that ate the most fruit. There is considerable Two cohort studies, 2 case-control studies, and 2 ecological
heterogeneity, perhaps explained by the broad and disparate studies investigated dietary selenium; 10 cohort studies, 7
nature of this category. case-control studies, and 4 ecological studies investigated
261
P A R T 2 E V I D E N C E A N D J U D G E M E N T S
plasma or serum selenium; and 3 cohort studies investigat- and polycyclic aromatic hydrocarbons (see box 4.3.4). Haem
ed selenium levels in nails. Most studies showed decreased promotes the formation of N-nitroso compounds and also
risk with increased intake. Meta-analysis of cohort data on contains iron. Free iron can lead to production of free radi-
plasma or serum selenium produced evidence of decreased cals (see box 4.3.3).
risk with a clear dose-response relationship.
Dietary selenium deficiency has been shown to cause a There is limited, inconsistent evidence suggesting that
lack of selenoprotein expression. Twenty-five selenoproteins processed meat is a cause of lung cancer.
have been identified in animals and a number of these have
important anti-inflammatory and antioxidant properties. 7.4.5.8 Total fat
Four are glutathione peroxidases, which protect against (Also see chapter 4.5.5.1.)
oxidative damage to biomolecules such as lipids, lipopro- Nine cohort studies, 17 case-control studies, and 4 ecologi-
teins, and DNA. Three are thioredoxin reductases and, cal studies investigated total fat intake. Most studies showed
among other functions, these regenerate oxidised ascorbic increased risk with increased intake, although cohort data
acid to its active antioxidant form. were less suggestive of an effect, and few studies were sta-
tistically significant. No evidence for plausible mechanisms
The evidence available is sparse. There is limited was found.
evidence to suggest that foods containing selenium
protect against lung cancer. The mixed results from cohort studies contrast with
the more consistent results from other studies. Overall,
7.4.5.5 Foods containing quercetin there is limited evidence suggesting that consumption
(Also see chapter 4.2.5.9.) of total fat is a cause of lung cancer. The Panel
Two cohort studies and three case-control studies investi- emphasises that the principle cause of lung cancer is
gated quercetin intake. Both cohort studies showed statisti- smoking tobacco.
cally significant decreased risk for the highest intake groups.
Data from case-control studies were more heterogeneous. 7.4.5.9 Butter
Quercetin is a flavonoid which directly inhibits expression (Also see chapter 4.5.5.1.1.)
of a cytochrome P450 enzyme that helps to metabolise tox- Two cohort studies and eight case-control studies investi-
ins, resulting in decreased DNA damage in laboratory exper- gated butter consumption. Most studies showed increased
iments.70 risk with increased intake, but cohort data were inconsistent.
No evidence for plausible mechanisms was found.
The evidence available is sparse and inconsistent.
There is limited evidence suggesting that foods There is a limited amount of inconsistent evidence
containing quercetin protect against lung cancer. suggesting that consumption of butter is a cause of
lung cancer.
7.4.5.6 Red meat
(Also see chapter 4.3.5.1.1.) 7.4.5.10 Arsenic in drinking water
One cohort study and nine case-control studies investigated (Also see chapter 4.7.5.1.1.)
red meat. The single cohort study and most of the case-con- Two cohort studies, 2 case-control studies, and 12 ecologi-
trol studies showed increased risk with increased intake. cal studies investigated arsenic in drinking water. All cohort
Red meat contains haem iron (see box 4.3.3). Free iron can and case-control studies, and most ecological studies,
lead to the production of free radicals. When cooked at high showed a relationship between increased levels of arsenic in
temperatures, red meat can also contain heterocyclic amines drinking water and increased incidence. Meta-analysis was
and polycyclic aromatic hydrocarbons (see box 4.3.4). not possible, but effect estimates tended to be large (an
increased risk of over 300 per cent for the highest levels).
There is limited evidence, mostly from inconsistent Soluble arsenic in drinking water induces lung cancers in
case-control studies, suggesting that red meat is a animal models.71 In humans, arsenic is a chromosomal muta-
cause of lung cancer. gen (an agent that induces mutations involving more than
one gene, typically large deletions or rearrangements). It can
7.4.5.7 Processed meat also act as a synergistic co-mutagen. Arsenic exposure also
(Also see chapter 4.3.5.1.2.) causes chronic lung disease.71 The Joint FAO/WHO Expert
Four cohort studies and 10 case-control studies investigated Committee on Food Additives has set a provisional tolerable
processed meat, most of which showed increased risk with weekly intake of 0.015 mg/kg of body weight.72
increased intake.
N-nitroso compounds are suspected mutagens and car- The evidence is ample and consistent, from cohort and
cinogens that are found in processed meats, and produced case-control as well as ecological studies. There is a
in the stomach from nitrates, including those used to pre- dose-response relationship, and the effect size is
serve meats.55 Many processed meats also contain high lev- relatively large. There is robust evidence for
els of salt and nitrite (see box 4.3.2). When cooked at high mechanisms. The evidence that arsenic in drinking
temperatures, meats can also contain heterocyclic amines water is a cause of lung cancer is convincing.
262
C H A P T E R 7 C A N C E R S
263
P A R T 2 E V I D E N C E A N D J U D G E M E N T S
The Panel is aware that since the conclusion of the SLR, one matrix entry for beta-carotene supplements. The previous
cohort study75 has been published. This new information does report did not review arsenic.
not change the Panel judgement. Also see box 3.8.
7.4.6.1 General
See section 7.1.6.1 of this chapter, and box 3.8 in chapter 3.
7.4.6.2 Specific
The previous report judged the evidence that vegetables and
fruits protect against lung cancer to be convincing. Evidence,
particularly from cohort studies published since the mid-
1990s, is more consistent for fruits than for vegetables.
The findings of the previous report for carotenoids, and for
pharmaceutical doses of beta-carotene given to smokers,
were identical to the current findings (for foods containing
carotenoids), although the previous report did not include a
264
C H A P T E R 7 C A N C E R S
7.5 Stomach
Cancer of the stomach is the fourth most common type of
cancer worldwide. Almost one million cases were recorded FOOD, NUTRITION, PHYSICAL ACTIVITY,
in 2002. Two out of three cases occur in men. Overall, it is AND CANCER OF THE STOMACH
decreasing rapidly in high-income countries, but remains
In the judgement of the Panel, the factors listed below modify the risk of
very common elsewhere in the world. It is usually fatal cancer of the stomach. Judgements are graded according to the strength
and is the second most common cause of death from of the evidence.
cancer.
Overall, the Panel judges that food and nutrition play an DECREASES RISK INCREASES RISK
important role in the prevention and causation of stomach
Convincing
cancer.
Probable Non-starchy Salt2
The Panel judges as follows: vegetables1 Salted and salty
Non-starchy vegetables, including specifically allium Allium vegetables1 foods
Fruits1
vegetables, as well as fruits probably protect against
stomach cancer.
Limited Pulses (legumes)3 Chilli1
Salt, and also salt-preserved foods, are probably causes suggestive Foods containing Processed meat5
of this cancer. selenium4 Smoked foods6
There is limited evidence suggesting that pulses Grilled (broiled)
(legumes), including soya and soya products, and also or barbecued
(charbroiled) animal
foods containing selenium protect against stomach cancer.
foods6
There is also limited evidence suggesting that chilli,
processed meat, smoked foods, and grilled (broiled) and Limited Cereals (grains) and their products; dietary fibre;
barbecued (charbroiled) animal foods are causes of no conclusion potatoes; starchy roots, tubers, and plantains; nuts
and seeds; herbs, spices, and condiments; meat
stomach cancer. (unprocessed); poultry; eggs; milk and dairy
Infection with the bacterium Helicobacter pylori is products; fats and oils; total fat; fatty acid
composition; cholesterol; sugars; sugar (sucrose);
established as a necessary cause of almost all cases of
fruit juices; coffee; tea; alcohol; dietary nitrate and
stomach cancer. It has been estimated that most cases nitrite, N-nitrosodimethylamine; drying or dried
of this cancer are preventable by appropriate diets and food; protein; thiamin; riboflavin; vitamin C;
vitamin D; multivitamin/mineral supplements;
associated factors. calcium; iron; selenium supplements; carotenoids;
In final summary, the strongest evidence, corresponding culturally defined diets; meal frequency; eating
to judgements of convincing and probable,shows that speed; body fatness; energy intake
There are two main types of stomach cancer. Distal gastric For an explanation of all the terms used in the matrix,
cancers (those of the lower portion of the stomach) are the please see chapter 3.5.1, the text of this section,
and the glossary.
predominant type. The other type is cancer of the gastric
cardia or of the gastro-oesophageal junction.4 The latter are
sometimes grouped with oesophageal adenocarcinomas.
Distal gastric cancers may be classified depending on their
appearance under the microscope as intestinal or diffuse 7.5.1 Trends, incidence, and survival
(from mucus-producing cells). The former is more common
and predominates in areas of high incidence; the latter has Age-adjusted rates of stomach cancer are decreasing, and in
a poorer prognosis, tends to occur at a younger age, and may 2002 (in many countries) were half what they were 30 years
also occur in the cardia.76 More than 95 per cent of gastric earlier. However, during the same period, two types of can-
cancers are adenocarcinomas.77 cer affecting the upper (proximal) section of the stomach
those of the gastro-oesophageal junction and gastric cardia
265
P A R T 2 E V I D E N C E A N D J U D G E M E N T S
7.5.2 Pathogenesis
Changes in the stomach mucosa, brought about by a variety The diffuse type of distal stomach cancers (those that
of environmental factors and ageing, can eventually lead to develop from mucus-producing cells) show some genetic pre-
atrophic gastritis. The chronic form of this condition, and the disposition, with an increased risk for people with blood
resulting changes in the characteristics of the stomach cells, group A. Genetic predisposition is thought to be a factor in
appear to be precursor conditions to the development of dis- 510 per cent of diffuse cancers.93 Stomach cancer is part of
tal stomach cancer.4 Food carcinogens can also potentially the spectrum of cancers associated with the germ line mis-
interact directly with the epithelial cells that line the stom- match repair (MMR) gene alterations that give rise to hered-
ach. However, cancer can also develop without these pre- itary nonpolyposis colorectal cancer (HNPCC).77 Also see
cursors, particularly when the bacterium H pylori is present chapter 7.9.2.
in the stomach (see box 7.5.1).81
Three independent cohort studies have shown the pro-
gression of gastritis from the non-atrophic to the atrophic 7.5.3 Other established causes
form. Epidemiological studies of atrophic gastritis have also
shown an association with dietary factors, especially a high (Also see chapter 2.4 and 7.1.3.1.)
intake of salt (mostly in the form of salty and salted foods).90
N-nitrosamines are known carcinogens produced in the Infection and infestation. The bacterium H pylori is an
stomach from nitrate in foods, and via nitrite from endoge- important cause of distal stomach cancers (see box 7.5.1).
nous nitric oxide production in chronic inflammation (see Also, Epstein-Barr virus is carcinogenic to humans and has
box 4.3.2). They may be potential causes of stomach can- been linked to stomach cancers (particularly gastric lym-
cer92 (see chapter 2.4.2.6). phoepithelial carcinomas and a smaller proportion of gastric
Cancers of the gastric cardia show many similarities to adenocarcinomas) in some studies.30
oesophageal cancer (see 7.3.1). There is a clear association
between Barretts oesophagus and adenocarcinoma of the Industrial chemicals.Industrial exposure to ethylene oxide
lower (distal) oesophagus and of the gastric cardia, caused is carcinogenic to humans and has led to increased risk of
by chronic acid damage. stomach cancer in some studies.94
266
C H A P T E R 7 C A N C E R S
7.5.4 Interpretation of the evidence Most studies showed decreased risk with increased intake.
However, cohort data were less consistent than case-control
7.5.4.1 General data. Meta-analysis of cohort data showed a 19 per cent
For general considerations that may affect interpretation of decreased risk per 50 g green-yellow vegetables/day; no other
the evidence, see chapters 3.3 and 3.5, and boxes 3.1, 3.2, subcategory analyses were statistically significant. Case-con-
3.6 and 3.7. trol data showed a 15 per cent decreased risk per 50 g veg-
Relative risk is used in this Report to denote ratio mea- etables/day (figures 4.2.8. and 4.2.9); a 21 per cent
sures of effect, including risk ratios, rate ratios, hazard decreased risk per 50 g green-yellow vegetables/day; a 57 per
ratios, and odds ratios. cent decreased risk per 50 g green, leafy vegetables/day; a
30 per cent decreased risk per 50 g tomatoes/day; and a 25
7.5.4.2 Specific per cent decreased risk per 50 g raw vegetables/day (figure
Considerations specific to cancer of the stomach include the 4.2.12). There was unexplained heterogeneity.
following. This is a wide and disparate category, and many different
plant food constituents are represented that could contribute
Classification. Most evidence relates to distal stomach can- to a protective effect of non-starchy vegetables. These include
cers, although cancers of the gastric cardia and gastro- dietary fibre, carotenoids, folate, selenium, glucosinolates,
oesophageal junction might be included in an outcome of dithiolthiones, indoles, coumarins, ascorbate, chlorophyll,
stomach cancer. It is now well recognised that proximal and flavonoids, allylsulphides, flavonoids, and phytoestrogens,
distal stomach cancers are quite different, but relatively few some of which are potentially antioxidants. Antioxidants trap
studies stratified results on the basis of subsite. For many free radicals and reactive oxygen molecules, protecting
early studies, most stomach cancer was probably distal in ori- against oxidation damage. It is difficult to unravel the rela-
gin, so the lack of stratification was less important. As the tive importance of each constituent and it is likely that any
incidence and overall proportion of proximal cancer have protective effect may result from a combination of influences
increased in recent years in high-income countries, there is on several pathways involved in carcinogenesis.
a greater likelihood that the general term stomach cancer
will represent a combination of the two subsites and there- A substantial amount of evidence is available,
fore results will be less informative. including on specific subtypes, particularly green-
yellow vegetables, with a dose-response relationship in
Measurement. Owing to low survival rates, both incidence case-control, but not cohort, data. There is evidence
and mortality can be assessed. Low survival times and rates for plausible mechanisms. Non-starchy vegetables
decrease the reliability of case-control studies, which often probably protect against stomach cancer.
rely on proxy reporting.
The Panel is aware that since the conclusion of the SLR, one
Confounding. H pylori infection is a necessary cause of dis- case-control study95 has been published. This new information
tal stomach cancer. This has only been established relative- does not change the Panel judgement. Also see box 3.8.
ly recently. Only recent studies have incorporated H pylori
status into their design and have adjusted or stratified for 7.5.5.2 Allium vegetables
infection. (Also see chapter 4.2.5.1.1.)
A total of 2 cohort studies, 27 case-control studies, and 2
ecological studies investigated allium vegetables; and 1
7.5.5 Evidence and judgements cohort study, 16 case-control studies, and 2 ecological stud-
ies investigated garlic. There was also one relevant inter-
In total, 722 publications were included in the SLR for stom- vention study that combined allitridium (a garlic extract
ach cancer. Fuller summaries of the epidemiological, exper- containing triallylsulphides) and selenium supplements.
imental, and mechanistic evidence are to be found in Most of the studies showed decreased risk with increased
Chapters 46. intake. Meta-analysis of cohort data showed a 23 per cent
The full SLR is contained on the CD included with this decreased risk per 50 g allium vegetables/day. Meta-analy-
Report. sis of case-control data showed a 20 per cent decreased risk
per 50 g allium vegetables/day (figure 4.2.14), and a 59 per
7.5.5.1 Non-starchy vegetables cent decreased risk per serving of garlic/day. The single trial
(Also see chapter 4.2.5.1.) of combined selenium and allitridium supplements showed
A total of 10 cohort studies, 45 case-control studies, and 19 a statistically significant decreased risk in men but not
ecological studies investigated total vegetables. Other group- women, after 5 years of follow-up.
ings examined were green-yellow vegetables (11 cohort, 21 Allium vegetables, particularly garlic, have antibiotic prop-
case-control, 8 ecological); green, leafy vegetables (6 cohort, erties. Although this may act directly against H pylori, stud-
13 case-control, 2 ecological); tomatoes (3 cohort, 19 case- ies in humans have not shown this effect. It is also possible
control); white or pale vegetables (2 cohort, 6 case-control); that antibacterial effects of garlic might inhibit the secondary
raw vegetables (6 cohort, 25 case-control, 3 ecological); or colonisation of the stomach after H pylori-induced atrophy.
non-starchy vegetables and fruits (5 cohort, 6 case-control). At present, there is no evidence to support or refute this idea.
267
P A R T 2 E V I D E N C E A N D J U D G E M E N T S
The evidence, though not copious and mostly from The evidence, mostly from case-control studies, is
case-control studies, is consistent, with a dose- inconsistent. There is limited evidence suggesting that
response relationship. There is evidence for plausible pulses (legumes), including soya and soya products,
mechanisms. Allium vegetables probably protect protect against stomach cancer.
against stomach cancer.
7.5.5.5 Foods containing selenium
7.5.5.3 Fruits (Also see chapter 4.2.5.8.)
(Also see chapter 4.2.5.2.) One case-control study and 5 ecological studies investigated
Sixteen cohort studies, 51 case-control studies, and 23 eco- dietary selenium; 3 cohort studies, 9 case-control studies and
logical studies investigated fruits. Most studies showed 3 ecological studies investigated blood selenium; and 1 cohort
decreased risk with increased intake, but there was unex- study and 1 case-control study investigated selenium in toe-
plained heterogeneity. Cohort studies suggested a non-sig- nails or hair. All of the studies for blood, nail, or hair seleni-
nificant relationship with decreased risk. Meta-analysis of um levels showed decreased risk with increased selenium
case-control data showed a 17 per cent decreased risk per intake. Meta-analysis of cohort data showed a non-significant
50 g fruits per day (figure 4.2.27). decreased risk, and meta-analysis of case-control data pro-
Fruits are sources of vitamin C and other antioxidants, duced statistically significant evidence of decreased risk.
such as carotenoids, phenols, and flavonoids, as well as other Dietary selenium deficiency has been shown to cause a
potentially bioactive phytochemicals. Antioxidants trap free lack of selenoprotein expression. Twenty-five selenoproteins
radicals and reactive oxygen molecules, protecting against have been identified in animals and a number of these have
oxidation damage. In addition, flavonoids found in fruits important anti-inflammatory and antioxidant properties.
directly inhibit the expression of a cytochrome P450 enzyme, Four are glutathione peroxidases, which protect against
which helps to metabolise toxins and has been associated oxidative damage to biomolecules such as lipids, lipopro-
with increased risk of lung cancer, primarily in smokers.68 It teins, and DNA. Three are thioredoxin reductases, which,
is difficult to unravel the relative importance of each con- among other functions, regenerate oxidised ascorbic acid to
stituent and it is likely that a protective effect may result from its active antioxidant form. Selenoproteins with powerful
a combination of influences on several pathways involved in antioxidant activity may provide protection against the
carcinogenesis. inflammatory effect of H pylori that can lead to gastric can-
cer in infected individuals.
The evidence is ample and more consistent, with a
dose-response relationship, for case-control studies A substantial amount of evidence was available on
than for cohorts. There is evidence for plausible selenium, from dietary questionnaires as well as blood,
mechanisms. Fruits probably protect against stomach nails, and hair, mostly from case-control studies. There
cancer. is limited evidence suggesting that foods containing
selenium protect against stomach cancer.
The Panel is aware that since the conclusion of the SLR, three
case-control studies95-97 have been published. This new infor- 7.5.5.6 Chilli
mation does not change the Panel judgement. Also see box 3.8. (Also see chapter 4.2.5.12.1.)
Fourteen case-control studies investigated chilli use. Most of
7.5.5.4 Pulses (legumes) including soya and soya these reported increased risk with increased use, although
products results were heterogeneous and data were not suitable for
(Also see chapter 4.2.5.10.) meta-analysis.
A total of 3 cohort studies, 22 case-control studies, and Anecdotally, chilli may be used to disguise off flavours in
16 ecological studies investigated pulses (legumes) and foods, so these data may be confounded by socioeconomic
stomach cancer; and 2 cohort studies, 9 case-control stud- status, the availability of refrigeration, and H pylori infection.
ies, and 2 ecological studies investigated soya and soya prod- Some constituents of chilli are irritants, which could there-
ucts. All of the cohort studies and most of the case-control fore plausibly increase inflammation in the stomach (also see
studies showed decreased risk with increased intake. chapter 2.4.1.3).
Ecological studies showed decreased risk for soya and soya
products, but were inconsistent for pulses (legumes). The evidence, from case-control studies only, is
Meta-analysis of cohort studies showed a non-significant inconsistent. There is limited evidence suggesting that
relationship with decreased risk. Meta-analysis of case-con- chilli is associated with an increased risk of stomach
trol studies produced evidence for a relationship with cancer.
decreased risk.
Pulses (legumes), particularly soya, contain high levels of 7.5.5.7 Processed meat
isoflavones that have shown anti-cancer properties in labo- (Also see chapter 4.3.5.1.2.)
ratory experiments. Saponins and other bioactive con- Eight cohort studies, 21 case-control studies, 1 cross-sec-
stituents of soya (and to a lesser extent, other pulses) may tional study, and 1 ecological study investigated processed
also have anti-cancer properties, although these are less well meat. Most of these showed increased risk with higher
demonstrated. intake. Meta-analysis of cohort data showed a non- signifi-
268
C H A P T E R 7 C A N C E R S
cant relationship with increased risk. Meta-analysis of case- specified the foods studied). Most studies showed increased
control data produced evidence of a statistically significant risk with increased intake.
dose-response relationship. Heterogeneity is likely to be Cooking methods involving grilling above a heat source
caused by the diverse nature of definitions for processed and barbecuing can produce marked differences in levels of
meat in different studies. carcinogens in foods cooked in these ways (see chapter
Nitrates are produced endogenously in gastric acid, and are 4.9.4). For example, fat dripping on hot surfaces can form
added as preservatives to processed meats. They may con- polycyclic aromatic hydrocarbons and heterocyclic amines
tribute to N-nitroso compound production and exposure. N- (see box 4.3.4), while oven grilling prevents this from hap-
nitroso compounds are suspected mutagens and carcinogens pening, resulting in much lower levels of these compounds
(see box 4.3.2).55 Many processed meats also contain high in the cooked foods.
levels of salt and nitrite. Meats cooked at high temperatures
can contain heterocyclic amines and polycyclic aromatic There is limited, inconsistent evidence, mostly from
hydrocarbons (see box 4.3.4). Haem promotes the formation case-control studies, that grilled (broiled) or
of N-nitroso compounds and also contains iron. Free iron can barbecued (charbroiled) animal foods are causes of
lead to the production of free radicals (see box 4.3.3). stomach cancer.
269
P A R T 2 E V I D E N C E A N D J U D G E M E N T S
studies showed increased risk with increased intake. Meta- selenium supplements. Two trials are now available, as well
analysis of cohort data showed a non-significant increased as increased numbers of cohort and case-control studies, but
risk; meta-analysis of case-control data showed a 5.2-fold the evidence is still limited and only suggestive of a protec-
increased risk per serving per day (figure 4.6.2). tive effect.
Heterogeneity may be partly explained by variation between
studies in the precise foods being assessed.
As stated above, assessment of salt intake is complicated. 7.5.7 Conclusions
Again, higher-quality studies report a greater or more sig-
nificant effect. The Panel concludes:
Again, salt has been shown to directly damage the stom- Non-starchy vegetables, and specifically allium vegetables,
ach lining in animal trials. It has also been shown to increase as well as fruits probably protect against stomach cancer.
endogenous N-nitroso compound formation (see box 4.3.2). Salt and salt-preserved foods are probably causes of this
cancer.
The evidence, both from case-control and cohort There is limited evidence suggesting that pulses (legumes)
studies, is consistent. A dose-response relationship is including soya and soya products and foods containing sele-
apparent from case-control but not cohort studies. nium protect against stomach cancer.
There is robust evidence for mechanisms operating in There is also limited evidence suggesting that chilli,
humans. Salted and salty foods are probable causes of processed meat, smoked foods, and grilled (broiled) and bar-
stomach cancer. becued (charbroiled) animal foods are causes of stomach
cancer.
The Panel is aware that since the conclusion of the SLR, two Infection with the bacterium H pylori is a necessary but
case-control studies95 99 have been published. This new infor- not sufficient cause of stomach cancer.
mation does not change the Panel judgement. Also see box 3.8.
7.5.6.1 General
See 7.1.6.1, and box 3.8.
7.5.6.2 Specific
The previous report judged the evidence that vegetables and
fruits protect against stomach cancer to be convincing. Since
then, the evidence from cohort studies has been rather equiv-
ocal, whereas evidence from case-control studies remains
strong and consistent. Previously, the compounds found in
allium vegetables were judged possibly to protect against
stomach cancer; more recent evidence for allium vegetables
is stronger.
The previous report found the evidence that refrigeration
protects against stomach cancer to be convincing. Also see
box 4.6.4.
Before the mid-1990s there were no published trials of
270
C H A P T E R 7 C A N C E R S
7.6 Pancreas
Cancer of the pancreas is the thirteenth most common
type of cancer worldwide. About 230 000 cases were FOOD, NUTRITION, PHYSICAL ACTIVITY,
recorded in 2002, accounting for around 2 per cent of AND CANCER OF THE PANCREAS
cancers overall. The incidence is somewhat more
In the judgement of the Panel, the factors listed below modify the risk of
common in men than in women. It is generally cancer of the pancreas. Judgements are graded according to the strength
increasing, particularly in high-income countries, of the evidence.
where it is most frequent. It is rare in Africa and Asia.
This cancer is almost always fatal and is the ninth most DECREASES RISK INCREASES RISK
common cause of cancer death.
Overall, the Panel is impressed by the strength of the Convincing Body fatness
evidence that body fatness, abdominal fatness, and the Probable Foods containing Abdominal fatness
factors that lead to greater adult attained height, or its folate1 Adult attained
consequences, are causes of cancer of the pancreas. height2
271
P A R T 2 E V I D E N C E A N D J U D G E M E N T S
relatively high in some countries in these areas, for exam- rates decrease the reliability of case-control studies, which
ple, Japan and Korea. In the USA, rates are higher among often rely on proxy reporting.
African-American people than in white people.3 The risk of
pancreatic cancer increases with age, with most diagnoses Confounding. High-quality studies adjust for smoking.
made in people between the ages of 60 and 80.
The early stages of this cancer do not usually produce
symptoms, so the disease is generally advanced when it is 7.6.5 Evidence and judgements
diagnosed. Survival rates are therefore low around 4 per
cent at 5 years. This cancer accounts for around 2 per cent In total, 318 publications were included in the SLR for this
of all cancer incidence, but somewhat over 3 per cent of all cancer. Fuller summaries of the epidemiological, experi-
cancer deaths.4 Also see box 7.1.1. mental, and mechanistic evidence are in Chapters 46.
The full SLR is contained on the CD included with this
Report.
7.6.2 Pathogenesis
7.6.5.1 Fruits
The ductal cells in the head of the pancreas are exposed to (Also see chapter 4.2.5.2.)
pancreatic secretions, as well as bile, and environmental car- Six cohort studies, 16 case-control studies, and 8 ecological
cinogens can reach these cells through those fluids or in the studies investigated fruits. All cohort studies and most other
blood (see 7.7). studies showed decreased risk with increased intake. Meta-
The pancreas is relatively inaccessible to routine medical analysis of cohort data showed a non-significant decreased
examination, so the progression of this cancer through pre- risk. Meta-analysis of case-control data showed a statistically
cursor lesions is not well understood. However, inflamma- significant decreased risk.
tion is implicated in this process through chronic pancreatitis, Fruits are sources of vitamin C and other antioxidants,
which is a risk factor for pancreatic cancer. The role of infec- such as carotenoids, phenols, and flavonoids, as well as other
tion with H pylori (see box 7.5.1) is the subject of ongoing potentially bioactive phytochemicals. Antioxidants trap free
research.105 Conditions that lead to high insulin levels in pan- radicals and reactive oxygen molecules, protecting against
creatic secretions, such as insulin resistance and type 2 dia- oxidation damage. In addition, flavonoids found in fruit
betes, may increase the risk of this cancer.106 directly inhibit the expression of the cytochrome P450
More than 90 per cent of pancreatic cancer cases are spo- enzyme, which helps to metabolise toxins and has been asso-
radic (due to spontaneous rather than inherited mutations), ciated with increased risk of lung cancer, primarily in smok-
although a family history increases risk, particularly where ers.68 It is difficult to unravel the relative importance of each
more than one family member is involved.105 Around 7590 constituent and is likely that a protective effect may result
per cent of pancreatic cancer cases involve a point mutation from a combination of influences on several pathways
in the K-ras oncogene107 (see box 2.2 in chapter 2). involved in carcinogenesis.
(Also see chapters 2.4 and 7.1.3.1.) The Panel is aware that since the conclusion of the SLR, one
cohort study108 has been published. This new information does
Tobacco use. Approximately 25 per cent of cases of pancre- not change the Panel judgement. Also see box 3.8.
atic cancer are attributable to tobacco smoking.
7.6.5.2 Foods containing folate
(Also see chapter 4.2.5.4.)
7.6.4 Interpretation of the evidence Three cohort studies, two case-control studies, and one eco-
logical study investigated folate from foods and/or folic acid
7.6.4.1 General from supplements. Meta-analysis of all three cohort studies
For general considerations that may affect interpretation of showed a non-significant decreased risk, with high hetero-
the evidence, see chapters 3.3 and 3.5, and boxes 3.1, 3.2, geneity. When stratified according to the source, both dietary
3.6 and 3.7. studies showed a non-significant decreased risk, and three
Relative risk is used in this Report to denote ratio mea- studies of supplements showed a non-significant increased
sures of effect, including risk ratios, rate ratios, hazard risk. One cohort study also analysed serum folate levels,
ratios, and odds ratios. showing a significant decreased risk of 55 per cent for the
highest levels compared with the lowest. Both the case-con-
7.6.4.2 Specific trol studies and the ecological study showed decreased risk
Considerations specific to cancer of the pancreas include: with increased intake. Folic acid supplements do not show
a protective effect.
Measurement. Owing to very low survival rates, both inci- Folate plays an important role in the synthesis and repair
dence and mortality can be assessed. Low survival times and of DNA. There is a known interaction between folate and
272
C H A P T E R 7 C A N C E R S
alcohol and the risk of some cancers (see chapter 4.8). Folate efficiency and capacity (the amount of work that it can per-
intake is strongly correlated with intake of non-starchy poly- form), as well as reducing blood pressure and insulin resis-
saccharide or dietary fibre. tance. In addition, low levels of physical activity decrease
gastrointestinal transit times. This alters bile content and
The evidence available is sparse but a dose-response secretion, as well as affecting pancreatic activity.111
relationship was apparent from cohort studies. There is
limited evidence suggesting that foods containing There is evidence from prospective studies showing
folate protect against pancreatic cancer. lower risk of pancreatic cancer with higher levels of
various types of physical activity, but it is rather
The Panel is aware that since the conclusion of the SLR, one inconsistent. There is limited evidence suggesting that
cohort study109 has been published. This new information does physical activity protects against pancreatic cancer.
not change the Panel judgement. Also see box 3.8.
The Panel is aware that since the conclusion of the SLR, one
7.6.5.3 Red meat cohort study112 has been published. This new information does
(Also see chapter 4.3.5.1.1.) not change the Panel judgement. Also see box 3.8.
Seven cohort studies and four case-control studies investi-
gated red meat. Nearly all of the studies showed increased 7.6.5.6 Body fatness
risk with increased intake. (Also see chapter 6.1.3.1.)
Red meat contains haem iron. Free iron can lead to the pro- Twenty-three cohort studies and 15 case-control studies
duction of free radicals (see box 4.3.3). When cooked at high investigated body fatness, as measured by BMI. Most cohort
temperatures, red meat can also contain heterocyclic amines studies showed increased risk with increased body fatness,
and polycyclic aromatic hydrocarbons (see box 4.3.4). but case-control studies were inconsistent. Meta-analysis of
cohort data showed a 14 per cent increased risk per 5 kg/m2
Evidence from cohort studies is less consistent than (figure 6.1.4). Heterogeneity appeared to be explained by a
that from case-control studies. There is limited number of studies failing to adjust for smoking, which is sep-
evidence suggesting that red meat is a cause of arately associated with both BMI and pancreatic cancer.
pancreatic cancer. It is biologically plausible that body fatness is a cause of
pancreatic cancer. There is an established connection
The Panel is aware that since the conclusion of the SLR, one between increasing BMI or body fatness and insulin resis-
cohort study110 has been published. This new information does tance and diabetes. The risk of this cancer is increased in
not change the Panel judgement. Also see box 3.8. people with insulin resistance or diabetes. It also directly
affects levels of many circulating hormones, such as insulin,
7.6.5.4 Coffee insulin-like growth factors, and oestrogens, creating an envi-
(Also see chapter 4.7.5.4.) ronment that encourages carcinogenesis and discourages
Eighteen cohort studies, 37 case-control studies, and 11 eco- apoptosis (see box 2.4). Body fatness stimulates the inflam-
logical studies investigated coffee. Analysis of cohort data matory response, which may contribute to the initiation and
showed an effect estimate close to null with low hetero- progression of several cancers (see chapter 2.4.1.3).
geneity. Data for case-control studies were less consistent.
There is ample epidemiological evidence, which is
There is ample evidence, including prospective data, generally consistent, and there is a dose-response
which is consistent and with low heterogeneity, and relationship. There is evidence for plausible
which fails to show an association. It is unlikely that mechanisms that operate in humans. The evidence
coffee has a substantial effect on the risk of pancreatic that greater body fatness is a cause of pancreatic
cancer. cancer is convincing.
7.6.5.5 Physical activity The Panel is aware that since the conclusion of the SLR, two
(Also see chapter 5.4.5.) cohort studies58 112 have been published. This new information
A total of three cohort studies and one case-control study does not change the Panel judgement. Also see box 3.8.
investigated total physical activity; three cohort studies and
two case-control studies investigated occupational activity; 7.6.5.7 Abdominal fatness
and nine cohort studies and three case-control studies inves- (Also see chapter 6.1.3.2.)
tigated recreational activity. Several studies also examined Three cohort studies investigated waist circumference, two
walking and transportation. Most of the studies showed cohort studies investigated waist to hip ratio, and one cohort
decreased risk with increased physical activity, though there study investigated patterns of weight gain, all of which
was heterogeneity in the direction of effect and no clear showed increased risk with increasing measures of abdom-
dose-response relationship. inal fatness. Half of all studies were statistically significant.
Sustained moderate physical activity raises the metabolic The general mechanisms through which abdominal fatness
rate and increases maximal oxygen uptake. In the long term, could plausibly cause cancer are outlined in chapter 6.1.3
regular periods of such activity increase the bodys metabolic (also see box 2.4). The hormonal and other biological effects
273
P A R T 2 E V I D E N C E A N D J U D G E M E N T S
of being overweight or obese are outlined in chapter 8. Many 7.6.6 Comparison with previous report
of these, such as increased circulating oestrogens and
decreased insulin sensitivity, are associated with abdominal 7.6.6.1 General
fatness independently of overall body fatness. See 7.1.6.1, and box 3.8 in chapter 3.
The Panel is aware that since the conclusion of the SLR, one
cohort study112 has been published. This new information does
not change the Panel judgement. Also see box 3.8.
274
C H A P T E R 7 C A N C E R S
7.7 Gallbladder
Cancer of the gallbladder accounts for somewhat over
2 per cent of all cancer incidence and rates are generally FOOD, NUTRITION, PHYSICAL ACTIVITY,
declining. The highest rates occur in eastern Asia and AND CANCER OF THE GALLBLADDER
eastern Europe, but it is rare in Africa. This cancer is
In the judgement of the Panel, the factors listed below modify the risk of
usually fatal and is the 17th most common cause of
cancer of the gallbladder. Judgements are graded according to the
cancer death. strength of the evidence.
The gallbladder is a small sac-like organ that forms part of For an explanation of all the terms used in the matrix,
please see chapter 3.5.1, the text of this section,
the biliary tract. Bile, produced in the liver, flows into the and the glossary.
gallbladder, where it is stored and concentrated until
released into the small intestine.
More than 90 per cent of gallbladder cancers are adeno-
carcinomas, while only a small proportion are squamous cell
carcinomas.4
Age-adjusted rates of gallbladder cancer are decreasing.1 The pathogenesis of gallbladder cancer is not well under-
Even in many of the countries where incidence had been rel- stood, partly because it is often diagnosed at a late stage.
atively high, such as in eastern Asia and eastern Europe, rates Having gallstones increases the risk of this cancer. The
have decreased and continued to fall, following a dramatic associated inflammation decreases the speed at which bile
rise in the 1970s and 1980s. empties from the gallbladder; gallstones may also have a
There is no clear geographical pattern to the distribution direct effect by blocking the transit of bile.115 Gallstones, like
of gallbladder cancer. Age-adjusted incidence rates range gallbladder cancers, are more common in women than men,
from 510 per 100 000 people in parts of eastern Asia and and the risk of cancer is proportional to the size of the gall-
eastern Europe to less than 1 per 100 000 in parts of Africa. stones.116 However, other factors must also be involved: in
In the USA, rates are higher among both Native- and high-income countries up to 1 person in 10 has gallstones
Hispanic-American people than in white people.113 Around (many asymptomatic),117 whereas gallbladder cancer is diag-
most of the world, gallbladder cancer is slightly more com- nosed in only around 1 in 50 000.
mon in women than men. In Japan and Korea, this trend is Many toxins, whether they come from diet, smoke inhala-
reversed, with around 60 per cent of cases in men.103 Risk tion, or other environmental sources (and their metabolic
increases with age, with more than two thirds of cases occur- products) are excreted and concentrated in the bile.
ring in people aged 65 years or older.114 Early stages of the disease include plaque-like lesions and
Gallbladder cancer is usually advanced at diagnosis. small ulcerations in the mucosal lining of the gallbladder,
Survival rates are poor: at 5 years less than 12 per cent for which are associated with chronic inflammation (cholecys-
advanced disease, but this is much higher (by up to 20 per titis). This may progress to carcinoma in situ, and then to
cent) when the cancer is caught early. Gallbladder cancer invasive tumours. This process probably takes at least 20
accounts for just over 2 per cent of all cancer incidence, and years (cholecystitis is seldom seen in people under 40),
the same proportion of all cancer deaths. Also see box 7.1.1. hence the age profile of gallbladder cancer. Chronic inflam-
275
P A R T 2 E V I D E N C E A N D J U D G E M E N T S
mation caused by other factors (such as in porcelain gall- case-control data showed a 19 per cent increased risk per 5
bladder or from chronic bacterial infection) may be a nec- kg/m2. Heterogeneity could be partly attributed to differ-
essary stage in the development of gallbladder cancer, ences in the study participants ethnicity or sex, or to the
although the evidence is not conclusive.4 118 119 number of adjustments made in the study.
A congenital deformity to the pancreatic ducts is associ- Body fatness directly affects levels of many circulating hor-
ated with most gallbladder cancers in eastern Asia.120 This mones, such as insulin, insulin-like growth factors, and
may account for the different epidemiology in this region, oestrogens, creating an environment that encourages car-
and could imply a distinct pathogenesis with different risk cinogenesis and discourages apoptosis (see box 2.4). It also
factors. Mutations of the tumour-suppressor p53 gene are fre- stimulates the bodys inflammatory response, which may
quent in gallbladder cancers (see box 2.2).121 contribute to the initiation and progression of several can-
cers (see chapter 2.4.1.3). In addition, obesity is a known
cause of gallstone formation, and having gallstones increas-
7.7.3 Other established causes es the risk of gallbladder cancer, possibly through bile cho-
lesterol supersaturation.
(Also see chapter 2.4 and 7.1.3.1 of this chapter.) Because having gallstones is a cause of gallbladder can-
cer, the Panel also reviewed the dietary causes of gallstones,
Other diseases.Having gallstones increases the risk of gall- especially in relation to body fatness. Having a relatively high
bladder cancer and can be identified as a cause of this can- BMI increases the risk of gallstones in a linear fashion; waist
cer. circumference is associated with gallstone risk in men, inde-
pendently of BMI. Gallstone formation is associated with
Other causes are not established; see 7.7.2. repeated dieting, especially where it involves rapid weight
loss, such as that from very low-energy diets and bariatric
surgery.
7.7.4 Interpretation of the evidence
There is a substantial amount of generally consistent
7.7.4.1 General epidemiological evidence with some evidence of a
For general considerations that may affect interpretation of dose-response relationship. There is evidence for
the evidence, see chapters 3.3 and 3.5, and boxes 3.1, 3.2, several plausible mechanisms. Greater body fatness is
3.6 and 3.7. a probable cause of gallbladder cancer, directly and
Relative risk is used in this Report to denote ratio mea- also indirectly through the formation of gallstones.
sures of effect, including risk ratios, rate ratios, hazard
ratios, and odds ratios. 7.7.5.2 Other exposures
Other exposures were evaluated. However, the data were
7.7.4.2 Specific either of too low quality, too inconsistent, or the number of
Considerations specific to cancer of the gallbladder include: studies too few to allow conclusions to be reached. These
included capsicums, fish, coffee, tea, alcohol, and vitamin C.
Confounding. Having gallstones increases the risk of gall-
bladder cancer. Exposures with an apparent link to gall-
bladder cancer may act indirectly, through gallstones, or 7.7.6 Comparison with previous report
directly, either after gallstone formation or in their absence.
It is not yet possible to separate these effects. See 7.7.7. 7.7.6.1 General
See 7.1.6.1, and box 3.8 of chapter 3.
276
C H A P T E R 7 C A N C E R S
7.8 Liver
Cancer of the liver is the sixth most common type of
cancer worldwide. Around 625 000 cases were recorded in FOOD, NUTRITION, PHYSICAL ACTIVITY,
2002, accounting for around 6 per cent of all cancers. AND CANCER OF THE LIVER
About half of all cases occur in China, and it is more
In the judgement of the Panel, the factors listed below modify the risk of
common in middle- and low-income countries. It is almost cancer of the liver. Judgements are graded according to the strength of
always fatal, and is the third most common cause of death the evidence.
from cancer, accounting for around 9 per cent of all
deaths. DECREASES RISK INCREASES RISK
Overall, the Panel notes that toxic compounds are the
Convincing Aflatoxins1
main causes of primary liver cancer related to foods and
drinks. Probable Alcoholic drinks2
277
P A R T 2 E V I D E N C E A N D J U D G E M E N T S
Hepatitis B and hepatitis C viruses are causes of liver cancer. The (Also see chapter 2.4 and 7.1.3.1.)
former appears to act directly by damaging cells and their DNA.
The latter shows an indirect effect, mediated by cirrhosis. For Other diseases. Cirrhosis of the liver increases the risk of, and
both, there is potential for nutrition status to have an effect at
so can be seen as a cause of, liver cancer.
several stages: susceptibility to and duration of infection, liver
damage, DNA damage, and cancer progression.129
Infection and infestation. Chronic viral hepatitis is a cause
Around 78 per cent of the worlds population is estimated to
be infected with hepatitis B virus. It is mostly spread by blood of liver cancer (see box 7.8.1).130 Infestation with liver flukes
and sexual transmission. In endemic areas, the carrier rate may is a cause of cholangiocarcinoma.
be 1020 per cent.130 It is often acquired at birth or in childhood,
and is endemic in areas of Africa and Asia. Chronic hepatitis B Medication. Oral contraceptives containing high doses of oestro-
virus carriers have a 100-fold greater chance of developing liver gen and progesterone may be a cause of this cancer.90 133
cancer than non-carriers. Those infected in adulthood have a
lower risk of this cancer than those infected in childhood because
there is less time for the virus to cause inflammation.130
7.8.4 Interpretation of the evidence
Vaccination against hepatitis B virus has been shown to reduce
the prevalence of liver cancer by 60 per cent.131
Liver cancer in hepatitis B virus carriers is not necessarily con-
7.8.4.1 General
nected with cirrhosis: up to 40 per cent of associated liver can- For general considerations that may affect interpretation of
cer cases are non-cirrhotic. Hepatitis B virus carries its genetic the evidence, see chapters 3.3 and 3.5, and boxes 3.1, 3.2,
code as DNA rather than RNA. Viral DNA can insert itself into liver 3.6 and 3.7.
cells and alter their DNA. Relative risk is used in this Report to denote ratio mea-
Around 3 per cent of the worlds population is estimated to sures of effect, including risk ratios, rate ratios, hazard
be infected with hepatitis C virus. It is more prevalent in high- ratios, and odds ratios.
income countries. Approximately 80 per cent of these infections
become chronic, of which 1520 per cent develops into cirrho-
7.8.4.2 Specific
sis. Of those, 14 per cent develops into liver cancer each year.
Considerations specific to cancer of the liver include:
Interruption of the sequence of chronic hepatitis developing into
cirrhosis prevents liver cancer. Also, there is an interaction
between hepatitis C virus infection, liver cancer risk, and con- Classification. Most of the data is on hepatocellular carci-
sumption of alcoholic drinks.132 There is no vaccine against noma, the most well characterised (and most common) form
hepatitis C. It is mostly spread by blood. of liver cancer. However, different outcomes are reported for
unspecified primary liver cancer, compared with hepato-
cellular carcinoma or cholangiocarcinoma. This suggests
different causation and so may therefore be a cause of
The early stages of liver cancer do not usually produce heterogeneity.
symptoms, so the disease is generally advanced when it is
diagnosed. Survival rates are poor: at 5 years, approximately Confounding. Hepatitis B and C viruses are possible con-
5 per cent.124 This cancer accounts for almost 6 per cent of founders or effect modifiers; high-quality studies adjust for
all cancer incidence, but around 9 per cent of all cancer them. Not all studies do so.
deaths.2 Also see box 7.1.1.
Measurement. Owing to low survival rates, both incidence
and mortality can be assessed. Low survival times and rates
7.8.2 Pathogenesis decrease the reliability of case-control studies, which often
rely on proxy reporting.
Liver cancer generally follows cirrhosis, so any cause of cir-
rhosis either viral (see box 7.8.1) or chemical is like-
ly to increase cancer risk. Approximately 80 per cent of 7.8.5 Evidence and judgements
hepatocellular carcinoma cases develop in cirrhotic livers.123
As for cancers at most sites, accumulated sequential In total, 273 publications were included in the SLR for liver
changes (see chapter 2.5), specifically in mature hepatocytes, cancer. Fuller summaries of the epidemiological, experi-
lead to the development of dysplastic nodules; over the mental, and mechanistic evidence are to be found in
course of around 5 years, 30 per cent may develop into Chapters 46.
tumours.125 Hepatocellular carcinoma cells show numerous The full SLR is contained on the CD included with this
genetic changes, perhaps accumulated during cellular pro- Report.
liferation, which is part of the normal liver repair process.126
The hepatitis B virus-related type (see box 7.8.1) appears to 7.8.5.1 Fruits
be more genetically unstable than others.127 128 (Also see chapter 4.2.5.2.)
The liver is a common site for metastasis of tumours orig- One cohort study and five case-control studies investigated
inating in other organs. fruits. The cohort study and most of the case-control stud-
278
C H A P T E R 7 C A N C E R S
ies showed decreased risk with increased fruit intake. No analysis of cohort data showed a 10 per cent increased risk
studies showed statistically significant increased risk. per 10 g ethanol/day. Meta-analysis of case-control data
Fruits are sources of vitamin C and other antioxidants, showed an 18 per cent increased risk per drink/week, or a
such as carotenoids, phenols, and flavonoids, as well as other 17 per cent increased risk per 10 g ethanol/day (figures
potentially bioactive phytochemicals. Antioxidants trap free 4.8.184.8.19).
radicals and reactive oxygen molecules, protecting against Heterogeneity in case-control studies may be explained by
oxidation damage. alcoholic behaviour, by proxy reporting, or by failure to
In addition, flavonoids found in fruit directly inhibit the adjust for hepatitis virus status. Several studies used partic-
expression of a cytochrome P450 enzyme, which helps to ipants judged to be at high risk of developing liver cancer
metabolise toxins and has been associated with increased (people who already had liver cirrhosis). These results are
risk of lung cancer, primarily in smokers.68 It is difficult to particularly difficult to interpret as cirrhosis status affects
unravel the relative importance of each constituent and drinking behaviour. Also, the cancer disease path may be dif-
is likely that a protective effect may result from a com- ferent in people with cirrhosis.
bination of influences on several pathways involved in It is biologically highly plausible that alcoholic drinks are
carcinogenesis. a cause of liver cancer. Reactive metabolites of alcohol such
as acetaldehyde can be carcinogenic. DNA mutations may be
The evidence is sparse and inconsistent. There is less efficiently repaired in the presence of alcohol. Alcohol
limited evidence suggesting that fruits protect against may also function as a solvent, enhancing penetration of
liver cancer. other carcinogenic molecules into cells. Additionally, the
effects of alcohol may be mediated through the production
The Panel is aware that since the conclusion of the SLR, one of prostaglandins, lipid peroxidation, and the generation of
case-control study134 has been published. This new information free radical oxygen species. Lastly, heavy consumers of alco-
does not change the Panel judgement. Also see box 3.8. hol may have diets low in essential nutrients, making tissues
susceptible to carcinogenesis. In addition, regular, high lev-
7.8.5.2 Aflatoxins els of alcohol consumption are known to cause liver dam-
(Also see chapter 4.1.5.4.) age. Tumour promotion has been linked to inflammation in
Five cohort studies and seven case-control studies investi- the liver through alcohol-associated fibrosis and hepatitis.
gated biomarkers of exposure to aflatoxins. All of the cohort Alcohol consumption, even at moderate levels, is associat-
studies and most of the case-control studies showed ed with increases in levels of circulating hepatitis C virus
increased risk with elevated measures of exposure. Most RNA in carriers of this infection. This infection is highly
cohort studies showed significant dose-response relation- prevalent among alcoholics with chronic liver disease, and
ships, although the variety of measures used prevented meta- appears to accelerate the course of alcoholic liver disease.
analysis. Effect estimates ranged from a three- to sevenfold
increased risk for the highest measures of exposure. There is ample, generally consistent evidence from
There is strong mechanistic evidence through the meta- both cohort and case-control studies. A dose-response
bolic product of aflatoxin B1, which is known to be geno- relationship is apparent. Alcohol is a cause of cirrhosis,
toxic and is formed in the liver. It directly damages DNA, which predisposes to liver cancer, but the factors that
forming adducts. The activity of GST enzymes can result in determine why some people are susceptible to
lower levels of adducts with varying efficiency between cirrhosis are not known. Alcoholic drinks are a
genotypes. There is clear and consistent evidence that GST- probable cause of liver cancer. No threshold was
positive genotypes protect against the increased risk of liver identified.
cancer from hepatitis infection combined with aflatoxin
exposure. This supports a causal role for aflatoxin B1 in The Panel is aware that since the conclusion of the SLR, one
hepatocellular carcinoma. case-control study135 has been published. This new information
does not change the Panel judgement. Also see box 3.8.
The evidence is ample and consistent and is supported
by strong evidence for mechanisms operating in 7.8.5.4 Body fatness
humans. A dose-response relationship is apparent from (Also see chapter 6.1.3.1).
both cohort and case-control studies. The evidence that Six cohort studies and two case-control studies investigated
aflatoxins and aflatoxin-contaminated foods are a body fatness, as measured by BMI, or obesity. All cohort stud-
cause of liver cancer is convincing. ies showed increased risk with increased body fatness, except
in one subgroup of African-American men. There was sub-
7.8.5.3 Alcoholic drinks stantial heterogeneity and none of the studies adjusted for
(Also see chapter 4.8.5.1.) hepatitis virus status. The two case-control studies provid-
A total of 15 cohort studies and 33 case-control studies inves- ed no clear evidence of any effect.
tigated alcoholic drinks, and 14 cohort studies and 21 case- Body fatness directly affects levels of many circulating hor-
control studies investigated total ethanol intake. Most studies mones, such as insulin, insulin-like growth factors, and
showed increased risk with increased alcohol intake, with oestrogens, creating an environment that encourages car-
none reporting statistically significant decreased risk. Meta- cinogenesis and discourages apoptosis (see box 2.4). It stim-
279
P A R T 2 E V I D E N C E A N D J U D G E M E N T S
280
C H A P T E R 7 C A N C E R S
FOOD, NUTRITION, PHYSICAL ACTIVITY, AND CANCERS OF THE COLON AND THE RECTUM
In the judgement of the Panel, the factors listed below modify the risk of cancers of the colon and the rectum. Judgements are graded according to the
strength of the evidence.
Limited Cereals (grains) and their products; potatoes; poultry; shellfish and other seafood; other dairy products; total fat; fatty acid
no conclusion composition; cholesterol; sugar (sucrose); coffee; tea; caffeine; total carbohydrate; starch; vitamin A; retinol; vitamin C; vitamin E;
multivitamins; non-dairy sources of calcium; methionine; beta-carotene; alpha-carotene; lycopene; meal frequency; energy intake
Substantial
effect on risk None identified
unlikely
For an explanation of all the terms used in the matrix, please see chapter 3.5.1, the text of this section, and the glossary.
The colon is the lower part of the intestinal tract. It extends resistant starch) to release energy and short chain fatty acids
from the caecum to the rectum. In the colon, water and salts that influence the health of the colonic mucosa. It may also
are absorbed from undigested foods, and muscles move the be infected with harmful types of bacteria. The colon is lined
waste products towards the rectum. The colon contains a vast with mucous membranes, and also contains lymphoid cells
population of many types of bacteria, which have potential- that form part of the bodys immune defences.
ly important functions. These include the fermentation of Approximately 95 per cent of colorectal cancers are ade-
unabsorbed carbohydrate (non-starch polysaccharides and nocarcinomas. Other types of cancer that can occur here
281
P A R T 2 E V I D E N C E A N D J U D G E M E N T S
include mucinous carcinomas and adenosquamous carcino- There are two characterised pathways to colorectal cancer,
mas.4 Adenocarcinomas are covered here. A systematic although they are likely to be linked the gatekeeper and
review of colorectal adenomas was conducted to understand the caretaker pathways.141 The gatekeeper pathway is
the contribution of food, nutrition, and physical activity to involved in 85 per cent of sporadic colorectal cancers, and
the pathogenesis of colorectal cancer, and contributed to is the one associated with FAP.140 It involves the disruption
interpretation of the underlying mechanisms. of genes that regulate growth, and for colorectal cancer, the
key one is the tumour-suppressor gene APC. The caretaker
pathway is characterised by disruption to genes that main-
7.9.1 Trends, incidence, and survival tain genetic stability. It leads to 15 per cent of sporadic can-
cers, and is involved in the development of HNPCC.140
There is no clear trend in global age-adjusted rates of col- Several tumour-suppressor genes are mutated in this path-
orectal cancer. There has, however, been a rapid increase in way142 (also see box 2.2 in chapter 2).
rates in high-income countries that have recently made the
transition from a relatively low-income economy, such as
Japan, Singapore, and eastern European countries. Rates 7.9.3 Other established causes
have at least doubled in many of these countries since the
mid-1970s.137 Colorectal cancer is mainly a disease of high- (Also see chapter 2.4 and 7.1.3.1.)
income countries, where overall rates are nearly four times
higher than in middle- to low-income countries. Around the Other diseases. Inflammatory bowel disease (Crohns disease
world, age-adjusted incidence rates range from more than and ulcerative colitis) increase the risk of, and so may be
40 per 100 000 people in North America, parts of Europe, seen as a cause of, colon cancer.
Australia, New Zealand, and Japan to less than 5 per
100 000 in much of Africa, Central America, and parts of Medication. Non-steroidal anti-inflammatory drugs such as
Asia.2 In the USA, rates are higher among African-American aspirin and hormone replacement therapy in postmeno-
people than in white people.3 This disease is slightly more pausal women have been shown to decrease colon cancer
common in men than in women, by seven to five. Risk risk.143 144
increases with age until old age, when it levels off.6
Colorectal cancer often produces symptoms at an early
enough stage to make it treatable, meaning that survival 7.9.4 Interpretation of the evidence
rates are relatively high. In addition, regular screening is
common in some countries such as the USA. The 5-year over- 7.9.4.1 General
all survival rate averages 50 per cent, with 55 per cent in For general considerations that may affect interpretation of
high-income countries and 39 per cent in middle- to low- the evidence, see chapters 3.3 and 3.5, and boxes 3.1, 3.2,
income countries.124 This cancer accounts for somewhat over 3.6 and 3.7.
9 per cent of all cancer incidence, but around 8 per cent of Relative risk is used in this Report to denote ratio mea-
all cancer deaths. Also see box 7.1.1. sures of effect, including risk ratios, rate ratios, hazard
ratios, and odds ratios.
282
C H A P T E R 7 C A N C E R S
increased intake. Meta-analysis of cohort data showed a 10 non-starchy vegetables protect against colorectal cancer.
per cent decreased risk per 10 g/day (see figure 4.1.1). The Panel is aware that since the conclusion of the SLR, three
Heterogeneity may be caused by variation in the definition case-control studies17 152 154 have been published. This new
of dietary fibre between studies. A pooled analysis of 8100 information does not change the Panel judgement. Also see box
colorectal cancer cases among 730 000 participants, fol- 3.8.
lowed up for 620 yeas, showed a non-significant decreased
risk for the groups that consumed the most dietary fibre. 7.9.5.3 Garlic
Data come predominantly from dietary sources, not supple- (Also see chapter 4.2.5.1.2.)
ments; therefore no effect can be attributed specifically to Two cohort studies and six case-control studies investigated
fibre, which is interpreted simply as a marker of consump- garlic. All studies reported decreased risk with increased
tion of foods containing it, although specific mechanisms intake, with none reporting contrary results. Most studies did
have been identified. not reach statistical significance, and meta-analysis was not
Fibre exerts several effects in the gastrointestinal tract, but possible.
the precise mechanisms for its probable protective role are There is considerable preclinical evidence with model car-
still not clearly understood. Fibre dilutes faecal content, cinogens and transplantable tumours that supports an anti-
decreases transit time, and increases stool weight. cancer effect of garlic and some of its allyl sulphur
Fermentation products, especially short-chain fatty acids, are components. Animal studies demonstrate that allyl sulphides
produced by the gut flora from a wide range of dietary car- effectively inhibit colon tumour formation, and also can
bohydrates and mucins that reach the colon. Short-chain inhibit cell growth in laboratory experiments.
fatty acids, such as butyrate, induce apoptosis, cell cycle
arrest, and differentiation in experimental studies. Fibre The evidence, though not copious and mostly from
intake is also strongly correlated with intake of folate, though case-control studies, is consistent, with a dose-
adjusting for this often does not affect the risk reduction response relationship. There is evidence for plausible
attributed to fibre. mechanisms. Garlic probably protects against
colorectal cancer.
A clear dose-response relationship is apparent from
generally consistent cohort studies, supported by The Panel is aware that since the conclusion of the SLR, one
evidence for plausible mechanisms, but residual case-control study17 has been published. This new information
confounding could not be excluded. Foods containing does not change the Panel judgement. Also see box 3.8.
dietary fibre probably protect against colorectal cancer.
7.9.5.4 Fruits
The Panel is aware that since the conclusion of the SLR, seven (Also see chapter 4.2.5.2.)
cohort studies145-151 and one case-control study152 have been Twenty cohort studies and 57 case-control studies investi-
published. This new information does not change the Panel gated fruits. More than half of the cohort studies showed
judgement. Also see box 3.8. decreased risk with increased intake. Meta-analysis of cohort
data produced no clear evidence of an overall association.
However, stratification by sex did show a statistically sig-
7.9.5.2 Non-starchy vegetables nificant decreased risk with increased intake among women,
(Also see chapter 4.2.5.1.) but not men.
Seventeen cohort studies and 71 case-control studies inves- This difference could be hormone-related, speculating
tigated non-starchy vegetables. Although meta-analysis of a connection with the protective effects observed in
cohort data produced no evidence of an association, a com- postmenopausal women provided by hormone replacement
parison of the groups with the highest intakes against those therapy. Another possibility is that this could be artefactual:
with the lowest was suggestive of an association. men may have not reported their diets as accurately as
This is a wide and disparate category, and many different women.
plant food constituents are represented that could contribute Because of the abundant prospective data from cohort
to a protective effect of non-starchy vegetables. These include studies, case-control studies were not summarised.
dietary fibre, carotenoids, folate, selenium, glucosinolates, Fruits are sources of vitamin C and other antioxidants,
dithiolthiones, indoles, coumarins, ascorbate, chlorophyll, such as carotenoids, phenols, and flavonoids, as well as other
flavonoids, allylsulphides, flavonoids, and phytoestrogens, potentially bioactive phytochemicals. Antioxidants trap free
some of which are potentially antioxidants. Antioxidants trap radicals and reactive oxygen molecules, protecting against
free radicals and reactive oxygen molecules, protecting oxidation damage. In addition, flavonoids found in fruit
against oxidation damage. It is difficult to unravel the rela- directly inhibit the expression of a cytochrome P450
tive importance of each constituent and it is likely that any enzyme, which helps to metabolise toxins and has been asso-
protective effect may result from a combination of influences ciated with increased risk of lung cancer, primarily in smok-
on several pathways involved in carcinogenesis. ers.68 It is difficult to unravel the relative importance of each
constituent and it is likely that a protective effect may result
A substantial amount of evidence is available but it is from a combination of influences on several pathways
inconsistent. There is limited evidence suggesting that involved in carcinogenesis.
283
P A R T 2 E V I D E N C E A N D J U D G E M E N T S
There is a substantial amount of evidence but it is A substantial amount of data was available, from case-
inconsistent. There is limited evidence suggesting that control studies only. There is limited evidence
fruits protect against colorectal cancer. suggesting that foods containing selenium protect
against colorectal cancer.
The Panel is aware that since the conclusion of the SLR, one
cohort147 153 155 and five case control studies152 154 156-158 have 7.9.5.7 Red meat
been published. This new information does not change the (Also see chapter 4.3.5.1.1.)
Panel judgement. Also see box 3.8. Sixteen cohort and 71 case-control studies investigated red
meat. Nearly all cohort studies showed increased risk with
7.9.5.5 Foods containing folate higher intake. Meta-analysis of cohort data showed a 43 per
(Also see chapter 4.2.5.4.) cent increased risk per time consumed/week (figure 4.3.2) or
Nine cohort studies investigated dietary folate and two a 15 per cent increased risk per 50 g/day (figure 4.3.3).
cohort studies investigated serum folate. Most studies Heterogeneity could not be fully explained but some studies
showed decreased risk with increased intake. Meta-analysis could have included processed meats in the red meat category.
of cohort data produced evidence of decreased risk with a There are several potential underlying mechanisms for a
clear dose-response relationship. Both studies that investi- positive association of red meat consumption with colorectal
gated serum folate levels, which may be a more accurate and cancer, including the generation of potentially carcinogenic
precise measure than dietary estimates, showed decreased N-nitroso compounds (see box 4.3.2). Some meats are also
risk for colon cancer, but not rectal cancer; this was statisti- cooked at high temperatures, resulting in the production of
cally significant in one study. Data come predominantly from heterocyclic amines and polycyclic aromatic hydrocarbons
dietary sources, not supplements; therefore no effect can be (see box 4.3.4). Red meat contains haem iron. Free iron can
attributed specifically to folate, which is interpreted simply lead to the production of free radicals (see box 4.3.3).
as a marker of consumption of foods containing it.
Folate plays an important role in the synthesis, repair, and A substantial amount of data from cohort and case-
methylation of DNA. Abnormal DNA methylation has been control studies showed a dose-response relationship,
linked to aberrant gene expression and also to cancers at sev- supported by evidence for plausible mechanisms
eral sites. Folate may also reduce HPV proliferation in cells operating in humans. Red meat is a convincing cause
(also see box 7.13.1). In addition, folate intake is also strong- of colorectal cancer.
ly correlated with intake of dietary fibre, which probably pro-
tects against colorectal cancer (see 7.9.5.1). The Panel is aware that since the conclusion of the SLR, six
cohort165-173 and four case-control studies154 156 157 174 have been
The evidence from cohort studies is plentiful, with a published. This new information does not change the Panel
dose-response relationship, but there is unexplained judgement. Also see box 3.8.
inconsistency. Residual confounding from dietary fibre
is possible. There is limited evidence suggesting that 7.9.5.8 Processed meat
foods containing folate protect against colorectal (Also see chapter 4.3.5.1.2.)
cancer. Fourteen cohort studies and 44 case-control studies investi-
gated processed meat. Nearly all cohort studies showed
The Panel is aware that since the conclusion of the SLR, four increased risk with higher intake. Meta-analysis of cohort
cohort159-163 and two case control studies152 164 have been pub- data showed a 21 per cent increased risk per 50 g/day (fig-
lished. This new information does not change the Panel judge- ure 4.3.6). Heterogeneity was low and explained by the dis-
ment. Also see box 3.8. parity in category definitions between studies, as well as by
improved adjustment for confounders in recent studies.
7.9.5.6 Foods containing selenium Nitrates are both produced endogenously in gastric acid
(Also see chapter 4.2.5.8.) and added as preservatives to processed meats. They may
Fifteen case-control studies investigated dietary selenium, all contribute to N-nitroso compound production and exposure.
of which showed decreased risk with increased intake. Meta- These compounds are suspected mutagens and carcinogens
analysis of case-control data produced evidence of decreased (see box 4.3.2).55 Many processed meats also contain high
risk with increased serum selenium levels, showing a clear levels of salt and nitrite. Meats cooked at high temperatures
dose-response relationship. can contain heterocyclic amines and polycyclic aromatic
Dietary selenium deficiency has been shown to cause a hydrocarbons (see box 4.3.4). Haem promotes the formation
lack of selenoprotein expression. Twenty-five selenoproteins of N-nitroso compounds and also contains iron. Free iron can
have been identified in animals, and a number of these have lead to production of free radicals (see box 4.3.3).
important anti-inflammatory and antioxidant properties.
Four are glutathione peroxidases, which protect against There is a substantial amount of evidence, with a dose-
oxidative damage to biomolecules such as lipids, lipopro- response relationship apparent from cohort studies.
teins, and DNA. Three are thioredoxin reductases, which There is strong evidence for plausible mechanisms
regenerate oxidised ascorbic acid to its active antioxidant operating in humans. Processed meat is a convincing
form, among other functions. cause of colorectal cancer.
284
C H A P T E R 7 C A N C E R S
The Panel is aware that since the conclusion of the SLR, five The Panel is aware that since the conclusion of the SLR, two
cohort153 165-169 171 173 175 and two case-control studies154 157 have case-control studies152 179 have been published. This new infor-
been published. This new information does not change the mation does not change the Panel judgement. Also see box 3.8.
Panel judgement. Also see box 3.8.
7.9.5.11 Foods containing iron
7.9.5.9 Fish (Also see chapter 4.3.5.6.)
(Also see chapter 4.3.5.3.) Four cohort studies and 23 case-control studies investigated
Nineteen cohort studies and 55 case-control studies investi- iron intake. All cohort studies showed increased risk with
gated fish. Most cohort studies showed decreased risk with increased intake, which was statistically significant in two.
higher intake. Meta-analysis showed a non-significant It is biologically plausible that iron increases colorectal can-
decreased risk. Heterogeneity may be partially explained by cer risk due to its catalytic activity on the formation of reac-
varying definitions of fish in different studies to include fresh tive oxygen species. However, this role has not been
and/or salted and dried fish. Also, high fish intake may be confirmed in animal studies. Another hypothesis relates to
associated with low meat intake, which is a potential con- dietary haem, which can induce colonic cytotoxicity and
founder that has not been adjusted for. hyperproliferation.180 Iron overload also activates oxidative
Because of the abundant prospective data from cohort responsive transcription factors, pro-inflammatory cytokines
studies, case-control studies were not summarised. and iron-induced hypoxia signalling.181 Also see box 4.3.3.
It is biologically plausible that long-chain fish n-3 polyun-
saturated fatty acids (PUFAs) protect against cancer (see The evidence is sparse, of poor quality, and
chapter 2.4.1.3). Fish oils reduce tumours in animal stud- inconsistent. There is limited evidence suggesting that
ies.176 Likely mechanisms are thought to include their role foods containing iron are in general a cause of
in reduction of n-6 PUFA-derived eicosanoid biosynthesis colorectal cancer. (Also see chapter 4.3 for evidence
(eicosanoids influence inflammation) and direct inhibition specifically on red and processed meat, which are
of cyclo-oxygenase-2, also implicated in the cancer process classified as convincing causes of colorectal cancer.)
This mechanism, though plausible, is not well supported.177
Alternative suggestions include the relatively high selenium The Panel is aware that since the conclusion of the SLR, two
or vitamin D content of fish. cohort studies175 182 have been published. This new information
does not change the Panel judgement. Also see box 3.8.
A substantial amount of data is available but the
results are inconsistent, and residual confounding by 7.9.5.12 Milk
meat could not be excluded. There is limited evidence (Also see chapter 4.4.5.1.2.)
suggesting that eating fish protects against colorectal Thirteen cohort studies and 36 case-control studies investi-
cancer. gated milk; 15 cohort studies and 58 case-control studies
investigated dietary calcium. Most cohort studies showed
The Panel is aware that since the conclusion of the SLR, six decreased risk with increased intake. A pooled analysis of 10
cohort147 165 167-169 171 178 and two case-control studies152 154 have cohort studies (nearly 5000 colorectal cancer cases among
been published. This new information does not change the more than 530 000 participants) showed a 15 per cent
Panel judgement. Also see box 3.8. decreased risk for the groups that drank the most milk, and
a 14 per cent decreased risk for the groups with the highest
7.9.5.10 Foods containing vitamin D dietary calcium intakes.183
(Also see chapter 4.3.5.5.) Most of the evidence used here comes from Western coun-
Eleven cohort studies and 17 case-control studies investi- tries, where dietary calcium intake can be taken as a mark-
gated total vitamin D and/or dietary vitamin D. Four cohort er for dairy consumption.
studies investigated plasma or serum vitamin D. Most of the Any effect of milk in reducing colorectal cancer risk is likely
studies of intake, and all of the studies of plasma or serum to be mediated at least in part by calcium, which has direct
vitamin D, showed decreased risk as measures of intake growth-restraining and differentiation- and apoptosis-inducing
increased. actions on normal and tumour colorectal cells.184 Milk includes
The effects of vitamin D and calcium are strongly interre- many bioactive constituents, which may also play a role.
lated because both are growth restraining, both induce dif-
ferentiation and apoptosis in intestinal cells, and The evidence on milk from cohort studies is reasonably
calcium-mediated effects are strongly dependent on vitamin consistent, supported by stronger evidence from dietary
D levels. Data from observational studies were limited by the calcium, as a dietary marker. There is evidence for
fact that levels of the biologically active form are not only plausible mechanisms. Milk probably protects against
dependent on diet but also on supplements, and ultraviolet colorectal cancer.
(UV) exposure of the skin.
The Panel is aware that since the conclusion of the SLR, three
The evidence on vitamin D was inconsistent. There is cohort185-188 and three case-control studies154 158 189 have been
limited evidence suggesting that foods containing vitamin published. This new information does not change the Panel
D or vitamin D status protect against colorectal cancer. judgement. Also see box 3.8.
285
P A R T 2 E V I D E N C E A N D J U D G E M E N T S
286
C H A P T E R 7 C A N C E R S
most of the cohort studies showed decreased risk with There is abundant epidemiological evidence from
supplementation. prospective studies showing lower risk of colorectal
Because of the abundant prospective data from cohort cancer with higher overall levels of physical activity, as
studies, case-control studies were not summarised. well as with greater frequency and intensity, and there
Calcium from diet is an important nutrient; intracellular is evidence of a dose-response effect. There is little
calcium is a pervasive second messenger acting on many cel- heterogeneity, except that the effect is not as clear for
lular functions including cell growth. Calcium has direct rectal cancer as it is for colon cancer. There is plausible
growth-restraining and differentiation- and apoptosis-induc- evidence for mechanisms operating in humans. The
ing actions on normal and tumour colorectal cells.184 evidence that higher levels of physical activity, within
the range studied, protect against colon cancer is
There is generally consistent evidence from several convincing.
cohort studies, and evidence from trials for colorectal
adenomas. There is evidence for plausible The Panel is aware that since the conclusion of the SLR, four
mechanisms. Calcium probably protects against cohort198-201 and four case-control studies154 202-204 have been
colorectal cancer. published. This new information does not change the Panel
judgement. Also see box 3.8.
7.9.5.18 Selenium
(Also see chapter 4.10.6.4.5.) 7.9.5.20 Body fatness
One randomised controlled trial and one cohort study inves- (Also see chapter 6.1.3.1.)
tigated selenium supplements. The trial showed a statistically Sixty cohort studies and 86 case-control studies investigat-
significant decreased risk with a daily supplement of 200 g ed body fatness, as measured by BMI. Most of the cohort
of selenium. This was a relatively small study (1321 partici- studies showed increased risk with increased body fatness.
pants; 8 cases in the supplement group and 19 in the control Meta-analysis of cohort data showed a 15 per cent increased
group) and colorectal cancer was a secondary outcome. The risk per 5 kg/m2 (figure 6.1.6). Heterogeneity is explained
cohort study showed non-significant decreased risk. partially by sexual and geographical differences, and also by
Dietary selenium deficiency has been shown to cause a cancer site. When stratified according to cancer site, data are
lack of selenoprotein expression. Twenty-five selenoproteins more consistent and suggest a larger increased risk for colon
have been identified in animals and a number of these have cancer (figure 6.1.7) than for rectal cancer (figure 6.1.8).
important anti-inflammatory and antioxidant properties. Because of the abundant prospective data from cohort
Four are glutathione peroxidases, which protect against studies, case-control studies were not summarised.
oxidative damage to biomolecules such as lipids, lipopro- Body fatness directly affects levels of many circulating hor-
teins, and DNA. Three are thioredoxin reductases and, mones, such as insulin, insulin-like growth factors, and
among other functions, these regenerate oxidised ascorbic oestrogens, creating an environment that encourages car-
acid to its active antioxidant form. cinogenesis and discourages apoptosis. It also stimulates the
bodys inflammatory response, which may contribute to the
The evidence is sparse. There is limited evidence to initiation and progression of several cancers. Also see chap-
suggest that selenium protects against colorectal ter 6.1.3 and box 2.4.
cancer.
There is abundant and consistent epidemiological
7.9.5.19 Physical activity evidence with a clear dose-response relationship, and
(Also see chapter 5.4.1.) evidence for plausible mechanisms that operate in
Eleven cohort studies investigated total physical activity; 12 humans. The evidence that greater body fatness is a
cohort studies investigated occupational physical activity; cause of colorectal cancer is convincing.
and 24 cohort studies investigated recreational activity. Most
studies reported an association between increased physical The Panel is aware that since the conclusion of the SLR, 15
activity and decreased cancer risk. Most studies were unsuit- cohort58 59 151 205-215 and 2 case-control studies216-218 have been
able for meta-analysis due to the disparate measures used published. This new information does not change the Panel
to assess physical activity. The data also suggested that the judgement. Also see box 3.8.
effect was reduced or removed for rectal cancer. The evi-
dence, overall, was broad and consistent. A published meta- 7.9.5.21 Abdominal fatness
analysis of 19 cohort studies reported a statistically (Also see chapter 6.1.3.2.)
significant decreased risk for physical activity for colon can- Seven cohort studies and two case-control studies investi-
cer, but not for rectal cancer. gated waist circumference; six cohort studies and four case-
Sustained moderate physical activity raises the metabolic control studies investigated waist to hip ratio. All cohort
rate and increases maximal oxygen uptake. In the long term, studies showed increased risk with either increased waist cir-
regular periods of such activity increase the bodys metabolic cumference or increased waist to hip ratio. Meta-analysis was
efficiency and capacity (the amount of work that it can per- possible on four cohort studies measuring waist circumfer-
form), as well as reducing blood pressure and insulin resis- ence and five cohort studies measuring waist to hip ratio.
tance. In addition, physical activity increases gut motility. This showed a 5 per cent increased risk per inch of waist cir-
287
P A R T 2 E V I D E N C E A N D J U D G E M E N T S
cumference, or a 30 per cent increased risk per 0.1 increment caffeine; tea; total carbohydrate; starch; sugar; total fat; fatty
of waist to hip ratio (figures 6.1.22 and 6.1.23). acid composition; cholesterol; vitamin A; retinol; beta-
The general mechanisms through which abdominal fatness carotene; alpha-carotene; lycopene; vitamin C; vitamin E;
could plausibly influence cancer risk are outlined in chapter methionine; multivitamins; meal frequency; and energy
6.1.3 (for more detail see box 2.4). The hormonal and other intake.
biological effects of being overweight or obese are outlined
in chapter 8. Many of these, such as increased circulating
oestrogens and decreased insulin sensitivity, are associated 7.9.6 Comparison with previous report
with abdominal fatness independently of overall body
fatness. 7.9.6.1 General
See 7.1.6.1, and box 3.8 in chapter 3.
There is ample consistent epidemiological evidence
with a clear dose-response relationship and robust 7.9.6.2 Specific
evidence for mechanisms that operate in humans. The The previous report judged the evidence that vegetables pro-
evidence that abdominal fatness is a cause of tect against colorectal cancer to be convincing. The results
colorectal cancer is convincing. of cohort studies since then have generally not been sup-
portive of this judgement.
The Panel is aware that since the conclusion of the SLR, three Evidence that red meat and, in particular, processed meat
cohort studies146 205 209 have been published. This new infor- are causes of colorectal cancer is now stronger.
mation does not change the Panel judgement. Also see box 3.8. The previous report noted the evidence showing that
greater adult height was a possible cause of colorectal can-
7.9.5.22 Adult attained height cer. The evidence now is stronger, as is that for body fatness
(Also see chapter 6.2.3.1.) and for abdominal fatness. The previous report found that
Twenty-one cohort studies and 16 case-control studies frequent meals or snacks possibly increased the risk of col-
investigated adult attained height. Most cohort studies orectal cancer; this was not found here.
showed increased risk with increased height. Meta-analysis The evidence that dietary fibre protects against colorectal
of cohort data showed a 9 per cent increased risk per 5 cm cancer is here judged to be stronger than it was previously.
of height (figure 6.2.1). Evidence that garlic, milk, and calcium supplements are
Because of the abundant prospective data from cohort probably protective was not found previously.
studies, case-control studies were not summarised.
The general mechanisms through which the factors that
lead to greater adult attained height, or its consequences, 7.9.7 Conclusions
could plausibly influence cancer risk are outlined in chapter
6.2.1.3 (for more detail see box 2.4). Many of these, such as The Panel concludes:
early-life nutrition, altered hormone profiles, and the rate of The evidence that physical activity protects against colorec-
sexual maturation, could plausibly increase cancer risk. tal cancer is convincing, although the evidence is stronger
for colon than for rectum.
There is ample prospective epidemiological evidence, The evidence that red meat, processed meat, substantial
which is consistent, and there is a clear dose-response consumption (more than about 30 g per day ethanol) of alco-
relationship, with evidence for plausible mechanisms holic drinks (by men, and probably by women), body fatness
operating in humans. The evidence that the factors and abdominal fatness, and the factors that lead to greater
that lead to greater adult attained height, or its adult attained height, or its consequences, are causes of col-
consequences, are a cause of colorectal cancer is orectal cancer is convincing.
convincing. The causal factor is unlikely to be tallness Foods containing dietary fibre, as well as garlic, milk, and
itself, but factors that promote linear growth in calcium, probably protect against this cancer.
childhood. There is limited evidence suggesting that non-starchy veg-
etables, fruits, foods containing folate, as well as fish, foods
The Panel is aware that since the conclusion of the SLR, four containing vitamin D, and also selenium and foods contain-
cohort studies146 151 206 207 209 have been published. This new ing it, protect against colorectal cancer, and that foods con-
information does not change the Panel judgement. Also see box taining iron, and also cheese, foods containing animal fats,
3.8. and foods containing sugars are causes of this cancer.
288
C H A P T E R 7 C A N C E R S
7.10 Breast
FOOD, NUTRITION, PHYSICAL ACTIVITY, FOOD, NUTRITION, PHYSICAL ACTIVITY, AND
AND CANCER OF THE BREAST (PREMENOPAUSE) CANCER OF THE BREAST (POSTMENOPAUSE)
In the judgement of the Panel, the factors listed below modify the risk of In the judgement of the Panel, the factors listed below modify the risk of
cancer of the breast (premenopause). Judgements are graded according cancer of the breast (postmenopause). Judgements are graded according
to the strength of the evidence. to the strength of the evidence.
Cancer of the breast is the most common cancer in women from cancer in women (fifth overall), accounting for 14
worldwide. Around 1.15 million cases were recorded in per cent of all cancer deaths worldwide.
2002, accounting for around 23 per cent of all cancers in Breast cancer is hormone related, and the factors that
women (11 per cent overall). modify the risk of this cancer when diagnosed
Observed rates of this cancer increase with premenopausally and when diagnosed (much more
industrialisation and urbanisation, and also with facilities commonly) postmenopausally are not the same.
for early detection. It remains much more common in Overall, the Panel is impressed by the pattern of
high-income countries but is now increasing rapidly in evidence showing the importance of early life events,
middle- and low-income countries, including within Africa, including food and nutrition, as well as factors that affect
much of Asia, and Latin America. Breast cancer is fatal in hormone status, in modification of the risk of breast
under half of all cases and is the leading cause of death cancer.
289
P A R T 2 E V I D E N C E A N D J U D G E M E N T S
290
C H A P T E R 7 C A N C E R S
(Also see chapter 2.4 and 7.1.3.1.) In total, 873 publications were included in the SLR for breast
cancer. Fuller summaries of the epidemiological, experi-
Life events. As stated above, lifetime exposure to oestrogen, mental, and mechanistic evidence are to be found in
influenced by early menarche, late natural menopause, not Chapters 46.
bearing children, and late (over 30) first pregnancy all The full SLR is contained on the CD included with this
increase the risk of, and may be seen as causes of, breast can- Report.
cer.220 222 The reverse also applies: late menarche, early
menopause, bearing children, and early pregnancy all reduce 7.10.5.1 Alcoholic drinks
the risk of, and may be seen as protective against, breast can- (Also see chapter 4.8.5.1.)
cer. Age of breast development and menopause are influ- A total of 11 cohort studies, 31 case-control studies, and 2
enced by nutrition, with high-energy diets promoting ecological studies investigated alcoholic drinks; 25 cohort
earlier puberty and late menopause, and low-energy diets studies, 29 case-control studies, and 4 ecological studies
delaying puberty and advancing menopause. investigated ethanol intake and all-age breast cancer.
Further studies investigated the relationship with alcoholic
Radiation. Ionising radiation exposure from medical treat- drinks in either pre- or postmenopausal breast cancer. Most
ment such as X-rays, particularly during puberty, increases studies showed increased risk with increased intake. Meta-
risk, even at low doses.227 analysis of cohort data showed a 10 per cent increased risk
per 10 g ethanol/day; meta-analysis of case-control data
Medication. Hormone replacement therapy is a cause of showed a 5 per cent increased risk per 5 drinks/week, and
breast cancer. The increased risk appears to disappear a few a 6 per cent increased risk per 10 g ethanol/day (figures
years after cessation.144 Oral contraceptives containing both 4.8.13, 4.8.15, and 4.8.16). Menopausal status did not sig-
oestrogen and progesterone cause a small, transient, nificantly alter the association. Two pooled analyses also
increased risk of breast cancer; the increased risk disappears showed statistically significant increased risks of 9 and 7 per
after cessation.133 cent per 10 g ethanol/day. The first was based on 6 cohort
studies with more than 320 000 participants, followed up
for up to 11 years, with more than 4300 breast cancer cases.
7.10.4 Interpretation of the evidence The other analysed 53 case-control studies, with more than
58 000 cases and more than 95 000 controls.228 229
7.10.4.1 General Reactive metabolites of alcohol, such as acetaldehyde,
For general considerations that may affect interpretation of may be carcinogenic. Additionally, the effects of alcohol may
the evidence, see chapters 3.3 and 3.5, and boxes 3.1, 3.2, be mediated through the production of prostaglandins, lipid
3.6 and 3.7. peroxidation, and the generation of free radical oxygen
Relative risk is used in this Report to denote ratio mea- species. Alcohol also acts as a solvent, enhancing penetra-
sures of effect, including risk ratios, rate ratios, hazard tion of carcinogens into cells. High consumers of alcohol
ratios, and odds ratios. may have diets deficient in essential nutrients, making tis-
sues susceptible to carcinogenesis. In addition, most exper-
7.10.4.2 Specific imental studies in animals have shown that alcohol intake
Considerations specific to breast cancer include: is associated with increased breast cancer risk. Alcohol inter-
feres with oestrogen metabolism and action in multiple
Patterns. The preponderance of data from high-income ways, influencing hormone levels and oestrogen receptors.
countries is a special issue with breast cancer. Breast cancer There is an interaction between folate and alcohol affect-
is hormone related, and factors that modify risk have dif- ing breast cancer risk: increased folate status partially mit-
ferent effects on cancers diagnosed pre- and postmenopause. igates the risk from increased alcohol consumption.230
Classification. Because of the importance of menopause as There is ample, generally consistent evidence from
an effect modifier, studies should stratify for menopause sta- case-control and cohort studies. A dose-response
tus. Many do not. relationship is apparent. There is robust evidence for
mechanisms operating in humans. The evidence that
Confounding. Hormone replacement therapy is an important alcoholic drinks are a cause of premenopausal and
possible confounder in postmenopausal breast cancer. A few postmenopausal breast cancer is convincing. No
studies also reported results separately for different hormone threshold was identified.
receptor profiles within cancers. High-quality studies adjust
for age, number of reproductive cycles, age at which children The Panel is aware that since the conclusion of the SLR, one
were born, and the taking of hormone-based medications. case-control study231 has been published. This new informa-
tion does not change the Panel judgement. Also see box 3.8.
291
P A R T 2 E V I D E N C E A N D J U D G E M E N T S
7.10.5.2 Lactation regular periods of such activity increase the bodys metabolic
(Also see chapter 6.3.3.) efficiency and capacity (the amount of work that it can per-
One cohort study and 37 case-control studies investigated form), as well as reducing blood pressure and insulin resis-
ever having breastfed as compared to never having breast- tance. In addition, it decreases levels of oestrogens and
fed; and 5 cohort studies and 55 case-control studies inves- androgens in postmenopausal women. Some trials have also
tigated the total duration of lactation. The single cohort shown decreases in circulating oestrogens, increased men-
study and most case-control studies showed decreased risk strual cycle length, and decreased ovulation in pre-
(age unspecified) with ever having breastfed compared with menopausal women with a high level of physical activity.
never. Most studies showed decreased risk with increasing
duration of breastfeeding. Meta-analysis of case-control data Premenopause: There is ample evidence from
showed a 3 per cent decreased risk per 5 months of total prospective studies, but it is inconsistent. There is limited
breastfeeding (figure 6.3.1); meta-analysis of cohort data evidence suggesting that physical activity protects
showed a non-significant decreased risk. Pooled analysis against premenopausal breast cancer.
from 47 epidemiological studies in 30 countries (more than
50 000 controls and nearly 97 000 breast cancer cases) Postmenopause: There is ample evidence from
showed a statistically significant decreased risk of breast can- prospective studies showing lower risk of
cer of 4.3 per cent for each 12 months of breastfeeding. postmenopausal breast cancer with higher levels of
Menopause status was not an effect modifier.228 386 physical activity, with a dose-response relationship,
Lactation is associated with increased differentiation of although there is some heterogeneity. There is little
breast cells and with lower exposure to endogenous sex hor- evidence on frequency, duration, or intensity of activity.
mones during amenorrhea accompanying lactation. In addi- There is robust evidence for mechanisms operating in
tion, the strong exfoliation of breast tissue during lactation, humans. Physical activity probably protects against
and the massive epithelial apoptosis at the end of lactation, postmenopausal breast cancer.
could decrease risk by elimination of cells with potential
DNA damage. The Panel is aware that since the conclusion of the SLR, one
case-control study232 has been published. This new information
There is abundant epidemiological evidence from both does not change the Panel judgement. Also see box 3.8.
prospective and case-control studies, which is
consistent and shows a dose-response relationship. 7.10.5.4 Body fatness
There is robust evidence for plausible mechanisms that (Also see chapter 6.1.3.1.)
operate in humans. The evidence that lactation Forty-three cohort studies, more than 100 case-control stud-
protects against both premenopausal and ies, and 2 ecological studies investigated body fatness, as
postmenopausal breast cancer is convincing. measured by BMI. When grouped for all ages, data were
inconsistent. However, a consistent effect emerged when
7.10.5.3 Physical activity they were stratified according to menopausal status. Most
(Also see chapter 5.4.2.) studies showed a decreased risk for premenopausal breast
Six cohort studies and 8 case-control studies investigated cancer and an increased risk for postmenopausal breast can-
total physical activity; 5 cohort studies and 7 case-control cer with increased body fatness. For cancer diagnosed pre-
studies investigated occupational activity; and 14 cohort menopause, meta-analysis of cohort data showed a 15 per
studies and 11 case-control studies investigated recreation- cent decreased risk per 5 kg/m2; meta-analysis of case-con-
al activity. trol data showed a 15 per cent increased risk per 5 kg/m2.
For cancer diagnosed postmenopause, meta-analysis of
Menopause age unspecified cohort data showed an 8 per cent increased risk per 5 kg/m2;
Most studies showed decreased risk with increased physical meta-analysis of case-control data showed a 13 per cent
activity. Meta-analysis of case-control data showed a 10 per increased risk per 5 kg/m2 (figures 6.1.116.1.16).
cent decreased risk per 7 MET-hours recreational activi- Two pooled analyses showed statistically significant
ty/week (figure 5.4.5). increased risk for postmenopausal cancer. One of these also
showed a statistically significant decreased risk for pre-
Premenopause menopausal breast cancer. One pooled analysis was based
Data were inconsistent for most categories, but data on occu- on 7 cohort studies with more than 337 000 participants, fol-
pational activity were suggestive of decreased risk. lowed up for up to 11 years, with more than 4300 breast can-
cer cases. It showed a 14 per cent decreased risk per 5 kg/m2
Postmenopause for cancer diagnosed premenopause and a 9 per cent
Nearly all of the cohort studies and most case-control stud- increased risk per 5 kg/m2 for cancer diagnosed post-
ies showed decreased risk with increased physical activity. menopause. The other pooled analysis, based on 53 case-
Meta-analysis of cohort data showed a 3 per cent decreased control studies with more than 58 000 cases and more than
risk per 7 MET-hours recreational activity/week (figure 5.4.6). 95 000 controls, showed a 19 per cent increased risk per 5
Sustained moderate physical activity raises the metabolic kg/m2 for postmenopausal breast cancer.233 234
rate and increases maximal oxygen uptake. In the long term, Body fatness directly affects levels of many circulating hor-
292
C H A P T E R 7 C A N C E R S
mones, such as insulin, insulin-like growth factors, and gated adult attained height and breast cancer at all ages, or
oestrogens, creating an environment that encourages car- unspecified menopausal status. Most of the studies showed
cinogenesis and discourages apoptosis (see box 2.4). It also increased risk. Meta-analysis of cohort data showed a 9 per
stimulates the bodys inflammatory response, which may cent increased risk per 5 cm of height; meta-analysis of case-
contribute to the initiation and progression of several can- control data showed a 3 per cent increased risk per 5 cm of
cers (see chapter 2.4.1.3). Adjusting for serum levels of height (figure 6.2.2).
oestradiol diminishes or destroys the association with BMI,
suggesting that hormones are a predominant mechanism.235 Premenopause
There is no single well established mechanism through Seventeen cohort studies and 38 case-control studies inves-
which body fatness could prevent premenopausal breast can- tigated adult attained height and premenopausal breast can-
cer. According to the oestrogen plus progesterone theory, cer. Most of the studies showed increased risk. Meta-analysis
overweight premenopausal women would be protected of cohort data showed a 9 per cent increased risk per 5 cm
because they would be more frequently anovulatory, and of height; meta-analysis of case-control data showed a 4 per
therefore less exposed to endogenous progesterone. cent increased risk per 5 cm of height (figure 6.2.4). A
However, this theory is not well supported by recent stud- pooled analysis of 7 cohort studies (more than 337 000 par-
ies, which suggest that natural progesterone could be pro- ticipants, followed up for up to 11 years, with more than
tective.236 Normal levels of natural progesterone are likely to 4300 breast cancer cases) showed a non-significant increased
be protective, and well nourished, or perhaps overnourished risk with greater adult attained height.234
women, who may become slightly overweight in adulthood,
may be protected by their natural fertile condition. Another There are fewer data for premenopausal than for
possible mechanism is that the increased adipose tissue- postmenopausal breast cancer. The epidemiological
derived oestrogen levels in overweight children could evidence is generally consistent, with a dose-response
induce early breast differentiation and eliminate some tar- relationship and evidence for plausible mechanisms.
gets for malignant transformation.237 Anovulation and The factors that lead to greater adult attained height,
abnormal hormone profiles are commonly associated with or its consequences, are probably a cause of
obesity.238 The age-specific pattern of association of breast premenopausal breast cancer. The causal factor is
cancer with BMI, therefore, is largely explained by its rela- unlikely to be tallness itself, but factors that promote
tionship with endogenous sex hormone levels. linear growth in childhood.
Breast cancer diagnosed postmenopause is much more
common. Therefore, throughout life, a decreased risk of pre- Postmenopause
menopausal breast cancer would be expected to be out- Twenty-two cohort studies and 34 case-control studies inves-
weighed by an increased risk of postmenopausal breast tigated adult attained height and postmenopausal breast
cancer. cancer. Nearly all of the cohort studies and most of the case-
control studies showed increased risk, with no studies show-
Premenopause: There is a substantial amount of ing statistically significant contrary results. Meta-analysis of
consistent epidemiological evidence with a dose- cohort data showed an 11 per cent increased risk per 5 cm
response relationship, but the mechanistic evidence is of height; meta-analysis of case-control data showed a 2 per
speculative. Greater body fatness probably protects cent increased risk per 5 cm of height (figure 6.2.3). A
against premenopausal breast cancer. pooled analysis of 7 cohort studies (more than 337 000 par-
ticipants, followed up for up to 11 years, with more than
Postmenopause: There is abundant and consistent 4300 breast cancer cases) showed a statistically significant
epidemiological evidence and a clear dose-response 7 per cent increased risk per 5 cm of height.234 The ecolog-
relationship with robust evidence for mechanisms ical studies provided supporting data.
operating in humans. The evidence that greater body The general mechanisms through which the factors that
fatness is a cause of postmenopausal breast cancer is lead to greater adult attained height, or its consequences,
convincing. could plausibly influence cancer risk are outlined in chapter
6.2.1.3 (for more detail see box 2.4). Many of these, such
The Panel is aware that since the conclusion of the SLR, one as early-life nutrition, altered hormone profiles, and the rate
cohort239 and one case-control study240 have been published. of sexual maturation, could plausibly increase cancer risk.
This new information does not change the Panel judgement.
Also see box 3.8. There is abundant prospective epidemiological
evidence, which is generally consistent, with a clear
7.10.5.5 Adult attained height dose-response relationship, and evidence for plausible
(Also see chapter 6.2.3.1.) mechanisms operating in humans. The evidence that
Thirty-three cohort studies, 56 case-control studies, and 3 the factors that lead to greater adult attained height,
ecological studies investigated adult attained height. or its consequences, are a cause of postmenopausal
breast cancer is convincing. The causal factor is
Age unspecified unlikely to be tallness itself, but factors that promote
Twenty cohort studies and 29 case-control studies investi- linear growth in childhood.
293
P A R T 2 E V I D E N C E A N D J U D G E M E N T S
The Panel is aware that since the conclusion of the SLR, one Meta-analysis of cohort data showed an 8 per cent increased
cohort study241 has been published. This new information does risk per kg (figure 6.2.8).
not change the Panel judgement. Also see box 3.8. The general mechanisms through which the factors that
lead to greater birth weight, or its consequences, could
7.10.5.6 Abdominal fatness (postmenopause) plausibly influence cancer risk are outlined in chapter
(Also see chapter 6.1.3.2.) 6.2.1.1. Many of these, such as long-term programming of
Eight cohort studies and three case-control studies investi- hormonal systems, could plausibly increase cancer risk.
gated waist circumference and postmenopausal breast Greater birth weight raises circulating maternal oestrogen
cancer; eight cohort studies and eight case-control levels and may increase insulin-like growth factor (IGF)-1
studies investigated waist to hip ratio. All of the waist-cir- activity; low birth weight raises both fetal and maternal lev-
cumference studies and most of those on waist to hip ratio els of IGF-1 binding protein. The action of both oestrogens
showed increased risk with increased measures of abdomi- and IGF-1 are thought to be important in fetal growth and
nal fatness. Meta-analysis of cohort data showed a 19 per mammary gland development, and play a central, synergis-
cent increased risk per 0.1 increment in waist to hip ratio tic role in the initiation and promotion of breast cancer.242
(figure 6.1.24). Animal experiments also provide evidence that exposure to
The general mechanisms through which abdominal fatness oestrogens during fetal and early postnatal development can
could plausibly cause cancer are outlined in chapter 6.1.3 (for increase the risk of mammary cancers.243
more detail see box 2.4). The hormonal and other biological
effects of being overweight or obese are outlined in chapter There is general consistency amongst the relatively few
8. Many of these, such as increased levels of circulating epidemiological studies, with some evidence for a
oestrogens and decreased insulin sensitivity, are associated dose-response relationship. The mechanistic evidence
with abdominal fatness independently of overall body fatness. is speculative. The factors that lead to greater birth
weight, or its consequences, are probably a cause of
There is a substantial amount of epidemiological premenopausal breast cancer.
evidence but some inconsistency. There is robust
evidence for mechanisms that operate in humans. The Panel is aware that since the conclusion of the SLR, one
Abdominal fatness is a probable cause of cohort study239 and one case-control study244 have been pub-
postmenopausal breast cancer. lished. This new information does not change the Panel judge-
ment. Also see box 3.8.
7.10.5.7 Adult weight gain (postmenopause)
(Also see chapter 6.1.3.3.) 7.10.5.9 Total fat (postmenopause)
Seven cohort studies and 17 case-control studies investigat- (Also see chapter 4.5.5.1.)
ed adult weight gain and postmenopausal breast cancer. Nine cohort studies and 16 case-control studies investigat-
Nearly all of the studies showed increased risk with ed total fat intake and postmenopausal breast cancer. Most
increased weight gain in adulthood. Meta-analysis of case- studies showed increased risk with increased intake. Meta-
control data showed a 5 per cent increased risk per 5 kg analysis of cohort data showed a non-significant increased
gained (figure 6.1.26). Heterogeneity may be explained by risk; meta-analysis of case-control data showed a statistically
failure to separate postmenopausal participants taking hor- significant increased risk. A pooled analysis (more than
mone replacement therapy. 350 000 participants and more than 7300 breast cancer
Body fatness directly affects levels of many circulating hor- cases) showed an overall non-significant decreased risk with
mones, such as insulin, insulin-like growth factors, and increased fat intake. Menopausal status did not significant-
oestrogens, creating an environment that encourages car- ly alter the result.245
cinogenesis and discourages apoptosis (see chapter 2.7.1.3). Higher endogenous oestrogen levels after menopause are
It also stimulates the bodys inflammatory response, which a known cause of breast cancer.235 246 Dietary fat may also
may contribute to the initiation and progression of several increase endogenous oestrogen production.247
cancers.
Evidence from prospective epidemiological studies of
There is ample, consistent epidemiological evidence different types on the whole shows inconsistent effects,
from both cohort and case-control studies. A dose- while case-control studies show a significant positive
response relationship was apparent from case-control association. Mechanistic evidence is speculative.
and cohort studies. Adult weight gain is a probable Overall, there is limited evidence suggesting that
cause of postmenopausal breast cancer. consumption of total fat is a cause of postmenopausal
breast cancer.
7.10.5.8 Greater birth weight (premenopause)
(Also see chapter 6.2.3.2.) 7.10.5.10 Other exposures
Six cohort studies and four case-control studies investigat- For premenopausal breast cancer, other exposures were eval-
ed birth weight. All cohort studies and most case-control uated. However, the data were either of too low quality, too
studies showed increased risk with greater birth weight, with inconsistent, or the number of studies too few to allow con-
none reporting statistically significant contrary results. clusions to be reached. These were as follows: cereals
294
C H A P T E R 7 C A N C E R S
(grains) and their products; potatoes; vegetables; fruits; not make a judgement on rates of growth. The previous
pulses (legumes); soya and soya products; meat; poultry; report did not make judgments on birth weight.
fish; eggs; fats and oils; vegetable fat; sugar; sugary foods The previous report judged it probable that vegetables and
and drinks; milk and dairy products; coffee; tea; carbohy- fruits decrease breast cancer risk. Cohort findings since then
drate; starch; dietary fibre; sugars; total fat; fatty acid com- have been equivocal.
position; trans-fatty acids; cholesterol; protein; vitamin A;
carotenoids; folate; riboflavin; vitamin B6; cobalamin;
vitamin C; vitamin D; vitamin E; iron; calcium; selenium; 7.10.7 Conclusions
isoflavones; dieldrin; trans-nonachlor; dichlorodiphenyl-
trichloroethane; dichlorodiphenyldichloroethylene; poly- The Panel concludes:
chlorinated biphenyls; hexachlorocyclohexane; hexachloro- The evidence that lactation protects against breast cancer at
benzene; energy intake; adult weight gain; adult attained all ages therafter is convincing. Physical activity probably
height; dietary patterns; culturally defined diets; glycaemic protects against postmenopausal breast cancer, and there is
index; and being breastfed. limited evidence suggesting that it protects against pre-
For postmenopausal breast cancer other exposures were menopausal breast cancer. The evidence that alcoholic drinks
evaluated. However, the data were either of too low quali- are a cause of breast cancer at all ages is convincing. The
ty, too inconsistent, or the number of studies too few to allow evidence that the factors that lead to greater attained adult
conclusions to be reached. These were as follows: cereals height or its consequences are a cause of postmenopausal
(grains) and their products; potatoes; vegetables and fruits; breast cancer is convincing; these are probably a cause of
pulses; soya and soya products; meat; poultry; fish; eggs; fats premenopausal breast cancer.
and oils; sugar; sugary drinks and foods; milk and dairy The factors that lead to greater birth weight or its conse-
products; coffee; tea; carbohydrate; starch; dietary fibre; veg- quences are probably a cause of breast cancer diagnosed pre-
etable fat; fatty acid composition; cholesterol; protein; vita- menopause. Adult weight gain is probably a cause of
min A and carotenoids; riboflavin; vitamin B6; vitamin B12; postmenopausal breast cancer. The evidence that body fat-
folate; vitamin C; vitamin D; vitamin E; isoflavones; iron; ness is a cause of postmenopausal breast cancer is convinc-
calcium; selenium; dieldrin; trans-nonachlor; dichloro- ing, and abdominal body fatness is probably a cause of this
diphenyltrichloroethane; dichlorodiphenyldichloroethylene; cancer. On the other hand, body fatness probably protects
polychlorinated biphenyls; hexachlorocyclohexane; hexa- against breast cancer diagnosed premenopause. There is lim-
chlorobenzene; energy intake; birth length; culturally ited evidence suggesting that total dietary fat is a cause of
defined diets; dietary patterns; glycaemic index; being postmenopausal breast cancer.
breastfed; and birth weight.
There is considerable speculation around a biologically
plausible interaction of soya and soya products with breast
cancer development, due to their high phytoestrogen con-
tent. Data on pulses (legumes) were sparse and inconsistent,
and there were insufficient studies available on soya con-
sumption to allow a conclusion to be reached.
7.10.6.1 General
See 7.1.6.1, and box 3.8.
7.10.6.2 Specific
One of the most striking differences between the two reports
is the finding here on lactation. The previous report men-
tioned studies indicating that breastfeeding may protect
against breast cancer, but it did not review or judge this
evidence.
The previous report found that high body mass probably
increases the risk for breast cancer diagnosed after the
menopause, while this Report found the evidence for body
fatness to be convincing. While the previous report made no
judgement on high body mass and premenopausal breast
cancer, this Report found that greater body fatness probably
decreases the risk. The previous report judged the evidence
to be convincing that rapid growth, together with greater
adult height, are causes of breast cancer. This Report does
295
P A R T 2 E V I D E N C E A N D J U D G E M E N T S
7.11 Ovary
Ovarian cancer is the seventh most common cancer in
women (and the 16th most common cancer overall) FOOD, NUTRITION, PHYSICAL ACTIVITY,
worldwide. Around 200 000 cases were recorded in 2002, AND CANCER OF THE OVARY
accounting for around 4 per cent of all new cases of
In the judgement of the Panel, the factors listed below modify the risk of
cancer in women (2 per cent overall). It is most frequent cancer of the ovary. Judgements are graded according to the strength of
in high-income countries. This cancer is usually fatal, and the evidence.
is the seventh most common cause of cancer death in
women worldwide (15th overall).
DECREASES RISK INCREASES RISK
7.11.1 Trends, incidence, and survival after the menopause, with most ovarian cancers occurring
after menopause. Only 1015 per cent of cases occur before
There is no clear global trend in ovarian cancer incidence. the menopause, although germ cell cancers peak in women
Rates appear to be high in high-income countries, and ris- aged between 15 and 35.4
ing in countries undergoing economic transition.137 For Ovarian cancer often has no symptoms at the early stages,
instance in Japan, there was a fourfold increase in the age- so the disease is generally advanced when it is diagnosed.
adjusted mortality rate (from 0.9 to 3.6 per 100 000 women) The 5-year survival rate ranges from approximately 30 to 50
between 1950 and 1997.248 per cent.3 6 This cancer accounts for about 7 per cent of all
Ovarian cancer rates are nearly three times higher in high- cancer incidence and 4 per cent of cancer deaths in women
than in middle- to low-income countries. Around the world, worldwide. Also see box 7.1.1.
age-adjusted incidence rates range from more than 10 per
100 000 women in Europe and North America, to less than
5 per 100 000 in parts of Africa and Asia. But rates are rel- 7.11.2 Pathogenesis
atively high elsewhere in Asia, for example in Singapore and
the Philippines.2 In the USA, rates are higher among white The pathogenesis of this disease is not well characterised,
women than in those from other ethnic groups; rates are also although various mechanisms have been suggested. Over
higher in Jewish women of Ashkenazi descent.3 249 many cycles of ovulation, the ovarian surface epithelium
Risk increases with age, although the rate of increase slows undergoes repeated disruption and repair. The epithelial cells
296
C H A P T E R 7 C A N C E R S
are stimulated to proliferate, which increases the probabili- 7.11.5 Evidence and judgements
ty of spontaneous mutations. Alternatively, following ovula-
tion, these cells may become trapped within the connective In total, 187 publications were included in the SLR for ovar-
tissue surrounding the ovary, which can lead to the forma- ian cancer. Fuller summaries of the epidemiological, exper-
tion of inclusion cysts. If this happens, the epithelial cells are imental, and mechanistic evidence are to be found in
subjected to a unique pro-inflammatory microenvironment, Chapters 46.
which may increase the rate of DNA damage. The full SLR is contained on the CD included with this
Most ovarian cancers occur spontaneously, although 510 Report.
per cent of cases develop due to a genetic predisposition.104
The latter, involving dysfunctional BRCA1 or BRCA2 genes 7.11.5.1 Non-starchy vegetables
(see chapter 2.4.1.1), produces high-grade carcinomas, with (Also see chapter 4.2.5.1.)
a poorer prognosis.250 A total of five cohort studies, eight case-control studies, and
two ecological studies investigated non-starchy vegetables;
three cohort studies and two case-control studies investi-
7.11.3 Other established causes gated green, leafy vegetables. All showed decreased risk with
increased intake, with none reporting contrary results. Meta-
(Also see chapter 2.4 and 7.1.3.1.) analysis of cohort data showed a statistically significant
decreased risk for non-starchy vegetables, with a clear dose-
Life events. The risk of ovarian cancer is affected by the num- response relationship. A pooled analysis of 12 cohort stud-
ber of menstrual cycles during a womans lifetime. Not bear- ies (more than 560 000 participants, followed up for 722
ing children increases the risk of, and may be seen as a cause years, with more than 2100 ovarian cancer cases) showed a
of, ovarian cancer. The reverse also applies: bearing children non-significant decreased risk for the highest intake group
reduces the risk of, and may be seen as protective against, of non-starchy vegetables.254
ovarian cancer.251-253 There is also substantial evidence that, This is a wide and disparate category, and many different
as with breast cancer, early menarche and late natural plant food constituents are represented that could contribute
menopause increase the risk of, and may be seen as causes to a protective effect of non-starchy vegetables. These
of, ovarian cancer. The reverse also applies: late menarche include dietary fibre, carotenoids, folate, selenium, glucosi-
and early menopause reduce the risk of, and may be seen as nolates, dithiolthiones, indoles, coumarins, ascorbate,
protective against, ovarian cancer.251-253 chlorophyll, flavonoids, allylsulphides, flavonoids, and phy-
toestrogens, some of which are potentially antioxidants.
Medication. Oral contraceptives protect against this cancer.133 Antioxidants trap free radicals and reactive oxygen mole-
cules, protecting against oxidation damage. It is difficult to
unravel the relative importance of each constituent and it is
7.11.4 Interpretation of the evidence likely that any protective effect may result from a combina-
tion of influences on several pathways involved in
7.11.4.1 General carcinogenesis.
For general considerations that may affect interpretation of
the evidence, see chapters 3.3 and 3.5, and boxes 3.1, 3.2, Evidence from cohort and case-control studies is
3.6 and 3.7. sparse. There is limited evidence suggesting that non-
Relative risk is used in this Report to denote ratio mea- starchy vegetables protect against ovarian cancer.
sures of effect, including risk ratios, rate ratios, hazard
ratios, and odds ratios. The Panel is aware that since the conclusion of the SLR, one
case-control study17 has been published. This new information
7.11.4.2 Specific does not change the Panel judgement. Also see box 3.8.
Considerations specific to cancer of the ovary include:
7.11.5.2 Adult attained height
Patterns. Because ovarian cancer is hormone related, factors (Also see chapter 6.2.3.1.)
that modify risk might have different effects at different Seven cohort studies, nine case-control studies, and two eco-
times of life. If so, this might partly explain heterogeneous logical studies investigated adult attained height. All cohort
results. studies and most other studies showed increased risk with
greater adult attained height. Meta-analysis of cohort data
Confounding. High-quality studies adjust for age, number of showed an 8 per cent increased risk per 5 cm of height (fig-
reproductive cycles, age at which children were born, and the ure 6.2.7); meta-analysis of case-control data showed no sta-
taking of hormone-based medications. tistically significant relationship. Heterogeneity in the latter
was derived almost entirely from one study.
Classification.There are different histological subtypes of The general mechanisms through which the factors that
ovarian cancer, which may have independent risk factors and lead to greater adult attained height, or its consequences,
disease progression patterns. Most studies combine these could plausibly influence cancer risk are outlined in chapter
subtypes. 6.2.1.3 (see box 2.4). Many of these, such as early-life
297
P A R T 2 E V I D E N C E A N D J U D G E M E N T S
nutrition, altered hormone profiles, and the rate of sexual 7.11.6 Comparison with previous report
maturation, could plausibly increase cancer risk.
7.11.6.1 General
There is some inconsistency, but the better quality See 7.1.6.1, and box 3.8 in chapter 3.
epidemiological data show a clearer effect, with a
dose-response relationship. There is evidence for 7.11.6.2 Specific
plausible mechanisms operating in humans. The The finding here on adult attained height is new.
factors that lead to greater adult attained height, or its
consequences, are probably a cause of ovarian cancer.
The causal factor is unlikely to be tallness itself, but 7.11.7 Conclusions
factors that promote linear growth in childhood.
The Panel concludes:
The Panel is aware that since the conclusion of the SLR, one The factors that lead to greater adult attained height, or its
cohort study255 and one case-control study256 have been pub- consequences, are probably a cause of cancer of the ovary.
lished. This new information does not change the Panel judge- There is limited evidence suggesting that non-starchy veg-
ment. Also see box 3.8. etables, and also lactation, protect against this cancer.
7.11.5.3 Lactation
(Also see chapter 6.3.3.)
One cohort study and 10 case-control studies investigated
lactation, most of which showed an association with
reduced risk. Meta-analysis of case-control data showed sta-
tistically significant decreased risk with increased accumu-
lated lifetime duration of breastfeeding, with a clear
dose-response relationship. Substantial heterogeneity is par-
tially explained by variation in the assessment of breast-
feeding when, for example, exclusivity of breastfeeding is not
always assessed.
Lactation delays the return of menstruation and ovulation
after childbirth. The general mechanisms through which lac-
tation could plausibly protect against cancer are outlined in
chapter 6.3.3. There is evidence that the reduced number of
menstrual cycles associated with breastfeeding protect
against some cancers.
The Panel is aware that since the conclusion of the SLR, one
case-control study257 has been published. This new information
does not change the Panel judgement. Also see box 3.8.
298
C H A P T E R 7 C A N C E R S
7.12 Endometrium
Endometrial cancer is the eighth most common cancer in
women (and the 17th most common cancer overall) FOOD, NUTRITION, PHYSICAL ACTIVITY,
worldwide. Around 200 000 cases were recorded in 2002, AND CANCER OF THE ENDOMETRIUM
accounting for around 4 per cent of all new cases of
In the judgement of the Panel, the factors listed below modify the risk of
cancer in women (2 per cent overall). It is most frequent cancer of the endometrium. Judgements are graded according to the
in high-income countries. Around three quarters of women strength of the evidence.
with this cancer survive for 5 years. It is the 13th most
common cause of cancer death in women worldwide (21st
DECREASES RISK INCREASES RISK
overall).
Overall, the Panel is impressed by the pattern of evidence Convincing Body fatness
showing the importance of physical activity and body Probable Physical activity1 Abdominal fatness
fatness, as well as factors that affect hormone status, in
modification of the risk of endometrial cancer. Limited Non-starchy vegetables2 Red meat3
suggestive Adult attained height4
The Panel judges as follows:
Limited Cereals (grains) and their products; dietary fibre;
The evidence that body fatness is a cause of cancer of the no conclusion fruits; pulses (legumes); soya and soya products;
endometrium is convincing; abdominal fatness is probably poultry; fish; eggs; milk and dairy products; total
fat; animal fats; saturated fatty acids; cholesterol;
a cause. Physical activity probably protects against this
coffee; alcohol; carbohydrates; protein; retinol;
cancer. There is limited evidence suggesting that non- vitamin C; vitamin E; beta-carotene; lactation;
starchy vegetables protect against endometrial cancer, and energy intake
that red meat, and also the factors that lead to greater
Substantial
adult attained height, or its consequences, are causes of
effect on risk None identified
this cancer. unlikely
Life events that protect against endometrial cancer
include bearing children and early menopause, which have 1 Physical activity of all types: occupational, household, transport,
the effect of reducing the number of menstrual cycles and and recreational.
2 Judgements on vegetables and fruits do not include those preserved by
therefore lifetime exposure to oestrogens. The reverse also salting and/or pickling.
applies. 3 The term red meat refers to beef, pork, lamb, and goat from
domesticated animals.
See chapter 8 for evidence and judgements on factors 4 Adult attained height is unlikely directly to modify the risk of cancer. It is a
marker for genetic, environmental, hormonal, and also nutritional factors
that modify the risk of body fatness and abdominal affecting growth during the period from preconception to completion of
fatness, including physical activity and sedentary ways of linear growth (see chapter 6.2.1.3).
life, the energy density of foods and drinks, and For an explanation of all the terms used in the matrix,
breastfeeding. please see chapter 3.5.1, the text of this section,
and the glossary.
In final summary, the strongest evidence, corresponding
to judgements of convincing and probable, shows that
body fatness and probably abdominal fatness are causes of
endometrial cancer, and that physical activity is protective.
299
P A R T 2 E V I D E N C E A N D J U D G E M E N T S
300
C H A P T E R 7 C A N C E R S
The evidence, mostly from case-control studies, is mones, such as insulin, insulin-like growth factors, and
sparse. There is limited evidence suggesting that red oestrogens, creating an environment that encourages car-
meat is a cause of endometrial cancer. cinogenesis and discourages apoptosis (see box 2.4). It also
stimulates the bodys inflammatory response, which may
The Panel is aware that since the conclusion of the SLR, one contribute to the initiation and progression of several can-
case-control study263 has been published. This new information cers (see chapter 2.4.1.3).
does not change the Panel judgement. Also see box 3.8.
There is abundant, consistent epidemiological
7.12.5.3 Physical activity evidence with a clear dose-response relationship, and
(Also see chapter 5.4.3.) robust evidence for mechanisms operating in humans.
Two cohort studies and 4 case-control studies investigated The evidence that greater body fatness is a cause of
total physical activity; 3 cohort studies and 10 case-control endometrial cancer is convincing.
studies investigated occupational activity; and 4 cohort stud-
ies and 10 case-control studies investigated recreational The Panel is aware that since the conclusion of the SLR, one
activity. Nearly all of the cohort studies and most of the other cohort study215 and one case-control study264 have been pub-
studies showed decreased risk with increased physical activ- lished. This new information does not change the Panel judge-
ity. Although meta-analysis was not possible due to the wide ment. Also see box 3.8.
variety in measures used, comparisons of high with low
activity levels showed a consistent association with 7.12.5.5 Abdominal fatness
decreased risk (figures 5.4.8 and 5.4.9). (Also see chapter 6.1.3.2.)
Sustained moderate physical activity raises the metabolic One cohort study and four case-control studies investigated
rate and increases maximal oxygen uptake. In the long term, waist circumference; one cohort study and six case-control
regular periods of such activity increase the bodys metabolic studies investigated waist to hip ratio. Both cohort studies
efficiency and capacity (the amount of work that it can per- and most case-control studies showed statistically significant
form), as well as reducing blood pressure and insulin resis- increased risk with increased abdominal fatness. Meta-analy-
tance. In addition, physical activity has been found to affect sis of case-control data showed a non-significant increased
serum levels of oestradiol, oestrone, and androgens in post- risk.
menopausal women, even after adjusting for BMI. More gen- The general mechanisms through which abdominal fatness
erally, effects on oestrogen metabolism may operate directly, could plausibly cause cancer are outlined in chapter 6.1.3
or through decreasing body fat stores. Physical activity is also (for more detail see box 2.4). The hormonal and other bio-
known to have favourable effects on insulin resistance, which logical effects of being overweight or obese are outlined in
may also result in decreased risk of endometrial cancer. chapter 8. Many of these, such as increased circulating
Physical activity also results in decreased risk of diabetes and oestrogens and decreased insulin sensitivity, are associated
high blood pressure, which are risk factors for endometrial with abdominal fatness independently of overall body
cancer. fatness.
There is generally consistent evidence, mostly from There is a substantial amount of generally consistent
case-control studies, showing lower risk of cancer of epidemiological evidence, but limited prospective
the endometrium with higher levels of physical activity. data. There is evidence for plausible mechanisms.
There is evidence for mechanisms operating in Greater abdominal fatness is a probable cause of
humans. Physical activity probably protects against endometrial cancer.
cancer of the endometrium.
7.12.5.6 Adult attained height
7.12.5.4 Body fatness (Also see chapter 6.2.3.1.)
(Also see chapter 6.1.3.1.) Ten cohort studies, 16 case-control studies and 1 ecological
Twenty-three cohort studies, 41 case-control studies and study investigated adult attained height. Most studies
2 cross-sectional studies investigated body fatness, as mea- showed increased risk with greater adult attained height.
sured by BMI. Three cohort studies and six case-control stud- Meta-analysis of cohort and case-control data showed non-
ies investigated BMI as a young adult. Nearly all of the significant increased risk.
studies showed increased risk with increased body fatness, The general mechanisms through which the factors that
more than half of which were statistically significant. Meta- lead to greater adult attained height, or its consequences,
analysis of cohort data showed an overall 52 per cent could plausibly influence cancer risk are outlined in chapter
increased risk per 5 kg/m2, or a 31 per cent increased risk 6.2.1.3 (for more detail see box 2.4). Many of these, such
per 5 kg/m2 as a young adult; meta-analysis of case-control as early-life nutrition, altered hormone profiles, and the rate
data showed an overall 56 per cent increased risk per 5 of sexual maturation, could plausibly increase cancer risk.
kg/m2, with a non-significant increased risk for BMI as a
young adult (figures 6.1.17 and 6.1.18). Heterogeneity exist- Although there is generally consistent evidence for
ed in the size, but not direction, of the effect. prospective epidemiological data, there is some
Body fatness directly affects levels of many circulating hor- inconsistency in the evidence between cohort and
301
P A R T 2 E V I D E N C E A N D J U D G E M E N T S
7.12.7 Conclusions
The cervix is the neck of the womb. The part of the cervix
The Panel concludes: inside the cervical canal is called the endocervix. The part on
The evidence that body fatness is a cause of cancer of the the outside is the ectocervix. Most cervical cancers start where
endometrium is convincing; abdominal fatness is probably these two parts meet. There are two main types, squamous
also a cause. cell carcinoma and adenocarcinoma. Occasionally, mixed car-
Physical activity probably protects against this cancer. cinomas, with features of both types, occur. Approximately
There is limited evidence suggesting that non-starchy veg- 80 per cent of cervical cancers are squamous cell carcinomas,
etables protect against endometrial cancer, and that red with most of the rest being adenocarcinomas.265 Both types
meat, and also the factors that lead to greater adult attained of cervical cancer are covered in this Report.
height, or its consequences, are causes of this cancer.
302
C H A P T E R 7 C A N C E R S
mortality does not follow the same pattern, and rises with
FOOD, NUTRITION, PHYSICAL ACTIVITY, age. Most women in high-income countries, and to varying
AND CANCER OF THE CERVIX degrees in other countries, have access to preventive
screening programmes that are designed to detect precan-
In the judgement of the Panel, the factors listed below modify the risk of
cancer of the cervix. Judgements are graded according to the strength of
cerous lesions. If these are identified and removed, the inci-
the evidence. dence of this cancer is reduced. After a screening programme
was implemented in the UK in 1988, cervical cancer inci-
DECREASES RISK INCREASES RISK
dence (age-standardised rate) has fallen by nearly 60 per
cent.6 It is generally well accepted that better access to cer-
Convincing vical screening programmes worldwide would decrease both
Probable the incidence and mortality rates for this cancer.267 More
recently vaccination against HPV has become a preventive
Limited Carrots1 option.
suggestive The overall 5-year survival rate is approximately 50 per
Limited Non-starchy vegetables; fruits; milk; retinol; vitamin E; cent: 61 per cent in high-income countries compared with
no conclusion alcoholism2; body fatness; adult attained height. 41 per cent in middle- to low-income countries.124 This can-
cer accounts for somewhat over 4 per cent of all cancer inci-
Substantial dence (around 10 per cent in women) but only around 4 per
effect on risk None identified
unlikely cent of all cancer deaths (just over 9 per cent in women).
Also see box 7.1.1.
1 Judgements on vegetables and fruits do not include those preserved by
salting and/or pickling.
2 Although data suggest that alcoholism is related to increased risk, the Panel
concludes that this is likely to be due to factors other than alcohol intake 7.13.2 Pathogenesis
itself.
For an explanation of all the terms used in the matrix, Virtually all cervical cancers are associated with HPV
please see chapter 3.5.1, the text of this section, infection (see box 7.13.1), and a womans nutrition
and the glossary.
status may influence her susceptibility to this infection.268
However, the majority of women with HPV do not develop
cervical cancer. Therefore, HPV infection is a necessary but
not a sufficient cause of cervical cancer. Women become sus-
ceptible to developing cervical cancer following HPV infec-
tion, but other environmental factors are required for the
in Asia, for example in India and Bangladesh. In the USA, cancer to develop.
rates are higher among both African-American and Hispanic- These factors may include toxins such as polycyclic aro-
American women than in white women. The incidence of matic hydrocarbons (see box 4.3.4) from tobacco smoke,
many cancers rises with age, but cervical cancer peaks in food, or other environmental sources, which have been
younger women, between the ages of 30 and 45.6 However, found in the mucus lining the cervix.269
303
P A R T 2 E V I D E N C E A N D J U D G E M E N T S
7.13.3 Other established causes Some carotenoids, including beta-carotene and alpha-
carotene, which are found at high levels in carrots, are pre-
(Also see chapter 2.4 and 7.1.3.1.) cursors of vitamin A. They also have properties independent
of their pro-vitamin A activity. Carotenoids are recognised
Life events. Early sexual experience and a relatively high antioxidants, and low blood levels of dietary antioxidants are
number of sexual partners increase the risk and severity of associated with HPV persistence.276
HPV infection, and may be seen as indirect causes of cervi-
cal cancer.220 222 The evidence, from case-control studies only, is sparse
but consistent. There is limited evidence suggesting
Tobacco use. Smoking tobacco makes a woman twice as like- that carrots protect against cervical cancer.
ly to develop cervical cancer.10 Tobacco by-products have been
found in the cervical mucus of women who smoke. The effect 7.13.5.2 Other exposures
of smoking is independent of that of viral infection.10 273 Other exposures were evaluated. However, the data were
either of too low quality, too inconsistent, or the number of
Infectious agents. HPV infection (see box 7.13.1) is a nec- studies too few to allow conclusions to be reached. These
essary but not sufficient cause of cervical cancer.273 274 were as follows: non-starchy vegetables; fruits; milk; retinol;
vitamin E; alcoholism; body fatness; and adult attained
Medication. Dethylstilboestrol (a synthetic oestrogen, now height.
withdrawn) used by women during pregnancy is a cause of Although data suggest that alcoholism is related to
vaginal and cervical clear-cell adenocarcinoma in their increased risk, the Panel concludes that this is likely to be due
daughters.275 to factors other than alcohol intake itself.
7.13.5.1 Carrots
(Also see chapter 4.2.5.1.3.)
Five case-control studies and one ecological study investi-
gated carrots. All of the case-control studies showed
decreased risk for the highest levels of intake compared with
the lowest, statistically significant in three. The case-control
studies all used hospital-based controls and none adjusted for
HPV status. The single ecological study showed non-signifi-
cant increased risk with high intake of carrots.
304
C H A P T E R 7 C A N C E R S
7.14 Prostate
Prostate cancer is the second most common cancer in men
(and the sixth most common cancer overall) worldwide. FOOD, NUTRITION, PHYSICAL ACTIVITY,
Around 680 000 cases were recorded in 2002, accounting AND CANCER OF THE PROSTATE
for around 12 per cent of all new cases of cancer in men
In the judgement of the Panel, the factors listed below modify the risk of
(6 per cent overall). It is most commonly diagnosed in
cancer of the prostate. Judgements are graded according to the strength
high-income countries, where screening is common. Five- of the evidence.
year survival rates are around 60 per cent. It is the sixth
most common cause of cancer death in men worldwide.
DECREASES RISK INCREASES RISK
Overall, the Panel notes the impressive recent evidence
from cohort studies and trials demonstrating effects, or Convincing
absence of effect, of specific foods and nutrients on Probable Foods containing
prostate cancer. lycopene1 2
Foods containing Diets high in
The Panel judges as follows: selenium1 calcium4 5
Selenium3
Foods containing lycopene, as well as selenium or foods
containing it, probably protect against prostate cancer.
Limited Pulses (legumes)6
Foods containing calcium are a probable cause of this suggestive Foods containing Processed meat8
cancer. It is unlikely that beta-carotene (whether from vitamin E1
foods or supplements) has a substantial effect on the risk Alpha-tocopherol7 Milk and dairy
of this cancer. There is limited evidence suggesting that products5
pulses (legumes) including soya and soya products, foods Limited Cereals (grains) and their products; dietary fibre;
containing vitamin E, and alpha-tocopherol supplements no conclusion potatoes; non-starchy vegetables; fruits; meat;
poultry; fish; eggs; total fat; plant oils; sugar
are protective; and that processed meat, and milk and (sucrose); sugary foods and drinks; coffee; tea;
dairy products are a cause of this cancer. alcohol; carbohydrate; protein; vitamin A; retinol;
In final summary, the strongest evidence, corresponding thiamin; riboflavin; niacin; vitamin C; vitamin D;
gamma-tocopherol; vitamin supplements;
to judgements of convincing and probable, shows that multivitamins; iron; phosphorus; zinc; other
foods containing lycopene, as well as selenium or foods carotenoids; physical activity; energy expenditure;
containing it, probably protect against prostate cancer, vegetarian diets; Seventh-day Adventist diets;
body fatness; abdominal fatness; birth weight;
and that foods containing calcium are a probable cause of energy intake
this cancer. It is unlikely that beta-carotene (whether from
foods or supplements) has a substantial effect on the risk Substantial
of this cancer. effect on risk Beta-carotene1 9
unlikely
1 Includes both foods naturally containing the constituent and foods which
The prostate is a walnut-sized gland in men that surrounds have the constituent added (see chapter 3.5.3).
the top of the urethra; it produces seminal fluid. Its growth 2 Mostly contained in tomatoes and tomato products. Also fruits such as
grapefruit, watermelon, guava, and apricot.
and function are controlled by male hormones such as 3 The evidence is derived from studies using supplements at a dose of
200 g/day. Selenium is toxic at high doses.
testosterone. 4 Includes diets that naturally contain calcium and that contain foods
Almost all prostate cancers are adenocarcinomas,4 the type fortified with calcium. See box 4.10.1.
5 Effect only apparent at high calcium intakes (around 1.5 g/day or more).
included here. Evidence for milk and dairy products (but not calcium) was derived only
from countries with populations that have high calcium and dairy
consumption.
6 Including soya and soya products.
7.14.1 Trends, incidence, and survival 7 The evidence is derived from studies using supplements at a dose of
50 mg/day.
8 The term processed meat refers to meats preserved by smoking, curing,
or salting, or addition of chemical preservatives.
Age-adjusted incidence rates of prostate cancer increased dra- 9 The evidence is derived from studies using supplements at doses of 20, 30,
matically between 1988 and 1992.137 This was largely and 50 mg/day.
because of the increased availability of screening for prostate- For an explanation of all the terms used in the matrix,
specific antigen (PSA) in men without symptoms of the dis- please see chapter 3.5.1, the text of this section,
and the glossary.
ease. This test leads to the detection of many prostate cancers
that are small and/or would otherwise remain unrecognised,
and which may or may not develop further into higher stage
disease (see 7.14.2). Rates were already increasing before the
availability of PSA testing, and have continued to increase in
middle-income countries where screening is still not widely
available.124 This suggests that prostate cancer is influenced
305
P A R T 2 E V I D E N C E A N D J U D G E M E N T S
306
C H A P T E R 7 C A N C E R S
307
P A R T 2 E V I D E N C E A N D J U D G E M E N T S
The evidence from cohort and case-control studies is oxidative damage to biomolecules such as lipids, lipopro-
consistent, with a dose-response relationship. There is teins, and DNA. Three are thioredoxin reductases; among
evidence for plausible mechanisms. Foods containing other functions, these regenerate oxidised ascorbic acid to
selenium probably protect against prostate cancer. its active antioxidant form. In addition, selenoproteins are
involved in testosterone production, which is an important
7.14.5.6 Foods containing lycopene regulator of both normal and abnormal prostate growth.
(Also see chapter 4.2.5.3.)
A total of 5 cohort studies, 9 case-control studies, and 3 eco- There is strong evidence from trials and cohort studies.
logical studies investigated tomatoes; 3 cohort studies and Selenium probably protects against prostate cancer.
14 case-control studies investigated dietary lycopene; and 6
cohort studies and 2 case-control studies investigated serum 7.14.5.8 Foods containing vitamin E
or plasma lycopene. Most of the studies showed decreased (Also see chapter 4.2.5.7.)
risk with increased intake. Studies of cumulative lycopene A total of 2 cohort studies, 13 case-control studies, and 1 eco-
intake, or of tomato sauce products (from which lycopene is logical study investigated dietary vitamin E; and 4 cohort
highly bioavailable), showed statistically significant studies and 1 case-control study investigated serum vitamin
decreased risk. Meta-analysis of cohort data on serum or E. Other groupings examined were serum or plasma alpha-
plasma lycopene, which are likely to be more precise and tocopherol (8 cohort, 2 case-control) and serum gamma-
accurate than dietary assessments, showed a 4 per cent tocopherol (6 cohort, 1 case-control). Most studies showed
decreased risk per 10 g lycopene/litre. decreased risk with increased intake. Meta-analysis of
Lycopene is best absorbed from vegetables and fruits that cohort data on serum gamma-tocopherol produced evidence
contain it after they are cooked and pureed. The best mea- of an association with decreased risk, with a clear dose-
sures, that take the degree of absorption into account, are response relationship.
therefore from studies on tomato sauce or serum/plasma Vitamin E is an antioxidant that has been reported to pre-
lycopene. The Panel also gave emphasis to studies on vent DNA damage, enhance DNA repair, prevent lipid per-
advanced or aggressive cancers, which may be better linked oxidation, and prevent activation of carcinogens such as
to prognosis than studies that include early stage or nitrosamines. Vitamin E protects vitamin A and selenium in
unrecognised disease. the body. In addition to acting as a free-radical scavenger,
Lycopene is the most potent carotenoid antioxidant, has vitamin E enhances the bodys immune response, which may
an antiproliferative effect, reduces plasma low-density play a role in cancer defences.
lipoprotein cholesterol, improves immune function, and
reduces inflammation. The evidence on vitamin E, mostly from case-control
studies, was inconsistent. There is limited evidence
There is a substantial amount of consistent evidence, suggesting that foods containing vitamin E protect
in particular on tomato products, from both cohort and against prostate cancer.
case-control studies. There is evidence for plausible
mechanisms. Foods containing lycopene probably The Panel is aware that since the conclusion of the SLR, two
protect against prostate cancer. cohort studies293 295 have been published. This new information
does not change the Panel judgement. Also see box 3.8.
The Panel is aware that since the conclusion of the SLR, two
cohort studies292 293 and one case-control study294 have been 7.14.5.9 Beta-carotene
published. This new information does not change the Panel (Also see chapters 4.2.5.3 and 4.10.6.4.2.)
judgement. Also see box 3.8. Six cohort studies and 21 case-control studies investigated
dietary beta-carotene; 10 cohort studies and 5 case-control
7.14.5.7 Selenium studies investigated serum or plasma beta-carotene; 3 ran-
(Also see chapter 4.10.6.4.5.) domised controlled trials and 2 cohort studies investigated
One randomised controlled trial and two cohort studies beta-carotene supplements. Meta-analyses of 6 cohort stud-
investigated selenium supplements. The randomised con- ies and 15 case-control studies that investigated beta-
trolled trial was conducted in 974 men with a history of skin carotene from food and 7 cohort studies that investigated
cancers, randomised to receive a daily supplement of 200 g serum or plasma beta-carotene produced evidence for there
selenium or a placebo. Prostate cancer was not a prior stat- being no association with prostate cancer risk. One ran-
ed outcome, and was assessed as a secondary endpoint. The domised controlled trial produced evidence of no associa-
trial showed a 63 per cent decreased risk from selenium sup- tion; the other two showed that it was unlikely that
plementation. Both cohort studies showed non-significant beta-carotene reduced incidence, but did not exclude an
decreased risk with selenium supplementation. effect of increasing incidence.
Dietary selenium deficiency has been shown to cause a
lack of selenoprotein expression. Twenty-five selenoproteins There is strong evidence from good quality trials
have been identified in animals and a number of these have and from cohort studies, which consistently fail
important anti-inflammatory and antioxidant properties. to demonstrate a protective effect. Beta-carotene
Four are glutathione peroxidases, which protect against supplements are unlikely to have a substantial
308
C H A P T E R 7 C A N C E R S
protective effect against prostate cancer. The evidence reflecting the recent intense research interest in prostate can-
is too limited to draw a conclusion on a harmful cer, including randomised controlled supplementation trials.
effect. It is unlikely that beta-carotene or foods
containing it have a substantial effect on the risk of
prostate cancer. 7.14.7 Conclusions
The Panel is aware that since the conclusion of the SLR, two The Panel concludes:
cohort studies293 295 have been published. This new information Foods containing lycopene, as well as selenium and foods
does not change the Panel judgement. Also see box 3.8. containing it, probably protect against prostate cancer. Diets
high in calcium are a probable cause of this cancer. It is
7.14.5.10 Alpha-tocopherol (vitamin E) unlikely that beta-carotene (whether from foods or supple-
(Also see chapter 4.10.6.4.3.) ments) has a substantial effect on the risk of this cancer.
One randomised controlled trial investigated alpha-toco- There is limited evidence suggesting that pulses (legumes)
pherol supplements and prostate cancer. The large ran- including soya and soya products, foods containing vitamin
domised controlled trial of male smokers given daily E, and alpha-tocopherol supplements are protective, and that
supplements of 50 mg of alpha-tocopherol and 20 mg of processed meat, and milk and dairy products are a cause of
beta-carotene showed a statistically significant 34 per cent this cancer.
decreased risk for alpha-tocopherol supplements. Prostate
cancer was not a prior-stated outcome for this trial.
Vitamin E exists in eight different forms (isomers): four
tocopherols and four tocotrienols. There is an alpha, beta,
gamma, and delta form of each. Each form has slightly dif-
ferent biological properties but all are antioxidants. Alpha-
tocopherol is thought to be the most biologically active
isomer of vitamin E. It inhibits cell proliferation, can direct-
ly activate certain enzymes, and exerts transcriptional con-
trol on several genes. Vitamin E may have a direct effect on
prostate growth by decreasing cellular concentrations of
testosterone, which could impair differentiation.
7.14.6.1 General
See 7.1.6.1, and box 3.8 in chapter 3.
7.14.6.2 Specific
The findings here on foods containing lycopene and/or cal-
cium, and on selenium or foods containing it, are new,
309
P A R T 2 E V I D E N C E A N D J U D G E M E N T S
7.15 Kidney
Cancer of the kidney is the 15th most common type
worldwide. Around 200 000 cases were recorded in 2002, FOOD, NUTRITION, PHYSICAL ACTIVITY,
accounting for around 2 per cent of all cancers. Average AND CANCER OF THE KIDNEY
overall survival rates are around 50 per cent at 5 years. It
In the judgement of the Panel, the factors listed below modify the risk of
is the 16th most common cause of death from cancer. cancer of the kidney. Judgements are graded according to the strength
Overall, the Panel is impressed by the pattern of evidence of the evidence.
showing the importance of body fatness as a cause of
cancer of the kidney. DECREASES RISK INCREASES RISK
Substantial
effect on risk Coffee; alcoholic drinks (adverse effect)2
The kidneys are at the back of the abdomen and outside the unlikely
peritoneal cavity. They filter waste products and water from
the blood, producing urine, which empties into the bladder
1 The International Agency for Research on Cancer has graded arsenic and
through the ureter. They are also important endocrine organs arsenic compounds as Class 1 carcinogens. The grading for this entry
concerned with salt and water metabolism, and convert vit- 2
applies specifically to inorganic arsenic in drinking water.
The evidence was sufficient to judge that alcoholic drinks were unlikely to
amin D to its active form. have an adverse effect on the risk of kidney cancer; but it was inadequate
to draw a conclusion regarding a protective effect.
Renal cell carcinoma is the most common kidney cancer,
accounting for approximately 85 per cent. The majority of For an explanation of all the terms used in the matrix,
please see chapter 3.5.1, the text of this section,
these are adenocarcinomas,4 the type included here. Kidney and the glossary.
cancers also include transition cell carcinomas of the renal
pelvis, sarcomas, and Wilms tumour (nephroblastoma), a
childhood cancer. This section refers mainly to renal cell in people between the ages of 60 and 80.296
carcinomas; some studies also examined transitional cell Kidney cancer is diagnosed at an early stage in more than
carcinomas. half of cases. The 5-year survival rate is about 95 per cent
for early stage cancers, and about 20 per cent at the most
advanced stages.296 Overall, 5-year survival rates are more
7.15.1 Trends, incidence, and survival than 50 per cent in high-income countries, but lower in mid-
dle- to low-income countries.3 6 This cancer accounts for
Age-adjusted rates of kidney cancer are increasing world- almost 2 per cent of all cancer incidence, and somewhat over
wide. Rates have doubled in many high-income countries 1 per cent of all cancer deaths. Also see box 7.1.1.
since the mid-1970s, with some of the largest increases in
countries in eastern Europe, for example, that are undergo-
ing profound economic transition.137 7.15.2 Pathogenesis
This is mainly a disease of high-income countries, where
rates are nearly five times higher overall than in middle- to Urine contains many waste products from food, drinks, and
low-income countries. Around the world, age-adjusted inci- other environmental sources, and some of these are poten-
dence rates range from 1020 per 100 000 people in North tial carcinogens, such as carcinogens from cigarette smoke,
America, parts of Europe, and Australia to less than 2 per and may play a role in kidney cancer.
100 000 in parts of Africa.2 In the USA, rates are higher It is not clear whether benign renal adenomas are a pre-
among African-American people than in white people. cursor of renal cell carcinoma. They are similar histologically
Globally, rates are higher in men than in women, by five to and are frequently distinguished predominantly by their size.
three.3 Risk increases with age, with most diagnoses made Most adult kidney cancers are sporadic renal cell carcino-
310
C H A P T E R 7 C A N C E R S
mas, which can be divided into two main types. The con- compared with the lowest. Effect sizes, particularly from eco-
ventional (or clear cell) type accounts for 75 per cent; 12 logical studies in areas of high exposure levels, tend to be
per cent of cases are of the papillary form,296 which are less relatively large.
likely to metastasise. In 60 per cent of conventional carci- Arsenic is carcinogenic to humans and causes chromoso-
noma cases, there is a mutation in the von HippelLindau mal abnormalities.217 Arsenic biotransformation is thought
tumour suppressor gene (VHL) (see box 2.2).297 VHL disease to lead to a state of oxidative stress. In addition, arsenic in
is also a cause of some familial kidney cancers. drinking water is well absorbed in the gastrointestinal tract,
and both inorganic arsenic and its methylated metabolites
are excreted in urine. Arsenic can modify the urinary excre-
7.15.3 Other established causes tion of porphyrins in animals and humans.
(Also see chapter 2.4 and 7.1.3.1.) The evidence is sparse. There is limited evidence
suggesting that arsenic in drinking water is a cause of
Tobacco use. Smoking is a cause of kidney cancer, increas- kidney cancer.
ing the risk approximately twofold.10 The association is
stronger for cancers of the renal pelvis.298 7.15.5.2 Coffee
(Also see chapter 4.7.5.4.)
Medication. Analgesics containing phenacetin are a cause of Five cohort studies, 18 case-control studies, and 1 ecologi-
cancer of the renal pelvis.299 Dialysis is a cause of kidney can- cal study investigated coffee. None of the cohort studies and
cer, perhaps through its role in the development of acquired only 1 of the case-control studies reported a statistically sig-
renal cystic disease.300 301 nificant association. Meta-analysis of case-control data pro-
duced evidence of no association.
7.15.4 Interpretation of the evidence There is substantial evidence, both from cohort and
case-control studies, which is consistent and of low
7.15.4.1 General heterogeneity, and which fails to show an association.
For general considerations that may affect interpretation of It is unlikely that coffee has a substantial effect on the
the evidence, see chapters 3.3 and 3.5, and boxes 3.1, 3.2, risk of kidney cancer.
3.6 and 3.7.
Relative risk is used in this Report to denote ratio mea- The Panel is aware that since the conclusion of the SLR, one
sures of effect, including risk ratios, rate ratios, hazard cohort study302 has been published. This new information does
ratios, and odds ratios. not change the Panel judgement. Also see box 3.8.
311
P A R T 2 E V I D E N C E A N D J U D G E M E N T S
7.15.6 Comparison with previous report 7.16.1 Trends, incidence, and survival
312
C H A P T E R 7 C A N C E R S
313
P A R T 2 E V I D E N C E A N D J U D G E M E N T S
7.16.5 Evidence and judgements anthin; lutein; zeaxanthin; folate; vitamin C; vitamin E; sele-
nium; multivitamin supplements; flavonoids; energy intake;
In total, 349 publications were included in the SLR for blad- physical activity; body fatness; and total fluid intake.
der cancer. Fuller summaries of the epidemiological, exper-
imental, and mechanistic evidence are to be found in
Chapters 46. 7.16.6 Comparison with previous report
The full SLR is contained on the CD included with this
Report. 7.16.6.1 General
See 7.1.6.1, and box 3.8.
7.16.5.1 Milk
(Also see chapter 4.4.5.1.1.) 7.16.6.2 Specific
Five cohort studies, 14 case-control studies, and 1 ecologi- The previous report judged that vegetables and fruits prob-
cal study investigated milk. All of the cohort studies and half ably protect against bladder cancer. As with other sites, the
of the case-control studies showed decreased risk with evidence for these foods is now considered to be weaker, in
increased intake of milk. Meta-analysis of cohort data pro- this case, very much so. The previous finding that coffee
duced evidence of an association with decreased risk, with (more than five cups per day) is a possible cause of bladder
a clear dose-response relationship. Meta-analysis of case-con- cancer was not found here.
trol data was inconclusive.
The possible effect of milk in reducing bladder cancer risk
is likely to be mediated at least in part by calcium, which has 7.16.7 Conclusions
direct growth-restraining and differentiation- and apoptosis-
inducing actions on normal and tumour cells.184 However, The Panel concludes:
milk includes many bioactive constituents, which may also There is limited evidence suggesting that milk protects
play a role. against bladder cancer and that arsenic in drinking water is
a cause.
The evidence is inconsistent and comes mainly from
evidence on dietary calcium. There is limited evidence
suggesting that milk protects against bladder cancer.
314
C H A P T E R 7 C A N C E R S
7.17 Skin
Cancer of the skin in its various forms is the most common
type of cancer worldwide. Around 90 per cent of all skin FOOD, NUTRITION, PHYSICAL ACTIVITY,
cancers are non-melanoma. Around 4 million cases were AND CANCER OF THE SKIN
recorded in 2002, but it is likely that many cases are not
In the judgement of the Panel, the factors listed below modify the risk of
referred, and this cancer is not included in the rankings in cancer of the skin. Judgements are graded according to the strength of
this Report. Around 160 000 cases of melanoma skin the evidence.
cancer were recorded in 2002, accounting for around 1.5
per cent of all cancers. Skin cancers are more common in
DECREASES RISK INCREASES RISK
high-income countries and among light-skinned people.
Overall rates of this cancer are increasing. Survival rates Convincing
of melanoma are high and also depend on access to Probable Arsenic in drinking
treatment. Five-year survival rates for non-melanoma skin water1
cancer are more than 99 per cent. Melanoma is the 22nd
most common cause of death from cancer. Limited Retinol2 Selenium supplements3
suggestive
Overall, the Panel emphasises that the main cause of skin
cancer is over-exposure to radiation from sunlight. Limited Potatoes; non-starchy vegetables; fruits; fish; eggs;
no conclusion milk; total fat; cholesterol; coffee; tea; alcohol;
protein; vitamin A; retinol (foods); folate; vitamin C;
The Panel judges as follows: vitamin D; vitamin E; multivitamins; selenium;
Arsenic in drinking water is probably a cause of skin carotenoids; beta-carotene (melanoma); alpha-
cancer. There is limited evidence suggesting that retinol carotene; lycopene; physical activity; body fatness;
energy intake
protects against squamous cell carcinomas of the skin, and
that selenium is a cause of skin cancer. It is unlikely that Substantial
beta-carotene or foods containing it have a substantial effect on risk Beta-carotene4 (non-melanoma)
effect on the risk of non-melanoma skin cancer. unlikely
315
P A R T 2 E V I D E N C E A N D J U D G E M E N T S
Despite the considerably higher incidence of non- AIDS patients is also associated with an increased risk of skin
melanoma skin cancer compared with melanoma (around 20 cancer (in addition to Kaposis sarcomas).325
to 1 in the USA), this less common type accounts for 79 per
cent of skin cancer deaths.318 The 5-year survival rate is Infection and infestation.
HPV can cause squamous cell car-
between 80 and 90 per cent in high-income countries, but cinomas, especially in immune-compromised people.325
just over half that in middle- to low-income countries.124 This
difference is partly due to a different, prevalent type of
melanoma (acral melanoma, on the soles of the feet), which 7.17.4 Interpretation of the evidence
has a poorer prognosis. Melanoma accounts for somewhat
over 1 per cent of all cancer incidence, but only around 0.5 7.17.4.1 General
per cent of all cancer deaths. Non-melanoma skin cancers are For general considerations that may affect interpretation of
almost never fatal.319 Also see box 7.1.1. the evidence, see chapters 3.3 and 3.5, and boxes 3.1, 3.2,
3.6 and 3.7.
Relative risk is used in this Report to denote ratio mea-
7.17.2 Pathogenesis sures of effect, including risk ratios, rate ratios, hazard
ratios, and odds ratios.
The skin changes with age and is affected by hormonal influ-
ences and exposure to the sun and wind. Skin pigmentation 7.17.4.2 Specific
varies between individuals and its structure also differs, Considerations specific to cancer of the skin include:
depending, for instance, on whether it covers the lips, the
soles of the feet, or the eyelids. All of these aspects influence Classification.Melanoma and non-melanoma cancers may
skin cancer risk. Both melanoma and non-melanoma skin have different causes; this would explain heterogeneity in
cancers are thought to be caused largely by UV irradiation studies that do not distinguish between these two types of
mainly from sunlight. There is a clear relationship between skin cancer. Non-melanoma skin cancer cases are common-
accumulated sun exposure and non-melanoma skin cancer, ly not recorded by cancer registries, and are therefore under-
but melanoma is more common in office workers than in out- estimated in many reports.
door workers, suggesting that damage from episodic expo-
sure and extreme occasional sun damage (blistering Confounding. High-quality studies adjust for sun exposure
sunburn) may be more important.4 The role of sun damage and distinguish between cancer types.
is supported by the association between measures of sun sen-
sitivity and skin cancer incidence, which is higher in people
who have freckles and skin that burns without tanning, more 7.17.5 Evidence and judgements
moles, blue eyes, and red hair.320 321
UV-damaged cells are usually removed by apoptosis (pro- In total, 167 publications were included in the SLR for skin
grammed cell death, see chapter 2.5.2) in a process involv- cancer. Fuller summaries of the epidemiological, experi-
ing the p53 protein. However, in non-melanoma skin cancer, mental, and mechanistic evidence are in Chapters 46.
the p53 tumour-suppressor gene is often damaged by UVB The full SLR is contained on the CD included with this
irradiation, so faulty cells are not removed from the skin. Report.
Both UVB and UVA irradiation also have direct and indirect
effects on the cutaneous immune system, lowering the skins 7.17.5.1 Arsenic in drinking water
cell-mediated immunity,322 which is another factor that may (Also see chapter 4.7.5.1.1.)
influence carcinogenesis. Two cohort studies, 5 case-control studies, 1 cross-sectional
People who have a family history of melanoma may be pre- study, and 11 ecological studies investigated arsenic in drink-
disposed to this type of skin cancer, although only one major ing water. Nearly all studies showed an association between
inherited mutation has been found, and less than 2 per cent increased arsenic and skin cancer. Two case-control studies
of melanomas are attributable to this inherited mutation.323 used toenail and fingernail measurements, which are thought
to be more reliable than dietary estimates. These studies both
showed increased risk, which was statistically significant in
7.17.3 Other established causes one. The single cross-sectional study and all ecological stud-
ies showed increased risk, with several reporting relatively
(Also see chapter 2.4 and 7.1.3.1.) large and statistically significant effect estimates.
Soluble arsenic in drinking water induces lung cancers in
Radiation. Over-exposure to UV radiation (mainly from sun- experimental animal models.71 In humans, arsenic is a chro-
light) is the chief cause of both non-melanoma and mosomal mutagen (an agent that induces mutations involving
melanoma skin cancers.324 In the case of melanoma, the more than one gene, typically large deletions or rearrange-
main cause is episodic skin exposure involving severe sun- ments). It can also act as a synergistic co-mutagen. Arsenic
burn, particularly in fair-skinned white people.317 exposure also causes chronic lung disease.71 These mechanisms
may also be applicable to skin cancer. The Joint FAO/WHO
Medication. Immune suppression in organ-transplant and Expert Committee on Food Additives has set a provisional tol-
316
C H A P T E R 7 C A N C E R S
erable weekly intake of 0.015 mg per kg body weight.72 All three randomised controlled trials that investigated
The evidence is consistent, from cohort, case-control, beta-carotene supplement interventions against placebo with
and ecological studies. There is robust mechanistic respect to non-melanoma skin cancer reported results very
evidence. Arsenic in drinking water is a probable cause close to null. Meta-analysis of the three trials produced evi-
of skin cancer. dence of no association. Two trials that investigated beta-
carotene supplement interventions against placebo with
7.17.5.2 Retinol respect to melanoma stated that there was no association
(Also see chapter 4.10.6.4.1.) with risk.
Two randomised controlled trials investigated retinol sup- Meta-analysis of cohort data on plasma or serum beta-
plements. Both trials included only participants at risk of carotene and non-melanoma skin cancer, and cohort data
developing non-melanoma skin cancer, and both gave results that investigated the same exposure in melanoma, showed
stratified according to this type. While neither trial report- no clear association. No clear association was shown with
ed a statistically significant association to basal cell carci- dietary beta-carotene.
noma, one of the two studies did report a statistically
significant relationship with decreased squamous cell carci- There is strong evidence from good quality trials that
noma risk. consistently fail to show an effect. It is unlikely that
The mechanism of anti-tumour action of the retinoids is beta-carotene has a substantial effect on the risk of
not completely understood, but retinol is known to bind to non-melanoma skin cancer. It is unlikely that foods
cell receptors with promotion of differentiation, alteration of containing beta-carotene have any substantial effect
membranes, and immunological adjuvant effects.326 on the risk of non-melanoma skin cancer.
The evidence is sparse and studies were conducted on 7.17.5.5 Other exposures
a narrowly defined population group (people at risk of Other exposures were evaluated. However, the data were
developing skin cancer). There is limited evidence either of too low quality, too inconsistent, or the number of
suggesting that retinol supplements protect against studies too few to allow conclusions to be reached. These
squamous cell skin cancer. were as follows: potatoes; non-starchy vegetables; fruits;
fish; eggs; milk; coffee; tea; alcohol; foods containing sele-
The Panel is aware that since the conclusion of the SLR, one nium; total fat; cholesterol; protein; vitamin A; retinol
case-control study327 has been published. This new information (foods); beta-carotene (melanoma); alpha-carotene;
does not change the Panel judgement. Also see box 3.8. carotenes; lycopene; folate; vitamin C; vitamin D; vitamin
E; multivitamins; physical activity; energy intake; and body
7.17.5.3 Selenium supplements fatness.
(Also see chapter 4.10.6.4.5.)
One randomised controlled trial and one cohort study inves-
tigated selenium supplements. The trial showed a statisti- 7.17.6 Comparison with previous report
cally significant increased risk of total non-melanoma skin
cancer with daily supplementation of 200 g selenium. Skin cancers were not reviewed in the previous report.
Subgroup analysis indicated that this risk might differ
according to cancer type, with a statistically significant
increased risk for squamous cell carcinoma but not basal cell 7.17.7 Conclusions
carcinoma. The single cohort study stated that there was no
statistically significant association. The Panel concludes:
No plausible mechanisms for how selenium might increase Arsenic in drinking water is probably a cause of skin cancer.
risk of skin cancer have been suggested. There is limited evidence suggesting that retinol protects
against squamous cell carcinomas of the skin and that sele-
The evidence is sparse, and no plausible mechanisms nium is a cause of skin cancer. It is unlikely that beta-
have been identified. There is limited evidence carotene or foods containing it have a substantial effect on
suggesting that selenium supplements are a cause of the risk of non-melanoma skin cancer. The main cause of
skin cancer. skin cancer is over-exposure to UV radiation from sunlight.
317
P A R T 2 E V I D E N C E A N D J U D G E M E N T S
Other cancers. The evidence on food, nutrition, physical 7.18.1.1.3 Body fatness
activity, and cancers of the musculoskeletal and nervous sys- One pooled analysis of 12 case-control studies (cases: 2056
tems is too limited to draw any conclusions. women and 417 men; controls: 3358 women and 965 men)
and 1 cohort study investigated BMI or obesity. Obesity was
associated with a statistically significant increased incidence
7.18.1 Thyroid in women, with a clear dose-response relationship. No asso-
ciation was observed in men (although this could have been
Thyroid cancer is the 21st most common type worldwide. An influenced by the relatively small number of cases). The
estimated 141 000 cases occurred in 2002, accounting for cohort study also showed a relationship with increased
just over 1 per cent overall. This cancer type is the 23rd most incidence.
common cause of cancer death. It is more common in high- Body size might affect iodine requirement and therefore,
income countries, with rates more than twice those of mid- indirectly, influence thyroid cancer risk.
dle- to low-income countries.
Thyroid cancer is not usually fatal, with a 5-year survival 7.18.1.1.4 Adult attained height
rate of approximately 70 per cent.2 It is increasing in inci- One pooled analysis of 12 case-control studies (cases: 2056
dence worldwide, although this may be partly explained by women and 417 men; controls: 3358 women and 965 men)
changing diagnostic practices.124 137 investigated adult attained height. Greater height was asso-
Thyroid cancer rates peak between the ages of 25 and 55, ciated with a statistically significant increased incidence in
then decline and rise again in the elderly. This cancer is more both women and men, with a clear dose-response relation-
common in women than in men. Also see box 7.1.1. ship. The effect was greater in men than in women.
Differentiated carcinomas account for 94 per cent of these Body size might affect iodine requirement and therefore,
cancers (80 per cent papillary and 14 per cent follicular car- indirectly, influence thyroid cancer risk. The association with
318
C H A P T E R 7 C A N C E R S
height in both men and women may indicate a potential 7.18.3 Lymphoid and haemopoietic
influence of some growth factor or hormone during child- system
hood or adolescence, but the potential role of growth fac-
tors on thyroid carcinogenesis is still poorly defined. Cancers of the lympho-haemopoietic system are predomi-
nantly lymphomas (Hodgkins or non-Hodgkins), leuk-
7.18.1.2 Conclusions aemias, and multiple myelomas. These cancers have
Thyroid cancer was reviewed in the previous report. It judged different non-dietary causes and there is no reason to believe
that both iodine deficiency (probably) and iodine excess that they might be affected by food, nutrition, and physical
(possibly) were causes of this cancer, and also that vegeta- activity in the same ways.
bles and fruits were possibly protective. If taken together, this group of cancers would be the sixth
The Panel concludes that the associations identified warrant most common type worldwide. An estimated 749 000 cases
more investigation into food, nutrition, and thyroid cancer. occurred in 2002, accounting for around 7 per cent overall.
Approximately 48 per cent of these cancers were lymphomas
(83 per cent non-Hodgkins; 17 per cent Hodgkins), and
7.18.2 Testis 40 per cent were leukaemias, with multiple myelomas
accounting for the remaining 12 per cent.2
Cancer of the testis is the 19th most common type in men. Non-Hodgkins lymphoma is the 11th most common cause
An estimated 49 000 cases occurred in 2002, accounting for of cancer incidence. It is increasing in incidence world-
around 0.5 per cent overall. This cancer is increasing world- wide.124 Non-Hodgkins lymphoma is most frequent in high-
wide, with rapid rises in many high-income countries and income countries, with rates more than twice those of
some transition countries.124 Rates are more than five times middle- to low-income countries. It is usually fatal, with a
higher than in middle- to low-income countries. 5-year survival rate of less than 35 per cent.4 This is not a
Cancer of the testis is usually not fatal where chemother- single cancer, but a wide group of cancers (such as Burkitts
apy is available, with a 5-year survival rate of more than 90 lymphoma and diffuse large B-cell lymphoma), each with a
per cent in high-income countries, but less than 60 per cent distinct geographical distribution, development path, age
in middle- to low-income countries.2 6 Also see box 7.1.1. profile, and prognosis.
Most (95 per cent) testicular cancers are germ cell cancers, Hodgkins lymphoma is the 25th most common type. It is
with seminomas being the other main subtype.4 most frequent in high-income countries, where rates are
The most well established risk factor for testicular cancer more than twice those of middle- to low-income countries.
is the failure of one testis or both to descend into the nor- It is not usually fatal, with a 5-year survival rate of approx-
mal position during fetal development.4 Rates peak in young imately 75 per cent in high-income countries and less than
adulthood. 60 per cent in middle- to low-income countries.2 4 This can-
cer occurs mainly in children, young adults, and the elder-
7.18.2.1 Evidence ly (tending to occur at a younger age or in old age in middle-
The evidence from the narrative review is summarised below. to low-income countries).124
Leukaemias are the 12th most common type and the 10th
7.18.2.1.1 Milk and dairy products most common cause of cancer death. They are gradually
Five case-control studies, one twin study, and four ecologi- increasing in incidence worldwide. They are most frequent
cal studies investigated milk and dairy consumption. All eco- in high-income countries, with rates more than twice those
logical studies and two of the case-control studies showed of middle- to low-income countries. Leukaemias are usual-
statistically significant relationships between increased milk ly fatal, with a 5-year survival rate of approximately 40 per
and dairy consumption and increased testicular cancer cent in high-income countries, and less than 20 per cent in
incidence. middle- to low-income countries.124 However, childhood
None of the other studies reported statistically significant leukaemias have a very high survival rate. This is not a sin-
associations, although non-significant associations were gle cancer, but a wide group of both acute and chronic
heterogeneous. leukaemias.
There are no well established mechanisms through which Multiple myeloma is the 24th most common type and the
milk could influence testicular cancer development. Milk and 19th most common cause of cancer death. It is gradually
dairy products contain fat, protein, and calcium, all of which increasing in incidence worldwide, and is most frequent in
may have an effect on testicular cancer risk. high-income countries with rates more than three times high-
er than in middle- to low-income countries. It is usually fatal,
7.18.2.2 Conclusions with a 5-year survival rate of less than 50 per cent in high-
Cancer of the testis was not reviewed in the previous report. income countries and less than 30 per cent in middle- to low-
income countries.2
The Panel concludes that the evidence does not warrant Infection with Epstein-Barr virus (see box 7.2.1) is a risk
significant investigation into food, nutrition, and testicular factor for developing Hodgkins lymphoma.329 HIV-1 infec-
cancer. tion, immune suppression (whatever the cause), and infec-
tion with Epstein-Barr and human T-cell leukaemia virus all
increase the risk of developing non-Hodgkins lymphoma.330
319
P A R T 2 E V I D E N C E A N D J U D G E M E N T S
Tobacco use, infection with human T-cell leukaemia virus, One animal study has shown that fish oils can inhibit the
radiation, and benzene are established causes of formation of lymphoid and haemopoietic cancers.
leukaemia.10 67 328 331 Exposure to ionising radiation is a cause
of multiple myeloma. Also see chapter 2.4. 7.18.3.1.5 Fat
Two cohort studies and four case-control studies investigat-
7.18.3.1 Evidence ed fat consumption. All showed statistically significant rela-
The evidence from the narrative review is summarised below. tionships with increased incidence. One case-control study
that reported separately on PUFAs described a significantly
7.18.3.1.1 Vegetables and fruits reduced incidence for that fatty acid type, while confirming
One cohort study and six case-control studies investigated a significant increased incidence for saturated fatty acids.
vegetables and fruits. The cohort study and five of the case- There are no postulated mechanisms by which fat could
control studies showed statistically significant associations increase lymphoid and haemopoietic cancers.
with increased vegetable and fruit intake and reduced inci-
dence of lymphoid and haemopoietic cancers. However, the 7.18.3.1.6 Alcoholic drinks
cohort study and two of the case-control studies reported on One pooled analysis of case-control studies representing
non-Hodgkins lymphoma only. The sixth case-control study 15 175 participants, with 6492 non-Hodgkins lymphoma
reported increased incidence with consumption of vegeta- cases, showed a statistically significant reduced incidence for
bles other than cruciferous, leafy, or yellow/orange. this type, particularly Burkitts lymphoma.
Vegetables and fruits contain many potentially protective There are no postulated mechanisms by which alcohol
substances, including several antioxidants, as well as phy- could decrease the incidence of lymphoid and haemopoiet-
tochemicals with antiproliferative capabilities. They are also ic cancers.
a rich source of folate, which plays an important role in the
synthesis, repair, and methylation of DNA. 7.18.3.1.7 Body fatness
Nine cohort studies and 11 case-control studies investigat-
7.18.3.1.2 Milk and dairy products ed BMI or obesity and non-Hodgkins lymphoma, leukaemia,
One cohort study, nine case-control studies, and one eco- or multiple myeloma. In each case, most studies reported an
logical study investigated milk and dairy products, with most association with increased incidence, with several reporting
reporting on non-Hodgkins lymphoma. The cohort study, the statistically significant relationships.
ecological study, and most of the case-control studies report- Obesity results in pathological states of inflammation and
ed statistically significant associations between increased altered immune responses, both of which are factors that can
milk and dairy consumption and increased incidence. influence lymphoid and haemopoietic cell function.
There are no well established mechanisms by which milk
could increase lymphoma incidence. Hypotheses include cal- 7.18.3.2 Conclusions
cium restricting the bioavailability of vitamin D (this vitamin These cancers were not reviewed in the previous report.
promotes differentiation and apoptosis and inhibits cancer
cell growth in the laboratory). Alternatively, organochlorines The Panel concludes that more work into mechanisms that
(which are potential carcinogens) may accumulate in dairy might underlie the associations identified is warranted. A
fat. A final hypothesis is that bovine leukaemia virus might more comprehensive and systematic review might also clar-
transmit through milk to humans, although there is no direct ify the epidemiology. The different cancer types should be
evidence for this. investigated separately unless there is reason to believe that
they have common causes.
7.18.3.1.3 Meat
One cohort study, seven case-control studies, and one eco-
logical study investigated meat or red meat. The cohort 7.18.4 Musculoskeletal system
study, the ecological study, and most of the case-control stud-
ies showed an association with increased incidence, with sev- Cancers of the musculoskeletal system are a diverse group,
eral reaching statistical significance. A review article came including those of the bones, muscles, and related tissues,
to the same conclusion. all around the body. These include liposarcomas, fibrosar-
There are no postulated mechanisms by which meat comas, osteosarcomas, and myosarcomas.
could increase the incidence of lymphoid and haemopoietic These cancers are all uncommon or rare, each accounting
cancers. for less than 1 per cent usually much less of all can-
cers. There is no reason to think that they have causes in
7.18.3.1.4 Fish common.
Two cohort studies and seven case-control studies investi- The narrative review did not produce any findings.
gated fish and lymphoid and haematopoietic cancers. Most Because these cancers are uncommon, any study investi-
studies showed a non-significant relationship with reduced gating their possible links with food, nutrition, and physical
incidence. This reached statistical significance in two case- activity would be unlikely to be fruitful. Because they are
control studies that reported results separately for non- diverse, any investigation that grouped all of them together
Hodgkins lymphoma. would also be unlikely to show consistent results.
320
C H A P T E R 7 C A N C E R S
7.18.4.1 Conclusions
These cancers were not reviewed in the previous report.
Cancers of the brain and central nervous system are the 18th
most common type worldwide. An estimated 189 000 cases
occurred in 2002, accounting for around 2 per cent overall.
These cancers are most frequent in high-income countries,
with rates more than twice those of middle- to low-income
countries. Brain tumours are relatively common among
childhood cancers. They are the 13th most common cause
of cancer death, and are usually fatal. The overall 5-year sur-
vival rate is less than 25 per cent, with higher rates for many
brain tumours that occur during childhood, and in high-
rather than in middle- to low-income countries.2 Also see box
7.1.1.
Tumours of neural tissue account for approximately half
of these cancers, with most of these being glioblastomas.4
Meningiomas are the other major type of central nervous sys-
tem tumour, with sellar tumours, cranial and spinal nerve
tumours, central nervous system lymphomas, and other rare
brain tumour types comprising the remainder.
The incidence of these cancers appears to be increasing
worldwide, although the trend is not entirely clear.124 The
causes of brain and central nervous system cancers have not
been well established.
The narrative review did not produce any findings.
Because these cancers are uncommon, any study investi-
gating their possible links with food, nutrition, and physical
activity would be unlikely to be fruitful. Because they are
diverse, any investigation that grouped all of them together
would also be unlikely to show consistent results.
7.18.5.1 Conclusions
These cancers were not reviewed in the previous report.
321
P A R T 2 E V I D E N C E A N D J U D G E M E N T S
C H A P T E R 8
322
C H A P T E R 8 D E T E R M I N A N T S O F W E I G H T G A I N , O V E R W E I G H T, A N D O B E S I T Y
323
P A R T 2 E V I D E N C E A N D J U D G E M E N T S
A concept central to the Panels thinking, Energy-dense foods are usually high in fats The Panel has given special emphasis to
assessments, and judgements in this chap- or oils, and/or processed starches and the substantial body of robust experimen-
ter is that of the energy density of foods added sugars. Fast foods (box 8.2), certain tal evidence, both in humans and in rele-
and drinks. baked goods, and confectionery are exam- vant animal models, underpinned by the
Energy density describes the amount of ples of high energy-dense foods. The ener- principles of thermodynamics. To reach its
energy per unit weight of foods or diets. gy density of meat depends on the amount conclusions, the Panel interpreted the epi-
The units of measure are kilocalories (kcal) of fat it contains and how it is cooked. Low demiological findings in the light of this
or kilojoules (kJ) per 100 grams (g). The energy-dense foods are often high in vita- experimental evidence. Thus, the Panel
body derives energy from the macronutri- mins and minerals and other bioactive con- notes the associations between specific
ents in foods and drinks. The metabolis- stituents. Processed, high energy-dense foods and food groups with weight gain,
able energy of carbohydrate and protein is foods are often low in micronutrients. overweight, and obesity, and has inter-
around 4 kcal (17 kJ)/g; of fat, 9 kcal (38 There is no evidence that drinking a lot preted them, in the light of the experi-
kJ)/g; and of ethanol from alcoholic of water with the consumption of energy- mental evidence, as indicating a general
drinks 7 kcal (29 kJ)/g. It follows that of dense foods mimics the intake of low effect of energy density rather than as
the macronutrients in pure form, fats and energy-dense foods. several different specific effects of particu-
oils are the most energy-dense, followed In general, people tend to consume lar foods and drinks. The Panel concludes
by ethanol; and protein and carbohydrate roughly the same amount of food from day that energy density is a probable causal
are least energy-dense.1 By contrast, to day, measured by bulk and weight. factor underlying the observed associations
dietary fibre generates around 1.5 kcal (6.3 Several human clinical studies have shown with specific foods and food groups,
kJ)/g.2 Water, like all foods and drinks, that high energy-dense diets can under- and therefore has decided that energy
requires some energy for its absorption mine normal appetite regulation a density is entered into the matrix as
and metabolism, but its energy value can, process that has been termed passive over- such. Similar principles apply to physical
for practical purposes, be counted as nil. consumption.3 4 Higher energy density activity although, unlike energy density,
The energy density of foods and diets diets tend to lead to greater energy intake. epidemiological studies estimate this more
varies depending on the water content Energy consumed in drinks appears to be directly.
and concentration of the different less easily recognised by appetite control The evidence, compelling on physiolog-
macronutrients, and of dietary fibre. In systems than energy in foods. Drinks by ical grounds and supported by experimen-
general, low energy-dense foods and diets their nature are generally high in water tal and observational evidence, is for diets
are high in fibre, and also in water. and so, compared to foods, have low ener- with plenty of low energy-dense foods to
Therefore, in terms of weight, they are gy density. However, altering the energy limit weight gain; and for diets with sub-
relatively dilute in energy-providing density of drinks, for instance by adding stantial amounts of high energy-dense
macronutrients. Cereals (grains) and veg- sugar, nevertheless does influence the over- foods to promote weight gain especial-
etables cooked in water, and most fruits, all amount of energy consumed, just as it ly when there is frequent consumption of
are examples of low energy-dense foods. does for foods, even though the absolute large portions of energy-dense foods and
By contrast, high energy-dense diets tend levels of energy density for drinks are lower drinks. Although drinks are characteristi-
to contain fewer fibre-rich foods and to be than that for foods. For this reason, caloric cally high in water and less energy dense
relatively concentrated in macronutrients. drinks may play a special role in contribut- than foods, the same principles apply,
Many processed foods are energy dense. ing to positive energy balance. within the drink category.
immediately available glycogen, followed by use of body fat 8.2 Trends and incidence
and of protein in the form of lean tissue. Balance (no weight
loss or gain) is achieved when energy input equals output, Brief summaries of the worldwide trends in BMI are given
over time. When body fat stores increase or decrease, there in Chapter 1. The more historical and detailed perspective
is an accompanying change in lean body mass, with around that follows provides an important evolutionary context for
three quarters of progressive weight gain or loss represent- interpretation of the clinical, epidemiological, and experi-
ing changes in body fat stores. mental data reviewed.
As stated in Chapter 6, body mass index (BMI) is the con-
ventional indicator of body fatness, and takes account of both 8.2.1 Human evolution and adaptation
height and weight. BMI is calculated as weight in kilograms Overweight and obesity became a public health issue only
divided by height in metres squared (BMI = kg/m2). This relatively recently in human history. Before industrialisation,
method does not always provide an accurate measure of underweight and weight loss, leading to debility caused by
body fatness. Unusually lean but muscular people have a rel- shortage or deficiency of energy from food, were the main
atively high BMI, even if they have little fat. The BMI crite- nutritional issues.10 Food insecurity is still a feature of life
ria for risk are now supplemented by measures of excess for the remaining gathererhunter and pastoralist commu-
abdominal fat, because this selective accumulation is a par- nities, and for many agricultural communities in adverse
ticular risk to health. But the BMI method provides a simple social or environmental circumstances. Periodic episodes of
measure of body fatness for most people, most of the time.8 food shortage are a defining characteristic of any type of
See table 8.1 and also Chapter 6. nomadic life. It is likely that the human species has evolved
324
C H A P T E R 8 D E T E R M I N A N T S O F W E I G H T G A I N , O V E R W E I G H T, A N D O B E S I T Y
The term fast food is used in lay publica- and are frequently offered in large portion ple who ate at fast-food restaurants or
tions and in common discourse, as well as sizes. In the literature, the term usually from takeaway outlets: most of the foods
in the scientific literature. It is also used as refers to fast food served in transnation- they consumed were high energy-dense
a category in research studies of food, al restaurants and the many fast foods products. There is no plausible basis for
nutrition, and the risk of diseases, includ- created in each country and region that weight gain being caused by the speed
ing cancer. In the literature, the term does imitate those served in such transnational with which a food is prepared or made
not refer to all foods that can be consumed restaurants. available. Indeed, many foods can be pre-
immediately or quickly, and certainly does Studies assessed in this chapter (see 8.8) pared speedily without also being energy
not refer to foods such as fruits. In gener- show an association between the con- dense. These studies support the Panels
al, the term refers to readily available, sumption of fast foods as defined in the conclusion that the energy density of
energy-dense meals, snacks, foods, and literature and a higher risk of weight gain foods and drinks is an important determi-
drinks. These tend to be consumed often and obesity. These studies examined peo- nant of body mass.
325
P A R T 2 E V I D E N C E A N D J U D G E M E N T S
326
C H A P T E R 8 D E T E R M I N A N T S O F W E I G H T G A I N , O V E R W E I G H T, A N D O B E S I T Y
Figure 8.1 Estimates of the prevalence of obesity and Figure 8.2 Estimates of the annual increases in
overweight in selected countries prevalence of overweight and obesity in
selected countries
Per cent
Per cent
80
BMI 25 2.5
70
BMI 30 BMI 25
60 BMI 2529.9
2.0 BMI 30
GDP = $US BMI 2529.9
50 GDP = $US
40 1.5
30
1.0
20
10 0.5
0
M F M F M F F M F M F M F M F M F M F M F 0.0
USA Australia UK Mexico Brazil Morocco Egypt S. Africa Thailand China Indonesia M F M F M F F M F M F M F M F M F
1999 2000 2003 1999 2003 19981999 1998 1998 1996 2000 2000 USA Australia UK Mexico Brazil Morocco Thailand China Indonesia
2002 (GDP (GDP (GDP (GDP (GDP (GDP (GDP (GDP (GDP (GDP 19992002 2000 2003 19881999 2003 19951999 19911996 2000 2000
(GDP $20 640) $21 410)$3840) $4630) $1240) $1290) $3310) $2160) $750) $640) (GDP (GDP (GDP (GDP (GDP (GDP (GDP (GDP (GDP
$29 240) $29 240) $20 640) $21 410) $3840) $4630) $1240) $2160) $750) $640)
Reproduced with permission from the American Journal of Reproduced with permission from the American Journal of
Clinical Nutrition37 Clinical Nutrition37
Estimates are given by country for men and women, for three BMI Estimates are given by country for men and women, for three BMI
ranges: 25; 30; and 2529.9. GDP = gross domestic product per ranges: 25; 30; and 2529.9. GDP = gross domestic product per
capita ($US). UK = United Kingdom. USA = United States of America. capita ($US). UK = United Kingdom. USA = United States of America.
ways of life for non-industrialised populations typically nationally representative studies among the very lowest
involve relatively high levels of physical activity. This income countries, women of child-bearing age were more
includes manual labour and walking, even when food sup- likely to be overweight than underweight, even in rural
plies are secure and plentiful; and staple foods cereals areas.39
(grains) or roots and tubers which are almost always of Obesity rates vary with socioeconomic status. In a cross-
relatively low energy density (box 8.1). In contrast, ways of country analysis, as national income rose, BMI increased
life in industrialised cities are more likely to be sedentary. rapidly, then flattened, and eventually declined.40
Modern urban food supplies are increasingly processed, with It increased most rapidly until an annual income of about
products that are relatively energy dense: low in dietary fibre $US 5000, and peaked at about $US 12 500 for women and
and relatively high in fats and oils, and refined starches and $US 17 000 for men. In countries whose gross national prod-
sugars. Modern urban food supplies also include more meat uct (GNP) per head is less than $US 2500, obesity in women
and energy-dense alcoholic and soft drinks. An additional is more common among those with a high income.41 But
factor, in what has been termed this obesogenic environ- even in a number of countries with GNP per capita below
ment, is the ready availability and low price of very many $US 2 500, such as China, more women of lower compared
processed foods and drinks. This makes it easy for poor as to higher socioeconomic status are overweight. As countries
well as rich people to consume more energy than their bod- use more money (measured by rises in national GNP), obe-
ies require.20 35 sity is increasingly becoming a disease of the poor.41
Obesity is still more common in high-income countries,
where about 22 per cent of the adult population (185 mil-
lion people) are now obese, compared with less than 4 per 8.3 Regulation of body fatness
cent (115 million people) in middle- to low-income coun-
tries.36 However, of the six countries where more than 60 per As stated, the physiological cause of weight gain, over-
cent of the adult population are overweight or obese, while weight, and obesity is the consumption of more energy from
three are higher income (the United States, Australia, foods and drinks than is used. Therefore both dietary intake
and Great Britain), three are lower-income (Mexico, Egypt, and energy expended, and physical activity, are determinants
and South Africa).37 In middle- and low-income countries, of energy balance. In particular, the systems responsible for
obesity, and the diseases caused by weight gain leading regulating appetite to match energy intake to expenditure
to obesity, coexist with diseases and disorders of undernutri- are crucial. This section summarises relevant points about
tion in the same communities and families.38 See figures 8.1 thermodynamics and the physiological mechanisms involved
and 8.2. in energy intake, expenditure, and balance.
In general, obesity is more common in women than in men,
although more men are overweight.1 Overweight and obesi- 8.3.1 Thermodynamics
ty rates usually increase up to middle age and then are lower The first law of thermodynamics states that energy cannot
in old age. Obesity rates rise first in cities and urban areas; be created or destroyed, but only transformed. In humans
rural communities are slower to show this increase.1 Of 38 and other animals, energy is supplied by the metabolism of
327
P A R T 2 E V I D E N C E A N D J U D G E M E N T S
food, using up oxygen in the process. Of the energy the body 8.3.3 Energy requirement and balance
liberates from food, about 10 per cent is used in its diges- The energy used to maintain the bodys functions (basal
tion, absorption, and metabolism. metabolism) fuels many physiological processes. These
Energy expenditure can be measured in a calorimeter, a include maintenance of the balance of minerals within cells
sealed chamber designed for this purpose, either directly as and the electrical potential difference across membranes.
heat production or indirectly by measuring the amounts of Energy is also required for processes such as DNA repair and
oxygen used and carbon dioxide produced. The amount of the production of new cells, and for the synthesis of proteins
energy metabolised can then be calculated. Studies using and other structural and functional molecules. The assimi-
calorimeters prove that the principles of thermodynamics, lation of food involves the production and secretion of var-
manifest as energy balance, with weight loss and weight gain ious enzymes and hormones that control the flow of nutrient
as described in this chapter, apply both in humans and in ani- molecules through different metabolic pathways.
mals.42 Such studies were the first to prove that restriction The regulation of these interrelated processes depends on
of energy from food results in weight loss.43 factors such as general health, age, and also genetic and
Energy restriction to less than is expended will result in other factors that vary between people.49
weight loss, independent of the type of macronutrients sup- Tissue deposition during growth in childhood, puberty,
plied in the diet. Recent trials,44-47 however, show that dif- and pregnancy and lactation, has additional energy costs.
ferent macronutrients may have different effects on Pregnant women have modestly increased energy require-
metabolism, independent of their energy content. For ments, but many are less physically active during pregnan-
instance, low-carbohydrate diets cause the body to cy. Lactating women require about an extra daily 750 kcal
metabolise carbohydrate stored in the body as glycogen; the (3150 kJ) of energy from food.
associated water excreted leads to loss of weight but not, The major energy cost above BMR comes from physical
unless there is a deficit in total energy, of tissue. Foods high activity (see Chapter 5).
in dietary fibre, such as wholegrain cereals and vegetables, For any given weight, BMR is largely a function of the pro-
promote satiety and therefore may influence weight regula- portion of lean body mass to total body mass; this varies with
tion by improving appetite regulation and tending to con- sex and age, and also health and nutrition status. In seden-
strain excess energy consumption.48 tary adults, lean mass (and so BMR) decreases with age:
older adolescents and young adults usually have higher ener-
8.3.2 Energy intake and output gy requirements than middle-aged and elderly people. This
Human energy needs comprise the amount of energy used means that as they age, people need to consume less ener-
to maintain the bodys functions (measured as basal meta- gy from foods and drinks if they are to stay in energy balance
bolic rate or BMR); to digest and assimilate food (diet- and not gain weight.
induced thermogenesis); and to provide fuel for physical Energy requirements the energy expended by the body
activity. This energy comes originally from foods and vary between people. A small, lean, elderly man weigh-
drinks, and is sourced by the body from stores of carbohy- ing 50 kg living in the tropics, who takes only light exercise,
drate, fat, and protein. might be in energy balance at around 1750 kcal (7350 kJ)
Human basal energy needs vary largely as a function of per day; whereas a young man weighing 80 kg, who is
the total mass of lean tissue, which in turn relates to sex, size, extremely active as a manual labourer, is likely to need over
and age. Physical activity levels vary from day to day, as does 3500 kcal (14.6 MJ) per day. A sedentary, elderly woman
energy intake from foods and drinks. Excess intake is stored; weighing 55 kg might be in energy balance at 1500 kcal
these stores are used to meet the needs of a higher output (6300 kJ) per day; whereas a young woman who trains with
as a result of extra physical activity, for example. In pre- weights daily might need up to 2750 kcal (11.5 MJ). Positive
menopausal women, basal needs vary to some extent with energy balance means consuming more energy than is
ovulatory and other cyclical hormonal changes. expended, in which case, the body will gain weight main-
Usually, body weight and energy stores balance over a ly as fat, but also as lean tissue, which increases BMR.
month or so. Short-term changes in weight are mostly caused Negative energy balance means consuming less energy than
by fluctuations in the bodys store of water, not in stored is expended, in which case the body will lose weight again
energy. Thus between meals and overnight, the short-term mainly fat, but also lean tissue. This, together with other
stores of carbohydrate (glycogen in liver and muscles) are adaptations such as reducing physical activity, tends to
mobilised and oxidised, with associated water. This causes mitigate weight loss.
weight loss, but mostly of water. Longer-term changes in In obesity there is excess stored energy, mainly as fat but
weight, by contrast, are due to alterations in the bodys fat also as lean tissue, which leads to increased energy expen-
tissue. Therefore substantial daily fluctuations in weight do diture, so that higher energy intake is needed to maintain
not reflect changes in energy stores, whereas consistent energy balance.
weight gain (or weight loss) over a substantial period of time As people gain weight and their BMR increases, they need
does. In undernourished people with negligible fat stores, more energy from foods and drinks to maintain their
weight loss reflects loss of lean tissue, used for energy. In increased weight. Over time, a new balance may be
sedentary adults who are not undernourished, changes in achieved, so that no more weight is gained, or the balance
weight over a period of time reflect changes mainly in the may remain positive even at the heavier weight, so that
bodys stores of fat. weight continues to be gained.50
328
C H A P T E R 8 D E T E R M I N A N T S O F W E I G H T G A I N , O V E R W E I G H T, A N D O B E S I T Y
8.3.4 Appetite and weight control 8.5 Risks of overweight and obesity
Humans have many physiological control systems to help
balance energy input and output. Underfeeding leads to The risk of ill health and of death rises with increasing BMI, from
increased appetite. Eating a meal normally leads to satiation, a point well below a BMI of 30 (figures 8.3 and 8.4).61-67
a feeling of fullness which stops the eating, and satiety, which The effects of overweight and obesity in the USA have
inhibits the desire to begin to eat. However, humans vary been thought to be declining because of improvements in the
with regard to the extent to which they are able to maintain medical treatment of complications such as high blood pres-
body weight over years or decades; some appear to main- sure, type 2 diabetes, and abnormal blood lipids. But large
tain energy balance readily, others can only do so with dif-
ficulty. The maintenance of energy balance involves various
processes including satiety responses, appetite control sys-
Figure 8.3 Relationship between BMI and
tems, and other homeostatic mechanisms. In the main, the risk of death
control systems are most effective in responding to under-
feeding, by increasing appetite, and are less effective at Death from cardiovascular disease (684 cases)
reducing intake with long-term overfeeding. Psychological, 11.86
8.0
social, and cultural factors are important underlying influ-
ences on dietary patterns and physical activity.
energy density51 and portion size appear to promote over- <21.0 21.0 23.0 25.0 27.0 30.0 33.0 35.0 40.0
22.9 24.9 26.9 29.9 32.9 34.9 39.9
consumption.52-54 BMI (kg/m2)
In rodents, various mechanisms have been identified that
Death from cancer (1740 cases)
affect appetite control and weight. Some of these, involving
3.62
the hormones leptin and ghrelin, for example, may turn out 3.0
2.5
stasis is most reliably achieved by relatively active ways of
2.0
life, together with low energy-dense diets. It is likely, in
1.5
humans at least, that energy homeostasis operates most
effectively within a range of physical activity and so also of 1.0
4.0
and obesity. A large number of genes are involved with com-
3.0
plex genegene and geneenvironment interactions.
Estimates of the extent to which relative body mass is inher- 2.0
ited, derived from studies of identical (monozygotic) twins
1.0
or adopted children and their biological parents, are consis-
tently high, ranging between 64 and 84 per cent.56 0.0
Correspondingly, relatively high energy intake and/or rela- <21.0 21.0 23.0 25.0 27.0 30.0 33.0 35.0 40.0
22.9 24.9 26.9 29.9 32.9 34.9 39.9
tively low energy expenditure, as well as levels of habitual
BMI (kg/m ) 2
329
P A R T 2 E V I D E N C E A N D J U D G E M E N T S
Hypercholesterolaemia
40 cial importance of environmental (economic, social, cultur-
al, and political) factors in determining weight-related
30
behaviour, interventions which focus on individual behav-
20 iour in isolation from the environment may fail to show long-
10 term impact.
0
The Panel therefore decided to exclude data from such stud-
18.524.9 25.026.9 27.029.9 30.034.9 35+ ies that are inherently problematic from the systematic lit-
BMI (kg/m2) erature review (SLR) of the clinical and epidemiological
Risk of type 2 diabetes, hypertension, and hypercholesterolaemia evidence. The literature review included trials or studies that
increases with increasing BMI, with no apparent threshold ran for, or included follow-up of, less than a year in the
review of underlying mechanisms. These were interpreted as
Reproduced with permission from the National Centre for contributing to understanding of mechanisms underpinning
Health Statistics (USA)66
regulation of body fatness, though not in themselves as evi-
dence of long-term impact on body fatness. The failure of
interventions that are successful in the short term to trans-
prospective studies with direct long-term monitoring of US late to the long term is probably due to the powerful influ-
women show increases in death rates when BMI exceeds 25 ences of sociocultural and other environmental factors in
(except in smokers who tend to be thin and die earlier than determining behaviour. Case-control studies were excluded,
non-smokers).67 due to the special bias inherent in retrospective dietary
Figure 8.3 shows relative risks for death among women reports related to weight gain. Trials that prescribed energy-
who had never smoked. The monotonic relationship held for restricted diets as the intervention were also excluded; only
deaths from cancer and, more strongly, for deaths from car- trials using ad libitum (unrestricted) diets as the interven-
diovascular causes. For other deaths, the increased risk in the tion were included. Studies in children under 5 years old
leanest group was primarily due to chronic obstructive pul- were also excluded. The restriction to include only studies
monary disease and cirrhosis. in free-living participants means that results from this SLR
When death rate is plotted graphically against BMI, U- or are relatively robust and generalisable.
J-shaped curves imply that having a low BMI both increas-
es the risk of death and reduces life expectancy. But care
needs to be taken to exclude the impact of smoking and of 8.7 Interpretation of the evidence
undiagnosed diseases such as cancer, which can lead to unin-
tended weight loss well before a diagnosis is made.68 Energy balance and body composition
Measuring energy intake and expenditure in free-living par-
ticipants taking part in prospective observational studies is
8.6 Method complex. Interpretation of measures of energy intake per se
is problematic, due to inaccuracies in assessment and the
As already stated (see Chapter 3), a full understanding of the complexity of its relationships with body mass and physical
biological factors that modify the risk of chronic diseases activity. Current techniques are not sufficiently precise to reli-
such as obesity requires a synthesis of several types of evi- ably detect the small imbalances that lead to weight gain,
dence. Each type has advantages and disadvantages, and all against a background of much higher levels of total energy
contribute to an overall picture. But there are special con- intake and expenditure. Studies addressing the effectiveness
siderations that need to be taken into account for weight of interventions designed to encourage weight loss are also
gain, overweight, and obesity. difficult to interpret from the point of view of what causes
First, this chapter includes consideration of thermody- weight gain in the first place. Interventions in free-living
namics, and the mechanisms of energy input, output, and populations tend to have relatively low compliance.
balance, to complement evidence from observational and Initial weight loss is hard to sustain in the long term, and
experimental studies. Evidence on the physiological mecha- so long-term studies tend to show less weight loss than pre-
nisms, including robust experimental evidence in humans, dicted by short-term interventions. While the causes of short-
is abundant. Reliable evidence for mechanisms by which a term weight loss or maintenance can be identified and
particular factor affects energy balance is an especially understood physiologically, the causes of long-term weight
important consideration when assessing and judging evi- loss or maintenance may be different. Weight-loss trials were
dence on biological causation. included in the review and informed the judgements report-
Next, clinical and epidemiological evidence in this area has ed here, but the causes of weight loss are not necessarily the
specific problems. Studies on obese subjects based on their converse of the causes of weight gain and obesity.
330
C H A P T E R 8 D E T E R M I N A N T S O F W E I G H T G A I N , O V E R W E I G H T, A N D O B E S I T Y
The Panel decided to include evidence on tively straightforward to measure the num- or sitting and talking. Also, time spent
television viewing, which is a discrete and ber of hours someone spends watching watching television displaces opportunities
measurable pastime associated with obesi- television. for more active pursuits and increases
ty. Subjective methods such as diaries or As shown in 8.8.8, watching television is exposure to promotion of foods that may
questionnaires, and more objective meth- associated with the development of obesi- promote weight gain. Further, watching
ods such as accelerometers, pedometers, or ty (as well as with metabolic and cardio- television may be accompanied by
heart rate monitoring, can be used to mea- vascular pathology). Such adverse effects relatively uninhibited consumption of
sure relatively complex patterns of physical are unlikely to be caused simply by the act energy-dense foods, which may be eaten
activity. However, all such methods are of watching television. Television watching in large portion sizes. Measuring the num-
prone to imprecision and bias. On the is a sedentary behaviour; the degree of ber of hours someone spends watching
other hand, the time spent on single, sim- physical inactivity during television watch- television not only measures physical inac-
ple activities such as viewing television can ing appears to be profound compared with tivity, but also a collection of related
be recalled more precisely, and it is rela- other sedentary activities such as reading, behaviour.70
Several of the studies that contributed data to this report More recent studies report an inverse relationship between
used self-reported body weight, which correlates well with physical activity and weight gain. While this could be
measured body weight, although under-reporting is com- explained by improvements in study design, publication bias
mon, particularly among more overweight subjects. may be present.
Self-reported information on food consumption has also
been used; this is prone to similar bias. Consumption of foods Being breastfed
or drinks regarded as unhealthy, for instance, those con- The definition and classification of breastfeeding varied
taining fat, sugars, and alcohol, tend to be under-reported between studies. Some studies included mixed feeding, per-
more than others. haps in a predominantly breastfed group; some reported
Designs and reporting methods vary between studies, mak- mixed feeding separately to exclusive feeding. In other stud-
ing it difficult to combine data. For most of the exposures ies, it was unclear what level of exclusiveness was used. The
assessed, many different measures are used. Study results can, duration of exclusive breastfeeding varied and was not
and have been compared, but meta-analysis was not usually always reported. Intervention trials of the effect of breast-
possible. Nevertheless, when epidemiological and trial data feeding are impossible for practical and ethical reasons.
are interpreted appropriately, and the results are assessed Results may remain confounded, because in high-income
together in the light of biological evidence, this research does countries where most studies are undertaken, mothers
identify aspects of food and nutrition, and ways of life such from higher socio-economic groups tend to breastfeed for
as being physically active, that are the most important deter- longer periods, and it is difficult to correct for social class
minants of overweight, weight gain, and obesity. completely.
Social (including economic and political) and environ-
mental factors are important determinants of behaviour,
including that which affects body fatness. Such factors are 8.8 Evidence and judgements
the subject of a further report to be published one year after
this Report. A total of 207 publications were included in the SLR for the
determinants of weight gain, overweight, and obesity. The
Physical activity evidence from these studies is summarised here and is fol-
Measurement of physical activity is complex (also see lowed by the Panels assessments and judgements.
Chapter 5). When exposure measurement is less precise than The evidence included observational epidemiology, trials,
outcome measurement, the apparent effect is attenuated. and mechanistic data, with particularly strong and robust
Most cohort studies used subjective assessment methods. evidence in humans, including data from short-term trials,
Although all studies are prospective, some studies do not which were interpreted as evidence of underlying mecha-
allow reverse causality to be excluded. That is, a high BMI nisms rather than of long-term impact. Each of these types
at the start of the study may be a cause of decreasing phys- of evidence is presented according to the particular expo-
ical activity and may also be independently associated with sures in the matrix. The exposures in the matrix reflect the
an increased risk of weight gain. Although many studies Panels interpretation of the causal pathway by which the
adjusted for potential confounders, the complexity of this exposures/interventions might influence the risk of obesity.
area makes residual confounding difficult to exclude. The Panel agreed that in the particular case of weight gain,
Trials of physical activity interventions and cohort studies overweight, and obesity, the epidemiological and trial evi-
that investigated the effects of physical activity on weight dence on cereals (grains), on vegetables, and on foods high
gain vary greatly in size, length, follow-up, intervention in dietary fibre, should be interpreted in the light of, and as
details, and study design, making comparisons problematic a marker of, their low energy density. It also agreed that, cor-
and precluding meta-analysis. In the case of physical activ- respondingly, epidemiological and trial evidence on animal
ity and obesity, cross-sectional data may also be valuable.69 fats should be interpreted on the basis of their high energy
331
P A R T 2 E V I D E N C E A N D J U D G E M E N T S
density (box 8.1). Therefore, the Panel concludes that the epi- though not after follow-up.
demiological associations between specific foods, and weight Also see 8.8.4, 8.8.5, 8.8.6, and 8.8.7 for dietary interventions.
gain and obesity, were probably due to a general effect of All nine trials showed a decreased risk of at least one mea-
the relative energy density of such foods and drinks rather sure of weight gain with interventions that included physi-
than any other characteristic. cal activity and diet advice. This tended to be removed or
The full SLR is contained on the CD included with this attenuated as follow-up periods extended past 12 months
Report. (table 8.4).
The first Pound of Prevention trial showed that 82 per cent
8.8.1 Physical activity of the intervention group maintained or lost weight, com-
Three randomised controlled trials (RCTs)71-73 and 16 pared with 56 per cent of the control group.90 The second
cohort studies74-89 investigated total physical activity and showed a statistically significant higher weight loss or main-
weight maintenance or change in adults. Nine RCTs investi- tenance in high-income women and men than in low-income
gated combined physical activity and diet interventions in women from intervention, but no statistically significant dif-
adults.90-100 Ten cohort studies101-110 and 1 case-cohort ference overall between intervention and control.91 At 3
study111 investigated occupational activity; 19 cohort stud- years, there was no statistically significant difference.92 In the
ies.73 78 86 87 102 104 106 111-121 and 1 case-cohort study111 inves- Womens Healthy Lifestyle Project, the intervention group
tigated recreational activity in adults; 2 cohort studies showed statistically significant reductions in weight and
investigated household activity86 122; 1 cohort study investi- waist to hip ratio levels compared with baseline. The con-
gated frequency of physical activity in adults107; 3 cohort trol group showed no statistically significant difference.93 94
studies investigated intensity of physical activity in adults.78 In Leermarkers trial,95 both intervention groups showed sta-
102 123
Two long-term RCTs,124 125 3 short-term RCTs,126-128 and tistically significant reductions in weight (-1.6 kg, whereas
15 cohort studies.129-145 investigated total physical activity in controls gained 0.2 kg; p < 0.01). (The 54-month follow-up
children, and 4 cohort studies investigated frequency of phys- showed statistically significant lower increases in low-den-
ical activity in children.145-148 sity lipoprotein cholesterol in the intervention group than in
the control group.95) In the Harrell trial, the intervention
Total physical activity in adults group showed statistically significant lesser body fat than the
Two trials showed at least one statistically significant control group.96
decreased measure of weight gain/body fatness with a phys- The Patient-centred Assessment and Counselling for
ical activity intervention.71 73 One trial showed no effect on Exercise trial showed no difference in BMI, but a non-signif-
weight maintenance.72 (See table 8.3.) icant lower percentage of body fat in the intervention group
In the Schmitz trial, at 39 weeks, the intervention group compared with the control group.97 The Burke trial showed
gained significantly more fat-free mass (0.89 kg, p = 0.009) no statistically significant effect on BMI, but fewer individu-
and lost more body fat (1.63 per cent, p = 0.006) compared als in the high-intensity group became overweight or
with controls.71 There was no statistically significant obese.98 The Pritchard trial showed a statistically significant
effect on weight or waist measurements. The Fogelholm greater weight loss in the diet than in the exercise group.99
trial showed lower weight regain and waist-circumference However, dual energy X-ray absorptiometry scans showed
measures in the moderate walking group than in either that 60 per cent of weight loss in dieters was fat tissue,
the control or high-intensity groups.73 The Borg trial showed compared to 80 per cent in the exercise group, which also
no statistically significant difference to weight mainte- showed better preservation of lean tissue. In the King trial,
nance.72 However, resistance training attenuated the the exercise-focused intervention showed statistically signif-
regain of body fat mass during the maintenance phase, icant better weight maintenance than diet or control.100
332
C H A P T E R 8 D E T E R M I N A N T S O F W E I G H T G A I N , O V E R W E I G H T, A N D O B E S I T Y
0.0050.0001; p = 0.049) per 1-unit increase in metabolic increased physical activity energy expenditure (correlation
equivalent (MET) hours per day83; a 0.91 kg decrease in men coefficient of -0.03; p value for trend 0.77) and physical
(95% CI 0.421.4) per physical activity score unit and a 2.14 activity level (correlation coefficient of -0.03; p value for
kg decrease in women (95% CI 1.352.93)81; a 0.12 kg trend 0.80) and subsequent weight gain.88
decrease (95% CI 0.070.16) per 0.10 MET change in phys-
ical activity level80; a 0.29 kg decrease ( 0.12 kg; p < 0.02) Other physical activity assessments in adults
per log physical activity score in women only79; a 0.38 cm Two cohort studies showed a statistically significant
decrease in waist circumference (95% CI 0.160.60) for an decreased risk of weight gain, overweight, or obesity with
increase in vigorous physical activity from baseline of 25 increased occupational activity108 110; two studies showed
MET hours per week (this effect was reduced to 0.19 cm statistically significant decreased risk in women only102 105;
(95% CI 0.030.35 cm) after controlling for change in four studies showed no significant association103 104 107 109;
BMI)78; a 2.98 kg decrease (95% CI 1.414.55) per 200 exer- two studies had mixed results101 106; and one study showed
cise units in white women, and change in physical activity a statistically significant increased risk (exposure was lift-
was inversely associated with change in body weight in all ing).111 There was considerable heterogeneity.
four race and sex subgroups (p < 0.0005)77; a 0.32 kg Six cohort studies showed a decreased risk of weight gain,
decrease (95% CI 0.160.48; p < 0.0001) per 1-unit, with- overweight, or obesity with increased recreational activity.73
in-woman increase in sports/exercise scale86; a 0.41 kg/m2 86 118-121
Six studies showed no significant association87 102 104
decrease in current BMI (95% CI 0.020.81; p value for trend 111 115 116
; five studies had mixed results,78 106 112-114 and one
0.042) per 1-unit increase in past sport participation75; a study showed a statistically significant increased risk.118
1.09 risk of increased BMI (95% CI 1.011.17) for the inac- One cohort study showed a statistically significant
tive group compared with the referent in the overweight, and decreased risk of weight gain, overweight, or obesity with
a 0.95 risk of increased BMI (95% CI 0.910.99) in the aver- increased household activity.122 One study showed no sig-
age compared to the active reference group in the overweight nificant association.86
subgroup.74 One study showed that the baseline physical One cohort study showed no statistically significant asso-
activity index was a significant predictor of weight gain (cor- ciation between frequency of physical activity and risk of
relation coefficient of 0.39; p value for trend < 0.05) and weight gain, overweight, or obesity.107
fat mass gain (correlation coefficient of 0.40; p value for Two cohort studies showed a statistically significant
trend < 0.05) when one outlier was removed (weight regain decreased risk of weight gain, overweight, or obesity with
of approximately 40 kg).82 One study stated that there was increased frequency of high-intensity physical activity.78 102
a non-significant trend for lower increases in BMI with One study showed no significant association.123
increased physical activity.84 One cohort study showed a statistically significant
One study showed a non-significant association between decreased risk of weight gain, overweight, or obesity with
333
P A R T 2 E V I D E N C E A N D J U D G E M E N T S
Mo-Suwan 1998 292 kindergarten children Randomised by class (n=10) into exercise or 2930 weeks 12 months
control group
Sallis 1993 549 school children Randomised by school to specialist-led or 18 months
(mean age 9.25) teacher-led physical activity programme, or
control condition
Flores 1995 110 children Randomised by class to Dance for Health 12 weeks
(mean age 12.6) or control conditions
Pangrazi 2003 606 children Randomised by school to usual physical 12 weeks
(mean age 9.8) education, PLAY (Promoting Lifetime Activity
for Youth) (intervention) and PLAY plus usual
physical education and control (no physical
education or PLAY)
Neumark-Sztainer 2003 201 physically inactive Randomised by school to multicomponent 24 weeks
girls (mean age 14.9 physical education class or control.
(intervention) and Intervention included 8-week maintenance
15.8 (control)) component of weekly meetings
increased number of steps climbed in a day.87 One study control girls.128 The Neumark-Stzainer trial showed no
showed a statistically significant decreased risk of weight statistically significant difference in BMI between the inter-
gain, overweight, or obesity with increased routine, daily vention and control schools, with non-significant improve-
physical activity level, and a non-significant decreased risk ments in several analyses.127
with change in daily physical activity level.86 Twelve cohort studies showed decreased risk for at least
Both long-term trials showed statistically significant one measure of weight gain, overweight, or obesity with
decreased risk of at least one measure of weight gain, over- increased physical activity in children, which was statistically
weight, or obesity.124 125 However, one of the trials also significant in 11 (including the 2 cohort studies that used
reported statistically significant lower BMIs in the control objective measures to assess physical activity).132-145 Three
group (table 8.5).125 studies stated that there was no statistically significant
Two short-term trials showed no statistically significant dif- association.129-131
ference with physical activity interventions.127 128 One short-
term trial showed a decreased risk of weight gain, General mechanisms
overweight, or obesity with a dance-based physical activity The general mechanisms through which physical activity
intervention, which was statistically significant in girls.126 could plausibly protect against weight gain, overweight, and
The Mo-Suwan trial showed a non-significant decreased obesity are outlined in 8.3 and in Chapter 5. In addition, an
prevalence of obesity in the intervention group (p = 0.057). important physiological consequence of physical activity is
Girls had a statistically significant decreased risk of increas- fat oxidation, although this effect may be attenuated in obese
ing BMI of 0.32 (95% CI 0.180.56); boys had a non-sig- people. Regular exercise has been shown to increase fat
nificant increased risk of 1.08 (95% CI 0.621.89). At 1 year, oxidation in both healthy and obese people, a mechanism
the prevalence of obesity (defined by 95th skinfold percentile) that is thought to occur as a result of improved insulin
decreased by 2.7 per cent in the intervention group and sensitivity,149 although this effect may be attenuated in obese
increased by 1.4 per cent in the controls.124 The Sallis trial people. Evidence has shown that physical activity could
showed statistically significant lower BMI at 6 and 12 potentially influence appetite control by: increasing the
months (p value for trend < 0.05), but not at 18 months, in sensitivity of satiety signals; altering food choice or macro-
the control group. However, boys in the specialist-led group nutrient preference; and modifying the pleasure response to
had thinner skinfold measurements at 6 and 12 months, but food, which may elevate hunger, food intake, and body
not at 18 months. Girls in the control group had lower BMI weight. Short- and medium-term studies have, however,
at each time point and this was statistically significant at 18 shown that individuals can tolerate substantial negative
months (p < 0.01).125 energy balance during sustained physical activity, thus result-
The Flores trial showed a decreased risk of weight gain ing in weight loss. Eventually, food intake will increase to
with intervention, which was statistically significant in girls compensate for the exercise-induced energy loss, although
only (BMI change -0.8 kg/m2 in intervention and 0.3 kg/m2 the degree of compensation may vary greatly between
control). Boys showed similar, though non-significant, individuals.150
trends.126 The Pangrazi trial showed no statistically signifi-
cant difference between the intervention and control The epidemiological evidence on physical activity is
schools. However, girls showed a statistically significant substantial and consistent. There is robust mechanistic
higher activity in two out of three of the interventions than evidence, particularly in relation to its impact on
334
C H A P T E R 8 D E T E R M I N A N T S O F W E I G H T G A I N , O V E R W E I G H T, A N D O B E S I T Y
appetite regulation and energy balance. Overall, the hours per week) compared with high (! 52 hours per week)
evidence that all types of physical activity protect sitting time.165
against weight gain, overweight, and obesity is The general mechanisms through which sedentary living
convincing. It has this effect by promoting appropriate could plausibly cause weight gain, overweight, and obesity
energy intake. Conversely, the evidence can be are outlined above and in Chapter 5.
interpreted as showing that sedentary living is a cause
of weight gain, overweight, and obesity. The epidemiological evidence that sedentary living
causes weight gain, overweight, and obesity is
The Panel is aware that since the conclusion of the SLR, nine relatively sparse, but there is robust mechanistic
RCTs151-159 and four cohort studies160-163 have been published. evidence in humans. The Panel concludes that the
This new information does not change the Panel judgement (see evidence that sedentary living causes weight gain,
box 3.8). overweight, and obesity is convincing.
8.8.2 Sedentary living The Panel is aware that since the conclusion of the SLR, one
One RCT investigated physical inactivity in children164 (see cohort study179 and one case-control study180 have been pub-
table 8.6) and three cohort studies investigated physical inac- lished. This new information does not change the Panel judge-
tivity in adults.87 122 165 In addition, one RCT164 and 16 cohort ment (see box 3.8).
studies129 143 147 166-178 investigated television viewing. These
data are summarised separately in 8.8.8. Television viewing 8.8.3 Being breastfed
is a behaviour that usually involves being highly sedentary, Two published SLRs181 182 and three subsequent cohort
although other activities, such as snacking, are also associ- studies98 171 183 investigated being breastfed.
ated with it (see box 8.4). The larger literature review included 61 studies that inves-
Sedentary living involves a high level of inactivity, with tigated being breastfed and later risk of obesity, of which 43
low levels of activity. The data reviewed here relate to phys- were cohort studies, 15 were cross-sectional studies, and 3
ical inactivity, which is only one component of sedentary liv- were case-control studies.182 It showed a statistically signif-
ing. Somebody who is inactive for considerable periods of icant decreased risk of obesity with breastfeeding. Meta-
time might also engage in regular, moderate, or vigorous analysis was possible on 28 studies, giving a summary effect
physical activity at other times, and therefore not be seden- estimate of 0.87 (95% CI 0.850.89) for breastfeeding com-
tary. The strong mechanistic evidence on the effects of pared with formula feeding.
sedentary living, particularly in an environment with easy Only two studies looked at adult obesity; the rest assessed
access to frequent, large portions of high energy-dense foods, obesity in those under 18 years. This effect was attenuated,
contribute to the Panels judgement on sedentary living. but still statistically significant, when only the six studies that
The single trial showed no significant relationship between adjusted for parental obesity, maternal smoking, and social
sedentary living and BMI. Post-intervention, BMI was class were included, with an effect estimate of 0.93 (95% CI
unchanged, but behaviour such as the number of children 0.880.99).182
watching more than 2 hours of television per day was sig- The smaller literature review included 28 studies that
nificantly lower in the intervention group, as was total num- investigated being breastfed and risk of obesity in later child-
ber of hours watched.164 hood.181 It showed a statistically significant decreased risk
Two cohort studies showed increased risk of weight gain of obesity with breastfeeding. Meta-analysis was possible on
with increased sitting time.122 165 One study stated that there nine studies (two cohort studies and seven cross-sectional
was no statistically significant relationship.87 Effect estimates studies), giving an adjusted summary effect estimate of 0.78
were 1.28 (95% CI 1.041.58) for the risk of becoming obese (95% CI 0.710.85) for breastfeeding compared with not.
in those sitting at work, or away from home, or driving for The assessment of exposure to breastfeeding differed
more than 40 hours per week compared with less than 1 between studies. One study compared children who were
hour a week; 1.11 (95% CI 0.851.45) in those who spent mostly or only breastfed in their first 6 months with those
> 40 hours a week sitting at home compared with 01 hours who were mostly or only formula-fed, while most of the stud-
per week122; and 0.80 (95% CI 0.700.91) for the likelihood ies compared children who were never breastfed with chil-
of weight maintenance (vs weight gain) with a low (< 33 dren always breastfed. Again, the effect was attenuated
when only maximally adjusted studies were
included.
Table 8.6 Sedentary behaviour interventions in children All three cohort studies published after the
conclusion of the above-mentioned litera-
Author Number of Intervention Length of Length of ture reviews showed decreased risk of obe-
participants intervention follow-up
sity with breastfeeding.98 171 183 However, the
Dennison 176 children Randomised by daycare 12 weeks effect was not statistically significant when
2004 from middle- centre (n=18) into fully adjusted in two studies,171 183 and one
income families intervention that addressed study showed a decreased risk of obesity,
(mean age 4.0) nutrition, reducing sedentary which was statistically significant in adoles-
behaviours, or control group
cence but not adulthood.98 Effect estimates
335
P A R T 2 E V I D E N C E A N D J U D G E M E N T S
were 0.70 (95% CI 0.540.91; minimally adjusted) but 1.22 effective than general energy restriction; some did not.
(95% CI 0.871.71) in the final model171; and 0.15 (95% CI Most trials with sufficient follow-up periods also showed
0.030.72) for being obese in adolescence and 0.34 (95% that weight loss was not commonly maintained after the
CI 0.121.01) for being obese in adulthood.98 One study intervention ended.
reported a regression coefficient of -0.30 (95% CI -0.053 to The Matvienko trial showed no significant difference from
-0.007; p value for trend 0.012) and BMI at age 8 years after analysis of the whole dataset, although participants with
adjustment for sex.183 The study stated that breastfeeding higher initial BMI showed improved weight maintenance
was not a statistically significant predictor of BMI after mul- with intervention, with statistically significant weight gain
tivariate adjustment. in the control group.200 The Epstein trial showed non-
significant weight loss in both intervention groups, with a
General mechanisms non-significantly greater weight loss in the decreased fat and
Exclusively breastfed children show different growth patterns sugar group.199 The Swinburn trial showed statistically
from those of formula-fed infants (also see chapter 6.2). significant weight loss with the low-fat diet at one year, but
Breastfed infants consume less total energy and less protein no significant difference at five years.195 The Flemming trial
than formula-fed infants.184 It is possible that the bioactive showed statistically significant weight loss with the low-fat
factors in human milk could modulate energy metabolism, diet and calorie-controlled interventions.197 The Dansinger
a process in which leptin (present in human milk but not for- trial showed statistically significant weight loss for all diets
mula) may be implicated. Alternatively, the effect of elevat- and no significant difference between them.198 The Harvey-
ed protein intake and plasma insulin concentrations in Berino trial showed statistically significant greater weight
formula-fed babies could stimulate fat deposition and early loss with calorie restriction than with the low-fat diet.196 The
adipocyte development. Jeffery trial showed statistically significant greater weight
loss with the low-fat diet at the end of the intervention; after
The epidemiological and mechanistic evidence that follow-up, both groups had returned to their original
being breastfed protects against overweight and weights.194 The Sheppard trial showed statistically significant
obesity is substantial and generally consistent. While greater weight loss in the low-fat diet group.193 The Shah
there are some issues to do with measurement and trial showed no statistically significant difference in weight
confounding, there is evidence for plausible loss between the low-fat and low-calorie diets.192 The Foster
mechanisms. Being breastfed is probably protective. trial showed statistically significant greater weight loss for
The epidemiological evidence relates to childhood the low carbohydrate diet at three and six months, but a non-
overweight and obesity; overweight children tend to significant greater weight loss at one year.45 The Stern trial
become obese adults. showed a non-significant greater weight loss with the low-
carbohydrate diet than the calorie-restricted diet.191 The
The Panel is aware that since the conclusion of the SLR, three Ebbeling trial showed statistically significant greater weight
cohort studies185-187 have been published. This new information loss with the reduced glycaemic load trial.190 The Simkin-
does not change the Panel judgement (see box 3.8). Silverman trial showed statistically significant greater weight
loss and/or maintenance for the intervention group.189 The
Toubro trial showed no significant difference between the
8.8.4 Low energy-dense foods two weight-loss regimes, but did show statistically significant
The Panel decided to group the epidemiological evidence maintenance (less regained weight) in the ad libitum main-
on foods that are low in energy (box 8.1) into this general tenance regime than in the fixed energy group.188
category. This decision was informed by the mechanistic
evidence. 8.8.4.1 Wholegrain cereals and cereal products
Four cohort studies investigated wholegrain cereals and
Nutrition interventions cereal products.
Fourteen randomised controlled trials investigated dietary All four cohort studies showed decreased risk of weight
interventions and weight loss, and prevention of weight gain, gain and/or obesity for the highest intake group when com-
overweight, or obesity.45 188-200 Most trials increased the pro- pared with the lowest, which was statistically significant in
portion of low energy-dense foods and drinks in peoples two.201-204 The two statistically significant results were both
diets. However, the stated aims of trials varied and some may from studies that investigated all food sources of whole-
not be directly relevant. In particular, low-carbohydrate diets grains. Effect estimates for higher wholegrain intake were
seem to lead to energy reduction with high energy density, 0.81 (95% CI 0.730.91; p value for trend 0.0002) for obe-
but the long-term health impact of such diets is not known sity and 0.77 (95% CI 0.591.01; p value for trend 0.03) for
(see table 8.7). major weight gain204; decreased weight gain with greater
All trials showed that restricted energy diets decreased the total wholegrain intake (p value for trend < 0.0001)203;
risk of weight gain, overweight, and obesity. All trials also regression coefficients of -0.07 (95% CI -0.30 to 0.17) for
showed that increasing the consumption of low energy-dense men and -0.20 (95% CI -0.49 to 0.09) for women for the
foods and decreasing the consumption of high energy-dense relationship between wholegrain bread intake and waist cir-
foods in diets decreased risk of weight gain, overweight, and cumference202; and 0.91 (95% CI 0.791.05; p value for
obesity. Some found that these varied approaches were more trend 0.13) for the relationship between wholegrain break-
336
C H A P T E R 8 D E T E R M I N A N T S O F W E I G H T G A I N , O V E R W E I G H T, A N D O B E S I T Y
fast cereal intake and risk of being overweight.201 in adults and two in children.115 173 203-206
Definitions of wholegrain foods remain contentious (see Five cohort studies showed decreased risk of weight gain
box 4.1.1). and/or obesity for the highest intake group when compared
Wholegrains (consisting of the grain endosperm, germ, with the lowest,115 203-206 which was statistically significant
and bran) provide an abundant source of dietary fibre, resis- in three.203-205 One study (in children) showed a non-signif-
tant starch, phytoestrogens, antioxidants, and other micronu- icant decreased risk in boys and a non-significant increased
trients (see chapter 4.1). The primary mechanism for an risk in girls.173 Of the two studies that showed non-signifi-
effect on weight gain is through low-energy density. cant decreased risk, one investigated the relationship
However, there are other mechanisms through which whole- between infant diets and adolescent obesity.206 Effect esti-
grains may have a physiological effect on weight gain. For mates in adults were 0.51 (95% CI 0.390.67; p value for
instance, several studies have demonstrated a positive rela- trend < 0.0001) for overweight and 0.66 (95% CI
tion between wholegrain consumption and improved blood 0.580.74; p value for trend < 0.0001) for obesity204;
insulin profiles, which could provide an indirect mechanism. p value for trend ! 0.001 for weight gain (no effect esti-
mate)205; 0.39 standard deviation (SD) g per day weight
Wholegrain cereals and cereal products are assessed change ( 0.2) for the highest intake group and 1.4 SD g
here as high-fibre foods and as a marker for low per day weight change ( 0.2) for the lowest, p value for
energy-dense foods. For this reason, no separate trend < 0.0001203; and the univariate model (adjusted for
judgement is made for wholegrain cereals and cereal retirement (yes/no); type of job (sedentary or active); inter-
products. action between retirement and type of job; age; smoking;
and the base level of the behaviour) showed a regression
8.8.4.2 Foods containing dietary fibre coefficient of -0.31, p value for trend < 0.01, and the mul-
Six cohort studies investigated foods containing fibre, four tivariable model (additionally adjusted for all other behav-
337
P A R T 2 E V I D E N C E A N D J U D G E M E N T S
iours examined, including physical activity and dietary vari- result in slowed gastric emptying and increased satiety. Fruits
ables) showed a regression coefficient of -0.17, p value for and vegetables contain high concentrations of a range of
trend 0.10.115 Effect estimates in children were 0.78 (95% important micronutrients such as antioxidants and phyto-
CI 0.601.02) for adolescent obesity with the highest intake estrogens that may also have a beneficial influence upon the
group of fibre foods at 3 years old206; and regression coeffi- energy homeostatic pathways.
cients of 0.0011 (95% CI -0.0073 to 0.0095; p value for trend
0.80) in girls and -0.0046 (95% CI -0.014 to 0.0046; p value Non-starchy vegetables are assessed here as high fibre
for trend 0.320) in boys.173 foods and as a marker for low energy-dense foods. For
Residual confounding is possible, as indicated by the max- this reason, no separate judgement is made for non-
imally adjusted cohort study above. People whose diets are starchy vegetables.
high in fibre from food often also have other habits regard- Overall, the epidemiological evidence that low
ed as healthy, which may be difficult to characterise precisely. energy-dense foods protect against weight gain,
On the other hand, there is considerable evidence for a spe- overweight, and obesity is substantial and generally
cific effect of dietary fibre on satiety and on mechanisms consistent. The mechanistic evidence, particularly that
relating to appetite regulation, such as gastric emptying.48 on appetite regulation and energy balance, is
Fibre from food has a low energy density, as it is not digest- compelling. Taking all types of evidence together, low
ed in the small bowel and can only undergo partial fermen- energy-dense foods probably protect against weight
tation in the large bowel. Fibre consumption may increase gain, overweight, and obesity. They have this effect by
satiation by increasing chewing, slowing gastric emptying promoting appropriate energy intake.
and elevating stomach distension, and stimulation of chole-
cystokinin. The increased viscosity of soluble fibre can reduce The Panel is aware that since the conclusion of the SLR, two
the overall rate and extent of digestion, which may also RCTs,212 213 three cohort studies,179 214 215 and one case-cohort
result in reduced energy from protein and fat and a blunted study216 have been published. This new information does not
post-prandial glycaemic and insulinaemic response to car- change the Panel judgement (see box 3.8).
bohydrates. Fibre-induced delayed absorption and the resul-
tant presence of macronutrients in the distal small intestine, 8.8.5 Energy-dense foods
known as the ileal brake, mediate the release of several gut The Panel decided to group the epidemiological evidence on
hormones.207 foods that are high in energy (box 8.1) into this general
category. This decision was informed by the mechanistic
The evidence on foods containing dietary fibre is evidence.
assessed here as a marker for low energy-dense foods, In addition to the evidence summarised below, several of
although there are specific mechanisms beyond energy the trials reviewed in 8.8.4 investigated the effect of reduc-
density. For this reason, no separate judgement is ing intake of energy-dense foods and drinks, which gener-
made for dietary fibre. ally decreased the risk of weight gain during the
intervention. The evidence on sugary drinks and fast foods
8.8.4.3 Non-starchy vegetables are also relevant to the judgement for this general category
Five cohort studies investigated non-starchy vegetables, four (see 8.8.6 and 8.8.7).
in adults and one in children.114 208-211
All five cohort studies showed decreased risk of weight 8.8.5.1 Animal fats
gain and/or obesity for the highest group of non-starchy veg- Three cohort studies investigated animal fats, two in adults
etables intake when compared with the lowest, which was and one in children.211 217 218
statistically significant in two.114 210 Effect estimates in adults All three cohort studies showed increased risk of weight
were 0.84 (95% CI 0.750.93; p value for trend < 0.0001) gain for the highest intake group when compared to the low-
for becoming obese and 0.76 (95% CI 0.590.99; p value for est, which was statistically significant in one study,218 and
trend 0.01) for major weight gain210; -0.12 kg/m2 mean in one analysis of data on children.217 Regression coefficients
change in BMI (95% CI -0.22 to -0.02; p value for trend in adults were 0.0032 (95% CI 0.00630.00006) linking ani-
0.012)114; regression coefficient of -0.05 (95% CI -1.24 to mal fat intake and increased risk of weight gain (height and
-0.63) with change in BMI211; and 0.99 (95% CI 0.871.13) weight were self-reported)218; and 4.85 (95% CI -3.5 to 13.2;
for weight gain.209 Weight and height were measured in the p value for trend 0.26) linking animal fat intake and weight
two statistically significant studies, and were self-reported in change (measured).211 The study in children (recording ani-
the two non-significant studies. The study in children showed mal fat intake from 1 to 7 years of age) showed a statisti-
a statistically significant decreased risk of raised BMI z-scores cally significant greater weight at 7 years for the highest
in boys (regression coefficient of -0.003, 95% CI -0.004 to intake group of 29.3 kg (SD2.0) compared with 23.7 kg
-0.001) but no relationship in girls.208 (SD1.2) in the lowest (p value for trend < 0.05).217 When
Increased consumption of non-starchy vegetables, which animal fat intake was measured as g/1000 kcal, g/kg body
are generally low in energy density, may result in a com- weight, or compared to Roher index (weight in g "
pensatory decrease in the consumption of more energy-dense 100/height in cm3), no statistically significant difference was
foods. Most non-starchy vegetables tend to have a low gly- apparent.
caemic index and contain soluble dietary fibre, which may As the most energy-dense macronutrient, there are several
338
C H A P T E R 8 D E T E R M I N A N T S O F W E I G H T G A I N , O V E R W E I G H T, A N D O B E S I T Y
plausible mechanisms by which dietary fat could lead to pos- (95% CI 1.142.24; p value for trend 0.02), also per drink/
itive energy balance and obesity. The efficiency of nutrient day.222
use is higher for fat than carbohydrate or protein. When There is considerable variation in the definition of sugary
energy balance is positive and fat is being stored, the stor- drinks between studies. The study that reported no associ-
age of this fat only requires a small degree of oxidation ation excluded fizzy drinks.
(approximately 3 per cent of the energy stored). The high Studies have demonstrated that, when consumed as part
energy density of fat may promote passive overconsumption. of a soft drink, the energy from sugars may not be compen-
Prolonged consumption of a high-fat diet may desensitise the sated for in the same way as when consumed as part of a
individual to a number of appetite controls. The palatabili- solid meal.224 Limited studies have shown that in adults,
ty of fat may induce voluntary overconsumption. short-term (10-week) intake of sugar-sweetened foods and
drinks (of which 80% were drinks) promoted weight gain,
The evidence on animal fats is assessed here as a whilst consumption of artificially sweetened foods resulted
marker for energy-dense foods. For this reason, no in weight loss.28
separate judgement is made for animal fats.
High energy-dense foods are probably a cause of The epidemiological and mechanistic evidence that
weight gain, overweight, and obesity, particularly drinks containing added sugars, including sucrose and
when large portion sizes are consumed regularly. They high-fructose corn syrup, are a cause of weight gain,
have this effect by promoting excess energy intake. overweight, and obesity is substantial and consistent.
Also see entries on sugary drinks (8.8.6), fast foods Sugary drinks probably cause weight gain, overweight,
(8.8.7), and television viewing (8.8.8). and obesity. Like energy-dense foods and drinks, they
have this effect by promoting excess energy intake.
The Panel is aware that since the conclusion of the SLR, one
cohort219 and one case-control study180 have been published. The Panel is aware that since the conclusion of the SLR, one
This new information does not change the Panel judgement (see RCT,225 one cohort,226 and one case-control study180 have been
box 3.8). published. This new information does not change the Panel
judgement (see box 3.8).
8.8.6 Sugary drinks
The evidence on sugary drinks is reviewed separately due to 8.8.7 Fast foods
its independent effect on body fatness. It also contributes to The evidence on fast foods is reviewed separately due to
the judgement on energy-dense foods and drinks. their independent effect on body fatness. It also contributes
One RCT220 and four cohort studies investigated sugary to the judgement on energy-dense foods and drinks.
drinks.115 221-223 Two cohort studies were in adults115 223; the Six cohort studies investigated fast foods (see box 8.2),
trial and two other cohort studies were in children.221 222 four in adults and two in children.165 227-231
The single trial included 644 children randomised by class All six cohort studies showed increased risk of weight gain
to receive teaching sessions to discourage consumption of with increased intake of fast foods, which was statistically
sugary, carbonated drinks or to control. After 12 months, significant in four,165 227 229 230 and in women but not men in
change in BMI z-score was non-significantly lower in the an additional study.231 Effect estimates in adults were a
intervention group, with a change of 0.7 (SD 0.2) compared regression coefficient of 0.85 (95% CI 0.431.27; p value for
with 0.8 (SD 0.3) in the control group.220 trend < 0.05) in low-income women and 0.39 (95% CI
Three cohort studies showed increased risk of weight gain 0.150.64; p value for trend < 0.05) for the association
when frequency of sugary drink intake increased,115 222 223 between number of fast-food meals per week and BMI231;
which was statistically significant in two.115 222 One study a 0.85 (95% CI 0.750.96) chance of maintaining weight
showed no association.221 This study was in children, and (equivalent to a 15 per cent increased risk of weight gain)165;
investigated intake of fruit drinks, but excluded fruit juice, a weight gain of 1.72 kg (95% CI 0.522.92; p value for
soda (fizzy drinks), or diet soda. The effect estimates for the trend 0.005) greater for black people who visited fast-food
two adult studies were mean weight gain of 4.69 kg for 1991 restaurants frequently compared to those who visited infre-
to 1995 and 4.20 kg for 1995 to 1999 in women who quently, and 1.84 kg (95% CI 0.862.82; p value for trend
increased their sugar-sweetened soft drink consumption, and < 0.0013) greater for the same comparison in white peo-
1.34 kg and 0.15 kg in women who decreased their con- ple230; and a 0.72 kg (95% CI 0.331.11; p value for trend
sumption223; regression coefficients of 0.20 (p value for trend < 0.01) greater weight gain for people who visited fast-food
< 0.01) for the univariate model relating weight gain to restaurants more than twice a week compared to those who
increase in intake of sugar-sweetened soft drinks and 0.12 visited infrequently.229 One study in children showed a sta-
(p value for trend 0.05) for the multivariable model (this tistically significant greater increase in BMI z-scores of 0.82
study also reported a statistically significant relationship with for those who ate food from quick-service outlets more than
increased waist circumference).115 The cohort study in chil- twice a week compared to 0.28 for those who never ate
dren that reported an effect estimate showed that BMI quick-service foods (p value for trend 0.0023).227 One study
increased by 0.24 kg/m2 (95% CI 0.100.30; p value for in children stated that there was a statistically significant
trend 0.03) per sugary drink (not including fruit juice)/day association between increased takeaway food intake and
and the effect estimate for the frequency of obesity was 1.60 BMI at the age of 8, but that after multivariable adjustment
339
P A R T 2 E V I D E N C E A N D J U D G E M E N T S
there was no statistically significant relationship.228 hours spent watching television and the risk of obesity (as
The energy density of a food reflects the energy content defined by triceps skinfolds on or above the 85th percentile)
per unit weight (box 8.1). Many of the highly consumed and 0.14 (p value for trend < 0.001) for triceps skinfolds
processed and fast foods have a high energy density, often on or above the 95th percentile174; regression coefficients of
due to a high content of fat and refined starches and sugars 0.037 (95% CI 0.0110.058; p value for trend 0.001) for the
and a correspondingly low water content.232 relationship between time spent watching television or play-
ing videogames in girls and 0.038 (95% CI 0.0180.059; p
The evidence that fast foods as defined in the value for trend 0.001) for the same relationship in boys173;
literature are a cause of weight gain, overweight, and correlation coefficient of 0.14 (95% CI 0.010.27; p value
obesity is strong and consistent. This epidemiological for trend < 0.05) for the relationship between time spent
evidence reinforces the Panels judgement on energy- watching television and subscapular skinfold thickness (as
dense foods. Other factors are that fast foods are a measure of body fatness)143; a regression coefficient of
promoted vigorously, are cheap, and are often 0.054 (p value for trend 0.82) for the relationship between
available in large portion sizes at low cost. Fast foods television viewing and BMI175; a regression coefficient of
probably cause weight gain, overweight, and obesity. 0.48 (standard error 0.19; p value for trend 0.012) for rela-
They have this effect by promoting excess energy tionship between television viewing in adolescence and BMI
intake. at 26 years in a maximally adjusted model167; a regression
coefficient of 0.47 (SE 0.21; p value for trend 0.02) for the
The Panel is aware that since the conclusion of the SLR, two relationship between television viewing and BMI166; a regres-
cohort studies226 233 and one case-control study180 have been sion coefficient of 0.19 (p value for trend < 0.01) for the
published. This new information does not change the Panel relationship between time spent watching television or play-
judgement (see box 3.8). ing videogames and BMI172; an effect estimate of 1.55 (95%
CI 1.132.12) for the group that watched the most televi-
8.8.8 Television viewing sion when compared to the lowest.171 Watching television or
The evidence on television viewing is reviewed separately videos, playing computer games, or listening to audio tapes
due to its independent effect on body fatness. It also was a positive predictor of body fat in 2 out of 4 models
contributes to the judgement on sedentary living (8.8.2) investigating variables related to percentage body fat at age
and may be a marker for other behaviour, such as 8 years170; a regression coefficient of 0.05 (95% CI
consumption of energy-dense foods (box 8.1).70 0.020.07; p value for trend < 0.01) for the relationship
One RCT234 and 16 cohort studies129 143 147 166-178 investi- between time spent watching television and BMI168; and a
gated television viewing, all in children, adolescents, or young BMI of 19.5 kg/m2 (95% CI 19.319.7) in the group that
adults. Some studies grouped other sedentary leisure-time watched the most television compared to a BMI of 19.6
activities, such as playing videogames, together with televi- kg/m2 (95% CI 19.419.9) in the group that watched the
sion viewing. least.169
The single RCT showed a statistically significant decreased
risk of body fatness with decreased television viewing. The Television viewing is a form of very sedentary
trial included 198 children randomised by school into an behaviour. The epidemiological evidence is mostly
intervention or control group for six months. The interven- consistent and generally free of methodological issues.
tion aimed to reduce television, videotape, and videogame Results from the intervention trial are impressive, and
use with supporting lessons, encouragement not to eat meals there is evidence of a dose-response relationship.
whilst watching television, and a seven hours per week tele- Television viewing may also be associated with
vision budget. The intervention group showed a 0.45 kg/m2 consumption of energy-dense foods and drinks.
greater decrease in BMI (95% CI -0.73 to -0.17) than the con- Studies were of children and adolescents, but these can
trol group. Statistically significant greater decreases were be taken to apply also to adults. Given that television
also seen in skinfold measurement, waist circumference, and viewing is a sedentary behaviour, the mechanistic
waist to hip ratio. The intervention group showed statisti- evidence, particularly that on energy input, output,
cally significant fewer hours of television viewing (p value and turnover, is compelling. Television viewing is
for trend < 0.001) and fewer meals eaten in front of the tele- probably a cause of weight gain, overweight, and
vision (p value for trend < 0.02).234 obesity. It has this effect by promoting an energy intake
Ten cohort studies showed increased risk of weight gain in excess of the relatively low level of energy
and/or obesity with increased television viewing,143 166-168 170-175 expenditure.
which were statistically significant in nine.143 166-168 170-174 Four
studies stated that there was no significant association129 8.8.9 Other exposures
176-178
and an additional study found an association with The following exposures were evaluated: total fat, refined
videogame-playing in girls but not boys, but no association cereals (grains)/cereal products, starchy roots, tubers and
with television viewing.147 One study showed a non-signifi- plantains, fruits, fruit juices, fish, milk and dairy products,
cant decreased risk.169 Effect estimates (four studies did not alcoholic drinks, sweeteners, and coffee. However, the data
report effect estimates) were a regression coefficient of 0.029 were either too low quality, too inconsistent, or the number
(p value for trend < 0.001) for the relationship between of studies too few to allow conclusions to be reached.
340
C H A P T E R 8 D E T E R M I N A N T S O F W E I G H T G A I N , O V E R W E I G H T, A N D O B E S I T Y
8.10 Conclusions
341
P A R T 2 E V I D E N C E A N D J U D G E M E N T S
C H A P T E R 9
Cancer survivors
Cancer survivors are people who are living with between cancers of various sites; and between the
a diagnosis of cancer, including those who have effects of the many types of conventional and other
recovered. therapies used.
Awareness of cancer survival has increased greatly
since the 1990s. So has the number of people living The Panel notes as follows:
with a diagnosis of cancer. The total number of Regular physical activity and other measures that
recorded cancer survivors in the world in 2002 was control body weight may help prevent recurrence, at
estimated to be just under 25 million, and by 2050 least of breast cancer. In any case, when able to do
may approach 70 million. so, cancer survivors are likely to gain general health
The term cancer survivor covers a very wide benefit, and a sense of control over their
variety of circumstances. Thus, the needs of people circumstances, from regular physical activity.
currently undergoing therapy are likely to be The evidence does not support the use of high-
different from those of people whose metabolic dose supplements of microconstituents as a means
functions have been altered as a result of therapy of improving outcome in people with a diagnosis of
and from those of people who are evidently fully cancer. Cancer survivors should consult their
recovered and whose functions are intact. physician and/or a qualified nutrition professional,
Nevertheless, the Panel accepts the validity of the who can evaluate the safety and efficacy of specific
concept of cancer survivor, welcomes the rising con- dietary supplements, and counsel an appropriate
sciousness that cancer is a disease best spoken of action based on current research relevant to their
and dealt with openly, and agrees that the best way particular clinical situation.
to improve quality of life and increase the chances In summary, evidence that some aspects of food,
of prolonged life and recovery from cancer is when nutrition, or physical activity specifically modify the
cancer survivors take responsibility for themselves, condition of cancer survivors is emerging, but is not
supported by associates, friends, and family, while yet sufficiently developed to enable the Panel to
always also consulting their professional advisors make judgements that apply specifically to cancer
and making best use of available medical care sys- survivors, as distinct from people without cancer.
tems and qualified social support.
Correspondingly, we the Panel collectively have
accepted a special responsibility to give our best
advice, having examined the evidence derived from
systematic reviews of the scientific literature done
according to our agreed methodology, and also
from our knowledge of the whole range of evidence
and consideration of the precautionary principle
and best clinical and public health practice.
Research on food, nutrition, physical activity, and
cancer survival is at an early stage. Overall, the
Panel agrees that it is not possible to make judge-
ments that apply specifically to cancer survivors,
based on the evidence reviewed for this Report. The
available evidence on cancer survivors has a number
of limitations: it is of variable quality; it is difficult
to interpret; and it has not yet produced any impres-
sive results. Definite general judgements are made
more problematic because of differences in the
health of cancer survivors at various stages;
342
C H A P T E R 9 C A N C E R S U R V I V O R S
343
P A R T 2 E V I D E N C E A N D J U D G E M E N T S
After recovery tinues to increase, and follows predictions made in the USA,
People who are alive 510 years after successful treatment and given a further increasing global population, the number
People who are alive 10+ years after successful treatment of recorded cancer survivors worldwide in 2025 will approach
(including those who had cancer as a child). 50 million, and in 2050 will approach 70 million. Such pro-
jections may be conservative, and also do not take into account
The definition of cancer survivor here does not include peo- people with cancer that is not diagnosed or recorded.
ple living with a diagnosis of a benign tumour, or tumours Among cancer survivors in the USA in 2002, the most
defined as premalignant, such as premalignant cervical common cancer diagnosed was breast cancer among women
lesions or polyps in the colon. (22 per cent), prostate cancer among men (18 per cent), and
Cancer survivors as defined here also does not include colorectal cancer among men and women combined (10 per
those living with people who are living with a diagnosis of can- cent).1 These figures are not proportional to incidence rates
cer. Sometimes this wider definition is used, and from the pub- because the average time of survival after diagnosis of dif-
lic, community, and family health points of view, issues that ferent cancers varies. In Europe, breast cancer was the most
concern cancer survivors are also of vital importance to their prevalent cancer in women (34 per cent), followed by colo-
partners, family members, and close friends.1 Such loved ones rectal cancer (10 per cent). In men, colorectal cancer (15
are most likely to want to know what to do, and will seek pro- per cent), prostate cancer (12 per cent), and lung cancer (10
fessional guidance, both for the person with diagnosed can- per cent) were most prevalent.2
cer, and also for themselves and family members.
This becomes most important practically when decisions
need to be made about family shopping and meal prepara- 9.3 Interpretation of the evidence
tion, and eating out. Should the family member with cancer
be treated differently? Or should the whole family follow the 9.3.1 General
same recommendations and advice? These are not questions For general considerations that may affect interpretation of
of direct professional concern to cancer researchers, but do the evidence, see chapters 3.3 and 3.5, and boxes 3.1, 3.2,
concern physicians, and other health professionals, whose 3.6 and 3.7.
responsibility includes passing on authoritative recommen-
dations, or else giving the best available advice and guidance. 9.3.2 Specific
Nature of the field. The main problem faced by reviews of
cancer survivors, as indicated in 9.1, is the scale and het-
9.2 Occurrence erogeneity of the field. The interventions reviewed were
studied in people with a number of different cancers, at dif-
The number of cancer survivors has greatly increased in ferent stages, and for different outcomes.
recent decades, especially in high-income countries. This is
partly because the general prevalence of cancer continues to Classification. There are many groups of cancer survivors.
rise, within a world population that is also rising. In addi- Some have been diagnosed but have not yet received treat-
tion, screening programmes for common cancers are identi- ment. Others are undergoing treatments that have damag-
fying many more cases, usually at relatively early stages. As ing effects and which, for some, have damaged the physical
already stated, the rapid rise in the recorded incidence of function of the body. Others have been overtly free from can-
prostate cancer in recent years is largely because of increased cer for several or many years. As yet, there are no general-
use of methods of detection (see chapter 7.14.1). Also, for ly agreed classifications of cancer survivors, or the different
some cancers, medical and surgical treatments and follow- stages of cancer survival, which makes comparisons of stud-
up care are increasing the time that people live with cancer; ies problematic.
these interventions are also improving rates of recovery. In
the USA, estimates of the number of cancer survivors have Study design. Studies should take into account and report
increased from around 3 million (1.5 per cent of the popu- the stage of treatment participants are at, and give details
lation) in 1970 to over 10 million (close to 4 per cent of the of this treatment. Studies need to have sufficient statistical
population) in 2002. The absolute number of cancer sur- power to address the research question being examined.
vivors aged 65 years and older is predicted to double in the
USA by the year 2050.1 Confounding. Clinical and pathological characteristics of the
Calculations of the type made in the USA have not been cancer, such as tissue of origin, stage at diagnosis, and spe-
made in Europe as a whole. European Union countries cific molecular characteristics, are the strongest predictors of
together now have a larger population than the USA, but outcome, and are powerful confounding factors, especially
given the overall differences between the two (somewhat in observational studies. Cancer treatments and their conse-
lower rates of screening, detection, and years of survival after quences may change the effects of interventions in ways that
diagnosis in Europe), a rough guess of 5 million European are not well understood. Different cancers may be modified
survivors (or 1 per cent of the population) seems reason- in different ways by food, nutrition, and physical activity.
able.2 In 2002, the total number of recorded cancer survivors This complexity is increased by the effects of treatment
in the world was estimated to be just under 25 million.3 and the disease itself, both of which can affect food
If prevalence of, and survival with, cancer worldwide con- consumption, digestion, absorption, and metabolism, and
344
C H A P T E R 9 C A N C E R S U R V I V O R S
also a persons physical condition or behaviour. This is par- of 53 nutritional intervention trials and 23 physical activity
ticularly important for studies that relate body fatness to can- trials. It assessed the quality of all the studies reviewed,
cer risk, as cancer often causes weight loss. In some cases, including the size of the study populations; the length of
surgery may have been performed to remove parts of the the interventions and of the follow-up programmes; the
gastrointestinal tract affected by cancer. Cancer often methods used to ensure randomisation; and the methods of
results in loss of appetite, and cancer treatments may cause statistical analysis.
nausea or a decreased ability to absorb nutrients from food.4 There were usually insufficient numbers of any type of
An important strength of randomised trials, provided they study to allow useful combining of data for meta-analysis.
are sufficiently large, is that confounding variables, both Overall, data were also insufficient to allow for separate
known and unknown, will on average be distributed equal- analyses of survivors before, during, and after treatment. The
ly between the treatment and control groups, and will there- Panels standard criteria used to grade the strength of evi-
fore not bias the study results (also see chapter 3.1.6). dence, and the matrices used to record the Panels judge-
ments, used in previous chapters, were not used in the case
of cancer survivors.
9.4 Evidence and judgements A narrative review of observational studies was also con-
ducted. As stated above, these are less suited in the study of
A systematic literature review (SLR) was undertaken to efficacy of treatments, and so in studies of cancer survivors
assess the role of food, nutrition, and physical activity in the their results should be treated with caution. Also see 9.3.
case of cancer survivors. This review addressed the efficacy The full SLR is contained on the CD included with this
of nutritional and physical activity interventions in cancer Report.
survivors in relation to mortality, disease-free survival, can-
cer recurrence, secondary cancers, quality of life, and 9.4.1 Randomised controlled trials
adverse effects of treatment regimens.5 9.4.1.1 Healthy diets
This SLR was designed differently from those on the caus- Food-based RCTs were defined as those using interventions
es of cancer in people assumed to be free from the disease, that offered advice about healthy eating (variously defined)
and used as the bases for judgements in previous chapters. or specific diets such as high-fibre diets and/or weight-loss
This decision was taken because the focus of the research programmes. Twelve trials met the criteria for inclusion in
questions was not on causation, but on the efficacy of par- the review of food-based interventions. Study designs tend-
ticular interventions. In addition, people with cancer are in ed to be of poor quality, and insufficient information was
a clinical situation and will often be receiving, or will have available about the methods used for randomisation and
received, medical, surgical, or other treatments that may blinding. Duration of interventions varied between seven
affect their nutritional status; this limits the value of some weeks and three years.
kinds of observational evidence. Small trials conducted in Russia, the Netherlands, and
For these and other reasons, it was decided in the case of Poland reported on the effects of healthy diet interventions
cancer survivors to give pre-eminence to randomised con- for breast cancer survivors, either during or after treatment,
trolled trials (RCTs), which are least likely to be confound- and cancer recurrence. A reduced fat and energy diet
ed, and are best suited to investigate the relatively short-term decreased the recurrence of breast cancer in the Russian
efficacy of specific interventions. The review undertaken was study.6 A study conducted both in the Netherlands and in
345
P A R T 2 E V I D E N C E A N D J U D G E M E N T S
in vegetables, fruits, and dietary fibre, and low in fat, in over 3000
Box 9.2 Use of supplements by cancer survivors
women with early stage breast cancer. After 7.3 years of follow-
In the USA and in other high-income countries, the use of supple- up, there was no difference in breast cancer recurrence, new breast
ments in physiological (low dose) and also pharmacological (high cancer, or all-cause mortality between the intervention and con-
dose) amounts is common among the general population and trol groups.19 Unlike the WINS study, in the WHEL study women
also among cancer survivors. in both the intervention group and the control group experienced
At least 50 per cent of the US population take vitamin and min-
small increases in weight, and this may partially account for the
eral supplements.52 Supplement use among US cancer survivors
different results in these two trials.
has been shown in two studies published in 2004 to be similar to
the average, but high-dose supplements may be more commonly
used by cancer survivors.53 54 Survivors are also reported to be high 9.4.1.2 Supplements
users of complementary and alternative medicines and other Data from 39 RCTs were assessed. The review included tri-
treatments.55 Several hundred web sites promote high-dose sup- als on supplements of retinol,20-26 beta-carotene,27-30 vitamin
plements with unsupported claims that they are active cancer B6,31 32 vitamin C,31 32 multivitamins,27 33 34 vitamin E,35-37
cures or can prevent recurrence. selenium,35-38 and isoflavones.39 40 Additionally, single trials
of each of evening primrose oil,41 glutamine,42 and N-acetyl-
cysteine26 and nine trials of commercial supplements were
Poland examined the effect of dietary advice and psycho- reviewed.43-51 Also see box 9.2.
logical support to achieve weight loss, but no significant Trial quality and number of participants tended to be
effect on breast cancer recurrence was reported, perhaps higher in supplement trials than in the dietary-intervention
because of the small size and limited power of the study.7 trials. Compliance was monitored in the majority of trials,
Six trials reported on the effect of healthy diets on quality and placebos were usually given to the control group.
of life. Of these, one study of people surviving breast, ovary, However, the controls in all seven retinol trials and in five
prostate, or testicular cancers showed a positive effect, in a pro- of the nine commercial supplement interventions were given
gramme that combined general dietary information with phys- usual treatment or an unrestricted diet.
ical training and coping skills.8 A study of people surviving head There was considerable variation in the methods and
and neck or gastrointestinal cancers showed a beneficial effect length and type of intervention used, and the overall quali-
with a programme of dietary counselling compared to usual ty of many studies was poor. Furthermore, the disparate vit-
care.9 The other studies reported no effect.10-13 amins and other bioactive substances used in these studies
Only one trial investigated food-based interventions and make comparison difficult. Results were null or non-signifi-
side-effects of treatment. This study found that individual cant in almost all cases.
nutritional advice, adapted to the patients own needs and Trials where data were sufficient and the exposures were
tastes, reduced adverse effects from radiotherapy in people homogeneous enough to allow meta-analysis included those
with head and neck cancers.14 examining retinol and all-cause or cancer mortality.
Three small trials examined food-based interventions and Comparing the intervention to usual treatment, the summary
all-cause mortality. The studies were conducted in survivors estimate from four trials that examined all-cause mortality
of non-melanoma skin cancer,15 colorectal or lung cancer,16 was 0.97 (95% CI 0.831.13)23-26; from three trials that
and breast, ovary, prostate, or testicular cancer.8 None of the examined cancer mortality, the summary estimate was 0.92
trials reported a significant association between the inter- (95% CI 0.651.31).23 24 26
vention and all-cause mortality. One small trial of bladder cancer survivors showed a sig-
nificant reduction in cancer recurrence. This trial compared
No conclusions can be derived from these results. supplementation with a multivitamin plus a high-dose
combination of vitamins A, B6, C, and E and zinc against a
The Panel is aware of two large, multicentre, randomised tri- multivitamin alone.33
als of breast cancer survivors, the WINS study, published in A larger trial designed to test the effect of 200 micrograms
2006, and the WHEL study, published in 2007. The WINS trial per day of selenium supplementation on recurrent non-
tested a dietary intervention to reduce fat intake in over 2000 melanoma skin cancer showed no effect on skin cancer, but
women with early stage breast cancer. After 5 years of follow- a protective effect on prostate cancer.36 37
up, the women in the intervention group had a 24 per cent Fifteen trials investigated types of supplementation and
reduced risk of recurrence compared with the control group (rel- side-effects of cancer treatment. One small study reported
ative risk 0.76, 95% CI 0.600.98).17 However, these findings higher treatment toxicity in survivors of haematological can-
cannot be easily translated into recommendations for breast cers with vitamin A supplementation (as retinol or beta-
cancer survivors, for several reasons. First, women in the inter- carotene).23 No significant results were reported in the other
vention group had more extensive surgical procedures. Also, studies.27 29 31 32 34 35 38-40 48 56-58
they lost weight during the trial and it is possible that weight
loss was responsible for their improved outcome. Finally, The evidence from this review of trials does not show
dietary fat reduction was most beneficial in women with oestro- that micronutrient supplements have any benefits in
gen- or progesterone-receptor negative tumours, a finding that cancer survivors. High-dose supplements may be
may be due to chance.18 harmful. Some micronutrients and other bioactive
The WHEL study tested the effect of a dietary intervention high compounds are known to be toxic at high doses.
346
C H A P T E R 9 C A N C E R S U R V I V O R S
9.4.1.3 Physical activity The Panel is aware of two large observational studies that
Twenty-three physical activity RCTs met the criteria for inclu- investigated physical activity in breast cancer survivors. A study
sion in the review. Interventions ranged from simple advice of nearly 3000 breast cancer survivors in the Nurses Health
to increase physical activity, to enrolment in supervised exer- Study reported reduced risk of breast cancer mortality in
cise programmes. These were mostly small trials and of short women who were physically active, compared with sedentary
duration. In half of the studies, compliance levels were women.73 In a second study of over 1200 women, physical
unclear, and the majority failed to record physical activity activity measured before diagnosis of breast cancer was asso-
levels in the control group, which severely limits their value. ciated with reduced all-cause mortality; this association was
Only three of the physical activity intervention trials statistically significant in women who were overweight or obese
reported on mortality or cancer recurrence.8 59 60 None of at diagnosis.74
these studies reported significant effects.
Twenty trials investigated quality of life outcomes with phys-
ical activity interventions. Nine of these trials were in survivors 9.5 Comparison with the previous report
of haematological cancer,61 lung cancer,62 prostate cancer,63
and in a combination of cancers.8 12 64-68. Eleven trials were in The previous report did not include any review, assessment,
breast cancer survivors.62-73 Two of the interventions in these or recommendations directed at cancer survivors. The panel
trials included nutrition components.12 64 responsible for that report stated that its recommendations
The physical activity interventions, assessment instru- were especially important for population groups and people
ments, and outcomes studied were varied. The interventions most susceptible to cancer.
included many types of supervised or home-based exercise
programmes. Several studies assessed well-being and qual-
ity of life using a version of the Functional Assessment of 9.6 Conclusions
Cancer Therapy scale,69 although other questionnaires and
scales were also used. Quality of life outcomes included a The Panel concludes:
range of measures of physical, functional, and emotional Research into the effects of food, nutrition, and physical
well-being, as well as measures of physical fitness. activity in cancer survivors is in its early stages. For this rea-
Of the 20 physical activity trials that investigated quality son, and also because of the scale and heterogeneity of the
of life, 18 reported a benefit from the intervention on at least field, the evidence reviewed here is inconclusive.
one of the outcome measures reported in the study. None of Regular physical activity and other measures that control
the trials reported harmful effects of the physical activity weight may help prevent recurrence of breast cancer and
interventions on any of the outcomes studied. improve quality of life. When able to do so, cancer survivors
may gain general health benefit and a sense of control over
Taken together, these trials provide some evidence for their circumstances from regular physical activity.
the benefit of physical activity on post-treatment The evidence does not support the use of high-dose
quality of life in cancer survivors. supplements of microconstituents as a means of improving
outcomes in people with a diagnosis of cancer.
9.4.2 Observational data Cancer survivors should consult their physician and/or a
Three reviews that examined data from 26 observational qualified nutrition professional who can evaluate the safety
cohort or case-control studies met the criteria for inclusion and efficacy of specific dietary supplements, and offer advice
in the review of observational data.70-72 based on current research relevant to their particular clini-
All of these compared breast cancer outcomes in cancer cal situation.
survivors to body fatness, as measured by body mass index As with all the chapters in Part 2 of this Report, the
(BMI) (see chapter 6.1). The results of these studies were Panels recommendations for cancer survivors are in Part 3,
generally consistent. An overall increased risk of mortality Chapter 12.
with increasing BMI was reported, although there was some
heterogeneity in study results.
Of 21 studies that followed cases for at least 5 years, 12
showed statistically significant associations between higher
BMI and worse outcome, while others showed insignificant
results or were null. One study found that mortality risk
decreased as BMI increased. Physical activity was associat-
ed with an enhanced quality of life in cancer survivors.
347
P A R T 2 E V I D E N C E A N D J U D G E M E N T S
C H A P T E R 1 0
The assessments and judgements made by the Panel activity, and cancer. These show where judgements
shown in the preceding chapters are based on and recommendations are consistent, and where
evidence from systematic literature reviews of they have changed, as science has developed and as
original research studies, compiled according to views on relative weight of evidence from different
specified criteria, on food, nutrition, physical types of research have evolved. In addition,
activity, and the risk of cancer. However, the Panel comparisons have been made in Chapters 4 to 7
recognises that recommendations on food, nutrition, between the findings of this Report and the previous
and physical activity are also made in relation to report, published in 1997.
other diseases. These include recommendations
designed to control and prevent chronic diseases
other than cancer, and those designed to influence
the dietary and activity patterns of populations and
individuals. Recommendations that address
nutritional adequacy (prevention of deficiencies),
and prevention and management of infectious
diseases (vulnerability to which is affected by
nutritional status) should also be taken into account.
The Panel has therefore decided that its
recommendations designed to control and prevent
the incidence of cancer, made in the following
chapters, should take into account the judgements
and recommendations of authoritative reports
related to the prevention and control of other
diseases. Any potential conflicts that might arise
between its own recommendations and others that
cover the same aspects of food, nutrition, and
physical activity are identified in this chapter.
As stated in its title, the present Report has a
global perspective. The importance of dietary issues
related to chronic diseases, relative to those for
nutritional adequacy and infectious diseases, varies
both between countries and between
subpopulations within countries. The approach taken
by this Report, to consider recommendations from
other reports, is particularly relevant for those parts
of the world now suffering the double burden of
endemic deficiencies and infection especially of
infancy and childhood as well as increasing
incidence of cancers of various sites, and of other
chronic diseases. Nevertheless, people, as well as
public health authorities, need integrated messages.
In Chapter 12 we state whether any recommendation
is affected as a result of the findings of other such
reports.
This chapter has also assembled the findings of
other recent reports on food, nutrition, physical
348
C H A P T E R 1 0 F I N D I N G S O F O T H E R R E P O R T S
Dietary guidelines produced by expert bodies have been part 10.1 Method
of national and international public health nutrition policies
since the early 20th century. At first, the recommended This chapter is based on a systematic review of secondary
dietary intakes for the planning of food supplies were literature that examines recommendations for dietary and
designed to prevent specific nutritional deficiencies. From physical activity produced since 1990 for the prevention of
the 1960s, a different type of guidance began to emerge, a number of diseases. Therefore, this chapter carries forward
designed to prevent food and nutrition-related chronic the work of the 19611991 review. The purpose is to give
diseases, including heart disease and cancer. an account of the recommendations of other reports and not
A previous review analysed the findings of 100 expert to assess the evidence therein. The full systematic literature
reports published between 1961 and 1991 that include review is contained on the CD included with this Report.
guidelines and recommendations to prevent various chron-
ic diseases.1 Some of the landmark reports produced over 10.1.1 Diseases and exposures
this period are The Causes of Cancer,2 The US Surgeon The diseases in this present review are categorised as nutri-
Generals Report on Nutrition and Health,3 Nutritional Goals tional deficiencies, infectious diseases, chronic diseases other
for Health in Latin America,4 Medical Aspects of Dietary than cancer, and cancer. These are diseases identified by the
Fibre published by the Royal College of Physicians of United Nations and other authoritative bodies as being
London,5 and Diet and Health and Diet, Nutrition, and causally linked with food, nutrition, and physical activity.
Cancer published by the US National Research Council.6 7 They are also identified as significant contributors to the
Towards the end of this 30-year period, dietary guidelines global burden of preventable disease in terms of prevalence
to prevent chronic diseases tended to move the emphasis and cost.
away from dietary constituents (such as saturated fat or vit- The exposures covered in this review are those identified
amins). Instead, the focus shifted to foods and drinks, and in the report that preceded this one8 as convincing or prob-
sometimes to dietary patterns as a whole. able modifiers of cancer risk together with those judged
The 19611991 review1 shows consistent agreement on by other reports to justify a recommendation designed to pre-
the types of diet recommended to protect against obesity, car- vent or control other diseases. The reports analysed include
diovascular disease (CVD), cancer of a number of sites, type recommendations on relevant foods and drinks (including
2 diabetes, gut disorders and diseases, osteoporosis, dental food production, preservation, processing, and preparation),
caries, and other chronic diseases. Compared with diets typ- and dietary constituents, physical activity, and energy
ically consumed in high-income countries, the recommend- balance.
ed diets are high in wholegrain or minimally processed
cereals (grains), vegetables and fruits, and are therefore high 10.1.2 Reports reviewed
in dietary fibre and bioactive microconstituents, relatively The reports reviewed were published between 1990 and
high in fish, and contain lean meat. These recommended 31 December 2004 in the English language. To be included
diets are also correspondingly low in total fat and saturated in the review, reports needed to:
fatty acids, sugars, and salt; fatty and salty foods; sugary Involve an expert panel
foods and drinks in general; and alcoholic drinks. The review Include an original review of relevant literature
also shows that the expert reports consistently recommend Include explicit disease-specific conclusions and
regular, sustained, physical activity. recommendations
However, almost without exception, expert reports on Base their conclusions on published peer-reviewed
chronic diseases treated these issues independently to those literature specified as a bibliography.
of nutritional adequacy (and the prevention of nutritional
deficiencies), or of the prevention and management of infec- This approach eliminated reports that simply restated pre-
tious diseases, notably of infancy and childhood, and vice vious recommendations. It also ensured that the review
versa. The separate consideration of these issues usually included only reports with the main aim of developing or
reflected the focus either on national concerns in high- updating nutrition-related recommendations. Reports
income societies, or the specific interests of specialists. commissioned by industry, business-interest organisations, or
349
P A R T 2 E V I D E N C E A N D J U D G E M E N T S
other interested parties were excluded. review alcohol, food additives and contaminants, or breast-
The criteria used for and timing of this review meant that feeding. For such reasons, most reports say nothing about
some important reports were not included. The Panel is aware many of the aspects of food, nutrition, and physical activity
of these exclusions and has supplemented the text where addressed in this Report. The summary below states where
such an omission would have given an incomplete picture. there is significant disagreement between reports. The Panel
Of more than 10 000 documents identified initially by data- decided not to include a tabulated summary of the recom-
base searches, applying these criteria reduced the mendations from reports on cancer because, in view of our
number to 207. All of these reports were read and 94 were own Report, this would be non-contributory.
included in the review: 16 reports from international organ- Until recently, few reports have used a systematic approach
isations,8-23 39 from North American organisations,24-62 22 to assess the prevention of nutritional deficiencies in gener-
from the European Union,63-84 14 from Australasia,85-98 al. Although it has been established that vulnerability to
2 from India,99 100 and 1 report from South Africa.101 The infectious diseases especially of infancy and childhood
recommendations in the 113 that were finally excluded are is crucially affected by nutritional status, only in the past few
generally consistent with those in the included reports. years has there been an extensive analysis and a coherent
The Panel is aware that other important reports have been approach to the recognition of the role of individual micronu-
published, which were either published subsequent to the trients such as vitamin A, zinc, and selenium in reducing life-
review for this chapter or did not meet the criteria for inclu- threatening infections, for example, of the respiratory and
sion. The organisations that produced these reports are: the gastrointestinal tracts, which continue to exact a huge bur-
American Cancer Society,102 the International Agency for den of disability and premature death.
Research on Cancer,103 the National Institute for Health and Many reports concerned with food, nutrition, and physi-
Clinical Excellence,104 and the US Department of Health and cal activity also stress the importance of not smoking or using
Human Services and the Department of Agriculture,105 and tobacco. This information is not included here.
the National Heart, Lung and Blood Institute and the World
Health Organization.106 106B The recommendations from
these reports were also taken into consideration during the 10.3 Nutritional deficiencies
formulation of the recommendations for this Report.
10.3.1 Background
Undernutrition and hunger remain common in parts of the
10.2 Interpretation of the data world where populations are impoverished and food is inse-
cure, largely for social (including political and economic) and
Some caution is needed when interpreting the information environmental reasons. Global rates of malnutrition (inade-
presented here. Most of the reports included have been com- quate energy intake) and micronutrient deficiencies remain
missioned by and for high-income countries and so reflect high, especially in low-income countries.
the nutrition concerns of such countries. Producing these Many diseases are caused by deficiencies of specific or
reports is expensive and is likely to be beyond the means of combined essential nutrients. These diseases, when severe
most individual middle- and low-income countries. Where a and prolonged, can be fatal. In the 1990s, relevant UN agen-
recommendation is made for diets high in vegetables and cies specified that certain micronutrient deficiencies were the
fruits, for example, this means high in relation to the diets most important global public health problems.107 108 Those
typical of high-income countries. Meeting such recommen- identified included deficiencies of iron (causing anaemia, las-
dations might mean increases in intake in some countries and situde, and learning difficulties), iodine (causing goitre and
maintaining already high intakes in others. Recommend- cretinism), and vitamin A (causing xerophthalmia, impaired
ations for vegetables and fruits usually do not include pota- night vision, and eventually blindness).
toes, which are generally grouped with roots and tubers (see Infants, young children, and pregnant and lactating
chapter 4.1.1). women have been, and remain, the main focus of recom-
Many of these reports are concerned with what are now mendations designed to prevent and control nutritional
pandemic diseases of the circulatory system (ischaemic heart deficiencies. Recommendations for combating specific defi-
and cerebrovascular diseases and their determinants such as ciencies include programmes of salt iodisation (iodine); con-
obesity, high levels of blood fats, and high blood pressure). sumption of foods containing readily absorbable iron,
Fewer reports are concerned specifically with cancer or dis- including meat and other foods of animal origin (iron); and
eases of other systems of the body, although an increasing consumption of foods high in carotenoids or retinol (vitamin
number now link obesity with type 2 diabetes, and cancer. A). Supplementation and fortification are also recommend-
Only a minority of the reports reviewed attempt to be com- ed.107 108 Other recommendations continue to promote exclu-
prehensive, and the terms of reference of these reports may sive breastfeeding, as well as the supply of adequate and
be limited. For example, of the 15 reports addressing can- varied weaning foods (preferably indigenous or local), and
cer, just 4 are concerned solely with cancers in general. Of water and food free from infectious agents.
the rest, 4 focus on chronic diseases including cancer, 2 are A number of trials and systematic analyses have assessed
concerned only with colorectal cancer, 2 with vitamin sup- the value of interventions with micronutrients. The results
plementation, 1 with oral health, 1 with childrens health, are sometimes different when tested in African, Asian, or
and 1 with fats and oils. Also, some reports on cancer do not Latin American children, and this probably reflects the
350
C H A P T E R 1 0 F I N D I N G S O F O T H E R R E P O R T S
different prevailing nutritional conditions. The results and reports on cancer and other chronic diseases do
emphasise the importance of ensuring that micronutrient not recommend diets without red meat.
intakes are adequate and that dietary factors that enhance The Panel agrees that these matters of emphasis and
micronutrient status form an important part of the diet of considerations should be taken into account in its
both children and adults, with particular attention being paid recommendations. See Chapter 12. Also see the Panels
to women before and during pregnancy. conclusions in 10.7.
10.3.2 Introduction
Few reports concerning nutritional deficiencies qualified for 10.4 Infectious diseases
inclusion in this review. Of the 95 included, 2 make recom-
mendations on preventing rickets,28 52 4 on preventing iron 10.4.1 Background
deficiency anaemia,11 13 51 92 and 4 on preventing vitamin A Vulnerability to a number of common infectious diseases is
deficiency.14 19 21 79 These reports come from 10 different affected by nutritional status; this is especially important in
organisations: 1 from Europe, 6 from international agencies, infants and young children.109 Interaction between nutrition
and 3 from North America. No reports were included whose and infection occurs with classic malnutrition inadequate
recommendations relate to malnutrition in general, or to energy from food and also with deficiencies of a range of
iodine deficiency. vitamins and minerals. Relevant diseases include diarrhoeal
diseases, respiratory infections, measles, whooping cough,
10.3.3 Foods and drinks and chickenpox.109 On a global basis, rates of dangerous
Vegetables, fruits, pulses (legumes), nuts, seeds, herbs, infectious diseases especially of infancy and childhood
and spices. Three reports recommended that various remain high, particularly in low-income countries. Con-
vegetables and fruits being those high in vitamin C versely, repeated infections impair nutritional status,
and folates should be included with meals to boost particularly during childhood.
iron absorption and hence prevent iron deficiency The usual recommendations in previous reports concern-
anaemia.11 13 51 Another report recommended that the com- ing food, nutrition, and infectious diseases of infants and
plementary diets of infants and young children should include young children have been for exclusive breastfeeding, ade-
vegetables and fruits high in vitamin A to prevent vitamin A quate and varied weaning foods (preferably indigenous or
deficiency.21 local), and water and food supplies free from infectious
agents.107
Meat, fish, and eggs. One report recommended including
foods that are high in absorbable iron, such as lean meat, to 10.4.2 Introduction
prevent iron deficiency anaemia.51 Few reports concerned with infections qualified for inclusion
in the review. Of the 95 reports accepted, 3 included rec-
Dietary constituents and supplements. For vitamin C, folic ommendations for the prevention or management of diar-
acid, and iron, see chapter 4.10. Also, one report recom- rhoea,10 17 91 3 for the management of HIV and AIDS,9 12 25
mended that after the age of 6 months, infants receiving 1 for the management of measles,85 and 1 for respiratory dis-
breastmilk or cows milk as their main drink, or those con- eases.91 These 7 reports were published by 6 organisations:
suming less than 500 ml/day of infant or follow-on formu- 2 from Australasia, 3 from international agencies, and 1 from
la, should receive a vitamin A supplement to prevent vitamin North America. No reports were found that make dietary
A deficiency.79 Two reports include recommendations for vit- recommendations to help prevent or manage dysentery,
amin A supplementation,14 19 and two recommended vitamin malaria, or tuberculosis.
D to prevent rickets.28 52
10.4.3 Foods and drinks
Breastfeeding. One report recommended that mothers Cereals (grains), roots, tubers, and plantains. One report
should breastfeed exclusively for the first 46 months of their recommended that people with HIV or AIDS should include
childs life to prevent iron deficiency in the child.19 staple foods with every meal.9 This report specified refined
starchy foods such as white rice, maize meals, white bread,
10.3.4 Comparison of reports noodles, and potatoes to avoid gastric aggravation.9
One difference in emphasis between these reports and those
on cancer (and other reports not included in the review) is Vegetables, fruits, pulses (legumes), nuts, seeds, herbs,
the stress given to the importance of extended, exclusive and spices. One report recommended that people with HIV
breastfeeding (see 10.4.3), and the importance of safe water or AIDS should eat a wide variety of vegetables, fruits, and
supplies. pulses (legumes) every day.9
Differences in recommendations for supplementation of
diets of infants and young children are not substantial. Meat, fish, and eggs. One report recommended that
An apparent difference between these reports, and those people with HIV or AIDS should eat meat, poultry, and
on cancer and other chronic diseases, is the recommenda- fish regularly.9 It advised that meat should be cooked
tion to consume meat as a source of absorbable iron to pre- thoroughly, and foods containing raw eggs avoided, to
vent anaemia. However, only modest amounts are proposed, prevent diarrhoea.9
351
P A R T 2 E V I D E N C E A N D J U D G E M E N T S
Milk and dairy products. One report recommended that The Panel agrees that these matters of emphasis should be
people with HIV or AIDS should consume milk products taken into account in its recommendations. On the impor-
regularly.9 tant issue of mothers with HIV or AIDS, the Panel endorses
the position of the WHO that exclusive breastfeeding is rec-
Fats and oils. One report recommended that people with ommended for HIV-infected women for the first 6 months
HIV or AIDS should include fats and oils in their diet to of life unless replacement feeding is acceptable, feasible,
maintain their weight.9 affordable, sustainable and safe for them and their infants
before that time. Also see Chapter 12.
Salt and sugar. One report recommended that people with Many of the specific recommendations to protect against
HIV or AIDS should include sugar and sugary foods in their deficiencies and infections in these reports (and others) are
diet to maintain their weight.9 in harmony with those designed to prevent chronic diseases;
few are inconsistent. On salt and the prevention of goitre,
Water, fruit juices, soft drinks, and hot drinks. One report and meat/iron and the prevention of deficiency, and the pro-
recommended that people with HIV or AIDS should drink motion of physical and mental health, see 10.5.7.
plenty of clean and safe water. If in doubt, and during an The recommendations made by the Panel in Chapter 12,
episode of diarrhoea, water should be boiled before use, and when these take into account prevention of nutritional defi-
coffee and tea avoided.9 ciencies and infectious diseases, are based additionally on
the expert judgement of Panel members experienced in these
Food production, processing, preservation, and prepara- areas. Many such reports were excluded by the criteria for
tion. Also see 10.5.3. Two reports made recommendations inclusion for systematic review. These usually emphasise the
on preventing diarrhoea: contaminated food and drink need for food security the constant availability of ade-
should be avoided; clean utensils should be used during quate, appropriate, and nourishing food. This fundamental
preparation and serving; and food should be stored safely priority does not contradict the findings of reports concerned
and served immediately after preparation.10 17 One of these with chronic diseases. Similarly, reports concerned with
reports also recommended that foods should be covered and deficiencies and infections, especially of infancy and child-
refrigerated where possible, for the same reason.17 Similarly, hood, emphasise the need for safe water (and safe water
another report recommended storing fresh food and leftovers supply and reliable sewage systems). This also does not
in a cool place or a refrigerator.9 Two reports recommended contradict the findings of reports concerned with chronic
that foods should be cooked thoroughly and leftovers reheat- diseases.
ed to a high temperature to prevent diarrhoea.9 17
Dietary constituents and supplements. One report rec- 10.5 Chronic diseases other than cancer
ommended that some people with measles should receive
vitamin A supplements.85 10.5.1 Background
In general, chronic diseases such as obesity, type 2 diabetes,
Breastfeeding. Three reports recommended that women and cardiovascular disease (CVD), as well as some cancers,
should breastfeed exclusively for the first 46 months of their appear to have been uncommon, even in older people, until
childs life to prevent the child having diarrhoea.10 17 91 Of recent history. With urbanisation and industrialisation, they
these, one further advised non-exclusive breastfeeding up to have become more prevalent, even among younger people.
2 years of age and beyond if possible.17 Another report made It is now generally accepted that the main causes of chron-
the same recommendation to prevent respiratory disease in ic diseases are environmental factors, including inappropri-
the infant.91 Two reports recommended that women infect- ate food and nutrition, and physical inactivity.
ed with HIV should avoid breastfeeding where possible to Expert reports concerning the impact of unbalanced food
prevent transmission of the virus to their child, and should and nutrition on the risk of chronic diseases began to appear
cease breastfeeding as soon as is feasible.12 25 One report in the 1970s.110 At first, these were concerned mostly with
recommended that clean, nutritious weaning foods should coronary heart disease (CHD), which had become the most
be introduced to an infant at 46 months of age, beginning common cause of total and premature mortality in various
initially with soft mashed foods to prevent the child high-income countries. Later reports began to consider other
having diarrhoea.17 chronic diseases, or chronic diseases in general. For exam-
ple, a report published by WHO in 1990 considered that a
10.4.4 Physical activity number of diseases could be prevented by appropriate food
One report recommended that people with HIV or AIDS and nutrition. These include cerebrovascular disease, CHD,
should take light exercise.9 dental caries, type 2 diabetes, obesity, osteoporosis, various
cancers, and various gut disorders.111
10.4.5 Comparison of reports Forty-two reports published mostly in high-income coun-
As with reports on nutritional deficiencies, one difference in tries between 1973 and 1988 were reviewed in 1990.111
emphasis between these reports and those on cancer is the These made recommendations for reducing the risk of chron-
stress given to the importance of extended, exclusive breast- ic diseases. They proposed that changes in consumption of
feeding and the importance of safe water supplies. certain foods and drinks were causing the rise in chronic
352
C H A P T E R 1 0 F I N D I N G S O F O T H E R R E P O R T S
diseases, as was physical inactivity. They identified foods and 10.5.3 Foods and drinks
drinks relatively concentrated in total fat and saturated fatty Cereals (grains), roots, tubers, and plantains. Fourteen
acids, sugar and salt, and alcohol, as well as diets low in rel- reports recommended including wholegrain cereals in the
atively unprocessed grains and other starchy foods, vegeta- diet.16 18 24 36 40 41 43 66 70 78 91 92 95 98 Four of these recommended
bles and fruits, and dietary fibre. Later reports noted that that people should consume 36 servings per day to prevent
obesity and type 2 diabetes in particular were becoming CVD,36 40 78 98 and those at risk of CVD should eat 612 serv-
more common in middle-income countries, and that these ings per day.98 Three recommended that people should limit
diseases were no longer diseases of affluence. their intake of refined carbohydrates, particularly from cere-
More or less the same dietary recommendations were als (grains).36 41 98
made for the prevention of all of these chronic diseases,
including cancer.1 For high-income countries, this has been Vegetables, fruits, pulses (legumes), nuts, seeds, herbs,
summarised as diets with: moderately low levels of fat, with and spices. Sixteen reports recommended consuming rela-
special emphasis on restriction of saturated fatty acids and tively high amounts of vegetables and fruits22 35 36 40 69 70 73
cholesterol; high levels of complex carbohydrates; only mod- 75 77 78 80 91 92 95 98 100
with 13 recommending at least 400 g
erate levels of protein, especially animal protein; and only per day (at least 5 servings).22 35 36 40 69 73 75 77 78 83 95 98 100
low levels of added sugars.7 Eleven reports recommended the consumption of pulses
Global population average nutrient goals for the preven- (legumes).16 22 24 36 37 41 43 70 88 91 98
tion of chronic diseases were published by WHO in 1990 as
follows: total fats 1530 per cent, saturated fats 010 per Meat, fish, and eggs. Eight reports recommended that con-
cent, and polyunsaturated fatty acids 37 per cent of total sumption of red meat should be moderated and lean meat
energy intake; cholesterol 0300 g/day; sugar 010 per cent preferred (unspecified amount).16 24 40 41 66 78 98 101 Seven
of total energy intake; salt less than 6 g/day; starch/complex reports recommended including fish in the diet.16 24 41 43 66 80
carbohydrates 5070 per cent of total energy intake; dietary 91
Nine reports recommended consuming oily fish.22 39 40 72
fibre 2740 g/day; and dietary protein 1015 per cent of 78 80 91 93 98
Eleven reports recommended that people should
total energy intake.111 consume 13 servings of fish a week.22 30 39 40 70 72 78 83 93 96 98
Two reports recommended that egg consumption should be
10.5.2 Introduction limited.16 98
This section presents the recommendations made since 1990
on chronic diseases other than cancer. Of the 95 reports Fats and oils. Twenty-five reports recommended that total
reviewed, 60 made recommendations relating to the pre- dietary fat intake should be limited.8 22 24 26 34 35 46 53 56 62 64 69
vention of obesity, type 2 diabetes, or CVD. These were pro- 70 77 78 80 84 87 89 91 94 98-101
Thirty-three reports recommended
duced by 34 different organisations: 6 from Australasia, 10 that intake of saturated fatty acids should be limited.8 16 22 24
from Europe, 2 from India, 2 from international agencies, 13 26 30 31 34-36 40 41 43 53 56 62 63 66 69 70 76-78 80 88 89 91 94 95 98-101
Three
from North America, and 1 from South Africa. Of these, 33 reports recommended that dietary fat intake should not be
discussed the prevention of CVD in general,16 22 30 32 34 36 37 restricted in children under 2 years of age.26 41 83 Seven reports
39-47 57 61-63 68 69 71 72 77 78 80 84 91 92 94 97 98
24 the prevention of recommended moderate intake of polyunsaturated fatty
CHD,8 22 24 26 30 35 36 53 62 64 66 73 75 81 88 91-93 95-97 99-101 14 the acid.24 30 35 66 70 80 93 One report recommended that if total fat
prevention of type 2 diabetes,22 30 31 45 53 57 62 69 76 77 88 89 91 92 intake is restricted, people who are inactive and overweight
8 the prevention of dyslipidaemia,16 30 53 57 77 87 91 98 16 the should still include some polyunsaturated fatty acids in their
prevention of hypertension,16 22 30 34 36 44 46 56 57 62 69 71 88 91 92 diet to prevent CHD.98 One report recommended that n-6
98
12 the prevention of overweight/obesity,8 16 18 22 27 53 62 69 fatty acids should form 58 per cent of energy intake to pre-
76 91 92 98
and 11 the prevention of stroke,30 36 38 40 42 62 70 77 88 vent stroke,70 while another suggested they should form 48
91 111
Nine reports included recommendations to prevent per cent to prevent CVD.69 One report recommended that to
osteoporosis22 23 33 48 58 59 88 91 92 and 10 to prevent dental prevent CHD, linoleic acid should make up no more than 10
caries.22 49 50 52 53 65 69 74 91 92 Two reports referred to the per cent of total energy, at a ratio of between 5:1 and 10:1
prevention of skeletal disorders in general30 82 and 3 to the with alpha-linolenic acid.8 Five reports recommended the
prevention of dental diseases in general.62 79 88 These have consumption of n-3 fatty acids.70 72 80 91 93 Two reports rec-
been produced by 16 different organisations: 1 from ommended that eicosapentaenoic acid and docosahexaenoic
Australasia, 4 from Europe, 1 from an international agency, acid should be included in the diet.23 39 Nine reports recom-
and 10 from North America. Some 5 reports made recom- mended restricting intake of trans-fatty acids.22 30 36 40 41 43 69
mendations to prevent gut diseases and disorders, produced 83 98
Three reports recommended restricting the combined
by 4 organisations: 2 from Australasia, 1 from Europe, and intake of trans- and saturated fatty acids.93 97 98 Four reports
1 from North America. Of these, 3 referred to the prevention recommended limiting the intake of hydrogenated, vegetable,
of constipation,9 60 91 2 to the prevention of diverticular and partially hydrogenated fats.24 62 66 91 Three reports rec-
disease,91 92 and 1 to the prevention of Crohns disease92 and ommended restricting myristic acid intake (including coconut
ulcerative colitis.92 Recommendations regarding food products).66 91 101
intolerances were found in 4 reports,79 86 91 92 of which 1 was
concerned with lactose intolerance88 and 1 with coeliac Salt and sugar. Twenty reports recommended that salt
disease.92 intake should be limited to no more than 6 g/day for
353
P A R T 2 E V I D E N C E A N D J U D G E M E N T S
354
C H A P T E R 1 0 F I N D I N G S O F O T H E R R E P O R T S
10.5.5 Growth, development, body composition lished since 1990 on food, nutrition, physical activity, and the
Two reports recommended that people should avoid being prevention of chronic diseases, which reinforce the findings
underweight to prevent skeletal disorders, including of earlier, less formally conducted work. The main evidence-
osteoporosis.23 82 based recommendations made by expert reports on cancer,
and by reports on chronic diseases other than cancer, are
10.5.6 Weight gain, overweight, obesity mostly harmonious and often practically identical. This in-
Fifteen reports recommended that a body mass index (BMI) cludes reports on obesity, type 2 diabetes, CVD, and disorders
of less than 25 is healthy.35 36 38 40 41 43 46 56 62 69 80 91 96 98 101 Eight of the digestive system, osteoporosis, and dental diseases.
of these reports specified a BMI range of 18.524.9.35 38 40 43
46 56 62 91
Two reports recommended a BMI range of 18.523
for Asian people.99 100 Twelve reports recommended that peo- 10.6 Cancer
ple should achieve and maintain a healthy weight.16 18 23 34 41
46 62 69 82 91 98 111
Six reports recommended that people should 10.6.1 Background
lose weight if they have a BMI of 25 or above.34 40 44 46 77 78 Throughout recorded history, cancer has been attributed
One report recommended that people who are overweight or at least in part to food and nutrition, as well as to other
obese should lose 510 kg to prevent CHD.73 One recom- environmental factors. Until the beginning of the 20th
mended that overweight people at risk of type 2 diabetes century, high consumption of meat and salt, and low
should lose 510 per cent of their bodyweight to prevent this consumption of bulky plant foods, vegetables, and fruits
disease.31 Nine reports recommended that men maintain a were thought to increase the risk of cancer in general. In the
waist circumference of no more than 40 inches (102 cm) and first two thirds of the 20th century, a series of laboratory and
women no more than 35 inches (89 cm).34-36 40 43 44 78 89 98 Two ecological studies found that energy restriction protected
recommended that Asian men should have a waist to hip ratio against cancer in laboratory animals, and that diets low in
of not more than 0.88; for Asian women this should not exceed fibre and high in meat, fat, salt, salty foods, and/or alcoholic
0.85.99 100 Three reports recommended that people should drinks seemed to increase the risk of some cancers in
limit their intake of energy-dense foods.36 62 89 particular.15
From the late 1970s, reports began to be published that
10.5.7 Comparison of reports summarised the scientific literature on food, nutrition, and
There is one significant difference between the reports that cancer, and provided dietary recommendations for the pre-
focus specifically on cancer (see 10.6) and those concerned vention of cancer. Between 1977 and 1989, 12 such reports
with chronic diseases other than cancer. The discussion in a were published in, or for, Canada (1), Europe (2), Japan (1),
number of these reports noted the evident protective effect Latin America (1), and USA (7). These reports have been
of modest alcohol consumption against CHD (but not cere- reviewed previously.1 They tended to recommend relatively
brovascular disease or other chronic diseases). However, no high consumption of cereals (grains), vegetables, and fruits
report included in this review explicitly recommended the (and so of dietary fibre and micronutrients); relatively low
consumption of alcoholic drinks. consumption of red meat, and smoked and cured meats; low
There are some significant differences at least in empha- consumption of salted and salty foods; low or no consump-
sis between reports that make recommendations to pre- tion of alcoholic drinks; maintenance of a healthy body
vent chronic diseases other than cancer, and those that make weight; and regular physical activity.
recommendations for preventing cancer specifically. Reports
concerned with preventing chronic diseases other than can- 10.6.2 Introduction
cer, particularly CVD, give more prominence to the impor- Following this work, this section presents the recommenda-
tance of diets high in cereals (grains) preferably tions made for controlling and preventing cancer since 1990.
wholegrain or minimally processed as well as diets high The order of the passages below follows that of the contents
in vegetables, fruits, and fish. High-fat milk and dairy prod- of the present Report. Overall, of the 95 reports reviewed,
ucts are judged to increase the risk of CVD, but these foods 15 include recommendations on preventing cancer. These
are not thought to be a major factor in the development of reports have been produced by 12 different organisations: 1
cancer. from Australasia, 3 from Europe, 5 in or for North America,
The iodisation of salt supplies, which is necessary to prevent and 3 from international agencies. There are no such reports
goitre, need not be in conflict with recommendations on max- from middle- or low-income countries. Of the 15 reports, 12
imum levels of salt intake. Recommendations to limit con- present recommendations relating to the prevention of can-
sumption of red meat need not conflict with recommendations cer in general 8 15 22 29 47 61 62 67 83 88 91 92 and 11 of these also
for iron intake to prevent clinical and subclinical deficiency, make recommendations on preventing site-specific cancers.
and to promote physical and mental development. These include cancers of the bladder (3)15 88 91; breast (7)15
The Panel agrees that these differences and considerations 29 62 67 88 91 92
; 2 for cervix, endometrium, kidney, larynx, liver,
be taken into account in its recommendations which, when nasopharynx, oesophagus, pancreas, and stomach15 67; colon
they are based partly on findings on diseases other than can- and rectum (9)15 20 29 62 67 88 90-92; lung (3)15 47 67; mouth/phar-
cer, are clearly identified as such. See Chapter 12. ynx (3)15 65 67; and 1 for ovary and prostate.15 The recom-
In general, the Panel notes the impressive consistency of find- mendations summarised in this section (10.6) are for
ings apparent from a systematic review of expert reports pub- preventing cancer in general, unless stated otherwise.
355
P A R T 2 E V I D E N C E A N D J U D G E M E N T S
The table below summarises recommendations from reports published since 1991 for the management, control, and prevention of chronic diseases, nutritional
deficiencies, and relevant infectious diseases. Recommendations related to cancer are not included here. Unless indicated otherwise, there is no disagreement
between reports. To present the findings of the review more easily, recommendations have only been included if they are made in three or more reports.
However, the Panel does not intend this as a measure of the quality of the recommendations themselves. For more detailed information, please refer to the
appropriate sections in this chapter.
Cereals (grains), roots, Include wholegrain cereals in the diet (unspecified amount) CVD,36 41 43 78 98 CHD16 24 66 91 92 95
tubers, and plantains
Suggested intake of 36 or more servings/day of wholegrain cereals CVD36 40 78 98
Foods high in iron should be eaten in combination with foods that enhance Iron deficiency anaemia11 13 51
rather than inhibit iron absorption: cereals (grains) should be consumed with
meals of low iron content, and foods high in ascorbic acid, such as tubers,
should be included with meals
Vegetables, fruits, pulses Include 400 g (5 or more servings)/day of vegetables and fruits CVD,36 40 69 77 78 80 98 111 CHD,35 40 73 75 95 100 111
(legumes), nuts, seeds, hypertension35 36 73 95 100 111
herbs, and spices
Include pulses (legumes) in the diet (unspecified amount) CVD,36 41 43 91 98 CHD16 24 88
Foods high in ascorbic acid, such as orange juice, carrots, and cauliflower, Iron deficiency anaemia11 13 51
should be included with meals
Meat, fish, and eggs Red meat consumption should be moderated and lean meat preferred CVD,16 40 41 78 98 CHD24 66 101
(unspecified amount)
Fats and oils Limit intake of hydrogenated/partially hydrogenated vegetable oils CHD24 62 66 91
and hard margarines (unspecified amount)
Total dietary fat to provide no more than 35% of total energy CHD,8 53 66 overweight/obesity22 53 69
Total dietary fat to provide no more than 30% of total energy CVD,22 69 78 CHD24 26 34 35 62 64 101
Dietary fat intake should not be restricted In children under 2 years of age26 41 80
Intake of saturated fat should be no more than 7% of energy CVD,34 36 41 43 44 CHD,35 99 100 people with,
or at risk of, CVD or with elevated LDL
cholesterol (including those with
diabetes)31 34-36 40 41 43 44
Intake of saturated fatty acid intake should be limited (unspecified amount) CHD53 88 98
Limit intake of dietary cholesterol to <200 mg/day CVD in people with diabetes, people at
risk of, or with pre-existing, CVD or those
with elevated LDL cholesterol,34 36 41 43 44 63
CHD in people with diabetes, people at
risk of, or with pre-existing, CVD or those
with elevated LDL cholesterol35 64 101
Limit intake of polyunsaturated fatty acids to no more than 10% of energy CHD24 66 93 101
356
C H A P T E R 1 0 F I N D I N G S O F O T H E R R E P O R T S
Salt and sugar Limit intake of sodium to no more than 100 mmol/day Hypertension30 46 56 80 88
Limit/reduce sodium intake (unspecified amount) CVD in children at risk of CVD and in
adults with hypertension40 41 44 46
Limit/reduce consumption of salt and salted foods to no more CVD,16 36 40 41 63 69 71 80 91 CHD,35 73 80 100
than 6 g of salt/day hypertension,30 46 56 62 69 71 80 88 91 98
stroke40 70 80
Limit the proportion of energy in the diet from sugar (unspecified amount) CVD,36 41 98 overweight/obesity62 91 92
Avoid consumption of sugary foods and drinks between meals Dental caries22 65 74 92
Milk and dairy products Eat low-fat versions of dairy products in preference to high-fat versions CVD,16 36 40 43 46 80 98 CHD24 66 101
Water, fruit juices, soft Avoid using sugary drinks in baby bottles Dental disease49 65 92
drinks, and hot drinks
Alcoholic drinks Limit intake of alcoholic drinks to two drinks for men and CVD,22 36 40 44 46 77 97 CHD,31 73 75 88 96
one drink for women per day hypertension,31 46 56 62 91 stroke31 40 62 70 77 91
Food production, Limit/reduce intake of refined carbohydrates/grain products and foods CVD36 41 98
processing, preservation,
and preparation
Dietary constituents and Include fibre in the diet (unspecified amount) CVD36 69 98
supplements
Brush teeth with fluoride toothpaste twice daily Dental caries50 65 74
Women should breastfeed exclusively for 6 months Food intolerances in the infant27 79 91 92
BMI, body mass index; CHD, coronary heart disease; CVD, cardiovascular disease; LDL, low density lipoprotein
357
P A R T 2 E V I D E N C E A N D J U D G E M E N T S
358
P A R T 2 E V I D E N C E A N D J U D G E M E N T S
C H A P T E R 1 1
Research issues
The evidence of causal relationships between food, processed meat, and breastfeeding.
nutrition, physical activity, body composition, and Until recently, epidemiological and experimental
cancer is and always will be incomplete. New research studies were typically carried out
methods of research, and new issues to study, are separately, and with different objectives. But to be
always being developed. However, this ongoing convincing, epidemiological evidence, however
work does not mean that the response to every consistent, needs to be supported by concrete
question is more research is needed. The previous evidence of biological mechanisms. A promising
chapters in this Report show that in many areas, the development is an increased tendency for
evidence of causal relationships is already strong epidemiologists and basic scientists to work as team
enough to justify public health goals and personal members, to mutual benefit. Future research should
recommendations, which are specified in Chapter 12. encourage this.
This chapter outlines future strategic research One broad category of research, not reviewed for
directions that the Panel sees as especially promising this Report, concerns the underlying social
to build on this current base of knowledge. (including economic and political) and broad
In many areas, as shown in the matrices environmental determinants of patterns of food,
introducing each section of Chapter 7, the evidence nutrition, and physical activity. This area is also
may be suggestive but inconclusive. These particular critical to the successful translation of the
areas are those in which new efforts to answer knowledge of the causes of cancer into improved
research questions may be most likely to result in health. This crucially important aspect of research is
findings that can advance scientific knowledge or contained in a separate report dedicated to this
change public health practice. The research directions topic to be published in late 2008.
identified here are often cross-cutting and
interdisciplinary. These could increase understanding
of the cancer process, and provide new evidence to
clarify and strengthen the recommendations made in
Chapter 12.
There are also many fields of study that are only
now beginning to be explored. These include
exposures in early life including before birth that
affect birth weight, growth in childhood, age at
menarche, and attained adult height. They also
include interactions between food and nutrition and
other factors, notably smoking, inflammation, and
infectious agents. There is as yet relatively little
epidemiological research on broad patterns of diets,
and the inter-relationship between elements of
diets: more understanding here will enable
recommendations to be made with increasing
confidence.
More needs to be known about the levels of
exposure that are critical as modifiers of cancer risk,
and the extent to which risk is decreased or
increased at different levels. In some areas,
understanding will be improved by general
agreement on the nature and definition of
exposures; examples include physical activity,
360
C H A P T E R 1 1 R E S E A R C H I S S U E S
The principles applied when identifying the research How can the evidence for specific nutritional or
questions specified here are as follows: physical activity exposures in relation to cancer be
strengthened?
Interdisciplinary
The research directions discussed here are focused not on Exposures judged probable or limited suggestive in
issues that are specific to separate disciplines, such as the matrices of this Report are most promising as a focus
epidemiology or cancer biology, but on interdisciplinary of further research when evidence is scant. Examples of
issues and questions that concern the relationships such exposures include calcium and dairy products as
between cancer and food, nutrition, physical activity, and related to cancer of the prostate; vitamin D and cancer of
obesity. the colon; folate and cancers of the oesophagus,
pancreas, and colorectum; and selenium and cancers of
Important the lung, colorectum, and prostate. Those already judged
The benefit of conducting more research where the convincing, by their very nature, are less likely to be
evidence is already convincing and well understood is influenced by new research. Also, people are increasingly
likely to be small. Research that investigates areas where using non-traditional therapies, and these should also be
the evidence is unclear is likely to be of especial value. a topic for more systematic research.
Research is also of most value when the results have a Study design options include pooling of prospective
large potential impact on the overall burden of disease. data (especially for rarer cancers), longer follow-up of
This may be because the exposure under consideration has existing cohorts, investigations with biomarker
a potentially profound effect on cancer risk or because the measurements of intake and biomarker endpoints, and
cancer site in question is particularly common. new randomised controlled trials (RCTs).
Innovative
Research questions need to be practical and yet innovative, For exposures where strong evidence exists of a causal
which implies that they should not be constrained by relationship, what are the effect sizes with respect to
conventional wisdom. More innovative research is needed. timing, dose, and duration of exposure?
Investigators should be imaginative and collaborate across
disciplines, and be willing to engage in research The evidence currently available for various exposures
programmes most likely to benefit public health. and cancer risk is limited in terms of timing, dose,
duration, and size of effect. This kind of evidence is
important for healthcare providers and policy-makers to
make informed decisions on public health programmes,
and for people to make better-informed choices.
Box 11.1 Updating the evidence Study design options include pooling of prospective
Research findings continue to accumulate. This evidence needs data (especially for less common cancers), longer follow-
to be identified, analysed, and interpreted. The World Cancer up of existing cohorts, and obtaining more information
Research Fund International, together with the American on early life dietary exposures. This research direction
Institute for Cancer Research, the organisations responsible for applies to a number of the questions addressed in this
commissioning this Report, have now commissioned a process Report. For example, more information on timing, dose,
of continuous updating of the literature. This will be the basis and duration of exposure is needed on the effects of body
for periodic updates of this Reports findings. The process will size and fatness at different times of life in relation to
continue to make use of systematic literature reviews and is
future risk of breast cancer and colorectal cancer; the
being overseen by an international expert steering group,
effects of timing, dose, and duration of use of alcohol and
including members of the Panel responsible for this Report.
breast cancer risk; and detailed dose-response
361
P A R T 2 E V I D E N C E A N D J U D G E M E N T S
information on red meat and processed meat in relation Increasingly with greater understanding of the interplay
to colorectal and other cancers. of nutritional state and genetic expression, programmes
of study that incorporate elements of different disciplines
and technologies should illuminate the fundamental
How do environmental and genetic factors modify the processes underpinning dietcancer links.
effects of exposures on cancer risk?
Further investigation into the presence of effect Which genetic polymorphisms and nutritional
modification is needed to deepen understanding of risk exposures that influence gene expression are useful for
among different population groups and to help health understanding the relationship between nutrition or
professionals and policy-makers provide more precise physical activity and cancer?
recommendations. Factors that should be studied as
potential effect modifiers include tobacco, exogenous Certain genetic polymorphisms (genetic variants that
hormones, medications (such as non-steroidal anti- appear in at least 1 per cent of the population) may
inflammatory drugs), metabolising genes, genes increase, while others may decrease, the extent to which
associated with various cancers, and other food, nutritional factors affect cancer risk. Studying
nutrition, and body composition exposures. genenutrient interactions is likely to yield better results
as technology allows the simultaneous examination of
multiple genenutrient interactions, and as better
What mechanisms link foods and drinks, dietary systems evolve for synthesising the large amounts of data
constituents, or other nutritional and physical activity that are generated by these newer techniques.
factors to cancer risk? Genetic make up can impact the extent to which our
bodies respond to nutritional factors. Also, genes express
There is general agreement that nutritional factors, body themselves (or switch on) to varying degrees depending
composition, and physical activity are important on the nutritional environment. Understanding the extent
determinants of cancer risk. However, it has been difficult to which nutrients affect gene expression in such a way as
to identify with confidence the precise pathways whereby to impact on both cancer risk itself and the
such exposures influence the process of cancer nutrient/cancer risk relationship is very important.
development. Inevitably, the impact of nutrition will Examples of genenutrient interactions include N-
ultimately be at the level of DNA and gene expression, acetyl transferase and meat. In certain cases, genetic
but the ways in which this occurs, either via genetic polymorphisms (for example, MTHFR 677 TT for low
mutation or epigenetic events, is only now beginning to folate intake and LCT lactase persistence for dairy
be explored. There are many nutritional factors for which food intake) can act as proxies for nutritional exposures.
epidemiological data suggest that a relationship exists, This can be examined using a Mendelian randomisation
but where complete understanding of the biological study design, controlling for confounding factors. For
pathways is lacking. Examples include adiposity, physical example, the effects of folate may be demonstrated by
activity, height, red meat, processed meat, vegetables, looking at the differences in cancer outcome between
alcoholic drinks, lactation, arsenic, dairy products, and people who have the MTHFR gene variant that mimics
whole grains. low folate intake (MTHFR 677 TT) and people who do
Dietary constituents that are especially favourable to not. Carrying this form of the gene is unlikely to be
this type of mechanistic investigation include beta- related to other potential confounding factors such as
carotene, calcium, vitamin D, folate, selenium, polycyclic smoking or socioeconomic status.
aromatic hydrocarbons, and dietary fibre. Intermediate
biological mechanisms potentially relevant to mechanistic
understanding include inflammation, insulin resistance, Does weight loss in overweight or obese people reduce
growth factors, oxidation, gut flora, hormonal changes, cancer risk?
and various cellular metabolic and molecular processes.
Such mechanisms may vary by the histopathological and Body fatness and weight gain increase the risk of several
molecular characteristics of the tumours. Intermediate cancers. But the effects of weight loss on cancer risk are
markers may clarify questions of causation and serve as poorly understood. Study design options for investigating
surrogate endpoints for observational and intervention this question include model systems with caloric
studies. restriction and weight loss, human metabolic studies with
Study designs that may be useful to examine these intermediate endpoints, and cohort studies with explicit
questions include human metabolic studies with cancer- inquiries about intentional weight loss.
related endpoints and metabolic studies added onto
existing nutrient RCTs. Intermediate endpoints should be
incorporated into large, prospective, observational or What are the relevant milestones in the timing of growth
intervention studies to better understand their links to and development that affect cancer risk and how can
both nutritional factors and cancer endpoints. they be modified by food, nutrition, and physical activity?
362
C H A P T E R 1 1 R E S E A R C H I S S U E S
Critical periods for exposure to factors that lead to How do relationships between food, nutrition, and
increased cancer risk during the life course should be physical activity and cancer risk differ in various parts
identified. For example, high birth weight and rapid of the world?
growth in height during adolescence are both associated
with an increased risk of breast cancer. Some countries In areas of the world where patterns of cancer and
have extensive child and adolescent growth data that can patterns of diet are different, the relationship between
be examined in relation to cancer outcomes using nutrition and cancer risk can also vary. For example, in
registries. middle- and low-income countries, the inverse relation
between body mass and premenopausal breast cancer is
usually not seen. It could be that there are factors such as
How can factors related to food production, processing, genes, body composition, or physical activity that modify
preservation, and cooking methods, which may affect the effect of body mass on cancer risk in some
cancer risk, best be studied in humans? populations.
363
Part 3
, i V i ` >
Chapter 12
Public health goals and personal
recommendations 368
P A R T 3
Introduction to Part 3
RECOMMENDATIONS
The culmination of the five-year process resulting in this Report is Chapter 12, in
which the Panels public health goals and personal recommendations are
specified. These are preceded by a statement of the principles that have guided
the Panel in its thinking.
The goals and recommendations are based on judgements made by the Panel in
Part 2, as shown in the introductory matrices. Such judgements are of a
convincing or probable causal effect, either of decreased or increased risk.
Eight general and two special goals and recommendations are specified. In each
case a general recommendation is followed by public health goals and personal
recommendations, together with footnotes when further explanation or
clarification is required. These are all shown in boxed text. The accompanying
text includes a summary of the evidence; justification of the goals and
recommendations; and guidance on how to achieve them.
Reliable judgements are carefully derived from good evidence. But specific
public health and personal goals and recommendations do not automatically
follow from the evidence, however strong and consistent. The process of moving
from evidence to judgements and to recommendations has been one of the
Panels main responsibilities, and has involved much discussion and debate until
final agreement has been reached. The goals and recommendations here have
been unanimously agreed.
Food, nutrition, body composition, and physical activity also affect the risk of
diseases other than cancer. Informed by the findings of other reports
summarised in Chapter 10, the goals and recommendations have therefore been
agreed with an awareness of their wider public health implications.
The goals and recommendations are followed by the Panels conclusions on the
dietary patterns most likely to protect against cancer. As conventionally
undertaken, epidemiological and experimental studies are usually sharply
focused. In order to discern the big picture of healthy and protective diets, it is
necessary to integrate a vast amount of detailed information. This also has been
part of the Panels task.
The main focus of this Report is on nutritional and other biological and
associated factors that modify the risk of cancer. The Panel is aware that, as with
other diseases, the risk of cancer is critically influenced by social, cultural,
economic, and ecological factors. Thus the foods and drinks that people consume
are not purely because of personal choice; often opportunities to access
adequate food or to undertake physical activity can be constrained, either for
reasons of ill health or geography, economics, or equally powerfully, by culture.
366
There is a limit to what can be achieved by individuals, families, communities,
and health professionals.
Identifying not only the nutritional and associated factors that affect the risk of
cancer but also the deeper factors enables a wider range of policy
recommendations and options to be identified. This is the subject of a separate
report to be published in late 2008.
The members of the Panel and supporting secretariat, and the executives of the
WCRF global network responsible for commissioning this Report, have been
constantly reminded of the importance of their work during its five-year
duration. The public health goals and personal recommendations of the Panel
that follow are offered as a significant contribution towards the prevention and
control of cancer throughout the world.
367
P A R T 3 R E C O M M E N D AT I O N S
C H A P T E R 1 2
368
C H A P T E R 1 2 P U B L I C H E A LT H G O A L S A N D P E R S O N A L R E C O M M E N D AT I O N S
12.1 Principles
The recommendations presented in this chapter are activity is most appropriate and enjoyable depends on indi-
designed as the basis for policies, programmes, and vidual abilities and preferences, as well as the settings in
personal choices to reduce the incidence of cancer in which populations, communities, families, and individuals
general. These are guided by a number of separate live.
principles and also by one overall principle, which is, The Panel has taken the same approach in considering the
that taken together, the recommendations provide an recommendations altogether. As a whole, the recommen-
integrated approach to establishing healthy patterns of dations contribute to whole diets and overall levels of phys-
diet and physical activity, and healthy ways of life. ical activity most likely to prevent cancer. This does not
In order to be useful both for health professionals who imply one particular diet, or a specific form of physical activ-
advise on cancer, and for people who are interested in ity, but rather key elements designed to be incorporated into
reducing their own risk of cancer, the recommendations existing and traditional diets and ways of life around the
are quantified wherever possible and appropriate. world. This is emphasised in section 12.3 of this chapter, on
See box 12.1. patterns of food, nutrition, and physical activity.
12.1.3 Global
12.1.1 Integrated This Report has a global perspective. It is therefore appro-
The Panel, in making its recommendations, has been con- priate that the recommendations here are for people and
cerned to ensure that most people in most situations populations all over the world; that they apply to people
throughout the world will be able to follow its advice. The irrespective of their state of health or their susceptibility to
recommendations are framed to emphasise aspects of food cancer; and that they include cancer survivors.
and nutrition, physical activity, and body composition that Some factors that modify the risk of cancer are more com-
protect against cancer. They are also integrated with exist- mon, and so of more concern, in some parts of the world
ing advice on promoting healthy ways of life, such as that than others. It is possible that such factors might become
to prevent other diseases. At the same time, the Panel has more widespread, but the recommendations on them in this
given special attention to making recommendations that can Report are in the context of their current local importance.
form the basis for rational policies, effective programmes, Just as peoples susceptibility to cancer varies, so will the
and healthy personal choices. extent to which they will benefit from following these rec-
ommendations, though most people can expect to benefit
12.1.2 Broad based to some extent from each of them.
In assessing the evidence, making its judgements, and in Recommendations for whole populations are usually now
framing its recommendations, the Panel has, where appro- identified as also being of importance for people who, while
priate, chosen to take a broad view. It has also agreed to base not being clinically symptomatic, have known risk factors
its advice on foods and whole diets rather than on specific for disease. People at higher risk of various cancers include
nutrients. Thus, recommendations 4 and 5 concern plant smokers and people regularly exposed to tobacco smoke;
foods and animal foods in general, while their specific pub- people infected with specific micro-organisms; overweight
lic health goals and personal recommendations are mostly and obese people; sedentary people; people with high
concerned with vegetables and fruits, and then with red intakes of alcoholic drinks; people who are immunosup-
meat and processed meat, where the evidence on cancer is pressed; and those with a family history of cancer. Such peo-
strongest. ple are often at higher risk of diseases other than cancer.
The same applies to physical activity. The evidence shows The Panel agrees that the recommendations here apply to
that all types and degrees of physical activity protect or these people.
probably protect against some common cancers. Recom- They also apply to cancer survivors, meaning people liv-
mendation 2 therefore does not specify any particular phys- ing with a diagnosis of cancer, including those identified as
ical activity (of which sport and exercise are having recovered from cancer (see Chapter 9). This is sub-
one type). Rather, it recommends sustained physical activi- ject to important qualifications, stated in the special rec-
ty as part of active ways of life. What type of physical ommendations for this group of people.
369
P A R T 3 R E C O M M E N D AT I O N S
nd
se
ynx
use
ob rwei gain,
au
ty ght a
x
9
s
ryn
lar
triu
r
pa
gu
um
op
de
ove ight
no
ha
ha
as
nx,
en
ch
ph uth,
lad
me
te
ect
pre ast
po st
y
cre
me
sop
ma
sop
sta
stm
ary
ne
ary
We
llb
lor
do
g
esi
er
Mo
Bre
Bre
n
Lun
Pan
Pro
Kid
Sto
Oe
Ski
Na
Ga
Liv
Ov
En
Co
1 4
Includes evidence on foods containing Evidence is from milk and studies using
KEY carotenoids for mouth, pharynx, larynx; foods supplements for colorectum
containing beta-carotene for oesophagus; foods 5
Includes 'fast foods'
containing vitamin C for oesophagus 6
2 Convincing harm for men and probable harm for
Includes evidence on foods containing
Convincing Probable Probable Convincing carotenoids for mouth, pharynx, larynx and 7
women for colorectum
The evidence is derived from studies using
decreased decreased increased increased lung; foods containing beta-carotene for
oesophagus; foods containing vitamin C for supplements for lung
risk risk risk risk oesophagus 8
Includes evidence on televison viewing
3 9
Includes evidence from supplements for Judgement for physical activity applies to colon
prostate and not rectum
This matrix displays the Panels most confident judgements on the strength of the evidence causally relating food, nutrition, and physical
activity to the risk of cancer. It is a synthesis of all the matrices introducing the text of Chapters 4, 5, 6, 7, and 8 of this Report, but shows
only judgements of convincing and probable, on which the following recommendations are based. It does not show a detailed
breakdown of the individual foods, drinks, and their constituents. The full matrix, which also includes judgements of limited
suggestive, is on the fold-out section, which can be found inside the back cover of this Report.
In this matrix, the columns correspond to the cancer sites that are the subject of Chapter 7 and body fatness that is the subject of
Chapter 8. The rows correspond to factors that the Panel judges to be convincing or probable, either as protective against or causative
of cancer of the sites specified, or of weight gain, overweight, or obesity. Such judgements usually justify public health goals and
personal recommendations. The strength of the evidence is shown by the height of the blocks in this matrix see the key.
370
C H A P T E R 1 2 P U B L I C H E A LT H G O A L S A N D P E R S O N A L R E C O M M E N D AT I O N S
Public health professionals who advise on factors need to be taken into account. The body mass index, which does not derive
preventing cancer, including those respon- quantified recommendations are therefore from the evidence on cancer. The implica-
sible for planning food supplies or exercise based on the evidence but are also a mat- tion is that upper as well as lower limits
programmes (for example, for schools, hos- ter of judgement. may need to be recommended.
pitals, or canteens), or those working in For example, the evidence on alcoholic These quantified recommendations are
clinical settings, need to be able to give spe- drinks and breast cancer, as shown in chap- also guided by the ranges of foods and
cific, actionable, and relevant advice that ters 4.8 and 7.10, does not show any safe drinks, physical activity, and body composi-
includes prevention of cancer. threshold. The risk evidently increases, tion identified in the studies whose results,
To do this they need to know how much albeit modestly, at any level of intake of taken together, form the basis for the
of what foods and drinks, what levels of any alcoholic drink. And there is no nutri- Panels judgements. High and low limits can
body fatness, and how much physical activ- tional need to consume alcohol. So in this be set by simply following the ranges in the
ity are most likely to protect against cancer. case, the appropriate recommendation studies themselves, mostly cohort studies.
So do people in general, as members of based solely on the evidence for breast can- The case for doing this is quite strong;
communities and families, as well as indi- cer would be not to consume alcoholic this prospective evidence provides a robust
viduals. For these reasons, the personal drinks; the quantified recommendation basis for defining the dose response. On the
and public health goals in each of the rec- would be zero. other hand, many studies have been carried
ommendations are quantified wherever However, the integrated approach that out among populations who have only a
possible. guides these recommendations means that rather narrow range of dietary intakes, lev-
Translation of an overall body of current the Panel has taken into account evidence els of physical activity, and degree of body
evidence into quantified recommendations for a likely protective effect of modest fatness, which makes detection of associa-
is a challenge for all expert panels respon- amounts of alcohol against coronary heart tions difficult. Further, these ranges may
sible for recommendations designed to disease, and has not made this recommen- not themselves be optimal, and this makes
guide public policy, and professional and dation based only on the evidence for can- it difficult to define what is healthy. In such
personal decisions. This process is not and cer (see recommendation 6). cases, a recommended range based only on
cannot be an exact science. Within any In addition, in some cases, there is evi- the results of such studies would be flawed.
population, people differ from one anoth- dence for adverse effects unrelated to can- Ecological studies, which often address a
er, and there are differences between pop- cer risk that might help to quantify much wider range of intakes, were also
ulations as well. A single, numerical recommendations. Physical activity is a case part of this review and, though not central
recommendation is not able to encompass in point. The evidence, as shown in to the judgement of causality, nevertheless
these differing needs and so will necessar- Chapters 5 and 7, shows that high levels of inform the quantification of the recom-
ily be imprecise. all types of physical activity protect or may mendations.
Furthermore, the evidence rarely shows protect against some cancers, and also that As well as considering the evidence from
a clear point above or below which risk low levels increase the risk of these cancers. studies on cancer, the Panel, in common
changes suddenly. Rather, there is usually a But there is also evidence (not derived from with others, has also used its collective
continuous relationship between the expo- the systematic literature reviews), that knowledge of other relevant considerations
sure, be it body fatness, physical activity, or above certain high levels, which vary in making the quantified recommendations
level of consumption of a food or drink, depending on peoples general state of fit- in this chapter. It has also taken into
and cancer risk. The shape of this dose ness, physical activity can provoke an unde- account the ranges of intake of foods and
response may vary sometimes it is a sirable inflammatory response. drinks, and the ranges of advisable body
straight line, or it may be curved, for The Panel also used such an approach in composition and physical activity recom-
instance J-shaped or U-shaped. All of these considering the minimum limit for healthy mended in other reports.
12.1.6 Prevention of other diseases taken into that its recommendations are supported or reinforced.
account Occasionally, recommendations to prevent other diseases
Chapter 10 of this Report is based on a systematic review of include factors that evidently do not apply to cancer: for
secondary sources other reports on other diseases where example, saturated fatty acids, contained mostly in animal
the risk is modified by food and nutrition and related factors. foods, are accepted to be a cause of coronary heart disease,
These diseases are nutritional deficiencies; relevant infectious but have no special relevance to the risk of cancer.
diseases, especially diarrhoea and respiratory infections of There are also some cases where recommendations to pre-
early childhood; and chronic diseases other than cancer. vent other diseases conflict, or seem to conflict, with those
As stated above, the recommendations here are designed for cancer. One example is alcoholic drinks. While no report
to prevent cancer as a whole. For similar reasons of public on cardiovascular disease has ever recommended consump-
health, the Panel, in considering and judging the secondary tion of alcoholic drinks, low levels of consumption of alco-
evidence presented in Chapter 10, has made sure that the holic drinks are likely to protect against coronary heart
recommendations here take the prevention of other diseases disease; whereas there is no evidence that alcoholic drinks
into account. at any level of consumption have any benefit for any can-
Often recommendations to prevent cancer are much the cer. In cases like this, the Panels recommendations may be
same as recommendations to control or prevent other modified to take such a conflict into account; this is clearly
diseases. When this is evidently so, the Panel has stated indicated in the recommendations.
371
P A R T 3 R E C O M M E N D AT I O N S
372
C H A P T E R 1 2 P U B L I C H E A LT H G O A L S A N D P E R S O N A L R E C O M M E N D AT I O N S
373
P A R T 3 R E C O M M E N D AT I O N S
374
C H A P T E R 1 2 P U B L I C H E A LT H G O A L S A N D P E R S O N A L R E C O M M E N D AT I O N S
Justification
Box 12.3 Height, weight, and ranges of
Maintenance of a healthy weight throughout life may be one body mass index (BMI)
of the most important ways to protect against cancer. This
will also protect against a number of other common chron-
ic diseases.
Height (ft, in)
410 5 52 54 56 58 510 6 62 64 66
Weight gain, overweight, and obesity are now generally 125 275
much more common than in the 1980s and 1990s. Rates of 120 264
115 253
overweight and obesity doubled in many high-income coun- 110 242
40
tries between 1990 and 2005. In most countries in Asia and 105 231
35
Latin America, and some in Africa, chronic diseases includ- 100 37.5 220
95 209
ing obesity are now more prevalent than nutritional defi- 30
Weight (kg)
Weight (lb)
90 32.5 198
ciencies and infectious diseases. 85 187
27.5 25
Being overweight or obese increases the risk of some can- 80 176
cers. Overweight and obesity also increase the risk of condi- 75 23 165
70 154
tions including dyslipidaemia, hypertension and stroke, type 65
18.5
143
2 diabetes, and coronary heart disease. Overweight in child- 60 132
hood and early life is liable to be followed by overweight and 55 121
50 110
obesity in adulthood. Further details of evidence and judge-
45 99
ments can be found in Chapters 6 and 8. Maintenance of a 40 88
healthy weight throughout life may be one of the most 145 150 155 160 165 170 175 180 185 190 195 200
Height (cm)
important ways to protect against cancer.
Underweight Overweight Extremely (morbidly) obese
Public health goals Obese Proposed additional cut offs
Normal
The points here are additional to those made in the footnotes for Asian populations
375
P A R T 3 R E C O M M E N D AT I O N S
Maintain body weight within The proportion of the population that is sedentary1
the normal range from age 21 to be halved every 10 years
These two related recommendations emphasise the impor- Average physical activity levels (PALs)1 to be above 1.6
tance of prevention of excess weight gain, overweight, and
obesity, beginning in early life indeed, in infancy and
childhood. As stated, the normal range of BMI is within 18.5 PERSONAL RECOMMENDATIONS
to 25, with some variation between countries; where the
agreed range is different this should be used as the guide. Be moderately physically active, equivalent
See box 12.3. to brisk walking,2 for at least 30 minutes every day
These recommendations do not mean that all healthy peo-
ple within the normal range of BMI need necessarily aim to As fitness improves, aim for 60 minutes or more
lower their BMI. However, people who have gained weight, of moderate, or for 30 minutes or more of
even within the normal range, are advised to aim to return vigorous, physical activity every day2 3
to their original weight.
People above the normal range of BMI are recommended Limit sedentary habits such as watching television
to lose weight to approach the normal range. See Guidance
and also recommendations 2 and 3.
1
The term sedentary refers to a PAL of 1.4 or less. PAL is a way of representing
the average intensity of daily physical activity. PAL is calculated as total energy
Avoid weight gain and increases in expenditure as a multiple of basal metabolic rate
waist circumference throughout adulthood 2
Can be incorporated in occupational, transport, household, or leisure activities
3
This is because physical activity of longer duration or greater intensity is more
beneficial
There may be specific adverse effects from gaining weight
during adulthood (see chapter 6.1.1.3), and so maintenance
of weight within the normal range throughout adult life is
recommended.
The World Health Organization reference values for waist Evidence
circumferences of 94 cm (37 inches) in men and 80 cm (31.5 The evidence that physical activity of all types protects
inches) in women (on a population basis) are based on their against cancer and also against obesity, and therefore indi-
rough equivalence to a BMI of around 25, whereas waist cir- rectly those cancers whose risk is increased by obesity, has
cumferences of 102 cm (40.2 inches) in men and 88 cm continued to accumulate since the early 1990s.
(34.6 inches) in women are equivalent to a BMI of around
30. For Asian populations, cut-offs for waist circumferences The evidence that physical activity protects against colon
of 90 cm (35.4 inches) for men and 80 cm (31.5 inches) for cancer is convincing. It probably protects against post-
women have been proposed. menopausal breast cancer and endometrial cancer. Also see
Chapter 5.
Guidance The evidence that physical activity protects against weight
This overall recommendation can best be achieved by being gain, overweight, and obesity is convincing. The evidence
physically active throughout life, and by choosing diets that sedentary living increases the risk of weight gain, over-
based on foods that have low energy density and avoiding weight, and obesity is also convincing. Television viewing, a
sugary drinks. form of very sedentary behaviour, is probably a cause of
weight gain, overweight, and obesity. Also see Chapter 8.
People who are already outside the normal BMI range should
seek advice from appropriately qualified professionals Justification
with a view to returning towards the normal range. Most populations, and people living in industrialised and
However, for weight control, recommendations 1, 2, and 3 urban settings, have habitual levels of activity below levels
can be followed. to which humans are adapted.
376
C H A P T E R 1 2 P U B L I C H E A LT H G O A L S A N D P E R S O N A L R E C O M M E N D AT I O N S
usual in high-income countries since the second half of the Average PALs for people in high income populations are
20th century. They are now common if not usual in most between around 1.4 and 1.6. PALs for people in the normal
countries. range of BMI often average around 1.6. The Panel empha-
All forms of physical activity protect against some cancers, sises that the goal is to move above a PAL of 1.6. Levels of
as well as against weight gain, overweight, and obesity; cor- 1.7 and more are readily achieved by active and fit people.
respondingly, sedentary ways of life are a cause of these can- See Chapter 5.
cers and of weight gain, overweight, and obesity. Weight
gain, overweight, and obesity are also causes of some can- Personal recommendations
cers independently of the level of physical activity. Further The points here are additional to those made in the footnotes
details of evidence and judgements can be found in to the recommendations above.
Chapters 5, 6, and 8.
The evidence summarised in Chapter 10 also shows that Be moderately physically active, equivalent to brisk
physical activity protects against other diseases and that walking for at least 30 minutes every day
sedentary ways of life are causes of these diseases.
As fitness improves, aim for 60 minutes or more of
Public health goals moderate, or for 30 minutes or more of
The points here are additional to those made in the footnotes vigorous, physical activity every day
to the goals above.
These recommendations are linked. The first derives from
The proportion of the population that is sedentary the evidence on cancer. The second derives from the evi-
to be halved every 10 years dence on overweight and obesity, themselves a cause of
some cancers. In making these two recommendations, the
As above, the context for this goal, which like the others spec- Panel also recognises that for people who have been habit-
ified here is designed as a guide for national and other pop- ually sedentary for some time, a first recommendation,
ulation policies, is the current general rapid rise in sedentary which is also meant to be intermediary, is sensible. Levels
ways of life. Again as above, the goal proposes a time-frame. of activity above those recommended here are likely to be
Its achievement will require leadership from governments, additionally beneficial, unless excessive, which may lead to
city planners, school boards, and others. Policy-makers are an acute inflammatory response indicated by muscle pain
encouraged to frame goals according to their specific cir- and vulnerability to infections.
cumstances.
The recommendation takes account of the magnitude of Limit sedentary habits such as watching television
health gain expected from moving, even modestly, from
sedentary ways of life, compared to increasing the level of Watching television is a form of very sedentary behaviour.
activity for already active people. Children may commonly watch television for more than
three hours a day, and are often also exposed to heavy mar-
Average physical activity levels to be above 1.6 keting of foods that are high in energy and of sugary drinks
on television.
This table provides guidance on the impact of specific periods of activity on overall physical activity levels. Increasing activity can be achieved in many
different ways. See Chapter 5.
The table lists some examples of the effect on average daily PAL of doing different activities for different periods of time. The estimates are approximate
and rounded.
So for a person with a PAL of 1.6, an extra 30 minutes daily of moderate activity would increase PAL to around 1.7.
Category Increase in daily PAL Increase in daily PAL Increase in daily PAL Increase in daily PAL Increase in daily PAL
(for an hour of (for 20 minutes of (for 30 minutes (for 40 minutes (for an hour of
activity a week) activity a day) of activity a day) of activity a day) activity a day)
Sedentary
Lying down quietly 0 0 0 0 0
Light
Walking slowly, 0.01 0.03 0.05 0.06 0.09
light gardening, housework
Moderate
Walking briskly, cycling, 0.03 0.07 0.10 0.13 0.20
dancing, swimming
Vigorous
Running, tennis, football 0.07 0.17 0.25 0.35 0.50
377
P A R T 3 R E C O M M E N D AT I O N S
Guidance RECOMMENDATION 3
Most people can readily build regular moderate, and some
vigorous, physical activity into their everyday lives. FOODS AND DRINKS THAT
PROMOTE WEIGHT GAIN
Moderate physical activity can readily be built into everyday
life. It is not necessary to devote a continuous half hour every Limit consumption of energy-dense foods1
day to moderate activity. With walking as an example, walk Avoid sugary drinks2
briskly all or part of the way to and from work, or on local
errands, or at school; take a break for a walk in the middle PUBLIC HEALTH GOALS
of the day or the evening; use stairs rather than the eleva-
tor. The same applies to other moderate activities. Average energy density of diets3 to be lowered
The best choice of vigorous physical activity is that which towards 125 kcal per 100 g
is most enjoyable for the family or the individual be it
swimming, running, dancing, rowing, cycling, hill walking, Population average consumption of sugary drinks2
aerobic workouts, or team games such as football and bad- to be halved every 10 years
minton. Resistance and balance training are also beneficial.
Some sports and recreations such as golf are not vigorously
active. A good test that activity is vigorous is that it involves PERSONAL RECOMMENDATIONS
sweating and raises heart rate to 6080 per cent of its max-
imum. Consume energy-dense foods1 4 sparingly
People whose work is sedentary should take special care
to build moderate and vigorous physical activity into their Avoid sugary drinks2
everyday lives.
It is also important to avoid long periods of sedentary Consume fast foods5 sparingly, if at all
behaviour, such as watching television. This behaviour is also
often associated with consumption of energy-dense food and
sugary drinks.
1
Energy-dense foods are here defined as those with an energy content of more
than about 225275 kcal per 100 g
A common misconception is that sport or exercise is the only 2
This principally refers to drinks with added sugars. Fruit juices should also be
way in which to be physically active. Physical activity includes limited
3
This does not include drinks
that involved with transport (such as walking and cycling), 4
Limit processed energy-dense foods (also see recommendation 4). Relatively
household (chores, gardening), and occupation (manual and unprocessed energy-dense foods, such as nuts and seeds, have not been shown
other active work), as well as recreational activity. to contribute to weight gain when consumed as part of typical diets, and these
and many vegetable oils are valuable sources of nutrients
See table 12.1 for guidance on how to achieve and main- 5
The term fast foods refers to readily available convenience foods that tend to
tain a healthy PAL. This table provides guidance on the be energy-dense and consumed frequently and in large portions
impact of specific periods of activity on overall PALs.
Increasing activity can be achieved in many different ways.
The table lists some examples of the effect on average daily
PAL of doing different activities for different periods of time. Evidence
The estimates are approximate and rounded. So for a per- Evidence shows that foods and diets that are high in energy,
son with a PAL of 1.6, an extra 30 minutes daily of moder- particularly those that are highly processed, and sugary drinks,
ate activity would increase their PAL to around 1.7. increase the risk of overweight and obesity. Some foods low
in energy density probably protect against some cancers.
Justification
Consumption of energy-dense foods and sugary drinks is
increasing worldwide and is probably contributing to the
global increase in obesity.
378
C H A P T E R 1 2 P U B L I C H E A LT H G O A L S A N D P E R S O N A L R E C O M M E N D AT I O N S
of evidence and judgements can be found in Chapter 8. This recommendation does not imply that all energy-dense
Energy density measures the amount of energy (in kcal or foods should be avoided. Some, such as certain oils of plant
kJ) per weight (usually 100 g) of food. Food supplies that are origin, nuts, and seeds, are important sources of nutrients;
mainly made up of processed foods, which often contain sub- their consumption has not been linked with weight gain, and
stantial amounts of fat or sugar, tend to be more energy-dense by their nature they tend to be consumed sparingly.
than food supplies that include substantial amounts of fresh
foods. Taken together, the evidence shows that it is not spe- Avoid sugary drinks
cific dietary constituents that are problematic, so much as the
contribution these make to the energy density of diets. This recommendation is especially targeted at soft drinks
Because of their water content, drinks are less energy-dense (including colas, sodas, and squashes) with added sugars.
than foods. However, sugary drinks provide energy but do not Consumption of such drinks, including in super-sizes, has
seem to induce satiety or compensatory reduction in subse- greatly increased in many countries. The evidence that such
quent energy intake, and so promote overconsumption of drinks fool the human satiety mechanism, thereby promoting
energy and thus weight gain. weight gain, is impressive. They are best not drunk at all. The
implication of this recommendation is to prefer water. Low-
Public health goals energy soft drinks, and coffee and tea (without added sugar),
The points here are additional to those made in the footnotes are also preferable. Fruit juices, even with no added sugar, are
to the goals above. likely to have the same effect and may promote weight gain,
and so they should not be drunk in large quantities.
Average energy density of diets to be
lowered towards 125 kcal per 100 g Consume fast foods sparingly, if at all
Diets appropriately low in energy density are identified as As already stated, fast foods does not refer to all foods (and
supplying around 125 kcal (or 525 kJ) per 100 g, excluding drinks) that are readily available for consumption. The term
any drinks. These of course will include foods whose energy refers to readily available convenience foods that tend to be
density is higher than this average. energy-dense, and that are often consumed frequently and in
large portions. Most of the evidence on fast foods is from
Population average consumption of sugary drinks studies of such foods, such as burgers, fried chicken pieces,
to be halved every 10 years French fries (chips), and fatty or sugary drinks, as served in
international franchised outlets.
The context for this goal, which like others specified here is
designed as a guide for national and other population policies, Guidance
is the current general rapid rise in weight gain, overweight, Foods and diets that are low in energy density, and avoidance
and obesity, especially in children and young people, and the of sugary drinks, are the best choices, in particular for peo-
rapid rise in consumption of sugary drinks. As above, the goal ple who lead generally sedentary lives.
proposes a time-frame. Achievement of this challenging goal
implies support from regulatory authorities and from manu- The recommendation above can be best achieved by replac-
facturers of sugary drinks. Policy-makers are encouraged to ing energy-dense foods, such as fatty and sugary processed
frame goals according to their specific circumstances. foods and fast foods, with those of low energy density, such
as plant foods including non-starchy vegetables, fruits, and rel-
Personal recommendations atively unprocessed cereals (grains) (see recommendation 4),
The points here are additional to those made in the footnotes and replacing sugary drinks with unsweetened drinks such as
to the recommendations above. water, and unsweetened tea or coffee.
The total energy content of diets is related not only to the
Consume energy-dense foods sparingly energy density of individual foods consumed, but also to the
frequency with which they are eaten and the portion size. The
Energy-dense foods are here defined as those supplying more physical capacity of the human stomach and digestive system
than about 225275 kcal (9501150 kJ) per 100 g. Foods nat- is limited. In general, people usually consume roughly the
urally high in dietary fibre or water, such as vegetables and same amount of food from day to day, measured by weight.
fruits, and cereals (grains) prepared without fats and oils, are Energy-dense diets can undermine normal appetite regulation
usually low in energy density. Non-starchy vegetables, roots and and therefore lead to greater energy intake.
tubers, and fruits provide roughly between 10 and 100 kcal per Sugary drinks are a particular problem as these can
100 g, and cereals (grains) and pulses (legumes) between be drunk in large quantities without a feeling of satiety.
about 60 and 150 kcal per 100 g. Breads and lean meat, poul- By replacing these foods and drinks with those of low energy
try, and fish usually provide between about 100 and 225 kcal density, such as vegetables and fruits, relatively unprocessed
per 100 g. Most foods containing substantial amounts of fats, cereals (grains) and pulses (legumes), water and non-caloric
oils, or added sugars, including many fast foods as defined drinks, the risk of weight gain is reduced, which there-
here, as well as many pre-prepared dishes and snacks, baked fore would be expected to reduce the risk of developing some
goods, desserts, and confectionery, are high in energy density. cancers.
379
P A R T 3 R E C O M M E N D AT I O N S
380
C H A P T E R 1 2 P U B L I C H E A LT H G O A L S A N D P E R S O N A L R E C O M M E N D AT I O N S
381
P A R T 3 R E C O M M E N D AT I O N S
RECOMMENDATION 5 weight, and 500 g cooked red meat to about 700750 g raw
weight. The exact conversion will depend on the cut of meat,
ANIMAL FOODS the proportions of lean and fat, and the method and degree
of cooking, so more specific guidance is not possible.
Limit intake of red meat1 and Red or processed meats are convincing or probable caus-
avoid processed meat2 es of some cancers. Diets with high levels of animal fats are
often relatively high in energy, increasing the risk of weight
gain. Further details of evidence and judgements can be
PUBLIC HEALTH GOAL found in Chapters 4 and 8.
Evidence
The evidence that red meat, and particularly processed
meat, is a cause of colorectal cancer is stronger now than it Other animal foods
was in the mid-1990s.
Many animal foods are not the subject of goals or recommen-
The evidence that red meat is a cause of colorectal cancer is dations.
convincing. The evidence that processed meat is a cause of
Poultry, fish. The evidence on poultry and the risk of cancer is
colorectal cancer is also convincing. Cantonese-style salted
not substantial. The evidence suggesting that fish protects
fish (see chapter 4.3, box 4.3.5, and also box 12.5) is a prob-
against colorectal cancer is limited. (Cantonese-style salted fish
able cause of nasopharyngeal cancer: this conclusion does is a special case see chapter 4.3.) However, people who eat
not apply to fish prepared (or salted) by other means. Milk flesh foods are advised to prefer poultry, and all types of fish, to
from cows probably protects against colorectal cancer. Diets red meat. Flesh from wild animals, birds, and fish, whose nutri-
high in calcium are a probable cause of prostate cancer; this tional profiles are different from those of domesticated and
effect is only apparent at high calcium intakes (around 1.5 industrially reared creatures, is also preferred. See chapter 4.3.
g per day or more). Also see chapters 4.3 and 4.4.
Eggs. The evidence on eggs and the risk of cancer is not sub-
Justification stantial. There is no basis for recommending avoidance of eggs
to prevent cancer. See chapter 4.3.
An integrated approach to the evidence also shows that
many foods of animal origin are nourishing and healthy if
Milk, cheese, other dairy products. The evidence on cows milk,
consumed in modest amounts. cheese, and foods high in calcium, and the risk of cancer, is hard
to interpret. The evidence on colorectal cancer and on prostate
People who eat various forms of vegetarian diets are at low cancer seems to be in conflict. After long discussion, the Panel
risk of some diseases including some cancers, although it is chose to make no recommendations here. See chapter 4.4.
not easy to separate out these benefits of the diets from other
aspects of their ways of life, such as not smoking, drinking Animal fats. The evidence suggesting that animal fats are a cause
little if any alcohol, and so forth. In addition, meat can be of colorectal cancer is limited. Animal fats are high in energy and
a valuable source of nutrients, in particular protein, iron, the Panel integrated the limited evidence suggesting that ani-
mal fats are a cause of overweight and obesity into its findings
zinc, and vitamin B12. The Panel emphasises that this over-
on energy-dense foods. The implication is that it is best to limit
all recommendation is not for diets containing no meat
consumption of animal fats, as part of meat and also as con-
or diets containing no foods of animal origin. The amounts tained in processed foods, in part because of the relation with
are for weight of meat as eaten. As a rough conversion, 300 cardiovascular disease. See chapter 4.5.
g of cooked red meat is equivalent to about 400450 g raw
382
C H A P T E R 1 2 P U B L I C H E A LT H G O A L S A N D P E R S O N A L R E C O M M E N D AT I O N S
Guidance
There are many ways to enjoy meat and other animal foods PERSONAL RECOMMENDATION
as part of plant-based diets.
If alcoholic drinks are consumed,
For those who eat flesh foods, the amount of red meat con- limit consumption to no more than two drinks a day
sumed can be limited by choosing poultry and fish instead. for men and one drink a day for women1 2 3
It is better also to consume the lean parts of red meat.
It is best that processed meats are avoided. They are gen-
erally energy-dense and can also contain high levels of salt
1
This recommendation takes into account that there is a likely protective effect
for coronary heart disease
(see recommendation 7). They also tend to be preserved by 2
Children and pregnant women not to consume alcoholic drinks
smoking, curing, or salting, or with the addition of chemi- 3
One drink contains about 1015 grams of ethanol
383
P A R T 3 R E C O M M E N D AT I O N S
384
C H A P T E R 1 2 P U B L I C H E A LT H G O A L S A N D P E R S O N A L R E C O M M E N D AT I O N S
tions. The evidence that aflatoxins are a cause of liver can- Limit consumption of processed foods with added salt
cer is convincing. Also see chapter 4.1. to ensure an intake of less than 6 g (2.4 g sodium) a day
Population average consumption of salt from Refrigeration. The epidemiological evidence associating use of
all sources to be less than 5 g (2 g of sodium) a day refrigeration with reduction of the risk of stomach cancer is sub-
stantial. The previous report judged this evidence to be convinc-
Proportion of the population consuming more than 6 g ing. The Panel responsible for this Report judged that the effect
of salt (2.4 g of sodium) a day to be halved every 10 years of refrigeration as such on cancer risk was not likely to be direct-
ly causative. Nevertheless, the benefits of industrial and domes-
tic freezing, refrigeration, and chilling include availability of
The reason for these linked goals, which like the others spec-
perishable foods, including vegetables and fruits, all year round,
ified above are designed as a guide for national and other protection against microbial contamination, and reduced need to
population policies, is the very high consumption of salt in preserve food by salting. In these respects, refrigeration is bene-
most countries. Again as above, one of the goals proposes a ficial. Also see box 4.6.4 in chapter 4.6.
time-frame. This time-frame implies a continuing effort into
the future to achieve levels that might seem difficult within Additives, contaminants. There is little epidemiological evidence
a single decade. Its achievement implies support from regu- on any relationship between food additives and contaminants,
latory authorities and from the manufacturers of salty and whose use is subject to regulation, and the risk of cancer. Also see
salted foods. Policy-makers are encouraged to frame goals chapter 4.9.
according to their specific circumstances.
Steaming, boiling, stewing, baking, roasting, frying, grilling (broil-
ing), barbecuing (charbroiling). While evidence suggesting that
Minimise exposure to aflatoxins grilled (broiled) and barbecued (charbroiled) animal foods are a
from mouldy cereals (grains) or pulses (legumes) cause of stomach cancer is limited, there is evidence from exper-
imental settings showing that carcinogens are formed when
Personal recommendations meats, animal foods, and some other foods are cooked at very
The points here are additional to those made in the footnotes high temperatures, and most of all when they are exposed to
to the recommendations above. direct flame. While the epidemiological evidence that these are
causes of cancer is limited, it is a wise precaution to avoid foods
Avoid salt-preserved, salted, or salty foods; cooked in this way. This effect is not found when foods are cooked
by use of boiling water. Also see chapter 4.9.
preserve foods without using salt
385
P A R T 3 R E C O M M E N D AT I O N S
Salt is just one way to add savour to foods. Many herbs and Maximise the proportion of the population achieving
spices can be used instead. After a period of time of limit- nutritional adequacy without dietary supplements
ing the use of salt, taste sensitivity to it increases, preference
decreases, and the natural savour of food becomes apparent.
Food labels give some guidance. Products advertised as PERSONAL RECOMMENDATION
reduced salt may still be high in salt.
Keep food fresh by use of refrigeration. Discard food show- Dietary supplements are not recommended
ing signs of mould (other than those such as some cheeses for cancer prevention
manufactured by use of benign moulds).
1
This may not always be feasible. In some situations of illness or dietary
inadequacy, supplements may be valuable
Evidence
Randomised controlled trials have produced strong evidence
that high-dose supplements of some nutrients modify the
risk of some cancers.
Justification
The evidence shows that high-dose nutrient supplements
can be protective or can cause cancer. The studies that
demonstrate such effects do not relate to widespread use
among the general population, in whom the balance of risks
and benefits cannot confidently be predicted. A general rec-
ommendation to consume supplements for cancer preven-
tion might have unexpected adverse effects. Increasing the
consumption of the relevant nutrients through the usual diet
is preferred.
386
C H A P T E R 1 2 P U B L I C H E A LT H G O A L S A N D P E R S O N A L R E C O M M E N D AT I O N S
of benefit may be different, and there may be unexpected consuming nutritionally inadequate diets. In such cases of
and uncommon adverse effects. Therefore it is unwise to rec- immediate need, supplementation is necessary. See box 12.4.
ommend widespread supplement use as a means of cancer
prevention. Further details of evidence and judgements can Personal recommendation
be found in Chapter 4. The points here are additional to that in the footnote above.
In general, for otherwise healthy people, inadequacy of
intake of nutrients is best resolved by nutrient-dense diets Dietary supplements are not recommended
and not by supplements, as these do not increase consump- for cancer prevention
tion of other potentially beneficial food constituents. The
Panel recognises that there are situations when supplements This recommendation applies to self-administration of low
are advisable. See box 12.4. (physiological) as well as high (pharmacological) doses of
supplements, unless on the advice of a qualified health pro-
Public health goal fessional who can assess potential risks and benefits.
The points here are additional to that in the footnote above.
Guidance
Maximise the proportion of the population achieving Choose nutrient-rich foods and drinks instead of dietary sup-
nutritional adequacy without dietary supplements plements.
In many parts of the world, nutritional inadequacy is endem- This can be done by following all the recommendations
ic. In cases of crisis, it is necessary to supply supplements of made here, in the context of appropriate general recom-
nutrients to such populations or to fortify food to ensure at mendations on food, nutrition, physical activity, and body
least minimum adequacy of nutritional status. The best composition, designed to protect against disease and to pro-
approach is to protect or improve local food systems so that mote health and well-being.
they are nutritionally adequate. The same applies in high-
income countries, where impoverished communities and
families, vulnerable people including those living alone, the
elderly, and the chronically ill or infirm, are also liable to be
387
P A R T 3 R E C O M M E N D AT I O N S
Aim to breastfeed infants exclusively2 Sustained, exclusive breastfeeding was the norm until the
up to six months and continue development and marketing of infant formulas, which large-
with complementary feeding thereafter3 ly replaced breastfeeding in high-income and then in most
countries by the second half of the 20th century.
While the practice of breastfeeding and exclusive breast-
feeding has been increasing in many countries in recent
1
Breastfeeding protects both mother and child
2
Exclusively means human milk only, with no other food or drink, including
water decades, in most countries now only a minority of mothers
3
In accordance with the UN Global Strategy on Infant and Young Child Feeding exclusively breastfeed their babies until four months, and an
even smaller number until six months.
This is the context for this goal, which like the others spec-
ified here, is designed as a guide for national and other
Evidence population policies. It does not imply that in any population
The evidence on cancer supports the evidence on well-being, where over half of all mothers breastfeed exclusively for
positive health, and prevention of other diseases: at the six months that the ultimate goal has been reached: the
beginning of life, human milk is best. greater the proportion, the better. Its achievement will
require increased support from regulatory authorities and
The evidence that lactation protects the mother against from the manufacturers of infant formulas. Policy-makers
breast cancer at all ages is convincing. There is limited evi- are encouraged to frame goals according to their specific
dence suggesting that lactation protects the mother against circumstances.
cancer of the ovary. Having been breastfed probably protects The Panel emphasises the importance of exclusive breast-
children against overweight and obesity, and therefore those feeding (other than vitamin drops where locally recom-
cancers for which weight gain, overweight, and obesity are mended), with no other sustenance, including water.
a cause. Overweight and obesity in children tend to track There are special situations where breastfeeding is rec-
into adult life. Also see recommendation 1 and chapters 6.3, ommended with caution or is not advised. The main special
7.10, and 8. situation is when mothers have HIV/AIDS. On this, the UN
Global Strategy as revised in late 2006 states: Exclusive
Justification breastfeeding is recommended for HIV-infected women for
The evidence on cancer as well as other diseases shows that the first six months of life unless replacement feeding is
sustained, exclusive breastfeeding is protective for the moth- acceptable, feasible, affordable, sustainable, and safe for
er as well as the child. them and their infants before that time.
This is the first major report concerned with the prevention Personal recommendation
of cancer to make a recommendation specifically on breast- The points here are additional to those made in the footnotes
feeding, to prevent breast cancer in mothers, and to prevent to the recommendations above.
overweight and obesity in children. Further details of evi-
dence and judgements can be found in Chapters 6 and 8. Aim to breastfeed infants exclusively
Other benefits of breastfeeding for mothers and their chil- up to six months and continue
dren are well known. Breastfeeding protects against infec- with complementary feeding thereafter
tions in infancy, protects the development of the immature
immune system, protects against other childhood diseases, This and the population goal are references to the UN Global
and is vital for the development of the bond between moth- Strategy on Infant and Young Child Feeding, which is
er and child. It has many other benefits. Breastfeeding is espe- endorsed by the Panel. None of the phrasing of the goals and
cially vital in parts of the world where water supplies are not recommendations here is designed to modify the Strategy,
safe and where impoverished families do not readily have the which allows for special circumstances, including those in
money to buy infant formula and other infant and young which mothers are not able to breastfeed their babies or may
child foods. otherwise be well advised not to do so.
388
C H A P T E R 1 2 P U B L I C H E A LT H G O A L S A N D P E R S O N A L R E C O M M E N D AT I O N S
1
Cancer survivors are people who are living with a diagnosis of cancer, including
those who have recovered from the disease
2
This recommendation does not apply to those who are undergoing active
treatment, subject to the qualifications in the text
3
This includes all cancer survivors, before, during, and after active treatment
Evidence
The available evidence on cancer survivors has limitations.
It is of variable quality; it is difficult to interpret; and it has
not yet produced impressive results. The evidence for this
review does not include the active treatment period.
Justification
Subject to the qualifications made here, the Panel has agreed
that its recommendations apply also to cancer survivors.
There may be specific situations where this advice may not
apply, for instance, where treatment has compromised gas-
trointestinal function.
389
P A R T 3 R E C O M M E N D AT I O N S
Recommendations
In the special circumstances of cancer survivors, who until
they have recovered from the disease are in a clinical setting,
the Panel decided not to separate public health goals and per-
sonal recommendations. The points here are additional to
those made in the footnotes above.
Guidance
The general purpose of the recommendations made in this
Report is to stop cancer before it starts. Crucial support will
be given to cancer survivors who decide to follow the over-
all recommendations made in this chapter, when the people
living closest to them also make this choice. As well as giv-
ing crucial support and improving the quality of life of the
cancer survivor, they will also be reducing their own risk of
cancer.
390
C H A P T E R 1 2 P U B L I C H E A LT H G O A L S A N D P E R S O N A L R E C O M M E N D AT I O N S
391
P A R T 3 R E C O M M E N D AT I O N S
ishing, and only the evidence on red meat and on processed ally with prevention of other chronic diseases.
meat is strong enough to justify specific recommendations. A number of the positive recommendations derive from
Nevertheless, with such precautions, the Panel has agreed evidence on foods that contribute various micronutrients to
that dietary patterns in which foods of plant origin are more the diet. These, including relatively unprocessed cereals
central, with red meat less so, are protective. (grains), vegetables and fruits, and pulses (legumes), as well
as various foods of animal origin, would be expected to sup-
12.3.2 Nutritional patterns ply ample vitamin A (mostly in the form of carotenoids),
The recommendations made in this Report do not specify folate, other B vitamins including vitamin B12, vitamin C,
every major type of food and drink. In this sense they do vitamin E, selenium, iron, zinc, potassium, and indeed
not, taken together, amount to whole diets. Nevertheless, sodium.
combined with the text that accompanies them, they are
likely to promote the nutritional adequacy of diets and 12.3.3 Integration with national
healthy body composition. For this and other reasons, they recommendations
will also be expected to help prevent nutritional deficien- In national settings, the recommendations of this Report will
cies and related infectious diseases. be best used in combination with recommendations issued
Thus, a diet based on these recommendations is likely to by governments or on behalf of nations, designed to prevent
have modest fat content (through limiting energy-dense chronic and other diseases. Also see box 12.5.
foods), especially in saturated fatty acids (limiting red and In the Panels judgement, based on its collective knowl-
processed meat); to be relatively high in starch and fibre edge of food, nutrition, physical activity, and disease pre-
(from emphasis on relatively unprocessed plant foods vention, and also experience of national contexts, the
including cereals (grains)), while being low in sugar (due recommendations here are likely to be harmonious with
to limiting energy-dense foods and sugary drinks). Overall, those designed to prevent disease in specific countries, which
the macronutrient profile is likely to be similar to that rec- take local and national dietary patterns, food cultures, and
ommended in authoritative reports concerned more gener- social and other circumstances into account.
The goals and recommendations specified and oesophagus. The product is commonly RECOMMENDATIONS
in 12.2 are generally relevant worldwide. available in supermarkets in many coun-
In three cases, evidence that is strong tries, but the evidence shows that the causal Avoid consumption of Cantonese-style
enough to be the basis for goals and rec- factor is mat drunk very hot through a salted fish.
ommendations is of importance only in dis- metal straw often left resting on the lip, the
Children not to eat this type of fish.
crete geographical regions. That is not to form traditional within Latin America. It is
say that if the same foods or drinks were probable that the cause of cancer is not the
consumed elsewhere they would not have herb but the thermic effect.
Arsenic in water
the same effect, but rather that currently,
Contamination of water supplies with
people in the rest of the world do not con- RECOMMENDATION
arsenic is a different type of special case.
sume them. These are the herbal drink
This may happen as a result of release of
mat, probably a cause of oesophageal can- Avoid consumption of mat as drunk
industrial effluents, and also because of
cer; Cantonese-style salted fish, probably a in parts of Latin America, very hot and
geological and other environmental cir-
cause of nasopharyngeal cancer; and cont- through a metal straw.
cumstances. High concentrations of arsenic
amination of water supplies with arsenic, a
in drinking water have been found in areas
cause of lung cancer and (probably) skin Cantonese-style salted fish
of Bangladesh, China, and West Bengal
cancer. The Panel considers that detailed Cantonese-style salted fish, as stated in
(India); and also in more localised areas of
goals and recommendations in these cases chapter 4.3 and elsewhere, is part of the
Argentina, Australia, Chile, Mexico, Taiwan,
are most appropriately set by local and/or traditional diet consumed by people living
China, the USA, and Vietnam. Arsenic is
regional regulatory authorities, other poli- around the Pearl River Delta region in
classed as a carcinogen by the International
cy-makers, and health professionals in the southern China, and has been given to chil-
Agency for Research on Cancer.
countries affected. dren, even as part of a weaning diet. This
style of fish is prepared with less salt than
RECOMMENDATIONS
Mat used on the northern Chinese littoral, is
As stated in chapter 4.7 and elsewhere, allowed to ferment, and so is eaten in a
Avoid use of any source of water
mat is a herbal infusion originally culti- decomposed state. While it is also con-
that may be contaminated with arsenic.
vated and drunk by the original inhabitants sumed by communities of emigrants from
in Argentina, Uruguay, and Rio Grande do the Pearl River Delta in other countries, this Authorities to ensure that
Sul in Brazil, where it is now adopted as a particular preparation of fish is not other- safe water supplies are available
staple drink. Reports on the prevention of wise an issue, and there is no good where such contamination occurs.
cancer have identified mat as a cause or evidence that other forms of preserved fish
possible cause of cancers of the oral cavity affect the risk of cancer.
392
C H A P T E R 1 2 P U B L I C H E A LT H G O A L S A N D P E R S O N A L R E C O M M E N D AT I O N S
12.3.4 General patterns late 2008 will deal with the social and environmental fac-
The Panel has not been able to base its recommendations on tors that influence the risk of cancer, with appropriate rec-
general patterns of food and nutrition, as stated above, on ommendations.
evidence specifically directed towards that question. Reasons
for this, as summarised in chapter 4.9, are that relatively few
epidemiological studies examine diets in an integrated form;
and of these, most do not define the nature of such diets in
a way that can be compared with other studies. Those that
do, such as studies of Seventh-day Adventists, often exam-
ine the effects of whole ways of life, including factors that
may confound findings specifically on food, nutrition, and
physical activity.
For the future, the Panel recommends that protocols be
agreed to enable well conducted epidemiological studies to
be carried out on patterns of food, nutrition, and of physi-
cal activity, using agreed definitions and methods that allow
comparisons and detailed analyses.
A number of traditional and more modern food systems
generate a variety of climatically and culturally appropriate,
delicious, and nourishing cuisines that are harmonious with
the recommendations made here. These include the many
traditional cuisines of the Mediterranean littoral, and of
South-East and East Asia, and some diets devised since the
industrialisation and internationalisation of food systems.
The latter are often adaptations of traditional diets, enjoyed
by people in higher income countries as part of generally
healthy ways of life.
393
i ` Vi
Appendix A
Project process 396
Appendix B
The first WCRF/AICR Expert Report 398
Appendix C
WCRF Global Network 400
Glossary 402
References 410
Index 506
395
F O O D , N U T R I T I O N , P H Y S I C A L A C T I V I T Y, A N D T H E P R E V E N T I O N O F C A N C E R : A G L O B A L P E R S P E C T I V E
A P P E N D I X A
Project process
How this Report has been achieved reporting the evidence. In 2002, a Methodology Task Force
This Report follows, develops, and replaces Food, Nutrition of experts in nutrition, cancer, epidemiology, methodology,
and the Prevention of Cancer: a global perspective, the first and statistics was convened. This Task Force drew on the
report commissioned by the World Cancer Research Fund accumulated experience of existing techniques to develop a
together with the American Institute for Cancer Research, unique new process. The methodology is described in a
which was published in 1997. Systematic Literature Review Specification Manual, which con-
In 2001, WCRF and AICR agreed that it was time to com- tains the instructions for conducting the systematic reviews.
mission a new report. Since the mid 1990s, the amount of The methods specified in the manual were tested at two
scientific literature on this subject has dramatically centres, one in the USA and the other in the UK, and as a
increased. New methods of analysing and assessing evidence result the manual was modified. It has formed the basis of
have been developed, facilitated by advances in electronic all the reviews of the literature on food, nutrition, physical
technology. There is more evidence, in particular on over- activity, and the risk of cancer for all relevant cancer sites
weight and obesity and on physical activity. Examining food, and on weight gain, overweight, and obesity.
nutrition, and physical activity in relation to cancer survivors
is a new field of study. The need for a new report was obvi- Reviewing the literature
ous, and a multilevel process involving global collaboration WCRF International then invited scientific centres to bid for
was put in place. the work of systematic literature review (SLR), and con-
tracted with nine institutions in Europe and North America
Commissioning this Report to conduct reviews of the literature on all cancer sites where
The goal of this second Report, Food, Nutrition, Physical evidence of links with food, nutrition, and associated factors
Activity, and the Prevention of Cancer: a Global Perspective, was already apparent, as well as that on determinants
has been to identify, review, and assess all the relevant of overweight and obesity, and on authoritative reports con-
research to date. It has used the most meticulous methods cerned with other diseases. The project team from each
for assessment and review in order to generate a compre- centre included expertise in epidemiology, nutrition, cancer,
hensive series of recommendations on food, nutrition, and mechanisms, statistics, and project management. Teams
physical activity suitable for all societies and designed to have been supported by a review coordinator a member
reduce the risk of cancer. The process has also been devised of the WCRF International Secretariat. All reviews have
as the basis for a continuous review that will keep the evi- included the relevant epidemiological and experimental
dence updated into the future. literature.
The process was organised into overlapping stages, Using the specification manual to ensure a comprehensive
designed to ensure objectivity and transparency as well as and consistent approach to the analysis plus a common for-
separation between the collection of evidence and the busi- mat for displaying the evidence, each centre undertook one
ness of assessing and judging it. First, an expert task force or more SLRs and produced a report on the evidence for each
developed a method for systematic review of the voluminous cancer site. The reports were subject to peer review both at
scientific literature. Second, research teams collected and the initial protocol stage and when the reports were sub-
reviewed the literature based upon this methodology. Third, mitted in complete form. They were then revised before
an expert Panel assessed and judged this evidence and being summarised and submitted to the Panel. The system-
agreed recommendations. The results are published in this atic reviews present the findings of the review teams based
Report. on the agreed protocol. They stop short of assessing or judg-
The whole project has taken six years, with the launch and ing the strength and implications of the evidence.
distribution of the second Report taking place in November
2007. Judging the evidence
The Panel of 21 experts was convened by WRCF
Agreeing the methodology International in 2003 to develop the second Report.
As a first stage, WCRF International developed an appro- Members of the Panel come from all the main continents and
priate method for collecting, synthesising, analysing, and from 11 countries. Its collective expertise includes nutrition,
396
A P P E N D I X A P R O J E C T P R O C E S S
cancer, obesity, other chronic diseases, physical activity, epi- International set up a multilevel process to manage the pro-
demiology, biochemistry, statistics, public health, and pub- ject, and an Executive Team was established with the specif-
lic policy. The Panel includes members of the Panel from the ic responsibility of directing it.
first WCRF/AICR report and relevant World Health
Organization expert consultations, as well as observers from Executive Team: Executive body responsible for Report.
the Methodology Task Force and the Mechanisms Working Composed of WCRF International and
Group and from six relevant United Nations and other inter- AICR executives and advisors.
national organisations. The Panel convened twice a year for Secretariat: Manages the whole report process.
three- or four-day meetings between 2003 and 2007. Advisory Group: Guides the Executive Team and the
The Panel has been responsible for assessing the evidence Panel on policy and strategic and
from the SLRs, for agreeing judgements based on their technical issues
assessments, and for agreeing a comprehensive set of rec-
ommendations. The Panel has also been responsible for iden- The Secretariat has included WCRF International staff in the
tifying issues arising from this work that would be UK, AICR staff in the USA, and consultants, including in the
appropriate topics for future research. following positions:
For the next stage, the Panel, supplemented by addition-
al expertise, examined the evidence on the determinants of Project Director: Overall responsibility for the report
dietary and activity patterns, and of obesity, and the effec- and its scientific content. Chair of
tiveness of interventions from personal to population level. Executive Team.
Publication of this separate report is due in late 2008. Chief Editor: Responsible for editorial quality of the
report. Chair of Advisory Group.
Managing the project Project Manager: Responsible for day-to-day
The second Report was commissioned by WCRF International management of the project; Chair of
and has been funded and published by WCRF/AICR. WCRF Secretariat.
Chapter Managers: Drive progress on chapters of the
report.
Keeping up to date
This Report is meant to guide future scientific research, can-
cer prevention education programmes, and health policy
around the world. It provides a solid evidence base for pol-
icy-makers, health professionals, researchers, and informed
and interested people to draw on and work with.
WCRF International has been mindful that the literature
is continually expanding, and has commissioned a continu-
ous review of the evidence. This process will be overseen by
an expert panel convened by WCRF International, responsi-
ble for assessing and judging the updated evidence as a basis
for recommendations and action to prevent cancer world-
wide.
397
F O O D , N U T R I T I O N , P H Y S I C A L A C T I V I T Y, A N D T H E P R E V E N T I O N O F C A N C E R : A G L O B A L P E R S P E C T I V E
A P P E N D I X B
398
A P P E N D I X B T H E F I R S T W C R F / A I C R E X P E R T R E P O R T
399
F O O D , N U T R I T I O N , P H Y S I C A L A C T I V I T Y, A N D T H E P R E V E N T I O N O F C A N C E R : A G L O B A L P E R S P E C T I V E
A P P E N D I X C
400
A P P E N D I X C T H E W O R L D C A N C E R R E S E A R C H F U N D G L O B A L N E T W O R K
401
F O O D , N U T R I T I O N , P H Y S I C A L A C T I V I T Y, A N D T H E P R E V E N T I O N O F C A N C E R : A G L O B A L P E R S P E C T I V E
Glossary
402
G L O S S A R Y
403
F O O D , N U T R I T I O N , P H Y S I C A L A C T I V I T Y, A N D T H E P R E V E N T I O N O F C A N C E R : A G L O B A L P E R S P E C T I V E
404
G L O S S A R Y
405
F O O D , N U T R I T I O N , P H Y S I C A L A C T I V I T Y, A N D T H E P R E V E N T I O N O F C A N C E R : A G L O B A L P E R S P E C T I V E
Hypoxia Jewett scale (see Whitemore and Jewett Magnetic resonance imaging (MRI)
Abnormally low levels of oxygen in blood or scales) A technique that produces images of parts of
tissues. the body using analysis of the behaviour of
K-ras water molecules within body tissues when
IARC One of a class of genes (proto-oncogenes) placed in a strong magnetic field.
International Agency for Research on Cancer which when mutated can malfunction to
(www.iarc.fr). become an oncogene, promoting the Malignant
transformation of normal cells into cancer cells A tumour with the capacity to spread to
IGF binding proteins (see box 2.2). surrounding tissue or to other sites in the
Proteins that bind to insulin-like growth body.
factors (which are implicated in the cancer Lactation
process, see Chapter 2) in the bloodstream. The production and secretion of milk by the Melanoma
mammary glands. Malignant tumour of the skin derived from
Immune response the pigment-producing cells (melanocytes).
The production of antibodies or specialised Lacto-ovo-vegetarian diet
cells in response to foreign proteins or other A vegetarian diet characterised by the Membrane potential
substances. inclusion of eggs and dairy products, but no The difference in electrical charge across the
other animal products. cell membrane.
Incidence rates
The number of new cases of a condition Latency Menarche
appearing during a specified period of time The period of time between the onset of a The beginning of menstruation (see boxes 6.1
expressed relative to the size of the disease process and its detection or clinical and 6.2).
population, for example 60 new cases of appearance.
breast cancer per 100 000 women per year. MET (see metabolic equivalent)
Lean body mass
Inflammation The mass of those parts of the body that are Meta-analysis
The immunologic response of tissues to injury not adipose tissue. Lean body mass includes The process of using statistical methods to
or infection. Inflammation is characterised by some lipid and is not synonymous with fat- combine the results of different studies.
accumulation of white blood cells that free mass.
produce several bioactive chemicals, causing Metabolic equivalent (MET)
redness, pain, and swelling. Lesion One MET equals the resting metabolic rate,
A general term for any abnormality of cells or measured as the rate of oxygen consumption,
Inflammatory bowel disease tissues, including those due to cancerous which is approximately 3.5 millilitres of oxygen
A term used to describe Crohns disease and change. per kilogram body weight per minute.
ulcerative colitis: both are characterised by Equivalent to physical activity ratio (see box
chronic inflammation of the gut. Linoleic acid 5.1).
An essential n-6 polyunsaturated fatty acid
Insulin (C18:2 n6). Metabolic syndrome
A protein hormone secreted by the pancreas A common cluster of a variety of several risk
that promotes the uptake and utilisation of Lipids factors for cardiovascular disease including
glucose, particularly in the liver and muscles. Naturally occurring organic molecules that are insulin resistance, abdominal obesity, high
Inadequate secretion of, or tissue response to, insoluble in water, including triglycerides; blood pressure, and abnormal blood lipids.
insulin leads to diabetes mellitus. fatty acids; phospholipids; lipoproteins;
carotenoids; cholesterol, which is a Metastasis
Intrinsic sugars precursor of steroid hormones and vitamin The spread of malignant cancer cells to
Sugars naturally integrated into the cellular D; and the other fat-soluble vitamins A, E, and distant locations around the body from the
structure of foods, for example those present K. Lipids are an essential component of cell original site.
in unprocessed fruits and vegetables. membranes and many metabolic processes.
Micronutrients
Intra-abdominal fat Low-density lipoprotein (LDL) cholesterol Vitamins and minerals present in foods and
Also known as visceral fat. Fat stored within A class of lipoproteins that is the major carrier required in the diet for normal body function
the abdomen surrounding the internal organs of cholesterol in the blood in humans. A high in small quantities, conventionally of less than
(see adipose tissue). blood LDL cholesterol concentration is a cause 1 g/day (see box 4.2.3).
of coronary artery disease.
In utero Migrant study
In the uterus; refers to events that occur Low-income countries A study of people who migrate from one
before birth. Countries with a gross average annual country to other countries with different
national product of less than an agreed environments and cultural backgrounds. The
Invasive cancer figure per head (in 2006 this was $US 875). experience, such as mortality or disease
Tumours that spread into surrounding healthy This term is less judgemental and more incidence, of the migrant group is compared
tissue. descriptive than economically developing with that of people in their current country of
countries. residence and in their country of origin.
406
G L O S S A R Y
407
F O O D , N U T R I T I O N , P H Y S I C A L A C T I V I T Y, A N D T H E P R E V E N T I O N O F C A N C E R : A G L O B A L P E R S P E C T I V E
Positive energy balance (see energy Red meat Single nucleotide polymorphism (SNP)
balance) Meat from domesticated cattle, pigs, sheep, DNA sequence variation where a single
and goats; not poultry and fish or meat from nucleotide in the DNA is altered. SNPs account
Prebiotic wild animals. for 90% of all human genetic variation (see
Dietary carbohydrate that reaches the colon, polymorphism and point mutation).
where it promotes growth of beneficial Refined sugars
bacterial flora (see box 4.10.2). Sugars obtained by purification from plants SLR (see systematic literature review)
which contain it, principally sugar cane or
Precursor beet.
A chemical compound from which another
compound is formed.
408
G L O S S A R Y
409
F O O D , N U T R I T I O N , P H Y S I C A L A C T I V I T Y, A N D T H E P R E V E N T I O N O F C A N C E R : A G L O B A L P E R S P E C T I V E
References
410
R E F E R E N C E S
41. Joint United Nations Programme on antiquity of cancer. Cancer 1970 66. Giedion S. Mechanization encounters the
HIV/AIDS. Report on the global AIDS 1977;40:1358-62. organic. Mechanization takes Command.
epidemic 2006. 53. Schaefer O. Eskimos (Inuit). In: Trowell H, Oxford: Oxford University Press, 1948.
http://www.unaids.org/en/HIV_data/200 Burkitt D, editors. Western Diseases: 67. Hoffmann W. 100 years of the margarine
6GlobalReport/default.asp. 2006. Their Emergence and Prevention. industry. In: van Stuyvenberg A, editor.
42. Vainio H, Bianchini F, editors. IARC London: Edward Arnold, 1981. Margarine. An Economic, Social and
Handbooks of Cancer Prevention, 54. Messer E. Maize. In: Kiple K, Ornelas K, Scientific History, 1869-1969. Liverpool:
Weight Control and Physical Activity. editors. The Cambridge World History of Liverpool University Press, 1969.
Lyon: International Agency for Research Food: Cambridge University Press, 2000. 68. Quandt S. Infant and child nutrition. In:
on Cancer, World Health Organization, 55. Miller N, Wetterstrom W. The beginnings Kiple K, Ornelas K, editors. The
2002. of agriculture: the ancient Near East. In: Cambridge World History of Food.
43. Vainio H, Bianchini F, editors. IARC Kiple K, Ornelas K, editors. The Cambridge: Cambridge University Press,
Handbooks of Cancer Prevention, Fruit Cambridge World History of Food. 2000.
and Vegetables. Lyon: International Cambridge: Cambridge University Press, 69. Hollingsworth D. The application of the
Agency for Research on Cancer, World 2000. newer knowledge of nutrition. In:
Health Organization, 2003. 56. Jacob H. Bread in the ancient world. Six Drummond J, Wilbraham A, editors. The
44. Vorster HH, Margetts BM, Venter CS, et al. Thousand Years of Bread. Its Holy and Englishmans Food. Five Centuries of
Integrated nutrition science: from theory Unholy History. New York: The Lyons English Diet. London, 1991.
to practice in South Africa. Public Health Press, 1997. 70. Food and Agriculture Organization of the
Nutr 2005;8:760-5. 57. Miller N, Wetterstrom W, Roger D, et al. United Nations. Globalization of Food
45. Waskiewicz A, Piotrowski W, Sygnowska E, Food and drink around the world. In: Systems in Developing Countries: Impact
et al. Did favourable trends in food Kiple K, Ornelas K, editors. The on Food Security and Nutrition. Rome,
consumption observed in the 1984-2001 Cambridge World History of Food. 2004.
period contribute to the decrease in Cambridge: Cambridge University Press, 71. Cordain L, Eaton SB, Sebastian A, et al.
cardiovascular mortality? Pol-MONICA 2000. Origins and evolution of the Western
Warsaw Project. Kardiol Pol 2006;64:16- 58. Sinnett P, Whyte M, Williams E, et al. diet: health implications for the 21st
23; discussion 4-5. Peasant Agriculturalists. In: Trowell H, century. Am J Clin Nutr 2005;81:341-54.
46. World Health Organization. WHO Global Burkitt D, editors. Western Diseases: 72. Fogel RW. Reconsidering Expectations of
Infobase. Their Emergence and Prevention. Economic Growth After World War II
http://www.who.int/ncd_surveillance/inf London: Edward Arnold, 1981. from the Perspective of 2004.
obase/web/InfoBasePolicyMaker/Reports 59. McMichael AJ. Infectious disease: humans International Monetary Fund (IMF) Staff
/reportListCountries.aspx. 2006. and microbes co-evolving. In: Press CU, Papers 2005;52.
47. Yamaguchi K. Overview of cancer control editor. Human Frontiers, Environments 73. Committee on Diet Nutrition and Cancer,
programs in Japan. Jpn J Clin Oncol and Disease. Past Patterns, Uncertain Assembly of Life Sciences, National
2002;32 Suppl:S22-31. Futures. Cambridge, 2001. Research Council (US). Diet, Nutrition
47A. Sproston K, Primatesa P, editors. Health 60. Proctor R. A question of civilization? and Cancer. Washington, DC: National
Survey for England 2002. London: Cancer Wars. How Politics Shapes What Academy Press, 1982.
Department of Health, 2003. We Know And Dont Know About 74. Committee on Diet and Health, Food and
47B. Rosenbaum S, Skinner R, Knight I, et al. A Cancer. New York: Basic Books, 1995. Nutrition Board, Commission on Life
survey of heights and weights of adults 61. Seymour J. Of industrial man: the land. The Sciences, et al. Diet and Health:
in Great Britain, 1980. Ann Hum Biol Ultimate Heresy. Bideford, Devon: Green Implications for Reducing Chronic
1985;12:115-27. Books, 1989. Disease Risk. Washington, DC: National
48. Eaton SB. The ancestral human diet: what 62. Nestle M. The Mediterannean (diets and Academy Press, 1989.
was it and should it be a paradigm for disease prevention). In: Kiple K, Ornelas 75. World Health Organization. Diet, Nutrition
contemporary nutrition? Proc Nutr Soc K, editors. The Cambridge World History and the Prevention of Chronic Diseases.
2006;65:1-6. of Food. Cambridge: Cambridge Geneva: WHO, 1990.
49. Cohen M. History, diet and hunter- University Press, 2000. 76. Hawkes C. The role of foreign direct
gatherers. In: Kiple K, Ornelas K, editors. 63. Popkin BM. The nutrition transition: an investment in the nutrition transition.
The Cambridge World History of Food. overview of world patterns of change. Public Health Nutr 2005;8:357-65.
Cambridge: Cambridge University Press, Nutr Rev 2004;62:S140-3. 77. Hawkes C. Uneven dietary development:
2000. 64. Pollan M. Industrial. The Omnivores linking the policies and processes of
50. Eaton B, Shostak M, Konner M. The stone Dilemma. The Search for a Prefect Meal globalization with the nutrition
age diet. The Paleolithic Prescription. in a Fast Food World. London: transition, obesity and diet-related
New York: Harper and Row, 1988. Bloomsbury, 2006. chronic diseases. Global Health 2006;2:4.
51. Eaton SB, Shostak M, Konner M. The first 65. Shallenberger R, Wretlind A, Page L. 78. Yach D, Hawkes C, Gould CL, et al. The
fitness formula. The Paleolithic Sugars in food: occurance and usage. In: global burden of chronic diseases:
Prescription. New York: Harper and Row, Sipple H, McNutt K, editors. Sugars in overcoming impediments to prevention
1988. Nutrition. A Nutrition Association and control. JAMA 2004;291:2616-22.
52. Zimmerman M. An experimental study of Monograph. New York: New York 79. Kuhnlein HV, Johns T. Northwest African
mummification pertinent to the Academy Press, 1974. and Middle Eastern food and dietary
411
F O O D , N U T R I T I O N , P H Y S I C A L A C T I V I T Y, A N D T H E P R E V E N T I O N O F C A N C E R : A G L O B A L P E R S P E C T I V E
change of indigenous peoples. Asia Pac J 98. Doll R, Peto R. The causes of cancer: Chapter 2
Clin Nutr 2003;12:344-9. quantitative estimates of avoidable risks
80. Kuhnlein HV, Receveur O, Soueida R, et al. of cancer in the United States today. J
Arctic indigenous peoples experience the Natl Cancer Inst 1981;66:1191-308. 1. Craig WJ. Phytochemicals: guardians of our
nutrition transition with changing 99. Kolonel LN, Hinds MW, Hankin JH. Cancer health. J Am Diet Assoc 1997;97:S199-
dietary patterns and obesity. J Nutr patterns among migrant and native- 204.
2004;134:1447-53. born Japanese in Hawaii in relation to 2. Finley JW. Bioavailability of selenium from
81. World Health Organization. WHO smoking, drinking and dietary habits. In: foods. Nutr Rev 2006;64:146-51.
Nutrition. www.WHO:int/nutrition/ Gelboin, H.V. et al (eds) Genetic and 3. McNaughton SA, Marks GC. Development of
topics/3-foodconsumption/en/print.html. Environmental factors in Experimental a food composition database for the
2006. and Human Cancer. Tokyo: Japan Sci Soc estimation of dietary intakes of
82. Popkin BM. The shift in stages of the Press pp 327-340 1980. glucosinolates, the biologically active
nutrition transition in the developing 100. McMichael AJ, McCall MG, Hartshorne constituents of cruciferous vegetables. Br
world differs from past experiences. JM, et al. Patterns of gastro-intestinal J Nutr 2003;90:687-97.
Public Health Nutr 2002;5:205-14. cancer in European migrants to 4. Finley JW. Proposed criteria for assessing the
83. Popkin BM. Global nutrition dynamics: the Australia: the role of dietary change. Int efficacy of cancer reduction by plant
world is shifting rapidly toward a diet J Cancer 1980;25:431-7. foods enriched in carotenoids,
linked with noncommunicable diseases. 101. McMichael AJ, Giles GG. Cancer in glucosinolates, polyphenols and
Am J Clin Nutr 2006;84:289-98. migrants to Australia: extending the selenocompounds. Ann Bot (Lond)
84. Wu Y. Overweight and obesity in China. descriptive epidemiological data. Cancer 2005;95:1075-96.
BMJ 2006;333:362-3. Res 1988;48:751-6. 5. Milner JA. Molecular targets for bioactive
85. Bell AC, Ge K, Popkin BM. Weight gain and 102. Yavari P, Hislop TG, Bajdik C, et al. food components. J Nutr
its predictors in Chinese adults. Int J Obes Comparison of cancer incidence in Iran 2004;134:2492S-8S.
2001;25:1079-86. and Iranian immigrants to British 6. Barker DJ. The fetal and infant origins of
86. Wang Y, Mi J, Shan XY, et al. Is China facing Columbia, Canada. Asian Pac J Cancer adult disease. BMJ 1990;301:1111.
an obesity epidemic and the Prev 2006;7:86-90. 7. Jackson AA, Bhutta ZA, Lumbiganon P.
consequences? The trends in obesity and 103. Nelson NJ. Migrant studies aid the search Nutrition as a preventative strategy
chronic disease in China. Int J Obes for factors linked to breast cancer risk. J against adverse pregnancy outcomes.
(Lond) 2007;31:177-88. Natl Cancer Inst 2006;98:436-8. Introduction. J Nutr 2003;133:1589S-91S.
87. Silventoinen K, Sans S, Tolonen H, et al. 104. Flood DM, Weiss NS, Cook LS, et al. 8. Bertram C, Trowern AR, Copin N, et al. The
Trends in obesity and energy supply in Colorectal cancer incidence in Asian maternal diet during pregnancy
the WHO MONICA Project. Int J Obes migrants to the United States and their programs altered expression of the
Relat Metab Disord 2004;28:710-8. descendants. Cancer Causes Control glucocorticoid receptor and type 2
88. Department of Health. Forecasting obesity 2000;11:403-11. 11beta-hydroxysteroid dehydrogenase:
to 2010. 105. Hemminki K, Li X. Cancer risks in second- potential molecular mechanisms
http://www.dh.gov.uk/PublicationsAndSt generation immigrants to Sweden. Int J underlying the programming of
atistics/Publications/PublicationsStatistics Cancer 2002;99:229-37. hypertension in utero. Endocrinology
/PublicationsStatisticsArticle/fs/en?CONT 106. Zagorsky JL. Health and wealth. The late- 2001;142:2841-53.
ENT_ID=4138630&chk=XVZ/60. 2006. 20th century obesity epidemic in the U.S. 9. Lillycrop KA, Phillips ES, Jackson AA, et al.
89. Mendez MA, Monteiro CA, Popkin BM. Econ Hum Biol 2005;3:296-313. Dietary protein restriction of pregnant
Overweight exceeds underweight rats induces and folic acid
among women in most developing supplementation prevents epigenetic
countries. Am J Clin Nutr 2005;81:714-21. modification of hepatic gene expression
90. Popkin BM. An overview on the nutrition in the offspring. J Nutr 2005;135:1382-6.
transition and its health implications: the 10. Khaw KT, Wareham N, Luben R, et al.
Bellagio meeting. Public Health Nutr Glycated haemoglobin, diabetes, and
2002;5:93-103. mortality in men in Norfolk cohort of
91. Bull F, Armstrong TP, Dixon T, et al. Physical European prospective investigation of
inactivity. In: Ezzati M, Lopez A, Rodgers cancer and nutrition (EPIC-Norfolk). BMJ
A, et al., editors. Comparative 2001;322:15-8.
quantification of health risks: global and 11. Barnard RJ, Aronson WJ, Tymchuk CN, et al.
regional burden of disease. Geneva: Prostate cancer: another aspect of the
World Health Organization, 2004. insulin-resistance syndrome? Obes Rev
92. National Center for Chronic Disease 2002;3:303-8.
Prevention and Health Promotion. 12. Uauy R, Solomons N. Diet, nutrition, and
Physical Activity and Health. A report of the life-course approach to cancer
the Surgeon General. prevention. J Nutr 2005;135:2934S-45S.
http://www.cdc.gov/nccdphp/sgr/sgr.htm. 13. Calle EE, Kaaks R. Overweight, obesity and
1999. cancer: epidemiological evidence and
93. Mackay J, Jemal A, Lee N, et al. The Cancer proposed mechanisms. Nat Rev Cancer
Atlas: American Cancer Society, 2006. 2004;4:579-91.
94. Parkin DM, Bray F, Ferlay J, et al. Global 14. Lane DP. Cancer. p53, guardian of the
cancer statistics, 2002. CA Cancer J Clin genome. Nature 1992;358:15-6.
2005;55:74-108. 15. Birch JM. Li-Fraumeni syndrome. Eur J
95. Parkin DM. International variation. Cancer 1994;30A:1935-41.
Oncogene 2004;23:6329-40. 16. Dashwood RH, Myzak MC, Ho E. Dietary
96. Parkin DM, Whelan SL, Ferlay J, et al. HDAC inhibitors: time to rethink weak
Cancer Incidence in Five Continents, Vol I ligands in cancer chemoprevention?
to VIII. IARC CancerBase 2005;7. Carcinogenesis 2006;27:344-9.
97. Key TJ, Allen NE, Spencer EA, et al. The 17. Esquela-Kerscher A, Slack FJ. Oncomirs
effect of diet on risk of cancer. Lancet microRNAs with a role in cancer. Nat Rev
2002;360:861-8. Cancer 2006;6:259-69.
412
R E F E R E N C E S
18. Romney SL, Ho GY, Palan PR, et al. Effects Nutritional modulation of DNA repair in Metab 2000;1:107-32.
of beta-carotene and other factors on a human intervention study. 54. Hubner RA, Houlston RS. MTHFR C677T
outcome of cervical dysplasia and human Carcinogenesis 2003;24:511-5. and colorectal cancer risk: A meta-
papillomavirus infection. Gynecol Oncol 37. Astley SB, Elliott RM, Archer DB, et al. analysis of 25 populations. Int J Cancer
1997;65:483-92. Evidence that dietary supplementation 2007;120:1027-35.
19. Kim YI, Giuliano A, Hatch KD, et al. Global with carotenoids and carotenoid-rich 55. Le Marchand L. Meat intake, metabolic
DNA hypomethylation increases foods modulates the DNA damage: genes and colorectal cancer. IARC Sci
progressively in cervical dysplasia and repair balance in human lymphocytes. Br Publ 2002;156:481-5.
carcinoma. Cancer 1994;74:893-9. J Nutr 2004;91:63-72. 56. Brennan P, Hsu CC, Moullan N, et al. Effect
20. Giovannucci E. Epidemiologic studies of 38. Tomasetti M, Alleva R, Borghi B, et al. In of cruciferous vegetables on lung cancer
folate and colorectal neoplasia: a review. vivo supplementation with coenzyme in patients stratified by genetic status: a
J Nutr 2002;132:2350S-5S. Q10 enhances the recovery of human mendelian randomisation approach.
21. Jordan CT, Guzman ML, Noble M. Cancer lymphocytes from oxidative DNA Lancet 2005;366:1558-60.
stem cells. N Engl J Med 2006;355:1253- damage. Faseb J 2001;15:1425-7. 57. Weinberg ED. The role of iron in cancer.
61. 39. Seo YR, Sweeney C, Smith ML. Eur J Cancer Prev 1996;5:19-36.
22. Polyak K, Hahn WC. Roots and stems: stem Selenomethionine induction of DNA 58. McCord JM. Iron, free radicals, and
cells in cancer. Nat Med 2006;12:296-300. repair response in human fibroblasts. oxidative injury. Semin Hematol
23. Al-Hajj M, Wicha MS, Benito-Hernandez A, Oncogene 2002;21:3663-9. 1998;35:5-12.
et al. Prospective identification of 40. Kiss I, Sandor J, Ember I. Allelic 59. Huang X. Iron overload and its association
tumorigenic breast cancer cells. Proc Natl polymorphism of GSTM1 and NAT2 with cancer risk in humans: evidence for
Acad Sci USA 2003;100:3983-8. genes modifies dietary-induced DNA iron as a carcinogenic metal. Mutat Res
24. Hemmati HD, Nakano I, Lazareff JA, et al. damage in colorectal mucosa. Eur J 2003;533:153-71.
Cancerous stem cells can arise from Cancer Prev 2000;9:429-32. 60. Lewin MH, Bailey N, Bandaletova T, et al.
pediatric brain tumors. Proc Natl Acad 41. Arab L, Steck-Scott S, Fleishauer AT. Red meat enhances the colonic
Sci USA 2003;100:15178-83. Lycopene and the lung. Exp Biol Med formation of the DNA adduct O6-
25. Singh SK, Clarke ID, Terasaki M, et al. (Maywood) 2002;227:894-9. carboxymethyl guanine: implications for
Identification of a cancer stem cell in 42. Aguiar M, Masse R, Gibbs BF. Regulation of colorectal cancer risk. Cancer Res
human brain tumors. Cancer Res cytochrome P450 by posttranslational 2006;66:1859-65.
2003;63:5821-8. modification. Drug Metab Rev 61. Talalay P, Fahey JW. Phytochemicals from
26. Bapat SA, Mali AM, Koppikar CB, et al. 2005;37:379-404. cruciferous plants protect against cancer
Stem and progenitor-like cells contribute 43. van Rees BP, Ristimaki A. Cyclooxygenase-2 by modulating carcinogen metabolism. J
to the aggressive behavior of human in carcinogenesis of the gastrointestinal Nutr 2001;131:3027S-33S.
epithelial ovarian cancer. Cancer Res tract. Scand J Gastroenterol 2001;36:897- 62. Kojima T, Tanaka T, Mori H.
2005;65:3025-9. 903. Chemoprevention of spontaneous
27. Collins AT, Berry PA, Hyde C, et al. 44. Hein DW. Molecular genetics and function endometrial cancer in female Donryu
Prospective identification of tumorigenic of NAT1 and NAT2: role in aromatic rats by dietary indole-3-carbinol. Cancer
prostate cancer stem cells. Cancer Res amine metabolism and carcinogenesis. Res 1994;54:1446-9.
2005;65:10946-51. Mutat Res 2002;506-507:65-77. 63. Kang ZC, Tsai SJ, Lee H. Quercetin inhibits
28. Ricci-Vitiani L, Lombardi DG, Pilozzi E, et al. 45. Sheweita SA, Tilmisany AK. Cancer and benzo[a]pyrene-induced DNA adducts in
Identification and expansion of human phase II drug-metabolizing enzymes. human Hep G2 cells by altering
colon-cancer-initiating cells. Nature Curr Drug Metab 2003;4:45-58. cytochrome P-450 1A1 gene expression.
2007;445:111-5. 46. Lee JS, Surh YJ. Nrf2 as a novel molecular Nutr Cancer 1999;35:175-9.
29. Houghton J, Stoicov C, Nomura S, et al. target for chemoprevention. Cancer Lett 64. Goodman GE, Thornquist MD, Balmes J, et
Gastric cancer originating from bone 2005;224:171-84. al. The Beta-Carotene and Retinol
marrow-derived cells. Science 47. Fujita K. Food-drug interactions via human Efficacy Trial: incidence of lung cancer
2004;306:1568-71. cytochrome P450 3A (CYP3A). Drug and cardiovascular disease mortality
30. Nkondjock A, Shatenstein B, Maisonneuve Metabol Drug Interact 2004;20:195-217. during 6-year follow-up after stopping
P, et al. Specific fatty acids and human 48. Harris RZ, Jang GR, Tsunoda S. Dietary beta-carotene and retinol supplements. J
colorectal cancer: an overview. Cancer effects on drug metabolism and Natl Cancer Inst 2004;96:1743-50.
Detect Prev 2003;27:55-66. transport. Clin Pharmacokinet 65. UK Food Standards Agency. Safe Upper
31. Roynette CE, Calder PC, Dupertuis YM, et 2003;42:1071-88. Levels for Vitamins and Minerals.
al. n-3 polyunsaturated fatty acids and 49. Okey AB, Boutros PC, Harper PA. http://www.food.gov.uk/multimedia/pdf
colon cancer prevention. Clin Nutr Polymorphisms of human nuclear s/vitmin2003.pdf. 2003.
2004;23:139-51. receptors that control expression of 66. Hursting SD, Lavigne JA, Berrigan D, et al.
32. Hoeijmakers JH. Genome maintenance drug-metabolizing enzymes. Calorie restriction, aging, and cancer
mechanisms for preventing cancer. Pharmacogenet Genomics 2005;15:371- prevention: mechanisms of action and
Nature 2001;411:366-74. 9. applicability to humans. Annu Rev Med
33. Larsen NB, Rasmussen M, Rasmussen LJ. 50. Davis CD, Milner J. Frontiers in 2003;54:131-52.
Nuclear and mitochondrial DNA repair: nutrigenomics, proteomics, 67. Stattin P, Lukanova A, Biessy C, et al.
similar pathways? Mitochondrion metabolomics and cancer prevention. Obesity and colon cancer: does leptin
2005;5:89-108. Mutat Res 2004;551:51-64. provide a link? Int J Cancer
34. Gonzalez C, Najera O, Cortes E, et al. 51. Hayes JD, Flanagan JU, Jowsey IR. 2004;109:149-52.
Hydrogen peroxide-induced DNA Glutathione transferases. Annu Rev 68. Chang S, Hursting SD, Contois JH, et al.
damage and DNA repair in lymphocytes Pharmacol Toxicol 2005;45:51-88. Leptin and prostate cancer. Prostate
from malnourished children. Environ 52. Seow A, Yuan JM, Sun CL, et al. Dietary 2001;46:62-7.
Mol Mutagen 2002;39:33-42. isothiocyanates, glutathione S- 69. The Endogenous Hormones and Breast
35. Wei Q, Shen H, Wang LE, et al. Association transferase polymorphisms and Cancer Collaborative Group.
between low dietary folate intake and colorectal cancer risk in the Singapore Endogenous sex hormones and breast
suboptimal cellular DNA repair capacity. Chinese Health Study. Carcinogenesis cancer in postmenopausal women:
Cancer Epidemiol Biomarkers Prev 2002;23:2055-61. reanalysis of nine prospective studies. J
2003;12:963-9. 53. Sheweita SA. Drug-metabolizing enzymes: Natl Cancer Inst 2002;94:606-16.
36. Collins AR, Harrington V, Drew J, et al. mechanisms and functions. Curr Drug 70. Kaaks R, Lukanova A, Kurzer MS. Obesity,
413
F O O D , N U T R I T I O N , P H Y S I C A L A C T I V I T Y, A N D T H E P R E V E N T I O N O F C A N C E R : A G L O B A L P E R S P E C T I V E
endogenous hormones, and endometrial 88. Trikha M, Corringham R, Klein B, et al. 105. Nishikawa A, Mori Y, Lee IS, et al.
cancer risk: a synthetic review. Cancer Targeted anti-interleukin-6 monoclonal Cigarette smoking, metabolic activation
Epidemiol Biomarkers Prev antibody therapy for cancer: a review of and carcinogenesis. Curr Drug Metab
2002;11:1531-43. the rationale and clinical evidence. Clin 2004;5:363-73.
71. Rexrode KM, Pradhan A, Manson JE, et al. Cancer Res 2003;9:4653-65. 106. Alberg A. The influence of cigarette
Relationship of total and abdominal 89. Dijsselbloem N, Vanden Berghe W, De smoking on circulating concentrations of
adiposity with CRP and IL-6 in women. Naeyer A, et al. Soy isoflavone phyto- antioxidant micronutrients. Toxicology
Ann Epidemiol 2003;13:674-82. pharmaceuticals in interleukin-6 2002;180:121-37.
72. Loffreda S, Yang SQ, Lin HZ, et al. Leptin affections. Multi-purpose nutraceuticals 107. Piyathilake CJ, Henao OL, Macaluso M, et
regulates proinflammatory immune at the crossroad of hormone al. Folate is associated with the natural
responses. Faseb J 1998;12:57-65. replacement, anti-cancer and anti- history of high-risk human
73. Le Roith D, Bondy C, Yakar S, et al. The inflammatory therapy. Biochem papillomaviruses. Cancer Res
somatomedin hypothesis: 2001. Endocr Pharmacol 2004;68:1171-85. 2004;64:8788-93.
Rev 2001;22:53-74. 90. Petersen AM, Pedersen BK. The anti- 108. Moller P, Loft S. Oxidative DNA damage in
74. Doll R, Peto R. The causes of cancer: inflammatory effect of exercise. J Appl human white blood cells in dietary
quantitative estimates of avoidable risks Physiol 2005;98:1154-62. antioxidant intervention studies. Am J
of cancer in the United States today. J 91. Nieman DC. Nutrition, exercise, and Clin Nutr 2002;76:303-10.
Natl Cancer Inst 1981;66:1191-308. immune system function. Clin Sports 109. Hites RA, Foran JA, Schwager SJ, et al.
75. World Health Organization and Med 1999;18:537-48. Global assessment of polybrominated
International Agency for Research on 92. Stickel F, Schuppan D, Hahn EG, et al. diphenyl ethers in farmed and wild
Cancer. World Cancer Report. Lyon: IARC Cocarcinogenic effects of alcohol in salmon. Environ Sci Technol
Press, 2003. hepatocarcinogenesis. Gut 2002;51:132- 2004;38:4945-9.
76. Coussens LM, Werb Z. Inflammation and 9. 110. Davies S. Subsequent malignant
cancer. Nature 2002;420:860-7. 93. Bowlus CL. The role of iron in T cell neoplasms in survivors of childhood
77. Smyth MJ, Dunn GP, Schreiber RD. Cancer development and autoimmunity. cancer: Childhood Cancer Survivor Study
immunosurveillance and Autoimmun Rev 2003;2:73-8. (CCSS) studies. Pediatr Blood Cancer
immunoediting: the roles of immunity in 94. Latunde-Dada GO, Young SP. Iron 2007;48:727-30.
suppressing tumor development and deficiency and immune responses. Scand 111. Hanahan D, Weinberg RA. The hallmarks
shaping tumor immunogenicity. Adv J Immunol Suppl 1992;11:207-9. of cancer. Cell 2000;100:57-70.
Immunol 2006;90:1-50. 95. Ekiz C, Agaoglu L, Karakas Z, et al. The 112. Sharpless NE, DePinho RA. Cancer: crime
78. Zitvogel L, Tesniere A, Kroemer G. Cancer effect of iron deficiency anemia on the and punishment. Nature 2005;436:636-7.
despite immunosurveillance: function of the immune system. Hematol 113. Bohnsack BL, Hirschi KK. Nutrient
immunoselection and J 2005;5:579-83. regulation of cell cycle progression.
immunosubversion. Nat Rev Immunol 96. Bosetti C, Negri E, Trichopoulos D, et al. Annu Rev Nutr 2004;24:433-53.
2006;6:715-27. Long-term effects of oral contraceptives 114. Lotan R. Aberrant expression of retinoid
79. Miura S, Tsuzuki Y, Hokari R, et al. on ovarian cancer risk. Int J Cancer receptors and lung carcinogenesis. J Natl
Modulation of intestinal immune system 2002;102:262-5. Cancer Inst 1999;91:989-91.
by dietary fat intake: relevance to 97. Genazzani A. Hormone Replacement 115. Palan PR, Chang CJ, Mikhail MS, et al.
Crohns disease. J Gastroenterol Hepatol Therapy and Cancer: The Current Status Plasma concentrations of micronutrients
1998;13:1183-90. of Research and Practice. New York: during a nine-month clinical trial of
80. Tlaskalova-Hogenova H, Tuckova L, Parthenon, 2002. beta-carotene in women with precursor
Lodinova-Zadnikova R, et al. Mucosal 98. Hannaford P, Elliott A. Use of exogenous cervical cancer lesions. Nutr Cancer
immunity: its role in defense and allergy. hormones by women and colorectal 1998;30:46-52.
Int Arch Allergy Immunol 2002;128:77- cancer: evidence from the Royal College 116. Butterworth C, Jr., Hatch K, Gore H, et al.
89. of General Practitioners Oral Improvement in cervical dysplasia
81. Hanna MK, Kudsk KA. Nutritional and Contraception Study. Contraception associated with folic acid therapy in users
pharmacological enhancement of gut- 2005;71:95-8. of oral contraceptives. Am J Clin Nutr,
associated lymphoid tissue. Can J 99. Collaborative Group on Hormonal Factors 1982:73-82.
Gastroenterol 2000;14 Suppl D:145D- in Breast Cancer. Breast cancer and 117. Abu J, Batuwangala M, Herbert K, et al.
51D. breastfeeding: collaborative reanalysis Retinoic acid and retinoid receptors:
82. Kudsk KA. Current aspects of mucosal of individual data from 47 potential chemopreventive and
immunology and its influence by epidemiological studies in 30 countries, therapeutic role in cervical cancer. Lancet
nutrition. Am J Surg 2002;183:390-8. including 50302 women with breast Oncol 2005;6:712-20.
83. Gleeson M, Nieman DC, Pedersen BK. cancer and 96973 women without the 118. Chen C, Kong AN. Dietary cancer-
Exercise, nutrition and immune function. disease. Lancet 2002;20:187-95. chemopreventive compounds: from
J Sports Sci 2004;22:115-25. 100. Smith JS, Green J, Berrington de Gonzalez signaling and gene expression to
84. Kubena KS, McMurray DN. Nutrition and A, et al. Cervical cancer and use of pharmacological effects. Trends
the immune system: a review of nutrient- hormonal contraceptives: a systematic Pharmacol Sci 2005;26:318-26.
nutrient interactions. J Am Diet Assoc review. Lancet 2003;361:1159-67. 119. Li N, Sun Z, Han C, et al. The
1996;96:1156-64; quiz 65-6. 101. Lacey JV, Jr., Mink PJ, Lubin JH, et al. chemopreventive effects of tea on
85. Levi RS, Sanderson IR. Dietary regulation of Menopausal hormone replacement human oral precancerous mucosa
gene expression. Curr Opin therapy and risk of ovarian cancer. JAMA lesions. Proc Soc Exp Biol Med
Gastroenterol 2004;20:139-42. 2002;288:334-41. 1999;220:218-24.
86. Wieringa FT, Dijkhuizen MA, West CE, et al. 102. Pike MC, Pearce CL, Wu AH. Prevention of 120. Strauss L, Santti R, Saarinen N, et al.
Reduced production of cancers of the breast, endometrium and Dietary phytoestrogens and their role in
immunoregulatory cytokines in vitamin ovary. Oncogene 2004;23:6379-91. hormonally dependent disease. Toxicol
A- and zinc-deficient Indonesian infants. 103. Mackay J, Eriksen M, Shafey O. The Lett 1998;102-103:349-54.
Eur J Clin Nutr 2004;58:1498-504. Tobacco Atlas. 2nd ed. Atlanta: American 121. Adlercreutz H. Phyto-oestrogens and
87. Marcos A, Nova E, Montero A. Changes in Cancer Society, 2006. cancer. Lancet Oncol 2002;3:364-73.
the immune system are conditioned by 104. Mackay J, Jemal A, Lee N, et al. The 122. Niculescu MD, Pop EA, Fischer LM, et al.
nutrition. Eur J Clin Nutr 2003;57 Suppl Cancer Atlas. Atlanta: American Cancer Dietary isoflavones differentially induce
1:S66-9. Society, 2006. gene expression changes in lymphocytes
414
R E F E R E N C E S
from postmenopausal women who form randomized clinical trial. Cancer from hyperoxia-induced apoptosis. J
equol as compared with those who do Epidemiol Biomarkers Prev Neurosci Res 1998;52:184-91.
not. J Nutr Biochem 2006;18:380-90. 2005;14:1020-1. 153. Folkman J. Fundamental concepts of the
123. Lamprecht S, Lipkin M. Cellular 137. Schmitz KH, Ahmed RL, Yee D. Effects of a angiogenic process. Curr Mol Med
mechanisms of calcium and vitamin D in 9-month strength training intervention 2003;3:643-51.
the inhibition of colorectal on insulin, insulin-like growth factor 154. Cao Y, Cao R. Angiogenesis inhibited by
carcinogenesis. Ann NY Acad Sci (IGF)-I, IGF-binding protein (IGFBP)-1, drinking tea. Nature 1999;398:381.
2001;952:73-87. and IGFBP-3 in 30-50-year-old women. 155. Rose DP, Connolly JM. Regulation of
124. Sesink AL, Termont DS, Kleibeuker JH, et Cancer Epidemiol Biomarkers Prev tumor angiogenesis by dietary fatty
al. Red meat and colon cancer: the 2002;11:1597-604. acids and eicosanoids. Nutr Cancer
cytotoxic and hyperproliferative effects 138. Colbert LH, Mai V, Perkins SN, et al. 2000;37:119-27.
of dietary heme. Cancer Res Exercise and intestinal polyp 156. Matsuura N, Miyamae Y, Yamane K, et al.
1999;59:5704-9. development in APCMin mice. Med Sci Aged garlic extract inhibits angiogenesis
125. Knowles LM, Milner JA. Possible Sports Exerc 2003;35:1662-9. and proliferation of colorectal
mechanism by which allyl sulfides 139. Thompson HJ, Zhu Z, Jiang W. Dietary carcinoma cells. J Nutr 2006;136:842S-6S.
suppress neoplastic cell proliferation. J energy restriction in breast cancer 157. Bailey AP, Shparago M, Gu JW. Exercise
Nutr 2001;131:1061S-6S. prevention. J Mammary Gland Biol increases soluble vascular endothelial
126. Rao CV, Hirose Y, Indranie C, et al. Neoplasia 2003;8:133-42. growth factor receptor-1 (sFlt-1) in
Modulation of experimental colon 140. Zhu Z, Jiang W, McGinley J, et al. Effects circulation of healthy volunteers. Med
tumorigenesis by types and amounts of of dietary energy repletion and IGF-1 Sci Monit 2006;12:CR45-50.
dietary fatty acids. Cancer Res infusion on the inhibition of mammary 158. Roomi MW, Ivanov V, Kalinovsky T, et al.
2001;61:1927-33. carcinogenesis by dietary energy Inhibition of matrix metalloproteinase-2
127. Gupta RA, Tan J, Krause WF, et al. restriction. Mol Carcinog 2005;3:170-6. secretion and invasion by human ovarian
Prostacyclin-mediated activation of 141. Mawson A, Lai A, Carroll JS, et al. cancer cell line SK-OV-3 with lysine,
peroxisome proliferator-activated Estrogen and insulin/IGF-1 cooperatively proline, arginine, ascorbic acid and
receptor delta in colorectal cancer. Proc stimulate cell cycle progression in MCF-7 green tea extract. J Obstet Gynaecol Res
Natl Acad Sci USA 2000;97:13275-80. breast cancer cells through differential 2006;32:148-54.
128. Price PT, Nelson CM, Clarke SD. Omega-3 regulation of c-Myc and cyclin D1. Mol 159. Hahn T, Szabo L, Gold M, et al. Dietary
polyunsaturated fatty acid regulation of Cell Endocrinol 2005;229:161-73. administration of the proapoptotic
gene expression. Curr Opin Lipidol 142. Wood JG, Rogina B, Lavu S, et al. Sirtuin vitamin E analogue {alpha}-
2000;11:3-7. activators mimic caloric restriction and tocopheryloxyacetic acid inhibits
129. Novak TE, Babcock TA, Jho DH, et al. NF- delay ageing in metazoans. Nature metastatic murine breast cancer. Cancer
kappa B inhibition by omega-3 fatty 2004;430:686-9. Res 2006;66:9374-8.
acids modulates LPS-stimulated 143. Fischer U, Schulze-Osthoff K. Apoptosis-
macrophage TNF-alpha transcription. based therapies and drug targets. Cell
Am J Physiol Lung Cell Mol Physiol Death Differ 2005;12 Suppl 1:942-61.
2003;284:L84-9. 144. Mihara M, Erster S, Zaika A, et al. p53 has
130. Collett ED, Davidson LA, Fan YY, et al. n-6 a direct apoptogenic role at the
and n-3 polyunsaturated fatty acids mitochondria. Mol Cell 2003;11:577-90.
differentially modulate oncogenic Ras 145. Thompson HJ, Zhu Z, Jiang W. Weight
activation in colonocytes. Am J Physiol control and breast cancer prevention:
Cell Physiol 2001;280:C1066-75. are the effects of reduced energy intake
131. Chapkin RS, Clark AE, Davidson LA, et al. equivalent to those of increased energy
Dietary fiber differentially alters cellular expenditure? J Nutr 2004;134:3407S-11S.
fatty acid-binding protein expression in 146. Salganik RI, Albright CD, Rodgers J, et al.
exfoliated colonocytes during tumor Dietary antioxidant depletion:
development. Nutr Cancer 1998;32:107- enhancement of tumor apoptosis and
12. inhibition of brain tumor growth in
132. LeRoith D, Baserga R, Helman L, et al. transgenic mice. Carcinogenesis
Insulin-like growth factors and cancer. 2000;21:909-14.
Ann Intern Med 1995;122:54-9. 147. Albright CD, Salganik RI, Van Dyke T.
133. Yakar S, Leroith D, Brodt P. The role of the Dietary depletion of vitamin E and
growth hormone/insulin-like growth vitamin A inhibits mammary tumor
factor axis in tumor growth and growth and metastasis in transgenic
progression: lessons from animal models. mice. J Nutr 2004;134:1139-44.
Cytokine Growth Factor Rev 148. Watson WH, Cai J, Jones DP. Diet and
2005;16:407-20. apoptosis. Annu Rev Nutr 2000;20:485-
134. Fenton JI, Hord NG, Lavigne JA, et al. 505.
Leptin, insulin-like growth factor-1, and 149. Khan H, Afaq F, Mukhtar H. Apoptosis by
insulin-like growth factor-2 are mitogens dietary factors: the suicide solution for
in ApcMin/+ but not Apc+/+ colonic delaying cancer growth. Carcinogenesis
epithelial cell lines. Cancer Epidemiol 2007;28:233-9.
Biomarkers Prev 2005;14:1646-52. 150. Sun S, Hail N, Lotan R. Apoptosis as a
135. Grimm JJ. Interaction of physical activity novel target for cancer
and diet: implications for insulin-glucose chemoprevention. J Natl Cancer Inst
dynamics. Public Health Nutr 1999;2:363- 2004;96:662-72.
8. 151. Gunawardena K, Murray DK, Meikle AW.
136. McTiernan A, Sorensen B, Yasui Y, et al. Vitamin E and other antioxidants inhibit
No effect of exercise on insulin-like human prostate cancer cells through
growth factor 1 and insulin-like growth apoptosis. Prostate 2000;44:287-95.
factor binding protein 3 in 152. Takahashi H, Kosaka N, Nakagawa S.
postmenopausal women: a 12-month alpha-Tocopherol protects PC12 cells
415
F O O D , N U T R I T I O N , P H Y S I C A L A C T I V I T Y, A N D T H E P R E V E N T I O N O F C A N C E R : A G L O B A L P E R S P E C T I V E
416
R E F E R E N C E S
50. Black RJ, Bray F, Ferlay J, et al. Cancer Chapter 4 14. Koh WP, Yuan JM, van den Berg D, et al.
incidence and mortality in the European Interaction between cyclooxygenase-2
Union: cancer registry data and gene polymorphism and dietary n-6
estimates of national incidence for 1990. Chapter 4.1 polyunsaturated fatty acids on colon
Eur J Cancer 1997;33:1075-107. cancer risk: The Singapore Chinese
51. Fritz AG, Percy C, Jack A, et al., editors. 1. Burkitt DP, Trowell HC. Dietary fibre and Health Study. Br J Cancer 2004;90:1760-4.
International Classification of Diseases western diseases. Ir Med J 1977;70:272-7. 15. Tjonneland AM, Overvad K, Bingham SA,
for Oncology. Geneva: World Health 2. Trowell H, Burkitt D. Physiological role of et al. Dietary fibers protect against
Organization, 2000. dietary fiber: a ten-year review. ASDC J colorectal cancer among the participants
52. Hill AB. The environment and disease: Dent Child 1986;53:444-7. in the European Prospective
association or causation? Proc R Soc Med 3. World Health Organization. 2003. Diet, Investigation into Cancer and Nutrition
1965;58:295-300. Nutrition and the Prevention of Chronic (EPiC) study. Ugeskr Laeger
53. US Surgeon Generals Advisory Committee Diseases: Report of a Joint WHO/FAO 2004;166:2458-60.
on Smoking and Health. Smoking and Expert Consultation. In: WHO Technical 16. Sellers TTA, Bazyk AAE, Bostick RRM, et al.
Health: Report of the Advisory Report Series no 916. Diet and risk of colon cancer in a large
Committee to the Surgeon General of http://www.who.int/entity/dietphysicalac prospective study of older women: an
the Public Health Service. Washington, tivity/publications/trs916/download/en/i analysis stratified on family history
DC: US Department of Health, ndex.html. (Iowa, United States). Cancer Causes
Education, and Welfare, 1964. 4. World Health Organization. 1990. Diet, Control 1998;9:357-67.
Nutrition, and the Prevention of Chronic 17. Michels KB, Fuchs CS, Giovannucci E, et al.
Diseases. Report of a WHO Study Group. Fiber intake and incidence of colorectal
In: WHO Technical Report Series no 797. cancer among 76,947 women and 47,279
5. International Agency for Research on men. Cancer Epidemiol Biomarkers Prev
Cancer. 2002. Some Traditional Herbal 2005;14:842-9.
Medicines, Some Mycotoxins, 18. Wark PA, Weijenberg MP, van t Veer P, et
Naphthalene and Styrene. In: IARC al. Fruits, vegetables, and hMLH1
Monogr Eval Carcinog Risks Hum no 82. protein-deficient and -proficient colon
http://monographs.iarc.fr/ENG/Monogra cancer: The Netherlands cohort study.
phs/vol82/volume82.pdf. Cancer Epidemiol Biomarkers Prev
6. Food and Agriculture Organization of the 2005;14:1619-25.
United Nations, World Health 19. Heilbrun LK, Nomura A, Hankin JH, et al.
Organization, United Nations Diet and colorectal cancer with special
Environment Programme International. reference to fiber intake. Int J Cancer
1999. Third Joint FAO/WHO/UNEP 1989;44:1-6.
International Conference on Mycotoxins. 20. Bostick RM, Potter JD, Sellers TA, et al.
ftp://ftp.fao.org/es/esn/food/meetings/m Relation of calcium, vitamin D, and dairy
ycotoxins_report_en.pdf. food intake to incidence of colon cancer
7. Bingham S. Food components and among older women. The Iowa Womens
mechanisms of interest in cancer and Health Study. Am J Epidemiol
diet in relation to their measurement. 1993;137:1302-17.
Eur J Clin Nutr 1993;47 Suppl 2:S73-7. 21. Konings EJ, Goldbohm RA, Brants HA, et al.
8. Englyst HN, Kingman SM, Cummings JH. Intake of dietary folate vitamers and risk
Classification and measurement of of colorectal carcinoma: results from The
nutritionally important starch fractions. Netherlands Cohort Study. Cancer
Eur J Clin Nutr 1992;46 Suppl 2:S33-50. 2002;95:1421-33.
9. Norat T, Bingham S, Ferrari P, et al. Meat, 22. Sanjoaquin MA, Appleby PN, Thorogood
fish, and colorectal cancer risk: the M, et al. Nutrition, lifestyle and
European Prospective Investigation into colorectal cancer incidence: a
cancer and nutrition. J Natl Cancer Inst prospective investigation of 10998
2005;97:906-16. vegetarians and non-vegetarians in the
10. Mathers JC. Pulses and carcinogenesis: United Kingdom. Br J Cancer
potential for the prevention of colon, 2004;90:118-21.
breast and other cancers. Br J Nutr 23. Wu AH, Paganini Hill A, Ross RK, et al.
2002;88 Suppl 3:S273-9. Alcohol, physical activity and other risk
11. Voorrips LE, Goldbohm RA, van Poppel G, factors for colorectal cancer: a
et al. Vegetable and fruit consumption prospective study. Br J Cancer
and risks of colon and rectal cancer in a 1987;55:687-94.
prospective cohort study: The 24. Colbert LH, Hartman TJ, Malila N, et al.
Netherlands Cohort Study on Diet and Physical activity in relation to cancer of
Cancer. Am J Epidemiol 2000;152:1081- the colon and rectum in a cohort of male
92. smokers. Cancer Epidemiol Biomarkers
12. Tangrea J, Helzlsouer K, Pietinen P, et al. Prev 2001;10:265-8.
Serum levels of vitamin D metabolites 25. McCullough ML, Robertson AS, Chao A, et
and the subsequent risk of colon and al. A prospective study of whole grains,
rectal cancer in Finnish men. Cancer fruits, vegetables and colon cancer risk.
Causes Control 1997;8:615-25. Cancer Causes Control 2003;14:959-70.
13. Wong HL, Seow A, Arakawa K, et al. 26. Mai V, Flood A, Peters U, et al. Dietary fibre
Vitamin D receptor start codon and risk of colorectal cancer in the Breast
polymorphism and colorectal cancer risk: Cancer Detection Demonstration Project
effect modification by dietary calcium (BCDDP) follow-up cohort. Int J
and fat in Singapore Chinese. Epidemiol 2003;32:234-9.
Carcinogenesis 2003;24:1091-5. 27. Higginbotham S, Zhang ZF, Lee IM, et al.
417
F O O D , N U T R I T I O N , P H Y S I C A L A C T I V I T Y, A N D T H E P R E V E N T I O N O F C A N C E R : A G L O B A L P E R S P E C T I V E
Dietary glycemic load and risk of calcium, fiber and other micronutrients Taiwan. Nutr. Res. 2003;23:1597-606.
colorectal cancer in the Womens Health in relation to colorectal cancer risk: 60. Sichieri R, Everhart JE, Mendona GAS. Diet
Study. J Natl Cancer Inst 2004;96:229-33. results from the Shanghai Womens and mortality from common cancers in
28. Bingham SA, Day NE, Luben R, et al. Health Study. Int J Cancer 2006;119:2938- Brazil: an ecological study. Cad Saude
Dietary fibre in food and protection 42. Publica 1996;12:53-9.
against colorectal cancer in the 44. Lin J, Zhang SM, Cook NR, et al. Dietary 61. Tzonou A, Lipworth L, Garidou A, et al.
European Prospective Investigation into intakes of fruit, vegetables, and fiber, Diet and risk of esophageal cancer by
Cancer and Nutrition (EPIC): an and risk of colorectal cancer in a histologic type in a low-risk population.
observational study. Lancet prospective cohort of women (United Int J Cancer 1996;68:300-4.
2003;361:1496-501. States). Cancer Causes Control 62. Terry P, Lagergren J, Hansen H, et al. Fruit
29. Steinmetz KA, Kushi LH, Bostick RM, et al. 2005;16:225-33. and vegetable consumption in the
Vegetables, fruit, and colon cancer in the 45. MacInnis RJ, English DR, Haydon AM, et al. prevention of oesophageal and cardia
Iowa Womens Health Study. Am J Body size and composition and risk of cancers. Eur J Cancer Prev 2001;10:365-9.
Epidemiol 1994;139:1-15. rectal cancer (Australia). Cancer Causes 63. Sun CA, Wang LY, Chen Chien J, et al.
30. Pietinen P, Malila N, Virtanen M, et al. Diet Control 2006;17:1291-7. Genetic polymorphisms of glutathione S-
and risk of colorectal cancer in a cohort 46. Bingham SA, Norat T, Moskal A, et al. Is the transferases M1 and T1 associated with
of Finnish men. Cancer Causes Control association with fiber from foods in susceptibility to aflatoxin-related
1999;10:387-96. colorectal cancer confounded by folate hepatocarcinogenesis among chronic
31. Glynn SA, Albanes D, Pietinen P, et al. intake? Cancer Epidemiol Biomarkers hepatitis B carriers: a nested case-control
Colorectal cancer and folate status: a Prev 2005;14:1552-6. study. Carcinogenesis 2001;22:1289-94.
nested case-control study among male 47. Wakai K, Hirose K, Matsuo K, et al. Dietary 64. Chen CJ, Yu MW, Liaw YF, et al. Chronic
smokers. Cancer Epidemiol Biomarkers risk factors for colon and rectal cancers: a hepatitis B carriers with null genotypes
Prev 1996;5:487-94. comparative case-control study. J of glutathione S-transferase M1 and T1
32. Giovannucci E. Intake of fat, meat and Epidemiol 2006;16:125-35. polymorphisms who are exposed to
fiber in relation to risk of colon cancer in 48. Kasum CM, Jacobs DR, Jr., Nicodemus K, et aflatoxin are at increased risk of
men. Cancer Res 1994;54:2390-7. al. Dietary risk factors for upper hepatocellular carcinoma. Am J Hum
33. Fuchs CS, Giovannucci EL, Colditz GA, et al. aerodigestive tract cancers. Int J Cancer Genet 1996;59:128-34.
Dietary fiber and the risk of colorectal 2002;99:267-72. 65. Yu MW, Lien JP, Chiu YH, et al. Effect of
cancer and adenoma in women. N Engl J 49. Tzonou A, Lipworth L, Kalandidi A, et al. aflatoxin metabolism and DNA adduct
Med 1999;340:169-76. Dietary factors and the risk of formation on hepatocellular carcinoma
34. Terry P, Giovannucci E, Michels KB, et al. endometrial cancer: a case - control among chronic hepatitis B carriers in
Fruit, vegetables, dietary fiber and risk of study in Greece. Br J Cancer Taiwan. J Hepatol 1997;27:320-30.
colorectal cancer. J Natl Cancer Inst 1996;73:1284-90. 66. Wang LY, Hatch M, Chen CJ, et al. Aflatoxin
2001;93:525-33. 50. Chen H, Tucker KL, Graubard BI, et al. exposure and risk of hepatocellular
35. Willett WC, Stampfer MJ, Colditz GA, et al. Nutrient intakes and adenocarcinoma of carcinoma in Taiwan. Int J Cancer
Relation of meat, fat, and fiber intake to the esophagus and distal stomach. Nutr 1996;67:620-5.
the risk of colon cancer in a prospective Cancer 2002;42:33-40. 67. Sun Z, Lu P, Gail MH, et al. Increased risk of
study among women. N Engl J Med 51. Terry P, Lagergren J, Ye W, et al. Inverse hepatocellular carcinoma in male
1990;323:1664-72. association between intake of cereal hepatitis B surface antigen carriers with
36. Kato I, Akhmedkhanov A, Koenig K, et al. fiber and risk of gastric cardia cancer. chronic hepatitis who have detectable
Prospective study of diet and female Gastroenterology 2001;120:387-91. urinary aflatoxin metabolite M1.
colorectal cancer: the New York 52. Soler M, Bosetti C, Franceschi S, et al. Fiber Hepatology 1999;30:379-83.
University Womens Health Study. Nutr intake and the risk of oral, pharyngeal 68. Ross RK, Yuan JM, Yu MC, et al. Urinary
Cancer 1997;28:276-81. and esophageal cancer. Int J Cancer aflatoxin biomarkers and risk of
37. Gaard M, Tretli S, Loken EB. Dietary factors 2001;91:283-7. hepatocellular carcinoma. Lancet
and risk of colon cancer: a prospective 53. Mayne ST, Risch HA, Dubrow R, et al. 1992;339:943-6.
study of 50,535 young Norwegian men Nutrient intake and risk of subtypes of 69. Qian GS, Ross RK, Yu MC, et al. A follow-up
and women. Eur J Cancer Prev esophageal and gastric cancer. Cancer study of urinary markers of aflatoxin
1996;5:445-54. Epidemiol Biomarkers Prev exposure and liver cancer risk in
38. Park Y, Hunter DJ, Spiegelman D, et al. 2001;10:1055-62. Shanghai, Peoples Republic of China.
Dietary fiber intake and risk of colorectal 54. De Stefani E, Ronco A, Mendilaharsu M, et Cancer Epidemiol Biomarkers Prev
cancer: a pooled analysis of prospective al. Diet and risk of cancer of the upper 1994;3:3-10.
cohort studies. JAMA 2005;294:2849-57. aerodigestive tract - II. Nutrients. Oral 70. Chen CJ, Wang LY, Lu SN, et al. Elevated
39. Giovannucci E, Rimm EB, Stampfer MJ, et Oncol 1999;35:22-6. aflatoxin exposure and increased risk of
al. Intake of fat, meat, and fiber in 55. Zhang ZF, Kurtz RC, Yu GP, et al. hepatocellular carcinoma. Hepatology
relation to risk of colon cancer in men. Adenocarcinomas of the esophagus and 1996;24:38-42.
Cancer Res 1994;54:2390-7. gastric cardia: the role of diet. Nutr 71. Lunn RM, Zhang Yu J, Wang LW, et al. p53
40. Cummings JH. Dietary fibre and large Cancer 1997;27:298-309. mutations, chronic hepatitis B virus
bowel cancer. Proc Nutr Soc 1981;40:7- 56. Brown LM, Swanson CA, Gridley G, et al. infection, and aflatoxin exposure in
14. Adenocarcinoma of the esophagus: role hepatocellular carcinoma in Taiwan.
41. Bowers K, Albanes D, Limburg P, et al. A of obesity and diet. J Natl Cancer Inst Cancer Res 1997;57:3471-7.
prospective study of anthropometric and 1995;87:104-9. 72. Tsuboi S, Kawamura K, Cruz ML, et al.
clinical measurements associated with 57. Tavani A, Negri E, Franceschi S, et al. Risk Aflatoxin B1 and primary hepatocellular
insulin resistance syndrome and factors for esophageal cancer in women carcinoma in Japan, Indonesia and the
colorectal cancer in male smokers. Am J in northern Italy. Cancer 1993;72:2531-6. Philippines. (Detection aflatoxin B1 in
Epidemiol 2006;164:652-64. 58. Kabat GC, Ng SK, Wynder EL. Tobacco, human serum and urine samples). ICMR
42. Otani T, Iwasaki M, Ishihara J, et al. Dietary alcohol intake, and diet in relation to Annals 1984;4:175-85.
fiber intake and subsequent risk of adenocarcinoma of the esophagus and 73. Srivatanakul P, Parkin DM, Khlat M, et al.
colorectal cancer: the Japan Public gastric cardia. Cancer Causes Control Liver-cancer in Thailand. 2. A case-
Health Center-based prospective study. 1993;4:123-32. control study of hepatocellular-
Int J Cancer 2006;119:1475-80. 59. Liaw Y-P, Huang Y-C, Lo P-Y, et al. Nutrient carcinoma. Int J Cancer 1991;48:329-32.
43. Shin A, Li H, Shu XO, et al. Dietary intake of intakes in relation to cancer mortality in 74. Salamat LA, Tsuboi S. Dietary aflatoxin: a
418
R E F E R E N C E S
possible factor in the etiology of primary 8. Pool-Zobel BL. Inulin-type fructans and Nutrition and cancer of the oral cavity
liver cancer. ICMR Annals 1985;5:131-8. reduction in colon cancer risk: review of and pharynx in north-east Italy. Int J
75. Ragab W, Kohail H. The possible experimental and human data. Br J Nutr Cancer 1991;47:20-5.
association of dietary aflatoxin with the 2005;93 Suppl 1:S73-90. 27. Zheng W, Blot WJ, Shu XO, et al. Risk
incidence of primary hepatic tumours. J 9. Jakubikova J, Sedlak J. Garlic-derived factors for oral and pharyngeal cancer in
Med Res Inst 1996;16:165-70. organosulfides induce cytotoxicity, Shanghai, with emphasis on diet. Cancer
76. Parkin DM, Srivatanakul P, Khlat M, et al. apoptosis, cell cycle arrest and oxidative Epidemiol Biomarkers Prev 1992;1:441-8.
Liver-cancer in Thailand. I. A case-control stress in human colon carcinoma cell 28. Zheng W, Blot WJ, Shu XO, et al. Diet and
study of cholangiocarcinoma. Int J lines. Neoplasma 2006;53:191-9. other risk factors for laryngeal cancer in
Cancer 1991;48:323-8. 10. McGee H. McGee on Food and Cooking. Shanghai, China. Am J Epidemiol
77. Mandishona E, MacPhail AP, Gordeuk VR, London: Hodder and Stoughton, 2004. 1992;136:178-91.
et al. Dietary iron overload as a risk 11. Lee HY, Oh SH, Woo JK, et al. 29. Zheng T, Boyle P, Willett WC, et al. A case-
factor for hepatocellular carcinoma in Chemopreventive effects of deguelin, a control study of oral cancer in Beijing,
Black Africans. Hepatology novel Akt inhibitor, on tobacco-induced Peoples Republic of China. Associations
1998;27:1563-6. lung tumorigenesis. J Natl Cancer Inst with nutrient intakes, foods and food
78. Bulatao Jayme J, Almero EM, Castro MC, et 2005;97:1695-9. groups. Eur J Cancer B Oral Oncol
al. A case-control dietary study of 12. Dewanto V, Wu X, Adom KK, et al. Thermal 1993;29B:45-55.
primary liver cancer risk from aflatoxin processing enhances the nutritional 30. De Stefani E, Oreggia F, Ronco A, et al.
exposure. Int J Epidemiol 1982;11:112-9. value of tomatoes by increasing total Salted meat consumption as a risk factor
79. Abaza H, El Mallah S, El Kady A, et al. antioxidant activity. J Agric Food Chem for cancer of the oral cavity and pharynx:
Mycotoxins and hepatocellular 2002;50:3010-4. a case-control study from Uruguay.
carcinoma (HCC) in Egypt. J Trop Med 13. Arab L, Steck S. Lycopene and Cancer Epidemiol Biomarkers Prev
1993;2:33-40. cardiovascular disease. Am J Clin Nutr 1994;3:381-5.
80. Eaton DL, Ramsdell HS, Neal G. 2000;71:1691S-5S; discussion 6S-7S. 31. Esteve J, Riboli E, Pequignot G, et al. Diet
Biotransformation of aflatoxins. In: 14. Song K, Milner JA. Heating garlic inhibits and cancers of the larynx and
Eaton DL, Groopman JD, editors. The its ability to suppress 7, 12- hypopharynx: the IARC multi-center
Toxicology of Aflatoxins: Human Health, dimethylbenz(a)anthracene-induced study in southwestern Europe. Cancer
Veterinary and Agricultural Significance. DNA adduct formation in rat mammary Causes Control 1996;7:240-52.
San Diego: Academic Press, 1994. tissue. J Nutr 1999;129:657-61. 32. Chatenoud L, La Vecchia C, Franceschi S, et
81. Luch A. Nature and nurture - lessons from 15. Leklem JE. Vitamin B-6. In: Shils M, Olson al. Refined-cereal intake and risk of
chemical carcinogenesis. Nat Rev Cancer JA, Shike M, et al., editors. Nutrition in selected cancers in Italy. Am J Clin Nutr
2005;5:113-25. Health and Disease. 9th ed. Baltimore: 1999;70:1107-10.
Williams & Wilkins, 1999. 33. De Stefani E, Boffetta P, Ronco AL, et al.
16. Geissler C, Powers H, editors. Human Dietary patterns and risk of cancer of the
Chapter 4.2 Nutrition. 11th ed. London: Elsevier oral cavity and pharynx in Uruguay. Nutr
Churchill Livingstone, 2005. Cancer 2005;51:132-9.
1. Kuhnlein HV. Promoting the nutritional and 17. Food and Agriculture Organization of the 34. Crosignani P, Russo A, Tagliabue G, et al.
cultural benefits of traditional food United Nations. FAOSTAT. Tobacco and diet as determinants of
systems of Indigenous People. Forum http://faostat.fao.org/site/345/default.as survival in male laryngeal cancer
Nutr 2003;56:222-3. px. 2006. patients. Int J Cancer 1996;65:308-13.
2. Cannon G. Food and Health: the Experts 18. Morabia A, Wynder EL. Dietary habits of 35. Kune GA, Kune S, Field B, et al. Oral and
Agree. An analysis of One Hundred smokers, people who never smoked, and pharyngeal cancer, diet, smoking,
Authoritative Scientific Reports on Food, exsmokers. Am J Clin Nutr 1990;52:933-7. alcohol, and serum vitamin A and beta-
Nutrition and Public Health Published 19. McPhillips JB, Eaton CB, Gans KM, et al. carotene levels: a case-control study in
Throughout the World in Thirty Years, Dietary differences in smokers and men. Nutr Cancer 1993;20:61-70.
Between 1961 and 1991. London: nonsmokers from two southeastern New 36. Takezaki T, Hirose K, Inoue M, et al.
Consumers Association, 1992. England communities. J Am Diet Assoc Tobacco, alcohol and dietary factors
3. World Cancer Research Fund, American 1994;94:287-92. associated with the risk of oral cancer
Institute for Cancer Research. Food, 20. Ursin G, Ziegler RG, Subar AF, et al. Dietary among Japanese. Jpn J Cancer Res
Nutrition and the Prevention of Cancer: patterns associated with a low-fat diet in 1996;87:555-62.
a Global Perspective. Washington, DC: the national health examination follow- 37. Levi F, Pasche C, La Vecchia C, et al. Food
AICR, 1997. up study: identification of potential groups and risk of oral and pharyngeal
4. World Health Organization. 2003. Diet, confounders for epidemiologic analyses. cancer. Int J Cancer 1998;77:705-9.
Nutrition and the Prevention of Chronic Am J Epidemiol 1993;137:916-27. 38. Franceschi S, Favero A, Conti E, et al. Food
Diseases: Report of a Joint WHO/FAO 21. De Stefani E, Correa P, Oreggia F, et al. Risk groups, oils and butter, and cancer of the
Expert Consultation. In: WHO Technical factors for laryngeal cancer. Cancer oral cavity and pharynx. Br J Cancer
Report Series no 916. 1987;60:3087-91. 1999;80:614-20.
http://www.who.int/entity/dietphysicalac 22. Notani PN, Jayant K. Role of diet in upper 39. De Stefani E, Boffetta P, Oreggia F, et al.
tivity/publications/trs916/download/en/i aerodigestive tract cancers. Nutr Cancer Plant foods and risk of laryngeal cancer:
ndex.html. 1987;10:103-13. A case-control study in Uruguay. Int J
5. Davidson A. The Penguin Companion to 23. Franco EL, Kowalski LP, Oliveira BV, et al. Cancer 2000;87:129-32.
Food. Revised ed. Harmondsworth: Risk factors for oral cancer in Brazil: a 40. De Stefani E, Deneo-Pellegrini H,
Penguin Books, 2002. case-control study. Int J Cancer Mendilaharsu M, et al. Diet and risk of
6. McCreight JD, Ryder EJ, editors. XXVI 1989;43:992-1000. cancer of the upper aerodigestive tract -
International Horticultural Congress: 24. Gridley G, McLaughlin JK, Block G, et al. I. Foods. Oral Oncol 1999;35:17-21.
Advances in Vegetable Breeding. Diet and oral and pharyngeal cancer 41. Garrote LF, Herrero R, Reyes RM, et al. Risk
Toronto: International Society for among blacks. Nutr Cancer 1990;14:219- factors for cancer of the oral cavity and
Horticultural Science, 2004. 25. oro-pharynx in Cuba. Br J Cancer
7. Aggarwal BB, Ichikawa H. Molecular targets 25. Oreggia F, De Stefani E, Correa P, et al. Risk 2001;85:46-54.
and anticancer potential of indole-3- factors for cancer of the tongue in 42. Bosetti C, La Vecchia C, Talamini R, et al.
carbinol and its derivatives. Cell Cycle Uruguay. Cancer 1991;67:180-3. Food groups and laryngeal cancer risk: a
2005;4:1201-15. 26. Franceschi S, Bidoli E, Baron AE, et al. case-control study from Italy and
419
F O O D , N U T R I T I O N , P H Y S I C A L A C T I V I T Y, A N D T H E P R E V E N T I O N O F C A N C E R : A G L O B A L P E R S P E C T I V E
Switzerland. Int J Cancer 2002;100:355- 60. Takezaki T, Shinoda M, Hatooka S, et al. 76. Maserejian NN, Giovannucci E, Rosner B, et
60. Subsite-specific risk factors for al. Prospective study of fruits and
43. Rajkumar T, Sridhar H, Balaram P, et al. Oral hypopharyngeal and esophageal cancer vegetables and risk of oral premalignant
cancer in Southern India: the influence (Japan). Cancer Causes Control lesions in men. Am J Epidemiol
of body size, diet, infections and sexual 2000;11:597-608. 2006;164:556-66.
practices. Eur J Cancer Prev 2003;12:135- 61. Maier H, Tisch M. Epidemiology of 77. Boeing H, Dietrich T, Hoffmann K, et al.
43. laryngeal cancer: results of the Intake of fruits and vegetables and risk
44. Marchioni DL, Fisberg RM, do Rosario M, et Heidelberg case-control study. Acta of cancer of the upper aero-digestive
al. Diet and cancer of oral cavity and Otolaryngol Suppl 1997;527:160-4. tract: the prospective EPIC-study. Cancer
pharynx: a case-control study in Sao 62. De Stefani E, Oreggia F, Boffetta P, et al. Causes Control 2006;17:957-69.
Paulo, Brazil. IARC Sci Publ 2002;156:559- Tomatoes, tomato-rich foods, lycopene 78. Galeone C, Pelucchi C, Levi F, et al. Onion
61. and cancer of the upper aerodigestive and garlic use and human cancer. Am J
45. Gaudet MM, Olshan AF, Poole C, et al. Diet, tract: a case-control in Uruguay. Oral Clin Nutr 2006;84:1027-32.
GSTM1 and GSTT1 and head and neck Oncol 2000;36:47-53. 79. Kreimer AR, Randi G, Herrero R, et al. Diet
cancer. Carcinogenesis 2004;25:735-40. 63. Tavani A, Gallus S, La Vecchia C, et al. Diet and body mass, and oral and
46. Lissowska J, Pilarska A, Pilarski P, et al. and risk of oral and pharyngeal cancer. oropharyngeal squamous cell
Smoking, alcohol, diet, dentition and An Italian case-control study. Eur J carcinomas: analysis from the IARC
sexual practices in the epidemiology of Cancer Prev 2001;10:191-5. multinational case-control study. Int J
oral cancer in Poland. Eur J Cancer Prev 64. Uzcudun AE, Retolaza IR, Fernandez PB, et Cancer 2006;118:2293-7.
2003;12:25-33. al. Nutrition and pharyngeal cancer: 80. Guo W, Blot WJ, Li JY, et al. A nested case-
47. McLaughlin JK, Gridley G, Block G, et al. results from a case-control study in control study of oesophageal and
Dietary factors in oral and pharyngeal Spain. Head Neck 2002;24:830-40. stomach cancers in the Linxian nutrition
cancer. J Natl Cancer Inst 1988;80:1237- 65. Pisa FE, Barbone F. Diet and the risk of intervention trial. Int J Epidemiol
43. cancers of the lung, oral cavity and 1994;23:444-50.
48. Day GL, Blot WJ, Austin DF, et al. Racial pharynx, and larynx: a population-based 81. Hirayama T. [A large scale cohort study on
differences in risk of oral and pharyngeal case-control study in north-east Italy. the effect of life styles on the risk of
cancer: alcohol, tobacco, and other IARC Sci Publ 2002;156:141-3. cancer by each site]. Gan No Rinsho
determinants. J Natl Cancer Inst 66. Kjaerheim K, Gaard M, Andersen A. The 1990;Spec No:233-42.
1993;85:465-73. role of alcohol, tobacco, and dietary 82. Yu Y, Taylor PR, Li JY, et al. Retrospective
49. Franceschi S, Barra S, La Vecchia C, et al. factors in upper aerogastric tract cancers: cohort study of risk-factors for
Risk factors for cancer of the tongue and a prospective study of 10,900 Norwegian esophageal cancer in Linxian, Peoples
the mouth. A case-control study from men. Cancer Causes Control 1998;9:99- Republic of China. Cancer Causes Control
northern Italy. Cancer 1992;70:2227-33. 108. 1993;4:195-202.
50. Sanchez MJ, Martinez C, Nieto A, et al. Oral 67. Lee KY, Lee C, Park YS, et al. A study of 83. Tran GD, Sun XD, Abnet CC, et al.
and oropharyngeal cancer in Spain: relation between dietary vitamin A Prospective study of risk factors for
influence of dietary patterns. Eur J intake and serum vitamin A levels and esophageal and gastric cancers in the
Cancer Prev 2003;12:49-56. cancer risk in Korea. Korean J Nutr Linxian general population trial cohort
51. Koo LC, Mang OW, Ho JH. An ecological 1985;18:301-11. in China. Int J Cancer 2005;113:456-63.
study of trends in cancer incidence and 68. Hebert JR, Landon J, Miller DR. 84. Li JY, Ershow AG, Chen ZJ, et al. A case-
dietary changes in Hong Kong. Nutr Consumption of meat and fruit in control study of cancer of the esophagus
Cancer 1997;28:289-301. relation to oral and esophageal cancer: a and gastric cardia in Linxian. Int J Cancer
52. Schrauzer GN. Cancer mortality correlation cross-national study. Nutr Cancer 1989;43:755-61.
studies. II. Regional associations of 1993;19:169-79. 85. Bosetti C, La Vecchia C, Talamini R, et al.
mortalities with the consumptions of 69. Kapil U, Singh P, Bahadur S, et al. Food groups and risk of squamous cell
foods and other commodities. Med Assessment of risk factors in laryngeal esophageal cancer in northern Italy. Int J
Hypotheses 1976;2:39-49. cancer in India: a case-control study. Cancer 2000;87:289-94.
53. Knox EG. Foods and diseases. Br J Prev Soc Asian Pac J Cancer Prev 2005;6:202-7. 86. Gao YT, McLaughlin JK, Gridley G, et al.
Med 1977;31:71-80. 70. Zheng W, Sellers TA, Doyle TJ, et al. Risk factors for esophageal cancer in
54. Boeing H. Alcohol and risk of cancer of the Retinol, antioxidant vitamins, and Shanghai, China. II. Role of diet and
upper gastrointestinal tract: first analysis cancers of the upper digestive tract in a nutrients. Int J Cancer 1994;58:197-202.
of the EPIC data. IARC Sci Publ prospective cohort study of 87. De Stefani E, Munoz N, Esteve J, et al. Mate
2002;156:151-4. postmenopausal women. Am J drinking, alcohol, tobacco, diet, and
55. Zatonski W, Becher H, Lissowska J, et al. Epidemiol 1995;142:955-60. esophageal cancer in Uruguay. Cancer
Tobacco, alcohol, and diet in the etiology 71. Kasum CM, Jacobs DR, Jr., Nicodemus K, et Res 1990;50:426-31.
of laryngeal cancer: a population-based al. Dietary risk factors for upper 88. Launoy G, Milan C, Day NE, et al. Diet and
case-control study. Cancer Causes Control aerodigestive tract cancers. Int J Cancer squamous-cell cancer of the oesophagus:
1991;2:3-10. 2002;99:267-72. a French multicentre case-control study.
56. Brown LM, Gridley G, Diehl SR, et al. Family 72. La Vecchia C, Negri E, DAvanzo B, et al. Int J Cancer 1998;76:7-12.
cancer history and susceptibility to oral Dietary indicators of oral and pharyngeal 89. Negri E, La Vecchia C, Franceschi S, et al.
carcinoma in Puerto Rico. Cancer cancer. Int J Epidemiol 1991;20:39-44. Vegetable and fruit consumption and
2001;92:2102-8. 73. La Vecchia C, Negri E, DAvanzo B, et al. cancer risk. Int J Cancer 1991;48:350-4.
57. Llewellyn CD, Linklater K, Bell J, et al. An Dietary indicators of laryngeal cancer 90. Rolon PA, Castellsague X, Benz M, et al.
analysis of risk factors for oral cancer in risk. Cancer Res 1990;50:4497-500. Hot and cold mate drinking and
young people: a case-control study. Oral 74. Fioretti F, Bosetti C, Tavani A, et al. Risk esophageal cancer in Paraguay. Cancer
Oncol 2004;40:304-13. factors for oral and pharyngeal cancer in Epidemiol Biomarkers Prev 1995;4:595-
58. Franceschi S, Bidoli E, La Vecchia C, et al. never smokers. Oral Oncol 1999;35:375- 605.
Tomatoes and risk of digestive-tract 8. 91. Sammon AM. Protease inhibitors and
cancers. Int J Cancer 1994;59:181-4. 75. Nishimoto IN, Pintos J, Schlecht NF, et al. carcinoma of the esophagus. Cancer
59. De Stefani E, Oreggia F, Rivero S, et al. Assessment of control selection bias in a 1998;83:405-8.
Salted meat consumption and the risk of hospital-based case-control study of 92. Sammon AM. A case-control study of diet
laryngeal cancer. Eur J Epidemiol upper aero-digestive tract cancers. J and social factors in cancer of the
1995;11:177-80. Cancer Epidemiol Prev 2002;7:131-41. esophagus in Transkei. Cancer
420
R E F E R E N C E S
1992;69:860-5. Jiangsu Province, China: comparison 126. Sharp L, Chilvers CE, Cheng KK, et al. Risk
93. Su W, Han XY, Wang YP, et al. Joint risks in with those in a high-epidemic area. Jpn J factors for squamous cell carcinoma of
a case-control study of esophageal Cancer Res 2001;92:1157-65. the oesophagus in women: a case-
cancer in Shanxi Province, Peoples 110. Zhang W, An F, Lin H. [A case-control control study. Br J Cancer 2001;85:1667-
Republic of China. Tohoku J Exp Med study on the risk factors of esophageal 70.
1994;174:177-80. cancer in Jieyang City of Guangdong in 127. Nakachi K, Imai K, Hoshiyama Y, et al. The
94. Tzonou A, Lipworth L, Garidou A, et al. China]. Zhonghua Liu Xing Bing Xue Za joint effects of two factors in the
Diet and risk of esophageal cancer by Zhi 2001;22:442-5. aetiology of oesophageal cancer in
histologic type in a low-risk population. 111. Chen H, Ward MH, Graubard BI, et al. Japan. J Epidemiol Community Health
Int J Cancer 1996;68:300-4. Dietary patterns and adenocarcinoma of 1988;42:355-64.
95. De Stefani E, Brennan P, Boffetta P, et al. the esophagus and distal stomach. Am J 128. Castelletto R, Castellsague X, Munoz N, et
Vegetables, fruits, related dietary Clin Nutr 2002;75:137-44. al. Alcohol, tobacco, diet, mate drinking,
antioxidants, and risk of squamous cell 112. Li K, Yu P. Food groups and risk of and esophageal cancer in Argentina.
carcinoma of the esophagus: a case- esophageal cancer in Chaoshan region Cancer Epidemiol Biomarkers Prev
control study in Uruguay. Nutr Cancer of China: a high-risk area of esophageal 1994;3:557-64.
2000;38:23-9. cancer. Cancer Invest 2003;21:237-40. 129. Gao CM, Takezaki T, Ding JH, et al.
96. Cheng KK, Sharp L, McKinney PA, et al. A 113. Brown LM, Blot WJ, Schuman SH, et al. Protective effect of allium vegetables
case-control study of oesophageal Environmental factors and high risk of against both esophageal and stomach
adenocarcinoma in women: a esophageal cancer among men in coastal cancer: a simultaneous case-referent
preventable disease. Br J Cancer South Carolina. J Natl Cancer Inst study of a high-epidemic area in Jiangsu
2000;83:127-32. 1988;80:1620-5. Province, China. Jpn J Cancer Res
97. Levi F, Pasche C, Lucchini F, et al. Food 114. De Stefani E, Boffetta P, Deneo-Pellegrini 1999;90:614-21.
groups and oesophageal cancer risk in H, et al. The role of vegetable and fruit 130. Terry P, Lagergren J, Wolk A, et al. Reflux-
Vaud, Switzerland. Eur J Cancer Prev consumption in the aetiology of inducing dietary factors and risk of
2000;9:257-63. squamous cell carcinoma of the adenocarcinoma of the esophagus and
98. Nayar D, Kapil U, Joshi YK, et al. oesophagus: a case-control study in gastric cardia. Nutr Cancer 2000;38:186-
Nutritional risk factors in esophageal Uruguay. Int J Cancer 2005;116:130-5. 91.
cancer. J Assoc Physicians India 115. Yang CX, Wang HY, Wang ZM, et al. Risk 131. Graham S, Marshall J, Haughey B, et al.
2000;48:781-7. factors for esophageal cancer: a case- Nutritional epidemiology of cancer of
99. Terry P, Lagergren J, Hansen H, et al. Fruit control study in South-western China. the esophagus. Am J Epidemiol
and vegetable consumption in the Asian Pac J Cancer Prev 2005;6:48-53. 1990;131:454-67.
prevention of oesophageal and cardia 116. Howell MA. Factor analysis of 132. Cheng KK, Day NE, Duffy SW, et al.
cancers. Eur J Cancer Prev 2001;10:365-9. international cancer mortality data and Pickled vegetables in the aetiology of
100. Onuk MD, Oztopuz A, Memik F. Risk per capita food consumption. Br J Cancer oesophageal cancer in Hong Kong
factors for esophageal cancer in eastern 1974;29:328-36. Chinese. Lancet 1992;339:1314-8.
Anatolia. Hepatogastroenterology 117. Hara N, Sakata K, Nagai M, et al. 133. Cheng KK, Duffy SW, Day NE, et al.
2002;49:1290-2. Statistical analyses on the pattern of Oesophageal cancer in never-smokers
101. Xibib S, Meilan H, Moller H, et al. Risk food consumption and digestive-tract and never-drinkers. Int J Cancer
factors for oesophageal cancer in cancers in Japan. Nutr Cancer 1995;60:820-2.
Linzhou, China: a case-control study. 1984;6:220-8. 134. Srivastava M, Kapil U, Chattopadhyaya
Asian Pac J Cancer Prev 2003;4:119-24. 118. Sichieri R, Everhart JE, Mendona GAS. TK, et al. Nutritional risk factors in
102. Hung HC, Huang MC, Lee JM, et al. Diet and mortality from common cancers carcinoma esophagus. Nutr Res
Association between diet and in Brazil: an ecological study. Cad Saude 1995;15:177-85.
esophageal cancer in Taiwan. J Publica 1996;12:53-9. 135. Phukan RK, Chetia CK, Ali MS, et al. Role
Gastroenterol Hepatol 2004;19:632-7. 119. Zhuo XG, Watanabe S. Factor analysis of of dietary habits in the development of
103. Cook-Mozaffari PJ, Azordegan F, Day NE, digestive cancer mortality and food esophageal cancer in Assam, the north-
et al. Oesophageal cancer studies in the consumption in 65 Chinese counties. J eastern region of India. Nutr Cancer
Caspian Littoral of Iran: results of a case- Epidemiol 1999;9:275-84. 2001;39:204-9.
control study. Br J Cancer 1979;39:293- 120. Pottern LM, Morris LE, Blot WJ, et al. 136. Tavani A, Negri E, Franceschi S, et al. Risk
309. Esophageal cancer among black men in factors for esophageal cancer in women
104. Ziegler RG, Morris LE, Blot WJ, et al. Washington, D.C. I. Alcohol, tobacco, in northern Italy. Cancer 1993;72:2531-6.
Esophageal cancer among black men in and other risk factors. J Natl Cancer Inst 137. Tao X, Zhu H, Matanoski GM. Mutagenic
Washington, D.C. II. Role of nutrition. J 1981;67:777-83. drinking water and risk of male
Natl Cancer Inst 1981;67:1199-206. 121. Mettlin C, Graham S, Priore R, et al. Diet esophageal cancer: a population-based
105. Tuyns AJ, Riboli E, Doornbos G, et al. Diet and cancer of the esophagus. Nutr case-control study. Am J Epidemiol
and esophageal cancer in Calvados Cancer 1981;2:143-7. 1999;150:443-52.
(France). Nutr Cancer 1987;9:81-92. 122. Yu MC, Garabrant DH, Peters JM, et al. 138. Wang M, Guo C, Li M. [A case-control
106. Ren A, Han X. [Dietary factors and Tobacco, alcohol, diet, occupation, and study on the dietary risk factors of upper
esophageal cancer: a case-control study]. carcinoma of the esophagus. Cancer Res digestive tract cancer]. Zhonghua Liu
Zhonghua Liu Xing Bing Xue Za Zhi 1988;48:3843-8. Xing Bing Xue Za Zhi 1999;20:95-7.
1991;12:200-4. 123. Engel LS, Chow WH, Vaughan TL, et al. 139. Chitra S, Ashok L, Anand L, et al. Risk
107. Hu J, Nyren O, Wolk A, et al. Risk factors Population attributable risks of factors for esophageal cancer in
for oesophageal cancer in northeast esophageal and gastric cancers. J Natl Coimbatore, southern India: a hospital-
China. Int J Cancer 1994;57:38-46. Cancer Inst 2003;95:1404-13. based case-control study. Indian J
108. Soler M, Bosetti C, Franceschi S, et al. 124. Brown LM, Swanson CA, Gridley G, et al. Gastroenterol 2004;23:19-21.
Fiber intake and the risk of oral, Adenocarcinoma of the esophagus: role 140. Gonzalez CA, Pera G, Agudo A, et al. Fruit
pharyngeal and esophageal cancer. Int J of obesity and diet. J Natl Cancer Inst and vegetable intake and the risk of
Cancer 2001;91:283-7. 1995;87:104-9. stomach and oesophagus
109. Takezaki T, Gao CM, Wu JZ, et al. Dietary 125. Zhang ZF, Kurtz RC, Yu GP, et al. adenocarcinoma in the European
protective and risk factors for Adenocarcinomas of the esophagus and Prospective Investigation into Cancer
esophageal and stomach cancers in a gastric cardia: the role of diet. Nutr and Nutrition (EPIC-EURGAST). Int J
low-epidemic area for stomach cancer in Cancer 1997;27:298-309. Cancer 2006;118:2559-66.
421
F O O D , N U T R I T I O N , P H Y S I C A L A C T I V I T Y, A N D T H E P R E V E N T I O N O F C A N C E R : A G L O B A L P E R S P E C T I V E
141. Decarli A, Liati P, Negri E, et al. Vitamin A 1985;122:947-59. 175. Gajalakshmi CK, Shanta V. Lifestyle and
and other dietary factors in the etiology 158. Yi Y. Analysis of etiological factors on risk of stomach cancer: a hospital-based
of esophageal cancer. Nutr Cancer gastric cancer in Fuzhou City China. case-control study. Int J Epidemiol
1987;10:29-37. Chinese Journal of Epidemiology 1996;25:1146-53.
142. Tavani A, Negri E, Franceschi S, et al. Risk 1986;7:48-50. 176. Lpez-Carrillo L, Lopez-Cervantes M,
factors for esophageal cancer in lifelong 159. You WC, Blot WJ, Chang YS, et al. Diet Ramirez-Espitia A, et al. Alcohol
nonsmokers. Cancer Epidemiol and high risk of stomach cancer in consumption and gastric cancer in
Biomarkers Prev 1994;3:387-92. Shandong, China. Cancer Res Mexico. Cad Saude Publica 1998;14:25-
143. Yokoyama A, Kato H, Yokoyama T, et al. 1988;48:3518-23. 32.
Esophageal squamous cell carcinoma 160. De Stefani E, Boffetta P, Mendilaharsu M, 177. Ye W, Yi Y, Luo R. [A case-control study on
and aldehyde dehydrogenase-2 et al. Dietary nitrosamines, heterocyclic diet and gastric cancer]. Chung Hua Yu
genotypes in Japanese females. Alcohol amines, and risk of gastric cancer: a case- Fang I Hsueh Tsa Chih 1998;32:100-2.
Clin Exp Res 2006;30:491-500. control study in Uruguay. Nutr Cancer 178. Ji BT, Chow WH, Yang G, et al. Dietary
144. Chyou PH, Nomura AM, Hankin JH, et al. 1998;30:158-62. habits and stomach cancer in Shanghai,
A case-cohort study of diet and stomach 161. De Stefani E, Correa P, Boffetta P, et al. China. Int J Cancer 1998;76:659-64.
cancer. Cancer Res 1990;50:7501-4. Dietary patterns and risk of gastric 179. Ward MH, Lpez-Carrillo L. Dietary factors
145. Kneller RW, McLaughlin JK, Bjelke E, et al. cancer: a case-control study in Uruguay. and the risk of gastric cancer in Mexico
A cohort study of stomach cancer in a Gastric Cancer 2004;7:211-20. City. Am J Epidemiol 1999;149:925-32.
high-risk American population. Cancer 162. De Stefani E, Correa P, Boffetta P, et al. 180. Mathew A, Gangadharan P, Varghese C,
1991;68:672-8. Plant foods and risk of gastric cancer: a et al. Diet and stomach cancer: a case-
146. Botterweck AA, van den Brandt PA, case-control study in Uruguay. Eur J control study in South India. Eur J Cancer
Goldbohm RA. A prospective cohort Cancer Prev 2001;10:357-64. Prev 2000;9:89-97.
study on vegetable and fruit 163. De Stefani E, Correa P, Fierro L, et al. 181. Cai L, Yu SZ, Zhang ZF. Helicobacter pylori
consumption and stomach cancer risk in Alcohol drinking and tobacco smoking in infection and risk of gastric cancer in
The Netherlands. Am J Epidemiol gastric cancer. A case-control study. Rev Changle County, Fujian Province, China.
1998;148:842-53. Epidemiol Sante Publique 1990;38:297- World J Gastroenterol 2000;6:374-6.
147. Hirvonen T, Virtamo J, Korhonen P, et al. 307. 182. Munoz N, Plummer M, Vivas J, et al. A
Flavonol and flavone intake and the risk 164. Boeing H, Jedrychowski W, Wahrendorf J, case-control study of gastric cancer in
of cancer in male smokers (Finland). et al. Dietary risk factors in intestinal and Venezuela. Int J Cancer 2001;93:417-23.
Cancer Causes Control 2001;12:789-96. diffuse types of stomach cancer: a 183. Sriamporn S, Setiawan V, Pisani P, et al.
148. McCullough ML, Robertson AS, Jacobs EJ, multicenter case-control study in Poland. Gastric cancer: the roles of diet, alcohol
et al. A prospective study of diet and Cancer Causes Control 1991;2:227-33. drinking, smoking and Helicobacter
stomach cancer mortality in United 165. Cai L. [A case-control study of stomach pylori in northeastern Thailand. Asian
States men and women. Cancer cancer in Changle, Fujian Province - by Pac J Cancer Prev 2002;3:345-52.
Epidemiol Biomarkers Prev the risk state analysis]. Chung Hua Liu 184. Kim HJ, Chang WK, Kim MK, et al. Dietary
2001;10:1201-5. Hsing Ping Hsueh Tsa Chih 1991;12:15-9. factors and gastric cancer in Korea: a
149. Fujino Y, Tamakoshi A, Ohno Y, et al. 166. Sanchez-Diez A, Hernandez-Mejia R, case-control study. Int J Cancer
Prospective study of educational Cueto-Espinar A. Study of the relation 2002;97:531-5.
background and stomach cancer in between diet and gastric cancer in a 185. Xibin S, Moller H, Evans HS, et al.
Japan. Prev Med 2002;35:121-7. rural area of the Province of Leon, Spain. Residential environment, diet and risk of
150. Kobayashi M, Tsubono Y, Sasazuki S, et al. Eur J Epidemiol 1992;8:233-7. stomach cancer: a case-control study in
Vegetables, fruit and risk of gastric 167. Boeing H, Frentzel-Beyme R, Berger M, et Linzhou, China. Asian Pac J Cancer Prev
cancer in Japan: a 10-year follow-up of al. Case-control study on stomach cancer 2002;3:167-72.
the JPHC Study Cohort I. Int J Cancer in Germany. Int J Cancer 1991;47:858-64. 186. Suh S, Koo B, Choi Y, et al. [The nutritional
2002;102:39-44. 168. Memik F, Nak SG, Gulten M, et al. Gastric intakes of the stomach cancer patients in
151. Crane PS, Rhee SU, Seel DJ. Experience carcinoma in northwestern Turkey: the Daegu and Gyeongbuk areas,
with 1,079 cases of cancer of the epidemiologic characteristics. J Environ Korea]. Korean J Comm Nutr 2003;8:202-
stomach seen in Korea from 1962 to Pathol Toxicol Oncol 1992;11:335-8. 19.
1968. Am J Surg 1970;120:747-51. 169. Ren D, Jin J, Wang D, et al. The nutritional 187. Sipetic S, Tomic-Kundakovic S, Vlajinac H,
152. Haenszel W, Kurihara M, Segi M, et al. factors related to gastric cancer in et al. [Diet and gastric cancer].
Stomach cancer among Japanese in Tianjin. Ying Yang Xue Bao 1992;14:325- Vojnosanit Pregl 2003;60:697-705.
Hawaii. J Natl Cancer Inst 1972;49:969- 8. 188. Hara M, Hanaoka T, Kobayashi M, et al.
88. 170. Wang R. [The epidemiological study of Cruciferous vegetables, mushrooms, and
153. Ye EC. [Case-control study of 100 gastric subtype risk factors of gastric cancer]. gastrointestinal cancer risks in a
cancer cases]. Chung Hua Yu Fang I Chung Hua Liu Hsing Ping Hsueh Tsa multicenter, hospital-based case-control
Hsueh Tsa Chih 1981;15:107-9. Chih 1993;14:295-9. study in Japan. Nutr Cancer 2003;46:138-
154. Funakoshi N, Kanoh T, Uchino H, et al. 171. Hansson LE, Nyren O, Bergstrom R, et al. 47.
Gastric cancer and diet. The analysis of Diet and risk of gastric cancer. A 189. Lpez-Carrillo L, Lopez-Cervantes M,
the epidemiological survey in Tango population-based case-control study in Robles-Diaz G, et al. Capsaicin
district of Kyoto prefecture. Naika Hokan Sweden. Int J Cancer 1993;55:181-9. consumption, Helicobacter pylori
1983;30:175-81. 172. Ramon JM, Serra L, Cerdo C, et al. Dietary positivity and gastric cancer in Mexico.
155. Ren TS. [Case-control study of gastric factors and gastric cancer risk. A case- Int J Cancer 2003;106:277-82.
cancer in ten rural counties in China]. control study in Spain. Cancer 190. Fei S, Xiao S. [Diet and gastric cancer: a
Chung Hua Liu Hsing Ping Hsueh Tsa 1993;71:1731-5. case-control study in Shanghai urban
Chih 1985;6:29-32. 173. Inoue M, Tajima K, Hirose K, et al. Life- districts]. Chin J Gastroenterol
156. Correa P, Fontham E, Pickle LW, et al. style and subsite of gastric cancer - joint 2003;8:143-7.
Dietary determinants of gastric cancer in effect of smoking and drinking habits. 191. Lissowska J, Gail MH, Pee D, et al. Diet
south Louisiana inhabitants. J Natl Int J Cancer 1994;56:494-9. and stomach cancer risk in Warsaw,
Cancer Inst 1985;75:645-54. 174. Cornee J, Pobel D, Riboli E, et al. A case- Poland. Nutr Cancer 2004;48:149-59.
157. Risch HA, Jain M, Choi NW, et al. Dietary control study of gastric cancer and 192. Lagiou P, Samoli E, Lagiou A, et al.
factors and the incidence of cancer of nutritional factors in Marseille, France. Flavonoids, vitamin C and
the stomach. Am J Epidemiol Eur J Epidemiol 1995;11:55-65. adenocarcinoma of the stomach. Cancer
422
R E F E R E N C E S
Causes Control 2004;15:67-72. 208. Takezaki T, Gao CM, Ding JH, et al. 1990;65:2344-8.
193. Boccia S, Persiani R, La Torre G, et al. Comparative study of lifestyles of 224. Lee HH, Wu HY, Chuang YC, et al.
Sulfotransferase 1A1 polymorphism and residents in high and low risk areas for Epidemiologic characteristics and
gastric cancer risk: a pilot case-control gastric cancer in Jiangsu Province, China; multiple risk factors of stomach cancer in
study. Cancer Lett 2005;229:235-43. with special reference to allium Taiwan. Anticancer Res 1990;10:875-81.
194. Nan HM, Park JW, Song YJ, et al. Kimchi vegetables. J Epidemiol 1999;9:297-305. 225. Kato I, Tominaga S, Ito Y, et al. A
and soybean pastes are risk factors of 209. Cai L, Yu SZ, Ye WM, et al. Fish sauce and comparative case-control analysis of
gastric cancer. World J Gastroenterol gastric cancer: an ecological study in stomach cancer and atrophic gastritis.
2005;11:3175-81. Fujian Province, China. World J Cancer Res 1990;50:6559-64.
195. Setiawan VW, Yu GP, Lu QY, et al. Allium Gastroenterol 2000;6:671-5. 226. Hoshiyama Y, Sasaba T. A case-control
vegetables and stomach cancer risk in 210. Hirayama T. Does daily intake of green- study of stomach cancer and its relation
China. Asian Pac J Cancer Prev yellow vegetables reduce the risk of to diet, cigarettes, and alcohol
2005;6:387-95. cancer in man? An example of the consumption in Saitama Prefecture,
196. Hayashi K, Watanabe Y, Uozumi G, et al. application of epidemiological methods Japan. Cancer Causes Control
An epidemiological study on intestinal to the identification of individuals at low 1992;3:441-8.
metaplasia of stomach analysis of risk. IARC Sci Publ 1982:531-40. 227. Youm PY, Kim SH. [A case-control study
correlation with atrophic gastritis and 211. Hirayama T. [Primary cancer prevention on dietary and other factors related to
dietary habits. J Kyoto Prefect Univ Med by life style modification]. 1989;35:163- stomach cancer incidence]. Korean J Nutr
1985;94:883-8. 70. 1998;31:62-71.
197. Maruchi N, Aoki S, Tsuda K, et al. Relation 212. Inoue M, Tajima K, Kobayashi S, et al. 228. Watabe K, Nishi M, Miyake H, et al.
of food consumption to cancer mortality Protective factor against progression Lifestyle and gastric cancer: a case-
in Japan, with special reference to from atrophic gastritis to gastric cancer - control study. Oncol Rep 1998;5:1191-4.
international figures. Gann 1977;68:1- data from a cohort study in Japan. Int J 229. Hamada GS, Kowalski LP, Nishimoto IN, et
13. Cancer 1996;66:309-14. al. Risk factors for stomach cancer in
198. Koifman S, Koifman RJ. Stomach cancer 213. Kato I, Tominaga S, Matsumoto K. A Brazil (II): a case-control study among
incidence in Brazil: an ecologic study prospective study of stomach cancer Japanese Brazilians in Sao Paulo. Jpn J
with selected risk factors. Cad Saude among a rural Japanese population: a 6- Clin Oncol 2002;32:284-90.
Publica 1997;13:85-92. year survey. Jpn J Cancer Res 230. Nishimoto IN, Hamada GS, Kowalski LP, et
199. Vutuc C, Kunze M, Gredler B. [Mortality 1992;83:568-75. al. Risk factors for stomach cancer in
of gastric, large intestine and rectal 214. Khan MM, Goto R, Kobayashi K, et al. Brazil (I): a case-control study among
cancer and food consumption in Austria Dietary habits and cancer mortality non-Japanese Brazilians in Sao Paulo.
(1953-1974)]. Wien Med Wochenschr among middle aged and older Japanese Jpn J Clin Oncol 2002;32:277-83.
1977;127:170-2. living in Hokkaido, Japan by cancer site 231. Ito LS, Inoue M, Tajima K, et al. Dietary
200. Tominaga S, Ogawa H, Kuroishi T. and sex. 2004;5:58-65. factors and the risk of gastric cancer
Usefulness of correlation analyses in the 215. Ngoan LT, Mizoue T, Fujino Y, et al. among Japanese women: a comparison
epidemiology of stomach cancer. Natl Dietary factors and stomach cancer between the differentiated and non-
Cancer Inst Monogr 1982;62:135-40. mortality. Br J Cancer 2002;87:37-42. differentiated subtypes. Ann Epidemiol
201. Inaba Y, Takagi H, Yanai H. [Correlation 216. Sauvaget C, Nagano J, Hayashi M, et al. 2003;13:24-31.
study of cancer mortality and food Vegetables and fruit intake and cancer 232. Zickute J, Strumylaite L, Dregval L, et al.
consumption]. Gan No Rinsho mortality in the Hiroshima/Nagasaki Life [Vegetables and fruits and risk of
1986;32:567-75. Span Study. Br J Cancer 2003;88:689-94. stomach cancer]. Medicina (Kaunas)
202. Shimada A. [Regional differences in 217. Sauvaget C, Lagarde F, Nagano J, et al. 2005;41:733-40.
gastric cancer mortality and eating Lifestyle factors, radiation and gastric 233. Wong BC, Ching CK, Lam SK, et al.
habits of people]. Gan No Rinsho cancer in atomic-bomb survivors (Japan). Differential north to south gastric
1986;32:692-8. Cancer Causes Control 2005;16:773-80. cancer-duodenal ulcer gradient in China.
203. Llopis A, Morales M, Rodriguez R. 218. Yatsuya H, Toyoshima H, Tamakoshi A, et China Ulcer Study Group. J Gastroenterol
Digestive cancer in relation to diet in al. Individual and joint impact of family Hepatol 1998;13:1050-7.
Spain. J Environ Pathol Toxicol Oncol history and Helicobacter pylori infection 234. Nagai M, Hashimoto T, Yanagawa H, et al.
1992;11:169-75. on the risk of stomach cancer: a nested Relationship of diet to the incidence of
204. Nasu K, Oguni I, Kanaya S, et al. case-control study. Br J Cancer esophageal and stomach cancer in
Differences in food intake and 2004;91:929-34. Japan. Nutr Cancer 1982;3:257-68.
nutritional status between the areas 219. Goiriena De Gandarias FJ, Santidrian MI, 235. Kato I, Tominaga S, Kuroishi T. Per capita
with low and high standardized Barranquero AM. Etiopathogenic study foods/nutrients intake and mortality
mortality ratio for stomach cancer in of cancer of the digestive tract in Biscay from gastrointestinal cancers in Japan.
Shizouka Prefecture. Jap J Nutr Spain with special emphasis on the role Jpn J Cancer Res 1987;78:453-9.
1992;50:133-44. played by diet and consumption of 236. Kneller RW, Guo WD, Hsing AW, et al.
205. Vioque J, Egea CM, Porta M. Stomach alcohol and tobacco. Rev Sanid Hig Risk factors for stomach cancer in sixty-
cancer mortality in Spain: an ecological Publica (Madr) 1987;62:1411-30. five Chinese counties. Cancer Epidemiol
analysis of diet, altitude, latitude, and 220. Hu JF. [Risk analysis of fuzzy states in data Biomarkers Prev 1992;1:113-8.
income. J Epidemiol Community Health of case-control study for stomach cancer 237. Imaizumi Y. Longitudinal gompertzian
1995;49:441-2. in Heilongjiang Province]. Zhonghua analysis of mortality from stomach
206. Azevedo LF, Salgueiro LF, Claro R, et al. Zhong Liu Za Zhi 1989;11:28-30. cancer in Japan, 1950-1993. Mech
Diet and gastric cancer in Portugal - a 221. Burr ML, Holliday RM. Fruit and stomach Ageing Dev 1995;85:133-45.
multivariate model. Eur J Cancer Prev cancer. J Hum Nutr Diet 1989;2:273-7. 238. Corella D, Cortina P, Guillen M, et al.
1999;8:41-8. 222. Jedrychowski W, Maugeri U, Dietary habits and geographic variation
207. Jansen MC, Bueno-De-Mesquita HB, Jedrychowska I, et al. The analytic in stomach cancer mortality in Spain. Eur
Rasanen L, et al. Consumption of plant epidemiologic study on occupational J Cancer Prev 1996;5:249-57.
foods and stomach cancer mortality in factors and stomach cancer occurrence. 239. Tominaga S, Kuroishi T. An ecological
the seven countries study. Is grain G Ital Med Lav 1990;12:3-8. study on diet/nutrition and cancer in
consumption a risk factor? Seven 223. Demirer T, Icli F, Uzunalimoglu O, et al. Japan. Int J Cancer 1997;Suppl:10-6.
Countries Study Research Group. Nutr Diet and stomach cancer incidence. A 240. Tsubono Y, Kobayashi M, Tsugane S. Food
Cancer 1999;34:49-55. case-control study in Turkey. Cancer consumption and gastric cancer
423
F O O D , N U T R I T I O N , P H Y S I C A L A C T I V I T Y, A N D T H E P R E V E N T I O N O F C A N C E R : A G L O B A L P E R S P E C T I V E
mortality in five regions of Japan. Nutr factors and stomach cancer: a case- condition of nasopharyngeal carcinoma
Cancer 1997;27:60-4. control study in Korea. Int J Epidemiol in Southern area of Fujian Province. J
241. Tokui N, Yoshimura T, Fujino Y, et al. 1995;24:33-41. Fujian Med College 1995;29:179-82.
Dietary habits and stomach cancer risk in 260. Huang XE, Tajima K, Hamajima N, et al. 276. Wang X, Chunyan Lin, Xiwen Sun, Yubo
the JACC Study. J Epidemiol 2005;15 Effect of life styles on the risk of subsite- Shi, Yanjie Liu, Xudong Dai. The
Suppl 2:S98-108. specific gastric cancer in those with and relationship between nasopharyngeal
242. Jedrychowski W, Boeing H, Popiela T, et without family history. J Epidemiol cancer and dietary as well as
al. Dietary practices in households as risk 1999;9:40-5. environmental factors in Heilongjiang
factors for stomach cancer: a familial 261. Huang XE, Hirose K, Wakai K, et al. province. J China Oncol 1993;15:75-6.
study in Poland. Eur J Cancer Prev Comparison of lifestyle risk factors by 277. Guo Y, Futian L, Wenqin J, et al. Study on
1992;1:297-304. family history for gastric, breast, lung incidence factors of nasopharyngeal
243. Tuyns AJ, Kaaks R, Haelterman M, et al. and colorectal cancer. Asian Pac J Cancer Carcinoma in Situ using small area
Diet and gastric cancer. A case-control Prev 2004;5:419-27. analysis model. Ai Zheng 2001;20:1272-5.
study in Belgium. Int J Cancer 1992;51:1- 262. Takezaki T, Gao CM, Wu JZ, et al. hOGG1 278. Armstrong RW, Imrey PB, Lye MS, et al.
6. Ser(326)Cys polymorphism and Nasopharyngeal carcinoma in Malaysian
244. Acheson ED, Doll R. Dietary factors in modification by environmental factors of Chinese: salted fish and other dietary
carcinoma of the stomach: a study of 100 stomach cancer risk in Chinese. Int J exposures. In: 12, editor. Int J Cancer,
cases and 200 controls. Gut 1964;5:126- Cancer 2002;99:624-7. 1998:228-35.
31. 263. Suh S, Koo B, Choi Y, et al. [Lifestyle and 279. Chen DL, Huang TB. A case-control study
245. Tajima K, Tominaga S. Dietary habits and eating behaviors of the stomach cancer of risk factors of nasopharyngeal
gastro-intestinal cancers: a comparative patients in Daegu and Kyungpook areas carcinoma. Cancer Lett 1997;117:17-22.
case-control study of stomach and large in Korea]. Korean J Nutr 2002;35:380-93. 280. Huang T, Chen D, Zhang J, et al. The
intestinal cancers in Nagoya, Japan. Jpn J 264. Lee SA, Kang D, Shim KN, et al. Effect of comparison of risk factors of
Cancer Res 1985;76:705-16. diet and Helicobacter pylori infection to nasopharyngeal cancer between
246. Li XX. [Case-control study of gastric cancer the risk of early gastric cancer. J Northen and Southern China. Ai Zheng
in high-incidence areas]. Chinese Journal Epidemiol 2003;13:162-8. 1997;16:324-5.
of Epidemiology 1986;7:340-2. 265. Terry P, Nyren O, Yuen J. Protective effect 281. Farrow DC, Vaughan TL, Berwick M, et al.
247. Buiatti E, Palli D, Decarli A, et al. A case- of fruits and vegetables on stomach Diet and nasopharyngeal cancer in a
control study of gastric cancer and diet cancer in a cohort of Swedish twins. Int J low-risk population. Int J Cancer
in Italy. Int J Cancer 1989;44:611-6. Cancer 1998;76:35-7. 1998;78:675-9.
248. Graham S, Haughey B, Marshall J, et al. 266. Dalgat DM, Aliev RG, Gireev GI, et al. 282. Alavanja MC, Dosemeci M, Samanic C, et
Diet in the epidemiology of gastric [Epidemiology of stomach cancer in al. Pesticides and lung cancer risk in the
cancer. Nutr Cancer 1990;13:19-34. Dagestan]. Vopr Onkol 1974;20:76-82. agricultural health study cohort. Am J
249. Moon HK. Diet and stomach cancer: a 267. Lpez-Carrillo L, Torres-Lopez J, Galvan- Epidemiol 2004;16:876-85.
case-control study in Korea. Korean J Portillo M, et al. Helicobacter pylori- 283. Breslow RA, Graubard BI, Sinha R, et al.
Epidemiol 1991;13:33-51. CagA seropositivity and nitrite and Diet and lung cancer mortality: a 1987
250. Gonzalez CA, Sanz JM, Marcos G, et al. ascorbic acid food intake as predictors National Health Interview Survey cohort
Dietary factors and stomach cancer in for gastric cancer. Eur J Cancer study. Cancer Causes Control
Spain: a multi-centre case-control study. 2004;40:1752-9. 2000;11:419-31.
Int J Cancer 1991;49:513-9. 268. Graham S, Lilienfe AM, Tidings JE. Dietary 284. Chow WH, Schuman LM, McLaughlin JK,
251. Jarebinski M, Adanja B, Vlajinac H, et al. and purgation factors in epidemiology et al. A cohort study of tobacco use, diet,
[Epidemiologic-anamnestic study of of gastric cancer. Cancer 1967;20:2224- occupation, and lung cancer mortality.
stomach cancer in relation to nutrition]. 34. Cancer Causes Control 1992;3:247-54.
Vojnosanit Pregl 1994;51:309-13. 269. Hoey J, Montvernay C, Lambert R. Wine 285. Feskanich D, Ziegler RG, Michaud DS, et
252. Appleby PN, Key TJ, Burr ML, et al. and tobacco: risk factors for gastric al. Prospective study of fruit and
Mortality and fresh fruit consumption. cancer in France. Am J Epidemiol vegetable consumption and risk of lung
IARC Sci Publ 2002;156:131-3. 1981;113:668-74. cancer among men and women. J Natl
253. Galanis DJ, Kolonel LN, Lee J, et al. Intakes 270. Trichopoulos D, Ouranos G, Day NE, et al. Cancer Inst 2000;92:1812-23.
of selected foods and beverages and the Diet and cancer of the stomach: a case- 286. Holick CN, Michaud DS, Stolzenberg-
incidence of gastric cancer among the control study in Greece. Int J Cancer Solomon R, et al. Dietary carotenoids,
Japanese residents of Hawaii: a 1985;36:291-7. serum beta-carotene, and retinol and
prospective study. Int J Epidemiol 271. La Vecchia C, Negri E, Decarli A, et al. A risk of lung cancer in the alpha-
1998;27:173-80. case-control study of diet and gastric tocopherol, beta-carotene cohort study.
254. Kato I, Tominaga S, Ito Y, et al. A cancer in northern Italy. Int J Cancer Am J Epidemiol 2002;156:536-47.
prospective study of atrophic gastritis 1987;40:484-9. 287. Jansen MC, Bueno-de-Mesquita HB,
and stomach cancer risk. Jpn J Cancer Res 272. Ward MH, Pan WH, Cheng YJ, et al. Feskens EJ, et al. Quantity and variety of
1992;83:1137-42. Dietary exposure to nitrite and fruit and vegetable consumption and
255. Graham S, Schotz W, Martino P. nitrosamines and risk of nasopharyngeal cancer risk. Nutr Cancer 2004;48:142-8.
Alimentary factors in the epidemiology carcinoma in Taiwan. Int J Cancer 288. Knekt P, Jarvinen R, Seppanen R, et al.
of gastric cancer. Cancer 1972;30:927-38. 2000;86:603-9. Dietary antioxidants and the risk of lung
256. Jedrychowski W, Popiela T, Tobiasz- 273. Yuan JM, Wang XL, Xiang YB, et al. cancer. Am J Epidemiol 1991;134:471-9.
Adamczyk B, et al. [Dietary factors and Preserved foods in relation to risk of 289. Knekt P, Jarvinen R, Teppo L, et al. Role of
laxatives in the epidemiology of stomach nasopharyngeal carcinoma in Shanghai, various carotenoids in lung cancer
cancer]. Nowotwory 1981;30:353-60. China. Int J Cancer 2000;85:358-63. prevention. J Natl Cancer Inst
257. Jedrychowski W, Wahrendorf J, Popiela T, 274. Ning JP, Yu MC, Wang QS, et al. 1999;91:182-4.
et al. A case-control study of dietary Consumption of salted fish and other risk 290. Liu Y, Sobue T, Otani T, et al. Vegetables,
factors and stomach cancer risk in factors for nasopharyngeal carcinoma fruit consumption and risk of lung cancer
Poland. Int J Cancer 1986;37:837-42. (NPC) in Tianjin, a low-risk region for among middle-aged Japanese men and
258. Coggon D, Barker DJ, Cole RB, et al. NPC in the Peoples Republic of China. J women: JPHC Study. Cancer Causes
Stomach cancer and food storage. J Natl Natl Cancer Inst 1990;82:291-6. Control 2004;15:349-57.
Cancer Inst 1989;81:1178-82. 275. Ye W, Yingnan Yi, Tianshu Zhou, Rutao 291. Miller AB. Vegetables and fruits and lung
259. Lee JK, Park BJ, Yoo KY, et al. Dietary Lin. A case-control study on risk cancer. IARC Sci Publ 2002;156:85-7.
424
R E F E R E N C E S
292. Miller AB, Altenburg HP, Bueno-de- 307. Darby S, Whitley E, Doll R, et al. Diet, lung cancer patients: results of a case-
Mesquita B, et al. Fruits and vegetables smoking and lung cancer: a case-control control study in males. Nutr Cancer
and lung cancer: Findings from the study of 1000 cases and 1500 controls in 1989;12:237-48.
European Prospective Investigation into South-West England. Br J Cancer 324. Pillow PC, Hursting SD, Duphorne CM, et
Cancer and Nutrition. Int J Cancer 2001;84:728-35. al. Case-control assessment of diet and
2004;108:269-76. 308. De Stefani E, Brennan P, Boffetta P, et al. lung cancer risk in African Americans
293. Neuhouser ML, Patterson RE, Thornquist Diet and adenocarcinoma of the lung: a and Mexican Americans. Nutr Cancer
MD, et al. Fruits and vegetables are case-control study in Uruguay. Lung 1997;29:169-73.
associated with lower lung cancer risk Cancer 2002;35:43-51. 325. Rachtan J. Dietary habits and lung cancer
only in the placebo arm of the beta- 309. De Stefani E, Brennan P, Ronco A, et al. risk among Polish women. Acta Oncol
carotene and retinol efficacy trial Food groups and risk of lung cancer in 2002;41:389-94.
(CARET). Cancer Epidemiol Biomarkers Uruguay. Lung Cancer 2002;38:1-7. 326. Ruano-Ravina A, Figueiras A, Dosil-Diaz
Prev 2003;12:350-8. 310. Dorgan JF, Ziegler RG, Schoenberg JB, et O, et al. A population-based case-control
294. Ocke MC, Bueno-de-Mesquita HB, al. Race and sex differences in study on fruit and vegetable intake and
Feskens EJ, et al. Repeated associations of vegetables, fruits, and lung cancer: a paradox effect? Nutr
measurements of vegetables, fruits, carotenoids with lung cancer risk in New Cancer 2002;43:47-51.
beta-carotene, and vitamins C and E in Jersey (United States). Cancer Causes 327. Stefani ED, Boffetta P, Deneo-Pellegrini H,
relation to lung cancer. The Zutphen Control 1993;4:273-81. et al. Dietary antioxidants and lung
Study. Am J Epidemiol 1997;145:358-65. 311. Fontham ET, Pickle LW, Haenszel W, et al. cancer risk: a case-control study in
295. Ratnasinghe D, Forman MR, Tangrea JA, Dietary vitamins A and C and lung cancer Uruguay. Nutr Cancer 1999;34:100-10.
et al. Serum carotenoids are associated risk in Louisiana. Cancer 1988;62:2267- 328. Swanson CA, Brown CC, Sinha R, et al.
with increased lung cancer risk among 73. Dietary fats and lung cancer risk among
alcohol drinkers, but not among non- 312. Forman MR, Yao SX, Graubard BI, et al. women: the Missouri Womens Health
drinkers in a cohort of tin miners. The effect of dietary intake of fruits and Study (United States). Cancer Causes
Alcohol Alcohol 2000;35:355-60. vegetables on the odds ratio of lung Control 1997;8:883-93.
296. Shibata A, Paganini-Hill A, Ross RK, et al. cancer among Yunnan tin miners. Int J 329. Wu-Williams AH, Dai XD, Blot W, et al.
Dietary beta-carotene, cigarette Epidemiol 1992;21:437-41. Lung cancer among women in north-
smoking, and lung cancer in men. Cancer 313. Hu J, Mao Y, Dryer D, et al. Risk factors for east China. Br J Cancer 1990;62:982-7.
Causes Control 1992;3:207-14. lung cancer among Canadian women 330. Ziegler RG, Mason TJ, Stemhagen A, et al.
297. Skuladottir H, Tjoenneland A, Overvad K, who have never smoked. Cancer Detect Carotenoid intake, vegetables, and the
et al. Does insufficient adjustment for Prev 2002;26:129-38. risk of lung cancer among white men in
smoking explain the preventive effects 314. Jain M, Burch JD, Howe GR, et al. Dietary New Jersey. Am J Epidemiol
of fruit and vegetables on lung cancer? factors and risk of lung cancer: results 1986;123:1080-93.
Lung Cancer 2004;45:1-10. from a case-control study, Toronto, 1981- 331. Lan L, Ding Y. Study on serum vitamin A
298. Stahelin HB, Gey KF, Eichholzer M, et al. 1985. Int J Cancer 1990;45:287-93. beta carotene and immune function in
Plasma antioxidant vitamins and 315. Kalandidi A, Katsouyanni K, Voropoulou lung cancer. Ying Yang Xue Bao
subsequent cancer mortality in the 12- N, et al. Passive smoking and diet in the 1990;12:228-32.
year follow-up of the prospective Basel etiology of lung cancer among non- 332. Khlat M, Bouchardy C, Parkin DM. [Cancer
Study. Am J Epidemiol 1991;133:766-75. smokers. Cancer Causes Control mortality in immigrants from the Near
299. Steinmetz KA, Potter JD, Folsom AR. 1990;1:15-21. East in Australia]. Rev Epidemiol Sante
Vegetables, fruit, and lung cancer in the 316. Ko YC, Lee CH, Chen MJ, et al. Risk factors Publique 1993;41:208-17.
Iowa Womens Health Study. Cancer Res for primary lung cancer among non- 333. Le Marchand L, Hankin JH, Bach F, et al.
1993;53:536-43. smoking women in Taiwan. Int J An ecological study of diet and lung
300. Voorrips LE, Goldbohm RA, Verhoeven Epidemiol 1997;26:24-31. cancer in the South Pacific. Int J Cancer
DT, et al. Vegetable and fruit 317. Kubik AK, Zatloukal P, Tomasek L, et al. 1995;63:18-23.
consumption and lung cancer risk in the Lung cancer risk among Czech women: a 334. Mulder I, Jansen MC, Smit HA, et al. Role
Netherlands Cohort Study on diet and case-control study. Prev Med of smoking and diet in the cross-cultural
cancer. Cancer Causes Control 2002;34:436-44. variation in lung-cancer mortality: the
2000;11:101-15. 318. Lagiou P, Samoli E, Lagiou A, et al. Seven Countries Study. Seven Countries
301. Agudo A, Esteve MG, Pallares C, et al. Flavonoid intake in relation to lung Study Research Group. Int J Cancer
Vegetable and fruit intake and the risk cancer risk: case-control study among 2000;88:665-71.
of lung cancer in women in Barcelona, women in Greece. Nutr Cancer 335. Taioli E, Nicolosi A, Wynder EL. Possible
Spain. Eur J Cancer 1997;33:1256-61. 2004;49:139-43. role of diet as a host factor in the
302. Alavanja MC, Brownson RC, Benichou J. 319. MacLennan R, Da Costa J, Day NE, et al. aetiology of tobacco-induced lung
Estimating the effect of dietary fat on Risk factors for lung cancer in Singapore cancer: an ecological study in southern
the risk of lung cancer in nonsmoking Chinese, a population with high female and northern Italy. Int J Epidemiol
women. Lung Cancer 1996;14 Suppl incidence rates. Int J Cancer 1977;20:854- 1991;20:611-4.
1:S63-74. 60. 336. Smith-Warner SA, Spiegelman D, Yaun SS,
303. Axelsson G, Rylander R. Diet as risk for 320. Marchand JL, Luce D, Goldberg P, et al. et al. Fruits, vegetables and lung cancer:
lung cancer: a Swedish case-control Dietary factors and the risk of lung a pooled analysis of cohort studies. Int J
study. Nutr Cancer 2002;44:145-51. cancer in New Caledonia (South Pacific). Cancer 2003;107:1001-11.
304. Biscevic A, Ustamujic A. Relative effects of Nutr Cancer 2002;42:18-24. 337. Jansen MC, Bueno-de-Mesquita HB,
nutrients on carcinogenesis. Med Arh 321. Mohr DL, Blot WJ, Tousey PM, et al. Rasanen L, et al. Cohort analysis of fruit
2004;58:347-50. Southern cooking and lung cancer. Nutr and vegetable consumption and lung
305. Caicoya M. [Lung cancer and vegetable Cancer 1999;35:34-43. cancer mortality in European men. Int J
consumption in Asturias, Spain. A case 322. Nyberg F, Agrenius V, Svartengren K, et al. Cancer 2001;92:913-8.
control study]. Med Clin (Barc) Dietary factors and risk of lung cancer in 338. Knekt P, Jarvinen R, Seppanen R, et al.
2002;119:206-10. never-smokers. Int J Cancer 1998;78:430- Dietary flavonoids and the risk of lung
306. Candelora EC, Stockwell HG, Armstrong 6. cancer and other malignant neoplasms.
AW, et al. Dietary intake and risk of lung 323. Pierce RJ, Kune GA, Kune S, et al. Dietary Am J Epidemiol 1997;146:223-30.
cancer in women who never smoked. and alcohol intake, smoking pattern, 339. Kvale G, Bjelke E, Gart JJ. Dietary habits
Nutr Cancer 1992;17:263-70. occupational risk, and family history in and lung cancer risk. Int J Cancer
425
F O O D , N U T R I T I O N , P H Y S I C A L A C T I V I T Y, A N D T H E P R E V E N T I O N O F C A N C E R : A G L O B A L P E R S P E C T I V E
1983;31:397-405. habits, and lung cancer risk. Int J Cancer 373. Sanjoaquin MA, Appleby PN, Thorogood
340. Ozasa K, Watanabe Y, Ito Y, et al. Dietary 1989;43:608-12. M, et al. Nutrition, lifestyle and
habits and risk of lung cancer death in a 357. Rachtan J. A case-control study of lung colorectal cancer incidence: a
large-scale cohort study (JACC Study) in cancer in Polish women. Neoplasma prospective investigation of 10998
Japan by sex and smoking habit. Jpn J 2002;49:75-80. vegetarians and non-vegetarians in the
Cancer Res 2001;92:1259-69. 358. Rachtan J, Sokolowski A. Risk factors for United Kingdom. Br J Cancer
341. Speizer FE, Colditz GA, Hunter DJ, et al. lung cancer among women in Poland. 2004;90:118-21.
Prospective study of smoking, Lung Cancer 1997;18:137-45. 374. Lin J, Zhang SM, Cook NR, et al. Dietary
antioxidant intake, and lung cancer in 359. Hsing AW, McLaughlin JK, Chow WH, et intakes of fruit, vegetables, and fiber,
middle-aged women (USA). Cancer al. Risk factors for colorectal cancer in a and risk of colorectal cancer in a
Causes Control 1999;10:475-82. prospective study among U.S. white prospective cohort of women (United
342. Bond GG, Thompson FE, Cook RR. Dietary men. Int J Cancer 1998;77:549-53. States). Cancer Causes Control
vitamin A and lung cancer: results of a 360. Shibata A, Paganini Hill A, Ross RK, et al. 2005;16:225-33.
case-control study among chemical Intake of vegetables, fruits, beta- 375. Tiemersma EW, Kampman E, Bueno de
workers. Nutr Cancer 1987;9:109-21. carotene, vitamin C and vitamin Mesquita HB, et al. Meat consumption,
343. Gao CM, Tajima K, Kuroishi T, et al. supplements and cancer incidence cigarette smoking, and genetic
Protective effects of raw vegetables and among the elderly: a prospective study. susceptibility in the etiology of colorectal
fruit against lung cancer among smokers Br J Cancer 1992;66:673-9. cancer: results from a Dutch prospective
and ex-smokers: a case-control study in 361. Giovannucci E, Rimm EB, Stampfer MJ, et study. Cancer Causes Control
the Tokai area of Japan. Jpn J Cancer Res al. Intake of fat, meat, and fiber in 2002;13:383-93.
1993;84:594-600. relation to risk of colon cancer in men. 376. Voorrips LE, Goldbohm RA, van Poppel G,
344. Harris RW, Key TJ, Silcocks PB, et al. A Cancer Res 1994;54:2390-7. et al. Vegetable and fruit consumption
case-control study of dietary carotene in 362. Steinmetz KA, Kushi LH, Bostick RM, et al. and risks of colon and rectal cancer in a
men with lung cancer and in men with Vegetables, fruit, and colon cancer in the prospective cohort study: The
other epithelial cancers. Nutr Cancer Iowa Womens Health Study. Am J Netherlands Cohort Study on Diet and
1991;15:63-8. Epidemiol 1994;139:1-15. Cancer. Am J Epidemiol 2000;152:1081-
345. Mayne ST, Janerich DT, Greenwald P, et al. 363. Michels KB, Edward G, Joshipura KJ, et al. 92.
Dietary beta carotene and lung cancer Prospective study of fruit and vegetable 377. Thun MJ, Calle EE, Namboodiri MM, et al.
risk in U.S. nonsmokers. J Natl Cancer Inst consumption and incidence of colon and Risk factors for fatal colon cancer in a
1994;86:33-8. rectal cancers. J Natl Cancer Inst large prospective study. J Natl Cancer Inst
346. Pawlega J, Rachtan J, Dyba T. Evaluation 2000;92:1740-52. 1992;84:1491-500.
of certain risk factors for lung cancer in 364. Terry P, Giovannucci E, Michels KB, et al. 378. Wark PA, Weijenberg MP, van t Veer P, et
Cracow (Poland) - a case-control study. Fruit, vegetables, dietary fiber and risk of al. Fruits, vegetables, and hMLH1
Acta Oncol 1997;36:471-6. colorectal cancer. J Natl Cancer Inst protein-deficient and -proficient colon
347. Pisani P, Berrino F, Macaluso M, et al. 2001;93:525-33. cancer: The Netherlands cohort study.
Carrots, green vegetables and lung 365. Colbert LH, Hartman TJ, Malila N, et al. Cancer Epidemiol Biomarkers Prev
cancer: a case-control study. Int J Physical activity in relation to cancer of 2005;14:1619-25.
Epidemiol 1986;15:463-8. the colon and rectum in a cohort of male 379. Sellers TTA, Bazyk AAE, Bostick RRM, et al.
348. Sankaranarayanan R, Varghese C, Duffy smokers. Cancer Epidemiol Biomarkers Diet and risk of colon cancer in a large
SW, et al. A case-control study of diet Prev 2001;10:265-8. prospective study of older women: an
and lung cancer in Kerala, south India. 366. McCullough ML, Robertson AS, Chao A, et analysis stratified on family history
Int J Cancer 1994;58:644-9. al. A prospective study of whole grains, (Iowa, United States). Cancer Causes
349. Suzuki I, Hamada GS, Zamboni MM, et al. fruits, vegetables and colon cancer risk. Control 1998;9:357-67.
Risk factors for lung cancer in Rio de Cancer Causes Control 2003;14:959-70. 380. Wakai K, Hirose K, Matsuo K, et al.
Janeiro, Brazil: a case-control study. Lung 367. Sato Y, Tsubono Y, Nakaya N, et al. Fruit Dietary risk factors for colon and rectal
Cancer 1994;11:179-90. and vegetable consumption and risk of cancers: a comparative case-control
350. Ziegler RG, Colavito EA, Hartge P, et al. colorectal cancer in Japan: The Miyagi study. J Epidemiol 2006;16:125-35.
Importance of alpha-carotene, beta- Cohort Study. Public Health Nutr 381. Fairfield KM, Hankinson SE, Rosner BA, et
carotene, and other phytochemicals in 2005;8:309-14. al. Risk of ovarian carcinoma and
the etiology of lung cancer. J Natl Cancer 368. Kato I, Akhmedkhanov A, Koenig K, et al. consumption of vitamins A, C, and E and
Inst 1996;88:612-5. Prospective study of diet and female specific carotenoids: a prospective
351. Axelsson G, Liljeqvist T, Andersson L, et al. colorectal cancer: the New York analysis. Cancer 2001;92:2318-26.
Dietary factors and lung cancer among University Womens Health Study. Nutr 382. Kushi LH, Mink PJ, Folsom AR, et al.
men in west Sweden. Int J Epidemiol Cancer 1997;28:276-81. Prospective study of diet and ovarian
1996;25:32-9. 369. Pietinen P, Malila N, Virtanen M, et al. cancer. Am J Epidemiol 1999;149:21-31.
352. Brennan P, Fortes C, Butler J, et al. A Diet and risk of colorectal cancer in a 383. Larsson SC, Holmberg L, Wolk A, et al.
multicenter case-control study of diet cohort of Finnish men. Cancer Causes Fruit and vegetable consumption in
and lung cancer among non-smokers. Control 1999;10:387-96. relation to ovarian cancer incidence: the
Cancer Causes Control 2000;11:49-58. 370. Schoen RE, Tangen CM, Kuller LH, et al. Swedish mammography cohort. Br J
353. Dai XD, Lin CY, Sun XW, et al. The etiology Increased blood glucose and insulin, Cancer 2004;90:2167-70.
of lung cancer in nonsmoking females in body size, and incident colorectal cancer. 384. Mommers M, Schouten LJ, Goldbohm RA,
Harbin, China. Lung Cancer 1996;14 J Natl Cancer Inst 1999;91:1147-54. et al. Consumption of vegetables and
Suppl 1:S85-91. 371. Bueno de Mesquita HB, Ferrari P, Riboli E. fruits and risk of ovarian carcinoma:
354. Koo LC. Dietary habits and lung cancer Plant foods and the risk of colorectal results from the Netherlands Cohort
risk among Chinese females in Hong cancer in Europe: preliminary findings. Study on Diet and Cancer. Cancer
Kong who never smoked. Nutr Cancer IARC Sci Publ 2002;156:89-95. 2005;104:1512-9.
1988;11:155-72. 372. Flood A, Velie EM, Chaterjee N, et al. Fruit 385. Schulz M, Lahmann PH, Boeing H, et al.
355. Kreuzer M, Heinrich J, Kreienbrock L, et and vegetable intakes and the risk of Fruit and vegetable consumption and
al. Risk factors for lung cancer among colorectal cancer in the Breast Cancer risk of epithelial ovarian cancer: the
nonsmoking women. Int J Cancer Detection Demonstration Project follow- European Prospective Investigation into
2002;100:706-13. up cohort. Am J Clin Nutr 2002;75:936- Cancer and Nutrition. Cancer Epidemiol
356. Mettlin C. Milk drinking, other beverage 43. Biomarkers Prev 2005;14:2531-5.
426
R E F E R E N C E S
386. Bosetti C, Negri E, Franceschi S, et al. Diet 403. Jain MG, Howe GR, Rohan TE. Nutritional high incidence area of stomach cancer.
and ovarian cancer risk: a case-control factors and endometrial cancer in Ying Yang Xue Bao 1992;14:150-4.
study in Italy. Int J Cancer 2001;93:911-5. Ontario, Canada. Cancer Control 419. Garcia-Closas R, Gonzalez CA, Agudo A,
387. McCann SE, Freudenheim JL, Marshall JR, 2000;7:288-96. et al. Intake of specific carotenoids and
et al. Risk of human ovarian cancer is 404. McCann SE, Freudenheim JL, Marshall JR, flavonoids and the risk of gastric cancer
related to dietary intake of selected et al. Diet in the epidemiology of in Spain. Cancer Causes Control
nutrients, phytochemicals and food endometrial cancer in western New York 1999;10:71-5.
groups. J Nutr 2003;133:1937-42. (United States). Cancer Causes Control 420. Xu HX. [Relation between the diet of the
388. McCann SE, Moysich KB, Mettlin C. 2000;11:965-74. residents and the incidence of gastric
Intakes of selected nutrients and food 405. Littman AJ, Beresford SA, White E. The cancer in Yantai District]. Chung Hua Liu
groups and risk of ovarian cancer. Nutr association of dietary fat and plant Hsing Ping Hsueh Tsa Chih 1985;6:245-7.
Cancer 2001;39:19-28. foods with endometrial cancer (United 421. You WC, Blot WJ, Chang YS, et al. Allium
389. Pan SY, Ugnat AM, Mao Y, et al. A case- States). Cancer Causes Control vegetables and reduced risk of stomach
control study of diet and the risk of 2001;12:691-702. cancer. J Natl Cancer Inst 1989;81:162-4.
ovarian cancer. Cancer Epidemiol 406. Petridou E, Kedikoglou S, Koukoulomatis 422. Li H, Chen XL, Li HQ. Polymorphism of
Biomarkers Prev 2004;13:1521-7. P, et al. Diet in relation to endometrial CYPIA1 and GSTM1 genes associated
390. Shu XO, Gao YT, Yuan JM, et al. Dietary cancer risk: a case-control study in with susceptibility of gastric cancer in
factors and epithelial ovarian cancer. Br J Greece. Nutr Cancer 2002;44:16-22. Shandong Province of China. World J
Cancer 1989;59:92-6. 407. Tao MH, Xu WH, Zheng W, et al. A case- Gastroenterol 2005;11:5757-62.
391. Tavani A, Bosetti C, Dal Maso L, et al. control study in Shanghai of fruit and 423. Li H, Li HQ, Wang Y, et al. An intervention
Influence of selected hormonal and vegetable intake and endometrial study to prevent gastric cancer by micro-
lifestyle factors on familial propensity to cancer. Br J Cancer 2005;92:2059-64. selenium and large dose of allitridum.
ovarian cancer. Gynecol Oncol 408. Barbone F, Austin H, Partridge EE. Diet Chin Med J (Engl) 2004;117:1155-60.
2004;92:922-6. and endometrial cancer: a case-control 424. Zheng GH, Li H, Fan WT, et al. [Study on
392. Zhang M, Yang ZY, Binns CW, et al. Diet study. Am J Epidemiol 1993;137:393-403. the long-time effect on allitridum and
and ovarian cancer risk: a case-control 409. Terry P, Wolk A, Vainio H, et al. Fatty fish selenium in prevention of digestive
study in China. Br J Cancer 2002;86:712- consumption lowers the risk of system cancers]. Zhonghua Liu Xing Bing
7. endometrial cancer: a nationwide case- Xue Za Zhi 2005;26:110-2.
393. Ganmaa D, Sato A. The possible role of control study in Sweden. Cancer 425. Graham DY, Anderson SY, Lang T. Garlic or
female sex hormones in milk from Epidemiol Biomarkers Prev 2002;11:143- jalapeno peppers for treatment of
pregnant cows in the development of 5. Helicobacter pylori infection. Am J
breast, ovarian and corpus uteri cancers. 410. Goodman MT, Hankin JH, Wilkens LR, et Gastroenterol 1999;94:1200-2.
Med Hypotheses 2005;65:1028-37. al. Diet, body size, physical activity, and 426. Iimuro M, Shibata H, Kawamori T, et al.
394. Rose DP, Boyar AP, Wynder EL. the risk of endometrial cancer. Cancer Suppressive effects of garlic extract on
International comparisons of mortality Res 1997;57:5077-85. Helicobacter pylori-induced gastritis in
rates for cancer of the breast, ovary, 411. Boone CW, Kelloff GJ, Malone WE. Mongolian gerbils. Cancer Lett
prostate, and colon, and per capita food Identification of candidate cancer 2002;187:61-8.
consumption. Cancer 1986;58:2363-71. chemopreventive agents and their 427. Franceschi S, Parpinel M, La Vecchia C, et
395. Engle A, Muscat JE, Harris RE. Nutritional evaluation in animal models and human al. Role of different types of vegetables
risk factors and ovarian cancer. Nutr clinical trials: a review. Cancer Res and fruit in the prevention of cancer of
Cancer 1991;15:239-47. 1990;50:2-9. the colon, rectum, and breast.
396. La Vecchia C, Decarli A, Negri E, et al. 412. Lampe JW, Chen C, Li S, et al. Modulation Epidemiology 1998;9:338-41.
Dietary factors and the risk of epithelial of human glutathione S-transferases by 428. Gong Y, Ji B, Gao Y, et al. The nutritional
ovarian cancer. J Natl Cancer Inst botanically defined vegetable diets. epidemiology of rectal cancer in a
1987;79:663-9. Cancer Epidemiol Biomarkers Prev population-based case-control study in
397. Koushik A, Hunter DJ, Spiegelman D, et 2000;9:787-93. Shanghai. Ying Yang Xue Bao
al. Fruits and vegetables and ovarian 413. Dorant E, van den Brandt PA, Goldbohm 1993;15:309-17.
cancer risk in a pooled analysis of 12 RA, et al. Consumption of onions and a 429. Hu JF, Liu YY, Yu YK, et al. Diet and cancer
cohort studies. Cancer Epidemiol reduced risk of stomach carcinoma. of the colon and rectum: a case-control
Biomarkers Prev 2005;14:2160-7. Gastroenterology 1996;110:12-20. study in China. Int J Epidemiol
398. Shu XO, Zheng W, Potischman N, et al. A 414. Gonzalez CA, Pera G, Agudo A, et al. Fruit 1991;20:362-7.
population-based case-control study of and vegetable intake and the risk of 430. Le Marchand L, Hankin JH, Wilkens LR, et
dietary factors and endometrial cancer stomach and oesophagus al. Dietary fiber and colorectal cancer
in Shanghai, Peoples Republic of China. adenocarcinoma in the European risk. Epidemiology 1997;8:658-65.
Am J Epidemiol 1993;137:155-65. Prospective Investigation into Cancer 431. Levi F, Pasche C, La Vecchia C, et al. Food
399. Potischman N, Swanson CA, Brinton LA, et and Nutrition (EPIC-EURGAST). Int J groups and colorectal cancer risk. Br J
al. Dietary associations in a case-control Cancer 2006;118:2559-66. Cancer 1999;79:1283-7.
study of endometrial cancer. Cancer 415. Csendes A, Medina E, Gaete MC, et al. 432. Yang G, Gao Y, Ji B. [Dietary factors and
Causes Control 1993;4:239-50. [Gastric cancer: an epidemiologic and cancer of the colon and rectum in a
400. Levi F, Franceschi S, Negri E, et al. Dietary dietary study in 100 patients and 100 population based case-control study in
factors and the risk of endometrial controls]. Rev Med Chil 1976;104:761-5. Shanghai]. Zhonghua Liu Xing Bing Xue
cancer. Cancer 1993;71:3575-81. 416. You WC. [A study on the relationship Za Zhi 1994;15:299-303.
401. Tzonou A, Lipworth L, Kalandidi A, et al. between consumption of allium 433. Yang G, Gao Y, Ji B. [Comparison of risk
Dietary factors and the risk of vegetables and gastric cancer]. Chung factors between left and right-sided
endometrial cancer: a case - control Hua Yu Fang I Hsueh Tsa Chih colon cancer]. Zhongguo Yi Xue Ke Xue
study in Greece. Br J Cancer 1988;22:321-3. Yuan Xue Bao 1994;16:63-8.
1996;73:1284-90. 417. Hu JF, Zhang SF, Jia EM, et al. Diet and 434. Yang G, Ji B, Gao Y. Diet and nutrients as
402. Goodman MT, Wilkens LR, Hankin JH, et cancer of the stomach: a case-control risk factors of colon cancer: a
al. Association of soy and fiber study in China. Int J Cancer 1988;41:331- population-based case control study in
consumption with the risk of 5. Shanghai. Ying Yang Xue Bao
endometrial cancer. Am J Epidemiol 418. Chen K, Jiao D, Lu L, et al. A case-control 1993;14:373-9.
1997;146:294-306. study on diet and stomach cancer in a 435. Kamal-Fouad K, Kishk N. Cancer colon:
427
F O O D , N U T R I T I O N , P H Y S I C A L A C T I V I T Y, A N D T H E P R E V E N T I O N O F C A N C E R : A G L O B A L P E R S P E C T I V E
occupational and nutritional association. Vitamin supplement use and reduced 468. Alavanja MC, Field RW, Sinha R, et al.
J Med Res Inst 2002;23:80-94. risk of oral and pharyngeal cancer. Am J Lung cancer risk and red meat
436. Xiao D, Lew KL, Kim YA, et al. Diallyl Epidemiol 1992;135:1083-92. consumption among Iowa women. Lung
trisulfide suppresses growth of PC-3 452. Toporcov TN, Antunes JL, Tavares MR. Fat Cancer 2001;34:37-46.
human prostate cancer xenograft in vivo food habitual intake and risk of oral 469. Hu J, Johnson KC, Mao Y, et al. A case-
in association with Bax and Bak cancer. Oral Oncol 2004;40:925-31. control study of diet and lung cancer in
induction. Clin Cancer Res 2006;12:6836- 453. Hanaoka T, Tsugane S, Ando N, et al. northeast China. Int J Cancer
43. Alcohol consumption and risk of 1997;71:924-31.
437. Chu Q, Lee DT, Tsao SW, et al. S- esophageal cancer in Japan: a case- 470. Ozturk O, Isbir T, Yaylim I, et al. GST M1
allylcysteine, a water-soluble garlic control study in seven hospitals. Jpn J and CYP1A1 gene polymorphism and
derivative, suppresses the growth of a Clin Oncol 1994;24:241-6. daily fruit consumption in Turkish
human androgen-independent prostate 454. Victora CG, Munoz N, Day NE, et al. Hot patients with non-small cell lung
cancer xenograft, CWR22R, under in vivo beverages and oesophageal cancer in carcinomas. In Vivo 2003;17:625-32.
conditions. BJU Int 2007;99:925-32. southern Brazil: a case-control study. Int J 471. Shimizu H, Morishita M, Mizuno K, et al.
438. Shukla Y, Kalra N. Cancer Cancer 1987;39:710-6. A case-control study of lung cancer in
chemoprevention with garlic and its 455. Gimeno SG, de Souza JM, Mirra AP, et al. nonsmoking women. Tohoku J Exp Med
constituents. Cancer Lett 2007;247:167- [Risk factors for cancer of the esophagus: 1988;154:389-97.
81. a case control study in a metropolitan 472. Xu Z, Brown LM, Pan GW, et al. Cancer
439. Milner JA. Preclinical perspectives on area of south-eastern Brazil]. Rev Saude risks among iron and steel workers in
garlic and cancer. J Nutr 2006;136:827S- Publica 1995;29:159-65. Anshan, China. Part II: Case-control
31S. 456. Wolfgarten E, Rosendahl U, Nowroth T, et studies of lung and stomach cancer. Am J
440. La Vecchia C, Decarli A, Fasoli M, et al. al. Coincidence of nutritional habits and Ind Med 1996;30:7-15.
Dietary vitamin A and the risk of esophageal cancer in Germany. 473. Sone Y, Sakamoto N, Suga K, et al.
intraepithelial and invasive cervical Onkologie 2001;24:546-51. Comparison of diets among elderly
neoplasia. Gynecol Oncol 1988;30:187- 457. Yanai H, Inaba Y, Takagi H, et al. female residents in two suburban
95. Multivariate analysis of cancer districts in Chiang Mai Province,
441. La Vecchia C, Franceschi S, Decarli A, et al. mortalities for selected sites in 24 Thailand, in dry season - survey on high-
Dietary vitamin A and the risk of invasive countries. Environ Health Perspect and low-risk districts of lung cancer
cervical cancer. Int J Cancer 1984;34:319- 1979;32:83-101. incidence. Appl Human Sci 1998;17:49-
22. 458. Guo WD, Li JY, Blot WJ, et al. Correlations 56.
442. Hirose K, Hamajima N, Takezaki T, et al. of dietary intake and blood nutrient 474. Tomioka F, Wakasugi H. Study on food
Smoking and dietary risk factors for levels with esophageal cancer mortality intake patterns in Korea. Jpn J Health
cervical cancer at different age group in in China. Nutr Cancer 1990;13:121-7. Hum Ecol 1995;61:317-28.
Japan. J Epidemiol 1998;8:6-14. 459. Barone J, Taioli E, Hebert JR, et al. Vitamin 475. Kang ZC, Tsai SJ, Lee H. Quercetin inhibits
443. Marshall JR, Graham S, Byers T, et al. Diet supplement use and risk for oral and benzo[a]pyrene-induced DNA adducts in
and smoking in the epidemiology of esophageal cancer. Nutr Cancer human Hep G2 cells by altering
cancer of the cervix. J Natl Cancer Inst 1992;18:31-41. cytochrome P-450 1A1 gene expression.
1983;70:847-51. 460. Wu M, Zhao JK, Hu XS, et al. Association Nutr Cancer 1999;35:175-9.
444. Rajkumar T, Franceschi S, Vaccarella S, et of smoking, alcohol drinking and dietary 476. Alexandrov K, Cascorbi I, Rojas M, et al.
al. Role of paan chewing and dietary factors with esophageal cancer in high- CYP1A1 and GSTM1 genotypes affect
habits in cervical carcinoma in Chennai, and low-risk areas of Jiangsu Province, benzo[a]pyrene DNA adducts in smokers
India. Br J Cancer 2003;88:1388-93. China. World J Gastroenterol lung: comparison with
445. Guo WD, Hsing AW, Li JY, et al. 2006;12:1686-93. aromatic/hydrophobic adduct formation.
Correlation of cervical cancer mortality 461. Fraser GE, Beeson WL, Phillips RL. Diet Carcinogenesis 2002;23:1969-77.
with reproductive and dietary factors, and lung cancer in California Seventh- 477. Le Marchand L, Murphy SP, Hankin JH, et
and serum markers in China. Int J day Adventists. Am J Epidemiol al. Intake of flavonoids and lung cancer. J
Epidemiol 1994;23:1127-32. 1991;133:683-93. Natl Cancer Inst 2000;92:154-60.
446. Giuliano AR, Papenfuss M, Nour M, et al. 462. Fu YY, Takezaki T, Tajima K. [Risk factors 478. Rylander R, Axelsson G. Lung cancer risks
Antioxidant nutrients: associations with of lung cancer - follow-up studies in in relation to vegetable and fruit
persistent human papillomavirus Nagoya Japan]. Zhonghua Liu Xing Bing consumption and smoking. Int J Cancer
infection. Cancer Epidemiol Biomarkers Xue Za Zhi 1997;18:328-30. 2006;118:739-43.
Prev 1997;6:917-23. 463. Knekt P. Vitamin E and smoking and the 479. Haenszel W, Kurihara M, Locke FB, et al.
447. Chyou PH, Nomura AMY, Stemmermann risk of lung cancer. Ann N Y Acad Sci Stomach cancer in Japan. J Natl Cancer
GN. Diet, alcohol, smoking and cancer of 1993;686:280-7; discussion 7-8. Inst 1976;56:265-74.
the upper aerodigestive tract: a 464. Kromhout D. Essential micronutrients in 480. Wu-Williams AH, Yu MC, Mack TM. Life-
prospective study among Hawaii relation to carcinogenesis. Am J Clin Nutr style, workplace, and stomach cancer by
Japanese men. Int J Cancer 1995;60:616- 1987;45:1361-7. subsite in young men of Los Angeles
21. 465. Olson JE, Yang P, Schmitz K, et al. County. Cancer Res 1990;50:2569-76.
448. Maier H, Dietz A, Gewelke U, et al. Differential association of body mass 481. Yu GP, Hsieh CC. Risk factors for stomach
Tobacco and alcohol and the risk of head index and fat distribution with three cancer: a population-based case-control
and neck cancer. Clin Investig major histologic types of lung cancer: study in Shanghai. Cancer Causes Control
1992;70:320-7. evidence from a cohort of older women. 1991;2:169-74.
449. Yang T, Xie X, Xie M, et al. [A comparative Am J Epidemiol 2002;156:606-15. 482. Falcao JM, Dias JA, Miranda AC, et al. Red
study on the risk factors for the 466. Takezaki T, Inoue M, Kataoka H, et al. Diet wine consumption and gastric cancer in
incidence of tongue cancer]. Hunan Yi and lung cancer risk from a 14-year Portugal: a case-control study. Eur J
Ke Da Xue Xue Bao 1998;23:141-2. population-based prospective study in Cancer Prev 1994;3:269-76.
450. Gallus S, Bosetti C, Franceschi S, et al. Japan: with special reference to fish 483. Kolonel LN, Nomura AM, Hirohata T, et al.
Laryngeal cancer in women: tobacco, consumption. Nutr Cancer 2003;45:160- Association of diet and place of birth
alcohol, nutritional, and hormonal 7. with stomach cancer incidence in Hawaii
factors. Cancer Epidemiol Biomarkers 467. Wang LD, Hammond EC. Lung cancer, Japanese and Caucasians. Am J Clin Nutr
Prev 2003;12:514-7. fruit, green salad and vitamin pills. Chin 1981;34:2478-85.
451. Gridley G, McLaughlin JK, Block G, et al. Med J (Engl) 1985;98:206-10. 484. Lucchin L, Masciullo C, Perina P, et al.
428
R E F E R E N C E S
[Correlation between nutrition and control study in The Netherlands. Int J relation to pancreatic cancer risk: a
tumours in Alto Adige: critical Cancer 1991;48:540-9. prospective study. Cancer Epidemiol
considerations]. Clinica Dietologica 500. Mizuno S, Watanabe S, Nakamura K, et al. Biomarkers Prev 2006;15:301-5.
1994;21:77-83. A multi-institute case-control study on 517. Sauvaget C, Kasagi F, Waldren CA. Dietary
485. Meyer F. [Relationship between diet and the risk factors of developing pancreatic factors and cancer mortality among
carcinoma of stomach, colon, rectum, cancer. Jpn J Clin Oncol 1992;22:286-91. atomic-bomb survivors. Mutat Res
and pancreas in France]. Gastroenterol 501. Lyon JL, Slattery ML, Mahoney AW, et al. 2004;551:145-52.
Clin Biol 1977;1:971-82. Dietary intake as a risk factor for cancer 518. Parkin DM, Srivatanakul P, Khlat M, et al.
486. Peri L, Pietraforte D, Scorza G, et al. of the exocrine pancreas. Cancer Liver-cancer in Thailand. I. A case-control
Apples increase nitric oxide production Epidemiol Biomarkers Prev 1993;2:513-8. study of cholangiocarcinoma. Int J
by human saliva at the acidic pH of the 502. Anderson KE, Kadlubar FF, Kulldorff M, et Cancer 1991;48:323-8.
stomach: a new biological function for al. Dietary intake of heterocyclic amines 519. Kuper H, Tzonou A, Lagiou P, et al. Diet
polyphenols with a catechol group? Free and benzo(a)pyrene: associations with and hepatocellular carcinoma: a case-
Radic Biol Med 2005;39:668-81. pancreatic cancer. Cancer Epidemiol control study in Greece. Nutr Cancer
487. Fei SJ, Xiao SD. Diet and gastric cancer: a Biomarkers Prev 2005;14:2261-5. 2000;38:6-12.
case-control study in Shanghai urban 503. Falk RT, Pickle LW, Fontham ET, et al. Life- 520. Yu SZ, Huang XE, Koide T, et al. Hepatitis
districts. Chin J Dig Dis 2006;7:83-8. style risk factors for pancreatic cancer in B and C viruses infection, lifestyle and
488. Phukan RK, Narain K, Zomawia E, et al. Louisiana: a case-control study. Am J genetic polymorphisms as risk factors for
Dietary habits and stomach cancer in Epidemiol 1988;128:324-36. hepatocellular carcinoma in Haimen,
Mizoram, India. J Gastroenterol 504. Voirol M, Infante F, Raymond L, et al. China. Jpn J Cancer Res 2002;93:1287-92.
2006;41:418-24. [Nutritional profile of patients with 521. Lam KC, Yu MC, Leung JW, et al. Hepatitis
489. Campos F, Carrasquilla G, Koriyama C, et cancer of the pancreas]. Schweiz Med B virus and cigarette smoking: risk
al. Risk factors of gastric cancer specific Wochenschr 1987;117:1101-4. factors for hepatocellular carcinoma in
for tumor location and histology in Cali, 505. Howe GR, Jain M, Miller AB. Dietary Hong Kong. Cancer Res 1982;42:5246-8.
Colombia. World J Gastroenterol factors and risk of pancreatic cancer: 522. Kweon S, Park KA, Choi H.
2006;12:5772-9. results of a Canadian population-based Chemopreventive effect of garlic
490. Zheng X, Yan L, Nilsson B, et al. Epstein- case-control study. Int J Cancer powder diet in diethylnitrosamine-
Barr virus infection, salted fish and 1990;45:604-8. induced rat hepatocarcinogenesis. Life
nasopharyngeal carcinoma. A case- 506. Ji BT, Chow WH, Gridley G, et al. Dietary Sci 2003;73:2515-26.
control study in southern China. Acta factors and the risk of pancreatic cancer: 523. Kweon S, Kim Y, Choi H. Grape extracts
Oncol 1994;33:867-72. a case-control study in Shanghai China. suppress the formation of preneoplastic
491. Armstrong RW, Kannan Kutty M, Cancer Epidemiol Biomarkers Prev foci and activity of fatty acid synthase in
Armstrong MJ. Self-specific 1995;4:885-93. rat liver. Exp Mol Med 2003;35:371-8.
environments associated with 507. Ohba S, Nishi M, Miyake H. Eating habits 524. Shukla Y, Arora A. Suppression of altered
nasopharyngeal carcinoma in Selangor, and pancreas cancer. Int J Pancreatol hepatic foci development by curcumin in
Malaysia. Soc Sci Med 1978;12:149-56. 1996;20:37-42. wistar rats. Nutr Cancer 2003;45:53-9.
492. Huang Z, Jiang Y, Fang Y. An 508. Soler M, Chatenoud L, La Vecchia C, et al. 525. Shukla Y, Kalra N, Katiyar S, et al.
epidemiological study on risk factors of Diet, alcohol, coffee and pancreatic Chemopreventive effect of indole-3-
nasopharyngeal carcinoma in Guangxi cancer: final results from an Italian study. carbinol on induction of preneoplastic
province. Ind Occup Dis 2002;28:193-6. Eur J Cancer Prev 1998;7:455-60. altered hepatic foci. Nutr Cancer
493. Iwase Y, Takemura Y, Ju-ichi M, et al. 509. Silverman DT, Swanson CA, Gridley G, et 2004;50:214-20.
Inhibitory effect of Epstein-Barr virus al. Dietary and nutritional factors and 526. Talamini R, Polesel J, Montella M, et al.
activation by Citrus fruits, a cancer pancreatic cancer: a case-control study Food groups and risk of hepatocellular
chemopreventor. Cancer Lett based on direct interviews. J Natl Cancer carcinoma: a multicenter case-control
1999;139:227-36. Inst 1998;90:1710-9. study in Italy. Int J Cancer 2006;119:2916-
494. Stolzenberg-Solomon RZ, Pietinen P, 510. Zhang Y, Cantor KP, Lynch CF, et al. 21.
Taylor PR, et al. Prospective study of diet Occupation and risk of pancreatic 527. Kojima M, Wakai K, Tamakoshi K, et al.
and pancreatic cancer in male smokers. cancer: a population-based case-control Diet and colorectal cancer mortality:
Am J Epidemiol 2002;155:783-92. study in Iowa. J Occup Environ Med results from the Japan collaborative
495. Shibata A, Mack TM, Paganini-Hill A, et 2005;47:392-8. cohort study. Nutr Cancer 2004;50:23-32.
al. A prospective study of pancreatic 511. Mori M, Hariharan M, Anandakumar M, 528. Singh PN, Fraser GE. Dietary risk factors
cancer in the elderly. Int J Cancer et al. A case-control study on risk factors for colon cancer in a low-risk population.
1994;58:46-9. for pancreatic diseases in Kerala, India. Am J Epidemiol 1998;148:761-74.
496. Mills PK, Beeson WL, Abbey DE, et al. Hepatogastroenterology 1999;46:25-30. 529. Phillips RL. Role of life-style and dietary
Dietary habits and past medical history 512. Benhamou S, Clavel F, Rezvani A, et al. habits in risk of cancer among seventh-
as related to fatal pancreas cancer risk [Relation between mortality in cancer of day adventists. Cancer Res 1975;35:3513-
among Adventists. Cancer 1988;61:2578- the pancreas and food and tobacco 22.
85. consumption in France]. Biomed 530. Tsubono Y, Otani T, Kobayashi M, et al. No
497. Chan JM, Wang F, Holly EA. Vegetable Pharmacother 1982;36:389-92. association between fruit or vegetable
and fruit intake and pancreatic cancer in 513. Kato I, Tajima K, Kuroishi T, et al. Latitude consumption and the risk of colorectal
a population-based case-control study in and pancreatic cancer. Jpn J Clin Oncol cancer in Japan. Br J Cancer
the San Francisco bay area. Cancer 1985;15:403-13. 2005;92:1782-4.
Epidemiol Biomarkers Prev 514. Vioque J, Gonzalez SL, Cayuela DA. 531. Turner F, Smith G, Sachse C, et al.
2005;14:2093-7. [Cancer of the pancreas: an ecologic Vegetable, fruit and meat consumption
498. Olsen GW, Mandel JS, Gibson RW, et al. A study]. Med Clin (Barc) 1990;95:121-5. and potential risk modifying genes in
case-control study of pancreatic cancer 515. Corella PD, Cortina GP, Coltell SO. relation to colorectal cancer. Int J Cancer
and cigarettes, alcohol, coffee and diet. [Nutritional factors and geographic 2004;112:259-64.
Am J Public Health 1989;79:1016-9. differences in pancreatic cancer 532. Juarranz Sanz M, Soriano Llora T, Calle
499. Bueno de Mesquita HB, Maisonneuve P, mortality in Spain]. Rev Sanid Hig Publica Puron ME, et al. [Influence of the diet on
Runia S, et al. Intake of foods and (Madr) 1994;68:361-76. the development of colorectal cancer in
nutrients and cancer of the exocrine 516. Larsson SC, Hakansson N, Naslund I, et al. a population of Madrid]. Rev Clin Esp
pancreas: a population-based case- Fruit and vegetable consumption in 2004;204:355-61.
429
F O O D , N U T R I T I O N , P H Y S I C A L A C T I V I T Y, A N D T H E P R E V E N T I O N O F C A N C E R : A G L O B A L P E R S P E C T I V E
533. Kuriki K, Hamajima N, Chiba H, et al. Biomarkers Prev 1993;2:189-93. Epidemiol 2005;15 Suppl 2:S140-9.
Increased risk of colorectal cancer due to 550. Bandera EV, Freudenheim JL, Marshall JR, 565. Ito Y, Kurata M, Hioki R, et al. Cancer
interactions between meat consumption et al. Diet and alcohol consumption and mortality and serum levels of
and the CD36 gene A52C polymorphism lung cancer risk in the New York State carotenoids, retinol, and tocopherol: a
among Japanese. Nutr Cancer Cohort (United States). Cancer Causes population-based follow-up study of
2005;51:170-7. Control 1997;8:828-40. inhabitants of a rural area of Japan.
534. Padayatty SJ, Katz A, Wang Y, et al. 551. Bandera EV, Freudenheim JL, Marshall JR, Asian Pac J Cancer Prev 2005;6:10-5.
Vitamin C as an antioxidant: evaluation et al. Impact of losses to follow-up on 566. Yuan JM, Ross RK, Chu XD, et al.
of its role in disease prevention. J Am diet/alcohol and lung cancer analyses in Prediagnostic levels of serum beta-
Coll Nutr 2003;22:18-35. the New York State Cohort. Nutr Cancer cryptoxanthin and retinol predict
535. Fountoulakis A, Martin IG, White KL, et al. 2002;42:41-7. smoking-related lung cancer risk in
Plasma and esophageal mucosal levels of 552. Michaud DS, Feskanich D, Rimm EB, et al. Shanghai, China. Cancer Epidemiol
vitamin C: role in the pathogenesis and Intake of specific carotenoids and risk of Biomarkers Prev 2001;10:767-73.
neoplastic progression of Barretts lung cancer in 2 prospective US cohorts. 567. Burgaz S, Torun M, Yardim S, et al. Serum
esophagus. Dig Dis Sci 2004;49:914-9. Am J Clin Nutr 2000;72:990-7. carotenoids and uric acid levels in
536. Liu RH, Liu J, Chen B. Apples prevent 553. Shekelle RB, Lepper M, Liu S, et al. Dietary relation to cancer. J Clin Pharm Ther
mammary tumors in rats. J Agric Food vitamin A and risk of cancer in the 1996;21:331-6.
Chem 2005;53:2341-3. Western Electric study. Lancet 568. LeGardeur BY, Lopez A, Johnson WD. A
537. Nomura AM, Ziegler RG, Stemmermann 1981;2:1185-90. case-control study of serum vitamins A,
GN, et al. Serum micronutrients and 554. Wright ME, Mayne ST, Stolzenberg- E, and C in lung cancer patients. Nutr
upper aerodigestive tract cancer. Cancer Solomon RZ, et al. Development of a Cancer 1990;14:133-40.
Epidemiol Biomarkers Prev 1997;6:407- comprehensive dietary antioxidant index 569. Luo X. [Vitamin nutritional status of a
12. and application to lung cancer risk in a high lung cancer risk population].
538. Zheng W, Blot WJ, Diamond EL, et al. cohort of male smokers. Am J Epidemiol Zhonghua Zhong Liu Za Zhi 1991;13:257-
Serum micronutrients and the 2004;160:68-76. 60.
subsequent risk of oral and pharyngeal 555. Yong LC, Brown CC, Schatzkin A, et al. 570. Stam J, Strankinga WF, Fikkert JJ, et al.
cancer. Cancer Res 1993;53:795-8. Intake of vitamins E, C, and A and risk of Vitamins and lung cancer. Lung 1990;168
539. Tavani A, Negri E, Franceschi S, et al. lung cancer. The NHANES I epidemiologic Suppl:1075-81.
Attributable risk for laryngeal cancer in followup study. First National Health and 571. Tominaga K, Saito Y, Mori K, et al. An
northern Italy. Cancer Epidemiol Nutrition Examination Survey. Am J evaluation of serum microelement
Biomarkers Prev 1994;3:121-5. Epidemiol 1997;146:231-43. concentrations in lung cancer and
540. Bidoli E, Bosetti C, La Vecchia C, et al. 556. Bandera EV, Freudenheim JL, Graham S, matched non-cancer patients to
Micronutrients and laryngeal cancer risk et al. Alcohol consumption and lung determine the risk of developing lung
in Italy and Switzerland: a case-control cancer in white males. Cancer Causes cancer: a preliminary study. Jpn J Clin
study. Cancer Causes Control Control 1992;3:361-9. Oncol 1992;22:96-101.
2003;14:477-84. 557. Cheng TJ, Christiani DC, Xu X, et al. 572. Rohan TE, Jain M, Howe GR, et al. A
541. Mackerras D, Buffler PA, Randall DE, et al. Increased micronucleus frequency in cohort study of dietary carotenoids and
Carotene intake and the risk of laryngeal lymphocytes from smokers with lung lung cancer risk in women (Canada).
cancer in coastal Texas. Am J Epidemiol cancer. Mutat Res 1996;349:43-50. Cancer Causes Control 2002;13:231-7.
1988;128:980-8. 558. Garcia J, Atalah E, Urteaga C, et al. 573. Voorrips LE, Goldbohm RA, Brants HA, et
542. Freudenheim JL, Graham S, Byers TE, et al. [Dietary carotene intake and lung cancer al. A prospective cohort study on
Diet, smoking, and alcohol in cancer of among men from Santiago]. Rev Med antioxidant and folate intake and male
the larynx: a case-control study. Nutr Chil 1995;123:51-60. lung cancer risk. Cancer Epidemiol
Cancer 1992;17:33-45. 559. Samet JM, Skipper BJ, Humble CG, et al. Biomarkers Prev 2000;9:357-65.
543. Negri E, Franceschi S, Bosetti C, et al. Lung cancer risk and vitamin A 574. Le Marchand L, Hankin JH, Kolonel LN, et
Selected micronutrients and oral and consumption in New Mexico. Am Rev al. Intake of specific carotenoids and
pharyngeal cancer. Int J Cancer Respir Dis 1985;131:198-202. lung cancer risk. Cancer Epidemiol
2000;86:122-7. 560. Wright ME, Mayne ST, Swanson CA, et al. Biomarkers Prev 1993;2:183-7.
544. Rossing MA, Vaughan TL, McKnight B. Dietary carotenoids, vegetables, and 575. Comstock GW, Alberg AJ, Huang HY, et al.
Diet and pharyngeal cancer. Int J Cancer lung cancer risk in women: the Missouri The risk of developing lung cancer
1989;44:593-7. womens health study (United States). associated with antioxidants in the
545. Knekt P, Aromaa A, Maatela J, et al. Cancer Causes Control 2003;14:85-96. blood: ascorbic acid, carotenoids, alpha-
Serum micronutrients and risk of cancers 561. Ziegler RG, Mason TJ, Stemhagen A, et al. tocopherol, selenium, and total peroxyl
of low incidence in Finland. Am J Dietary carotene and vitamin A and risk radical absorbing capacity. Cancer
Epidemiol 1991;134:356-61. of lung cancer among white men in New Epidemiol Biomarkers Prev 1997;6:907-
546. Drozdz M, Gierek T, Jendryczko A, et al. Jersey. J Natl Cancer Inst 1984;73:1429- 16.
Zinc, vitamins A and E, and retinol- 35. 576. Goodman GE, Schaffer S, Omenn GS, et al.
binding protein in sera of patients with 562. Connett JE, Kuller LH, Kjelsberg MO, et al. The association between lung and
cancer of the larynx. Neoplasma Relationship between carotenoids and prostate cancer risk, and serum
1989;36:357-62. cancer. The Multiple Risk Factor micronutrients: results and lessons
547. Abiaka C, Al-Awadi F, Gulshan S, et al. Intervention Trial (MRFIT) Study. Cancer learned from beta-carotene and retinol
Plasma concentrations of alpha- 1989;64:126-34. efficacy trial. Cancer Epidemiol
tocopherol and urate in patients with 563. Ito Y, Wakai K, Suzuki K, et al. Serum Biomarkers Prev 2003;12:518-26.
different types of cancer. J Clin Pharm carotenoids and mortality from lung 577. Ratnasinghe DL, Yao SX, Forman M, et al.
Ther 2001;26:265-70. cancer: a case-control study nested in the Gene-environment interactions between
548. De Stefani E, Ronco A, Mendilaharsu M, et Japan Collaborative Cohort (JACC) study. the codon 194 polymorphism of XRCC1
al. Diet and risk of cancer of the upper Cancer Sci 2003;94:57-63. and antioxidants influence lung cancer
aerodigestive tract - II. Nutrients. Oral 564. Ito Y, Wakai K, Suzuki K, et al. Lung cancer risk. Anticancer Res 2003;23:627-32.
Oncol 1999;35:22-6. mortality and serum levels of 578. Bakker Schut TC, Puppels GJ, Kraan YM,
549. Negri E, La Vecchia C, Franceschi S, et al. carotenoids, retinol, tocopherols, and et al. Intracellular carotenoid levels
Attributable risk for oral cancer in folic acid in men and women: a case- measured by Raman microspectroscopy:
northern Italy. Cancer Epidemiol control study nested in the JACC Study. J comparison of lymphocytes from lung
430
R E F E R E N C E S
cancer patients and healthy individuals. Lutheran Brotherhood Cohort Study. 611. Grant WB. A multicountry ecologic study
Int J Cancer 1997;74:20-5. Cancer Res 1990;50:6836-40. of risk and risk reduction factors for
579. Mannisto S, Smith-Warner SA, 595. Hodge AM, English DR, McCredie MRE, et prostate cancer mortality. Eur Urol
Spiegelman D, et al. Dietary carotenoids al. Foods, nutrients and prostate cancer. 2004;45:271-9.
and risk of lung cancer in a pooled Cancer Causes Control 2004;15:11-20. 612. Platz EA, Leitzmann MF, Hollis BW, et al.
analysis of seven cohort studies. Cancer 596. Vogt TM, Mayne ST, Graubard BI, et al. Plasma 1,25-dihydroxy- and 25-
Epidemiol Biomarkers Prev 2004;13:40-8. Serum lycopene, other serum hydroxyvitamin D and subsequent risk of
580. Abnet CC, Qiao YL, Dawsey SM, et al. carotenoids, and risk of prostate cancer prostate cancer. Cancer Causes Control
Prospective study of serum retinol, beta- in US Blacks and Whites. Am J Epidemiol 2004;15:255-65.
carotene, beta-cryptoxanthin, and 2002;155:1023-32. 613. Schuurman AG, Goldbohm RA, Brants HA,
lutein/zeaxanthin and esophageal and 597. Kolonel LN, Hankin JH, Whittemore AS, et et al. A prospective cohort study on
gastric cancers in China. Cancer Causes al. Vegetables, fruits, legumes and intake of retinol, vitamins C and E, and
Control 2003;14:645-55. prostate cancer: a multiethnic case- carotenoids and prostate cancer risk
581. Jendryczko A, Drozdz M, Pardela M, et al. control study. Cancer Epidemiol (Netherlands). Cancer Causes Control
[Vitamins A and E and vitamin A-binding Biomarkers Prev 2000;9:795-804. 2002;13:573-82.
proteins in the blood serum of patients 598. Norrish AE, Jackson RT, Sharpe SJ, et al. 614. Parker AS, Cerhan JR, Putnam SD, et al. A
with esophageal cancer]. Przegl Lek Prostate cancer and dietary carotenoids. cohort study of farming and risk of
1989;46:632-5. Am J Epidemiol 2000;151:119-23. prostate cancer in Iowa. Epidemiology
582. Valsecchi MG. Modelling the relative risk 599. Jain MG, Hislop GT, Howe GR, et al. Plant 1999;10:452-5.
of esophageal cancer in a case-control foods, antioxidants, and prostate cancer 615. Yoshizawa K, Willett WC, Morris SJ, et al.
study. J Clin Epidemiol 1992;45:347-55. risk: findings from case-control studies in Study of prediagnostic selenium level in
583. Mayne ST, Risch HA, Dubrow R, et al. Canada. Nutr Cancer 1999;34:173-84. toenails and the risk of advanced
Nutrient intake and risk of subtypes of 600. Villeneuve PJ, Johnson KC, Kreiger N, et prostate cancer. J Natl Cancer Inst
esophageal and gastric cancer. Cancer al. Risk factors for prostate cancer: 1998;90:1219-24.
Epidemiol Biomarkers Prev results from the Canadian National 616. McCann SE, Ambrosone CB, Moysich KB,
2001;10:1055-62. Enhanced Cancer Surveillance System. et al. Intakes of selected nutrients,
584. Smith AH, Waller KD. Serum beta- The Canadian Cancer Registries foods, and phytochemicals and prostate
carotene in persons with cancer and Epidemiology Research Group. Cancer cancer risk in Western New York. Nutr
their immediate families. Am J Epidemiol Causes Control 1999;10:355-67. Cancer 2005;53:33-41.
1991;133:661-71. 601. Key TJ, Silcocks PB, Davey GK, et al. A 617. Cohen JH, Kristal AR, Stanford JL. Fruit
585. Franceschi S, Bidoli E, Negri E, et al. Role case-control study of diet and prostate and vegetable intakes and prostate
of macronutrients, vitamins and minerals cancer. Br J Cancer 1997;76:678-87. cancer risk. J Natl Cancer Inst 2000;92:61-
in the aetiology of squamous-cell 602. Jian L, Du CJ, Lee AH, et al. Do dietary 8.
carcinoma of the oesophagus. Int J lycopene and other carotenoids protect 618. Sanderson M, Coker AL, Logan P, et al.
Cancer 2000;86:626-31. against prostate cancer? Int J Cancer Lifestyle and prostate cancer among
586. Terry P, Lagergren J, Ye W, et al. 2005;113:1010-4. older African-American and Caucasian
Antioxidants and cancers of the 603. Sonoda T, Nagata Y, Mori M, et al. A case- men in South Carolina. Cancer Causes
esophagus and gastric cardia. Int J control study of diet and prostate cancer Control 2004;15:647-55.
Cancer 2000;87:750-4. in Japan: possible protective effect of 619. Lu QY, Hung JC, Heber D, et al. Inverse
587. Chen H, Tucker KL, Graubard BI, et al. traditional Japanese diet. Cancer Sci associations between plasma lycopene
Nutrient intakes and adenocarcinoma of 2004;95:238-42. and other carotenoids and prostate
the esophagus and distal stomach. Nutr 604. Tzonou A, Signorello LB, Lagiou P, et al. cancer. Cancer Epidemiol Biomarkers
Cancer 2002;42:33-40. Diet and cancer of the prostate: a case- Prev 2001;10:749-56.
588. Platz EA, De Marzo AM, Erlinger TP, et al. control study in Greece. Int J Cancer 620. Deneo-Pellegrini H, De Stefani E, Ronco
No association between pre-diagnostic 1999;80:704-8. A, et al. Foods, nutrients and prostate
plasma C-reactive protein concentration 605. Hayes RB, Ziegler RG, Gridley G, et al. cancer: a case-control study in Uruguay.
and subsequent prostate cancer. Prostate Dietary factors and risks for prostate Br J Cancer 1999;80:591-7.
2004;59:393-400. cancer among blacks and whites in the 621. van Gils CH, Bostick RM, Stern MC, et al.
589. Schuurman AG, Goldbohm RA, Dorant E, United States. Cancer Epidemiol Differences in base excision repair
et al. Vegetable and fruit consumption Biomarkers Prev 1999;8:25-34. capacity may modulate the effect of
and prostate cancer risk: a cohort study 606. Le Marchand L, Hankin JH, Kolonel LN, et dietary antioxidant intake on prostate
in The Netherlands. Cancer Epidemiol al. Vegetable and fruit consumption in cancer risk: an example of
Biomarkers Prev 1998;7:673-80. relation to prostate cancer risk in polymorphisms in the XRCC1 gene.
590. Giovannucci E, Rimm EB, Liu Y, et al. A Hawaii: a reevaluation of the effect of Cancer Epidemiol Biomarkers Prev
prospective study of tomato products, dietary beta-carotene. Am J Epidemiol 2002;11:1279-84.
lycopene, and prostate cancer risk. J Natl 1991;133:215-9. 622. Norrish AE, Jackson RT, Sharpe SJ, et al.
Cancer Inst 2002;94:391-8. 607. Lagiou A, Trichopoulos D, Tzonou A, et al. Men who consume vegetable oils rich in
591. Giovannucci E, Ascherio A, Rimm EB, et al. Are there age-dependent effects of diet monounsaturated fat: their dietary
Intake of carotenoids and retinol in on prostate cancer risk? Soz patterns and risk of prostate cancer
relation to risk of prostate cancer. J Natl Praventivmed 2001;46:329-34. (New Zealand). Cancer Causes Control
Cancer Inst 1995;87:1767-76. 608. Rao AV, Fleshner N, Garwal S. Serum and 2000;11:609-15.
592. Mills PK, Beeson WL, Phillips RL, et al. tissue lycopene and biomarkers of 623. Norrish AE, Skeaff CM, Arribas GL, et al.
Cohort study of diet, lifestyle, and oxidation in prostate cancer patients: a Prostate cancer risk and consumption of
prostate cancer in Adventist men. Cancer case-control study. Nutr Cancer fish oils: a dietary biomarker-based case-
1989;64:598-604. 1999;33:159-64. control study. Br J Cancer 1999;81:1238-
593. Mills PK, Beeson WL, Phillips RL, et al. 609. Ganmaa D, Li XM, Wang J, et al. Incidence 42.
Cancer incidence among California and mortality of testicular and prostatic 624. Bosetti C, Talamini R, Montella M, et al.
Seventh-day Adventists, 1976-1982. Am J cancers in relation to world dietary Retinol, carotenoids and the risk of
Clin Nutr 1994;59:1136S-42S. practices. Int J Cancer 2002;98:262-7. prostate cancer: a case-control study
594. Hsing AW, McLaughlin JK, Schuman LM, 610. Grant WB. An ecologic study of dietary from Italy. Int J Cancer 2004;112:689-92.
et al. Diet, tobacco use, and fatal links to prostate cancer. Altern Med Rev 625. Meyer F, Bairati I, Fradet Y, et al. Dietary
prostate cancer: results from the 1999;4:162-9. energy and nutrients in relation to
431
F O O D , N U T R I T I O N , P H Y S I C A L A C T I V I T Y, A N D T H E P R E V E N T I O N O F C A N C E R : A G L O B A L P E R S P E C T I V E
preclinical prostate cancer. Nutr Cancer Adult dietary intake and prostate cancer 656. Vinceti M, Pellacani G, Malagoli C, et al. A
1997;29:120-6. risk in Utah: a case-control study with population-based case-control study of
626. Huang HY, Alberg AJ, Norkus EP, et al. special emphasis on aggressive tumors. diet and melanoma risk in northern Italy.
Prospective study of antioxidant Cancer Causes Control 1991;2:85-94. Public Health Nutr 2005;8:1307-14.
micronutrients in the blood and the risk 640. Kolonel LN, Yoshizawa CN, Hankin JH. 657. Millen AE, Tucker MA, Hartge P, et al. Diet
of developing prostate cancer. Am J Diet and prostatic cancer: a case-control and melanoma in a case-control study.
Epidemiol 2003;157:335-44 [published study in Hawaii. Am J Epidemiol Cancer Epidemiol Biomarkers Prev
erratum: Am J Epidemiol 2003;157:1126]. 1988;127:999-1012. 2004;13:1042-51.
627. Gann PH, Ma J, Giovannucci E, et al. 641. Talamini R, Franceschi S, La Vecchia C, et 658. Hakim IA, Harris RB. Joint effects of citrus
Lower prostate cancer risk in men with al. Diet and prostatic cancer: a case- peel use and black tea intake on the risk
elevated plasma lycopene levels: results control study in northern Italy. Nutr of squamous cell carcinoma of the skin.
of a prospective analysis. Cancer Res Cancer 1992;18:277-86. BMC Dermatology, 2001:3.
1999;59:1225-30. 642. Ohno Y, Yoshida O, Oishi K, et al. Dietary 659. Hakim IA, Harris RB, Ritenbaugh C. Citrus
628. Wu K, Erdman JW, Jr., Schwartz SJ, et al. beta-carotene and cancer of the peel use is associated with reduced risk
Plasma and dietary carotenoids, and the prostate: a case-control study in Kyoto, of squamous cell carcinoma of the skin.
risk of prostate cancer: a nested case- Japan. Cancer Res 1988;48:1331-6. Nutr Cancer 2000;37:161-8.
control study. Cancer Epidemiol 643. Rohan TE, Howe GR, Burch JD, et al. 660. Kirkpatrick CS, White E, Lee JA. Case-
Biomarkers Prev 2004;13:260-9. Dietary factors and risk of prostate control study of malignant melanoma in
629. Nomura AM, Stemmermann GN, Lee J, et cancer: a case-control study in Ontario, Washington State. II. Diet, alcohol, and
al. Serum micronutrients and prostate Canada. Cancer Causes Control obesity. Am J Epidemiol 1994;139:869-80.
cancer in Japanese Americans in Hawaii. 1995;6:145-54. 661. Naldi L, Gallus S, Tavani A, et al. Risk of
Cancer Epidemiol Biomarkers Prev 644. Ross RK, Shimizu H, Paganini-Hill A, et al. melanoma and vitamin A, coffee and
1997;6:487-91. Case-control studies of prostate cancer in alcohol: a case-control study from Italy.
630. Comstock GW, Helzlsouer KJ, Bush TL. blacks and whites in southern California. Eur J Cancer Prev 2004;13:503-8.
Prediagnostic serum levels of J Natl Cancer Inst 1987;78:869-74. 662. Sahl WJ, Glore S, Garrison P, et al. Basal
carotenoids and vitamin E as related to 645. La Vecchia C, Negri E, DAvanzo B, et al. cell carcinoma and lifestyle
subsequent cancer in Washington Dairy products and the risk of prostatic characteristics. Int J Dermatol
County, Maryland. Am J Clin Nutr cancer. Oncology 1991;48:406-10. 1995;34:398-402.
1991;53:260S-4S. 646. Mettlin C, Selenskas S, Natarajan N, et al. 663. Bain C, Green A, Siskind V, et al. Diet and
631. Heber D, Lu QY. Overview of mechanisms Beta-carotene and animal fats and their melanoma. An exploratory case-control
of action of lycopene. Exp Biol Med relationship to prostate cancer risk. A study. Ann Epidemiol 1993;3:235-8.
(Maywood) 2002;227:920-3. case-control study. Cancer 1989;64:605- 664. Feskanich D, Willett WC, Hunter DJ, et al.
632. Stram DO, Hankin JH, Wilkens LR, et al. 12. Dietary intakes of vitamins A, C, and E
Prostate cancer incidence and intake of 647. Oishi K, Okada K, Yoshida O, et al. A case- and risk of melanoma in two cohorts of
fruits, vegetables and related control study of prostatic cancer with women. Br J Cancer 2003;88:1381-7.
micronutrients: the multiethnic cohort reference to dietary habits. Prostate 665. Fung TT, Hunter DJ, Spiegelman D, et al.
study (United States). Cancer Causes 1988;12:179-90. Vitamins and carotenoids intake and the
Control 2006;17:1193-207. 648. Yoshida O, Okada K, Oishi K, et al. [A case- risk of basal cell carcinoma of the skin in
633. Kirsh VA, Mayne ST, Peters U, et al. A control study of prostatic cancer - with women (United States). Cancer Causes
prospective study of lycopene and reference to dietary history]. Gan No Control 2002;13:221-30.
tomato product intake and risk of Rinsho 1986;32:591-6. 666. Fung TT, Spiegelman D, Egan KM, et al.
prostate cancer. Cancer Epidemiol 649. Cook NR, Stampfer MJ, Ma J, et al. Beta- Vitamin and carotenoid intake and risk
Biomarkers Prev 2006;15:92-8. carotene supplementation for patients of squamous cell carcinoma of the skin.
634. Goodman M, Bostick RM, Ward KC, et al. with low baseline levels and decreased Int J Cancer 2003;103:110-5.
Lycopene intake and prostate cancer risk: risks of total and prostate carcinoma. 667. Schaumberg DA, Frieling UM, Rifai N, et
effect modification by plasma Cancer 1999;86:1783-92. al. No effect of beta-carotene
antioxidants and the XRCC1 genotype. 650. Weinstein SJ, Wright ME, Pietinen P, et al. supplementation on risk of
Nutr Cancer 2006;55:13-20. Serum alpha-tocopherol and gamma- nonmelanoma skin cancer among men
635. Woodson K, Tangrea JA, Lehman TA, et al. tocopherol in relation to prostate cancer with low baseline plasma beta-carotene.
Manganese superoxide dismutase risk in a prospective study. J Natl Cancer Cancer Epidemiol Biomarkers Prev
(MnSOD) polymorphism, alpha- Inst 2005;97:396-9. 2004;13:1079-80.
tocopherol supplementation and 651. Knekt P, Aromaa A, Maatela J, et al. 668. Karagas MR, Greenberg ER, Nierenberg D,
prostate cancer risk in the alpha- Serum vitamin A and subsequent risk of et al. Risk of squamous cell carcinoma of
tocopherol, beta-carotene cancer cancer: cancer incidence follow-up of the the skin in relation to plasma selenium,
prevention study (Finland). Cancer Finnish Mobile Clinic Health Examination alpha-tocopherol, beta-carotene, and
Causes Control 2003;14:513-8. Survey. Am J Epidemiol 1990;132:857-70. retinol: a nested case-control study.
636. Daviglus ML, Dyer AR, Persky V, et al. 652. Meyer F, Galan P, Douville P, et al. Cancer Epidemiol Biomarkers Prev
Dietary beta-carotene, vitamin C, and Antioxidant vitamin and mineral 1997;6:25-9.
risk of prostate cancer: results from the supplementation and prostate cancer 669. Hsueh YM, Chiou HY, Huang YL, et al.
Western Electric Study. Epidemiology prevention in the SU.VI.MAX trial. Int J Serum beta-carotene level, arsenic
1996;7:472-7. Cancer 2005;116:182-6. methylation capability, and incidence of
637. Andersson SO, Wolk A, Bergstrom R, et al. 653. Hayes RB, Bogdanovicz JF, Schroeder FH, skin cancer. Cancer Epidemiol Biomarkers
Energy, nutrient intake and prostate et al. Serum retinol and prostate cancer. Prev 1997;6:589-96.
cancer risk: a population-based case- Cancer 1988;62:2021-6. 670. Breslow RA, Alberg AJ, Helzlsouer KJ, et
control study in Sweden. Int J Cancer 654. Davies TW, Treasure FP, Welch AA, et al. al. Serological precursors of cancer:
1996;68:716-22. Diet and basal cell skin cancer: results malignant melanoma, basal and
638. Ghadirian P, Lacroix A, Maisonneuve P, et from the EPIC-Norfolk cohort. Br J squamous cell skin cancer, and
al. Nutritional factors and prostate Dermatol 2002;146:1017-22. prediagnostic levels of retinol, beta-
cancer: a case-control study of French 655. McNaughton SA, Marks GC, Gaffney P, et carotene, lycopene, alpha-tocopherol,
Canadians in Montreal, Canada. Cancer al. Antioxidants and basal cell carcinoma and selenium. Cancer Epidemiol
Causes Control 1996;7:428-36. of the skin: a nested case-control study. Biomarkers Prev 1995;4:837-42.
639. West DW, Slattery ML, Robison LM, et al. Cancer Causes Control 2005;16:609-18. 671. Wald NJ, Thompson SG, Densem JW, et al.
432
R E F E R E N C E S
Serum beta-carotene and subsequent and colon cancer risk: evidence from and rectal cancer. Cancer Detect Prev
risk of cancer: results from the BUPA NHANES I epidemiologic follow-up 2005;29:146-54.
Study. Br J Cancer 1988;57:428-33. study. Ann Epidemiol 2001;11:65-72. 702. Otani T, Iwasaki M, Hanaoka T, et al.
672. Dorgan JF, Boakye NA, Fears TR, et al. 687. Giovannucci E, Rimm EB, Ascherio A, et al. Folate, vitamin B6, vitamin B12, and
Serum carotenoids and alpha-tocopherol Alcohol, low-methionine - low-folate vitamin B2 intake, genetic
and risk of nonmelanoma skin cancer. diets, and risk of colon cancer in men. J polymorphisms of related enzymes, and
Cancer Epidemiol Biomarkers Prev Natl Cancer Inst 1995;87:265-73. risk of colorectal cancer in a hospital-
2004;13:1276-82. 688. Fuchs CS, Willett WC, Colditz GA, et al. based case-control study in Japan. Nutr
673. Kune GA, Bannerman S, Field B, et al. The influence of folate and multivitamin Cancer 2005;53:42-50.
Diet, alcohol, smoking, serum beta- use on the familial risk of colon cancer in 703. Prinz-Langenohl R, Fohr I, Pietrzik K.
carotene, and vitamin A in male women. Cancer Epidemiol Biomarkers Beneficial role for folate in the
nonmelanocytic skin cancer patients and Prev 2002;11:227-34. prevention of colorectal and breast
controls. Nutr Cancer 1992;18:237-44. 689. Larsson SC, Giovannucci E, Wolk A. A cancer. Eur J Nutr 2001;40:98-105.
674. Stryker WS, Stampfer MJ, Stein EA, et al. prospective study of dietary folate 704. Kim YI. Role of folate in colon cancer
Diet, plasma levels of beta-carotene and intake and risk of colorectal cancer: development and progression. J Nutr
alpha-tocopherol, and risk of malignant modification by caffeine intake and 2003;133:3731S-9S.
melanoma. Am J Epidemiol cigarette smoking. Cancer Epidemiol 705. Tuyns AJ. Protective effect of citrus fruit
1990;131:597-611. Biomarkers Prev 2005;14:740-3. on esophageal cancer. Nutr Cancer
675. Block G, Patterson B, Subar A. Fruit, 690. Flood A, Caprario L, Chaterjee N, et al. 1983;5:195-200.
vegetables, and cancer prevention: a Folate, methionine, alcohol, and 706. Kabat GC, Ng SK, Wynder EL. Tobacco,
review of the epidemiological evidence. colorectal cancer in a prospective study alcohol intake, and diet in relation to
Nutr Cancer 1992;18:1-29. of women in the United States. Cancer adenocarcinoma of the esophagus and
676. van Poppel G, Goldbohm RA. Causes Control 2002;13:551-61. gastric cardia. Cancer Causes Control
Epidemiologic evidence for beta- 691. Harnack L, Jacobs DR, Jr., Nicodemus K, et 1993;4:123-32.
carotene and cancer prevention. Am J al. Relationship of folate, vitamin B-6, 707. Rogers MA, Vaughan TL, Davis S, et al.
Clin Nutr 1995;62:1393S-402S. vitamin B-12, and methionine intake to Consumption of nitrate, nitrite, and
677. Stolzenberg-Solomon RZ, Pietinen P, incidence of colorectal cancers. Nutr nitrosodimethylamine and the risk of
Barrett MJ, et al. Dietary and other Cancer 2002;43:152-8. upper aerodigestive tract cancer. Cancer
methyl-group availability factors and 692. Konings EJ, Goldbohm RA, Brants HA, et Epidemiol Biomarkers Prev 1995;4:29-36.
pancreatic cancer risk in a cohort of male al. Intake of dietary folate vitamers and 708. Liaw Y-P, Huang Y-C, Lo P-Y, et al.
smokers. Am J Epidemiol 2001;153:680-7. risk of colorectal carcinoma: results from Nutrient intakes in relation to cancer
678. Skinner HG, Michaud DS, Giovannucci EL, The Netherlands Cohort Study. Cancer mortality in Taiwan. Nutr. Res.
et al. A prospective study of folate 2002;95:1421-33. 2003;23:1597-606.
intake and the risk of pancreatic cancer 693. Terry P, Jain M, Miller AB, et al. Dietary 709. Lee KW, Lee HJ, Surh YJ, et al. Vitamin C
in men and women. Am J Epidemiol intake of folic acid and colorectal cancer and cancer chemoprevention:
2004;160:248-58. risk in a cohort of women. Int J Cancer reappraisal. Am J Clin Nutr 2003;78:1074-
679. Baghurst PA, McMichael AJ, Slavotinek 2002;97:864-7. 8.
AH, et al. A case-control study of diet 694. Glynn SA, Albanes D, Pietinen P, et al. 710. Veugelers PJ, Porter GA, Guernsey DL, et
and cancer of the pancreas. Am J Colorectal cancer and folate status: a al. Obesity and lifestyle risk factors for
Epidemiol 1991;134:167-79. nested case-control study among male gastroesophageal reflux disease, Barrett
680. Stolzenberg-Solomon RZ, Albanes D, smokers. Cancer Epidemiol Biomarkers esophagus and esophageal
Nieto FJ, et al. Pancreatic cancer risk and Prev 1996;5:487-94. adenocarcinoma. Dis Esophagus
nutrition-related methyl-group 695. Kato I, Dnistrian AM, Schwartz M, et al. 2006;19:321-8.
availability indicators in male smokers. J Serum folate, homocysteine and 711. Taylor PR, Qiao YL, Abnet CC, et al.
Natl Cancer Inst 1999;91:535-41. colorectal cancer risk in women: a nested Prospective study of serum vitamin E
681. Larsson SC, Hakansson N, Giovannucci E, case-control study. Br J Cancer levels and esophageal and gastric
et al. Folate intake and pancreatic cancer 1999;79:1917-22. cancers. J Natl Cancer Inst 2003;95:1414-
incidence: a prospective study of 696. Giovannucci E, Stampfer MJ, Colditz GA, 6.
Swedish women and men. J Natl Cancer et al. Multivitamin use, folate, and colon 712. Han P. Levels of vitamin A, E and C in
Inst 2006;98:407-13. cancer in women in the Nurses Health serum of cancer patients. Chin J Clin
682. Jaskiewicz K. Oesophageal carcinoma: Study. Ann Intern Med 1998;129:517-24. Oncol 1993;20:759-61.
cytopathology and nutritional aspects in 697. Sanjoaquin MA, Allen N, Couto E, et al. 713. Hartman TJ, Albanes D, Pietinen P, et al.
aetiology. Anticancer Res 1989;9:1847- Folate intake and colorectal cancer risk: The association between baseline
52. a meta-analytical approach. Int J Cancer vitamin E, selenium, and prostate cancer
683. Jaskiewicz K, Marasas WF, Lazarus C, et al. 2005;113:825-8. in the alpha-tocopherol, beta-carotene
Association of esophageal cytological 698. de Vogel S, van Engeland M, Luchtenborg cancer prevention study. Cancer
abnormalities with vitamin and M, et al. Dietary folate and APC Epidemiol Biomarkers Prev 1998;7:335-
lipotrope deficiencies in populations at mutations in sporadic colorectal cancer. J 40.
risk for esophageal cancer. Anticancer Nutr 2006;136:3015-21. 714. Ramon JM, Bou R, Romea S, et al. Dietary
Res 1988;8:711-5. 699. Brink M, Weijenberg MP, de Goeij AF, et fat intake and prostate cancer risk: a
684. Tan W, Miao X, Wang L, et al. Significant al. Dietary folate intake and k-ras case-control study in Spain. Cancer
increase in risk of gastroesophageal mutations in sporadic colon and rectal Causes Control 2000;11:679-85.
cancer is associated with interaction cancer in The Netherlands Cohort Study. 715. Lee MM, Wang RT, Hsing AW, et al. Case-
between promoter polymorphisms in Int J Cancer 2005;114:824-30. control study of diet and prostate cancer
thymidylate synthase and serum folate 700. Zhang SM, Moore SC, Lin J, et al. Folate, in China. Cancer Causes Control
status. Carcinogenesis 2005;26:1430-5. vitamin B6, multivitamin supplements, 1998;9:545-52.
685. Piyathilake CJ, Henao OL, Macaluso M, et and colorectal cancer risk in women. Am 716. Hietanen E, Bartsch H, Bereziat JC, et al.
al. Folate is associated with the natural J Epidemiol 2006;163:108-15. Diet and oxidative stress in breast, colon
history of high-risk human 701. Jiang Q, Chen K, Ma X, et al. Diets, and prostate cancer patients: a case-
papillomaviruses. Cancer Res polymorphisms of control study. Eur J Clin Nutr
2004;64:8788-93. methylenetetrahydrofolate reductase, 1994;48:575-86.
686. Su LJ, Arab L. Nutritional status of folate and the susceptibility of colon cancer 717. Allen NE, Morris JS, Ngwenyama RA, et al.
433
F O O D , N U T R I T I O N , P H Y S I C A L A C T I V I T Y, A N D T H E P R E V E N T I O N O F C A N C E R : A G L O B A L P E R S P E C T I V E
A case-control study of selenium in nails levels and subsequent risk of lung and levels and cancer among women. J Natl
and prostate cancer risk in British men. stomach cancer in Japan. Cancer Cancer Inst 1995;87:497-505.
Br J Cancer 2004;90:1392-6. Epidemiol Biomarkers Prev 1994;3:465-9. 748. Hartman TJ, Taylor PR, Alfthan G, et al.
718. Hsing AW, Comstock GW, Abbey H, et al. 732. Knekt P, Aromaa A, Maatela J, et al. Toenail selenium concentration and lung
Serologic precursors of cancer. Retinol, Serum selenium and subsequent risk of cancer in male smokers (Finland). Cancer
carotenoids, and tocopherol and risk of cancer among Finnish men and women. J Causes Control 2002;13:923-8.
prostate cancer. J Natl Cancer Inst Natl Cancer Inst 1990;82:864-8. 749. van den Brandt PA, Goldbohm RA, van t
1990;82:941-6. 733. Knekt P, Marniemi J, Teppo L, et al. Is low Veer P, et al. A prospective cohort study
719. Eichholzer M, Stahelin HB, Gey KF, et al. selenium status a risk factor for lung on selenium status and the risk of lung
Prediction of male cancer mortality by cancer? Am J Epidemiol 1998;148:975-82. cancer. Cancer Res 1993;53:4860-5.
plasma levels of interacting vitamins: 17- 734. Kornitzer M, Valente F, De Bacquer D, et 750. Vinceti M, Nacci G, Rocchi E, et al.
year follow-up of the prospective Basel al. Serum selenium and cancer mortality: Mortality in a population with long-term
study. Int J Cancer 1996;66:145-50. a nested case-control study within an exposure to inorganic selenium via
720. Eichholzer M, Stahelin HB, Gutzwiller F, et age- and sex-stratified sample of the drinking water. J Clin Epidemiol
al. Association of low plasma cholesterol Belgian adult population. Eur J Clin Nutr 2000;53:1062-8.
with mortality for cancer at various sites 2004;58:98-104. 751. Vlajinac H, Ilic M, Sipetic S, et al. A case-
in men: 17-y follow-up of the prospective 735. Menkes MS, Comstock GW, Vuilleumier JP, control study of diet and prostate cancer.
Basel study. Am J Clin Nutr 2000;71:569- et al. Serum beta-carotene, vitamins A J BUON 2001;6:177-81.
74. and E, selenium, and the risk of lung 752. Hardell L, Degerman A, Tomic R, et al.
721. Eichholzer M, Stahelin HB, Ludin E, et al. cancer. N Engl J Med 1986;315:1250-4. Levels of selenium in plasma and
Smoking, plasma vitamins C, E, retinol, 736. Nomura A, Heilbrun LK, Morris JS, et al. glutathione peroxidase in erythrocytes in
and carotene, and fatal prostate cancer: Serum selenium and the risk of cancer, by patients with prostate cancer or benign
seventeen-year follow-up of the specific sites: case-control analysis of hyperplasia. Eur J Cancer Prev 1995;4:91-
prospective Basel study. Prostate prospective data. J Natl Cancer Inst 5.
1999;38:189-98. 1987;79:103-8. 753. Schrauzer GN, White DA, Schneider CJ.
722. Willett WC, Polk BF, Underwood BA, et al. 737. Salonen JT, Salonen R, Lappetelainen R, et Cancer mortality correlation studies - IV:
Relation of serum vitamins A and E and al. Risk of cancer in relation to serum associations with dietary intakes and
carotenoids to the risk of cancer. N Engl J concentrations of selenium and vitamins blood levels of certain trace elements,
Med 1984;310:430-4. A and E: matched case-control analysis of notably Se-antagonists. Bioinorg Chem
723. Knekt P, Aromaa A, Maatela J, et al. prospective data. BMJ 1985;290:417-20. 1977;7:35-56.
Serum vitamin E and risk of cancer 738. Ujiie S, Kikuchi H. The relation between 754. Shamberger RJ, Rukovena E, Longfield
among Finnish men during a 10-year serum selenium value and cancer in AK, et al. Antioxidants and cancer. I.
follow-up. Am J Epidemiol 1988;127:28- Miyagi, Japan: 5-year follow up study. Selenium in the blood of normals and
41. Tohoku J Exp Med 2002;196:99-109. cancer patients. J Natl Cancer Inst
724. Helzlsouer KJ, Huang HY, Alberg AJ, et al. 739. Gromadzinska J, Wasowicz W, Rydzynski 1973;50:863-70.
Association between alpha-tocopherol, K, et al. Oxidative-stress markers in blood 755. Li HJ, Stampfer MJ, Giovannucci EL, et al.
gamma-tocopherol, selenium, and of lung cancer patients occupationally A prospective study of plasma selenium
subsequent prostate cancer. J Natl exposed to carcinogens. Biol Trace Elem levels and prostate cancer risk. J Natl
Cancer Inst 2000;92:2018-23. Res 2003;91:203-15. Cancer Inst 2004;96:696-703.
725. Laaksonen DE, Laukkanen JA, Niskanen L, 740. Hu JF, Liu YY, Yu YK. [Estimation of 756. Jacobs ET, Giuliano AR, Martinez ME, et
et al. Serum linoleic and total latency period of lung cancer]. al. Plasma levels of 25-hydroxyvitamin D,
polyunsaturated fatty acids in relation to Zhonghua Zhong Liu Za Zhi 1994;16:18- 1,25-dihydroxyvitamin D and the risk of
prostate and other cancers: a 21. prostate cancer. J Steroid Biochem Mol
population-based cohort study. Int J 741. Torun M, Aldemir H, Yardim S. Serum Biol 2004;89-90:533-7.
Cancer 2004;111:444-50. selenium levels in various cancer types. 757. Brooks JD, Metter EJ, Chan DW, et al.
726. Fleshner N, Fair WR, Huryk R, et al. Trace Elem Electrolytes 1995;12:186-90. Plasma selenium level before diagnosis
Vitamin E inhibits the high-fat diet 742. Wei HJ, Luo XM, Xing J, et al. [Selenium and the risk of prostate cancer
promoted growth of established human intake and metabolic study in workers of development. J Urol 2001;166:2034-8.
prostate LNCaP tumors in nude mice. J the Yunnan Tin Mine]. Zhongguo Yi Xue 758. Nomura AM, Lee J, Stemmermann GN, et
Urol 1999;161:1651-4. Ke Xue Yuan Xue Bao 1987;9:198-201. al. Serum selenium and subsequent risk
727. Willis MS, Wians FH. The role of nutrition 743. Zachara BA, Marchaluk-Wisniewska E, of prostate cancer. Cancer Epidemiol
in preventing prostate cancer: a review Maciag A, et al. Decreased selenium Biomarkers Prev 2000;9:883-7.
of the proposed mechanism of action of concentration and glutathione 759. Coates RJ, Weiss NS, Daling JR, et al.
various dietary substances. Clin Chim peroxidase activity in blood and increase Serum levels of selenium and retinol and
Acta 2003;330:57-83. of these parameters in malignant tissue the subsequent risk of cancer. Am J
728. Clark LC, Cantor KP, Allaway WH. of lung cancer patients. Lung Epidemiol 1988;128:515-23.
Selenium in forage crops and cancer 1997;175:321-32. 760. Peleg I, Morris S, Hames CG. Is serum
mortality in U.S. counties. Arch Environ 744. Chen J, Geissler C, Parpia B, et al. selenium a risk factor for cancer? Med
Health 1991;46:37-42. Antioxidant status and cancer mortality Oncol Tumor Pharmacother 1985;2:157-
729. Schrauzer GN, White DA, Schneider CJ. in China. Int J Epidemiol 1992;21:625-35. 63.
Cancer mortality correlation studies - III: 745. Lange JH. Reanalysis of epidemiological 761. Willett WC, Polk BF, Morris JS, et al.
statistical associations with dietary data for selenium anti-cancer activity. Prediagnostic serum selenium and risk of
selenium intakes. Bioinorg Chem Toxicol Ind Health 1991;7:319-25. cancer. Lancet 1983;2:130-4.
1977;7:23-31. 746. Nakachi K, Limtrakul P, Sonklin P, et al. 762. Virtamo J, Valkeila E, Alfthan G, et al.
730. Goodman GE, Schaffer S, Bankson DD, et Risk factors for lung cancer among Serum selenium and risk of cancer. A
al. Predictors of serum selenium in Northern Thai women: epidemiological, prospective follow-up of nine years.
cigarette smokers and the lack of nutritional, serological, and Cancer 1987;60:145-8.
association with lung and prostate bacteriological surveys of residents in 763. Criqui MH, Bangdiwala S, Goodman DS, et
cancer risk. Cancer Epidemiol Biomarkers high- and low-incidence areas. Jpn J al. Selenium, retinol, retinol-binding
Prev 2001;10:1069-76. Cancer Res 1999;90:1187-95. protein, and uric acid. Associations with
731. Kabuto M, Imai H, Yonezawa C, et al. 747. Garland M, Morris JS, Stampfer MJ, et al. cancer mortality in a population-based
Prediagnostic serum selenium and zinc Prospective study of toenail selenium prospective case-control study. Ann
434
R E F E R E N C E S
Epidemiol 1991;1:385-93. Selenium and age-adjusted human al. Serologic precursors of cancer. I.
764. Ringstad J, Jacobsen BK, Tretli S, et al. cancer mortality. Arch Environ Health Prediagnostic serum nutrients and colon
Serum selenium concentration 1976;31:231-5. cancer risk. Am J Epidemiol
associated with risk of cancer. J Clin 779. Chen J. Dietary practices and cancer 1987;126:1033-41.
Pathol 1988;41:454-7. mortality in China. IARC Sci Publ 794. Wang HH, Wu CC. Clinical evaluation of
765. Salonen JT, Alfthan G, Huttunen JK, et al. 1991;105:18-21. serum trace elements in colorectal
Association between serum selenium 780. Saito K, Saito T, Hosokawa T, et al. Blood cancer. Chin J Gastroenterol 1995;12:9-
and the risk of cancer. Am J Epidemiol selenium level and the interaction of 14.
1984;120:342-9. copper, zinc and manganese in stomach 795. Milde D, Novak O, Stu ka V, et al. Serum
766. Vogt TM, Ziegler RG, Graubard BI, et al. cancer. Trace Elem Med 1984;1:148-52. levels of selenium, manganese, copper,
Serum selenium and risk of prostate 781. Burguera JL, Burguera M, Gallignani M, et and iron in colorectal cancer patients.
cancer in U.S. blacks and whites. Int J al. Blood serum selenium in the province Biol Trace Elem Res 2001;79:107-14.
Cancer 2003;103:664-70. of Merida, Venezuela, related to sex, 796. Ganther HE. Selenium metabolism,
767. Tsachev K, Tsvetkov M, Kumanov K, et al. cancer incidence and soil selenium selenoproteins and mechanisms of
[Serum selenium levels of patients with content. J Trace Elem Electrolytes Health cancer prevention: complexities with
adenoma and carcinoma of the prostate Dis 1990;4:73-7. thioredoxin reductase. Carcinogenesis
gland]. Khirurgiia (Sofiia) 1987;40:33-5. 782. Liu XG. [Serum and tissue copper, zinc and 1999;20:1657-66.
768. van den Brandt PA, Zeegers MP, Bode P, et selenium levels in patients with gastric 797. Combs GF, Jr. Status of selenium in
al. Toenail selenium levels and the carcinoma]. Chung Hua Chieh Ho Ho Hu prostate cancer prevention. Br J Cancer
subsequent risk of prostate cancer: a Hsi Hsi Chi Ping Tsa Chih 1991;13:93-6. 2004;91:195-9.
prospective cohort study. Cancer 783. Pawlowicz Z, Zachara BA, Trafikowska U, 798. Knekt P, Kumpulainen J, Jarvinen R, et al.
Epidemiol Biomarkers Prev 2003;12:866- et al. Blood selenium concentrations and Flavonoid intake and risk of chronic
71. glutathione peroxidase activities in diseases. Am J Clin Nutr 2002;76:560-8.
769. Ghadirian P, Maisonneuve P, Perret C, et patients with breast cancer and with 799. Garcia-Closas R, Agudo A, Gonzalez CA,
al. A case-control study of toenail advanced gastrointestinal cancer. J Trace et al. Intake of specific carotenoids and
selenium and cancer of the breast, colon, Elem Electrolytes Health Dis 1991;5:275- flavonoids and the risk of lung cancer in
and prostate. Cancer Detect Prev 7. women in Barcelona, Spain. Nutr Cancer
2000;24:305-13. 784. Scieszka M, Danch A, Machalski M, et al. 1998;32:154-8.
770. Lipsky K, Zigeuner R, Zischka M, et al. Plasma selenium concentration in 800. Haenszel W, Correa P, Cuello C, et al.
Selenium levels of patients with newly patients with stomach and colon cancer Gastric cancer in Colombia. II. Case-
diagnosed prostate cancer compared in the Upper Silesia. Neoplasma control epidemiologic study of precursor
with control group. Urology 1997;44:395-7. lesions. J Natl Cancer Inst 1976;57:1021-
2004;63:912-6. 785. Beno I, Klvanova J, Magalova T, et al. 6.
771. Morris JS, Rohan T, Soskolne CL, et al. Blood levels of natural antioxidants in 801. Zaldivar R. Epidemiology of gastric and
Selenium status and cancer mortality in gastric and colorectal precancerous colo-rectal cancer in United-States and
subjects residing in four Canadian lesions and cancers in Slovakia. Chile with particular reference to the
provinces. J Radio Nucl Chem Neoplasma 2000;47:37-40. role of dietary and nutritional variables,
2001;249:421-7. 786. Yu SY, Chu YJ, Gong XL, et al. Regional nitrate fertilizer pollution, and N-
772. Duffield-Lillico AJ, Dalkin BL, Reid ME, et variation of cancer mortality incidence nitroso compounds. Zentralbl Bakteriol
al. Selenium supplementation, baseline and its relation to selenium levels in Mikrobiol Hyg [B] 1977;164:193-217.
plasma selenium status and incidence of China. Biol Trace Elem Res 1985;7:21-9. 802. Ahn YO. Diet and stomach cancer in
prostate cancer: an analysis of the 787. van den Brandt PA, Goldbohm RA, vant Korea. Int J Cancer 1997;Suppl 10:7-9.
complete treatment period of the Veer P, et al. A prospective cohort study 803. Nagata C, Takatsuka N, Kawakami N, et
Nutritional Prevention of Cancer Trial. on toenail selenium levels and risk of al. A prospective cohort study of soy
BJU Int 2003;91:608-12. gastrointestinal cancer. J Natl Cancer Inst product intake and stomach cancer
773. Clark LC, Dalkin B, Krongrad A, et al. 1993;85:224-9. death. Br J Cancer 2002;87:31-6.
Decreased incidence of prostate cancer 788. Li DG. [A preliminary investigation on the 804. Nagata C. Ecological study of the
with selenium supplementation: results role of selenium and other trace association between soy product intake
of a double-blind cancer prevention elements in the pathogenesis of gastric and mortality from cancer and heart
trial. Br J Urol 1998;81:730-4. cancer]. Chung Hua Liu Hsing Ping Hsueh disease in Japan. Int J Epidemiol
774. Redman C, Scott JA, Baines AT, et al. Tsa Chih 1987;8:276-80. 2000;29:832-6.
Inhibitory effect of selenomethionine on 789. Mark SD, Qiao YL, Dawsey SM, et al. 805. Tatsuta M, Iishi H, Baba M, et al.
the growth of three selected human Prospective study of serum selenium Attenuation by genistein of sodium-
tumor cell lines. Cancer Lett levels and incident esophageal and chloride-enhanced gastric carcinogenesis
1998;125:103-10. gastric cancers. J Natl Cancer Inst induced by N-methyl-N-nitro-N-
775. Pathak SK, Sharma RA, Mellon JK. 2000;92:1753-63. nitrosoguanidine in Wistar rats. Int J
Chemoprevention of prostate cancer by 790. Wei WQ, Abnet CC, Qiao YL, et al. Cancer 1999;80:396-9.
diet-derived antioxidant agents and Prospective study of serum selenium 806. Watanabe H, Uesaka T, Kido S, et al.
hormonal manipulation (review). Int J concentrations and esophageal and Influence of concomitant miso or NaCl
Oncol 2003;22:5-13. gastric cardia cancer, heart disease, treatment on induction of gastric tumors
776. Qiu JL, Chen K, Wang XB, et al. [A case- stroke, and total death. Am J Clin Nutr by N-methyl-N-nitro-N-nitrosoguanidine
control study on the relationship 2004;79:80-5. in rats. Oncol Rep 1999;6:989-93.
between nutrition and gastric cancer in 791. Whanger PD. Selenium and its 807. Li X-M, Liu X-F, Akio S. Relationship
islanders]. Chung Hua Liu Hsing Ping relationship to cancer: an update between the incidence rates of testicular
Hsueh Tsa Chih 2004;25 487-91. dagger. Br J Nutr 2004;91:11-28. and prostatic cancers and food
777. Shamberger RJ, Tytko S, Willis CE. 792. Fernandez Banares F, Cabre E, Esteve M, consumptions. Chinese Journal of Cancer
Antioxidants in cereals and in food et al. Serum selenium and risk of large Research 2002;. 14:240-5.
preservatives and declining gastric size colorectal adenomas in a 808. Hebert JR, Hurley TG, Olendzki BC, et al.
cancer mortality. Cleve Clin Q geographical area with a low selenium Nutritional and socioeconomic factors in
1972;39:119-24. status. Am J Gastroenterol 2002;97:2103- relation to prostate cancer mortality: a
778. Shamberger RJ, Tytko SA, Willis CE. 8. cross-national study. J Natl Cancer Inst
Antioxidants and cancer. Part VI. 793. Schober SE, Comstock GW, Helsing KJ, et 1998;90:1637-47.
435
F O O D , N U T R I T I O N , P H Y S I C A L A C T I V I T Y, A N D T H E P R E V E N T I O N O F C A N C E R : A G L O B A L P E R S P E C T I V E
809. Armstrong B, Doll R. Environmental mutagens/carcinogens produced during acetyltransferase genotype, red meat
factors and cancer incidence and cooking of meat and fish. Cancer Sci intake, and risk of colorectal cancer.
mortality in different countries, with 2004;95:290-9. Cancer Res 1998;58:3307-11.
special reference to dietary practices. Int 5. Kazerouni N, Sinha R, Hsu CH, et al. Analysis 21. Tiemersma EW, Kampman E, Bueno de
J Cancer 1975;15:617-31. of 200 food items for benzo[a]pyrene Mesquita HB, et al. Meat consumption,
810. Allen NE, Sauvaget C, Roddam AW, et al. and estimation of its intake in an cigarette smoking, and genetic
A prospective study of diet and prostate epidemiologic study. Food Chem Toxicol susceptibility in the etiology of colorectal
cancer in Japanese men. Cancer Causes 2001;39:423-36. cancer: results from a Dutch prospective
Control 2004;15:911-20. 6. Ibanez R, Agudo A, Berenguer A, et al. study. Cancer Causes Control
811. Hirayama T. Epidemiology of prostate Dietary intake of polycyclic aromatic 2002;13:383-93.
cancer with special reference to the role hydrocarbons in a Spanish population. J 22. Feskanich D, Ma J, Fuchs CS, et al. Plasma
of diet. Natl Cancer Inst Monogr Food Prot 2005;68:2190-5. vitamin D metabolites and risk of
1979:149-55. 7. Food and Agriculture Organization of the colorectal cancer in women. Cancer
812. Severson RK, Nomura AM, Grove JS, et al. United Nations. FAOSTAT. Epidemiol Biomarkers Prev
A prospective study of demographics, http://faostat.fao.org/site/345/default.as 2004;13:1502-8.
diet, and prostate cancer among men of px. 2006. 23. Phillips RL. Role of life-style and dietary
Japanese ancestry in Hawaii. Cancer Res 8. Bostick RM, Potter JD, Kushi LH, et al. Sugar, habits in risk of cancer among seventh-
1989;49:1857-60. meat, and fat intake, and non-dietary day adventists. Cancer Res 1975;35:3513-
813. Jacobsen BK, Knutsen SF, Fraser GE. Does risk factors for colon cancer incidence in 22.
high soy milk intake reduce prostate Iowa women (United States). Cancer 24. Sellers TTA, Bazyk AAE, Bostick RRM, et al.
cancer incidence? The Adventist Health Causes Control 1994;5:38-52. Diet and risk of colon cancer in a large
Study (United States). Cancer Causes 9. Willett WC, Stampfer MJ, Colditz GA, et al. prospective study of older women: an
Control 1998;9:553-7. Relation of meat, fat, and fiber intake to analysis stratified on family history
814. Jian L, Zhang DH, Lee AH, et al. Do the risk of colon cancer in a prospective (Iowa, United States). Cancer Causes
preserved foods increase prostate cancer study among women. N Engl J Med Control 1998;9:357-67.
risk? Br J Cancer 2004;90:1792-5. 1990;323:1664-72. 25. Larsson SC, Wolk A. Meat consumption and
815. Lee MM, Gomez SL, Chang JS, et al. Soy 10. Giovannucci E, Rimm EB, Stampfer MJ, et risk of colorectal cancer: a meta-analysis
and isoflavone consumption in relation al. Intake of fat, meat, and fiber in of prospective studies. Int J Cancer
to prostate cancer risk in China. Cancer relation to risk of colon cancer in men. 2006;119:2657-64.
Epidemiol Biomarkers Prev 2003;12:665- Cancer Res 1994;54:2390-7. 26. Sesink AL, Termont DS, Kleibeuker JH, et al.
8. 11. Singh PN, Fraser GE. Dietary risk factors for Red meat and colon cancer: the cytotoxic
816. Sung JF, Lin RS, Pu YS, et al. Risk factors colon cancer in a low-risk population. and hyperproliferative effects of dietary
for prostate carcinoma in Taiwan: a case- Am J Epidemiol 1998;148:761-74. heme. Cancer Res 1999;59:5704-9.
control study in a Chinese population. 12. Fraser GE. Associations between diet and 27. Chao A, Thun MJ, Connell CJ, et al. Meat
Cancer 1999;86:484-91. cancer, ischemic heart disease, and all- consumption and risk of colorectal
817. Rao AV, Sung MK. Saponins as cause mortality in non-Hispanic white cancer. Am Med Ass 2005;293:172-82.
anticarcinogens. J Nutr 1995;125:717S- California Seventh-day Adventists. Am J 28. Lin J, Zhang SM, Cook NR, et al. Dietary fat
24S. Clin Nutr 1999;70:532S-8S. and fatty acids and risk of colorectal
818. Yanagihara K, Ito A, Toge T, et al. 13. Jarvinen R, Knekt P, Hakulinen T, et al. cancer in women. Am J Epidemiol
Antiproliferative effects of isoflavones Dietary fat, cholesterol and colorectal 2004;160:1011-22.
on human cancer cell lines established cancer in a prospective study. Br J Cancer 29. Chan AT, Tranah GJ, Giovannucci EL, et al.
from the gastrointestinal tract. Cancer 2001;85:357-61. Prospective study of N-acetyltransferase-
Res 1993;53:5815-21. 14. English DR, MacInnis RJ, Hodge AM, et al. 2 genotypes, meat intake, smoking and
819. Borges C, Villalobos Perez JJ. [Gastric Red meat, chicken, and fish consumption risk of colorectal cancer. Int J Cancer
cancer. I. Epidemiology]. Rev Invest Clin and risk of colorectal cancer. Cancer 2005;115:648-52.
1968;20:11-23. Epidemiol Biomarkers Prev 30. Brink M, Weijenberg MP, de Goeij AF, et al.
820. Llanos J, Valdes E. [Cigarette consumption 2004;13:1509-14. Meat consumption and K-ras mutations
and food habits in patients with peptic 15. Norat T, Bingham S, Ferrari P, et al. Meat, in sporadic colon and rectal cancer in The
ulcer and gastric cancer]. Rev Med Chil fish, and colorectal cancer risk: the Netherlands Cohort Study. Br J Cancer
1985;113:433-5. European Prospective Investigation into 2005;92:1310-20.
821. Lpez-Carrillo L, Hernandez AM, Dubrow cancer and nutrition. J Natl Cancer Inst 31. Sato Y, Nakaya N, Kuriyama S, et al. Meat
R. Chili pepper consumption and gastric 2005;97:906-16. consumption and risk of colorectal
cancer in Mexico: a case-control study. 16. Kato I, Akhmedkhanov A, Koenig K, et al. cancer in Japan: the Miyagi Cohort
Am J Epidemiol 1994;139:263-71. Prospective study of diet and female Study. Eur J Cancer Prev 2006;15:211-8.
colorectal cancer: the New York 32. Oba S, Shimizu N, Nagata C, et al. The
University Womens Health Study. Nutr relationship between the consumption
Chapter 4.3 Cancer 1997;28:276-81. of meat, fat, and coffee and the risk of
17. Pietinen P, Malila N, Virtanen M, et al. Diet colon cancer: a prospective study in
1. McGee H. McGee on Food and Cooking. and risk of colorectal cancer in a cohort Japan. Cancer Lett 2006;244:260-7.
London: Hodder and Stoughton, 2004. of Finnish men. Cancer Causes Control 33. Huang XE, Hirose K, Wakai K, et al.
2. Institute of Environmental Science and 1999;10:387-96. Comparison of lifestyle risk factors by
Research Limited. 2004. Nitrates and 18. Larsson SC, Rafter J, Holmberg L, et al. Red family history for gastric, breast, lung
Nitrites Dietary Exposure and Risk meat consumption and risk of cancers of and colorectal cancer. Asian Pac J Cancer
Assessment. the proximal colon, distal colon and Prev 2004;5:419-27.
3. International Agency for Research on rectum: the Swedish Mammography 34. Butler LM, Duguay Y, Millikan RC, et al.
Cancer. In preparation. Ingested Nitrates Cohort. Int J Cancer 2005;113:829-34. Joint effects between UDP-
and Nitrites. In: IARC Monogr Eval 19. Wei EK, Giovannucci E, Wu K, et al. glucuronosyltransferase 1A7 genotype
Carcinog Risks Hum no 94. Comparison of risk factors for colon and and dietary carcinogen exposure on risk
http://monographs.iarc.fr/ENG/Meetings/ rectal cancer. Int J Cancer 2004;108:433- of colon cancer. Cancer Epidemiol
94-nitratenitrite.pdf. 42. Biomarkers Prev 2005;14:1626-32.
4. Sugimura T, Wakabayashi K, Nakagama H, 20. Chen JJ, Stampfer MMJ, Hough HHL, et al. 35. Turner F, Smith G, Sachse C, et al.
et al. Heterocyclic amines: A prospective study of N- Vegetable, fruit and meat consumption
436
R E F E R E N C E S
and potential risk modifying genes in Cancer and Nutrition (EPIC). J Natl Predictors of pancreatic cancer mortality
relation to colorectal cancer. Int J Cancer Cancer Inst 2006;98:345-54. among a large cohort of United States
2004;112:259-64. 52. Breslow RA, Graubard BI, Sinha R, et al. adults. Cancer Causes Control
36. Juarranz Sanz M, Soriano Llora T, Calle Diet and lung cancer mortality: a 1987 2000;11:915-23.
Puron ME, et al. [Influence of the diet on National Health Interview Survey cohort 69. Khan MM, Goto R, Kobayashi K, et al.
the development of colorectal cancer in study. Cancer Causes Control Dietary habits and cancer mortality
a population of Madrid]. Rev Clin Esp 2000;11:419-31. among middle aged and older Japanese
2004;204:355-61. 53. Alavanja MC, Brownson RC, Benichou J. living in Hokkaido, Japan by cancer site
37. Rolon PA, Castellsague X, Benz M, et al. Estimating the effect of dietary fat on and sex. 2004;5:58-65.
Hot and cold mate drinking and the risk of lung cancer in nonsmoking 70. Lyon JL, Slattery ML, Mahoney AW, et al.
esophageal cancer in Paraguay. Cancer women. Lung Cancer 1996;14 Suppl Dietary intake as a risk factor for cancer
Epidemiol Biomarkers Prev 1995;4:595- 1:S63-74. of the exocrine pancreas. Cancer
605. 54. Alavanja MC, Field RW, Sinha R, et al. Lung Epidemiol Biomarkers Prev 1993;2:513-8.
38. Brown LM, Swanson CA, Gridley G, et al. cancer risk and red meat consumption 71. Anderson KE, Sinha R, Kulldorff M, et al.
Adenocarcinoma of the esophagus: role among Iowa women. Lung Cancer Meat intake and cooking techniques:
of obesity and diet. J Natl Cancer Inst 2001;34:37-46. associations with pancreatic cancer.
1995;87:104-9. 55. De Stefani E, Brennan P, Ronco A, et al. Mutat Res 2002;506-507:225-31.
39. Zhang ZF, Kurtz RC, Yu GP, et al. Food groups and risk of lung cancer in 72. Zhang Y, Cantor KP, Lynch CF, et al.
Adenocarcinomas of the esophagus and Uruguay. Lung Cancer 2002;38:1-7. Occupation and risk of pancreatic
gastric cardia: the role of diet. Nutr 56. De Stefani E, Fontham ET, Chen V, et al. cancer: a population-based case-control
Cancer 1997;27:298-309. Fatty foods and the risk of lung cancer: a study in Iowa. J Occup Environ Med
40. De Stefani E, Deneo-Pellegrini H, Boffetta case-control study from Uruguay. Int J 2005;47:392-8.
P, et al. Meat intake and risk of Cancer 1997;71:760-6. 73. Mainz DL, Black O, Webster PD. Hormonal
squamous cell esophageal cancer: a case- 57. Hu J, Mao Y, Dryer D, et al. Risk factors for control of pancreatic growth. J Clin
control study in Uruguay. Int J Cancer lung cancer among Canadian women Invest 1973;52:2300-4.
1999;82:33-7. who have never smoked. Cancer Detect 74. Summerskill WH, Wolpert E. Ammonia
41. De Stefani E, Deneo-Pellegrini H, Prev 2002;26:129-38. metabolism in the gut. Am J Clin Nutr
Mendilaharsu M, et al. Diet and risk of 58. Kubik AK, Zatloukal P, Tomasek L, et al. 1970;23:633-9.
cancer of the upper aerodigestive tract - Dietary habits and lung cancer risk 75. Zheng W. Dietary intake of energy and
I. Foods. Oral Oncol 1999;35:17-21. among non-smoking women. Eur J animal foods and endometrial cancer
42. De Stefani E, Deneo-Pellegrini H, Ronco AL, Cancer Prev 2004;13:471-80. incidence. Am J Epidemiol 1995;142:388-
et al. Food groups and risk of squamous 59. Marchand JL, Luce D, Goldberg P, et al. 94.
cell carcinoma of the oesophagus: a Dietary factors and the risk of lung 76. Potischman N, Swanson CA, Brinton LA, et
case-control study in Uruguay. Br J cancer in New Caledonia (South Pacific). al. Dietary associations in a case-control
Cancer 2003;89:1209-14. Nutr Cancer 2002;42:18-24. study of endometrial cancer. Cancer
43. Barone J, Taioli E, Hebert JR, et al. Vitamin 60. Sinha R, Kulldorff M, Curtin J, et al. Fried, Causes Control 1993;4:239-50.
supplement use and risk for oral and well-done red meat and risk of lung 77. Shu XO, Zheng W, Potischman N, et al. A
esophageal cancer. Nutr Cancer cancer in women (United States). Cancer population-based case-control study of
1992;18:31-41. Causes Control 1998;9:621-30. dietary factors and endometrial cancer
44. Bosetti C, La Vecchia C, Talamini R, et al. 61. Swanson CA, Brown CC, Sinha R, et al. in Shanghai, Peoples Republic of China.
Food groups and risk of squamous cell Dietary fats and lung cancer risk among Am J Epidemiol 1993;137:155-65.
esophageal cancer in northern Italy. Int J women: the Missouri Womens Health 78. Goodman MT, Hankin JH, Wilkens LR, et al.
Cancer 2000;87:289-94. Study (United States). Cancer Causes Diet, body size, physical activity, and the
45. Levi F, Pasche C, Lucchini F, et al. Food Control 1997;8:883-93. risk of endometrial cancer. Cancer Res
groups and oesophageal cancer risk in 62. Zhou W, Park S, Liu G, et al. Dietary iron, 1997;57:5077-85.
Vaud, Switzerland. Eur J Cancer Prev zinc, and calcium and the risk of lung 79. Jain MG, Howe GR, Rohan TE. Nutritional
2000;9:257-63. cancer. Epidemiology 2005;16:772-9. factors and endometrial cancer in
46. Tavani A, La Vecchia C, Gallus S, et al. Red 63. Stolzenberg-Solomon RZ, Pietinen P, Taylor Ontario, Canada. Cancer Control
meat intake and cancer risk: a study in PR, et al. Prospective study of diet and 2000;7:288-96.
Italy. Int J Cancer 2000;86:425-8. pancreatic cancer in male smokers. Am J 80. McCann SE, Freudenheim JL, Marshall JR,
47. Yu MC, Garabrant DH, Peters JM, et al. Epidemiol 2002;155:783-92. et al. Diet in the epidemiology of
Tobacco, alcohol, diet, occupation, and 64. Nothlings U, Wilkens LR, Murphy SP, et al. endometrial cancer in western New York
carcinoma of the esophagus. Cancer Res Meat and fat intake as risk factors for (United States). Cancer Causes Control
1988;48:3843-8. pancreatic cancer: the multiethnic 2000;11:965-74.
48. Brown LM, Blot WJ, Schuman SH, et al. cohort study. J Natl Cancer Inst 81. Lissner L, Kroon UB, Bjorntorp P, et al.
Environmental factors and high risk of 2005;97:1458-65. Adipose tissue fatty acids and dietary fat
esophageal cancer among men in coastal 65. Larsson SC, Hakanson N, Permert J, et al. sources in relation to endometrial
South Carolina. J Natl Cancer Inst Meat, fish, poultry and egg consumption cancer: a retrospective study of cases in
1988;80:1620-5. in relation to risk of pancreatic cancer: a remission, and population-based
49. Ward MH, Sinha R, Heineman EF, et al. Risk prospective study. Int J Cancer controls. Acta Obstet Gynecol Scand
of adenocarcinoma of the stomach and 2006;118:2866-70. 1993;72:481-7.
esophagus with meat cooking method 66. Michaud DS, Giovannucci E, Willett WC, et 82. Xu WH, Dai Q, Xiang YB, et al. Animal food
and doneness preference. Int J Cancer al. Dietary meat, dairy products, fat, and intake and cooking methods in relation
1997;71:14-9. cholesterol and pancreatic cancer risk in to endometrial cancer risk in Shanghai.
50. Chen H, Ward MH, Graubard BI, et al. a prospective study. Am J Epidemiol Br J Cancer 2006;95:1586-92.
Dietary patterns and adenocarcinoma of 2003;157:1115-25. 83. Huang X. Iron overload and its association
the esophagus and distal stomach. Am J 67. Zheng W, McLaughlin JK, Gridley G, et al. A with cancer risk in humans: evidence for
Clin Nutr 2002;75:137-44. cohort study of smoking, alcohol iron as a carcinogenic metal. Mutat Res
51. Gonzalez CA, Jakszyn P, Pera G, et al. Meat consumption, and dietary factors for 2003;533:153-71.
intake and risk of stomach and pancreatic cancer (United States). Cancer 84. Flood A, Velie EM, Sinha R, et al. Meat, fat,
esophageal adenocarcinoma within the Causes Control 1993;4:477-82. and their subtypes as risk factors for
European Prospective Investigation Into 68. Coughlin SS, Calle EE, Patel AV, et al. colorectal cancer in a prospective cohort
437
F O O D , N U T R I T I O N , P H Y S I C A L A C T I V I T Y, A N D T H E P R E V E N T I O N O F C A N C E R : A G L O B A L P E R S P E C T I V E
of women. Am J Epidemiol 2003;158:59- Cancer Epidemiol Biomarkers Prev of cancer of the digestive tract in Biscay
68. 1996;5:515-9. Spain with special emphasis on the role
85. Goldbohm RA, van den Brandt PA, van t 100. Goodman MT, Hankin JH, Wilkens LR, et played by diet and consumption of
Veer P, et al. A prospective cohort study al. High-fat foods and the risk of lung alcohol and tobacco. Rev Sanid Hig
on the relation between meat cancer. Epidemiology 1992;3:288-99. Publica (Madr) 1987;62:1411-30.
consumption and the risk of colon 101. Kreuzer M, Heinrich J, Kreienbrock L, et 116. Coggon D, Barker DJ, Cole RB, et al.
cancer. Cancer Res 1994;54:718-23. al. Risk factors for lung cancer among Stomach cancer and food storage. J Natl
86. Sato Y, Tsubono Y, Nakaya N, et al. Fruit nonsmoking women. Int J Cancer Cancer Inst 1989;81:1178-82.
and vegetable consumption and risk of 2002;100:706-13. 117. Buiatti E, Palli D, Decarli A, et al. A case-
colorectal cancer in Japan: The Miyagi 102. Mettlin C. Milk drinking, other beverage control study of gastric cancer and diet
Cohort Study. Public Health Nutr habits, and lung cancer risk. Int J Cancer in Italy. Int J Cancer 1989;44:611-6.
2005;8:309-14. 1989;43:608-12. 118. Moon HK. Diet and stomach cancer: a
87. Balder HF, Vogel J, Jansen MC, et al. Heme 103. Mohr DL, Blot WJ, Tousey PM, et al. case-control study in Korea. Korean J
and chlorophyll intake and risk of Southern cooking and lung cancer. Nutr Epidemiol 1991;13:33-51.
colorectal cancer in the Netherlands Cancer 1999;35:34-43. 119. Gonzalez CA, Sanz JM, Marcos G, et al.
cohort study. Cancer Epidemiol 104. Pisa FE, Barbone F. Diet and the risk of Dietary factors and stomach cancer in
Biomarkers Prev 2006;15:717-25. cancers of the lung, oral cavity and Spain: a multi-centre case-control study.
88. Huang XE, Hirose K, Wakai K, et al. pharynx, and larynx: a population-based Int J Cancer 1991;49:513-9.
Comparison of lifestyle risk factors by case-control study in north-east Italy. 120. Boeing H, Frentzel-Beyme R, Berger M, et
family history for gastric, breast, lung IARC Sci Publ 2002;156:141-3. al. Case-control study on stomach cancer
and colorectal cancer. Asian Pac J Cancer 105. Galanis DJ, Kolonel LN, Lee J, et al. Intakes in Germany. Int J Cancer 1991;47:858-64.
Prev 2004;5:419-27. of selected foods and beverages and the 121. Hansson LE, Nyren O, Bergstrom R, et al.
89. Kjaerheim K, Gaard M, Andersen A. The incidence of gastric cancer among the Diet and risk of gastric cancer. A
role of alcohol, tobacco, and dietary Japanese residents of Hawaii: a population-based case-control study in
factors in upper aerogastric tract cancers: prospective study. Int J Epidemiol Sweden. Int J Cancer 1993;55:181-9.
a prospective study of 10,900 Norwegian 1998;27:173-80. 122. Inoue M, Tajima K, Hirose K, et al. Life-
men. Cancer Causes Control 1998;9:99- 106. McCullough ML, Robertson AS, Jacobs EJ, style and subsite of gastric cancer - joint
108. et al. A prospective study of diet and effect of smoking and drinking habits.
90. Chyou PH, Nomura AMY, Stemmermann stomach cancer mortality in United Int J Cancer 1994;56:494-9.
GN. Diet, alcohol, smoking and cancer of States men and women. Cancer 123. Cornee J, Pobel D, Riboli E, et al. A case-
the upper aerodigestive tract: a Epidemiol Biomarkers Prev control study of gastric cancer and
prospective study among Hawaii 2001;10:1201-5. nutritional factors in Marseille, France.
Japanese men. Int J Cancer 1995;60:616- 107. Ngoan LT, Mizoue T, Fujino Y, et al. Eur J Epidemiol 1995;11:55-65.
21. Dietary factors and stomach cancer 124. Lpez-Carrillo L, Lopez-Cervantes M,
91. Pottern LM, Morris LE, Blot WJ, et al. mortality. Br J Cancer 2002;87:37-42. Ramirez-Espitia A, et al. Alcohol
Esophageal cancer among black men in 108. Nomura A, Grove JS, Stemmermann GN, consumption and gastric cancer in
Washington, D.C. I. Alcohol, tobacco, et al. A prospective study of stomach Mexico. Cad Saude Publica 1998;14:25-
and other risk factors. J Natl Cancer Inst cancer and its relation to diet, cigarettes, 32.
1981;67:777-83. and alcohol consumption. Cancer Res 125. Youm PY, Kim SH. [A case-control study on
92. Ziegler RG, Morris LE, Blot WJ, et al. 1990;50:627-31. dietary and other factors related to
Esophageal cancer among black men in 109. van den Brandt PA, Botterweck AA, stomach cancer incidence]. Korean J Nutr
Washington, D.C. II. Role of nutrition. J Goldbohm RA. Salt intake, cured meat 1998;31:62-71.
Natl Cancer Inst 1981;67:1199-206. consumption, refrigerator use and 126. De Stefani E, Boffetta P, Mendilaharsu M,
93. Levi F, Pasche C, Lucchini F, et al. Processed stomach cancer incidence: a prospective et al. Dietary nitrosamines, heterocyclic
meat and the risk of selected digestive cohort study (Netherlands). Cancer amines, and risk of gastric cancer: a case-
tract and laryngeal neoplasms in Causes Control 2003;14:427-38. control study in Uruguay. Nutr Cancer
Switzerland. Ann Oncol 2004;15:346-9. 110. Zheng W, Sellers TA, Doyle TJ, et al. 1998;30:158-62.
94. Yang CX, Wang HY, Wang ZM, et al. Risk Retinol, antioxidant vitamins, and 127. Watabe K, Nishi M, Miyake H, et al.
factors for esophageal cancer: a case- cancers of the upper digestive tract in a Lifestyle and gastric cancer: a case-
control study in South-western China. prospective cohort study of control study. Oncol Rep 1998;5:1191-4.
Asian Pac J Cancer Prev 2005;6:48-53. postmenopausal women. Am J 128. Ward MH, Lpez-Carrillo L. Dietary factors
95. Ozasa K, Watanabe Y, Ito Y, et al. Dietary Epidemiol 1995;142:955-60. and the risk of gastric cancer in Mexico
habits and risk of lung cancer death in a 111. Acheson ED, Doll R. Dietary factors in City. Am J Epidemiol 1999;149:925-32.
large-scale cohort study (JACC Study) in carcinoma of the stomach: a study of 100 129. De Stefani E, Ronco A, Brennan P, et al.
Japan by sex and smoking habit. Jpn J cases and 200 controls. Gut 1964;5:126- Meat consumption and risk of stomach
Cancer Res 2001;92:1259-69. 31. cancer in Uruguay: a case-control study.
96. Veierod MB, Laake P, Thelle DS. Dietary fat 112. Funakoshi N, Kanoh T, Uchino H, et al. Nutr Cancer 2001;40:103-7.
intake and risk of lung cancer: a Gastric cancer and diet. The analysis of 130. Sipetic S, Tomic-Kundakovic S, Vlajinac H,
prospective study of 51,452 Norwegian the epidemiological survey in Tango et al. [Diet and gastric cancer].
men and women. Eur J Cancer Prev district of Kyoto prefecture. Naika Hokan Vojnosanit Pregl 2003;60:697-705.
1997;6:540-9. 1983;30:175-81. 131. Lpez-Carrillo L, Lopez-Cervantes M,
97. Bond GG, Thompson FE, Cook RR. Dietary 113. Tajima K, Tominaga S. Dietary habits and Robles-Diaz G, et al. Capsaicin
vitamin A and lung cancer: results of a gastro-intestinal cancers: a comparative consumption, Helicobacter pylori
case-control study among chemical case-control study of stomach and large positivity and gastric cancer in Mexico.
workers. Nutr Cancer 1987;9:109-21. intestinal cancers in Nagoya, Japan. Jpn J Int J Cancer 2003;106:277-82.
98. De Stefani E, Brennan P, Boffetta P, et al. Cancer Res 1985;76:705-16. 132. De Stefani E, Correa P, Boffetta P, et al.
Diet and adenocarcinoma of the lung: a 114. Jedrychowski W, Wahrendorf J, Popiela T, Dietary patterns and risk of gastric
case-control study in Uruguay. Lung et al. A case-control study of dietary cancer: a case-control study in Uruguay.
Cancer 2002;35:43-51. factors and stomach cancer risk in Gastric Cancer 2004;7:211-20.
99. De Stefani E, Fierro L, Correa P, et al. Mate Poland. Int J Cancer 1986;37:837-42. 133. Nomura A, Yamakawa H, Ishidate T, et al.
drinking and risk of lung cancer in males: 115. Goiriena De Gandarias FJ, Santidrian MI, Intestinal metaplasia in Japan:
a case-control study from Uruguay. Barranquero AM. Etiopathogenic study association with diet. J Natl Cancer Inst
438
R E F E R E N C E S
1982;68:401-5. 151. Hirayama T. [A large scale cohort study on of colorectal cancer. Int J Cancer
134. Llopis A, Morales M, Rodriguez R. the effect of life styles on the risk of 2006;119:297-303.
Digestive cancer in relation to diet in cancer by each site]. Gan No Rinsho 166. Wakai K, Hirose K, Matsuo K, et al.
Spain. J Environ Pathol Toxicol Oncol 1990;Spec No:233-42. Dietary risk factors for colon and rectal
1992;11:169-75. 152. Hsing AW, McLaughlin JK, Chow WH, et cancers: a comparative case-control
135. Larsson SC, Bergkvist L, Wolk A. Processed al. Risk factors for colorectal cancer in a study. J Epidemiol 2006;16:125-35.
meat consumption, dietary nitrosamines prospective study among U.S. white 167. Zou X, Li J, Li J, et al. The preliminary
and stomach cancer risk in a cohort of men. Int J Cancer 1998;77:549-53. results of epidemiology investigation in
Swedish women. Int J Cancer 153. Hirayama T. Association between alcohol the role of Epstein-Barr virus and salty
2006;119:915-9. consumption and cancer of the sigmoid fish in nasopharyngeal carcinoma in
136. Phukan RK, Narain K, Zomawia E, et al. colon: observations from a Japanese Sihu area, Guangdong province. China
Dietary habits and stomach cancer in cohort study. Lancet 1989;2:725-7. Carcinoma 1994;3:23-5.
Mizoram, India. J Gastroenterol 154. Kearney J, Giovannucci E, Rimm EB, et al. 168. Ward MH, Pan WH, Cheng YJ, et al.
2006;41:418-24. Calcium, vitamin D, and dairy foods and Dietary exposure to nitrite and
137. Strumylaite L, Zickute J, Dudzevicius J, et the occurrence of colon cancer in men. nitrosamines and risk of nasopharyngeal
al. Salt-preserved foods and risk of Am J Epidemiol 1996;143:907-17. carcinoma in Taiwan. Int J Cancer
gastric cancer. Medicina (Kaunas) 155. Knekt P, Jarvinen R, Dich J, et al. Risk of 2000;86:603-9.
2006;42:164-70. colorectal and other gastro-intestinal 169. Yuan JM, Wang XL, Xiang YB, et al.
138. Cross AJ, Peters U, Kirsh VA, et al. A cancers after exposure to nitrate, nitrite Preserved foods in relation to risk of
prospective study of meat and meat and N-nitroso compounds: a follow-up nasopharyngeal carcinoma in Shanghai,
mutagens and prostate cancer risk. study. Int J Cancer 1999;80:852-6. China. Int J Cancer 2000;85:358-63.
Cancer Res 2005;65:11779-84. 156. Sanjoaquin MA, Appleby PN, Thorogood 170. Armstrong RW, Imrey PB, Lye MS, et al.
139. Veierod MB, Laake P, Thelle DS. Dietary M, et al. Nutrition, lifestyle and Nasopharyngeal carcinoma in Malaysian
fat intake and risk of prostate cancer: a colorectal cancer incidence: a Chinese: salted fish and other dietary
prospective study of 25,708 Norwegian prospective investigation of 10998 exposures. In: 12, editor. Int J Cancer,
men. Int J Cancer 1997;73:634-8. vegetarians and non-vegetarians in the 1998:228-35.
140. Le Marchand L, Kolonel LN, Wilkens LR, et United Kingdom. Br J Cancer 171. Lee HP, Gourley L, Duffy SW, et al.
al. Animal fat consumption and prostate 2004;90:118-21. Preserved foods and nasopharyngeal
cancer: a prospective study in Hawaii. 157. Kojima M, Wakai K, Tamakoshi K, et al. carcinoma: a case-control study among
Epidemiology 1994;5:276-82. Diet and colorectal cancer mortality: Singapore Chinese. In: 13, editor. Int J
141. Michaud DS, Augustsson K, Rimm EB, et results from the Japan collaborative Cancer, 1994:585-90.
al. A prospective study on intake of cohort study. Nutr Cancer 2004;50:23-32. 172. Zheng X, Christensson B, Drettner B.
animal products and risk of prostate 158. Ma J, Giovannucci E, Pollak M, et al. Milk Studies on etiological factors of
cancer. Cancer Causes Control intake, circulating levels of insulin-like nasopharyngeal carcinoma. Acta
2001;12:557-67. growth factor-I, and risk of colorectal Otolaryngol 1993;113:455-7.
142. McCann SE, Ambrosone CB, Moysich KB, cancer in men. J Natl Cancer Inst 173. Zheng X, Yan L, Nilsson B, et al. Epstein-
et al. Intakes of selected nutrients, 2001;93:1330-6. Barr virus infection, salted fish and
foods, and phytochemicals and prostate 159. Luchtenborg M, Weijenberg MP, de Goeij nasopharyngeal carcinoma. A case-
cancer risk in Western New York. Nutr AF, et al. Meat and fish consumption, control study in southern China. Acta
Cancer 2005;53:33-41. APC gene mutations and hMLH1 Oncol 1994;33:867-72.
143. Nowell S, Ratnasinghe DL, Ambrosone CB, expression in colon and rectal cancer: a 174. Zheng YM, Tuppin P, Hubert A, et al.
et al. Association of SULT1A1 phenotype prospective cohort study (The Environmental and dietary risk factors
and genotype with prostate cancer risk Netherlands). Cancer Causes Control for nasopharyngeal carcinoma: a case-
in African-Americans and Caucasians. 2005;16:1041-54. control study in Zangwu County,
Cancer Epidemiol Biomarkers Prev 160. Gaard M, Tretli S, Loken EB. Dietary Guangxi, China. Br J Cancer 1994;69:508-
2004;13:270-6. factors and risk of colon cancer: a 14.
144. Bosetti C, Micelotta S, Dal Maso L, et al. prospective study of 50,535 young 175. West S, Hildesheim A, Dosemeci M. Non-
Food groups and risk of prostate cancer Norwegian men and women. Eur J viral risk factors for nasopharyngeal
in Italy. Int J Cancer 2004;110:424-8. Cancer Prev 1996;5:445-54. carcinoma in the Philippines: results
145. Deneo-Pellegrini H, De Stefani E, Ronco 161. Phillips RL, Snowdon DA. Dietary from a case-control study. Int J Cancer
A, et al. Foods, nutrients and prostate relationships with fatal colorectal cancer 1993;55:722-7.
cancer: a case-control study in Uruguay. among Seventh-Day Adventists. J Natl 176. Sriamporn S, Vatanasapt V, Pisani P, et al.
Br J Cancer 1999;80:591-7. Cancer Inst 1985;74:307-17. Environmental risk factors for
146. Ewings P, Bowie C. A case-control study of 162. Rao CV, Hirose Y, Indranie C, et al. nasopharyngeal carcinoma: a case-
cancer of the prostate in Somerset and Modulation of experimental colon control study in northeastern Thailand.
east Devon. Br J Cancer 1996;74:661-6. tumorigenesis by types and amounts of Cancer Epidemiol Biomarkers Prev
147. De Stefani E, Fierro L, Barrios E, et al. dietary fatty acids. Cancer Res 1992;1:345-8.
Tobacco, alcohol, diet and risk of 2001;61:1927-33. 177. Yu MC, Huang TB, Henderson BE. Diet
prostate cancer. Tumori 1995;81:315-20. 163. MacLean CH, Newberry SJ, Mojica WA, et and nasopharyngeal carcinoma: a case-
148. Rodriguez C, McCullough ML, Mondul al. Effects of omega-3 fatty acids on control study in Guangzhou, China. Int J
AM, et al. Meat consumption among cancer risk: a systematic review. JAMA Cancer 1989;43:1077-82.
Black and White men and risk of 2006;295:403-15. 178. Ning JP, Yu MC, Wang QS, et al.
prostate cancer in the Cancer Prevention 164. Lin J, Zhang SM, Cook NR, et al. Dietary Consumption of salted fish and other
Study II Nutrition Cohort. Cancer intakes of fruit, vegetables, and fiber, risk factors for nasopharyngeal
Epidemiol Biomarkers Prev 2006;15:211- and risk of colorectal cancer in a carcinoma (NPC) in Tianjin, a low-risk
6. prospective cohort of women (United region for NPC in the Peoples Republic
149. Wu K, Hu FB, Willett WC, et al. Dietary States). Cancer Causes Control of China. J Natl Cancer Inst 1990;82:291-
patterns and risk of prostate cancer in 2005;16:225-33. 6.
U.S. men. Cancer Epidemiol Biomarkers 165. Siezen CL, Bueno-de-Mesquita HB, 179. Armstrong RW, Armstrong MJ.
Prev 2006;15:167-71. Peeters PH, et al. Polymorphisms in the Environmental risk factors and
150. Goldman R, Shields PG. Food mutagens. J genes involved in the arachidonic acid- nasopharyngeal carcinoma in Selangor,
Nutr 2003;133 Suppl 3:965S-73S. pathway, fish consumption and the risk Malaysia: A cross-ethnic perspective. Ecol
439
F O O D , N U T R I T I O N , P H Y S I C A L A C T I V I T Y, A N D T H E P R E V E N T I O N O F C A N C E R : A G L O B A L P E R S P E C T I V E
Dis 1983;2:185-98. 194. Jeannel D, Hubert A, de Vathaire F, et al. dairy products and the risk of colorectal
180. Henderson BE, Louie E, SooHoo Jing J, et Diet, living conditions and adenoma and cancer among French
al. Risk factors associated with nasopharyngeal carcinoma in Tunisiaa women of the E3N-EPIC prospective
nasopharyngeal carcinoma. The New case-control study. Int J Cancer study. Int J Cancer 2005;117:137-44.
England journal of medicine 1990;46:421-5. 209. Heilbrun LK, Nomura A, Hankin JH, et al.
1976;295:1101-6. 195. Geser A, Charnay N, Day NE, et al. Diet and colorectal cancer with special
181. Yang XR, Diehl S, Pfeiffer R, et al. Environmental factors in the etiology of reference to fiber intake. Int J Cancer
Evaluation of risk factors for nasopharyngeal carcinoma: report on a 1989;44:1-6.
nasopharyngeal carcinoma in high-risk case-control study in Hong Kong. IARC 210. Tangrea J, Helzlsouer K, Pietinen P, et al.
nasopharyngeal carcinoma families in Sci Publ 1978:213-29. Serum levels of vitamin D metabolites
Taiwan. Cancer Epidemiol Biomarkers 196. Zou X, Li J, Lu S, et al. Volatile N- and the subsequent risk of colon and
Prev 2005;14:900-5. nitrosamines in salted fish samples from rectal cancer in Finnish men. Cancer
182. Ye W, Yingnan Yi, Tianshu Zhou, Rutao high- and low-risk areas for NPC in Causes Control 1997;8:615-25.
Lin. A case-control study on risk China. Chin Med Sci J 1992;7:201-4. 211. Garland CF, Comstock GW, Garland FC, et
condition of nasopharyngeal carcinoma 197. Zou XN, Lu SH, Liu B. Volatile N- al. Serum 25-hydroxyvitamin D and colon
in Southern area of Fujian Province. J nitrosamines and their precursors in cancer: eight-year prospective study.
Fujian Med College 1995;29:179-82. Chinese salted fish - a possible etological Lancet 1989;2:1176-8.
183. Ye W, Yi Y, Lin R, et al. A case-control factor for NPC in China. Int J Cancer 212. Braun MM, Helzlsouer KJ, Hollis BW, et al.
study for nasopharyngeal carcinoma in 1994;59:155-8. Colon cancer and serum vitamin D
Minan prefecture, Fujian province China. 198. Kongruttanachok N, Sukdikul S, Setavarin metabolite levels 10-17 years prior to
Chronic Diesease Prevention and Control S, et al. Cytochrome P450 2E1 diagnosis. Am J Epidemiol 1995;142:608-
1995;3:158-61. polymorphism and nasopharyngeal 11.
184. Cai L, Yi Y. A matched study with various carcinoma development in Thailand: a 213. Slattery ML, Neuhausen SL, Hoffman M,
controls in Nasopharyngeal carcinoma correlative study. BMC Cancer 2001;1:4. et al. Dietary calcium, vitamin D, VDR
epidemiology in Fujian province. Journal 199. Bostick RM, Potter JD, Sellers TA, et al. genotypes and colorectal cancer. Int J
of Fujian Medical College 1996;30:199- Relation of calcium, vitamin D, and dairy Cancer 2004;111:750-6.
202. food intake to incidence of colon cancer 214. Wurzelmann JI, Silver A, Schreinemachers
185. Chen W, Yu L, Wei X, et al. Etiology study among older women. The Iowa Womens DM, et al. Iron intake and the risk of
of nasopharyngeal cancer in Guanxi Tin Health Study. Am J Epidemiol colorectal cancer. Cancer Epidemiol
mines- relationship between dust 1993;137:1302-17. Biomarkers Prev 1996;5:503-7.
exposure and nasopharyngeal cancer. 200. Garland C, Shekelle RB, Barrett Connor E, 215. Glynn SA, Albanes D, Pietinen P, et al.
Industrial Health and Occupational et al. Dietary vitamin D and calcium and Colorectal cancer and folate status: a
Disease 1994;20:25-8. risk of colorectal cancer: a 19-year nested case-control study among male
186. Wang X, Chunyan Lin, Xiwen Sun, Yubo prospective study in men. Lancet smokers. Cancer Epidemiol Biomarkers
Shi, Yanjie Liu, Xudong Dai. The 1985;1:307-9. Prev 1996;5:487-94.
relationship between nasopharyngeal 201. Zheng W, Anderson KE, Kushi LH, et al. A 216. Kato I, Dnistrian AM, Schwartz M, et al.
cancer and dietary as well as prospective cohort study of intake of Iron intake, body iron stores and
environmental factors in Heilongjiang calcium, vitamin D, and other colorectal cancer risk in women: a nested
province. J China Oncol 1993;15:75-6. micronutrients in relation to incidence of case-control study. Int J Cancer
187. Zou J, Sun Q, Yuan Y, et al. A case-control rectal cancer among postmenopausal 1999;80:693-8.
study of nasopharyngeal carcinoma women. Cancer Epidemiol Biomarkers 217. Konings EJ, Goldbohm RA, Brants HA, et
among inhabitants in high background Prev 1998;7:221-5. al. Intake of dietary folate vitamers and
radiation areas of Yangjinag, China. 202. Martinez ME, Giovannucci EL, Colditz GA, risk of colorectal carcinoma: results from
China Journal of Radiology Medicine and et al. Calcium, vitamin D, and the The Netherlands Cohort Study. Cancer
Protection 1999;19:94-. occurrence of colorectal cancer among 2002;95:1421-33.
188. Yu MC, Ho JH, Lai SH, et al. Cantonese- women. J Natl Cancer Inst 1996;88:1375- 218. Lee DH, Anderson KE, Harnack LJ, et al.
style salted fish as a cause of 82. Heme iron, zinc, alcohol consumption,
nasopharyngeal carcinoma: report of a 203. Jarvinen R, Knekt P, Hakulinen T, et al. and colon cancer: Iowa Womens Health
case-control study in Hong Kong. Cancer Prospective study on milk products, Study. J Natl Cancer Inst 2004;96:403-7.
Res 1986;46:956-61. calcium and cancers of the colon and 219. Chan AT, Ma J, Tranah GJ, et al.
189. Yu MC, Mo CC, Chong WX, et al. rectum. Eur J Clin Nutr 2001;55:1000-7. Hemochromatosis gene mutations, body
Preserved foods and nasopharyngeal 204. Terry P, Baron JA, Bergkvist L, et al. iron stores, dietary iron, and risk of
carcinoma: a case-control study in Dietary calcium and vitamin D intake and colorectal adenoma in women. J Natl
Guangxi, China. Cancer Res risk of colorectal cancer: a prospective Cancer Inst 2005;97:917-26.
1988;48:1954-9. cohort study in women. Nutr Cancer 220. Hoshiyama Y, Sasaba T. A case-control
190. Armstrong RW, Eng AC. Salted fish and 2002;43:39-46. study of single and multiple stomach
nasopharyngeal carcinoma in Malaysia. 205. McCullough ML, Robertson AS, Rodriguez cancers in Saitama Prefecture, Japan. Jpn
Soc Sci Med 1983;17:1559-67. C, et al. Calcium, vitamin D, dairy J Cancer Res 1992;83:937-43.
191. Na Y, Hu M. Case-control study on NCP. products, and risk of colorectal cancer in 221. Dalgat DM, Aliev RG, Gireev GI, et al.
Journal of China Epidemiology the Cancer Prevention Study II Nutrition [Epidemiology of stomach cancer in
1988;9:224. Cohort (United States). Cancer Causes Dagestan]. Vopr Onkol 1974;20:76-82.
192. Hildesheim A, Anderson LM, Chen CJ, et Control 2003;14:1-12. 222. Jedrychowski W, Popiela T, Tobiasz-
al. CYP2E1 genetic polymorphisms and 206. Lin J, Zhang SM, Cook NR, et al. Intakes of Adamczyk B, et al. [Dietary factors and
risk of nasopharyngeal carcinoma in calcium and vitamin D and risk of laxatives in the epidemiology of stomach
Taiwan. J Natl Cancer Inst 1997;89:1207- colorectal cancer in women. Am J cancer]. Nowotwory 1981;30:353-60.
12. Epidemiol 2005;161:755-64. 223. Ye EC. [Case-control study of 100 gastric
193. Lanier A, Bender T, Talbot M, et al. 207. Giovannucci E, Stampfer MJ, Colditz GA, cancer cases]. Chung Hua Yu Fang I
Nasopharyngeal carcinoma in Alaskan et al. Multivitamin use, folate, and colon Hsueh Tsa Chih 1981;15:107-9.
Eskimos Indians, and Aleuts: a review of cancer in women in the Nurses Health 224. Ren TS. [Case-control study of gastric
cases and study of Epstein-Barr virus, Study. Ann Intern Med 1998;129:517-24. cancer in ten rural counties in China].
HLA, and environmental risk factors. 208. Kesse E, Boutron Ruault MC, Norat T, et al. Chung Hua Liu Hsing Ping Hsueh Tsa
Cancer 1980;46:2100-6. Dietary calcium, phosphorus, vitamin D, Chih 1985;6:29-32.
440
R E F E R E N C E S
225. Risch HA, Jain M, Choi NW, et al. Dietary Cancer Causes Control 2005;16:773-80. Cancer Causes Control 2001;12:557-67.
factors and the incidence of cancer of 242. Ikeda M, Yoshimoto K, Yoshimura T, et al. 10. Chan JM, Stampfer MJ, Ma J, et al. Dairy
the stomach. Am J Epidemiol A cohort study on the possible products, calcium, and prostate cancer
1985;122:947-59. association between broiled fish intake risk in the Physicians Health Study. Am J
226. Choi NW, Miller AB, Fodor JG, et al. and cancer. Gann 1983;74:640-8. Clin Nutr 2001;74:549-54.
Consumption of precursors of N-nitroso 243. Hoshiyama Y, Sasaba T. A case-control 11. Chan JM, Pietinen P, Virtanen M, et al. Diet
compounds and human gastric cancer. study of stomach cancer and its relation and prostate cancer risk in a cohort of
IARC Sci Publ 1987;84:492-6. to diet, cigarettes, and alcohol smokers, with a specific focus on calcium
227. Lee HH, Wu HY, Chuang YC, et al. consumption in Saitama Prefecture, and phosphorus (Finland). Cancer Causes
Epidemiologic characteristics and Japan. Cancer Causes Control Control 2000;11:859-67.
multiple risk factors of stomach cancer in 1992;3:441-8. 12. Hsing AW, McLaughlin JK, Schuman LM, et
Taiwan. Anticancer Res 1990;10:875-81. 244. Graham S, Schotz W, Martino P. al. Diet, tobacco use, and fatal prostate
228. Sanchez-Diez A, Hernandez-Mejia R, Alimentary factors in the epidemiology cancer: results from the Lutheran
Cueto-Espinar A. Study of the relation of gastric cancer. Cancer 1972;30:927-38. Brotherhood Cohort Study. Cancer Res
between diet and gastric cancer in a 245. Wu-Williams AH, Yu MC, Mack TM. Life- 1990;50:6836-40.
rural area of the Province of Leon, Spain. style, workplace, and stomach cancer by 13. Gann PH, Hennekens CH, Sacks FM, et al.
Eur J Epidemiol 1992;8:233-7. subsite in young men of Los Angeles Prospective study of plasma fatty acids
229. Wang R. [The epidemiological study of County. Cancer Res 1990;50:2569-76. and risk of prostate cancer. J Natl Cancer
subtype risk factors of gastric cancer]. 246. Kim HJ, Chang WK, Kim MK, et al. Dietary Inst 1994;86:281-6.
Chung Hua Liu Hsing Ping Hsueh Tsa factors and gastric cancer in Korea: a 14. Allen NE, Sauvaget C, Roddam AW, et al. A
Chih 1993;14:295-9. case-control study. Int J Cancer prospective study of diet and prostate
230. Ramon JM, Serra L, Cerdo C, et al. Dietary 2002;97:531-5. cancer in Japanese men. Cancer Causes
factors and gastric cancer risk. A case- 247. Suh S, Koo B, Choi Y, et al. [Lifestyle and Control 2004;15:911-20.
control study in Spain. Cancer eating behaviors of the stomach cancer 15. Rodriguez C, Jacobs EJ, Patel AV, et al.
1993;71:1731-5. patients in Daegu and Kyungpook areas Jewish ethnicity and prostate cancer
231. Falcao JM, Dias JA, Miranda AC, et al. Red in Korea]. Korean J Nutr 2002;35:380-93. mortality in two large US cohorts. Cancer
wine consumption and gastric cancer in 248. Boccia S, Persiani R, La Torre G, et al. Causes Control 2002;13:271-7.
Portugal: a case-control study. Eur J Sulfotransferase 1A1 polymorphism and 16. McCann SE, Ambrosone CB, Moysich KB, et
Cancer Prev 1994;3:269-76. gastric cancer risk: a pilot case-control al. Intakes of selected nutrients, foods,
232. Ji BT, Chow WH, Yang G, et al. Dietary study. Cancer Lett 2005;229:235-43. and phytochemicals and prostate cancer
habits and stomach cancer in Shanghai, risk in Western New York. Nutr Cancer
China. Int J Cancer 1998;76:659-64. 2005;53:33-41.
233. Liu X, Wang Q, Ma J. [A case-control study Chapter 4.4 17. Sanderson M, Coker AL, Logan P, et al.
on the risk factors of stomach cancer in Lifestyle and prostate cancer among
Tianjin City]. Chung Hua Liu Hsing Ping 1. McGee H. McGee on Food and Cooking. older African-American and Caucasian
Hsueh Tsa Chih 2001;22:362-4. London: Hodder and Stoughton, 2004. men in South Carolina. Cancer Causes
234. Fei S, Xiao S. [Diet and gastric cancer: a 2. Food and Agriculture Organization of the Control 2004;15:647-55.
case-control study in Shanghai urban United Nations. FAOSTAT. 18. Hodge AM, English DR, McCredie MRE, et
districts]. Chin J Gastroenterol http://faostat.fao.org/site/345/default.as al. Foods, nutrients and prostate cancer.
2003;8:143-7. px. 2006. Cancer Causes Control 2004;15:11-20.
235. Lissowska J, Gail MH, Pee D, et al. Diet 3. Davidson A. The Penguin Companion to 19. Chan JM, Giovannucci E, Andersson SO, et
and stomach cancer risk in Warsaw, Food. Revised ed. Harmondsworth: al. Dairy products, calcium, phosphorous,
Poland. Nutr Cancer 2004;48:149-59. Penguin Books, 2002. vitamin D, and risk of prostate cancer
236. Rudan I, Vadla D, Strnad M, et al. [The 4. Platz EA, Leitzmann MF, Hollis BW, et al. (Sweden). Cancer Causes Control
Mediterranean diet and occurrence of Plasma 1,25-dihydroxy- and 25- 1998;9:559-66.
malignant tumors of the digestive hydroxyvitamin D and subsequent risk of 20. Lee MM, Wang RT, Hsing AW, et al. Case-
system in the Croatian islands]. Lijec prostate cancer. Cancer Causes Control control study of diet and prostate cancer
Vjesn 2003;125:60-7. 2004;15:255-65. in China. Cancer Causes Control
237. Dungal N, Sigurjonsson J. Gastric cancer 5. Schuurman AG, van den Brandt PA, Dorant 1998;9:545-52.
and diet. A pilot study on dietary habits E, et al. Animal products, calcium and 21. Sonoda T, Nagata Y, Mori M, et al. A case-
in two districts differing markedly in protein and prostate cancer risk in The control study of diet and prostate cancer
respect of mortality from gastric cancer. Netherlands Cohort Study. Br J Cancer in Japan: possible protective effect of
Br J Cancer 1967;21:270-6. 1999;80:1107-13. traditional Japanese diet. Cancer Sci
238. Garcia-Falcon MS, Simal-Gandara J. 6. Tseng M, Breslow RA, Graubard BI, et al. 2004;95:238-42.
Polycyclic aromatic hydrocarbons in Dairy, calcium, and vitamin D intakes and 22. Deneo-Pellegrini H, De Stefani E, Ronco A,
smoke from different woods and their prostate cancer risk in the National et al. Foods, nutrients and prostate
transfer during traditional smoking into Health and Nutrition Examination cancer: a case-control study in Uruguay.
chorizo sausages with collagen and tripe Epidemiologic Follow-up Study cohort. Br J Cancer 1999;80:591-7.
casings. Food Addit Contam 2005;22:1-8. Am J Clin Nutr 2005;81:1147-54. 23. Tzonou A, Signorello LB, Lagiou P, et al.
239. Campos F, Carrasquilla G, Koriyama C, et 7. Rodriguez C, McCullough ML, Mondul AM, Diet and cancer of the prostate: a case-
al. Risk factors of gastric cancer specific et al. Calcium, dairy products, and risk of control study in Greece. Int J Cancer
for tumor location and histology in Cali, prostate cancer in a prospective cohort 1999;80:704-8.
Colombia. World J Gastroenterol of United States men. Cancer Epidemiol 24. Hayes RB, Ziegler RG, Gridley G, et al.
2006;12:5772-9. Biomarkers Prev 2003;12:597-603. Dietary factors and risks for prostate
240. Kato I, Tominaga S, Matsumoto K. A 8. Berndt SI, Carter HB, Landis PK, et al. cancer among blacks and whites in the
prospective study of stomach cancer Calcium intake and prostate cancer risk United States. Cancer Epidemiol
among a rural Japanese population: a 6- in a long-term aging study: the Biomarkers Prev 1999;8:25-34.
year survey. Jpn J Cancer Res Baltimore Longitudinal Study of Aging. 25. Andersson SO, Baron J, Wolk A, et al. Early
1992;83:568-75. Urology 2002;60:1118-23. life risk factors for prostate cancer: a
241. Sauvaget C, Lagarde F, Nagano J, et al. 9. Michaud DS, Augustsson K, Rimm EB, et al. population-based case-control study in
Lifestyle factors, radiation and gastric A prospective study on intake of animal Sweden. Cancer Epidemiol Biomarkers
cancer in atomic-bomb survivors (Japan). products and risk of prostate cancer. Prev 1995;4:187-92.
441
F O O D , N U T R I T I O N , P H Y S I C A L A C T I V I T Y, A N D T H E P R E V E N T I O N O F C A N C E R : A G L O B A L P E R S P E C T I V E
26. Chen YC, Chiang CI, Lin RS, et al. Diet, prostate cancer. Tumori 1995;81:315-20. 61. Howell MA. Factor analysis of international
vegetarian food and prostate carcinoma 44. Talamini R, Franceschi S, La Vecchia C, et al. cancer mortality data and per capita
among men in Taiwan. Br J Cancer Diet and prostatic cancer: a case-control food consumption. Br J Cancer
2005;93:1057-61. study in northern Italy. Nutr Cancer 1974;29:328-36.
27. Ewings P, Bowie C. A case-control study of 1992;18:277-86. 62. Chan JM, Stampfer MJ, Giovannucci E, et
cancer of the prostate in Somerset and 45. Mettlin C, Selenskas S, Natarajan N, et al. al. Plasma insulin-like growth factor-I
east Devon. Br J Cancer 1996;74:661-6. Beta-carotene and animal fats and their and prostate cancer risk: a prospective
28. Talamini R, La Vecchia C, Decarli A, et al. relationship to prostate cancer risk. A study. Science 1998;279:563-6.
Nutrition, social factors and prostatic case-control study. Cancer 1989;64:605- 63. Morris JK, George LM, Wu T, et al. Insulin-
cancer in a Northern Italian population. 12. like growth factors and cancer: no role in
Br J Cancer 1986;53:817-21. 46. Sung JF, Lin RS, Pu YS, et al. Risk factors for screening. Evidence from the BUPA study
29. Chaklin AV, Plotnikov SV. [Importance of prostate carcinoma in Taiwan: a case- and meta-analysis of prospective
various factors in the occurrence of control study in a Chinese population. epidemiological studies. Br J Cancer
prostatic cancer]. Urol Nefrol (Mosk) Cancer 1999;86:484-91. 2006;95:112-7.
1984;4:46-51. 47. La Vecchia C, Negri E, DAvanzo B, et al. 64. Giovannucci E, Liu Y, Stampfer MJ, et al. A
30. Colli JL, Colli A. Comparisons of prostate Dairy products and the risk of prostatic prospective study of calcium intake and
cancer mortality rates with dietary cancer. Oncology 1991;48:406-10. incident and fatal prostate cancer.
practices in the United States. Urol Oncol 48. Mettlin CJ, Schoenfeld ER, Natarajan N. Cancer Epidemiol Biomarkers Prev
2005;23:390-8. Patterns of milk consumption and risk of 2006;15:203-10.
31. Ganmaa D, Li XM, Wang J, et al. Incidence cancer. Nutr Cancer 1990;13:89-99. 65. Kesse E, Bertrais S, Astorg P, et al. Dairy
and mortality of testicular and prostatic 49. Mishina T, Watanabe H, Araki H, et al. products, calcium and phosphorus
cancers in relation to world dietary [High risk group for prostatic cancer by intake, and the risk of prostate cancer:
practices. Int J Cancer 2002;98:262-7. matched pair analysis]. Nippon results of the French prospective
32. Gronberg H, Damber L, Damber JE. Total Hinyokika Gakkai Zasshi 1981;72:1256- SU.VI.MAX (Supplementation en
food consumption and body mass index 79. Vitamines et Mineraux Antioxydants)
in relation to prostate cancer risk: a case- 50. Mishina T, Watanabe H, Araki H, et al. study. Br J Nutr 2006;95:539-45.
control study in Sweden with Epidemiological study of prostatic cancer 66. Gallus S, Bravi F, Talamini R, et al. Milk,
prospectively collected exposure data. J by matched-pair analysis. Prostate dairy products and cancer risk (Italy).
Urol 1996;155:969-74. 1985;6:423-36. Cancer Causes Control 2006;17:429-37.
33. Le Marchand L, Kolonel LN, Wilkens LR, et 51. Rotkin ID. Studies in the epidemiology of 67. Phillips RL. Role of life-style and dietary
al. Animal fat consumption and prostate prostatic cancer: expanded sampling. habits in risk of cancer among seventh-
cancer: a prospective study in Hawaii. Cancer Treat Rep 1977;61:173-80. day adventists. Cancer Res 1975;35:3513-
Epidemiology 1994;5:276-82. 52. Zhang J, Kesteloot H. Milk consumption in 22.
34. Ursin G, Bjelke E, Heuch I, et al. Milk relation to incidence of prostate, breast, 68. Phillips RL, Snowdon DA. Dietary
consumption and cancer incidence: a colon, and rectal cancers: is there an relationships with fatal colorectal cancer
Norwegian prospective study. Br J Cancer independent effect? Nutr Cancer among Seventh-Day Adventists. J Natl
1990;61:456-9. 2005;53:65-72. Cancer Inst 1985;74:307-17.
35. Severson RK, Nomura AM, Grove JS, et al. A 53. Li XM, Ganmaa D, Qin LQ, et al. [The 69. Hirayama T. [A large scale cohort study on
prospective study of demographics, diet, effects of estrogen-like products in milk the effect of life styles on the risk of
and prostate cancer among men of on prostate and testes]. [Chinese]. Zhong cancer by each site]. Gan No Rinsho
Japanese ancestry in Hawaii. Cancer Res Hua Nan Ke Xue 2003;9:186-90. 1990;Spec No:233-42.
1989;49:1857-60. 54. Li X-M, Liu X-F, Akio S. Relationship 70. Khan MM, Goto R, Kobayashi K, et al.
36. Snowdon DA, Phillips RL, Choi W. Diet, between the incidence rates of testicular Dietary habits and cancer mortality
obesity, and risk of fatal prostate cancer. and prostatic cancers and food among middle aged and older Japanese
Am J Epidemiol 1984;120:244-50. consumptions. Chinese Journal of Cancer living in Hokkaido, Japan by cancer site
37. Veierod MB, Laake P, Thelle DS. Dietary fat Research 2002;. 14:240-5. and sex. 2004;5:58-65.
intake and risk of prostate cancer: a 55. Hebert JR, Hurley TG, Olendzki BC, et al. 71. Hirayama T. Association between alcohol
prospective study of 25,708 Norwegian Nutritional and socioeconomic factors in consumption and cancer of the sigmoid
men. Int J Cancer 1997;73:634-8. relation to prostate cancer mortality: a colon: observations from a Japanese
38. Giovannucci E, Ascherio A, Rimm EB, et al. cross-national study. J Natl Cancer Inst cohort study. Lancet 1989;2:725-7.
Intake of carotenoids and retinol in 1998;90:1637-47. 72. Kearney J, Giovannucci E, Rimm EB, et al.
relation to risk of prostate cancer. J Natl 56. Tominaga S, Kuroishi T. An ecological study Calcium, vitamin D, and dairy foods and
Cancer Inst 1995;87:1767-76. on diet/nutrition and cancer in Japan. Int the occurrence of colon cancer in men.
39. Snowdon DA. Animal product J Cancer 1997;Suppl:10-6. Am J Epidemiol 1996;143:907-17.
consumption and mortality because of 57. Decarli A, La VC. Environmental factors and 73. Gaard M, Tretli S, Loken EB. Dietary factors
all causes combined, coronary heart cancer mortality in Italy: correlational and risk of colon cancer: a prospective
disease, stroke, diabetes, and cancer in exercise. Oncology 1986;43:116-26. study of 50,535 young Norwegian men
Seventh-day Adventists. Am J Clin Nutr 58. Rose DP, Boyar AP, Wynder EL. and women. Eur J Cancer Prev
1988;48:739-48. International comparisons of mortality 1996;5:445-54.
40. Hirayama T. Epidemiology of prostate rates for cancer of the breast, ovary, 74. Jarvinen R, Knekt P, Hakulinen T, et al.
cancer with special reference to the role prostate, and colon, and per capita food Prospective study on milk products,
of diet. Natl Cancer Inst Monogr consumption. Cancer 1986;58:2363-71. calcium and cancers of the colon and
1979:149-55. 59. Schrauzer GN. Cancer mortality correlation rectum. Eur J Clin Nutr 2001;55:1000-7.
41. Jain MG, Hislop GT, Howe GR, et al. Plant studies. II. Regional associations of 75. Wu K, Willett WC, Fuchs CS, et al. Calcium
foods, antioxidants, and prostate cancer mortalities with the consumptions of intake and risk of colon cancer in women
risk: findings from case-control studies in foods and other commodities. Med and men. J Natl Cancer Inst 2002;94:437-
Canada. Nutr Cancer 1999;34:173-84. Hypotheses 1976;2:39-49. 46.
42. Bosetti C, Micelotta S, Dal Maso L, et al. 60. Armstrong B, Doll R. Environmental factors 76. McCullough ML, Robertson AS, Rodriguez
Food groups and risk of prostate cancer and cancer incidence and mortality in C, et al. Calcium, vitamin D, dairy
in Italy. Int J Cancer 2004;110:424-8. different countries, with special products, and risk of colorectal cancer in
43. De Stefani E, Fierro L, Barrios E, et al. reference to dietary practices. Int J the Cancer Prevention Study II Nutrition
Tobacco, alcohol, diet and risk of Cancer 1975;15:617-31. Cohort (United States). Cancer Causes
442
R E F E R E N C E S
443
F O O D , N U T R I T I O N , P H Y S I C A L A C T I V I T Y, A N D T H E P R E V E N T I O N O F C A N C E R : A G L O B A L P E R S P E C T I V E
444
R E F E R E N C E S
25. Pillow PC, Hursting SD, Duphorne CM, et 1996;126:2757-64. Intake of conjugated linoleic acid, fat,
al. Case-control assessment of diet and 41. Gaard M, Tretli S, Lken EB. Dietary fat and and other fatty acids in relation to
lung cancer risk in African Americans the risk of breast cancer: a prospective postmenopausal breast cancer: the
and Mexican Americans. Nutr Cancer study of 25,892 Norwegian women. Int J Netherlands Cohort Study on Diet and
1997;29:169-73. Cancer 1995;63:13-7. Cancer. Am J Clin Nutr 2002;76:873-82.
26. Scali J, Astre C, Segala C, et al. Relationship 42. Giovannucci E, Stampfer MJ, Colditz GA, et 57. Willett WC, Stampfer MJ, Colditz GA, et al.
of serum cholesterol, dietary and plasma al. A comparison of prospective and Dietary fat and the risk of breast cancer.
beta-carotene with lung cancer in male retrospective assessments of diet in the N Engl J Med 1987;316:22-8.
smokers. Eur J Cancer Prev 1995;4:169- study of breast cancer. Am J Epidemiol 58. Willett WC, Hunter DJ, Stampfer MJ, et al.
74. 1993;137:502-11. Dietary fat and fiber in relation to risk of
27. Schabath MB, Hernandez LM, Wu X, et al. 43. Graham S, Zielezny M, Marshall J, et al. breast cancer. An 8-year follow-up.
Dietary phytoestrogens and lung cancer Diet in the epidemiology of JAMA 1992;268:2037-44.
risk. JAMA 2005;294:1493-504. postmenopausal breast cancer in the 59. Wirfalt E, Mattisson I, Gullberg B, et al.
28. Shen H, Wei Q, Pillow PC, et al. Dietary New York State Cohort. Am J Epidemiol Postmenopausal breast cancer is
folate intake and lung cancer risk in 1992;136:1327-37. associated with high intakes of omega6
former smokers: a case-control analysis. 44. Horn-Ross PL, Hoggatt KJ, West DW, et al. fatty acids (Sweden). Cancer Causes
Cancer Epidemiol Biomarkers Prev Recent diet and breast cancer risk: the Control 2002;13:883-93.
2003;12:980-6. California Teachers Study (USA). Cancer 60. Wolk A, Bergstrom R, Hunter D, et al. A
29. Tan AJ, He SP, Huang MX. [A matched case- Causes Control 2002;13:407-15. prospective study of association of
control study on the relations between 45. Howe GR, Friedenreich CM, Jain M, et al. A monounsaturated fat and other types of
beta-carotene and lung cancer]. cohort study of fat intake and risk of fat with risk of breast cancer. Arch Intern
Zhonghua Liu Xing Bing Xue Za Zhi breast cancer. J Natl Cancer Inst Med 1998;158:41-5.
1995;16:199-202. 1991;83:336-40. 61. Ames HG, Gee MI, Hawrysh ZJ. Taste
30. Zhou B, Wang T, Sun G, et al. A case- 46. Jones DY, Schatzkin A, Green SB, et al. perception and breast cancer: evidence
control study of the relationship Dietary fat and breast cancer in the of a role for diet. J Am Diet Assoc
between dietary factors and risk of lung National Health and Nutrition 1993;93:541-6.
cancer in women of Shenyang, China. Examination Survey I Epidemiologic 62. Aro A, Mannisto S, Salminen I, et al. Inverse
Oncol Rep 1999;6:139-43. Follow-up Study. J Natl Cancer Inst association between dietary and serum
31. Mohr DL, Blot WJ, Tousey PM, et al. 1987;79:465-71. conjugated linoleic acid and risk of
Southern cooking and lung cancer. Nutr 47. Kinlen LJ. Meat and fat consumption and breast cancer in postmenopausal
Cancer 1999;35:34-43. cancer mortality: a study of strict women. Nutr Cancer 2000;38:151-7.
32. Swanson CA, Brown CC, Sinha R, et al. religious orders in Britain. Lancet 63. Bonilla-Fernandez P, Lopez-Cervantes M,
Dietary fats and lung cancer risk among 1982;1:946-9. Torres-Sanchez LE, et al. Nutritional
women: the Missouri Womens Health 48. Knekt P, Aromaa A, Maatela J, et al. Serum factors and breast cancer in Mexico. Nutr
Study (United States). Cancer Causes vitamin A and subsequent risk of cancer: Cancer 2003;45:148-55.
Control 1997;8:883-93. cancer incidence follow-up of the Finnish 64. Braga C, La Vecchia C, Negri E, et al. Intake
33. Le Marchand L, Hankin JH, Bach F, et al. An Mobile Clinic Health Examination Survey. of selected foods and nutrients and
ecological study of diet and lung cancer Am J Epidemiol 1990;132:857-70. breast cancer risk: an age- and
in the South Pacific. Int J Cancer 49. Kushi LH, Potter JD, Bostick RM, et al. menopause-specific analysis. Nutr Cancer
1995;63:18-23. Dietary fat and risk of breast cancer 1997;28:258-63.
34. Mulder I, Jansen MC, Smit HA, et al. Role of according to hormone receptor status. 65. Challier B, Perarnau JM, Viel JF. Garlic,
smoking and diet in the cross-cultural Cancer Epidemiol Biomarkers Prev onion and cereal fibre as protective
variation in lung-cancer mortality: the 1995;4:11-9. factors for breast cancer: a French case-
Seven Countries Study. Seven Countries 50. Kushi LH, Sellers TA, Potter JD, et al. control study. Eur J Epidemiol
Study Research Group. Int J Cancer Dietary fat and postmenopausal breast 1998;14:737-47.
2000;88:665-71. cancer. J Natl Cancer Inst 1992;84:1092-9. 66. Cooper JA, Rohan TE, Cant EL, et al. Risk
35. Schrauzer GN. Cancer mortality correlation 51. Mattisson I, Wirfalt E, Wallstrom P, et al. factors for breast cancer by oestrogen
studies. II. Regional associations of High fat and alcohol intakes are risk receptor status: a population-based case-
mortalities with the consumptions of factors of postmenopausal breast cancer: control study. Br J Cancer 1989;59:119-
foods and other commodities. Med a prospective study from the Malmo diet 25.
Hypotheses 1976;2:39-49. and cancer cohort. Int J Cancer 67. Dai Q, Shu XO, Jin F, et al. Consumption of
36. Tomioka F, Wakasugi H. Study on food 2004;110:589-97. animal foods, cooking methods, and risk
intake patterns in Korea. Jpn J Health 52. Sieri S, Krogh V, Muti P, et al. Fat and of breast cancer. Cancer Epidemiol
Hum Ecol 1995;61:317-28. protein intake and subsequent breast Biomarkers Prev 2002;11:801-8.
37. Smith-Warner SA, Ritz J, Hunter DJ, et al. cancer risk in postmenopausal women. 68. DAvanzo B, Negri E, Gramenzi A, et al.
Dietary fat and risk of lung cancer in a Nutr Cancer 2002;42:10-7. Fats in seasoning and breast cancer risk:
pooled analysis of prospective studies. 53. Thiebaut AC, Clavel-Chapelon F. [Fat an Italian case-control study. Eur J Cancer
Cancer Epidemiol Biomarkers Prev consumption and breast cancer: 1991;27:420-3.
2002;11:987-92. preliminary results from the E3N-Epic 69. De Stefani E, Deneo-Pellegrini H,
38. Barrett-Connor E, Friedlander NJ. Dietary cohort]. Bull Cancer (Paris) 2001;88:954- Mendilaharsu M, et al. Essential fatty
fat, calories, and the risk of breast cancer 8. acids and breast cancer: a case-control
in postmenopausal women: a 54. Toniolo P, Riboli E, Shore RE, et al. study in Uruguay. Int J Cancer
prospective population-based study. J Consumption of meat, animal products, 1998;76:491-4.
Am Coll Nutr 1993;12:390-9. protein, and fat and risk of breast 70. De Stefani E, Ronco A, Mendilaharsu M, et
39. Bingham SA, Luben R, Welch A, et al. Are cancer: a prospective cohort study in al. Meat intake, heterocyclic amines, and
imprecise methods obscuring a relation New York. Epidemiology 1994;5:391-7. risk of breast cancer: a case-control study
between fat and breast cancer? Lancet 55. Van den Brandt PA, Vant Veer P, in Uruguay. Cancer Epidemiol
2003;362:212-4. Goldbohm RA, et al. A prospective Biomarkers Prev 1997;6:573-81.
40. Byrne C, Ursin G, Ziegler RG. A comparison cohort study on dietary fat and the risk 71. Do MH, Lee SS, Jung PJ, et al. Intake of
of food habit and food frequency data of postmenopausal breast cancer. Cancer dietary fat and vitamin in relation to
as predictors of breast cancer in the Res 1993;53:75-82. breast cancer risk in Korean women: a
NHANES I/NHEFS cohort. J Nutr 56. Voorrips LE, Brants HA, Kardinaal AF, et al. case-control study. J Korean Med Sci
445
F O O D , N U T R I T I O N , P H Y S I C A L A C T I V I T Y, A N D T H E P R E V E N T I O N O F C A N C E R : A G L O B A L P E R S P E C T I V E
2003;18:534-40. of diet in the development of breast 102. Richardson SGMCS. The role of fat, animal
72. Dos Santos Silva I, Mangtani P, McCormack cancer: a case-control study of patients protein and some vitamin consumption
V, et al. Lifelong vegetarianism and risk with breast cancer, benign epithelial in breast cancer: a case control study in
of breast cancer: a population-based hyperplasia and fibrocystic disease of the southern France. Int J Cancer 1991;48:1-
case-control study among South Asian breast. Br J Cancer 1991;64:187-91. 9. 44 ref.
migrant women living in England. Int J 88. Iscovich JM, Iscovich RB, Howe G, et al. A 103. Ronco A, De Stefanii E, Mendilaharsu M,
Cancer 2002;99:238-44. case-control study of diet and breast et al. Meat, fat and risk of breast cancer:
73. Ewertz M. Breast cancer in Denmark. cancer in Argentina. Int J Cancer a case-control study from Uruguay. Int J
Incidence, risk factors, and characteristics 1989;44:770-6. Cancer 1996;65:328-31.
of survival. Acta Oncol 1993;32:595-615. 89. Jakovljevic J, Touillaud MS, Bondy ML, et al. 104. Santiago E, Gonzlez MJ, Matos MI, et al.
74. Franceschi S, Favero A, Decarli A, et al. Dietary intake of selected fatty acids, Association between dietary fat and
Intake of macronutrients and risk of cholesterol and carotenoids and breast cancer in Puerto Rican
breast cancer. Lancet 1996;347:1351-6. estrogen receptor status in postmenopausal women attending a
75. Gerber M, Richardson S, Crastes de Paulet premenopausal breast cancer patients. breast cancer clinic. P R Health Sci J
P, et al. Relationship between vitamin E Breast Cancer Res Treat 2002;75:5-14. 1998;17:235.
and polyunsaturated fatty acids in breast 90. Katsouyanni K, Willett W, Trichopoulos D, 105. Sarin R, Tandon RK, Paul S, et al. Diet,
cancer: nutritional and metabolic et al. Risk of breast cancer among Greek body fat and plasma lipids in breast
aspects. Cancer 1989;64:2347-52. women in relation to nutrient intake. cancer. Indian J Med Res 1985;81:493-8.
76. Ghadirian P, Lacroix A, Perret C, et al. Cancer 1988;61:181-5. 106. Xiao OS, Jin F, Dai Q, et al. Soyfood intake
Breast cancer risk and nutrient intake 91. Katsouyanni K, Trichopoulou A, Stuver S, et during adolescence and subsequent risk
among French Canadians in Montreal: A al. The association of fat and other of breast cancer among Chinese women.
case-control study. Breast 1998;7:108-13. macronutrients with breast cancer: a Cancer Epidemiol Biomarkers Prev
77. Goodman MT, Nomura AM, Wilkens LR, et case-control study from Greece. Br J 2001;10:483-8.
al. The association of diet, obesity, and Cancer 1994;70:537-41. 107. Shu XO, Jin F, Dai Q, et al. Association of
breast cancer in Hawaii. Cancer 92. Kumar NB, Riccardi D, Cantor A, et al. A body size and fat distribution with risk of
Epidemiol Biomarkers Prev 1992;1:269- case-control study evaluating the breast cancer among chinese women. Int
75. association of purposeful physical J Cancer 2001;94:449-55.
78. Goodstine SL, Zheng TZ, Holford TR, et al. activity, body fat distribution, and 108. Toniolo P, Riboli E, Protta F, et al. Calorie-
Dietary (n-3)/(n-6) fatty acid ratio: steroid hormones on premenopausal providing nutrients and risk of breast
possible relationship to premenopausal breast cancer risk. Breast J 2005;11:266- cancer. J Natl Cancer Inst 1989;81:278-86.
but not postmenopausal breast cancer 72. 109. vant Veer P, Kok FJ, Hermus RJ, et al.
risk in U.S. women. J Nutr 2003;133:1409- 93. Landa MC, Frago N, Tres A. Diet and the Alcohol dose, frequency and age at first
14. risk of breast cancer in Spain. Eur J exposure in relation to the risk of breast
79. Graham S, Hellmann R, Marshall J, et al. Cancer Prev 1994;3:313-20. cancer. Int J Epidemiol 1989;18:511-7.
Nutritional epidemiology of 94. Lee MM, Chang IY, Horng CF, et al. Breast 110. Van t Veer P, van Leer EM, Rietdijk A, et
postmenopausal breast cancer in cancer and dietary factors in Taiwanese al. Combination of dietary factors in
western New York. Am J Epidemiol women. Cancer Causes Control relation to breast-cancer occurrence. Int
1991;134:552-66. 2005;16:929-37. J Cancer 1991;47:649-53.
80. Hankin JH, Zhao LP, Wilkens LR, et al. 95. Lee HP, Gourley L, Duffy SW, et al. Dietary 111. Vant Veer P, Kok FJ, Brants HA, et al.
Attributable risk of breast, prostate, and effects on breast-cancer risk in Dietary fat and the risk of breast cancer.
lung cancer in Hawaii due to saturated Singapore. Lancet 1991;337:1197-200. Int J Epidemiol 1990;19:12-8.
fat. Cancer Causes Control 1992;3:17-23. 96. London SJ, Sacks FM, Stampfer MJ, et al. 112. Wakai K, Dillon DS, Ohno Y, et al. Fat
81. Henquin N, Trostler N, Horn Y. Nutritional Fatty acid composition of the intake and breast cancer risk in an area
risk factors and breast cancer in Jewish subcutaneous adipose tissue and risk of where fat intake is low: a case-control
and Arab women. Cancer Nurs proliferative benign breast disease and study in Indonesia. Int J Epidemiol
1994;17:326-33. breast cancer. J Natl Cancer Inst 2000;29:20-8.
82. Hermann S, Linseisen J, Chang-Claude J. 1993;85:785-93. 113. Witte JS, Ursin G, Siemiatycki J, et al. Diet
Nutrition and breast cancer risk by age 97. McCann SE, Ip C, Ip MM, et al. Dietary and premenopausal bilateral breast
50: A population-based case-control intake of conjugated linoleic acids and cancer: a case-control study. Breast
study in Germany. Nutr Cancer risk of premenopausal and Cancer Res Treat 1997;42:243-51.
2002;44:23-34. postmenopausal breast cancer, Western 114. Yu SZ, Lu RF, Xu DD, et al. A case-control
83. Hietanen E, Bartsch H, Bereziat JC, et al. New York exposures and cancer study study of dietary and nondietary risk
Diet and oxidative stress in breast, colon (WEB study). Cancer Epidemiol factors for breast cancer in Shanghai.
and prostate cancer patients: a case- Biomarkers Prev 2004;13:1480-4. Cancer Res 1990;50:5017-21.
control study. Eur J Clin Nutr 98. Miller AB, Kelly A, Choi NW, et al. A study 115. Yuan JM, Wang QS, Ross RK, et al. Diet
1994;48:575-86. of diet and breast cancer. Am J Epidemiol and breast cancer in Shanghai and
84. Hirohata T, Nomura AM, Hankin JH, et al. 1978;107:499-509. Tianjin, China. Br J Cancer 1995;71:1353-
An epidemiologic study on the 99. Potischman N, Swanson CA, Coates RJ, et 8.
association between diet and breast al. Dietary relationships with early onset 116. Zaridze D, Lifanova Y, Maximovitch D, et
cancer. J Natl Cancer Inst 1987;78:595- (under age 45) breast cancer in a case- al. Diet, alcohol consumption and
600. control study in the United States: reproductive factors in a case-control
85. Hirohata T, Shigematsu T, Nomura AM, et Influence of chemotherapy treatment. study of breast cancer in Moscow. Int J
al. Occurrence of breast cancer in Cancer Causes Control 1997;8:713-21. Cancer 1991;48:493-501.
relation to diet and reproductive history: 100. Potischman N, Coates RJ, Swanson CA, et 117. Zheng T, Holford TR, Mayne ST, et al.
a case-control study in Fukuoka, Japan. al. Increased risk of early-stage breast Lactation and breast cancer risk: a case-
Natl Cancer Inst Monogr 1985;69:187-90. cancer related to consumption of sweet control study in Connecticut. Br J Cancer
86. Holmberg L, Ohlander EM, Byers T, et al. foods among women less than age 45 in 2001;84:1472-6.
Diet and breast cancer risk. Results from the United States. Cancer Causes Control 118. Zheng T, Holford TR, Tessari J, et al. Breast
a population-based, case-control study in 2002;13:937-46. cancer risk associated with congeners of
Sweden. Arch Intern Med 1994;154:1805- 101. Pryor M, Slattery ML, Robinson LM, et al. polychlorinated biphenyls. Am J
11. Adolescent diet and breast cancer in Epidemiol 2000;152:50-8.
87. Ingram DM, Nottage E, Roberts T. The role Utah. Cancer Res 1989;49:2161-7. 119. Armstrong B, Doll R. Environmental
446
R E F E R E N C E S
factors and cancer incidence and 135. Romieu I, Lazcano-Ponce E, Sanchez- 151. Giovannucci E, Rimm EB, Stampfer MJ, et
mortality in different countries, with Zamorano LM, et al. Carbohydrates and al. Intake of fat, meat, and fiber in
special reference to dietary practices. Int the risk of breast cancer among Mexican relation to risk of colon cancer in men.
J Cancer 1975;15:617-31. women. Cancer Epidemiol Biomarkers Cancer Res 1994;54:2390-7.
120. Boing H, Martinez L, Frentzel Beyme R, et Prev 2004;13:1283-9. 152. Bostick RM, Potter JD, Kushi LH, et al.
al. Regional nutritional pattern and 136. Zhu Z, Parviainen M, Mannisto S, et al. Sugar, meat, and fat intake, and non-
cancer mortality in the Federal Republic Vitamin E concentration in breast dietary risk factors for colon cancer
of Germany. Nutr Cancer 1985;7:121-30. adipose tissue of breast cancer patients incidence in Iowa women (United
121. Grant WB. An ecologic study of dietary (Kuopio, Finland). Cancer Causes Control States). Cancer Causes Control 1994;5:38-
and solar ultraviolet-B links to breast 1996;7:591-5. 52.
carcinoma mortality rates. Cancer 137. Key T, Appleby P, Barnes I, et al. 153. Sanjoaquin MA, Appleby PN, Thorogood
2002;94:272-81. Endogenous sex hormones and breast M, et al. Nutrition, lifestyle and
122. Gray GE, Pike MC, Henderson BE. Breast- cancer in postmenopausal women: colorectal cancer incidence: a
cancer incidence and mortality rates in reanalysis of nine prospective studies. J prospective investigation of 10998
different countries in relation to known Natl Cancer Inst 2002;94:606-16. vegetarians and non-vegetarians in the
risk factors and dietary practices. Br J 138. Kaaks R, Berrino F, Key T, et al. Serum sex United Kingdom. Br J Cancer
Cancer 1979;39:1-7. steroids in premenopausal women and 2004;90:118-21.
123. Hems G. The contributions of diet and breast cancer risk within the European 154. Goldbohm RA, van den Brandt PA, van t
childbearing to breast-cancer rates. Br J Prospective Investigation into Cancer Veer P, et al. A prospective cohort study
Cancer 1978;37:974-82. and Nutrition (EPIC). J Natl Cancer Inst on the relation between meat
124. Hursting SD, Thornquist M, Henderson 2005;97:755-65. consumption and the risk of colon
MM. Types of dietary fat and the 139. Wu AH, Pike MC, Stram DO. Meta- cancer. Cancer Res 1994;54:718-23.
incidence of cancer at five sites. Prev analysis: dietary fat intake, serum 155. Lin J, Zhang SM, Cook NR, et al. Dietary
Med 1990;19:242-53. estrogen levels, and the risk of breast fat and fatty acids and risk of colorectal
125. Ishimoto H, Nakamura H, Miyoshi T. cancer. J Natl Cancer Inst 1999;91:529-34. cancer in women. Am J Epidemiol
Epidemiological study on relationship 140. Bruning PF, Bonfrer JM. Free fatty acid 2004;160:1011-22.
between breast cancer mortality and concentrations correlated with the
dietary factors. Tokushima J Exp Med available fraction of estradiol in human
1994;41:103-14. plasma. Cancer Res 1986;46:2606-9. Chapter 4.6
126. Kolonel LN, Hankin JH, Lee J, et al. 141. Ozasa K, Watanabe Y, Ito Y, et al. Dietary
Nutrient intakes in relation to cancer habits and risk of lung cancer death in a 1. World Health Organization. 2003. Diet,
incidence in Hawaii. Br J Cancer large-scale cohort study (JACC Study) in Nutrition and the Prevention of Chronic
1981;44:332-9. Japan by sex and smoking habit. Jpn J Diseases: Report of a Joint WHO/FAO
127. Liaw YP, Chen HL, Cheng CW, et al. An Cancer Res 2001;92:1259-69. Expert Consultation. In: WHO Technical
international epidemiologic study of 142. Axelsson G, Liljeqvist T, Andersson L, et al. Report Series no 916.
breast cancer mortality and total fat Dietary factors and lung cancer among http://www.who.int/entity/dietphysicalac
intake in postmenopausal women. Nutr men in west Sweden. Int J Epidemiol tivity/publications/trs916/download/en/i
Res 2005;25:823-34. 1996;25:32-9. ndex.html.
128. Rose DP, Boyar AP, Wynder EL. 143. Bond GG, Thompson FE, Cook RR. Dietary 2. Ye W, Yi Y, Luo R. [A case-control study on
International comparisons of mortality vitamin A and lung cancer: results of a diet and gastric cancer]. Chung Hua Yu
rates for cancer of the breast, ovary, case-control study among chemical Fang I Hsueh Tsa Chih 1998;32:100-2.
prostate, and colon, and per capita food workers. Nutr Cancer 1987;9:109-21. 3. Xibin S, Moller H, Evans HS, et al. Residential
consumption. Cancer 1986;58:2363-71. 144. Brennan P, Fortes C, Butler J, et al. A environment, diet and risk of stomach
129. Hunter DJ, Spiegelman D, Adami HO, et multicenter case-control study of diet cancer: a case-control study in Linzhou,
al. Non-dietary factors as risk factors for and lung cancer among non-smokers. China. Asian Pac J Cancer Prev
breast cancer, and as effect modifiers of Cancer Causes Control 2000;11:49-58. 2002;3:167-72.
the association of fat intake and risk of 145. Darby S, Whitley E, Doll R, et al. Diet, 4. Munoz N, Plummer M, Vivas J, et al. A case-
breast cancer. Cancer Causes Control smoking and lung cancer: a case-control control study of gastric cancer in
1997;8:49-56. study of 1000 cases and 1500 controls in Venezuela. Int J Cancer 2001;93:417-23.
130. Smith-Warner SA, Spiegelman D, Adami South-West England. Br J Cancer 5. Mathew A, Gangadharan P, Varghese C, et
HO, et al. Types of dietary fat and breast 2001;84:728-35. al. Diet and stomach cancer: a case-
cancer: a pooled analysis of cohort 146. De Stefani E, Fontham ET, Chen V, et al. control study in South India. Eur J Cancer
studies. Int J Cancer 2001;92:767-74. Fatty foods and the risk of lung cancer: a Prev 2000;9:89-97.
131. Holmes MD, Hunter DJ, Colditz GA, et al. case-control study from Uruguay. Int J 6. Liu X, Wang Q, Ma J. [A case-control study
Association of dietary intake of fat and Cancer 1997;71:760-6. on the risk factors of stomach cancer in
fatty acids with risk of breast cancer. 147. Goodman MT, Hankin JH, Wilkens LR, et Tianjin City]. Chung Hua Liu Hsing Ping
JAMA 1999;281:914-20. al. High-fat foods and the risk of lung Hsueh Tsa Chih 2001;22:362-4.
132. Velie E, Kulldorff M, Schairer C, et al. cancer. Epidemiology 1992;3:288-99. 7. Fei S, Xiao S. [Diet and gastric cancer: a case-
Dietary fat, fat subtypes, and breast 148. Pierce RJ, Kune GA, Kune S, et al. Dietary control study in Shanghai urban
cancer in postmenopausal women: a and alcohol intake, smoking pattern, districts]. Chin J Gastroenterol
prospective cohort study. J Natl Cancer occupational risk, and family history in 2003;8:143-7.
Inst 2000;92:833-9. lung cancer patients: results of a case- 8. Demirer T, Icli F, Uzunalimoglu O, et al. Diet
133. Wakai K, Tamakoshi K, Date C, et al. control study in males. Nutr Cancer and stomach cancer incidence. A case-
Dietary intakes of fat and fatty acids and 1989;12:237-48. control study in Turkey. Cancer
risk of breast cancer: a prospective study 149. Rachtan J. A case-control study of lung 1990;65:2344-8.
in Japan. Cancer Sci 2005;96:590-9. cancer in Polish women. Neoplasma 9. Buiatti E, Palli D, Decarli A, et al. A case-
134. Wirfalt E, Vessby B, Mattisson I, et al. No 2002;49:75-80. control study of gastric cancer and diet
relations between breast cancer risk and 150. Willett WC, Stampfer MJ, Colditz GA, et in Italy. Int J Cancer 1989;44:611-6.
fatty acids of erythrocyte membranes in al. Relation of meat, fat, and fiber intake 10. van den Brandt PA, Botterweck AA,
postmenopausal women of the Malmo to the risk of colon cancer in a Goldbohm RA. Salt intake, cured meat
Diet Cancer cohort (Sweden). Eur J Clin prospective study among women. N Engl consumption, refrigerator use and
Nutr 2004;58:761-70. J Med 1990;323:1664-72. stomach cancer incidence: a prospective
447
F O O D , N U T R I T I O N , P H Y S I C A L A C T I V I T Y, A N D T H E P R E V E N T I O N O F C A N C E R : A G L O B A L P E R S P E C T I V E
cohort study (Netherlands). Cancer women. Cancer Epidemiol Biomarkers 45. Erkisi M, Colakoglu S, Koksal F, et al.
Causes Control 2003;14:427-38. Prev 2005;14:138-47. Relationship of Helicobacter pylori
11. McGee H. McGee on Food and Cooking. 28. Poulsen M, Molck AM, Thorup I, et al. The infection to several malignant and non-
London: Hodder and Stoughton, 2004. influence of simple sugars and starch malignant gastrointestinal diseases. J
12. Willett WC, Howe GR, Kushi LH. given during pre- or post-initiation on Exp Clin Cancer Res 1997;16:289-93.
Adjustment for total energy intake in aberrant crypt foci in rat colon. Cancer 46. Setiawan VW, Zhang ZF, Yu GP, et al. GSTT1
epidemiologic studies. Am J Clin Nutr Lett 2001;167:135-43. and GSTM1 null genotypes and the risk
1997;65:1220S-8S; discussion 9S-31S. 29. Nagata C, Takatsuka N, Kawakami N, et al. of gastric cancer: a case-control study in
13. Phillips RL. Role of life-style and dietary A prospective cohort study of soy a Chinese population. Cancer Epidemiol
habits in risk of cancer among seventh- product intake and stomach cancer Biomarkers Prev 2000;9:73-80.
day adventists. Cancer Res 1975;35:3513- death. Br J Cancer 2002;87:31-6. 47. Tsukino H, Hanaoka T, Otani T, et al.
22. 30. Tsugane S, Sasazuki S, Kobayashi M, et al. hOGG1 Ser326Cys polymorphism,
14. Macquart Moulin G, Riboli E, Cornee J, et Salt and salted food intake and interaction with environmental
al. Case-control study on colorectal subsequent risk of gastric cancer among exposures, and gastric cancer risk in
cancer and diet in Marseilles. Int J Cancer middle-aged Japanese men and women. Japanese populations. Cancer Sci
1986;38:183-91. Br J Cancer 2004;90:128-34. 2004;95:977-83.
15. Benito E, Obrador A, Stiggelbout A, et al. A 31. Csendes A, Medina E, Gaete MC, et al. 48. Setiawan VW, Yu GP, Lu QY, et al. Allium
population-based case-control study of [Gastric cancer: an epidemiologic and vegetables and stomach cancer risk in
colorectal cancer in Majorca. I. Dietary dietary study in 100 patients and 100 China. Asian Pac J Cancer Prev
factors. Int J Cancer 1990;45:69-76. controls]. Rev Med Chil 1976;104:761-5. 2005;6:387-95.
16. Bidoli E, Franceschi S, Talamini R, et al. 32. Haenszel W, Kurihara M, Locke FB, et al. 49. Correa P, Cuello C, Fajardo LF, et al. Diet
Food consumption and cancer of the Stomach cancer in Japan. J Natl Cancer and gastric cancer: nutrition survey in a
colon and rectum in north-eastern Italy. Inst 1976;56:265-74. high-risk area. J Natl Cancer Inst
Int J Cancer 1992;50:223-9. 33. Funakoshi N, Kanoh T, Uchino H, et al. 1983;70:673-8.
17. Franceschi S, Favero A. The role of energy Gastric cancer and diet. The analysis of 50. Koifman S, Koifman RJ. Stomach cancer
and fat in cancers of the breast and the epidemiological survey in Tango incidence in Brazil: an ecologic study
colon-rectum in a southern European district of Kyoto prefecture. Naika Hokan with selected risk factors. Cad Saude
population. Ann Oncol 1999;10 Suppl 1983;30:175-81. Publica 1997;13:85-92.
6:61-3. 34. Correa P, Fontham E, Pickle LW, et al. 51. Wong BC, Ching CK, Lam SK, et al.
18. Tuyns AJ, Kaaks R, Haelterman M. Dietary determinants of gastric cancer in Differential north to south gastric
Colorectal cancer and the consumption south Louisiana inhabitants. J Natl cancer-duodenal ulcer gradient in China.
of foods: a case-control study in Belgium. Cancer Inst 1985;75:645-54. China Ulcer Study Group. J Gastroenterol
Nutr Cancer 1988;11:189-204. 35. Goiriena De Gandarias FJ, Santidrian MI, Hepatol 1998;13:1050-7.
19. Miller AB, Howe GR, Jain M, et al. Food Barranquero AM. Etiopathogenic study 52. Kono S, Ikeda M, Ogata M. Salt and
items and food groups as risk factors in a of cancer of the digestive tract in Biscay geographical mortality of gastric cancer
case-control study of diet and colo-rectal Spain with special emphasis on the role and stroke in Japan. J Epidemiol
cancer. Int J Cancer 1983;32:155-61. played by diet and consumption of Community Health 1983;37:43-6.
20. Slattery ML, Potter JD, Ma KN, et al. alcohol and tobacco. Rev Sanid Hig 53. Hara N, Sakata K, Nagai M, et al.
Western diet, family history of colorectal Publica (Madr) 1987;62:1411-30. [Geographical difference of mortality of
cancer, NAT2, GSTM-1 and risk of colon 36. You WC, Blot WJ, Chang YS, et al. Diet and digestive cancers and food
cancer. Cancer Causes Control 2000;11:1- high risk of stomach cancer in Shandong, consumption]. Gan No Rinsho
8. China. Cancer Res 1988;48:3518-23. 1984;30:1665-74.
21. Chyou PH, Nomura AM, Stemmermann GN. 37. Hu JF, Zhang SF, Jia EM, et al. Diet and 54. Lu JB, Qin YM. Correlation between high
A prospective study of colon and rectal cancer of the stomach: a case-control salt intake and mortality rates for
cancer among Hawaii Japanese men. study in China. Int J Cancer 1988;41:331- oesophageal and gastric cancers in
Ann Epidemiol 1996;6:276-82. 5. Henan Province, China. Int J Epidemiol
22. Terry PD, Jain M, Miller AB, et al. Glycemic 38. Negri E, La Vecchia C, DAvanzo B, et al. 1987;16:171-6.
load, carbohydrate intake, and risk of Salt preference and the risk of 55. Tsugane S, Akabane M, Inami T, et al.
colorectal cancer in women: a gastrointestinal cancers. Nutr Cancer Urinary salt excretion and stomach
prospective cohort study. J Natl Cancer 1990;14:227-32. cancer mortality among four Japanese
Inst 2003;95:914-6. 39. Graham S, Haughey B, Marshall J, et al. populations. Cancer Causes Control
23. Bostick RM, Potter JD, Kushi LH, et al. Diet in the epidemiology of gastric 1991;2:165-8.
Sugar, meat, and fat intake, and non- cancer. Nutr Cancer 1990;13:19-34. 56. Honjo S, Kono S, Yamaguchi M. Salt and
dietary risk factors for colon cancer 40. Cai L. [A case-control study of stomach geographic variation in stomach cancer
incidence in Iowa women (United cancer in Changle, Fujian Province - by mortality in Japan. Cancer Causes
States). Cancer Causes Control 1994;5:38- the risk state analysis]. Chung Hua Liu Control 1994;5:285-6.
52. Hsing Ping Hsueh Tsa Chih 1991;12:15-9. 57. Imaizumi Y. Longitudinal gompertzian
24. Higginbotham S, Zhang ZF, Lee IM, et al. 41. Boeing H, Frentzel-Beyme R, Berger M, et analysis of mortality from stomach
Dietary glycemic load and risk of al. Case-control study on stomach cancer cancer in Japan, 1950-1993. Mech
colorectal cancer in the Womens Health in Germany. Int J Cancer 1991;47:858-64. Ageing Dev 1995;85:133-45.
Study. J Natl Cancer Inst 2004;96:229-33. 42. Ren D, Jin J, Wang D, et al. The nutritional 58. Tominaga S, Kuroishi T. An ecological study
25. Roberts Thomson IC, Ryan P, Khoo KK, et al. factors related to gastric cancer in on diet/nutrition and cancer in Japan. Int
Diet, acetylator phenotype, and risk of Tianjin. Ying Yang Xue Bao 1992;14:325- J Cancer 1997;Suppl:10-6.
colorectal neoplasia. Lancet 8. 59. Zhuo XG, Watanabe S. Factor analysis of
1996;347:1372-4. 43. Nazario CM, Szklo M, Diamond E, et al. Salt digestive cancer mortality and food
26. Terry P, Giovannucci E, Michels KB, et al. and gastric cancer: a case-control study consumption in 65 Chinese counties. J
Fruit, vegetables, dietary fiber and risk of in Puerto Rico. Int J Epidemiol Epidemiol 1999;9:275-84.
colorectal cancer. J Natl Cancer Inst 1993;22:790-7. 60. Cai L, Yu SZ, Ye WM, et al. Fish sauce and
2001;93:525-33. 44. Ramon JM, Serra L, Cerdo C, et al. Dietary gastric cancer: an ecological study in
27. Michaud DS, Fuchs CS, Liu S, et al. Dietary factors and gastric cancer risk. A case- Fujian Province, China. World J
glycemic load, carbohydrate, sugar, and control study in Spain. Cancer Gastroenterol 2000;6:671-5.
colorectal cancer risk in men and 1993;71:1731-5. 61. Nomura A, Grove JS, Stemmermann GN, et
448
R E F E R E N C E S
al. A prospective study of stomach case-control study. Nutr Cancer habits and stomach cancer in Shanghai,
cancer and its relation to diet, cigarettes, 2005;52:138-46. China. Int J Cancer 1998;76:659-64.
and alcohol consumption. Cancer Res 79. Machida-Montani A, Sasazuki S, Inoue M, 96. Ward MH, Lpez-Carrillo L. Dietary factors
1990;50:627-31. et al. Association of Helicobacter pylori and the risk of gastric cancer in Mexico
62. Tuyns AJ. Salt and gastrointestinal cancer. infection and environmental factors in City. Am J Epidemiol 1999;149:925-32.
Nutr Cancer 1988;11:229-32. non-cardia gastric cancer in Japan. 97. Huang XE, Tajima K, Hamajima N, et al.
63. Coggon D, Barker DJ, Cole RB, et al. Gastric Cancer 2004;7:46-53. Effect of life styles on the risk of subsite-
Stomach cancer and food storage. J Natl 80. Fontham ET, Ruiz B, Perez A, et al. specific gastric cancer in those with and
Cancer Inst 1989;81:1178-82. Determinants of Helicobacter pylori without family history. J Epidemiol
64. Boeing H, Jedrychowski W, Wahrendorf J, infection and chronic gastritis. Am J 1999;9:40-5.
et al. Dietary risk factors in intestinal and Gastroenterol 1995;90:1094-101. 98. Sriamporn S, Setiawan V, Pisani P, et al.
diffuse types of stomach cancer: a 81. Bergin IL, Sheppard BJ, Fox JG. Gastric cancer: the roles of diet, alcohol
multicenter case-control study in Poland. Helicobacter pylori infection and high drinking, smoking and Helicobacter
Cancer Causes Control 1991;2:227-33. dietary salt independently induce pylori in northeastern Thailand. Asian
65. Gonzalez CA, Sanz JM, Marcos G, et al. atrophic gastritis and intestinal Pac J Cancer Prev 2002;3:345-52.
Dietary factors and stomach cancer in metaplasia in commercially available 99. Kim HJ, Chang WK, Kim MK, et al. Dietary
Spain: a multi-centre case-control study. outbred Mongolian gerbils. Dig Dis Sci factors and gastric cancer in Korea: a
Int J Cancer 1991;49:513-9. 2003;48:475-85. case-control study. Int J Cancer
66. Falcao JM, Dias JA, Miranda AC, et al. Red 82. Takahashi M. [Enhancing effect of a high 2002;97:531-5.
wine consumption and gastric cancer in salt diet on gastrointestinal 100. Nasu K, Oguni I, Kanaya S, et al.
Portugal: a case-control study. Eur J carcinogenesis]. Gan No Rinsho Differences in food intake and
Cancer Prev 1994;3:269-76. 1986;32:667-73. nutritional status between the areas
67. Lpez-Carrillo L, Lopez-Cervantes M, 83. Shikata K, Kiyohara Y, Kubo M, et al. A with low and high standardized
Ramirez-Espitia A, et al. Alcohol prospective study of dietary salt intake mortality ratio for stomach cancer in
consumption and gastric cancer in and gastric cancer incidence in a defined Shizouka Prefecture. Jap J Nutr
Mexico. Cad Saude Publica 1998;14:25- Japanese population: the Hisayama 1992;50:133-44.
32. study. Int J Cancer 2006;119:196-201.
68. Lpez-Carrillo L, Lopez-Cervantes M, Ward 84. Strumylaite L, Zickute J, Dudzevicius J, et
MH, et al. Nutrient intake and gastric al. Salt-preserved foods and risk of Chapter 4.7
cancer in Mexico. Int J Cancer gastric cancer. Medicina (Kaunas)
1999;83:601-5. 2006;42:164-70. 1. World Health Organization. Guidelines for
69. Nishimoto IN, Hamada GS, Kowalski LP, et 85. Phukan RK, Narain K, Zomawia E, et al. Drinking-water Quality. 3rd ed. Geneva:
al. Risk factors for stomach cancer in Dietary habits and stomach cancer in WHO, 2006.
Brazil (I): a case-control study among Mizoram, India. J Gastroenterol 2. World Health Organization, United Nations
non-Japanese Brazilians in Sao Paulo. 2006;41:418-24. Childrens Fund (UNICEF). 2005. Water
Jpn J Clin Oncol 2002;32:277-83. 86. Galanis DJ, Kolonel LN, Lee J, et al. Intakes for Life: Making it Happen.
70. Hamada GS, Kowalski LP, Nishimoto IN, et of selected foods and beverages and the http://www.who.int/entity/water_sanitat
al. Risk factors for stomach cancer in incidence of gastric cancer among the ion_health/waterforlife.pdf.
Brazil (II): a case-control study among Japanese residents of Hawaii: a 3. International Agency for Research on
Japanese Brazilians in Sao Paulo. Jpn J prospective study. Int J Epidemiol Cancer. 1991. Coffee, Tea, Mate,
Clin Oncol 2002;32:284-90. 1998;27:173-80. Methylxanthines and Methylglyoxal. In:
71. Sipetic S, Tomic-Kundakovic S, Vlajinac H, 87. Kato I, Tominaga S, Matsumoto K. A IARC Monogr Eval Carcinog Risks Hum
et al. [Diet and gastric cancer]. prospective study of stomach cancer no 51.
Vojnosanit Pregl 2003;60:697-705. among a rural Japanese population: a 6- 4. World Health Organization. Arsenic in
72. Chyou PH, Nomura AM, Hankin JH, et al. A year survey. Jpn J Cancer Res drinking water. Fact sheet no 210.
case-cohort study of diet and stomach 1992;83:568-75. http://www.who.int/mediacentre/factshe
cancer. Cancer Res 1990;50:7501-4. 88. Khan MM, Goto R, Kobayashi K, et al. ets/fs210/en/index.html. 2006.
73. Ward MH, Sinha R, Heineman EF, et al. Risk Dietary habits and cancer mortality 5. International Agency for Research on
of adenocarcinoma of the stomach and among middle aged and older Japanese Cancer. 2004. Some Drinking-water
esophagus with meat cooking method living in Hokkaido, Japan by cancer site Disinfectants and Contaminants,
and doneness preference. Int J Cancer and sex. 2004;5:58-65. including Arsenic. In: IARC Monogr Eval
1997;71:14-9. 89. Ngoan LT, Mizoue T, Fujino Y, et al. Dietary Carcinog Risks Hum no 84.
74. Palli D, Russo A, Decarli A. Dietary factors and stomach cancer mortality. Br http://monographs.iarc.fr/ENG/Monogra
patterns, nutrient intake and gastric J Cancer 2002;87:37-42. phs/vol84/volume84.pdf.
cancer in a high-risk area of Italy. Cancer 90. Gajalakshmi CK, Shanta V. Lifestyle and risk 6. International Agency for Research on
Causes Control 2001;12:163-72. of stomach cancer: a hospital-based case- Cancer. 1994. Schistosomes, Liver Flukes
75. Suh S, Koo B, Choi Y, et al. [The nutritional control study. Int J Epidemiol and Helicobacter Pylori. In: IARC Monogr
intakes of the stomach cancer patients in 1996;25:1146-53. Eval Carcinog Risks Hum no 61.
the Daegu and Gyeongbuk areas, 91. Dalgat DM, Aliev RG, Gireev GI, et al. http://monographs.iarc.fr/ENG/Monogra
Korea]. Korean J Comm Nutr 2003;8:202- [Epidemiology of stomach cancer in phs/vol61/volume61.pdf.
19. Dagestan]. Vopr Onkol 1974;20:76-82. 7. Kris-Etherton PM, Hecker KD, Bonanome A,
76. Lissowska J, Gail MH, Pee D, et al. Diet and 92. Modan B, Lubin F, Barell V, et al. The role et al. Bioactive compounds in foods:
stomach cancer risk in Warsaw, Poland. of starches in etiology of gastric cancer. their role in the prevention of
Nutr Cancer 2004;48:149-59. Cancer 1974;34:2087-92. cardiovascular disease and cancer. Am J
77. Qiu JL, Chen K, Wang XB, et al. [A case- 93. Ye EC. [Case-control study of 100 gastric Med 2002;113 Suppl 9B:71S-88S.
control study on the relationship cancer cases]. Chung Hua Yu Fang I 8. McGee H. McGee on Food and Cooking.
between nutrition and gastric cancer in Hsueh Tsa Chih 1981;15:107-9. London: Hodder and Stoughton, 2004.
islanders]. Chung Hua Liu Hsing Ping 94. Hirayama T. Life-style and cancer: from 9. World Health Organization. Guidelines for
Hsueh Tsa Chih 2004;25 487-91. epidemiological evidence to public Drinking-water Quality. 3rd ed. Geneva:
78. Kim HJ, Kim MK, Chang WK, et al. Effect of behavior change to mortality reduction WHO, 2006.
nutrient intake and Helicobacter pylori of target cancers. 1992:65-74. 10. International Agency for Research on
infection on gastric cancer in Korea: a 95. Ji BT, Chow WH, Yang G, et al. Dietary Cancer. 2004. Arsenic in Drinking Water.
449
F O O D , N U T R I T I O N , P H Y S I C A L A C T I V I T Y, A N D T H E P R E V E N T I O N O F C A N C E R : A G L O B A L P E R S P E C T I V E
In: IARC Monogr Eval Carcinog Risks Hum 26. Guo HR. Arsenic Level in Drinking Water 32.
no 84. and Mortality of Lung Cancer (Taiwan). 41. Tseng WP. Effects and dose - response
11. Zenith International. 2005. Zenith Report Cancer Causes Control 2004;15:171-7. relationships of skin cancer and
on Global Soft Drinks. 27. Hopenhayn-Rich C, Biggs ML, Smith AH. blackfoot disease with arsenic. Environ
12. Chen CJ, Wu MM, Lee SS, et al. Lung and kidney cancer mortality Health Perspect 1977;19:109-19.
Atherogenicity and carcinogenicity of associated with arsenic in drinking water 42. Morton W, Starr G, Pohl D, et al. Skin
high-arsenic artesian well water. in Cordoba, Argentina. Int J Epidemiol cancer and water arsenic in Lane County,
Multiple risk factors and related 1998;27:561-9. Oregon. Cancer 1976;37:2523-32.
malignant neoplasms of blackfoot 28. Schrauzer GN, White DA, Schneider CJ. 43. Tseng WP, Chu HM, How SW, et al.
disease. Arteriosclerosis 1988;8:452-60. Cancer mortality correlation studies - IV: Prevalence of skin cancer in an endemic
13. Chen CL, Hsu LI, Chiou HY, et al. Ingested associations with dietary intakes and area of chronic arsenicism in Taiwan. J
arsenic, cigarette smoking, and lung blood levels of certain trace elements, Natl Cancer Inst 1968;40:453-63.
cancer risk: a follow-up study in notably Se-antagonists. Bioinorg Chem 44. Kurttio P, Pukkala E, Kahelin H, et al.
arseniasis-endemic areas in Taiwan. 1977;7:35-56. Arsenic concentrations in well water and
JAMA 2004;292:2984-90. 29. Smith AH, Goycolea M, Haque R, et al. risk of bladder and kidney cancer in
14. Chiou HY, Hsueh YM, Liaw KF, et al. Marked increase in bladder and lung Finland. Environ Health Perspect
Incidence of internal cancers and cancer mortality in a region of Northern 1999;107:705-10.
ingested inorganic arsenic: a seven-year Chile due to arsenic in drinking water. 45. Chiou HY, Chiou ST, Hsu YH, et al. Incidence
follow-up study in Taiwan. Cancer Res Am J Epidemiol 1998;147:660-9. of transitional cell carcinoma and arsenic
1995;55:1296-300. 30. Tsai SM, Wang TN, Ko YC. Mortality for in drinking water: a follow-up study of
15. Nakadaira H, Endoh K, Katagiri M, et al. certain diseases in areas with high levels 8,102 residents in an arseniasis-endemic
Elevated mortality from lung cancer of arsenic in drinking water. Arch area in northeastern Taiwan. Am J
associated with arsenic exposure for a Environ Health 1999;54:186-93. Epidemiol 2001;153:411-8.
limited duration. J Occup Environ Med 31. Hsueh YM, Chiou HY, Huang YL, et al. 46. Yang CY, Chiu HF, Wu TN, et al. Reduction
2002;44:291-9. Serum beta-carotene level, arsenic in kidney cancer mortality following
16. Tsuda T, Nagira T, Yamamoto M, et al. methylation capability, and incidence of installation of a tap water supply system
Malignant neoplasms among residents skin cancer. Cancer Epidemiol Biomarkers in an arsenic-endemic area of Taiwan.
who drank well water contaminated by Prev 1997;6:589-96. Arch Environ Health 2004;59:484-8.
arsenic from a kings yellow factory. J 32. Lewis DR, Southwick JW, Ouellet-Hellstrom 47. Hinwood AL, Jolley DJ, Sim MR. Cancer
UOEH 1989;11 Suppl:289-301. R, et al. Drinking water arsenic in Utah: a incidence and high environmental
17. Tsuda T, Babazono A, Yamamoto E, et al. cohort mortality study. Environ Health arsenic concentrations in rural
Ingested arsenic and internal cancer: a Perspect 1999;107:359-65. populations: results of an ecological
historical cohort study followed for 33 33. Chen YC, Guo YL, Su HJ, et al. Arsenic study. Int J Environ Health Res 1999;.
years. Am J Epidemiol 1995;141:198-209. methylation and skin cancer risk in 9:131-41.
18. Chen CJ, Chuang YC, You SL, et al. A southwestern Taiwan. J Occup Environ 48. Chen CJ, Chen CW, Wu MM, et al. Cancer
retrospective study on malignant Med 2003;45:241-8. potential in liver, lung, bladder and
neoplasms of bladder, lung and liver in 34. Chen YC, Xu L, Guo YL, et al. Genetic kidney due to ingested inorganic arsenic
blackfoot disease endemic area in polymorphism in p53 codon 72 and skin in drinking water. Br J Cancer
Taiwan. Br J Cancer 1986;53:399-405. cancer in southwestern Taiwan. J Environ 1992;66:888-92.
19. Ferreccio C, Gonzalez C, Milosavjlevic V, et Sci Health A Tox Hazard Subst Environ 49. Tchounwou PB, Patlolla AK, Centeno JA.
al. Lung cancer and arsenic Eng 2003;38:201-11. Carcinogenic and systemic health effects
concentrations in drinking water in 35. Pesch B, Ranft U, Jakubis P, et al. associated with arsenic exposure - a
Chile. Epidemiology 2000;11:673-9. Environmental arsenic exposure from a critical review. Toxicol Pathol
20. Brueschweiler BJ, Schlatter JR, de Weck D, coal-burning power plant as a potential 2003;31:575-88.
et al. Occurrence of arsenic in drinking risk factor for nonmelanoma skin 50. Apostoli P, Sarnico M, Bavazzano P, et al.
water of the canton of Valais Part II: carcinoma: results from a case-control Arsenic and porphyrins. Am J Ind Med
epidemiological comparison between study in the district of Prievidza, 2002;42:180-7.
arsenic concentrations and cancer Slovakia. Am J Epidemiol 2002;155:798- 51. Michaud DS, Wright ME, Cantor KP, et al.
incidence rates. Mitt 809. Arsenic concentrations in prediagnostic
Lebensmitteluntersuchung Hyg 36. Beane Freeman LE, Dennis LK, Lynch CF, et toenails and the risk of bladder cancer in
2005;96:106-17. al. Toenail arsenic content and a cohort study of male smokers. Am J
21. Buchet JP, Lison D. Mortality by cancer in cutaneous melanoma in Iowa. Am J Epidemiol 2004;160:853-9.
groups of the Belgian population with a Epidemiol 2004;160:679-87. 52. Yang CY, Chiu HF, Chang CC, et al. Bladder
moderately increased intake of arsenic. 37. Karagas MR, Stukel TA, Morris JS, et al. Skin cancer mortality reduction after
Int Arch Occup Environ Health cancer risk in relation to toenail arsenic installation of a tap-water supply system
1998;71:125-30. concentrations in a US population-based in an arsenious-endemic area in
22. Chen CJ, Wang CJ. Ecological correlation case-control study. Am J Epidemiol southwestern Taiwan. Environ Res
between arsenic level in well water and 2001;153:559-65. 2005;98:127-32.
age-adjusted mortality from malignant 38. Hsueh YM, Cheng GS, Wu MM, et al. 53. Bates MN, Rey OA, Biggs ML, et al. Case-
neoplasms. Cancer Res 1990;50:5470-4. Multiple risk factors associated with control study of bladder cancer and
23. Chen CJ, Kuo TL, Wu MM. Arsenic and arsenic-induced skin cancer: effects of exposure to arsenic in Argentina. Am J
cancers. Lancet 1988;1:414-5. chronic liver disease and malnutritional Epidemiol 2004;159:381-9.
24. Chen CJ, Chuang YC, Lin TM, et al. status. Br J Cancer 1995;71:109-14. 54. Bates MN, Smith AH, Cantor KP. Case-
Malignant neoplasms among residents 39. Guo HR, Yu HS, Hu H, et al. Arsenic in control study of bladder cancer and
of a blackfoot disease-endemic area in drinking water and skin cancers: cell- arsenic in drinking water. Am J
Taiwan: high-arsenic artesian well water type specificity (Taiwan, ROC). Cancer Epidemiol 1995;141:523-30.
and cancers. Cancer Res 1985;45:5895-9. Causes Control 2001;12:909-16. 55. Steinmaus C, Yuan Y, Bates MN, et al. Case-
25. Chiu HF, Ho SC, Yang CY. Lung cancer 40. Wu MM, Kuo TL, Hwang YH, et al. Dose- control study of bladder cancer and
mortality reduction after installation of response relation between arsenic drinking water arsenic in the western
tap-water supply system in an arseniasis- concentration in well water and United States. Am J Epidemiol
endemic area in Southwestern Taiwan. mortality from cancers and vascular 2003;158:1193-201.
Lung Cancer 2004;46:265-70. diseases. Am J Epidemiol 1989;130:1123- 56. Chen YC, Su HJ, Guo YL, et al. Arsenic
450
R E F E R E N C E S
methylation and bladder cancer risk in Study. Cancer Epidemiol Biomarkers Prev Cancer 1989;43:17-21.
Taiwan. Cancer Causes Control 1997;6:1081-6. 90. Cuzick J, Babiker AG. Pancreatic cancer,
2003;14:303-10. 73. Jacobsen BK, Bjelke E, Kvale G, et al. alcohol, diabetes mellitus and gall-
57. Chen YC, Su HJ, Guo YL, et al. Interaction Coffee drinking, mortality, and cancer bladder disease. Int J Cancer
between environmental tobacco smoke incidence: results from a Norwegian 1989;43:415-21.
and arsenic methylation ability on the prospective study. J Natl Cancer Inst 91. Pfeffer F, Avilas RH, Vargas F, et al.
risk of bladder cancer. Cancer Causes 1986;76:823-31. [Smoking, consumption of alcoholic
Control 2005;16:75-81. 74. Stensvold I, Jacobsen BK. Coffee and beverages and coffee as factors
58. Chen YC, Xu L, Guo YL, et al. cancer: a prospective study of 43,000 associated with the development of
Polymorphisms in GSTT1 and p53 and Norwegian men and women. Cancer cancer of the pancreas]. Rev Invest Clin
urinary transitional cell carcinoma in Causes Control 1994;5:401-8. 1989;41:205-8.
south-western Taiwan: a preliminary 75. Michaud DS, Giovannucci E, Willett WC, et 92. Olsen GW, Mandel JS, Gibson RW, et al. A
study. Biomarkers 2004;9:386-94. al. Coffee and alcohol consumption and case-control study of pancreatic cancer
59. Su HJ, Guo L, Lai MD, et al. The NAT2* slow the risk of pancreatic cancer in two and cigarettes, alcohol, coffee and diet.
acetylator genotype is associated with prospective United States cohorts. Am J Public Health 1989;79:1016-9.
bladder cancer in Taiwanese, but not in Cancer Epidemiol Biomarkers Prev 93. Bueno de Mesquita HB, Maisonneuve P,
the black foot disease endemic area 2001;10:429-37. Moerman CJ, et al. Lifetime consumption
population. Pharmacogenetics 76. Lin Y, Tamakoshi A, Kawamura T, et al. Risk of alcoholic beverages, tea and coffee
1998;8:187-90. of pancreatic cancer in relation to and exocrine carcinoma of the pancreas:
60. Karagas MR, Tosteson TD, Morris JS, et al. alcohol drinking, coffee consumption a population-based case-control study in
Incidence of transitional cell carcinoma and medical history: findings from the The Netherlands. Int J Cancer
of the bladder and arsenic exposure in Japan collaborative cohort study for 1992;50:514-22.
New Hampshire. Cancer Causes Control evaluation of cancer risk. Int J Cancer 94. Lyon JL, Mahoney AW, French TK, et al.
2004;15:465-72. 2002;99:742-6. Coffee consumption and the risk of
61. Lamm SH, Engel A, Kruse MB, et al. Arsenic 77. Elinder CG, Millqvist K, Floderus-Myrhed B, cancer of the exocrine pancreas: a case-
in drinking water and bladder cancer et al. Swedish studies do not support the control study in a low-risk population.
mortality in the United States: an hypothesis about a connection between 1992;3:164-70.
analysis based on 133 U.S. counties and coffee and cancer of the pancreas. 95. Mizuno S, Watanabe S, Nakamura K, et al.
30 years of observation. J Occup Environ Lakartidningen 1981;78:3676-7. A multi-institute case-control study on
Med 2004;46:298-306. 78. Whittemore AS, Paffenbarger RS, Jr., the risk factors of developing pancreatic
62. Guo HR, Tseng YC. Arsenic in drinking Anderson K, et al. Early precursors of cancer. Jpn J Clin Oncol 1992;22:286-91.
water and bladder cancer: comparison pancreatic cancer in college men. J 96. Kalapothaki V, Tzonou A, Hsieh CC, et al.
between studies based on cancer registry Chronic Dis 1983;36:251-6. Tobacco, ethanol, coffee, pancreatitis,
and death certificates. Environ Geochem 79. Snowdon DA, Phillips RL. Coffee diabetes mellitus, and cholelithiasis as
Health 2000;22:83-91. consumption and risk of fatal cancers. risk factors for pancreatic carcinoma.
63. Guo HR, Chiang HS, Hu H, et al. Arsenic in Am J Public Health 1984;74:820-3. Cancer Causes Control 1993;4:375-82.
drinking water and incidence of urinary 80. Hirayama T. Epidemiology of pancreatic 97. Sciallero S, Bonelli L, Saccomanno S, et al.
cancers. Epidemiology 1997;8:545-50. cancer in Japan. Jpn J Clin Oncol Socioeconomic characteristics, life style,
64. Hopenhayn-Rich C, Biggs ML, Fuchs A, et 1989;19:208-15. diabetes, family history of cancer and
al. Bladder cancer mortality associated 81. Zheng W, McLaughlin JK, Gridley G, et al. A risk of pancreatic cancer. Eur J
with arsenic in drinking water in cohort study of smoking, alcohol Gastroenterol Hepatol 1993;5:367-71.
Argentina. Epidemiology 1996;7:117-24. consumption, and dietary factors for 98. Kreiger N, LaCroix J, Sloan M. Hormonal
65. Buchet J, Lison D. Clues and uncertainties pancreatic cancer (United States). Cancer factors and pancreatic cancer in women.
in the risk assessment of arsenic in Causes Control 1993;4:477-82. Ann Epidemiol 2001;11:563-7.
drinking water. Food Chem Toxicol 82. Klatsky AL, Armstrong MA, Friedman GD. 99. Falk RT, Pickle LW, Fontham ET, et al. Life-
2000;38:S81-5. Coffee, tea, and mortality. Ann style risk factors for pancreatic cancer in
66. Gebel T. Confounding variables in the Epidemiol 1993;3:375-81. Louisiana: a case-control study. Am J
environmental toxicology of arsenic. 83. Khan MM, Goto R, Kobayashi K, et al. Epidemiol 1988;128:324-36.
Toxicology 2000;144:155-62. Dietary habits and cancer mortality 100. Wynder EL, Hall NE, Polansky M.
67. Stolzenberg-Solomon RZ, Pietinen P, Taylor among middle aged and older Japanese Epidemiology of coffee and pancreatic
PR, et al. Prospective study of diet and living in Hokkaido, Japan by cancer site cancer. Cancer Res 1983;43:3900-6.
pancreatic cancer in male smokers. Am J and sex. 2004;5:58-65. 101. Kinlen LJ, McPherson K. Pancreas cancer
Epidemiol 2002;155:783-92. 84. Gold EB, Gordis L, Diener MD, et al. Diet and coffee and tea consumption: a case-
68. Nomura A, Heilbrun LK, Stemmermann and other risk factors for cancer of the control study. Br J Cancer 1984;49:93-6.
GN. Prospective study of coffee pancreas. Cancer 1985;55:460-7. 102. Goiriena De Gandarias FJ, Santidrian MI,
consumption and the risk of cancer. J 85. Mack TM, Yu MC, Hanisch R, et al. Pancreas Barranquero AM. Etiopathogenic study
Natl Cancer Inst 1986;76:587-90. cancer and smoking, beverage of cancer of the digestive tract in Biscay
69. Hiatt RA, Klatsky AL, Armstrong MA. consumption, and past medical history. J Spain with special emphasis on the role
Pancreatic cancer, blood glucose and Natl Cancer Inst 1986;76:49-60. played by diet and consumption of
beverage consumption. Int J Cancer 86. Stefanati A, Saletti C, Califano A, et al. alcohol and tobacco. Rev Sanid Hig
1988;41:794-7. Coffee, alcohol, smoking and risk of Publica (Madr) 1987;62:1411-30.
70. Friedman GD, van den Eeden SK. Risk cancer of the pancreas: a case-control 103. La Vecchia C, Liati P, Decarli A, et al.
factors for pancreatic cancer: an study. J Prev Med Hyg 1992;33:65-70. Coffee consumption and risk of
exploratory study. Int J Epidemiol 87. MacMahon B, Yen S, Trichopoulos D, et al. pancreatic cancer. Int J Cancer
1993;22:30-7. Coffee and cancer of the pancreas. N 1987;40:309-13.
71. Shibata A, Mack TM, Paganini-Hill A, et al. Engl J Med 1981;304:630-3. 104. Voirol M, Infante F, Raymond L, et al.
A prospective study of pancreatic cancer 88. Norell SE, Ahlbom A, Erwald R, et al. Diet [Nutritional profile of patients with
in the elderly. Int J Cancer 1994;58:46-9. and pancreatic cancer: a case-control cancer of the pancreas]. Schweiz Med
72. Harnack LJ, Anderson KE, Zheng W, et al. study. Am J Epidemiol 1986;124:894-902. Wochenschr 1987;117:1101-4.
Smoking, alcohol, coffee, and tea intake 89. Clavel F, Benhamou E, Auquier A, et al. 105. Gorham ED, Garland CF, Garland FC, et al.
and incidence of cancer of the exocrine Coffee, alcohol, smoking and cancer of Coffee and pancreatic cancer in a rural
pancreas: the Iowa Womens Health the pancreas: a case-control study. Int J California county. 1988;148:48-53.
451
F O O D , N U T R I T I O N , P H Y S I C A L A C T I V I T Y, A N D T H E P R E V E N T I O N O F C A N C E R : A G L O B A L P E R S P E C T I V E
106. Farrow DC, Davis S. Risk of pancreatic commodities. Med Hypotheses Cigarette smoking, obesity, diuretic use,
cancer in relation to medical history and 1976;2:39-49. and coffee consumption as risk factors
the use of tobacco, alcohol and coffee. 122. Cuckle HS, Kinlen LJ. Coffee and cancer of for renal cell carcinoma. J Natl Cancer
Int J Cancer 1990;45:816-20. the pancreas. Br J Cancer 1981;44:760-1. Inst 1986;77:351-6.
107. Ghadirian P, Simard A, Baillargeon J. 123. Benhamou S, Clavel F, Rezvani A, et al. 140. Mclaughlin JK, Mandel JS, Blot WJ, et al.
Tobacco, alcohol, and coffee and cancer [Relation between mortality in cancer of A population-based case-control study of
of the pancreas. A population-based, the pancreas and food and tobacco renal cell carcinoma. J Natl Cancer Inst
case-control study in Quebec, Canada. consumption in France]. Biomed 1984;72:275-84.
Cancer 1991;67:2664-70. Pharmacother 1982;36:389-92. 141. Benhamou S, Lenfant MH, Ory-Paoletti C,
108. Baghurst PA, McMichael AJ, Slavotinek 124. Benarde MA, Weiss W. Coffee et al. Risk factors for renal-cell carcinoma
AH, et al. A case-control study of diet consumption and pancreatic cancer: in a French case-control study. Int J
and cancer of the pancreas. Am J temporal and spatial correlation. BMJ Cancer 1993;55:32-6.
Epidemiol 1991;134:167-79. 1982;284:400-2. 142. Goodman MT, Morgenstern H, Wynder
109. Jain M, Howe GR, St Louis P, et al. Coffee 125. Binstock M, Krakow D, Stamler J, et al. EL. A case-control study of factors
and alcohol as determinants of risk of Coffee and pancreatic cancer: an analysis affecting the development of renal cell
pancreas cancer: a case-control study of international mortality data. Am J cancer. Am J Epidemiol 1986;124:926-41.
from Toronto. Int J Cancer 1991;47:384-9. Epidemiol 1983;118:630-40. 143. Armstrong B, Garrod A, Doll R. A
110. Cortes Vizcaino C, Sabater Pons A, 126. Hara N, Sakata K, Nagai M, et al. retrospective study of renal cancer with
Calatayud Sarthoud A, et al. A case- [Geographical difference of mortality of special reference to coffee and animal
control study of cancer of the pancreas. digestive cancers and food protein consumption. Br J Cancer
Oncologia 1993;16:65-9. consumption]. Gan No Rinsho 1976;33:127-36.
111. Zatonski WA, Boyle P, Przewozniak K, et 1984;30:1665-74. 144. Wynder EL, Mabuchi K, Whitmore WF, Jr.
al. Cigarette smoking, alcohol, tea and 127. Kato I, Tajima K, Kuroishi T, et al. Latitude Epidemiology of adenocarcinoma of the
coffee consumption and pancreas cancer and pancreatic cancer. Jpn J Clin Oncol kidney. J Natl Cancer Inst 1974;53:1619-
risk: a case-control study from Opole, 1985;15:403-13. 34.
Poland. Int J Cancer 1993;53:601-7. 128. Decarli A, La VC. Environmental factors 145. Boeing H, Schlehofer B, Wahrendorf J.
112. Gullo L, Pezzilli R, Morselli-Labate AM. and cancer mortality in Italy: Diet, obesity and risk for renal cell
Coffee and cancer of the pancreas: an correlational exercise. Oncology carcinoma: results from a case control-
Italian multicenter study. The Italian 1986;43:116-26. study in Germany. Z Ernahrungswiss
Pancreatic Cancer Study Group. 129. Vioque J, Gonzalez SL, Cayuela DA. 1997;36:3-11.
1995;11:223-9. [Cancer of the pancreas: an ecologic 146. Wolk A, Gridley G, Niwa S, et al.
113. Partanen T, Hemminki K, Vainio H, et al. study]. Med Clin (Barc) 1990;95:121-5. International renal cell cancer study. VII.
Coffee consumption not associated with 130. Cortes VC, Saiz SC, Gimenez Fernandez FJ, Role of diet. Int J Cancer 1996;65:67-73.
risk of pancreas cancer in Finland. Prev et al. Ecologic correlation of 147. Chow WH, Gridley G, Mclaughlin JK, et al.
Med 1995;24:213-6. consumption in Spain and pancreas Protein intake and risk of renal cell
114. Kokic NZ, Adanja JB, Vlajinac DH, et al. cancer mortality. Oncologia 1992;15:190- cancer. J Natl Cancer Inst 1994;86:1131-9.
Case-control study of pancreatic cancer 7. 148. Mclaughlin JK, Gao YT, Gao RN, et al. Risk
in Serbia, Yugoslavia. 1996;43:353-6. 131. Prineas RJ, Folsom AR, Zhang ZM, et al. factors for renal-cell cancer in Shanghai,
115. Nishi M, Ohba S, Hirata K, et al. Dose- Nutrition and other risk factors for renal China. Int J Cancer 1992;52:562-5.
response relationship between coffee cell carcinoma in postmenopausal 149. Maclure M, Willett W. A case-control
and the risk of pancreas cancer. Jpn J Clin women. Epidemiology 1997;8:31-6. study of diet and risk of renal
Oncol 1996;26:42-8. 132. Hiatt RA, Tolan K, Quesenberry CP, Jr. adenocarcinoma. Epidemiology
116. Silverman DT, Swanson CA, Gridley G, et Renal cell carcinoma and thiazide use: a 1990;1:430-40.
al. Dietary and nutritional factors and historical, case-control study (California, 150. Asal NR, Risser DR, Kadamani S, et al. Risk
pancreatic cancer: a case-control study USA). Cancer Causes Control 1994;5:319- factors in renal cell carcinoma: I.
based on direct interviews. J Natl Cancer 25. Methodology, demographics, tobacco,
Inst 1998;90:1710-9. 133. Washio M, Mori M, Sakauchi F, et al. Risk beverage use, and obesity. Cancer Detect
117. Villeneuve PJ, Johnson KC, Hanley AJ, et factors for kidney cancer in a Japanese Prev 1988;11:359-77.
al. Alcohol, tobacco and coffee population: findings from the JACC 151. McCredie M, Ford JM, Stewart JH. Risk
consumption and the risk of pancreatic study. J Epidemiol 2005;15:S203-S11. factors for cancer of the renal
cancer: results from the Canadian 134. Nicodemus KK, Sweeney C, Folsom AR. parenchyma. Int J Cancer 1988;42:13-6.
Enhanced Surveillance System case- Evaluation of dietary, medical and 152. Talamini R, Baron AE, Barra S, et al. A
control project. Canadian Cancer lifestyle risk factors for incident kidney case-control study of risk factor for renal
Registries Epidemiology Research Group. cancer in postmenopausal women. Int J cell cancer in northern Italy. Cancer
Eur J Cancer Prev 2000;9:49-58. Cancer 2004;108:115-21. Causes Control 1990;1:125-31.
118. Alguacil J, Kauppinen T, Porta M, et al. 135. Mucci LA, Lindblad P, Steineck G, et al. 153. Armstrong B, Doll R. Environmental
Risk of pancreatic cancer and Dietary acrylamide and risk of renal cell factors and cancer incidence and
occupational exposures in Spain. cancer. Int J Cancer 2004;109:774-6. mortality in different countries, with
PANKRAS II Study Group. Ann Occup Hyg 136. Mattioli S, Truffelli D, Baldasseroni A, et special reference to dietary practices. Int
2000;44:391-403. al. Occupational risk factors for renal cell J Cancer 1975;15:617-31.
119. Mori M, Hariharan M, Anandakumar M, cancer: a case - control study in northern 154. Lee JE, Giovannucci E, Smith-Warner SA,
et al. A case-control study on risk factors Italy. J Occup Environ Med 2002;44:1028- et al. Total fluid intake and use of
for pancreatic diseases in Kerala, India. 36. individual beverages and risk of renal
Hepatogastroenterology 1999;46:25-30. 137. Yuan JM, Gago-Dominguez M, Castelao cell cancer in two large cohorts. Cancer
120. Stocks P. Cancer mortality in relation to JE, et al. Cruciferous vegetables in Epidemiol Biomarkers Prev
national consumption of cigarettes, solid relation to renal cell carcinoma. Int J 2006;15:1204-11.
fuel, tea and coffee. Br J Cancer Cancer 1998;77:211-6. 155. Vassallo A, Correa P, De Stefani E, et al.
1970;24:215-25. 138. Kreiger N, Marrett LD, Dodds L, et al. Risk Esophageal cancer in Uruguay: a case-
121. Schrauzer GN. Cancer mortality factors for renal cell carcinoma: results of control study. J Natl Cancer Inst
correlation studies. II. Regional a population-based case-control study. 1985;75:1005-9.
associations of mortalities with the Cancer Causes Control 1993;4:101-10. 156. Victora CG, Munoz N, Day NE, et al. Hot
consumptions of foods and other 139. Yu MC, Mack TM, Hanisch R, et al. beverages and oesophageal cancer in
452
R E F E R E N C E S
southern Brazil: a case-control study. Int the upper aerodigestive tract: a 1999;90:614-21.
J Cancer 1987;39:710-6. prospective study among Hawaii 189. Zhang W, An F, Lin H. [A case-control
157. De Stefani E, Munoz N, Esteve J, et al. Japanese men. Int J Cancer 1995;60:616- study on the risk factors of esophageal
Mate drinking, alcohol, tobacco, diet, 21. cancer in Jieyang City of Guangdong in
and esophageal cancer in Uruguay. 174. Kinjo Y, Cui Y, Akiba S, et al. Mortality China]. Zhonghua Liu Xing Bing Xue Za
Cancer Res 1990;50:426-31. risks of oesophageal cancer associated Zhi 2001;22:442-5.
158. Rolon PA, Castellsague X, Benz M, et al. with hot tea, alcohol, tobacco and diet 190. Yang CX, Wang HY, Wang ZM, et al. Risk
Hot and cold mate drinking and in Japan. J Epidemiol 1998;8:235-43. factors for esophageal cancer: a case-
esophageal cancer in Paraguay. Cancer 175. Tran GD, Sun XD, Abnet CC, et al. control study in South-western China.
Epidemiol Biomarkers Prev 1995;4:595- Prospective study of risk factors for Asian Pac J Cancer Prev 2005;6:48-53.
605. esophageal and gastric cancers in the 191. Hung HC, Huang MC, Lee JM, et al.
159. Dietz J, Pardo SH, Furtado CD, et al. [Risk Linxian general population trial cohort Association between diet and
factors related to esophageal cancer in in China. Int J Cancer 2005;113:456-63. esophageal cancer in Taiwan. J
Rio Grande do Sul, Brazil]. Rev Assoc 176. Guo W, Blot WJ, Li JY, et al. A nested case- Gastroenterol Hepatol 2004;19:632-7.
Med Bras 1998;44:269-72. control study of oesophageal and 192. Tavani A, Negri E, Franceschi S, et al. Risk
160. Castelletto R, Castellsague X, Munoz N, et stomach cancers in the Linxian nutrition factors for esophageal cancer in women
al. Alcohol, tobacco, diet, mate drinking, intervention trial. Int J Epidemiol in northern Italy. Cancer 1993;72:2531-6.
and esophageal cancer in Argentina. 1994;23:444-50. 193. Terry P, Lagergren J, Ye W, et al.
Cancer Epidemiol Biomarkers Prev 177. De Jong UW, Breslow N, Hong JG, et al. Antioxidants and cancers of the
1994;3:557-64. Aetiological factors in oesophageal esophagus and gastric cardia. Int J
161. Sewram V, De Stefani E, Brennan P, et al. cancer in Singapore Chinese. Int J Cancer Cancer 2000;87:750-4.
Mate consumption and the risk of 1974;13:291-303. 194. Nakachi K, Imai K, Hoshiyama Y, et al. The
squamous cell esophageal cancer in 178. Gao YT, McLaughlin JK, Gridley G, et al. joint effects of two factors in the
Uruguay. Cancer Epidemiol Biomarkers Risk factors for esophageal cancer in aetiology of oesophageal cancer in
Prev 2003;12:508-13. Shanghai, China. II. Role of diet and Japan. J Epidemiol Community Health
162. De Stefani E, Boffetta P, Deneo-Pellegrini nutrients. Int J Cancer 1994;58:197-202. 1988;42:355-64.
H, et al. The role of vegetable and fruit 179. Hanaoka T, Tsugane S, Ando N, et al. 195. Cheng KK, Day NE, Duffy SW, et al.
consumption in the aetiology of Alcohol consumption and risk of Pickled vegetables in the aetiology of
squamous cell carcinoma of the esophageal cancer in Japan: a case- oesophageal cancer in Hong Kong
oesophagus: a case-control study in control study in seven hospitals. Jpn J Chinese. Lancet 1992;339:1314-8.
Uruguay. Int J Cancer 2005;116:130-5. Clin Oncol 1994;24:241-6. 196. Cheng KK, Duffy SW, Day NE, et al.
163. De Stefani E, Deneo-Pellegrini H, Ronco 180. Srivastava M, Kapil U, Chattopadhyaya Oesophageal cancer in never-smokers
AL, et al. Food groups and risk of TK, et al. Nutritional risk factors in and never-drinkers. Int J Cancer
squamous cell carcinoma of the carcinoma esophagus. Nutr Res 1995;60:820-2.
oesophagus: a case-control study in 1995;15:177-85.
Uruguay. Br J Cancer 2003;89:1209-14. 181. Garidou A, Tzonou A, Lipworth L, et al.
164. Sichieri R, Everhart JE, Mendona GAS. Life-style factors and medical conditions Chapter 4.8
Diet and mortality from common cancers in relation to esophageal cancer by
in Brazil: an ecological study. Cad Saude histologic type in a low-risk population. 1. Kjaerheim K, Gaard M, Andersen A. The role
Publica 1996;12:53-9. Int J Cancer 1996;68:295-9. of alcohol, tobacco, and dietary factors
165. De Stefani E, Correa P, Oreggia F, et al. 182. Nayar D, Kapil U, Joshi YK, et al. in upper aerogastric tract cancers: a
Risk factors for laryngeal cancer. Cancer Nutritional risk factors in esophageal prospective study of 10,900 Norwegian
1987;60:3087-91. cancer. J Assoc Physicians India men. Cancer Causes Control 1998;9:99-
166. Franco EL, Kowalski LP, Oliveira BV, et al. 2000;48:781-7. 108.
Risk factors for oral cancer in Brazil: a 183. Phukan RK, Chetia CK, Ali MS, et al. Role 2. Boeing H. Alcohol and risk of cancer of the
case-control study. Int J Cancer of dietary habits in the development of upper gastrointestinal tract: first analysis
1989;43:992-1000. esophageal cancer in Assam, the north- of the EPIC data. IARC Sci Publ
167. Oreggia F, De Stefani E, Correa P, et al. eastern region of India. Nutr Cancer 2002;156:151-4.
Risk factors for cancer of the tongue in 2001;39:204-9. 3. Zheng W, Sellers TA, Doyle TJ, et al. Retinol,
Uruguay. Cancer 1991;67:180-3. 184. Terry P, Lagergren J, Wolk A, et al. antioxidant vitamins, and cancers of the
168. Pintos J, Franco EL, Oliveira BV, et al. Drinking hot beverages is not associated upper digestive tract in a prospective
Mate, coffee, and tea consumption and with risk of oesophageal cancers in a cohort study of postmenopausal women.
risk of cancers of the upper Western population. Br J Cancer Am J Epidemiol 1995;142:955-60.
aerodigestive tract in southern Brazil. 2001;84:120-1. 4. Gronbaek M, Becker U, Johansen D, et al.
Epidemiology 1994;5:583-90. 185. Sharp L, Chilvers CE, Cheng KK, et al. Risk Population based cohort study of the
169. Nishimoto IN, Pintos J, Schlecht NF, et al. factors for squamous cell carcinoma of association between alcohol intake and
Assessment of control selection bias in a the oesophagus in women: a case- cancer of the upper digestive tract. BMJ
hospital-based case-control study of control study. Br J Cancer 2001;85:1667- 1998;317:844-7.
upper aero-digestive tract cancers. J 70. 5. Kasum CM, Jacobs DR, Jr., Nicodemus K, et
Cancer Epidemiol Prev 2002;7:131-41. 186. Onuk MD, Oztopuz A, Memik F. Risk al. Dietary risk factors for upper
170. Toporcov TN, Antunes JL, Tavares MR. Fat factors for esophageal cancer in eastern aerodigestive tract cancers. Int J Cancer
food habitual intake and risk of oral Anatolia. Hepatogastroenterology 2002;99:267-72.
cancer. Oral Oncol 2004;40:925-31. 2002;49:1290-2. 6. Kato I, Nomura AM, Stemmermann GN, et
171. Goldenberg D. Mate: a risk factor for oral 187. Hu J, Nyren O, Wolk A, et al. Risk factors al. Prospective study of the association
and oropharyngeal cancer. Oral Oncol for oesophageal cancer in northeast of alcohol with cancer of the upper
2002;38:646-9. China. Int J Cancer 1994;57:38-46. aerodigestive tract and other sites.
172. Goldenberg D, Golz A, Joachims HZ. The 188. Gao CM, Takezaki T, Ding JH, et al. Cancer Causes Control 1992;3:145-51.
beverage mate: a risk factor for cancer Protective effect of allium vegetables 7. Crosignani P, Russo A, Tagliabue G, et al.
of the head and neck. Head Neck against both esophageal and stomach Tobacco and diet as determinants of
2003;25:595-601. cancer: a simultaneous case-referent survival in male laryngeal cancer
173. Chyou PH, Nomura AMY, Stemmermann study of a high-epidemic area in Jiangsu patients. Int J Cancer 1996;65:308-13.
GN. Diet, alcohol, smoking and cancer of Province, China. Jpn J Cancer Res 8. Maier H, Dietz A, Gewelke U, et al. Tobacco
453
F O O D , N U T R I T I O N , P H Y S I C A L A C T I V I T Y, A N D T H E P R E V E N T I O N O F C A N C E R : A G L O B A L P E R S P E C T I V E
and alcohol and the risk of head and case-control study. Int J Cancer cancer in non-users of tobacco. J Natl
neck cancer. Clin Investig 1992;70:320-7. 1989;43:992-1000. Cancer Inst 1993;85:743-5.
9. Wynder EL, Covey LS, Mabuchi K, et al. 26. Merletti F, Boffetta P, Ciccone G, et al. Role 43. Hedberg K, Vaughan TL, White E, et al.
Environmental factors in cancer of the of tobacco and alcoholic beverages in Alcoholism and cancer of the larynx: a
larynx: a second look. Cancer the etiology of cancer of the oral case-control study in western
1976;38:1591-601. cavity/oropharynx in Torino, Italy. Cancer Washington (United States). Cancer
10. Rothman K, Keller A. The effect of joint Res 1989;49:4919-24. Causes Control 1994;5:3-8.
exposure to alcohol and tobacco on risk 27. Falk RT, Pickle LW, Brown LM, et al. Effect 44. Rao DN, Ganesh B, Rao RS, et al. Risk
of cancer of the mouth and pharynx. J of smoking and alcohol consumption on assessment of tobacco, alcohol and diet
Chronic Dis 1972;25:711-6. laryngeal cancer risk in coastal Texas. in oral cancer - a case-control study. Int J
11. Bross ID, Coombs J. Early onset of oral Cancer Res 1989;49:4024-9. Cancer 1994;58:469-73.
cancer among women who drink and 28. Sankaranarayanan R, Duffy SW, 45. Bundgaard T, Wildt J, Frydenberg M, et al.
smoke. Oncology 1976;33:136-9. Padmakumary G, et al. Risk factors for Case-control study of squamous cell
12. Graham S, Dayal H, Rohrer T, et al. cancer of the buccal and labial mucosa in cancer of the oral cavity in Denmark.
Dentition, diet, tobacco, and alcohol in Kerala, southern India. J Epidemiol Cancer Causes Control 1995;6:57-67.
the epidemiology of oral cancer. J Natl Community Health 1990;44:286-92. 46. Guo X, Cheng M, Fei S. A case-control study
Cancer Inst 1977;59:1611-8. 29. Sankaranarayanan R, Duffy SW, of the etiology of laryngeal cancer in
13. Jafarey NA, Mahmood Z, Zaidi SH. Habits Padmakumary G, et al. Tobacco chewing, Liaoning Province. Chin Med J (Engl)
and dietary pattern of cases of alcohol and nasal snuff in cancer of the 1995;108:347-50.
carcinoma of the oral cavity and gingiva in Kerala, India. Br J Cancer 47. Takezaki T, Hirose K, Inoue M, et al.
oropharynx. J Pak Med Assoc 1989;60:638-43. Tobacco, alcohol and dietary factors
1977;27:340-3. 30. La Vecchia C, Negri E, DAvanzo B, et al. associated with the risk of oral cancer
14. Herity B, Moriarty M, Bourke GJ, et al. A Dietary indicators of laryngeal cancer among Japanese. Jpn J Cancer Res
case-control study of head and neck risk. Cancer Res 1990;50:4497-500. 1996;87:555-62.
cancer in the Republic of Ireland. Br J 31. Zheng TZ, Boyle P, Hu HF, et al. Tobacco 48. Sanderson RJ, de Boer MF, Damhuis RA, et
Cancer 1981;43:177-82. smoking, alcohol consumption, and risk al. The influence of alcohol and smoking
15. Herity B, Moriarty M, Daly L, et al. The role of oral cancer: a case-control study in on the incidence of oral and
of tobacco and alcohol in the aetiology Beijing, Peoples Republic of China. oropharyngeal cancer in women. Clin
of lung and larynx cancer. Br J Cancer Cancer Causes Control 1990;1:173-9. Otolaryngol 1997;22:444-8.
1982;46:961-4. 32. Franceschi S, Barra S, La Vecchia C, et al. 49. Dosemeci M, Gokmen I, Unsal M, et al.
16. Bruzzi P, Margarino G, Tonetti R, et al. [A Risk factors for cancer of the tongue and Tobacco, alcohol use, and risks of
controlled-case study on risk factors in the mouth. A case-control study from laryngeal and lung cancer by subsite and
tumors of the oral cavity. Perspectives northern Italy. Cancer 1992;70:2227-33. histologic type in Turkey. Cancer Causes
and indications for early diagnosis]. 33. Franceschi S, Talamini R, Barra S, et al. Control 1997;8:729-37.
Minerva Med 1983;74:19-24. Smoking and drinking in relation to 50. Zheng T, Holford T, Chen Y, et al. Risk of
17. Elwood JM, Pearson JC, Skippen DH, et al. cancers of the oral cavity, pharynx, tongue cancer associated with tobacco
Alcohol, smoking, social and larynx, and esophagus in northern Italy. smoking and alcohol consumption: a
occupational factors in the aetiology of Cancer Res 1990;50:6502-7. case-control study. Oral Oncol
cancer of the oral cavity, pharynx and 34. Choi SY, Kahyo H. Effect of cigarette 1997;33:82-5.
larynx. Int J Cancer 1984;34:603-12. smoking and alcohol consumption in the 51. Rao DN, Desai PB. Risk assessment of
18. Zagraniski RT, Kelsey JL, Walter SD. aetiology of cancer of the oral cavity, tobacco, alcohol and diet in cancers of
Occupational risk factors for laryngeal pharynx and larynx. Int J Epidemiol base tongue and oral tongue - a case
carcinoma: Connecticut, 1975-1980. Am J 1991;20:878-85. control study. Indian J Cancer
Epidemiol 1986;124:67-76. 35. La Vecchia C, Negri E, DAvanzo B, et al. 1998;35:65-72.
19. De Stefani E, Correa P, Oreggia F, et al. Risk Dietary indicators of oral and pharyngeal 52. Su WZ, Ohno Y, Tohnai I, et al. Case-control
factors for laryngeal cancer. Cancer cancer. Int J Epidemiol 1991;20:39-44. study of oral cancer in Shenyang,
1987;60:3087-91. 36. Freudenheim JL, Graham S, Byers TE, et al. northeastern China. Int J Clin Oncol
20. Zemla B, Day N, Swiatnicka J, et al. Larynx Diet, smoking, and alcohol in cancer of 1998;3:13-8.
cancer risk factors. Neoplasma the larynx: a case-control study. Nutr 53. Wasnik KS, Ughade SN, Zodpey SP, et al.
1987;34:223-33. Cancer 1992;17:33-45. Tobacco consumption practices and risk
21. Brownson RC, Chang JC. Exposure to 37. Zheng W, Blot WJ, Shu XO, et al. Risk of oro-pharyngeal cancer: a case-control
alcohol and tobacco and the risk of factors for oral and pharyngeal cancer in study in Central India. Southeast Asian J
laryngeal cancer. Arch Environ Health Shanghai, with emphasis on diet. Cancer Trop Med Public Health 1998;29:827-34.
1987;42:192-6. Epidemiol Biomarkers Prev 1992;1:441-8. 54. Pintos J, Franco EL, Kowalski LP, et al. Use
22. Mackerras D, Buffler PA, Randall DE, et al. 38. Zheng W, Blot WJ, Shu XO, et al. Diet and of wood stoves and risk of cancers of the
Carotene intake and the risk of laryngeal other risk factors for laryngeal cancer in upper aero-digestive tract: a case-control
cancer in coastal Texas. Am J Epidemiol Shanghai, China. Am J Epidemiol study. Int J Epidemiol 1998;27:936-40.
1988;128:980-8. 1992;136:178-91. 55. Smith EM, Hoffman HT, Summersgill KS, et
23. Tuyns AJ, Esteve J, Raymond L, et al. Cancer 39. Lopez-Abente G, Pollan M, Monge V, et al. al. Human papillomavirus and risk of oral
of the larynx/hypopharynx, tobacco and Tobacco smoking, alcohol consumption, cancer. Laryngoscope 1998;108:1098-103.
alcohol: IARC international case-control and laryngeal cancer in Madrid. Cancer 56. Chatenoud L, La Vecchia C, Franceschi S, et
study in Turin and Varese (Italy), Detect Prev 1992;16:265-71. al. Refined-cereal intake and risk of
Zaragoza and Navarra (Spain), Geneva 40. Negri E, La Vecchia C, Franceschi S, et al. selected cancers in Italy. Am J Clin Nutr
(Switzerland) and Calvados (France). Int J Attributable risk for oral cancer in 1999;70:1107-10.
Cancer 1988;41:483-91. northern Italy. Cancer Epidemiol 57. Franceschi S, Levi F, La Vecchia C, et al.
24. Sankaranarayanan R, Duffy SW, Day NE, et Biomarkers Prev 1993;2:189-93. Comparison of the effect of smoking and
al. A case-control investigation of cancer 41. Mashberg A, Boffetta P, Winkelman R, et alcohol drinking between oral and
of the oral tongue and the floor of the al. Tobacco smoking, alcohol drinking, pharyngeal cancer. Int J Cancer
mouth in southern India. Int J Cancer and cancer of the oral cavity and 1999;83:1-4.
1989;44:617-21. oropharynx among U.S. veterans. Cancer 58. Fioretti F, Bosetti C, Tavani A, et al. Risk
25. Franco EL, Kowalski LP, Oliveira BV, et al. 1993;72:1369-75. factors for oral and pharyngeal cancer in
Risk factors for oral cancer in Brazil: a 42. Ng SK, Kabat GC, Wynder EL. Oral cavity never smokers. Oral Oncol 1999;35:375-
454
R E F E R E N C E S
455
F O O D , N U T R I T I O N , P H Y S I C A L A C T I V I T Y, A N D T H E P R E V E N T I O N O F C A N C E R : A G L O B A L P E R S P E C T I V E
107. De Stefani E, Deneo-Pellegrini H, 124. Hirayama T. [A large scale cohort study on Epidemiol Biomarkers Prev 1995;4:595-
Mendilaharsu M, et al. Diet and risk of the effect of life styles on the risk of 605.
cancer of the upper aerodigestive tract - cancer by each site]. Gan No Rinsho 140. Vizcaino AP, Parkin DM, Skinner ME. Risk
I. Foods. Oral Oncol 1999;35:17-21. 1990;Spec No:233-42. factors associated with oesophageal
108. De Stefani E, Correa P, Oreggia F, et al. 125. Yu Y, Taylor PR, Li JY, et al. Retrospective cancer in Bulawayo, Zimbabwe. Br J
Black tobacco, wine and mate in cohort study of risk-factors for Cancer 1995;72:769-73.
oropharyngeal cancer. A case-control esophageal cancer in Linxian, Peoples 141. Srivastava M, Kapil U, Chattopadhyaya
study from Uruguay. Rev Epidemiol Republic of China. Cancer Causes Control TK, et al. Nutritional risk factors in
Sante Publique 1988;36:389-94. 1993;4:195-202. carcinoma esophagus. Nutr Res
109. Oreggia F, De Stefani E, Correa P, et al. 126. Tao X, Zhu H, Matanoski GM. Mutagenic 1995;15:177-85.
Risk factors for cancer of the tongue in drinking water and risk of male 142. Garidou A, Tzonou A, Lipworth L, et al.
Uruguay. Cancer 1991;67:180-3. esophageal cancer: a population-based Life-style factors and medical conditions
110. Knox EG. Foods and diseases. Br J Prev Soc case-control study. Am J Epidemiol in relation to esophageal cancer by
Med 1977;31:71-80. 1999;150:443-52. histologic type in a low-risk population.
111. Olsen GW, Mandel JS, Gibson RW, et al. A 127. Bradshaw E, Schonland M. Smoking, Int J Cancer 1996;68:295-9.
case-control study of pancreatic cancer drinking and oesophageal cancer in 143. Zhang ZF, Kurtz RC, Sun M, et al.
and cigarettes, alcohol, coffee and diet. African males of Johannesburg, South Adenocarcinomas of the esophagus and
Am J Public Health 1989;79:1016-9. Africa. Br J Cancer 1974;30:157-63. gastric cardia: medical conditions,
112. Zatonski W, Becher H, Lissowska J, et al. 128. Tuyns AJ, Pequignot G, Gignoux M, et al. tobacco, alcohol, and socioeconomic
Tobacco, alcohol, and diet in the etiology Cancers of the digestive tract, alcohol factors. Cancer Epidemiol Biomarkers
of laryngeal cancer: a population-based and tobacco. Int J Cancer 1982;30:9-11. Prev 1996;5:761-8.
case-control study. Cancer Causes Control 129. Adelhardt M, Moller Jensen O, Sand 144. Gammon MD, Schoenberg JB, Ahsan H, et
1991;2:3-10. Hansen H. Cancer of the larynx, pharynx, al. Tobacco, alcohol, and socioeconomic
113. Sokic SI, Adanja BJ, Marinkovic JP, et al. and oesophagus in relation to alcohol status and adenocarcinomas of the
Case-control study of risk factors in and tobacco consumption among Danish esophagus and gastric cardia. J Natl
laryngeal cancer. Neoplasma 1994;41:43- brewery workers. Dan Med Bull Cancer Inst 1997;89:1277-84.
7. 1985;32:119-23. 145. Dietz J, Pardo SH, Furtado CD, et al. [Risk
114. Longnecker MP, Wolz M, Parker DA. 130. Wang HH, Antonioli DA, Goldman H. factors related to esophageal cancer in
Ethnicity, distilled spirits consumption Comparative features of esophageal and Rio Grande do Sul, Brazil]. Rev Assoc
and mortality in Pennsylvania. J Stud gastric adenocarcinomas: recent changes Med Bras 1998;44:269-72.
Alcohol 1981;42:791-6. in type and frequency. Hum Pathol 146. Zambon P, Talamini R, La Vecchia C, et al.
115. Maserejian NN, Giovannucci E, Rosner B, 1986;17:482-7. Smoking, type of alcoholic beverage and
et al. Prospective study of fruits and 131. La Vecchia C, Negri E. The role of alcohol squamous-cell oesophageal cancer in
vegetables and risk of oral premalignant in oesophageal cancer in non-smokers, northern Italy. Int J Cancer 2000;86:144-
lesions in men. Am J Epidemiol and of tobacco in non-drinkers. Int J 9.
2006;164:556-66. Cancer 1989;43:784-5. 147. Levi F, Pasche C, Lucchini F, et al. Food
116. Garavello W, Bosetti C, Gallus S, et al. Type 132. Rao DN, Sanghvi LD, Desai PB. groups and oesophageal cancer risk in
of alcoholic beverage and the risk of Epidemiology of esophageal cancer. Vaud, Switzerland. Eur J Cancer Prev
laryngeal cancer. Eur J Cancer Prev Semin Surg Oncol 1989;5:351-4. 2000;9:257-63.
2006;15:69-73. 133. De Stefani E, Munoz N, Esteve J, et al. 148. Nayar D, Kapil U, Joshi YK, et al.
117. Vlajinac HD, Marinkovic JM, Sipetic SB, et Mate drinking, alcohol, tobacco, diet, Nutritional risk factors in esophageal
al. Case-control study of oropharyngeal and esophageal cancer in Uruguay. cancer. J Assoc Physicians India
cancer. Cancer Detect Prev 2006;30:152- Cancer Res 1990;50:426-31. 2000;48:781-7.
7. 134. Wang YP, Han XY, Su W, et al. Esophageal 149. Sharp L, Chilvers CE, Cheng KK, et al. Risk
118. Petti S, Scully C. Association between cancer in Shanxi Province, Peoples factors for squamous cell carcinoma of
different alcoholic beverages and Republic of China: a case-control study in the oesophagus in women: a case-
leukoplakia among non- to moderate- high and moderate risk areas. Cancer control study. Br J Cancer 2001;85:1667-
drinking adults: a matched case-control Causes Control 1992;3:107-13. 70.
study. Eur J Cancer 2006;42:521-7. 135. Kabat GC, Ng SK, Wynder EL. Tobacco, 150. Boonyaphiphat P, Thongsuksai P, Sriplung
119. Vaezi MF, Qadeer MA, Lopez R, et al. alcohol intake, and diet in relation to H, et al. Lifestyle habits and genetic
Laryngeal cancer and gastroesophageal adenocarcinoma of the esophagus and susceptibility and the risk of esophageal
reflux disease: a case-control study. Am J gastric cardia. Cancer Causes Control cancer in the Thai population. Cancer
Med 2006;119:768-76. 1993;4:123-32. Lett 2002;186:193-9.
120. Kono S, Ikeda M, Tokudome S, et al. 136. Gao YT, McLaughlin JK, Blot WJ, et al. Risk 151. Gao CM, Takezaki T, Wu JZ, et al.
Cigarette smoking, alcohol and cancer factors for esophageal cancer in Glutathione-S-transferases M1 (GSTM1)
mortality: a cohort study of male Shanghai, China. I. Role of cigarette and GSTT1 genotype, smoking,
Japanese physicians. Jpn J Cancer Res smoking and alcohol drinking. Int J consumption of alcohol and tea and risk
1987;78:1323-8. Cancer 1994;58:192-6. of esophageal and stomach cancers: a
121. Kinjo Y, Cui Y, Akiba S, et al. Mortality 137. Hanaoka T, Tsugane S, Ando N, et al. case-control study of a high-incidence
risks of oesophageal cancer associated Alcohol consumption and risk of area in Jiangsu Province, China. Cancer
with hot tea, alcohol, tobacco and diet in esophageal cancer in Japan: a case- Lett 2002;188:95-102.
Japan. J Epidemiol 1998;8:235-43. control study in seven hospitals. Jpn J 152. Znaor A, Brennan P, Gajalakshmi V, et al.
122. Sakata K, Hoshiyama Y, Morioka S, et al. Clin Oncol 1994;24:241-6. Independent and combined effects of
Smoking, alcohol drinking and 138. Brown LM, Silverman DT, Pottern LM, et tobacco smoking, chewing and alcohol
esophageal cancer: findings from the al. Adenocarcinoma of the esophagus drinking on the risk of oral, pharyngeal
JACC Study. J Epidemiol 2005;15 Suppl and esophagogastric junction in white and esophageal cancers in Indian men.
2:S212-9. men in the United States: alcohol, Int J Cancer 2003;105:681-6.
123. Tran GD, Sun XD, Abnet CC, et al. tobacco, and socioeconomic factors. 153. Wang AH, Sun CS, Li LS, et al. Genetic
Prospective study of risk factors for Cancer Causes Control 1994;5:333-40. susceptibility and environmental factors
esophageal and gastric cancers in the 139. Rolon PA, Castellsague X, Benz M, et al. of esophageal cancer in Xian. World J
Linxian general population trial cohort Hot and cold mate drinking and Gastroenterol 2004;10:940-4.
in China. Int J Cancer 2005;113:456-63. esophageal cancer in Paraguay. Cancer 154. Jozala E, Infante S, Marchini JS, et al.
456
R E F E R E N C E S
[Alcoholism, smoking and epidermoid 170. Bosetti C, La Vecchia C, Negri E, et al. 1979;32:83-101.
carcinoma of the middle third of the Wine and other types of alcoholic 186. Kendell RE. The beneficial consequences
esophagus: a case-control study]. Rev beverages and the risk of esophageal of the United Kingdoms declining per
Saude Publica 1983;17:221-5. cancer. Eur J Clin Nutr 2000;54:918-20. capita consumption of alcohol in 1979-
155. Rossi M, Ancona E, Mastrangelo G, et al. 171. Takezaki T, Gao CM, Wu JZ, et al. Dietary 82. Alcohol Alcohol 1984;19:271-6.
[Epidemiologic findings in esophageal protective and risk factors for 187. Thouez JP, Ghadirian P. [Geographical
cancer in the Veneto region]. Minerva esophageal and stomach cancers in a relations between mortality from cancer
Med 1982;73:1531-40. low-epidemic area for stomach cancer in of the esophagus, cirrhosis of the liver,
156. Tuyns AJ. Oesophageal cancer in non- Jiangsu Province, China: comparison alcohol and tobacco: case of the
smoking drinkers and in non-drinking with those in a high-epidemic area. Jpn J Province of Quebec]. Soc Sci Med
smokers. Int J Cancer 1983;32:443-4. Cancer Res 2001;92:1157-65. 1986;22:611-8.
157. Decarli A, Liati P, Negri E, et al. Vitamin A 172. Lee JM, Lee YC, Yang SY, et al. Genetic 188. Guo WD, Li JY, Blot WJ, et al. Correlations
and other dietary factors in the etiology polymorphisms of XRCC1 and risk of the of dietary intake and blood nutrient
of esophageal cancer. Nutr Cancer esophageal cancer. Int J Cancer levels with esophageal cancer mortality
1987;10:29-37. 2001;95:240-6. in China. Nutr Cancer 1990;13:121-7.
158. Choi SY, Kahyo H. Effect of cigarette 173. Wu MM, Kuo TL, Hwang YH, et al. Dose- 189. Macfarlane GJ, Macfarlane TV, Lowenfels
smoking and alcohol consumption in the response relation between arsenic AB. The influence of alcohol
etiology of cancers of the digestive tract. concentration in well water and consumption on worldwide trends in
Int J Cancer 1991;49:381-6. mortality from cancers and vascular mortality from upper aerodigestive tract
159. Valsecchi MG. Modelling the relative risk diseases. Am J Epidemiol 1989;130:1123- cancers in men. J Epidemiol Community
of esophageal cancer in a case-control 32. Health 1996;50:636-9.
study. J Clin Epidemiol 1992;45:347-55. 174. Engel LS, Chow WH, Vaughan TL, et al. 190. De Jong UW, Breslow N, Hong JG, et al.
160. Cheng KK, Day NE, Duffy SW, et al. Population attributable risks of Aetiological factors in oesophageal
Pickled vegetables in the aetiology of esophageal and gastric cancers. J Natl cancer in Singapore Chinese. Int J Cancer
oesophageal cancer in Hong Kong Cancer Inst 2003;95:1404-13. 1974;13:291-303.
Chinese. Lancet 1992;339:1314-8. 175. Chitra S, Ashok L, Anand L, et al. Risk 191. Segal I, Reinach SG, de Beer M. Factors
161. Castelletto R, Castellsague X, Munoz N, et factors for esophageal cancer in associated with oesophageal cancer in
al. Alcohol, tobacco, diet, mate drinking, Coimbatore, southern India: a hospital- Soweto, South Africa. Br J Cancer
and esophageal cancer in Argentina. based case-control study. Indian J 1988;58:681-6.
Cancer Epidemiol Biomarkers Prev Gastroenterol 2004;23:19-21. 192. Sammon AM. Protease inhibitors and
1994;3:557-64. 176. Parkin DM, Vizcaino AP, Skinner ME, et al. carcinoma of the esophagus. Cancer
162. Vaughan TL, Davis S, Kristal A, et al. Cancer patterns and risk factors in the 1998;83:405-8.
Obesity, alcohol, and tobacco as risk African population of southwestern 193. Mettlin C, Graham S, Priore R, et al. Diet
factors for cancers of the esophagus and Zimbabwe, 1963-1977. Cancer Epidemiol and cancer of the esophagus. Nutr
gastric cardia: adenocarcinoma versus Biomarkers Prev 1994;3:537-47. Cancer 1981;2:143-7.
squamous cell carcinoma. Cancer 177. Trivers KF, De Roos AJ, Gammon MD, et al. 194. Victora CG, Munoz N, Day NE, et al. Hot
Epidemiol Biomarkers Prev 1995;4:85-92. Demographic and lifestyle predictors of beverages and oesophageal cancer in
163. Cheng KK, Duffy SW, Day NE, et al. survival in patients with esophageal or southern Brazil: a case-control study. Int
Oesophageal cancer in never-smokers gastric cancers. Clin Gastroenterol J Cancer 1987;39:710-6.
and never-drinkers. Int J Cancer Hepatol 2005;3:225-30. 195. Yu MC, Garabrant DH, Peters JM, et al.
1995;60:820-2. 178. Sankaranarayanan R, Duffy SW, Tobacco, alcohol, diet, occupation, and
164. Cheng KK, Duffy SW, Day NE, et al. Padmakumary G, et al. Risk factors for carcinoma of the esophagus. Cancer Res
Stopping drinking and risk of cancer of the oesophagus in Kerala, 1988;48:3843-8.
oesophageal cancer. BMJ 1995;310:1094- India. Int J Cancer 1991;49:485-9. 196. Brown LM, Blot WJ, Schuman SH, et al.
7. 179. Lee CH, Lee JM, Wu DC, et al. Environmental factors and high risk of
165. Gimeno SG, de Souza JM, Mirra AP, et al. Independent and combined effects of esophageal cancer among men in coastal
[Risk factors for cancer of the esophagus: alcohol intake, tobacco smoking and South Carolina. J Natl Cancer Inst
a case control study in a metropolitan betel quid chewing on the risk of 1988;80:1620-5.
area of south-eastern Brazil]. Rev Saude esophageal cancer in Taiwan. Int J 197. Graham S, Marshall J, Haughey B, et al.
Publica 1995;29:159-65. Cancer 2005;113:475-82. Nutritional epidemiology of cancer of
166. Nandakumar A, Anantha N, 180. Yang CX, Wang HY, Wang ZM, et al. Risk the esophagus. Am J Epidemiol
Pattabhiraman V, et al. Importance of factors for esophageal cancer: a case- 1990;131:454-67.
anatomical subsite in correlating risk control study in South-western China. 198. Chilvers C, Fraser P, Beral V. Alcohol and
factors in cancer of the oesophagus - Asian Pac J Cancer Prev 2005;6:48-53. oesophageal cancer: an assessment of
report of a case-control study. Br J 181. Tavani A, Negri E, Franceschi S, et al. Risk the evidence from routinely collected
Cancer 1996;73:1306-11. factors for esophageal cancer in women data. J Epidemiol Community Health
167. Gao CM, Takezaki T, Ding JH, et al. in northern Italy. Cancer 1993;72:2531-6. 1979;33:127-33.
Protective effect of allium vegetables 182. Tavani A, Negri E, Franceschi S, et al. Risk 199. Llopis A, Morales M, Rodriguez R.
against both esophageal and stomach factors for esophageal cancer in lifelong Digestive cancer in relation to diet in
cancer: a simultaneous case-referent nonsmokers. Cancer Epidemiol Spain. J Environ Pathol Toxicol Oncol
study of a high-epidemic area in Jiangsu Biomarkers Prev 1994;3:387-92. 1992;11:169-75.
Province, China. Jpn J Cancer Res 183. Thun MJ, Peto R, Lopez AD, et al. Alcohol 200. Hinds MW, Kolonel LN, Lee J, et al.
1999;90:614-21. consumption and mortality among Associations between cancer incidence
168. Cheng KK, Sharp L, McKinney PA, et al. A middle-aged and elderly U.S. adults. N and alcohol/cigarette consumption
case-control study of oesophageal Engl J Med 1997;337:1705-14. among five ethnic groups in Hawaii. Br J
adenocarcinoma in women: a 184. Kono S, Ikeda M. Correlation between Cancer 1980;41:929-40.
preventable disease. Br J Cancer cancer mortality and alcoholic beverage 201. Vassallo A, Correa P, De Stefani E, et al.
2000;83:127-32. in Japan. Br J Cancer 1979;40:449-55. Esophageal cancer in Uruguay: a case-
169. Bosetti C, Franceschi S, Levi F, et al. 185. Yanai H, Inaba Y, Takagi H, et al. control study. J Natl Cancer Inst
Smoking and drinking cessation and the Multivariate analysis of cancer 1985;75:1005-9.
risk of oesophageal cancer. Br J Cancer mortalities for selected sites in 24 202. Hu J, Nyren O, Wolk A, et al. Risk factors
2000;83:689-91. countries. Environ Health Perspect for oesophageal cancer in northeast
457
F O O D , N U T R I T I O N , P H Y S I C A L A C T I V I T Y, A N D T H E P R E V E N T I O N O F C A N C E R : A G L O B A L P E R S P E C T I V E
China. Int J Cancer 1994;57:38-46. Gut 2003;52:861-7. and colon cancer risk: evidence from
203. Ishikawa A, Kuriyama S, Tsubono Y, et al. 219. Wei EK, Giovannucci E, Wu K, et al. NHANES I epidemiologic follow-up study.
Smoking, alcohol drinking, green tea Comparison of risk factors for colon and Ann Epidemiol 2001;11:65-72.
consumption and the risk of esophageal rectal cancer. Int J Cancer 2004;108:433- 234. Tiemersma EW, Kampman E, Bueno de
cancer in Japanese men. J Epidemiol 42. Mesquita HB, et al. Meat consumption,
2006;16:185-92. 220. Kjaerheim K, Andersen A, Helseth A. cigarette smoking, and genetic
204. Yokoyama A, Kato H, Yokoyama T, et al. Alcohol abstainers: a low-risk group for susceptibility in the etiology of colorectal
Esophageal squamous cell carcinoma cancer - a cohort study of Norwegian cancer: results from a Dutch prospective
and aldehyde dehydrogenase-2 teetotalers. Cancer Epidemiol study. Cancer Causes Control
genotypes in Japanese females. Alcohol Biomarkers Prev 1993;2:93-7. 2002;13:383-93.
Clin Exp Res 2006;30:491-500. 221. Schoen RE, Tangen CM, Kuller LH, et al. 235. Konings EJ, Goldbohm RA, Brants HA, et
205. Wu M, Zhao JK, Hu XS, et al. Association Increased blood glucose and insulin, al. Intake of dietary folate vitamers and
of smoking, alcohol drinking and dietary body size, and incident colorectal cancer. risk of colorectal carcinoma: results from
factors with esophageal cancer in high- J Natl Cancer Inst 1999;91:1147-54. The Netherlands Cohort Study. Cancer
and low-risk areas of Jiangsu Province, 222. Flood A, Caprario L, Chaterjee N, et al. 2002;95:1421-33.
China. World J Gastroenterol Folate, methionine, alcohol, and 236. Garland C, Shekelle RB, Barrett Connor E,
2006;12:1686-93. colorectal cancer in a prospective study et al. Dietary vitamin D and calcium and
206. Wu IC, Lu CY, Kuo FC, et al. Interaction of women in the United States. Cancer risk of colorectal cancer: a 19-year
between cigarette, alcohol and betel nut Causes Control 2002;13:551-61. prospective study in men. Lancet
use on esophageal cancer risk in Taiwan. 223. Sanjoaquin MA, Appleby PN, Thorogood 1985;1:307-9.
Eur J Clin Invest 2006;36:236-41. M, et al. Nutrition, lifestyle and 237. Stemmermann GN, Nomura AM, Heilbrun
207. Veugelers PJ, Porter GA, Guernsey DL, et colorectal cancer incidence: a LK. Dietary fat and the risk of colorectal
al. Obesity and lifestyle risk factors for prospective investigation of 10998 cancer. Cancer Res 1984;44:4633-7.
gastroesophageal reflux disease, Barrett vegetarians and non-vegetarians in the 238. Kreger BE, Anderson KM, Schatzkin A, et
esophagus and esophageal United Kingdom. Br J Cancer al. Serum cholesterol level, body mass
adenocarcinoma. Dis Esophagus 2004;90:118-21. index, and the risk of colon cancer. The
2006;19:321-8. 224. Sidney S, Friedman GD, Hiatt RA. Serum Framingham Study. Cancer 1992;70:1038-
208. Hirayama T. Mortality in Japanese with cholesterol and large bowel cancer. A 43.
life-styles similar to Seventh-Day case-control study. Am J Epidemiol 239. Gapstur SM, Potter JD, Folsom AR.
Adventists: strategy for risk reduction by 1986;124:33-8. Alcohol consumption and colon and
life-style modification. Natl Cancer Inst 225. Koh WP, Yuan JM, van den Berg D, et al. rectal cancer in postmenopausal women.
Monogr 1985;69:143-53. Interaction between cyclooxygenase-2 Int J Epidemiol 1994;23:50-7.
209. Jacobs EJ, Connell CJ, Patel AV, et al. gene polymorphism and dietary n-6 240. Chyou PH, Nomura AM, Stemmermann
Multivitamin use and colon cancer polyunsaturated fatty acids on colon GN. A prospective study of colon and
mortality in the Cancer Prevention Study cancer risk: The Singapore Chinese rectal cancer among Hawaii Japanese
II cohort (United States). Cancer Causes Health Study. Br J Cancer 2004;90:1760-4. men. Ann Epidemiol 1996;6:276-82.
Control 2001;12:927-34. 226. Chen J, Ma J, Stampfer MJ, et al. Alcohol 241. Colbert LH, Hartman TJ, Malila N, et al.
210. Hirayama T. Association between alcohol dehydrogenase 3 genotype is not Physical activity in relation to cancer of
consumption and cancer of the sigmoid predictive for risk of colorectal cancer. the colon and rectum in a cohort of male
colon: observations from a Japanese Cancer Epidemiol Biomarkers Prev smokers. Cancer Epidemiol Biomarkers
cohort study. Lancet 1989;2:725-7. 2001;10:1303-4. Prev 2001;10:265-8.
211. Williams RR, Sorlie PD, Feinleib M, et al. 227. Murata M, Takayama K, Choi BC, et al. A 242. Fuchs CS, Willett WC, Colditz GA, et al.
Cancer incidence by levels of cholesterol. nested case-control study on alcohol The influence of folate and multivitamin
JAMA 1981;245:247-52. drinking, tobacco smoking, and cancer. use on the familial risk of colon cancer in
212. Pollack ES, Nomura AM, Heilbrun LK, et Cancer Detect Prev 1996;20:557-65. women. Cancer Epidemiol Biomarkers
al. Prospective study of alcohol 228. Hsing AW, McLaughlin JK, Chow WH, et Prev 2002;11:227-34.
consumption and cancer. N Engl J Med al. Risk factors for colorectal cancer in a 243. Harnack L, Jacobs DR, Jr., Nicodemus K, et
1984;310:617-21. prospective study among U.S. white al. Relationship of folate, vitamin B-6,
213. Klatsky AL, Armstrong MA, Friedman GD, men. Int J Cancer 1998;77:549-53. vitamin B-12, and methionine intake to
et al. The relations of alcoholic beverage 229. Ford ES. Body mass index and colon incidence of colorectal cancers. Nutr
use to colon and rectal cancer. Am J cancer in a national sample of adult US Cancer 2002;43:152-8.
Epidemiol 1988;128:1007-15. men and women. Am J Epidemiol 244. Nakaya N, Tsubono Y, Kuriyama S, et al.
214. Stemmermann GN, Nomura AM, Chyou 1999;150:390-8. Alcohol consumption and the risk of
PH, et al. Prospective study of alcohol 230. Otani T, Iwasaki M, Yamamoto S, et al. cancer in Japanese men: the Miyagi
intake and large bowel cancer. Dig Dis Alcohol consumption, smoking, and cohort study. Eur J Cancer Prev
Sci 1990;35:1414-20. subsequent risk of colorectal cancer in 2005;14:169-74.
215. Suadicani P, Hein HO, Gyntelberg F. middle-aged and elderly Japanese men 245. Wu AH, Paganini Hill A, Ross RK, et al.
Height, weight, and risk of colorectal and women: Japan Public Health Center- Alcohol, physical activity and other risk
cancer. An 18-year follow-up in a cohort based prospective study. Cancer factors for colorectal cancer: a
of 5249 men. Scand J Gastroenterol Epidemiol Biomarkers Prev prospective study. Br J Cancer
1993;28:285-8. 2003;12:1492-500. 1987;55:687-94.
216. Giovannucci E, Rimm EB, Ascherio A, et al. 231. Kato I, Dnistrian AM, Schwartz M, et al. 246. Malila N, Virtamo J, Virtanen M, et al.
Alcohol, low-methionine - low-folate Serum folate, homocysteine and Dietary and serum alpha-tocopherol,
diets, and risk of colon cancer in men. J colorectal cancer risk in women: a nested beta-carotene and retinol, and risk for
Natl Cancer Inst 1995;87:265-73. case-control study. Br J Cancer colorectal cancer in male smokers. Eur J
217. Singh PN, Fraser GE. Dietary risk factors 1999;79:1917-22. Clin Nutr 2002;56:615-21.
for colon cancer in a low-risk population. 232. Glynn SA, Albanes D, Pietinen P, et al. 247. Glynn SA, Albanes D, Pietinen P, et al.
Am J Epidemiol 1998;148:761-74. Alcohol consumption and risk of Colorectal cancer and folate status: a
218. Pedersen A, Johansen C, Gronbaek M. colorectal cancer in a cohort of Finnish nested case-control study among male
Relations between amount and type of men. Cancer Causes Control 1996;7:214- smokers. Cancer Epidemiol Biomarkers
alcohol and colon and rectal cancer in a 23. Prev 1996;5:487-94.
Danish population based cohort study. 233. Su LJ, Arab L. Nutritional status of folate 248. Feskanich D, Ma J, Fuchs CS, et al. Plasma
458
R E F E R E N C E S
vitamin D metabolites and risk of mutations in sporadic colorectal breast cancer risk. Cancer Causes Control
colorectal cancer in women. Cancer adenomas. Int J Cancer 2005;113:126-32. 1999;10:369-77.
Epidemiol Biomarkers Prev 263. Byrne C, Ursin G, Ziegler RG. A 278. Freudenheim JL, Bonner M, Krishnan S, et
2004;13:1502-8. comparison of food habit and food al. Diet and alcohol consumption in
249. Goldbohm RA, Van den Brandt PA, Van t frequency data as predictors of breast relation to p53 mutations in breast
Veer P, et al. Prospective study on alcohol cancer in the NHANES I/NHEFS cohort. J tumors. Carcinogenesis 2004;25:931-9.
consumption and the risk of cancer of Nutr 1996;126:2757-64. 279. Haile RW, Witte JS, Ursin G, et al. A case-
the colon and rectum in the 264. Feigelson HS, E. CE, Robertson AS, et al. control study of reproductive variables,
Netherlands. Cancer Causes Control Alcohol consumption increases the risk alcohol, and smoking in premenopausal
1994;5:95-104. of fatal breast cancer (United States). bilateral breast cancer. Breast Cancer Res
250. Pietinen P, Malila N, Virtanen M, et al. Cancer Causes Control 2001;12:895-902. Treat 1996;37:49-56.
Diet and risk of colorectal cancer in a 265. Hoyer AP, Engholm G. Serum lipids and 280. Harvey EB, Schairer C, Brinton LA, et al.
cohort of Finnish men. Cancer Causes breast cancer risk: a cohort study of Alcohol consumption and breast cancer.
Control 1999;10:387-96. 5,207 Danish women. Cancer Causes J Natl Cancer Inst 1987;78:657-61.
251. Longnecker MMP, Orza MMJ, Adams Control 1992;3:403-8. 281. Hirose K, Tajima K, Hamajima N, et al. A
MME, et al. A meta-analysis of alcoholic 266. Key TJ, Sharp GB, Appleby PN, et al. Soya large-scale, hospital-based case-control
beverage consumption in relation to risk foods and breast cancer risk: a study of risk factors of breast cancer
of colorectal cancer. Cancer Causes prospective study in Hiroshima and according to menopausal status. Jpn J
Control 1990;1:59. Nagasaki, Japan. Br J Cancer Cancer Res 1995;86:146-54.
252. Cho E, Smith-Warner SA, Ritz J, et al. 1999;81:1248-56. 282. Holmberg L, Ohlander EM, Byers T, et al.
Alcohol intake and colorectal cancer: a 267. Morch LS, Becker U, Olsen J, et al. [Should Diet and breast cancer risk. Results from
pooled analysis of 8 cohort studies. Ann the sensible drinking limits for adults be a population-based, case-control study
Intern Med 2004;140:603-13. changed?]. Ugeskr Laeger in Sweden. Arch Intern Med
253. Murata M, Tagawa M, Watanabe S, et al. 2005;167:3777-9. 1994;154:1805-11.
Genotype difference of aldehyde 268. Petri AL, Tjonneland A, Gamborg M, et al. 283. Hu YH, Nagata C, Shimizu H, et al.
dehydrogenase 2 gene in alcohol Alcohol intake, type of beverage, and Association of body mass index, physical
drinkers influences the incidence of risk of breast cancer in pre- and activity, and reproductive histories with
Japanese colorectal cancer patients. Jpn postmenopausal women. Alcohol Clin breast cancer: a case-control study in
J Cancer Res 1999;90:711-9. Exp Res 2004;28:1084-90. Gifu, Japan. Breast Cancer Res Treat
254. Tiemersma EW, Wark PA, Ocke MC, et al. 269. Pike MC, Kolonel LN, Henderson BE, et al. 1997;43:65-72.
Alcohol consumption, alcohol Breast cancer in a multiethnic cohort in 284. Katsouyanni K, Trichopoulou A, Stuver S,
dehydrogenase 3 polymorphism, and Hawaii and Los Angeles: risk factor- et al. Ethanol and breast cancer: an
colorectal adenomas. Cancer Epidemiol adjusted incidence in Japanese equals association that may be both
Biomarkers Prev 2003;12:419-25. and in Hawaiians exceeds that in whites. confounded and causal. Int J Cancer
255. Jin MJ, Chen K, Song L, et al. The Cancer Epidemiol Biomarkers Prev 1994;58:356-61.
association of the DNA repair gene 2002;11:795-800. 285. Kikuchi S, Okamoto N, Suzuki T, et al. [A
XRCC3 Thr241Met polymorphism with 270. Vachon CM, Cerhan JR, Vierkant RA, et al. case control study of breast cancer,
susceptibility to colorectal cancer in a Investigation of an interaction of alcohol mammary cyst and dietary, drinking or
Chinese population. Cancer Genet intake and family history on breast smoking habit in Japan]. Gan No Rinsho
Cytogenet 2005;163:38-43. cancer risk in the Minnesota Breast 1990;Spec No:365-9.
256. Jiang Q, Chen K, Ma X, et al. Diets, Cancer Family Study. Cancer 286. Kinney AY, Millikan RC, Lin YH, et al.
polymorphisms of 2001;92:240-8. Alcohol consumption and breast cancer
methylenetetrahydrofolate reductase, 271. Wu K, Helzlsouer KJ, Comstock GW, et al. among black and white women in North
and the susceptibility of colon cancer A prospective study on folate, B12, and Carolina (United States). Cancer Causes
and rectal cancer. Cancer Detect Prev pyridoxal 5-phosphate (B6) and breast Control 2000;11:345-57.
2005;29:146-54. cancer. Cancer Epidemiol Biomarkers 287. Lash TL, Aschengrau A. Alcohol drinking
257. Wakai K, Kojima M, Tamakoshi K, et al. Prev 1999;8:209-17. and risk of breast cancer. Breast J
Alcohol consumption and colorectal 272. Althuis MD, Brogan DD, Coates RJ, et al. 2000;6:396-9.
cancer risk: findings from the JACC Breast cancers among very young 288. Lee KM, Abel J, Ko Y, et al. Genetic
Study. J Epidemiol 2005;15 Suppl 2:S173- premenopausal women (United States). polymorphisms of cytochrome P450 19
9. Cancer Causes Control 2003;14:151-60. and 1B1, alcohol use, and breast cancer
258. Chen K, Jiang Q, Ma X, et al. Alcohol 273. Atalah E, Urteaga C, Rebolledo A, et al. risk in Korean women. Br J Cancer
drinking and colorectal cancer: a [Breast cancer risk factors in women in 2003;88:675-8.
population-based prospective cohort Santiago, Chile]. Rev Med Chil 289. Lenz SK, Goldberg MS, Labreche F, et al.
study in China. Eur J Epidemiol 2000;128:137-43. Association between alcohol
2005;20:149-54. 274. Baumgartner KB, Annegers JF, McPherson consumption and postmenopausal
259. Huang XE, Hirose K, Wakai K, et al. RS, et al. Is alcohol intake associated breast cancer: results of a case-control
Comparison of lifestyle risk factors by with breast cancer in Hispanic women? study in Montreal, Quebec, Canada.
family history for gastric, breast, lung The New Mexico Womens Health Study. Cancer Causes Control 2002;13:701-10.
and colorectal cancer. Asian Pac J Cancer Ethn Dis 2002;12:460-9. 290. Marcus PM, Newman B, Millikan RC, et al.
Prev 2004;5:419-27. 275. Brinton LA, Potischman NA, Swanson CA, The associations of adolescent cigarette
260. Kim DH, Ahn YO, Lee BH, et al. et al. Breastfeeding and breast cancer smoking, alcoholic beverage
Methylenetetrahydrofolate reductase risk. Cancer Causes Control 1995;6:199- consumption, environmental tobacco
polymorphism, alcohol intake, and risks 208. smoke, and ionizing radiation with
of colon and rectal cancers in Korea. 276. Freudenheim JL, Marshall JR, Graham S, subsequent breast cancer risk (United
Cancer Lett 2004;216:199-205. et al. Lifetime alcohol consumption and States). Cancer Causes Control
261. Hong YC, Lee KH, Kim WC, et al. risk of breast cancer. Nutr Cancer 2000;11:271-8.
Polymorphisms of XRCC1 gene, alcohol 1995;23:1-11. 291. Mayberry RM, Stoddard-Wright C. Breast
consumption and colorectal cancer. Int J 277. Freudenheim JL, Ambrosone CB, Moysich cancer risk factors among black women
Cancer 2005;116:428-32. KB, et al. Alcohol dehydrogenase 3 and white women: similarities and
262. Diergaarde B, Tiemersma EW, Braam H, et genotype modification of the differences. Am J Epidemiol
al. Dietary factors and truncating APC association of alcohol consumption with 1993;136:1445-56.
459
F O O D , N U T R I T I O N , P H Y S I C A L A C T I V I T Y, A N D T H E P R E V E N T I O N O F C A N C E R : A G L O B A L P E R S P E C T I V E
292. McCredie MRE, Dite GS, Giles GG, et al. Cancer Inst 1977;58:525-47. Cancer Prev 1994;3:313-20.
Breast cancer in Australian women under 309. Yim DS, Parkb SK, Yoo KY, et al. 326. Li CI, Malone KE, Porter PL, et al. The
the age of 40. Cancer Causes Control Relationship between the Val158Met relationship between alcohol use and
1998;9:189-98. polymorphism of catechol O-methyl risk of breast cancer by histology and
293. Peacock SL, White E, Daling JR, et al. transferase and breast cancer. hormone receptor status among women
Relation between obesity and breast Pharmacogenetics 2001;11:279-86. 65-79 years of age. Cancer Epidemiol
cancer in young women. Am J Epidemiol 310. Zheng T, Holford TR, Zahm SH, et al. Biomarkers Prev 2003;12:1061-6.
1999;149:339-46. Glutathione S-transferase M1 and T1 327. Lucena RA, Allam MF, Costabeber IH, et al.
294. Potischman N, Swanson CA, Coates RJ, et genetic polymorphisms, alcohol Breast cancer risk factors: PCB congeners.
al. Dietary relationships with early onset consumption and breast cancer risk. Br J Eur J Cancer Prev 2001;10:117-9.
(under age 45) breast cancer in a case- Cancer 2003;88:58-62. 328. McElroy JA, Kanarek MS, Trentham-Dietz
control study in the United States: 311. Anglin L, Mann RE, Smart RG. Changes in A, et al. Potential exposure to PCBs, DDT
Influence of chemotherapy treatment. cancer mortality rates and per capita and PBDEs from sport-caught fish
Cancer Causes Control 1997;8:713-21. alcohol consumption in Ontario, 1963- consumption in relation to breast cancer
295. Rosenberg L, Slone D, Shapiro S, et al. 1983. Int J Addict 1995;30:489-95. risk in Wisconsin. Environ Health
Breast cancer and alcoholic-beverage 312. Guo WD, Chow WH, Zheng W, et al. Diet, Perspect 2004;112:156-62.
consumption. Lancet 1982;1:267-70. serum markers and breast cancer 329. Mendonca GAS, Eluf-Neto J, Andrada-
296. Rosenberg L, Palmer JR, Miller DR, et al. A mortality in China. Jpn J Cancer Res Serpa MJ, et al. Organochlorines and
case-control study of alcoholic beverage 1994;85:572-7. breast cancer: a case-control study in
consumption and breast cancer. Am J 313. Baglietto L, English DR, Gertig DM, et al. Brazil. Int J Cancer 1999;83:596-600.
Epidemiol 1990;131:6-14. Does dietary folate intake modify effect 330. Moorman PG, Ricciuti MF, Millikan RC, et
297. Sneyd MJ, Paul C, Spears GF, et al. Alcohol of alcohol consumption on breast cancer al. Vitamin supplement use and breast
consumption and risk of breast cancer. risk? Prospective cohort study. BMJ cancer in a North Carolina population.
Int J Cancer 1991;48:812-5. 2005;331:807. Public Health Nutr 2001;4:821-7.
298. Sturmer T, Wang-Gohrke S, Arndt V, et al. 314. Colditz GA, Rosner B. Cumulative risk of 331. Okobia MN, Bunker CH, Lee LL, et al.
Interaction between alcohol breast cancer to age 70 years according Case-control study of risk factors for
dehydrogenase II gene, alcohol to risk factor status: data from the breast cancer in Nigerian women: a pilot
consumption, and risk for breast cancer. Nurses Health Study. Am J Epidemiol study. East Afr Med J 2005;82:14-9.
Br J Cancer 2002;87:519-23. 2000;152:950-64. 332. Webster LA, Layde PM, Wingo PA, et al.
299. Swanson CA, Coates RJ, Schoenberg JB, et 315. Holmberg L, Baron JA, Byers T, et al. Alcohol consumption and risk of breast
al. Body size and breast cancer risk Alcohol intake and breast cancer risk: cancer. Lancet 1983;2:724-6.
among women under age 45 years. Am J effect of exposure from 15 years of age. 333. Zaridze D, Lifanova Y, Maximovitch D, et
Epidemiol 1996;143:698-706. Cancer Epidemiol Biomarkers Prev al. Diet, alcohol consumption and
300. Swanson CA, Coates RJ, Malone KE, et al. 1995;4:843-7. reproductive factors in a case-control
Alcohol consumption and breast cancer 316. Hoyer AP, Grandjean P, Jorgensen T, et al. study of breast cancer in Moscow. Int J
risk among women under age 45 years. Organochlorine exposure and risk of Cancer 1991;48:493-501.
Epidemiology 1997;8:231-7. breast cancer. Lancet 1998;352:1816-20. 334. Barrett-Connor E, Friedlander NJ. Dietary
301. Tajima K, Hirose K, Ogawa H, et al. 317. Adami HO, Lund E, Bergstrom R, et al. fat, calories, and the risk of breast cancer
[Hospital epidemiology - a comparative Cigarette smoking, alcohol consumption in postmenopausal women: a
case control study of breast and cervical and risk of breast cancer in young prospective population-based study. J
cancers]. Gan No Rinsho 1990;Spec women. Br J Cancer 1988;58:832-7. Am Coll Nutr 1993;12:390-9.
No:351-64. 318. Bowlin SJ, Leske MC, Varma A, et al. 335. Chen WY, Colditz GA, Rosner B, et al. Use
302. Talamini R, La Vecchia C, Decarli A, et al. Breast cancer risk and alcohol of postmenopausal hormones, alcohol,
Social factors, diet and breast cancer in a consumption: results from a large case- and risk for invasive breast cancer. Ann
northern Italian population. Br J Cancer control study. Int J Epidemiol Intern Med 2002;137:798-804.
1984;49:723-9. 1997;26:915-23. 336. Colditz GA, Rosner BA, Chen WY, et al.
303. Tavani A, Gallus S, La Vecchia C, et al. Risk 319. Claus EB, Stowe M, Carter D. Breast Risk factors for breast cancer according
factors for breast cancer in women under carcinoma in situ: Risk factors and to estrogen and progesterone receptor
40 years. Eur J Cancer 1999;35:1361-7. screening patterns. J Natl Cancer Inst status. J Natl Cancer Inst 2004;96:218-28.
304. Thorand B, Kohlmeier L, Simonsen N, et 2001;93:1811-7. 337. Duffy C, Assaf AR, Cyr MG, et al. Alcohol
al. Intake of fruits, vegetables, folic acid 320. Fioretti F, Tavani A, Bosetti C, et al. Risk and folate intake and breast cancer risk.
and related nutrients and risk of breast factors for breast cancer in nulliparous J Gen Intern Med 2004;19:115.
cancer in postmenopausal women. women. Br J Cancer 1999;79:1923-8. 338. Dumeaux V, Lund E, Hjartaker A. Use of
Public Health Nutr 1998;1:147-56. 321. Gallus S, Franceschi S, La Vecchia C. oral contraceptives, alcohol, and risk for
305. Toniolo P, Riboli E, Protta F, et al. Breast Alcohol, postmenopausal hormones, and invasive breast cancer. Cancer Epidemiol
cancer and alcohol consumption: a case- breast cancer. Ann Intern Med Biomarkers Prev 2004;13:1302-7.
control study in northern Italy. Cancer 2003;139:601-2. 339. Feigelson HS, Jonas CR, Robertson AS, et
Res 1989;49:5203-6. 322. Hirose K, Tajima K, Hamajima N, et al. al. Alcohol, folate, methionine, and risk
306. Vecchia C, la Negri E, Parazzini F, et al. Impact of established risk factors for of incident breast cancer in the American
Alcohol and breast cancer: update from breast cancer in nulligravid Japanese Cancer Society Cancer Prevention Study II
an Italian case-control study. Eur J Cancer women. Breast Cancer 2003;10:45-53. Nutrition Cohort. Cancer Epidemiol
Clin Oncol 1989;25:1711-7. 323. Ibarluzea JM, Fernandez MF, Santa- Biomarkers Prev 2003;12:161-4.
307. Viladiu P, Izquierdo A, de Sanjose S, et al. Marina L, et al. Breast cancer risk and the 340. Friedenreich CM, Howe GR, Miller AB, et
A breast cancer case-control study in combined effect of environmental al. A cohort study of alcohol
Girona, Spain. Endocrine, familial and estrogens. Cancer Causes Control consumption and risk of breast cancer.
lifestyle factors. Eur J Cancer Prev 2004;15:591-600. Am J Epidemiol 1993;137:512-20.
1996;5:329-35. 324. Iscovich JM, Iscovich RB, Howe G, et al. A 341. Fuchs CS, Stampfer MJ, Colditz GA, et al.
308. Williams RR, Horm JW. Association of case-control study of diet and breast Alcohol consumption and mortality
cancer sites with tobacco and alcohol cancer in Argentina. Int J Cancer among women. N Engl J Med
consumption and socioeconomic status 1989;44:770-6. 1995;332:1245-50.
of patients: interview study from the 325. Landa MC, Frago N, Tres A. Diet and the 342. Gapstur SM, Potter JD, Sellers TA, et al.
Third National Cancer Survey. J Natl risk of breast cancer in Spain. Eur J Increased risk of breast cancer with
460
R E F E R E N C E S
461
F O O D , N U T R I T I O N , P H Y S I C A L A C T I V I T Y, A N D T H E P R E V E N T I O N O F C A N C E R : A G L O B A L P E R S P E C T I V E
exposure in relation to the risk of breast 1985;109:82-5. prospective study in Haimen City, China.
cancer. Int J Epidemiol 1989;18:511-7. 404. Kono S, Ikeda M, Tokudome S, et al. Intervirology 1995;38:155-61.
389. Viel JF, Perarnau JM, Challier B, et al. Alcohol and mortality: a cohort study of 419. Sakoda LC, Graubard BI, Evans AA, et al.
Alcoholic calories, red wine consumption male Japanese physicians. Int J Epidemiol Toenail selenium and risk of
and breast cancer among 1986;15:527-32. hepatocellular carcinoma mortality in
premenopausal women. Eur J Epidemiol 405. Inaba Y, Kikuchi S, Namihisa T, et al. [The Haimen City, China. Int J Cancer
1997;13:639-43. effect of smoking and drinking habit on 2005;115:618-24.
390. Yoo K, Tajima K, Park S, et al. the process from liver cirrhosis to liver 420. Yu MW, Horng IS, Hsu KH, et al. Plasma
Postmenopausal obesity as a breast cancer]. Gan No Rinsho 1990;Spec selenium levels and risk of hepatocellular
cancer risk factor according to estrogen No:299-304. carcinoma among men with chronic
and progesterone receptor status 406. Inaba Y, Namihisa T, Ichikawa S, et al. [A hepatitis virus infection. Am J Epidemiol
(Japan). Cancer Lett 2001;167:57-63. long-term follow-up study of the 1999;150:367-74.
391. Zhu K, Davidson NE, Hunter S, et al. histologically confirmed chronic liver 421. Meng W, Tang JG, Shen FM, et al. Nested
Methyl-group dietary intake and risk of diseases in the Juntedo University case-control study on risk factors of
breast cancer among African-American Hospital]. Gan No Rinsho 1989;35:221-6. hepatocellular carcinoma. Fudan Univ J
women: a case-control study by 407. Yuan JM, Ross RK, Gao YT, et al. Follow up Med Sci 2002;29:368-71.
methylation status of the estrogen study of moderate alcohol intake and 422. Ross RK, Yuan JM, Yu MC, et al. Urinary
receptor alpha genes. Cancer Causes mortality among middle aged men in aflatoxin biomarkers and risk of
Control 2003;14:827-36. Shanghai, China. BMJ 1997;314:18-23. hepatocellular carcinoma. Lancet
392. Boing H, Martinez L, Frentzel Beyme R, et 408. Tu JT, Gao RN, Zhang DH, et al. Hepatitis B 1992;339:943-6.
al. Regional nutritional pattern and virus and primary liver cancer on 423. Chalasani N, Baluyut A, Ismail A, et al.
cancer mortality in the Federal Republic Chongming Island, Peoples Republic of Cholangiocarcinoma in patients with
of Germany. Nutr Cancer 1985;7:121-30. China. Natl Cancer Inst Monogr primary sclerosing cholangitis: a
393. Ewertz M, Duffy SW. Incidence of female 1985;69:213-5. multicenter case-control study.
breast cancer in relation to prevalence of 409. Nishiuchi M, Shinji Y. [Increased incidence Hepatology 2000;31:7-11.
risk factors in Denmark. Int J Cancer of hepatocellular carcinoma in abstinent 424. Kuper H, Lagiou P, Mucci LA, et al. Risk
1994;56:783-7. patients with alcoholic cirrhosis]. Gan To factors for cholangiocarcinoma in a low
394. Grant WB. An ecologic study of dietary Kagaku Ryoho 1990;17:1-6. risk Caucasian population. Soz
and solar ultraviolet-B links to breast 410. Goodman MT, Moriwaki H, Vaeth M, et al. Praventivmed 2001;46:182-5.
carcinoma mortality rates. Cancer Prospective cohort study of risk factors 425. Austin H, Delzell E, Grufferman S, et al. A
2002;94:272-81. for primary liver cancer in Hiroshima and case-control study of hepatocellular
395. Lagiou P, Trichopoulou A, Henderickx HK, Nagasaki, Japan. Epidemiology carcinoma and the hepatitis B virus,
et al. Household budget survey 1995;6:36-41. cigarette smoking, and alcohol
nutritional data in relation to mortality 411. Tanaka K, Sakai H, Hashizume M, et al. A consumption. Cancer Res 1986;46:962-6.
from coronary heart disease, colorectal long-term follow-up study on risk factors 426. La Vecchia C, Negri E, Decarli A, et al. Risk
cancer and female breast cancer in for hepatocellular carcinoma among factors for hepatocellular carcinoma in
European countries. Eur J Clin Nutr Japanese patients with liver cirrhosis. Jpn northern Italy. Int J Cancer 1988;42:872-
1999;53:328-32. J Cancer Res 1998;89:1241-50. 6.
396. Smith-Warner SA, Spiegelman D, Yaun SS, 412. Evans AA, Chen G, Ross EA, et al. Eight- 427. Tsukuma H, Hiyama T, Oshima A, et al. A
et al. Alcohol and breast cancer in year follow-up of the 90,000-person case-control study of hepatocellular
women: a pooled analysis of cohort Haimen City cohort: I. hepatocellular carcinoma in Osaka, Japan. Int J Cancer
studies. JAMA 1998;279:535-40. carcinoma mortality, risk factors, and 1990;45:231-6.
397. Hamajima N, Hirose K, Tajima K, et al. gender differences. Cancer Epidemiol 428. Qureshi H, Zuberi SJ, Jafarey NA, et al.
Alcohol, tobacco and breast cancer - Biomarkers Prev 2002;11:369-76. Hepatocellular carcinoma in Karachi. J
collaborative reanalysis of individual 413. Wang LY, Hatch M, Chen CJ, et al. Gastroenterol Hepatol 1990;5:1-6.
data from 53 epidemiological studies, Aflatoxin exposure and risk of 429. Yu MW, You SL, Chang AS, et al.
including 58,515 women with breast hepatocellular carcinoma in Taiwan. Int J Association between hepatitis C virus
cancer and 95,067 women without the Cancer 1996;67:620-5. antibodies and hepatocellular carcinoma
disease. Br J Cancer 2002;87:1234-45. 414. Wang LY, You SL, Lu SN, et al. Risk of in Taiwan. Cancer Res 1991;51:5621-5.
398. Dumitrescu RG, Shields PG. The etiology hepatocellular carcinoma and habits of 430. Chen CJ, Liang KY, Chang AS, et al. Effects
of alcohol-induced breast cancer. Alcohol alcohol drinking, betel quid chewing and of hepatitis B virus, alcohol drinking,
2005;35:213-25. cigarette smoking: a cohort of 2416 cigarette smoking and familial tendency
399. Boffetta P, Hashibe M. Alcohol and cancer. HBsAg-seropositive and 9421 HBsAg- on hepatocellular carcinoma.
Lancet Oncol 2006;7:149-56. seronegative male residents in Taiwan. Hepatology 1991;13:398-406.
400. Li CI, Daling JR, Malone KE, et al. Cancer Causes Control 2003;14:241-50. 431. Yamaguchi G. Hepatocellular carcinoma
Relationship between established breast 415. Kato I, Tominaga S, Ikari A. The risk and and its risk factors - their annual changes
cancer risk factors and risk of seven predictive factors for developing liver and effects on the age at onset. Kurume
different histologic types of invasive cancer among patients with Med J 1993;40:33-40.
breast cancer. Cancer Epidemiol decompensated liver cirrhosis. Jpn J Clin 432. Braga C, La Vecchia C, Negri E, et al.
Biomarkers Prev 2006;15:946-54. Oncol 1992;22:278-85. Attributable risks for hepatocellular
401. Chen CJ, Wang LY, Lu SN, et al. Elevated 416. Thygesen LC, Albertsen K, Johansen C, et carcinoma in northern Italy. Eur J Cancer
aflatoxin exposure and increased risk of al. Cancer incidence among Danish 1997;33:629-34.
hepatocellular carcinoma. Hepatology brewery workers. Int J Cancer 433. La Vecchia C, Negri E, Cavalieri dro L, et
1996;24:38-42. 2005;116:774-8. al. Liver cirrhosis and the risk of primary
402. Ogimoto I, Shibata A, Kurozawa Y, et al. 417. Hirayama T. A large-scale cohort study on liver cancer. Eur J Cancer Prev
Risk of death due to hepatocellular risk factors for primary liver cancer, with 1998;7:315-20.
carcinoma among drinkers and ex- special reference to the role of cigarette 434. Mukaiya M, Nishi M, Miyake H, et al.
drinkers. Univariate analysis of JACC smoking. Cancer Chemother Pharmacol Chronic liver diseases for the risk of
study data. Kurume Med J 2004;51:59-70. 1989;23 Suppl:S114-7. hepatocellular carcinoma: a case-control
403. Kono S, Ikeda M, Tokudome S, et al. 418. London WT, Evans AA, McGlynn K, et al. study in Japan. Etiologic association of
Alcohol and cancer in male Japanese Viral, host and environmental risk factors alcohol consumption, cigarette smoking
physicians. J Cancer Res Clin Oncol for hepatocellular carcinoma: a and the development of chronic liver
462
R E F E R E N C E S
diseases. Hepatogastroenterology 450. Wang A. [An epidemiologic study on the of hepatocellular carcinoma in male
1998;45:2328-32. etiology of primary hepatocellular hepatitis B surface antigen carriers with
435. Mandishona E, MacPhail AP, Gordeuk VR, carcinoma in Shaanxi]. Zhonghua Liu chronic hepatitis who have detectable
et al. Dietary iron overload as a risk Xing Bing Xue Za Zhi 1993;14:208-11. urinary aflatoxin metabolite M1.
factor for hepatocellular carcinoma in 451. Wang ZJ, Zhou YP, Cheng B. [An Hepatology 1999;30:379-83.
Black Africans. Hepatology epidemiologic study on the aetiological 465. Khan KN, Yatsuhashi H. Effect of alcohol
1998;27:1563-6. factors of primary liver cancer in Shunde consumption on the progression of
436. Kuper H, Tzonou A, Kaklamani E, et al. City of Guangdong province]. Zhonghua hepatitis C virus infection and risk of
Tobacco smoking, alcohol consumption Liu Xing Bing Xue Za Zhi 1996;17:141-4. hepatocellular carcinoma in Japanese
and their interaction in the causation of 452. Stemhagen A, Slade J, Altman R, et al. patients. Alcohol Alcohol 2000;35:286-
hepatocellular carcinoma. Int J Cancer Occupational risk factors and liver 95.
2000;85:498-502. cancer. A retrospective case-control 466. Sharp GB, Lagarde F, Mizuno T, et al.
437. Kuper H, Tzonou A, Lagiou P, et al. Diet study of primary liver cancer in New Relationship of hepatocellular
and hepatocellular carcinoma: a case- Jersey. Am J Epidemiol 1983;117:443-54. carcinoma to soya food consumption: a
control study in Greece. Nutr Cancer 453. Olubuyide IO, Bamgboye EA. A case- cohort-based, case-control study in
2000;38:6-12. controlled study of the current role of Japan. Int J Cancer 2005;115:290-5.
438. Omer RE, Verhoef L, Vant Veer P, et al. cigarette smoking and alcohol 467. Dutta U, Byth K, Kench J, et al. Risk
Peanut butter intake, GSTM1 genotype consumption in primary liver cell factors for development of
and hepatocellular carcinoma: a case- carcinoma in Nigerians. Afr J Med Med hepatocellular carcinoma among
control study in Sudan. Cancer Causes Sci 1990;19:191-4. Australians with hepatitis C: a case-
Control 2001;12:23-32. 454. Fukuda K, Shibata A, Hirohata I, et al. A control study. Aust N Z J Med
439. Tsai JF, Chuang LY, Jeng JE, et al. Betel hospital-based case-control study on 1999;29:300-7.
quid chewing as a risk factor for hepatocellular carcinoma in Fukuoka 468. Oshima A, Tsukuma H, Hiyama T, et al.
hepatocellular carcinoma: a case-control and Saga prefectures, Northern Kyushu, Follow-up study of HBs Ag-positive
study. Br J Cancer 2001;84:709-13. Japan. Jpn J Cancer Res 1993;84:708-14. blood donors with special reference to
440. Donato F, Tagger A, Gelatti U, et al. 455. Tsai JF, Jeng JE, Chuang LY, et al. Habitual effect of drinking and smoking on
Alcohol and hepatocellular carcinoma: betel quid chewing and risk for development of liver cancer. Int J Cancer
the effect of lifetime intake and hepatocellular carcinoma complicat ing 1984;34:775-9.
hepatitis virus infections in men and cirrhosis. Medicine (Baltimore) 469. Parkin DM, Srivatanakul P, Khlat M, et al.
women. Am J Epidemiol 2002;155:323- 2004;83:176-87. Liver-cancer in Thailand. I. A case-control
31. 456. Gelatti U, Covolo L, Franceschini M, et al. study of cholangiocarcinoma. Int J
441. Yu SZ, Huang XE, Koide T, et al. Hepatitis Coffee consumption reduces the risk of Cancer 1991;48:323-8.
B and C viruses infection, lifestyle and hepatocellular carcinoma independently 470. Shin HR, Lee CU, Park HJ, et al. Hepatitis B
genetic polymorphisms as risk factors for of its aetiology: a case-control study. J and C virus, Clonorchis sinensis for the
hepatocellular carcinoma in Haimen, Hepatol 2005;42:528-34. risk of liver cancer: a case-control study
China. Jpn J Cancer Res 2002;93:1287-92. 457. Lam KC, Yu MC, Leung JW, et al. Hepatitis in Pusan, Korea. Int J Epidemiol
442. Yu H, Harris RE, Kabat GC, et al. Cigarette B virus and cigarette smoking: risk 1996;25:933-40.
smoking, alcohol consumption and factors for hepatocellular carcinoma in 471. Colloredo Mels G, Paris B, Bertone V, et al.
primary liver cancer: a case-control study Hong Kong. Cancer Res 1982;42:5246-8. [Primary hepatocarcinoma.
in the USA. Int J Cancer 1988;42:325-8. 458. Lin J. [A study on aetiological factors of Epidemiologic case-control study in the
443. Munaka M, Kohshi K, Kawamoto T, et al. primary hepato-carcinoma in Tianjin province of Bergamo]. Minerva Med
Genetic polymorphisms of tobacco- and China]. Zhonghua Liu Xing Bing Xue Za 1986;77:297-306.
alcohol-related metabolizing enzymes Zhi 1991;12:346-9. 472. Srivatanakul P, Parkin DM, Khlat M, et al.
and the risk of hepatocellular carcinoma. 459. Tanaka K, Hirohata T, Takeshita S. Blood Liver-cancer in Thailand. 2. A case-
J Cancer Res Clin Oncol 2003;129:355-60. transfusion, alcohol consumption, and control study of hepatocellular-
444. Yuan JM, Govindarajan S, Arakawa K, et cigarette smoking in causation of carcinoma. Int J Cancer 1991;48:329-32.
al. Synergism of alcohol, diabetes, and hepatocellular carcinoma: a case-control 473. Tanaka K, Hirohata T, Takeshita S, et al.
viral hepatitis on the risk of study in Fukuoka, Japan. Jpn J Cancer Hepatitis B virus, cigarette smoking and
hepatocellular carcinoma in blacks and Res 1988;79:1075-82. alcohol consumption in the
whites in the U.S. Cancer 2004;101:1009- 460. Yu MC, Tong MJ, Govindarajan S, et al. development of hepatocellular
17. Nonviral risk factors for hepatocellular carcinoma: a case-control study in
445. Buckley JD, Sather H, Ruccione K, et al. A carcinoma in a low-risk population, the Fukuoka, Japan. Int J Cancer
case-control study of risk factors for non-Asians of Los Angeles County, 1992;51:509-14.
hepatoblastoma. A report from the California. J Natl Cancer Inst 474. Cordier S, Le TB, Verger P, et al. Viral
Childrens Cancer Study Group. Cancer 1991;83:1820-6. infections and chemical exposures as risk
1989;64:1169-76. 461. Jee SH, Ohrr H, Sull JW, et al. Cigarette factors for hepatocellular carcinoma in
446. Inaba Y, Maruchi N, Matsuda M, et al. A smoking, alcohol drinking, hepatitis B, Vietnam. Int J Cancer 1993;55:196-201.
case-control study on liver cancer with and risk for hepatocellular carcinoma in 475. Pyong SJ, Tsukuma H, Hiyama T. Case-
special emphasis on the possible Korea. J Natl Cancer Inst 2004;96:1851-6. control study of hepatocellular
aetiological role of schistosomiasis. Int J 462. Miyakawa H, Sato C, Izumi N, et al. carcinoma among Koreans living in
Epidemiol 1984;13:408-12. Hepatitis C virus infection in alcoholic Osaka, Japan. Jpn J Cancer Res
447. Hiyama T, Tsukuma H, Oshima A, et al. liver cirrhosis in Japan: its contribution 1994;85:674-9.
[Liver cancer and life style - drinking to the development of hepatocellular 476. Arico S, Corrao G, Torchio P, et al. A
habits and smoking habits]. Gan No carcinoma. Alcohol Alcohol Suppl strong negative association between
Rinsho 1990;Spec No:249-56. 1993;1a:85-90. alcohol consumption and the risk of
448. Newton R, Ngilimana PJ, Grulich A, et al. 463. Miyakawa H, Izumi N, Marumo F, et al. hepatocellular carcinoma in cirrhotic
Cancer in Rwanda. Int J Cancer Roles of alcohol, hepatitis virus infection, patients. A case-control study. Eur J
1996;66:75-81. and gender in the development of Epidemiol 1994;10:251-7.
449. Lu SN, Lin TM, Chen CJ, et al. A case- hepatocellular carcinoma in patients 477. Zhang JY, Wang X, Han SG, et al. A case-
control study of primary hepatocellular with liver cirrhosis. Alcohol Clin Exp Res control study of risk factors for
carcinoma in Taiwan. Cancer 1996;20:91a-4a. hepatocellular carcinoma in Henan, China.
1988;62:2051-5. 464. Sun Z, Lu P, Gail MH, et al. Increased risk Am J Trop Med Hyg 1998;59:947-51.
463
F O O D , N U T R I T I O N , P H Y S I C A L A C T I V I T Y, A N D T H E P R E V E N T I O N O F C A N C E R : A G L O B A L P E R S P E C T I V E
478. Tagger A, Donato F, Ribero ML, et al. al. Alcohol consumption and risk of renal renal cell carcinoma in relation to
Case-control study on hepatitis C virus cell carcinoma: a prospective study of occupation, smoking, and alcohol
(HCV) as a risk factor for hepatocellular Swedish women. Int J Cancer consumption. Arch Environ Health
carcinoma: the role of HCV genotypes 2005;117:848-53. 1988;43:238-41.
and the synergism with hepatitis B virus 493. Washio M, Mori M, Sakauchi F, et al. Risk 510. Mahabir S, Leitzmann MF, Virtanen MJ, et
and alcohol. Brescia HCC Study. Int J factors for kidney cancer in a Japanese al. Prospective study of alcohol drinking
Cancer 1999;81:695-9. population: findings from the JACC and renal cell cancer risk in a cohort of
479. Hassan MM, Hwang LY, Hatten CJ, et al. study. J Epidemiol 2005;15:S203-S11. Finnish male smokers. Cancer Epidemiol
Risk factors for hepatocellular 494. Hu J, Mao Y, White K, et al. Overweight Biomarkers Prev 2005;14:170-5.
carcinoma: synergism of alcohol with and obesity in adults and risk of renal 511. Prineas RJ, Folsom AR, Zhang ZM, et al.
viral hepatitis and diabetes mellitus. cell carcinoma in Canada. Soz Nutrition and other risk factors for renal
Hepatology 2002;36:1206-13. Praventivmed 2003;48:178-85. cell carcinoma in postmenopausal
480. Donato F, Gelatti U, Tagger A, et al. 495. Mucci LA, Dickman PW, Steineck G, et al. women. Epidemiology 1997;8:31-6.
Intrahepatic cholangiocarcinoma and Dietary acrylamide and cancer of the 512. Nicodemus KK, Sweeney C, Folsom AR.
hepatitis C and B virus infection, alcohol large bowel, kidney, and bladder: Evaluation of dietary, medical and
intake, and hepatolithiasis: a case- absence of an association in a lifestyle risk factors for incident kidney
control study in Italy. Cancer Causes population-based study in Sweden. Br J cancer in postmenopausal women. Int J
Control 2001;12:959-64. Cancer 2003;88:84-9. Cancer 2004;108:115-21.
481. Yu MC, Mack T, Hanisch R, et al. Hepatitis, 496. Parker AS, Cerhan JR, Lynch CF, et al. 513. Hirvonen T, Virtamo J, Korhonen P, et al.
alcohol consumption, cigarette smoking, Gender, alcohol consumption, and renal Flavonol and flavone intake and the risk
and hepatocellular carcinoma in Los cell carcinoma. Am J Epidemiol of cancer in male smokers (Finland).
Angeles. Cancer Res 1983;43:6077-9. 2002;155:455-62. Cancer Causes Control 2001;12:789-96.
482. Infante F, Voirol M, Brahime Reteno O, et 497. Augustsson K, Skog K, Jagerstad M, et al. 514. Mattioli S, Truffelli D, Baldasseroni A, et
al. [Alcohol, tobacco and food Dietary heterocyclic amines and cancer al. Occupational risk factors for renal cell
consumption in liver cancer and cirrhosis. of the colon, rectum, bladder, and cancer: a case - control study in northern
Preliminary results]. Schweiz Med kidney: a population-based study. Lancet Italy. J Occup Environ Med 2002;44:1028-
Wochenschr 1980;110:875-6. 1999;353:703-7. 36.
483. Bulatao Jayme J, Almero EM, Castro MC, 498. Yuan JM, Gago-Dominguez M, Castelao 515. Lindblad P, Wolk A, Bergstrom R, et al.
et al. A case-control dietary study of JE, et al. Cruciferous vegetables in Diet and risk of renal cell cancer: a
primary liver cancer risk from aflatoxin relation to renal cell carcinoma. Int J population-based case-control study.
exposure. Int J Epidemiol 1982;11:112-9. Cancer 1998;77:211-6. Cancer Epidemiol Biomarkers Prev
484. Mayans MV, Calvet X, Bruix J, et al. Risk 499. Pelucchi C, La Vecchia C, Negri E, et al. 1997;6:215-23.
factors for hepatocellular carcinoma in Alcohol drinking and renal cell 516. Talamini R, Baron AE, Barra S, et al. A
Catalonia, Spain. Int J Cancer carcinoma in women and men. Eur J case-control study of risk factor for renal
1990;46:378-81. Cancer Prev 2002;11:543-5. cell cancer in northern Italy. Cancer
485. Hardell L, Bengtsson NO, Jonsson U, et al. 500. Goodman MT, Morgenstern H, Wynder Causes Control 1990;1:125-31.
Aetiological aspects on primary liver EL. A case-control study of factors 517. Lee JE, Giovannucci E, Smith-Warner SA,
cancer with special regard to alcohol, affecting the development of renal cell et al. Total fluid intake and use of
organic solvents and acute intermittent cancer. Am J Epidemiol 1986;124:926-41. individual beverages and risk of renal
porphyria - an epidemiological 501. Wynder EL, Mabuchi K, Whitmore WF, Jr. cell cancer in two large cohorts. Cancer
investigation. Br J Cancer 1984;50:389- Epidemiology of adenocarcinoma of the Epidemiol Biomarkers Prev
97. kidney. J Natl Cancer Inst 1974;53:1619- 2006;15:1204-11.
486. Prior P. Long-term cancer risk in 34.
alcoholism. Alcohol Alcohol 1988;23:163- 502. Hu J, Ugnat AM, Canadian Cancer
71. Registries Epidemiology Research Group. Chapter 4.9
487. Mohamed AE, Kew MC, Groeneveld HT. Active and passive smoking and risk of
Alcohol consumption as a risk factor for renal cell carcinoma in Canada. Eur J 1. United States Environmental Protection
hepatocellular carcinoma in urban Cancer 2005;41:770-8. Agency. 2004. Pesticides Industry Sales
southern African blacks. Int J Cancer 503. Boeing H, Schlehofer B, Wahrendorf J. and Usage: 2000 and 2001 Market
1992;51:537-41. Diet, obesity and risk for renal cell Estimates.
488. Bartsch H, Nair J. Chronic inflammation carcinoma: results from a case control- http://www.epa.gov/oppbead1/pestsales/
and oxidative stress in the genesis and study in Germany. Z Ernahrungswiss 01pestsales/market_estimates2001.pdf.
perpetuation of cancer: role of lipid 1997;36:3-11. 2. International Agency for Research on
peroxidation, DNA damage, and repair. 504. Wolk A, Gridley G, Niwa S, et al. Cancer. 1987. Androgenic (Anabolic)
Langenbecks Arch Surg 2006;391:499- International renal cell cancer study. VII. Steroids. In: IARC Monogr Eval Carcinog
510. Role of diet. Int J Cancer 1996;65:67-73. Risks Hum no S7.
489. Seitz HK, Stickel F. Risk factors and 505. Chow WH, Gridley G, Mclaughlin JK, et al. 3. Rietjens IM, Boersma MG, van der Woude H,
mechanisms of hepatocarcinogenesis Protein intake and risk of renal cell et al. Flavonoids and alkenylbenzenes:
with special emphasis on alcohol and cancer. J Natl Cancer Inst 1994;86:1131-9. mechanisms of mutagenic action and
oxidative stress. Biol Chem 2006;387:349- 506. Mclaughlin JK, Gao YT, Gao RN, et al. Risk carcinogenic risk. Mutat Res
60. factors for renal-cell cancer in Shanghai, 2005;574:124-38.
490. Franceschi S, Montella M, Polesel J, et al. China. Int J Cancer 1992;52:562-5. 4. Jukes D. Food additives in the European
Hepatitis viruses, alcohol, and tobacco in 507. Yu MC, Mack TM, Hanisch R, et al. Union.
the etiology of hepatocellular carcinoma Cigarette smoking, obesity, diuretic use, http://www.foodlaw.rdg.ac.uk/additive.h
in Italy. Cancer Epidemiol Biomarkers and coffee consumption as risk factors tm. 2006.
Prev 2006;15:683-9. for renal cell carcinoma. J Natl Cancer 5. From the Centers for Disease Control. Public
491. Hiatt RA, Tolan K, Quesenberry CP, Jr. Inst 1986;77:351-6. Health Service report on fluoride
Renal cell carcinoma and thiazide use: a 508. Benhamou S, Lenfant MH, Ory-Paoletti C, benefits and risks. JAMA 1991;266:1061-
historical, case-control study (California, et al. Risk factors for renal-cell carcinoma 2, 6-7.
USA). Cancer Causes Control 1994;5:319- in a French case-control study. Int J 6. National Research Council. Fluoride in
25. Cancer 1993;55:32-6. Drinking Water. A Scientific Review of
492. Rashidkhani B, Akesson A, Lindblad P, et 509. Brownson RC. A case-control study of EPAs Standards. Washington, DC:
464
R E F E R E N C E S
National Academy Press, 2006. and cardiovascular disease. N Engl J Med Gene-environment interactions between
7. Bassin EB, Wypij D, Davis RB, et al. Age- 1996;334:1150-5. the codon 194 polymorphism of XRCC1
specific fluoride exposure in drinking 10. Omenn GS, Goodman GE, Thornquist MD, and antioxidants influence lung cancer
water and osteosarcoma (United States). et al. Risk factors for lung cancer and for risk. Anticancer Res 2003;23:627-32.
Cancer Causes Control 2006;17:421-8. intervention effects in CARET, the Beta- 24. Liu C, Russell RM, Wang XD. Low dose
8. Douglass CW, Joshipura K. Caution needed Carotene and Retinol Efficacy Trial. J Natl beta-carotene supplementation of
in fluoride and osteosarcoma study. Cancer Inst 1996;88:1550-9. ferrets attenuates smoke-induced lung
Cancer Causes Control 2006;17:481-2. 11. Musk AW, de Klerk NH, Ambrosini GL, et phosphorylation of JNK, p38 MAPK, and
9. Centres for Disease Control and Prevention. al. Vitamin A and cancer prevention I: p53 proteins. The Journal of nutrition
CDC Statement on water fluoridation observations in workers previously 2004;134:2705-10.
and osteosarcoma. exposed to asbestos at Wittenoom, 25. Goodman GE, Schaffer S, Omenn GS, et al.
http://www.cdc.gov/fluoridation/safety/o Western Australia. Int J Cancer The association between lung and
steosarcoma.htm. 2007. 1998;75:355-61. prostate cancer risk, and serum
10. Food and Agriculture Organization of the 12. Paganini-Hill A, Chao A, Ross RK, et al. micronutrients: results and lessons
United Nations, World Health Vitamin A, beta-carotene, and the risk of learned from beta-carotene and retinol
Organization. Summary of evaluations cancer: a prospective study. J Natl Cancer efficacy trial. Cancer Epidemiol
performed by the Joint FAO/WHO Expert Inst 1987;79:443-8. Biomarkers Prev 2003;12:518-26.
Committee on Food Additives. 13. Shibata A, Paganini Hill A, Ross RK, et al. 26. Heinonen OP, Albanes D, Virtamo J, et al.
http://jecfa.ilsi.org/. 2006. Intake of vegetables, fruits, beta- Prostate cancer and supplementation
carotene, vitamin C and vitamin with alpha-tocopherol and beta-
supplements and cancer incidence carotene: incidence and mortality in a
Chapter 4.10 among the elderly: a prospective study. controlled trial.[see comment]. J Natl
Br J Cancer 1992;66:673-9. Cancer Inst 1998;90:440-6.
1. WHO. 2002. Diet, nutrition and the 14. Samet JM, Skipper BJ, Humble CG, et al. 27. Wu K, Erdman Jr JW, Schwartz SJ, et al.
prevention of chronic diseases: report of Lung cancer risk and vitamin A Plasma and Dietary Carotenoids, and the
a joint WHO/FAO expert consultation. In: consumption in New Mexico. Am Rev Risk of Prostate Cancer: A Nested Case-
WHO Technical Report Series no 916. Respir Dis 1985;131:198-202. Control Study. Cancer Epidemiol
http://www.who.int/entity/dietphysicalac 15. Wu AH, Yu MC, Thomas DC, et al. Personal Biomarkers Prev 2004;. 13:260-9.
tivity/publications/trs916/download/en/i and family history of lung disease as risk 28. Cook NR, Stampfer MJ, Ma J, et al. Beta-
ndex.html. factors for adenocarcinoma of the lung. carotene supplementation for patients
2. Calder PC. n-3 polyunsaturated fatty acids, Cancer Res 1988;48:7279-84. with low baseline levels and decreased
inflammation, and inflammatory 16. Virtamo J, Pietinen P, Huttunen JK, et al. risks of total and prostate carcinoma.[see
diseases. The American journal of clinical Incidence of cancer and mortality comment]. Cancer 1999;86:1783-92.
nutrition 2006;83:1505S-19S. following alpha-tocopherol and beta- 29. Frieling UM, Schaumberg DA, Kupper TS,
3. Bentley TG, Willett WC, Weinstein MC, et al. carotene supplementation: a et al. A randomised, 12-year primary-
Population-level changes in folate intake postintervention follow-up. JAMA prevention trial of beta carotene
by age, gender, and race/ethnicity after 2003;290:476-85. supplementation for nonmelanoma skin
folic acid fortification. Am J Public 17. Albanes D, Heinonen OP, Taylor PR, et al. cancer in the physicians health
Health 2006;96:2040-7. Alpha-Tocopherol and beta-carotene study.[see comment]. Archives of
4. Levine N, Moon TE, Cartmel B, et al. Trial of supplements and lung cancer incidence Dermatology 2000;136:179-84.
retinol and isotretinoin in skin cancer in the alpha-tocopherol, beta-carotene 30. Hennekens CH, Buring JE, Manson JE, et al.
prevention: a randomised, double-blind, cancer prevention study: effects of base- Lack of effect of long-term
controlled trial. Southwest Skin Cancer line characteristics and study supplementation with beta carotene on
Prevention Study Group. Cancer compliance. J Natl Cancer Inst the incidence of malignant neoplasms
Epidemiol Biomarkers Prev 1997;6:957- 1996;88:1560-70. and cardiovascular disease. N Engl J Med
61. 18. Cook NR, Le IM, Manson JE, et al. Effects of 1996;334:1145-9.
5. Moon TE, Levine N, Cartmel B, et al. Effect beta-carotene supplementation on 31. Green A, Williams G, Neale R, et al. Daily
of retinol in preventing squamous cell cancer incidence by baseline sunscreen application and betacarotene
skin cancer in moderate-risk subjects: a characteristics in the Physicians Health supplementation in prevention of basal-
randomised, double-blind, controlled Study (United States). Cancer Causes cell and squamous-cell carcinomas of the
trial. Southwest Skin Cancer Prevention Control 2000;11:617-26. skin: a randomised controlled trial.
Study Group. Cancer Epidemiol 19. Lee IM, Cook NR, Manson JE, et al. Beta- Lancet 1999;354:723-9.
Biomarkers Prev 1997;6:949-56. carotene supplementation and incidence 32. Greenberg, E.R., Baron, et al. A clinical trial
6. Levine N, Meyskens FL. Topical vitamin-A- of cancer and cardiovascular disease: the of beta carotene to prevent basal-cell
acid therapy for cutaneous metastatic Womens Health Study. JNCI Cancer and squamous-cell cancers of the skin.
melanoma. Lancet 1980;2:224-6. Spectrum 1999;91:2102-6. The Skin Cancer Prevention Study Group
7. Le Marchand L, Saltzman BS, Hankin JH, et 20. de Klerk NH, Musk AW, Ambrosini GL, et [published erratum appears in N Engl J
al. Sun exposure, diet, and melanoma in al. Vitamin A and cancer prevention II: Med 1991 Oct 31;325(18):1324] [see
Hawaii Caucasians. Am J Epidemiol comparison of the effects of retinol and comments]. N Engl J Med 1990;323:789-
2006;164:232-45. beta-carotene. Int J Cancer 1998;75:362- 95.
8. Goodman GE, Thornquist, M. D., Balmes, J., 7. 33. McNaughton SA, Marks GC, Gaffney P, et
Cullen, M. R., Meyskens, F. L. Jr, Omenn, 21. Michaud DS, Feskanich D, Rimm EB, et al. al. Antioxidants and basal cell carcinoma
G. S., Valanis, B., and Williams, J. H. Jr. Intake of specific carotenoids and risk of of the skin: a nested case-control study.
The Beta-Carotene and Retinol Efficacy lung cancer in 2 prospective US cohorts. Cancer Causes Control 2005;16:609-18.
Trial: incidence of lung cancer and Am J Clin Nutr 2000;72:990-7. 34. Willis MS, Wians FH. The role of nutrition
cardiovascular disease mortality during 22. Woodson K, Stewart C, Barrett M, et al. in preventing prostate cancer: a review
6-year follow-up after stopping beta- Effect of vitamin intervention on the of the proposed mechanism of action of
carotene and retinol supplements. J Natl relationship between GSTM1, smoking, various dietary substances. Clinica
Cancer Inst 2004;96:1743-50. and lung cancer risk among male chimica acta; international journal of
9. Omenn GS, Goodman GE, Thornquist MD, et smokers. Cancer Epidemiol Biomarkers clinical chemistry 2003;330:57-83.
al. Effects of a combination of beta Prev 1999;8:965-70. 35. Fleshner N, Fair WR, Huryk R, et al. Vitamin
carotene and vitamin A on lung cancer 23. Ratnasinghe DL, Yao SX, Forman M, et al. E inhibits the high-fat diet promoted
465
F O O D , N U T R I T I O N , P H Y S I C A L A C T I V I T Y, A N D T H E P R E V E N T I O N O F C A N C E R : A G L O B A L P E R S P E C T I V E
growth of established human prostate polyps: a double-blind 3-year Epidemiol Biomarkers Prev 2002;11:630-
LNCaP tumors in nude mice. The Journal intervention with calcium and 9.
of urology 1999;161:1651-4. antioxidants. Digestion 1998;59:148-56. 63. Bostick RM, Potter JD, McKenzie DR, et al.
36. Bostick RM, Potter JD, Sellers TA, et al. 50. Hartman TJ, Albert PS, Snyder K, et al. The Reduced risk of colon cancer with high
Relation of calcium, vitamin D, and dairy association of calcium and vitamin D intake of vitamin E: the Iowa Womens
food intake to incidence of colon cancer with risk of colorectal adenomas. J Nutr Health Study. Cancer Res 1993;53:4230-7.
among older women. The Iowa Womens 2005;135:252-9. 64. Ganther HE. Selenium metabolism,
Health Study. Am J Epidemiol 51. Hyman J, Baron JA, Dain BJ, et al. Dietary selenoproteins and mechanisms of
1993;137:1302-17. and supplemental calcium and the cancer prevention: complexities with
37. Kampman E, Goldbohm RA, van den recurrence of colorectal adenomas. thioredoxin reductase. Carcinogenesis
Brandt PA, et al. Fermented dairy Cancer Epidemiol Biomarkers Prev 1999;20:1657-66.
products, calcium, and colorectal cancer 1998;7:291-5. 65. Combs GF, Jr. Status of selenium in prostate
in The Netherlands Cohort Study. Cancer 52. Martinez ME, Marshall JR, Sampliner R, et cancer prevention. Br J Cancer
Res 1994;54:3186-90. al. Calcium, vitamin D, and risk of 2004;91:195-9.
38. Zheng W, Anderson KE, Kushi LH, et al. A adenoma recurrence (United States).
prospective cohort study of intake of Cancer Causes Control 2002;13:213-20.
calcium, vitamin D, and other 53. Platz EA, Hankinson SE, Hollis BW, et al. Chapter 4.11
micronutrients in relation to incidence of Plasma 1,25-dihydroxy- and 25-
rectal cancer among postmenopausal hydroxyvitamin D and adenomatous 1. Cannon G. The rise and fall of dietetics and
women. Cancer Epidemiol Biomarkers polyps of the distal colorectum. Cancer of nutrition science, 4000 BCE-2000 CE.
Prev 1998;7:221-5. Epidemiol Biomarkers Prev 2000;9:1059- Public Health Nutr 2005;8:701-5.
39. Wu K, Willett WC, Fuchs CS, et al. Calcium 65. 2. Food and Agriculture Organization of the
intake and risk of colon cancer in women 54. Cho E, Smith-Warner SA, Spiegelman D, et United Nations. 2004. Globalization of
and men. J Natl Cancer Inst 2002;94:437- al. Dairy foods, calcium, and colorectal Food Systems in Developing Countries:
46. cancer: a pooled analysis of 10 cohort Impact on Food Security and Nutrition.
40. McCullough ML, Robertson AS, Rodriguez studies. J Natl Cancer Inst 2004;96:1015- In: FAO Food Nutr Pap no 83.
C, et al. Calcium, vitamin D, dairy 22. 3. World Health Organization. Globalization,
products, and risk of colorectal cancer in 55. Lamprecht SA, Lipkin M. Cellular Diets and Noncommunicable Diseases.
the Cancer Prevention Study II Nutrition mechanisms of calcium and vitamin D in Geneva: WHO, 2002.
Cohort (United States). Cancer Causes the inhibition of colorectal 4. Nestle M. The Mediterranean (diets and
Control 2003;14:1-12. carcinogenesis. Ann N Y Acad Sci disease prevention). In: Kiple KF, Ornelas-
41. Feskanich D, Ma J, Fuchs CS, et al. Plasma 2001;952:73-87. Kiple CK, editors. The Cambridge World
vitamin D metabolites and risk of 56. Clark LC, Dalkin B, Krongrad A, et al. History of Food and Nutrition.
colorectal cancer in women . Cancer Decreased incidence of prostate cancer Cambridge: Cambridge University Press,
Epidemiology Biomarkers and with selenium supplementation: results 2000.
Prevention 2004;13:1502-8. of a double-blind cancer prevention trial. 5. Prentice AM, Jebb SA. Fast foods, energy
42. Lin J, Zhang SM, Cook NR, et al. Intakes of Br J Urol 1998;81:730-4. density and obesity: a possible
calcium and vitamin D and risk of 57. Duffield-Lillico AJ, Dalkin BL, Reid ME, et mechanistic link. Obes Rev 2003;4:187-
colorectal cancer in women. Am J al. Selenium supplementation, baseline 94.
Epidemiol 2005;161:755-64. plasma selenium status and incidence of 6. Huijbregts P, Feskens E, Rasanen L, et al.
43. Flood A, Peters U, Chatterjee N, et al. prostate cancer: an analysis of the Dietary pattern and 20 year mortality in
Calcium from diet and supplements is complete treatment period of the elderly men in Finland, Italy, and The
associated with reduced risk of colorectal Nutritional Prevention of Cancer Trial. Netherlands: longitudinal cohort study.
cancer in a prospective cohort of women. BJU Int 2003;91:608-12. BMJ 1997;315:13-7.
Cancer Epidemiol Biomarkers Prev 58. Platz EA, Leitzmann MF, Hollis BW, et al. 7. Lagiou P, Trichopoulos D, Sandin S, et al.
2005;14:126-32. Plasma 1,25-dihydroxy- and 25- Mediterranean dietary pattern and
44. Baron JA, Beach M, Mandel JS, et al. hydroxyvitamin D and subsequent risk of mortality among young women: a
Calcium supplements for the prevention prostate cancer. Cancer Causes Control cohort study in Sweden. Br J Nutr
of colorectal adenomas. Calcium Polyp 2004;15:255-65. 2006;96:384-92.
Prevention Study Group.[comment]. N 59. Reid ME, Duffield-Lillico AJ, Garland L, et 8. Cottet V, Bonithon-Kopp C, Kronborg O, et
Engl J Med 1999;340:101-7. al. Selenium supplementation and lung al. Dietary patterns and the risk of
45. Grau MV, Baron JA, Sandler RS, et al. cancer incidence: an update of the colorectal adenoma recurrence in a
Vitamin D, calcium supplementation, nutritional prevention of cancer trial. European intervention trial. Eur J Cancer
and colorectal adenomas: results of a Cancer Epidemiol Biomarkers Prev Prev 2005;14:21-9.
randomised trial.[see comment]. J Natl 2002;11:1285-91. 9. Kim MK, Sasaki S, Sasazuki S, et al.
Cancer Inst 2003;95:1765-71. 60. Combs GF, Jr., Clark LC, Turnbull BW. Prospective study of three major dietary
46. Baron JA, Beach M, Mandel JS, et al. Reduction of cancer mortality and patterns and risk of gastric cancer in
Calcium supplements and colorectal incidence by selenium supplementation. Japan. Int J Cancer 2004;110:435-42.
adenomas. Polyp Prevention Study Med Klin 1997;92 Suppl 3:42-5. 10. Kim MK, Sasaki S, Otani T, et al. Dietary
Group. Ann N Y Acad Sci 1999;889:138- 61. Clark LC, Combs GF, Jr., Turnbull BW, et al. patterns and subsequent colorectal
45. Effects of selenium supplementation for cancer risk by subsite: a prospective
47. Wallace K, Baron JA, Cole BF, et al. Effect of cancer prevention in patients with cohort study. Int J Cancer 2005;115:790-
calcium supplementation on the risk of carcinoma of the skin. A randomised 8.
large bowel polyps.[see comment]. J Natl controlled trial. Nutritional Prevention 11. Wu K, Hu FB, Willett WC, et al. Dietary
Cancer Inst 2004;96:921-5. of Cancer Study Group. JAMA patterns and risk of prostate cancer in
48. Bonithon-Kopp C, Kronborg O, Giacosa A, 1996;276:1957-63. U.S. men. Cancer Epidemiol Biomarkers
et al. Calcium and fibre supplementation 62. Duffield-Lillico AJ, Reid ME, Turnbull BW, Prev 2006;15:167-71.
in prevention of colorectal adenoma et al. Baseline characteristics and the 12. Terry P, Hu FB, Hansen H, et al. Prospective
recurrence: A randomised intervention effect of selenium supplementation on study of major dietary patterns and
trial. Lancet 2000;356:1300-6. cancer incidence in a randomised clinical colorectal cancer risk in women. Am J
49. Hofstad B, Almendingen K, Vatn M, et al. trial: a summary report of the Nutritional Epidemiol 2001;154:1143-9.
Growth and recurrence of colorectal Prevention of Cancer Trial. Cancer 13. Ronco AL, De Stefani E, Boffetta P, et al.
466
R E F E R E N C E S
Food patterns and risk of breast cancer: Biomarkers Prev 2005;14:483-90. Chih 1985;6:29-32.
a factor analysis study in Uruguay. Int J 30. Dixon LB, Balder HF, Virtanen MJ, et al. 48. You WC, Blot WJ, Chang YS, et al. Diet and
Cancer 2006;119:1672-8. Dietary patterns associated with colon high risk of stomach cancer in Shandong,
14. De Stefani E, Correa P, Boffetta P, et al. and rectal cancer: results from the China. Cancer Res 1988;48:3518-23.
Dietary patterns and risk of gastric Dietary Patterns and Cancer (DIETSCAN) 49. Tajima K, Tominaga S. Dietary habits and
cancer: a case-control study in Uruguay. Project. Am J Clin Nutr 2004;80:1003-11. gastro-intestinal cancers: a comparative
Gastric Cancer 2004;7:211-20. 31. Markaki I, Linos D, Linos A. The influence case-control study of stomach and large
15. Bahmanyar S, Ye W. Dietary patterns and of dietary patterns on the development intestinal cancers in Nagoya, Japan. Jpn J
risk of squamous-cell carcinoma and of thyroid cancer. Eur J Cancer Cancer Res 1985;76:705-16.
adenocarcinoma of the esophagus and 2003;39:1912-9. 50. Graham S, Lilienfe AM, Tidings JE. Dietary
adenocarcinoma of the gastric cardia: a 32. Handa K, Kreiger N. Diet patterns and the and purgation factors in epidemiology
population-based case-control study in risk of renal cell carcinoma. Public Health of gastric cancer. Cancer 1967;20:2224-
Sweden. Nutr Cancer 2006;54:171-8. Nutr 2002;5:757-67. 34.
16. Tominaga S, Kuroishi T, Ogawa H, et al. 33. De Stefani E, Boffetta P, Ronco AL, et al. 51. Youm PY, Kim SH. [A case-control study on
Epidemiologic aspects of biliary tract Dietary patterns and risk of cancer of the dietary and other factors related to
cancer in Japan. Natl Cancer Inst Monogr oral cavity and pharynx in Uruguay. Nutr stomach cancer incidence]. Korean J Nutr
1979:25-34. Cancer 2005;51:132-9. 1998;31:62-71.
17. Ishimoto H, Nakamura H, Miyoshi T. 34. Nkondjock A, Krewski D, Johnson KC, et al. 52. Rachtan J. [Clinical control studies of the
Epidemiological study on relationship Dietary patterns and risk of pancreatic role of dietary habits in the etiology of
between breast cancer mortality and cancer. Int J Cancer 2005;114:817-23. stomach cancer]. Przegl Lek 1986;43:543-
dietary factors. Tokushima J Exp Med 35. Key TJ, Thorogood M, Appleby PN, et al. 6.
1994;41:103-14. Dietary habits and mortality in 11,000 53. Csendes A, Medina E, Gaete MC, et al.
18. Rashidkhani B, Akesson A, Lindblad P, et al. vegetarians and health conscious [Gastric cancer: an epidemiologic and
Major dietary patterns and risk of renal people: results of a 17 year follow up. dietary study in 100 patients and 100
cell carcinoma in a prospective cohort of BMJ 1996;313:775-9. controls]. Rev Med Chil 1976;104:761-5.
Swedish women. J Nutr 2005;135:1757- 36. Hirayama T. [A large scale cohort study of 54. Dalgat DM, Aliev RG, Gireev GI, et al.
62. dietary habits and cancer mortality]. Gan [Epidemiology of stomach cancer in
19. Adebamowo CA, Hu FB, Cho E, et al. No Rinsho 1986;32:610-22. Dagestan]. Vopr Onkol 1974;20:76-82.
Dietary patterns and the risk of breast 37. Jensen OM. Cancer risk among Danish 55. Demirer T, Icli F, Uzunalimoglu O, et al. Diet
cancer. Ann Epidemiol 2005;15:789-95. male Seventh-Day Adventists and other and stomach cancer incidence. A case-
20. Michaud DS, Skinner HG, Wu K, et al. temperance society members. J Natl control study in Turkey. Cancer
Dietary patterns and pancreatic cancer Cancer Inst 1983;70:1011-4. 1990;65:2344-8.
risk in men and women. J Natl Cancer 38. Berkel J, de Waard F. Mortality pattern and 56. Boeing H, Jedrychowski W, Wahrendorf J,
Inst 2005;97:518-24. life expectancy of Seventh-Day et al. Dietary risk factors in intestinal and
21. Fung TT, Hu FB, Holmes MD, et al. Dietary Adventists in the Netherlands. Int J diffuse types of stomach cancer: a
patterns and the risk of postmenopausal Epidemiol 1983;12:455-9. multicenter case-control study in Poland.
breast cancer. Int J Cancer 2005;116:116- 39. Kuratsune M, Ikeda M, Hayashi T. Cancer Causes Control 1991;2:227-33.
21. Epidemiologic studies on possible health 57. Cai L. [A case-control study of stomach
22. Walker M, Aronson KJ, King W, et al. effects of intake of pyrolyzates of foods, cancer in Changle, Fujian Province - by
Dietary patterns and risk of prostate with reference to mortality among the risk state analysis]. Chung Hua Liu
cancer in Ontario, Canada. Int J Cancer Japanese Seventh-Day Adventists. Hsing Ping Hsueh Tsa Chih 1991;12:15-9.
2005;116:592-8. Environ Health Perspect 1986;67:143-6. 58. Ren D, Jin J, Wang D, et al. The nutritional
23. Palli D, Russo A, Decarli A. Dietary 40. Lemon FR, Walden RT, Woods RW. Cancer factors related to gastric cancer in
patterns, nutrient intake and gastric of the lung and mouth in Seventh-day Tianjin. Ying Yang Xue Bao 1992;14:325-
cancer in a high-risk area of Italy. Cancer Adventists. Preliminary report on a 8.
Causes Control 2001;12:163-72. population study. Cancer 1964;17:486- 59. Ji BT, Chow WH, Yang G, et al. Dietary
24. Slattery ML, Boucher KM, Caan BJ, et al. 97. habits and stomach cancer in Shanghai,
Eating patterns and risk of colon cancer. 41. Phillips RL, Garfinkel L, Kuzma JW, et al. China. Int J Cancer 1998;76:659-64.
Am J Epidemiol 1998;148:4-16. Mortality among California Seventh-Day 60. Watabe K, Nishi M, Miyake H, et al.
25. Slattery ML, Edwards SL, Boucher KM, et al. Adventists for selected cancer sites. J Lifestyle and gastric cancer: a case-
Lifestyle and colon cancer: an assessment Natl Cancer Inst 1980;65:1097-107. control study. Oncol Rep 1998;5:1191-4.
of factors associated with risk. Am J 42. Mills PK, Beeson WL, Phillips RL, et al. 61. Ye W, Yi Y, Luo R. [A case-control study on
Epidemiol 1999;150:869-77. Cancer incidence among California diet and gastric cancer]. Chung Hua Yu
26. Kesse E, Clavel-Chapelon F, Boutron-Ruault Seventh-day Adventists, 1976-1982. Am J Fang I Hsueh Tsa Chih 1998;32:100-2.
MC. Dietary patterns and risk of Clin Nutr 1994;59:1136S-42S. 62. Gao CM, Takezaki T, Ding JH, et al.
colorectal tumors: a cohort of French 43. Hirayama T. [Primary cancer prevention by Protective effect of allium vegetables
women of the National Education life style modification]. 1989;35:163-70. against both esophageal and stomach
System (E3N). Am J Epidemiol 44. Mills PK, Beeson WL, Abbey DE, et al. cancer: a simultaneous case-referent
2006;164:1085-93. Dietary habits and past medical history study of a high-epidemic area in Jiangsu
27. Sieri S, Krogh V, Pala V, et al. Dietary as related to fatal pancreas cancer risk Province, China. Jpn J Cancer Res
patterns and risk of breast cancer in the among Adventists. Cancer 1988;61:2578- 1999;90:614-21.
ORDET cohort. Cancer Epidemiol 85. 63. Cai L, Yu SZ, Ye WM, et al. Fish sauce and
Biomarkers Prev 2004;13:567-72. 45. Mills PK, Beeson WL, Phillips RL, et al. gastric cancer: an ecological study in
28. Velie EM, Schairer C, Flood A, et al. Cohort study of diet, lifestyle, and Fujian Province, China. World J
Empirically derived dietary patterns and prostate cancer in Adventist men. Cancer Gastroenterol 2000;6:671-5.
risk of postmenopausal breast cancer in 1989;64:598-604. 64. Suh S, Koo B, Choi Y, et al. [Lifestyle and
a large prospective cohort study. Am J 46. Ye EC. [Case-control study of 100 gastric eating behaviors of the stomach cancer
Clin Nutr 2005;82:1308-19. cancer cases]. Chung Hua Yu Fang I patients in Daegu and Kyungpook areas
29. Balder HF, Goldbohm RA, van den Brandt Hsueh Tsa Chih 1981;15:107-9. in Korea]. Korean J Nutr 2002;35:380-93.
PA. Dietary patterns associated with 47. Ren TS. [Case-control study of gastric 65. Fei S, Xiao S. [Diet and gastric cancer: a
male lung cancer risk in the Netherlands cancer in ten rural counties in China]. case-control study in Shanghai urban
Cohort Study. Cancer Epidemiol Chung Hua Liu Hsing Ping Hsueh Tsa districts]. Chin J Gastroenterol
467
F O O D , N U T R I T I O N , P H Y S I C A L A C T I V I T Y, A N D T H E P R E V E N T I O N O F C A N C E R : A G L O B A L P E R S P E C T I V E
468
R E F E R E N C E S
35. Gerhardsson M, Norell SE, Kiviranta H, et 2002;13:383-93. Physical activity, physical function, and
al. Sedentary jobs and colon cancer. Am J 51. Wannamethee SG, Shaper AG, Walker M. the risk of breast cancer in a prospective
Epidemiol 1986;123:775-80. Physical activity and risk of cancer in study among elderly women. J Gerontol
36. Pukkala E, Kaprio J, Koskenvuo M, et al. middle-aged men. Br J Cancer A Biol Sci Med Sci 1998;53:M351-56.
Cancer incidence among Finnish world 2001;85:1311-6. 58. Colditz GA, Feskanich D, Chen WY, et al.
class male athletes. Int J Sports Med 52. Lee DH, Jacobs DR, Folsom AR. A Physical activity and risk of breast cancer
2000;21:216-20. hypothesis: interaction between in premenopausal women. Br J Cancer
37. Bostick RM, Potter JD, Kushi LH, et al. supplemental iron intake and 2003;89:847-51.
Sugar, meat, and fat intake, and non- fermentation affecting the risk of colon 59. Dorgan JF, Brown C, Barrett M, et al.
dietary risk factors for colon cancer cancer. The Iowa Womens Health Study. Physical activity and risk of breast cancer
incidence in Iowa women (United States). Nutr Cancer 2004;48:1-5. in the Framingham Heart Study. Am J
Cancer Causes Control 1994;5:38-52. 53. Singh PN, Fraser GE. Dietary risk factors for Epidemiol 1994;139:662-9.
38. Chao A, Connell CJ, Jacobs EJ, et al. colon cancer in a low-risk population. Am 60. Hoyer AP, Grandjean P, Jorgensen T, et al.
Amount, type, and timing of recreational J Epidemiol 1998;148:761-74. Organochlorine exposure and risk of
physical activity in relation to colon and 54. Samad AK, Taylor RS, Marshall T, et al. A breast cancer. Lancet 1998;352:1816-20.
rectal cancer in older adults: the Cancer meta-analysis of the association of 61. Lee SY, Kim MT, Kim SW, et al. Effect of
Prevention Study II Nutrition Cohort. physical activity with reduced risk of lifetime lactation on breast cancer risk: a
Cancer Epidemiol Biomarkers Prev colorectal cancer. Colorectal Dis Korean womens cohort study. Int J
2004;13:2187-95. 2005;7:204-13. Cancer 2003;105:390-3.
39. Davey Smith G, Shipley MJ, Batty GD, et al. 55. Calle EE, Kaaks R. Overweight, obesity and 62. Wyrwich KW, Wolinsky FD. Physical activity,
Physical activity and cause-specific cancer: epidemiological evidence and disability, and the risk of hospitalization
mortality in the Whitehall study. Public proposed mechanisms. Nat Rev Cancer for breast cancer among older women. J
Health 2000;114:308-15. 2004;4:579-91. Gerontol A Biol Sci Med Sci
40. Ford ES. Body mass index and colon cancer 56. Lewin MH, Bailey N, Bandaletova T, et al. 2000;55:M418-21.
in a national sample of adult US men and Red meat enhances the colonic 63. Tavani A, Braga C, La Vecchia C, et al.
women. Am J Epidemiol 1999;150:390-8. formation of the DNA adduct O6- Physical activity and risk of cancers of the
41. Giovannucci E, Ascherio A, Rimm EB, et al. carboxymethyl guanine: implications for colon and rectum: an Italian case-control
Physical activity, obesity, and risk for colorectal cancer risk. Cancer Res study. Br J Cancer 1999;79:1912-6.
colon cancer and adenoma in men. Ann 2006;66:1859-65. 64. Fioretti F, Tavani A, Bosetti C, et al. Risk
Intern Med 1995;122:327-34. 56A. Chao A, Connell CJ, Jacobs EJ, et al. factors for breast cancer in nulliparous
42. Glynn SA, Albanes D, Pietinen P, et al. Amount, type, and timing of women. Br J Cancer 1999;79:1923-8.
Colorectal cancer and folate status: a recreational physical activity in relation 65. Friedenreich CM, Courneya KS, Bryant HE.
nested case-control study among male to colon and rectal cancer in older Influence of physical activity in different
smokers. Cancer Epidemiol Biomarkers adults: the Cancer Prevention Study II age and life periods on the risk of breast
Prev 1996;5:487-94. Nutrition Cohort. Cancer Epidemiol cancer. Epidemiology 2001;12:604-12.
43. Hsing AW, McLaughlin JK, Chow WH, et al. Biomarkers Prev 2004;13:2187-95. 66. Hirose K, Hamajima N, Takezaki T, et al.
Risk factors for colorectal cancer in a 56B. Friedenreich C, Norat T, Steindorf K, et al. Physical exercise reduces risk of breast
prospective study among U.S. white men. Physical activity and risk of colon and cancer in Japanese women. Cancer Sci
Int J Cancer 1998;77:549-53. rectal cancers: the European prospective 2003;94:193-9.
44. Lee IM, Paffenbarger RS, Jr. Physical investigation into cancer and nutrition. 67. John EM, Horn-Ross PL, Koo J. Lifetime
activity and its relation to cancer risk: a Cancer Epidemiol Biomarkers Prev physical activity and breast cancer risk in
prospective study of college alumni. Med 2006;15:2398-407. a multiethnic population: the San
Sci Sports Exerc 1994;26:831-7. 56C. Schnohr P, Gronbaek M, Petersen L, et al. Francisco Bay area breast cancer study.
45. Malila N, Virtamo J, Virtanen M, et al. Physical activity in leisure-time and risk Cancer Epidemiol Biomarkers Prev
Dietary and serum alpha-tocopherol, of cancer: 14-year follow-up of 28,000 2003;12:1143-52.
beta-carotene and retinol, and risk for Danish men and women. Scand J Public 68. Mezzetti M, La Vecchia C, Decarli A, et al.
colorectal cancer in male smokers. Eur J Health 2005;33:244-9. Population attributable risk for breast
Clin Nutr 2002;56:615-21. 56D. Calton BA, Lacey JV, Jr., Schatzkin A, et al. cancer: diet, nutrition, and physical
46. Martinez ME, Giovannucci E, Spiegelman Physical activity and the risk of colon exercise. J Natl Cancer Inst 1998;90:389-
D, et al. Leisure-time physical activity, cancer among women: a prospective 94.
body size, and colon cancer in women. cohort study (United States). Int J Cancer 69. Rattanamongkolgul S, Muir K, Armstrong
Nurses Health Study Research Group. J 2006;119:385-91. S, et al. Diet, energy intake and breast
Natl Cancer Inst 1997;89:948-55. 56E. Steindorf K, Jedrychowski W, Schmidt M, cancer risk in an Asian country. IARC Sci
47. Polednak AP. College atheletics, body size, et al. Case-control study of lifetime Publ 2002;156:543-5.
and cancer mortality. Cancer occupational and recreational physical 70. Wenten M, Gilliland FD, Baumgartner K, et
1976;38:382-87. activity and risks of colon and rectal al. Associations of weight, weight
48. Sanjoaquin MA, Appleby PN, Thorogood cancer. Eur J Cancer Prev 2005;14:363-71. change, and body mass with breast
M, et al. Nutrition, lifestyle and 56F. Hou L, Ji BT, Blair A, et al. Commuting cancer risk in Hispanic and non-Hispanic
colorectal cancer incidence: a prospective physical activity and risk of colon cancer white women. Ann Epidemiol
investigation of 10998 vegetarians and in Shanghai, China. Am J Epidemiol 2002;12:435-4.
non-vegetarians in the United Kingdom. 2004;160:860-7. 71. Byrne C, Ursin G, Ziegler RG. A comparison
Br J Cancer 2004;90:118-21. 56G. Zhang Y, Cantor KP, Dosemeci M, et al. of food habit and food frequency data as
49. Thun MJ, Calle EE, Namboodiri MM, et al. Occupational and leisure-time physical predictors of breast cancer in the
Risk factors for fatal colon cancer in a activity and risk of colon cancer by NHANES I/NHEFS cohort. J Nutr
large prospective study. J Natl Cancer Inst subsite. J Occup Environ Med 1996;126:2757-64.
1992;84:1491-500. 2006;48:236-43. 72. Thune I, Brenn T, Lund E, et al. Physical
50. Tiemersma EW, Kampman E, Bueno de 56H. Huang XE, Hirose K, Wakai K, et al. activity and the risk of breast cancer. N
Mesquita HB, et al. Meat consumption, Comparison of lifestyle risk factors by Engl J Med 1997;336:1269-75.
cigarette smoking, and genetic family history for gastric, breast, lung 73. Moradi T, Adami H-O, Bergstrom R, et al.
susceptibility in the etiology of colorectal and colorectal cancer. Asian Pac J Cancer Occupational physical activity and risk for
cancer: results from a Dutch prospective Prev 2004;5:419-27. breast cancer in a nationwide cohort
study. Cancer Causes Control 57. Cerhan JR, Chiu BC-H, Wallace RB, et al. study in Sweden. Cancer Causes Control
469
F O O D , N U T R I T I O N , P H Y S I C A L A C T I V I T Y, A N D T H E P R E V E N T I O N O F C A N C E R : A G L O B A L P E R S P E C T I V E
1999;10:423-30. Physical activity in different periods of 103. Shu XO, Hatch MC, Zheng W, et al.
74. Mertens AJ, Sweeney C, Shahar E, et al. life and the risk of breast cancer: the Physical activity and risk of endometrial
Physical activity and breast cancer Norwegian-Swedish Womens Lifestyle cancer. Epidemiology 1993;4:342-9.
incidence in middle-aged women: a and Health cohort study. Cancer 104. Levi F, La Vecchia C, Negri E, et al. Selected
prospective cohort study. Breast Cancer Epidemiol Biomarkers Prev 2005;14:27- physical activities and the risk of
Res Treat 2006;79:209-14. 32. endometrial cancer. Br J Cancer
75. Coogan PF, Newcomb PA, Clapp RW, et al. 90. Patel AV, Calle EE, Bernstein L, et al. 1993;67:846-51.
Physical activity in usual occupation and Recreational physical activity and risk of 105. Moradi T, Nyren O, Bergstrom R, et al. Risk
risk of breast cancer (United States). postmenopausal breast cancer in a large for endometrial cancer in relation to
Cancer Causes Control 1997;8:626-31. cohort of US women. Cancer Causes occupational physical activity: a
76. Ueji M, Ueno E, Osei-Hyiaman D, et al. Control 2003;14:519-29. nationwide cohort study in Sweden. Int J
Physical activity and the risk of breast 91. Schnohr P, Gronbaek M, Petersen L, et al. Cancer 1998;76:665-70.
cancer: a case-control study of Japanese Physical activity in leisure-time and risk of 106. Weiderpass E, Pukkala E, Vasama-
women. J Epidemiol 1998;8:116-22. cancer: 14-year follow-up of 28,000 Neuvonen K, et al. Occupational
77. Friedenreich CM, Bryant HE, Courneya KS. Danish men and women. Scand J Public exposures and cancers of the
Case-control study of lifetime physical Health 2005;33:244-9. endometrium and cervix uteri in Finland.
activity and breast cancer risk. Am J 92. Verloop J, Rookus MA, van der Kooy K, et Am J Ind Med 2001;39:572-80.
Epidemiol 2001;154:336-47. al. Physical activity and breast cancer risk 107. Furberg AS, Thune I. Metabolic
78. Dorn J, Vena J, Brasure J, et al. Lifetime in women aged 20-54 years. J Natl Cancer abnormalities (hypertension,
physical activity and breast cancer risk in Inst 2000;92:128-35. hyperglycemia and overweight), lifestyle
pre- and postmenopausal women. Med 93. Matthews CE, Shu XO, Jin F, et al. Lifetime (high energy intake and physical
Sci Sports Exerc 2003;35:278-85. physical activity and breast cancer risk in inactivity) and endometrial cancer risk in
79. Kruk J, Aboul-Enein HY. Occupational the Shanghai breast cancer study. Br J a Norwegian cohort. Int J Cancer
physical activity and the risk of breast Cancer 2001;84:994-1001. 2003;104:669-76.
cancer. Cancer Detect Prev 2003;27:187- 94. Moradi T, Nyren O, Zack M, et al. Breast 108. Olson SH, Vena JE, Dorn JP, et al. Exercise,
92. cancer risk and lifetime leisure-time and occupational activity, and risk of
80. Steindorf K, Schmidt M, Kropp S, et al. occupational physical activity (Sweden). endometrial cancer. Ann Epidemiol
Case-control study of physical activity and Cancer Causes Control 2000;11:523-31. 1997;7:46-53.
breast cancer risk among premenopausal 95. Gilliland FD, Li YF, Baumgartner K, et al. 109. Jain MG, Rohan TE, Howe GR, et al. A
women in Germany. Am J Epidemiol Physical activity and breast cancer risk in cohort study of nutritional factors and
2003;157:121-30. hispanic and non-hispanic white women. endometrial cancer. Eur J Epidemiol
81. Yang D, Bernstein L, Wu AH. Physical Am J Epidemiol 2001;154:442-50. 2000;16:899-905.
activity and breast cancer risk among 96. Chen CL, White E, Malone KE, et al. 110. Moradi T, Weiderpass E, Signorello LB, et
Asian-American women in Los Angeles: a Leisure-time physical activity in relation al. Physical activity and postmenopausal
case-control study. Cancer 2003;97:2565- to breast cancer among young women endometrial cancer risk (Sweden). Cancer
75. (Washington, United States). Cancer Causes Control 2000;11:829-37.
82. Sesso HD, Paffenbarger RS, Jr., Lee IM. Causes Control 1997;8:77-84. 111. Matthews CE, Xu WH, Zheng W, et al.
Physical activity and breast cancer risk in 97. Carpenter CL, Ross RK, Paganini-Hill A, et Physical activity and risk of endometrial
the college alumni health study (United al. Effect of family history, obesity and cancer: a report from the Shanghai
States). Cancer Causes Control exercise on breast cancer risk among endometrial cancer study. Cancer
1998;9:433-9. postmenopausal women. Int J Cancer Epidemiol Biomarkers Prev 2005;14:779-
83. Moore DB, Folsom AR, Mink PJ, et al. 2003;106:96-102. 85.
Physical activity and incidence of 98. Bernstein L, Patel AV, Ursin G, et al. 112. Dosemeci M, Hayes RB, Vetter R, et al.
postmenopausal breast cancer. Lifetime recreational exercise activity and Occupational physical activity,
Epidemiology 2000;11:292-6. breast cancer risk among black women socioeconomic status, and risks of 15
84. Breslow RA, Ballard-Barbash R, Munoz K, and white women. J Natl Cancer Inst cancer sites in Turkey. Cancer Causes
et al. Long-term recreational physical 2005;97:1671-9. Control 1993;4:313-21.
activity and breast cancer in the National 98A. Adams SA, Matthews CE, Hebert JR, et al. 113. Kalandidi A, Tzonou A, Lipworth L, et al.
Health and Nutrition Examination Survey Association of physical activity with A case-control study of endometrial
I epidemiologic follow-up study. Cancer hormone receptor status: the Shanghai cancer in relation to reproductive,
Epidemiol Biomarkers Prev 2001;10:805- Breast Cancer Study. Cancer Epidemiol somatometric, and life-style variables.
8. Biomarkers Prev 2006;15:1170-8. Oncology 1996;53:354-9.
85. Dirx MJ, Voorrips LE, Goldbohm RA, et al. 99. Colbert LH, Lacey JV, Jr., Schairer C, et al. 114. Goodman MT, Hankin JH, Wilkens LR, et
Baseline recreational physical activity, Physical activity and risk of endometrial al. Diet, body size, physical activity, and
history of sports participation, and cancer in a prospective cohort study the risk of endometrial cancer. Cancer Res
postmenopausal breast carcinoma risk in (United States). Cancer Causes Control 1997;57:5077-85.
the Netherlands Cohort Study. Cancer 2003;14:559-67. 115. Terry P, Baron JA, Weiderpass E, et al.
2001;92:1638-49. 100. Silvera SA, Rohan TE, Jain M, et al. Lifestyle and endometrial cancer risk: a
86. Drake DA. A longitudinal study of physical Glycaemic index, glycaemic load and risk cohort study from the Swedish Twin
activity and breast cancer prediction. of endometrial cancer: a prospective Registry. Int J Cancer 1999;82:38-42.
Cancer Nurs 2001;24:371-7. cohort study. Public Health Nutr 116. Schouten LJ, Goldbohm RA, van den
87. Lee IM, Rexrode KM, Cook NR, et al. 2005;8:912-9. Brandt PA. Anthropometry, physical
Physical activity and breast cancer risk: 101. Salazar-Martinez E, Lazcano-Ponce EC, activity, and endometrial cancer risk:
the Womens Health Study (United Lira-Lira GG, et al. Case-control study of results from the Netherlands Cohort
States). Cancer Causes Control diabetes, obesity, physical activity and Study. J Natl Cancer Inst 2004;96:1635-8.
2001;12:137-45. risk of endometrial cancer among 117. Folsom AR, Demissie Z, Harnack L.
88. McTiernan A, Kooperberg C, White E, et al. Mexican women. Cancer Causes Control Glycemic index, glycemic load, and
Recreational physical activity and the risk 2000;11:707-11. incidence of endometrial cancer: the
of breast cancer in postmenopausal 102. Sturgeon SR, Brinton LA, Berman ML, et Iowa womens health study. Nutr Cancer
women: the womens health initiative al. Past and present physical activity and 2003;46:119-24.
cohort study. JAMA 2003;290:1331-6. endometrial cancer risk. Br J Cancer 118. Littman AJ, Voigt LF, Beresford SA, et al.
89. Margolis KL, Mucci L, Braaten T, et al. 1993;68:584-9. Recreational physical activity and
470
R E F E R E N C E S
471
F O O D , N U T R I T I O N , P H Y S I C A L A C T I V I T Y, A N D T H E P R E V E N T I O N O F C A N C E R : A G L O B A L P E R S P E C T I V E
Chapter 6 15. Dagenais GR, Yi Q, Mann JF, et al. Epidemiol Biomarkers Prev 1995;4:85-92.
Prognostic impact of body weight and 29. Wu MM, Kuo TL, Hwang YH, et al. Dose-
1. Fogel R. The Escape from Hunger and abdominal obesity in women and men response relation between arsenic
Premature Death, 1700-2100. Europe, with cardiovascular disease. Am Heart J concentration in well water and
America and the Third World. 2005;149:54-60. mortality from cancers and vascular
Cambridge: Cambridge University Press, 16. Han TS, van Leer EM, Seidell JC, et al. Waist diseases. Am J Epidemiol 1989;130:1123-
2004. circumference action levels in the 32.
2. Commission on the Nutrition Challenges of identification of cardiovascular risk 30. Samanic C, Chow WH, Gridley G, et al.
the 21st Century. 2000. Ending factors: prevalence study in a random Relation of body mass index to cancer
Malnutrition by 2020: An Agenda for sample. BMJ (Clin Res Ed) 1995;311:1401- risk in 362,552 Swedish men. Cancer
Change in the Millennium. 5. Causes Control 2006;17:901-9.
http://www.unsystem.org/scn/Publication 17. Lean ME, Han TS, Morrison CE. Waist 31. MacInnis RJ, English DR, Hopper JL, et al.
s/UN_Report.PDF. circumference as a measure for Body size and composition and the risk
3. World Health Organization. 2000. Obesity: indicating need for weight of gastric and oesophageal
Preventing and Managing the Global management. BMJ (Clin Res Ed) adenocarcinoma. Int J Cancer
Epidemic. In: Technical Report Series no 1995;311:158-61. 2006;118:2628-31.
894. 18. Misra A, Wasir JS, Vikram NK. Waist 32. Ryan AM, Rowley SP, Fitzgerald AP, et al.
http://whqlibdoc.who.int/trs/WHO_TRS_ circumference criteria for the diagnosis Adenocarcinoma of the oesophagus and
894.pdf. of abdominal obesity are not applicable gastric cardia: male preponderance in
4. Deurenberg P, Weststrate JA, Seidell JC. uniformly to all populations and ethnic association with obesity. Eur J Cancer
Body mass index as a measure of body groups. Nutrition 2005;21:969-76. 2006;42:1151-8.
fatness: age- and sex-specific prediction 19. Lindblad M, Rodriguez LA, Lagergren J. 33. de Jonge PJ, Steyerberg EW, Kuipers EJ, et
formulas. Br J Nutr 1991;65:105-14. Body mass, tobacco and alcohol and risk al. Risk factors for the development of
5. World Health Organization. 1995. Physical of esophageal, gastric cardia, and gastric esophageal adenocarcinoma in Barretts
Status: The Use and Interpretation of non-cardia adenocarcinoma among men esophagus. Am J Gastroenterol
Anthropometry. In: Technical Report and women in a nested case-control 2006;101:1421-9.
Series no 854. study. Cancer Causes Control 34. Bu X, Ma Y, Der R, et al. Body mass index is
http://whqlibdoc.who.int/trs/WHO_TRS_ 2005;16:285-94. associated with Barrett esophagus and
854.pdf. 20. Tretli S, Robsahm TE. Height, weight and cardiac mucosal metaplasia. Dig Dis Sci
6. James WPT, Jackson-Leach R, Ni Mhurchu C, cancer of the oesophagus and stomach: a 2006;51:1589-94.
et al. Overweight and obesity (high body follow-up study in Norway. Eur J Cancer 35. Wu M, Zhao JK, Hu XS, et al. Association of
mass index). In: Ezzati M, Lopez AD, Prev 1999;8:115-22. smoking, alcohol drinking and dietary
Rodgers A, et al., editors. Comparative 21. Engeland A, Tretli S, Bjorge T. Height and factors with esophageal cancer in high-
Quantification of Health Risks. Global body mass index in relation to and low-risk areas of Jiangsu Province,
and Regional Burden of Disease esophageal cancer; 23-year follow-up of China. World J Gastroenterol
Attributable to Selected Major Risk two million Norwegian men and women. 2006;12:1686-93.
Factors. Geneva: World Health Cancer Causes Control 2004;15:837-43. 36. Veugelers PJ, Porter GA, Guernsey DL, et al.
Organization, 2004. 22. Blot WJ, Li JY, Taylor PR, et al. Nutrition Obesity and lifestyle risk factors for
7. World Health Organization/International intervention trials in Linxian, China: gastroesophageal reflux disease, Barrett
Association for the Study of supplementation with specific esophagus and esophageal
Obesity/International Obesity Taskforce. vitamin/mineral combinations, cancer adenocarcinoma. Dis Esophagus
The Asia-Pacific Perspective: Redefining incidence, and disease-specific mortality 2006;19:321-8.
Obesity and its Treatment. Melbourne: in the general population.[see 37. Friedman GD, van den Eeden SK. Risk
Health Communications Australia, 2000. comment]. J Natl Cancer Inst factors for pancreatic cancer: an
8. James WP, Chunming C, Inoue S. 1993;85:1483-92. exploratory study. Int J Epidemiol
Appropriate Asian body mass indices? 23. Brown LM, Swanson CA, Gridley G, et al. 1993;22:30-7.
Obesity reviews 2002;3:139. Adenocarcinoma of the esophagus: role 38. Shibata A, Mack TM, Paganini-Hill A, et al.
9. World Health Organization Expert of obesity and diet. J Natl Cancer Inst A prospective study of pancreatic cancer
Consultation. Appropriate body-mass 1995;87:104-9. in the elderly. Int J Cancer 1994;58:46-9.
index for Asian populations and its 24. Chen H, Tucker KL, Graubard BI, et al. 39. Gapstur SM, Gann PH, Lowe W, et al.
implications for policy and intervention Nutrient intakes and adenocarcinoma of Abnormal glucose metabolism and
strategies. Lancet 2004;363:157-63. the esophagus and distal stomach. Nutr pancreatic cancer mortality. JAMA
10. Deurenberg-Yap M, Deurenberg P. Is a re- Cancer 2002;42:33-40. 2000;283:2552-8.
evaluation of WHO body mass index cut- 25. Chow WH, Blot WJ, Vaughan TL, et al. Body 40. Michaud DS, Giovannucci E, Willett WC, et
off values needed? The case of Asians in mass index and risk of adenocarcinomas al. Physical activity, obesity, height, and
Singapore. Nutr Rev 2003;61:S80-7. of the esophagus and gastric cardia. J the risk of pancreatic cancer. JAMA
11. Swinburn BA, Caterson I, Seidell JC, et al. Natl Cancer Inst 1998;90:150-5. 2001;286:921-9.
Diet, nutrition and the prevention of 26. Kabat GC, Ng SK, Wynder EL. Tobacco, 41. Stolzenberg-Solomon RZ, Pietinen P, Taylor
excess weight gain and obesity. Public alcohol intake, and diet in relation to PR, et al. A prospective study of medical
Health Nutr 2004;7:123-46. adenocarcinoma of the esophagus and conditions, anthropometry, physical
12. Sanchez-Castillo CP, Velasquez-Monroy O, gastric cardia. Cancer Causes Control activity, and pancreatic cancer in male
Lara-Esqueda A, et al. Diabetes and 1993;4:123-32. smokers (Finland). Cancer Causes Control
hypertension increases in a society with 27. Trivers KF, De Roos AJ, Gammon MD, et al. 2002;13:417-26.
abdominal obesity: results of the Demographic and lifestyle predictors of 42. Calle EE, Rodriguez C, Walker-Thurmond K,
Mexican National Health Survey 2000. survival in patients with esophageal or et al. Overweight, obesity, and mortality
Public Health Nutr 2005;8:53-60. gastric cancers. Clin Gastroenterol from cancer in a prospectively studied
13. Arner P. Regional adipocity in man. J Hepatol 2005;3:225-30. cohort of U.S. adults. N Engl J Med
Endocrinol 1997;155:191-2. 28. Vaughan TL, Davis S, Kristal A, et al. 2003;348:1625-38.
14. Bigaard J, Tjonneland A, Thomsen BL, et al. Obesity, alcohol, and tobacco as risk 43. Lee IM, Sesso HD, Oguma Y, et al. Physical
Waist circumference, BMI, smoking, and factors for cancers of the esophagus and activity, body weight, and pancreatic
mortality in middle-aged men and gastric cardia: adenocarcinoma versus cancer mortality. Br J Cancer
women. Obes Res 2003;11:895-903. squamous cell carcinoma. Cancer 2003;88:679-83.
472
R E F E R E N C E S
44. Batty GD, Shipley MJ, Jarrett RJ, et al. providing nutrients related to exocrine Biomarkers Prev 2006;15:879-85.
Obesity and overweight in relation to carcinoma of the pancreas? Int J Cancer 75. Garland C, Shekelle RB, Barrett Connor E,
organ-specific cancer mortality in 1990;46:435-44. et al. Dietary vitamin D and calcium and
London (UK): findings from the original 60. Howe GR, Jain M, Miller AB. Dietary factors risk of colorectal cancer: a 19-year
Whitehall study. Int J Obes 2005;29:1267- and risk of pancreatic cancer: results of a prospective study in men. Lancet
74. Canadian population-based case-control 1985;1:307-9.
45. Kuriyama S, Tsubono Y, Hozawa A, et al. study. Int J Cancer 1990;45:604-8. 76. Stahelin HB, Rosel F, Buess E, et al. Dietary
Obesity and risk of cancer in Japan. Int J 61. Ghadirian P, Simard A, Baillargeon J, et al. risk factors for cancer in the Basel Study.
Cancer 2005;113:148-57. Nutritional factors and pancreatic cancer Bibl Nutr Dieta 1986:144-53.
46. Larsson SC, Permert J, Hakansson N, et al. in the francophone community in 77. Klatsky AL, Armstrong MA, Friedman GD,
Overall obesity, abdominal adiposity, Montreal, Canada. Int J Cancer et al. The relations of alcoholic beverage
diabetes and cigarette smoking in 1991;47:1-6. use to colon and rectal cancer. Am J
relation to the risk of pancreatic cancer 62. Zatonski W, Przewozniak K, Howe GR, et Epidemiol 1988;128:1007-15.
in two Swedish population-based al. Nutritional factors and pancreatic 78. Gerhardsson M, Floderus B, Norell SE.
cohorts. Br J Cancer 2005;93:1310-5. cancer: a case-control study from south- Physical activity and colon cancer risk. Int
47. Navarro Silvera SA, Miller AB, Rohan TE. west Poland. Int J Cancer 1991;48:390-4. J Epidemiol 1988;17:743-6.
Hormonal and reproductive factors and 63. Ji BT, Hatch MC, Chow WH, et al. 79. Willett WC, Stampfer MJ, Colditz GA, et al.
pancreatic cancer risk: a prospective Anthropometric and reproductive Relation of meat, fat, and fiber intake to
cohort study. Pancreas 2005;30:369-74. factors and the risk of pancreatic cancer: the risk of colon cancer in a prospective
48. Nothlings U, Wilkens LR, Murphy SP, et al. a case-control study in Shanghai, China. study among women. N Engl J Med
Meat and fat intake as risk factors for Int J Cancer 1996;66:432-7. 1990;323:1664-72.
pancreatic cancer: the multiethnic 64. Silverman DT, Swanson CA, Gridley G, et al. 80. Chute CG, Willett WC, Colditz GA, et al. A
cohort study. J Natl Cancer Inst Dietary and nutritional factors and prospective study of body mass, height,
2005;97:1458-65. pancreatic cancer: a case-control study and smoking on the risk of colorectal
49. Patel AV, Rodriguez C, Bernstein L, et al. based on direct interviews. J Natl Cancer cancer in women. Cancer Causes Control
Obesity, recreational physical activity, Inst 1998;90:1710-9. 1991;2:117-24.
and risk of pancreatic cancer in a large 65. Kreiger N, LaCroix J, Sloan M. Hormonal 81. Thun MJ, Calle EE, Namboodiri MM, et al.
U.S. Cohort. Cancer Epidemiol factors and pancreatic cancer in women. Risk factors for fatal colon cancer in a
Biomarkers Prev 2005;14:459-66. Ann Epidemiol 2001;11:563-7. large prospective study. J Natl Cancer
50. Rapp K, Schroeder J, Klenk J, et al. Obesity 66. Pan SY, Johnson KC, Ugnat AM, et al. Inst 1992;84:1491-500.
and incidence of cancer: a large cohort Association of obesity and cancer risk in 82. Bostick RM, Potter JD, McKenzie DR, et al.
study of over 145,000 adults in Austria. Canada. Am J Epidemiol 2004;159:259- Reduced risk of colon cancer with high
Br J Cancer 2005;93:1062-7. 68. intake of vitamin E: the Iowa Womens
51. Sinner PJ, Schmitz KH, Anderson KE, et al. 67. Eberle CA, Bracci PM, Holly EA. Health Study. Cancer Res 1993;53:4230-7.
Lack of association of physical activity Anthropometric factors and pancreatic 83. Suadicani P, Hein HO, Gyntelberg F. Height,
and obesity with incident pancreatic cancer in a population-based case- weight, and risk of colorectal cancer. An
cancer in elderly women. Cancer control study in the San Francisco Bay 18-year follow-up in a cohort of 5249
Epidemiol Biomarkers Prev area. Cancer Causes Control men. Scand J Gastroenterol 1993;28:285-
2005;14:1571-3. 2005;16:1235-44. 8.
52. Lukanova A, Bjor O, Kaaks R, et al. Body 68. Fryzek JP, Schenk M, Kinnard M, et al. The 84. Bostick RM, Potter JD, Kushi LH, et al.
mass index and cancer: results from the association of body mass index and Sugar, meat, and fat intake, and non-
Northern Sweden Health and Disease pancreatic cancer in residents of dietary risk factors for colon cancer
Cohort. Int J Cancer 2006;118:458-66. southeastern Michigan, 1996-1999. Am J incidence in Iowa women (United
53. Nilsen TIL, Vatten LJ. A prospective study of Epidemiol 2005;162:222-8. States). Cancer Causes Control 1994;5:38-
lifestyle factors and the risk of 69. Lin Y, Tamakoshi A, Hayakawa T, et al. 52.
pancreatic cancer in Nord-Trondelag, Nutritional factors and risk of pancreatic 85. Chyou PH, Nomura AM, Stemmermann GN.
Norway. Cancer Causes Control cancer: a population-based case-control A prospective study of colon and rectal
2000;11:645-52. study based on direct interview in Japan. cancer among Hawaii Japanese men.
54. Moller H, Mellemgaard A, Lindvig K, et al. J Gastroenterol 2005;40:297-301. Ann Epidemiol 1996;6:276-82.
Obesity and cancer risk: a Danish record- 70. Pezzilli R, Morselli-Labate AM, Migliori M, 86. Gapstur SM, Potter JD, Folsom AR. Alcohol
linkage study. Eur J Cancer et al. Obesity and the risk of pancreatic consumption and colon and rectal cancer
1994;30A:344-50. cancer: an Italian multicenter study. in postmenopausal women. Int J
55. Wolk A, Gridley G, Svensson M, et al. A Pancreas 2005;31:221-4. Epidemiol 1994;23:50-7.
prospective study of obesity and cancer 71. Rousseau MC, Parent ME, Siemiatycki J. 87. Giovannucci E, Ascherio A, Rimm EB, et al.
risk (Sweden). Cancer Causes Control Comparison of self-reported height and Physical activity, obesity, and risk for
2001;12:13-21. weight by cancer type among men from colon cancer and adenoma in men. Ann
56. Samanic C, Gridley G, Chow WH, et al. Montreal, Canada. Eur J Cancer Prev Intern Med 1995;122:327-34.
Obesity and cancer risk among white 2005;14:431-8. 88. Chyou PH, Nomura AM, Stemmermann GN.
and black United States veterans. Cancer 72. Lyon JL, Slattery ML, Mahoney AW, et al. A prospective study of weight, body
Causes Control 2004;15:35-43. Dietary intake as a risk factor for cancer mass index and other anthropometric
57. Oh SW, Yoon YS, Shin SA. Effects of excess of the exocrine pancreas. Cancer measurements in relation to site-specific
weight on cancer incidences depending Epidemiol Biomarkers Prev 1993;2:513-8. cancers. Int J Cancer 1994;57:313-7.
on cancer sites and histologic findings 73. Wynder EL, Dieck GS, Hall NE. Case-control 89. Glynn SA, Albanes D, Pietinen P, et al.
among men: Korea National Health study of decaffeinated coffee Colorectal cancer and folate status: a
Insurance Corporation Study. J Clin consumption and pancreatic cancer. nested case-control study among male
Oncol 2005;23:4742-54. Cancer Res 1986;46:5360-3. smokers. Cancer Epidemiol Biomarkers
58. Robsahm TE, Tretli S. Height, weight and 74. Berrington de Gonzalez A, Spencer EA, Prev 1996;5:487-94.
gastrointestinal cancer: a follow-up Bueno-de-Mesquita HB, et al. 90. Key TJ, Thorogood M, Appleby PN, et al.
study in Norway. Eur J Cancer Prev Anthropometry, physical activity, and the Dietary habits and mortality in 11,000
1999;8:105-13. risk of pancreatic cancer in the European vegetarians and health conscious
59. Bueno de Mesquita HB, Moerman CJ, prospective investigation into cancer people: results of a 17 year follow up.
Runia S, et al. Are energy and energy- and nutrition. Cancer Epidemiol BMJ 1996;313:775-9.
473
F O O D , N U T R I T I O N , P H Y S I C A L A C T I V I T Y, A N D T H E P R E V E N T I O N O F C A N C E R : A G L O B A L P E R S P E C T I V E
91. Kato I, Akhmedkhanov A, Koenig K, et al. 107. Okasha M, McCarron P, McEwen J, et al. Study. Int J Obes Relat Metab Disord
Prospective study of diet and female Body mass index in young adulthood and 2004;28:551-8.
colorectal cancer: the New York cancer mortality: a retrospective cohort 121. Terry PD, Miller AB, Rohan TE. Obesity
University Womens Health Study. Nutr study. J Epidemiol Community Health and colorectal cancer risk in women. Gut
Cancer 1997;28:276-81. 2002;56:780-4. 2002;51:191-4.
92. Martinez ME, Giovannucci E, Spiegelman 108. Colangelo LA, Gapstur SM, Gann PH, et al. 122. Tulinius H, Sigfusson N, Sigvaldason H, et
D, et al. Leisure-time physical activity, Colorectal cancer mortality and factors al. Risk factors for malignant diseases: a
body size, and colon cancer in women. related to the insulin resistance cohort study on a population of 22,946
Nurses Health Study Research Group. J syndrome. Cancer Epidemiol Biomarkers Icelanders. Cancer Epidemiol Biomarkers
Natl Cancer Inst 1997;89:948-55. Prev 2002;11:385-91. Prev 1997;6:863-73.
93. Gaard M, Tretli S, Urdal P. Blood lipid and 109. Tiemersma EW, Kampman E, Bueno de 123. van Wayenburg CA, van der Schouw YT,
lipoprotein levels and the risk of cancer Mesquita HB, et al. Meat consumption, van Noord PA, et al. Age at menopause,
of the colon and rectum. A prospective cigarette smoking, and genetic body mass index, and the risk of
study of 62,173 Norwegian men and susceptibility in the etiology of colorectal colorectal cancer mortality in the Dutch
women. Scand J Gastroenterol cancer: results from a Dutch prospective Diagnostisch Onderzoek
1997;32:162-8. study. Cancer Causes Control Mammacarcinoom (DOM) cohort.
94. Singh PN, Fraser GE. Dietary risk factors for 2002;13:383-93. Epidemiology 2000;11:304-8.
colon cancer in a low-risk population. 110. Wu AH, Paganini-Hill A, Ross RK, et al. 124. Wei EK, Giovannucci E, Wu K, et al.
Am J Epidemiol 1998;148:761-74. Alcohol, physical activity and other risk Comparison of risk factors for colon and
95. Ford ES. Body mass index and colon cancer factors for colorectal cancer: a rectal cancer. Int J Cancer 2004;108:433-
in a national sample of adult US men and prospective study. Br J Cancer 42.
women. Am J Epidemiol 1999;150:390-8. 1987;55:687-94. 125. Kreger BE, Anderson KM, Schatzkin A, et
96. Pietinen P, Malila N, Virtanen M, et al. Diet 111. Kmet LM, Cook LS, Weiss NS, et al. Risk al. Serum cholesterol level, body mass
and risk of colorectal cancer in a cohort factors for colorectal cancer following index, and the risk of colon cancer. The
of Finnish men. Cancer Causes Control breast cancer. Breast Cancer Res Treat Framingham Study. Cancer 1992;70:1038-
1999;10:387-96. 2003;79:143-7. 43.
97. Schoen RE, Tangen CM, Kuller LH, et al. 112. Saydah SH, Platz EA, Rifai N, et al. 126. Le Marchand L, Wilkens LR, Mi MP.
Increased blood glucose and insulin, Association of markers of insulin and Obesity in youth and middle age and risk
body size, and incident colorectal cancer. glucose control with subsequent of colorectal cancer in men. Cancer
J Natl Cancer Inst 1999;91:1147-54. colorectal cancer risk. Cancer Epidemiol Causes Control 1992;3:349-54.
98. Kato I, Dnistrian AM, Schwartz M, et al. Biomarkers Prev 2003;12:412-8. 127. Lee IM, Paffenbarger RS, Jr. Quetelets
Serum folate, homocysteine and 113. Wong HL, Seow A, Arakawa K, et al. index and risk of colon cancer in college
colorectal cancer risk in women: a nested Vitamin D receptor start codon alumni. J Natl Cancer Inst 1992;84:1326-
case-control study. Br J Cancer polymorphism and colorectal cancer risk: 31.
1999;79:1917-22. effect modification by dietary calcium 128. Must A, Jacques PF, Dallal GE, et al. Long-
99. Murphy TK, Calle EE, Rodriguez C, et al. and fat in Singapore Chinese. term morbidity and mortality of
Body mass index and colon cancer Carcinogenesis 2003;24:1091-5. overweight adolescents. A follow-up of
mortality in a large prospective study. 114. Koh WP, Yuan JM, van den Berg D, et al. the Harvard Growth Study of 1922 to
Am J Epidemiol 2000;152:847-54. Interaction between cyclooxygenase-2 1935. N Engl J Med 1992;327:1350-5.
100. Jarvinen R, Knekt P, Hakulinen T, et al. gene polymorphism and dietary n-6 129. Nomura A, Heilbrun LK, Stemmermann
Prospective study on milk products, polyunsaturated fatty acids on colon GN. Body mass index as a predictor of
calcium and cancers of the colon and cancer risk: The Singapore Chinese cancer in men. J Natl Cancer Inst
rectum. Eur J Clin Nutr 2001;55:1000-7. Health Study. Br J Cancer 2004;90:1760-4. 1985;74:319-23.
101. Nilsen TI, Vatten LJ. Prospective study of 115. MacInnis RJ, English DR, Hopper JL, et al. 130. Jarvinen R, Knekt P, Hakulinen T, et al.
colorectal cancer risk and physical Body size and composition and colon Dietary fat, cholesterol and colorectal
activity, diabetes, blood glucose and cancer risk in men. Cancer Epidemiol cancer in a prospective study. Br J Cancer
BMI: exploring the hyperinsulinaemia Biomarkers Prev 2004;13:553-9. 2001;85:357-61.
hypothesis. Br J Cancer 2001;84:417-22. 116. Sanjoaquin MA, Appleby PN, Thorogood 131. Meyerhardt JA, Catalano PJ, Haller DG, et
102. Colbert LH, Hartman TJ, Malila N, et al. M, et al. Nutrition, lifestyle and al. Influence of body mass index on
Physical activity in relation to cancer of colorectal cancer incidence: a outcomes and treatment-related toxicity
the colon and rectum in a cohort of male prospective investigation of 10998 in patients with colon carcinoma. Cancer
smokers. Cancer Epidemiol Biomarkers vegetarians and non-vegetarians in the 2003;98:484-95.
Prev 2001;10:265-8. United Kingdom. Br J Cancer 132. Hara M, Mori M, Shono N, et al. Body
103. Field AE, Coakley EH, Must A, et al. Impact 2004;90:118-21. mass index and risk of cancer in men and
of overweight on the risk of developing 117. Tangrea J, Helzlsouer K, Pietinen P, et al. women. Tumor Research 1999;34:29-39.
common chronic diseases during a 10- Serum levels of vitamin D metabolites 133. Tartter PI, Slater G, Papatestas AE, et al.
year period. Arch Intern Med and the subsequent risk of colon and Cholesterol, weight, height, Quetelets
2001;161:1581-6. rectal cancer in Finnish men. Cancer index, and colon cancer recurrence. J
104. Terry P, Giovannucci E, Bergkvist L, et al. Causes Control 1997;8:615-25. Surg Oncol 1984;27:232-5.
Body weight and colorectal cancer risk in 118. Moore LL, Bradlee ML, Singer MR, et al. 134. Sidney S, Friedman GD, Hiatt RA. Serum
a cohort of Swedish women: relation BMI and waist circumference as cholesterol and large bowel cancer. A
varies by age and cancer site. Br J Cancer predictors of lifetime colon cancer risk in case-control study. Am J Epidemiol
2001;85:346-9. Framingham Study adults. Int J Obes 1986;124:33-8.
105. Lund Nilsen TI, Vatten LJ. Colorectal Relat Metab Disord 2004;28:559-67. 135. Bostick RM, Potter JD, Sellers TA, et al.
cancer associated with BMI, physical 119. Shimizu N, Nagata C, Shimizu H, et al. Relation of calcium, vitamin D, and dairy
activity, diabetes, and blood glucose. Height, weight, and alcohol food intake to incidence of colon cancer
IARC Sci Publ 2002;156:257-8. consumption in relation to the risk of among older women. The Iowa Womens
106. Malila N, Virtamo J, Virtanen M, et al. colorectal cancer in Japan: a prospective Health Study. Am J Epidemiol
Dietary and serum alpha-tocopherol, study. Br J Cancer 2003;88:1038-43. 1993;137:1302-17.
beta-carotene and retinol, and risk for 120. Tamakoshi K, Wakai K, Kojima M, et al. A 136. Feskanich D, Ma J, Fuchs CS, et al. Plasma
colorectal cancer in male smokers. Eur J prospective study of body size and colon vitamin D metabolites and risk of
Clin Nutr 2002;56:615-21. cancer mortality in Japan: The JACC colorectal cancer in women. Cancer
474
R E F E R E N C E S
475
F O O D , N U T R I T I O N , P H Y S I C A L A C T I V I T Y, A N D T H E P R E V E N T I O N O F C A N C E R : A G L O B A L P E R S P E C T I V E
179. Mills PK, Beeson WL, Phillips RL, et al. 194. Van den Brandt PA, Vant Veer P, height in urban Nigerian women with
Dietary habits and breast cancer Goldbohm RA, et al. A prospective breast cancer. Ann Epidemiol
incidence among Seventh-day cohort study on dietary fat and the risk 2003;13:455-61.
Adventists. Cancer 1989;64:582-90. of postmenopausal breast cancer. Cancer 209. Agurs-Collins T, Kim KS, Dunston GM, et
180. Morimoto LM, White E, Chen Z, et al. Res 1993;53:75-82. al. Plasma lipid alterations in African-
Obesity, body size, and risk of 195. Vatten LJ, Kvinnsland S. Body mass index American women with breast cancer. J
postmenopausal breast cancer: The and risk of breast cancer. A prospective Cancer Res Clin Oncol 1998;124:186-90.
Womens Health Initiative (United study of 23,826 Norwegian women. Int J 210. Althuis MD, Brogan DD, Coates RJ, et al.
States). Cancer Causes Control Cancer 1990;45:440-4. Breast cancers among very young
2002;13:741-51. 196. Vatten LJ, Kvinnsland S. Prospective study premenopausal women (United States).
181. Overvad K, Wang DY, Olsen J, et al. of height, body mass index and risk of Cancer Causes Control 2003;14:151-60.
Selenium in human mammary breast cancer. Acta Oncol 1992;31:195- 211. Atalah E, Urteaga C, Rebolledo A, et al.
carcinogenesis: a case-cohort study. Eur J 200. [Breast cancer risk factors in women in
Cancer 1991;27:900-2. 197. Vatten LJ, Solvoll K, Loken EB. Coffee Santiago, Chile.] Rev Med Chil
182. Patel AV, Calle EE, Bernstein L, et al. consumption and the risk of breast 2000;128:137-43.
Recreational physical activity and risk of cancer. A prospective study of 14,593 212. Bagga D, Anders KH, Wang H-J, et al.
postmenopausal breast cancer in a large Norwegian women. Br J Cancer Long-chain n-3-to-n-6 polyunsaturated
cohort of US women. Cancer Causes 1990;62:267-70. fatty acid ratios in breast adipose tissue
Control 2003;14:519-29. 198. Weiderpass E, Braaten T, Magnusson C, et from women with and without breast
183. Petrelli JM, Calle EE, Rodriguez C, et al. al. A prospective study of body size in cancer. Nutr Cancer 2002;42:180-5.
Body mass index, height, and different periods of life and risk of 213. Bonilla-Fernandez P, Lopez-Cervantes M,
postmenopausal breast cancer mortality premenopausal breast cancer. Cancer Torres-Sanchez LE, et al. Nutritional
in a prospective cohort of US women. Epidemiol Biomarkers Prev factors and breast cancer in Mexico. Nutr
Cancer Causes Control 2002;13:325-32. 2004;13:1121-7. Cancer 2003;45:148-55.
184. Rissanen H, Knekt P, Jarvinen R, et al. 199. Wirfalt E, Mattisson I, Gullberg B, et al. 214. Bouchardy C, Le MG, Hill C. Risk factors
Serum fatty acids and breast cancer Postmenopausal breast cancer is for breast cancer according to age at
incidence. Nutr Cancer 2003;45:168-75. associated with high intakes of omega 6 diagnosis in a French case-control study. J
185. Saadatian-Elahi M, Toniolo P, Ferrari P, et fatty acids (Sweden). Cancer Causes Clin Epidemiol 1990;43:267-75.
al. Serum fatty acids and risk of breast Control 2002;13:883-93. 215. Bowlin SJ, Leske MC, Varma A, et al.
cancer in a nested case-control study of 200. Wirfalt E, Vessby B, Mattisson I, et al. No Breast cancer risk and alcohol
the New York University Womens Health relations between breast cancer risk and consumption: results from a large case-
Study. Cancer Epidemiol Biomarkers Prev fatty acids of erythrocyte membranes in control study. Int J Epidemiol
2002;11:1353-60. postmenopausal women of the Malmo 1997;26:915-23.
186. Schatzkin A, Carter CL, Green SB, et al. Is Diet Cancer cohort (Sweden). Eur J Clin 216. Brinton LA, Potischman NA, Swanson CA,
alcohol consumption related to breast Nutr 2004;58:761-70. et al. Breastfeeding and breast cancer
cancer? Results from the Framingham 201. Wolk A, Bergstrom R, Hunter D, et al. A risk. Cancer Causes Control 1995;6:199-
Heart Study. J Natl Cancer Inst prospective study of association of 208.
1989;81:31-5. monounsaturated fat and other types of 217. Brinton LA, Swanson CA. Height and
187. Sellers TA, Davis J, Cerhan JR, et al. fat with risk of breast cancer. Arch Intern weight at various ages and risk of breast
Interaction of waist/hip ratio and family Med 1998;158:41-5. cancer. Ann Epidemiol 1992;2:597-609.
history on the risk of hormone receptor- 202. Wu K, Helzlsouer KJ, Comstock GW, et al. 218. Bruning PF, Bonfrer JM, Hart AA, et al.
defined breast cancer in a prospective A prospective study on folate, B12, and Body measurements, estrogen
study of postmenopausal women. Am J pyridoxal 5-phosphate (B6) and breast availability and the risk of human breast
Epidemiol 2002;155:225-33. cancer. Cancer Epidemiol Biomarkers cancer: a case-control study. Int J Cancer
188. Silvera SA, Jain M, Howe GR, et al. Energy Prev 1999;8:209-17. 1992;51:14-9.
balance and breast cancer risk: a 203. Wu MH, Chou YC, Yu JC, et al. Hormonal 219. Calderon-Garciduenas AL, Paras-
prospective cohort study. Breast Cancer and body-size factors in relation to Barrientos FU, Cardenas-Ibarra L, et al.
Res Treat 2006;97:97-106. breast cancer risk: a prospective study of Risk factors of breast cancer in Mexican
189. Sonnenschein E, Toniolo P, Terry MB, et al. 11,889 women in a low-incidence area. women. Salud Publica Mex 2000;42:26-
Body fat distribution and obesity in pre- Ann Epidemiol 2005. 33.
and postmenopausal breast cancer. Int J 204. Zhang SM, Willett WC, Selhub J, et al. 220. Carpenter CL, Ross RK, Paganini-Hill A, et
Epidemiol 1999;28:1026-31. Plasma folate, vitamin B6, vitamin B12, al. Effect of family history, obesity and
190. Toniolo P, Riboli E, Shore RE, et al. homocysteine, and risk of breast cancer. J exercise on breast cancer risk among
Consumption of meat, animal products, Natl Cancer Inst 2003;95:373-80. postmenopausal women. Int J Cancer
protein, and fat and risk of breast 205. Adami HO, Rimsten A, Stenkvist B, et al. 2003;106:96-102.
cancer: a prospective cohort study in Influence of height, weight and obesity 221. Challier B, Perarnau JM, Viel JF. Garlic,
New York. Epidemiology 1994;5:391-7. on risk of breast cancer in an unselected onion and cereal fibre as protective
191. Tornberg SA, Holm LE, Carstensen JM. Swedish population. Br J Cancer factors for breast cancer: a French case-
Breast cancer risk in relation to serum 1977;36:787-92. control study. Eur J Epidemiol
cholesterol, serum beta-lipoprotein, 206. Adams-Campbell LL, Kim KS, Dunston G, 1998;14:737-47.
height, weight, and blood pressure. Acta et al. The relationship of body mass 222. Chang S, Buzdar AU, Hursting SD.
Oncol 1988;27:31-7. index to reproductive factors in pre- and Inflammatory breast cancer and body
192. Tornberg SA, Carstensen JM. Relationship postmenopausal African-American mass index. J Clin Oncol 1998;16:3731-5.
between Quetelets index and cancer of women with and without breast cancer. 223. Chen CL, White E, Malone KE, et al.
breast and female genital tract in 47,000 Obes Res 1996;4:451-6. Leisure-time physical activity in relation
women followed for 25 years. Br J 207. Adebamowo CA, Ogundiran TO, to breast cancer among young women
Cancer 1994;69:358-61. Adenipekun AA, et al. Waist-hip ratio (Washington, United States). Cancer
193. van den Brandt PA, Dirx MJ, Ronckers CM, and breast cancer risk in urbanized Causes Control 1997;8:77-84.
et al. Height, weight, weight change, Nigerian women. Breast Cancer Res 224. Chie WC, Chen CF, Lee WC, et al. Body size
and postmenopausal breast cancer risk: 2003;5:R18-R24. and risk of pre- and post-menopausal
The Netherlands Cohort Study. Cancer 208. Adebamowo CA, Ogundiran TO, breast cancer in Taiwan. Anticancer Res
Causes Control 1997;8:39-47. Adenipekun AA, et al. Obesity and 1996;16:3129-32.
476
R E F E R E N C E S
225. Chie WC, Li CY, Huang CS, et al. Body size Body size indices and breast cancer risk risk factors with breast cancer risk
as a factor in different ages and breast before and after menopause. Int J among Japanese premenopausal and
cancer risk in Taiwan. Anticancer Res Cancer 1996;67:181-6. postmenopausal women. Cancer Causes
1998;18:565-70. 242. Friedenreich CM, Courneya KS, Bryant HE. Control 2001;12:349-58.
226. Chow LW, Lui KL, Chan JC, et al. Case-control study of anthropometric 258. Hirose K, Takezaki T, Hamajima N, et al.
Association between body mass index measures and breast cancer risk. Int J Dietary factors protective against breast
and risk of formation of breast cancer in Cancer 2002;99:445-52. cancer in Japanese premenopausal and
Chinese women. Asian J Surg 243. Friedenreich CM, Bryant HE, Courneya KS. postmenopausal women. Int J Cancer
2005;28:179-84. Case-control study of lifetime physical 2003;107:276-82.
227. Chu SY, Lee NC, Wingo PA, et al. The activity and breast cancer risk. Am J 259. Hislop TG, Coldman AJ, Elwood JM, et al.
relationship between body mass and Epidemiol 2001;154:336-47. Childhood and recent eating patterns
breast cancer among women enrolled in 244. Furberg H, Newman B, Moorman P, et al. and risk of breast cancer. Cancer Detect
the Cancer and Steroid Hormone Study. J Lactation and breast cancer risk. Int J Prev 1986;9:47-58.
Clin Epidemiol 1991;44:1197-206. Epidemiol 1999;28:396-402. 260. Holmberg L, Ohlander EM, Byers T, et al.
228. Coates RJ, Uhler RJ, Hall HI, et al. Risk of 245. Gerber M, Cavallo F, Marubini E, et al. Diet and breast cancer risk. Results from
breast cancer in young women in Liposoluble vitamins and lipid a population-based, case-control study
relation to body size and weight gain in parameters in breast cancer. A joint in Sweden. Arch Intern Med
adolescence and early adulthood. Br J study in northern Italy and southern 1994;154:1805-11.
Cancer 1999;81:167-74. France. Int J Cancer 1988;42:489-94. 261. Hsieh CC, Trichopoulos D, Katsouyanni K,
229. Cooper JA, Rohan TE, Cant EL, et al. Risk 246. Graham S, Hellmann R, Marshall J, et al. et al. Age at menarche, age at
factors for breast cancer by oestrogen Nutritional epidemiology of menopause, height and obesity as risk
receptor status: A population-based postmenopausal breast cancer in factors for breast cancer: associations
case-control study. Br J Cancer western New York. Am J Epidemiol and interactions in an international case-
1989;59:119-25. 1991;134:552-66. control study. Int J Cancer 1990;46:796-
230. Dai Q, Shu XO, Jin F, et al. Consumption of 247. Hall IJ, Newman B, Millikan RC, et al. Body 800.
animal foods, cooking methods, and risk size and breast cancer risk in black 262. Hu YH, Nagata C, Shimizu H, et al.
of breast cancer. Cancer Epidemiol women and white women: the Carolina Association of body mass index, physical
Biomarkers Prev 2002;11:801-8. Breast Cancer Study. Am J Epidemiol activity, and reproductive histories with
231. de Vasconcelos AB, Azevedo e Silva 2000;151:754-64. breast cancer: a case-control study in
Mendonca G, Sichieri R. Height, weight, 248. Hansen S, Cold S, Petersen PH, et al. Gifu, Japan. Breast Cancer Res Treat
weight change and risk of breast cancer Estimates of the sources of variation 1997;43:65-72.
in Rio de Janeiro, Brazil. Sao Paulo Med J (variance components) of bioelectric 263. Huang CS, Chern HD, Shen CY, et al.
2001;119:62-6. impedance and anthropometric Association between N-acetyltransferase
232. Do MH, Lee SS, Jung PJ, et al. Intake of measurements in an epidemiological 2 (NAT2) genetic polymorphism and
dietary fat and vitamin in relation to case-control study of breast cancer. Eur J development of breast cancer in post-
breast cancer risk in Korean women: a Clin Nutr 1997;51:764-70. menopausal Chinese women in Taiwan,
case-control study. J Korean Med Sci 249. Harris RE, Namboodiri KK, Wynder EL. an area of great increase in breast cancer
2003;18:534-40. Breast cancer risk: effects of estrogen incidence. Int J Cancer 1999;82:175-9.
233. Dorn J, Vena J, Brasure J, et al. Lifetime replacement therapy and body mass. J 264. Ibarluzea JM, Fernandez MF, Santa-
physical activity and breast cancer risk in Natl Cancer Inst 1992;84:1575-82. Marina L, et al. Breast cancer risk and the
pre- and postmenopausal women. Med 250. Helmrich SP, Shapiro S, Rosenberg L, et al. combined effect of environmental
Sci Sports Exerc 2003;35:278-85. Risk factors for breast cancer. Am J estrogens. Cancer Causes Control
234. Drewnowski A, Henderson SA, Hann CS, Epidemiol 1983;117:35-45. 2004;15:591-600.
et al. Genetic taste markers and 251. Henquin N, Trostler N, Horn Y. Nutritional 265. Ingram DM, Nottage E, Roberts T. The
preferences for vegetables and fruit of risk factors and breast cancer in Jewish role of diet in the development of breast
female breast care patients. J Am Diet and Arab women. Cancer Nurs cancer: a case-control study of patients
Assoc 2000;100:191-7. 1994;17:326-33. with breast cancer, benign epithelial
235. Eid A, Berry EM. The relationship 252. Hietanen E, Bartsch H, Bereziat JC, et al. hyperplasia and fibrocystic disease of the
between dietary fat, adipose tissue Diet and oxidative stress in breast, colon breast. Br J Cancer 1991;64:187-91.
composition, and neoplasms of the and prostate cancer patients: a case- 266. Ingram D, Nottage E, Ng S, et al. Obesity
breast. Nutr Cancer 1988;11:173-7. control study. Eur J Clin Nutr and breast disease. The role of the
236. Enger SM, Ross RK, Paganini-Hill A, et al. 1994;48:575-86. female sex hormones. Cancer
Body size, physical activity, and breast 253. Hirose K, Tajima K, Hamajima N, et al. A 1989;64:1049-53.
cancer hormone receptor status: Results large-scale, hospital-based case-control 267. Joensuu H, Tuominen J, Hinkka S, et al.
from two case-control studies. Cancer study of risk factors of breast cancer Risk factors for screen-detected breast
Epidemiol Biomarkers Prev 2000;9:681-7. according to menopausal status. Jpn J cancer. A case-control study. Acta Oncol
237. Favero A, Parpinel M, Franceschi S. Diet Cancer Res 1995;86:146-54. 1992;31:729-32.
and risk of breast cancer: major findings 254. Hirose K, Tajima K, Hamajima N, et al. 268. Kampert JB, Whittemore AS,
from an Italian case-control study. Comparative case-referent study of risk Paffenbarger RS, Jr. Combined effect of
Biomed Pharmacother 1998;52:109-15. factors among hormone-related female childbearing, menstrual events, and
238. Ferraroni M, Decarli A, Willett WC, et al. cancers in Japan. Jpn J Cancer Res body size on age-specific breast cancer
Alcohol and breast cancer risk: a case- 1999;90:255-61. risk. Am J Epidemiol 1988;128:962-79.
control study from northern Italy. Int J 255. Hirose K, Tajima K, Hamajima N, et al. 269. Kato I, Miura S, Kasumi F, et al. A case-
Epidemiol 1991;20:859-64. Effect of body size on breast-cancer risk control study of breast cancer among
239. Fioretti F, Tavani A, Bosetti C, et al. Risk among Japanese women. Int J Cancer Japanese women: with special reference
factors for breast cancer in nulliparous 1999;80:349-55. to family history and reproductive and
women. Br J Cancer 1999;79:1923-8. 256. Hirose K, Tajima K, Hamajima N, et al. dietary factors. Breast Cancer Res Treat
240. Fowke JH, Chung FL, Jin F, et al. Urinary Impact of established risk factors for 1992;24:51-9.
isothiocyanate levels, brassica, and breast cancer in nulligravid Japanese 270. Katsouyanni K, Trichopoulou A, Stuver S,
human breast cancer. Cancer Res women. Breast Cancer 2003;10:45-53. et al. The association of fat and other
2003;63:3980-6. 257. Hirose K, Tajima K, Hamajima N, et al. macronutrients with breast cancer: a
241. Franceschi S, Favero A, La Vecchia C, et al. Association of family history and other case-control study from Greece. Br J
477
F O O D , N U T R I T I O N , P H Y S I C A L A C T I V I T Y, A N D T H E P R E V E N T I O N O F C A N C E R : A G L O B A L P E R S P E C T I V E
478
R E F E R E N C E S
folate intake and breast cancer risk: cancer and alcohol consumption: a case- based, case-control study of blood C-
results from the Shanghai breast cancer control study in northern Italy. Cancer peptide level and breast cancer risk.
study. Cancer Res 2001;61:7136-41. Res 1989;49:5203-6. Cancer Epidemiol Biomarkers Prev
318. Shu XO, Jin F, Dai Q, et al. Association of 335. Torres-Sanchez L, Lopez-Carrillo L, Lopez- 2001;10:1207-11.
body size and fat distribution with risk Cervantes M, et al. Food sources of 351. Yim DS, Parkb SK, Yoo KY, et al.
of breast cancer among chinese women. phytoestrogens and breast cancer risk in Relationship between the Val158Met
Int J Cancer 2001;94:449-55. Mexican women. Nutr Cancer polymorphism of catechol O-methyl
319. Silva ID, Mangtani P, McCormack V, et al. 2000;37:134-9. transferase and breast cancer.
Phyto-oestrogen intake and breast 336. Toti A, Agugiaro S, Amadori D, et al. Pharmacogenetics 2001;11:279-86.
cancer risk in South Asian women in Breast cancer risk factors in Italian 352. Yoo K, Tajima K, Park S, et al.
England: findings from a population- women: a multicentric case-control Postmenopausal obesity as a breast
based case-control study. Cancer Causes study. Tumori 1986;72:241-9. cancer risk factor according to estrogen
Control 2004;15:805-18. 337. Tovar-Guzman V, Hernandez-Giron C, and progesterone receptor status
320. Soliman AS, Wang X, DiGiovanni J, et al. Lazcano-Ponce E, et al. Breast cancer in (Japan). Cancer Lett 2001;167:57-63.
Serum organochlorine levels and history Mexican women: an epidemiological 353. Young TB. A case-control study of breast
of lactation in Egypt. Environ Res study with cervical cancer control. Rev cancer and alcohol consumption habits.
2003;92:110-7. Saude Publica 2000;34:113-9. Cancer 1989;64:552-8.
321. Sonnichsen AC, Lindlacher U, Richter WO, 338. Trentham-Dietz A, Newcomb PA, Egan 354. Zaroukian S, Pineault R, Gandini S, et al.
et al. Obesity, body fat distribution and KM, et al. Weight change and risk of Correlation between nutritional
the incidence of mammary, cervical, postmenopausal breast cancer (United biomarkers and breast cancer: a case-
endometrial and ovarian carcinoma. States). Cancer Causes Control control study. Breast 2005;14:209-23.
Dtsch Med Wochenschr 1990;115:1906- 2000;11:533-42. 355. Zheng T, Holford TR, Mayne ST, et al.
10. 339. Trentham-Dietz A, Newcomb PA, Storer Lactation and breast cancer risk: a case-
322. Sonnichsen AC, Richter WO, Schwandt P. BE, et al. Body size and risk of breast control study in Connecticut. Br J Cancer
Body fat distribution and risk for breast cancer. Am J Epidemiol 1997;145:1011-9. 2001;84:1472-6.
cancer. Ann Intern Med 1990;112:882. 340. Trentham-Dietz A, Newcomb PA, Storer 356. Zheng T, Holford TR, Tessari J, et al. Breast
323. Staszewski J. Breast cancer and body BE, et al. Risk factors for carcinoma in cancer risk associated with congeners of
build. Prev Med 1977;6:410-5. situ of the breast. Cancer Epidemiology polychlorinated biphenyls. Am J
324. Swanson CA, Brinton LA, Taylor PR, et al. Biomarkers and Prevention 2000;9:697- Epidemiol 2000;152:50-8.
Body size and breast cancer risk assessed 703. 357. Zhu Z, Parviainen M, Mannisto S, et al.
in women participating in the Breast 341. Tung HT, Tsukuma H, Tanaka H, et al. Risk Vitamin E concentration in breast
Cancer Detection Demonstration Project. factors for breast cancer in Japan, with adipose tissue of breast cancer patients
Am J Epidemiol 1989;130:1133-41. special attention to anthropometric (Kuopio, Finland). Cancer Causes Control
325. Swanson CA, Coates RJ, Malone KE, et al. measurements and reproductive history. 1996;7:591-5.
Alcohol consumption and breast cancer Jpn J Clin Oncol 1999;29:137-46. 358. Zhu ZR, Parviainen M, Mannisto S, et al.
risk among women under age 45 years. 342. Ueji M, Ueno E, Osei-Hyiaman D, et al. Vitamin A concentration in breast
Epidemiology 1997;8:231-7. Physical activity and the risk of breast adipose tissue of breast cancer patients.
326. Swanson CA, Coates RJ, Schoenberg JB, et cancer: a case-control study of Japanese Anticancer Res 1995;15:1593-6.
al. Body size and breast cancer risk women. J Epidemiol 1998;8:116-22. 359. Zhu K, Caulfield J, Hunter S, et al. Body
among women under age 45 years. Am J 343. vant Veer P, Dekker JM, Lamers JW, et al. mass index and breast cancer risk in
Epidemiol 1996;143:698-706. Consumption of fermented milk African American women. Ann
327. Taioli E, Barone J, Wynder EL. A case- products and breast cancer: a case- Epidemiol 2005;15:123-8.
control study on breast cancer and body control study in The Netherlands. Cancer 360. Guo WD, Chow WH, Zheng W, et al. Diet,
mass. The American Health Foundation - Res 1989;49:4020-3. serum markers and breast cancer
Division of Epidemiology. Eur J Cancer 344. Vant Veer P, Kok FJ, Brants HA, et al. mortality in China. Jpn J Cancer Res
1995;31A:723-8. Dietary fat and the risk of breast cancer. 1994;85:572-7.
328. Taioli E, Wynder EL. Family history, body- Int J Epidemiol 1990;19:12-8. 361. Hakama M, Soini I, Kuosma E, et al. Breast
fat distribution, and the risk of breast 345. vant Veer P, Kok FJ, Hermus RJ, et al. cancer incidence: geographical
cancer. N Engl J Med 1992;327:958-9. Alcohol dose, frequency and age at first correlations in Finland. Int J Epidemiol
329. Talamini R, La Vecchia C, Decarli A, et al. exposure in relation to the risk of breast 1979;8:33-40.
Social factors, diet and breast cancer in a cancer. Int J Epidemiol 1989;18:511-7. 362. van den Brandt PA, Spiegelman D, Yaun
northern Italian population. Br J Cancer 346. Verla-Tebit E, Chang-Claude J. SS, et al. Pooled analysis of prospective
1984;49:723-9. Anthropometric factors and the risk of cohort studies on height, weight, and
330. Tavani A, Gallus S, La Vecchia C, et al. Risk premenopausal breast cancer in breast cancer risk. Am J Epidemiol
factors for breast cancer in women Germany. Eur J Cancer Prev 2005;14:419- 2000;152:514-27.
under 40 years. Eur J Cancer 26. 363. Michels KB, Giovannucci E, Chan AT, et al.
1999;35:1361-7. 347. Viladiu P, Izquierdo A, de Sanjose S, et al. Fruit and vegetable consumption and
331. Terry P, Rohan TE, Wolk A, et al. Fish A breast cancer case-control study in colorectal adenomas in the Nurses
consumption and breast cancer risk. Nutr Girona, Spain. Endocrine, familial and Health Study. Cancer Res 2006;66:3942-
Cancer 2002;44:1-6. lifestyle factors. Eur J Cancer Prev 53.
332. Thomas E, Cade J, Vail A. Risk factor 1996;5:329-35. 364. Garcia-Closas M, Brinton LA, Lissowska J,
analysis of data from assessment clinics 348. Walker ARP, Walker BF, Funani S, et al. et al. Established breast cancer risk
in the UK breast screening programme: a Characteristics of black women with factors by clinically important tumour
case-control study in Portsmouth and breast cancer in Soweto, South Africa. characteristics. Br J Cancer 2006;95:123-
Southampton. J Epidemiol Community Cancer Journal 1989;2:316-9. 9.
Health 1996;50:144-8. 349. Wenten M, Gilliland FD, Baumgartner K, 365. Campagnoli C, Abba C, Ambroggio S, et
333. Thorand B, Kohlmeier L, Simonsen N, et et al. Associations of weight, weight al. Pregnancy, progesterone and
al. Intake of fruits, vegetables, folic acid change, and body mass with breast progestins in relation to breast cancer
and related nutrients and risk of breast cancer risk in Hispanic and non-Hispanic risk. The Journal of Steroid Biochemistry
cancer in postmenopausal women. white women. Ann Epidemiol and Molecular Biology 2005;97:441-50.
Public Health Nutr 1998;1:147-56. 2002;12:435-4. 366. Hilakivi-Clarke L, Forsen T, Eriksson JG, et
334. Toniolo P, Riboli E, Protta F, et al. Breast 350. Yang G, Lu G, Jin F, et al. Population- al. Tallness and overweight during
479
F O O D , N U T R I T I O N , P H Y S I C A L A C T I V I T Y, A N D T H E P R E V E N T I O N O F C A N C E R : A G L O B A L P E R S P E C T I V E
childhood have opposing effects on 381. Pukkala E, Kyyronen P, Sankila R, et al. Subsite (cervix/endometrium)-specific
breast cancer risk. Br J Cancer Tamoxifen and toremifene treatment of risk and protective factors in uterus
2001;85:1680-4. breast cancer and risk of subsequent cancer. Jpn J Cancer Res 1996;87:1001-9.
367. Pasquali R, Pelusi C, Genghini S, et al. endometrial cancer: a population-based 397. Horn-Ross PL, John EM, Canchola AJ, et al.
Obesity and reproductive disorders in case-control study. Int J Cancer Phytoestrogen intake and endometrial
women. Hum Reprod Update 2002;100:337-41. cancer risk. J Natl Cancer Inst
2003;9:359-72. 382. Schouten LJ, Goldbohm RA, van den 2003;95:1158-64.
368. Anderson KE, Anderson E, Mink PJ, et al. Brandt PA. Anthropometry, physical 398. Hou Q, Wang QS, Wang JF. [A case control
Diabetes and endometrial cancer in the activity, and endometrial cancer risk: study on risk factors of endometrial
Iowa womens health study. Cancer results from the Netherlands Cohort carcinoma in Tianjin.] Zhonghua Fu Chan
Epidemiol Biomarkers Prev 2001;10:611- Study. J Natl Cancer Inst 2004;96:1635-8. Ke Za Zhi 1994;29:30-2, 61.
6. 383. Silvera SA, Rohan TE, Jain M, et al. 399. La Vecchia C, Franceschi S, Gallus G, et al.
369. Baanders-van Halewijn EA, Poortman J. A Glycaemic index, glycaemic load and risk Oestrogens and obesity as risk factors for
case-control study of endometrial cancer of endometrial cancer: a prospective endometrial cancer in Italy. Int J
within a cohort. Maturitas 1985;7:69-76. cohort study. Public Health Nutr Epidemiol 1982;11:120-6.
370. Bernstein L, Deapen D, Cerhan JR, et al. 2005;8:912-9. 400. La Vecchia C, Decarli A, Fasoli M, et al.
Tamoxifen therapy for breast cancer and 384. Yamazawa K, Miyazawa Y, Suzuki M, et Nutrition and diet in the etiology of
endometrial cancer risk. J Natl Cancer al. Tamoxifen and the risk of endometrial cancer. Cancer
Inst 1999;91:1654-62. endometrial cancer in Japanese women 1986;57:1248-53.
371. de Waard F, de Ridder CM, Baanders-van with breast cancer. Surg Today 401. La Vecchia C, Decarli A, Negri E, et al.
Halewyn EA, et al. Endometrial cancer in 2006;36:41-6. Epidemiological aspects of diet and
a cohort screened for breast cancer. Eur J 385. Zeleniuch-Jacquotte A, Akhmedkhanov A, cancer: a summary review of case-control
Cancer Prev 1996;5:99-104. Kato I, et al. Postmenopausal studies from northern Italy. Oncology
372. Ewertz M, Machado SG, Boice JD, Jr., et al. endogenous oestrogens and risk of 1988;45:364-70.
Endometrial cancer following treatment endometrial cancer: results of a 402. La Vecchia C, Parazzini F, Negri E, et al.
for breast cancer: a case-control study in prospective study. Br J Cancer Anthropometric indicators of
Denmark. Br J Cancer 1984;50:687-92. 2001;84:975-81. endometrial cancer risk. Eur J Cancer
373. Folsom AR, Demissie Z, Harnack L. 386. Augustin LS, Gallus S, Bosetti C, et al. 1991;27:487-90.
Glycemic index, glycemic load, and Glycemic index and glycemic load in 403. Levi F, Franceschi S, Negri E, et al. Dietary
incidence of endometrial cancer: the endometrial cancer. Int J Cancer factors and the risk of endometrial
Iowa womens health study. Nutr Cancer 2003;105:404-7. cancer. Cancer 1993;71:3575-81.
2003;46:119-24. 387. Augustin LSA, Dal Maso L, Franceschi S, et 404. Matthews CE, Xu WH, Zheng W, et al.
374. Folsom AR, Kaye SA, Potter JD, et al. al. Association between components of Physical activity and risk of endometrial
Association of incident carcinoma of the the insulin-like growth factor system and cancer: a report from the Shanghai
endometrium with body weight and fat endometrial cancer risk. Oncology endometrial cancer study. Cancer
distribution in older women: early 2004;67:54-9. Epidemiol Biomarkers Prev 2005;14:779-
findings of the Iowa Womens Health 388. Austin H, Austin JM, Jr., Partridge EE, et 85.
Study. Cancer Res 1989;49:6828-31. al. Endometrial cancer, obesity, and body 405. McCann SE, Freudenheim JL, Marshall JR,
375. Furberg AS, Thune I. Metabolic fat distribution. Cancer Res 1991;51:568- et al. Diet in the epidemiology of
abnormalities (hypertension, 72. endometrial cancer in western New York
hyperglycemia and overweight), lifestyle 389. Brinton LA, Berman ML, Mortel R, et al. (United States). Cancer Causes Control
(high energy intake and physical Reproductive, menstrual, and medical 2000;11:965-74.
inactivity) and endometrial cancer risk in risk factors for endometrial cancer: 406. McElroy JA, Newcomb PA, Trentham-
a Norwegian cohort. Int J Cancer results from a case-control study. Am J Dietz A, et al. Endometrial cancer
2003;104:669-76. Obstet Gynecol 1992;167:1317-25. incidence in relation to electric blanket
376. Gapstur SM, Potter JD, Sellers TA, et al. 390. Cusimano R, Dardanoni G, Dardanoni L, et use. Am J Epidemiol 2002;156:262-7.
Alcohol consumption and al. Risk factors of female cancers in 407. Newcomb PA, Trentham-Dietz A. Patterns
postmenopausal endometrial cancer: Ragusa population (Sicily) - 1. of postmenopausal progestin use with
results from the Iowa Womens Health Endometrium and cervix uteri cancers. estrogen in relation to endometrial
Study. Cancer Causes Control 1993;4:323- Eur J Epidemiol 1989;5:363-71. cancer (United States). Cancer Causes
9. 391. Elwood JM, Cole P, Rothman KJ, et al. Control 2003;14:195-201.
377. Jain MG, Rohan TE, Howe GR, et al. A Epidemiology of endometrial cancer. J 408. Newcomer LM, Newcomb PA, Trentham-
cohort study of nutritional factors and Natl Cancer Inst 1977;59:1055-60. Dietz A, et al. Hormonal risk factors for
endometrial cancer. Eur J Epidemiol 392. Ewertz M, Schou G, Boice JD, Jr. The joint endometrial cancer: modification by
2000;16:899-905. effect of risk factors on endometrial cigarette smoking (United States).
378. Lacey JV, Jr., Brinton LA, Lubin JH, et al. cancer. Eur J Cancer Clin Oncol Cancer Causes Control 2001;12:829-35.
Endometrial carcinoma risks among 1988;24:189-94. 409. Olson SH, Trevisan M, Marshall JR, et al.
menopausal estrogen plus progestin and 393. Geraci P, Mancuso A, Maggio S, et al. Risk Body mass index, weight gain, and risk
unopposed estrogen users in a cohort of factors of endometrial cancer in of endometrial cancer. Nutr Cancer
postmenopausal women. Cancer Palermo. Clin Exp Obstet Gynecol 1995;23:141-9.
Epidemiol Biomarkers Prev 1988;15:129-33. 410. Okamura C, Tsubono Y, Ito K, et al.
2005;14:1724-31. 394. Goodman MT, Wilkens LR, Hankin JH, et Lactation and risk of endometrial cancer
379. Le Marchand L, Wilkens LR, Mi MP. Early- al. Association of soy and fiber in Japan: a case-control study. Tohoku J
age body size, adult weight gain and consumption with the risk of Exp Med 2006;208:109-15.
endometrial cancer risk. Int J Cancer endometrial cancer. Am J Epidemiol 411. Parazzini F, La Vecchia C, DAvanzo B, et
1991;48:807-11. 1997;146:294-306. al. Alcohol and endometrial cancer risk:
380. Olson JE, Sellers TA, Anderson KE, et al. 395. Gruber SB, Thompson WD, Rubin GL, et al. findings from an Italian case-control
Does a family history of cancer increase A population-based study of study. Nutr Cancer 1995;23:55-62.
the risk for postmenopausal endometrial endometrial cancer and familial risk in 412. Parazzini F, La Vecchia C, Negri E, et al.
carcinoma? A prospective cohort study younger women. Cancer Epidemiol Smoking and risk of endometrial cancer:
and a nested case-control family study of Biomarkers Prev 1996;5:411-7. results from an Italian case-control study.
older women. Cancer 1999;85:2444-9. 396. Hirose K, Tajima K, Hamajima N, et al. Gynecol Oncol 1995;56:195-9.
480
R E F E R E N C E S
413. Potischman N, Hoover RN, Brinton LA, et [Evaluation of epidemiologic risk factors serum lipids and lipoprotein levels.
al. Case-control study of endogenous for endometrial carcinoma based on a Cancer Epidemiol Biomarkers Prev
steroid hormones and endometrial case-control study.] Zentralbl Gynakol 1994;3:575-81.
cancer. J Natl Cancer Inst 1996;88:1127- 1995;117:368-74. 446. Lissner L, Kroon UB, Bjorntorp P, et al.
35. 430. Jain MG, Howe GR, Rohan TE. Nutritional Adipose tissue fatty acids and dietary fat
414. Salazar-Martinez E, Lazcano-Ponce EC, factors and endometrial cancer in sources in relation to endometrial
Lira-Lira GG, et al. Case-control study of Ontario, Canada. Cancer Control cancer: a retrospective study of cases in
diabetes, obesity, physical activity and 2000;7:288-96. remission, and population-based
risk of endometrial cancer among 431. Niwa K, Imai A, Hashimoto M, et al. A controls. Acta Obstet Gynecol Scand
Mexican women. Cancer Causes Control case-control study of uterine 1993;72:481-7.
2000;11:707-11. endometrial cancer of pre- and post- 447. Littman AJ, Beresford SA, White E. The
415. Shoff SM, Newcomb PA. Diabetes, body menopausal women. Oncol Rep association of dietary fat and plant
size, and risk of endometrial cancer. Am J 2000;7:89-93. foods with endometrial cancer (United
Epidemiol 1998;148:234-40. 432. Yamazawa K, Matsui H, Seki K, et al. A States). Cancer Causes Control
416. Shu XO, Brinton LA, Zheng W, et al. case-control study of endometrial cancer 2001;12:691-702.
Relation of obesity and body fat after antipsychotics exposure in 448. Moradi T, Weiderpass E, Signorello LB, et
distribution to endometrial cancer in premenopausal women. Oncology al. Physical activity and postmenopausal
Shanghai, China. Cancer Res 2003;64:116-23. endometrial cancer risk (Sweden).
1992;52:3865-70. 433. Beard CM, Hartmann LC, Keeney GL, et al. Cancer Causes Control 2000;11:829-37.
417. Shu XO, Hatch MC, Zheng W, et al. Endometrial cancer in Olmsted County, 449. Newcomb PA, Trentham-Dietz A, Storer
Physical activity and risk of endometrial MN: trends in incidence, risk factors and BE. Alcohol consumption in relation to
cancer. Epidemiology 1993;4:342-9. survival. Ann Epidemiol 2000;10:97-105. endometrial cancer risk. Cancer
418. Shu XO, Zheng W, Potischman N, et al. A 434. Iemura A, Douchi T, Yamamoto S, et al. Epidemiol Biomarkers Prev 1997;6:775-8.
population-based case-control study of Body fat distribution as a risk factor of 450. Olson SH, Vena JE, Dorn JP, et al. Exercise,
dietary factors and endometrial cancer endometrial cancer. J Obstet Gynaecol occupational activity, and risk of
in Shanghai, Peoples Republic of China. Res 2000;26:421-5. endometrial cancer. Ann Epidemiol
Am J Epidemiol 1993;137:155-65. 435. Kalandidi A, Tzonou A, Lipworth L, et al. 1997;7:46-53.
419. Swanson CA, Potischman N, Wilbanks GD, A case-control study of endometrial 451. Terry P, Wolk A, Vainio H, et al. Fatty fish
et al. Relation of endometrial cancer risk cancer in relation to reproductive, consumption lowers the risk of
to past and contemporary body size and somatometric, and life-style variables. endometrial cancer: a nationwide case-
body fat distribution. Cancer Epidemiol Oncology 1996;53:354-9. control study in Sweden. Cancer
Biomarkers Prev 1993;2:321-7. 436. Petridou E, Kedikoglou S, Koukoulomatis Epidemiol Biomarkers Prev 2002;11:143-
420. Trentham-Dietz A, Nichols HB, Hampton P, et al. Diet in relation to endometrial 5.
JM, et al. Weight change and risk of cancer risk: a case-control study in 452. Webster LA, Weiss NS. Alcoholic beverage
endometrial cancer. Int J Epidemiol Greece. Nutr Cancer 2002;44:16-22. consumption and the risk of endometrial
2006;35:151-8. 437. Douchi T, Yamamoto S, Nakamura S, et al. cancer. Cancer and Steroid Hormone
421. Troisi R, Potischman N, Hoover RN, et al. Bone mineral density in postmenopausal Study Group. Int J Epidemiol
Insulin and endometrial cancer. Am J women with endometrial cancer. 1989;18:786-91.
Epidemiol 1997;146:476-82. Maturitas 1999;31:165-70. 453. Weiderpass E, Adami HO, Baron JA, et al.
422. Weiderpass E, Persson I, Adami HO, et al. 438. Gao J, Xiang YB, Xu WH, et al. [Green tea Organochlorines and endometrial cancer
Body size in different periods of life, consumption and the risk of endometrial risk. Cancer Epidemiol Biomarkers Prev
diabetes mellitus, hypertension, and risk cancer: a population-based case-control 2000;9:487-93.
of postmenopausal endometrial cancer study in urban Shanghai.] Zhonghua Liu 454. Weiderpass E, Baron JA. Cigarette
(Sweden). Cancer Causes Control Xing Bing Xue Za Zhi 2005;26:323-7. smoking, alcohol consumption, and
2000;11:185-92. 439. Hardell L, van Bavel B, Lindstrom G, et al. endometrial cancer risk: a population-
423. Tao MH, Xu WH, Zheng W, et al. A case- Adipose tissue concentrations of p,p- based study in Sweden. Cancer Causes
control study in Shanghai of fruit and DDE and the risk for endometrial cancer. Control 2001;12:239-47.
vegetable intake and endometrial Gynecol Oncol 2004;95:706-11. 455. Xu WH, Matthews CE, Xiang YB, et al.
cancer. Br J Cancer 2005;92:2059-64. 440. Inoue M, Okayama A, Fujita M, et al. A Effect of adiposity and fat distribution
424. Xu W, Dai Q, Ruan Z, et al. Obesity at case-control study on risk factors for on endometrial cancer risk in Shanghai
different ages and endometrial cancer uterine endometrial cancer in Japan. Jpn women. Am J Epidemiol 2005;161:939-
risk factors in urban Shanghai, China. J Cancer Res 1994;85:346-50. 47.
Zhonghua Liu Xing Bing Xue Za Zhi 441. Levi F, La Vecchia C, Negri E, et al. Body 456. Blitzer PH, Blitzer EC, Rimm AA.
2002;23:347-51. mass at different ages and subsequent Association between teen-age obesity
425. Xu WH, Xiang YB, Zheng W, et al. Weight endometrial cancer risk. Int J Cancer and cancer in 56,111 women: all cancers
history and risk of endometrial cancer 1992;50:567-71. and endometrial carcinoma. Prev Med
among Chinese women. Int J Epidemiol 442. Salazar-Martinez E, Lazcano-Ponce E, 1976;5:20-31.
2006;35:159-66. Sanchez-Zamorano LM, et al. Dietary 457. Dahlgren E, Friberg LG, Johansson S, et al.
426. Zang EA, Wynder EL. The association factors and endometrial cancer risk. Endometrial carcinoma; ovarian
between body mass index and the Results of a case-control study in Mexico. dysfunction - a risk factor in young
relative frequencies of diseases in a Int J Gynecol Cancer 2005;15:938-45. women. Eur J Obstet Gynecol Reprod
sample of hospitalized patients. Nutr 443. Salazar-Martinez E, Lazcano-Ponce EC, Biol 1991;41:143-50.
Cancer 1994;21:247-61. Gonzalez Lira-Lira G, et al. Reproductive 458. Dahlgren E, Johansson S, Oden A, et al. A
427. Zhang CY, Wang TG. [A case-control study factors of ovarian and endometrial model for prediction of endometrial
of endometrial cancer in Beijing.] cancer risk in a high fertility population cancer. Acta Obstet Gynecol Scand
Zhonghua Liu Xing Bing Xue Za Zhi in Mexico. Cancer Res 1999;59:3658-62. 1989;68:507-10.
1989;10:235-7. 444. Soler M, Chatenoud L, Negri E, et al. 459. Iatrakis G, Zervoudis S, Saviolakis A, et al.
428. Benshushan A, Paltiel O, Rojansky N, et al. Hypertension and hormone-related Women younger than 50 years with
IUD use and the risk of endometrial neoplasms in women. Hypertension endometrial cancer. Eur J Gynaecol
cancer. Eur J Obstet Gynecol Reprod Biol 1999;34:320-5. Oncol 2006;27:399-400.
2002;105:166-9. 445. Swanson CA, Potischman N, Barrett RJ, et 460. Gamble JF, Pearlman ED, Nicolich MJ. A
429. Hagen A, Morack G, Grulich D. al. Endometrial cancer risk in relation to nested case-control study of kidney
481
F O O D , N U T R I T I O N , P H Y S I C A L A C T I V I T Y, A N D T H E P R E V E N T I O N O F C A N C E R : A G L O B A L P E R S P E C T I V E
cancer among refinery/petrochemical 476. Mattioli S, Truffelli D, Baldasseroni A, et 492. De Stefani E, Fierro L, Mendilaharsu M, et
workers. Environ Health Perspect al. Occupational risk factors for renal cell al. Meat intake, mate drinking and
1996;104:642-50. cancer: a case-control study in northern renal cell cancer in Uruguay: a case-
461. van Dijk BA, Schouten LJ, Kiemeney LA, et Italy. J Occup Environ Med 2002;44:1028- control study. Br J Cancer 1998;78:1239-
al. Relation of height, body mass, energy 36. 43.
intake, and physical activity to risk of 477. Hu J, Mao Y, White K. Renal cell 493. Benhamou S, Lenfant MH, Ory-Paoletti C,
renal cell carcinoma: results from the carcinoma and occupational exposure to et al. Risk factors for renal-cell carcinoma
Netherlands Cohort Study. Am J chemicals in Canada. Occup Med (Lond) in a French case-control study. Int J
Epidemiol 2004;160:1159-67. 2002;52:157-64. Cancer 1993;55:32-6.
462. Hiatt RA, Tolan K, Quesenberry CP, Jr. 478. Bergstrom A, Lindblad P, Wolk A. Birth 494. Talamini R, Baron AE, Barra S, et al. A
Renal cell carcinoma and thiazide use: a weight and risk of renal cell cancer. case-control study of risk factor for renal
historical, case-control study (California, Kidney Int 2001;59:1110-3. cell cancer in northern Italy. Cancer
USA). Cancer Causes Control 1994;5:319- 479. Augustsson K, Skog K, Jagerstad M, et al. Causes Control 1990;1:125-31.
25. Dietary heterocyclic amines and cancer 495. Goodman MT, Morgenstern H, Wynder
463. Washio M, Mori M, Sakauchi F, et al. Risk of the colon, rectum, bladder, and EL. A case-control study of factors
factors for kidney cancer in a Japanese kidney: a population-based study.[see affecting the development of renal cell
population: findings from the JACC comment]. Lancet 1999;353:703-7. cancer. Am J Epidemiol 1986;124:926-41.
study. J Epidemiol 2005;15:S203-S11. 480. Yuan JM, Castelao JE, Gago-Dominguez 496. Mucci LA, Dickman PW, Steineck G, et al.
464. Flaherty KT, Fuchs CS, Colditz GA, et al. A M, et al. Hypertension, obesity and their Dietary acrylamide and cancer of the
prospective study of body mass index, medications in relation to renal cell large bowel, kidney, and bladder:
hypertension, and smoking and the risk carcinoma. Br J Cancer 1998;77:1508-13. absence of an association in a
of renal cell carcinoma (United States). 481. Boeing H, Schlehofer B, Wahrendorf J. population-based study in Sweden. Br J
Cancer Causes Control 2005;16:1099-106. Diet, obesity and risk for renal cell Cancer 2003;88:84-9.
465. Bjorge T, Tretli S, Engeland A. Relation of carcinoma: results from a case control- 497. Parker AS, Cerhan JR, Lynch CF, et al.
height and body mass index to renal cell study in Germany. Z Ernahrungswiss Gender, alcohol consumption, and renal
carcinoma in two million Norwegian 1997;36:3-11. cell carcinoma. Am J Epidemiol
men and women. Am J Epidemiol 482. Chow WH, Mclaughlin JK, Mandel JS, et 2002;155:455-62.
2004;160:1168-76. al. Obesity and risk of renal cell cancer. 498. Pesch B, Haerting J, Ranft U, et al.
466. Nicodemus KK, Sweeney C, Folsom AR. Cancer Epidemiol Biomarkers Prev Occupational risk factors for renal cell
Evaluation of dietary, medical and 1996;5:17-21. carcinoma: agent-specific results from a
lifestyle risk factors for incident kidney 483. Mellemgaard A, Mclaughlin JK, Overvad case-control study in Germany. MURC
cancer in postmenopausal women. Int J K, et al. Dietary risk factors for renal cell Study Group. Multicenter urothelial and
Cancer 2004;108:115-21. carcinoma in Denmark. Eur J Cancer renal cancer study. Int J Epidemiol
467. Bergstrom A, Terry P, Lindblad P, et al. 1996;32A:673-82. 2000;29:1014-24.
Physical activity and risk of renal cell 484. Lindblad P, Wolk A, Bergstrom R, et al. 499. Sweeney C, Farrow DC, Schwartz SM, et
cancer. Int J Cancer 2001;92:155-7. The role of obesity and weight al. Glutathione S-transferase M1, T1, and
468. Chow WH, Gridley G, Fraumeni JF, Jr., et fluctuations in the etiology of renal cell P1 polymorphisms as risk factors for
al. Obesity, hypertension, and the risk of cancer: a population-based case-control renal cell carcinoma: a case-control
kidney cancer in men. N Engl J Med study. Cancer Epidemiol Biomarkers Prev study. Cancer Epidemiol Biomarkers Prev
2000;343:1305-11. 1994;3:631-9. 2000;9:449-54.
469. Whittemore AS, Paffenbarger RS, Jr., 485. Mellemgaard A, Engholm G, Mclaughlin 500. Finkle WD, Mclaughlin JK, Rasgon SA, et
Anderson K, et al. Early precursors of JK, et al. Risk factors for renal-cell al. Increased risk of renal cell cancer
urogenital cancers in former college carcinoma in Denmark. III. Role of among women using diuretics in the
men. J Urol 1984;132:1256-61. weight, physical activity and United States. Cancer Causes Control
470. Kurttio P, Pukkala E, Kahelin H, et al. reproductive factors. Int J Cancer 1993;4:555-8.
Arsenic concentrations in well water and 1994;56:66-71. 501. Yu MC, Mack TM, Hanisch R, et al.
risk of bladder and kidney cancer in 486. Kreiger N, Marrett LD, Dodds L, et al. Risk Cigarette smoking, obesity, diuretic use,
Finland. Environ Health Perspect factors for renal cell carcinoma: results of and coffee consumption as risk factors
1999;107:705-10. a population-based case-control study. for renal cell carcinoma. J Natl Cancer
471. Hirvonen T, Virtamo J, Korhonen P, et al. Cancer Causes Control 1993;4:101-10. Inst 1986;77:351-6.
Flavonol and flavone intake and the risk 487. McCredie M, Stewart JH. Risk factors for 502. Muscat JE, Hoffmann D, Wynder EL. The
of cancer in male smokers (Finland). kidney cancer in New South Wales, epidemiology of renal cell carcinoma. A
Cancer Causes Control 2001;12:789-96. Australia. II. Urologic disease, second look. Cancer 1995;75:2552-7.
472. Prineas RJ, Folsom AR, Zhang ZM, et al. hypertension, obesity, and hormonal 503. Jones SC, Saunders HJ, Qi W, et al.
Nutrition and other risk factors for renal factors. Cancer Causes Control Intermittent high glucose enhances cell
cell carcinoma in postmenopausal 1992;3:323-31. growth and collagen synthesis in
women. Epidemiology 1997;8:31-6. 488. Mclaughlin JK, Gao YT, Gao RN, et al. Risk cultured human tubulointerstitial cells.
473. Fraser GE, Phillips RL, Beeson WL. factors for renal-cell cancer in Shanghai, Diabetologia 1999;42:1113-9.
Hypertension, antihypertensive China. Int J Cancer 1992;52:562-5. 504. Takahashi Y, Okimura Y, Mizuno I, et al.
medication and risk of renal carcinoma 489. Maclure M, Willett W. A case-control Leptin induces tyrosine phosphorylation
in California Seventh-Day Adventists. Int study of diet and risk of renal of cellular proteins including STAT-1 in
J Epidemiol 1990;19:832-8. adenocarcinoma. Epidemiology human renal adenocarcinoma cells,
474. Hu J, Ugnat AM, Canadian Cancer 1990;1:430-40. ACHN. Biochem Biophys Res Commun
Registries Epidemiology Research Group. 490. Asal NR, Risser DR, Kadamani S, et al. Risk 1996;228:859-64.
Active and passive smoking and risk of factors in renal cell carcinoma: I. 505. Chiu BC, Gapstur SM, Chow WH, et al.
renal cell carcinoma in Canada. Eur J Methodology, demographics, tobacco, Body mass index, physical activity, and
Cancer 2005;41:770-8. beverage use, and obesity. Cancer Detect risk of renal cell carcinoma. Int J Obes
475. Zhang YW, Cantor KP, Lynch CF, et al. A Prev 1988;11:359-77. (Lond) 2006;30:940-7.
population-based case-control study of 491. Mclaughlin JK, Mandel JS, Blot WJ, et al. 506. Moerman CJ, Bueno de Mesquita HB,
occupation and renal cell carcinoma risk A population-based case-control study of Runia S. Smoking, alcohol consumption
in Iowa. J Occup Environ Med renal cell carcinoma. J Natl Cancer Inst and the risk of cancer of the biliary tract;
2004;46:235-40. 1984;72:275-84. a population-based case-control study in
482
R E F E R E N C E S
483
F O O D , N U T R I T I O N , P H Y S I C A L A C T I V I T Y, A N D T H E P R E V E N T I O N O F C A N C E R : A G L O B A L P E R S P E C T I V E
551. De Stefani E, Brennan P, Boffetta P, et al. beta-carotene, vitamin E, vitamin C and 583. French SA, Folsom AR, Jeffery RW, et al.
Diet and adenocarcinoma of the lung: a malondialdehyde levels in several types Weight variability and incident disease in
case-control study in Uruguay. Lung of cancer. J Clin Pharm Ther 1995;20:259- older women: the Iowa Womens Health
Cancer 2002;35:43-51. 63. Study. Int J Obes Relat Metab Disord
552. Fiorenza AM, Branchi A, Sommariva D. 569. Tsai YY, McGlynn KA, Hu Y, et al. Genetic 1997;21:217-23.
Serum lipoprotein profile in patients susceptibility and dietary patterns in 584. Lahmann PH, Schulz M, Hoffmann K, et al.
with cancer. A comparison with non- lung cancer. Lung Cancer 2003;41:269-81. Long-term weight change and breast
cancer subjects. Int J Clin Lab Res 570. Xiang Y, Gao Y, Zhong L, et al. [A case- cancer risk: the European prospective
2000;30:141-5. control study on relationship between investigation into cancer and nutrition
553. Goodman MT, Wilkens LR. Relation of body mass index and lung cancer in non- (EPIC). Br J Cancer 2005;93:582-9.
body size and the risk of lung cancer. smoking women.] Zhonghua Yu Fang Yi 585. Radimer KL, Ballard-Barbash R, Miller JS,
Nutr Cancer 1993;20:179-86. Xue Za Zhi 1999;33:9-12. et al. Weight change and the risk of late-
554. Gorlova OY, Zhang Y, Schabath MB, et al. 571. Yu M, Rao K, Chen Y. [A case-control study onset breast cancer in the original
Never smokers and lung cancer risk: a of the risk factors of lung cancer in Framingham cohort. Nutr Cancer
case-control study of epidemiological Beijing, Tianjin, Shanghai, Chongqing 2004;49:7-13.
factors. Int J Cancer 2006;118:1798-804. metropolitan areas.] Zhonghua Yu Fang 586. Harvie M, Howell A, Vierkant RA, et al.
555. Kanashiki M, Sairenchi T, Saito Y, et al. Yi Xue Za Zhi 2000;34:227-31. Association of gain and loss of weight
Body mass index and lung cancer: a case- 572. Zang EA, Wynder EL. Reevaluation of the before and after menopause with risk of
control study of subjects participating in confounding effect of cigarette smoking postmenopausal breast cancer in the
a mass-screening program. Chest on the relationship between alcohol use Iowa womens health study. Cancer
2005;128:1490-6. and lung cancer risk, with larynx cancer Epidemiol Biomarkers Prev 2005;14:656-
556. Kollarova H, Janout V, Cizek L. [Risk used as a positive control. Prev Med 61.
factors of lifestyles and lung cancer.] 2001;32:359-70. 587. Jernstrom H, Barrett-Connor E. Obesity,
Hygiena 2003;48:79-87. 573. Zhou BS, Wang TJ, Guan P, et al. Indoor air weight change, fasting insulin,
557. Kubik AK, Zatloukal P, Tomasek L, et al. pollution and pulmonary proinsulin, C-peptide, and insulin-like
Lung cancer risk among Czech women: a adenocarcinoma among females: a case- growth factor-1 levels in women with
case-control study. Prev Med control study in Shenyang, China. Oncol and without breast cancer: the Rancho
2002;34:436-44. Rep 2000;7:1253-9. Bernardo Study. J Womens Health Gend
558. LeGardeur BY, Lopez A, Johnson WD. A 574. Liaw YP, Huang YC, Lo PY, et al. Nutrient Based Med 1999;8:1265-72.
case-control study of serum vitamins A, intakes in relation to cancer mortality in 588. Radimer K, Siskind V, Bain C, et al.
E, and C in lung cancer patients. Nutr Taiwan. Nutr Res 2003;23:1597-606. Relation between anthropometric
Cancer 1990;14:133-40. 575. Huang Z, Willett WC, Colditz GA, et al. indicators and risk of breast cancer
559. Mendilaharsu M, De Stefani E, Deneo- Waist circumference, waist:hip ratio, and among Australian women. Am J
Pellegrini H, et al. Phytosterols and risk risk of breast cancer in the Nurses Epidemiol 1993;138:77-89.
of lung cancer: a case-control study in Health Study. Am J Epidemiol 589. Han D, Muti P, Trevisan M, et al. Effects of
Uruguay. Lung Cancer 1998;21:37-45. 1999;150:1316-24. lifetime weight gain on breast cancer
560. Ozturk O, Isbir T, Yaylim I, et al. GST M1 576. Lahmann P, Key T, Tjoenneland A, et al. risk. Am J Epidemiol 2004;159:S13-S.
and CYP1A1 gene polymorphism and Adult weight change and 590. Eng SM, Gammon MD, Terry MB, et al.
daily fruit consumption in Turkish postmenopausal breast cancer risk: Body size changes in relation to
patients with non-small cell lung Findings from the European Prospective postmenopausal breast cancer among
carcinomas. In Vivo 2003;17:625-32. Investigation into Cancer and nutrition women on Long Island, New York. Am J
561. Rauscher GH, Mayne ST, Janerich DT. (EPIC). Int J Obes 2004;28:S4-S. Epidemiol 2005;162:229-37.
Relation between body mass index and 577. Mattisson I, Wirfalt E, Wallstrom P, et al. 591. McElroy JA, Kanarek MS, Trentham-Dietz
lung cancer risk in men and women High fat and alcohol intakes are risk A, et al. Potential exposure to PCBs, DDT
never and former smokers. Am J factors of postmenopausal breast cancer: and PBDEs from sport-caught fish
Epidemiol 2000;152:506-13. a prospective study from the Malmo diet consumption in relation to breast cancer
562. Scali J, Astre C, Segala C, et al. and cancer cohort. Int J Cancer risk in Wisconsin. Environ Health
Relationship of serum cholesterol, 2004;110:589-97. Perspect 2004;112:156-62.
dietary and plasma beta-carotene with 578. Schapira DV, Kumar NB, Lyman GH, et al. 592. World Cancer Research Fund/American
lung cancer in male smokers. Eur J Upper-body fat distribution and Institute for Cancer Research. Food,
Cancer Prev 1995;4:169-74. endometrial cancer risk. JAMA Nutrition and the Prevention of Cancer:
563. Schabath MB, Hernandez LM, Wu X, et al. 1991;266:1808-11. a Global Perspective. Washington, DC:
Dietary phytoestrogens and lung cancer 579. Goodman MT, Hankin JH, Wilkens LR, et AICR, 1997.
risk. JAMA 2005;294:1493-504. al. Diet, body size, physical activity, and 593. World Health Organization. WHO Child
564. Shen H, Wei Q, Pillow PC, et al. Dietary the risk of endometrial cancer. Cancer Growth Standards: Length/Height-for-
folate intake and lung cancer risk in Res 1997;57:5077-85. age, Weight-for-age, Weight-for-length,
former smokers: a case-control analysis. 580. Elliott EA, Matanoski GM, Rosenshein NB, Weight-for-height and Body Mass Index-
Cancer Epidemiol Biomarkers Prev et al. Body fat patterning in women with for age. Geneva: WHO, 2006.
2003;12:980-6. endometrial cancer. Gynecol Oncol 594. de Onis M, Garza C, Habicht JP. Time for a
565. Stam J, Strankinga WF, Fikkert JJ, et al. 1990;39:253-8. new growth reference. Pediatrics
Vitamins and lung cancer. Lung 1990;168 581. Barnes-Josiah D, Potter JD, Sellers TA, et 1997;100:E8.
Suppl:1075-81. al. Early body size and subsequent 595. Karlberg J. The infancy-childhood growth
566. Stefani ED, Boffetta P, Deneo-Pellegrini H, weight gain as predictors of breast spurt. Acta Paediatr Scand 1990;367:111-
et al. Dietary antioxidants and lung cancer incidence (Iowa, United States). 8.
cancer risk: a case-control study in Cancer Causes Control 1995;6:112-8. 596. Ong KK, Dunger DB. Birth weight, infant
Uruguay. Nutr Cancer 1999;34:100-10. 582. Breslow RA, Ballard-Barbash R, Munoz K, growth and insulin resistance. Eur J
567. Swanson CA, Brown CC, Sinha R, et al. et al. Long-term recreational physical Endocrinol 2004;151 Suppl 3:U131-9.
Dietary fats and lung cancer risk among activity and breast cancer in the National 597. Dabelea D, Hanson RL, Lindsay RS, et al.
women: the Missouri Womens Health Health and Nutrition Examination Survey Intrauterine exposure to diabetes
Study (United States). Cancer Causes I epidemiologic follow-up study. Cancer conveys risks for type 2 diabetes and
Control 1997;8:883-93. Epidemiol Biomarkers Prev 2001;10:805- obesity: a study of discordant sibships.
568. Torun M, Yardim S, Gonenc A, et al. Serum 8. Diabetes 2000;49:2208-11.
484
R E F E R E N C E S
598. Leon DA, Lithell HO, Vagero D, et al. al. Non-dietary factors as risk factors for 9.
Reduced fetal growth rate and increased breast cancer, and as effect modifiers of 628. Colditz GA, Rosner B. Cumulative risk of
risk of death from ischaemic heart the association of fat intake and risk of breast cancer to age 70 years according
disease: cohort study of 15 000 Swedish breast cancer. Cancer Causes Control to risk factor status: Data from the
men and women born 1915-29. BMJ 1997;8:49-56. Nurses Health Study. Am J Epidemiol
(Clin Res Ed) 1998;317:241-5. 614. Clavel-Chapelon F, Gerber M. 2000;152:950-64.
599. Lucas A, Fewtrell MS, Cole TJ. Fetal origins Reproductive factors and breast cancer 629. De Stavola BL, dos Santos Silva I,
of adult disease-the hypothesis revisited. risk. Do they differ according to age at McCormack V, et al. Childhood growth
BMJ 1999;319:245-9. diagnosis? Breast Cancer Res Treat and breast cancer. Am J Epidemiol
600. Ross MG, Desai M. Gestational 2002;72:107-15. 2004;159:671-82.
programming: population survival 615. Clavel-Chapelon F. Differential effects of 630. Drake DA. A longitudinal study of
effects of drought and famine during reproductive factors on the risk of pre- physical activity and breast cancer
pregnancy. Am J Physiol Regul Integr and postmenopausal breast cancer. prediction. Cancer Nurs 2001;24:371-7.
Comp Physiol 2005;288:R25-33. Results from a large cohort of French 631. Freni SC, Eberhardt MS, Turturro A, et al.
601. Cripps RL, Martin-Gronert MS, Ozanne SE. women. Br J Cancer 2002;86:723-7. Anthropometric measures and metabolic
Fetal and perinatal programming of 616. de Waard F, Thijssen JH. Hormonal aspects rate in association with risk of breast
appetite. Clin Sci (Lond) 2005;109:1-11. in the causation of human breast cancer: cancer (United States). Cancer Causes
602. Remacle C, Bieswal F, Reusens B. epidemiological hypotheses reviewed, Control 1996;7:358-65.
Programming of obesity and with special reference to nutritional 632. Hoyer AP, Grandjean P, Jorgensen T, et al.
cardiovascular disease. Int J Obes Relat status and first pregnancy. The Journal Organochlorine exposure and risk of
Metab Disord 2004;28 Suppl 3:S46-53. of Steroid Biochemistry and Molecular breast cancer. Lancet 1998;352:1816-20.
603. Job JC, Quelquejay C. Growth and Biology 2005;97:451-8. 633. Nilsen TIL, Vatten LJ. Adult height and
puberty in a fostered kindred. Eur J 617. Apter D, Reinila M, Vihko R. Some risk of breast cancer: A possible effect of
Pediatr 1994;153:642-5. endocrine characteristics of early early nutrition. Br J Cancer 2001;85:959-
604. Gunnell D, Okasha M, Smith GD, et al. menarche, a risk factor for breast cancer, 61.
Height, leg length, and cancer risk: a are preserved into adulthood. Int J 634. Palmer JR, Rao RS, Adams-Campbell LL, et
systematic review. Epidemiol Rev Cancer 1989;44:783-7. al. Height and breast cancer risk: Results
2001;23:313-42. 618. Stoll BA, Secreto G. New hormone-related from the Black Womens Health Study
605. Wadsworth ME, Hardy RJ, Paul AA, et al. markers of high risk to breast cancer. (United States). Cancer Causes Control
Leg and trunk length at 43 years in Ann Oncol 1992;3:435-8. 2001;12:343-8.
relation to childhood health, diet and 619. Kaaks R, Berrino F, Key T, et al. Serum sex 635. Swanson CA, Jones DY, Schatzkin A, et al.
family circumstances; evidence from the steroids in premenopausal women and Breast cancer risk assessed by
1946 national birth cohort. Int J breast cancer risk within the European anthropometry in the NHANES I
Epidemiol 2002;31:383-90. Prospective Investigation into Cancer epidemiological follow-up study. Cancer
606. Jousilahti P, Tuomilehto J, Vartiainen E, et and Nutrition (EPIC). J Natl Cancer Inst Res 1988;48:5363-7.
al. Relation of adult height to cause- 2005;97:755-65. 636. Tryggvadottir L, Tulinius H, Eyfjord JE, et
specific and total mortality: a 620. Kaaks R, Rinaldi S, Key TJ, et al. al. Breast cancer risk factors and age at
prospective follow-up study of 31,199 Postmenopausal serum androgens, diagnosis: an Icelandic cohort study. Int J
middle-aged men and women in oestrogens and breast cancer risk: the Cancer 2002;98:604-8.
Finland. Am J Epidemiol 2000;151:1112- European prospective investigation into 637. Vatten LJ, Kvinnsland S. Body height and
20. cancer and nutrition. Endocr Relat risk of breast cancer. A prospective study
607. Goldbourt U, Tanne D. Body height is Cancer 2005;12:1071-82. of 23,831 Norwegian women. Br J
associated with decreased long-term 621. Smith GD, Hart C, Upton M, et al. Height Cancer 1990;61:881-5.
stroke but not coronary heart disease and risk of death among men and 638. Adebamowo CA, Adekunle OO. Case-
mortality? Stroke; a Journal of Cerebral women: aetiological implications of controlled study of the epidemiological
Circulation 2002;33:743-8. associations with cardiorespiratory risk factors for breast cancer in Nigeria.
608. McCarron P, Okasha M, McEwen J, et al. disease and cancer mortality. J Epidemiol Br J Surg 1999;86:665-8.
Height in young adulthood and risk of Community Health 2000;54:97-103. 639. Amaral T, de Almeida MD, Barros H. Diet
death from cardiorespiratory disease: a 622. Thune I, Lund E. Physical activity and risk and postmenopausal breast cancer in
prospective study of male former of colorectal cancer in men and women. Portugal. IARC Sci Publ 2002;156:297-9.
students of Glasgow University, Br J Cancer 1996;73:1134-40. 640. Choi NW, Howe GR, Miller AB, et al. An
Scotland. Am J Epidemiol 2002;155:683- 623. Hebert PR, Ajani U, Cook NR, et al. Adult epidemiologic study of breast cancer.
7. height and incidence of cancer in male Am J Epidemiol 1978;107:510-21.
609. Dunger DB, Ahmed ML, Ong KK. Effects physicians (United States). Cancer Causes 641. Dubin N, Pasternack BS, Strax P.
of obesity on growth and puberty. Best Control 1997;8:591-7. Epidemiology of breast cancer in a
Pract Res Clin Endocrinol Metab 624. Giovannucci E, Rimm EB, Liu Y, et al. screened population. Cancer Detect Prev
2005;19:375-90. Height, predictors of C-peptide and 1984;7:87-102.
610. Parent AS, Teilmann G, Juul A, et al. The cancer risk in men. Int J Epidemiol 642. Kolonel LN, Nomura AM, Lee J, et al.
timing of normal puberty and the age 2004;33:217-25. Anthropometric indicators of breast
limits of sexual precocity: variations 625. Albanes D, Taylor PR. International cancer risk in postmenopausal women in
around the world, secular trends, and differences in body height and weight Hawaii. Nutr Cancer 1986;8:247-56.
changes after migration. Endocr Rev and their relationship to cancer 643. Magnusson C, Colditz G, Rosner B, et al.
2003;24:668-93. incidence. Nutr Cancer 1990;14:69-77. Association of family history and other
611. Wang Y. Is obesity associated with early 626. Berkey CS, Frazier AL, Gardner JD, et al. risk factors with breast cancer risk
sexual maturation? A comparison of the Adolescence and breast carcinoma risk. (Sweden). Cancer Causes Control
association in American boys versus girls. Cancer 1999;85:2400-9. 1998;9:259-67.
Pediatrics 2002;110:903-10. 627. Cerhan JR, Grabrick DM, Vierkant RA, et 644. Swerdlow AJ, De Stavola BL, Floredus B,
612. Kulin HE, Bwibo N, Mutie D, et al. The al. Interaction of adolescent et al. Risk factors for breast cancer at
effect of chronic childhood malnutrition anthropometric characteristics and young ages in twins: An international
on pubertal growth and development. family history on breast cancer risk in a population-based study. J Natl Cancer
Am J Clin Nutr 1982;36:527-36. Historical Cohort Study of 426 families Inst 2002;94:1238-46.
613. Hunter DJ, Spiegelman D, Adami HO, et (USA). Cancer Causes Control 2004;15:1- 645. Ursin G, Paganini-Hill A, Siemiatycki J, et
485
F O O D , N U T R I T I O N , P H Y S I C A L A C T I V I T Y, A N D T H E P R E V E N T I O N O F C A N C E R : A G L O B A L P E R S P E C T I V E
al. Early adult body weight, body mass participants in the population study of 676. Koumantaki Y, Tzonou A, Koumantakis E,
index, and premenopausal bilateral women in Gothenburg, Sweden. Int J et al. A case-control study of cancer of
breast cancer: data from a case-control Obes 1988;12:361-8. endometrium in Athens. Int J Cancer
study. Breast Cancer Res Treat 661. Lukanova A, Toniolo P, Lundin E, et al. 1989;43:795-9.
1995;33:75-82. Body mass index in relation to ovarian 677. Shu XO, Brinton LA, Zheng W, et al. A
646. Zhang Y, Rosenberg L, Colton T, et al. cancer: a multi-centre nested case- population-based case-control study of
Adult height and risk of breast cancer control study. Int J Cancer 2002;99:603-8. endometrial cancer in Shanghai, China.
among white women in a case-control 662. Rodriguez C, Calle EE, Fakhrabadi- Int J Cancer 1991;49:38-43.
study. Am J Epidemiol 1996;143:1123-8. Shokoohi D, et al. Body mass index, 678. De Stavola BL, Hardy R, Kuh D, et al.
647. Ziegler RG, Hoover RN, Nomura AM, et al. height, and the risk of ovarian cancer Birthweight, childhood growth and risk
Relative weight, weight change, height, mortality in a prospective cohort of of breast cancer in a British cohort. Br J
and breast cancer risk in Asian-American postmenopausal women. Cancer Cancer 2000;83:964-8.
women. J Natl Cancer Inst 1996;88:650- Epidemiol Biomarkers Prev 2002;11:822- 679. Kaijser M, Akre O, Cnattingius S, et al.
60. 8. Preterm birth, birth weight, and
648. Gray GE, Pike MC, Henderson BE. Breast- 663. Schouten LJ, Goldbohm RA, van den subsequent risk of female breast cancer.
cancer incidence and mortality rates in Brandt PA. Height, weight, weight Br J Cancer 2003;89:1664-6.
different countries in relation to known change, and ovarian cancer risk in the 680. McCormack VA, dos Santos Silva I, Koupil
risk factors and dietary practices. Br J Netherlands cohort study on diet and I, et al. Birth characteristics and adult
Cancer 1979;39:1-7. cancer. Am J Epidemiol 2003;157:424-33. cancer incidence: Swedish cohort of over
649. Baer HJ, Rich-Edwards JW, Colditz GA, et 664. Cramer DW, Welch WR, Hutchison GB, et 11,000 men and women. Int J Cancer
al. Adult height, age at attained height, al. Dietary animal fat in relation to 2005;115:611-7.
and incidence of breast cancer in ovarian cancer risk. Obstet Gynecol 681. Vatten LJ, Nilsen TI, Tretli S, et al. Size at
premenopausal women. Int J Cancer 1984;63:833-8. birth and risk of breast cancer:
2006;119:2231-5. 665. Dal Maso L, Franceschi S, Negri E, et al. prospective population-based study. Int J
650. Giovannucci E. Intake of fat, meat and Body size indices at different ages and Cancer 2005;114:461-4.
fiber in relation to risk of colon cancer in epithelial ovarian cancer risk. Eur J 682. Kaijser M, Lichtenstein P, Granath F, et al.
men. Cancer Res 1994;54:2390-7. Cancer 2002;38:1769-74. In utero exposures and breast cancer: a
651. Ogren M, Hedberg M, Berglund G, et al. 666. Kuper H, Cramer DW, Titus-Ernstoff L. Risk study of opposite-sexed twins. J Natl
Risk of pancreatic carcinoma in smokers of ovarian cancer in the United States in Cancer Inst 2001;93:60-2.
enhanced by weight gain. Results from relation to anthropometric measures: 683. Mellemkjaer L, Olsen ML, Sorensen HT, et
10-year follow-up of the Malmo does the association depend on al. Birth weight and risk of early-onset
preventive Project Cohort Study. Int J menopausal status? Cancer Causes breast cancer (Denmark). Cancer Causes
Pancreatol 1996;20:95-101. Control 2002;13:455-63. Control 2003;14:61-4.
652. Song YM, Smith GD, Sung J. Adult height 667. Mori M, Nishida T, Sugiyama T, et al. 684. Barba M, McCann SE, Nie J, et al. Perinatal
and cause-specific mortality: a large Anthropometric and other risk factors exposures and breast cancer risk in the
prospective study of South Korean men. for ovarian cancer in a case-control Western New York Exposures and Breast
Am J Epidemiol 2003;158:479-85. study. Jpn J Cancer Res 1998;89:246-53. Cancer (WEB) Study. Cancer Causes
653. Mack TM, Yu MC, Hanisch R, et al. 668. Polychronopoulou A, Tzonou A, Hsieh CC, Control 2006;17:395-401.
Pancreas cancer and smoking, beverage et al. Reproductive variables, tobacco, 685. Schack-Nielsen L, Michaelsen KF. Breast
consumption, and past medical history. J ethanol, coffee and somatometry as risk feeding and future health. Curr Opin
Natl Cancer Inst 1986;76:49-60. factors for ovarian cancer. Int J Cancer Clin Nutr Metab Care 2006;9:289-96.
654. Bueno de Mesquita HB, Maisonneuve P, 1993;55:402-7. 686. Leung AK, Sauve RS. Breast is best for
Moerman CJ, et al. Anthropometric and 669. Tzonou A, Day NE, Trichopoulos D, et al. babies. J Natl Med Assoc 2005;97:1010-9.
reproductive variables and exocrine The epidemiology of ovarian cancer in 687. World Health Organization/United
carcinoma of the pancreas: a population- Greece: a case-control study. Eur J Cancer Nations Childrens Fund. Global Strategy
based case-control study in The Clin Oncol 1984;20:1045-52. for Infant and Young Children Feeding.
Netherlands. Int J Cancer 1992;52:24-9. 670. Zhang M, Xie X, Holman CD. Body weight Geneva: WHO/UNICEF, 2003.
655. Kalapothaki V, Tzonou A, Hsieh CC, et al. and body mass index and ovarian cancer 688. World Health Organization. 2001. Report
Tobacco, ethanol, coffee, pancreatitis, risk: a case-control study in China. of the Expert Consultation on the
diabetes mellitus, and cholelithiasis as Gynecol Oncol 2005;98:228-34. Optimal Duration of Exclusive
risk factors for pancreatic carcinoma. 671. Barker DJ, Osmond C, Golding J. Height Breastfeeding.
Cancer Causes Control 1993;4:375-82. and mortality in the counties of England http://www.who.int/entity/nutrition/topi
656. Sarles H, Cros RC, Bidart JM. A multicenter and Wales. Ann Hum Biol 1990;17:1-6. cs/optimal_duration_of_exc_bfeeding_re
inquiry into the etiology of pancreatic 672. Lacey JV, Jr., Leitzmann M, Brinton LA, et port_eng.pdf.
diseases. Digestion 1979;19:110-25. al. Weight, height, and body mass index 689. World Cancer Research Fund/American
657. La Vecchia C, Negri E, Parazzini F, et al. and risk for ovarian cancer in a cohort Institute for Cancer Research. In press.
Height and cancer risk in a network of study. Ann Epidemiol 2006;16:869-76. Policy and Action for Cancer Prevention.
case-control studies from northern Italy. 673. Peterson NB, Trentham-Dietz A, Food, Nutrition and Physical Activity: a
Int J Cancer 1990;45:275-9. Newcomb PA, et al. Relation of Global Perspective. www.wcrf.org.
658. Anderson JP, Ross JA, Folsom AR. anthropometric measurements to 690. Wright A, Schanler R. The resurgence of
Anthropometric variables, physical ovarian cancer risk in a population-based breastfeeding at the end of the second
activity, and incidence of ovarian cancer: case-control study (United States). millennium. The Journal of Nutrition
The Iowa Womens Health Study. Cancer Cancer Causes Control 2006;17:459-67. 2001;131:421S-5S.
2004;100:1515-21. 674. Terry P, Baron JA, Weiderpass E, et al. 691. Yngve A, Sjostrom M. Breastfeeding in
659. Engeland A, Tretli S, Bjorge T. Height, Lifestyle and endometrial cancer risk: a countries of the European Union and
body mass index, and ovarian cancer: a cohort study from the Swedish Twin EFTA: current and proposed
follow-up of 1.1 million Norwegian Registry. Int J Cancer 1999;82:38-42. recommendations, rationale, prevalence,
women. J Natl Cancer Inst 2003;95:1244- 675. Tretli S, Magnus K. Height and weight in duration and trends. Public Health Nutr
8. relation to uterine corpus cancer 2001;4:631-45.
660. Lapidus L, Helgesson O, Merck C, et al. morbidity and mortaliy. A follow-up 692. Davies-Adetugbo AA, Ojofeitimi EO.
Adipose tissue distribution and female study of 570,000 women in Norway. Int J Maternal education, breastfeeding
carcinomas. A 12-year follow-up of Cancer 1990;46:165-72. behaviours and lactational
486
R E F E R E N C E S
amenorrhoea: studies among two ethnic association between lactation and breast 725. Abou-Daoud KT. Cancer of the breast and
communities in Ile Ife, Nigeria. Nutr cancer in an international case-control breast-feeding. Study of 279 parous
Health 1996;11:115-26. study: a re-analysis by menopausal women and matched controls. Cancer
693. Scott JA, Binns CW. Factors associated status. Int J Cancer 1997;71:166-9. 1971;28:781-4.
with the initiation and duration of 710. Tajima K, Hirose K, Ogawa H, et al. 726. Becher H, Schmidt S, Chang-Claude J.
breastfeeding: a review of the literature. [Hospital epidemiology - a comparative Reproductive factors and familial
Breastfeed Rev 1999;7:5-16. case control study of breast and cervical predisposition for breast cancer by age
694. Taylor JS, Risica PM, Geller L, et al. cancers.] Gan No Rinsho 1990;Spec 50 years. A case-control-family study for
Duration of breastfeeding among first- No:351-64. assessing main effects and possible gene-
time mothers in the United States: 711. Tashiro H, Nomura Y, Hisamatu K. [A case- environment interaction. Int J Epidemiol
results of a national survey. Acta control study of risk factors of breast 2003;32:38-48.
Paediatr 2006;95:980-4. cancer detected by mass screening.] Gan 727. Brandt B, Hermann S, Straif K, et al.
695. Dop MC. [Breastfeeding in Africa: will No Rinsho 1990;36:2127-30. Modification of breast cancer risk in
positive trends be challenged by the 712. Tessaro S, Beria JU, Tomasi E, et al. young women by a polymorphic
AIDS epidemic?] Sante 2002;12:64-72. Breastfeeding and breast cancer: a case- sequence in the egfr gene. Cancer Res
696. Tryggvadottir L, Tulinius H, Eyfjord JE, et control study in Southern Brazil. Cad 2004;64:7-12.
al. Breastfeeding and reduced risk of Saude Publica 2003;19:1593-601. 728. Byers T, Graham S, Rzepka T, et al.
breast cancer in an Icelandic cohort 713. Ursin G, Bernstein L, Lord SJ, et al. Lactation and breast cancer. Evidence for
study. Am J Epidemiol 2001;154:37-42. Reproductive factors and subtypes of a negative association in premenopausal
697. Abramson JH. Breastfeeding and breast breast cancer defined by hormone women. Am J Epidemiol 1985;121:664-
cancer. A study of cases and matched receptor and histology. Br J Cancer 74.
controls in Jerusalem. Isr J Med Sci 2005;93:364-71. 729. Chang-Claude J, Eby N, Kiechle M, et al.
1966;2:457-64. 714. Ursin G, Bernstein L, Wang Y, et al. Breastfeeding and breast cancer risk by
698. Behery A, Kotb. Genetic and Reproductive factors and risk of breast age 50 among women in Germany.
environmental risk factors for breast carcinoma in a study of white and Cancer Causes Control 2000;11:687-95.
cancer in Alexandria, Egypt. J Med Res African-American women. Cancer 730. Chie W, Lee W, Li C, et al. Lactation,
Inst 2002;23:117-28. 2004;101:353-62. lactation suppression hormones and
699. Brignone G, Cusimano R, Dardanoni G, et 715. Wu AH, Ziegler RG, Pike MC, et al. breast cancer: a hospital-based case-
al. A case-control study on breast cancer Menstrual and reproductive factors and control study for parous women in
risk factors in a southern European risk of breast cancer in Asian-Americans. Taiwan. Oncol Rep 1997;4:319-26.
population. Int J Epidemiol 1987;16:356- Br J Cancer 1996;73:680-6. 731. Coogan PF, Rosenberg L, Shapiro S, et al.
61. 716. Yang PS, Yang TL, Liu CL, et al. A case- Lactation and breast carcinoma risk in a
700. Charlier CJ, Albert AI, Zhang LY, et al. control study of breast cancer in Taiwan - South African population. Cancer
Polychlorinated biphenyls a low-incidence area. Br J Cancer 1999;86:982-9.
contamination in women with breast 1997;75:752-6. 732. Chilvers CED, McPherson K, Peto J, et al.
cancer. Clin Chim Acta 2004;347:177-81. 717. Yavari P, Mosavizadeh M, Sadrol-Hefazi B, Breast feeding and risk of breast cancer
701. Enger SM, Ross RK, Paganini-Hill A, et al. et al. Reproductive characteristics and in young women. BMJ 1993;307:17-20.
Breastfeeding experience and breast the risk of breast cancer - a case-control 733. Enger SM, Ross RK, Henderson B, et al.
cancer risk among postmenopausal study in Iran. Asian Pac J Cancer Prev Breastfeeding history, pregnancy
women. Cancer Epidemiol Biomarkers 2005;6:370-5. experience and risk of breast cancer. Br J
Prev 1998;7:365-9. 37 ref. 718. Yoo KY, Tajima K, Kuroishi T, et al. Cancer 1997;76:118-23.
702. Freudenheim JL, Marshall JR, Vena JE, et Independent protective effect of 734. Jernstrom H, Lubinski J, Lynch HT, et al.
al. Lactation history and breast cancer lactation against breast cancer: a case- Breast-feeding and the risk of breast
risk. Am J Epidemiol 1997;146:932-8. control study in Japan. Am J Epidemiol cancer in BRCA1 and BRCA2 mutation
703. Gao YT, Shu XO, Dai Q, et al. Association 1992;135:726-33. carriers. J Natl Cancer Inst 2004;96:1094-
of menstrual and reproductive factors 719. Yu SZ, Lu RF, Xu DD, et al. A case-control 8.
with breast cancer risk: results from the study of dietary and nondietary risk 735. Lai FM, Chen P, Ku HC, et al. A case-
Shanghai Breast Cancer Study. Int J factors for breast cancer in Shanghai. control study of parity, age at first full-
Cancer 2000;87:295-300. Cancer Res 1990;50:5017-21. term pregnancy, breast feeding and
704. Haring MH, Rookus MA, van Leeuwen FE. 720. Lubin JH, Burns PE, Blot WJ, et al. Risk breast cancer in Taiwanese women. Proc
[Does breast feeding protect against factors for breast cancer in women in Natl Sci Counc Repub China B
breast cancer? An epidemiological northern Alberta, Canada, as related to 1996;20:71-7.
study.] Ned Tijdschr Geneeskd age at diagnosis. J Natl Cancer Inst 736. Layde PM, Webster LA, Baughman AL, et
1992;136:743-7. 1982;68:211-7. al. The independent associations of
705. Katsouyanni K, Lipworth L, Trichopoulou 721. Kvale GHI. Lactation and cancer risk: is parity, age at first full term pregnancy,
A, et al. A case-control study of lactation there a relation specific to breast cancer? and duration of breastfeeding with the
and cancer of the breast. Br J Cancer J Epidemiol Community Health risk of breast cancer. J Clin Epidemiol
1996;73:814-8. 1988;42:30-7. 1989;42:963-73.
706. Kuo HW, Chen SF, Wu CC, et al. Serum and 722. Li W, Ray RM, Lampe JW, et al. Dietary 737. Lee EO, Ahn SH, You C, et al. Determining
tissue trace elements in patients with and other risk factors in women having the main risk factors and high-risk
breast cancer in Taiwan. Biol Trace Elem fibrocystic breast conditions with and groups of breast cancer using a
Res 2002;89:1-11. without concurrent breast cancer: a predictive model for breast cancer risk
707. Romieu I, Hernandez-Avila M, Lazcano E, nested case-control study in Shanghai, assessment in South Korea. Cancer Nurs
et al. Breast cancer and lactation history China. Int J Cancer 2005;115:981-93. 2004;27:400-6.
in Mexican women. Am J Epidemiol 723. London SJ, Colditz GA, Stampfer MJ, et al. 738. Lucena RA, Allam MF, Costabeber IH, et
1996;143:543-52. Lactation and risk of breast cancer in a al. Breast cancer risk factors: PCB
708. Rundle A, Tang D, Hibshoosh H, et al. The cohort of US women. Am J Epidemiol congeners. Eur J Cancer Prev
relationship between genetic damage 1990;132:17-26. 2001;10:117-9.
from polycyclic aromatic hydrocarbons in 724. Michels KB, Willett WC, Rosner BA, et al. 739. Marcus PM, Baird DD, Millikan RC, et al.
breast tissue and breast cancer. Prospective assessment of breastfeeding Adolescent reproductive events and
Carcinogenesis 2000;21:1281-9. and breast cancer incidence among 89 subsequent breast cancer risk. Am J
709. Stuver SO, Hsieh CC, Bertone E, et al. The 887 women. Lancet 1996;347:431-6. Public Health 1999;89:1244-7.
487
F O O D , N U T R I T I O N , P H Y S I C A L A C T I V I T Y, A N D T H E P R E V E N T I O N O F C A N C E R : A G L O B A L P E R S P E C T I V E
740. Schecter A, Toniolo P, Dai LC, et al. Blood study. Gynecol Oncol 2001;83:575-85. Chapter 7
levels of DDT and breast cancer risk 757. Risch HA, Marrett LD, Jain M, et al.
among women living in the North of Differences in risk factors for epithelial 1. World Health Organization. WHO mortality
Vietnam. Arch Environ Contam Toxicol ovarian cancer by histologic type. Results database.
1997;33:453-6. of a case-control study. Am J Epidemiol http://www.who.int/whosis/mort/en/.
741. Siskind V, Schofield E, Rice D, et al. Breast 1996;144:363-72. 2006.
cancer and breastfeeding: results from 758. Yen ML, Yen BL, Bai CH, et al. Risk factors 2. International Agency for Research on
an Australian case-control study. Am J for ovarian cancer in Taiwan: a case- Cancer. Globocan 2002. http://www-
Epidemiol 1989;130:229-36. control study in a low-incidence dep.iarc.fr/. 2006.
742. Tao SC, Yu MC, Ross RK, et al. Risk factors population. Gynecol Oncol 2003;89:318- 3. Jemal A, Clegg LX, Ward E, et al. Annual
for breast cancer in Chinese women of 24. report to the nation on the status of
Beijing. Int J Cancer 1988;42:495-8. 759. Zhang M, Lee AH, Binns CW. Reproductive cancer, 1975-2001, with a special feature
743. Thomas DB, Noonan EA. Breast cancer and dietary risk factors for epithelial regarding survival. Cancer 2004;101:3-27.
and prolonged lactation. The WHO ovarian cancer in China. Gynecol Oncol 4. Kufe D, Pollock R, Weichselbaum R, et al.
Collaborative Study of Neoplasia and 2004;. 92. Holland Frei Cancer Medicine. 6 ed.
Steroid Contraceptives. Int J Epidemiol 760. Zhang M, Xie X, Lee AH, et al. Prolonged Hamilton, Ontario: BC Decker, 2003.
1993;22:619-26. lactation reduces ovarian cancer risk in 5. Vikram B. Changing patterns of failure in
744. Wang QS, Ross RK, Yu MC, et al. A case- Chinese women. Eur J Cancer Prev advanced head and neck cancer. Arch
control study of breast cancer in Tianjin, 2004;13:499-502. Otolaryngol 1984;110:564-5.
China. Cancer Epidemiol Biomarkers Prev 761. Huusom LD, Frederiksen K, Hogdall EV, et 6. Cancer Research UK. UK Cancer statistics.
1992;1:435-9. al. Association of reproductive factors, http://info.cancerresearchuk.org/cancerst
745. Wrensch M, Chew T, Farren G, et al. Risk oral contraceptive use and selected ats/. 2006.
factors for breast cancer in a population lifestyle factors with the risk of ovarian 7. Weaver EM. Association between
with high incidence rates. Breast Cancer borderline tumors: a Danish case-control gastroesophageal reflux and sinusitis,
Res 2003;5:R88-102. study. Cancer Causes Control otitis media, and laryngeal malignancy: a
746. Yang CP, Weiss NS, Band PR, et al. History 2006;17:821-9. systematic review of the evidence. Am J
of lactation and breast cancer risk. Am J Med 2003;115 Suppl 3A:81S-9S.
Epidemiol 1993;138:1050-6. 8. Wilson JA. What is the evidence that
747. Yuan JM, Yu MC, Ross RK, et al. Risk gastroesophageal reflux is involved in
factors for breast cancer in Chinese the etiology of laryngeal cancer? Curr
women in Shanghai. Cancer Res Opin Otolaryngol Head Neck Surg
1988;48:1949-53. 2005;13:97-100.
748. Zheng T, Duan L, Liu Y, et al. Lactation 9. Franceschi S, Levi F, La Vecchia C, et al.
reduces breast cancer risk in Shandong Comparison of the effect of smoking and
Province, China. Am J Epidemiol alcohol drinking between oral and
2000;152:1129-35. pharyngeal cancer. Int J Cancer
749. Collaborative Group on Hormonal Factors 1999;83:1-4.
in Breast Cancer. Breast cancer and 10. International Agency for Research on
breastfeeding: collaborative reanalysis Cancer. Tobacco smoking and tobacco
of individual data from 47 smoke: Lyon: International Agency for
epidemiological studies in 30 countries, Research on Cancer, 2004.
including 50302 women with breast 11. International Agency for Research on
cancer and 96973 women without the Cancer. 2004. Betel-quid and areca-nut
disease. Lancet 2002;360:187-95. chewing. In: IARC Monogr Eval Carcinog
750. Mink PJ, Folsom AR, Sellers TA, et al. Risks Hum no 85.
Physical activity, waist-to-hip ratio, and http://monographs.iarc.fr/ENG/Mfonogra
other risk factors for ovarian cancer: a phs/vol85/volume85.pdf.
follow-up study of older women. 12. Ha PK, Califano JA. The role of human
Epidemiology 1996;7:38-45. papillomavirus in oral carcinogenesis.
751. Booth M, Beral V, Smith P. Risk factors for Crit Rev Oral Biol Med 2004;15:188-96.
ovarian cancer: a case-control study. Br J 13. International Agency for Research on
Cancer 1989;60:592-8. Cancer. 2005. Human papillomaviruses.
752. Chiaffarino F, Pelucchi C, Negri E, et al. In: IARC Monogr Eval Carcinog Risks
Breastfeeding and the risk of epithelial Hum.
ovarian cancer in an Italian population. 14. Syrjanen S. Human papillomavirus (HPV) in
Gynecol Oncol 2005;98:304-8. head and neck cancer. J Clin Virol
753. Greggi S, Parazzini F, Paratore MP, et al. 2005;32 Suppl 1:S59-66.
Risk factors for ovarian cancer in central 15. Maserejian NN, Giovannucci E, Rosner B, et
Italy. Gynecol Oncol 2000;79:50-4. al. Prospective study of fruits and
754. Mori M, Harabuchi I, Miyake H, et al. vegetables and risk of oral premalignant
Reproductive, genetic, and dietary risk lesions in men. Am J Epidemiol
factors for ovarian cancer. Am J 2006;164:556-66.
Epidemiol 1988;128:771-7. 16. Boeing H, Dietrich T, Hoffmann K, et al.
755. Purdie D, Green A, Bain C, et al. Intake of fruits and vegetables and risk
Reproductive and other factors and risk of cancer of the upper aero-digestive
of epithelial ovarian cancer: an tract: the prospective EPIC-study. Cancer
Australian case-control study. Survey of Causes Control 2006;17:957-69.
Womens Health Study Group. Int J 17. Galeone C, Pelucchi C, Levi F, et al. Onion
Cancer 1995;62:678-84. and garlic use and human cancer. Am J
756. Riman T, Dickman PW, Nilsson S, et al. Risk Clin Nutr 2006;84:1027-32.
factors for epithelial borderline ovarian 18. Kreimer AR, Randi G, Herrero R, et al. Diet
tumors: results of a Swedish case-control and body mass, and oral and
488
R E F E R E N C E S
oropharyngeal squamous cell Carcinog Risks Hum no 6. and low-risk areas of Jiangsu Province,
carcinomas: analysis from the IARC 36. Iwase Y, Takemura Y, Ju-ichi M, et al. China. World J Gastroenterol
multinational case-control study. Int J Inhibitory effect of Epstein-Barr virus 2006;12:1686-93.
Cancer 2006;118:2293-7. activation by Citrus fruits, a cancer 52. Galeone C, Pelucchi C, Levi F, et al. Folate
19. Goldenberg D. Mate: a risk factor for oral chemopreventor. Cancer Lett intake and squamous-cell carcinoma of
and oropharyngeal cancer. Oral Oncol 1999;139:227-36. the oesophagus in Italian and Swiss men.
2002;38:646-9. 37. Ayan I, Kaytan E, Ayan N. Childhood Ann Oncol 2006;17:521-5.
20. Goldenberg D, Golz A, Joachims HZ. The nasopharyngeal carcinoma: from 53. Veugelers PJ, Porter GA, Guernsey DL, et al.
beverage mate: a risk factor for cancer biology to treatment. Lancet Oncol Obesity and lifestyle risk factors for
of the head and neck. Head Neck 2003;4:13-21. gastroesophageal reflux disease, Barrett
2003;25:595-601. 38. Shao YM, Poirier S, Ohshima H, et al. esophagus and esophageal
21. Garavello W, Bosetti C, Gallus S, et al. Type Epstein-Barr virus activation in Raji cells adenocarcinoma. Dis Esophagus
of alcoholic beverage and the risk of by extracts of preserved food from high 2006;19:321-8.
laryngeal cancer. Eur J Cancer Prev risk areas for nasopharyngeal carcinoma. 54. Gonzalez CA, Jakszyn P, Pera G, et al. Meat
2006;15:69-73. Carcinogenesis 1988;9:1455-7. intake and risk of stomach and
22. Vlajinac HD, Marinkovic JM, Sipetic SB, et 39. Pera M, Manterola C, Vidal O, et al. esophageal adenocarcinoma within the
al. Case-control study of oropharyngeal Epidemiology of esophageal European Prospective Investigation Into
cancer. Cancer Detect Prev 2006;30:152- adenocarcinoma. J Surg Oncol Cancer and Nutrition (EPIC). J Natl
7. 2005;92:151-9. Cancer Inst 2006;98:345-54.
23. Petti S, Scully C. Association between 40. Brown LM, Devesa SS. Epidemiologic 55. Goldman R, Shields PG. Food mutagens. J
different alcoholic beverages and trends in esophageal and gastric cancer Nutr 2003;133 Suppl 3:965S-73S.
leukoplakia among non- to moderate- in the United States. Surg Oncol Clin N 56. Ishikawa A, Kuriyama S, Tsubono Y, et al.
drinking adults: a matched case-control Am 2002;11:235-56. Smoking, alcohol drinking, green tea
study. Eur J Cancer 2006;42:521-7. 41. Yang CS. Research on esophageal cancer in consumption and the risk of esophageal
24. Vaezi MF, Qadeer MA, Lopez R, et al. China: a review. Cancer Res cancer in Japanese men. J Epidemiol
Laryngeal cancer and gastroesophageal 1980;40:2633-44. 2006;16:185-92.
reflux disease: a case-control study. Am J 42. Lagergren J, Bergstrom R, Lindgren A, et 57. Wu IC, Lu CY, Kuo FC, et al. Interaction
Med 2006;119:768-76. al. Symptomatic gastroesophageal reflux between cigarette, alcohol and betel nut
25. Yu MC, Yuan JM. Epidemiology of as a risk factor for esophageal use on esophageal cancer risk in Taiwan.
nasopharyngeal carcinoma. Semin adenocarcinoma. N Engl J Med Eur J Clin Invest 2006;36:236-41.
Cancer Biol 2002;12:421-9. 1999;340:825-31. 58. Samanic C, Chow WH, Gridley G, et al.
26. Buell P. The effect of migration on the risk 43. Cameron AJ. Epidemiology of columnar- Relation of body mass index to cancer
of nasopharyngeal cancer among lined esophagus and adenocarcinoma. risk in 362,552 Swedish men. Cancer
Chinese. Cancer Res 1974;34:1189-91. Gastroenterol Clin North Am Causes Control 2006;17:901-9.
27. Wei WI, Sham JS. Nasopharyngeal 1997;26:487-94. 59. MacInnis RJ, English DR, Hopper JL, et al.
carcinoma. Lancet 2005;365:2041-54. 44. Cameron AJ, Zinsmeister AR, Ballard DJ, et Body size and composition and the risk
28. Chan AT, Teo PM, Johnson PJ. al. Prevalence of columnar-lined of gastric and oesophageal
Nasopharyngeal carcinoma. Ann Oncol (Barretts) esophagus. Comparison of adenocarcinoma. Int J Cancer
2002;13:1007-15. population-based clinical and autopsy 2006;118:2628-31.
29. Niedobitek G. Epstein-Barr virus infection findings. Gastroenterology 1990;99:918- 60. Ryan AM, Rowley SP, Fitzgerald AP, et al.
in the pathogenesis of nasopharyngeal 22. Adenocarcinoma of the oesophagus and
carcinoma. Mol Pathol 2000;53:248-54. 45. Sandler RS, Nyren O, Ekbom A, et al. The gastric cardia: male preponderance in
30. International Agency for Research on risk of esophageal cancer in patients association with obesity. Eur J Cancer
Cancer. 1994. Epstein-Barr Virus and with achalasia. A population-based 2006;42:1151-8.
Kaposis Sarcoma Herpesvirus/Human study. JAMA 1995;274:1359-62. 61. de Jonge PJ, Steyerberg EW, Kuipers EJ, et
Herpesvirus 8. In: IARC Monogr Eval 46. Streitz JM, Jr., Ellis FH, Jr., Gibb SP, et al. al. Risk factors for the development of
Carcinog Risks Hum no 70. Achalasia and squamous cell carcinoma esophageal adenocarcinoma in Barretts
http://monographs.iarc.fr/ENG/Monogra of the esophagus: analysis of 241 esophagus. Am J Gastroenterol
phs/vol70/volume70.pdf. patients. Ann Thorac Surg 1995;59:1604- 2006;101:1421-9.
31. Young LS, Rickinson AB. Epstein-Barr virus: 9. 62. Bu X, Ma Y, Der R, et al. Body mass index is
40 years on. Nature reviews 2004;4:757- 47. Maillefer RH, Greydanus MP. To B or not to associated with Barrett esophagus and
68. B: is tylosis B truly benign? Two North cardiac mucosal metaplasia. Dig Dis Sci
32. Raab-Traub N, Flynn K. The structure of the American genealogies. Am J 2006;51:1589-94.
termini of the Epstein-Barr virus as a Gastroenterol 1999;94:829-34. 63. Proctor RN. Tobacco and the global lung
marker of clonal cellular proliferation. 48. Syrjanen KJ. HPV infections and cancer epidemic. Nature reviews
Cell 1986;47:883-9. oesophageal cancer. J Clin Pathol 2001;1:82-6.
33. International Agency for Research on 2002;55:721-8. 64. Hoffman PC, Mauer AM, Vokes EE. Lung
Cancer. In preparation. Formaldehyde, 2- 49. Gonzalez CA, Pera G, Agudo A, et al. Fruit cancer. Lancet 2000;355:479-85.
Butoxyethanol and 1-tert-Butoxy-2- and vegetable intake and the risk of 65. Worden FP, Kalemkerian GP. Therapeutic
propanol. In: IARC Monogr Eval Carcinog stomach and oesophagus advances in small cell lung cancer. Expert
Risks Hum no 88. adenocarcinoma in the European opinion on investigational drugs
http://monographs.iarc.fr/ENG/Meetings/ Prospective Investigation into Cancer 2000;9:565-79.
88-formaldehyde.pdf. and Nutrition (EPIC-EURGAST). Int J 66. WHO. The smokers body.
34. Hildesheim A, Dosemeci M, Chan CC, et al. Cancer 2006;118:2559-66. http://www.who.int/entity/tobacco/resou
Occupational exposure to wood, 50. Yokoyama A, Kato H, Yokoyama T, et al. rces/publications/smokersbody_en_fr.pdf
formaldehyde, and solvents and risk of Esophageal squamous cell carcinoma . 2006.
nasopharyngeal carcinoma. Cancer and aldehyde dehydrogenase-2 67. International Agency for Research on
Epidemiol Biomarkers Prev genotypes in Japanese females. Alcohol Cancer. 1987. Overall evaluations of
2001;10:1145-53. Clin Exp Res 2006;30:491-500. carcinogenicity: An updating of IARC
35. International Agency for Research on 51. Wu M, Zhao JK, Hu XS, et al. Association of Monographs Volumes 1 to 42. In: IARC
Cancer. 2004. Wood dust and smoking, alcohol drinking and dietary Monogr Eval Carcinog Risks Hum no
formaldehyde. In: IARC Monogr Eval factors with esophageal cancer in high- Supplement 7.
489
F O O D , N U T R I T I O N , P H Y S I C A L A C T I V I T Y, A N D T H E P R E V E N T I O N O F C A N C E R : A G L O B A L P E R S P E C T I V E
490
R E F E R E N C E S
115. Cottam DR, Mattar SG, Barinas-Mitchell E, Therapy. In: IARC Monogr Eval Carcinog Int J Cancer 2006;119:1475-80.
et al. The chronic inflammatory Risks Hum no 72. 150. Michels KB, Fuchs CS, Giovannucci E, et al.
hypothesis for the morbidity associated http://monographs.iarc.fr/ENG/Monogra Fiber intake and incidence of colorectal
with morbid obesity: implications and phs/vol72/volume72.pdf. cancer among 76,947 women and 47,279
effects of weight loss. Obes Surg 134. Talamini R, Polesel J, Montella M, et al. men. Cancer Epidemiol Biomarkers Prev
2004;14:589-600. Food groups and risk of hepatocellular 2005;14:842-9.
116. Diehl AK. Gallstone size and the risk of carcinoma: A multicenter case-control 151. Bowers K, Albanes D, Limburg P, et al. A
gallbladder cancer. JAMA study in Italy. Int J Cancer 2006;119:2916- prospective study of anthropometric and
1983;250:2323-6. 21. clinical measurements associated with
117. Shaffer EA. Epidemiology and risk factors 135. Franceschi S, Montella M, Polesel J, et al. insulin resistance syndrome and
for gallstone disease: has the paradigm Hepatitis viruses, alcohol, and tobacco in colorectal cancer in male smokers. Am J
changed in the 21st century? Curr the etiology of hepatocellular carcinoma Epidemiol 2006;164:652-64.
Gastroenterol Rep 2005;7:132-40. in Italy. Cancer Epidemiol Biomarkers 152. Wakai K, Hirose K, Matsuo K, et al.
118. Misra S, Chaturvedi A, Misra NC, et al. Prev 2006;15:683-9. Dietary risk factors for colon and rectal
Carcinoma of the gallbladder. Lancet 136. NKontchou G, Paries J, Htar MT, et al. cancers: a comparative case-control
Oncol 2003;4:167-76. Risk factors for hepatocellular carcinoma study. J Epidemiol 2006;16:125-35.
119. Wistuba, II, Gazdar AF. Gallbladder in patients with alcoholic or viral C 153. Sato Y, Tsubono Y, Nakaya N, et al. Fruit
cancer: lessons from a rare tumour. Nat cirrhosis. Clin Gastroenterol Hepatol and vegetable consumption and risk of
Rev Cancer 2004;4:695-706. 2006;4:1062-8. colorectal cancer in Japan: The Miyagi
120. Hu B, Gong B, Zhou DY. Association of 137. Parkin DM, Whelan SL, Ferlay J, et al. Cohort Study. Public Health Nutr
anomalous pancreaticobiliary ductal Cancer Incidence in Five Continents, Vol. 2005;8:309-14.
junction with gallbladder carcinoma in I to VIII. Lyon: IARC 2005. 154. Huang XE, Hirose K, Wakai K, et al.
Chinese patients: an ERCP study. 138. Itzkowitz SH, Yio X. Inflammation and Comparison of lifestyle risk factors by
Gastrointest Endosc 2003;57:541-5. cancer IV. Colorectal cancer in family history for gastric, breast, lung
121. Fujii K, Yokozaki H, Yasui W, et al. High inflammatory bowel disease: the role of and colorectal cancer. Asian Pac J Cancer
frequency of p53 gene mutation in inflammation. Am J Physiol Gastrointest Prev 2004;5:419-27.
adenocarcinomas of the gallbladder. Liver Physiol 2004;287:G7-17. 155. Tsubono Y, Otani T, Kobayashi M, et al. No
Cancer Epidemiol Biomarkers Prev 139. Lynch HT, de la Chapelle A. Hereditary association between fruit or vegetable
1996;5:461-6. colorectal cancer. N Engl J Med consumption and the risk of colorectal
122. Parkin DM, Bray F, Ferlay J, et al. 2003;348:919-32. cancer in Japan. Br J Cancer
Estimating the world cancer burden: 140. Weitz J, Koch M, Debus J, et al. Colorectal 2005;92:1782-4.
Globocan 2000. Int J Cancer 2001;94:153- cancer. Lancet 2005;365:153-65. 156. Turner F, Smith G, Sachse C, et al.
6. 141. Kinzler KW, Vogelstein B. Cancer- Vegetable, fruit and meat consumption
123. Llovet JM, Burroughs A, Bruix J. susceptibility genes. Gatekeepers and and potential risk modifying genes in
Hepatocellular carcinoma. Lancet caretakers. Nature 1997;386:761, 3. relation to colorectal cancer. Int J Cancer
2003;362:1907-17. 142. Lynch JP, Hoops TC. The genetic 2004;112:259-64.
124. Parkin DM, Bray F, Ferlay J, et al. Global pathogenesis of colorectal cancer. 157. Juarranz Sanz M, Soriano Llora T, Calle
cancer statistics, 2002. CA Cancer J Clin Hematol Oncol Clin North Am Puron ME, et al. [Influence of the diet on
2005;55:74-108. 2002;16:775-810. the development of colorectal cancer in
125. Bruix J, Boix L, Sala M, et al. Focus on 143. Asano TK, McLeod RS. Nonsteroidal anti- a population of Madrid]. Rev Clin Esp
hepatocellular carcinoma. Cancer Cell inflammatory drugs and aspirin for the 2004;204:355-61.
2004;5:215-9. prevention of colorectal adenomas and 158. Kuriki K, Hamajima N, Chiba H, et al.
126. Coleman WB. Mechanisms of human cancer: a systematic review. Dis Colon Increased risk of colorectal cancer due to
hepatocarcinogenesis. Curr Mol Med Rectum 2004;47:665-73. interactions between meat consumption
2003;3:573-88. 144. Post-menopausal oestrogen therapy. IARC and the CD36 gene A52C polymorphism
127. Buendia MA. Genetics of hepatocellular Monogr Eval Carcinog Risks Hum among Japanese. Nutr Cancer
carcinoma. Semin Cancer Biol 1999;72:399-530 2005;51:170-7.
2000;10:185-200. 145. Bingham SA, Norat T, Moskal A, et al. Is 159. Jiang Q, Chen K, Ma X, et al. Diets,
128. Thorgeirsson SS, Grisham JW. Molecular the association with fiber from foods in polymorphisms of
pathogenesis of human hepatocellular colorectal cancer confounded by folate methylenetetrahydrofolate reductase,
carcinoma. Nat Genet 2002;31:339-46. intake? Cancer Epidemiol Biomarkers and the susceptibility of colon cancer
129. Vitaglione P, Morisco F, Caporaso N, et al. Prev 2005;14:1552-6. and rectal cancer. Cancer Detect Prev
Dietary antioxidant compounds and liver 146. MacInnis RJ, English DR, Haydon AM, et 2005;29:146-54.
health. Crit Rev Food Sci Nutr al. Body size and composition and risk of 160. Zhang SM, Moore SC, Lin J, et al. Folate,
2004;44:575-86. rectal cancer (Australia). Cancer Causes vitamin B6, multivitamin supplements,
130. International Agency for Research on Control 2006;17:1291-7. and colorectal cancer risk in women. Am
Cancer. 1994. Hepatitis viruses. In: IARC 147. Lin J, Zhang SM, Cook NR, et al. Dietary J Epidemiol 2006;163:108-15.
Monogr Eval Carcinog Risks Hum no 59. intakes of fruit, vegetables, and fiber, 161. Brink M, Weijenberg MP, de Goeij AF, et
131. Chang MH, Chen CJ, Lai MS, et al. and risk of colorectal cancer in a al. Dietary folate intake and k-ras
Universal hepatitis B vaccination in prospective cohort of women (United mutations in sporadic colon and rectal
Taiwan and the incidence of States). Cancer Causes Control cancer in The Netherlands Cohort Study.
hepatocellular carcinoma in children. 2005;16:225-33. Int J Cancer 2005;114:824-30.
Taiwan Childhood Hepatoma Study 148. Shin A, Li H, Shu XO, et al. Dietary intake 162. Larsson SC, Giovannucci E, Wolk A. A
Group. N Engl J Med 1997;336:1855-9. of calcium, fiber and other prospective study of dietary folate
132. Pessione F, Degos F, Marcellin P, et al. micronutrients in relation to colorectal intake and risk of colorectal cancer:
Effect of alcohol consumption on serum cancer risk: Results from the Shanghai modification by caffeine intake and
hepatitis C virus RNA and histological Womens Health Study. Int J Cancer cigarette smoking. Cancer Epidemiol
lesions in chronic hepatitis C. Hepatology 2006;119:2938-42. Biomarkers Prev 2005;14:740-3.
1998;27:1717-22. 149. Otani T, Iwasaki M, Ishihara J, et al. 163. de Vogel S, van Engeland M, Luchtenborg
133. International Agency for Research on Dietary fiber intake and subsequent risk M, et al. Dietary folate and APC
Cancer. 1999. Hormonal Contraception of colorectal cancer: the Japan Public mutations in sporadic colorectal cancer. J
and Post-menopausal Hormonal Health Center-based prospective study. Nutr 2006;136:3015-21.
491
F O O D , N U T R I T I O N , P H Y S I C A L A C T I V I T Y, A N D T H E P R E V E N T I O N O F C A N C E R : A G L O B A L P E R S P E C T I V E
164. Otani T, Iwasaki M, Hanaoka T, et al. pathway, fish consumption and the risk Chinese population. Cancer Genet
Folate, vitamin B6, vitamin B12, and of colorectal cancer. Int J Cancer Cytogenet 2005;163:38-43.
vitamin B2 intake, genetic 2006;119:297-303. 193. Wakai K, Kojima M, Tamakoshi K, et al.
polymorphisms of related enzymes, and 179. Slattery ML, Neuhausen SL, Hoffman M, Alcohol consumption and colorectal
risk of colorectal cancer in a hospital- et al. Dietary calcium, vitamin D, VDR cancer risk: findings from the JACC
based case-control study in Japan. Nutr genotypes and colorectal cancer. Int J Study. J Epidemiol 2005;15 Suppl 2:S173-
Cancer 2005;53:42-50. Cancer 2004;111:750-6. 9.
165. Larsson SC, Rafter J, Holmberg L, et al. 180. Sesink AL, Termont DS, Kleibeuker JH, et 194. Chen K, Jiang Q, Ma X, et al. Alcohol
Red meat consumption and risk of al. Red meat and colon cancer: the drinking and colorectal cancer: a
cancers of the proximal colon, distal cytotoxic and hyperproliferative effects population-based prospective cohort
colon and rectum: the Swedish of dietary heme. Cancer Res study in China. Eur J Epidemiol
Mammography Cohort. Int J Cancer 1999;59:5704-9. 2005;20:149-54.
2005;113:829-34. 181. Huang X. Iron overload and its association 195. Kim DH, Ahn YO, Lee BH, et al.
166. Chao A, Thun MJ, Connell CJ, et al. Meat with cancer risk in humans: evidence for Methylenetetrahydrofolate reductase
consumption and risk of colorectal iron as a carcinogenic metal. Mutation polymorphism, alcohol intake, and risks
cancer. JAMA 2005;293:172-82. research 2003;533:153-71. of colon and rectal cancers in Korea.
167. Lin J, Zhang SM, Cook NR, et al. Dietary 182. Chan AT, Ma J, Tranah GJ, et al. Cancer Lett 2004;216:199-205.
fat and fatty acids and risk of colorectal Hemochromatosis gene mutations, body 196. Hong YC, Lee KH, Kim WC, et al.
cancer in women. Am J Epidemiol iron stores, dietary iron, and risk of Polymorphisms of XRCC1 gene, alcohol
2004;160:1011-22. colorectal adenoma in women. J Natl consumption and colorectal cancer. Int J
168. Norat T, Bingham S, Ferrari P, et al. Meat, Cancer Inst 2005;97:917-26. Cancer 2005;116:428-32.
fish, and colorectal cancer risk: the 183. Cho E, Smith-Warner SA, Spiegelman D, et 197. Diergaarde B, Tiemersma EW, Braam H, et
European Prospective Investigation into al. Dairy foods, calcium, and colorectal al. Dietary factors and truncating APC
cancer and nutrition. J Natl Cancer Inst cancer: a pooled analysis of 10 cohort mutations in sporadic colorectal
2005;97:906-16. studies. J Natl Cancer Inst 2004;96:1015- adenomas. Int J Cancer 2005;113:126-32.
169. English DR, MacInnis RJ, Hodge AM, et al. 22. 198. Chao A, Connell CJ, Jacobs EJ, et al.
Red meat, chicken, and fish consumption 184. Lamprecht SA, Lipkin M. Cellular Amount, type, and timing of
and risk of colorectal cancer. Cancer mechanisms of calcium and vitamin D in recreational physical activity in relation
Epidemiol Biomarkers Prev the inhibition of colorectal to colon and rectal cancer in older
2004;13:1509-14. carcinogenesis. Ann N Y Acad Sci adults: the Cancer Prevention Study II
170. Chan AT, Tranah GJ, Giovannucci EL, et al. 2001;952:73-87. Nutrition Cohort. Cancer Epidemiol
Prospective study of N-acetyltransferase- 185. Lin J, Zhang SM, Cook NR, et al. Intakes of Biomarkers Prev 2004;13:2187-95.
2 genotypes, meat intake, smoking and calcium and vitamin D and risk of 199. Friedenreich C, Norat T, Steindorf K, et al.
risk of colorectal cancer. Int J Cancer colorectal cancer in women. Am J Physical activity and risk of colon and
2005;115:648-52. Epidemiol 2005;161:755-64. rectal cancers: the European prospective
171. Brink M, Weijenberg MP, de Goeij AF, et 186. Larsson SC, Bergkvist L, Rutegard J, et al. investigation into cancer and nutrition.
al. Meat consumption and K-ras Calcium and dairy food intakes are Cancer Epidemiol Biomarkers Prev
mutations in sporadic colon and rectal inversely associated with colorectal 2006;15:2398-407.
cancer in The Netherlands Cohort Study. cancer risk in the Cohort of Swedish 200. Schnohr P, Gronbaek M, Petersen L, et al.
Br J Cancer 2005;92:1310-20. Men. Am J Clin Nutr 2006;83:667-73; quiz Physical activity in leisure-time and risk
172. Sato Y, Nakaya N, Kuriyama S, et al. Meat 728-9. of cancer: 14-year follow-up of 28,000
consumption and risk of colorectal 187. Larsson SC, Bergkvist L, Wolk A. High-fat Danish men and women. Scand J Public
cancer in Japan: the Miyagi Cohort dairy food and conjugated linoleic acid Health 2005;33:244-9.
Study. Eur J Cancer Prev 2006;15:211-8. intakes in relation to colorectal cancer 201. Calton BA, Lacey JV, Jr., Schatzkin A, et al.
173. Oba S, Shimizu N, Nagata C, et al. The incidence in the Swedish Mammography Physical activity and the risk of colon
relationship between the consumption Cohort. Am J Clin Nutr 2005;82:894-900. cancer among women: a prospective
of meat, fat, and coffee and the risk of 188. Kesse E, Boutron-Ruault MC, Norat T, et cohort study (United States). Int J Cancer
colon cancer: a prospective study in al. Dietary calcium, phosphorus, vitamin 2006;119:385-91.
Japan. Cancer Lett 2006;244:260-7. D, dairy products and the risk of 202. Steindorf K, Jedrychowski W, Schmidt M,
174. Butler LM, Duguay Y, Millikan RC, et al. colorectal adenoma and cancer among et al. Case-control study of lifetime
Joint effects between UDP- French women of the E3N-EPIC occupational and recreational physical
glucuronosyltransferase 1A7 genotype prospective study. Int J Cancer activity and risks of colon and rectal
and dietary carcinogen exposure on risk 2005;117:137-44. cancer. Eur J Cancer Prev 2005;14:363-71.
of colon cancer. Cancer Epidemiol 189. Gallus S, Bravi F, Talamini R, et al. Milk, 203. Hou L, Ji BT, Blair A, et al. Commuting
Biomarkers Prev 2005;14:1626-32. dairy products and cancer risk (Italy). physical activity and risk of colon cancer
175. Balder HF, Vogel J, Jansen MC, et al. Heme Cancer Causes Control 2006;17:429-37. in Shanghai, China. Am J Epidemiol
and chlorophyll intake and risk of 190. Department of Health 1998. Nutritional 2004;160:860-7.
colorectal cancer in the Netherlands Aspects of the Development of Cancer. 204. Zhang Y, Cantor KP, Dosemeci M, et al.
cohort study. Cancer Epidemiol Report of the Working Group on Diet Occupational and leisure-time physical
Biomarkers Prev 2006;15:717-25. and Cancer of the Committee on Medical activity and risk of colon cancer by
176. Rao CV, Hirose Y, Indranie C, et al. Aspects of Food and Nutrition Policy. In: subsite. J Occup Environ Med
Modulation of experimental colon Report on Health and Social Subjects no 2006;48:236-43.
tumorigenesis by types and amounts of 48. 205. Ahmed RL, Schmitz KH, Anderson KE, et
dietary fatty acids. Cancer Res 191. Cho E, Smith-Warner SA, Ritz J, et al. al. The metabolic syndrome and risk of
2001;61:1927-33. Alcohol intake and colorectal cancer: a incident colorectal cancer. Cancer
177. MacLean CH, Newberry SJ, Mojica WA, et pooled analysis of 8 cohort studies. 2006;107:28-36.
al. Effects of omega-3 fatty acids on Annals of internal medicine 206. Otani T, Iwasaki M, Inoue M. Body mass
cancer risk: a systematic review. JAMA 2004;140:603-13. index, body height, and subsequent risk
2006;295:403-15. 192. Jin MJ, Chen K, Song L, et al. The of colorectal cancer in middle-aged and
178. Siezen CL, Bueno-de-Mesquita HB, association of the DNA repair gene elderly Japanese men and women: Japan
Peeters PH, et al. Polymorphisms in the XRCC3 Thr241Met polymorphism with public health center-based prospective
genes involved in the arachidonic acid- susceptibility to colorectal cancer in a study. Cancer Causes Control
492
R E F E R E N C E S
2005;16:839-50. Reproduction and cancer of the breast. 238. Pasquali R, Pelusi C, Genghini S, et al.
207. Engeland A, Tretli S, Austad G, et al. Cancer 1993;71:3185-8. Obesity and reproductive disorders in
Height and body mass index in relation 223. Lippman ME, Dickson RB, Gelmann EP, et women. Human reproduction update
to colorectal and gallbladder cancer in al. Growth regulation of human breast 2003;9:359-72.
two million Norwegian men and carcinoma occurs through regulated 239. Michels KB, Giovannucci E, Chan AT, et al.
women. Cancer Causes Control growth factor secretion. J Cell Biochem Fruit and vegetable consumption and
2005;16:987-96. 1987;35:1-16. colorectal adenomas in the Nurses
208. Rapp K, Schroeder J, Klenk J, et al. 224. Murray PA, Barrett-Lee P, Travers M, et al. Health Study. Cancer Res 2006;66:3942-
Obesity and incidence of cancer: a large The prognostic significance of 53.
cohort study of over 145,000 adults in transforming growth factors in human 240. Garcia-Closas M, Brinton LA, Lissowska J,
Austria. Br J Cancer 2005;93:1062-7. breast cancer. Br J Cancer 1993;67:1408- et al. Established breast cancer risk
209. Pischon T, Lahmann PH, Boeing H, et al. 12. factors by clinically important tumour
Body size and risk of colon and rectal 225. Anderson DE, Badzioch MD. Familial characteristics. Br J Cancer 2006;95:123-
cancer in the European Prospective breast cancer risks. Effects of prostate 9.
Investigation Into Cancer and Nutrition and other cancers. Cancer 1993;72:114-9. 241. Baer HJ, Rich-Edwards JW, Colditz GA, et
(EPIC). J Natl Cancer Inst 2006;98:920-31. 226. Blackwood MA, Weber BL. BRCA1 and al. Adult height, age at attained height,
210. Lin J, Zhang SM, Cook NR, et al. Body BRCA2: from molecular genetics to and incidence of breast cancer in
mass index and risk of colorectal cancer clinical medicine. J Clin Oncol premenopausal women. Int J Cancer
in women (United States). Cancer Causes 1998;16:1969-77. 2006;119:2231-5.
Control 2004;15:581-9. 227. Modan B, Chetrit A, Alfandary E, et al. 242. Innes K, Byers T, Schymura M. Birth
211. Eichholzer M, Bernasconi F, Jordan P, et al. Increased risk of breast cancer after low- characteristics and subsequent risk for
Body mass index and the risk of male dose irradiation. Lancet 1989;1:629-31. breast cancer in very young women. Am
cancer mortality of various sites: 17-year 228. Hamajima N, Hirose K, Tajima K, et al. J Epidemiol 2000;152:1121-8.
follow-up of the Basel cohort study. Alcohol, tobacco and breast cancer 243. Hilakivi-Clarke L. Mechanisms by which
Swiss Med Wkly 2005;135:27-33. collaborative reanalysis of individual high maternal fat intake during
212. Kuriyama S, Tsubono Y, Hozawa A, et al. data from 53 epidemiological studies, pregnancy increases breast cancer risk in
Obesity and risk of cancer in Japan. Int J including 58,515 women with breast female rodent offspring. Breast Cancer
Cancer 2005;113:148-57. cancer and 95,067 women without the Res Treat 1997;46:199-214.
213. Lukanova A, Bjor O, Kaaks R, et al. Body disease. Br J Cancer 2002;87:1234-45. 244. Barba M, McCann SE, Nie J, et al. Perinatal
mass index and cancer: results from the 229. Smith-Warner SA, Spiegelman D, Yaun SS, exposures and breast cancer risk in the
Northern Sweden Health and Disease et al. Alcohol and breast cancer in Western New York Exposures and Breast
Cohort. Int J Cancer 2006;118:458-66. women: a pooled analysis of cohort Cancer (WEB) Study. Cancer Causes
214. Oh SW, Yoon YS, Shin SA. Effects of excess studies. JAMA 1998;279:535-40. Control 2006;17:395-401.
weight on cancer incidences depending 230. Boffetta P, Hashibe M. Alcohol and 245. Smith-Warner SA, Spiegelman D, Adami
on cancer sites and histologic findings cancer. The Lancet Oncology 2006;7:149- HO, et al. Types of dietary fat and breast
among men: Korea National Health 56. cancer: a pooled analysis of cohort
Insurance Corporation Study. J Clin 231. Li CI, Daling JR, Malone KE, et al. studies. Int J Cancer 2001;92:767-74.
Oncol 2005;23:4742-54. Relationship between established breast 246. Kaaks R, Berrino F, Key T, et al. Serum sex
215. Sherman ME, Lacey JV, Buys SS, et al. cancer risk factors and risk of seven steroids in premenopausal women and
Ovarian volume: determinants and different histologic types of invasive breast cancer risk within the European
associations with cancer among breast cancer. Cancer Epidemiol Prospective Investigation into Cancer
postmenopausal women. Cancer Biomarkers Prev 2006;15:946-54. and Nutrition (EPIC). J Natl Cancer Inst
Epidemiol Biomarkers Prev 232. Adams SA, Matthews CE, Hebert JR, et al. 2005;97:755-65.
2006;15:1550-4. Association of physical activity with 247. Wu AH, Pike MC, Stram DO. Meta-
216. Hou L, Ji BT, Blair A, et al. Body mass index hormone receptor status: the Shanghai analysis: dietary fat intake, serum
and colon cancer risk in Chinese people: Breast Cancer Study. Cancer Epidemiol estrogen levels, and the risk of breast
menopause as an effect modifier. Eur J Biomarkers Prev 2006;15:1170-8. cancer. J Natl Cancer Inst 1999;91:529-34.
Cancer 2006;42:84-90. 233. Key TJ, Appleby PN, Reeves GK, et al. 248. Tamakoshi K, Kondo T, Yatsuya H, et al.
217. International Agency for Research on Body mass index, serum sex hormones, Trends in the mortality (1950-1997) and
Cancer. Arsenic in drinking water. IARC and breast cancer risk in incidence (1975-1993) of malignant
Monogr Eval Carcinog Risks Hum postmenopausal women. J Natl Cancer ovarian neoplasm among Japanese
2004;84. Inst 2003;95:1218-26. women: analyses by age, time, and birth
218. Chung YW, Han DS, Park YK, et al. 234. van den Brandt PA, Spiegelman D, Yaun cohort. Gynecol Oncol 2001;83:64-71.
Association of obesity, serum glucose SS, et al. Pooled analysis of prospective 249. Chaitchik S, Ron IG, Baram A, et al.
and lipids with the risk of advanced cohort studies on height, weight, and Population differences in ovarian cancer
colorectal adenoma and cancer: a case- breast cancer risk. Am J Epidemiol in Israel. Gynecol Oncol 1985;21:155-60.
control study in Korea. Dig Liver Dis 2000;152:514-27. 250. Bell DA. Origins and molecular pathology
2006;38:668-72. 235. Key T, Appleby P, Barnes I, et al. of ovarian cancer. Mod Pathol 2005;18
219. Sainsbury JR, Anderson TJ, Morgan DA. Endogenous sex hormones and breast Suppl 2:S19-32.
ABC of breast diseases: breast cancer. cancer in postmenopausal women: 251. Jordan SJ, Webb PM, Green AC. Height,
BMJ 2000;321:745-50. reanalysis of nine prospective studies. J age at menarche, and risk of epithelial
220. McPherson K, Steel CM, Dixon JM. ABC of Natl Cancer Inst 2002;94:606-16. ovarian cancer. Cancer Epidemiol
breast diseases. Breast cancer- 236. Campagnoli C, Abba C, Ambroggio S, et Biomarkers Prev 2005;14:2045-8.
epidemiology, risk factors, and genetics. al. Pregnancy, progesterone and 252. Riman T, Nilsson S, Persson IR. Review of
BMJ 2000;321:624-8. progestins in relation to breast cancer epidemiological evidence for
221. Ries L, Eisner M, Kosary C, et al., editors. risk. The Journal of steroid biochemistry reproductive and hormonal factors in
SEER Cancer Statistics Review, 1975-2002. and molecular biology 2005;97:441-50. relation to the risk of epithelial ovarian
Bethesda, MD: National Cancer Institute, 237. Hilakivi-Clarke L, Forsen T, Eriksson JG, et malignancies. Acta obstetricia et
2005. al. Tallness and overweight during gynecologica Scandinavica 2004;83:783-
222. MacMahon B. General Motors Cancer childhood have opposing effects on 95.
Research Prizewinners Laureates breast cancer risk. Br J Cancer 253. Brekelmans CT. Risk factors and risk
Lectures. Charles S. Mott Prize. 2001;85:1680-4. reduction of breast and ovarian cancer.
493
F O O D , N U T R I T I O N , P H Y S I C A L A C T I V I T Y, A N D T H E P R E V E N T I O N O F C A N C E R : A G L O B A L P E R S P E C T I V E
Curr Opin Obstet Gynecol 2003;15:63-8. history of high-risk human Prev 2006;15:167-71.
254. Koushik A, Hunter DJ, Spiegelman D, et papillomaviruses. Cancer Res 287. Rodriguez C, McCullough ML, Mondul
al. Fruits and vegetables and ovarian 2004;64:8788-93. AM, et al. Calcium, dairy products, and
cancer risk in a pooled analysis of 12 271. Romney SL, Ho GY, Palan PR, et al. Effects risk of prostate cancer in a prospective
cohort studies. Cancer Epidemiol of beta-carotene and other factors on cohort of United States men. Cancer
Biomarkers Prev 2005;14:2160-7. outcome of cervical dysplasia and human Epidemiol Biomarkers Prev 2003;12:597-
255. Lacey JV, Jr., Leitzmann M, Brinton LA, et papillomavirus infection. Gynecol Oncol 603.
al. Weight, height, and body mass index 1997;65:483-92. 288. Lokeshwar BL, Schwartz GG, Selzer MG, et
and risk for ovarian cancer in a cohort 272. Piyathilake CJ, Macaluso M, Brill I, et al. al. Inhibition of prostate cancer
study. Ann Epidemiol 2006;16:869-76. Lower red blood cell folate enhances the metastasis in vivo: a comparison of 1,23-
256. Peterson NB, Trentham-Dietz A, HPV-16-associated risk of cervical dihydroxyvitamin D (calcitriol) and
Newcomb PA, et al. Relation of intraepithelial neoplasia. Nutrition EB1089. Cancer Epidemiol Biomarkers
anthropometric measurements to (Burbank, Los Angeles County, Calif Prev 1999;8:241-8.
ovarian cancer risk in a population-based 2007;23:203-10. 289. Morris JK, George LM, Wu T, et al. Insulin-
case-control study (United States). 273. IARC. Human Papillomaviruses: IARC, In like growth factors and cancer: no role in
Cancer Causes Control 2006;17:459-67. preparation. screening. Evidence from the BUPA study
257. Huusom LD, Frederiksen K, Hogdall EV, et 274. Stanley M. HPV and pathogenesis of and meta-analysis of prospective
al. Association of reproductive factors, cervical cancer. 2006. epidemiological studies. Br J Cancer
oral contraceptive use and selected 275. International Agency for Research on 2006;95:112-7.
lifestyle factors with the risk of ovarian Cancer. 1998. General conclusions on sex 290. Kesse E, Bertrais S, Astorg P, et al. Dairy
borderline tumors: a Danish case-control hormones. In: IARC Monogr Eval products, calcium and phosphorus
study. Cancer Causes Control Carcinog Risks Hum no 21. intake, and the risk of prostate cancer:
2006;17:821-9. http://monographs.iarc.fr/ENG/Monogra results of the French prospective
258. Hicks ML, Phillips JL, Parham G, et al. The phs/vol21/volume21.pdf SU.VI.MAX (Supplementation en
National Cancer Data Base report on 276. Giuliano AR, Papenfuss M, Nour M, et al. Vitamines et Mineraux Antioxydants)
endometrial carcinoma in African- Antioxidant nutrients: associations with study. Br J Nutr 2006;95:539-45.
American women. Cancer 1998;83:2629- persistent human papillomavirus 291. Giovannucci E, Liu Y, Stampfer MJ, et al. A
37. infection. Cancer Epidemiol Biomarkers prospective study of calcium intake and
259. Pecorelli S. 23rd FIGO Annual Report on Prev 1997;6:917-23. incident and fatal prostate cancer.
the Results of Treatment in 277. Oliver SE, May MT, Gunnell D. Cancer Epidemiol Biomarkers Prev
Gynaecological Cancer: Martin Dunitz, International trends in prostate-cancer 2006;15:203-10.
1998. mortality in the PSA ERA. Int J Cancer 292. Kirsh VA, Mayne ST, Peters U, et al. A
260. Amant F, Moerman P, Neven P, et al. 2001;92:893-8. prospective study of lycopene and
Endometrial cancer. Lancet 278. Gronberg H. Prostate cancer tomato product intake and risk of
2005;366:491-505. epidemiology. Lancet 2003;361:859-64. prostate cancer. Cancer Epidemiol
261. Hardiman P, Pillay OC, Atiomo W. 279. Frankel S, Smith GD, Donovan J, et al. Biomarkers Prev 2006;15:92-8.
Polycystic ovary syndrome and Screening for prostate cancer. Lancet 293. Stram DO, Hankin JH, Wilkens LR, et al.
endometrial carcinoma. Lancet 2003;361:1122-8. Prostate cancer incidence and intake of
2003;361:1810-2. 280. Etzioni R, Penson DF, Legler JM, et al. fruits, vegetables and related
262. Lochen ML, Lund E. Childbearing and Overdiagnosis due to prostate-specific micronutrients: the multiethnic cohort
mortality from cancer of the corpus antigen screening: lessons from U.S. study (United States). Cancer Causes
uteri. Acta obstetricia et gynecologica prostate cancer incidence trends. J Natl Control 2006;17:1193-207.
Scandinavica 1997;76:373-7. Cancer Inst 2002;94:981-90. 294. Goodman M, Bostick RM, Ward KC, et al.
263. Xu WH, Dai Q, Xiang YB, et al. Animal 281. Loman N, Bladstrom A, Johannsson O, et Lycopene intake and prostate cancer risk:
food intake and cooking methods in al. Cancer incidence in relatives of a effect modification by plasma
relation to endometrial cancer risk in population-based set of cases of early- antioxidants and the XRCC1 genotype.
Shanghai. Br J Cancer 2006;95:1586-92. onset breast cancer with a known BRCA1 Nutr Cancer 2006;55:13-20.
264. Iatrakis G, Zervoudis S, Saviolakis A, et al. and BRCA2 mutation status. Breast 295. Kirsh VA, Hayes RB, Mayne ST, et al.
Women younger than 50 years with Cancer Res 2003;5:R175-86. Supplemental and dietary vitamin E,
endometrial cancer. Eur J Gynaecol Oncol 282. Kirchhoff T, Satagopan JM, Kauff ND, et beta-carotene, and vitamin C intakes and
2006;27:399-400. al. Frequency of BRCA1 and BRCA2 prostate cancer risk. J Natl Cancer Inst
265. Waggoner SE. Cervical cancer. Lancet mutations in unselected Ashkenazi 2006;98:245-54.
2003;361:2217-25. Jewish patients with colorectal cancer. J 296. Cohen HT, McGovern FJ. Renal-cell
266. Schorge JO, Knowles LM, Lea JS. Natl Cancer Inst 2004;96:68-70. carcinoma. N Engl J Med 2005;353:2477-
Adenocarcinoma of the cervix. Curr Treat 283. Chan JM, Stampfer MJ, Giovannucci E, et 90.
Options Oncol 2004;5:119-27. al. Plasma insulin-like growth factor-I 297. Kim WY, Kaelin WG. Role of VHL gene
267. Holcomb K, Runowicz CD. Cervical cancer and prostate cancer risk: a prospective mutation in human cancer. J Clin Oncol
screening. Surg Oncol Clin N Am study. Science 1998;279:563-6. 2004;22:4991-5004.
2005;14:777-97. 284. Cunha GR, Hayward SW, Wang YZ, et al. 298. McLaughlin JK, Blot W, Devesa S. Renal
268. Garcia-Closas R, Castellsague X, Bosch X, Role of the stromal microenvironment in cancer. In: Schottenfeld D, Fraumeni JJ,
et al. The role of diet and nutrition in carcinogenesis of the prostate. Int J editors. Cancer Epidemiology and
cervical carcinogenesis: a review of Cancer 2003;107:1-10. Prevention. 2nd ed. New York: Oxford
recent evidence. Int J Cancer 285. Rodriguez C, McCullough ML, Mondul University Press, 1996.
2005;117:629-37. AM, et al. Meat consumption among 299. International Agency for Research on
269. Melikian AA, Sun P, Prokopczyk B, et al. Black and White men and risk of Cancer. 1987. Phenacetin and analgesic
Identification of benzo[a]pyrene prostate cancer in the Cancer Prevention mixtures containing phenacetin. In: IARC
metabolites in cervical mucus and DNA Study II Nutrition Cohort. Cancer Monogr Eval Carcinog Risks Hum.
adducts in cervical tissues in humans by Epidemiol Biomarkers Prev 2006;15:211- 300. MacDougall ML, Welling LW, Wiegmann
gas chromatography-mass spectrometry. 6. TB. Renal adenocarcinoma and acquired
Cancer Lett 1999;146:127-34. 286. Wu K, Hu FB, Willett WC, et al. Dietary cystic disease in chronic hemodialysis
270. Piyathilake CJ, Henao OL, Macaluso M, et patterns and risk of prostate cancer in patients. Am J Kidney Dis 1987;9:166-71.
al. Folate is associated with the natural U.S. men. Cancer Epidemiol Biomarkers 301. Bisceglia M, Galliani CA, Senger C, et al.
494
R E F E R E N C E S
495
F O O D , N U T R I T I O N , P H Y S I C A L A C T I V I T Y, A N D T H E P R E V E N T I O N O F C A N C E R : A G L O B A L P E R S P E C T I V E
496
R E F E R E N C E S
predicting mortality among women. N minimize weight gain in previously workplace setting. Am J Prev Med
Engl J Med 2004;351:2694-703. obese women? Am J Clin Nutr 2003;24:218-26.
68. Lean ME. Pathophysiology of obesity. Proc 1997;66:551-6. 98. Burke V, Giangiulio N, Gillam HF, et al.
Nutr Soc 2000;59:331-6. 83. Ma Y, Olendzki B, Chiriboga D, et al. Physical activity and nutrition programs
69. Fogelholm M, Kukkonen-Harjula K, Oja P. Association between dietary for couples: A randomized controlled
Eating control and physical activity as carbohydrates and body weight. Am J trial. J Clin Epidemiol 2003;56:421-32.
determinants of short-term weight Epidemiol 2005;161:359-67. 99. Pritchard JE, Nowson CA, Wark JD. A
maintenance after a very-low-calorie 84. Taylor CB, Jatulis DE, Winkleby MA, et al. worksite program for overweight
diet among obese women. Int J Obes Effects of life-style on body mass index middle-aged men achieves lesser weight
Relat Metab Disord 1999;23:203-10. change. Epidemiology 1994;5:599-603. loss with exercise than with dietary
70. Ludwig DS, Gortmaker SL. Programming 85. Sundquist J, Johansson SE. The influence of change. J Am Diet Assoc 1997;97:37-42.
obesity in childhood. Lancet socioeconomic status, ethnicity and 100. King AC, Freyhewitt B, Dreon DM, et al.
2004;364:226-7. lifestyle on body mass index in a Diet vs exercise in weight maintenance -
71. Schmitz KH, Jensen MD, Kugler KC, et al. longitudinal study. Int J Epidemiol the effects of minimal intervention
Strength training for obesity prevention 1998;27:57-63. strategies on long-term outcomes in
in midlife women. Int J Obes 86. Sternfeld B, Wang H, Quesenberry CP, et al. men. Arch Intern Med 1989;149:2741-6.
2003;27:326-33. Physical activity and changes in weight 101. Lefevre J, Philippaerts R, Delvaux K, et al.
72. Borg P, Kukkonen-Harjula K, Fogelholm M, and waist circumference in midlife Relation between cardiovascular risk
et al. Effects of walking or resistance women: findings from the Study of factors at adult age, and physical activity
training on weight loss maintenance in Womens Health Across the Nation. Am J during youth and adulthood: The
obese, middle-aged men: a randomized Epidemiol 2004;160:912-22. Leuven Longitudinal Study on Lifestyle,
trial. Int J Obes 2002;26:676-83. 87. Sammel MD, Grisson JA, Freeman EW, et al. Fitness and Health. Int J Sports Med
73. Fogelholm M, Kukkonen-Harjula K, Weight gain among women in the late 2002;23:S32-8.
Nenonen A, et al. Effects of walking reproductive years. Fam Pract 102. Sherwood NE, Jeffery RW, French SA, et
training on weight maintenance after a 2003;20:401-9. al. Predictors of weight gain in the
very-low-energy diet in premenopausal 88. Tataranni PA, Harper IT, Snitker S, et al. Pound of Prevention study. Int J Obes
obese women: a randomized controlled Body weight gain in free-living Pima 2000;24:395-403.
trial. Arch Intern Med 2000;160:2177-84. Indians: effect of energy intake vs 103. Klesges RC, Isbell TR, Klesges LM.
74. Wen W, Gao YT, Shu XO, et al. expenditure. Int J Obes 2003;27:1578-83. Relationship between dietary restraint,
Sociodemographic, behavioral, and 89. Macdonald HM, New SA, Campbell MK, et energy intake, physical activity, and body
reproductive factors associated with al. Longitudinal changes in weight in weight: a prospective analysis. J Abnorm
weight gain in Chinese women. Int J perimenopausal and early Psychol 1992;101:668-74.
Obes 2003;27:933-40. postmenopausal women: effects of 104. Eck LH, Pascale RW, Klesges RC, et al.
75. Alfano CM, Klesges RC, Murray DM, et al. dietary energy intake, energy Predictors of waist circumference change
History of sport participation in relation expenditure, dietary calcium intake and in healthy young adults. Int J Obes
to obesity and related health behaviors hormone replacement therapy. Int J 1995;19:765-9.
in women. Prev Med 2002;34:82-9. Obes 2003;27:669-76. 105. Paeratakul S, Popkin BM, Keyou G, et al.
76. Heitmann BL, Kaprio J, Harris JR, et al. Are 90. Forster JL, Jeffery RW, Schmid TL, et al. Changes in diet and physical activity
genetic determinants of weight gain Preventing weight gain in adults: a affect the body mass index of Chinese
modified by leisure-time physical Pound of Prevention. Health Psychol adults. Int J Obes 1998;22:424-31.
activity? A prospective study of Finnish 1988;7:515-25. 106. Klesges RC, Klesges LM, Haddock CK, et
twins. Am J Clin Nutr 1997;66:672-8. 91. Jeffery RW, French SA. Preventing weight al. A longitudinal analysis of the impact
77. Schmitz KH, Jacobs DR, Jr., Leon AS, et al. gain in adults: design, methods and one of dietary intake and physical activity on
Physical activity and body weight: year results from the Pound of weight change in adults. Am J Clin Nutr
associations over ten years in the Prevention study. Int J Obes Relat Metab 1992;55:818-22.
CARDIA Study. Int J Obes 2000;24:1475- Disord 1997;21:457-64. 107. He XZ, Baker DW. Changes in weight
87. 92. Jeffery RW, French SA. Preventing weight among a nationally representative
78. Koh-Banerjee P, Chu N, Spiegelman D, et gain in adults: the Pound of Prevention cohort of adults aged 51 to 61, 1992 to
al. Prospective study of the association study. Am J Public Health 1999;89:747- 2000. Am J Prev Med 2004;27:8-15.
of changes in dietary intake, physical 51. 108. Hannerz H, Albertsen K, Nielsen ML, et al.
activity, alcohol consumption, and 93. Kuller LH, Simkin-Silverman LR, Wing RR, Occupational Factors and 5-Year Weight
smoking with 9-y gain in waist et al. Womens Healthy Lifestyle Project: Change among Men in a Danish
circumference among a randomized clinical trial: results at 54 National Cohort. Health Psychol
16587 US men. Am J Clin Nutr months. Circulation 2001;103:32-7. 2004;23:283-8.
2003;78:719-27. 94. Simkin-Silverman L, Wing RR, Hansen DH, 109. Parkes KR. Demographic and lifestyle
79. Hughes VA, Frontera WR, Roubenoff R, et et al. Prevention of cardiovascular risk predictors of body mass index among
al. Longitudinal changes in body factor elevations in healthy offshore oil industry workers: cross-
composition in older men and women: premenopausal women. Prev Med sectional and longitudinal findings.
Role of body weight change and physical 1995;24:509-17. Occup Med 2003;53:213-21.
activity. Am J Clin Nutr 2002;76:473-81. 95. Leermarkers EA, Jakicic JM, Viteri J, et al. 110. Bell AC, Ge K, Popkin BM. Weight gain
80. Di Pietro L, Dziura J, Blair SN. Estimated Clinic-based vs. home-based and its predictors in Chinese adults. Int J
change in physical activity level (PAL) interventions for preventing weight gain Obes 2001;25:1079-86.
and prediction of 5-year weight change in men. Obes Res 1998;6:346-52. 111. Bak H, Petersen L, Sorensen TIA. Physical
in men: The Aerobics Center 96. Harrell JS, Johnston LF, Griggs TR, et al. An activity in relation to development and
Longitudinal Study. Int J Obes occupation based physical activity maintenance of obesity in men with and
2004;28:1541-7. intervention program: improving fitness without juvenile onset obesity. Int J Obes
81. Wier LT, Ayers GW, Jackson AS, et al. and decreasing obesity. AAOHN J 2004;28:99-104.
Determining the amount of physical 1996;44:377-84. 112. Williamson DF, Madans J, Anda RF, et al.
activity needed for long-term weight 97. Proper KI, Hildebrandt VH, Van Der Beek Recreational physical activity and ten-
control. Int J Obes 2001;25:613-21. AJ, et al. Effect of individual counseling year weight change in a US national
82. Schoeller DA, Shay K, Kushner RF. How on physical activity fitness and health: A cohort. Int J Obes Relat Metab Disord
much physical activity is needed to randomized controlled trial in a 1993;17:279-86.
497
F O O D , N U T R I T I O N , P H Y S I C A L A C T I V I T Y, A N D T H E P R E V E N T I O N O F C A N C E R : A G L O B A L P E R S P E C T I V E
113. Haapanen N, Miilunpalo S, Pasanen M, et adolescents. Public Health Rep Physical activity and adiposity: a
al. Association between leisure time 1995;110:189-93. longitudinal study from birth to
physical activity and 10-year body mass 127. Neumark-Sztainer D, Story M, Hannan PJ, childhood. J Pediatr 1985;106:734-8.
change among working-aged men and et al. New Moves: a school-based obesity 141. Tammelin T, Laitinen J, Nayha S. Change
women. Int J Obes Relat Metab Disord prevention program for adolescent girls. in the level of physical activity from
1997;21:288-96. Prev Med 2003;37:41-51. adolescence into adulthood and obesity
114. Kahn HS, Tatham LM, Rodriguez C, et al. 128. Pangrazi R. Impact of promoting lifestyle at the age of 31 years. Int J Obes 2004;
Stable behaviors associated with adults activity for youth (PLAY) on childrens 28:775-82.
10-year change in body mass index and physical activity. J Sch Health 142. Ku LC, Shapiro LR, Crawford PB, et al.
likelihood of gain at the waist. Am J 2003;73:317-21. Body composition and physical activity in
Public Health 1997;87:747-54. 129. Maffeis C, Talamini G, Tato L. Influence of 8-year-old children. Am J Clin Nutr
115. Nooyens ACJ, Visscher TLS, Schuit AJ, et al. diet, physical activity and parents 1981;34:2770-5.
Effects of retirement on lifestyle in obesity on childrens adiposity: a four- 143. Horn OK, Paradis G, Potvin L, et al.
relation to changes in weight and waist year longitudinal study. Int J Obes Relat Correlates and predictors of adiposity
circumference in Dutch men: a Metab Disord 1998;22:758-64. among Mohawk children. Prev Med
prospective study. Public Health Nutr 130. Mo-suwan L, Tongkumchum P, 2001;33:274-81.
2005;8:1266-74. Puetpaiboon A. Determinants of 144. Burke V, Beilin LJ, Dunbar D. Family
116. Fortier MD, Katzmarzyk PT, Bouchard C. overweight tracking from childhood to lifestyle and parental body mass index as
Physical activity, aerobic fitness, and adolescence: a 5 y follow-up study of Hat predictors of body mass index in
seven-year changes in adiposity in the Yai schoolchildren. Int J Obes Australian children: A longitudinal study.
Canadian population. Can J Appl Physiol 2000;24:1642-7. Int J Obes 2001;25:147-57.
2002;27:449-62. 131. Davison KK, Birch LL. Child and parent 145. Berkey CS, Rockett HRH, Gillman MW, et
117. Droyvold WB, Holmen J, Kruger O, et al. characteristics as predictors of change in al. One-year changes in activity and in
Leisure time physical activity and change girls body mass index. Int J Obes inactivity among 10- to 15-year-old boys
in body mass index: An 11-year follow-up 2001;25:1834-42. and girls: Relationship to change in body
study of 9357 normal weight healthy 132. Twisk JW, Kemper HC, van Mechelen W, et mass index. Pediatrics 2003;111:836-43.
women 20-49 years old. Journal of al. Which lifestyle parameters 146. Janz KF, Dawson JD, Mahoney LT.
Womens Health (Larchmt) 2004;13:55- discriminate high- from low-risk Increases in physical fitness during
62. participants for coronary heart disease childhood improve cardiovascular health
118. Droyvold WB, Holmen J, Midthjell K, et al. risk factors. Longitudinal analysis during adolescence: the Muscatine
BMI change and leisure time physical covering adolescence and young Study. Int J Sports Med 2002;23:Suppl 1
activity (LTPA): An 11-y follow-up study adulthood. J Cardiovasc Risk 1997;4:393- S15-21.
in apparently healthy men aged 20-69 y 400. 147. OLoughlin J, Gray-Donald K, Paradis G, et
with normal weight at baseline. Int J 133. Twisk JWR, Kemper HCG, Van Mechelen al. One- and two-year predictors of
Obes 2004;28:410-7. W. The relationship between physical excess weight gain among elementary
119. Delvaux K, Lysens R, Philippaerts R, et al. fitness and physical activity during schoolchildren in multiethnic, low-
Associations between physical activity, adolescence and cardiovascular disease income, inner-city neighborhoods. Am J
nutritional practices and health-related risk factors at adult age. The Amsterdam Epidemiol 2000;152:739-46.
anthropometry in Flemish males: a 5- Growth and Health Longitudinal Study. 148. Datar A, Sturm R. Physical education in
year follow-up study. Int J Obes Int J Sports Med 2002;23:S8-S14. elementary school and body mass index:
1999;23:1233-41. 134. Twisk JWR, Kemper HCG, van Mechelen evidence from the Early Childhood
120. Petersen L, Schnohr P, Sorensen TIA. W, et al. Body fatness: longitudinal Longitudinal Study. Am J Public Health
Longitudinal study of the long-term relationship of body mass index and the 2004;94:1501-6.
relation between physical activity and sum of skinfolds with other risk factors 149. Achten J, Jeukendrup AE. Optimizing fat
obesity in adults. Int J Obes 2004;28:105- for coronary heart disease. Int J Obes oxidation through exercise and diet.
12. 1998;22:915-22. Nutrition 2004;20:716-27.
121. Wagner A, Simon C, Ducimetiere P, et al. 135. van Lenthe FJ, van Mechelen W, Kemper 150. Blundell JE, Stubbs RJ, Hughes DA, et al.
Leisure-time physical activity and regular HCG, et al. Behavioral variables and Cross talk between physical activity and
walking or cycling to work are associated development of a central pattern of appetite control: does physical activity
with adiposity and 5 y weight gain in body fat from adolescence into stimulate appetite? Proc Nutr Soc
middle-aged men: The PRIME study. Int J adulthood in normal-weight whites: The 2003;62:651-61.
Obes 2001;25:940-8. Amsterdam Growth and Health Study. 151. Reilly JJ, Kelly L, Montgomery C, et al.
122. Hu FB, Li TY, Colditz GA, et al. Television Am J Clin Nutr 1998;67:846-52. Physical activity to prevent obesity in
watching and other sedentary behaviors 136. Stevens J, Suchindran C, Ring K, et al. young children: cluster randomised
in relation to risk of obesity and type 2 Physical activity as a predictor of body controlled trial. BMJ 2006;333:1041.
diabetes mellitus in women. JAMA composition in American Indian children. 152. Daley AJ, Copeland RJ, Wright NP, et al.
2003;289:1785-91. Obes Res 2004;12:1974-80. Exercise therapy as a treatment for
123. Mosca CL, Marshall JA, Grunwald GK, et 137. Moore LL, Gao D, Bradlee ML, et al. Does psychopathologic conditions in obese
al. Insulin resistance as a modifier of the early physical activity predict body fat and morbidly obese adolescents: a
relationship between dietary fat intake change throughout childhood? Prev randomized, controlled trial. Pediatrics
and weight gain. Int J Obes 2004;28:803- Med 2003;37:10-7. 2006;118:2126-34.
12. 138. Moore LL, Nguyen USDT, Rothman KJ, et 153. Goldfield GS, Mallory R, Parker T, et al.
124. Mo-suwan L, Pongprapai S, Junjana C, et al. Preschool physical activity level and Effects of open-loop feedback on
al. Effects of a controlled trial of a change in body fatness in young physical activity and television viewing in
school-based exercise program on the children. The Framingham Childrens overweight and obese children: a
obesity indexes of preschool children. Study. Am J Epidemiol 1995;142:982-8. randomized, controlled trial. Pediatrics
Am J Clin Nutr 1998;68:1006-11. 139. Figueroa-Colon R, Arani RB, Goran MI, et 2006;118:e157-66.
125. Sallis J. Project SPARK. Effects of physical al. Paternal body fat is a longitudinal 154. Meyer AA, Kundt G, Lenschow U, et al.
education on adiposity in children. Ann predictor of changes in body fat in Improvement of early vascular changes
N Y Acad Sci 1993;699:127-36. premenarcheal girls. Am J Clin Nutr and cardiovascular risk factors in obese
126. Flores R. Dance for health: Improving 2000;71:829-34. children after a six-month exercise
fitness in African American and Hispanic 140. Berkowitz RI, Agras WS, Korner AF, et al. program. J Am Coll Cardiol
498
R E F E R E N C E S
2006;48:1865-70. calcium intake is negatively related to 1993 birth cohort study. Int J Obes (Lond)
155. Kim HD, Park JS. [The effect of an exercise childrens body fat indexes. J Am Diet 2006;30:500-6.
program on body composition and Assoc 2003;103:1626-31. 186. Burdette HL, Whitaker RC, Hall WC, et al.
physical fitness in obese female college 171. Reilly JJ, Armstrong J, Dorosty AR, et al. Breastfeeding, introduction of
students.] Taehan Kanho Hakhoe Chi Early life risk factors for obesity in complementary foods, and adiposity at 5
2006;36:5-14. childhood: cohort study. BMJ y of age. Am J Clin Nutr 2006;83:550-8.
156. Atlantis E, Chow CM, Kirby A, et al. 2005;330:1357. 187. Ong KK, Emmett PM, Noble S, et al.
Worksite intervention effects on physical 172. Elgar FJ, Roberts C, Moore L, et al. Dietary energy intake at the age of 4
health: a randomized controlled trial. Sedentary behaviour, physical activity months predicts postnatal weight gain
Health Promot Int 2006;21:191-200. and weight problems in adolescents in and childhood body mass index.
157. Fenkci S, Sarsan A, Rota S, et al. Effects of Wales. Public Health 2005;119:518-24. Pediatrics 2006;117:e503-8.
resistance or aerobic exercises on 173. Berkey CS, Rockett HR, Field AE, et al. 188. Toubro S, Astrup A. Randomised
metabolic parameters in obese women Activity, dietary intake, and weight comparison of diets for maintaining
who are not on a diet. Adv Ther changes in a longitudinal study of obese subjects weight after major
2006;23:404-13. preadolescent and adolescent boys and weight loss: ad lib, low fat, high
158. Racette SB, Weiss EP, Villareal DT, et al. girls. Pediatrics 2000;105:E56. carbohydrate diet v fixed energy intake.
One year of caloric restriction in humans: 174. Dietz WH, Gortmaker SL. Do we fatten BMJ 1997;314:29-34.
feasibility and effects on body our children at the television set? 189. Simkin-Silverman LR, Wing RR, Boraz MA,
composition and abdominal adipose Obesity and television viewing in et al. Maintenance of cardiovascular risk
tissue. J Gerontol A Biol Sci Med Sci children and adolescents. Pediatrics factor changes among middle-aged
2006;61:943-50. 1985;75:807-12. women in a lifestyle intervention trial.
159. Hays NP, Bathalon GP, Roubenoff R, et al. 175. Robinson TN, Hammer LD. Does television Womens Health 1998;4:255-71.
Eating behavior and weight change in viewing increase obesity and reduce 190. Ebbeling CB, Leidig MM, Sinclair KB, et al.
healthy postmenopausal women: results physical activity? Pediatrics 1993;91:273- A reduced-glycemic load diet in the
of a 4-year longitudinal study. J Gerontol 80. treatment of adolescent obesity. Arch
A Biol Sci Med Sci 2006;61:608-15. 176. Saelens BE, Sallis J. Home environmental Pediatr Adolesc Med 2003;157:773-9.
160. Yang X, Telama R, Viikari J, et al. Risk of influences on childrens television 191. Stern L, Iqbal N, Seshadri P, et al. The
obesity in relation to physical activity watching from early to middle effects of low-carbohydrate versus
tracking from youth to adulthood. Med childhood. J Dev Behav Pediatr conventional weight loss diets in
Sci Sports Exerc 2006;38:919-25. 2002;23:127-32. severely obese adults: one-year follow-
161. Parsons TJ, Manor O, Power C. Physical 177. Bogaert N, Steinbeck KS, Baur LA, et al. up of a randomized trial. Ann Intern
activity and change in body mass index Food, activity and family - environmental Med 2004;140:778-85.
from adolescence to mid-adulthood in vs biochemical predictors of weight gain 192. Shah M, Baxter JE. Nutrient and food
the 1958 British cohort. Int J Epidemiol in children. Eur J Clin Nutr 2003;57:1242- intake in obese women on a low-fat or
2006;35:197-204. 9. low-calorie diet. Am J Health Promot
162. Williams PT, Thompson PD. Dose- 178. Skinner JD, Bounds W, Carruth BR, et al. 1996;10:179-82.
dependent effects of training and Predictors of childrens body mass index: 193. Sheppard L, Kristal AR, Kushi LH. Weight-
detraining on weight in 6406 runners A longitudinal study of diet and growth loss in women participating in a
during 7.4 years. Obesity (Silver Spring) in children aged 2-8y. Int J Obes randomized trial of low-fat diets. Am J
2006;14:1975-84. 2004;28:476-82. Clin Nutr 1991;54:821-8.
163. Williams PT, Wood PD. The effects of 179. Karnehed N, Tynelius P, Heitmann BL, et 194. Jeffery RW, Hellerstedt WL, French SA, et
changing exercise levels on weight and al. Physical activity, diet and gene- al. A randomized trial of counseling for
age-related weight gain. Int J Obes environment interactions in relation to fat restriction versus calorie restriction in
(Lond) 2006;30:543-51. body mass index and waist the treatment of obesity. Int J Obes
164. Dennison BA, Russo TJ, Burdick PA, et al. circumference: the Swedish young male 1995;19:132-7.
An Intervention to Reduce Television twins study. Public Health Nutr 195. Swinburn BA, Metcalf PA, Ley SJ. Long-
Viewing by Preschool Children. Arch 2006;9:851-8. term (5-year) effects of a reduced-fat
Pediatr Adolesc Med 2004;158:170-6. 180. Silveira D, Taddei JA, Escrivao MA, et al. diet intervention in individuals with
165. Ball K, Brown W, Crawford D. Who does Risk factors for overweight among glucose intolerance. Diabetes Care
not gain weight? Prevalence and Brazilian adolescents of low-income 2001;24:619-24.
predictors of weight maintenance in families: a case-control study. Public 196. Harvey-Berino J. Calorie restriction is
young women. Int J Obes 2002;26:1570- Health Nutr 2006;9:421-8. more effective for obesity treatment
8. 181. Arenz S, Ruckerl R, Koletzko B, et al. than dietary fat restriction. Ann Behav
166. Kaur H, Choi WS. Duration of television Breast-feeding and childhood obesity - a Med 1999;21:35-9.
watching is associated with increased systematic review. Int J Obes Relat 197. Fleming RM. The effect of high-,
body mass index. J Pediatr 2003;143:506- Metab Disord 2004;28:1247-56. moderate-, and low-fat diets on weight
11. 182. Owen CG, Martin RM, Whincup PH, et al. loss and cardiovascular disease risk
167. Hancox RJ, Milne BJ. Association between The effect of breastfeeding on mean factors. Preventive Cardiology
child and adolescent television viewing body mass index throughout life: a 2002;5:110-8.
and adult health: a longitudinal birth quantitative review of published and 198. Dansinger ML, Gleason JA, Griffith JL, et
cohort study. Lancet 2004;364:257-62. unpublished observational evidence. Am al. Comparison of the Atkins, Ornish,
168. Jago R, Nicklas T, Yang S, et al. Physical J Clin Nutr 2005;82:1298-307. Weight Watchers, and Zone diets for
activity and health enhancing dietary 183. Kvaavik E, Tell GS, Klepp KI. Surveys of weight loss and heart disease risk
behaviors in young adults: Bogalusa Norwegian youth indicated that breast reduction: a randomized trial. JAMA
Heart Study. Prev Med 2005;41:194-202. feeding reduced subsequent risk of 2005;293:43-53.
169. Kettaneh AJ, Oppert M. Changes in obesity. J Clin Epidemiol 2005;58:849-55. 199. Epstein LH, Gordy CC, Raynor HA, et al.
physical activity explain paradoxical 184. Butte NF. The role of breastfeeding in Increasing fruit and vegetable intake
relationship between baseline physical obesity. Pediatr Clin North Am and decreasing fat and sugar intake in
activity and adiposity changes in 2001;48:189-98. families at risk for childhood obesity.
adolescent girls: the FLVS II study. Int J 185. Araujo CL, Victora CG, Hallal PC, et al. Obes Res 2001;9:171-8.
Obes 2005;29:586-93. Breastfeeding and overweight in 200. Matvienko O, Lewis DS, Schafer E. A
170. Skinner JD, Bounds W. Longitudinal childhood: evidence from the Pelotas college nutrition science course as an
499
F O O D , N U T R I T I O N , P H Y S I C A L A C T I V I T Y, A N D T H E P R E V E N T I O N O F C A N C E R : A G L O B A L P E R S P E C T I V E
intervention to prevent weight gain in Obesity (Silver Spring) 2006;14:106-14. 229. French SA, Harnack L, Jeffery RW. Fast
female college freshmen. J Nutr Educ 215. Bes-Rastrollo M, Martinez-Gonzalez MA, food restaurant use among women in
2001;33:95-101. Sanchez-Villegas A, et al. Association of the Pound of Prevention study: Dietary,
201. Bazzano LA, Song Y, Bubes V, et al. fiber intake and fruit/vegetable behavioral and demographic correlates.
Dietary intake of whole and refined consumption with weight gain in a Int J Obes 2000;24:1353-9.
grain breakfast cereals and weight gain Mediterranean population. Nutrition 230. Pereira MA, Kartashov AI, Ebbeling CB, et
in men. Obes Res 2005;13:1952-60. 2006;22:504-11. al. Fast-food habits, weight gain, and
202. Halkjaer J, Sorensen TIA, Tjonneland A, et 216. Lindstrom J, Peltonen M, Eriksson JG, et insulin resistance (the CARDIA study): 15-
al. Food and drinking patterns as al. High-fibre, low-fat diet predicts long- year prospective analysis. Lancet
predictors of 6-year BMI-adjusted term weight loss and decreased type 2 2005;365:36-42.
changes in waist circumference. Br J Nutr diabetes risk: the Finnish Diabetes 231. Jeffery RW, French SA. Epidemic obesity in
2004;92:735-48. Prevention Study. Diabetologia the United States: are fast foods and
203. Koh-Banerjee P, Franz MV, Sampson L, et 2006;49:912-20. television viewing contributing? Am J
al. Changes in whole-grain, bran, and 217. Nicklas TA, Farris RP, Smoak CG, et al. Public Health 1998;88:277-80.
cereal fiber consumption in relation to 8- Dietary factors relate to cardiovascular 232. Isganaitis E, Lustig RH. Fast food, central
y weight gain among men. Am J Clin risk factors in early life. Bogalusa Heart nervous system insulin resistance, and
Nutr 2004;80:1237-45. Study. Arteriosclerosis 1988;8:193-9. obesity. Arterioscler Thromb Vasc Biol
204. Liu S, Willett WC, Manson JE, et al. 218. Colditz GA, Willett WC, Stampfer MJ, et 2005;25:2451-62.
Relation between changes in intakes of al. Patterns of weight change and their 233. Niemeier HM, Raynor HA, Lloyd-
dietary fiber and grain products and relation to diet in a cohort of healthy Richardson EE, et al. Fast food
changes in weight and development of women. Am J Clin Nutr 1990;51:1100-5. consumption and breakfast skipping:
obesity among middle-aged women. Am 219. Halkjaer J, Tjonneland A, Thomsen BL, et predictors of weight gain from
J Clin Nutr 2003;78:920-7. al. Intake of macronutrients as predictors adolescence to adulthood in a nationally
205. Ludwig DS, Pereira MA, Kroenke CH, et al. of 5-y changes in waist circumference. representative sample. J Adolesc Health
Dietary fiber, weight gain, and Am J Clin Nutr 2006;84:789-97. 2006;39:842-9.
cardiovascular disease risk factors in 220. James J, Thomas P, Cavan D, et al. 234. Robinson TN. Reducing childrens
young adults. JAMA 1999;282:1539-46. Preventing childhood obesity by television viewing to prevent obesity: a
206. Ishihara T, Takeda Y, Mizutani T, et al. reducing consumption of carbonated randomized controlled trial. JAMA
[Relationship between infant lifestyle drinks: cluster randomised controlled 1999;282:1561-7.
and adolescent obesity. The Enzan trial. BMJ (Clin Res Ed) 2004;328:1237.
maternal-and-child health longitudinal 221. Newby PK, Peterson KE, Berkey CS, et al.
study.] Nippon Koshu Eisei Zasshi Beverage consumption is not associated
2003;50:106-17. with changes in weight and body mass
207. Burton-Freeman B. Dietary fiber and index among low-income preschool
energy regulation. J Nutr 2000;130:272S- children in North Dakota. J Am Diet
5S. Assoc 2004;104:1086-94.
208. Field AE, Gillman MW, Rosner B, et al. 222. Ludwig DS, Peterson KE, Gortmaker SL.
Association between fruit and vegetable Relation between consumption of sugar-
intake and change in body mass index sweetened drinks and childhood obesity:
among a large sample of children and a prospective, observational analysis.
adolescents in the United States. Int J Lancet 2001;357:505-8.
Obes 2003;27:821-6. 223. Schulze MB, Manson JE, Ludwig DS, et al.
209. Schulz M, Kroke A, Liese AD, et al. Food Sugar-sweetened beverages, weight
groups as predictors for short-term gain, and incidence of type 2 diabetes in
weight changes in men and women of young and middle-aged women. JAMA
the EPIC-Potsdam cohort. J Nutr 2004;292:927-34.
2002;132:1335-40. 224. Bray GA. The epidemic of obesity and
210. He K, Hu FB, Colditz GA, et al. Changes in changes in food intake: the Fluoride
intake of fruits and vegetables in Hypothesis. Physiol Behav 2004;82:115-
relation to risk of obesity and weight 21.
gain among middle-aged women. Int J 225. Ebbeling CB, Feldman HA, Osganian SK,
Obes 2004;28:1569-74. et al. Effects of decreasing sugar-
211. Parker DR, Gonzalez S, Derby CA, et al. sweetened beverage consumption on
Dietary factors in relation to weight body weight in adolescents: a
change among men and women from randomized, controlled pilot study.
two southeastern New England Pediatrics 2006;117:673-80.
communities. Int J Obes Relat Metab 226. Bes-Rastrollo M, Sanchez-Villegas A,
Disord 1997;21:103-9. Gomez-Gracia E, et al. Predictors of
212. McAuley KA, Smith KJ, Taylor RW, et al. weight gain in a Mediterranean cohort:
Long-term effects of popular dietary the Seguimiento Universidad de Navarra
approaches on weight loss and features Study 1. Am J Clin Nutr 2006;83:362-70;
of insulin resistance. Int J Obes (Lond) quiz 94-5.
2006;30:342-9. 227. Thompson OM, Ballew C, Resnicow K, et
213. Howard BV, Manson JE, Stefanick ML, et al. Food purchased away from home as a
al. Low-fat dietary pattern and weight predictor of change in BMI z-score
change over 7 years: the Womens Health among girls. Int J Obes 2004;28:282-9.
Initiative Dietary Modification Trial. 228. Burke V, Beilin LJ, Simmer K, et al.
JAMA 2006;295:39-49. Predictors of body mass index and
214. Iqbal SI, Helge JW, Heitmann BL. Do associations with cardiovascular risk
energy density and dietary fiber factors in Australian children: A
influence subsequent 5-year weight prospective cohort study. Int J Obes
changes in adult men and women? 2005;29:15-23.
500
R E F E R E N C E S
Chapter 9 15. Black HS, Thornby JI, Wolf JE, et al. Study Group. N Engl J Med
Evidence that a low-fat diet reduces the 1990;323:789-95.
occurrence of non-melanoma skin 29. Mayne ST, Cartmel B, Baum M, et al.
1. Hewitt M, Greenfield S, Stovall E, editors. cancer. Int J Cancer 1995;62:165-9. Randomized trial of supplemental beta-
From Cancer Patient to Cancer Survivor: 16. Evans WK, Nixon DW, Daly JM, et al. A carotene to prevent second head and
Lost in Transition / Committee on Cancer randomized study of oral nutritional neck cancer. Cancer Res 2001;61:1457-63.
Survivorship: Improving Care and Quality support versus ad lib nutritional intake 30. Toma S, Bonelli L, Sartoris A, et al. Beta-
of Life. Washington, DC: The National during chemotherapy for advanced carotene supplementation in patients
Academies Press, 2006. colorectal and non-small-cell lung radically treated for stage I-II head and
2. Micheli A, Mugno E, Krogh V, et al. Cancer cancer. J Clin Oncol 1987;5:113-24. neck cancer: results of a randomized
prevalence in European registry areas. 17. Chlebowski RT, Blackburn GL, Thomson CA, trial. Oncol Rep 2003;10:1895-901.
Ann Oncol 2002;13:840-65. et al. Dietary fat reduction and breast 31. Creagan ET, Moertel CG, OFallon JR, et al.
3. Mackay J, Jemal A, Lee NC, et al. The Cancer cancer outcome: interim efficacy results Failure of high-dose vitamin C (ascorbic
Atlas. Atlanta, Georgia: American Cancer from the Womens Intervention acid) therapy to benefit patients with
Society, 2006. Nutrition Study. J Natl Cancer Inst advanced cancer. A controlled trial. N
4. Doyle C, Kushi LH, Byers T, et al. Nutrition 2006;98:1767-76. Engl J Med 1979;301:687-90.
and physical activity during and after 18. Thiebaut AC, Schatzkin A, Ballard-Barbash 32. Moertel CG, Fleming TR, Creagan ET, et al.
cancer treatment: an American Cancer R, et al. Dietary fat and breast cancer: High-dose vitamin C versus placebo in
Society guide for informed choices. CA contributions from a survival trial. J Natl the treatment of patients with advanced
Cancer J Clin 2006;56:323-53. Cancer Inst 2006;98:1753-5. cancer who have had no prior
5. Davies AA, Davey Smith G, Harbord R, et al. 19. Pierce JP, Natarajan L, Caan BJ, et al. chemotherapy. A randomized double-
Nutritional interventions and outcome Influence of a diet very high in blind comparison. N Engl J Med
in patients with cancer or preinvasive vegetables, fruit, and fiber and low in 1985;312:137-41.
lesions: systematic review. J Natl Cancer fat on prognosis following treatment for 33. Lamm DL, Riggs DR, Shriver JS, et al.
Inst 2006;98:961-73. breast cancer. JAMA 2007;298:289-98. Megadose vitamins in bladder cancer: a
6. Sopotsinskaia EB, Balitskii KP, Tarutinov VI, 20. Jyothirmayi R, Ramadas K, Varghese C, et double-blind clinical trial. J Urol
et al. [Experience with the use of a low- al. Efficacy of vitamin A in the 1994;151:21-6.
calorie diet in breast cancer patients to prevention of loco-regional recurrence 34. Pathak AK, Bhutani M, Guleria R, et al.
prevent metastasis]. Vopr Onkol and second primaries in head and neck Chemotherapy alone vs. chemotherapy
1992;38:592-9. cancer. Eur J Cancer B Oral Oncol plus high dose multiple antioxidants in
7. de Waard F, Ramlau R, Mulders Y, et al. A 1996;32B:373-6. patients with advanced non small cell
feasibility study on weight reduction in 21. Kokron O, Alth G, Cerni C, et al. [Results of lung cancer. J Am Coll Nutr 2005;24:16-
obese postmenopausal breast cancer a comparative therapy study for 21.
patients. Eur J Cancer Prev 1993;2:233-8. inoperable lung cancer]. Onkologie 35. Clark LC, Combs GF Jr, Turnbull BW, et al.
8. Berglund G, Bolund C, Gustafsson UL, et al. 1982;5:20-2. Effects of selenium supplementation for
One-year follow-up of the Starting 22. Kucera H. [Adjuvanticity of vitamin A in cancer prevention in patients with
Again group rehabilitation programme advanced irradiated cervical cancer carcinoma of the skin. A randomized
for cancer patients. Eur J Cancer (authors transl)]. Wien Klin Wochenschr controlled trial. Nutritional Prevention
1994;30A:1744-51. Suppl 1980;118:1-20. of Cancer Study Group. JAMA
9. Isenring EA, Capra S, Bauer JD. Nutrition 23. Meyskens FL Jr, Kopecky KJ, Appelbaum 1996;276:1957-63.
intervention is beneficial in oncology FR, et al. Effects of vitamin A on survival 36. Duffield-Lillico AJ, Dalkin BL, Reid ME, et
outpatients receiving radiotherapy to in patients with chronic myelogenous al. Selenium supplementation, baseline
the gastrointestinal or head and neck leukemia: a SWOG randomized trial. plasma selenium status and incidence of
area. Br J Cancer 2004;91:447-52. Leuk Res 1995;19:605-12. prostate cancer: an analysis of the
10. Ovesen L, Allingstrup L, Hannibal J, et al. 24. Meyskens FL Jr, Liu PY, Tuthill RJ, et al. complete treatment period of the
Effect of dietary counseling on food Randomized trial of vitamin A versus Nutritional Prevention of Cancer Trial.
intake, body weight, response rate, observation as adjuvant therapy in high- BJU Int 2003;91:608-12.
survival, and quality of life in cancer risk primary malignant melanoma: a 37. Duffield-Lillico AJ, Reid ME, Turnbull BW,
patients undergoing chemotherapy: a Southwest Oncology Group study. J Clin et al. Baseline characteristics and the
prospective, randomized study. J Clin Oncol 1994;12:2060-5. effect of selenium supplementation on
Oncol 1993;11:2043-9. 25. Pastorino U, Infante M, Maioli M, et al. cancer incidence in a randomized clinical
11. Persson CR, Johansson BB, Sjoden PO, et al. Adjuvant treatment of stage I lung trial: a summary report of the
A randomized study of nutritional cancer with high-dose vitamin A. J Clin Nutritional Prevention of Cancer Trial.
support in patients with colorectal and Oncol 1993;11:1216-22. Cancer Epidemiol Biomarkers Prev
gastric cancer. Nutr Cancer 2002;42:48- 26. van Zandwijk N, Dalesio O, Pastorino U, et 2002;11:630-9.
58. al. EUROSCAN, a randomized trial of 38. Reid ME, Stratton MS, Lillico AJ, et al. A
12. Petersson LM, Nordin K, Glimelius B, et al. vitamin A and N-acetylcysteine in report of high-dose selenium
Differential effects of cancer patients with head and neck cancer or supplementation: response and
rehabilitation depending on diagnosis lung cancer. For the European toxicities. J Trace Elem Med Biol
and patients cognitive coping style. Organization for Research and 2004;18:69-74.
Psychosom Med 2002;64:971-80. Treatment of Cancer Head and Neck and 39. MacGregor CA, Canney PA, Patterson G, et
13. Ravasco P, Monteiro-Grillo I, Vidal PM, et Lung Cancer Cooperative Groups. J Natl al. A randomised double-blind
al. Impact of nutrition on outcome: a Cancer Inst 2000;92:977-86. controlled trial of oral soy supplements
prospective randomized controlled trial 27. Bairati I, Meyer F, Gelinas M, et al. A versus placebo for treatment of
in patients with head and neck cancer randomized trial of antioxidant vitamins menopausal symptoms in patients with
undergoing radiotherapy. Head Neck to prevent second primary cancers in early breast cancer. Eur J Cancer
2005;27:659-68. head and neck cancer patients. J Natl 2005;41:708-14.
14. Macia E, Moran J, Santos J, et al. Cancer Inst 2005;97:481-8. 40. Van Patten CL, Olivotto IA, Chambers GK,
Nutritional evaluation and dietetic care 28. Greenberg ER, Baron JA, Stukel TA, et al. A et al. Effect of soy phytoestrogens on
in cancer patients treated with clinical trial of beta carotene to prevent hot flashes in postmenopausal women
radiotherapy: prospective study. basal-cell and squamous-cell cancers of with breast cancer: a randomized,
Nutrition 1991;7:205-9. the skin. The Skin Cancer Prevention controlled clinical trial. J Clin Oncol
501
F O O D , N U T R I T I O N , P H Y S I C A L A C T I V I T Y, A N D T H E P R E V E N T I O N O F C A N C E R : A G L O B A L P E R S P E C T I V E
2002;20:1449-55. in the Vitamins and Lifestyle (VITAL) 68. Thorsen L, Skovlund E, Stromme SB, et al.
41. van der Merwe CF, Booyens J, Joubert HF, study cohort. J Altern Complement Med Effectiveness of physical activity on
et al. The effect of gamma-linolenic acid, 2004;10:660-6. cardiorespiratory fitness and health-
an in vitro cytostatic substance contained 54. Rock CL, Newman VA, Neuhouser ML, et al. related quality of life in young and
in evening primrose oil, on primary liver Antioxidant supplement use in cancer middle-aged cancer patients shortly
cancer. A double-blind placebo survivors and the general population. J after chemotherapy. J Clin Oncol
controlled trial. Prostaglandins Leukot Nutr 2004;134:3194S-5S. 2005;23:2378-88.
Essent Fatty Acids 1990;40:199-202. 55. Jones LW, Demark-Wahnefried W. Diet, 69. Cella DF, Tulsky DS, Gray G, et al. The
42. Jebb SA, Osborne RJ, Maughan TS, et al. 5- exercise, and complementary therapies Functional Assessment of Cancer
fluorouracil and folinic acid-induced after primary treatment for cancer. Therapy scale: development and
mucositis: no effect of oral glutamine Lancet Oncol 2006;7:1017-26. validation of the general measure. J Clin
supplementation. Br J Cancer 56. Barton DL, Loprinzi CL, Quella SK, et al. Oncol 1993;11:570-9.
1994;70:732-5. Prospective evaluation of vitamin E for 70. Chlebowski RT, Aiello E, McTiernan A.
43. Arnold C, Richter MP. The effect of oral hot flashes in breast cancer survivors. J Weight loss in breast cancer patient
nutritional supplements on head and Clin Oncol 1998;16:495-500. management. J Clin Oncol 2002;20:1128-
neck cancer. Int J Radiat Oncol Biol Phys 57. Delanian S, Porcher R, Balla-Mekias S, et al. 43.
1989;16:1595-9. Randomized, placebo-controlled trial of 71. Courneya KS. Exercise in cancer survivors:
44. Breitkreutz R, Tesdal K, Jentschura D, et al. combined pentoxifylline and tocopherol an overview of research. Med Sci Sports
Effects of a high-fat diet on body for regression of superficial radiation- Exerc 2003;35:1846-52.
composition in cancer patients receiving induced fibrosis. J Clin Oncol 72. Rock CL, Demark-Wahnefried W. Nutrition
chemotherapy: a randomized controlled 2003;21:2545-50. and survival after the diagnosis of breast
study. Wien Klin Wochenschr 58. Gothard L, Cornes P, Earl J, et al. Double- cancer: a review of the evidence. J Clin
2005;117:685-92. blind placebo-controlled randomised Oncol 2002;20:3302-16.
45. Douglass HO, Milliron S, Nava H, et al. trial of vitamin E and pentoxifylline in 73. Holmes MD, Chen WY, Feskanich D, et al.
Elemental diet as an adjuvant for patients with chronic arm lymphoedema Physical activity and survival after breast
patients with locally advanced and fibrosis after surgery and cancer diagnosis. JAMA 2005;293:2479-
gastrointestinal cancer receiving radiotherapy for breast cancer. 86.
radiation therapy: a prospectively Radiother Oncol 2004;73:133-9. 74. Abrahamson PE, Gammon MD, Lund MJ, et
randomized study. J Parenter Enteral 59. Cunningham BA, Morris G, Cheney CL, et al. Recreational physical activity and
Nutr 1978;2:682-6. al. Effects of resistive exercise on skeletal survival among young women with
46. Elkort RJ, Baker FL, Vitale JJ, et al. Long- muscle in marrow transplant recipients breast cancer. Cancer 2006;107:1777-85.
term nutritional support as an adjunct to receiving total parenteral nutrition. JPEN
chemotherapy for breast cancer. J J Parenter Enteral Nutr 1986;10:558-63.
Parenter Enteral Nutr 1981;5:385-90. 60. Nieman DC, Cook VD, Henson DA, et al.
47. Meng WC, Leung KL, Ho RL, et al. Moderate exercise training and natural
Prospective randomized control study on killer cell cytotoxic activity in breast
the effect of branched-chain amino acids cancer patients. Int J Sports Med
in patients with liver resection for 1995;16:334-7.
hepatocellular carcinoma. Aust N Z J 61. Marchese VG, Chiarello LA, Lange BJ.
Surg 1999;69:811-5. Effects of physical therapy intervention
48. Ovesen L, Allingstrup L. Different for children with acute lymphoblastic
quantities of two commercial liquid diets leukemia. Pediatric Blood Cancer
consumed by weight-losing cancer 2004;42:127-33.
patients. J Parenter Enteral Nutr 62. Wall LM. Changes in hope and power in
1992;16:275-8. lung cancer patients who exercise. Nurs
49. Poon RT, Yu WC, Fan ST, et al. Long-term Sci Q 2000;13:234-42.
oral branched chain amino acids in 63. Segal RJ, Reid RD, Courneya KS, et al.
patients undergoing chemoembolization Resistance exercise in men receiving
for hepatocellular carcinoma: a androgen deprivation therapy for
randomized trial. Aliment Pharmacol prostate cancer. J Clin Oncol
Ther 2004;19:779-88. 2003;21:1653-9.
50. Ravasco P, Monteiro-Grillo I, Vidal PM, et 64. Berglund G, Bolund C, Gustavsson UL, et al.
al. Dietary counseling improves patient A randomized study of a rehabilitation
outcomes: a prospective, randomized, program for cancer patients: the
controlled trial in colorectal cancer Starting Again group. Psychooncology
patients undergoing radiotherapy. J Clin 1994;3:109-20.
Oncol 2005;23:1431-8. 65. Burnham TR, Wilcox A. Effects of exercise
51. Yu-Chung C, Fukuda T, Hamazoe R, et al. on physiological and psychological
Long-term oral administration of variables in cancer survivors. Med Sci
branched chain amino acids after Sports Exerc 2002;34:1863-7.
curative resection of hepatocellular 66. Dimeo F, Fetscher S, Lange W, et al. Effects
carcinoma: a prospective randomized of aerobic exercise on the physical
trial. The San-in Group of Liver Surgery. performance and incidence of
Br J Surg 1997;84:1525-31. treatment-related complications after
52. National Institutes of Health State-of-the- high-dose chemotherapy. Blood
Science Panel. NIHSS conference 1997;90:3390-4.
statement: multivitamin/mineral 67. Dimeo FC, Thomas F, Raabe-Menssen C, et
supplements and chronic disease al. Effect of aerobic exercise and
prevention. Ann Intern Med relaxation training on fatigue and
2006;145:364-71. physical performance of cancer patients
53. Greenlee H, White E, Patterson RE, et al. after surgery. A randomised controlled
Supplement use among cancer survivors trial. Support Care Cancer 2004;12:774-9.
502
R E F E R E N C E S
503
F O O D , N U T R I T I O N , P H Y S I C A L A C T I V I T Y, A N D T H E P R E V E N T I O N O F C A N C E R : A G L O B A L P E R S P E C T I V E
48. Cheung AM, Feig DS, Kapral M, et al. vitamin supplementation to prevent 77. Scottish Intercollegiate Guidelines
Prevention of osteoporosis and cancer and cardiovascular disease: Network. 2001. Hypertension in Older
osteoporotic fractures in post- recommendations and rationale. Ann People. In: SIGN Publication no 49.
menopausal women: recommendation Intern Med 2003;139:51-5. 78. Third Joint Task Force of European
statement from the Canadian Task Force 62. US Department of Agriculture, Advisory Societies. European guidelines on
on Preventive Health Care. Can Med Committee on the Dietary Guidelines for cardiovascular disease prevention in
Assoc J 2004;170:1665-7. Americans. The American National clinical practice. Eur Heart J
49. Lewis DW, Ismail AI. Periodic health Dietary Guidelines. Washington DC: 2003;24:1601-10.
examination, 1995 update: 2. Prevention USDA, 2000. 79. UK Department of Health. 1994. Weaning
of dental caries. The Canadian Task Force 63. British Diabetic Association. Dietary and the Weaning Diet. Report of the
on the Periodic Health Examination. Can recommendations for people with Working Group on the Weaning Diet of
Med Assoc J 1995;152:836-46. diabetes: an update for the 1990s. the Committee on Medical Aspects of
50. Centers for Disease Control and Diabetic Med 1992;9:189-202. Food Policy. In: Report on Health and
Prevention. Recommendations for using 64. British Hyperlipidaemia Association. Social Subjects no 45.
fluoride to prevent and control dental Management of hyperlipidaemia: 80. UK Department of Health. 1994.
caries in the United States. MMWR guidelines of the British Hyperlipidaemia Nutritional Aspects of Cardiovascular
Recomm Rep 2001;50:1-42. Association. Postgrad Med J 1993;69:359- Disease. Report of the Cardiovascular
51. Centers for Disease Control and 69. Review Group Committee on Medical
Prevention. Recommendations to 65. Arens U, editor. The Report of the British Aspects of Food Policy. In: Report on
prevent and control iron deficiency in Nutrition Foundations Task Force. Oral Health and Social Subjects no 46.
the United States. MMWR Recomm Rep Health: Diet and Other Factors. 81. UK Department of Health. 1997.
1998;47:1-36. Amsterdam: Elsevier, 1999. Preventing Coronary Heart Disease: the
52. National Academy of Sciences, Institute of 66. Aggett PJ, Haschke F, Heine W, et al. Role of Antioxidants, Vegetables and
Medicine, Food and Nutrition Board. Committee report: childhood diet and Fruit. Report of an Expert Meeting.
1997. Dietary Reference Intakes for prevention of coronary heart disease. 82. UK Department of Health. 1998. Nutrition
Calcium, Phosporus, Magnesium, ESPGAN Committee on Nutrition. and Bone Health with Particular
Vitamin D, and Fluoride. European Society of Pediatric Reference to Calcium and Vitamin D.
53. National Academy of Sciences, Institute of Gastroenterology and Nutrition. J Report of the Subgroup on Bone Health:
Medicine, Food and Nutrition Board. Pediatr Gastroenterol Nutr 1994;19:261- Working Group on the Nutritional Status
2002. Dietary Reference Intakes for 9. of the Population of the Committee on
Energy, Carbohydrates, Fiber, Fat, 67. Boyle P, Autier P, Bartelink H, et al. Medical Aspects of Food and Nutrition
Protein and Amino Acids European Code Against Cancer and Policy. In: Report on Health and Social
(Macronutrients). scientific justification: third version Subjects no 49.
54. National Academy of Sciences, Institute of (2003). Ann Oncol 2003;14:973-1005. 83. UK Department of Health. 1998.
Medicine, Food and Nutrition Board. 68. The European Heart Network. 1999. Nutritional Aspects of the Development
2004. Dietary Reference Intakes for Physical Activity and Cardiovascular of Cancer. Committee on Medical
Water, Potassium, Sodium, Chloride and Disease Prevention in the European Aspects of Food Policy: Working Group
Sulfate. Union. on Diet and Cancer. In: Report on Health
55. National High Blood Pressure Education 69. The European Heart Network. 2002. Food, and Social Subjects no 48.
Program Working Group. Report on Nutrition and Cardiovascular Disease 84. UK Heart Health and Thoracic Dieticians
primary prevention of hypertension. Prevention in the European Region: Specialist Group of the British Dietetic
Arch Intern Med 1993;153:186-208. Challenges for the New Millenium. Association. Dietetic guidelines: diet in
56. Whelton PK, He J, Appel LJ, et al. Primary 70. Rotilio G, Berni Canani R, Barba G, et al. the secondary prevention of
prevention of hypertension: clinical and Nutritional recommendations for the cardiovascular disease (first update, June
public health advisory from the National prevention of ischemic stroke. Nutr 2003). J Hum Nutr Diet 2004;17:337-49.
High Blood Pressure Education Program. Metab Cardiovasc Dis 2004;14:115-20. 85. Australian College of Pediatrics. Policy
JAMA 2002;288:1882-8. 71. Scientific Advisory Committee on statement: vitamin A supplementation in
57. National Institutes of Health Consensus Nutrition. Salt and Health. London: The measles. J Pediatr Child Health
Development Panel on Physical Activity Stationery Office, 2003. 1996;32:209-10.
and Cardiovascular Health. Physical 72. Scientific Advisory Committee on 86. Australian College of Pediatrics. Policy
activity and cardiovascular health: NIH Nutrition. Advice on Fish Consumption: statement: soy protein formula. J Pediatr
consensus statement. JAMA Benefits and Risks. London: The Child Health 1998;34:318-9.
1996;276:241-6. Stationery Office, 2004. 87. Dieticians Association of Australia and the
58. North American Society for Pediatric 73. Scottish Intercollegiate Guidelines Australian College of Paediatrics.
Gastroenterology Hepatology and Network. 1999. Lipids and the Primary Recommendations for dietary
Nutrition. Nutrition support for pediatric Prevention of Coronary Heart Disease. In: intervention in the prevention and
patients with inflammatory bowel SIGN Publication no 40. treatment of hyperlipidaemia in
disease: a clinical report of the North 74. Scottish Intercollegiate Guidelines childhood. J Paediatr Child Health
American Society for Pediatric Network. 2000. Preventing Dental Caries 1995;31:79-82.
Gastroenterology, Hepatology and in Children at High Caries Risk: Targeted 88. National Health and Medical Research
Nutrition. J Pediatr Gastroenterol Nutr Prevention of Dental Caries in the Council (Australia). 1999. Dietary
2004;39:15-27. Permanent Teeth of 6-16 Year Olds Guidelines for Older Australians.
59. Osteoporosis Society of Canada. 2002 Presenting for Dental Care. In: SIGN 89. National Health and Medical Research
clinical practice guidelines for the Publication no 47. Council (Australia). 1999. Evidence-based
diagnosis and management of 75. Scottish Intercollegiate Guidelines Guidelines for Type 2 Diabetes: Primary
osteoporosis in Canada. Can Med Assoc J Network. 2000. Secondary Prevention of Prevention, Case Detection and
2002;167:S1-S34. Coronary Heart Disease Following Diagnosis.
60. Registered Nurses Association of Ontario. Myocardial Infarction. In: SIGN 90. National Health and Medical Research
Prevention of Constipation in the Older Publication no 41. Council (Australia). 1999. Guidelines for
Adult Population. Toronto: Nursing Best 76. Scottish Intercollegiate Guidelines the Prevention, Early Detection and
Practice Guidelines Project, 2002. Network. 2001. Management of Management of Colorectal Cancer.
61. US Preventative Task Force. Routine Diabetes. In: SIGN Publication no 55. 91. National Health and Medical Research
504
R E F E R E N C E S
505
F O O D , N U T R I T I O N , P H Y S I C A L A C T I V I T Y, A N D T H E P R E V E N T I O N O F C A N C E R : A G L O B A L P E R S P E C T I V E
Index
A Animal products
Abdominal fatness, 21314, 2257 consumption trends, 1112
breast cancer, 294 goals and recommendations, 3823
colorectal cancer, 2256, 2878 see also Meat
endometrial cancer, 227, 301 Antigrowth signal insensitivity, 42
pancreatic cancer, 226, 2734 Antioxidants, 38
Adaptation, weight gain, 3245 Apoptosis evasion, 446
Adaptive immunity, 38 Appetite, 329
Additives, 1756, 385 Arsenic, 150, 1524, 392
Adipose tissue-derived oestrogen, 221 bladder cancer, 153, 314
Adiposity rebound, early childhood, 232 kidney cancer, 153, 311
Adrenal sex hormones, 232 lung cancer, 152, 262, 316
Adult attained height, 231, 2327 skin cancer, 1523, 31617
birth weight, 374 Ascorbic acid (vitamin C), 78, 1078, 256
body fatness, 39 Asian diets, 191, 194
breast cancer, 2335, 2934 Asian populations, body mass index, 213
colorectal cancer, 2323, 288 Aspergillus flavus, 70
endometrial cancer, 237, 3012 Aspergillus parasiticus, 70
obesity, 39 Australia, 27
ovarian cancer, 2367, 2978
pancreatic cancer, 2356, 274
thyroid cancer, 31819 B
Aflatoxins, 70, 279 Bacteria, 40
dietary fibre, 723 Baking, 176
liver cancer, 73 Barbecuing, 177
AIDS, 3512 Barretts oesophagus, 38, 254
Alcohol, 39, 15771 Beers
breast cancer, 1658, 291 composition, 158
chronic disease, 354 consumption patterns, 159
colorectal cancer, 1645, 286 liver cancer, 169
composition, 158 mouth, pharynx, and larynx cancer, 161
consumption patterns, 159 oesophageal cancer, 163
definition, 158 sources, 158
evidence and judgements, 15971 Beta-carotene, 1857
evidence interpretation, 159 lung cancer, 185, 263
kidney cancer, 1701, 311 oesophageal cancer, 103, 256
laryngeal cancer, 1602 oral cancers, 101
liver cancer, 16870, 279 prostate cancer, 105, 3089
lymphoid and haemopoietic cancers, 320 skin cancer, 105, 1867, 317
mouth cancer, 1602, 248 Beta-cryptoxanthin, lung cancer, 102
oesophageal cancer, 1624, 257 Betel quid, oral cancers, 246
pharyngeal cancer, 1602 Binge drinking, 159
psychological effects, 157 Biological pathways, 545
public health goals, 3834 Biomarkers, 56, 363
recommendations, 3834, 391 Birth weight, 230
report comparisons, 171, 358 Black tea, consumption trends, 149
sources, 158 Bladder cancer, 153, 31214
types, 159 dairy products, 133
Alkenylbenzenes, 1756 Egypt, 7
Allium vegetables, 923, 2678 evidence and judgements, 314
colorectal cancer, 934 evidence interpretation, 313
oesophageal cancer, 86 milk and dairy products, 133
stomach cancer, 923 previous report comparisons, 314
Alpha-carotene, 101 supplements, 346
Alpha-linolenic acid, 136 trends, incidence, and survival, 31213
Alpha-tocopherol, 187 Body composition, 21042
prostate cancer, 109, 3089 Body fatness, 21128
Amenorrhea, 240 adult attained height, 39
Animal fats assessment, 212
colorectal cancer, 286 body mass index, 212, 325
weight gain determinants, 3389 breast cancer, 21819, 2923
506
I N D E X
507
F O O D , N U T R I T I O N , P H Y S I C A L A C T I V I T Y, A N D T H E P R E V E N T I O N O F C A N C E R : A G L O B A L P E R S P E C T I V E
508
I N D E X
509
F O O D , N U T R I T I O N , P H Y S I C A L A C T I V I T Y, A N D T H E P R E V E N T I O N O F C A N C E R : A G L O B A L P E R S P E C T I V E
510
I N D E X
511
F O O D , N U T R I T I O N , P H Y S I C A L A C T I V I T Y, A N D T H E P R E V E N T I O N O F C A N C E R : A G L O B A L P E R S P E C T I V E
512
I N D E X
513
F O O D , N U T R I T I O N , P H Y S I C A L A C T I V I T Y, A N D T H E P R E V E N T I O N O F C A N C E R : A G L O B A L P E R S P E C T I V E
S
Q Salt, 1417
Quantification of risk, 58 chronic disease, 3534
Quercetin, 78 composition, 143
lung cancer, 112, 262 consumption patterns, 143
definition, 142
evidence and judgements, 1447
R evidence interpretation, 1434
Radiation, 40, 291, 316 report comparisons, 147, 358
Randomised controlled trials (RCT), 51, 3457 sources, 142
Rapeseed oil, 137 stomach cancer, 269
Raw vegetables Salted foods, 143
oesophageal cancer, 85 recommendations, 385
514
I N D E X
515
F O O D , N U T R I T I O N , P H Y S I C A L A C T I V I T Y, A N D T H E P R E V E N T I O N O F C A N C E R : A G L O B A L P E R S P E C T I V E
516
I N D E X
trends, 3247
Western diets, 192, 1945
colorectal cancer, 194
kidney cancer, 195
lung cancer, 195
oesophageal cancer, 194
pharyngeal cancer, 195
stomach cancer, 194
White vegetables, stomach cancer, 889
Wholegrain cereals, 68, 3367
Whole milk, composition, 130
Wines
composition, 158
consumption patterns, 159
laryngeal cancer, 161
liver cancer, 169
mouth cancer, 161
oesophageal cancer, 1634
pharyngeal cancer, 161
sources, 158
Womens Healthy Lifestyle Project, 332
World Bank Living Standards Measurement Study, 13
Y
Yoghurt, 130
517